<SEC-DOCUMENT>0001060955-24-000010.txt : 20240223
<SEC-HEADER>0001060955-24-000010.hdr.sgml : 20240223
<ACCEPTANCE-DATETIME>20240223163959
ACCESSION NUMBER:		0001060955-24-000010
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		169
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240223
DATE AS OF CHANGE:		20240223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		24672062

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>iclr-20231231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iclr="http://www.iconplc.com/20231231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iclr-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-40">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-41">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-42">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-43">0001060955</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-957">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-959">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-961">http://fasb.org/us-gaap/2023#NontradeReceivablesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-964">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-965">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1012">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-1013">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iclr-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>iclr:Employee</xbrli:measure></xbrli:unit><xbrli:unit id="location"><xbrli:measure>iclr:Location</xbrli:measure></xbrli:unit><xbrli:unit id="country"><xbrli:measure>iclr:Country</xbrli:measure></xbrli:unit><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2023-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-20</xbrli:startDate><xbrli:endDate>2023-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202108Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="instrument"><xbrli:measure>iclr:instrument</xbrli:measure></xbrli:unit><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>iclr:vote</xbrli:measure></xbrli:unit><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-22</xbrli:startDate><xbrli:endDate>2016-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-18</xbrli:startDate><xbrli:endDate>2022-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2024To2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2024To2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20382042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20382042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2024To2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AptivSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1997-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-05-11</xbrli:startDate><xbrli:endDate>2015-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iclr:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-20</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_1"></div><div style="min-height:31.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WASHINGTON, D.C.20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">______________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">20-F</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="f-2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration statement pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-3">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Annual report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-5"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December&#160;31</ix:nonNumeric>, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="f-7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> Shell company report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-8">333-08704</ix:nonNumeric> </span></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"/><td style="width:28.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ICON PUBLIC LIMITED COMPANY</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of Registrant as Specified in its Charter)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-9">ICON PLC</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Translation of Registrant&#8217;s name into English)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-10">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-11">South County Business Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-12">Leopardstown</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">Dublin 18</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">D18 X5R3</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-15">Ireland</ix:nonNumeric>.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"/><td style="width:28.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.930%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelName" id="f-16">Brendan Brennan</ix:nonNumeric>, Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-17">South County Business Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine2" id="f-18">Leopardstown</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-19">Dublin 18</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-20">D18 X5R3</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-21">Ireland</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelEmailAddress" id="f-22">Brendan.Brennan@iconplc.com</ix:nonNumeric> | +<ix:nonNumeric contextRef="c-2" name="dei:CountryRegion" id="f-23">353</ix:nonNumeric>-<ix:nonNumeric contextRef="c-2" name="dei:CityAreaCode" id="f-24">1</ix:nonNumeric>-<ix:nonNumeric contextRef="c-2" name="dei:LocalPhoneNumber" id="f-25">291-2000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, telephone number, email and/or facsimile number and address of Company contact person) </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;Trading symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-26">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-27">ICLR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-28">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities registered or to be registered pursuant to section 12(g) of the Act:</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NONE</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NONE&#160;</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-29">82,495,086</ix:nonFraction> O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">rdinary Shares.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as determined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-30">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160; &#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-31">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-32">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-33">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer or an emerging growth company.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-34">Large accelerated filer</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-35">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-36">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-37">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAccountingStandard" id="f-38">U.S. GAAP</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; International Financial Reporting Standards as issued &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     &#160;&#160;&#160;&#160;Other </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-indent:164.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> by the International Accounting Standards Board </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> Item 18 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-39">&#9746;</ix:nonNumeric></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_10">General Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_13">Cautionary Statement</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_13">1</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_19">Item 1. Identity of Directors, Senior Management and Advisors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_22">Item 2. Offer Statistics and Expected Timetable</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_25">Item 3. Key Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_25">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_49">Item 4. Information on the Company</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_49">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_52">Item 4A. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_52">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_55">Item 5. Operating and Financial Review and Prospects</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_55">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_58">Item 6. Directors, Senior Management and Employees</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_58">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_61">Item 7. Major Shareholders and Related Party Transactions</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_61">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_64">Item 8. Financial Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_64">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_67">Item 9. The Offer and Listing</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_67">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_70">Item 10. Additional Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_70">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_73">Item 11. Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_73">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_76">Item 12. Description of Securities Other than Equity Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_76">92</a></span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_82">Item 13. Defaults, Dividend Arrearages and Delinquencies</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_82">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_85">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_85">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_88">Item 15. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_88">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_91">Item 16. Reserved</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_91">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_94">Item 16A. Audit Committee Financial Expert</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_94">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_97">Item 16B. Code of Ethical Conduct</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_97">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_100">Item 16C. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_100">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_103">Item 16D. Exemptions from the Listing Standards for Audit Committees</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_103">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_106">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_106">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_109">Item 16F. Changes in Registrant&#8217;s Certifying Accountant</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_109">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_112">Item 16G. Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_112">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_115">Item 16H. Mine Safety Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_115">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_118">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_118">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_1855">Item 16J. Insider Trading Policies  </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_118">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_1862">Item 16K. Cybersecurity </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_124">96</a></span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_124">Item 17. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_124">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_127">Item 18. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_127">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_250">Item 19. Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_250">150</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_253">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_253">151</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, &#8220;ICON plc&#8221;, &#8220;ICON&#8221;, "ICON Group", the &#8220;Company&#8221; and &#8220;we&#8221;, "our" or &#8220;us&#8221; refer to ICON public limited company and its consolidated subsidiaries, unless the context requires otherwise.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless otherwise indicated, ICON plc&#8217;s financial statements and other financial data contained in this Form 20-F are presented in United States dollars (&#8220;$&#8221;) and are prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In this Form 20-F, references to "U.S. dollars", "U.S.$" or "$" are to the lawful currency of the United States, references to &#8220;euro&#8221; or &#8220;&#8364;&#8221; are to the European single currency adopted by nineteen members of the European Union, references to "pound sterling", "sterling", "&#163;", "pence" or "p" are to the lawful currency of the United Kingdom. ICON publishes its consolidated financial statements in U.S. dollars.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 1, 2021, the Company completed the Acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA and its subsidiaries became wholly owned subsidiaries within the ICON Group. The financial information presented in this Form 20-F reflect the results of the combined Company for the years ended December&#160;31, 2023 and 2022. The financial information presented for the year ended December&#160;31, 2021&#160;is as previously reported and does not reflect the pre-Merger results of PRA before July 1, 2021, other than where clearly stated and required by GAAP.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> Cautionary Statement Regarding Forward-looking Statements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Statements included herein which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;).&#160;Forward-looking statements may be identified by the use of future tense or other forward looking words such as &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;may&#8221;, &#8220;strategy&#8221;, or other variations or comparable terminology. The forward looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, our results could be materially adversely affected. The risks and uncertainties include, but are not limited to, dependence on the pharmaceutical industry and certain clients, the need to regularly win projects and then to execute them efficiently and correctly, the challenges presented by rapid growth, competition and the continuing consolidation of the industry, the dependence on certain key executives, changes in the regulatory environment, exchange rate fluctuations, inflation and rising labor costs, and other factors identified in the Company&#8217;s United States Securities and Exchange Commission filings and in the &#8220;Risk Factors&#8221; included on pages 3 through 21. The Company has no obligation under the PSLRA to update any forward looking statements and does not intend to do so.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part I</span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_19"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Identity of Directors, Senior Management and Advisers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_22"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Offer Statistics and Expected Timetable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">.&#160; Key Information.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">[Reserved]</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  Capitalization and indebtedness</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents our capitalization as of December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Debt, Net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,775,589</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,654,187</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share capital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,942,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,840,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,433,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,240,743</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,497,963</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Capitalization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,016,332</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,152,150</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). In conjunction with the completion of the merger, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). As of December&#160;31, 2023, $2,264 million of the senior secured term loan facility has been repaid from cash generated by the Company in the period since the completion of the Merger. In addition to the Senior Secured Credit Facilities, the Company, issued </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$500&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in aggregate principal amount of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.875%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> senior secured notes in a private offering ("Senior Secured Notes"). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. As at December&#160;31, 2023, $445.0&#160;million remained undrawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Reasons for the offer and use of proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Risk Factors</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Various risk factors that are relevant to our business and the services we provide are outlined below. The occurrence of any of these events may materially and adversely affect our business operations, financial condition and results of operations and future prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_28"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Below is a summary of some of the principal risks that could adversely affect our business, operations and financial results:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The inability of biotechnology customers to raise adequate financing or funding could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may face challenges retaining employees which could cause disruption to our integration plans and day-to-day activities which may result in additional costs to the business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Clim</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A disease outbreak, epidemic or pandemic, such as COVID-19, could adversely affect our business performance. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Improper performance of our services could adversely impact our reputation and our financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">costly intellectual property lawsuits.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in a highly competitive and dynamic market.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our exposure to exchange rate fluctuations could adversely affect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Inflation and rising labor costs could adversely affect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the combined Company&#8217;s business, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business opportunities as a result of health care reform and the expansion of managed care organiz</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our international operations expose us to risks as a result of changes in global political conditions which could adversely affect our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business as a result of changes in the regulatory environment.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Environmental, social and governance matters may impact our business and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">An investor's return may be reduced if we lose our foreign private issuer status. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_31"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clients may discontinue using our services completely or cancel some projects either without notice or upon short notice. The termination or delay of a large contract, or of multiple contracts, could have a material adverse effect on our revenue and profitability. Historically, clients have canceled or discontinued projects and may in the future cancel their contracts with us for reasons including, amongst others:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">the failure of products being tested to satisfy safety or efficacy requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">unexpected or undesired clinical results of the product;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decision that a particular study is no longer necessary or viable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">poor project performance, quality concerns, insufficient patient enrollment or investigator recruitment; and&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">production problems resulting in shortages of the drug.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result, contract terminations, delays or other changes are part of our clinical services business. In the event of termination, our contracts often provide for fees for winding down the trial but these fees may not be sufficient for us to maintain our margins, and termination may result in lower resource utilization rates. In addition, we may not realize the full benefits of our unsatisfied performance obligation of contractually committed services if our clients cancel, delay or reduce their commitments under our contracts with them.  Therefore, the loss, early termination or delay of a large contract or contracts could adversely affect our revenues and profitability.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is dependent on our ability to generate new business awards from new and existing customers and maintain existing customer contracts. If we were unable to generate new business awards on a timely basis and contract for those awards, that could have a material impact on our business, financial condition, results of operations or cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While no customers individually contributed more than 10% of our revenues during the years ended December&#160;31, 2023 and December&#160;31, 2022, our top five customers represented 26.8% and 28.3% of our revenues, respectively. The loss of, or a significant decrease in, business from one or more of these key customers could have a material adverse impact on our results of operations and financial results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">The inability of biotechnology customers to raise adequate financing or funding could affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A portion of our revenue is generated from sales and services to the biotechnology industry. The clients we serve are commonly subject to financial pressures, including, but not limited to, the ability to obtain adequate financing or generate sufficient funding. To the extent our clients face such pressures, or they change how they utilize our offerings, the demand for our services, or the prices our clients are willing to pay for those services, may decline. Any such decline could have a material adverse effect on our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Many of our contracts are long-term fixed price or fixed unit price contracts for services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Revenue recognized on these service contracts are based on an assessment of progress towards completion being the cost of time and other third party costs as a percentage of total estimated time and other third party costs to deliver our services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Estimating time and costs to complete requires judgment and includes consideration of the complexity of the study, the number of geographical sites where trials are to be conducted and the number of patients to be recruited at each site. We regularly review the estimated hours on each contract to determine if the budget accurately reflects the agreed tasks to be performed, taking into account the state of progress at the time of review. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We bear the risk of cost overruns unless the scope of activity is revised from the contract specifications and we are able to negotiate a contract modification. We endeavor to ensure that any changes in scope are appropriately monitored and change orders or contract modifications are promptly negotiated and documented for changes in scope.&#160;If we fail to successfully negotiate change orders for changes in the resources required or the scope of the work to be performed, and the costs of performance of these contracts exceeded their fixed fees, it could materially adversely affect our operations and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A key element of our growth strategy is the successful development and marketing of new services or entering new markets that complement or expand our existing business.  As we develop new services or enter new markets, we may not have or be able to adequately build the competencies necessary to perform such services satisfactorily, may not receive market acceptance for such services or may face increased competition. If we are unable to succeed in developing new services, entering new markets or attracting a client base for our new services or in new markets, we will be unable to implement this element of our growth strategy, and our future business, reputation, results of operations could be adversely impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business, future success and ability to continue to expand operations depends upon our ability to attract, hire, train and retain qualified professional, scientific and technical operating people. We compete for qualified professionals with other Clinical Research Organizations (&#8220;CROs&#8221;), temporary staffing agencies and the in-house departments of pharmaceutical, biotechnology and medical device companies. An inability to attract and retain a sufficient number of high caliber clinical research professionals (in particular, key personnel and executives) at an acceptable cost would impact our ability to provide our services, our future performance and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may face challenges retaining employees which could cause disruption to our integration plans and day-to-day activities, which may result in additional costs to the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The attraction, development and retention of our talent is critical to the success of the Company, and we continue to strengthen processes around these areas to minimize retention risk. The Company, led by the Chief Human Resource Officer, is taking meaningful action to retain employees. Through our annual Talent Review process we have identified opportunities for improvement as it relates to employee retention. Our People Plans have set specific goals for each functional area in terms of three critical areas: talent attraction, development and retention. However, we can provide no assurances that our efforts in this respect will be successful.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business. We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. Our success depends on the knowledge, capabilities, and quality of our people.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The successful completion of clinical trials is dependent upon the ability to recruit suitable and willing patients on which to test the drug under study. The availability of suitable patients for enrollment in studies is dependent upon many factors including, amongst others, the size of the patient population, the design of the study protocol, eligibility criteria, the referral practices of physicians, the perceived risks and benefits of the drug under study and the availability of alternative medication, including medication undergoing separate clinical trials.&#160;Insufficient or inappropriate patient enrollment may result in the termination or delay of a study which could have a material adverse impact on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is focused on continuing to develop its expertise in patient recruitment with the establishment in 2020 of Accellacare, a global clinical research network, offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The focus is on making it easier for the site and the patient to actively participate in a trial to ensure increased predictability, enrollment and retention. Our site and patient solutions group includes upfront planning of site and patient management including identification, enrollment and engagement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Improved site selection is achieved through:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">leading technology to identify where the patients are that match the protocol;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">assessment of the qualification of sites based on real data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">partnerships with leading technology vendors and developing the capability to enable Electronic Medical Record (EMR) interrogation into clinical insights such as sub-populations and larger pre-screened pools where the technology and regulations are enabled.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The burden on the site, in ensuring patient enrollment and engagement, is achieved through integrated site networks. ICON has a number of site alliance partners. During 2018, we enhanced our site and patient recruitment capabilities with an expansion of the PMG Research network through a partnership with the DuPage Medical Group. During 2019, we further enhanced our site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN. In 2020, ICON announced the launch of Accellacare, a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research, MeDiNova and CRN. Also in 2020, we entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates as a specialized oncology site network in the US and EMEA regions. This site network is focused on implementing a range of commercial models with specialist oncology healthcare providers in the US and EMEA, to accelerate the recruitment and retention of patients into oncology trials. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The oncology site network was operated as a joint venture between the Company and a third party until April 2023, at which point the Company acquired the third party's interest in Oncacare such that Oncacare became a wholly-owned subsidiary of the Company. We also use digital solutions to drive site performance, including pre-screening, eConsent, learning management, document tracking and management with key applications.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians located in hospitals, clinics or other similar sites, who serve as investigators in conducting clinical trials to test new drugs on their patients. Investigators supervise administration of the study drug to patients during the course of the clinical trial. The successful conduct of a clinical trial is dependent upon the integrity, experience and capabilities of the investigators conducting the trial. Insufficient investigator recruitment, which in turn may lead to insufficient or inappropriate patient enrollment, may result in the termination or delay of a study which could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In recent years, extreme weather events and changing weather patterns such as storms, flooding, droughts and temperature changes have become more common. As a result, we are potentially exposed to varying natural disaster or extreme weather risks such as hurricanes, tornadoes, droughts or floods, or other events that may result from the impact of climate change on the environment, such as sea level rise. As a result, we could experience increased costs, business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations. The potential impacts of climate change may also include increased operating costs associated with additional regulatory requirements and investments in reducing energy, water use and greenhouse gas emissions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A disease outbreak, epidemic or pandemic, such as COVID-19, could adversely affect our business performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A disease outbreak, such as influenza or coronavirus, could negatively impact our operations. We could experience restrictions on our ability to travel, or the ability of patients or other service providers to travel, to monitor our clinical trials and to ensure laboratory samples are collected and analyzed on time as a result of an outbreak. The potential impact of an epidemic or pandemic may also result in increased operating costs and result in a requirement to increase investment in impact prevention. COVID-19 has affected, and may continue to affect, our business performance and could adversely affect the economies and financial markets worldwide, resulting in an economic downturn that could impact our business, financial condition and results of operations.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the global nature of our business and our reliance on information systems to provide our services, we use web-enabled and other integrated information systems in delivering our services. We will continue to increase the use of these systems&#160;and such systems will either be developed internally or provided in conjunction with third parties. We also provide access to similar information systems to certain clients in connection with the services we provide them. As the use, scope and complexity of our information systems continue to grow, we are exposed to, and will increasingly be exposed to, the risks inherent in the development, integration and ongoing operation of evolving information systems, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disruption or failure of data centers, telecommunications facilities or other key infrastructure platforms;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber attacks or other failures or malfunctions in our application or information systems or their associated hardware or other systems that we have access to, or that we rely upon, or that have access to our systems; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber attacks or malfunctions with key suppliers or partners who we rely on to provide services to customers; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">excessive costs, excessive delays or other deficiencies in, or problems with, systems development and deployment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The materialization of any of these risks may impede our ability to provide services, the processing of data, the delivery of databases and services and the day-to-day management of our business and could result in the corruption, loss or unauthorized disclosure of proprietary, confidential or other data, as well as reputational harm. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, as Artificial Intelligence (&#8220;AI&#8221;) powered cyber threats evolve, our cybersecurity program strives to keep pace through the development of advanced detection and mitigation mechanisms. However, the dynamic nature of AI-driven attacks poses an ongoing challenge, as staying one step ahead requires constant adaptation and innovation in defensive strategies to effectively protect the organization against emerging threats.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While we have cybersecurity controls and disaster recovery plans in place, they might not adequately protect us in the event of a system failure, security breach or cyber attack. To date, no cyber attacks have had a material impact on operations or financial reporting. Additionally, despite any precautions we take, damage from fire, floods, hurricanes, power loss, telecommunications failures, computer viruses, information system security breaches, cyber attacks and similar events that impact our various computer facilities could result in interruptions in the flow of data to our servers and from our servers to our clients. Corruption or loss of data may result in the need to repeat a trial at no cost to the client, but at significant cost to us, or result in the termination of one or more contracts, legal proceedings or claims against us or damage to our reputation. Additionally, significant delays in system enhancements or inadequate performance of new or upgraded systems once completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events such as security breaches, cyber attacks, natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, could adversely affect our business.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unauthorized disclosure of sensitive or confidential data, whether through system failure or employee negligence, fraud or misappropriation, could damage our reputation and cause us to lose clients. Similarly, despite investing in information and cybersecurity controls, there is a risk that unauthorized access to our information systems or those we develop for our clients, whether by our employees or third parties, including a cyber attack by computer programmers and hackers who may attack ICON systems, develop and deploy viruses, worms, ransomware or other malicious software programs, could result in negative publicity, significant remediation costs, legal liability, loss of customers and damage to our reputation and could have a material adverse effect on our results of operations and financial results. In addition, our liability insurance might not be sufficient in type, the cover provided or amount to adequately cover us against claims related to security breaches, cyber attacks and other related breaches. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may also face cybersecurity risks due to our reliance on hybrid work arrangements, which could create additional opportunities for cybercriminals to exploit vulnerabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Continued efficient operation of our business requires that we implement standardized global business processes and evolve our information systems to enable this implementation. We have continued to undertake significant programs to optimize business processes with respect to our services. A failure to effectively manage the implementation and adapt to new processes designed into these new or upgraded systems in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have entered into agreements with certain vendors to provide systems development and integration services that develop or license to us the IT platform for programs to optimize our business processes. If such vendors fail to perform as required or if there are substantial delays in developing, implementing and updating the IT platform, our customer delivery may be impaired and we may have to make substantial further investments, internally or with third parties, to achieve our objectives. Additionally, our progress may be limited by parties with existing or claimed patents who seek to prevent us from using preferred technology or seek license payments from us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Meeting our objectives is dependent on a number of factors which may not take place as we anticipate, including obtaining adequate technology-enabled services, creating IT-enabled services that our customers will find desirable and implementing our business model with respect to these services. We are continuing to develop opportunities for automation across ICON using state of the art automation tools including Robotic Process Automation (RPA), the development of new applications and capabilities, and enabling deeper integration across our digital ecosystem. To remain competitive within our industry and keep pace with the rapid evolution of the technological landscape, it is critical that we continue to innovate and expand the capabilities of our current technologies. This applies in particular to our ICONIK, Firecrest, ADDPLAN, Integrated Dataverse (IDV&#174;) and One Search services. Also, increased requirements for investment in information technology may negatively impact our financial condition, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to pursue business transformation initiatives to embed technology and innovation and deliver operational efficiencies. As part of these initiatives, we seek to improve our productivity, flexibility, quality, functionality and cost savings by our on-going investment in global technologies, continuous improvement of our business processes and functions to deliver </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">economies of scale. These initiatives may not deliver their intended gains or be completed in a timely manner which may adversely impact our competitiveness and our ability to meet our growth objectives and therefore, could adversely affect our business and operating results, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We develop and maintain computer run and web based interactive response technologies to automatically manage the randomization of patients in trials, assign the study drug and adjust the dosage when required for patients enrolled in trials we support. An error in the design, programming or validation of these systems could lead to inappropriate assignment or dosing of patients, which could give rise to patient safety issues and invalidation of the trial and/or liability claims against the Company, amongst other things, any of which could have a material effect on our financial condition and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made a number of acquisitions, including the Merger, and continue to review new acquisition opportunities. If we are unable to identify suitable acquisition targets, complete an acquisition or successfully integrate an acquired company or business, our business may be disrupted. The success of an acquisition will depend upon, among other things, our ability to:</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">effectively and quickly assimilate the operations and services or products of the acquired company or business;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">integrate acquired personnel;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">retain and motivate key employees;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">retain customers; and&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">minimize the diversion of management's attention from other business concerns.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event that the operations of an acquired company or business do </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">not meet our performance expectations, we may have to restructure the acquired company or business or write-off the value of some, or all, of the assets of the acquired company or business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Improper performance of our services could adversely impact our reputation and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The performance of clinical development services is complex and time-consuming. We or vendors we engage may make mistakes in conducting a clinical trial that could negatively impact or damage the usefulness of the clinical trial or cause the results to be reported improperly. If the clinical trial results are compromised, we could be subject to significant costs or liability, which could have an adverse impact on our ability to perform our services. Large clinical trials are costly, and while we endeavor to contractually limit our exposure to such risks, improper performance of our services could have an adverse effect on our financial condition, damage our reputation and result in the cancellation of current contracts or failure to obtain new contracts from affected or other clients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry is highly competitive, with biopharmaceutical companies each seeking to persuade payers, providers and patients that their drug therapies are better and more cost-effective than competing therapies marketed or being developed by competing companies. In addition to the adverse competitive interests that biopharmaceutical companies have with each other, biopharmaceutical companies also have adverse interests with respect to drug selection and reimbursement with other participants in the healthcare industry, including payers and providers. Biopharmaceutical companies also compete to be first to market with new drug therapies. We regularly provide services to biopharmaceutical companies who compete with each other and we sometimes provide services to such customers regarding competing drugs in development. Our existing or future relationships with our biopharmaceutical customers may therefore deter other biopharmaceutical customers from using our services or may result in our customers seeking to place limits on our ability to serve other biopharmaceutical industry participants. In addition, our further expansion into the broader healthcare market may adversely impact our relationships with biopharmaceutical customers and such customers may elect not to use our services, reduce the scope of services that we provide to them or seek to place restrictions on our ability to serve customers in the broader healthcare market with interests that are adverse to theirs. Any loss of customers or reductions in the level of revenues from a customer could have a material adverse effect on our results of operations, business and prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends, in part, upon our ability to develop, use and protect our proprietary methodologies, analytics, systems, technologies and other intellectual property. Existing laws of the various countries in which we provide services or solutions offer only limited protection of our intellectual property rights and the protection in some countries may be very limited. We rely upon a combination of trade secrets, confidentiality policies, non-disclosure, invention assignment and other contractual arrangements and patent, copyright and trademark laws, to protect our intellectual property rights. These laws are subject to change at any time and certain agreements may not be fully enforceable, which could further restrict our ability to protect our innovations. Intellectual property rights may not prevent competitors from independently developing services similar to, or duplicative of, ours. Further, the steps we take in this regard might not be adequate to prevent or deter infringement or other misappropriation of our intellectual property by competitors, former employees or other third parties and we might not be able to detect unauthorized use of, or take appropriate and timely steps to enforce our intellectual property rights. Enforcing our rights might also require considerable time, money and oversight and we may not be successful in enforcing our rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry has a history of intellectual property litigation, and these lawsuits will likely continue in the future. Accordingly, we may face patent infringement legal proceedings by companies that have patents for similar business processes or other legal proceedings alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive, take significant time and divert management&#8217;s attention from other business concerns, regardless of the outcome of the litigation. If we do not prevail in an infringement lawsuit brought against us, we might have to pay damages and we could be required to stop the infringing activity or obtain a license to use technology on unfavorable terms. Any infringement or other legal processing related to intellectual property could have a material adverse effect on our operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We act as authorized representative pursuant to Medical Devices Directive 93/42/EEC (&#8220;MDD&#8221;), Medical Devices Regulation 2017/745 (&#8220;MDR&#8221;) and Active Implantable Medical Devices Directive 90/385/EEC (&#8220;AIMD&#8221;) for certain clients who are located outside of the European Union. As authorized representative, we act on behalf of medical device manufacturers in relation to specified tasks with regard to their obligations under MDR. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also act as legal representative pursuant to European Clinical Trials Directive (2021/20/EC) (&#8220;CTD&#8221;), EU Clinical Trials Regulation (No.536/2014) (&#8220;CTR&#8221;), MDD, MDR and AIMD, for certain clients who are located outside of the European Union with respect to clinical trials being carried out by those clients in the European Union. We also perform similar legal representative services for certain clients in other non-EU jurisdictions, where the client is located outside the relevant local jurisdiction, ICON has an established local legal entity in that jurisdiction and analogous local regulations have a similar requirement for a local legal representative for clinical trials being carried out in those jurisdictions. As legal representative, we are responsible for ensuring compliance with the client&#8217;s obligations pursuant to CTD, CTR and MDR or analogous local legislation and we are the addressee for all communications with the client provided for under CTD, CTR and MDR or analogous local legislation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide these services subject to certain terms and conditions which are contained in our agreements with clients pertaining to these services. We aim to reduce any potential liability associated with these activities by seeking contractual indemnification from our clients and by maintaining an appropriate level of insurance cover. However, there is no guarantee that the specific insurance will be available or that a client will fulfill its obligations in relation to their indemnity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> increase our cost to obtain, restrict our use of, or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our services are derived from, or include, the use of data we collect from third parties. We have several data suppliers that provide us with a broad and diverse scope of information that we collect, use in our business and sell.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We generally enter into long-term contractual arrangements with many of our data suppliers. At the time we enter into a new data supply contract or renew an existing contract, suppliers may increase our cost to obtain and use the data provided by such supplier, increase restrictions on our ability to use or sell such data, or altogether refuse to license the data to us. Also, our data suppliers may fail to meet or adhere to our quality control standards or fail to deliver the data to us. Although no single supplier is material to our business, if suppliers that collectively provide a significant amount of the data we receive or use were to increase our costs to obtain or use such data, further restrict our access to or use of such data, fail to meet or adhere to our quality control standards, refuse to provide or fail to deliver data to us, our ability to provide data-dependent services to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">clients may be adversely impacted, which could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We depend on certain third parties to provide us with products and services critical to our business. Such services include, among others, suppliers of drugs for patients participating in trials, suppliers of kits for use in our laboratories, suppliers of reagents for use in our testing equipment and providers of maintenance services for our equipment. The failure of any of these third parties to adequately provide the required products or services, or to do so in compliance with applicable regulatory requirements, could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Some of our services rely on intellectual property, technology and other similar property owned and/or controlled by third parties. Our licenses to this property and technology could terminate or expire and we might not be able to replace these licenses in a timely manner. Also, we might not be able to renew these licenses on similar terms and conditions. Failure to renew these licenses, or renewals of these licenses on less advantageous terms, could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are dependent upon the ability and willingness of the pharmaceutical, biotechnology and medical device companies to continue to spend on research and development and to outsource the services that we provide. We are therefore subject to risks, uncertainties and trends that affect companies in these industries that we do not control. We have benefited to date from the tendency of pharmaceutical, biotechnology and medical device companies to outsource clinical research projects. Any downturn in these industries or reduction in spending or outsourcing could materially adversely affect our business. The following could each result in such a downturn:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if pharmaceutical, biotechnology or medical device companies expanded upon their in-house clinical or development capabilities, they would be less likely to utilize our services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if governmental regulations were changed, it could affect the ability of our clients to operate profitably, which may lead to a decrease in research spending and therefore this could have a material adverse effect on our business; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if unfavorable economic conditions or disruptions in the credit and capital markets negatively impacted our clients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large pharmaceutical companies are continually seeking to drive efficiencies in their development processes to both reduce costs associated with the development of new drug candidates and accelerate time to market. As a result, large pharmaceutical companies, in particular, are increasingly looking to consolidate the number of outsource providers with which they engage, with many entering strategic partnership arrangements with a limited number of outsource providers.&#160;The failure to enter strategic partnership arrangements with customers or the loss of existing customers as a result of them entering strategic partnership arrangements with our competitors could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain pharmaceutical companies have begun to collaborate in seeking to develop new drug candidates. Increased collaboration amongst pharmaceutical companies may lead to fewer research opportunities, which in turn may lead to fewer outsource opportunities for companies within the CRO industry. A reduction in outsource opportunities as a result of this increased collaboration could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive and dynamic market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly competitive. In particular, we compete with other large global CROs for strategic relationships with large pharmaceutical companies. If we are unable to retain and renew existing strategic relationships and win new strategic relationships, there could be a material adverse impact on our results. Similarly, we compete with other CROs for work which comes outside of these strategic relationships and being unable to win work outside of these strategic relationships could have a material adverse impact on our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The type and depth of services provided by CROs has changed in recent years. Failure to develop and market new services or expand existing service offerings could adversely affect our business and operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New entrants may also enter the market which would further increase competition and could adversely affect our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide services to biopharmaceutical, biotechnology, medical device and government organizations and our revenue is dependent on expenditures by these customers.  Our business could therefore be adversely impacted by mergers, consolidation, business failures, distress in financial markets or other factors resulting in a decrease in the number of potential customers or therapeutic products being developed through the drug development progress. There has been consolidation in the biopharmaceutical market in recent years. If the number of our potential customers were to decline in the future, they may be able to negotiate price discounts or other terms for services that are less favorable to us than they have been historically. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_37"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations in any quarter can fluctuate or differ from expected or forecast results depending upon or due to, among other things, the number and scope of ongoing client projects, the commencement, postponement, variation,&#160;cancellation or termination of projects in a quarter, the mix of activity, cost overruns, employee hiring, employee attrition and other factors. Our revenue in any period is directly related to the number of employees who were working on billable projects together with investigator activity during that period. We may be unable to compensate for periods of under-utilization during one part of a fiscal period by earning revenue during another part of that period. We believe that operating results for any particular quarter are not necessarily a meaningful indicator of future results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Also, if in future quarters, we are unable to continue to deliver operational efficiencies and our expenses grow faster than our revenues, our operating margins, profitability and overall financial condition may be materially adversely impacted.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our exposure to exchange rate fluctuations could adversely affect our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contracts with clients are sometimes denominated in currencies other than the currency in which we incur expenses related to such contracts. Where expenses are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material adverse effect on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we are also subject to translation exposures as our consolidated financial results are presented in U.S. dollars, while the local results of a certain number of our subsidiaries are prepared in currencies other than U.S. dollars, including, amongst others, the pound sterling and the euro. Accordingly, changes in exchange rates between the U.S. dollar and those other currencies will affect the translation of subsidiary companies' financial results into U.S. dollars in reporting our consolidated financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Inflation and rising labor costs could adversely affect our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inflation and rising labor costs may result in significant increases to the cost of our services, which we may not be able to recover from our customers. Our contracts with clients are often fixed price or fixed price-per-unit contracts. If macroeconomic forces, such as inflation, cause the cost of inputs required to deliver these contracts to increase significantly, we may be unable to pass along these cost to our customers. A sustained increase in these costs may require us to increase the price of future service offerings. These actions could adversely affect our future revenue, gross margin, or both.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our quarterly effective tax rate has depended and will continue to depend on the geographic distribution of our taxable earnings amongst the multiple tax jurisdictions (such as Ireland, United States and United Kingdom) in which we operate and the tax laws in those jurisdictions. Changes in the geographic mix of our results of operations amongst these jurisdictions may have a significant impact on our effective tax rate from quarter-to-quarter. Changes in tax law in one or more jurisdictions could also have a significant impact on our tax rate and results. In addition, as we operate in multiple tax jurisdictions, we may be subject to audits in certain jurisdictions. These audits may involve complex issues which could require an extended time period before being resolved. The resolution of audit issues may lead to additional taxes, interest as well as fines and/or penalties being imposed which could have a material adverse impact on our effective tax rate and our consolidated financial results. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In terms of recent legislative changes which could potentially impact our effective tax rate, on August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 ("IRA"). The IRA introduced a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases, and several tax incentives to promote clean energy, with </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">those tax changes becoming effective in 2023. While these changes did not have any impact on the Company for the year ended December 31, 2023, we are continuing to monitor any potential future tax impacts in this regard.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In terms of a global minimum tax rate, the Organization for Economic Co-operation and Development's ("OECD") Global Anti-Base Erosion ("GloBE") Model Rules proposed a global minimum tax rate of 15% and recommended that it be effective from 2024. European Union member states adopted a global minimum tax in December 2022 and member states were obliged to implement the rules by December 31, 2023, which impact large multinational groups with a consolidated revenue of over &#8364;750 million. Although there is no assurance that every country in which ICON has a presence will implement GloBE, where a particular jurisdiction has a minimum effective tax rate of less than 15%, the head office location may be obliged to pay a top-up tax. Ireland has also recently implemented global minimum tax legislation which will apply from 2024. The global tax environment is becoming increasingly complex and management continues to review the impact of a global minimum tax on the Company&#8217;s financial performance.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation is the amount of awards that has not yet converted to revenue. This value is not necessarily a meaningful predictor of future results due to the potential for the cancellation or delay of projects included in the unsatisfied performance obligation.&#160;No assurances can be given that we will be able to realize this unsatisfied performance obligation in full as revenue. A failure to realize these awards could have a material adverse impact on our results of operations. In addition, as the length and complexity of projects increases, the rate at which awards convert to revenue may be slower than in the past. A significant reduction in the rate of conversion could have a material impact on our results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s treasury function manages our available cash resources and invests significant cash balances in various financial institutions to try to ensure optimum returns for our surplus cash balances.&#160;These balances are classified as cash and cash equivalents, or short term investments, depending on the maturity of the related investment. Cash and cash equivalents comprise cash and highly liquid investments with maturities of three months or less.&#160;Short term investments comprise highly liquid investments with maturities of greater than three months and minimum &#8220;A-&#8221; rated fixed and floating rate securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;Given the global nature of our business, we are exposed to various risks in relation to these balances including liquidity risk, credit risk associated with the counterparties with whom we invest, interest rate risk on floating rate securities, sovereign risk (our principle sovereign risk relates to investments in U.S. Treasury funds) and other factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we have not recognized any significant losses to date on our cash and cash equivalents or short term investments, any significant declines in their market values could have a material adverse effect on our financial position and operating results.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We prepare our financial statements in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") which are revised on an on-going basis by the authoritative bodies. It is possible that future accounting standard updates may require changes to the accounting treatment that we apply in preparation of our financial statements. These changes may also require significant changes to our reporting systems. These updates may result in unexpected variability in the timing of recognition of revenue or expenses and therefore in our operating results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_40"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the Company&#8217;s business, financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following completion of the Merger and the other transactions contemplated by the Merger Agreement, the Company has a substantial amount of debt. ICON borrowed approximately $6,015.0 million in order to pay PRA stockholders the cash consideration due to them as merger consideration under the Merger Agreement, pay related fees and transaction costs in connection with the transactions, and refinance existing indebtedness. The total remaining transaction related debt balance at December&#160;31, 2023 was $3,751.2&#160;million. This level of borrowings could adversely affect the Company in a number of ways, including, but not limited to, causing us to incur substantial fees from time to time in connection with debt amendments or refinancing, making it more difficult for the Company to satisfy its obligations with respect to its debt or to its trade or other creditors, requiring a substantial portion of the Company&#8217;s cash flows from operations for the payment of interest on the Company&#8217;s debt, reducing the Company&#8217;s flexibility to respond to changing business and economic conditions, and reducing funds available for the Company&#8217;s investments in research and development, capital expenditures and other activities. If ICON cannot service its debt, it may have to take actions such as selling assets, seeking additional debt or equity, or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities and the indenture include certain customary covenants that limit our ability to, amongst other things, subject to certain exceptions:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">make dividends, investments and other restricted payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into sale and leaseback transactions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">engage in share buybacks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">incur or assume liens or additional debt;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">engage in mergers or reorganizations; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into certain types of transactions with affiliates.</span></div><div style="text-indent:43.2pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">              On December 8, 2023, ICON notified the holders of the Senior Secured Notes of the upgrade of the instrument rating to investment grade and the consequent suspension of certain of the covenants under the Indenture. The suspension of these covenants remains in place so long as the instrument remains at investment grade.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The revolving credit facility also includes a financial covenant that requires us to comply with a maximum consolidated leverage ratio. Our ability to comply with this financial covenant may be affected by events beyond our control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the original principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December&#160;31, 2023, $55.0 million was outstanding under the revolving loan facility while there was also </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3.7&#160;million (December&#160;31, 2022: $4.5&#160;million)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because the Company has variable rate debt, fluctuations in interest rates affect our business. We attempt to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate cap and interest rate swap derivative financial instruments. We have entered into certain interest rate cap and interest rate swap agreements with three financial institutions with respect to a portion of our outstanding debt. Accordingly, any change in market value associated with these agreements may be offset by the opposite market impact on the portion of the debt covered by such agreements. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note 14 - Derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business opportunities as a result of healthcare reform and the expansion of managed care organizations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Numerous governments, including the U.S. government, have undertaken efforts to control growing healthcare costs through legislation, regulation and voluntary agreements with medical care providers and drug companies. If these efforts are successful, pharmaceutical, biotechnology and medical device companies may react by spending less on research and development and therefore this could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to healthcare reform proposals, the expansion of managed care organizations in the health care market may result in reduced spending on research and development. Managed care organizations' efforts to cut costs by limiting expenditures on pharmaceuticals and medical devices could result in pharmaceutical, biotechnology and medical device companies spending less on research and development. If this were to occur, we would have fewer business opportunities and our revenues could decrease, possibly materially.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations and financial conditions could be affected by changes in healthcare spending and policy.&#160; The healthcare industry is subject to changing political, regulatory and other influences. It is possible that legislation will be introduced and passed in the United States repealing, modifying or invalidating the current healthcare reform legislation, in whole or in part, and signed into law. Because of the continued uncertainty about the implementation of the current healthcare reform legislation, including the potential for further legal challenges or repeal of that legislation, we cannot quantify or predict with any certainty the likely impact of the&#160;current&#160;healthcare&#160;reform legislation&#160;or its repeal on the healthcare sector, on our customers and ultimately on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As previously noted, on August 16, 2022, the U.S. government enacted the IRA, which among other things, authorizes the U.S. Department of Health and Human Services to establish prices for certain single-source drugs and biologics within the Medicare program, commencing in 2026. Furthermore, the IRA contains provisions which impose rebate obligations on manufacturers if price increases outpace inflation. While the full impact of these IRA provisions on our customers in the biopharmaceutical industry remains somewhat uncertain, any resultant pressure on our customers&#8217; operating results could lead to a reduction in research and development spend and related outsourcing activities, which could have an adverse impact on our operating results and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our international operations expose us to risks as a result of changes in global political conditions which could adversely affect our results of operations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Political and/or financial instability and armed conflict in various regions of the world, including, but not limited to, Ukraine, Israel and the conflict area in the Middle East, can lead to sanctions, economic uncertainty and currency exchange rate fluctuations and may interrupt our operations in those areas, which may adversely impact our results of operations. The current conflict in Ukraine has led to, among other things, hardship and the imposition of international economic sanctions aimed at the region. While the situation is subject to change, there remains the possibility of additional and harsher sanctions if the conflict intensifies. If that were to happen, our operations in the region may be severely curtailed or eliminated, which could adversely affect our results of operations. In addition, if the current unrest broadens or further escalates, our operations may be severely curtailed, which could adversely affect our results of operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor developments in Israel and the conflict area in the Middle East. Further broadening or escalation of the conflict, or the imposition of international economic sanctions, could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business as a result of changes in the regulatory environment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Various regulatory bodies throughout the world may enact legislation, rules and guidance which could introduce changes to the regulatory environment for drug development and research. The adoption and implementation of such legislation, rules and guidance is difficult to predict and therefore could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration, ("FDA"), and other regulatory and government authorities and agencies inspect and audit us from time to time to ensure that we comply with their regulations and guidelines, including environmental, health and safety matters, and other requirements imposed in connection with the performance of government contracts.&#160; We must comply with the applicable regulatory requirements governing the conduct of clinical trials and contracting with the government in all countries in which we operate. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we or vendors we engage fail to comply with any of these requirements we could suffer some or all of:&#160;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">termination of or delay in any research;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disqualification of data;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">denial of the right to conduct business;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">criminal penalties;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">financial penalties;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other enforcement actions including debarment from government contracts;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">loss of clients and/or business; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation from clients and/or patients and/or regulatory authorities and/or other affected third parties, and resulting material penalties, damages and costs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span id="i341b4edef22c4d46a9d60b92ff99e633_94413"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of a small group of organizations with the capability and expertise to conduct clinical trials on a global basis. We believe that this capability to provide our services globally in most major and developing pharmaceutical markets enhances our ability to compete for new business from large multinational pharmaceutical, biotechnology and medical device companies. We have expanded geographically in the past and intend to continue expanding in regions that have the potential to increase our client base or increase our investigator and patient populations. We expect that revenues earned in emerging markets will continue to account for an increasing portion of our total revenues.&#160;However, emerging market operations may present several risks, including civil disturbances, health concerns, cultural differences such as employment, regulatory and business practices, compliance with economic sanctions laws and regulations, volatility in gross domestic product, economic and governmental instability, the potential for nationalization of private assets and the imposition of exchange controls. In addition, operating globally means the Company faces the challenges associated with coordinating its services across different countries, time zones and cultures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the political and regulatory environment in the international markets in which we operate such as price or exchange controls could impact our revenue and profitability and could lead to penalties, sanctions and reputational damages if we are not compliant with those regulations. Political uncertainty and a lack of institutional continuity in some of the emerging, developing or other countries in which we operate could affect the orderly operation of markets in these economies.&#160;In addition, in countries with a large and complicated structure of government and administration, national, regional, local and other governmental bodies may issue inconsistent decisions and opinions that could increase our cost of regulatory compliance and/or have a material adverse effect on our business. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states.  These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Uncertainty of the legal environment in some emerging countries could also limit our ability to enforce our rights.&#160;In certain emerging and developing countries we enjoy less comprehensive protection for some of our rights, including intellectual property rights, which could undermine our competitive position. Proceedings to enforce our future patent rights, if any, in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If any of the above risks or similar risks associated with our international operations were to materialize, our results of operations and financial condition could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("UK Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FCPA, UK Bribery Act and similar anti-corruption laws in other jurisdictions prohibit us and our officers, directors, employees and third parties acting on our behalf, including agents, from corruptly offering, promising, authorizing, or providing anything of value to a "foreign official" for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. In addition, the FCPA imposes certain books, records and accounting control obligations on public companies and other issuers. The UK Bribery Act also prohibits "commercial" bribery and accepting bribes. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global business operations also must be conducted in compliance with applicable export controls and economic sanctions laws and regulations, including those administered by the U.S. Department of the Treasury&#8217;s (the &#8220;U.S. Treasury&#8221;) Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury and other relevant trade compliance authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our internal policies mandate compliance with these anti-corruption and trade compliance laws and regulations. We also operate in many jurisdictions in which bribery or corruption can be common and compliance with anti-bribery laws may conflict with local customs and practices. Despite our training and compliance program safeguards, we cannot assure that our internal control policies, procedures and safeguards will protect us from acts in violation of anti-corruption and trade compliance laws and regulations committed by employees or other third parties associated with us and our continued expansion, including in developing countries, could increase such risk in the future. Violations of anti-corruption, economic sanctions and trade control laws and regulations, or even allegations of such violations, could disrupt our business and result in a material adverse effect on our financial condition, results of operations, cash flows and reputation. For example, violations of anti-corruption and trade compliance laws can result in restatements of, or irregularities in, our financial statements, disgorgement of profits, related stockholder lawsuits as well as severe criminal or civil sanctions. In some cases, companies that violate anti-corruption and trade compliance laws might be debarred by the U.S. government and/or lose their U.S. export privileges. In addition, the U.S. government or other governments may seek to hold us liable based on successor liability for violations of anti-corruption and trade compliance laws committed by companies that we acquire or in which we invest. Changes in anti-corruption and trade compliance laws or enforcement priorities could also result in increased compliance requirements and related costs which could materially adversely affect our business, financial condition, results of operations and cash flows. The recent increase in economic sanctions and trade controls, particularly relating to our ongoing operations in Russia, Ukraine and Belarus, has increased the amount of resources necessary to ensure compliance in this area.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a strong privacy posture, driven by the implementation of a core privacy governance strategy and the adoption of policies and procedures designed to help ensure that ICON, including our employees and contractors, can comply with applicable data protection laws (including, but not limited to, the General Data Protection Regulation (&#8220;GDPR&#8221;) (EU) 2016/679). Notwithstanding these measures, failure to comply with applicable data protection laws may occur and could result in increased risk of liability or increased costs to us or could limit our service offerings. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative fines</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The GDPR introduced a new regime of administrative fines for data protection infringements and provided for a tiered penalty structure based on the nature of the infringement. The EU supervisory authorities for the GDPR can directly impose fines on organizations found to be in breach of the GDPR. Lower tier administrative fines allow for fines of up to 2% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines allow for fines of up to 4% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines are more likely to be levied for major infringements of the GDPR and core data protection principles (e.g. transparency, data retention, accountability). </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Penalties</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The GDPR also permits Member States to implement rules on other penalties applicable to infringements of the GDPR, in particular, for infringements which are not subject to administrative fines under the GDPR itself. Therefore, Member States may legislate for further fines or penalties that may be criminal in nature. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any fines levied under the GDPR must be effective, proportionate, and dissuasive. Supervisory authorities have been strengthening enforcement activities across the EU in recent years in respect of breaches of GDPR. The risk of fines and penalties under the GDPR carries increased risk of liability to ICON and can result in increased costs and disruption to the delivery of our services. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Right to compensation of data subjects</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. In addition to the risk of administrative and criminal penalties, the GDPR also provides that any person who has suffered material or non-material damage as a result of an infringement of the GDPR shall have the right to receive compensation for the damage suffered, from the controller or processor responsible for the infringement. The level of award of damages is set by the competent court in the applicable EU Member State. This carries increased risk of liability for ICON. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">Corrective Powers of the supervisory authorities.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">  Each supervisory authority across the Member States of the EU also has corrective powers. Supervisory authorities have the power to order ICON to bring processing operations into compliance with the provisions of the GDPR in a specified manner within a specified time period, or to impose a temporary or definitive limitation including a ban on processing, and to order the suspension of data flows to a recipient in a third country or to an international organization. Supervisory authorities also have powers to conduct audits and investigations of ICON and instruct ICON to take certain actions. The exercise of these powers by supervisory authorities has the potential to increase costs for ICON and cause disruption to the business and delivery of our services. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From a US perspective, the confidentiality, collection, use and disclosure of personal data, including clinical trial patient-specific information, is subject to governmental regulation generally in the country that the personal data was collected or used. For example, United States federal regulations under the Health Insurance Portability and Accountability Act of 1996, or ("HIPAA"), and as amended in 2014 by the Health Information Technology for Economic and Clinical Health (&#8220;HITECH&#8221;) Act, require individuals&#8217; written authorization, in addition to any required informed consent, before Protected Health Information may be used for research. HIPAA specifies standards for de-identifications and for limited data sets. We are both directly and indirectly affected by the privacy provisions surrounding individual authorizations because many investigators and organizations with whom we are involved in clinical trials and in our other services are directly subject to them as a HIPAA &#8220;covered entity&#8221; and because we obtain identifiable health information from third parties that are subject to such regulations. As there are some instances where we are a HIPAA &#8220;business associate&#8221; of a &#8220;covered entity&#8221;, we can also be directly liable to the covered entity contractually for mishandling protected health information and, under HIPAA&#8217;s enforcement scheme, we can be subject to up to $1.9 million per year in civil money penalties for identical HIPAA violations. The per violation penalties and calendar year cap on penalties are adjusted annually for inflation under the Federal Civil Penalties Inflation Adjustment Act.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foundational principles of the GDPR have helped shape the development of many other privacy laws globally. Internationally, data protection laws continue to be introduced at a rapid rate, with greater protections afforded to personal data than ever before, and greater risk of liability to organizations processing that personal data. As a global organization, ICON must ensure that our privacy posture continues to adapt to these new laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional legislation or regulation of this type might, among other things, require us to implement new security measures and processes which may require substantial expenditures or limit our ability to offer some of our services. Additionally, if we violate applicable laws, regulations or duties relating to the use, processing or security of personal data, we could be subject to civil liability or criminal prosecution, be forced to alter our business practices or suffer reputational harm. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with governmental regulations, comply with federal and state healthcare fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies or data or documentation fraud or manipulation, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines or other sanctions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues from our government customers are derived from sales to federal, state and local governmental departments and agencies through various contracts. Sales to public segment customers are highly regulated. Noncompliance with contract provisions, government procurement regulations or other applicable laws or regulations (including but not limited to the False Claims Act) could result in civil, criminal and administrative liability, including substantial monetary fines or damages, termination of government contracts or other public segment customer contracts, and suspension, debarment or ineligibility from doing business with the government and other customers in the public segment. In addition, generally contracts in the public segment are terminable at any time for convenience of the contracting agency or upon default. The effect of any of these possible actions by any governmental department or agency could adversely affect our business, results of operations or cash flows. In addition, the adoption of new or modified procurement regulations and other requirements may increase our compliance costs and reduce our gross margins, which could have a negative effect on our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We may face legal claims involving stockholders, consumers, clinical trial subjects, competitors, regulators and other parties. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">'Legal Proceedings'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in Part A, Item 8 of this Form 20-F. Litigation and other legal proceedings are inherently uncertain, and adverse rulings could occur, including monetary damages, or an injunction stopping us from engaging in business practices, or requiring other remedies, including, but not limited to, compulsory licensing of patents. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Customer Claims</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we breach the terms of an agreement with a customer (for example if we fail to comply with the agreement, all applicable regulations or Good Clinical Practice) this could result in claims against us for substantial damages which could have a material adverse effect on our business. As we provide staff to deliver our services, there is a risk that our management, quality and control structures fail to quickly detect a failure by one or more employees or contractors to comply with all applicable regulations and Good Clinical Practice and our internal requirements and standard operating procedures thereby exposing us to the risk of claims by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims relating to Investigators</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians who serve as investigators in conducting clinical trials to test new drugs on their patients. These patients will generally have underlying health conditions and this testing creates the risk of liability for personal injury to the patient or the risk of a serious adverse event occurring. Although investigators are generally required by law to maintain their own liability insurance, we could be named in lawsuits and incur expenses arising from any professional malpractice or other actions brought against the investigators with whom we contract.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indemnification from Customers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indemnifications provided by our customers&#160;against the risk of liability for personal injury to or death of the patients arising from a study drug vary from customer to customer and from trial to trial and may not be sufficient in scope or amount, or our customer&#160;may not have the financial ability to fulfill their indemnification obligations. Furthermore, we would be liable for our own negligence and negligence of our employees which could lead to litigation from customers or action or enforcement by regulatory authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Insurance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain what we believe is an appropriate level of worldwide Professional Liability/Error and Omissions Insurance. In the future we may be unable to maintain or continue our current insurance coverage on the same or similar terms. If we are liable for a claim or settlement that is beyond the level of insurance coverage, we may be responsible for paying all or part of any award or settlement amount. Also, the insurance policies contain exclusions which mean that the policy will not respond or provide cover in certain circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims to Date</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To date, we have not been subject to any liability claims that are expected to have a material effect on our business; however, there can be no assurance that we will not become subject to such claims in the future or that such claims will not have a material effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance matters may impact our business and reputation.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Increasingly, in addition to the importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance (ESG) matters, which are considered to contribute to the long-term sustainability of companies&#8217; performance. A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. Customers may have specific ESG related requirements or targets and if we fail to meet these targets, we may lose business. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the Company&#8217;s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the Company&#8217;s board of directors in supervising various sustainability issues. We actively manage a broad range of such ESG matters, taking into consideration their expected impact on the sustainability of our business over time, and the potential impact of our business on society and the environment. However, in light of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">stakeholders&#8217; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">increased focus on ESG matters, there can be no certainty that we will manage such issues successfully, or that we will successfully meet society&#8217;s perceived expectations as to our proper role. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, share price, financial condition, or results of operations, including the sustainability of our business over time.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Increasing focus on ESG matters has resulted in, and is expected to continue to result in, the adoption of legal and regulatory requirements designed to mitigate the effects of climate change on the environment, as well as legal and regulatory requirements requiring climate, human rights and supply chain-related disclosures. If new laws or regulations are more stringent than current legal or regulatory requirements, we may experience increased compliance burdens and costs to meet such obligations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, our selection of voluntary disclosure frameworks and standards, and the interpretation or application of those frameworks and standards, may change from time to time or may not meet the expectations of investors or other stakeholders. Our ability to achieve our ESG commitments is subject to numerous risks, many of which are outside of our control. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The market price of our common stock has experienced volatility in the past and may experience volatility in the future which could lead to losses for investors. Factors impacting volatility in the market price of our common stock include, amongst others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">general market and economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our results of operations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">issuance of new or changed securities analysts&#8217; reports or recommendations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">developments impacting the industry or our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">declines in the market prices of stocks generally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">strategic actions by us or our competitors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.81pt">announcements by us or our competitors of significant contracts, new products, acquisitions, joint marketing relationships, joint ventures, other strategic relationships or capital commitments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">the public's reaction to press releases, other public announcements by us or third parties, including our filings with the SEC;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">guidance, if any, that we provide to the public, any changes in this guidance or failure to meet this guidance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changes in the credit rating of our debt;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">sale, or anticipated sale, of large blocks of our stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">additions or departures of key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">regulatory or political developments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our performance on ESG matters</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation and governmental investigations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changing economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">exchange rate fluctuations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">changes in accounting principles; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other events or factors, including those resulting from natural disasters, war, acts of terrorism or responses to those events.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, stock markets have from time to time experienced significant price and volume fluctuations unrelated to the operating performance of particular companies. Future fluctuations in stock markets may lead to volatility in the market price of our common stock which could lead to losses by investors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">An investor's return may be reduced if we lose our foreign private issuer status.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer,&#8221; as such term is defined in Rule 405 under the U.S. Securities Act 1933, and, therefore, we are not required to file quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC. In addition, the proxy rules and Section 16 reporting and short-swing profit recapture rules are not applicable to us. If we lose our status as a foreign private issuer by our election or otherwise and we become subject to the full reporting regime of the United States securities laws, we will be subject to additional reporting obligations and proxy solicitation obligations under the Exchange Act and our officers, directors and 10% shareholders would become subject to the short-swing profit rules. The imposition of these reporting rules would increase our costs and the obligations of those affected by the short-swing rules.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We currently do not expect to declare dividends on our common stock and have not done so in the past. We continue to anticipate that our earnings will be used to provide working capital, to support operations, to make debt repayments and to finance the growth and development of our business. They may also be used to continue our share repurchase program. Any determination to declare or pay dividends in the future will be at the discretion of our board of directors, subject to relevant laws and dependent on a number of factors, including our earnings, capital requirements and overall financial condition. Therefore, the only opportunity for stockholders to achieve a return on their investment may be if the market price of our common stock appreciates and shares are sold at a profit. The market price for our common stock may not appreciate and may fall below the price stockholders paid for such common stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company (DTC), may be subject to Irish stamp duty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transfers of ICON ordinary shares effected by means of the transfer of book entry interests in the DTC should not be subject to Irish stamp duty where ICON ordinary shares are traded through DTC, either directly or through brokers that hold such shares on behalf of customers through DTC. However, if ICON ordinary shares are held as of record rather than beneficially through DTC, any transfer of ICON ordinary shares could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. The potential for Irish stamp duty to arise could adversely affect the price of ICON ordinary shares.</span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_49"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Information on the Company.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">History and development</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON public limited company (&#8220;ICON plc&#8221;) is a clinical research organization (&#8220;CRO&#8221;), founded in Dublin, Ireland in 1990. For over thirty years we have grown significantly to become a leading global provider of outsourced development and services to pharmaceutical, biotechnology, medical device and government and public health organizations. Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a public limited company in Ireland and operate under the Irish Companies Acts. Our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000. Our website is www.iconplc.com. Additionally, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our service offering includes clinical development, functional outsourcing and laboratory services. Our clinical development services include all phases of development (Phases I-IV), peri and post approval, data solutions and site and patient access services. Our laboratory services include a range of high value testing services, including bionanalytical, biomarker, vaccine, good manufacturing practice ('GMP') and central laboratory services. We also offer full-service and functional service partnerships to our customers.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since ICON was founded, the Company has expanded through organic growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process and to broaden the service portfolio and add scale to existing services. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><img src="iclr-20231231_g1.gif" alt="20F-1.gif" style="height:292px;margin-bottom:5pt;vertical-align:text-bottom;width:681px"/></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recent investments, which continue to strengthen our service offerings to meet the needs of our customers include: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 2, 2023, the Company acquired 100% of the equity of BioTel Research, LLC which comprised the business </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">formerly known as Philips Pharma Solutions, a leading provider of medical imaging and cardiac safety monitoring services. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's 51% voting share capital of Oncacare Limited (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">,  a global network of oncology research sites that provide a unique patient recruitment and delivery solution for the clinical research industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA became a wholly owned subsidiary within the ICON Group. The Acquisition has transformed the scale and capabilities of the Company. The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The combined Company retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Acquisition has brought together two high-quality, innovative, growing organizations with similar cultures and values to create the world's leading clinical research organization with a singular focus on clinical research and commercialization. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The total value of the Merger consideration was $12.0&#160;billion and has resulted in the recognition of goodwill of $8.1&#160;billion, intangible assets of $4.9&#160;billion and an associated deferred tax liability of $1.1&#160;billion. The accounting for the Merger was final as of June 30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on the London Interbank Offered Rate ("LIBOR") or other base rate (as elected by the borrower), plus an applicable margin. On November 29, 2022, the Company agreed with its lenders to the adoption of the Secured Overnight Financing Rate ("SOFR") as the benchmark rate within the Senior Secured Credit Facilities, thus LIBOR is no longer the benchmark rate available to the Company under the terms of the Senior Secured Credit Facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company repaid $950.0&#160;million of the senior secured term loan facility  (December&#160;31, 2022: $800 million). At December&#160;31, 2023, $55&#160;million was outstanding under the senior secured revolving loan facility (December&#160;31, 2022: $Nil) in addition to $3.7&#160;million (December&#160;31, 2022: $4.5&#160;million) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in letters of credit given to landlords to guarantee lease arrangements.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The financial information presented in this Form 20-F reflect the results of the combined Company for the year ended December&#160;31, 2023 and December&#160;31, 2022. The financial information presented for the year ended December&#160;31, 2021&#160;is as previously reported and does not reflect the pre-Merger results of PRA before July 1, 2021, other than where clearly stated and required by GAAP.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With approximately 41,100 employees across the globe, ICON has established relationships with a majority of the world&#8217;s top pharmaceutical and biotech companies. We believe the Company now has the expertise, technology, and data assets to lead the industry into a new paradigm for bringing clinical research to more patients and enabling expanded capabilities for customers. We believe the Merger will deliver a transformational effect on ICON through:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Scale:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> With a deeper clinical, commercialization and consulting services portfolio, a broader geographic footprint, depth in therapeutic expertise, and data-driven healthcare technology, the Company can deliver enhanced globally scaled expertise &amp; solutions for all customers and patients.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Focus:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company will have a singular focus on clinical research and commercialization, leveraging transformational technology and innovation to execute clinical trials from Phase 1 to post-approval studies with the highest quality, expertise and speed. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Speed to market</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Our extensive services portfolio, digital and data technology capabilities, and enhanced access to more diverse patient populations, have been combined with flexible delivery approaches and partnership models &#8211; all with the aim of reducing development time and costs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Flexible partnership models:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON has partnerships with a majority of world&#8217;s top biopharma and biotech companies worldwide. ICON is a global leader in Functional Service Provision and a top global provider of full service clinical research. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Differentiated DCT platform, healthcare intelligence &amp; technology:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON can deliver differentiated decentralized and hybrid trial solutions through a suite of capabilities, including mobile health, commercial connected health platforms, real world data and information solutions, a global site network, home health services and wearables expertise.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Access to patients:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON offers customers enhanced access to a larger global pool of more diverse patients through its global site network (Accellacare), specialized oncology network (Oncacare), a pediatric site network, in-home clinical services and a network of six Phase I clinical research units across the United States and Europe. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company has entered into derivative financial instruments to manage exposures to interest rate fluctuations. On November 29, 2022, the Company entered into two interest rate cap agreements and one interest rate swap agreement with notional amounts of $2,101 million and $1,101 million, respectively. These derivative financial instruments are used to limit the Company's exposure to changes in the variable interest rate on its Senior Secured Credit Facilities by fixing the interest rates on approximately 49% of ICON's term loan facility as at December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 18, 2022, the Board authorized the repurchase of up to $100 million of the Company's common stock. The share repurchase program was completed during the year ended&#160;December&#160;31, 2022 with a total of 420,530 ordinary shares redeemed by the Company for a total consideration of $100.0 million. All ordinary shares that were redeemed under the repurchase program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required by Irish Company law. No repurchase program occurred in 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ukraine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 24, 2022 Russia invaded Ukraine, creating significant instability and unrest in the region. Since that time, the Company's key focus has been on the safety of our employees and their families, patients, investigators and on the mitigation of adverse impacts on ongoing clinical trials. The Company has worked to ensure the safety of employees and their families based in Ukraine through the implementation of a number of employee assistance programs. These programs aim to provide affected employees and their families with transportation, accommodation in neighboring countries, financial assistance, communications and other support services as needed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operations in these affected regions have been significantly curtailed as a result of these events. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states. These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">have a material adverse effect on the results of our operations. The financial impact of the conflict was not material to the  Company during the years ended December&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Israel and the conflict area in the Middle East</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are all saddened by recent developments in Israel and the conflict area in the Middle East. The Company's key focus has been on the safety of our employees and their families, patients, investigators and on the mitigation of adverse impacts</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">on ongoing clinical trials. The Company has worked to ensure the safety of employees and their families through the implementation of a number of employee assistance programs. The team have been advised to work remotely as they continue to support our customers&#8217; studies. The financial impact of the conflict was not material to the Company during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Foreign exchange</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company prepares its financial statements in United States dollars while the local results of a certain number of our subsidiaries are prepared in currencies other than United States dollars, including, amongst others, the pound sterling and the euro. In addition, the Company's contracts with clients are sometimes denominated in currencies other than the United States dollar. Finally, the Company is exposed to a wider variety of currencies in the expenses line due to most expenses being incurred in the local currencies of where our global operations are based. Accordingly, changes in exchange rates between the United States dollar and those other currencies could have a material adverse effect on the Company&#8217;s financial results. In the year ended December 31, 2023, the Company recorded foreign currency losses of $12.9&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Business Overview</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is a leading global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer a full range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV clinical studies. We earn revenue by providing a number of different services to our customers. Those services are integral components of the clinical development process and include clinical trial management, consulting, contract staffing, data solutions and laboratory services. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><img src="iclr-20231231_g2.gif" alt="20F-3.gif" style="height:336px;margin-bottom:5pt;vertical-align:text-bottom;width:676px"/><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development. We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in the major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full-service solution. In order to achieve this vision, we are capitalizing on the enhanced scale, technology and data analytics capabilities that the recent acquisition of PRA Health Sciences delivered. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains a sustained focus on research and development. We continue to enhance our portfolio of data solutions and decentralized clinical trial technology through the development of industry-leading technologies and processes to support our clients. ICON is leading the industry transformation through four key levers: transforming clinical trials, site and patient centricity, healthcare intelligence and applied innovation, and seamless, integrated service delivery.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023, we employed approximately 41,100 employees in 106 locations in 53 countries. During the year ended December&#160;31, 2023, we derived approximately 40.4%, 48.7% and 10.9% of our revenue in the United States, Europe and Rest of World, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The ICON strategy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have achieved strong growth since our foundation in 1990, as a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations.  We focus our innovation on those factors that are critical to our clients - reducing time to market, reducing cost and increasing quality. Our global team has extensive experience in a broad range of therapeutic areas. ICON has been recognized as one of the world's leading Contract Research Organizations (''CROs") through a number of high-profile industry awards (see www.iconplc.com/awards).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As our market has evolved, biopharmaceutical companies are tackling productivity challenges, budget constraints and greater demands to demonstrate product value; all of which are placing increased pressure on their revenues and levels of profitability. However, these trends have generally been positive for CROs, as increased outsourcing has been adopted by these companies as they seek to create greater efficiencies in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory and reimbursement pressures will increase the emphasis on late stage (post marketing) research, while increasing requirements to demonstrate the economic value of new treatments. As a result, outcomes and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should create further growth opportunities for both biopharma companies and their outsource development partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect that continued outsourcing will be a core strategy of clients in the near term as they respond to the increased pressures on their revenues and profitability. Larger clients were the first to form strategic partnerships with global CROs in an effort to reduce the number of outsource partners with whom they engage and to reduce inefficiencies in their current drug development models. More recently we have seen the increasing adoption of this partner model with mid-tier pharmaceutical and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">biotechnology firms as they also seek to drive development efficiencies. As outsourcing penetration increases, we believe clients may seek a greater level of integration of service offerings from CROs, although some will continue to purchase services on a stand-alone basis. Creating greater connectivity and &#8220;seamlessness&#8221; between our services and the sharing of &#8220;real-time&#8221; clinical, operational and &#8220;real world&#8221; data with clients will therefore become increasingly important for CROs. ICON will seek to benefit from this increased outsourcing by clients to grow our business by increasing market share with our existing client base and adding new clients within the Phase I-IV outsourced development services market; the aim being to ensure we will be considered for all major Phase I-IV projects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access &amp; Engagement (ii) Career Development &amp; Employer of choice (iii) Enduring Customer Partnerships and (iv) Healthcare Intelligence &amp; Applied Innovation. </span></div><div style="text-align:justify"><img src="iclr-20231231_g3.gif" alt="20F-4.gif" style="height:334px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient Access &amp; Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a focused patient, site and data strategy, which is helping us to improve site identification, study placement and patient recruitment and retention. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare is ICON's global clinical research network offering customers a wide range of stand-alone and integrated solutions at site or in patients' homes as part of decentralized trials. Our patient centric approach accelerates study start-up and increases patient recruitment and retention for the pharmaceutical, biotechnology and medical device industries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare In-Home Services takes study visits directly to patients where they live, work, study or play in all phases and therapeutic areas of clinical trials. By bringing trial visits directly to patients, we ease the burden of participating in clinical research to increase patient recruitment, retention and diversity. Accellacare In-Home Services has experience in more than 450 clinical trials, tailoring our services to fit each study's specific requirements across more than 50 countries. This cohesive approach is leading to higher patient recruitment and retention rates. Accellacare is also achieving faster study start-up for its customers through efficiencies gained in central process management including budget and contracting, which can otherwise be a source of delay. This combined with a finely tuned feasibility approach allows the network to identify and recruit more patients to studies, in a wide range of therapeutic areas, in a shorter time frame. Accellacare is an important part of the integrated patient, site and data strategy, helping us to improve patient recruitment and retention. Through Accellacare, we are committed to delivering on the promise of patient centricity in clinical research whilst also providing investigators with innovative treatments for their patients with a quality-focused clinical research infrastructure supported by experienced professionals globally.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Accellacare Site Network encompasses more than 50 sites across 6 countries covering the United States, Europe and South Africa. Accellacare offers a quality focused clinical research infrastructure delivering value and benefits to sponsors. Accellacare supports customers with faster start-up and the time from site selection to site initiation visit is on average 30% faster when compared to other sites. Furthermore, Accellacare achieves an average of 40% more patients per site when compared to other sites.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In 2023, Accellacare Site Network optimized its site partnerships and focused on enhancing capabilities within its US locations with a continued focus on Central nervous system (CNS) capabilities. ICON fully acquired the Oncacare site network in April 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finding and engaging suitable patients to conduct clinical trials is one of the biggest issues facing the drug development industry today. Less than 1% of the US population participates in clinical trials and the performance of investigative sites that do take part in research is uneven, hard to predict and many trials do not meet the initial recruitment goals. The current market challenge in patient enrollment creates an opportunity for ICON to differentiate its service offering and we are working to reduce patient recruitment times through enhanced site and investigator selection based on key performance metrics and through use of our proprietary FIRECREST technology which is used to train and support sites during the development process. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's site networks enhance our ability to enroll patients onto the clinical studies we perform. We have also developed strategic alliances with investigator site groups and healthcare systems in all major global research markets. In partnership with others, we are pioneering patient recruitment solutions that leverage cognitive computing to transform clinical trial matching and allow a data-driven approach to deliver the right patients for trials. One Search is our intuitive, integrated workflow and interrogation tool that enables access to multiple data sources and provides the visualization and tools necessary for optimum&#160;site identification&#160;based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Career development and employer of choice</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Enduring customer partnerships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to focus on expanding and deepening our partnerships with existing customers, while also developing new customer relationships. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Strategic client relationships will increasingly manifest themselves in many different forms. Many of these relationships will require innovative forms of collaboration across ICON service areas and departments and will therefore require increased flexibility to offer services on both a standalone functional basis and as part of a fully integrated service solution. To support this objective, we continue to evolve our collaboration and delivery models, invest in technology that will enable closer data integration across our service areas and enhance our project and program management capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To meet the evolving needs of both our existing and new clients we continue to enhance our capabilities through both organic service developmen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">t and targeted acquisitions. In addition, we continue to enhance our scientific and therapeutic expertise to support our customers in specific areas including oncology, orphan and rare diseases, CNS, dermatology, infectious disease and women's health. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has extensive experience in vaccine clinical development for commercial businesses, governments and NGOs. This experience enabled us to play a significant role in the search for vaccines and treatments for COVID-19. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Of particular note was our work in partnering with Pfizer and BioNTech on their investigational COVID-19 vaccine program - the first to announce positive efficacy results from a Phase 3, late-stage study of a COVID-19 vaccine and to receive Emergency Use Authorization in individuals 16 years of age or older from the U.S. Food and Drug Administration.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON mobilized a large global team of therapeutic and operational specialists to partner on the implementation of Pfizer&#8216;s and BioNTech&#8217;s strategic plan and framework for the monitoring of the trial, which included a high level of remote clinical monitoring and source data verification in addition to on-site monitoring, safeguarding data quality and integrity in the evolving pandemic environment. The team combined the benefits of full service and functional service provider clinical operating models to increase efficiency and ensure rapid study start-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON worked with 153 sites in the US, Europe, South Africa and Latin America to ensure the recruitment of more than 44,000 trial participants over a four-month period in late 2020. ICON provided site training, document management and operational support for patient Informed Consent Form review, coordinated eConsent in most countries, and assisted with clinical supply management services. Achieving the unprecedented trial timelines, while maintaining high standards of quality, undertaken in response to the pandemic required collaboration and strong communication between the ICON and sponsor project teams.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to target growth in under-penetrated CRO market segments. Penetration within medical device companies has lagged that of bio-pharma firms but is beginning to accelerate. EU regulatory reform enacted in 2017 is a further catalyst to growth in this segment as it included stricter requirements to perform clinical evaluations and post-sale surveillance. In early 2020, ICON acquired MedPass which has further enhanced our value offering in this area.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also invested significantly in our site and patient network (Accellacare), and consider our expertise and offering in this area as one of our strategic pillars.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Healthcare intelligence and applied innovation</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients&#8217; drug and device development programs, providing true transparency across all areas of a study.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is focused on applying innovation that can help our customers improve their development outcomes. We are focusing this innovation in three critical areas: improving clinical trial design and execution; faster and more predictable patient recruitment; and evolving clinical trials to be more patient centric which includes data collection and analysis directly from patient&#8217;s digital devices. Our approach to developing solutions to these challenges incorporates partnering with best-in-class technology providers but is also supported by a suite of differentiated ICON proprietary technologies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Through an informatics strategy built around key platforms including ICONIK and Health Cloud, we have continued to invest in building our capabilities in the gathering, analysis and application of real world patient data within both the clinical trial and post-trial observational study environments. ICONIK and Health Cloud enable ICON to deliver services such as Risk Based Monitoring (RBM) which uses near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON&#8217;s proprietary One Search tool helps to efficiently and effectively identify optimum trial sites. It synthesizes multiple data sources, applying AI machine learning and rich data visualization for optimum site identification, resulting in improved study start-up and site cycle times, significant reductions in the percentage of low performing sites and increasing the percentage of studies meeting planned First Patient In (FPI).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FIRECREST is ICON&#8217;s proprietary comprehensive site performance management system. It is a web-based solution which enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to investigative sites. It allows site behavior to be tracked to ensure training is understood, procedures are being followed and that timelines and study parameters are met. It can significantly reduce the number of data queries originated from investigator sites. FIRECREST is now integrated into the ICON Safety Reporting Solution and provides a Site Question Management Tool. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The ICON Patient Engagement Platform was developed</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">to support improved patient experience and enrollment in clinical trials. The web-based patient engagement platform, provides patients with study specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases visibility of potential study participants for sponsors and sites. An easy to navigate, user friendly interface guides the patient to new and ongoing studies in their particular indication and a pre-qualification questionnaire helps to determine if the study is a right fit for them. If the patient decides to register interest, they are given the option to select their nearest investigative site. This establishes connection with the site and the patient can then choose to contact the site or ask to be contacted for pre-screening.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We positively impact patients&#8217; lives by understanding their journeys and how they can benefit from drugs currently in development and on the market. We do this by developing a holistic, global data environment across pharmaceutical and biotech companies (development to commercial) that gives insights into patients, and how best to serve them. Alongside the application of these technology solutions we are also focused on innovation through the redesign and where appropriate the automation of current clinical trial processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operational excellence, quality and delivery</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality is the foundation of our success. The quality of our work is vital to our mission of bringing better medications to patients around the world. We are committed to maintaining, supporting, checking and improving our quality systems to meet or exceed the quality standards demanded by our clients, patients and regulatory authorities. We focus our innovation on the factors that are critical to our clients &#8211; reducing time to market, reducing cost and increasing quality &#8211; and our global team of experts has extensive experience in a broad range of therapeutic areas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality project execution underpins all that we do and we have an ongoing focus on developing our people and&#160;processes to continue to&#160;enhance our service delivery. We also deploy supporting technologies which we believe will enable faster and deeper insights into the quality of trial data.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on operational excellence across our support functions, and we operate a global business support infrastructure across functions including finance, information technology, facilities, human resources, legal and quality assurance. This enables us to enhance the service levels across these support areas whilst driving down the costs of the service provision.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Capabilities and service offerings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is the world&#8217;s largest pure-play clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. Our focus is on delivering Healthcare Intelligence to customers to address the full spectrum of clinical development challenges, not just point-of-service delivery. The synthesis of our experience, expertise, best practices, technology and data provides patient centric processes, commercially optimized for global success, and is driving transformation of trials to improve R&amp;D return on investment.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With an expansive portfolio of integrated clinical, commercialization and consulting services, global presence, depth in therapeutic expertise, and data-driven healthcare technology, we deliver globally scaled expertise &amp; solutions for all customers and patients. Solutions span the Clinical Development lifecycle from compound selection to Phase I-IV clinical studies and post approval outcome research and market access consulting solutions, and can be adapted to suit local trials or large global programs:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><img src="iclr-20231231_g4.jpg" alt="Services Overview.jpg" style="height:950px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Industry overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry provides independent product development solutions and services for the pharmaceutical, biotechnology and medical device industries. Companies in these industries outsource services to CROs in order to manage the drug and device development process more efficiently and to bring both patent-protected bio-similars and medical devices to market faster to enhance patient well-being and maximize their return on investment. The CRO industry has evolved since the 1970s from a small number of companies that provided limited clinical development services to a larger number of CROs that offer a range of services that encompass the entire research and development process, including pre-clinical development, clinical trials management, clinical data management, study design, bio statistical analyses, post market surveillance, regulatory affairs, central laboratory and market access services. CROs are required to provide services in accordance with good clinical and laboratory practices, as governed by the applicable regulatory authorities.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly fragmented, consisting of several hundred small, limited-service providers, medium sized CROs and a small number of large CROs with global operations. Although there are few barriers to entry for small, specialist service providers, we believe there are significant barriers to becoming a CRO with global capabilities and expertise. These barriers include the infrastructure and experience necessary to serve the global demands of clients (sponsors), the ability to recruit sites and patients globally, the simultaneous management of complex clinical trials, the ability to offer customers a variety of delivery models, broad therapeutic expertise and the development and maintenance of the complex information technology systems required to integrate these capabilities. In recent years, the CRO industry has experienced consolidation, resulting in the emergence of a select group of CROs that have the capital, technical resources, integrated global capabilities, data and expertise to manage the development programs of pharmaceutical, biotechnology and medical device companies. We believe that large and medium-sized pharmaceutical companies are selecting a limited number of CRO service providers with which they deal rather than utilizing many, in order to form strategic partnerships with global CROs in an effort to drive incremental development efficiencies and leverage the scientific and medical expertise. We believe that this trend will continue to concentrate the market share among the larger CROs with a track record of quality, speed, flexibility, responsiveness, global capabilities and access to patients and overall development experience and expertise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New drug development overview </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> ethical pharmaceuticals and biologics</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Before a new drug or biologic may be marketed, it must undergo extensive testing and regulatory review to determine that it is safe and effective. The following discussion primarily relates to the FDA approval process for such products. Similar procedures must be followed for product development with other global regulatory agencies. The stages of this development process are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Preclinical Research</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8220;In vitro&#8221; (test tube) and animal studies must be conducted in accordance with applicable regulations to establish the relative toxicity of the drug over a wide range of doses and to detect any potential to cause birth defects, affect vital organs, cause mutations or cancer. Many of these tests must be performed before a new investigational therapy can progress into human studies. If results warrant continuing development of the drug or biologic, the sponsor or owner of the asset will file for an Investigational New Drug Application, or ("IND"), which must be approved by the FDA before starting the proposed clinical trials.  However, preclinical studies will continue to be conducted in parallel with the clinical trials, some of which can take up to 3 years to complete. Preclinical research is not commonly provided by ICON as a service to its customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials (approximately 3.5 to 7 years)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Exploratory development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase I</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 6 months to 1 year)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> consists of basic safety and tolerability testing in small numbers of human subjects, initially in healthy volunteers, and includes studies which may show the drug is having an effect on the body, if it is safe, how it is affected by other drugs, where it goes in the body, how long it remains active and how it is broken down by and eliminated from the body. After single and multiple dose studies have been conducted, the asset can progress into Phase II, however, Phase I studies will continue to be done to help support the development of the asset in new populations such as children or the elderly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase II</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 2 to 3 years</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) includes basic efficacy and dose-range testing in a limited patient population (usually) 100 to 200 patients to help provide preliminary safety and evidence that the drug is likely to be effective in the target disease. If the Phase II results are satisfactory the sponsor may decide to proceed to Phase III studies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Confirmatory development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase III </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">(2 years or greater)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consists of efficacy and safety studies in several hundred to a few thousand patients at multiple investigational sites (hospitals and clinics), often in multiple geographies. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FDA approval, through submission of an IND, is necessary for all clinical trials, regardless of the phase of development. In addition, parallel independent committee approval is also required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">NDA or BLA Preparation and Submission.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Upon completion of Phase III trials, the sponsor assembles the statistically analyzed data from all phases of development into a single large submission along with the Chemistry, Manufacturing and Controls (CMC) and preclinical data and the proposed labelling into the New Drug Application (NDA), or Biologics License Application (BLA) and submits them for assessment and approval by the relevant division of the FDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Expanded Access Programs (EAPs).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Sometimes a study drug may continue to be provided to subjects after completion of a clinical trial, also called compassionate use. EAPs refer to the regulated use of a study drug outside of a clinical trial by patients with serious or life-threatening conditions where there is no alternative therapy available. In this context the FDA may allow the sponsor to make the study drug available to a larger number of patients for treatment use. </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">FDA review and approval of NDA or BLA (1 to 1.5 years).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Data from all phases of development is scrutinized to confirm that the applicant company has complied with all applicable regulations and that the benefit to risk ratio for the drug or biologic is positive for the specific use (or &#8220;indication&#8221;) under study. The FDA may refuse to accept the NDA or BLA if the application has administrative or content criteria which do not meet FDA standards. The FDA may also deny approval of the drug or biologic product if applicable regulatory requirements are not satisfied, if the drug has not adequately shown to be effective or if there are safety concerns. Often a company will be required to conduct specific studies after the approval of a drug. These are called post approval commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Post-market surveillance, Phase IV studies and health outcomes.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Once approved by the FDA, it requires the drug or biologic license holder to collect and periodically report to them additional safety (and perhaps efficacy) data on the drug or biologic for as long as the license holder markets it (post-market surveillance, including pharmacovigilance). If the product is marketed outside the U.S., these reports must include data from all countries in which the drug is sold. Additional studies (Phase III and Phase IV) may be undertaken after initial approval to find new uses for the drug, to test new dosage formulations, or to confirm selected non-clinical benefits, e.g., increased cost-effectiveness or improved quality of life. Additionally, the FDA and other regulatory agencies require license holders of drugs or biologics to prepare risk management plans that are aimed at assessing areas of product risk and actively managing such risks throughout the product lifecycle.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Key trends affecting the CRO industry</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs derive substantially all their revenue from the research and development expenditures of pharmaceutical, biotechnology and medical device companies. We believe that the following trends create further growth opportunities for global CROs, although there is no assurance that growth will materialize.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Continued innovation and development of enabling technologies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Innovation driving new drug development activity </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New technologies together with improved understanding of disease pathology (driven by scientific advances such as the mapping of the human genome) have increased the number of new drug candidates being investigated in early development. This has greatly broadened the number of biological mechanisms being targeted, which increasingly include rare or orphan diseases that currently have no effective treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These developments should lead to increased activity in both preclinical and Phase I development and in turn lead to more treatments in Phase II-III clinical trials. As the number of trials that need to be performed increases and these trials become focused in indications where finding suitable patients is increasingly challenging, we believe that drug developers will increasingly rely on CROs to manage these trials to leverage their global expertise and to continue to focus their own competences on drug discovery and sales and marketing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Decentralized and hybrid trials</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Decentralized and hybrid trials have existed for quite some time, but the coronavirus pandemic accelerated the demand when the pharma industry was challenged to move to remote models to protect patient safety and ensure data integrity for COVID-19 vaccine trials and other ongoing trials. The pandemic has provided an opportunity to move many technologies and remote patient care solutions from pilot phase to supporting patients and research. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As an industry, we have an opportunity to make decentralized and hybrid the standard moving forward. The ways the industry have been conducting clinical research in a traditional site-based approach need to flex so we can implement these tools, techniques and processes in everyday research to bring about a more patient-centric approach. Each new element needs to be evaluated to assess the impact for the individual patients and study sites. Recent experiences in the industry have shown:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Using fewer countries and fewer sites can reduce costs, decrease timelines for start-up and minimize the risk of disruption during and post pandemic. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Hybrid studies, utilizing digital health, in-home health, and telehealth, can reduce the number and frequency of onsite patient visits and therefore reduce patient burden.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Home-based patient visits and direct-to-patient contacts can increase patient satisfaction, compliance and retention, providing greater trial resilience. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Harmonizing data from disparate data sources will provide real-time access and consistent data visibility, helping to improve safety monitoring and enabling the visualization of data trends. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Regulatory easement during the pandemic has resulted in a number of positive changes to clinical trial procedures, enabling studies to continue and in some cases progress at a faster pace, and improvements to the process of CTA and IND approvals. Regulatory authorities have been clear that regulatory easement related to the pandemic will not be extended. However, many regulatory authorities have instead released guidance or position statements on the use of DCT elements, such as technology and off-site conduct, more generally in clinical trials, benefiting the patient and healthcare advancement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ultimately, we are trying to increase the speed at which drugs can meet approval guidelines and help treatable populations. By using decentralized tools, technologies and processes, we will reduce the burden on patients, increase satisfaction and provide them with the same standard of care during a virtual or home visit that they would receive in a clinic, thereby fulfilling the promise of clinical research as a care option. While reduced costs may not be seen in the early phase of adoption (in fact investment may be required initially) choosing the right solution for the specific study characteristics has the potential to increase patient recruitment and retention which can result in reduced overall research costs and quicker time to market. To find the best clinical trial design to suit their needs, sponsors will need to take patient centricity into consideration from the outset and at every step along the way, because what benefits the patient will ultimately benefit the sponsor in outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">New technology enabling more efficient development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Technology innovation is playing an increasingly important role in helping to support more efficient drug development. Leveraging differentiated technology solutions and data collaborations drives better execution in clinical trials. The larger CROs have been at the forefront of this innovation developing technology solutions that support the integration of trial data across multiple systems, data repositories that enable sponsors to get real time clinical insights on the performance of their drugs and tools that support better trial designs and operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The emergence of modern healthcare technologies ("mHealth") that build on the global prevalence of mobile and digital technologies also have an influence on drug development. It is now possible to capture health data using mobile devices and wearables. This enables sponsors to gather new clinical and &#8220;real-world&#8221; patient insights and will also be used to enhance patient engagement and adherence throughout the development process. As these devices mature it will also be possible to complete more &#8220;decentralized and hybrid trials&#8221; based on remote monitoring of patients in their home environment which may drive further efficiencies in the trial process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Social media is also becoming an important platform for life sciences companies to strengthen patient engagement programs and collaborate with other stakeholders in the healthcare system. Many sufferers of specific diseases are forming patient groups and actively collaborating using social media. These groups represent an important potential source of patients for new clinical studies but can also provide valuable insights into effectiveness and safety of new treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the influence of technology on drug development grows, it broadens the potential number of partners that CROs will work with in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Expanded use of new patient data sources  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical companies are looking to access a variety of new healthcare data sources containing medical and prescribing records to help improve development programs and to get better evidence of the value their treatments are bringing to patients once they are launched in the market. The larger global CROs have significant data management experience which can be leveraged to support these efforts and have invested in analytics capabilities to help deliver better insights for customers during the product lifecycle. Global CROs are also forging collaborations to access specific data sets that can provide further patient insights to support better matching of patients to the clinical trial process. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Improving productivity and operating efficiencies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Continuing focus on productivity within research and development programs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical and biotechnology companies continue to seek ways to improve the productivity of their development efforts and increasingly see the use of CROs as a strategic component of these efforts. They are leveraging the expertise of CROs to help identify the most promising drug candidates in early development and discontinue developing those that have safety issues, limited efficacy or that will have significant reimbursement challenges. These companies are also initiating programs to drive more efficiency in their development programs. One example of this has been the efforts to achieve a more seamless transition across development phases, particularly Phase I-III. In parallel, regulatory initiatives such as the 21</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">st</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Century Cures Act and the emergence of clinical trial techniques such as adaptive trial design, risk based clinical trial monitoring, decentralized and hybrid trials are enhancing development, allowing effective treatments to get to patients quicker at reduced development costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost containment pressures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Over the past several years, drug companies have sought more efficient ways of conducting business due to margin pressures stemming from patent expirations, greater acceptance of generic drugs, pricing pressures caused by the impact of managed care, purchasing alliances and regulatory consideration of the economic benefit of new drugs. Consequently, drug companies are centralizing research and development, streamlining their internal structures and outsourcing certain functions to CROs, thereby converting previously fixed costs to variable costs. Larger companies (and more recently medium sized companies) are actively entering strategic partnerships with a limited number of CROs in an effort to drive increased efficiencies. The CRO industry and, in particular, large CROs with global capabilities, considerable scientific knowledge and expertise are often able to perform the needed services with greater focus and at a lower cost than the client could perform internally, although CRO companies themselves are facing increased cost containment pressures as drug companies seek to further reduce their cost base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Global trends influencing the CRO industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pressure to accelerate time to markets and globalization of the marketplace</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reducing product development time maximizes the client&#8217;s potential period of patent exclusivity, which in turn maximizes potential economic returns. We believe that clients are increasingly using CROs that have the appropriate expertise and innovation to improve the speed of product development to assist them in improving economic returns. In addition, applying for regulatory approval in multiple markets and for multiple indications simultaneously, rather than sequentially, reduces product development time and thereby maximizes economic returns. We believe that CROs with global capabilities, considerable knowledge and experience in a broad range of therapeutic areas are key resources to support a global regulatory approval strategy. Alongside this, the increasing need to access pools of new patients is leading to the conduct of clinical trials in new &#8220;emerging regions&#8221; such as Eastern Europe, Latin America, Asia-Pacific and South America. We believe that having access to both traditional and emerging clinical research markets gives global CROs a competitive advantage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Growth within the biotechnology sector</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of the drugs being developed is continuing to change. Biotechnology is enabling the development of targeted drugs with diagnostic tests to determine whether a drug will be effective given a patient&#8217;s genomic profile. An increasing proportion of research and development expenditure is being spent on the development of highly technical drugs to treat very specific therapeutic areas in sectors of unmet medical need. Much of this discovery expertise is found in biotechnology firms. We believe that it is to these organizations that the large pharmaceutical companies will look for an increasing proportion of their new drug pipelines. Whether it is through licensing agreements, joint ventures or equity investment, we believe we may see the emergence of more strategic relationships between small discovery firms and the larger pharmaceutical groups. As the majority of these biotechnology companies do not have a clinical development infrastructure, we believe that the services offered by CROs will continue to be in demand from such companies providing they have the necessary funding. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing number of large long-term studies and an increasing requirement to show the economic value of new treatments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that to establish competitive claims and demonstrate product value, to obtain reimbursement authorization from bodies such as the National Institute for Health and Clinical Excellence in the UK, and to encourage drug prescription by physicians in some large and competitive categories, more clients need to conduct outcome studies to demonstrate, for example, that mortality rates are reduced by certain drugs. To verify such outcomes, very large patient numbers are required, and they must be monitored over long time periods. We believe that as these types of studies increase there will be a commensurate increase in demand for the services of CROs who have the ability to quickly assemble large patient populations, globally if necessary, and manage this complex process throughout its duration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rising costs of healthcare in most developed countries also means there is an increasing pressure to show that new medical treatments are more cost effective and deliver better patient outcomes than existing treatment regimes. This also means that sponsors need to increasingly generate outcome data both as part of the product approval submissions and as part of post-approval research programs. This is creating opportunities for CROs who can offer support in developing and interpreting this data.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">A focus on long-term product safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical trial approval process can only detect major and common adverse side effects of drugs; less common but no less serious side effects may only become apparent after many years of use. As a result, there is an increase in the number of drugs given &#8220;conditional approvals&#8221; where further &#8216;post-approval&#8217; studies are being mandated. In addition, prudent sponsors undertake similar studies to detect early warning signs of any potential problems with their products. Such studies may take the form of prospective long-term safety studies, simpler observational studies or registries where patients meeting specific criteria for disease or drug use are followed for long periods to detect any safety issues. CROs are well positioned to perform these studies on behalf of sponsors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing regulatory demands</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory agencies increasingly require more data to support new drug approvals and are seeking more evidence that new drugs are safer and more effective than existing products. As a result, the complexity of clinical trials, the number of procedures required to be conducted in these trials and the size of regulatory submissions are driving the demand for services provided by CROs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Environment, Social and Governance ('ESG')</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We are passionate about providing innovative solutions for customers, we are better together working as one team, we value diversity and care about the success of our people, and we care about doing the right thing. We are advancing clinical research while offering customers broader and deeper experience, scale, and focus, complemented by continuity of delivery and speed to market. Our business model is described in the preceding sections. Consistent with our values, we seek to not only operate in compliance with applicable laws but also to positively influence our global workforce, the communities that we operate in, the environment and society as a whole. Doing so makes us a stronger, more resilient organization by every measure.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values underpin our mission and drive a culture and mind-set of ownership at ICON. "Own it at ICON", as set out below, is a statement of values that has remained at the very heart of ICON&#8217;s culture, encouraging our people to seize the opportunity and bring flexibility, innovation, and determination to every situation. We believe our culture of ownership personifies who we are as a company &#8212; it also helps us apply our expertise, collaborate to get things done, and succeed at our mission.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">       </span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                 </span><img src="iclr-20231231_g5.jpg" alt="jpeg image (2).jpg" style="height:374px;margin-bottom:5pt;vertical-align:text-bottom;width:365px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our values underpin how we work together to deliver on our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. These values and our Code of Ethical Conduct, which underpins these values, form the core of what we do, and how we do it. It applies to all of our officers, directors, employees, consultants and agents globally. All employees and temporary workers are mandated to complete annual global ethics training.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, we care about conducting business sustainably. We care about our people, patients, and the communities in which we live. We care about doing the right thing and we are committed to working to the highest ethical standards and demonstrating our commitment to honesty, transparency, and quality. As a testament to our commitment, we launched our &#8220;ICON Cares&#8221; program at the start of 2023 which incorporates all our Environment, Social and Governance (ESG), Diversity, Inclusion and Belonging (DIB), and CSR initiatives into one program. ICON&#8217;s Environment, Social, and Governance Committee ('ESG Committee') brings together all these initiatives and efforts under one umbrella to ensure consistency, enhance monitoring, reveal areas for development and facilitate reporting to the Board. The ESG Committee is chaired by the Chief Administrative Officer and General Counsel (CAO), who is responsible for reporting to the ICON executive leadership team, the Nominating, Sustainability and Governance Committee and the Board on ESG matters. The CAO reports on ESG matters to the Nominating, Sustainability and Governance Committee quarterly and reports to the Board at least annually whilst also providing periodic ESG updates to the executive leadership team.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ESG Committee is focused on developing our strategy and initiatives relating to the environment, social matters, health and safety, community engagement, corporate governance, sustainability, and other public policy matters relevant to the Company. The ESG Committee is a cross-functional management committee of the Company including representation from facilities, health and safety, corporate communications, finance, legal, investor relations, procurement, commercial, marketing, and human resources departments. The Committee meets regularly to assist and support executive management and the Nominating, Sustainability and Governance Committee of the Company in:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">determining and setting the strategy relating to ESG matters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">developing, implementing and monitoring initiatives and policies based on that strategy; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">communicating these strategies, initiatives, and their results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to building and developing our ESG strategies and reporting. In 2020 we launched our ESG page on the ICON website and have an internal ICON Cares ESG page on our MyICON intranet portal to engage with our employees and provide information and updates relating to ESG matters and our commitment to sustainability. In 2021, as a testament to our commitment to managing ICON responsibly and sustainably, we became a participant in the United Nations Global Compact (UNGC), a set of Ten Principles covering the areas of human rights, labor, environment, and anti-corruption. In our 2022 ESG report, released in 2023, we reported under the Global Reporting Initiative (GRI, 2021) standards, the Task Force on Climate-Related Financial Disclosures (TCFD) and the Sustainability Accounting Standards Board (SASB) index. Our report summarizes our current policies, priorities, commitments, achievements, and progress in respect to ESG matters. During </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023, ICON received a silver medal from EcoVadis in recognition of our environment, social and governance efforts throughout ICON. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ESG page on our website is available at https://www.iconplc.com/about/esg/.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The global landscape in respect to regulatory and legislative requirements relating to ESG reporting and disclosure requirements is rapidly evolving, and we are monitoring potential requirements so that we are positioned to adhere to any additional requirements in due course. This includes mandatory reporting under the Corporate Sustainability Reporting Disclosure (CSRD) from the EU and the SEC Climate Risk Disclosure Rule which is</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> pending finalizatio</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">n</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Building a sustainable future &#8211; our commitment to the United Nations Sustainable Development Goals</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a global company, we maintain an ethical and sustainable presence in hundreds of locations worldwide. At its core, ICON&#8217;s mission is to improve health and lives. We are also committed to contributing to the 2030 United Nations Sustainable Development Goals (SDGs) and are proud that our work contributes to their advancement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our research, our work with customers and patients and our on-the-ground efforts to meet the diverse needs across our communities align with the SDGs. We focus these efforts on a subset of themes where we have identified the greatest opportunity to effect change:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 3 &#8211; Good health and well-being</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 5 &#8211; Gender equality </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 9 &#8211; Industry, innovation and infrastructure</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 10 &#8211; Reduced inequalities</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 12 &#8211; Responsible consumption and production</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 13 &#8211; Climate action </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">SDG 17 &#8211; Partnerships for the goals</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Further details on the ways ICON contributes to these SDGs and their targets are set out in our ESG Report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Environment: Conducting business sustainably</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to delivering excellence in care to our communities. To improve our overall sustainability, this commitment means tracking and improving our environmental performance across all business activities. We achieve this by pursuing sustainability strategies that recognize the impact of our operations as a CRO on the environment, addressing greenhouse gas (GHG) emissions, energy use, waste generation and procurement-related activities. Our employees, directors, officers, contractors, and temporary workers are expected to support our sustainability objectives.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Environmental Management Policy and Environmental Management Plan is part of our ICON Cares program for managing environmental sustainability initiatives. The implementation of the plan is led by our facilities team, reporting to our Chief Administrative Officer and General Counsel (CAO). The CAO is responsible for reporting on the ICON Cares program and environmental initiatives and progress to the ICON executive leadership team and Nominating, Sustainability and Governance Committee and the Board.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON set environmental goals around the use of renewable energy and carbon emissions in 2019 and we are working towards achieving these goals which are as follows: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:13.8pt">100% renewable electricity by 2025</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:13.8pt">20% reduction in kilowatt hours (kWh) of electricity by 2030</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:13.8pt">Net zero carbon emissions on Scope 1 &amp; 2 by 2030</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In April 2023, following Board approval, ICON made a commitment to the Science Based Targets initiative (SBTi), when we submitted our near-term commitment letter to the SBTi.  In February 2024, the Board approved furthering our SBTi commitment to include a long-term company-wide emissions reduction target in line with science-based net-zero. Accordingly, we have submitted our commitment letter to SBTi to set net-zero targets, including a long-term science-based target and are preparing to submit both our near-term and long-term science-based targets for validation.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have programs in place to manage and minimize climate impacts of business activities. To continue to improve processes and reduce our environmental impact, we track, calculate, and report our Scope 1, Scope 2 and Scope 3 business travel GHG footprint. We apply the GHG Protocol Corporate Standard, which is the global corporate accounting and reporting standard for calculating carbon emissions. Carbon Trust provides annual verification of our Scope 1 and 2 GHG emissions data. In 2023, we worked with Carbon Trust to conduct a full Scope 3 footprint, which we are analyzing with a view to annual public reporting in due course.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Aligned with our goal to be net-zero on Scopes 1 and 2 by 2030, ICON&#8217;s combined Scope 1 and 2 GHG emissions have decreased since 2018. We recognize that although the combined Scopes 1 and 2 emissions have fallen year-on-year, ICON&#8217;s Scope 1 emissions have increased slightly each year. To reach our net-zero goal, our decarbonization strategy is currently focused on reducing Scope 2 emissions, the largest contributor to our Scope 1 and 2 footprint. Following on from our Scope 2 emissions reduction efforts, we plan to launch efforts that target our Scope 1 emissions in the coming years.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2020, following pandemic-related closures and a reduction in business travel, our Scope 3 GHG emissions declined significantly. Since 2021, as more normal operations resumed, we have seen an overall increase in our total GHG emissions driven by an increase in business travel (Scope 3).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although Scope 1 and 3 emissions have increased, we remain below our 2018 pre-COVID overall emissions, and are committed to continue our work towards reducing emissions. Additionally, our emissions intensity has decreased substantially as our business has grown. Since 2018, our emissions intensity per million in revenue and our emissions intensity per FTE employee has decreased.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moving forward, ICON expects to see further emission reductions relative to revenue and the number of employees due to a reduction in offices, strategic energy efficiency projects and a flexible work policy that allows eligible employees to work from home 40% of the time.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON participates in CDP (formerly the Carbon Disclosure Project) on an annual basis. CDP is a globally recognized organization that allows companies to measure and manage their environmental impacts. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We received a B score from CDP for 2023 on our 2022 Climate Change response which was an improvement on the C score that we received from CDP in 2022 on our 2021 Climate Change response.  The improved score is a reflection of our efforts and the progress that we are making in respect to environmental sustainability.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our CDP responses are available at https://www.cdp.net/en/.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on reducing energy use and increasing renewable energy use across our global operations as specific environmental goals. Waste reduction is embedded into our environmental policies and practices and is one of the objectives of ICON&#8217;s Environmental Management Policy. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON leases most of our offices and facilities, and therefore we work closely with our landlords and leasing agents to implement measures to ensure we operate in an environmentally sustainable manner. Throughout</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 202</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> we continued</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">real estate harmonization efforts </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">which resulted in downsizing or closing</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 19 locations t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o align with new working styles and business needs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, this also helps to reduce our environmental footprint</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Experts from our real estate team factor environmental considerations into decisions around new office locations or building improvements. We&#8217;ve also implemented a series of measures globally to reduce the local footprint of our offices while promoting comfort and efficiency. These </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">include:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Installing energy-efficient LED lighting.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Using motion detectors.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Purchasing recycled office supplies. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Reducing paper consumption by promoting paperless office processes and defaulting double-sided output.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Building recycling areas into business centers and kitchens/canteens. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Planting green spaces to improve internal air quality.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Selecting building materials and vendors for their low environmental impact.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We require our suppliers to abide by our Global Supplier Code of Conduct which includes a commitment to comply with applicable environment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">al</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> laws and regulations, our expectations around waste management and sustainable use of resources.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We care about making a positive impact on the communities in which we work and live and we have aligned our community efforts to a broader vision for social impact, including by aligning priorities with our organizational goals of diversity, inclusion, and belonging.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our community engagement activities are focused on two core areas:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Supporting education and building closer ties between industry and academia; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Improving the welfare of people in the communities in which we live.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Supporting education and building closer ties between industry and academia </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A core area of community support includes building ties between industry and academia to inspire the next generation of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">leaders in business and science. Our existing partnerships continue with the following organizations:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">The ICON-McKeon Research Fellowship in Motor Neuron Disease ('MND')</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in honor of Mr. Declan McKeon, former Board member, acting Chairman, Lead Independent Director and Chair of the ICON Audit committee. The ICON-McKeon Research Fellow in MND carries out research in the areas of machine-learning and artificial intelligence to derive insights from multimodal clinical, imaging neuro-electric signaling, in the context of the neurodegenerative disease of ALS. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%;padding-left:14.81pt">Partnership with Trinity Centre for People with Intellectual Disabilities ('TCPID')</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> - TCPID situated within the School of Education, Trinity College Dublin, aims to promote the inclusion of people with intellectual disabilities in education and society. The Centre provides people who have intellectual disabilities with the opportunity to participate in a higher education program designed to enhance their capacity to fully participate in society as independent adults. The 2-year education program includes work placements and internships to enable students to experience and participate in the work environment. In 2023, we were delighted to host a student visit from TCPID students to our global headquarters in Dublin, where they enjoyed learning about the different phases of a clinical trial and also experienced a working laboratory during a tour of the facility. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%;padding-left:14.85pt">Partnership with Junior Achievement to inspire schoolchildren.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Junior Achievement encourages young people to remain in education and teaches them the skills they need to succeed in a changing world. ICON volunteers take time out of their working day to deliver Junior Achievement programs, teaching primary and secondary-level students valuable business, STEM (Science, Technology, Engineering &amp; Mathematics) and entrepreneurship skills that will serve them throughout their professional lives. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Aligned with our ambitions to build closer ties between industry and academia, create a more diverse graduate pool of talented and ambitious STEM professionals who can help to ensure the future success of the life sciences industry, and provide increased opportunities for underrepresented groups to study STEM courses, our STEM scholarship program continued in 2023. Through the program, ICON is partnering with three universities in Ireland &#8211; Dublin City University (DCU), Trinity College Dublin </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(TCD) and the University of Limerick (UL) &#8211; as well as with the Thurgood Marshall College Fund (TMCF) in the US, to fund 33 scholarships for students of STEM courses. TMCF is a not-for-profit organization that supports nearly 300,000 students attending its 47 member-schools that include publicly-supported Historically Black Colleges and Universities (HBCUs). </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improving the welfare of people in the communities in which we live</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Through volunteering, donations and other charitable initiatives, our employees across the world are making a positive difference to their communities. We support causes that are important to our employees and have several programs that support the welfare of people in our local communities. In November 2023, 360 ICON colleagues from across the globe united in person and virtually to take part in Run in the Dark for the fourth conservative year. Team ICON raised $10,000 to support Mark Pollock's Collaborative Cures foundation whose mission is to bring people together to cure paralysis in our lifetime. A team of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON cyclists from </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> countries also participated in our annual ICON cycle challenge,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which covered 350km from Zurich to Munich, across 3 days and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which raised funds for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mission Rabies, a global charity that aims to control the spread of rabies through vaccination of dogs in endemic areas</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since 2012, ICON&#8217;s annual employee-nominated charity donation program has supported over 100 charities worldwide, donating $10,000 to each organization. The selected organizations focus on a range of critical issues, such as building a more inclusive society, improving child welfare and supporting patients who are battling chronic diseases. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">chosen charities align with ICON&#8217;s corporate mission, our ICON Cares program diversity and inclusion goals and support our efforts to advance the United Nations Sustainable Development Goals (SDGs).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, ICON donated to UNICEF in support of humanitarian efforts following the devastating earthquakes in Syria and Turkey. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Talent and People </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people are core to our ability to deliver our services and drive better patient outcomes. Through diversity, inclusion and belonging, industry-leading talent management practices, a sincere attention to our employees&#8217; needs, well-being and health and safety, we continue to power the potential of together. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">At the core of our strategy is our people </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Learning and development of our staff is a key focus for us</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader where talented people come to do important work and where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge as well as behavioral competencies. Programs include </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate and Functional Onboarding for all ICON employees t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ailored CRA academies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; Data Management and Biostats &amp; Programming Academies; a Commercial Skills Academy; </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a range of project management curricula, therapeutic-focused programs, and People Leader development programs. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our People Leader development program focuses on providing our People Leaders with the relevant skills to effectively manage themselves, their team and their business, including leveraging psychometrics to raise awareness of their behavioral preferences and the preference of others. ICON also invest</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in Harvard Manage Mentor, an online learning platform providing People Leaders with access to learning available at any time with topics ranging from change management, diversity &amp; inclusion, retaining employees and developing employees.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide our people with a personalized and flexible learning experience, delivered through a combination of in-person and technology-driven programs that suit their learning styles and can flex to suit their schedules. Through our industry </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">leading Career Hub, ICON employees are encouraged to broaden their scientific, technical, leadership, and business knowledge. By tapping into development programs and partnerships with leading academic institutions, team members can use the hub to develop competencies that advance their careers. We also collaborate with UCD Smurfit School Executive Development to deliver customized leadership development programs for global employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">As an organization we are keen to hear directly from our employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To attract and retain the best talent, we must listen and respond to employees&#8217; needs. This begins with a focus on diversity, inclusion and belonging, and extends to every aspect of our work, from recruitment and onboarding, to training, engagement, enablement, and reward. We pursue best-in-class approaches to building employee engagement and these include, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Comprehensive global employee surveys, which measure how people feel about their work and whether they feel they have the tools to do their jobs well. Feedback from these studies informs detailed action plans at the group, function, and team level.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Pulse check surveys, which are smaller-scale studies designed to measure employee sentiment on specific topics and initiatives.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Fostering an environment of diversity, inclusion and belonging where everyone is valued.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Stay interviews to help managers understand why staff stay and to uncover what might put them at risk of departing.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Skip-level meetings to develop trust and rapport between senior leaders and employees.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our listening strategy supports our efforts to reduce employee turnover, which we monitor closely through analytics. Qualitative information is collected through formal exit interviews and, where we believe they&#8217;ll make an impact, we intervene via retention plans and related efforts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employee well-being </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s commitment to improving health and enriching lives extends beyond the work we do with our customers. Employees worldwide have access to tools and resources designed to support all facets of their well-being, from physical to financial to psychological and beyond.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global Employee Assistance Program (EAP) ensures that all employees, and their families, have access to a range of different, confidential resources and experts to help them better manage their working life and personal life. Employees can also access a wide range of tools, information and support services online in local languages.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health and safety</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, the health and safety of our employees, customers and clinical trial patients are our most important priorities. We take guidance from global and regional health authorities and governments to protect the safety and welfare of employees, as well as abide by government directives. Our global health and safety management system ensures we deliver on all local and national requirements. Our priority objectives are the safety of our staff, clinical trial patients, protecting the environment, maintaining business continuity, and ensuring all sensitive health and safety data is protected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to providing a safe working environment for our people. We achieve this goal by working in ways that protect the safety, health, and welfare of all our employees, clinical trial patients, and visitors. Risk assessment is the basis of the safety management system, and we work to identify, mitigate, and monitor existing and emerging health or environment risks that may be associated with our business activities. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fostering diversity, inclusion and belonging</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to being a workplace where all employees are included and feel a sense of belonging. As a global, values-driven organization, we acknowledge and celebrate our differences in gender, ethnicity, culture and abilities. Respecting diverse viewpoints and experiences is foundational to our interactions with each other and with our patients, customers and suppliers. Moreover, we strive to build teams that reflect the various geographies and communities in which we live and work and the patients we serve.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We recognize the critical importance of diversity in clinical trials ensuring all types of patients who will eventually receive therapies are represented on clinical trials, as well as offering clinical trials as a care option for those who may not otherwise have access to medical treatment. In furtherance of our aim to increase diversity within clinical trials, we appointed a Global </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Head of Diversity in Clinical Trials to lead a team of cross functional experts who can advise customers how to build diversity at every stage of the clinical trial.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diversity, inclusion, and belonging (DIB) are fundamental to our culture and values. Diversity makes us more innovative and more creative. ICON&#8217;s approach to DIB is a key focus area. To reflect this, inclusion is one of our core values and our DIB strategy revolves around four key ambitions: our people, our patients, our customers, and our communities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="iclr-20231231_g6.jpg" alt="jpeg image (3).jpg" style="height:318px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For each of these ambitions, ICON&#8217;s DIB Operating Committee brings together individuals from across the company to create and execute work streams that are committed to advancing our DIB strategy. A central team manages the overarching efforts, ensuring alignment and collaboration across each of the ambitions. Each ambition has a sponsor from ICON&#8217;s executive leadership team who advocates for and supports the agenda, in addition to providing leadership. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The growth of community groups enabled ICON to retire the role of the DIB advocates who were recruited from across the organization to support leadership and the DIB Operating Committee with DIB strategy and activities. Now, all community group members and allies act as advocates across the company. Their aim: to align activities, promote events and share information back to their service lines. It is our aspiration that all our employees will act as DIB advocates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe in a workplace culture that embraces diverse perspectives and empowers our team members to grow &#8212; at work, at home and in their communities. The key areas of focus for our diversity, inclusion, and belonging agenda include talent management, country-level inclusion policies, rewards, training, mentoring and communications.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The DIB community groups we have at ICON are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.492%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20231231_g7.jpg" alt="image (4).jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DAWN:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Disability Awareness Network is a community group focused on developing and fostering a mind-set towards creating an inclusive workplace and working environment where everyone is treated equally with respect and dignity, irrespective of any visible or hidden disabilities.<br/></span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20231231_g8.jpg" alt="image (5).jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EmbRACE:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">EmbRACE is a community group supporting all race and ethnic backgrounds in creating an inclusive workplace culture. Our ambition is to build a culture that is inclusive, collaborative and accountable, supporting all our people and removing barriers that prevent them from doing their best work and being their true selves at ICON.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.492%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20231231_g9.jpg" alt="image (6).jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOW@ICON:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Networking Organization for Women at ICON is committed to inspiring and connecting current and potential leaders through an inclusive environment of targeted initiatives and supportive mentorship.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20231231_g10.jpg" alt="image (7).jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pride@ICON:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Pride group supports LGBTQ+ colleagues and allies, ensuring that no matter where employees are in the world, our offices are a safe space where they are welcomed, respected, and valued.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20231231_g11.jpg" alt="image (8).jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SPACE:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SPACE is a Community Group that Supports Parents And Carers Everywhere. We aim to create awareness and education, with a view to building an effective SPACE community that provides individual, group and regional support connections for parents and carers.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2023 each community group launched a mentoring program to support networking and career development at ICON.  This was a huge success with over 300 mentor and mentee matches across the five community groups with mentors and mentees receiving training and toolkits to make the most of their mentoring relationship. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a testament to our commitment to diversity, ICON are aiming for gender parity at the VP level and above by 2025. As at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">January 31, 2024, women represent 46%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of the positions at the VP level and above. Our strong focus on talent management, succession planning and talent development ensures we work towards building strong talent pipelines for VP level roles with equal number of female and male candidates shortlisted for all our senior roles.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Establishing a truly inclusive workplace requires offering fair pay. Using best-in-class methodology, we regularly review salary ranges to establish fair pay among employees regardless of gender, race or ethnicity. We also consider legitimate business factors that explain differences, such as performance, tenure and experience. ICON has made and will continue to make significant investments in organizational design structures, tools and education that uphold and support our pay principles.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to ensuring fair employment practices. For every jurisdiction in which we operate, we act in compliance with relevant laws relating to labor rights and labor relations as well as market competitive benefits. We believe in fair and equal treatment for all our people, without regard to gender, race, ethnicity, sexual orientation, marital status, physical or mental disability, age, pregnancy, veteran status, nationality, religion, or any other legally protected status. We do not tolerate our employees being subjected to physical, sexual, racial, psychological, verbal, or any other form of harassment. We encourage our employees to report any issues of harassment or discrimination. We prohibit retaliation against any employee who rejects, protests, or complains about unlawful discrimination or harassment. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Human rights</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to human rights and in 2021, ICON became a participant in the UN Global Compact (UNGC), signaling our commitment to uphold the UNGC&#8217;s 10 Principles, including those related to human rights across our global operations. Our business model and our policies, including our Global Code of Ethical Conduct and Global Supplier Code of Conduct, are intended to fully comply with applicable human rights legislation in the countries where we operate. Our zero-tolerance policy on forced labor, slavery, and human trafficking is defined clearly in these policies, which are available to employees, suppliers, customers, and the public.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are opposed to forced labor, slavery, and human trafficking. We will not knowingly support or conduct business with any organization involved in such activities. We do not employ anyone below the minimum employment age in the jurisdictions in which we operate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Supplier Code of Conduct incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for responsible supply chain management, including for labor. Before doing business with ICON, suppliers must certify that they will comply with the ICON Global Supplier Code of Conduct or their own materially equivalent internal code, which includes human rights protections. We perform pre-engagement due diligence on our suppliers, including in relation to labor issues, which we support through periodic re-screening. We hold our suppliers accountable for meeting their contractual obligations. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ethics and Compliance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">             ICON&#8217;s commitment to ethics and integrity is embedded in our company values. We act with integrity and integrate ethical principles into our business practices and culture. ICON&#8217;s Global Code of Ethical Conduct (the Code) establishes our core principles and standards for honest, fair, and ethical behavior. This Code addresses the core values expected of our people in our internal interactions with each other as well as in external dealings with patients, customers, healthcare professionals, regulators, investors, vendors and other third parties.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Ethics and Compliance program</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> is designed to protect the interests of the company and its shareholders by preventing, detecting, investigating and responding to potential misconduct and violations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Ethics &amp; Compliance team (E&amp;C) provides day-to-day independent oversight for the program. The team works collaboratively with risk and compliance functions and leadership across the business to align on and optimize its reach and impact. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Head of E&amp;C provides day-to-day independent oversight for the program. The team is independent of the business and reports to the Deputy General Counsel, who reports to the Chief Administrative Officer and General Counsel (CAO). The CAO reports on the program to ICON&#8217;s executive leadership team, the Nominating, Sustainability and Governance Committee and the Board. The program supports all functional areas globally and is dedicated to the implementation of standardized global policies, procedures, training, guidance, communications, monitoring, investigations, issue management, assessing compliance-related risk and mitigations, and reporting to ensure the overall compliance program is effectively functioning. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where appropriate, the program also implements regional and/or country specific policies, procedure, training and guidance.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has incorporated a third-party system, Ethics Line, for employees and third parties to confidentially report ethics and compliance questions, as well as concerns, and to track reports through follow-up and resolution.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> An independent company administers this hotline, which is available all hours of every day and can accommodate calls in over 75 languages.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> These tools also provide visibility into our risks while highlighting opportunities to address them. ICON&#8217;s Ethics and Compliance program will continue to grow and evolve in response to changes in our business and in the global business climate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All personnel are required to receive ethics and compliance training during initial onboarding and through annual refresher sessions. Training modules explain the many channels available for reporting suspected unethical or illegal practices. The training supports our values and our ways of working and incorporates the key principles of our policies and codes and includes interactive scenarios where applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, we promote a Speak Up culture that encourages compliance, openness, and accountability without retaliation. The Speak Up Policy aims to support our culture and values and seeks to encourage the prompt reporting or surfacing of concerns or violations about values, ethics or other standards without fear of retaliation. Reported ethics concerns and other ethics and compliance-related data are reported via the CAO to the Board as appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Anti-bribery and Corruption</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is guided by the foundational principle that we do not tolerate bribery or any other form of corruption or fraud. Our anti-bribery and anti-corruption (ABAC) program is a core element of our Ethics and Compliance program. ICON and all ICON directors, employees, consultants, agents and all third parties acting on ICON's behalf must act in compliance with international laws and regulations relating to bribery, corruption, and illicit payments, including the US Foreign Corrupt Practices Act and the UK Bribery Act 2010.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains the ISO 37001:2016 certification for our Anti-Bribery Management System, which establishes the framework for the controls that prevent, detect and mitigate the risk of bribery. Our program is designed to ensure our compliance with anti-corruption laws, including due diligence, training, policies, procedures, and internal controls.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Bribery and corruption remain a business risk as we conduct our business across the globe and enter partnerships and collaborations. There is no certainty that all employees and third-party business partners (including our vendors, suppliers, agents, contractors, and other partners) will comply with anti-bribery laws. When working with third parties, we are committed to working with only those who embrace high standards of ethical behavior consistent with our own. Bribery and corruption risks are a focus of our third-party diligence and management process. We hold our suppliers accountable for meeting their contractual obligations with ICON, including commitments that are made with regard to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business with ICON. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's internal audit teams conduct ABAC program audits. Internal Audit focuses on testing for compliance and design effectiveness of the overall ABAC program. Internal Audit incorporates an assessment of ABAC measures in all audits, as appropriate. In this approach, bribery and corruption risks are incorporated into the risk assessment and scoping process of each audit.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Privacy and Information Security </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Data privacy and information security are fundamental to our business and key to retaining customers, building investors&#8217; trust, protecting patients, and complying with global and regional regulations. We recognize and respect that our customers, employees, patients, and all those who do business with us expect that we will protect their personal information in accordance with our legal obligations and policy commitments. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Data Protection Policy regulates the processing of personal data in accordance with the applicable data protection laws of the countries where we operate, including Europe&#8217;s General Data Protection Regulation (GDPR) framework. This policy governs ICON&#8217;s and its employees&#8217; obligations concerning the processing of personal data, including core privacy issues such as how we address data subject rights, data protection impact assessments and our obligations to maintain records of processing activities (ROPAs).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a separate Personal Data Incident and Breach Response Policy and Process that governs the management of personal data incidents and breaches within ICON. The policy requires incidents to be reported to ICON&#8217;s Global Data Protection Officer (DPO) and Privacy Team, who manage them in collaboration with relevant internal stakeholders (e.g., IT Security, Quality &amp; Compliance), to ensure we comply with our legal and contractual obligations, including our reporting obligations. In 2023, in combination with our existing ISO 27001 certification, ICON&#8217;s data protection policies and procedures were certified to ISO 27701. Our privacy program is overseen by the CAO.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people and partners play a critical role in safeguarding data. ICON has training in place for all employees and contingent workers on information security and privacy practices so that they understand their responsibilities with respect to data security and privacy. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has also established a robust Privacy and Security Champion (PSC) network. The PSC network acts as an extension of the Privacy and Information Security teams. In line with the PSC charter, champions provide a key touch point in relevant business units, bolster awareness of ICON&#8217;s respective privacy and security programs and provide direct support in response to priorities dictated by ICON&#8217;s Privacy and Security Council (chaired by ICON&#8217;s Global Data Protection Officer and Head of Information Security).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For information about our cybersecurity program see Item 16K - Cybersecurity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sustainable procurement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains policies and processes to support responsible, sustainable, and ethical business practices. Our goal is to source from suppliers whose values align with our own, who share our commitment to diversity and inclusion, and who are socially and environmentally responsible and conscious.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We manage our suppliers through our Global Procurement department. The onboarding of all new suppliers is completed through a robust centrally managed due diligence process. Environmental sustainability, bribery, and corruption risks are a focus of our third-party assessment and management process. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON performs pre-engagement due diligence on our suppliers. This includes screening of sanctions lists, debarment, and adverse media. Suppliers are continuously monitored against sanctions and debarment lists and are periodically re-screened. Suppliers deemed higher risk are subject to enhanced due diligence and controls, which may include periodic training, auditing, and assessments. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We require our suppliers to abide by our Global Supplier Code of Conduct which incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for Responsible Supply Chain Management and sets out our standards and expectations regarding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Ethics and compliance</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Labor and human rights</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Health and safety</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Environmental stewardship</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Supplier Code of Conduct also outlines channels to report concerns or grievances related to our suppliers, such as our Ethics Line. We operate a strict anti-retaliation policy and expect suppliers to do the same. We hold our suppliers accountable for meeting their contractual obligations, including commitments relating to the Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship and exclusion from future business with our company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To further support the development of our sustainable procurement program, ICON has engaged with EcoVadis, CDP and Supplier IO to help assess our key suppliers and gather data around sustainability maturity, GHG emissions and diversity status and classifications. This data allows us to factor sustainability related factors into our supplier selection activities and embed sustainability into our procurement practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our marketing strategy is focused on building a differentiated brand position for ICON and supporting our business development efforts to develop and build relationships with pharmaceutical, biotechnology, medical device, and government and public health organizations. Our marketing activities are coordinated centrally to ensure a consistent and differentiated market positioning for ICON and to ensure all marketing efforts align to the overall strategic objectives of the business. Our business development teams are located throughout the Americas, Europe and Asia Pacific regions. Business development activities are carried out by account executives with assigned territories and global account directors supporting our large accounts. Specialized business development teams focus on growing each of our business areas. Collectively, our business development team, senior executives and project team leaders share responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our client base to gain repeat business and enable us new opportunities to penetrate into other therapeutic indications and adjacent service lines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is fragmented, consisting of many small, niche service providers, a declining number of medium-sized providers and a smaller number of large CROs, including ICON, that are differentiated by the scale of their global operations, breadth of service portfolios and supporting technology infrastructure. The need to conduct complex research and access patients on a global basis is driving market share to these global CROs. When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., Fortrea and Syneos Health. In some specific markets, for example biotech and mid-tier pharma, ICON may also compete against mid-tier CROs. Competition also exists for acquisition candidates in addition to competition for customers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs generally compete on the basis of previous product experience, the ability to recruit patients on a global basis, the depth of therapeutic and scientific expertise, the strength of project teams, price and increasingly on the ability to apply new innovation that can drive significant time and cost savings throughout the development process. An evolving area of competition is the need to provide services that can help generate the evidence of the economic value of new treatments that payers and regulators require. This requires access to new data sources which includes information to support the identification of suitable investigator sites and patient populations as well as data on the value delivered by new products following marketing approval. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we compete favorably in all these areas and we continue to invest in our capabilities to ensure that we remain competitive in the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Customers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, revenue was earned from a wide range of clients and 26.8% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.9% of revenue for the year.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, 28.3% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.8% of revenue for the year ended December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, 31.6% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.0% of revenue for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The loss of, or a significant decrease in business from one or more of our key customers could have a material adverse impact on our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unsatisfied Performance Obligation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation consists of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2023 we had contracted unsatisfied performance obligation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $14.8 billion.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;We</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize this unsatisfied performance obligation as revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information Systems</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Having access to accurate and timely information is critical in the management, delivery and quality of all aspects of drug development. ICON utilizes an extensive range of both on premise and cloud based applications that support its services including clinical trial design and planning, site and patient identification and recruitment, site start-up, patient consent, site payments, content management, clinical data analysis and real world evidence generation, customer relationship management (CRM), performance management, compliance and safety reporting and master data management. These solutions are to allow healthcare companies to manage, optimize and execute their clinical and commercial strategies in an orchestrated manner while addressing their regulatory obligations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has developed an informatics strategy built around key platforms including ICONIK and Health Cloud, web-based information platforms that enable the management, reporting, analysis and visualization of all data relating to drug development. The ICONIK and Health Cloud platforms collect, manage and standardize study data from multiple sources, including Electronic Data Capture (EDC), patient engagement, EMR/EHR, mobile health, Telehealth, Wearables, Central Laboratories, Symphony Health and Imaging platforms to provide a single view of study information. ICONIK and Health Cloud enable ICON to deliver services such as Risk Based Monitoring (RBM) which uses near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to managing clinical data, ICONIK and Health Cloud collect operational data, such as project management, clinical trials management system (CTMS) and metrics information to drive trial efficiency and transparency. Investigator data, such as payments, site details and performance, can also be incorporated. ICONIK and Health Cloud can be accessed via a portal that allows clients access to study-related information via a secure web-based environment. Data analysis from ICONIK and Health Cloud Informatics Hubs and CDRP allows us to enhance the design and delivery of our projects, through stronger engagement with investigators and patients. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Data management and collection is a key business process for Symphony Health through its Integrated Dataverse (IDV&#174;) platform. Integrated Dataverse (IDV&#174;) is a comprehensive and longitudinal source of healthcare data in the industry, bringing together our vast claims resources &#8211; medical, hospital, and prescription &#8211; with our rich point-of-sale prescription data, non-retail invoice data, and demographic data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Firecrest, our site management and training technology, is another important component of our informatics strategy. Firecrest provides an on-line web-based portal to access visit by visit study guides which drive site performance and quality. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON also utilizes a range of enterprise applications that enable the delivery of our business services in a global environment. The focus is to provide ease of access and capture of study information for our staff and clients globally. Our current information systems are built on open standards and leading commercial business applications from vendors including Microsoft, Amazon, Oracle, Dell, SAS, Veeva, Dassault, Salesforce and BOX. IT expenditure is authorized by strict IT governance policies requiring senior level approval of all strategic IT expenditure based on defined business strategy and measurable business benefits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In Clinical Operations, we have deployed a suite of software applications that assist in the management and tracking of our clinical trial activities. These software applications are both internally developed and commercially available applications from external vendors. These include a clinical trial management application that tracks all relevant data in a trial and automates all management and reporting processes. In our Data Management function, we have both leading clinical data management solutions including EDC and Clinical Data Warehouse solutions from external vendors as well as our proprietary EDC capability NEXTrials Prism eClinical. This allows us to guarantee the integrity of client data and provide consolidated information across client studies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within Clinical Operations, we also provide the ICON Digital Platform enabling the delivery of Decentralized and Hybrid Clinical Trial services, maximizing patient recruitment and retention and at the same time expanding access to diverse and remote patient populations. We develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximize safety and efficiency and make data-driven decisions for every study.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our clinical trials management area, Firecrest Clinical provides a comprehensive site performance management system that improves compliance, consistency and efficient execution of activities at investigative sites. The web-based solution enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to sites. Site behavior can then be tracked to ensure training is understood, procedures are being followed, timelines are met and study parameters are maintained. As well as meeting day to day operational requirements, this system feeds data into the ICONIK and Health Cloud platforms.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide interactive response technology (IXR) to enable centralized patient randomization, drug inventory management and patient diary collection, providing our clients with a fully flexible multi-channel data retrieval solution which can be utilized via telephone, internet browser or a mobile device. In our central laboratory business, we utilize a comprehensive suite of software, including a laboratory information management system (LIMS), a kit / sample management system and a web </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">interface system to allow clients to review results online. Our Laboratory also utilizes IMRA, a web based laboratory review application that allows global access to the latest laboratory data on a study. IMRA facilitates detailed analysis of any trends, signals, alerts or patient-specific data on a real-time basis. ICON provides imaging and cardio safety services through the use of its internally developed MIRA &amp; Maestro platforms and also utilizes Medidata&#8217;s Rave Commercial Imaging for collecting, managing and processing data to support its imaging capabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its Pharmacovigilance Services using Oracle&#8217;s ARGUS safety database. The system is FDA regulation 21 CFR Part 11 compliant and generates all the standard regulatory required reports, as well the periodic reports required to support operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON supports Population Pharmacokinetics and Pharmacokinetic Pharmacodynamic modeling through the use of its proprietary software NONMEM&#174;. NONMEM&#174; is a nonlinear mixed effects modeling tool that can be used to fit models to many different types of data. Statistical analysis with NONMEM&#174; using the appropriate model helps pharmaceutical companies determine appropriate dosing strategies for their products, and increase their understanding of drug mechanisms and interactions. NONMEM&#174; can also be accompanied with PDx-Pop proprietary software. PDx-Pop software is a graphical interface for NONMEM&#174; which has its own automation methodology which expedites the iterative process of population pharmacokinetic modeling and analysis. ICON also utilizes PREDPP, which is a powerful package of subroutines handling population PK data, as well as general linear and nonlinear models, which can free the user from coding standard kinetic-type equations while simultaneously allowing complicated patient-type data to be easily analyzed. Finally, ICON utilizes NM-TRAN, which is a preprocessor allowing control and other needed inputs to be specified in a user-friendly manner. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's configurable Real World Data &#8220;Evidence&#8221; platform is a fit-for-purpose solution to support and enhance observational research. The platform gathers disparate real world data assets into a common data model, provides analytics to support multiple audiences across the product lifecycle, and serves as a central repository and analytic platform for all Real World Data assets.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s Integrated Dataverse (IDV&#174;) is one of the largest integrated repositories of healthcare data consisting of 280 million patient lives, 1.8 million prescribers and 16 thousand health plans which provides powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. We transform data into decisions and give deeper insight into the relationships that sponsor brands have with the market by allowing a holistic view of the impacts of payer, prescriber, and patient behavior. Our proprietary Tokenisation technology Synoma&#174; simplifies the anonymization, exchange and connection of industry data sources to provide an integrated view of a patient&#8217;s data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s strategy of using technology to enhance our global processes is evident from our deployment of platforms like ICONIK, Health Cloud, Veeva CDMS/EDMS/QMS (our global SOP Document Management system), iLearn and Cornerstone (our Web-based training delivery solution), ServiceNow (workflow and automation platform), Sailpoint (identity management and governance), and Pega and ARGUS (pharmacovigilance). The Electronic Trial Master File is delivered via ICON&#8217;s proprietary software ICOMaster or the Wingspan and PhlexGlobal software platforms. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s global finance operations utilize Oracle&#8217;s eBusiness suite, with the integrated Excel4Apps reporting tool, to serve the organization&#8217;s financial and project accounting requirements. Workday is used to fulfill our HR people management requirements. Our business development and contracting teams use Salesforce CRM.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our IT systems are operated from two data center hubs in Europe (Dublin, Ireland; Groningen, Netherlands), four in North America (Philadelphia, Pennsylvania; Lenexa, Kansas; Charlottesville, Virginia; Dallas, Texas) and one in Asia (Singapore). These hubs reside within purpose-built data center facility locations. Other offices are linked to these hubs through a network managed by Verizon, a tier one global telecommunications provider. This network provides global connectivity for our applications and allows collaboration and communication using tools like Microsoft Teams, Cisco Jabber, Sharepoint and Box. Mobile staff can also access all systems via secure remote access facilities. A global corporate intranet portal provides access to all authorized data and applications for our internal staff as well as providing an internal platform for company-wide communication. IT systems are protected with robust information security controls which are independently audited biannually as part of maintaining ICON&#8217;s ISO27001:2013 certification. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON enables its patient site and data strategy through the services delivered via Accellacare, Oncacare and Veradigm Allscripts. We also work with biopharmaceutical companies and other life science providers (e.g. medical devices companies) to develop and deploy bespoke stakeholder engagement solutions. ICON&#8217;s patient engagement services enable site staff to engage directly with patients to help improve their disease and medication understanding through interventional and non-interventional support.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is the leading provider of Functional Service Provision (FSP) globally. Our team of operational, functional and therapeutic specialists offer a range of FSP models. We offer FSP solutions across all major functions from clinical monitoring and project management through data management, statistical programming and beyond. Our teams leverage either Sponsor or ICON&#8217;s IT Infrastructure to deliver services. Our team has extensive experience managing the migration of systems and can support system upgrades as part of the ramp-up phase.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides molecular diagnostic laboratory capabilities that enables the development and commercialization of precision medicines in oncology. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other key innovations and new technologies include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">FLEX ADVANTAGE, our interactive response technology platform (accessible through the web and web-enabled mobile devices) for managing patient randomization, investigator sites and clinical suppliers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PubsHub brings speed and efficiency to medical teams by delivering easy-to-use, web-based solutions that bridge process gaps for system harmonization across companies. ICON utilizes PubsHub to automate medical and scientific communications and publications management.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The ICON Patient Engagement Platform features an easy to navigate, user friendly website enabling patients to explore new and ongoing studies available, opt-in and connect with their nearest clinical research site.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">One-Search, an intuitive, integrated workflow and interrogation tool from ICON, enables access to multiple data sources and provides the visualization and tools necessary for optimum site identification based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">ADDPLAN for simulation and design of exploratory/pilot and confirmatory/pivotal adaptive clinical trials (ADDPLAN&#174; DF (Dose Finder), ADDPLAN&#174; Base, ADDPLAN&#174; MC (Multiple Comparison) and ADDPLAN&#174; PE (Population Enrichment)).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">AptivAdvantage which is an integrated platform comprising EDC, randomization and drug supply management specifically created for execution of adaptive clinical trials and used to deliver risk-based monitoring; and Aptiv Insite which is a novel approach to risk-based monitoring, using Verification by Statistical Sampling (VSS) to manage data quality and site related risks.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Sample Inventory Management System (SIMS) is an interactive reporting module in ICOLabs for use by sponsors and study teams. It offers near real time, high level traceability of all patient samples in a clinical trial as they move from accessioning through disposition. SIMS provides detailed sample inventory reports and summaries of sample status and location with drill down capabilities. It helps locate samples more rapidly, particularly at critical study junctures.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">APECS for Investigator Payments ensures timely and accurate payments to sites for the work performed in the care and management of patients as they participate within clinical trials.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The PredictivvTM platform is a fully integrated solution for designing, planning, managing and optimizing the execution of global clinical studies. Designed around a unified Salesforce platform that harmonizes data, processes, and people across every aspect of a clinical study, PredictivvTM enables unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">EXACT&#8482; allows users to quickly construct re-usable programs for data extraction, data transformation, statistical reporting and electronic publishing, in a visual environment with limited code writing. The EXACT&#8482; system is used to simplify and automate the production of multiple Clinical Data Interchange Standards Consortium (CDISC) guidelines as well as tables, figures and listings in trial reports.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">Cassandra &#8211; AI capability which predicts the needs for FDA &amp; EMA Post marketing studies.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">ICONex &#8211; AI Powered capability which enables the KOL&#8217;s and their networks to be more easily identified.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Contractual Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are generally awarded projects based upon our responses to requests for proposals received from companies in the pharmaceutical, biotechnology and medical device industries, or through strategic partnership agreements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues on long term contracts are recognized based on an assessment of progress towards completion. Payment terms usually provide either for payments based on the delivery of certain identified milestones, units delivered or monthly payments, according to a contracted payment schedule over the life of the contract. Where there are changes in the scope of a trial or in the services to be provided by us, a change order or amendment is issued which may result either in an increase or decrease in the contract value. We also contract on a "fee-for-service" or "time and materials" basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contract periods may range from several weeks to several years depending on the nature of the work to be performed. In most cases, an upfront portion of the contract fee is paid at the time the study or trial is started. The balance of the contract fee is generally payable in installments over the study or trial duration and may be based on the completion of certain performance targets or "milestones", on units delivered, or on a fixed monthly payment schedule. For instance, installment payments may be based on patient enrollment progress or delivery of the study database. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The progress towards completion for clinical service contracts is measured based on total project costs (direct fees are therefore inclusive of third party costs). Reimbursable costs include payments to investigators, travel and accommodation costs and various other expenses incurred over the course of the clinical trial which are fully reimbursable by the client. Reimbursable expenses are included within the contract and are invoiced on a monthly basis based on actual expenses incurred. Expenses incurred are determined by reference to activity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred, we usually negotiate currency fluctuation clauses in our contracts which allow for price adjustments if changes in the relative value of those currencies exceed predetermined tolerances.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our contracts are terminable immediately by the client with justifiable cause or with 30 to 90 days&#8217; notice without cause. In the event of termination, we are usually entitled to all sums owed for work performed and expenses incurred through the notice of termination and certain costs associated with termination of the study. Termination or delay in the performance of a contract occurs for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client's decision to de-emphasize a particular trial, inadequate patient enrollment or investigator recruitment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Chief Executive Officer and other members of the executive management team are responsible for day-to-day risk management of the Company and our Board oversees management's activities through both the full Board and its committees. Our Chief Executive Officer and other members of the executive management team are members of ICON&#8217;s Quality and Risk Forum, which reviews risk. Our executive management team regularly reports to the Board and its Committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. The Board oversees general business and market risk management, our Audit Committee oversees risk management with respect to financial statements, accounting and financial controls and our Compensation and Organization Committee oversees risk management with respect to our compensation plans, policies and procedures and our Nominating, Sustainability and Governance Committee oversees risks relating to ESG matters. Internal audit reports functionally and administratively to our Chief Financial Officer and directly to the Audit Committee. With respect to non-financial risk management, including cybersecurity, legal compliance, privacy and enterprise risk, the Board and its Committees receive updates from the appropriate executives on the primary risks facing the Company and the measures the Company is taking to mitigate such risks. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government Regulation  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical investigation of new drugs is highly regulated by government agencies. The standard for the conduct of clinical research and development studies is Good Clinical Practice (&#8220;GCP&#8221;), which stipulates procedures designed to ensure the quality and integrity of data obtained from clinical testing and to protect the rights and safety of clinical subjects. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FDA and other prominent regulators have promulgated regulations and guidelines that pertain to applications to initiate trials of products, the approval and conduct of studies, report and record retention, informed consent, applications for the approval of drugs and post-marketing requirements. Pursuant to these regulations and guidelines, service providers that assume the obligations of a drug sponsor are required to comply with applicable regulations and are subject to regulatory action for failure to comply with such regulations and guidelines. In the United States and Europe, the trend has been in the direction of increased regulation and enforcement by the applicable regulatory authority. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In providing services in the United States, we are obligated to comply with FDA requirements governing such activities. These include ensuring that the study is approved by an appropriate Independent Review Board (&#8220;IRB&#8221;) and Ethics Committee, obtaining patient informed consents, verifying qualifications of investigators, reporting patients&#8217; adverse reactions to drugs and maintaining thorough and accurate records. We must maintain critical documents for each study for specified periods, and such documents may be reviewed by the study sponsor and the FDA.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The services we provide outside the United States are ultimately subject to similar regulation by the relevant regulatory authority. In addition, our activities in Europe are affected by the European Medicines Agency.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We must retain records for each study for specified periods for inspection by the client and by the applicable regulatory authority during audits. If we fail to comply with applicable regulations and guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines, debarment, termination or suspension of ongoing research, the disqualification of data or litigation by clients, any of which could also result in a material adverse effect.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Potential Liability and Insurance &#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our business exposes us to potential liability including, but not limited to, potential liability for (i) breach of contract or negligence claims by our customers; and, (ii) third party (such as patients) claims in respect of our performance of services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, although we do not believe we are legally responsible for acts of third party investigators (physicians running trials), we could be subject to claims arising as a result of the actions of these investigators.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We try to reduce this potential liability by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.85pt">Seeking contractual indemnification from customers in relation to certain activities. However, the terms and scope of indemnification varies from customer to customer and project to project and the performance of these indemnities is not secured. As a result, we bear the risk that indemnification may not be relevant or sufficient or that the indemnifying party may not have the financial ability to fulfill its indemnification obligations. This indemnification does not protect us against our own acts or omissions such as our negligence or where our performance does not reach the required contractual, industry or regulatory standard.</span></div><div style="padding-left:45pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.85pt">Maintaining worldwide professional liability insurance. While we maintain the types and amounts of insurance we view as customary in the industries and countries in which we operate, there is no guarantee that we will continue to be able to maintain such insurance coverage on terms acceptable to us, if at all, or that the relevant policy will respond and provide cover when we want it to.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We could be materially adversely affected if ICON is required to pay damages or bear the costs of defending or settling any claim which a) is outside the scope of or in excess of a contractual indemnification provision, b) an indemnifying party does not fulfill its indemnification obligations, c) the claim is in excess of the level of our insurance coverage or d) the relevant circumstances are not covered by our insurance policies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span id="i5d6bb8168831487587e557a7e54136dd_498523"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Organizational Structure </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Details of the Company&#8217;s significant subsidiaries or entities under the Company's control at December&#160;31, 2023 are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Pty Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research PTY Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medpass International Pty Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Austria GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Austria GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Bel, FLLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belarus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Belgium B.V. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Belgium N.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Bermuda,&#160;Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bermuda</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Pesquisas Cl&#237;nicas Ltda.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ltda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS do Brasil Servi&#231;os de Pesquisas Ltda. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS China Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Virgin Islands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Bulgaria EOOD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research EOOD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services de Recherche Pharmaceutique Srl</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3065613 Nova Scotia Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Canada) Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates ULC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oxford Outcomes LTD.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Life Sciences Canada Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Chile Limitada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Chile SpA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences China, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing No.2) Co., Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing) Co., Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Colombia Ltda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Costa Rica, LTDA.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Research Ltd. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates d.o.o. za klinicka ispitivanja</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Czech Republic s.r.o. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Denmark ApS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Nordic Countries A/S</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Egypt Limited Liability Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Estonia O&#220;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estonia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Finland Oy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Finland Oy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services France S.A.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.R.L. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Research Trust*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare France SAS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics Georgia LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Georgia LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Germany GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare (Germany) GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Averion Europe GmbH i.L</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Greece A.E.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Guatemala, S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guatemala</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences (Hong Kong) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Hong Kong Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Hungary Research and Development Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Limited Liability Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Iceland ehf.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Iceland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates India Private Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research India Private Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical International Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Development (Ireland) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Clinical Research International Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Five Unlimited Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Four Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Resourcing Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Holdings (Ireland) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services (Outsourcing Ireland) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (Ireland) Unlimited Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Clinical Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Israel Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Israel Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Italy S.r.l.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Italy S.r.l</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research GK</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jersey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Kenya Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenya</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latvia SIA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latvia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UAB RPS Lithuania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lithuania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Malaysia Sdn. Bhd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON CRO Malaysia Sdn. Bhd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research M&#233;xico, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Servicios, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research M&#233;xico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Mexico S. de R.L. de C. V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International B.V. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services Netherlands B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Group B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Operations B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates New Zealand Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (New Zealand) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Norway AS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Panama Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Per&#250; S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Per&#250; S.A.C.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Philippines,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Services Philippines, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Sp. z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Clinical Research Sp z.o.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Poland Sp z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Portugal, Unipessoal, Lda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Puerto Rico,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Romania S.R.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.R.L. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joint Stock Company IMP Logistics </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Rus) LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research doo Beograd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates doo Belgrade </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Pte) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Life Sciences Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates SK s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Slovakia, s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Pharmaceutical S A (Proprietary) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research South Africa (Proprietary) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare South Africa (PTY) LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Korea Yuhan Hoesa/ Mapi Korea LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Korea Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Korea Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS ReSearch Ib&#233;rica, S.L.U.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare (Spain), S.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Spain S.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Espa&#241;a, S.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Espa&#241;a, S.A.U.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Espa&#241;a S.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Sweden AB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Sweden AB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Switzerland GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Switzerland) GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Switzerland AG</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Taiwan Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Taiwan,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Thailand) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research (Thailand) Co.,&#160;Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Ankara Klinik Arastirma Dis Ticaret Anonim Sirketi</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pra Turkey Sa&#287;lik Ara&#351;tirma Ve Geli&#351;tirme Limited &#350;irketi </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Ukraine LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Ukraine LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ukraine, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 4 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 5 Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (U.K.) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Lakeside Clinical Research Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Merc (UK) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VSK (Kenilworth) Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Improving Treatments Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aptiv Solutions (UK) Ltd </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 2 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 3 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Development Solutions Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments (UK) Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medeval Group Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OncaCare (U.K.) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates (UK) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sterling Synergy Systems Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 6 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latin America S.A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VirtualScopics, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Delaware </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BioTel Research, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Delaware </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON HF Corp. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Delaware </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Early Phase Services, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Texas</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Virginia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ClinStar LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nextrials, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates CIS, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Eastern Europe, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addplan, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beacon Bioscience, Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">C4 MedSolutions, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHC Group, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI NewCo,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI Worldwide, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN NORTH AMERICA, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Pharmaceutical Strategies Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Investments, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Tennessee, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON US Holdings Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Consulting, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Group, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MolecularMD Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Parallel 6, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Early Development Research, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Holdings,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Receivables, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PriceSpective LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PubsHub LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Source Healthcare Analytics, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research, LP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Medical Technical Consultants, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roy RPS Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global Holdings,&#160;LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Parent Holding LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunset Hills, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Resource Network, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Illinois</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Christie Clinic, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Illinois</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI International, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- New Jersey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Global, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- New Jersey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Care Strategic Solutions, L.L.C. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- New Jersey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare US Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charlotte, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Hickory, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Raleigh, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Rocky Mount, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Salisbury, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Wilmington, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Winston-Salem, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Healthcare Communications LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Pennsylvania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Publication Solutions, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Pennsylvania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charleston, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- South Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Bristol, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Tennessee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lifetree Clinical Research, LC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Utah</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Government and Public Health Solutions, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Virginia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Mapi Research Trust is an association, its members are ICON Subsidiary entities</span></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_52"></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Description of Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal executive offices are </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">located in South County Business Park, Leopardstown, Dublin, Republic of Ireland, where we own an office facility of approximately 15,000 squ</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are meters. We lease all other properties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain forty-nine offices in Europe; ten of our offices are in the UK, five in the Netherlands, four in each of Germany and Spain, two in each of France, Hungary, Ireland, Poland, Russia, Sweden, Turkey and Ukraine, and one in each of Belarus, Belgium, Bulgaria, Czech Republic, Georgia, Israel, Italy, Latvia, Romania and Slovakia. We maintain thirty-three offices in North America; twenty-nine in the United States, two in Canada and two in Mexico. We have sixteen offices in Asia; five in China (including one in Hong Kong), three in India, two in each of Japan and Singapore, and one in each of South Korea, Taiwan, Thailand and the Philippines. We have two offices in Australia. We have five offices in South America; one in each of Argentina, Brazil, Chile, Colombia and Peru. We maintain one office in South Africa.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4A. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Operating and Financial Review and Prospects.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with our consolidated financial statements, accompanying notes and other financial information, appearing in Item 18. The consolidated financial statements have been prepared in accordance with U.S. GAAP. The information included in the discussion and analysis below provides details on the information for the years ended December&#160;31, 2023 and December&#160;31, 2022. Information related to the year ended December&#160;31, 2021 has not been included. It can be found in the Company's filing of the form 20-F for the year ended December&#160;31, 2022.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a CRO, providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integ</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">rated &#8220;full-service&#8221; solution. At December&#160;31, 2023, we employed approximately 41,100 employees, in 106 locations in 53 countries. During the year ended December&#160;31, 2023 we derived approximately 40.4%, 48.7% and 10.9% of our revenue in the United States, Europe, and the rest of the world, respectively (During the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">December&#160;31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.2%, 46.5% and 7.3% respectively).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue consists of fees earned under contracts with third-party clients. In most cases, a portion of the contract fee is paid at the time the study or trial is started, with the balance of the contract fee generally payable in installments over the study or trial duration, based on the delivery of certain performance targets or milestones. Revenue from long term contracts is recognized on a proportional performance method based on the relationship between cost incurred and the total estimated costs of the trial or on a fee-for-service basis according to the particular circumstances of the contract. As is customary in the CRO industry, we contract with third party investigators in connection with clinical trials. Investigator costs and certain other third party costs are included in our assessment of progress towards completion and costs incurred in measuring revenue. Where these costs are reimbursed by clients, they are included in the total contract value recognized over time, based on our assessment of progress towards completion. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the nature of our business involves the management of projects, the majority of which have a duration of one to four years, the commencement or completion of projects in a fiscal year can have a material impact on revenues earned with the relevant clients in such years. In addition, as we typically work with some, but not all divisions of a client, fluctuations in the number and status of available projects within such divisions can also have a material impact on revenues earned from such clients from year to year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Termination or delay in the performance of an individual contract may occur for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client&#8217;s decision to de-emphasize a particular trial or inadequate patient enrollment or investigator recruitment. In the event of termination the Company is usually entitled to all sums owed for work performed through the notice of termination and certain costs associated with the termination of the study. In addition, contracts generally contain provisions for renegotiation in the event of changes in the scope, nature, duration, or volume of services of the contract.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation comprises our assessment of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2023, we had unsatisfied performance obligations of approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $14.8 billion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.&#160;We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results, due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize the unsatisfied performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we are domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be materially affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to translation exposures, we are also subject to transaction exposures because the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred.&#160;Our operations in the United States are not materially exposed to such currency differences as the majority of our revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts are usually priced in a single currency, most often U.S. Dollars or Euros, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging, due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our currency exposures.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we conduct operations on a global basis, our effective tax rate has depended and will depend on the geographic distribution of our revenue and earnings among locations with varying tax rates. Our results therefore may be affected by changes in the tax rates of the various jurisdictions. In particular, as the geographic mix of our results of operations among various tax jurisdictions changes, our effective tax rate may vary significantly from period to period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;Operating Results</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, certain financial data as a percentage of revenue and the percentage change in these items compared to the prior comparable period. The trends illustrated in the following table may not be indicative of future results.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 to 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage<br/>Increase/(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Year ended December&#160;31, 2023 compared to year ended December&#160;31, 2022</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.739%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue for the year ended December&#160;31, 2023 increased by $378.8 million, or 4.9%, to $8,120.2 million, compared to $7,741.4 million for the year ended December&#160;31, 2022. Revenue increased by 4.6% in constant currency terms. The increase in revenues in the year ended December&#160;31, 2023 is due to the continued organic growth across the Company's markets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023 the Company derived approximately 40.4%, 48.7% and 10.9% of our revenue in the United States, Europe and Rest of World respectively. Revenues from our top five customers amounted to $2,174.8 million in the year ended December&#160;31, 2023 compared to $2,189.6 million in the year ended December&#160;31, 2022 or 26.8% and 28.3% respectively.  New customer accounts are continually added across the full portfolio of large pharma customer, mid-tier pharma customers and biotech customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in Ireland increased by $392.5 million in the year ended December&#160;31, 2023, to $2,377.1 million, compared to $1,984.6 million for the year ended December&#160;31, 2022.&#160;Revenue in Ireland during the year ended December&#160;31, 2023 increased by 19.8% compared to an overall increase in Group revenue of 4.9%.&#160;Revenue in Ireland is principally a function of our global contracting model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in the Rest of Europe decreased by $43.6 million or 2.7%, to $1,574.8 million, compared to $1,618.4 million for the year ended December&#160;31, 2022. Revenue in the U.S. decreased by $290.8 million or 8.1%, to $3,283.8 million, compared to $3,574.6 million for the year ended December&#160;31, 2022. Revenue in our Rest of World (&#8216;Other&#8217;) region increased by $320.6 million or 56.9%, to $884.5 million, compared to $563.9 million for the year ended December&#160;31, 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,719,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,527,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs for the year ended December&#160;31, 2023 increased by $192.9 million, or 3.5%, to $5,719.9 million, compared to $5,527.0 million for the year ended December&#160;31, 2022. Direct costs consist primarily of investigator and other reimbursable costs, compensation, associated fringe benefits and share based compensation expense for project-related employees and other direct project driven costs. The increase in direct costs arose due to an increase in personnel related costs, laboratory costs, travel and other direct project driven costs. This was offset by a decrease in third party investigator and other reimbursable costs in the year. As a percentage of revenue, direct costs have decreased to 70.4% of revenue during the year ended December&#160;31, 2023 compared to 71.4% for the year ended December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">768,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year ended December&#160;31, 2023 decreased by $10.2 million, or 1.3%, to $768.6 million, compared to $778.8 million for the year ended December&#160;31, 2022. Selling, general and administrative expenses comprise primarily of compensation, related fringe benefits and routine share based compensation expense for non-project-related employees, recruitment expenditures, professional service costs, advertising costs and all costs related to facilities and information systems. As a percentage of revenue, selling, general and administrative expenses decreased to 9.4% of revenue during the year ended December&#160;31, 2023, compared to 10.0% of  revenue for the year ended December&#160;31, 2022. The decrease in costs for the year ended December&#160;31, 2023 primarily reflects decreases in general overhead, personnel costs, share compensation expense and marketing costs offset by movements in professional fees, foreign exchange and facilities costs. Further the Company recorded a gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$6.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> related to the Oncacare acquisition during the year ended December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:51.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation expense for the year increased by $19.7 million or 18.5%, to $126.1 million, compared to $106.4 million for the year ended December&#160;31, 2022. The depreciation charge reflects the investments in facilities, information systems and equipment supporting the Company&#8217;s continued growth. As a percentage of revenue, the depreciation expense increased to 1.6% of revenues, for the year ended December&#160;31, 2023 compared to 1.4% for the year December&#160;31, 2022.&#160;The increase in the depreciation charge for the years ended December&#160;31, 2023 is due to the increase in our depreciable asset base and additional spend related to computer hardware and software. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense for the year ended December&#160;31, 2023 decreased by $3.2 million or 0.7%, to $459.9 million, compared to $463.1 million for the year ended December&#160;31, 2022. The amortization expense represents the amortization of intangible assets acquired in connection with business combinations. As a percentage of revenue, the amortization expense decreased to 5.7% for the year ended December&#160;31, 2023, compared to 6.0% of revenue for the year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, transaction and integration-related expenses associated with the Merger</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:51.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company incurred $89.6 million for restructuring, transaction and integration-related expenses. The charge includes transaction and integration costs of $44.2 million associated with professional fees, retention agreements and ongoing integration activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has also undertaken a restructuring program aimed at realigning its workforce as well as reviewing its global office footprint and optimizing its locations to best fit the requirements of the Company. This program has resulted in a charge of $45.4 million in the year ended December&#160;31, 2023. In the year ended December&#160;31, 2022, a restructuring charge of $31.1 million was recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to incur some additional expenses associated with the Merger; however, the timing and the amount of these expenses depends on various factors including the execution of integration activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income from operations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations increased by $160.9 million, or 20.2%, to $956.2 million, compared to $795.2 million for the year ended December&#160;31, 2022. As a percentage of revenue, income from operations increased to 11.8% of revenues compared to 10.3% of revenues for year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations in Ireland increased to $432.0 million compared to $218.1 million for the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the Rest of Europe region, income from operations decreased to $153.5 million compared to $253.8 million for the year ended December&#160;31, 2022. As a percentage of  revenue, income from operations in the Rest of Europe region decreased to 9.7% compared to 15.7% for the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the U.S. region, income from operations increased by $55.5 million, to $310.3 million, compared to $254.8 million for the year ended December&#160;31, 2022. As a percentage of revenue, income from operations in the U.S. region increased to 9.5% compared to 7.1% for the year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In other regions, income from operations decreased by $8.2 million to $60.3 million compared to $68.5 million for the year ended December&#160;31, 2022. As percentage of  revenue, income from operations in the other regions decreased to 6.8% compared to 12.1% for the year ended December&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest income and expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:35.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,014&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(336,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense increased to $336.7 million compared to $229.7 million for the year ended December&#160;31, 2022. The increase in the year reflects the impact of rising interest rates incurred on the Company's debt facilities, notwithstanding significant repayments of the Company's loan facilities. Interest income for the year ended December&#160;31, 2023 increased to $5.0 million, compared to $2.3 million for the year ended December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:35.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Provision for income taxes for the year decreased to $11.7 million compared to $59.4 million for the year ended December&#160;31, 2022.&#160;The Company&#8217;s effective tax rate for the year ended December&#160;31, 2023 was 1.9%&#160;compared to 10.5% for the year ended December&#160;31, 2022 primarily due to the release of significant unrecognized tax benefits acquired in connection with the Merger which was partially offset by a deferred tax provision on unrepatriated earnings. With the exception of the foregoing, the Company&#8217;s effective tax rate remains principally a function of the distribution of pre-tax profits amongst the territories in which it operates.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B. &#160;&#160;&#160;&#160;Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is generally not capital intensive. The Group&#8217;s principal operating cash needs are payment of salaries, office rents, travel expenditures and payments to investigators. Investing activities primarily reflect capital expenditures for facilities and information systems enhancements, the purchase and sale of short term investments and acquisitions. Financing activities primarily reflect the servicing of the Company's external debt.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clinical research and development contracts are generally fixed price with some variable components and range in duration from a few weeks to several years. Revenue from contracts is generally recognized as income on the basis of the relationship between costs incurred and the total estimated contract costs. The cash flow from contracts typically consists of a small down payment at the time the contract is entered into, with the balance paid in installments over the contract duration, in some cases on the achievement of certain milestones. Therefore, cash receipts do not correspond to costs incurred and revenue recognized on contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash and cash equivalents and net borrowings</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Drawn<br/>down)/<br/>repaid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash inflow/</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(outflow)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other non-cash adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of exchange rates</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">dollars in thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">288,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities &amp; Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,654,187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">895,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,775,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash and cash equivalents and borrowings </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4,363,706)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">895,000</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">90,572</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(997)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3,395,533)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents and available for sale investments at December&#160;31, 2023 amounted to $380.1 million compared with cash and available for sale investments of $290.5 million at December&#160;31, 2022.&#160;The Company&#8217;s cash and cash equivalents and available for sale investments at December&#160;31, 2023 comprised cash and cash equivalents of $378.1 million and available for sale investments of $2.0 million. The Company&#8217;s cash and available for sale investments at December&#160;31, 2022 comprised cash and cash equivalents of $288.8 million and available for sale investments of $1.7 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger").  In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The Senior Secured Credit Facility and Senior Secured Notes were issued at a discount of $27.6 million. On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the applicable margin is 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. As at December&#160;31, 2023, $445.0&#160;million remained undrawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Borrowers (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers' and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2023 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $7.9&#160;million (December&#160;31, 2022: $7.8&#160;million)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2023, the Company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">drew down $370.0&#160;million (December&#160;31, 2022: $75.0&#160;million) of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">senior secured revolving loan facility and repaid $315.0&#160;million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2022: $75.0&#160;million ) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">as shown below. As at December&#160;31, 2023, $55 million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2022: $nil) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">was drawn under the senior secured revolving loan facility in addition to $3.7&#160;million (December&#160;31, 2022: $4.5&#160;million) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">in letters of credit given to landlords to guarantee lease arrangements.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has contractual liabilities for lease arrangements of $176.9&#160;million which will be predominantly settled over the next five year period through cash payments.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash from operating activities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Net cash provided by operating activities increased by $597.7 million to $1,161.0 million for the year ended December&#160;31, 2023 as compared to net cash provided by operating activities of $563.3 million for the year ended December&#160;31, 2022. The increase in net cash provided by operating activities of $597.7&#160;million is primarily due to an increase in underlying operating activity and improved working capital management. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Investments in net receivables (accounts receivable, unbilled services and unearned revenue) improved by $93.8&#160;million during the 12 months ended December&#160;31, 2023 reducing from $1,181.6&#160;million at December&#160;31, 2022 to $1,087.8&#160;million at December&#160;31, 2023. The days&#8217; revenue outstanding at December&#160;31, 2023 was&#160;47 days compared to 54 days at December&#160;31, 2022. A decrease in the number of days&#8217; revenue outstanding during a period will result in cash inflows to the Company while an increase in days revenue outstanding will lead to cash outflows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Cash generated from working capital and days&#8217; revenue outstanding may be positively or negatively impacted by, amongst others, the scheduling of contractual milestones over a study or trial duration, the achievement of a particular milestone during the period, the timing of receipt of invoices from third parties for reimbursable costs and the timing of cash receipts from customers. Contract fees are generally payable in installments based on the achievement of certain performance targets or &#8220;milestones&#8221; (e.g. target patient enrollment rates, clinical testing sites initiated or case report forms completed), such milestones being specific to the terms of each individual contract, while revenues on contracts are recognized as contractual obligations are performed.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash used in investing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net cash used in investing activities was $226.7 million for the year ended December&#160;31, 2023 compared to net cash used in investing activities of $145.9 million for the year ended December&#160;31, 2022. Net cash used in investing activities for the year ended December&#160;31, 2023 was primarily related to cash outflows of $140.7 million for capital expenditures made mainly relating to investment in facilities and IT infrastructure, $71.8 million in relation to acquisition of BioTel Research LLC and the majority investor's 51% voting share capital of Oncacare Limited, net of cash acquired, and $14.0 million in relation to investments in long-term equity. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash used in financing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net cash used in financing activities amounted to $844.0 million for the year ended December&#160;31, 2023 compared with net cash used in financing activities of $864.2 million for the year ended December&#160;31, 2022. In the year ended December&#160;31, 2023, the Company made a net repayment of $895.0 million on external financing. This was offset by $51.0 million received by the Company from the exercise of share options. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash inflow</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of these cash flows, cash and cash equivalents increased by $89.3 million for the year ended December&#160;31, 2023 compared to a decrease of $463.4 million for the year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C. &#160;&#160;&#160;&#160;Research and development, patents and licenses</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plays a critical role in new drug development by undertaking activities in each of the different stages of the drug development process. Clinical trials result in an advancement in the field of medical science as they establish the safety and efficacy of new drugs, thus resolving scientific uncertainty. As one of a number of world leaders in clinical research and commercialization, ICON is a trusted partner for pharmaceutical and medical device companies in helping them to accelerate the development of drugs and devices that save lives and improve the quality of life. ICON's role in ensuring that the trial design is scientifically valid is a crucial part of the design and involves scientists, medical doctors and biostatisticians. ICON works with the sponsors in designing the conduct of the clinical research trial. ICON's role of conducting clinical trials is an integral part of the research and development process leading ultimately to a decision as to whether or not each drug is safe for human consumption, has the desired effect on targeted diseases and the best means of delivering that drug to the patient. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D. &#160;&#160;&#160;&#160;Trend information</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, or commitments or events since December&#160;31, 2023 that are reasonably likely to have a material adverse effect on our revenues, income, profitability, liquidity or capital resources, or that would cause the reported financial information in this annual report to be not necessarily indicative of future operating results or financial conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E. &#160;&#160;&#160;&#160;Critical Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 2 to the audited consolidated financial statements provided elsewhere in this Form 20-F describes the significant accounting policies used in the preparation of the consolidated financial statements. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the period.  We base our estimates and judgments on historical experience and on the other factors that we believe are reasonable under current circumstances. Actual results may differ from these estimates if these assumptions prove to be incorrect or if conditions develop other than as assumed for the purposes of such estimates. The following is a discussion of the critical accounting estimates and judgments used by management. The application of these critical accounting estimates is discussed with the Audit Committee of the Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition - Clinical Trial Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Clinical trial services are a single performance obligation satisfied over time i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. We have concluded that ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research project. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/reimbursable expenses) adjusted to reflect a realizable contract value. An assessment of the realizable contract value is judgmental in nature. The realizable value assessment is updated at each reporting period, having regard to (i) contract terms and (ii) customer experience.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized on a percentage completion basis as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs (inclusive of third party costs) at each reporting period. Measurement of the progress towards completion involves judgment and estimation. Assessment of completion requires an evaluation of labor and related time cost incurred at the reporting date and third party costs incurred at the reporting date. The assessment of third party costs incurred (principally investigator costs) requires a review of activity performed and recorded by the third party services providers. The timing of payments to third parties in respect of cost incurred reflect invoicing by third parties. The timing difference between the activity performed and receipt of invoices from third parties may result in significant accrued amounts at reporting periods.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assessment of progress towards completion also requires an up to date evaluation of the forecast costs to complete in respect of these projects. Given the long-term nature of the clinical trials, and the complex nature of those trials, the forecast costs to complete (being internal direct costs and costs that will be incurred by third parties (principally investigators)) is judgmental. Forecast time (and related costs) is determined by reference to (i) contract terms and (ii) past experience. Forecast third party costs to complete are determined by project by reference to (i) contract terms and (ii) past experience. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use the acquisition method to account for business combinations, and accordingly, the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree are recorded at their estimated fair values on the date of the acquisition. We use significant judgments, estimates and assumptions in determining the estimated fair value of assets acquired, liabilities assumed and any non-controlling interest. Estimated fair values were based on various valuation methodologies, including an income approach that uses discounted cash flow techniques for acquired customer relationship intangible assets. The aforementioned income methods utilize management's estimates of future operating results and cash flows discounted using a weighted-average cost of capital that reflects market participant assumptions. We have recorded and allocated to our reporting units the excess of the purchase price over the fair value of the net assets acquired, known as goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Goodwill and Long-Lived Assets</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company assesses its goodwill for impairment annually or when events or circumstances indicate a possible impairment. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the Company elects to perform a qualitative assessment, events and circumstances considered for each reporting unit may include: (i) current year results, (ii) financial performance versus management&#8217;s annual and multi-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company may utilize a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income-based fair value methodology requires management's assumptions and judgments regarding economic conditions in the markets in which the Company operates and conditions in the capital markets, many of which are outside of management's control. At the reporting unit level, fair value estimation requires management's assumptions and judgments regarding the effects of overall economic conditions on the specific reporting unit, along with assessment of the reporting unit's strategies and forecasts of future cash flows, terminal growth rates and discount rates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the market-based fair value methodology, judgment may be required in evaluating market multiples and recent transactions. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company completed its most recent annual goodwill impairment testing as of September 30, 2023, a date which is consistent with the prior year. For the years ended December&#160;31, 2023 and 2022, the Company determined that there was no impairment of goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other long lived assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company assesses long-lived assets (such as intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group might not be recoverable. If indicators of impairment are present, we evaluate the carrying value of long-lived asset in relation to estimates of future undiscounted cash flows. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Taxation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Given the global nature of our business and the multiple taxing jurisdictions in which we operate, the determination of the Company&#8217;s provision for income taxes requires significant judgments and estimates, the ultimate tax outcome of which may not be certain.  Although we believe our estimates are reasonable, the final outcome of these matters may be different than those reflected in our historical income tax provisions and accruals.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The provision for income taxes includes federal, state, local and foreign taxes. We apply the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. We account for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and therefore have not provided for deferred taxes in respect of this item. Recognition of deferred income tax assets is based on management&#8217;s belief that it is more likely than not that the income tax benefit associated with certain temporary differences, income tax operating loss, capital loss carryforwards, and income tax credits, would be realized. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. We recognize the effect of income tax positions only if those positions will more likely than not be sustained. We determined the amount of the valuation allowance based, in part, on our assessment of future taxable income and in light of our ongoing income tax strategies. If our estimate of future taxable income or tax strategies changes at any time in the future, we would record an adjustment to our valuation allowance. Recording such an adjustment could have a material effect on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6. Directors, Senior Management and Employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Directors and Senior Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table and accompanying biographies set forth certain information concerning each of ICON plc&#8217;s Directors, officers and other key employees as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;23, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:33.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:55.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler (1)(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan (1)(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (2)(3)(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (2)(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (3)(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (3)(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diarmaid Cunningham</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Administrative Officer, General Counsel &amp; Company Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Named Executive Officer of the Company.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Compensation and Organization Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Audit Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Nominating, Sustainability and Governance Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Execution Committee.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ciaran Murray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray graduated with a Bachelor of Commerce degree from University College Dublin in 1982. Mr. Murray subsequently qualified as a chartered accountant with PwC.&#160;Following qualification, Mr. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Murray gained extensive global experience working as an executive in the fast moving consumer goods and technology sectors in Ireland, Italy, the UK and the US.&#160;Mr. Murray has been the Chair of ICON plc since March 2017 and an outside Director since May 2018. Mr. Murray served as Chief Executive Officer from October 2011 until March 2017 and was Chief Financial Officer from joining ICON plc in 2005 until his appointment as Chief Executive Officer in 2011.&#160;During his time with ICON plc, Mr. Murray was recognized for his leadership of ICON and the CRO industry.&#160; Mr. Murray served as Chair of the Association of Clinical Research Organizations (ACRO) which represents the CRO industry globally. In addition, Mr. Murray was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the bio pharma industry.&#160;University College Dublin awarded Mr. Murray an honorary degree of Doctor of Laws in 2013 for his support of third level research and innovation in Ireland. In 2018, the Royal Dublin Society awarded Mr. Murray the RDS Gold Medal for Enterprise for making an exceptional impact on Irish industry and commerce. Mr. Murray is also a member of the advisory Board of UCD Smurfit Business School. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017, having previously served as Chief Operating Officer from January 2014. Dr. Cutler served as Group President of Clinical Research Services since November 2011 until his appointment as Chief Operating Officer.&#160;Dr. Cutler was appointed to the Board of ICON plc in November 2015. Prior to joining the Company, Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer.&#160;Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe, as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. Dr. Cutler holds a B.Sc. and a Ph.D. from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Brendan Brennan</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan has served as Chief Financial Officer since February 2012. Mr. Brennan joined ICON in 2006 and he has served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. Prior to this he developed his broad financial experience in Cement Roadstone Holdings, a major Irish building materials organization. Mr. Brennan also spent a number of years in public accounting with PwC. Mr. Brennan is a Fellow of the Institute of Chartered Accountants in Ireland and holds a bachelor&#8217;s degree in Accounting and Finance from Dublin City University. Over his years in the CRO industry, Mr. Brennan has been involved in many industry organizations and developments including ACRO (Association of Clinical Research Organizations) where he was the founding Chairman of the industry CFO round table group, a group formed to aid CROs dealing with the various industry challenges. Mr. Brennan held the position of Chairman&#160;of the round table from its foundation in 2017 to December 31, 2019.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">R&#243;n&#225;n Murphy</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as an outside Director of the Company since October 2016.&#160;He was appointed as Lead Independent Director in January 2019. Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992. Mr. Murphy is presently Chairman of Greencoat Renewables PLC. Mr. Murphy previously served as a council member of the ESRI, as Chair of Business in the Community Ireland and as a non-executive Director of Davy Stockbrokers. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Dr. John Climax</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009 and as Chief Executive Officer from June 1990 to October 2002.&#160;Since January 2010 he has held a position as an outside Director of the Company.&#160;Dr. Climax has over 30 years of experience in the clinical research industry. Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his Ph.D. in pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland and an honorary professorship at the National University of Singapore. He is currently Executive Chairman of DS Biopharma and CEO of Afimmune, both of which are private companies.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Joan Garahy&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ms. Joan Garahy was appointed as an outside Director of ICON plc in November 2017. Ms. Garahy is a Non-Executive Director of Irish Residential Properties REIT plc, IPB Insurance CLG and UNICEF Ireland. Ms. Garahy&#8217;s previous executive roles include founder and CEO of ClearView Investment &amp; Pensions Limited, a financial advisory company, Managing Director of HBCL Investment &amp; Pensions Ltd, Director of Investments at HC Financial Services Group, Head of Research at the Irish National Pension Reserve Fund, Head of Research at Hibernian Investment Managers and her equity analyst roles with Goodbody Stockbrokers and NCB Group. Ms. Garahy was also previously Senior Independent Non-Executive Director of Kerry Group plc, a Non-Executive Director of Harvest Financial Services Ltd and a Non-Executive director at Galway University Foundation and The Irish Chamber Orchestra. Ms. Garahy is a Qualified Financial Advisor, she holds a Bachelor of Science degree from University College Galway, a Master of Science from University College Dublin and a Diploma in Accounting &amp; Finance from ACCA.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Eugene McCague</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague was appointed as an outside Director of the Company in October 2017. Mr. McCague was a corporate partner of Arthur Cox, one of Ireland&#8217;s premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and chairman of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations. Mr. McCague currently serves on the board of the Irish branch of AON Insurance and he also serves as chairman of Ibec, Ireland&#8217;s leading business representative association. Mr. McCague&#8217;s previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, chairman of the governing body of the Dublin Institute of Technology, chairman of the Dublin Institute of Technology Foundation and chairman of the governing authority of University College Dublin and director of Fly Leasing Limited. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006. Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin.&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Julie O&#8217;Neill</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O&#8217;Neill has served as an outside Director of ICON plc since July 2019. Ms. O&#8217;Neill was formerly Executive Vice President, Global Operations of Alexion Pharmaceuticals, Inc., where she was responsible for global manufacturing operations and expanding and improving supply chain and quality operations in the US, Europe, and Asia. Before joining Alexion, Ms. O&#8217;Neill was Vice President of Operations and General Manager for Ireland at Gilead Sciences and earlier in her career, Ms. O'Neill held leadership positions in operations, manufacturing and quality functions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. Ms. O&#8217;Neill serves as a Board Member of DBV Technologies, Hookipa Pharma Inc., ILC Dover, Achilles Therapeutics plc and Advancion (formerly Angus Chemical Company). She also chairs the board of Ireland&#8217;s National Institute for Bioprocessing Research and Training. Ms. O&#8217;Neill holds a Bachelor of Science in Pharmacy from Trinity College Dublin, a Masters of Business Administration from University College Dublin and is a Chartered Director of The Institute of Directors in Ireland. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as an outside Director of ICON plc since July 2021 having previously served as a member of the PRA Health Sciences board from October 2015 to July 2021. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc. from June 2012 to December 2017. Prior to her employment by Ocera, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich &amp; Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Corvus Pharmaceuticals and Arca Biopharma, Inc., sits on the compensation and audit committees of Arca Biopharma, Inc and the audit committee of Corvus Pharmaceuticals. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Diarmaid Cunningham</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel and Company Secretary. Mr. Cunningham joined the Company as General Counsel in November 2009.  From 2009 until 2013, Mr. Cunningham was based in the Company&#8217;s global headquarters in Dublin.  In 2013, Mr. Cunningham was seconded to the Company&#8217;s US headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin. In July 2016, Mr. Cunningham&#8217;s role expanded to include Chief Administrative Officer in addition to General Counsel which added responsibility for the Company&#8217;s Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company&#8217;s Legal group. In 2023, Symphony Health (ICON's data business) moved to report to Mr. Cunningham and was also added to his group. Mr. Cunningham graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997, qualified as a lawyer in 2001 and completed the Stanford Executive Program at Stanford University in California in 2015.  Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013, 2014, 2020 and 2021. ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups. Prior to joining the Company, Mr. Cunningham spent 10 years with A&amp;L Goodbody, one of Ireland's premier corporate law firms. In January 2021, Mr. Cunningham was appointed as a non-executive director of the Irish charity The Jack &amp; Jill Foundation. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Board Diversity Matrix</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:34.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board Diversity Matrix</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">February 23, 2024</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">February 24, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Number of Directors</span></td><td colspan="6" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="6" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part I: Gender Identity</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Male</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Male</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part II: Demographic Background</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LGBTQ+</span></td><td colspan="6" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="6" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Did Not Disclose Demographic Background</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Compensation Discussion &amp; Analysis </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Remuneration policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Organization Committee seeks to achieve the following goals with the Company&#8217;s executive compensation programs: to attract, motivate and retain key executives and to reward executives for value creation. The Committee seeks to foster a performance-oriented environment by ensuring that a significant portion of each executive&#8217;s cash and equity compensation is based on the achievement of performance targets that are important to the Company, its shareholders and other stakeholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executive compensation program has three main elements: base salary, a bonus plan and equity incentives in the form of share related awards granted under the Company&#8217;s equity incentive plans. All elements of key executives&#8217; compensation are determined by the Compensation and Organization Committee based on the achievement of the Group&#8217;s and individual performance objectives. Base salary, bonus awards and Directors&#8217; fees were determined by the Compensation and Organization Committee in U.S. dollars, euro or British pound sterling.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outside Directors&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are remunerated by way of Directors&#8217; fees and are also eligible for participation in the share equity incentive schemes. During 2023, each outside Director (excluding the Board Chairman) was paid an annual retainer of $90,000 and additional fees for Board Committee service. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Murray&#8217;s Executive Chairman term expired on May 12, 2018 and he transitioned to the outside Director role of Chair. The current arrangement with the Chair provides for payment of &#8364;330,000 (translated at average rate for the year: $356,235) annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019 and receives an additional annual fee of $40,000 for this role.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are not eligible for performance related bonuses and no pension contributions are made on their behalf. The Compensation and Organization Committee sets outside Directors' remuneration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Executive Directors&#8217; and Key Executive Officers&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash compensation is divided into a base salary portion and a bonus incentive portion. The Committee targets total cash compensation with regard to healthcare/biopharmaceutical companies of similar market capitalization and peer CRO companies, adjusted upward or downward based on individual performance and experience and level of responsibility. The Compensation and Organization Committee believes that the higher the executive&#8217;s level of responsibility within the Company, the greater the percentage of the executive&#8217;s compensation that should be tied to the Company&#8217;s performance. Target bonus incentive for executive officers range between 75% and 125% of salary, with actual pay outs for 2023 ranging from 64% to 100%, of salary, based on Group and individual performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A total bonus of $1.6&#160;million was awarded to the following individuals; Dr. Steve Cutler Chief Executive Officer ($1.2&#160;million) and Mr. Brendan Brennan Chief Financial Officer ($0.4&#160;million) to reflect their contribution to the performance of the Company during 2023.&#160;These amounts were approved by the Compensation and Organization Committee and will be paid during the year ended December 31, 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executives are eligible to receive equity incentives, including stock options, Restricted Share Units and Performance Share Units, granted under the Company&#8217;s equity incentive plans. If executives receive equity incentive grants, they are normally approved annually at the first scheduled meeting of the Committee in the fiscal year. The grant date and value is determined by the Committee and the number of units granted is determined based on the closing price of the Company's shares on the day of grant. Newly hired executives may receive sign-on grants. In addition, the Committee may, at its discretion, issue additional equity incentive awards to executives if the Committee determines such awards are necessary to ensure appropriate incentives are in place. The equity awards granted to each participant are determined by the Committee at the start of each year based on peer group data, advice from independent compensation consultants, and Committee judgment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2023, Performance Share Units (&#8220;PSUs&#8221;) which were awarded subject to vesting in 2020 vested for Dr. Steve Cutler Chief Executive Officer in the amount of 22,404 from a potential grant of 22,404. The percentage granted reflects service and the Company's achievements of diluted non GAAP specified EPS targets over the three year period from 2020 - 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2023, Performance Share Units (&#8220;PSUs&#8221;) which were awarded subject to vesting in 2020 vested for Mr. Brendan Brennan Chief Financial Officer in the amount of 4,850 from a potential grant of 4,850. The percentage granted reflects service and the Company's achievements of diluted non GAAP specified EPS targets over the three year period from 2020 - 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All executive officers are eligible to participate in applicable pension plans. The Company&#8217;s contributions are generally a fixed percentage of their annual compensation, supplementing contributions by the executive. The Company has the discretion to make additional contributions if deemed appropriate by the Committee. The Company&#8217;s contributions are determined at the peer group median of comparable Irish companies and peer CRO companies. Contributions to this plan are recorded as an expense in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Third party Agreements and Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has not identified any arrangements or agreements relating to compensation or other payments provided by a third party to ICON&#8217;s directors or director nominees in connection with their candidacy or board service as required to be disclosed pursuant to NASDAQ Rule&#160;5250(b)(3).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2023</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.380%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension<br/>contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">62</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,646</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,306</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2022</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary </span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension<br/>contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,724</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,515</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">195</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,495</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,132</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,671</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director Compensation</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2023</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:19.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>Compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Climax</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linda Grais</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,191</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,228</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,544</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,813</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-right:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2022</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:19.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary </span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>Compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hugh Brady*</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Climax</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William Hall*</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast*</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colin Shannon**</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linda Grais</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,204</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,497</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,140</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,354</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,991</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Professor Hugh Brady, Professor William Hall and Ms. Mary Pendergast resigned from the Board on July 26, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Mr. Colin Shannon resigned from the Board on December 9, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of Compensation Agreements</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employment Contracts, Termination of Employment and Change in Control Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does not have any termination or change of control agreements with its named executive officers other than as set out below and in the agreements relating to their equity incentives which provide for accelerated vesting on change of control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; and Executive Officers&#8217; service agreements and letters of engagement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following information reflects the agreements in effect as of December&#160;31, 2023.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Ciaran Murray</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray has served as Chair of the Board of Directors since May 2018 having served as Executive Chairman of the Board of Directors from March 2017 until May 2018. Mr. Murray served as Chief Executive Officer of the Company from October 2011 until March 2017. Mr. Murray has served as a Director of the Company since September 2011. He previously served as Chief Financial Officer of the Company from October 2005 until October 2011. Mr. Murray entered into an agreement with the Company in respect of his role as Executive Chairman which was effective from March 2017. Mr. Murray&#8217;s Executive Chairman term expired on May 12, 2018 and he transitioned to Chair.  The current arrangement with Mr. Murray provides for the payment to him of fees of  &#8364;330,000 (translated at average rate for the year: $356,235) per annum in respect of his position as Chairman. His previous service agreement as Executive Chairman included termination provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions which still apply. As Chief Financial Officer, Chief Executive and Executive Chairman, Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units. The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018 were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018. He was previously granted and held at February&#160;23, 2024 1,389 Restricted Share Units, which vest in May 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler has served as Chief Executive Officer since March 2017 having served as Chief Operating Officer of the Company from January 2014 until March 2017. Prior to his appointment as Chief Operating Officer he served as Group President Clinical Research Services since November 2011. He has served as an Executive Director of the Company since November 2015. The Chief Executive Officer service agreement with Dr. Cutler is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Dr. Cutler is entitled to receive an annual salary of $1,196,716 effective from April 1, 2023 and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">contribution, a car allowance of $12,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February&#160;23, 2024 222,001 ordinary share options at exercise prices ranging from $83.47 to $233.88 per share, 18,146 Restricted Share Units which vest on various dates between March 2024 and March 2026 and 31,594 (up to a maximum of 63,188) Performance Share Units which vest between March 2024 and March 2026 subject to the fulfillment of certain performance conditions. His Chief Executive Officer service agreement requires him to devote his full time and attention </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to his duties for the Company excepting certain outside director positions authorized by the Company. The agreement with Dr. Cutler includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions. Dr. Cutler has a separate agreement with the Company in respect to his role as a director of ICON plc. Under the terms of this agreement he is entitled to receive an annual fee of $44,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Brendan Brennan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan has served as Chief Financial Officer since February 2012 having previously served as acting Chief Financial Officer since October 2011.&#160;Prior to this appointment, he served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. The service agreement with Mr. Brennan is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Mr. Brennan is entitled to receive an annual </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">salary of $591,558 (&#8364;547,993) effective from April 1, 2023 and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension contribution, a car allowance of &#8364;20,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February&#160;23, 2024 32,952 ordinary share options at exercise prices ranging from $140.38 to $233.88 per share, 3,758 Restricted Share Units, which vest on various dates between March 2024 and March 2026, and 6,739 (up to a maximum of 13,478) Performance Share Units which vest between March 2024 and March 2026 subject to the fulfillment of certain performance conditions. His service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside Director positions authorized by the Board. The agreement with Mr. Bre</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nnan includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as Lead Independent Director from January 2019 having served as an outside Director of the Company since October 2016. The current arrangements with Mr. Murphy provide for the payment to him of Directors fees of $162,500 per annum. He was previously granted and held at February&#160;23, 2024 8,084 ordinary share options at an exercise prices ranging from $90.03 to $125.74 and 926 Restricted Share Units, which vest in May 2024.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. John Climax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009. He also served as Chief Executive Officer of the Company from June 1990 to October 2002 and is currently an outside Director of the Company. The current arrangements with Dr. Climax provide for the payment to him of Directors fees of $90,000 per annum. He was previously granted and held at February&#160;23, 2024 23,255 ordinary share options at exercise prices ranging from $65.60 to $125.74 per share and 926 Restricted Share Units, which vest in May 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Joan Garahy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Joan Garahy has served as an outside Director of the Company since November 2017. The current arrangements with Ms. Garahy provide for the payment to her of Directors fees of $122,500 per annum. She was previously granted and held at February&#160;23, 2024 5,005 ordinary share options at an exercise price of $125.74 and 926 Restricted Share Units, which vest in May 2024.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Eugene McCague</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has served as an outside Director of the Company since October 2017. The current arrangements with Mr. McCague provide for the payment to him of Directors fees of $122,500 per annum. He was previously granted and held at February&#160;23, 2024 5,005 ordinary share options at an exercise price of $125.74 and 926 Restricted Share Units, which vest in May 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Julie O'Neill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O'Neill has served as an outside Director of the Company since July 2019. The current arrangements with Ms. O'Neill provide for the payment to her of Directors fees of $115,000 per annum. She was previously granted and held at February&#160;23, 2024 926 Restricted Share Units, which vest in May 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as an outside Director of the Company since July 2021 having served as a member of the PRA Health Sciences, Inc. board since October 2015. The current arrangements with Dr. Grais provide for the payment to her of Director fees of $102,500 per annum. She was previously granted and held at February&#160;23, 2024 926 Restricted Share Units, which vest in May 2024. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Board Practices</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board of Directors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The business of the Company is managed by the Directors who may exercise all the powers of the Company which are not required by the Companies Act 2014 of Ireland or by the Constitution of the Company to be exercised by the Company in general meeting.  A meeting of Directors, at which a quorum is present, may exercise all powers exercisable by the Directors. The Directors may delegate (with power to sub-delegate) to any Director holding any executive office and to any Committee consisting of one or more Directors, together with such other persons as may be appointed to such Committee by the Directors, provided that a majority of the members of each Committee appointed by the Directors shall at all times consist of Directors and that no resolution of any such Committee shall be effective unless two of the members of the Committee present at the meeting at which it was passed are Directors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board comprises one executive and seven outside Directors at the date of this report.&#160;The outside Directors bring independent judgment to bear on issues of strategy, performance, resources, key appointments and standards.&#160;The Company considers all of its outside Directors to be of complementary skills, experience and knowledge and each outside Director has specific skills, experience and knowledge that are valuable to the Company. The Board members between them have strong financial, pharmaceutical, CRO, scientific, medical and other skills and knowledge which are harnessed to address the challenges facing the Group. The Board meets regularly throughout the year and all Directors have full and timely access to the information necessary for them to discharge their duties. The Directors have access to the advice and services of the Company Secretary and may seek external independent professional advice where required. The Board considers its current size (8 Directors) to be adequate but continues to look for suitable qualified potential candidates to join the Board.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As set out below, certain other matters are delegated to Board Committees and all Board Committees report to the Board. The Company maintains what it considers an appropriate level of insurance cover in respect of legal action against its Directors. The Board, through the Nominating, Sustainability and Governance Committee, engages in succession planning for the Board and in so doing considers the strength and depth of the Board and the levels of knowledge, skills and experience of the Directors necessary for the Company to achieve its objectives. The Board meets at least four times each year. During the year ended December&#160;31, 2023 the Board held five board meetings. All Directors allocated sufficient time to the Company during the year ended December&#160;31, 2023 to effectively discharge their responsibilities to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; retirement and re-election</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company&#8217;s Constitution provides that, unless otherwise determined by the Company at a general meeting, the number of Directors shall not be more than 15 nor less than 3. The Constitution also provides that one third of the Directors who are subject to retirement by rotation, rounded down to the next whole number if it is a fractional number, shall retire from office at each annual general meeting. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Board of Directors adopted a Non-Executive Director Policy for Service on April 24, 2018. The Policy was amended on April 21, 2020 and provides that, subject to individual waiver by the Board, an outside Director of ICON plc shall serve on the Board of the Directors for an initial term which expires at the fourth annual general meeting after their appointment. Each outside director may serve a further term of 3 years, subject to the Board&#8217;s approval. After the second 3 year term the Board may request that the outside Director serve up to 3 further terms of 1 year each. After a third 1 year term the Board may request that the outside director serve for further 1 year terms in the event that the Board has particular requirement or desire for the outside director&#8217;s skill, knowledge or experience. For an outside Director who previously served as an executive of the Company, the initial 3 year term referred to in this policy is deemed to commence on the date that he/she is determined to be independent as per the NASDAQ Rules. This policy does not apply to Dr. John Climax as he is a founder of the Company.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at the Annual General Meeting (AGM). Accordingly, at the AGM of the Company held in 2023, all directors retired and offered themselves for re-election and the same approach will be followed for 2024.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Lead Independent Director </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors adopted a Lead Independent Director Charter on February 14, 2017 which provides that in circumstances where the Chairman of the Board is not independent, the independent members of the Board of Directors shall appoint, from among their number, a Lead Independent Director. The Lead Independent Director shall generally assist in optimizing the effectiveness and independence of the Board of Directors by performing such duties as described in the charter, on behalf of the Board of Directors, including coordinating the meetings of the other non-employee and independent directors, and such other duties as determined from time to time by the Board of Directors and/or its independent members. Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board Committees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Board has delegated some of its responsibilities to Board Committees. There are currently four Committees. These are the Audit Committee, the Compensation and Organization Committee, the Nominating, Sustainability and Governance Committee and the Execution Committee. Each Committee has been charged with specific responsibilities and each has written terms of reference that are reviewed periodically. Minutes of Committee meetings are available to all members of the Board. The Company Secretary is available to act as secretary to each of the Board Committees if required. Appropriate key executives are regularly invited to attend meetings of the Board Committees. The Audit Committee, Compensation and Organization Committee and Nominating, Sustainability and Governance Committee each completed a self-evaluation of the performance of the Committee in respect to the year ended December 31, 2022 and each Committee was satisfied with their performance. The evaluations in respect to the year ended December&#160;31, 2023 will be completed in 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee meets a minimum of four times a year. It reviews the quarterly and annual financial statements, the effectiveness of the system of internal control and recommends the appointment and removal of the external auditors. It monitors the adequacy of internal accounting practices and addresses all issues raised and recommendations made by the external auditors.  The Audit Committee pre-approves all audit and non-audit services provided to the Company by its external auditors on a quarterly basis. The Audit Committee, on a case by case basis, may approve additional services not covered by the quarterly pre-approval, as the need for such services arises. The Audit Committee reviews all services which are provided by the external auditor to review the independence and objectivity of the external auditor, taking into consideration relevant professional and regulatory requirements. The Chief Financial Officer, the Head of Internal Audit, the Chief Administrative Officer and General Counsel and the external auditors normally attend all meetings of the Audit Committee and have direct access to the Committee Chairperson at all times. The Audit Committee Charter was updated in February 2024 to include specific responsibilities in respect to the oversight and monitoring of the external reporting on environmental, social and governance (ESG) matters included in the financial statements and data quality related to such reporting in coordination with the Nominating, Sustainability and Governance Committee. The Audit Committee is currently comprised of three independent Directors: R&#243;n&#225;n Murphy (Chairperson), Eugene McCague and Julie O'Neill. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Organization Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Compensation and Organization Committee is responsible for senior executive remuneration. The Committee aims to ensure that remuneration packages are competitive so that individuals are appropriately rewarded relative to their responsibility, experience and value to the Company.  Annual bonuses for the executive Directors and senior executive management are determined by the Committee based on the achievement of the Company&#8217;s objectives. The Committee also oversees succession planning for the Company&#8217;s senior management and also oversees the Company&#8217;s overall compensation strategy and programs which management approve and implement. The Compensation and Organization Committee is currently comprised of the following independent Directors:  Joan Garahy (Chairperson), R&#243;n&#225;n Murphy and Linda Grais. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Nominating, Sustainability and Governance Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Nominating, Sustainability and Governance Committee is responsible for Board succession, oversight of the Board and committee composition and performance and oversight of the Company's corporate governance and business ethics initiatives and strategies and activities in respect to environmental, social and governance (ESG) matters.  The Committee reviews the membership of the Board of the Company and Board Committees on an ongoing basis. As part of this, it regularly evaluates the balance of skills, knowledge, experience and diversity on the Board and then, based on this evaluation, identifies and, if appropriate, recommends individuals to join the Board of the Company.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> In selecting candidates for recommendation to the Board, the Committee makes proposals based on merit while seeking to achieve a mix of Board members that enhances the diversity of background, skills and experience on the Board, including with respect to professional skills, relevant industry experience, specialized expertise, international experience, gender, race and ethnicity. When conducting a formal search for new director candidates, the Committee endeavors to include qualified female and racially or ethnically diverse candidates on the initial list of candidates from which new director nominees are chosen. The Committee uses external search consultants as needed to assist it in identifying potential new outside Directors. Any external search consultants engaged to assist in the search shall also be instructed to endeavor to include such candidates on the initial list. Once potential suitable candidates are identified either by the external search consultants or by members of the Nominating, S</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ustainability and Governance Committee, the Committee then discusses and considers the skills, knowledge and experience of the potential candidate. The Committee will assess if the Board of the Company requires and would benefit from the potential candidate&#8217;s skills, knowledge and experience </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">and, if it decides the potential candidate is suitable, the Committee would recommend to the Board of the Company that the potential candidate be appointed. The Board of the Company then decides whether or not to appoint the candidate. The Nominating, Sustainability and Governance Committee currently comprises the following independent Directors: Eugene McCague (Chairperson), Joan Garahy and Julie O'Neill. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Execution Committee</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The primary function of the Execution Committee is to exercise the powers and authority of the Board in intervals between meetings of the Board within the limits set out in the Charter of the Execution Committee. The Execution Committee exercises business judgment to act in what the Committee members reasonably believe to be in the best interest of the Company and its shareholders. All powers exercised by the Execution Committee are ratified at board meetings. This Committee convenes as often as it determines to be necessary or appropriate. The Execution Committee is currently comprised of the following Directors and Officers: Steve Cutler (Chairperson), R&#243;n&#225;n Murphy and Brendan Brennan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attendance at Board and Committee meetings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Attendance at Board and Committee meetings by the Directors who held office during 2023 are set out as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Directors&#8217; Attendance Table</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit (3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation<br/>and<br/>Organization</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating, Sustainability<br/>and<br/>Governance</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Execution Committee <br/>(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director</span></td><td colspan="15" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of meetings attended / number of meetings eligible to attend as a Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais (1)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Independent Director as defined under NASDAQ Rule 5605(a)(2). </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">All decisions by the Execution Committee were made by written resolution and therefore no meetings were held.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">In addition to these meetings, the Audit Committee of the Company engaged in a competitive audit tender process</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Refer to Item 16F. Changes in Registrant's Certifying Accountant.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%;padding-left:9.01pt">Employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 we employed approximately 41,100, 41,100 and 38,330 people respectively. Our employees are not unionized and we believe we have a satisfactory relationship with our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Share Ownership</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Shares</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;23, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">regarding beneficial ownership of our ordinary shares by all of our current Directors and executive officers. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>Shares (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">449,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Julie O'Neill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in these tables, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e. the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as o</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;23, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> r</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">egarding beneficial ownership of Restricted Share Units (&#8220;RSUs&#8221;) and Performance Share Units (&#8220;PSUs&#8221;) which have been issued to our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>RSUs </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,389</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,354&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy </span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:7.02pt">Of the issued PSUs, performance conditions will determine how many vest. If performance targets are exceeded, additional PSUs will be issued and will vest in accordance with the terms of the relevant PSU award. The PSUs vest based on service and specified EPS targets over the periods 2021 &#8211; 2023, 2022 &#8211; 2024 and 2023 - 2025. Depending on the actual amount of EPS from 2021 to 2025, up to a maximum of 38,333 additional PSUs may also be granted to Dr. Steve Cutler and Mr. Brendan Brennan.</span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as o</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f February&#160;23, 2024 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">regarding options to acquire ordinary shares of the Company by all of our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="7" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$83.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$115.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$231.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2030</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$233.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2031</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$231.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2030</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$233.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2031</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$65.60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 20, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The title of securities covered by all of the above options are non-qualified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or Non-Executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to Non-Executive Directors vest over twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the &#8220;2013 RSU Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan.&#160;On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of ordinary shares that can be issued under the RSU Plan by 2.5 million shares.&#160;Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the &#8220;2008 Employee Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the &#8220;2008 Consultants Plan&#8221;), pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any consultant, adviser or Non-Executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the &#8220;2008 Option Plans&#8221;) were amended and restated in order to increase the number of options&#160;that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan under which a limit of 1.0 million shares applies.&#160;Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans will be a nonqualified stock option, or NSO and not an incentive stock option as described in Section 422&#160;of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however, option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share option awards are granted with an exercise price equal to the market price of the Company&#8217;s shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. Share options granted to Non-Executive Directors during 2018 vest over 12 months and expire eight years from the date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Legacy PRA Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021 as to grants of future awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#8220;the 2020 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#8220;2014 Plan&#8221;). On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Disclosure of a registrant's action to recover erroneously awarded compensation </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 7. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Major Shareholders and Related Party Transactions.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Major Shareholders</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information regarding beneficial ownership of ICON's ordinary shares as of February&#160;23, 2024&#160;(i) by each person that beneficially owns more than 5% of the outstanding ordinary shares, based upon information known to us and publicly available information; and (ii) by all of our current Directors, officers and other key employees as a group. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law. None of the persons listed below have voting rights that differ from any other person listed below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.867%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.390%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 (4)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 (5)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 (6)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or Identity of Group</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">WCM Investment Management (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,869,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,885,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,179,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Massachusetts Financial Services Company (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,532,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,119,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,228,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Directors, officers and other key employees as a group (3)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,129,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in this table, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Neither the Company nor any of its officers, Directors or affiliates holds any voting power in this entity.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes 319,729 ordinary shares issuable upon the exercise of stock options granted by the Company, 31,856 RSUs awarded by the Company to Directors, officers and other key employees and 86,936 PSUs awarded by the Company to Directors, officers and other key employees. Of the PSUs, performance conditions determine how many of them will vest and, if performance targets are exceeded, additional PSUs will be issued and vest in accordance with the terms of the relevant PSU award, the figure included is the maximum amount of PSUs that may be issued.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No. 9 filed with the SEC by WCM Investment Management on January 30, 2024 for shares held on December 31, 2023; and the Schedule 13G, Amendment No. 3, filed with the SEC by Massachusetts Financial Services Company on February 9, 2024 for shares held on December 29, 2023, respectively. </span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No. 8 filed with the SEC by WCM Investment Management on February 10, 2023 for shares held on December 31, 2022; and the Schedule 13G, Amendment No. 2, filed with the SEC by Massachusetts Financial Services Company on February 8, 2023 for shares held on December 30, 2022, respectively.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No.7  filed with the SEC by WCM Investment Management on February 10, 2022 for shares held on December 31, 2021; and the Schedule 13G, Amendment No. 1, filed with the SEC by Massachusetts Financial Services Co on February 2, 2022 for shares held on December 31, 2021, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc, is not directly or indirectly, owned or controlled by another corporation or by any government. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Related Party Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $243,000 (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$428,000) from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder</span><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">of Corvus Pharmaceuticals. $101,000 (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$231,000) was noted as due from Corvus Pharmaceuticals at December&#160;31, 2023. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $45,000 (December&#160;31, 2022: $235,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $47,000 was noted as due from Afimmune Limited at December&#160;31, 2023 (December&#160;31, 2022: $263,000).&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), a specialized oncology site network in the US and EMEA regions, with a third party. The Company invested $4.9&#160;million to obtain a 49% interest in the voting share capital of Oncacare. On April 20, 2023, the Company completed the purchase of the majority investor&#8217;s 51% majority voting share capital of Oncacare. The consideration paid by ICON to purchase the 51% majority voting share capital was $5.1&#160;million. As a result of this transaction (the "Oncacare acquisition"), Oncacare and its subsidiaries became wholly owned subsidiaries of the ICON Group. Prior to the Oncacare acquisition, the Company recorded losses of $0.4&#160;million and $3.1&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023 and December&#160;31, 2022, respectively. The Oncacare acquisition also resulted in goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$13.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and gave rise to an acquisition-related gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$6.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Interests of experts and counsel</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_64"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 8. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Financial Information.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Consolidated Statements and Other Financial Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 18.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We do not expect any current litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Dividend Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have not paid cash dividends on our ordinary shares and do not currently intend to pay cash dividends on our ordinary shares in the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Significant Changes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no significant changes to our business that we believe could reasonably be expected to have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_67"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 9. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; The Offer and Listing.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Offer and listing details</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.&#160;ICON plc&#8217;s American Depositary Receipt ("ADR") program was terminated on January 31, 2013 and ICON plc&#8217;s ordinary shares began directly trading on NASDAQ on February 4, 2013.&#160;Prior to that date, ICON plc&#8217;s American Depositary Shares ("ADSs") were traded on NASDAQ and ICON plc&#8217;s Depository for the ADSs was The Bank of New York Mellon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Plan of distribution</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Markets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Selling shareholders</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Dilution </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Expenses of the issue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> Additional Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Share Capital</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Memorandum and articles of association </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Constitution </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We hereby incorporate by reference our Constitution, as amended, located under the heading &#8220;Constitution of the Company&#8221; in Exhibit 3.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of certain provisions of the current Constitution of the Company. This summary does not purport to be complete and is qualified in its entirety by reference to the complete text of the Constitution of the Company, which are included as an exhibit to this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Objects</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is incorporated under the name ICON&#160;plc, and is registered in Ireland under registered number&#160;145835. The Company's objects, which are detailed in the Constitution of the Company, are broad and include, but are not limited to the carrying on the business of an investment holding company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subject to certain exceptions, Directors may not vote on matters in which they have a material interest. Any Director who holds any executive office, serves on any Committee or otherwise performs services, which, in the opinion of the Directors, are outside the scope of the ordinary duties of a Director, may be paid such extra remuneration as the Directors may determine. The Directors may exercise all the powers of the Company to borrow money. These powers may be amended by special resolution of the shareholders.  There is no requirement for Directors to hold shares set out in the Constitution. The Directors are not required to retire at any particular age. The Constitution provides that one-third of the Directors must retire and offer themselves for re-election at each Annual General Meeting ("AGM") of the Company and that the Directors to retire by rotation are those who have been longest in office since their last appointment or reappointment. However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at each AGM. All of the shareholders entitled to attend and vote at the AGM may vote on the re-election of Directors.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Rights, Preferences and Dividends Attaching to Shares </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Action Necessary to Change the Rights of Shareholders </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Annual and General Meetings</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Limitations on the Right to Own Shares </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no limitations on the right to own shares in the Constitution of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Share Ownership </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Provisions of the Constitution</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no provisions in the Constitution of the Company:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares; or</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Material Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of each contract (not being a contract entered into in the ordinary course of business) that has been entered into: (a) within the two years immediately preceding the date of this Form 20-F which are, or may be, material to us; or (b) at any time which contain obligations or entitlements which is, or may be, material to us as at the date of this Form 20-F:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Agreement and Plan of Merge</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">r</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 24, 2021, we entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with PRA Health Sciences, Inc. (&#8220;PRA&#8221;), ICON US Holdings Inc., a Delaware corporation and subsidiary of ICON (&#8220;US HoldCo&#8221;), and Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON and US HoldCo (&#8220;Merger Subsidiary&#8221;). On July 1, 2021 (the &#8220;Closing Date&#8221;), pursuant to the terms and subject to the conditions of the Merger Agreement, Merger Sub was merged with and into PRA, with PRA surviving as a subsidiary of ICON and US HoldCo.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of the Merger, each share of PRA common stock issued and outstanding immediately prior to the completion of the Merger (other than shares held by any shareholder who properly demands and perfects his, her or its appraisal rights with respect to such shares and treasury shares held by PRA) was canceled and converted into the right to receive: (i) from ICON, 0.4125 of one ICON ordinary share and (ii) from US Holdco and the surviving corporation $80.00 in cash, without interest.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Equity awards of PRA that are outstanding prior to the effective time of the Merger were generally treated as follows (subject to the terms and conditions set forth in the Merger Agreement):</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Each outstanding PRA stock option and restricted stock unit was assumed by ICON on the same terms and conditions (including vesting conditions) and converted to a stock option or restricted stock unit based on ICON ordinary shares with the number of ICON ordinary shares and exercise price in the case of stock options determined at a conversion ratio as set forth under the Merger Agreement; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Each outstanding share of PRA restricted stock was vested at the Closing and was canceled and converted into the right to receive the per share merger consideration.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foregoing description of the Merger and the Merger Agreement, and the related transactions contemplated thereby, does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Merger Agreement which is attached as Exhibit 2.1 to ICON&#8217;s Current Report on Form 6-K filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 24, 2021 and incorporated herein by reference herein.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300 million to $500 million. The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's senior secured notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity.  The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25% (with a step up of 0.25% if the first lien net leverage ratio exceeds 4.00 to 1.00). The senior secured term loan facility is subject to a floor of 0.50%. The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">S&amp;P and Moody's have upgraded the instrument rating of the secured term loan facility of $5,515 million and $500 million senior secured revolving loan facility from BB+ to BBB- and Baa3 to Ba1 in the fourth quarter of 2023. The Borrowers&#8217; (as defined in the Senior Secured Credit Facilities) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all assets of the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. In addition, the revolving credit loan facility contains a financial covenant that requires ICON to maintain a Total Net Leverage Ratio (as defined in the Senior Secured Credit Facilities) of 5.75:1.00 prior to June 30, 2023 and 4.50:1.00 on and after June 30, 2023, subject to a step-down of 0.50:1.00 following a Material Acquisition (as defined in the Senior Secured Credit Facilities), which will be tested at the end of any fiscal quarter only if amounts are drawn under the revolving credit loan facility (excluding cash collateralized and backstopped letters of credit) in excess of 30% of the revolving commitments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities provide that, upon the occurrence of certain events of default, the obligations thereunder may be accelerated. Such events of default will include payment defaults to the lenders thereunder, material inaccuracies of representations and warranties, covenant defaults, cross-defaults to other material indebtedness, voluntary and involuntary bankruptcy proceedings, material money judgments, material pension-plan events, change of control and other customary events of default.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, Indigo Merger Sub, Inc. (which was merged with and into PRA Health Sciences, Inc.) (the &#8220;Issuer&#8221;), a wholly-owned subsidiary of the Company, issued $500.0 million in aggregate principal amount of 2.875% senior secured notes due July 2026 (the &#8220;Senior Secured Notes&#8221;) in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. The Issuer will pay interest on the Senior Secured Notes on January 15 and July 15 of each year. Interest on the Senior Secured Notes will accrue at a rate of 2.875% per annum.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries that guarantee the Senior Secured Credit Facilities. The Senior Secured Notes are secured by a lien on substantially all of ICON&#8217;s, the Issuer&#8217;s and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Notes have a first-priority lien on such assets, which rank pari passu with the liens securing the Senior Secured Credit Facilities, subject to other permitted liens.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At any time prior to July 15, 2023, the Issuer could have redeemed all or part of the Senior Secured Notes at a redemption price equal to 100% of the principal amount of the Senior Secured Notes plus an applicable make whole premium and accrued and unpaid interest to, but not including the redemption date. At any time prior to July 15, 2023, the Issuer could have, with the proceeds of certain equity offerings, redeemed up to 40% of the aggregate principal amount of the Senior Secured Notes at a redemption price of 102.875% of the principal amount plus accrued and unpaid interest to, but not including, the date of redemption. In addition, at any time prior to July 15, 2023, the Issuer could have redeemed up to 10% per annum of the aggregate principal amount of the Senior Secured Notes at a redemption price of 103.000% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. Further, at any time on or after July 15, 2023 to July 14, 2024 the Issuer may redeem all or part of the Senior Secured Notes at a redemption price equal to 101.438% of the principal amount of the Senior Secured Notes plus accrued and unpaid interest to, but not including the redemption date. At any time on or after July 15, 2024 to July 14, 2025 the Issuer may redeem all or part of the Senior Secured Notes at a redemption price equal to 100.719% of the principal amount of the Senior Secured Notes plus accrued and unpaid interest to, but not including the redemption date</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">S&amp;P and Moody's upgraded the instrument rating of the $500 million senior secured notes from BB+ to BBB- and Baa3 to Ba1 in the fourth quarter of 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Indenture contains contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. The Indenture contains customary events of default and remedies. As of December 8, 2023 ICON notified the holders of the Senior Secured Notes of the upgrade of the instrument rating to investment grade and the consequent suspension of certain of the covenants under the Indenture. The suspension of these covenants remains in place so long as the instrument remains at investment grade.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Exchange Controls </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Irish exchange control regulations ceased to apply from and after December 31, 1992. Except as indicated below, there are no restrictions on non-residents of Ireland dealing in domestic securities, which includes shares or depository receipts of Irish companies. Except as indicated below, dividends and redemption proceeds also continue to be freely transferable to non-resident holders of such securities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 gives power to the Minister for Finance of Ireland to make provision for the restriction of financial transfers between Ireland and other countries and persons. Financial transfers are broadly defined, and include all transfers which would be movements of capital or payments within the meaning of the treaties governing the European Communities. The acquisition or disposal of shares issued by an Irish incorporated company and associated payments may fall within this definition. In addition, dividends or payments on redemption or purchase of shares and payments on a liquidation of an Irish incorporated company would fall within this definition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 prohibits financial transfers involving a number of persons, entities and bodies, which is subject to amendment on an ongoing, regular basis and currently includes, but is not limited to: certain persons, entities, bodies and activities in Belarus, Bosnia &amp; Herzegovina, Burundi, Sudan, South Sudan, the Central African Republic, Libya, Lebanon, Mali, the Democratic People's Republic of Korea, Myanmar/Burma, Tunisia, Zimbabwe, Venezuela, Syrian Arab Republic, the Republic of Guinea-Bissau, Nicaragua, Democratic Republic of Congo, Iran, Ukraine and Russia; persons associated with the Taliban, ISIL (Da&#8217;esh) and Al-Qaeda, Turkey&#8217;s unauthorized drilling activities in the Eastern Mediterranean, certain known terrorists and terrorist groups and countries that harbor certain terrorist groups, without the prior permission of the Central Bank of Ireland.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no restrictions under the Company&#8217;s Constitution or under Irish Law that limit the right of non-residents or foreign owners to hold the Company&#8217;s ordinary shares or vote at general meetings of the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Taxation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">        The following discussion is</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> based on existing Irish tax law, Irish court decisions and the practice of the Revenue Commissioners of Ireland, and the convention between the United States and Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to taxes on income and capital gains (the "Treaty"). This discussion does not purport to deal with the tax consequences of owning the ordinary shares for all categories of investors, some of which may be subject to special rules. Prospective purchasers of ordinary shares are advised to consult their own tax advisors concerning the overall tax consequences arising in their own particular situations under Irish law. Each prospective investor should understand that future legislative, administrative and judicial changes could modify the tax consequences described below, possibly with retroactive effect.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As used herein, the term "U.S. Holder" means a beneficial owner of ordinary shares that (i) owns the ordinary shares as capital assets; (ii) for U.S. federal income tax purposes, is an individual who is a U.S. citizen or resident, a U.S. corporation, an estate the income of which is subject to U.S. federal income taxation regardless of its source or a trust that (x) meets the following two tests: (A) a U.S. court is able to exercise primary supervision over the administration of the trust, and (B) one or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">more U.S. persons have the authority to control all substantial decisions of the trust, or (y) has elected to be treated as a U.S. person for federal income tax purposes; and for the purpose of the discussion under Irish Taxation of U.S. Holders (A) is not a resident of, or ordinarily resident in, Ireland for the purposes of Irish tax; and (B) is not engaged in trade or business in Ireland through a permanent establishment.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">AS USED HEREIN, REFERENCES TO THE ORDINARY SHARES SHALL INCLUDE SHARES HELD IN THE ACCOUNTS OF PARTICIPANTS THROUGH THE DEPOSITARY TRUST COMPANY (&#8220;THE DTC&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Irish Taxation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish corporation tax on income</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON is a public limited company incorporated and resident for tax purposes in Ireland by virtue of its place of central management and control being in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Companies which are resident in the Republic of Ireland ("Ireland") are subject to Irish corporation tax on their total profits (wherever arising and, generally, whether or not remitted to Ireland). The question of residence, by virtue of management and control, is essentially one of fact. It is the present intention of the Company's management to continue to manage and control the Company from Ireland, so that the Company will continue to be resident in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The standard rate of Irish corporation tax on trading income (with certain exceptions) is currently 12.5%. Corporation tax is charged at the rate of 25% on a company's non-trading income and certain types of trading income not eligible for the lower rate of 12.5% referred to above. An Irish Qualifying Domestic Top-up tax ("QDTT") and Income Inclusion rule ("IIR"), applying to businesses with consolidated group revenues of &#8364;750m or more in at least two of the four preceding fiscal years, has been enacted with effect 1 January 2024, providing for a minimum effective tax rate of 15% on Irish profits (QDTT) and a top up to a minimum of 15% on overseas profits of subsidiaries, if applicable (IIR).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">A research and development tax credit is available in Ireland where an Irish resident company incurs qualifying expenditure on research and development activities. Qualifying expenditure incurred in accounting periods commencing on or before 31 December 2023 results in a tax credit of 25% of that expenditure. For accounting period commencing on or after 1 January 2024, the tax credit will be increased to 30%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capital gains arising to an Irish resident company are liable to tax at 33%. However, a capital gains tax exemption is available in Ireland for qualifying Irish resident companies in respect of disposals of certain qualifying shareholdings.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The exemption from capital gains tax on the disposal of shares by an Irish resident company will apply where certain conditions are met. These conditions principally are:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The company claiming the exemption must hold (directly or indirectly) at least 5% of the ordinary share capital of the company in which the interest is being disposed of, throughout a continuous period of at least 12 months, in the two-year period prior to disposal;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares being disposed of must be in a company, which at the date of disposal, is resident in a Member State of the European Communities or in a country with which Ireland has signed or made specific arrangements to sign a double tax agreement (together a &#8220;Relevant Territory&#8221;);</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must be in a company which is primarily a trading company or the company making the disposal together with its &#8220;5% plus subsidiaries&#8221; should be primarily a trading group; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must not derive the greater part of their value from land or mineral rights in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Unless specifically exempted, all dividends paid by the Company, will be subject to Irish withholding tax. The current rate for dividend withholding tax is 25%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An individual shareholder who is neither resident nor ordinarily resident for tax purposes in Ireland but is resident in a country with which Ireland has a double tax treaty (which includes the U.S.), or in a member state of the European Communities, other than Ireland (together, a Relevant Territory), will be exempt from withholding tax provided he or she makes the requisite declaration.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident corporate shareholders will be exempt from withholding tax. Where the shareholding held by the recipient company, in the company paying the dividend is not 51% or greater, a declaration must be made to avail of the exemption.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-Irish resident corporate shareholders will be exempt from withholding tax on the production of the appropriate certificates and declarations where they:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are resident in a Relevant Territory and are not controlled (directly or indirectly) by Irish residents;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are ultimately controlled (directly or indirectly) by residents of a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">have the principal class of their shares, or shares of a 75% parent, substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are wholly owned by two or more companies, each of whose principal class of shares is substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. holders of ordinary shares should note, however, that detailed documentation requirements may need to be complied with. Special arrangements are available in the case of an interest in shares held in Irish companies through a depositary or in accounts of participants through the DTC. In certain cases, the depositary or the DTC can receive and pass on a dividend from an Irish company without deducting withholding tax, provided the depositary or the DTC is a qualifying intermediary, and provided the person beneficially entitled to the distribution would meet the same conditions outlined above for the withholding tax exemption to apply and has provided the qualifying intermediary with the appropriate declarations. The depositary or the DTC shall be regarded as a qualifying intermediary provided the following conditions are met:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC is resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have entered into a qualifying intermediary agreement with the Irish tax authorities (Irish Revenue Commissioners); and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have been authorized by the Irish Revenue Commissioners as a qualifying intermediary and such authorization has not expired or been revoked.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish income tax on dividends</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will generally be liable to Irish income tax on dividend income at their marginal rate of income tax. This income may also be liable to Pay Related Social Insurance (&#8220;PRSI&#8221;) of up to 4% and the Universal Social Charge (&#8220;USC&#8221;) of up to 11% (up to 15% in total).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under certain circumstances, non-Irish resident shareholders will be subject to Irish income tax on dividend income. Where withholding tax of 25% has been deducted, this will fully satisfy the non-Irish resident shareholder&#8217;s tax liability. No PRSI or USC should apply in these circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">However, a non-Irish resident shareholder will not have an Irish income tax liability on dividends from the Company if the holder is neither resident nor ordinarily resident in Ireland and the holder is:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">an individual resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is ultimately controlled by person(s) resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation whose principal class of shares (or its 75% or greater parent&#8217;s principal class of shares) is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation resident in another EU member state or in a Relevant Territory, which is not controlled directly or indirectly by Irish residents; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is wholly owned by two or more corporations each of whose principal class of shares is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. Holders who do not qualify for the above income tax exemption may be able to obtain treaty benefits under the Treaty.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish domicile levy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certain non-Irish resident individuals that are domiciled in Ireland will be subject to an annual levy of &#8364;200,000 if the market value of their Irish-located property on 31 December exceeds &#8364;5,000,000, their worldwide annual income exceeds &#8364;1,000,000 and their liability to Irish income tax in that year is less than &#8364;200,000.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish capital gains tax on disposal of shares</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will be liable to capital gains tax at 33% on gains arising from the disposal or part disposal of their shareholding.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A person who is not resident or ordinarily resident in Ireland, who has not been an Irish resident within the past five years and who does not carry on a trade in Ireland through a branch or agency will not be subject to Irish capital gains tax on the disposal of ordinary shares or shares held in accounts of participants through the DTC, so long as the shares do not derive the greater part of their value from Irish land or mineral rights</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There are provisions to subject a person who disposes of an interest in a company while temporarily being a non-Irish resident, to Irish capital gains tax. This treatment will apply to Irish domiciled individuals:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who cease to be an Irish resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who beneficially own the relevant assets when they cease to be a resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">if there are not more than 5 years of assessment between the last year of Irish tax residence prior to becoming temporarily non-resident and the tax year that he/she resumes Irish tax residency;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who dispose of the relevant assets during this temporary non-residence; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the interest disposed of represents 5% or greater of the issued share capital of the company or is worth at least &#8364;500,000.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In these circumstances the person will be deemed, for Irish capital gains tax purposes, to have sold and immediately reacquired the interest in the company on the date of his or her departure and will be subject to tax at 33% of the taxable gain.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Irish capital acquisitions tax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish capital acquisitions tax (referred to as CAT) applies to gifts and inheritances. Subject to certain tax-free thresholds, gifts and inheritances are liable to tax at 33%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Where a gift or inheritance is taken under a disposition made after December 1, 1999 it will be within the charge to CAT:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">to the extent that the property of which the gift or inheritance consists is situated in Ireland at the date of the gift or inheritance;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person making the gift or inheritance is or was resident or ordinarily resident in Ireland at the date of the disposition under which the gift or inheritance is taken;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">in the case of a gift taken under a discretionary trust where the person from whom the gift is taken was resident or ordinarily resident in Ireland at the date he/she made the settlement, or at the date of the gift or, if he/she is dead at the date of the gift, at the date of his/her death; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person receiving the gift or inheritance is resident or ordinarily resident in Ireland at the date of the gift or inheritance. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">For these purposes a non-Irish domiciled individual will not be regarded as resident or ordinarily resident in the Republic of Ireland on a particular date unless they are resident or ordinarily resident in Ireland on that date and have been resident for the 5 consecutive tax years immediately preceding the year of assessment in which the date falls.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person who receives the gift or inheritance (&#8220;the beneficiary&#8221;) is primarily liable for CAT. In the case of an inheritance, where a beneficiary and personal representative of the deceased are both non-residents, a solicitor must be appointed to be responsible for paying inheritance tax. Taxable gifts or inheritances received by an individual since December 5, 1991 from donors in the same threshold class are aggregated and only the excess over a specified tax-free threshold is taxed. The tax-free threshold is dependent on the relationship between the donor and the beneficiary and the aggregation since December 5, 1991 of all previous gifts and inheritances, within the same tax threshold.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The tax-free threshold amounts that apply are:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;16,250 in the case of persons who are not related to one another;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;32,500 in the case of gifts or inheritances received from inter alia a brother or sister or from a brother or sister of a parent or from a grandparent; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;335,000 in the case of gifts and inheritances received by a child from a parent (or by a minor child of a deceased child of a grandparent) and specified inheritances received by a parent from a child for gifts or inheritances taken on or after October 9, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gifts and inheritances passing between spouses are exempt from CAT.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A gift or inheritance of the ordinary shares or American Depositary Shares (ADSs) in the Company will be within the charge to CAT, notwithstanding that the person from whom or by whom the gift or inheritance is received is domiciled or resident outside Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Estate Tax Convention between Ireland and the United States generally provides for CAT paid on inheritances in Ireland to be credited against Federal Estate tax payable in the U.S. and for tax paid in the U.S. to be credited against tax payable in Ireland, based on priority rules set forth in the Estate Tax Convention. The Estate Tax Convention does not apply to CAT paid on gifts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish stamp duty </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish stamp duty, which is a tax on certain documents, is payable on all transfers of ordinary shares (other than between spouses) whenever a document of transfer is executed. Where the transfer is attributable to a sale of shares, stamp duty will be charged at a rate of 1%, rounded to the nearest euro. The stamp duty is calculated on the amount or value of the consideration (i.e. purchase price) or, if the transfer is by way of a gift (subject to certain exceptions) or for consideration less than the market value, on the market value of the shares. Where the consideration for the sale is expressed in a currency other than euro, the duty will be charged on the euro equivalent calculated at the rate of exchange prevailing on the date of the transfer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers through the DTC of book entry interests in shares are not subject to Irish stamp duty.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A transfer of ordinary shares by a shareholder to a depositary or custodian for deposit and a transfer of ordinary shares from the depositary or the custodian for the purposes of the withdrawal of the underlying ordinary shares in accordance with the terms of a deposit agreement will be subject to stamp duty at the 1% rate if the transfer relates to a sale, a contemplated sale, a gift or any other change in the beneficial ownership of such ordinary shares. However, transfers of ordinary shares into or out of the DTC are not subject to Irish stamp duty where no change in beneficial ownership of the shares has occurred and provided a contract for sale in respect of the transferring shares is not in place.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person accountable for payment of stamp duty is normally the transferee or, in the case of a transfer by way of gift, or for a consideration less than the market value, all parties to the transfer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers of ordinary shares between associated companies (broadly, companies within a 90% group relationship and subject to the satisfaction of certain conditions) are exempt from stamp duty in Ireland. In the case of transfers of ordinary shares where no beneficial interest passes (e.g. a transfer of shares from a beneficial owner to his nominee), no stamp duty arises.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">No stamp duty shall arise on the transfer of ordinary shares where the consideration for the transfer does not exceed &#8364;1,000, provided the instrument contains a statement certifying that the transaction does not form part of a larger transaction or a series of larger transactions, in respect of which the amount of the total consideration attributable to the shares would exceed &#8364;1,000.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Dividends and paying agents</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">G.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:8.5pt">Statement by experts</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">H.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Documents on Display</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and file reports and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC at http://www.sec.gov.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We &#8220;incorporate by reference&#8221; information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this report and more recent information automatically updates and supersedes more dated information contained or incorporated by reference in this report. Our SEC file number for Exchange Act reports is 333-08704.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a foreign private issuer, we are exempt from certain rules under the Exchange Act, including prescribing the furnishing and content of proxy statements to shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We will provide without charge to each person, including any beneficial owner, on the written or oral request of such person, a copy of any or all documents referred to above which have been or may be incorporated by reference in this report (not including exhibits to such incorporated information that are not specifically incorporated by reference into such information). Requests for such copies should be directed to us at the following address: ICON plc, South County Business Park, Leopardstown, Dublin 18, Ireland, D18 X5R3 Attention: Corporate Governance, email: corporate.governance@iconplc.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:13pt">Subsidiary Information</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">J.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.5pt">Annual Report to Security Holders</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is required to provide an annual report to security holders in response to the requirements of Form 6-K and will submit the annual report in electronic format. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exemptions From Corporate Governance Listing Requirements Under the NASDAQ Marketplace Rules</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ may provide exemptions from certain NASDAQ corporate governance standards to a foreign private issuer if, among other reasons those standards are contrary to a law, rule or regulation of a public authority exercising jurisdiction over such issuer or contrary to generally accepted business practices in the issuer&#8217;s home country of domicile, provided, that, the foreign private issuer properly notifies NASDAQ and makes the required disclosure except to the extent that such exemptions would be contrary to United States federal securities laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The exemptions that the Company relies on, and the practices the Company adheres to, are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5620(c), which requires each issuer (other than limited partnerships) to provide for a quorum in its by-laws for any meeting of the holders of common stock, which shall in no case be less than 33.33% of the outstanding shares of the issuer&#8217;s common voting stock. The Company&#8217;s Constitution requires that only 3 members be present, in person or by proxy, at a shareholder meeting to constitute a quorum. This quorum requirement is in accordance with Irish law and generally accepted business practices in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5635(c) which requires (other than for certain specified exceptions) shareholder approval prior to the establishment or material amendment of a stock option or purchase plan or other equity compensation arrangement made or materially amended, pursuant to which stock may be acquired by officers, Directors, employees or consultants. Irish law does not require shareholder approval with respect to equity compensation arrangements. Accordingly, the 2019 Consultants and Directors Restricted Share Unit Plan, the 2013 Employees Restricted Share Unit Plan and the amendments to the Employee Share Option Plan 2008 and Consultants Share Option Plan 2008 were adopted by the Board of Directors without shareholder approval.</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5605(b)(2), which requires independent Directors to hold regularly scheduled meetings at which only independent Directors are present. Irish law does not require independent Directors to hold regularly scheduled meetings at which only independent Directors are present. The Company holds regularly scheduled meetings which all of the Directors may attend and the Lead Independent Director may call meetings of the independent Directors and non-employee Directors of the Board, as appropriate, in accordance with the Lead Independent Director Charter.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_73"></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 11</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Quantitative and Qualitative Disclosures about Market Risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The principal market risks (i.e. risk of loss arising from adverse changes in market rates and prices) to which we are exposed include foreign currency risk and interest rate risk.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a number of foreign currency risks given the global nature of our operations. The principal foreign currency risks to which the business is subject to includes both foreign currency translation risk and foreign currency transaction risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are also subject to foreign currency transaction exposures as the currency in which our contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts may be priced in a single currency, most often U.S. dollars, or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our foreign currency exposures and enter into forward currency contracts to manage our exposure. We had no open foreign currency contracts at December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following significant exchange rates applied during the year:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Rate</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro:USD</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0795</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1039</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pound Sterling:USD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2382</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2731</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to interest rate risk in respect of our cash and cash equivalents and available for sale investments. Our treasury function actively manages our available cash resources and invests surplus cash balances to ensure optimum returns for the Company. Financial instruments are classified either as cash and cash equivalents or available for sale investments depending upon the maturity of the related investment. Funds may be invested in the form of floating rate notes and medium term minimum &#8220;A-&#8221; rated corporate securities. We may be subject to interest rate risk in respect of interest rate changes on amounts invested. Interest rate risk is managed by monitoring the composition of the Company&#8217;s investment portfolio on an ongoing basis having regard to current market interest rates and future trends.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Because the Company has variable rate debt, fluctuations in interest rates affect our business.  We attempt to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate cap and interest rate swap derivative agreements.  We have entered into certain interest rate cap and interest rate swap agreements with three financial institutions with respect to a portion of our outstanding debt.  Accordingly, any change in market value associated with these agreements is offset by the opposite market impact on the portion of the debt covered by such agreements.  As December&#160;31, 2023, we have interest rate cap agreements with a notional value of $1.6&#160;billion </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">to minimize interest rate risk on approximately $3.3 billion of variable rate indebtedness</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  Because we do not attempt to hedge all of our variable rate debt, we may incur higher interest costs for the portions of our unhedged debt. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We regularly evaluate our debt arrangements, as well as market conditions, and we will explore the opportunity to modify our existing arrangements or pursue additional financing arrangements that may result in the issuance of new debt securities by us or our affiliates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sensitivity analysis below represents the hypothetical change in the net interest payable of a 1% movement in market interest rates.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest for the year ended December 31, 2023 <br/>(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% increase in<br/>market interest rate<br/>(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% decrease in<br/>market interest rate<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,073&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($336,699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($376,036)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($297,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($331,685)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($367,963)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($295,409)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*5% of the interest costs fixed due to high yield bond issuance. $16.4&#160;million of merger related financing fees have been allocated to interest cost which are not impacted by a change in interest rate. </span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_76"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 12</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Description of Securities Other than Equity Securities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_79"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part II</span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_82"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 13</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Defaults, Dividend Arrearages and Delinquencies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_85"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 14.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Material Modifications to the Rights of Security Holders and Use of Proceeds.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_88"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 15.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Disclosure controls and procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures as at December&#160;31, 2023. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Management's Annual Report on Internal Accounting Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 98 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Attestation Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 101 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Changes in Internal Controls over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There were no changes in our internal controls over financial reporting during the period covered by this Form 20-F that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reserved.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_94"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16A. Audit Committee Financial Expert</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy acts as the Audit Committee financial expert serving on our Audit Committee and Board of Directors. The Board has determined that Mr. Murphy is independent. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16B. Code of Ethical Conduct </span></div><div style="text-align:justify;text-indent:-40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Code of Ethical Conduct applies to all officers, directors (including a non-executive director when carrying out their duties as a director of ICON plc), and employees of ICON plc, its subsidiaries and branches. There are no waivers from the provisions of the Code of Ethical Conduct that are required to be disclosed. This Code of Ethical Conduct is available on our website at: </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">https://investor.iconplc.com/corporate-governance/governance-documents</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16C. Principal Accountant Fees and Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal accountants for the years ended December&#160;31, 2023 and December&#160;31, 2022 were KPMG, Dublin, Ireland (Audit firm ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-44">1116</ix:nonNumeric>). The table below summarizes the fees for professional services rendered by KPMG for the audit of our annual financial statements for the years ended December&#160;31, 2023 and December&#160;31, 2022 and fees billed for other services rendered by KPMG.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="12" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023 </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit fees (1)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit related fees (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax compliance and the preparation of tax returns and refund claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total audit, audit related and tax compliance fees</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other tax planning and consulting services (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax advice relating to integration of ICON and PRA (4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-audit service fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total fees</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,995</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,933</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Audit fees include annual audit and quarterly review fees for the Company and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Audit related fees principally consist of fees for assurance and related services, such as financial due diligence services, fees for the audit of employee benefit plans and fees for pension reviews. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Other tax planning and consulting services represents services across a number of areas including in relation to the Group's financing facilities and other ad hoc tax advisory and planning.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">(4) Tax advice relating to the integration of ICON and PRA are fees directly related to the Merger and subsequent integration of PRA and are not expected to recur in future periods. These fees directly related to tax advice on the steps required to integrate and eliminate legal entities of PRA and ICON following the merger. The fees also included detailed transfer pricing advice on business model integration. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no other fees billed to the company in the &#8220;all other fees&#8221; category in the years ended December 31, 2023 and December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee pre-approves all audit and non-audit services provided to the Company by its auditors.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_103"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16D. Exemptions from the Listing Standards for Audit Committees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No ordinary shares were redeemed by the Company during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2022, 420,530 ordinary shares were redeemed by the Company at an average price of $237.75 per share for a total consideration of $100.0 million. All ordinary shares that were redeemed under the repurchase program were canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the repurchase programs, a broker purchased the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The programs are designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information, applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker were irrevocable and the trading decisions in respect of the repurchase programs were made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the programs. In addition, acquisitions under the programs may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the programs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_109"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16F. Changes in Registrant's Certifying Accountant</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">While there has been no change yet in our certifying accountant, in 2023, the Audit Committee of the Company engaged in a competitive audit tender process for the position of statutory auditor. Based on the results of this process, the Audit Committee is recommending that Ernst &amp; Young be appointed as statutory auditors and independent registered public accounting firm to the Company in respect of the financial year ending December 3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1, 2025. Ernst &amp; Young's appointment will be subject to the passing of an ordinary resolution confirming the appointment at the Company's 2025 Annual General Meeting. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">KPMG, our current independent registered public accounting firm, who will audit the financial statements for the year ending December 31, 2024, is expected to resign shortly after completion of the audit of the Company's financial statements for the year ending December 31, 2024. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the two fiscal years ended December 31, 2023 and December 31, 2022 and any subsequent interim period there were: (1) no disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement, and (2) no reportable events as defined under Item 16F(a)(1)(v).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The audit reports of KPMG on the financial statements of the Company as of and for the years ended December 31, 2023 and 2022, did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company requested that KPMG furnish it with a letter addressed to the SEC stating whether or not it agrees with the above statements. A copy of such letter, dated February&#160;23, 2024 is filed as Exhibit 16.1 to this annual report.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_112"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16G. Corporate Governance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 10 "Exemptions from Corporate Governance Listing Requirements under the NASDAQ Marketplace Rules".</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_115"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16H. Mine Safety Disclosure</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_118"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_1855"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16J. Insider Trading Policies  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_1862"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16K. Cybersecurity </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a cybersecurity strategy and program designed to protect our information systems and data from an evolving cyber threat landscape. The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp; Information Security as well as the overall security team have many years&#8217; experience and are all appropriately qualified. ICON&#8217;s cybersecurity processes are integrated into ICON&#8217;s overall risk management processes which are monitored by ICON&#8217;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The underlying controls of the cyber risk management program are based on recognized best practices and standards for cybersecurity and information technology, including the National Institute of Standards and Technology (&#8220;NIST&#8221;) Cybersecurity Framework (&#8220;CSF&#8221;) and the International Organization Standardization (&#8220;ISO&#8221;) 27001 Information Security Management System Requirements. ICON has an enterprise-wide assessment, performed twice annually by a third party, of the Company&#8217;s cyber risk management program against ISO 27001. We also conduct an annual independent maturity review with a third party which is based on the NIST cybersecurity framework. ICON also maintains the Cyber Essentials certification.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a dedicated Cybersecurity Operations Center that continuously monitors for threats and unauthorized access. The Cybersecurity Operations Center is staffed by appropriately qualified cyber and information security professionals. ICON has put in place controls and processes to inform and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. These controls and procedures are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by executive management in a timely manner. The escalation processes are based on defined prioritization and severity assessment criteria.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON partners with leading cybersecurity experts and organizations, leveraging third-party technology and expertise. ICON engages with these partners to monitor and maintain the performance and effectiveness of products and services that are deployed in ICON&#8217;s environment. We leverage the knowledge and expertise of external cybersecurity experts and vendors and employ an array of third-party tools to secure ICON&#8217;s information infrastructure and protect systems and information from unauthorized access. We engage third-party services to conduct evaluations of our security controls, whether through penetration testing, independent audits or consulting on best practices to address new challenges. These evaluations include testing both the design and operational effectiveness of security controls.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has training in place for all employees and contingent workers on information security and privacy practices so that they understand their responsibilities with respect to data security and privacy. Annual training includes topics such as data protection and IT security essentials. We also annually host cyber crisis response simulations with management and other employees to practice rapid cyber incident response. We work with our customers, peers and other partners within the wider healthcare, pharmaceutical and biotech communities to continuously share and receive cyber threat intelligence through various avenues, such as the Health-ISAC. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a Supplier Risk Management program which governs the use of approved suppliers within ICON. All suppliers must be on-boarded and approved for use in line with the Supplier Onboarding, Assessment and Management procedure. Security due diligence is conducted in line with industry good practice. As part of the onboarding assessment, the Information Security team uses an industry leading solution to risk profile of the supplier. This information is leveraged by the security team with the vendor during the assessment. In addition, we require our third-party providers to meet appropriate security requirements, controls and responsibilities and as applicable, we investigate security incidents that have impacted our third-party providers. We rely on the third-parties we use to implement security programs commensurate with their risk, and we cannot ensure in all circumstances that their efforts will be successful.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During an acquisition process, we conduct security and privacy due diligence and risk assessments, implement policies, deliver employee training, and securely integrate IT systems.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To date, no cyber-attacks have had a material impact on operations or financial reporting. For more information about the cybersecurity risks we face, please see Item 3D- Risk Factors.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part III</span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_124"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 17. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See item 18.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Financial Statements.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following consolidated financial statements of ICON plc and its subsidiaries, and the independent registered public accounting firm's report thereon, are included in Part III, Item 18 of this Annual Report: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_130">Management's Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_130">98</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_133">Reports of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_133">99</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_136">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_136">102</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_139">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_139">103</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_142">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_142">104</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_145">Consolidated Statements of Shareholders' Equity and Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_145">105</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_148">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_148">108</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_151">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic99b143eeb0141b5b05d5432a6bc5066_151">109</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's internal control over financial reporting is a process designed by, or under the supervision of, the Company's executive and financial officers and effected by the Company's board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorization of management and Directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the inherent limitation due to, for example, the potential for human error or circumvention of control, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company's </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">internal control over financial reporting </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as of December&#160;31, 2023. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework 2013</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Based upon the assessment performed, we determined that, as of December&#160;31, 2023 the Company's internal control over financial reporting was effective.</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes in the Company's internal control over financial reporting during 2023 that have materially affected, or are reasonably likely to affect materially, the Group's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">KPMG, an independent registered public accounting firm, has audited the consolidated financial statements of ICON plc and subsidiaries as of and for the year ended December&#160;31, 2023, included herein, and has issued an audit report on the effectiveness of our internal control over financial reporting, which is included below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Opinion on the Consolidated Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of ICON plc and subsidiaries (the Company) as of December&#160;31, 2023 and 2022, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and comprehensive income, and cash flows for each of the years in the three&#8209;year period ended December&#160;31, 2023, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended December&#160;31, 2023, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2023, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">February&#160;23, 2024 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Critical Audit Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition for clinical trial service contracts.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As discussed in Note 3 to the consolidated financial statements, the Company recognized revenue of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $8,120,176&#160;thousand </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the year ended 31 December 2023, a portion of which relates to clinical trial service revenue. As discussed in Note 2 to the consolidated financial statements, clinical trial service revenue is recognized over time, using an input measure, being total project costs (inclusive of third-party costs, principally pass-through/ reimbursable expenses) incurred at each reporting period as a percentage of forecasted total project costs, to measure progress towards satisfying the Company&#8217;s performance obligation. The transaction price is based on the contract or latest change order value, adjusted to reflect the estimated realizable contract value.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We identified the evaluation of revenue recognition for clinical trial service revenue as a critical audit matter. Complex and subjective auditor judgment was required to evaluate the Company&#8217;s estimate of total forecast project costs and the estimated realizable contract values.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We evaluated the design and tested the operating effectiveness of certain internal controls related to the revenue process, including controls over total forecast project costs and estimated realizable contract values.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We tested the total forecast project costs and the realizable contract values for a selection of clinical trial service contracts, by evaluating:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">direct costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the direct costs by comparing the amounts to source data</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">third-party costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the third-party costs incurred by comparing the costs to invoices received</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">findings from interviews with operational personnel of the Company to assess progress to date, the estimate of remaining costs to be incurred and factors impacting the amount of time and costs to complete the selected contracts, including an understanding of the nature and complexity of the work to be performed</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">correspondence of amendments to the scope or contract value, if any, between the Company and the customer for the selected contracts as part of our evaluation of contract progress</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">quarterly movements in forecast project costs and project margins and investigating the reasons for those movements, and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">the reasonableness of the Company&#8217;s adjustments from total contract value to arrive at realizable contract value. We confirmed total contract value with customers and compared the assumptions used to derive the adjustments from total contract value to realizable contract value to underlying records.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also evaluated the Company&#8217;s methods, assumptions and data used to accurately estimate total forecast project costs and realizable contract values, by comparing historical estimates developed at contract inception to actual results for a selection of clinical trial service contracts.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(signed) <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-45">KPMG</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 1990.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-46">Dublin, Ireland</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;23, 2024</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Opinion on Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited ICON plc and subsidiaries's (the Company) internal control over financial reporting as of December&#160;31, 2023, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2023, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;31, 2023 and 2022, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and comprehensive income, and cash flows for each of the years in the three-year period ended December&#160;31, 2023, and the related notes (collectively, the consolidated financial statements), and our report dated </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;23, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(signed) KPMG</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dublin, Ireland</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;23, 2024</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-47">378,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-48">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (Note 8a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">1,790,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">1,731,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled revenue (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">951,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">957,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">65,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">63,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">132,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">137,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-59">91,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-60">48,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">3,411,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">3,229,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-63">361,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-64">350,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill (Note 10)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-65">9,022,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-66">8,971,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-67">3,855,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-68">4,278,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use assets (Note 15)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-69">140,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-70">153,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">78,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">70,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:fixed-zero" scale="3" id="f-73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">21,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax asset (Note 20)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-75">73,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-76">76,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity-long term (Note 8b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-77">46,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-78">32,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-79">16,989,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-80">17,185,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">131,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">81,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">1,654,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">1,507,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities (Note 12)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">915,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">1,005,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">13,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">41,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current bank credit lines and loan facilities (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">110,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="f-90">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">2,825,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">2,690,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current bank credit lines and loan facilities (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-93">3,665,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-94">4,599,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities (Note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-95">126,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">131,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (Note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">45,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">38,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">186,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">239,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability (Note 20)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-101">899,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-102">988,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 17)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="f-103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="f-104">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-105">7,749,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-106">8,687,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders' Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares par value <ix:nonFraction unitRef="eurPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-107"><ix:nonFraction unitRef="eurPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-108">6</ix:nonFraction></ix:nonFraction> euro cents per share;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-109"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-110">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized (Note 18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-111"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-112">82,495,086</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2023 and<br/><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-113"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-114">81,723,555</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2022.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-115">6,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-116">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-117">6,942,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-118">6,840,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital (Note 18b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="f-119">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="f-120">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss (Note 25)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-121">143,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-122">171,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-123">2,433,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-124">1,821,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Shareholders' Equity</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-125">9,240,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-126">8,497,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-127">16,989,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-128">17,185,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-129">8,120,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-130">7,741,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-131">5,480,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs (excluding depreciation and amortization) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-132">5,719,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-133">5,527,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-134">3,972,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-135">768,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-136">778,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-137">585,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-138">585,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-139">569,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-140">314,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-141">44,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-142">39,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-143">198,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring (Note 19)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-144">45,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-145">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-146">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-147">7,164,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-148">6,946,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-149">5,102,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-150">956,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-151">795,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-152">378,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-153">5,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-154">2,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-155">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-156">336,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-157">229,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-158">182,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-159">624,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-160">567,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-161">196,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (Note 20)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-162">11,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-163">59,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-164">41,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before share of losses from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-165">612,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-166">508,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-167">155,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of losses from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-168">383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-169">3,136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-170">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-171">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-172">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-173">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per ordinary share (Note 24):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-174">7.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-175">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-176">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-177">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-178">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-179">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding (Note 24):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-180">82,101,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-181">81,532,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-182">67,110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-183">82,717,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-184">82,468,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-185">68,068,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-186">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-187">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-188">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-189">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-190">89,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-191">60,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-192">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-193">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-194">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="f-195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="f-196">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-197">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain/(loss) on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-198">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-199">3,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-200">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-201">640,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-202">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-203">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_145"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.942%"><tr><td style="width:1.0%"/><td style="width:37.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.990%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="18" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-204">52,788,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-206">617,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">35,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-209">1,262,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-210">1,850,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive Income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-211">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-212">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-213">60,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-214">60,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-215">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-216">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-217">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-218">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-219">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-220">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-221">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-222">1,065,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-223">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-224">118,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-225">118,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-226">328,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-227">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-228">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-229">133,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-230">133,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-231">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-232">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of shares associated with a business combination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-233">27,372,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-234">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-235">5,656,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-236">5,658,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="f-237">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="f-238">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-239">81,554,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-240">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-241">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-242">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-243">90,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-244">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-245">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.056%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.060%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="18" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-246">81,554,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-247">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-248">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-249">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-250">90,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-251">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-252">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-253">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-254">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-255">89,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-256">89,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-257">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-258">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-259">3,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-260">3,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-261">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-262">348,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-263">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-264">35,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-265">35,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-266">241,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-267">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-268">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-269">70,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-270">70,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-271">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-272">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-273">420,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-274">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-275">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-276">99,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-277">99,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="f-278">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="f-279">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-280">81,723,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-281">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-282">6,840,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-283">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-284">171,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-285">1,821,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-286">8,497,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.056%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.060%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="18" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-287">81,723,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-288">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-289">6,840,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-290">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-291">171,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-292">1,821,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-293">8,497,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-294">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-295">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-296">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-297">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-298">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-299">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-300">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-301">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-302">640,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-303">535,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-304">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-305">50,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-306">50,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-307">235,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-308">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-309">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-310">51,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-311">51,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-312">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-313">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-314">82,495,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-315">6,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-316">6,942,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-317">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-318">143,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-319">2,433,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-320">9,240,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_148"></div><hr style="page-break-after:always"/><div style="min-height:21.6pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-321">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-322">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-323">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-324">585,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-325">569,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-326">314,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of long lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-327">8,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-328">28,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-329">20,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reduction in carrying value of operating right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-330">41,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-331">45,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-332">45,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-333">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-334">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-335">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:num-dot-decimal" scale="3" id="f-336">6,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:fixed-zero" scale="3" id="f-337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:fixed-zero" scale="3" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charge on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="f-339">2,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:fixed-zero" scale="3" id="f-340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:fixed-zero" scale="3" id="f-341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs and debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-342">16,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-343">17,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-344">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-345">55,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-346">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-347">133,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-350">14,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on issuance of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:GainLossOnIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:GainLossOnIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="f-352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="iclr:GainLossOnIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-353">59,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-354">85,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-355">124,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-356">60,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized foreign exchange movements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-357">19,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-358">13,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-359">6,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-360">24,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-361">11,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-362">4,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-363">83,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-364">420,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-365">113,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="f-366">4,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="f-367">332,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="f-368">17,656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-369">134,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-370">192,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-371">69,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other net assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-372">170,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-373">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-374">108,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-375">1,161,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-376">563,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-377">829,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-378">140,692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-379">142,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-380">93,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of subsidiary undertakings (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-381">71,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="f-382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-383">5,914,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-386">2,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loan to equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="f-388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-389">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of available for sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-390">2,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="f-391">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="f-392">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of available for sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-393">2,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="f-394">482</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="f-395">480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from investments in equity - long term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:fixed-zero" scale="3" id="f-396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-397">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="3" id="f-398">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of investments in equity - long term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-399">13,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-400">5,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-401">4,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-402">226,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-403">145,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-404">6,024,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-407">30,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drawdown of credit lines and facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-408">370,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-409">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-410">5,905,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of credit lines and facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-411">1,265,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-412">875,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-413">877,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the exercise of equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-414">50,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-415">35,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-416">118,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-417">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-418">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-419">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-421">99,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-422">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" format="ixt:fixed-zero" scale="3" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" scale="3" id="f-424">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" format="ixt:fixed-zero" scale="3" id="f-425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in)/provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-426">844,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-427">864,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-428">5,114,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate movements on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-429">997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-430">16,720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-431">7,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net increase/(decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-432">89,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-433">463,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-434">88,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-435">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-436">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-437">840,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-438">378,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-439">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-440">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_154"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-441" continuedAt="f-441-1" escape="true">Description of Business </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-441-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development serv</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ices on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2023 we had approximately <ix:nonFraction unitRef="employee" contextRef="c-3" decimals="0" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="f-442">41,100</ix:nonFraction> employees, in <ix:nonFraction unitRef="location" contextRef="c-3" decimals="INF" name="iclr:NumberOfLocations" scale="0" id="f-443">106</ix:nonFraction> locations in <ix:nonFraction unitRef="country" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="f-444">53</ix:nonFraction> countries. During the year ended December&#160;31, 2023, we derived approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ly <ix:nonFraction unitRef="number" contextRef="c-42" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-445">40.4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-43" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-446">48.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-44" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-447">10.9</ix:nonFraction>% </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div></ix:continuation><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_157"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-448" continuedAt="f-448-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-448-1" continuedAt="f-448-2"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-449" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div></ix:nonNumeric><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-450" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination and income taxation.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-451" continuedAt="f-451-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-448-2" continuedAt="f-448-3"><ix:continuation id="f-451-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short-term debt or equity as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by Level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The changes in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses, other than temporary, which reduce the carrying amount below cost are recognized in the Consolidated Statement of Operations.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-452" continuedAt="f-452-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-453" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. <ix:nonNumeric contextRef="c-1" name="iclr:ForeignCurrencyDisclosureTableTextBlock" id="f-454" continuedAt="f-454-1" escape="true">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-454-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts charged/(credited)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-455">12,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-456">25,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-457">14,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-458" continuedAt="f-458-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-458-1" continuedAt="f-458-2"><ix:continuation id="f-448-3" continuedAt="f-448-4"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-448-4" continuedAt="f-448-5"><ix:continuation id="f-458-2"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="f-459" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-460" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-461" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value Measurements ("ASC 820")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Any increases or decreases in fair value are recognized in earnings in the period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-448-5" continuedAt="f-448-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-462" continuedAt="f-462-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-462-1" continuedAt="f-462-2"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing </span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-462-2">("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-463" continuedAt="f-463-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" id="f-464" continuedAt="f-464-1" escape="true">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</ix:nonNumeric></span></div><ix:continuation id="f-464-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-45" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-465">40</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-46" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-466">2</ix:nonNumeric> - <ix:nonNumeric contextRef="c-47" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-467">8</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-48" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-468">8</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-49" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-469">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-50" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-470">5</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-463-1">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-471" continuedAt="f-471-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2023 and December&#160;31, 2022, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-448-6" continuedAt="f-448-7"><ix:continuation id="f-471-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="f-472" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-473" continuedAt="f-473-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-51" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-474">16</ix:nonNumeric> - <ix:nonNumeric contextRef="c-52" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-475">23</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-53" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-476">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-54" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-477">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-55" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-478">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-56" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-479">5</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="f-480" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtPolicyTextBlock" id="f-481" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-482" continuedAt="f-482-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-448-7" continuedAt="f-448-8"><ix:continuation id="f-482-1"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-483" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:GovernmentGrantsPolicyTextBlock" id="f-484" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:ResearchandDevelopmentCreditsPolicyTextBlock" id="f-485" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="f-486" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for these plans in accordance with ASC Subtopic 715-30, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans &#8211; Pension</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-487" continuedAt="f-487-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 718")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-448-8"><ix:continuation id="f-487-1"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div></ix:continuation><div><span><br/></span></div><ix:continuation id="f-452-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="f-488" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-489" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-490" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounting pronouncements, effective for the year ended December 31, 2023, did not have any significant impact on the Company&#8217;s consolidated financial statements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following accounting pronouncements have been issued, but not yet adopted, as of December 31, 2023:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting &#8211; Improvements to Reportable Segment Disclosures </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(&#8220;ASU 2023-07&#8221;), which amends the guidance in ASC Topic 280,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis. Furthermore, all disclosures about a reportable segment&#8217;s profit or loss, which are currently required annually, will be mandated for interim periods. The additional disclosures required by ASU 2023-07 apply to entities with a single reportable segment. The amended guidance is effective for fiscal periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with retrospective application required. The Company is currently evaluating the impact of this ASU on disclosures within its consolidated financial statements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">which requires disaggregated information about an entity&#8217;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-491" continuedAt="f-491-1" escape="true">Disaggregation of Revenue</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-492" escape="true"><ix:continuation id="f-491-1" continuedAt="f-491-2"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.658%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-493">721,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-494">683,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-495">441,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-496">1,453,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-497">1,506,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-498">1,291,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-499">1,188,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-500">1,112,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-501">752,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-502">1,743,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-503">1,585,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-504">1,077,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-505">3,012,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-506">2,853,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-507">1,918,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-508">8,120,176</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-509">7,741,386</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-510">5,480,826</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-491-2" continuedAt="f-491-3">Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.</ix:continuation>  </span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_163"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4. <ix:continuation id="f-491-3" continuedAt="f-491-4">Contract Balances</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="f-491-4" continuedAt="f-491-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-511" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.676%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="f-512">1,821,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="f-513">1,751,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-514">31,533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-515">20,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-516">1,790,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-517">1,731,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-518">951,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-519">957,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-520">2,742,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-521">2,689,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:44.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-522">951,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-523">957,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-524">5,719</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" scale="-2" id="f-525">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-526">1,654,507</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-527">1,507,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-528">147,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" scale="-2" id="f-529">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-530">702,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-531">549,794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-532">152,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" scale="-2" id="f-533">27.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and December&#160;31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="f-534">333.0</ix:nonFraction>&#160;million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="f-535">406.3</ix:nonFraction>&#160;million (see</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-491-5" continuedAt="f-491-6"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2023 decreased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="f-536">5.7</ix:nonFraction> million as compared to December&#160;31, 2022. Unearned revenue increased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-537">147.1</ix:nonFraction> million over the same period resulting in an increase of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-538">152.8</ix:nonFraction> million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2022 and December&#160;31, 2023. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Company's receivables and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">unbilled services was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="f-539">24.6</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="f-540">17.8</ix:nonFraction>&#160;million for the year ended December&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-491-6" continuedAt="f-491-7"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="f-541">14.8</ix:nonFraction> billion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="f-542">13.7</ix:nonFraction>&#160;billion as of December&#160;31, 2022. As of December&#160;31, 2023 the Company expects to recognize revenue on approximately <ix:nonFraction unitRef="number" contextRef="c-72" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-543">52</ix:nonFraction>% </span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-491-7">of the unsatisfied performance obligation over the next <ix:nonNumeric contextRef="c-73" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-544"><ix:nonNumeric contextRef="c-74" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-545">twelve months</ix:nonNumeric></ix:nonNumeric> compared to <ix:nonFraction unitRef="number" contextRef="c-75" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-546">52</ix:nonFraction>% as of December&#160;31, 2022, with the remainder recognized thereafter over the duration of the customer contracts.</ix:continuation>  </span></div><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_166"></div><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:AllowanceForCreditLossesTextBlock" id="f-547" continuedAt="f-547-1" escape="true">Allowance for Credit Losses</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-548" escape="true"><ix:continuation id="f-547-1"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December&#160;31, 2022 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-549">20,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-550">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="3" id="f-551">13,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="3" id="f-552">3,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" format="ixt:num-dot-decimal" scale="3" id="f-553">24,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" format="ixt:num-dot-decimal" scale="3" id="f-554">17,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="f-555">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="f-556">406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-557">31,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-558">20,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_169"></div><hr style="page-break-after:always"/><div style="background-color:#ffffff"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-559" continuedAt="f-559-1" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-559-1" continuedAt="f-559-2"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">BioTel Research LLC Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#8220;BioTel&#8221;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-560">68.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Cash acquired amounted to $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-561">1.4</ix:nonFraction>&#160;million. The purchase price allocation, as of the date of acquisition, was based on a preliminary valuation and may be subject to revision. Preliminarily, the BioTel acquisition resulted in the initial recognition of intangible assets of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-562">36.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> and goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-563">23.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Preliminary g</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">oodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of BioTel and the expected synergies of the acquisition. The goodwill recognized is deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Oncacare Limited Acquisition</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's <ix:nonFraction unitRef="number" contextRef="c-78" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-564">51</ix:nonFraction>% majority voting share capital of Oncacare Limited ("Oncacare") for $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-565">5.1</ix:nonFraction>&#160;million, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-566">13.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and also gave rise to an acquisition-related gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-567">6.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The combined company has retained the name ICON and brought together approximately <ix:nonFraction unitRef="employee" contextRef="c-80" decimals="-3" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="f-568">38,000</ix:nonFraction> (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">ASC Topic 805</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The combined company has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received, per share, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-81" decimals="INF" name="iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" scale="0" id="f-569">80</ix:nonFraction> in cash and <ix:nonFraction unitRef="shares" contextRef="c-82" decimals="4" name="iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" scale="0" id="f-570">0.4125</ix:nonFraction> shares of ICON stock. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Company incurred Merger-related expenses of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-571">44.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-572">39.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-573">198.3</ix:nonFraction> million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 the Company incurred approximate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ly $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-574">16.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-575">17.7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> and $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-576">86.7</ix:nonFraction> million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-577" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-578">5,308,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="f-579">5,658,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" format="ixt:num-dot-decimal" scale="3" id="f-580">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="f-581">865,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="f-582">12,041,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="f-583">401.6</ix:nonFraction>&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119</span></div></div></div></div><hr style="page-break-after:always"/><div style="background-color:#ffffff"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-559-2" continuedAt="f-559-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="f-584" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, <br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-585">259,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="f-586">934,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-587">125,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-588">156,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-589">180,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-590">8,084,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-591">4,919,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-592">25,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-593">33,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-594">50,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-595">380,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-596">36,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-597">739,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-598">147,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-599">1,119,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-600">204,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-601">12,041,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="f-602" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-603">3,938,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-87" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-604">23</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-605">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-89" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-606">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-607">202,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-91" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-608">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-609">168,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-93" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-610">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-611">111,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-95" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-612">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-613">4,919,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120</span></div></div></div></div><hr style="page-break-after:always"/><div style="background-color:#ffffff"><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-559-3"><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" id="f-614" continuedAt="f-614-1" escape="true">In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:</ix:nonNumeric></span></div><ix:continuation id="f-614-1"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.515%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" format="ixt:fixed-zero" scale="3" id="f-616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-617">14,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-618">6,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-619">11,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-620">70,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-621">44,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-622">147,039</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-623">1,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" format="ixt:fixed-zero" scale="3" id="f-624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-625">37,496</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-626">1,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" format="ixt:num-dot-decimal" scale="3" id="f-627">19,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-628">10,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-629">193,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-630">151,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December&#160;31, 2022, the Company incurred a $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="f-631">2.2</ix:nonFraction>&#160;million amortization expense which related to the year ended December&#160;31, 2021 due to the timing of the measurement period adjustment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" format="ixt:num-dot-decimal" scale="6" id="f-632">16.0</ix:nonFraction>&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div></ix:continuation></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_172"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-633" continuedAt="f-633-1" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-633-1" continuedAt="f-633-2"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short maturities of these instruments. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">121</span></div></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-633-2" continuedAt="f-633-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="f-635" continuedAt="f-635-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-634" continuedAt="f-634-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-636">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-639">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-640">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-643">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-644">46,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-645">46,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-651">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-653">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-654">46,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-655">48,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-657">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-660">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-662">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-665">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-666">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-670">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-674">32,631</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-675">32,631</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-111" xsi:nil="true" name="us-gaap:DerivativeAssets" id="f-676"></ix:nonFraction></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="f-677">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-113" xsi:nil="true" name="us-gaap:DerivativeAssets" id="f-678"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-114" xsi:nil="true" name="us-gaap:DerivativeAssets" id="f-679"></ix:nonFraction></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="f-680">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-681">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="f-682">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-684">32,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-685">34,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-687">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-690">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-691">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-692">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-693">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-695">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-635-1"><ix:continuation id="f-634-1">(c) Represents the fair value of the interest rate caps and the interest rate swap.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2023, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-696">12,878.0</ix:nonFraction> million (December&#160;31, 2022:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-697">13,250.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and are identified as Level 3 assets. These assets are comprised of goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-698">9,022.1</ix:nonFraction> million (December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-699">8,971.7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-700">3,855.9</ix:nonFraction> million (December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-701">4,278.7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-633-3"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-702">3,793.5</ix:nonFraction>&#160;million at December&#160;31, 2023 (December 31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-703">4,650.3</ix:nonFraction>&#160;million). The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value, due to the short term duration.</span></div></ix:continuation><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_175"></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-704" continuedAt="f-704-1" escape="true">Investments</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-704-1" continuedAt="f-704-2"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Available for sale investments (short-term)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at December&#160;31, 2023, the Company held $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-705">2.0</ix:nonFraction> million of available for sale investments (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-706">1.7</ix:nonFraction> million). Short-term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. The Company classifies its short- term investments as available for sale.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short term investments at December&#160;31, 2023 have an average maturity of <ix:nonNumeric contextRef="c-1" name="iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" format="ixt-sec:duryear" id="f-707">3.6</ix:nonNumeric> years compared to <ix:nonNumeric contextRef="c-5" name="iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" format="ixt-sec:duryear" id="f-708">2.8</ix:nonNumeric> years at December&#160;31, 2022. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company's practice and intention in respect of these investments. The Company recognizes the unrealized losses in equity as these unrealized losses on short-term investments have been considered as temporary.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Available for sale investments (long-term)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. During the year ended December&#160;31, 2023, capital totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" format="ixt:num-dot-decimal" scale="6" id="f-709">14.0</ix:nonFraction> million (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" format="ixt:num-dot-decimal" scale="6" id="f-710">3.7</ix:nonFraction> million) had been advanced under the terms of the subscription agreements. The Company determined that the interest in funds meets the definition of equity securities without readily determinable fair values. The Company therefore concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-704-2" continuedAt="f-704-3"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was an increase in fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-711">0.2</ix:nonFraction> million (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-712">6.3</ix:nonFraction> million) recognized in net income during the year bringing the carrying value of the subscriptions to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-713">46.8</ix:nonFraction> million at December&#160;31, 2023 (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-714">32.6</ix:nonFraction> million).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-704-3" continuedAt="f-704-4">December&#160;31, 2023, the Company had committed to future investments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:CommitmentToAcquireLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-715">66.4</ix:nonFraction> million in respect of these funds.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_178"></div><ix:continuation id="f-704-4" continuedAt="f-704-5"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160; Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 24, 2020, the Company obtained a <ix:nonFraction unitRef="number" contextRef="c-118" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-716">49</ix:nonFraction>% interest in the voting share capital of Oncacare in exchange for consideration of $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-717">4.9</ix:nonFraction>&#160;million. At that time, the Company&#8217;s investment in Oncacare was accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare. The Company recorded its pro rata share of the earnings/losses of this investment in 'Share of losses in equity investments' in the Consolidated Statement of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded losses of $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-718">0.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-719">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-720">2.2</ix:nonFraction> million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's <ix:nonFraction unitRef="number" contextRef="c-78" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-721">51</ix:nonFraction>% majority voting share capital of </span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-704-5">Oncacare, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-722" continuedAt="f-722-1" escape="true">Property, Plant and Equipment, net</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-722-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-723" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-724">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-725">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-726">70,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-727">70,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="f-728">550,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="f-729">500,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="f-730">45,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="f-731">50,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-732">56,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-733">59,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-734">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-735">65,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:VehiclesGross" scale="3" id="f-736">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:VehiclesGross" scale="3" id="f-737">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-738">781,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-739">750,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-740">419,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-741">400,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-742">361,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-743">350,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The depreciation expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-744">126.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-745">106.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-746">75.5</ix:nonFraction> million for the twelve months ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2023 and the year ended December&#160;31, 2022, certain fully depreciated assets were written off as they were no longer used by the Company.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_184"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillDisclosureTextBlock" id="f-747" continuedAt="f-747-1" escape="true">Goodwill</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-747-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-748" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-749">8,971,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-750">9,037,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-751">36,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="f-752">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-754">35,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-755">13,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-756">30,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-757">9,022,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-758">8,971,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-759"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-760">no</ix:nonFraction></ix:nonFraction> goodwill impairment losses for the years ended December&#160;31, 2023 and 2022.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">124</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-761" continuedAt="f-761-1" escape="true">Intangible Assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-761-1"><ix:continuation id="f-473-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-762">4,090,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-763">4,076,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-764">541,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-765">536,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-766">204,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-767">204,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-768">170,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-769">170,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-770">141,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-771">120,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-772">5,147,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-773">5,109,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-774">1,292,106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-775">830,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-776">3,855,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-777">4,278,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The amortization expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-778">459.9</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-779">463.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-780">239.5</ix:nonFraction> million for the twelve months ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#8220;BioTel&#8221;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-781">68.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> The acquisition resulted in the recognition of intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-782">36.4</ix:nonFraction> million, comprising  customer relationships of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-783">12.5</ix:nonFraction> million, order backlog of $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-784">3.9</ix:nonFraction> million and technology assets of $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-785">20.0</ix:nonFraction> million. These assets will be amortized over their expected useful lives of between <ix:nonNumeric contextRef="c-131" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-786">3</ix:nonNumeric> and <ix:nonNumeric contextRef="c-132" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-787">16</ix:nonNumeric> years. In total, $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-788">1.5</ix:nonFraction> million has been amortized in the period since the date of acquisition.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-789">3,938.0</ix:nonFraction>&#160;million, Order backlog of $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-790">500.0</ix:nonFraction>&#160;million, Trade names of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-791">202.0</ix:nonFraction>&#160;million, Patient database of $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-792">168.0</ix:nonFraction>&#160;million and Technology assets of $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-793">111.0</ix:nonFraction>&#160;million. These assets are being amortized over their expected useful lives of between <ix:nonNumeric contextRef="c-134" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-794">3</ix:nonNumeric> and <ix:nonNumeric contextRef="c-135" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-795">23</ix:nonNumeric> years. The valuation of these assets was finalized in June 30, 2022. In total, $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-796">1,128.5</ix:nonFraction>&#160;million has been amortized in the period since the date of acquisition, $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-797">451.4</ix:nonFraction>&#160;million has been amortized in the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-798" escape="true"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2024 to December 31, 2028 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-799">344,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-800">229,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-801">214,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-802">202,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-803">189,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet" format="ixt:num-dot-decimal" scale="3" id="f-804">1,180,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="f-805" continuedAt="f-805-1" escape="true">Other Liabilities</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherLiabilitiesTableTextBlock" id="f-806" escape="true"><ix:continuation id="f-805-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-807">463,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-808">530,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-809">385,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-810">395,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-811">36,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-812">43,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-813">11,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-814">16,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-815">13,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-816">12,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:RestructuringReserveandOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-817">4,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:RestructuringReserveandOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-818">5,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:CapitalGovernmentGrantsCurrent" scale="3" id="f-819">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:CapitalGovernmentGrantsCurrent" scale="3" id="f-820">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-821">915,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-822">1,005,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="f-823">333.0</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> at December&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="f-824">406.3</ix:nonFraction> million at December&#160;31, 2022.</span></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_193"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:LongTermDebtTextBlock" id="f-825" continuedAt="f-825-1" escape="true">Bank Credit Lines and Loan Facilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-826" continuedAt="f-826-1" escape="true"><ix:continuation id="f-825-1" continuedAt="f-825-2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2023 and 2022:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-137" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-827">7.860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-138" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-828">7.092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-829">3,251,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-830">4,201,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-139" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-831">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-140" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-832">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-833">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-834">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-141" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-835">6.720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-142" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" id="f-836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-837">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" id="f-838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-839">3,806,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-840">4,701,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-841">110,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-842">55,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-843">3,696,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-844">4,646,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-845">30,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-846">47,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-847">3,665,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-848">4,599,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-825-2" continuedAt="f-825-3"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2023,  December&#160;31, 2022 and December&#160;31, 2021 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-849">16.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-850">17.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-851">86.7</ix:nonFraction> million of transaction related financing costs, inclusive of the amortization of financing fees which were previously capitalized, associated with the debt facilities used to finance the Merger. </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" id="f-852" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-853">311,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-854">209,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-855">93,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of merger related financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-856">16,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-857">17,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-858">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-861">75,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:InterestExpenseCreditOther" format="ixt:num-dot-decimal" scale="3" id="f-862">9,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:InterestExpenseCreditOther" format="ixt:num-dot-decimal" scale="3" id="f-863">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:InterestExpenseCreditOther" scale="3" id="f-864">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-865">336,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-866">229,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-867">182,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Includes costs associated with the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-868" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-869">110,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-870">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-871">555,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="f-872">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:LongTermDebtMaturityYearFiveAndThereafter" format="ixt:num-dot-decimal" scale="3" id="f-873">3,030,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-874">3,806,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger").  In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-875">5,515</ix:nonFraction>&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-876">300</ix:nonFraction>&#160;million (the "Senior Secured Credit Facilities"). The Senior Secured Credit Facility and Senior Secured Notes were issued at a discount of $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="f-877">27.6</ix:nonFraction>&#160;million. On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-878">300</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-879">500</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-143" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-880">1.00</ix:nonFraction>% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the applicable margin is <ix:nonFraction unitRef="number" contextRef="c-147" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-881">2.25</ix:nonFraction>%. The senior secured term loan facility is subject to a floor of <ix:nonFraction unitRef="number" contextRef="c-148" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-882">0.50</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="c-149" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-883">1.00</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-150" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-884">0.60</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-151" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-885">0.25</ix:nonFraction>% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="c-152" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-886">2.00</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-887">1.60</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-888">1.25</ix:nonFraction>% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. As at December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-889">445.0</ix:nonFraction>&#160;million remained undrawn under the senior secured revolving loan facility.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-825-3" continuedAt="f-825-4"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" id="f-890" escape="true"><div style="text-align:justify;text-indent:14.25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2023 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-891">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-892">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-893">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-894">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-895">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-896">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-897">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-898">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" format="ixt:num-dot-decimal" scale="3" id="f-899">950,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" format="ixt:num-dot-decimal" scale="3" id="f-900">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="f-901">7.9</ix:nonFraction>&#160;million (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="f-902">7.8</ix:nonFraction>&#160;million)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">drew down $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-903">370.0</ix:nonFraction>&#160;million (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-904">75.0</ix:nonFraction>&#160;million) of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility and repaid $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="f-905">315.0</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="f-906">75.0</ix:nonFraction>&#160;million) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as shown below. As at December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-907">55.0</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:fixed-zero" scale="6" id="f-908">nil</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">was drawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-826-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="f-909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="f-910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-912">180,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-913">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-914">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-915">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-916">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-917">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-918">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-919">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-920">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-921">65,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-922">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-923">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-924">370,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-925">315,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-926">500</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="c-175" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-927">2.875</ix:nonFraction>% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-825-4">The estimated fair value of the Company&#8217;s debt was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-928">3,793.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-929">4,650.3</ix:nonFraction>&#160;million at December&#160;31, 2023 and December&#160;31, 2022, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value due to the short term duration.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-930" continuedAt="f-930-1" escape="true">Derivatives</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-930-1"><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as cash flow hedges.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into <ix:nonFraction unitRef="instrument" contextRef="c-176" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" id="f-931">two</ix:nonFraction> interest rate cap agreements ("2022 Caps") with an initial total notional value of $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-932">2,101</ix:nonFraction>&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps expire on December 31, 2024. The Company pays a fixed rate of <ix:nonFraction unitRef="number" contextRef="c-176" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-933">0.42</ix:nonFraction>% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds <ix:nonFraction unitRef="number" contextRef="c-177" decimals="4" name="iclr:DerivativeVariableInterestRateReferenceRateInExcessOf" scale="-2" id="f-934">4.75</ix:nonFraction>%. </span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-935">1,101</ix:nonFraction>&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap begins accruing on December 31, 2024 and the interest rate swap expires on September 30, 2026. The Company pays a fixed rate of <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-936">3.4</ix:nonFraction>% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2022 Caps and the 2022 Swap are designated as cash flow hedges. G</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ains and losses are initially reported as a component of other comprehensive income/loss and subsequently recognized in net income.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">      <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-937" continuedAt="f-937-1" escape="true">The fair values of the Company&#8217;s derivative financial instruments, on a gross basis, are summarized in the following table:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-937-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-939">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-940">1,600,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="f-941">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-942">3,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-943">2,100,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-945">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-946">1,100,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-947">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-948">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-949">1,100,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-951">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-952">2,701,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="f-953">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-954">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-955">3,201,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the Company recognized a current derivative liability of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-956">1.9</ix:nonFraction> million within <span style="-sec-ix-hidden:f-957">other liabilities</span> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-958">3.3</ix:nonFraction> million within <span style="-sec-ix-hidden:f-959">other liabilities</span> and $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-4" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-960">0.01</ix:nonFraction> million within <span style="-sec-ix-hidden:f-961">other receivables</span></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and a non current derivative liability of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-962">0.5</ix:nonFraction> million (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December 31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-963">0.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">within <span style="-sec-ix-hidden:f-964"><span style="-sec-ix-hidden:f-965">non-current other liabilities</span></span>. </span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> the year ended December&#160;31, 2023, the Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="6" id="f-966">1.6</ix:nonFraction> million within other comprehensive income/loss (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="6" id="f-967">3.7</ix:nonFraction> million loss) after a reclassification of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-968">2.4</ix:nonFraction>&#160;million from other comprehensive income/loss to the income statement (December 31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-969">0.1</ix:nonFraction>&#160;million).</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> the next 12 months, the Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="f-970">3.2</ix:nonFraction> million will be reflected as interest expense in the consolidated statements.</span></div></ix:continuation><div style="text-indent:14.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">129</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-971" continuedAt="f-971-1" escape="true">Operating Leases</ix:nonNumeric></span></div><ix:continuation id="f-971-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-972" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-973">46,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-974">53,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-975">51,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-976">1,103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-977">1,165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-978">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-979">45,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-980">52,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-981">49,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-982">45.7</ix:nonFraction> million incurred in the year ended December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-983">37.9</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-984">7.8</ix:nonFraction> million is recorded within direct costs. Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-985">52.7</ix:nonFraction> million incurred in the year ended December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-986">48.3</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-987">4.4</ix:nonFraction> million is recorded within direct costs. Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-988">49.9</ix:nonFraction>&#160;million incurred in the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-989">47.5</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-990">2.4</ix:nonFraction> million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, during the years ended December&#160;31, 2023 and December&#160;31, 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-991">37.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-992">28.7</ix:nonFraction> million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-993">8.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="f-994">24.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-995">15.4</ix:nonFraction> million, respectively, as part of an office consolidation program (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 19 - Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2023 were <ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-996">6.72</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-3" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-997">3.29</ix:nonFraction>%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2022 were <ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-998">6.90</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-999">2.45</ix:nonFraction>%, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1000" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2023 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental <br/>payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1001">40,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1002">34,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1003">29,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1004">23,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1005">15,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1006">33,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1007">176,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1008">14,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1009">162,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1010">36.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1011">43.7</ix:nonFraction> million have been included in <span style="-sec-ix-hidden:f-1012"><span style="-sec-ix-hidden:f-1013">other liabilities</span></span> as at December&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">130</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" id="f-1014" continuedAt="f-1014-1" escape="true">Non-current other liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="f-1015" escape="true"><ix:continuation id="f-1014-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1016">14,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1017">13,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1018">31,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1019">25,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1020">45,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1021">38,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_205"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1022" continuedAt="f-1022-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1022-1"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next <ix:nonNumeric contextRef="c-3" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1023">sixteen years</ix:nonNumeric>. These leases g</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">enerally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Operating leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2023, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and 2021 and future minimum rental commitments as of December&#160;31, 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_208"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1024" continuedAt="f-1024-1" escape="true">Share Capital</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1024-1" continuedAt="f-1024-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have <ix:nonFraction unitRef="vote" contextRef="c-1" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="f-1025">one</ix:nonFraction> vote, for each ordinary share held with no individual having more than <ix:nonFraction unitRef="vote" contextRef="c-1" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="f-1026">one</ix:nonFraction> vote. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Employee share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-189" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1027">535,705</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-189" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1028">95.12</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1029">51.0</ix:nonFraction> million. During the year ended December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-190" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1030">188,800</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="c-191" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-1031">47,026</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="c-192" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1032">348,286</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-192" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1033">102.87</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1034">35.8</ix:nonFraction> million. During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="c-193" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1035">195,029</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="c-194" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-1036">46,087</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="c-195" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1037">1,065,529</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1038">111.29</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1039">118.6</ix:nonFraction> million. During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="c-196" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1040">446,404</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="c-197" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-1041">44,132</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-198" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-1042">27,372,427</ix:nonFraction> shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1024-2"><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to <ix:nonFraction unitRef="number" contextRef="c-199" decimals="INF" name="iclr:StockRepurchaseProgramAuthorizedPercentage" scale="-2" id="f-1043">10</ix:nonFraction>% of the outstanding shares in the Company. This resolution has been renewed annually thereafter.&#160;On February 18, 2022, the Company commenced a share buyback program which was fully complete at&#160;March 31, 2022. Under this buyback program, <ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-1044">420,530</ix:nonFraction> ordinary shares were redeemed by the Company for total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-1045">100.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_211"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-1046" continuedAt="f-1046-1" escape="true">Restructuring Charges</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1046-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended, December 31, 2023, a restructuring charge of $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-1047">45.4</ix:nonFraction>&#160;million was recognized in the Consolidated Statements of Operations under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected a workforce reduction of $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-1048">34.1</ix:nonFraction>&#160;million and an office consolidation program to optimize the Company's office footprint of  $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:OtherRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-1049">11.3</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-1050" escape="true"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1051">45,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1052">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1053">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1054">45,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1055">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1056">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023, a total liability of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="f-1057">7.0</ix:nonFraction> million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="f-1058">3.0</ix:nonFraction> million of facilities related liabilities of which $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1059">1.0</ix:nonFraction> million is included within other liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1060">2.0</ix:nonFraction> million is included within non-current other liabilities. The remaining provision of $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="f-1061">4.0</ix:nonFraction> million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="f-1062" escape="true"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1063">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1064">10,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-1065">36,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-1066">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="f-1067">35,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="f-1068">8,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1069">6,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1070">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">132</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_217"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1071" continuedAt="f-1071-1" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1071-1" continuedAt="f-1071-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:IncomeBeforeIncomeTaxTableTextBlock" id="f-1072" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1073">624,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1074">432,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1075">231,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1076">352,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1077">270,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1078">278,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1079">352,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1080">405,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1081">243,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1082">624,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1083">567,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1084">196,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1085" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1086">80,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1087">53,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1088">18,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1089">42,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1090">60,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1091">35,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1092">59,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1093">70,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1094">48,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1095">97,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1096">184,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1097">101,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1098">45,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1099">6,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-1100">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1101">143,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1102">118,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1103">52,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1104">12,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-1105">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1106">8,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1107">85,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1108">124,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1109">60,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1110">11,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1111">59,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1112">41,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-1113">3,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-1114">7,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-1115">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="f-1116">301</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:fixed-zero" id="f-1117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:fixed-zero" id="f-1118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="f-1119">8,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="f-1120">66,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="f-1121">43,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1071-2" continuedAt="f-1071-3"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory trading income tax rate, the rate of our country of domicile, is 12.5%. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1122" continuedAt="f-1122-1" escape="true">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1122-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1123">78,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1124">70,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1125">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1126">71,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1127">59,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1128">31,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1129">35,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1130">52,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1131">51,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1132">3,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1133">2,608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1134">3,120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1135">1,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="f-1136">777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1137">3,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1138">3,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="f-1139">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="f-1140">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease)/ increase in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1141">54,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1142">8,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1143">5,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investor tax expense on foreign subsidiary earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" format="ixt:num-dot-decimal" scale="3" id="f-1144">39,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1145">11,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1146">8,756</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1147">9,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="f-1148">2,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-1149">654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-1150">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1151">11,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1152">59,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1153">41,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1154" continuedAt="f-1154-1" escape="true">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</ix:nonNumeric></span></div><ix:continuation id="f-1154-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1155">7,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1156">10,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1157">16,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1158">23,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1159">39,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1160">37,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-1161">950,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-1162">1,078,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in foreign subsidiaries </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="3" id="f-1163">52,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="3" id="f-1164">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1165">7,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1166">7,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1167">1,073,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1168">1,158,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1169">124,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1170">88,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1171">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1172">6,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1173">20,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1174">27,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1175">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1176">3,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="f-1177">17,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="f-1178">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1179">84,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1180">66,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-1181">23,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-1182">66,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1183">8,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1184">9,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1185">290,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1186">290,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1187">42,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1188">43,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1189">247,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1190">247,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1191">825,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1192">911,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1071-3" continuedAt="f-1071-4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1193">16.9</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1194">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1195">331.4</ix:nonFraction> million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1196">1.7</ix:nonFraction> million U.S. federal NOLs, approximately $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="iclr:OperatingLossCarryforwardsUSFederal" format="ixt:num-dot-decimal" scale="6" id="f-1197">1.2</ix:nonFraction> million is currently available for offset against future U.S. federal taxable income. The subsidiaries' ability to use the remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. All $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1198">1.7</ix:nonFraction> million of the U.S. federal NOLs are limited by Section 382 and expire between 2024 - 2037. As of December&#160;31, 2023, U.S subsidiaries also had disallowed interest carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1199">204</ix:nonFraction>&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="f-1200" continuedAt="f-1200-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span></ix:nonNumeric></div><ix:continuation id="f-1200-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024-2037</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1201">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1202">271,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2038-2042</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:fixed-zero" scale="3" id="f-1203">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1204">50,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:fixed-zero" scale="3" id="f-1205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1206">9,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1207">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1208">331,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" format="ixt:num-dot-decimal" scale="6" id="f-1209">0.8</ix:nonFraction> million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1210">42.9</ix:nonFraction> million. At December&#160;31, 2023 those subsidiaries also had additional operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1211">12.9</ix:nonFraction> million which are due to expire between 2024 and 2030. In addition, at December&#160;31, 2023 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1212">4.3</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2023 was approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1213">43.0</ix:nonFraction> million. The valuation allowance for deferred tax assets as of December&#160;31, 2022 and December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1214">43.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1215">45.5</ix:nonFraction> million respectively. The net change in the total valuation allowance was a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1216">0.4</ix:nonFraction> million during 2023 and a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1217">2.1</ix:nonFraction> million during 2022. Of the total decrease of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1218">0.4</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="INF" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1219">1.1</ix:nonFraction> million was recognized within income tax expense and a increase of $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1220">0.7</ix:nonFraction> million was recognized in Other Comprehensive Income. Of the total decrease of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1221">2.1</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1222">0.8</ix:nonFraction> million was recognized within income tax expenses and $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1223">1.3</ix:nonFraction> million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2023 and December&#160;31, 2022 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and tax planning strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has recognized a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="f-1224">52.4</ix:nonFraction> million (2022: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="f-1225">1.6</ix:nonFraction> million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. Given changes in various tax laws during 2023, the group has taken the decision to repatriate certain excess earnings which will not be permanently reinvested and consequently have provided for the relevant tax in the current year. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1071-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="f-1226" escape="true"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1227">217,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1228">202,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1229">19,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:fixed-zero" scale="3" id="f-1230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:fixed-zero" scale="3" id="f-1231">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="f-1232">170,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1233">1,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1234">16,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1235">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1236">918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1237">5,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1238">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1239">4,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1240">5,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1241">18,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="f-1242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="f-1243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="f-1244">844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="f-1245">62,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="f-1246">838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="f-1247">3,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1248">160,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1249">217,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1250">202,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="f-1251">65.0</ix:nonFraction> million could potentially expire during 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2023 were potential benefits of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1252">160.0</ix:nonFraction> million, which if recognized, would affect the effective rate on income from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2022 and December&#160;31, 2021 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1253">217.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1254">202.1</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2023 amounted to a net charge of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1255">4.2</ix:nonFraction> million (2022: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1256">7.1</ix:nonFraction> million, 2021: $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1257">1.9</ix:nonFraction> million) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2023 and December&#160;31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1258">27.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="f-1259">22.6</ix:nonFraction> million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. In the United States, tax periods open to audit include the years ended December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_220"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">21.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1260" continuedAt="f-1260-1" escape="true">Employee Benefits</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1260-1" continuedAt="f-1260-2"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of <ix:nonFraction unitRef="number" contextRef="c-228" decimals="3" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-1261">4.5</ix:nonFraction>% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1262">40.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1263">45.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1264">23.7</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pension and Postretirement Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="f-1265" continuedAt="f-1265-1" escape="true">The balances recorded to the balance sheet are as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1265-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1266">6,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1267">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1268">14,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1269">13,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the specific defined benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-1270">12.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="f-1271">11.6</ix:nonFraction>&#160;million recorded to non-current other liabilities as of December&#160;31, 2023 and December&#160;31, 2022, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Development Solutions Limited, a subsidiary of ICON Plc, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 and December&#160;31, 2022  consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="f-1272" continuedAt="f-1272-1" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1273">20,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1274">19,558</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1275">27,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1276">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded surplus</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="f-1277">6,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="f-1278">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December&#160;31, 2023 and December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1260-2" continuedAt="f-1260-3"><ix:continuation id="f-1272-1" continuedAt="f-1272-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1279">19,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1280">41,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1281">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1282">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1283">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1284">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="f-1285">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="f-1286">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="f-1287">318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="f-1288">514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="f-1289">335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1290">18,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1291">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1292">3,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1293">20,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1294">19,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1295">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1296">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1297">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1298">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-1299">910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1300">7,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="f-1301">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="f-1302">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="f-1303">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="f-1304">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="f-1305">318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="f-1306">514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1307">1,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1308">3,676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1309">27,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1310">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="f-1311" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit (credit)/cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1312">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1313">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1314">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1315">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1316">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1317">665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1318">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1319">1,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1320">1,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net (gain)/loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="f-1321">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="f-1322">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="f-1323">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit)/cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="f-1324">272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="f-1325">241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="f-1326">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="f-1327" continuedAt="f-1327-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit (credit)/cost for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1328">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1329">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-1330">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1331">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1332">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="f-1333">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-238" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1334">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1335">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1336">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1260-3" continuedAt="f-1260-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="f-1337" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income/(loss)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" scale="3" id="f-1338">335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="f-1339">18,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="f-1340">2,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) - plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="f-1341">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1342">7,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1343">1,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="f-1344">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="f-1345">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="f-1346">625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" scale="3" id="f-1347">849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1348">11,559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1349">3,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income/(loss) into net periodic benefit cost over the next year are $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="f-1350">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="INF" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" format="ixt:fixed-zero" scale="6" id="f-1351">nil</ix:nonFraction> respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1327-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1352">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-236" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1353">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-1354">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-236" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="f-1355">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a <ix:nonNumeric contextRef="c-238" name="iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" format="ixt-sec:duryear" id="f-1356">19</ix:nonNumeric> year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2023 resulted from changes in the assumptions compared to those adopted at December 2022. Changes in the assumptions reflect the changes in market conditions from December 2022 to December 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="f-1357" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1358">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1359">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-243" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1360">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1361">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-245" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1362">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-246" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-1363">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company&#8217;s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is <ix:nonFraction unitRef="number" contextRef="c-247" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1364"><ix:nonFraction unitRef="number" contextRef="c-248" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-1365">3.8</ix:nonFraction></ix:nonFraction>% at December&#160;31, 2023 and December&#160;31, 2022, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="f-1366" escape="true"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1367">21,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1368">22,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1369">6,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1370">3,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1371">27,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1372">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of assets held by the plan are represented by quoted prices in active markets for identical assets and are therefore classified as level 1 investments.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1260-4" continuedAt="f-1260-5"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="f-1373">0.1</ix:nonFraction> million to the pension fund in the year ending December 31, 2024. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="f-1374" continuedAt="f-1374-1" escape="true">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</ix:nonNumeric></span></div><ix:continuation id="f-1374-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="3" id="f-1375">379</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="3" id="f-1376">420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="3" id="f-1377">679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="3" id="f-1378">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="3" id="f-1379">612</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2029 - 2033</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="f-1380">4,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next <ix:nonNumeric contextRef="c-238" name="iclr:ExpectedRetirementPeriod" format="ixt-sec:duryear" id="f-1381">10</ix:nonNumeric> years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1260-5" continuedAt="f-1260-6"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired <ix:nonFraction unitRef="number" contextRef="c-256" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1382">100</ix:nonFraction>% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 and December&#160;31, 2022 consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1272-2" continuedAt="f-1272-3"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded deficit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1383">6,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1384">5,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1385">6,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1386">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="f-1387">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="f-1388">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 were <ix:nonFraction unitRef="number" contextRef="c-257" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1389">1.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-258" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1390">2.3</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1391">5,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1392">7,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1393">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1394">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1395">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1396">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="f-1397">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="f-1398">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="f-1399">645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="f-1400">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="f-1401">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="f-1402">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="f-1403">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="f-1404">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="f-1405">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1406">1,527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="f-1407">578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="f-1408">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1409">6,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1410">5,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1411">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1412">6,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="f-1413">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="f-1414">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-1415">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-1416">987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="f-1417">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="f-1418">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="f-1419">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="f-1420">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="f-1421">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="f-1422">182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="f-1423">645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="f-1424">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="f-1425">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="f-1426">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1427">6,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1428">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1260-6"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 consist of units held in independently administered funds. <ix:continuation id="f-1272-3" continuedAt="f-1272-4">Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, </ix:continuation></span><ix:continuation id="f-1272-4" continuedAt="f-1272-5"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1272-5"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded deficit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1429">7,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1430">5,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1431">5,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1432">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="f-1433">2,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="f-1434">1,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="c-264" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1435">1.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-265" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-1436">2.3</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1437">5,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1438">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1439">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="f-1440">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1441">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-1442">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="f-1443">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="f-1444">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="f-1445">753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="f-1446">844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="f-1447">795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" format="ixt:num-dot-decimal" scale="3" id="f-1448">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="f-1449">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="f-1450">627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="f-1451">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="f-1452">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1453">7,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-1454">5,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1455">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1456">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="f-1457">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="f-1458">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (loss)/gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-1459">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-1460">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="f-1461">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="f-1462">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="f-1463">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="f-1464">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="f-1465">795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" format="ixt:num-dot-decimal" scale="3" id="f-1466">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="f-1467">753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="f-1468">844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="f-1469">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="f-1470">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1471">5,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1472">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">142</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1473" continuedAt="f-1473-1" escape="true">Equity Incentive Schemes and Stock Compensation Charges</ix:nonNumeric></span></div><ix:continuation id="f-1473-1" continuedAt="f-1473-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from <ix:nonFraction unitRef="shares" contextRef="c-269" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1474">0.4</ix:nonFraction> million to <ix:nonFraction unitRef="shares" contextRef="c-270" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1475">1.0</ix:nonFraction> million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of <ix:nonFraction unitRef="shares" contextRef="c-271" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1476">6.0</ix:nonFraction> million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of <ix:nonFraction unitRef="shares" contextRef="c-272" decimals="-5" name="iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" format="ixt:num-dot-decimal" scale="6" id="f-1477">1.0</ix:nonFraction> million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be <ix:nonFraction unitRef="shares" contextRef="c-273" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="f-1478">0.4</ix:nonFraction> million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than <ix:nonFraction unitRef="number" contextRef="c-274" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-1479">100</ix:nonFraction>% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of <ix:nonNumeric contextRef="c-275" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1480">five years</ix:nonNumeric> from date of grant and expire <ix:nonNumeric contextRef="c-275" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-1481">eight years</ix:nonNumeric> from date of grant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#8221;), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan")  were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="c-276" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1482">2.5</ix:nonFraction>&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="c-277" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1483">2.0</ix:nonFraction>&#160;million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1473-2" continuedAt="f-1473-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1484" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-278" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1485">553,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-278" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1486">108.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" format="ixt:num-dot-decimal" scale="0" id="f-1487">2,177,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-279" decimals="2" name="iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" scale="0" id="f-1488">108.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1489">100,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-279" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1490">177.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1491">1,065,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-279" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1492">111.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1493">70,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-279" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1494">128.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-280" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1495">1,695,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-280" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1496">110.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-281" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1497">108,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1498">229.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-281" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1499">348,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1500">102.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-281" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1501">77,698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1502">143.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1503">1,378,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-282" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1504">119.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1505">82,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1506">232.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-283" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1507">535,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1508">95.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-283" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1509">22,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1510">196.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1511">902,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1512">142.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1513">654,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-1514">119.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2023, was <ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1515">4.42</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1516">3.89</ix:nonNumeric> years respectively (2022: <ix:nonNumeric contextRef="c-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1517">4.69</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1518">4.25</ix:nonNumeric> years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outstanding and exercisable share options:</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-1519" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-285" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:num-dot-decimal" scale="0" id="f-1520">20.83</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="c-285" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1521">96.15</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1522">201,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-287" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1523">2.29</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1524">201,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:num-dot-decimal" scale="0" id="f-1525">103.81</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1526">121.68</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-289" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1527">132,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-290" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1528">4.54</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-289" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1529">132,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-291" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:num-dot-decimal" scale="0" id="f-1530">125.74</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="c-291" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1531">147.26</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1532">249,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-293" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1533">4.45</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1534">233,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:num-dot-decimal" scale="0" id="f-1535">159.33</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1536">233.88</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-295" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1537">319,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-296" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1538">5.69</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-295" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1539">86,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" format="ixt:num-dot-decimal" scale="0" id="f-1540">20.83</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1541">233.88</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1542">902,806</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-283" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1543">4.42</ix:nonNumeric></span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1544">142.96</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1545">654,386</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-1546">119.67</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December&#160;31, 2023. Options exercisable represent options which have vested at December&#160;31, 2023. From the date of grant, substantially all options vest over a <ix:nonNumeric contextRef="c-189" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1547">five year</ix:nonNumeric> period.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1473-3" continuedAt="f-1473-4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 was calculated using the Black-Scholes option pricing model. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-1548" continuedAt="f-1548-1" escape="true">The weighted average fair values and assumptions were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1548-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-189" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1549">85.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-192" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1550">68.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1551">49.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1552">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1553">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1554">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1558">4.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-192" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1559">1.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1560">0.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-189" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1561">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-192" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1562">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-195" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1563">5.0</ix:nonNumeric> years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-297" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1564">107.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1565">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1567">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-297" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1568">3.5</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by <ix:nonFraction unitRef="shares" contextRef="c-298" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1569">2.5</ix:nonFraction> million shares. Accordingly, an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-299" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1570">4.1</ix:nonFraction> million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.  No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. <ix:nonFraction unitRef="shares" contextRef="c-300" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1571">250,000</ix:nonFraction> ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors vest over <ix:nonNumeric contextRef="c-301" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1572">twelve months</ix:nonNumeric>. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1473-4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" id="f-1573" continuedAt="f-1573-1" escape="true">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2023:</ix:nonNumeric></span></div><ix:continuation id="f-1573-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-302" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1574">152,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-302" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1575">192.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-303" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1576">582,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-303" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1577">207.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-191" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1578">60,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-191" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1579">232.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-190" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1580">308,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-190" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1581">218.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-191" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1582">47,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-191" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1583">159.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-190" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1584">188,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-190" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1585">187.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-191" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1586">60,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-191" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1587">198.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-190" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1588">81,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-190" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1589">216.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-304" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1590">105,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-304" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1591">226.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-305" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1592">621,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-305" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1593">218.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2023 totaled $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1594">35.4</ix:nonFraction> million (2022: $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1595">34.1</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-306" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1596">159.33</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-307" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1597">265.96</ix:nonFraction> (2022: $<ix:nonFraction unitRef="usdPerShare" contextRef="c-308" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1598">137.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-309" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1599">265.96</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2023 totaled $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1600">7.5</ix:nonFraction> million (2022: $<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1601">6.5</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-310" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1602">159.33</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-311" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1603">166.51</ix:nonFraction> (2022: $<ix:nonFraction unitRef="usdPerShare" contextRef="c-312" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1604">137.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-313" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1605">166.51</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period  2021 &#8211; 2023, 2022 &#8211; 2024, and 2023 - 2025. Depending on the actual amount of EPS from 2021 to 2025, up to an additional <ix:nonFraction unitRef="shares" contextRef="c-314" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-1606">49,340</ix:nonFraction> PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2023 is stated after charging $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="f-1607">55.7</ix:nonFraction> million in respect of stock compensation expense (inclusive of employer related taxes). <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock" id="f-1608" continuedAt="f-1608-1" escape="true">Stock compensation expense has been allocated as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1608-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1609">26,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1610">22,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1611">18,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1612">29,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1613">47,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1614">41,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-1615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-1616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1617">73,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1618">55,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1619">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1620">133,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2023 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1621">20.0</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="f-1622">10.9</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1623">12.9</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="f-1624">7.7</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1625">22.7</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2021 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="f-1626">23.9</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_229"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">23. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1627" continuedAt="f-1627-1" escape="true">Business Segment and Geographical Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1627-1" continuedAt="f-1627-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#8216;CODM&#8217;) in accordance with ASC 280, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-1628">one</ix:nonFraction> reportable segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1627-2" continuedAt="f-1627-3"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the Group on the basis of an arm&#8217;s length return for the services they perform in each of their local territories. The arm&#8217;s length return for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The arm&#8217;s length return  is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model has been completed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the arm&#8217;s length revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the arm&#8217;s length revenues attributable to the activities performed outside Ireland. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the overall basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-1629" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December&#160;31, 2023 and December&#160;31, 2022 and for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1630">2,377,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1631">1,984,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1632">1,365,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1633">1,574,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1634">1,618,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1635">1,175,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1636">3,283,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1637">3,574,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1638">2,581,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1639">884,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1640">563,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1641">358,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1642">8,120,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1643">7,741,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1644">5,480,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) <ix:nonNumeric contextRef="c-1" name="iclr:OperatingIncomeByGeographyTableTextBlock" id="f-1645" continuedAt="f-1645-1" escape="true">The distribution of income from operations (including Restructuring) by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1645-1" continuedAt="f-1645-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1646">432,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1647">218,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1648">131,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1649">153,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1650">253,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1651">177,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1652">310,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1653">254,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1654">39,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1655">60,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1656">68,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1657">29,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1658">956,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1659">795,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1660">378,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:continuation id="f-1645-2">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-1627-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-1661" continuedAt="f-1661-1" escape="true">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1661-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1662">199,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1663">143,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1664">94,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1665">99,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1666">159,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1667">213,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1668">49,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1669">48,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span id="ib1b5cc593b5a4d838e37be253e511406_6-1-1-1-225727"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1670">501,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1671">504,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_235"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1672" continuedAt="f-1672-1" escape="true">Net Income Per Ordinary Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1672-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1673" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1674">82,101,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1675">81,532,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1676">67,110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1677">615,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1678">936,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1679">958,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1680">82,717,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1681">82,468,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1682">68,068,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1683" escape="true"><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1684">7.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1685">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1686">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1687">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1688">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1689">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_238"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">25. <ix:nonNumeric contextRef="c-1" name="iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock" id="f-1690" continuedAt="f-1690-1" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-1691" escape="true"><ix:continuation id="f-1690-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1692">149,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1693">175,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1694">7,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1695">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1696">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1697">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1698">143,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1699">171,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:5pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_241"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">26. <ix:nonNumeric contextRef="c-1" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="f-1700" continuedAt="f-1700-1" escape="true">Supplemental Disclosure of Cash Flow Information</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="f-1701" escape="true"><ix:continuation id="f-1700-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1702">317,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1703">210,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1704">106,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1705">163,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1706">116,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1707">55,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:3pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_244"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">27.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1708" continuedAt="f-1708-1" escape="true">Related Parties </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1708-1" continuedAt="f-1708-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="0" id="f-1709">243,000</ix:nonFraction> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="0" id="f-1710">428,000</ix:nonFraction>) from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder</span><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">of Corvus Pharmaceuticals. $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-3" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="0" id="f-1711">101,000</ix:nonFraction> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-3" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="0" id="f-1712">231,000</ix:nonFraction>) was noted as due from Corvus Pharmaceuticals at December&#160;31, 2023. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="0" id="f-1713">45,000</ix:nonFraction> (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="0" id="f-1714">235,000</ix:nonFraction>) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-3" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="0" id="f-1715">47,000</ix:nonFraction> was noted as due from Afimmune Limited at December&#160;31, 2023 (December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-3" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="0" id="f-1716">263,000</ix:nonFraction>).&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-1708-2" continuedAt="f-1708-3"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), a specialized oncology site network in the US and EMEA regions, with a third party. The Company invested $<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1717">4.9</ix:nonFraction>&#160;million to obtain a <ix:nonFraction unitRef="number" contextRef="c-340" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1718">49</ix:nonFraction>% interest in the voting share capital of Oncacare. On April 20, 2023, the Company completed the purchase of the majority investor&#8217;s <ix:nonFraction unitRef="number" contextRef="c-78" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1719">51</ix:nonFraction>% majority voting share capital of Oncacare. The consideration paid by ICON to purchase the <ix:nonFraction unitRef="number" contextRef="c-78" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1720">51</ix:nonFraction>% majority voting share capital was $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-1721">5.1</ix:nonFraction>&#160;million. As a result of this transaction (the "Oncacare acquisition"), Oncacare and its subsidiaries became wholly owned subsidiaries of the ICON Group. Prior to the Oncacare acquisition, the Company recorded losses of $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1722">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1723">3.1</ix:nonFraction> million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023 and December&#160;31, 2022, respectively. The Oncacare acquisition also resulted in goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-1724">13.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and gave rise to an acquisition-related gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1725">6.2</ix:nonFraction> million</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-1708-3">.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_247"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">28.  </span><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1726" continuedAt="f-1726-1" escape="true"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Subsequent Events</span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="f-1726-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has evaluated subsequent events from the Balance Sheet date through February&#160;23, 2024, the date at which the consolidated financial statements were available to be issued. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">n February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-1727">500</ix:nonFraction>&#160;million of the outstanding ordinary shares of the Company. All ordinary shares that are redeemed under the buyback program will be </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has determined that there are no other items to disclose.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">149</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_250"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 19. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibits of ICON plc and subsidiaries</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:81.917%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121006002/nc10020781x8_ex2-1.htm">2.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of February 24, 2021, by and among ICON plc, ICON US Holdings Inc., Indigo Merger Sub, Inc and PRA Health Sciences, Inc. (incorporated by reference to exhibit 2.1 to the Form 6-K (file No. 333-08704) filed on February 24, 2021).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-2023.htm">2.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of Securities Registered Under Section 12 of the Exchange Act.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-1.htm">2.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Credit Agreement, dated as of July 1, 2021, by and among ICON Luxembourg, S.&#192; R.L., ICON Clinical Investments, LLC, Indigo Merger Sub, Inc. (which, after giving effect to the Merger on the Closing Date was succeeded by PRA Health Sciences, Inc.), ICON Public Limited Company, the other borrowers party thereto from time to time, the subsidiary guarantors party thereto from time to time, lenders party thereto Citibank, N.A., as administrative agent, and Citibank, N.A., London Branch, as collateral agent (incorporated by reference to exhibit 99.1 to the Form 6-K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-2.htm">2.4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of July 1, 2021, by and among Indigo Merger Sub, Inc., PRA Health Sciences, Inc., the guarantors party thereto and Citibank, N.A., London Branch as trustee, notes collateral agent, paying agent, transfer agent and registrar (incorporated by reference to exhibit 99.2 to the Form 6-K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000106095523000007/exhibit25-2022.htm">2.5</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amendment No. 1 to the Credit Agreement referred to at Exhibit 2.3, dated as of November 29, 2022, by and among ICON Public Limited Company and Citibank, N.A., as administrative agent. (incorporated by reference to exhibit 2.5 to the Form 20-F (File No. 333-08704) filed on February 24, 2023).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000106095523000027/exhibit991-q22023.htm">2.6</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second Amendment to Credit Agreement, dated as of May 2, 2023, by and among various subsidiaries of ICON plc, Citibank, N.A., as administrative agent and swingline lender, and various revolving lenders. (incorporated by reference to exhibit 99.1 to the Form 6-K (File No. 333-08704) filed on July 28, 2023).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1060955/000115752316006157/a51386268ex99_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of the Constitution of the Company (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 25, 2016).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit121-2023.htm">12.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 302 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit122-2023.htm">12.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 906 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit161.htm">16.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Letter from KPMG to the Securities and Exchange Commission, dated February&#160;23, 2024.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5d6bb8168831487587e557a7e54136dd_498523">21.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">List of Subsidiaries (incorporated by reference to Item 4 of Form 20-F filed herewith).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2023.htm">23.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consent of KPMG, Independent Registered Public Accounting Firm.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit97.htm">97*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON plc Clawback Policy, adopted on July 25, 2023 relating to recovery of erroneously awarded compensation, as required by applicable listing standards adopted pursuant to 17 CFR 240.10D-1. </span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interactive Data Files (Inline XBRL &#8211; Related Documents).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* &#160; Filed herewith</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150</span></div></div></div><div id="ic99b143eeb0141b5b05d5432a6bc5066_253"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;Brendan Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date: February&#160;23, 2024 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">151</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>exhibit22-2023.htm
<DESCRIPTION>EX-2.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i3b009521f0654c299c1f4f8fd8d0e3b2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 2.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Description of Securities  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">    Registered Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 ICON plc (&#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had the following series of securities registered pursuant to Section 12(b) of the Exchange Act&#58; </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares, nominal value &#8364;0.06 per share</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICLR</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NASDAQ Global Select Market</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Ordinary Shares </font></div><div style="padding-left:180pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.General</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.1. Limitations or qualifications </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.2. Other rights </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.3. Type and class of securities </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each ICON plc share has nominal value of &#8364;0.06 per share. The respective number of shares that have been issued as of December&#160;31, 2023 is given in the Consolidated Balance Sheet of the annual report on Form 20-F for the fiscal year ended December&#160;31, 2023. All ICON shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities or profit-sharing certificates have been issued. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.4. Pre-emptive rights</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.B Memorandum and articles of association</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> 10.B.1 Shareholder Rights, Preferences and Dividends Attaching to Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.2. Action Necessary to Change the Rights of Shareholders </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.3  Annual and General Meetings</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.4 Limitations on the Right to Own Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no limitations on the right to own shares in the Constitution of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.5 Disclosure of Share Ownership </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.6 Other Provisions of the Constitution</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no provisions in the Constitution of the Company&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>exhibit121-2023.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ib905f711fecd456c9713482c4a75d1eb_1"></div><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 12.1</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:179.45pt;padding-right:179.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification of Chief Financial Officer</font></div><div style="margin-top:0.45pt;padding-left:193.95pt;padding-right:193.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:121%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:390.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I, Brendan Brennan, certify that&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:196.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.65pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.55pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.7pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">c)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Dated&#58; February&#160;23, 2024</font></div><div style="padding-right:3.6pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Brendan Brennan      </font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib905f711fecd456c9713482c4a75d1eb_4"></div><hr style="page-break-after:always"><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:177.95pt;padding-right:177.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification of Chief Executive Officer</font></div><div style="margin-top:0.45pt;padding-left:193.95pt;padding-right:193.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:121%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:411.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I, Steve Cutler, certify that&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:196.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.65pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.55pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.7pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Dated&#58; February&#160;23, 2024</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:8.15pt;padding-right:452.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steve Cutler              </font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:465pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:423.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>exhibit122-2023.htm
<DESCRIPTION>EX-12.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ia82395fee885464c9a07a7c4b69348c6_1"></div><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 12.2</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:157.05pt;padding-right:157.05pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-top:0.45pt;padding-left:108.52pt;padding-right:108.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Brendan Brennan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58; February&#160;23, 2024</font></div><div style="margin-top:0.2pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Brendan Brennan      </font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:12.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia82395fee885464c9a07a7c4b69348c6_4"></div><hr style="page-break-after:always"><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:157.05pt;padding-right:157.05pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-top:0.45pt;padding-left:108.52pt;padding-right:108.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Steve Cutler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:40.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="padding-left:5.5pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58; February&#160;23, 2024</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:8.15pt;padding-right:452.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steve Cutler               </font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:465pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:423.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:111%">Chief Executive Officer</font></div><div style="margin-top:0.75pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>5
<FILENAME>exhibit161.htm
<DESCRIPTION>EX-16.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i4a5cca2a43694abc86e6e4e8e7969aa6_1"></div><div style="min-height:156.24pt;width:100%"><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 16.1</font></div></div><div style="margin-bottom:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">February&#160;23, 2024</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Securities and Exchange Commission<br>Washington, D.C. 20549</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are currently principal accountants for ICON plc and, under the date of February&#160;23, 2024, we reported on the consolidated financial statements of ICON plc as of and for the years ended December&#160;31, 2023 and 2022 and the effectiveness of internal control over financial reporting as of December&#160;31, 2023. In 2024 we were notified that ICON plc intend to appoint Ernst &#38; Young Chartered Accountants as its principal accountant for the year ending December&#160;31, 2025 and that the auditor-client relationship with KPMG will cease upon completion of the audit of ICON plc's consolidated financial statements as of and for the year ended December&#160;31, 2024, and the effectiveness of internal control over financial reporting as of December&#160;31, 2024, and the issuance of our reports thereon. We have read ICON plc&#8217;s statements included under Item 16F of its Form 20-F dated February&#160;23, 2024, and we agree with such statements, except that we are not in a position to agree or disagree with ICON plc&#8217;s statement that the appointment will be subject to the passing of an ordinary resolution confirming the appointment at the Company's 2025 Annual General Meeting.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Very truly yours,</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#47;s&#47; KPMG</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>exhibit231-2023.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if7a8dc31adb14ca08615efafd9633e7c_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:63pt"><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 23.1</font></div><div style="margin-bottom:0.1pt;padding-right:5.45pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">We consent to the incorporation by reference in the registration statements (No. 333-231527, 333-204153, 333-190068, 333-152802, 333-257578 and 333-254891) on Form S-8 of our reports dated February&#160;23, 2024 with respect to the consolidated financial statements of ICON plc and the effectiveness of internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;text-decoration:underline">&#47;s&#47; KPMG             </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Dublin, Ireland</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February&#160;23, 2024</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>7
<FILENAME>exhibit97.htm
<DESCRIPTION>EX-97
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="idcc5998f98f640eaa7fb8b3aa3da1a1e_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 97</font></div></div><div style="margin-bottom:40pt;margin-top:12pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:51px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ICON plc Clawback Policy</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Adopted on 25 July 2023</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Clawback Policy (this&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) provides the standards for the recoupment of certain erroneously awarded executive compensation in the event of an accounting restatement due to the material noncompliance of ICON plc (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ICON</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with any reporting requirement under the securities laws.  This Policy has been designed to ensure that ICON is in compliance with the requirements of Section 10D of the Securities Exchange Act of 1934, as amended (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Rule 10D-1 promulgated by the Securities and Exchange Commission under the Exchange Act and the listing rules of the NASDAQ Global Select Market (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NASDAQ</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  This Policy applies with respect to all incentive compensation, including annual cash incentives and restricted share units subject to performance conditions, received by members of the ICON Executive Team and other current and former executive officers of ICON, each as provided below.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Persons Covered</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Policy applies to all current or former executive officers of ICON within the meaning of NASDAQ Listing Rule 5608 and Exchange Act Rule 10D-1. This Policy will also apply to other members of senior management of ICON designated by the Board of Directors of ICON (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) from time to time.  Each executive officer or other individual to whom this Policy applies is referred to as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Covered Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Compensation</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Policy applies with respect to compensation, including annual cash incentives and restricted share units subject to performance conditions, that is granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure within the meaning of NASDAQ Listing Rule 5608, including the attainment of earnings per share (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Incentive-Based Compensation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Incentive-Based Compensation does not include stock options or restricted stock units that vest (without any performance condition) upon completion of a specified employment period or bonus awards that are discretionary or based on subjective goals unrelated to financial performance.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Effective Date</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Policy is effective as of 2 October 2023 (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and applies to all Incentive-Based Compensation received on or after the Effective Date by any Covered Executive who served as a member of the ICON Executive Team or in any other position as a Covered Executive at any time during the performance period that is covered by the Incentive-Based Compensation.  For purposes of this Policy, Incentive-Based Compensation is &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">received</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ICON&#8217;s fiscal period during which the financial reporting measure specified for the compensation has been attained.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Restatement</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Incentive-Based Compensation may be subject to recovery under this Policy in the event ICON is required to prepare an accounting restatement due to the material noncompliance of ICON with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restatement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Recovery Period</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Incentive-Based Compensation received by a Covered Executive on or after the Effective Date is subject to recovery under this Policy if the Covered Executive served in any position as a Covered Executive at any time during the performance period, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Incentive-Based Compensation is received after the beginning of the Covered Executive&#8217;s service as a Covered Executive and during the last three completed fiscal years immediately preceding the date that ICON is required to prepare a Restatement (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recovery Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The date that ICON is required to prepare a Restatement is the earlier of (x)&#160;the date the Board, a committee of the Board, or the officer or officers of ICON authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that ICON is required to prepare a Restatement, or (y)&#160;the date a court, regulator or other legally authorized body directs ICON to prepare a Restatement.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Recovery Amount</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event ICON is required to prepare a Restatement, ICON will recover reasonably promptly the amount of Incentive-Based Compensation received during the Recovery Period that exceeds the amount of the Incentive-Based Compensation that would have been received had it been determined based on the Restatement, without regard to taxes paid (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recovery Amount</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  For any Incentive-Based Compensation based on share price or total shareholder return, and where the Recovery Amount is not subject to mathematical recalculation directly from the information in the Restatement, the Recovery Amount will instead be determined based on a reasonable estimate of the effect of the Restatement on the share price or total shareholder return.</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ICON will recover the Recovery Amount in compliance with this Policy except to the extent that the Compensation &#38; Organisation Committee of the Board (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) has determined that recovery would be impracticable </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i)&#160;the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered and ICON has made a reasonable attempt to recover the Recovery Amount, (ii)&#160;recovery would violate home country law adopted prior to November 28, 2022, or (iii)&#160;recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to ICON employees, to fail to meet the requirements of 26 U.S.C. 401(a)(13 or 26 U.S. C. 411(a) and the regulations thereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Administration</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board and, if designated by the Board, the Committee will administer and will have full authority to interpret and to enforce this Policy consistent with the requirements of NASDAQ Listing Rule 5608 and Exchange Act Rule 10D-1 and to determine the method for recovering Incentive-Based Compensation subject to recovery under this Policy.  Any determinations made by the Board or Committee in accordance with this Policy shall be final and binding on all persons.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Miscellaneous </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.23pt">ICON may not indemnify any Covered Executive against the loss of Incentive-Based Compensation.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.23pt">This Policy will be binding on and enforceable against all Covered Executives and each of their beneficiaries, heirs, executors, administrators and legal representatives. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.84pt">The Board may amend, modify or terminate this Policy in whole or in part and at any time.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Non-Exclusivity</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ICON intends that this Policy will be applied to the fullest extent of the law and may require that any employment agreement, equity award agreement, or similar agreement require a Covered Executive to agree to abide by the terms of this Policy as a condition to the grant of any right or benefit thereunder. Any right of recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment or recovery that may be available pursuant to the terms of any similar clawback or recovery policy or in any employment agreement, equity award agreement, or similar agreement, or any other rights or remedies available under applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>iclr-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0c105b40-162f-4950-b2b2-c13f61a02230,g:35370e08-e85b-4be7-afdb-42ad7a0d101f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iclr="http://www.iconplc.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.iconplc.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.iconplc.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.iconplc.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Descriptionofbusiness" roleURI="http://www.iconplc.com/role/Descriptionofbusiness">
        <link:definition>0000009 - Disclosure - Description of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpolicies" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenue" roleURI="http://www.iconplc.com/role/DisaggregationofRevenue">
        <link:definition>0000011 - Disclosure - Disaggregation of Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalances" roleURI="http://www.iconplc.com/role/ContractBalances">
        <link:definition>0000012 - Disclosure - Contract Balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLosses" roleURI="http://www.iconplc.com/role/AllowancesforCreditLosses">
        <link:definition>0000013 - Disclosure - Allowances for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.iconplc.com/role/BusinessCombinations">
        <link:definition>0000014 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.iconplc.com/role/FairValue">
        <link:definition>0000015 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.iconplc.com/role/Investments">
        <link:definition>0000016 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnet" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet">
        <link:definition>0000017 - Disclosure - Property, Plant and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.iconplc.com/role/Goodwill">
        <link:definition>0000018 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.iconplc.com/role/IntangibleAssets">
        <link:definition>0000019 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilities" roleURI="http://www.iconplc.com/role/OtherLiabilities">
        <link:definition>0000020 - Disclosure - Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilities" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilities">
        <link:definition>0000021 - Disclosure - Bank Credit Lines and Loan Facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.iconplc.com/role/Derivatives">
        <link:definition>0000022 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.iconplc.com/role/OperatingLeases">
        <link:definition>0000023 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Noncurrentotherliabilities" roleURI="http://www.iconplc.com/role/Noncurrentotherliabilities">
        <link:definition>0000024 - Disclosure - Non-current other liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.iconplc.com/role/CommitmentsandContingencies">
        <link:definition>0000025 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapital" roleURI="http://www.iconplc.com/role/ShareCapital">
        <link:definition>0000026 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.iconplc.com/role/RestructuringCharges">
        <link:definition>0000027 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.iconplc.com/role/IncomeTaxes">
        <link:definition>0000028 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://www.iconplc.com/role/EmployeeBenefits">
        <link:definition>0000029 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationCharges" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges">
        <link:definition>0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformation" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation">
        <link:definition>0000031 - Disclosure - Business Segment and Geographical Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShare" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare">
        <link:definition>0000032 - Disclosure - Net Income Per Ordinary Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>0000033 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformation" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation">
        <link:definition>0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://www.iconplc.com/role/RelatedParties">
        <link:definition>0000035 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.iconplc.com/role/SubsequentEvents">
        <link:definition>0000036 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesPolicies" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesTables" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables">
        <link:definition>9954472 - Disclosure - Summary of Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueTables" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables">
        <link:definition>9954473 - Disclosure - Disaggregation of Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesTables" roleURI="http://www.iconplc.com/role/ContractBalancesTables">
        <link:definition>9954474 - Disclosure - Contract Balances (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLossesTables" roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesTables">
        <link:definition>9954475 - Disclosure - Allowances for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.iconplc.com/role/BusinessCombinationsTables">
        <link:definition>9954476 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.iconplc.com/role/FairValueTables">
        <link:definition>9954477 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetTables" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables">
        <link:definition>9954478 - Disclosure - Property, Plant and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.iconplc.com/role/GoodwillTables">
        <link:definition>9954479 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.iconplc.com/role/IntangibleAssetsTables">
        <link:definition>9954480 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesTables" roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables">
        <link:definition>9954481 - Disclosure - Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesTables" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables">
        <link:definition>9954482 - Disclosure - Bank Credit Lines and Loan Facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.iconplc.com/role/DerivativesTables">
        <link:definition>9954483 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.iconplc.com/role/OperatingLeasesTables">
        <link:definition>9954484 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentotherliabilitiesTables" roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables">
        <link:definition>9954485 - Disclosure - Non-current other liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesTables" roleURI="http://www.iconplc.com/role/RestructuringchargesTables">
        <link:definition>9954486 - Disclosure - Restructuring charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.iconplc.com/role/IncomeTaxesTables">
        <link:definition>9954487 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://www.iconplc.com/role/EmployeeBenefitsTables">
        <link:definition>9954488 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesTables" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables">
        <link:definition>9954489 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationTables" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables">
        <link:definition>9954490 - Disclosure - Business Segment and Geographical Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareTables" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables">
        <link:definition>9954491 - Disclosure - Net Income Per Ordinary Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>9954492 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationTables" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables">
        <link:definition>9954493 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofbusinessDetails" roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails">
        <link:definition>9954494 - Disclosure - Description of business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails">
        <link:definition>9954495 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails">
        <link:definition>9954496 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails">
        <link:definition>9954497 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueDetails" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails">
        <link:definition>9954498 - Disclosure - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesContractswithCustomersDetails" roleURI="http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails">
        <link:definition>9954499 - Disclosure - Contract Balances - Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesNarrativeDetails" roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails">
        <link:definition>9954500 - Disclosure - Contract Balances - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesNarrativeDetails_1" roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1">
        <link:definition>9954500 - Disclosure - Contract Balances - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLossesDetails" roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesDetails">
        <link:definition>9954501 - Disclosure - Allowances for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeBiotelAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails">
        <link:definition>9954502 - Disclosure - Business Combinations - Narrative, Biotel Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeOncacareAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails">
        <link:definition>9954503 - Disclosure - Business Combinations - Narrative, Oncacare Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativePRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails">
        <link:definition>9954504 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails">
        <link:definition>9954505 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails">
        <link:definition>9954506 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails">
        <link:definition>9954507 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails">
        <link:definition>9954508 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails">
        <link:definition>9954509 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueNarrativeDetails" roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails">
        <link:definition>9954510 - Disclosure - Fair value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails">
        <link:definition>9954511 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetDetails" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails">
        <link:definition>9954512 - Disclosure - Property, Plant and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetNarrativeDetails" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails">
        <link:definition>9954513 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofGoodwillDetails" roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails">
        <link:definition>9954514 - Disclosure - Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.iconplc.com/role/GoodwillNarrativeDetails">
        <link:definition>9954515 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails">
        <link:definition>9954516 - Disclosure - Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>9954517 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails">
        <link:definition>9954518 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesDetails" roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails">
        <link:definition>9954519 - Disclosure - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails">
        <link:definition>9954520 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesNarrativeDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails">
        <link:definition>9954521 - Disclosure - Bank Credit Lines and Loan Facilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails">
        <link:definition>9954522 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails">
        <link:definition>9954523 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails">
        <link:definition>9954524 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Principal payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails">
        <link:definition>9954525 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Movement on Debt Instrument (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesNarrativeDetails" roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails">
        <link:definition>9954526 - Disclosure - Derivatives - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails">
        <link:definition>9954527 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesLeaseCostsDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails">
        <link:definition>9954528 - Disclosure - Operating Leases - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesNarrativeDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails">
        <link:definition>9954529 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails">
        <link:definition>9954530 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1">
        <link:definition>9954530 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentotherliabilitiesDetails" roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails">
        <link:definition>9954531 - Disclosure - Non-current other liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>9954532 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapitalDetails" roleURI="http://www.iconplc.com/role/ShareCapitalDetails">
        <link:definition>9954533 - Disclosure - Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesNarrativeDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails">
        <link:definition>9954534 - Disclosure - Restructuring charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesScheduleofRestructuringChargesDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails">
        <link:definition>9954535 - Disclosure - Restructuring charges - Schedule of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>9954536 - Disclosure - Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails">
        <link:definition>9954537 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
        <link:definition>9954538 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails">
        <link:definition>9954539 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954540 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9954541 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesExpectedExpiryDatesofNOLsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails">
        <link:definition>9954542 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails">
        <link:definition>9954543 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNarrativeDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails">
        <link:definition>9954544 - Disclosure - Employee Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails">
        <link:definition>9954545 - Disclosure - Employee Benefits - Schedule of Amounts Recognized in Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsFundedStatusDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails">
        <link:definition>9954546 - Disclosure - Employee Benefits - Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangeinBenefitObligationsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails">
        <link:definition>9954547 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangeinPlanAssetsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails">
        <link:definition>9954548 - Disclosure - Employee Benefits - Change in Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>9954549 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails">
        <link:definition>9954550 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails">
        <link:definition>9954551 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails">
        <link:definition>9954552 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails">
        <link:definition>9954553 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAnnualBenefitPaymentsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails">
        <link:definition>9954554 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails">
        <link:definition>9954555 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails">
        <link:definition>9954556 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails">
        <link:definition>9954557 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails">
        <link:definition>9954558 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails">
        <link:definition>9954559 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails">
        <link:definition>9954560 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationNarrativeDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails">
        <link:definition>9954561 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails">
        <link:definition>9954562 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails">
        <link:definition>9954563 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails">
        <link:definition>9954564 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails">
        <link:definition>9954565 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails">
        <link:definition>9954566 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails">
        <link:definition>9954567 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationDetails" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails">
        <link:definition>9954568 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartiesDetails" roleURI="http://www.iconplc.com/role/RelatedPartiesDetails">
        <link:definition>9954569 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.iconplc.com/role/SubsequentEventsDetails">
        <link:definition>9954570 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" abstract="false" name="AdjustmentToRetainedEarningShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeBeforeIncomeTaxTableTextBlock" abstract="false" name="IncomeBeforeIncomeTaxTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NonexecutiveDirectorMember" abstract="true" name="NonexecutiveDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_VariableRateComponentAxis" abstract="true" name="VariableRateComponentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_Range2Member" abstract="true" name="Range2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_TransactionAndIntegrationExpenseMember" abstract="true" name="TransactionAndIntegrationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" abstract="false" name="DerivativeVariableInterestRateReferenceRateInExcessOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_The2018LegacyPRAPlanMember" abstract="true" name="The2018LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" abstract="false" name="DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="AdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestructuringReserveUtilizations" abstract="false" name="RestructuringReserveUtilizations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Clients1125Member" abstract="true" name="Clients1125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" abstract="false" name="BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AwardDateAllYearsExcluding2018Member" abstract="true" name="AwardDateAllYearsExcluding2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_LongTermDebtExcludingCurrentMaturitiesGross" abstract="false" name="LongTermDebtExcludingCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PRASwitzerlandAGPensionPlanMember" abstract="true" name="PRASwitzerlandAGPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" abstract="false" name="ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_OperatingIncomeByGeographyTableTextBlock" abstract="false" name="OperatingIncomeByGeographyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_VariableRateComponentTwoMember" abstract="true" name="VariableRateComponentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherGeographicLocationsMember" abstract="true" name="OtherGeographicLocationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" abstract="false" name="OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" abstract="false" name="AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ContractsReceivableGross" abstract="false" name="ContractsReceivableGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear2024To2030Member" abstract="true" name="TaxYear2024To2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" abstract="false" name="OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_AptivSolutionsPensionPlanMember" abstract="true" name="AptivSolutionsPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_LongTermDebtCurrentMaturitiesGross" abstract="false" name="LongTermDebtCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_CorvusPharmaceuticalsMember" abstract="true" name="CorvusPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DiversifiedBondsMember" abstract="true" name="DiversifiedBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_RestructuringReserveandOtherLiabilitiesCurrent" abstract="false" name="RestructuringReserveandOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" abstract="false" name="ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_A2021RestructuringPlanMember" abstract="true" name="A2021RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ExpectedRetirementPeriod" abstract="false" name="ExpectedRetirementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_PRAHealthSciencesIncMember" abstract="true" name="PRAHealthSciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" abstract="false" name="DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PaymentsForShareRepurchaseCosts" abstract="false" name="PaymentsForShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_StockOptionAndAwardPlansMember" abstract="true" name="StockOptionAndAwardPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear2024To2037Member" abstract="true" name="TaxYear2024To2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ResearchandDevelopmentCreditsPolicyTextBlock" abstract="false" name="ResearchandDevelopmentCreditsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iclr_TaxYear20382042Member" abstract="true" name="TaxYear20382042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_IncomeTaxBenefitMember" abstract="true" name="IncomeTaxBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" abstract="false" name="DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" abstract="true" name="ICONDevelopmentSolutionsLimitedPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" abstract="false" name="BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestOfEuropeAndOtherCountriesMember" abstract="true" name="RestOfEuropeAndOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" abstract="false" name="DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_InterestRateCapAndInterestRateSwapMember" abstract="true" name="InterestRateCapAndInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfNonCashStockCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesTable" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_Clients610Member" abstract="true" name="Clients610Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" abstract="true" name="ConsultantsRestrictedStockUnitsTwentyNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_EmployeeStockPlanTwentyZeroEightPlanMember" abstract="true" name="EmployeeStockPlanTwentyZeroEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AfimmuneLimitedMember" abstract="true" name="AfimmuneLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_LeaseLiabilityMember" abstract="true" name="LeaseLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_GainLossOnIssuanceOfDebt" abstract="false" name="GainLossOnIssuanceOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" abstract="false" name="ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" abstract="true" name="SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DeferredTaxAssetContractWithCustomerLiability" abstract="false" name="DeferredTaxAssetContractWithCustomerLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BuybackProgramMember" abstract="true" name="BuybackProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapitalMember" abstract="true" name="OtherUndenominatedCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_TransactionAndOneTimeFinancingCosts" abstract="false" name="TransactionAndOneTimeFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" abstract="false" name="IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestOfEuropeMember" abstract="true" name="RestOfEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_BiotelResearchLLCMember" abstract="true" name="BiotelResearchLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredRevolvingLoanFacilityMember" abstract="true" name="SeniorSecuredRevolvingLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapital" abstract="false" name="OtherUndenominatedCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_CapitalGovernmentGrantsCurrent" abstract="false" name="CapitalGovernmentGrantsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_The2020LegacyPRAPlanMember" abstract="true" name="The2020LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_RestrictedStockUnitsTwentyThirteenMember" abstract="true" name="RestrictedStockUnitsTwentyThirteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_NumberOfLocations" abstract="false" name="NumberOfLocations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_AptivSolutionsMember" abstract="true" name="AptivSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" abstract="false" name="IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range1Member" abstract="true" name="Range1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" abstract="false" name="LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_OtherRetirementPlansMember" abstract="true" name="OtherRetirementPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ContractsReceivableNet" abstract="false" name="ContractsReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" abstract="false" name="ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentDomain" abstract="true" name="VariableRateComponentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesMember" abstract="true" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AccountsReceivableCreditLossExpense" abstract="false" name="AccountsReceivableCreditLossExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_LongTermDebtMaturityYearFiveAndThereafter" abstract="false" name="LongTermDebtMaturityYearFiveAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_StockRepurchaseProgramAuthorizedPercentage" abstract="false" name="StockRepurchaseProgramAuthorizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_OtherCustomersMember" abstract="true" name="OtherCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ConsultantsStockPlan2008PlanMember" abstract="true" name="ConsultantsStockPlan2008PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_CommitmentToAcquireLongTermInvestments" abstract="false" name="CommitmentToAcquireLongTermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NumberOfVotes" abstract="false" name="NumberOfVotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PerformanceBasedGrantsMember" abstract="true" name="PerformanceBasedGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_GovernmentGrantsPolicyTextBlock" abstract="false" name="GovernmentGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range4Member" abstract="true" name="Range4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" abstract="false" name="BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iclr_VehiclesGross" abstract="false" name="VehiclesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range3Member" abstract="true" name="Range3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" abstract="false" name="OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Clients25Member" abstract="true" name="Clients25Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ForeignCurrencyDisclosureTableTextBlock" abstract="false" name="ForeignCurrencyDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" abstract="false" name="DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TopClientMember" abstract="true" name="TopClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" abstract="false" name="AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_InterestExpenseCreditOther" abstract="false" name="InterestExpenseCreditOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_PerformanceShareUnitMember" abstract="true" name="PerformanceShareUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OncacareMember" abstract="true" name="OncacareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" abstract="false" name="ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_OperatingLossCarryforwardsUSFederal" abstract="false" name="OperatingLossCarryforwardsUSFederal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentOneMember" abstract="true" name="VariableRateComponentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OptionPlans2008Member" abstract="true" name="OptionPlans2008Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_GovernmentBondsMember" abstract="true" name="GovernmentBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanSchemeContributions" abstract="false" name="DefinedBenefitPlanSchemeContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ComputerEquipmentAndCapitalizedSoftwareMember" abstract="true" name="ComputerEquipmentAndCapitalizedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>iclr-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0c105b40-162f-4950-b2b2-c13f61a02230,g:35370e08-e85b-4be7-afdb-42ad7a0d101f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d765296-8928-449e-9ecd-354312afa1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d765296-8928-449e-9ecd-354312afa1ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c67e0e61-88b9-412b-8e04-76af42338461" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c67e0e61-88b9-412b-8e04-76af42338461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f82aaa3e-ffd5-4b05-a2dd-081fc9764cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f82aaa3e-ffd5-4b05-a2dd-081fc9764cba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_74c96515-5259-4170-9279-66a37da9e6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_74c96515-5259-4170-9279-66a37da9e6e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_0c1ee0c9-b513-4292-b3f9-6dfe441026a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_0c1ee0c9-b513-4292-b3f9-6dfe441026a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a990fe84-018c-4232-bbe1-de8f14a7394d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a990fe84-018c-4232-bbe1-de8f14a7394d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_108c73b2-aeca-4ca7-9e7a-10eb43619694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3fafd5bb-2cbc-4a0b-9250-05c5208847e3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_108c73b2-aeca-4ca7-9e7a-10eb43619694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2907735b-bee3-4aa9-9b13-e0b7e77a7090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_LiabilitiesCurrent_2907735b-bee3-4aa9-9b13-e0b7e77a7090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_6fff3f42-2bcb-41c5-ab53-b382abae4f79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_LongTermLineOfCredit_6fff3f42-2bcb-41c5-ab53-b382abae4f79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0223bb37-f361-4849-9203-76fdf9c147cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0223bb37-f361-4849-9203-76fdf9c147cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_93f7851f-bd01-4d05-9c8b-3c464e1e6850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_93f7851f-bd01-4d05-9c8b-3c464e1e6850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_9d458a8a-78e9-4c3a-af6b-73f5b010e9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_9d458a8a-78e9-4c3a-af6b-73f5b010e9d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_24985dbb-150d-4973-80d8-80d63df16858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_24985dbb-150d-4973-80d8-80d63df16858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6f3403ab-3321-4c12-908e-8ab10c07866f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_289cc528-37a6-4d45-b83d-6f1f7e23a0c0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6f3403ab-3321-4c12-908e-8ab10c07866f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_989cab30-af3e-401f-8f66-4286af66567f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f30bbba7-a705-45e4-aa4c-4a15e4e3dda8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_989cab30-af3e-401f-8f66-4286af66567f" xlink:to="loc_us-gaap_CommonStockValue_f30bbba7-a705-45e4-aa4c-4a15e4e3dda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0219dacd-019f-49b6-af14-536c35894c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_989cab30-af3e-401f-8f66-4286af66567f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0219dacd-019f-49b6-af14-536c35894c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_d9cfd305-e190-4a17-8ffe-516605347b69" xlink:href="iclr-20231231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_989cab30-af3e-401f-8f66-4286af66567f" xlink:to="loc_iclr_OtherUndenominatedCapital_d9cfd305-e190-4a17-8ffe-516605347b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_09fe1bc4-64c8-4b6b-9e98-77d1ca60f606" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_989cab30-af3e-401f-8f66-4286af66567f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_09fe1bc4-64c8-4b6b-9e98-77d1ca60f606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8b752d2a-928d-4d48-b4c4-30b39b7c67a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_989cab30-af3e-401f-8f66-4286af66567f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8b752d2a-928d-4d48-b4c4-30b39b7c67a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_40cc839c-fd78-4b13-8123-1ac4cec5dd78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_40cc839c-fd78-4b13-8123-1ac4cec5dd78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7071c575-34a3-497f-8d65-be5ff4b80dad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7071c575-34a3-497f-8d65-be5ff4b80dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_ac58d563-e369-4444-a893-84f66363529c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_ac58d563-e369-4444-a893-84f66363529c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6e841dd4-5812-40b9-bfc4-4c8bda3c0576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6e841dd4-5812-40b9-bfc4-4c8bda3c0576" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e5752791-38c7-48e5-897e-f169b290aac9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e5752791-38c7-48e5-897e-f169b290aac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_022d6704-aa0c-4019-808e-179f415bf942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_OtherLongTermInvestments_022d6704-aa0c-4019-808e-179f415bf942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bd0d4ee0-1d3a-4321-badc-d3b1f8cd6af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_AssetsCurrent_bd0d4ee0-1d3a-4321-badc-d3b1f8cd6af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c59323be-833b-49f7-adc4-a45c14260c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c59323be-833b-49f7-adc4-a45c14260c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f51ca12b-d142-407a-b71a-960a11c056b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0bae44aa-5ca9-4a55-9fa6-79b732f5c5ad" xlink:to="loc_us-gaap_Goodwill_f51ca12b-d142-407a-b71a-960a11c056b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_28bca695-0e84-42ca-a3f9-f8f2973298a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_07f17255-e83d-4016-919a-04af927290b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_28bca695-0e84-42ca-a3f9-f8f2973298a8" xlink:to="loc_us-gaap_AccountsPayableCurrent_07f17255-e83d-4016-919a-04af927290b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c61af752-ede8-4f18-9f68-fdcc560bca86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_28bca695-0e84-42ca-a3f9-f8f2973298a8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c61af752-ede8-4f18-9f68-fdcc560bca86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f6c38845-df42-4a28-a009-b3f732a173ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_28bca695-0e84-42ca-a3f9-f8f2973298a8" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f6c38845-df42-4a28-a009-b3f732a173ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_1e98eaf1-e7d1-4df8-9a7e-b504805e1d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_28bca695-0e84-42ca-a3f9-f8f2973298a8" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_1e98eaf1-e7d1-4df8-9a7e-b504805e1d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_6f9259f5-548e-46d4-87d3-97dfd26e8d49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_28bca695-0e84-42ca-a3f9-f8f2973298a8" xlink:to="loc_us-gaap_LinesOfCreditCurrent_6f9259f5-548e-46d4-87d3-97dfd26e8d49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3371e73f-9320-4ac0-bfa7-5fd9ca6c3e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_56cc0898-27d9-45c0-8104-6179f6c6e321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3371e73f-9320-4ac0-bfa7-5fd9ca6c3e0b" xlink:to="loc_us-gaap_Liabilities_56cc0898-27d9-45c0-8104-6179f6c6e321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3a65eaee-3ebc-46aa-b8bb-4d29e5fdf958" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3371e73f-9320-4ac0-bfa7-5fd9ca6c3e0b" xlink:to="loc_us-gaap_StockholdersEquity_3a65eaee-3ebc-46aa-b8bb-4d29e5fdf958" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3d3d066f-6d8b-473a-84df-2cca307d1601" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_94520501-e270-4445-b7e3-21f82b70952c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3d3d066f-6d8b-473a-84df-2cca307d1601" xlink:to="loc_us-gaap_RestructuringCosts_94520501-e270-4445-b7e3-21f82b70952c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b9f16cd2-f2fd-4f49-a821-c5822a75d33b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3d3d066f-6d8b-473a-84df-2cca307d1601" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b9f16cd2-f2fd-4f49-a821-c5822a75d33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d4b7f470-c488-457c-b0df-820211651847" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3d3d066f-6d8b-473a-84df-2cca307d1601" xlink:to="loc_us-gaap_DepreciationAndAmortization_d4b7f470-c488-457c-b0df-820211651847" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_94769ef7-bb73-40f7-b19a-6a4772028c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3d3d066f-6d8b-473a-84df-2cca307d1601" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_94769ef7-bb73-40f7-b19a-6a4772028c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d69dc0d6-8200-4a5f-9744-1e67ca15f1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3d3d066f-6d8b-473a-84df-2cca307d1601" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d69dc0d6-8200-4a5f-9744-1e67ca15f1cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_2fbc7cc1-2cfd-48af-a914-2d1727bfaec2" xlink:href="iclr-20231231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_98c4655a-bd67-4474-85f9-5545fc6201c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_2fbc7cc1-2cfd-48af-a914-2d1727bfaec2" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_98c4655a-bd67-4474-85f9-5545fc6201c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c0c07e30-d488-4bec-b533-f2802e9acf97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_2fbc7cc1-2cfd-48af-a914-2d1727bfaec2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c0c07e30-d488-4bec-b533-f2802e9acf97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f1e1a5cc-31c7-48a8-9cf9-563c84797d98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0937aac2-28e4-4925-bf73-69f534bcfbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f1e1a5cc-31c7-48a8-9cf9-563c84797d98" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0937aac2-28e4-4925-bf73-69f534bcfbf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_3bd73b46-86c3-49ed-a0f1-1cee380df1f6" xlink:href="iclr-20231231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f1e1a5cc-31c7-48a8-9cf9-563c84797d98" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_3bd73b46-86c3-49ed-a0f1-1cee380df1f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_95cf5493-20bd-4e9e-9e6d-ea880f65409b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_aa095364-8499-40c6-a7ed-0880e48409f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_95cf5493-20bd-4e9e-9e6d-ea880f65409b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_aa095364-8499-40c6-a7ed-0880e48409f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0e49813-3f1c-4897-a947-352ac782802d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_95cf5493-20bd-4e9e-9e6d-ea880f65409b" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0e49813-3f1c-4897-a947-352ac782802d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_cfee37a6-0bc9-4557-bb0d-1b53d5f27d28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_95cf5493-20bd-4e9e-9e6d-ea880f65409b" xlink:to="loc_us-gaap_InterestExpense_cfee37a6-0bc9-4557-bb0d-1b53d5f27d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2d88daca-66ba-4271-b496-6822fc83d53b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_38ae43bc-062b-466c-b482-5444986a464f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2d88daca-66ba-4271-b496-6822fc83d53b" xlink:to="loc_us-gaap_CostsAndExpenses_38ae43bc-062b-466c-b482-5444986a464f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90eefb15-0876-4ef4-8fd2-eb03eebe76af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2d88daca-66ba-4271-b496-6822fc83d53b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90eefb15-0876-4ef4-8fd2-eb03eebe76af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba760c4c-0228-4b4d-ab70-bb4f9e18d4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0d3e0274-30f9-4ab4-8336-10a622a1c7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba760c4c-0228-4b4d-ab70-bb4f9e18d4b9" xlink:to="loc_us-gaap_ProfitLoss_0d3e0274-30f9-4ab4-8336-10a622a1c7cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2922d0eb-d3fa-4bd0-8c1c-9286da2ffed9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba760c4c-0228-4b4d-ab70-bb4f9e18d4b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2922d0eb-d3fa-4bd0-8c1c-9286da2ffed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c96660cb-b49b-4fb2-a61e-645f52471d71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba760c4c-0228-4b4d-ab70-bb4f9e18d4b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c96660cb-b49b-4fb2-a61e-645f52471d71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_c99602ef-fa00-4a91-8a55-f7e6f20422ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba760c4c-0228-4b4d-ab70-bb4f9e18d4b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_c99602ef-fa00-4a91-8a55-f7e6f20422ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a614b96c-0d50-4954-b992-bc645729eb35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ba760c4c-0228-4b4d-ab70-bb4f9e18d4b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a614b96c-0d50-4954-b992-bc645729eb35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_184e307e-9879-4e91-80db-97d1048d872c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d3e0f82-5fe9-4d1c-a13f-3b36e9e9338e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_184e307e-9879-4e91-80db-97d1048d872c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d3e0f82-5fe9-4d1c-a13f-3b36e9e9338e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87a5cd19-d88f-4631-8e9a-6fef0cd36178" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_184e307e-9879-4e91-80db-97d1048d872c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87a5cd19-d88f-4631-8e9a-6fef0cd36178" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bddb3b24-fc1a-439c-8075-28661db37d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_184e307e-9879-4e91-80db-97d1048d872c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bddb3b24-fc1a-439c-8075-28661db37d9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83e60842-a0db-405a-9250-4d7d38aaddaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_184e307e-9879-4e91-80db-97d1048d872c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83e60842-a0db-405a-9250-4d7d38aaddaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_7a6d5dda-fe18-4c70-916a-d0c19bab045f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_7a6d5dda-fe18-4c70-916a-d0c19bab045f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_b8380c71-4e34-4163-a3f5-67499881695a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_b8380c71-4e34-4163-a3f5-67499881695a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_ce64a651-2677-4487-b273-1d35ff801609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_ce64a651-2677-4487-b273-1d35ff801609" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b5f60742-21cc-4374-903a-f995be330a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b5f60742-21cc-4374-903a-f995be330a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_37e0a895-8dab-4be4-9b97-ad32e48376fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_37e0a895-8dab-4be4-9b97-ad32e48376fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts_d311dc8f-4744-4dbc-bd93-7508c2142b2a" xlink:href="iclr-20231231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_iclr_PaymentsForShareRepurchaseCosts_d311dc8f-4744-4dbc-bd93-7508c2142b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_6293d4c1-5d72-480a-9948-4d6b481a29ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c42a7c7e-ac51-46ed-831f-d0d3a9cbfe9e" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_6293d4c1-5d72-480a-9948-4d6b481a29ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_db4b42ba-2d22-4c1b-8d0d-730fd45b319d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_db4b42ba-2d22-4c1b-8d0d-730fd45b319d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8fa7243-d6f7-4d6f-8fa0-39af5e105fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8fa7243-d6f7-4d6f-8fa0-39af5e105fee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a7aa4ddb-bdab-4315-8b68-46520ab99e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a7aa4ddb-bdab-4315-8b68-46520ab99e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_cec7901f-0afe-489e-b51f-055af8366a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_cec7901f-0afe-489e-b51f-055af8366a98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e2d5475-3a62-41a4-8e0f-70d311387514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e2d5475-3a62-41a4-8e0f-70d311387514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65f206a5-0f96-4607-8e9d-d8175ced2e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_ProfitLoss_65f206a5-0f96-4607-8e9d-d8175ced2e5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_247603d8-259e-453e-889f-29b761b26037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_ShareBasedCompensation_247603d8-259e-453e-889f-29b761b26037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b71fc012-2eed-479b-8b17-2c2e91a4aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b71fc012-2eed-479b-8b17-2c2e91a4aeb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7ec1d167-3304-4ce7-81fe-64a8f91d3442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7ec1d167-3304-4ce7-81fe-64a8f91d3442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_17d5c144-1e26-4ad4-be34-e36b19d665c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_17d5c144-1e26-4ad4-be34-e36b19d665c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_de8fe180-efce-49eb-9243-fb59bf851573" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_de8fe180-efce-49eb-9243-fb59bf851573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_05811562-1860-462b-b9d4-cd3747f7f8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_05811562-1860-462b-b9d4-cd3747f7f8d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b0837094-89e6-4190-bf11-05c9602a9873" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b0837094-89e6-4190-bf11-05c9602a9873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_bbc8901f-3c9e-4092-9267-3b55e060a7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_bbc8901f-3c9e-4092-9267-3b55e060a7a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_22b7cdda-ff0b-4b13-b497-873c7803a3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_22b7cdda-ff0b-4b13-b497-873c7803a3ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GainLossOnIssuanceOfDebt_a109dcd7-ae48-4d1b-9f72-85ebe7629081" xlink:href="iclr-20231231.xsd#iclr_GainLossOnIssuanceOfDebt"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_iclr_GainLossOnIssuanceOfDebt_a109dcd7-ae48-4d1b-9f72-85ebe7629081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_a7115894-793e-4516-8c13-4769b33e31f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_a7115894-793e-4516-8c13-4769b33e31f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_3ac0a2f7-8636-4d7d-aa4c-0ced40f75dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2abf7d9-f799-4443-9972-810d15f04ba9" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_3ac0a2f7-8636-4d7d-aa4c-0ced40f75dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_93f83296-aa26-4ce1-b834-3c1978ae0e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_93f83296-aa26-4ce1-b834-3c1978ae0e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_56279a70-ad70-4e37-a8cc-2ec8e298aad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_56279a70-ad70-4e37-a8cc-2ec8e298aad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_34aece02-baa9-4a34-bcd9-6ffcfbdab004" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_34aece02-baa9-4a34-bcd9-6ffcfbdab004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49320d7d-5843-4b1c-9849-1c78293c1c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49320d7d-5843-4b1c-9849-1c78293c1c8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e1604443-0a6f-4c39-8a52-7e1c40e4d21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e1604443-0a6f-4c39-8a52-7e1c40e4d21c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_966871ca-70fd-439c-8b15-aaf217c1b33f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_966871ca-70fd-439c-8b15-aaf217c1b33f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_e08f3e45-0d97-4780-995c-1aeab9b5ca5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_e08f3e45-0d97-4780-995c-1aeab9b5ca5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_ca320619-aa1a-4ffd-a07a-17e3fec1e368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7bf37ed-0abe-469e-b552-51ce8da00d56" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_ca320619-aa1a-4ffd-a07a-17e3fec1e368" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesContractswithCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_83a883e4-430c-4d6d-86e4-33d018fbbaac" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_19c0a423-1679-4800-84b8-1180633ef242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BilledContractReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_83a883e4-430c-4d6d-86e4-33d018fbbaac" xlink:to="loc_us-gaap_BilledContractReceivables_19c0a423-1679-4800-84b8-1180633ef242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_afe0d500-6315-4a28-84be-fdc5596efb53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_83a883e4-430c-4d6d-86e4-33d018fbbaac" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_afe0d500-6315-4a28-84be-fdc5596efb53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_913bc588-fd3a-4885-b13c-7043ce4d3a44" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_772ed942-7c05-401b-9846-81e2ade44a07" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_913bc588-fd3a-4885-b13c-7043ce4d3a44" xlink:to="loc_iclr_ContractsReceivableGross_772ed942-7c05-401b-9846-81e2ade44a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_83cff53a-a6e8-49af-90f1-25aa621da1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_913bc588-fd3a-4885-b13c-7043ce4d3a44" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_83cff53a-a6e8-49af-90f1-25aa621da1a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_3d2a8ebf-99f3-445a-ab0c-e388c1f3322b" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_3fcd0249-9f17-4924-bdb1-1875b38ee377" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_3d2a8ebf-99f3-445a-ab0c-e388c1f3322b" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_3fcd0249-9f17-4924-bdb1-1875b38ee377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_d536b49b-b350-409b-a746-5d5380c6e4fe" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_3d2a8ebf-99f3-445a-ab0c-e388c1f3322b" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_d536b49b-b350-409b-a746-5d5380c6e4fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_00ab72ca-96cf-4a6e-923a-fffc308f709c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8587209f-6013-4bbd-88b7-74bb6f32850a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_00ab72ca-96cf-4a6e-923a-fffc308f709c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8587209f-6013-4bbd-88b7-74bb6f32850a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7b77357a-6db6-457d-bd15-c4092878e532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_00ab72ca-96cf-4a6e-923a-fffc308f709c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7b77357a-6db6-457d-bd15-c4092878e532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c15e07f7-e093-4990-95e6-818ef40e4f04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_00ab72ca-96cf-4a6e-923a-fffc308f709c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c15e07f7-e093-4990-95e6-818ef40e4f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_944ae67c-e483-4564-af6e-7ed35f2e220b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_00ab72ca-96cf-4a6e-923a-fffc308f709c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_944ae67c-e483-4564-af6e-7ed35f2e220b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_69f1db41-71f0-4739-8798-b1ea7bc7bd35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_69f1db41-71f0-4739-8798-b1ea7bc7bd35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_3d6a5cd8-17e7-437e-ad0f-5779b5f4a2c4" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_3d6a5cd8-17e7-437e-ad0f-5779b5f4a2c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c7e433ff-f308-4225-8b1a-c636c081e8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c7e433ff-f308-4225-8b1a-c636c081e8b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a21f2f2-544a-4d77-a995-b7c6f9c26f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a21f2f2-544a-4d77-a995-b7c6f9c26f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e40de549-1390-447f-a540-49dac2a4c4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_Goodwill_e40de549-1390-447f-a540-49dac2a4c4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bc005d43-60e6-47f2-8e3c-4fb4fb75ea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bc005d43-60e6-47f2-8e3c-4fb4fb75ea6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_205d32ef-2568-4be8-852c-f730a492598e" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_205d32ef-2568-4be8-852c-f730a492598e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_95934ba8-0871-4b64-b6a0-907e7a3713d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_95934ba8-0871-4b64-b6a0-907e7a3713d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_210eadf5-fcb1-4d57-879f-dd1f82b0f39b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_210eadf5-fcb1-4d57-879f-dd1f82b0f39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5892ad78-788c-4e34-ab61-2d9fdedde404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5892ad78-788c-4e34-ab61-2d9fdedde404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_18dc8b39-f991-43d7-80a2-e705b2436166" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_18dc8b39-f991-43d7-80a2-e705b2436166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_3cd30197-13e4-46c6-b488-2f758f19899e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_3cd30197-13e4-46c6-b488-2f758f19899e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_29bb5cde-6870-4d06-990a-5ab35c4eae62" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_29bb5cde-6870-4d06-990a-5ab35c4eae62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ec599ad4-fc3e-4f17-a7b6-778d45910cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ec599ad4-fc3e-4f17-a7b6-778d45910cdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_49578d51-047a-4592-b1da-2c02a1f0b330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_49578d51-047a-4592-b1da-2c02a1f0b330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_8472a0de-6dfa-4ff5-a56b-cd7b8e244d2a" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_84612040-8848-40d8-a2f3-bfecb3878061" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_8472a0de-6dfa-4ff5-a56b-cd7b8e244d2a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f950290c-b478-4efe-836d-607ba3343b16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_acd6c6c3-47d5-47d9-ad15-6ceac0742a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f950290c-b478-4efe-836d-607ba3343b16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_acd6c6c3-47d5-47d9-ad15-6ceac0742a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ef3ab33-a0bb-40e8-a4b5-be6863d2e74c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f950290c-b478-4efe-836d-607ba3343b16" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ef3ab33-a0bb-40e8-a4b5-be6863d2e74c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_f5e79f71-6b38-4435-952f-d2fef6557df4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_us-gaap_Land_f5e79f71-6b38-4435-952f-d2fef6557df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_ba804cf6-683e-46c2-b89c-678ed7193545" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_ba804cf6-683e-46c2-b89c-678ed7193545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_1933a63b-3ad0-4751-be4f-13fcbb00483d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_1933a63b-3ad0-4751-be4f-13fcbb00483d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_110e63e2-681a-4312-88f8-83bd34d68de9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_110e63e2-681a-4312-88f8-83bd34d68de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_21c7bb9c-5b20-4b45-b408-b4773aced0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_21c7bb9c-5b20-4b45-b408-b4773aced0f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_a07f5483-8550-4e50-8fd4-5a193a3b5fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_a07f5483-8550-4e50-8fd4-5a193a3b5fed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_f2513f67-53a5-4ce0-a13d-eb04d1ef78fc" xlink:href="iclr-20231231.xsd#iclr_VehiclesGross"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0fd81154-ac85-475d-bf42-aed283d482f5" xlink:to="loc_iclr_VehiclesGross_f2513f67-53a5-4ce0-a13d-eb04d1ef78fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6b02bb57-40c8-48d3-b293-95bf822046f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fd555ae4-a78e-4082-86e2-7241260e1f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6b02bb57-40c8-48d3-b293-95bf822046f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fd555ae4-a78e-4082-86e2-7241260e1f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b82ed710-fdda-4c4a-9b3e-c4b047265ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6b02bb57-40c8-48d3-b293-95bf822046f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b82ed710-fdda-4c4a-9b3e-c4b047265ef9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9be53759-bf45-4512-a3a4-3cb57de3a3dd" xlink:href="iclr-20231231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_018e84aa-c89f-4581-a5da-886b2c25e746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9be53759-bf45-4512-a3a4-3cb57de3a3dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_018e84aa-c89f-4581-a5da-886b2c25e746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8b300935-6109-441c-8d70-69e6287cf175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9be53759-bf45-4512-a3a4-3cb57de3a3dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8b300935-6109-441c-8d70-69e6287cf175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1208273d-917c-449e-9d44-e1a1489d6bed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9be53759-bf45-4512-a3a4-3cb57de3a3dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1208273d-917c-449e-9d44-e1a1489d6bed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d788d6d3-6c59-4db9-9856-0b6b9d1c936b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9be53759-bf45-4512-a3a4-3cb57de3a3dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d788d6d3-6c59-4db9-9856-0b6b9d1c936b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e716ce20-3f05-4aed-8dc5-b6479e1cb199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9be53759-bf45-4512-a3a4-3cb57de3a3dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e716ce20-3f05-4aed-8dc5-b6479e1cb199" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_0d37ec92-89d1-493c-b892-f9f87221632f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_0d37ec92-89d1-493c-b892-f9f87221632f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_67d85540-1ebe-44fe-a792-e77de131f707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_67d85540-1ebe-44fe-a792-e77de131f707" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_df5baca6-003f-43e3-8b1d-46db42f5aeba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_df5baca6-003f-43e3-8b1d-46db42f5aeba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_bf4ab487-fb03-4978-bdef-bbff68f74293" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_bf4ab487-fb03-4978-bdef-bbff68f74293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ed1289d8-6abf-4a4c-85f9-f928160ae006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ed1289d8-6abf-4a4c-85f9-f928160ae006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_85ada712-118f-4263-828e-4be1c54e2b26" xlink:href="iclr-20231231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_85ada712-118f-4263-828e-4be1c54e2b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent_3b78ad18-fc5a-4814-8941-b007482cb207" xlink:href="iclr-20231231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_e4022734-e43a-4041-be29-f86ff5fc7810" xlink:to="loc_iclr_CapitalGovernmentGrantsCurrent_3b78ad18-fc5a-4814-8941-b007482cb207" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_501061e3-54f5-4d5f-94e6-6647235cf4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_76d9839c-634d-4c1d-a3a9-455026c4981d" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_501061e3-54f5-4d5f-94e6-6647235cf4e7" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_76d9839c-634d-4c1d-a3a9-455026c4981d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aa6adacd-0494-4e2b-bcff-bf1e0f05c727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_501061e3-54f5-4d5f-94e6-6647235cf4e7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aa6adacd-0494-4e2b-bcff-bf1e0f05c727" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f6c59116-bdea-4868-ad81-ee5ed90492f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_de6c0c43-21fd-4a5a-a787-020782335560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_f6c59116-bdea-4868-ad81-ee5ed90492f2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_de6c0c43-21fd-4a5a-a787-020782335560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_0e3ffcbc-1862-4c78-9375-40c82b964eb8" xlink:href="iclr-20231231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_f6c59116-bdea-4868-ad81-ee5ed90492f2" xlink:to="loc_iclr_InterestExpenseCreditOther_0e3ffcbc-1862-4c78-9375-40c82b964eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_0d787c92-b3b4-4461-bfef-d7d530def476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_f6c59116-bdea-4868-ad81-ee5ed90492f2" xlink:to="loc_us-gaap_InterestExpenseDebt_0d787c92-b3b4-4461-bfef-d7d530def476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_8c7c2afb-7309-442b-8aa2-3f4cf4e74d11" xlink:href="iclr-20231231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_f6c59116-bdea-4868-ad81-ee5ed90492f2" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_8c7c2afb-7309-442b-8aa2-3f4cf4e74d11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ff9568f6-dff7-4624-abc2-024bd567fb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c7cc1a13-e456-4dce-a697-af7786a1a584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff9568f6-dff7-4624-abc2-024bd567fb7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c7cc1a13-e456-4dce-a697-af7786a1a584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_52fa5774-1544-4ad9-bec4-5160f8be4572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff9568f6-dff7-4624-abc2-024bd567fb7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_52fa5774-1544-4ad9-bec4-5160f8be4572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_652b7ea4-f4b4-47da-acdc-ce90cd24bae1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff9568f6-dff7-4624-abc2-024bd567fb7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_652b7ea4-f4b4-47da-acdc-ce90cd24bae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_c44acdb3-b5f7-46ae-b8a3-ac2b9ada7588" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff9568f6-dff7-4624-abc2-024bd567fb7f" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_c44acdb3-b5f7-46ae-b8a3-ac2b9ada7588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_06e710f3-3154-4fa8-bd9d-8035377b9acc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ff9568f6-dff7-4624-abc2-024bd567fb7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_06e710f3-3154-4fa8-bd9d-8035377b9acc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_7a024fe0-eb60-4cab-9f8c-e8c1faf23bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_bbbe07f1-fe5b-4e4a-b0f3-fb54af1e7127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_7a024fe0-eb60-4cab-9f8c-e8c1faf23bc2" xlink:to="loc_us-gaap_SubleaseIncome_bbbe07f1-fe5b-4e4a-b0f3-fb54af1e7127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_c8d45ec0-09e6-47d6-8c40-377738af84ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_7a024fe0-eb60-4cab-9f8c-e8c1faf23bc2" xlink:to="loc_us-gaap_OperatingLeaseCost_c8d45ec0-09e6-47d6-8c40-377738af84ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_552ce629-eeac-4c7a-ac0d-a83d64400f16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d03a5cd6-e769-496c-be89-6e335ec35313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_552ce629-eeac-4c7a-ac0d-a83d64400f16" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d03a5cd6-e769-496c-be89-6e335ec35313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9af7d1a7-4779-4960-90df-4664c8824d26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_552ce629-eeac-4c7a-ac0d-a83d64400f16" xlink:to="loc_us-gaap_OperatingLeaseLiability_9af7d1a7-4779-4960-90df-4664c8824d26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c74b0509-5915-4b1f-b50a-5f19607e3e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c74b0509-5915-4b1f-b50a-5f19607e3e17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5fc4b701-8e06-4030-bf1b-f1dfdfcceb43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5fc4b701-8e06-4030-bf1b-f1dfdfcceb43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9aad66a3-7067-4ea9-a510-b316b26aedac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9aad66a3-7067-4ea9-a510-b316b26aedac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b906c07-1ac3-4fe6-9167-d63ea22433c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b906c07-1ac3-4fe6-9167-d63ea22433c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_945089b1-d824-4c17-8f41-ef62bcdad47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_945089b1-d824-4c17-8f41-ef62bcdad47f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ac446cc9-d11b-4c71-9b6a-b18a35767c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ac3ff2a-46ad-49e6-9a81-bb5c7b72e6c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ac446cc9-d11b-4c71-9b6a-b18a35767c8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#NoncurrentotherliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e462139c-429f-4919-8c99-bd559e953da8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_63a28f40-6745-4938-a131-771cce9b7e09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_e462139c-429f-4919-8c99-bd559e953da8" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_63a28f40-6745-4938-a131-771cce9b7e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_908edd6e-7a4b-488a-9c7e-ee0f6ebb6383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_e462139c-429f-4919-8c99-bd559e953da8" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_908edd6e-7a4b-488a-9c7e-ee0f6ebb6383" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_efc591f7-c57e-4d26-ab57-83cb2ccc438c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7b0bd5ea-a4d0-4e05-a10f-12bf5fbd38e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_efc591f7-c57e-4d26-ab57-83cb2ccc438c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7b0bd5ea-a4d0-4e05-a10f-12bf5fbd38e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f367fcb7-f245-4475-91f7-eb8d22246f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_efc591f7-c57e-4d26-ab57-83cb2ccc438c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f367fcb7-f245-4475-91f7-eb8d22246f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_7644ce73-8413-4948-998c-35509c5890bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cd60a2c8-1657-49b2-ba4e-a54de5c94bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_7644ce73-8413-4948-998c-35509c5890bd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cd60a2c8-1657-49b2-ba4e-a54de5c94bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_17e222fd-b983-432b-8bb6-f6dfcaaeb4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_7644ce73-8413-4948-998c-35509c5890bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_17e222fd-b983-432b-8bb6-f6dfcaaeb4fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_449e3a05-1560-4cb2-accd-33b5a4f11bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_7644ce73-8413-4948-998c-35509c5890bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_449e3a05-1560-4cb2-accd-33b5a4f11bb1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9b80d9da-9be3-4d52-a334-5e57cd8fdf69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9b80d9da-9be3-4d52-a334-5e57cd8fdf69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4b8ba84c-2e6f-44a9-878e-db9cdbb9caca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4b8ba84c-2e6f-44a9-878e-db9cdbb9caca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a9f1e439-34d8-42ef-a0dc-24ec3c77b697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a9f1e439-34d8-42ef-a0dc-24ec3c77b697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e5925e30-1c79-4e2f-a0f8-48b9c2aba778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e5925e30-1c79-4e2f-a0f8-48b9c2aba778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7028dfa2-7d04-47d9-8820-6d15a8db6fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7028dfa2-7d04-47d9-8820-6d15a8db6fe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c029ea6d-0dd3-42a4-a953-c2eae4a4a117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c029ea6d-0dd3-42a4-a953-c2eae4a4a117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_28ccb541-e0ab-4f92-8210-1f5d10492e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_28ccb541-e0ab-4f92-8210-1f5d10492e9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_a18705d0-717f-4fa4-9bcb-3148f60209fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_a18705d0-717f-4fa4-9bcb-3148f60209fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_936eaa7f-640f-4690-a61b-888aec2becda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_936eaa7f-640f-4690-a61b-888aec2becda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_46b68a39-8126-4e74-a186-bc3c4554e310" xlink:href="iclr-20231231.xsd#iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c291a15f-6087-40ee-893a-ad291a516a17" xlink:to="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_46b68a39-8126-4e74-a186-bc3c4554e310" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_d6e84b3b-6cd1-44e4-b579-3a87c18c5484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_d6e84b3b-6cd1-44e4-b579-3a87c18c5484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_eaf2f1f5-cebf-4880-b0c8-5173ef0d39bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_eaf2f1f5-cebf-4880-b0c8-5173ef0d39bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f25a414e-acf0-4929-a84a-b22cb2eede36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f25a414e-acf0-4929-a84a-b22cb2eede36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4f2195e4-2c99-4e34-9644-332d5f3e64b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4f2195e4-2c99-4e34-9644-332d5f3e64b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_b8b70838-2435-4c88-8f97-13fd67ab79f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_b8b70838-2435-4c88-8f97-13fd67ab79f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_951e11b8-a5fe-4261-88c9-7b5eb89f5283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_393800a5-45db-468e-a17d-43a8b2d9e528" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_951e11b8-a5fe-4261-88c9-7b5eb89f5283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_5c0b1469-3f4e-47bf-86aa-a634e76c2295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_84033fb0-cb23-4172-9773-4aa0a4ed45e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5c0b1469-3f4e-47bf-86aa-a634e76c2295" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_84033fb0-cb23-4172-9773-4aa0a4ed45e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_7b737106-c216-40a5-893d-14cf548a8b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5c0b1469-3f4e-47bf-86aa-a634e76c2295" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_7b737106-c216-40a5-893d-14cf548a8b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_ee30f05e-0072-4b55-a05e-2c58aa7f8cf0" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_ee30f05e-0072-4b55-a05e-2c58aa7f8cf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8a462e1f-d436-4577-b07a-03c7182d26ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8a462e1f-d436-4577-b07a-03c7182d26ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_09f365bd-8e23-4c12-aae0-ed7f8c91d5b1" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_09f365bd-8e23-4c12-aae0-ed7f8c91d5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_faf573c9-7c39-4860-9ccc-105d84711e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_faf573c9-7c39-4860-9ccc-105d84711e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_3bba9519-679e-4592-a810-ab782cb4b442" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_3bba9519-679e-4592-a810-ab782cb4b442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_6b515347-6c3d-4108-bc9e-d756142d74ec" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_6b515347-6c3d-4108-bc9e-d756142d74ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_69723f13-9dc1-4741-9f18-1ce9aa7810cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_69723f13-9dc1-4741-9f18-1ce9aa7810cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_e3f279c1-7393-43e9-b5e3-7f17f5d12153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ef4d7c6d-9e19-49ed-a509-4e2c303a31fe" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_e3f279c1-7393-43e9-b5e3-7f17f5d12153" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_eed60a55-0361-4c31-b8cc-e6ed1687ff2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9e2d008d-82d7-4741-acb2-ff4c37f2600b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_eed60a55-0361-4c31-b8cc-e6ed1687ff2e" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9e2d008d-82d7-4741-acb2-ff4c37f2600b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d923d1fd-165f-4edb-9bda-5858a6bf5b94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_eed60a55-0361-4c31-b8cc-e6ed1687ff2e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d923d1fd-165f-4edb-9bda-5858a6bf5b94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9bb0ceea-cda7-4289-8461-ab246a89e984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_959d4d0e-933d-4966-9515-cf70c02acd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9bb0ceea-cda7-4289-8461-ab246a89e984" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_959d4d0e-933d-4966-9515-cf70c02acd9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b45a99ba-5d17-4211-aedf-accb8969a601" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9bb0ceea-cda7-4289-8461-ab246a89e984" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b45a99ba-5d17-4211-aedf-accb8969a601" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_79832c3a-8568-4433-b280-32f5f3a3b0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_d2292128-4137-404a-84cf-8415c5300ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_79832c3a-8568-4433-b280-32f5f3a3b0c1" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_d2292128-4137-404a-84cf-8415c5300ae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f0edec09-ae97-47bf-a40c-4c765e6c6e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_79832c3a-8568-4433-b280-32f5f3a3b0c1" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f0edec09-ae97-47bf-a40c-4c765e6c6e2f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7be20100-4175-4453-bd6b-eaf326b951d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_05539602-3e46-4997-af8c-8a1a7743df92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7be20100-4175-4453-bd6b-eaf326b951d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_05539602-3e46-4997-af8c-8a1a7743df92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_afba9439-4ac3-4247-83b5-0192521b10c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7be20100-4175-4453-bd6b-eaf326b951d6" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_afba9439-4ac3-4247-83b5-0192521b10c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_072d6b9e-d6c7-4e56-bbe0-cc5a2c7435bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7be20100-4175-4453-bd6b-eaf326b951d6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_072d6b9e-d6c7-4e56-bbe0-cc5a2c7435bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_30d5ebdd-2aa4-4682-a684-435e1d05759e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7be20100-4175-4453-bd6b-eaf326b951d6" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_30d5ebdd-2aa4-4682-a684-435e1d05759e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_63f39cd9-3b73-4c33-8809-6db147873180" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_b3913550-ca13-4657-bb0d-a0fbcbf9582e" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_63f39cd9-3b73-4c33-8809-6db147873180" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_b3913550-ca13-4657-bb0d-a0fbcbf9582e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_687cb677-a7e4-4491-a556-1104a103bf73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_63f39cd9-3b73-4c33-8809-6db147873180" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_687cb677-a7e4-4491-a556-1104a103bf73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_475deb86-ac54-4f21-bc21-24046e66ebd1" xlink:href="iclr-20231231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_63f39cd9-3b73-4c33-8809-6db147873180" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_475deb86-ac54-4f21-bc21-24046e66ebd1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_867ab776-1082-49e1-8be8-b56935a133e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34fb47dc-c9f4-4282-b7b9-145cb7fc3c72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_867ab776-1082-49e1-8be8-b56935a133e1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34fb47dc-c9f4-4282-b7b9-145cb7fc3c72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f184567f-3441-49f0-a1da-b0053b13410f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_867ab776-1082-49e1-8be8-b56935a133e1" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f184567f-3441-49f0-a1da-b0053b13410f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b28076b-c424-4343-8474-57d0d8cb0afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_a5ab7e77-efed-4131-ab76-c9d23dbaf6f8" xlink:href="iclr-20231231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b28076b-c424-4343-8474-57d0d8cb0afa" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_a5ab7e77-efed-4131-ab76-c9d23dbaf6f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3f6a4435-4669-46a7-8c98-0d66ba366527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b28076b-c424-4343-8474-57d0d8cb0afa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3f6a4435-4669-46a7-8c98-0d66ba366527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_177abb44-e758-47dc-b1df-6bf698123ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b28076b-c424-4343-8474-57d0d8cb0afa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_177abb44-e758-47dc-b1df-6bf698123ea7" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>iclr-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0c105b40-162f-4950-b2b2-c13f61a02230,g:35370e08-e85b-4be7-afdb-42ad7a0d101f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20231231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_8ea15efe-b9a0-4738-8846-469547d56f03_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:to="loc_dei_AddressTypeDomain_8ea15efe-b9a0-4738-8846-469547d56f03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_8c538643-e31a-4083-a600-2d744e7676b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:to="loc_dei_AddressTypeDomain_8c538643-e31a-4083-a600-2d744e7676b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_35aac587-72e5-4397-ac39-016556b20127" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_8c538643-e31a-4083-a600-2d744e7676b7" xlink:to="loc_dei_BusinessContactMember_35aac587-72e5-4397-ac39-016556b20127" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d92eb515-4aed-47cd-a279-818399b7b99c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentType_d92eb515-4aed-47cd-a279-818399b7b99c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_c5268201-a046-438a-9f4e-4a8ab4b49b4f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentRegistrationStatement_c5268201-a046-438a-9f4e-4a8ab4b49b4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_56a29018-f749-410d-957e-0312695a4cab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentAnnualReport_56a29018-f749-410d-957e-0312695a4cab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a2f75f2a-ca79-42b6-81ce-d5c508af7581" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentPeriodEndDate_a2f75f2a-ca79-42b6-81ce-d5c508af7581" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_39762b0d-24c7-4c2a-b9e6-b748425213c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_CurrentFiscalYearEndDate_39762b0d-24c7-4c2a-b9e6-b748425213c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a35caf83-d4bf-4fa0-b5e6-6581c0d4668a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentTransitionReport_a35caf83-d4bf-4fa0-b5e6-6581c0d4668a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_7514df55-5320-4f14-bdbe-7f02e2f896ec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentShellCompanyReport_7514df55-5320-4f14-bdbe-7f02e2f896ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d40f0ab5-ba58-4fe3-8150-ed5221a04bae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityFileNumber_d40f0ab5-ba58-4fe3-8150-ed5221a04bae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ee4f62ff-5da2-4716-8c77-3650f271aad9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityRegistrantName_ee4f62ff-5da2-4716-8c77-3650f271aad9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b87779e9-8c98-47bf-ac97-311774604572" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b87779e9-8c98-47bf-ac97-311774604572" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_24b4d976-709c-4f89-884b-27662805c53b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressAddressLine1_24b4d976-709c-4f89-884b-27662805c53b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_c8170c99-6aad-4db8-8e85-9741cd6a8149" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressAddressLine2_c8170c99-6aad-4db8-8e85-9741cd6a8149" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1c8dafb5-49a6-40b2-935b-9801c56fc9ac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressCityOrTown_1c8dafb5-49a6-40b2-935b-9801c56fc9ac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_82821e3f-e54c-4c1a-8801-74650b3322d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressPostalZipCode_82821e3f-e54c-4c1a-8801-74650b3322d1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_bb5107d8-4222-4ba3-8836-49262880dd4d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressCountry_bb5107d8-4222-4ba3-8836-49262880dd4d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_0384a538-d8b6-49a0-bbd4-d0ccdfcdc50f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_ContactPersonnelName_0384a538-d8b6-49a0-bbd4-d0ccdfcdc50f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_015f75de-4bc3-4011-a519-99b91c0a57ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_ContactPersonnelEmailAddress_015f75de-4bc3-4011-a519-99b91c0a57ff" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_7873bea2-7d65-47d4-ac81-bafec1d97b52" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_CountryRegion_7873bea2-7d65-47d4-ac81-bafec1d97b52" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a87e8bb7-a224-4f3f-90fc-ffb82592df6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_CityAreaCode_a87e8bb7-a224-4f3f-90fc-ffb82592df6e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e50093e-cab3-445a-a353-79f6f0f5f427" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_LocalPhoneNumber_1e50093e-cab3-445a-a353-79f6f0f5f427" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7bfa2851-6770-4b16-8de4-6b7a39ed1c99" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_Security12bTitle_7bfa2851-6770-4b16-8de4-6b7a39ed1c99" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_69a13724-b085-44ee-bdb7-928074fe1886" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_TradingSymbol_69a13724-b085-44ee-bdb7-928074fe1886" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b0f9bb12-cdcc-4669-97ff-ffb6fac4ea9b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_SecurityExchangeName_b0f9bb12-cdcc-4669-97ff-ffb6fac4ea9b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_238395bd-2e32-42df-8749-49451bd6d510" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_238395bd-2e32-42df-8749-49451bd6d510" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_c5d1fae6-cd42-4dbb-a9ef-45a3673d30f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_c5d1fae6-cd42-4dbb-a9ef-45a3673d30f0" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_5480a009-e8c3-4cfe-88b0-e2d37b826a56" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityVoluntaryFilers_5480a009-e8c3-4cfe-88b0-e2d37b826a56" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1cb85514-1310-4d5b-aa9f-df18bd356a58" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityCurrentReportingStatus_1cb85514-1310-4d5b-aa9f-df18bd356a58" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_af4fca3d-fc5b-4dee-96ac-fd428f999a77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityInteractiveDataCurrent_af4fca3d-fc5b-4dee-96ac-fd428f999a77" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3a296d76-0779-4968-a6ea-bd562faba1f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityFilerCategory_3a296d76-0779-4968-a6ea-bd562faba1f9" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_59157c08-f697-4010-b78a-e6d555c32d54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityEmergingGrowthCompany_59157c08-f697-4010-b78a-e6d555c32d54" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_9bc97748-ce51-4e91-8b2b-06efbefe5311" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_IcfrAuditorAttestationFlag_9bc97748-ce51-4e91-8b2b-06efbefe5311" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_3f38db29-139b-49bf-a683-4a835f295117" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_3f38db29-139b-49bf-a683-4a835f295117" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_50136012-eadc-4ac6-8562-6ca85db8f798" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentAccountingStandard_50136012-eadc-4ac6-8562-6ca85db8f798" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e19376ae-211a-4b50-93c5-b19bbb0511c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityShellCompany_e19376ae-211a-4b50-93c5-b19bbb0511c7" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e9508b97-c408-4159-8844-22c96ccd08d4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_AmendmentFlag_e9508b97-c408-4159-8844-22c96ccd08d4" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f26be34e-9dcd-4ee0-8ba3-64271c850ab6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentFiscalYearFocus_f26be34e-9dcd-4ee0-8ba3-64271c850ab6" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0d1d3b99-5327-407a-8ee0-2acba7e4c2f7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0d1d3b99-5327-407a-8ee0-2acba7e4c2f7" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dec6cef8-69c5-4d05-8255-2e9d69fe9040" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityCentralIndexKey_dec6cef8-69c5-4d05-8255-2e9d69fe9040" xlink:type="arc" order="37"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a01c685-83e0-4138-8683-bb02b43592d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4a01c685-83e0-4138-8683-bb02b43592d2" xlink:to="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_18e57360-4a3d-4fda-94e0-b362b416b828_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:to="loc_us-gaap_EquityComponentDomain_18e57360-4a3d-4fda-94e0-b362b416b828_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:to="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3884f93c-61f7-4882-b590-4258e3abc9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_CommonStockMember_3884f93c-61f7-4882-b590-4258e3abc9d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f47d82c0-c920-40a3-8d71-79931b4137f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f47d82c0-c920-40a3-8d71-79931b4137f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_2bbe9838-cb20-472e-a7bd-fd0c82b96aaf" xlink:href="iclr-20231231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_2bbe9838-cb20-472e-a7bd-fd0c82b96aaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c137b54d-eead-4d7b-a380-bde9673f3af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c137b54d-eead-4d7b-a380-bde9673f3af6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9707ee15-3bac-48c7-a116-fd9a685f0533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_RetainedEarningsMember_9707ee15-3bac-48c7-a116-fd9a685f0533" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a01c685-83e0-4138-8683-bb02b43592d2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f330ece9-5033-4fac-94cb-83a0873126f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_CommonStockSharesIssued_f330ece9-5033-4fac-94cb-83a0873126f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1ff0d58a-68ba-422b-bc9c-a4995748f8de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockholdersEquity_1ff0d58a-68ba-422b-bc9c-a4995748f8de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ccb6766f-d451-41f2-bf9d-6a6c40d94786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_NetIncomeLoss_ccb6766f-d451-41f2-bf9d-6a6c40d94786" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0e5aa325-f87f-4308-9964-edcce3a55126" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0e5aa325-f87f-4308-9964-edcce3a55126" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_94a7b296-af81-4a1b-8c2e-20ccf7c430bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_94a7b296-af81-4a1b-8c2e-20ccf7c430bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b76e34e3-3da3-491c-bed7-1c4b148e0292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b76e34e3-3da3-491c-bed7-1c4b148e0292" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ecb850a8-87e3-49f6-844b-30ad0ecb7bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ecb850a8-87e3-49f6-844b-30ad0ecb7bec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe6223f6-935b-470e-b01d-ac4009d538ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe6223f6-935b-470e-b01d-ac4009d538ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_af6875ef-432c-4ec0-b54e-e4d9edddc319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_af6875ef-432c-4ec0-b54e-e4d9edddc319" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b18e4556-d82a-4552-86b1-140694f4a23e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b18e4556-d82a-4552-86b1-140694f4a23e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c99bbb2e-e03a-4fbc-bcbc-b90d6fdac33b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c99bbb2e-e03a-4fbc-bcbc-b90d6fdac33b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d07def32-ad85-4561-9493-e43505e1af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d07def32-ad85-4561-9493-e43505e1af5f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a90fa19f-da45-403f-8016-cb81dcac7694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a90fa19f-da45-403f-8016-cb81dcac7694" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_38bf6c22-f800-45e6-a5a4-249a8cf78de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_38bf6c22-f800-45e6-a5a4-249a8cf78de4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_bbfe4776-f06d-4864-bde9-ab9fb0a42355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_bbfe4776-f06d-4864-bde9-ab9fb0a42355" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c186b1e8-7fe5-477e-89ba-5e2225c34608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c186b1e8-7fe5-477e-89ba-5e2225c34608" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_3ec9af7a-865e-4f3c-b9b3-50f5f66ab4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_3ec9af7a-865e-4f3c-b9b3-50f5f66ab4aa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_dfa9af41-5f25-4f3e-bf38-43f6a32342a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_dfa9af41-5f25-4f3e-bf38-43f6a32342a6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_55cff373-97d3-45ce-ad47-c5e9b9999e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_55cff373-97d3-45ce-ad47-c5e9b9999e2f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_2e8de659-4705-4baf-bd40-0d0da992d448" xlink:href="iclr-20231231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_2e8de659-4705-4baf-bd40-0d0da992d448" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_15d9e4d5-13de-48ff-9dab-1b42d036ede4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65bd80c2-cf46-41b2-a597-bce3e3b3c6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DescriptionofbusinessDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a86d9476-2da9-42dd-9853-5af355e41383_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a86d9476-2da9-42dd-9853-5af355e41383_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3fa43d3d-ea3b-40cc-80a9-9962db9f4415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3fa43d3d-ea3b-40cc-80a9-9962db9f4415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_f74bac39-8a82-42c4-bbfc-c9620ff4594f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3fa43d3d-ea3b-40cc-80a9-9962db9f4415" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_f74bac39-8a82-42c4-bbfc-c9620ff4594f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4c7298fc-2cd0-480c-b3f6-739d90e7fd50_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:to="loc_srt_SegmentGeographicalDomain_4c7298fc-2cd0-480c-b3f6-739d90e7fd50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:to="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e05f0b9d-e0c4-46ee-baf5-ea2443d6a357" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:to="loc_country_US_e05f0b9d-e0c4-46ee-baf5-ea2443d6a357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b86444fc-2a76-43a8-b474-bdcee482ae39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:to="loc_srt_EuropeMember_b86444fc-2a76-43a8-b474-bdcee482ae39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_fae3fa95-bda0-4d54-975a-591284031354" xlink:href="iclr-20231231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:to="loc_iclr_OtherGeographicLocationsMember_fae3fa95-bda0-4d54-975a-591284031354" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_77639bda-3642-4ed4-8d7b-84d6f331d42d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_77639bda-3642-4ed4-8d7b-84d6f331d42d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_35ce2d18-1621-4654-add7-92639cc303eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_35ce2d18-1621-4654-add7-92639cc303eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_7fe9cf4e-18bb-411a-8787-7f064674e0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_35ce2d18-1621-4654-add7-92639cc303eb" xlink:to="loc_us-gaap_SalesRevenueNetMember_7fe9cf4e-18bb-411a-8787-7f064674e0a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_5b8a5050-28af-4e57-849a-f1f38b595352" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_dei_EntityNumberOfEmployees_5b8a5050-28af-4e57-849a-f1f38b595352" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_d7c69aa6-7ea1-4b2b-b447-767c91285de9" xlink:href="iclr-20231231.xsd#iclr_NumberOfLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_iclr_NumberOfLocations_d7c69aa6-7ea1-4b2b-b447-767c91285de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_69082e68-da48-45d0-8ff6-c1565ac74363" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_69082e68-da48-45d0-8ff6-c1565ac74363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0c45fe37-48fb-43fd-80d5-008957489d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0c45fe37-48fb-43fd-80d5-008957489d34" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3a364a9f-9e80-45d2-80da-a6ffcf2e0b88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3a364a9f-9e80-45d2-80da-a6ffcf2e0b88" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:to="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:to="loc_srt_RangeMember_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:to="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5d82ccd9-0049-4f0d-88ce-3d1d37af12b4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:to="loc_srt_MinimumMember_5d82ccd9-0049-4f0d-88ce-3d1d37af12b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3819285d-f5a9-4087-8848-b09b0ab09873" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:to="loc_srt_MaximumMember_3819285d-f5a9-4087-8848-b09b0ab09873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c77ef560-9479-4c49-b098-d7ca3df46f67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c77ef560-9479-4c49-b098-d7ca3df46f67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_cc4afcd0-739e-402c-b09d-b92012cfb3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_BuildingMember_cc4afcd0-739e-402c-b09d-b92012cfb3fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_8788f9b1-fcf7-49cf-9e21-ca86cbdfb2da" xlink:href="iclr-20231231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_8788f9b1-fcf7-49cf-9e21-ca86cbdfb2da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_30fe88f3-e16d-430a-8025-457ac1a115f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_30fe88f3-e16d-430a-8025-457ac1a115f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_3339d533-0de5-4829-a6b5-a17f5241dbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_EquipmentMember_3339d533-0de5-4829-a6b5-a17f5241dbfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_624e95f7-adb6-4b9e-aebe-2b60bc018130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_VehiclesMember_624e95f7-adb6-4b9e-aebe-2b60bc018130" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bdd4c760-c9ff-4bc2-acd1-c343fd384dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3a364a9f-9e80-45d2-80da-a6ffcf2e0b88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bdd4c760-c9ff-4bc2-acd1-c343fd384dc9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_eaf7f23d-86d6-445a-b6eb-487ff5b7c032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_eaf7f23d-86d6-445a-b6eb-487ff5b7c032" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c7dbfbb-fea5-48fd-93fc-7e982f31147f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c7dbfbb-fea5-48fd-93fc-7e982f31147f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9ba7b250-c336-419a-899e-74eecf8ee42e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9ba7b250-c336-419a-899e-74eecf8ee42e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_b79ffa5f-fe41-4caa-af4b-cd505c666afd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_b79ffa5f-fe41-4caa-af4b-cd505c666afd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4ba08e71-e6fc-4aa3-8029-b4aed631a22b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_TradeNamesMember_4ba08e71-e6fc-4aa3-8029-b4aed631a22b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_cf793eee-57c9-4afa-96dd-78601b87fcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_DatabasesMember_cf793eee-57c9-4afa-96dd-78601b87fcbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0acb112d-f83e-4cd9-a0f1-efcedb43c04d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0acb112d-f83e-4cd9-a0f1-efcedb43c04d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:to="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fdf248ba-3a48-4d5b-b3a7-970c09f73365_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:to="loc_srt_RangeMember_fdf248ba-3a48-4d5b-b3a7-970c09f73365_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:to="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8069fbcd-3542-4484-999f-7f174bab72ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:to="loc_srt_MinimumMember_8069fbcd-3542-4484-999f-7f174bab72ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_422318d0-01ee-4963-97d8-e4ee4b3eeb98" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:to="loc_srt_MaximumMember_422318d0-01ee-4963-97d8-e4ee4b3eeb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_19b5e9f8-375c-41ef-8837-723b30d5d6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_eaf7f23d-86d6-445a-b6eb-487ff5b7c032" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_19b5e9f8-375c-41ef-8837-723b30d5d6aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_178b6c1c-c750-42ed-9ae2-c88d211c7473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_178b6c1c-c750-42ed-9ae2-c88d211c7473" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:to="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:to="loc_srt_NameOfMajorCustomerDomain_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:to="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_3f75b4d3-0a8f-4402-9511-af3e8aa7d010" xlink:href="iclr-20231231.xsd#iclr_TopClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_TopClientMember_3f75b4d3-0a8f-4402-9511-af3e8aa7d010" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_bccde3f0-27a6-4e8a-a060-604a62b1dff6" xlink:href="iclr-20231231.xsd#iclr_Clients25Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_Clients25Member_bccde3f0-27a6-4e8a-a060-604a62b1dff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_fe084083-e5d2-44a3-8723-62662c686017" xlink:href="iclr-20231231.xsd#iclr_Clients610Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_Clients610Member_fe084083-e5d2-44a3-8723-62662c686017" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_39927b97-5c1b-4c8e-85f5-0f2750d19629" xlink:href="iclr-20231231.xsd#iclr_Clients1125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_Clients1125Member_39927b97-5c1b-4c8e-85f5-0f2750d19629" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_9e41db31-1287-44c6-bdfe-e864d116d6c9" xlink:href="iclr-20231231.xsd#iclr_OtherCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_OtherCustomersMember_9e41db31-1287-44c6-bdfe-e864d116d6c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a412e063-df54-4317-bc60-16628b774a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_178b6c1c-c750-42ed-9ae2-c88d211c7473" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a412e063-df54-4317-bc60-16628b774a78" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_76cf3d98-3764-48dc-bd62-3a57cf4947b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_76cf3d98-3764-48dc-bd62-3a57cf4947b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_5fe5b8ee-0e79-4faf-8f9e-c47a022b12eb" xlink:href="iclr-20231231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_5fe5b8ee-0e79-4faf-8f9e-c47a022b12eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5f442e71-22be-432d-b7ef-91f2cade5e20" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5f442e71-22be-432d-b7ef-91f2cade5e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f05d02de-506e-488f-9a86-fcc14447eaf1" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f05d02de-506e-488f-9a86-fcc14447eaf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_76a55ca7-f6ef-42fe-8eee-1fc335aada63" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_76a55ca7-f6ef-42fe-8eee-1fc335aada63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4dc5d26b-2c88-4dbb-8149-083e6b82ed4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4dc5d26b-2c88-4dbb-8149-083e6b82ed4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_82f07692-f54a-4329-a957-5d525cdc67b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_82f07692-f54a-4329-a957-5d525cdc67b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_2765ba2b-969d-4a89-ad53-e3df4132074b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_2765ba2b-969d-4a89-ad53-e3df4132074b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b35712b9-432d-4670-857c-61990ba0b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b35712b9-432d-4670-857c-61990ba0b6af" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_5fe5b8ee-0e79-4faf-8f9e-c47a022b12eb" xlink:href="iclr-20231231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_5fe5b8ee-0e79-4faf-8f9e-c47a022b12eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5f442e71-22be-432d-b7ef-91f2cade5e20" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5f442e71-22be-432d-b7ef-91f2cade5e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f05d02de-506e-488f-9a86-fcc14447eaf1" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f05d02de-506e-488f-9a86-fcc14447eaf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_76a55ca7-f6ef-42fe-8eee-1fc335aada63" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_76a55ca7-f6ef-42fe-8eee-1fc335aada63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4dc5d26b-2c88-4dbb-8149-083e6b82ed4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4dc5d26b-2c88-4dbb-8149-083e6b82ed4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_82f07692-f54a-4329-a957-5d525cdc67b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_82f07692-f54a-4329-a957-5d525cdc67b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_2765ba2b-969d-4a89-ad53-e3df4132074b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_2765ba2b-969d-4a89-ad53-e3df4132074b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b35712b9-432d-4670-857c-61990ba0b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b35712b9-432d-4670-857c-61990ba0b6af" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsNarrativeBiotelAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14c03045-2e44-438d-afea-81624447debd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14c03045-2e44-438d-afea-81624447debd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3b4064f-63a9-42c4-a3e5-39e84f736310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3b4064f-63a9-42c4-a3e5-39e84f736310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_f067873d-8493-4331-93c5-5faf614472ce" xlink:href="iclr-20231231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3b4064f-63a9-42c4-a3e5-39e84f736310" xlink:to="loc_iclr_BiotelResearchLLCMember_f067873d-8493-4331-93c5-5faf614472ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_71ede171-d823-49b7-9eaf-138a610c9a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_71ede171-d823-49b7-9eaf-138a610c9a42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_6e6fa75c-abef-4624-9db1-ec9be242f017" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_6e6fa75c-abef-4624-9db1-ec9be242f017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_868296df-dc3d-4287-9d34-0471f44a4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_868296df-dc3d-4287-9d34-0471f44a4d73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac54c6b8-9b0d-4506-b151-079218975663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_Goodwill_ac54c6b8-9b0d-4506-b151-079218975663" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsNarrativeOncacareAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91e999ec-f0b6-425b-af10-8d5b61a58853_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91e999ec-f0b6-425b-af10-8d5b61a58853_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f4a8930-bd6f-45a2-9ef4-6fc0503e9330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f4a8930-bd6f-45a2-9ef4-6fc0503e9330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_6a0696f6-0540-4206-a962-5ddc20e68883" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f4a8930-bd6f-45a2-9ef4-6fc0503e9330" xlink:to="loc_iclr_OncacareMember_6a0696f6-0540-4206-a962-5ddc20e68883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2c609c69-039a-475f-a20b-1853b7953d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2c609c69-039a-475f-a20b-1853b7953d61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_63faef61-426b-4183-847e-9ae32f19bd85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_63faef61-426b-4183-847e-9ae32f19bd85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a0620f17-8871-4b09-a16d-ee519ff69d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_Goodwill_a0620f17-8871-4b09-a16d-ee519ff69d05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_95dcf968-a5a2-497b-92de-cac75fbd2689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_95dcf968-a5a2-497b-92de-cac75fbd2689" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsNarrativePRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dce466d-ab21-44a5-820e-9e0f6b378754_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4dce466d-ab21-44a5-820e-9e0f6b378754_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ea0264-9659-4302-8112-3ab247cf7950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ea0264-9659-4302-8112-3ab247cf7950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_62e6b2a6-1a64-4313-84e3-54547427991d" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ea0264-9659-4302-8112-3ab247cf7950" xlink:to="loc_iclr_PRAHealthSciencesIncMember_62e6b2a6-1a64-4313-84e3-54547427991d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_41e62ec0-091e-4409-8919-f8c51b024831" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_dei_EntityNumberOfEmployees_41e62ec0-091e-4409-8919-f8c51b024831" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_a5ae4526-27a0-49ae-b004-6003d41ba05a" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_a5ae4526-27a0-49ae-b004-6003d41ba05a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_028fadf5-c09e-49fb-b803-3e809b6ae4e1" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_028fadf5-c09e-49fb-b803-3e809b6ae4e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_859e1d32-4ec0-411a-a523-64b506f697af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_859e1d32-4ec0-411a-a523-64b506f697af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0b364f3f-f4f9-4164-9082-db4f40c007cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_us-gaap_InterestExpense_0b364f3f-f4f9-4164-9082-db4f40c007cc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44ab7959-c336-406d-8bf5-8a062c32f27f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44ab7959-c336-406d-8bf5-8a062c32f27f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_729ac040-0f42-4526-aa9d-3b135dcbd926" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_729ac040-0f42-4526-aa9d-3b135dcbd926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_58dfa88c-5bf8-4e35-be68-a50d6862c94e" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_729ac040-0f42-4526-aa9d-3b135dcbd926" xlink:to="loc_iclr_PRAHealthSciencesIncMember_58dfa88c-5bf8-4e35-be68-a50d6862c94e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_5e79eb32-1d76-4776-a873-b021dc634d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_5e79eb32-1d76-4776-a873-b021dc634d4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_14188b2c-6590-4013-b82d-d8a81600523b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_14188b2c-6590-4013-b82d-d8a81600523b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f48186ab-686d-44c7-b64f-3af0cbfc9b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f48186ab-686d-44c7-b64f-3af0cbfc9b3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_be3acbc4-8ea5-4216-bffc-34dee56870cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_be3acbc4-8ea5-4216-bffc-34dee56870cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e6f6864d-8ad7-4cd7-ad74-a15e433c6d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e6f6864d-8ad7-4cd7-ad74-a15e433c6d0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_8b3f8d0c-ff45-414d-be46-ba646f7f5d39" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_8b3f8d0c-ff45-414d-be46-ba646f7f5d39" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fac9540c-b175-4af0-bd0b-990032b56d65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fac9540c-b175-4af0-bd0b-990032b56d65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb12c56-1e4a-48ba-9383-1e4ec75dbda7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb12c56-1e4a-48ba-9383-1e4ec75dbda7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_b3db0603-d42b-48c1-b463-bb3f6181ee56" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb12c56-1e4a-48ba-9383-1e4ec75dbda7" xlink:to="loc_iclr_PRAHealthSciencesIncMember_b3db0603-d42b-48c1-b463-bb3f6181ee56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04e411af-284b-4da9-94d9-be39369e6b29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04e411af-284b-4da9-94d9-be39369e6b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_542080d1-7bd8-4842-8398-5b9bf988fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_542080d1-7bd8-4842-8398-5b9bf988fc31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_f709ba66-c4c1-470a-b1cf-33b1ca171e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_f709ba66-c4c1-470a-b1cf-33b1ca171e7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac1f1939-c998-47f2-870c-07defb00bcce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac1f1939-c998-47f2-870c-07defb00bcce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_78146e6c-282c-4de7-acea-0ac953b80fb2" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_78146e6c-282c-4de7-acea-0ac953b80fb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b662c795-948b-45b8-bb5a-3115d35a448a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_Goodwill_b662c795-948b-45b8-bb5a-3115d35a448a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d96f6b21-50ac-4443-8e04-41ed15a0d9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d96f6b21-50ac-4443-8e04-41ed15a0d9e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c2431226-72f5-4192-83ad-3bc629951921" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c2431226-72f5-4192-83ad-3bc629951921" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e7e14173-27c5-46a6-b2bb-8e0ec85a30df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e7e14173-27c5-46a6-b2bb-8e0ec85a30df" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3eedafed-23c3-4314-a6b6-10d98ea0ab14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3eedafed-23c3-4314-a6b6-10d98ea0ab14" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c8954beb-1e31-40f0-9db5-44dabe9b16a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c8954beb-1e31-40f0-9db5-44dabe9b16a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_01de9e56-659b-493b-87fe-34e32eb79fea" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_01de9e56-659b-493b-87fe-34e32eb79fea" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_4f45494e-1383-4769-aded-99eeb8f65bf6" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_4f45494e-1383-4769-aded-99eeb8f65bf6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7fdf5203-6e14-4a7d-acb4-25331be3b502" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7fdf5203-6e14-4a7d-acb4-25331be3b502" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a62afe84-de77-4d02-be4a-ecd0775ee8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a62afe84-de77-4d02-be4a-ecd0775ee8f5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_615f6d9e-5435-4c4b-9f4a-63ee681f0c26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_615f6d9e-5435-4c4b-9f4a-63ee681f0c26" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ecfbb95e-b515-446e-b055-450e2e7a04d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ecfbb95e-b515-446e-b055-450e2e7a04d9" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a86d35-b976-4b58-89f0-6796ffdc3137_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6a86d35-b976-4b58-89f0-6796ffdc3137_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ac97ccba-2f49-4804-bdbc-fe5b08bdca19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ac97ccba-2f49-4804-bdbc-fe5b08bdca19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_197d11ab-35c7-4daf-a5d2-2aa233c7bb70" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ac97ccba-2f49-4804-bdbc-fe5b08bdca19" xlink:to="loc_iclr_PRAHealthSciencesIncMember_197d11ab-35c7-4daf-a5d2-2aa233c7bb70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75e2118-70eb-4d9b-8589-e011413fe8cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75e2118-70eb-4d9b-8589-e011413fe8cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cb49f1e8-48c7-4a0e-bb6c-f92c8039503c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cb49f1e8-48c7-4a0e-bb6c-f92c8039503c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_33e096cd-6fc0-4f00-8504-fd5d08594c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_33e096cd-6fc0-4f00-8504-fd5d08594c8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_34a7a78c-ebb1-4e44-8a0a-a3d2754090ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_TradeNamesMember_34a7a78c-ebb1-4e44-8a0a-a3d2754090ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_6bb26bc9-f4ca-46bc-915f-eaadb49e4f26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_DatabasesMember_6bb26bc9-f4ca-46bc-915f-eaadb49e4f26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_678683b9-4bdc-4799-a990-a15bd9837e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_678683b9-4bdc-4799-a990-a15bd9837e7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_325ab4d4-fdc5-4987-8b33-de58caa7924d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_325ab4d4-fdc5-4987-8b33-de58caa7924d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44f73c9d-1077-4e27-994a-8a5a48399682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44f73c9d-1077-4e27-994a-8a5a48399682" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6217dbfb-bba8-438c-9302-319862e05011_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6217dbfb-bba8-438c-9302-319862e05011_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55292648-1218-4e9f-9db9-3de0a955246b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55292648-1218-4e9f-9db9-3de0a955246b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_3de015f3-d69f-4843-b841-fed6d0b9e5c2" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55292648-1218-4e9f-9db9-3de0a955246b" xlink:to="loc_iclr_PRAHealthSciencesIncMember_3de015f3-d69f-4843-b841-fed6d0b9e5c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_bbdf5a76-10b2-400f-b135-b5411fcae71a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_bbdf5a76-10b2-400f-b135-b5411fcae71a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_a376e2b9-0baa-4a39-8f60-68a9241d4642" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_a376e2b9-0baa-4a39-8f60-68a9241d4642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202108Member_e0021944-7c3c-4eb9-9fb7-c5a625cf838a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate202108Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a376e2b9-0baa-4a39-8f60-68a9241d4642" xlink:to="loc_us-gaap_AccountingStandardsUpdate202108Member_e0021944-7c3c-4eb9-9fb7-c5a625cf838a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_71ad4330-c494-4b8d-8544-004ec5080013" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_71ad4330-c494-4b8d-8544-004ec5080013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_a6d2b999-b672-4a97-9213-a7c8df49b22f" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_a6d2b999-b672-4a97-9213-a7c8df49b22f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_e28c33ce-39d6-4639-89b7-b350e2183c76" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_e28c33ce-39d6-4639-89b7-b350e2183c76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_32ce7092-52d0-4830-adb6-8b2f73d9ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_32ce7092-52d0-4830-adb6-8b2f73d9ffd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_657b0f02-d2f1-41c6-b35b-57eea7164d3b" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_657b0f02-d2f1-41c6-b35b-57eea7164d3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_91dff363-12ed-4884-a8a4-2b5399814e83" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_91dff363-12ed-4884-a8a4-2b5399814e83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_6814cb1e-afd9-4dbe-b908-6359e471a599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_6814cb1e-afd9-4dbe-b908-6359e471a599" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_f8a7ff0f-f0f7-40fd-84d0-9c22b2185649" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_f8a7ff0f-f0f7-40fd-84d0-9c22b2185649" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_cea4f2f5-452f-4fbc-bef8-08313a34887b" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_cea4f2f5-452f-4fbc-bef8-08313a34887b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_a9658fd9-5705-42f0-9596-41af5b9df033" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_a9658fd9-5705-42f0-9596-41af5b9df033" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_00a512ba-2bc4-425b-ad98-a687aed72329" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_00a512ba-2bc4-425b-ad98-a687aed72329" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_38ddbb39-5fcd-4c72-bb9d-3e882ea6b2d5" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_38ddbb39-5fcd-4c72-bb9d-3e882ea6b2d5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_281f28a5-9d96-4b14-b3ee-ab6e9850c54e" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_281f28a5-9d96-4b14-b3ee-ab6e9850c54e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_0e28e4cb-f7d6-43a4-9af5-aad77af13174" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_0e28e4cb-f7d6-43a4-9af5-aad77af13174" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_9bb4b0b2-ed2c-4a92-9979-2eca05e53ec5" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_9bb4b0b2-ed2c-4a92-9979-2eca05e53ec5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_2a0ee6dc-5bb0-40e7-9d4d-82e2dc06cd80" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_2a0ee6dc-5bb0-40e7-9d4d-82e2dc06cd80" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_b7f5b343-bb0e-4b75-b6bc-6387657f4aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_b7f5b343-bb0e-4b75-b6bc-6387657f4aa9" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34774a3a-3a5d-46e5-8a00-00ce3088ef52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34774a3a-3a5d-46e5-8a00-00ce3088ef52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b64a0e67-92cf-4587-ad20-d2604f3c6a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b64a0e67-92cf-4587-ad20-d2604f3c6a5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_287be85d-4dcc-4ed2-a3e0-649b1f7f18d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_287be85d-4dcc-4ed2-a3e0-649b1f7f18d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b9d8dd0e-09e4-4ee3-bac4-05c8c2699068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b9d8dd0e-09e4-4ee3-bac4-05c8c2699068" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_adcc9af5-29e7-4dd2-bbb1-74172d4092ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_adcc9af5-29e7-4dd2-bbb1-74172d4092ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_294694fb-9b5e-49bc-9a1d-668eed2044f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_294694fb-9b5e-49bc-9a1d-668eed2044f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f4b3cb98-f86f-4056-9573-76c01d427120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f4b3cb98-f86f-4056-9573-76c01d427120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_7b862f97-2f96-441e-8c3f-052cd7570e50" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f4b3cb98-f86f-4056-9573-76c01d427120" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_7b862f97-2f96-441e-8c3f-052cd7570e50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_99bfd841-d141-4551-b01b-55758197ebd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:to="loc_us-gaap_HedgingDesignationDomain_99bfd841-d141-4551-b01b-55758197ebd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5c7fb512-37fe-44f2-b1d5-4b1293f3b394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:to="loc_us-gaap_HedgingDesignationDomain_5c7fb512-37fe-44f2-b1d5-4b1293f3b394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6b53990c-4a66-4238-bc2c-2fa82a614b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5c7fb512-37fe-44f2-b1d5-4b1293f3b394" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6b53990c-4a66-4238-bc2c-2fa82a614b69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:to="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2e3c0cd0-74e0-4c8a-9df4-6552c3ef3d67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2e3c0cd0-74e0-4c8a-9df4-6552c3ef3d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_35f9dd44-4496-4877-9bcc-7ae1e139cfac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_35f9dd44-4496-4877-9bcc-7ae1e139cfac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_48c82fbb-1a80-4deb-9b51-f0168121a9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_DerivativeAssets_48c82fbb-1a80-4deb-9b51-f0168121a9e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_de217414-f10d-4690-95bc-6ca3d96363ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_de217414-f10d-4690-95bc-6ca3d96363ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:to="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d84066a8-29d9-4117-b200-28d2cacbcdab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:to="loc_us-gaap_DerivativeLiabilities_d84066a8-29d9-4117-b200-28d2cacbcdab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dd45864a-889b-4a9c-8967-a855a91b016c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_dd45864a-889b-4a9c-8967-a855a91b016c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#FairvalueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3b3da25b-328b-4cdd-bebb-dbf424d11523_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3b3da25b-328b-4cdd-bebb-dbf424d11523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e63959e-90d4-4c2d-ac10-d11f39f13bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e63959e-90d4-4c2d-ac10-d11f39f13bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5728e439-9c18-446f-9a49-be1a817a2b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e63959e-90d4-4c2d-ac10-d11f39f13bea" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5728e439-9c18-446f-9a49-be1a817a2b8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa48f751-584f-4b84-be57-9b316de37d90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa48f751-584f-4b84-be57-9b316de37d90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11c69470-a866-4ac4-8a45-a3c1bd88d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11c69470-a866-4ac4-8a45-a3c1bd88d32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7672b207-658d-440f-ba8d-d570652265f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11c69470-a866-4ac4-8a45-a3c1bd88d32e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7672b207-658d-440f-ba8d-d570652265f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0ef3015d-67a1-4dda-b3b3-746f79702ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_0ef3015d-67a1-4dda-b3b3-746f79702ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_45ff6ecd-7613-4664-8e1f-1ae90e96b563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_45ff6ecd-7613-4664-8e1f-1ae90e96b563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_e9810fca-9364-4a91-b6f0-bec129168f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_e9810fca-9364-4a91-b6f0-bec129168f67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_1e71768b-54f0-4d96-bd3a-6a1c3bc1506b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_LongTermDebtFairValue_1e71768b-54f0-4d96-bd3a-6a1c3bc1506b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_45bf1e10-afc9-4825-983d-528bde5d9c4f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_45bf1e10-afc9-4825-983d-528bde5d9c4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d80305b5-99da-4d7b-874d-6d49b6803f07" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d80305b5-99da-4d7b-874d-6d49b6803f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_d3b9bb34-6387-44f6-9a44-3bf486fa88f0" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d80305b5-99da-4d7b-874d-6d49b6803f07" xlink:to="loc_iclr_OncacareMember_d3b9bb34-6387-44f6-9a44-3bf486fa88f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cd76cc2e-738d-4651-973e-8b7185c74998_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cd76cc2e-738d-4651-973e-8b7185c74998_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e21046d-80c6-429b-89a3-c35ce1e6ad83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e21046d-80c6-429b-89a3-c35ce1e6ad83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_950a17f5-a1fe-4409-b663-b0cd2818d4df" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e21046d-80c6-429b-89a3-c35ce1e6ad83" xlink:to="loc_iclr_OncacareMember_950a17f5-a1fe-4409-b663-b0cd2818d4df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0ae27934-5388-45a0-bedf-78dd58bc6030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0ae27934-5388-45a0-bedf-78dd58bc6030" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_28f58985-56a8-4c58-82ae-6b81c4f540ea" xlink:href="iclr-20231231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_28f58985-56a8-4c58-82ae-6b81c4f540ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_1a27d1f8-23a5-4bf8-aa6a-ad5cbbca681f" xlink:href="iclr-20231231.xsd#iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_1a27d1f8-23a5-4bf8-aa6a-ad5cbbca681f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_c88f67cf-9cba-448a-ba01-33bf7aa83bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_c88f67cf-9cba-448a-ba01-33bf7aa83bf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_90f0415b-36e5-439a-8ae8-0e47bff70817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_90f0415b-36e5-439a-8ae8-0e47bff70817" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_b9382d09-1dbc-4126-9754-ec5aec919eca" xlink:href="iclr-20231231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_b9382d09-1dbc-4126-9754-ec5aec919eca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b7ee155-cdbe-4a43-ad17-248254562e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b7ee155-cdbe-4a43-ad17-248254562e9a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7bd750be-c637-4614-bff7-62a48ff519ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_EquityMethodInvestments_7bd750be-c637-4614-bff7-62a48ff519ef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_95a47a00-fda5-4552-af9d-c21de381f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_95a47a00-fda5-4552-af9d-c21de381f58e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_eb12a3ca-1655-4437-9523-0000c6683add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_eb12a3ca-1655-4437-9523-0000c6683add" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ede95ab3-098e-4423-a3da-3cb261263717_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ede95ab3-098e-4423-a3da-3cb261263717_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_901a1e21-d55e-4858-99fe-9d8061de23f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_901a1e21-d55e-4858-99fe-9d8061de23f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_3032c410-00ea-4198-9bb3-297392e88e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_3032c410-00ea-4198-9bb3-297392e88e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_d7b79c4c-036c-4f6b-abaa-2b68d38bb1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_TradeNamesMember_d7b79c4c-036c-4f6b-abaa-2b68d38bb1e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_4217b1e5-bc3f-4392-ba87-61e7e64bf952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_DatabasesMember_4217b1e5-bc3f-4392-ba87-61e7e64bf952" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d693fb7-0014-4b00-93a4-92ba60c1c30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d693fb7-0014-4b00-93a4-92ba60c1c30f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_760ac196-3352-40ed-9242-386cbad8338e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_760ac196-3352-40ed-9242-386cbad8338e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_57a9245d-561b-48c3-b2ef-84c2e309fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_57a9245d-561b-48c3-b2ef-84c2e309fa74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b0f0f71-0119-4dc8-9c7f-63f4e2c78fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b0f0f71-0119-4dc8-9c7f-63f4e2c78fa9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d3df537-8c8b-4cd7-896d-364acc252d35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d3df537-8c8b-4cd7-896d-364acc252d35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_f7ff76b1-233b-42e1-b188-3fb62efbb2b1" xlink:href="iclr-20231231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:to="loc_iclr_BiotelResearchLLCMember_f7ff76b1-233b-42e1-b188-3fb62efbb2b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_e60b8a86-8753-4bf1-bc99-2de3accff053" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:to="loc_iclr_PRAHealthSciencesIncMember_e60b8a86-8753-4bf1-bc99-2de3accff053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56699ab6-f91f-4f29-b53d-11f15b318500_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56699ab6-f91f-4f29-b53d-11f15b318500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_61baba69-31b9-4aae-986d-55c077a49bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_CustomerRelationshipsMember_61baba69-31b9-4aae-986d-55c077a49bcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_98a0c2a1-4b7a-4f3d-a1e6-7b1ee4aba6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_98a0c2a1-4b7a-4f3d-a1e6-7b1ee4aba6a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_212b7c9f-c0a7-4e12-b5b0-9ecf7b3eb8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_TradeNamesMember_212b7c9f-c0a7-4e12-b5b0-9ecf7b3eb8cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_6d2cef16-f6d8-4950-b922-a3091ab79f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_DatabasesMember_6d2cef16-f6d8-4950-b922-a3091ab79f85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_477210d7-7f8b-4023-aa8a-bccd234b68e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_477210d7-7f8b-4023-aa8a-bccd234b68e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:to="loc_srt_RangeMember_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:to="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b7fcdd5e-7040-431f-8206-f1eec5a88cd3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:to="loc_srt_MinimumMember_b7fcdd5e-7040-431f-8206-f1eec5a88cd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68fc0d88-144c-488d-95b0-025c513d3a59" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:to="loc_srt_MaximumMember_68fc0d88-144c-488d-95b0-025c513d3a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1460cc11-32fe-4c0b-bb2f-9d9afbdffe55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1460cc11-32fe-4c0b-bb2f-9d9afbdffe55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_228c9d26-c510-4f4a-bb1b-97f087a8318f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_228c9d26-c510-4f4a-bb1b-97f087a8318f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46042a22-8e81-4f7b-88bb-cd32fb2d93b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46042a22-8e81-4f7b-88bb-cd32fb2d93b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bd68c820-4bf7-478a-90fb-0ae944fe23d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bd68c820-4bf7-478a-90fb-0ae944fe23d4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_964449c8-a81b-48ee-a63c-54e3f0eb9864_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_964449c8-a81b-48ee-a63c-54e3f0eb9864_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_98f6ac5c-6d49-47b6-97dd-38d47000aa81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:to="loc_us-gaap_SecuredDebtMember_98f6ac5c-6d49-47b6-97dd-38d47000aa81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_07445e18-157d-4c98-b837-7e7f156d6b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_07445e18-157d-4c98-b837-7e7f156d6b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d73d93cd-7e47-40b3-8264-40b600767574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d73d93cd-7e47-40b3-8264-40b600767574" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:to="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_568f7183-096c-4fdb-972e-289c59fecd4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_568f7183-096c-4fdb-972e-289c59fecd4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_66f89207-3c03-4ce0-984b-69e73bbfd3b9" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:to="loc_iclr_TermLoanFacilityMember_66f89207-3c03-4ce0-984b-69e73bbfd3b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_15b9831f-22c1-4b6d-9b9a-eafd1cd79540" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:to="loc_iclr_SeniorSecuredNotesMember_15b9831f-22c1-4b6d-9b9a-eafd1cd79540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c09c3b12-e185-47e5-b8c4-38f54df8bf90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c09c3b12-e185-47e5-b8c4-38f54df8bf90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d42c0102-07d6-43dd-a68d-c48d0882a0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d42c0102-07d6-43dd-a68d-c48d0882a0d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_cce4f2ea-2262-476f-a316-b87ba4d080b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_cce4f2ea-2262-476f-a316-b87ba4d080b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_6bf68583-65bc-4991-8771-6e4b39c0eb0b" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_6bf68583-65bc-4991-8771-6e4b39c0eb0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_f9671652-006c-4617-aa60-01ae71aa6996" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_f9671652-006c-4617-aa60-01ae71aa6996" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a46db43b-e137-4706-8f7d-d43bbecc5499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a46db43b-e137-4706-8f7d-d43bbecc5499" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c9c09d48-e786-4d3b-acf3-9ed2e75e2184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c9c09d48-e786-4d3b-acf3-9ed2e75e2184" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_add8629d-3a96-4168-ab1b-0e8605452b2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_add8629d-3a96-4168-ab1b-0e8605452b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9464e15-4ba6-4eea-aaf3-4c8ea66208f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9464e15-4ba6-4eea-aaf3-4c8ea66208f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_efda2275-c855-40d4-b227-1c3c2f04571e" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9464e15-4ba6-4eea-aaf3-4c8ea66208f5" xlink:to="loc_iclr_PRAHealthSciencesIncMember_efda2275-c855-40d4-b227-1c3c2f04571e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_07aeba5b-b13a-4182-ae1c-1ff392d30515_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_07aeba5b-b13a-4182-ae1c-1ff392d30515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e24a8889-1553-40c6-bb7f-4a905e9f8cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:to="loc_us-gaap_SecuredDebtMember_e24a8889-1553-40c6-bb7f-4a905e9f8cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0871c30b-ff87-4246-be80-a2b2e248419f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:to="loc_us-gaap_LineOfCreditMember_0871c30b-ff87-4246-be80-a2b2e248419f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_2441a465-f0aa-49c5-b27d-fb76eb6fb7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_2441a465-f0aa-49c5-b27d-fb76eb6fb7ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_435a967d-074f-456e-ab90-5fbb8c0a31d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_435a967d-074f-456e-ab90-5fbb8c0a31d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_b9c7c64b-6210-4ae5-a91b-7a72952b44a1" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_TermLoanFacilityMember_b9c7c64b-6210-4ae5-a91b-7a72952b44a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_bf407012-bfcc-418d-b038-68b94810739e" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_bf407012-bfcc-418d-b038-68b94810739e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_eb3f3caa-49c1-42f8-bb25-f947f65bef0d" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_eb3f3caa-49c1-42f8-bb25-f947f65bef0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_aaf752da-0695-4565-8063-5865d5a5b314" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_SeniorSecuredNotesMember_aaf752da-0695-4565-8063-5865d5a5b314" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ea1acb0b-82cd-469d-9e1f-7af83c82fde1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:to="loc_us-gaap_CreditFacilityDomain_ea1acb0b-82cd-469d-9e1f-7af83c82fde1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f944f78f-85c4-4748-a20a-9132578e6f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:to="loc_us-gaap_CreditFacilityDomain_f944f78f-85c4-4748-a20a-9132578e6f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b02b12d4-cb3e-4439-887d-149039c2aa9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f944f78f-85c4-4748-a20a-9132578e6f11" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b02b12d4-cb3e-4439-887d-149039c2aa9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_b53712af-2d06-45d0-bbbc-6dec06346e98_default" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:to="loc_iclr_VariableRateComponentDomain_b53712af-2d06-45d0-bbbc-6dec06346e98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:to="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_e74a1783-dc0f-455d-be85-5316b0fc7c80" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:to="loc_iclr_VariableRateComponentOneMember_e74a1783-dc0f-455d-be85-5316b0fc7c80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_07565fde-dafc-49bf-9ead-b476d98db514" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:to="loc_iclr_VariableRateComponentTwoMember_07565fde-dafc-49bf-9ead-b476d98db514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9d9d80d9-a9ed-469f-8c23-be7525a87fc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:to="loc_us-gaap_VariableRateDomain_9d9d80d9-a9ed-469f-8c23-be7525a87fc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:to="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_81010f6a-9805-4c0b-98f1-9c614b52e7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_81010f6a-9805-4c0b-98f1-9c614b52e7d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_f99973e0-dc86-45a7-b149-51d7531b365f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:to="loc_us-gaap_BaseRateMember_f99973e0-dc86-45a7-b149-51d7531b365f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1cace2cd-7925-4d5a-9124-d796deeb0c34_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:to="loc_srt_RangeMember_1cace2cd-7925-4d5a-9124-d796deeb0c34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:to="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08155e9f-a5c1-4031-9e1f-681a322d2802" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:to="loc_srt_MaximumMember_08155e9f-a5c1-4031-9e1f-681a322d2802" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2073e6d7-c69c-4ad3-863f-e72c3adadbf9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:to="loc_srt_MinimumMember_2073e6d7-c69c-4ad3-863f-e72c3adadbf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c5ae7cf0-db86-4e7e-952c-ed0faa8ba757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_InterestExpense_c5ae7cf0-db86-4e7e-952c-ed0faa8ba757" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_683381c6-1892-491c-9dd2-f5b2c55d9b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_683381c6-1892-491c-9dd2-f5b2c55d9b55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7db91a6b-99f4-429e-bbf4-acd74ae3102e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7db91a6b-99f4-429e-bbf4-acd74ae3102e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1f3f4e1e-9d15-4aa6-b5a1-fd89ac3cd431" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1f3f4e1e-9d15-4aa6-b5a1-fd89ac3cd431" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_336899e8-c70e-4cae-8fde-24a7dbac4b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_336899e8-c70e-4cae-8fde-24a7dbac4b56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_753217c4-95b0-4f9c-b91a-739045ce203a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_753217c4-95b0-4f9c-b91a-739045ce203a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_47b26d18-bd79-4560-9bd4-05e7f88668e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_47b26d18-bd79-4560-9bd4-05e7f88668e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_4ff93188-04f2-403f-b3c5-c6c603428593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_4ff93188-04f2-403f-b3c5-c6c603428593" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b096702a-1d7f-4da7-a3b3-e653a4b8e9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b096702a-1d7f-4da7-a3b3-e653a4b8e9e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_69a3f89d-19ac-48f8-be3a-b6913b32eb04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_69a3f89d-19ac-48f8-be3a-b6913b32eb04" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_4ce2f5c5-1512-4b0d-810c-e3654f7ab004" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_LongTermDebtFairValue_4ce2f5c5-1512-4b0d-810c-e3654f7ab004" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:to="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a605a4d3-2cd6-4250-8fe9-e2635b04caf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a605a4d3-2cd6-4250-8fe9-e2635b04caf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_907691bb-62c7-46f2-b569-71bad94ac8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_907691bb-62c7-46f2-b569-71bad94ac8e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_20268733-6a0c-41eb-a8c6-74f9643f2832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_907691bb-62c7-46f2-b569-71bad94ac8e5" xlink:to="loc_us-gaap_SecuredDebtMember_20268733-6a0c-41eb-a8c6-74f9643f2832" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:to="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e9b4f476-4100-42a1-8679-6adc05adf41e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e9b4f476-4100-42a1-8679-6adc05adf41e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e35547d-8c47-4ab9-a273-71e956bfd445" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e35547d-8c47-4ab9-a273-71e956bfd445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_a116559e-fd0a-4e52-971d-ec23346d8a78" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7e35547d-8c47-4ab9-a273-71e956bfd445" xlink:to="loc_iclr_TermLoanFacilityMember_a116559e-fd0a-4e52-971d-ec23346d8a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_fa094519-e997-4a7a-9de4-645f3b511c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_fa094519-e997-4a7a-9de4-645f3b511c85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_b9375a6c-f8e6-44d0-8598-e5419305594e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_b9375a6c-f8e6-44d0-8598-e5419305594e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b6bebe11-3fe9-4247-a8c6-732d78b01fad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:to="loc_us-gaap_CreditFacilityDomain_b6bebe11-3fe9-4247-a8c6-732d78b01fad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f1642c94-46ef-4900-8f4b-b6ff75f97642" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:to="loc_us-gaap_CreditFacilityDomain_f1642c94-46ef-4900-8f4b-b6ff75f97642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5626a8a2-480c-4447-ba66-6615a6992d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f1642c94-46ef-4900-8f4b-b6ff75f97642" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5626a8a2-480c-4447-ba66-6615a6992d1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d810816-9848-4457-a430-7bae71299a0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d810816-9848-4457-a430-7bae71299a0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a1aaf2db-3af3-463b-9ca0-fa51c273937d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a1aaf2db-3af3-463b-9ca0-fa51c273937d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_b3809de3-59fe-47ec-9165-85215b0f6e06" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a1aaf2db-3af3-463b-9ca0-fa51c273937d" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_b3809de3-59fe-47ec-9165-85215b0f6e06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_64ccb12b-fe86-443f-8126-3134ec3420fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_64ccb12b-fe86-443f-8126-3134ec3420fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8b40ed7-955b-4f55-8273-52d94073789c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8b40ed7-955b-4f55-8273-52d94073789c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bf813122-2175-46e2-a877-d263cb4c85f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d8b40ed7-955b-4f55-8273-52d94073789c" xlink:to="loc_us-gaap_LineOfCreditMember_bf813122-2175-46e2-a877-d263cb4c85f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_3564b223-b45c-4ffd-973f-726a14a7616f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_3564b223-b45c-4ffd-973f-726a14a7616f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_f95177f5-7854-463d-be6e-09d83c09f5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_f95177f5-7854-463d-be6e-09d83c09f5ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9059aee-fd33-4bed-9b67-6d80852a115b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_LongTermDebt_b9059aee-fd33-4bed-9b67-6d80852a115b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DerivativesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5d0d0211-1127-4a0e-b43a-8b5c76173efb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5d0d0211-1127-4a0e-b43a-8b5c76173efb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_ab06d769-fccd-4eaf-9a31-ccb0afd02f32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:to="loc_us-gaap_InterestRateCapMember_ab06d769-fccd-4eaf-9a31-ccb0afd02f32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8c2c6d4e-75f9-4873-92a8-07430cf48476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:to="loc_us-gaap_InterestRateSwapMember_8c2c6d4e-75f9-4873-92a8-07430cf48476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_d8e53e30-549f-4046-a81e-5d2c601872dc" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_d8e53e30-549f-4046-a81e-5d2c601872dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2b5b4cca-a081-4826-91bf-fbe8391c902b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:to="loc_us-gaap_HedgingDesignationDomain_2b5b4cca-a081-4826-91bf-fbe8391c902b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e0ff3d49-ab5d-4e00-a1bc-c52a14c9f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:to="loc_us-gaap_HedgingDesignationDomain_e0ff3d49-ab5d-4e00-a1bc-c52a14c9f91c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_68b8f4f7-20ca-4e3e-95bc-cfdc6cfa5f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_e0ff3d49-ab5d-4e00-a1bc-c52a14c9f91c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_68b8f4f7-20ca-4e3e-95bc-cfdc6cfa5f43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_27206381-b527-4e2d-9d19-5d3130a60b71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:to="loc_us-gaap_VariableRateDomain_27206381-b527-4e2d-9d19-5d3130a60b71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e9f27869-25c3-4c88-84f8-198ec988039f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:to="loc_us-gaap_VariableRateDomain_e9f27869-25c3-4c88-84f8-198ec988039f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_773aabd0-52f0-4c77-94df-f4869ecfba52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e9f27869-25c3-4c88-84f8-198ec988039f" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_773aabd0-52f0-4c77-94df-f4869ecfba52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5437c8e-e94d-4902-bb27-4f0e657760fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5437c8e-e94d-4902-bb27-4f0e657760fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1af9d111-31b6-4fa1-8b0b-94812dda8ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1af9d111-31b6-4fa1-8b0b-94812dda8ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_935b02c1-fafc-455d-adc0-8919d04f2f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1af9d111-31b6-4fa1-8b0b-94812dda8ffa" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_935b02c1-fafc-455d-adc0-8919d04f2f99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_3ff44054-7ada-4161-89ae-53ff906912dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_3ff44054-7ada-4161-89ae-53ff906912dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_911e1c6a-e653-4ace-abba-f71f28c72e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeNotionalAmount_911e1c6a-e653-4ace-abba-f71f28c72e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_1a9ea1c4-6285-4730-92f8-73d1ae68e793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_1a9ea1c4-6285-4730-92f8-73d1ae68e793" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_c7d41aa1-350c-4a50-bd1b-f0a4ad787558" xlink:href="iclr-20231231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_c7d41aa1-350c-4a50-bd1b-f0a4ad787558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_d8100459-e093-456d-8f4c-eee78850a331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_d8100459-e093-456d-8f4c-eee78850a331" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_b59fc658-6fac-40bb-bd28-e937c6653533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_b59fc658-6fac-40bb-bd28-e937c6653533" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_84560b50-bc8d-496f-9588-bd012914c5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_84560b50-bc8d-496f-9588-bd012914c5b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_d7d5506b-f461-4aae-bf26-e093106eee39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_d7d5506b-f461-4aae-bf26-e093106eee39" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_5755468a-486e-496c-8620-e9c8a1921f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_5755468a-486e-496c-8620-e9c8a1921f00" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_1c606a40-38ad-4062-9c17-92486284c899" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_1c606a40-38ad-4062-9c17-92486284c899" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b8fb9029-06e7-4ccb-9424-ee8a9f13d7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b8fb9029-06e7-4ccb-9424-ee8a9f13d7fc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cca45d8a-9bf4-4c85-bdd8-4861d427f979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cca45d8a-9bf4-4c85-bdd8-4861d427f979" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_58141bda-a358-4d58-82eb-ed624b8f0e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_58141bda-a358-4d58-82eb-ed624b8f0e5b" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b63924d-7617-42b4-8d5b-413382ba616d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b63924d-7617-42b4-8d5b-413382ba616d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_5e9b80ea-e1dc-48cd-a4b2-96952d67ab82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:to="loc_us-gaap_InterestRateCapMember_5e9b80ea-e1dc-48cd-a4b2-96952d67ab82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5d200dfe-b149-4f2c-80fa-0a3e0676cd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:to="loc_us-gaap_InterestRateSwapMember_5d200dfe-b149-4f2c-80fa-0a3e0676cd8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_ee02a52e-5383-4b07-bf31-c3059630465f" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_ee02a52e-5383-4b07-bf31-c3059630465f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:to="loc_us-gaap_HedgingDesignationDomain_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f23747ec-4e5e-4575-99a1-96a74bac6515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:to="loc_us-gaap_HedgingDesignationDomain_f23747ec-4e5e-4575-99a1-96a74bac6515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_562a0204-230e-4553-ae63-1c745aa74413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f23747ec-4e5e-4575-99a1-96a74bac6515" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_562a0204-230e-4553-ae63-1c745aa74413" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_561a57c5-9a1c-4331-bd39-09fe8912f998_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_561a57c5-9a1c-4331-bd39-09fe8912f998_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d027132-0ebb-4fa7-a856-da7334851b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d027132-0ebb-4fa7-a856-da7334851b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_78d62c04-fa92-407e-8df8-0a1cfb2fe0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d027132-0ebb-4fa7-a856-da7334851b06" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_78d62c04-fa92-407e-8df8-0a1cfb2fe0a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c9e6f7a7-3def-4389-a876-fc8eb8933558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeAssets_c9e6f7a7-3def-4389-a876-fc8eb8933558" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_50bdbc32-d7ce-4272-9dd5-b85b52a91aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeLiabilities_50bdbc32-d7ce-4272-9dd5-b85b52a91aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0b6f80f3-0427-4cac-ab27-f3d0b78da5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0b6f80f3-0427-4cac-ab27-f3d0b78da5ed" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f0e8f56e-cd16-4480-bee3-f3750af8e61f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f0e8f56e-cd16-4480-bee3-f3750af8e61f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_945abb91-78ab-4d7a-bb37-9f74e19a74aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_945abb91-78ab-4d7a-bb37-9f74e19a74aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8e52be96-2a56-4088-9ba2-1b4ab4e992a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:to="loc_us-gaap_CostOfSalesMember_8e52be96-2a56-4088-9ba2-1b4ab4e992a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e78db12c-2647-43f4-ab05-d5c8835c6755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_LeaseCost_e78db12c-2647-43f4-ab05-d5c8835c6755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e6c22a9b-4bb1-4368-975d-9a339842eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e6c22a9b-4bb1-4368-975d-9a339842eb8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_0de2193c-0dc4-4d45-803a-c1f244989668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_0de2193c-0dc4-4d45-803a-c1f244989668" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_64f187bb-038e-404b-8025-47eb9b3fd596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_64f187bb-038e-404b-8025-47eb9b3fd596" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_37891cf0-5c5f-4346-ac7b-cc026502c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_37891cf0-5c5f-4346-ac7b-cc026502c4cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7603d019-3b87-4efb-853c-5b41bba169ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7603d019-3b87-4efb-853c-5b41bba169ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7594a552-a5f3-47a2-a289-f512ba884100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7594a552-a5f3-47a2-a289-f512ba884100" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#ShareCapitalDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72a17f2c-236a-4ec3-afed-93eb3cb29ead_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:to="loc_us-gaap_EquityComponentDomain_72a17f2c-236a-4ec3-afed-93eb3cb29ead_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_09cfd171-7a92-4ff7-bdb6-c9b6eb17c2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:to="loc_us-gaap_EquityComponentDomain_09cfd171-7a92-4ff7-bdb6-c9b6eb17c2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_99637137-2b9b-4a18-a2aa-fb16b9262dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_09cfd171-7a92-4ff7-bdb6-c9b6eb17c2f3" xlink:to="loc_us-gaap_CommonStockMember_99637137-2b9b-4a18-a2aa-fb16b9262dd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dd7fe82-4dca-43c2-836d-0492623def4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3dd7fe82-4dca-43c2-836d-0492623def4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_75c408f9-728a-48ae-ac57-7ff0ffd544d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:to="loc_us-gaap_EmployeeStockOptionMember_75c408f9-728a-48ae-ac57-7ff0ffd544d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bdc5a27e-a112-403e-8ca0-2e7ad5aec5df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bdc5a27e-a112-403e-8ca0-2e7ad5aec5df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_04249a92-76b6-4109-bb70-ec8e6e0cef01" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:to="loc_iclr_PerformanceShareUnitMember_04249a92-76b6-4109-bb70-ec8e6e0cef01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e91426ce-1b32-448c-94f3-829b5a20cb9d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:to="loc_srt_RangeMember_e91426ce-1b32-448c-94f3-829b5a20cb9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_544ed05f-2a55-4a2e-8b61-67e6fa0211e4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:to="loc_srt_RangeMember_544ed05f-2a55-4a2e-8b61-67e6fa0211e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2db82115-6c37-45f3-9412-356df4fe0fad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_544ed05f-2a55-4a2e-8b61-67e6fa0211e4" xlink:to="loc_srt_MaximumMember_2db82115-6c37-45f3-9412-356df4fe0fad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5ec11783-9cf6-48b7-b6b6-2cc64106d17c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5ec11783-9cf6-48b7-b6b6-2cc64106d17c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_af46050c-2bfa-4b8f-80e1-8107072eac29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_af46050c-2bfa-4b8f-80e1-8107072eac29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_660a8a49-e00a-425a-b1ea-2723be2cf39d" xlink:href="iclr-20231231.xsd#iclr_BuybackProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_af46050c-2bfa-4b8f-80e1-8107072eac29" xlink:to="loc_iclr_BuybackProgramMember_660a8a49-e00a-425a-b1ea-2723be2cf39d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_f7372930-6f30-4891-9733-d65008fedd90" xlink:href="iclr-20231231.xsd#iclr_NumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_iclr_NumberOfVotes_f7372930-6f30-4891-9733-d65008fedd90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8770fa4d-1f15-4e5a-89de-824f9df1795a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8770fa4d-1f15-4e5a-89de-824f9df1795a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cd6c556-b857-461e-9caf-b7d00bc3e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cd6c556-b857-461e-9caf-b7d00bc3e3b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26285c73-17a8-4d54-a714-662edf501eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26285c73-17a8-4d54-a714-662edf501eb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_089d7604-f8f3-4b30-ba97-a597f951acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_089d7604-f8f3-4b30-ba97-a597f951acdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_94a4d396-48af-44b1-8837-bd925ccda39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_94a4d396-48af-44b1-8837-bd925ccda39c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3ccd3d28-15b1-444b-bfdb-f13a5fed6336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3ccd3d28-15b1-444b-bfdb-f13a5fed6336" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_738434a2-dd6b-44ef-a51e-1902b17ca5d3" xlink:href="iclr-20231231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_738434a2-dd6b-44ef-a51e-1902b17ca5d3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1c105d6a-f476-4b65-84a9-19875db65d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1c105d6a-f476-4b65-84a9-19875db65d35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_70e25814-f0e5-4a6e-9e15-ac11b5f84fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_70e25814-f0e5-4a6e-9e15-ac11b5f84fb5" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:to="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7d1e449c-53bb-4069-84fb-50a226934963_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:to="loc_us-gaap_RestructuringPlanDomain_7d1e449c-53bb-4069-84fb-50a226934963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_962286da-f74b-4904-b4e2-d23132b305be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:to="loc_us-gaap_RestructuringPlanDomain_962286da-f74b-4904-b4e2-d23132b305be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_66e9ae24-9c41-429c-bcd3-16f30dff87ea" xlink:href="iclr-20231231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_962286da-f74b-4904-b4e2-d23132b305be" xlink:to="loc_iclr_A2021RestructuringPlanMember_66e9ae24-9c41-429c-bcd3-16f30dff87ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6daab919-399b-492d-8ef3-637ee764150d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6daab919-399b-492d-8ef3-637ee764150d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember_4255cd79-0723-4b43-9e1e-ce1ef60f83e4" xlink:href="iclr-20231231.xsd#iclr_LeaseLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:to="loc_iclr_LeaseLiabilityMember_4255cd79-0723-4b43-9e1e-ce1ef60f83e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_679b3882-8cfe-4889-a6a3-eee50f718850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:to="loc_us-gaap_EmployeeSeveranceMember_679b3882-8cfe-4889-a6a3-eee50f718850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_9b42a37e-4739-4414-a711-7fc964fad3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringCosts_9b42a37e-4739-4414-a711-7fc964fad3aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c8b53fe3-9555-479f-a346-1d74bb8548b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_SeveranceCosts1_c8b53fe3-9555-479f-a346-1d74bb8548b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_f849b6e7-f391-4022-ac9b-4b028369f904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_OtherRestructuringCosts_f849b6e7-f391-4022-ac9b-4b028369f904" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_888b74ed-ffb8-4617-a51c-cf1de6e608c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringReserve_888b74ed-ffb8-4617-a51c-cf1de6e608c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_b9158f97-15f4-42e4-b314-77b10164dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringReserveCurrent_b9158f97-15f4-42e4-b314-77b10164dd86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_8d44b4cf-6a82-4a63-9773-5873d057b76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_8d44b4cf-6a82-4a63-9773-5873d057b76f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_2d9d5d78-4682-44a1-bf14-b9b842127af0" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_2d9d5d78-4682-44a1-bf14-b9b842127af0" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:to="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_68066ff9-6c65-4cbf-9452-5a8750b0afc2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:to="loc_srt_SegmentGeographicalDomain_68066ff9-6c65-4cbf-9452-5a8750b0afc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:to="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_834b030d-a7dd-47c3-959b-02239bdd6021" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:to="loc_country_IE_834b030d-a7dd-47c3-959b-02239bdd6021" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b0409524-c50e-43c0-8087-1e0c3b489180" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:to="loc_country_US_b0409524-c50e-43c0-8087-1e0c3b489180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_ad999701-6bd5-4785-bd02-d20d2933d1fa" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_ad999701-6bd5-4785-bd02-d20d2933d1fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d14067d3-5f32-4330-9866-58fb091e4c10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_2d9d5d78-4682-44a1-bf14-b9b842127af0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d14067d3-5f32-4330-9866-58fb091e4c10" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:href="iclr-20231231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:href="iclr-20231231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:to="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_239a3ac6-191e-4b12-96b4-7eee9230c579_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:to="loc_srt_SegmentGeographicalDomain_239a3ac6-191e-4b12-96b4-7eee9230c579_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:to="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_d4266006-bcc6-48a9-b445-e1dee2465750" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:to="loc_country_IE_d4266006-bcc6-48a9-b445-e1dee2465750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_68fa5197-353d-4575-a8fc-202828fa470a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:to="loc_country_US_68fa5197-353d-4575-a8fc-202828fa470a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_374f1629-3fba-4ee0-9e44-71b5d94a497e" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_374f1629-3fba-4ee0-9e44-71b5d94a497e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d336784c-7f87-4cc3-acab-d3444dd06b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d336784c-7f87-4cc3-acab-d3444dd06b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6db1f25a-ba9e-46ff-8ca1-f22fca0d794a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d336784c-7f87-4cc3-acab-d3444dd06b17" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6db1f25a-ba9e-46ff-8ca1-f22fca0d794a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f28ce530-ddd1-4451-ad01-21f736a31db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f28ce530-ddd1-4451-ad01-21f736a31db8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2bada3d0-8014-4246-9737-20826f644907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f28ce530-ddd1-4451-ad01-21f736a31db8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2bada3d0-8014-4246-9737-20826f644907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b0d69087-6482-4ec4-a2a4-e72ff8b4aaca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b0d69087-6482-4ec4-a2a4-e72ff8b4aaca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2eecf868-0b61-41dd-92f6-f0eb78566c28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2eecf868-0b61-41dd-92f6-f0eb78566c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f175db23-2113-4387-8a91-f3473f2cbabf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f175db23-2113-4387-8a91-f3473f2cbabf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_adf80966-f19e-435e-a025-f4e532ea12c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_adf80966-f19e-435e-a025-f4e532ea12c1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_07d20e70-0e85-4945-b299-f243821b8d64_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:to="loc_srt_SegmentGeographicalDomain_07d20e70-0e85-4945-b299-f243821b8d64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:to="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_5ffb1e6c-b876-431c-a9c6-5603aca70643" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:to="loc_country_IE_5ffb1e6c-b876-431c-a9c6-5603aca70643" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_129e748c-165b-48a4-aeea-96fb6600f3d1" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:to="loc_country_US_129e748c-165b-48a4-aeea-96fb6600f3d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_43169638-1458-460c-ac58-9dee970b9500" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:to="loc_iclr_OtherCountriesMember_43169638-1458-460c-ac58-9dee970b9500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_21ce8081-2218-4a67-8690-54c496bff1ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_21ce8081-2218-4a67-8690-54c496bff1ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_1967af3a-b4bd-4d2b-b0d1-69177e57c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:to="loc_us-gaap_ForeignCountryMember_1967af3a-b4bd-4d2b-b0d1-69177e57c78d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f815bf98-aae1-45db-a9c4-2ef26c4cf46a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f815bf98-aae1-45db-a9c4-2ef26c4cf46a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_3e244e4e-f9b8-4b50-b21f-c8b191e85300_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_3e244e4e-f9b8-4b50-b21f-c8b191e85300_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5ae0d10b-676a-410d-9cb5-f0bbe24ea17d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5ae0d10b-676a-410d-9cb5-f0bbe24ea17d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_bb09b172-52bb-4ad4-97a6-ed2bfc90e71f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5ae0d10b-676a-410d-9cb5-f0bbe24ea17d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_bb09b172-52bb-4ad4-97a6-ed2bfc90e71f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_50703469-ca33-4716-8fcd-eb65c5b0a0f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:to="loc_us-gaap_TaxPeriodDomain_50703469-ca33-4716-8fcd-eb65c5b0a0f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_785cf896-814f-4650-8b5f-6ded9bc67137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:to="loc_us-gaap_TaxPeriodDomain_785cf896-814f-4650-8b5f-6ded9bc67137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2024To2030Member_3722b086-383b-488e-9c3a-05a186ef83f8" xlink:href="iclr-20231231.xsd#iclr_TaxYear2024To2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_785cf896-814f-4650-8b5f-6ded9bc67137" xlink:to="loc_iclr_TaxYear2024To2030Member_3722b086-383b-488e-9c3a-05a186ef83f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_70e1b7f3-953c-4f5b-9d82-60d01952c8ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_70e1b7f3-953c-4f5b-9d82-60d01952c8ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_159a0855-767f-45ad-a05c-573c32881def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_159a0855-767f-45ad-a05c-573c32881def" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_2fb7299d-f963-4391-a4b3-5cb90296508d" xlink:href="iclr-20231231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a0855-767f-45ad-a05c-573c32881def" xlink:to="loc_iclr_IncomeTaxBenefitMember_2fb7299d-f963-4391-a4b3-5cb90296508d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ec1022cd-3a6c-4b16-95ac-403802bc6eff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ec1022cd-3a6c-4b16-95ac-403802bc6eff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_441a49d1-2635-4c39-918c-f762fd4054ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_441a49d1-2635-4c39-918c-f762fd4054ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ca5c8f24-9268-4cce-b23b-f05c9c639182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_441a49d1-2635-4c39-918c-f762fd4054ff" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ca5c8f24-9268-4cce-b23b-f05c9c639182" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_7886ac1b-527c-41b6-a033-5b263516a548" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_7886ac1b-527c-41b6-a033-5b263516a548" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5709cca2-3002-4001-acc9-1b1d51a655ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5709cca2-3002-4001-acc9-1b1d51a655ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal_4166b63e-e94e-48d5-a29c-1654e16a9782" xlink:href="iclr-20231231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_iclr_OperatingLossCarryforwardsUSFederal_4166b63e-e94e-48d5-a29c-1654e16a9782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7d8875e4-1dca-4549-a196-94e3d19f73e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7d8875e4-1dca-4549-a196-94e3d19f73e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_7d573f6d-128a-4518-801c-a4015d0e9dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_7d573f6d-128a-4518-801c-a4015d0e9dec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5a88df40-dd2e-4507-8f31-aaef52f8372d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5a88df40-dd2e-4507-8f31-aaef52f8372d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5df6fbb8-2387-4c47-8bb0-0c2208d598ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5df6fbb8-2387-4c47-8bb0-0c2208d598ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fff2373f-e45d-41d1-8691-66f0ff20a9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fff2373f-e45d-41d1-8691-66f0ff20a9fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e31b79b6-03b2-4643-bff6-f890d867553e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e31b79b6-03b2-4643-bff6-f890d867553e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_f45f38eb-145f-4898-a66e-9d6a5751f968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_f45f38eb-145f-4898-a66e-9d6a5751f968" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_9510346c-ef07-4275-a00b-1940eeae6aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_9510346c-ef07-4275-a00b-1940eeae6aeb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_23ee2824-8521-4b0e-9d08-c86360a6930f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_23ee2824-8521-4b0e-9d08-c86360a6930f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_fec3e3c0-1899-47f0-8ace-5644afcbc033" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_fec3e3c0-1899-47f0-8ace-5644afcbc033" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_5c3f1ccf-4256-4768-99c9-c111150e9346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_5c3f1ccf-4256-4768-99c9-c111150e9346" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:to="loc_srt_SegmentGeographicalDomain_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c4ea3b6d-5148-4dc7-b067-f1db4bfb9a47" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:to="loc_srt_SegmentGeographicalDomain_c4ea3b6d-5148-4dc7-b067-f1db4bfb9a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fbe4cfc5-27e5-4804-91f3-1026b1196b27" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c4ea3b6d-5148-4dc7-b067-f1db4bfb9a47" xlink:to="loc_country_US_fbe4cfc5-27e5-4804-91f3-1026b1196b27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_c97f23fa-092e-40b1-b92f-0a15956adf21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_c97f23fa-092e-40b1-b92f-0a15956adf21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab335a21-01ed-4aea-8c83-b10d0c2ebb64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab335a21-01ed-4aea-8c83-b10d0c2ebb64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_6650ef7d-bed9-45a0-ba28-f14439e02877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab335a21-01ed-4aea-8c83-b10d0c2ebb64" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_6650ef7d-bed9-45a0-ba28-f14439e02877" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_28dd172a-abab-42f7-a38c-282aab7cc0ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_28dd172a-abab-42f7-a38c-282aab7cc0ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_17ea7476-e0ad-4a7d-a700-dc39a6eb6285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_17ea7476-e0ad-4a7d-a700-dc39a6eb6285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d24ef509-6adb-4987-af76-2b0d2024d63a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17ea7476-e0ad-4a7d-a700-dc39a6eb6285" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d24ef509-6adb-4987-af76-2b0d2024d63a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:to="loc_us-gaap_TaxPeriodDomain_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:to="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2024To2037Member_cca9628a-cda1-45d0-ba4f-709a04f66781" xlink:href="iclr-20231231.xsd#iclr_TaxYear2024To2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:to="loc_iclr_TaxYear2024To2037Member_cca9628a-cda1-45d0-ba4f-709a04f66781" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20382042Member_c307acc5-069f-4155-b04b-75310e0266dd" xlink:href="iclr-20231231.xsd#iclr_TaxYear20382042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:to="loc_iclr_TaxYear20382042Member_c307acc5-069f-4155-b04b-75310e0266dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_01639094-7b96-4849-905c-b9f9fef53bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_01639094-7b96-4849-905c-b9f9fef53bb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_dcd2160a-119f-4479-8650-4491c24d0a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_dcd2160a-119f-4479-8650-4491c24d0a55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_05f660a8-0d92-4cde-8c39-f91922203fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_05f660a8-0d92-4cde-8c39-f91922203fc8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d6658b97-b4d3-431e-bd1c-1dc04343fd4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d6658b97-b4d3-431e-bd1c-1dc04343fd4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4bfc01ce-9eb3-46e7-94ee-cae9696314d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4bfc01ce-9eb3-46e7-94ee-cae9696314d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4bfc01ce-9eb3-46e7-94ee-cae9696314d9" xlink:to="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_71800169-9519-497a-bddb-2a677b95f20a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:to="loc_country_US_71800169-9519-497a-bddb-2a677b95f20a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4844138b-0f6a-4886-b4e5-424de22e8698" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:to="loc_country_GB_4844138b-0f6a-4886-b4e5-424de22e8698" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_298af1eb-2153-40e9-b2b4-b2e242a81da1" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:to="loc_country_CH_298af1eb-2153-40e9-b2b4-b2e242a81da1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_597caf97-8c88-4c4b-b8ba-9e38c064c07a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_597caf97-8c88-4c4b-b8ba-9e38c064c07a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember_eb2fe0c1-556f-455d-ada3-edcf1196a5dd" xlink:href="iclr-20231231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_OtherRetirementPlansMember_eb2fe0c1-556f-455d-ada3-edcf1196a5dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1b61174a-fe12-4a64-a6d9-87a44f861a65" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1b61174a-fe12-4a64-a6d9-87a44f861a65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_527636ae-4e39-4190-9c49-d280607460f1" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_527636ae-4e39-4190-9c49-d280607460f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_91cc6af6-baf2-4c17-bda7-70f43a0e2406" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_91cc6af6-baf2-4c17-bda7-70f43a0e2406" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0912605c-8bf4-4a9a-9d28-38e3fdd3643d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0912605c-8bf4-4a9a-9d28-38e3fdd3643d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ac629be-73b6-4dfc-bec7-550d5dc4a146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ac629be-73b6-4dfc-bec7-550d5dc4a146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember_d07828ae-fdc2-4373-8127-4e34d400f3ba" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ac629be-73b6-4dfc-bec7-550d5dc4a146" xlink:to="loc_iclr_AptivSolutionsMember_d07828ae-fdc2-4373-8127-4e34d400f3ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_11acc42e-f8f9-46f1-9334-39ac4ba84621" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_11acc42e-f8f9-46f1-9334-39ac4ba84621" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_a2402341-48cf-4fc8-9a01-4421cf23bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_a2402341-48cf-4fc8-9a01-4421cf23bdb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ac31b9c5-64ce-406c-9d31-b142db70e192" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ac31b9c5-64ce-406c-9d31-b142db70e192" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_bc29c60f-dc74-43c5-a75d-622469b169b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_bc29c60f-dc74-43c5-a75d-622469b169b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_cdedf32d-fd10-4732-8253-03351f4adcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_cdedf32d-fd10-4732-8253-03351f4adcb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a6cd694c-3c7d-4fc7-840e-80866115ebb7" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a6cd694c-3c7d-4fc7-840e-80866115ebb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_6121339b-717a-41d5-a0c2-2750da6bd57d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_6121339b-717a-41d5-a0c2-2750da6bd57d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_7f575dc0-e21b-43eb-a44e-679532eb024a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_7f575dc0-e21b-43eb-a44e-679532eb024a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod_63e1ad7a-aa72-4f83-85da-9f3682bcb819" xlink:href="iclr-20231231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_iclr_ExpectedRetirementPeriod_63e1ad7a-aa72-4f83-85da-9f3682bcb819" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f56be1ca-7c17-4c42-b37f-c757c329842f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f56be1ca-7c17-4c42-b37f-c757c329842f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7dd89d54-474f-4d41-858d-28424ba5b8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7dd89d54-474f-4d41-858d-28424ba5b8d8" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1820346c-16a5-44ae-9a52-a091c7b36362_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1820346c-16a5-44ae-9a52-a091c7b36362_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a172abbb-a62f-4197-a446-ba63ea19bb12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a172abbb-a62f-4197-a446-ba63ea19bb12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7dc062c5-1422-4403-ab46-4060489da155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a172abbb-a62f-4197-a446-ba63ea19bb12" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7dc062c5-1422-4403-ab46-4060489da155" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6ea12c6d-6260-448b-8f66-b5aaf31d29bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6ea12c6d-6260-448b-8f66-b5aaf31d29bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ecd98b6c-0fe2-44a6-b5b7-63b2aad22cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ecd98b6c-0fe2-44a6-b5b7-63b2aad22cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_6b87dd62-1fff-417f-88d7-ab7e07dc42a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ecd98b6c-0fe2-44a6-b5b7-63b2aad22cc5" xlink:to="loc_us-gaap_ForeignPlanMember_6b87dd62-1fff-417f-88d7-ab7e07dc42a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_85975f04-9e81-4ff2-bcbe-caf9ec2587cf" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_6b87dd62-1fff-417f-88d7-ab7e07dc42a6" xlink:to="loc_country_US_85975f04-9e81-4ff2-bcbe-caf9ec2587cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_e4ec3936-ece1-497e-b6b2-48ab8980dd11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_e4ec3936-ece1-497e-b6b2-48ab8980dd11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_784ad9d2-234c-4734-adf7-e8242e8144ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_784ad9d2-234c-4734-adf7-e8242e8144ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_25169cc4-14cc-4c74-bd65-376f75ee8294_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_25169cc4-14cc-4c74-bd65-376f75ee8294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8cb04b88-24be-4a06-9384-6770913b7dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8cb04b88-24be-4a06-9384-6770913b7dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8cb04b88-24be-4a06-9384-6770913b7dd8" xlink:to="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ab982119-4f91-4f61-938d-66f73e838a0d" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:to="loc_country_GB_ab982119-4f91-4f61-938d-66f73e838a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_dee403c3-929d-478a-b169-f3d15a97f588" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:to="loc_country_CH_dee403c3-929d-478a-b169-f3d15a97f588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:to="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_cf71c319-29fb-4c0b-8d86-ef785a6516fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:to="loc_us-gaap_RetirementPlanNameDomain_cf71c319-29fb-4c0b-8d86-ef785a6516fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:to="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_97707bb7-c91f-4a05-a5b9-811d39907b90" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_97707bb7-c91f-4a05-a5b9-811d39907b90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_d99c5cbb-03e4-4923-8713-40b041c1acfe" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_d99c5cbb-03e4-4923-8713-40b041c1acfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_777662e0-f89a-4f05-b256-175ae36250f8" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_777662e0-f89a-4f05-b256-175ae36250f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_acf73eda-c2e1-4dad-978a-82a94a4d2125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_acf73eda-c2e1-4dad-978a-82a94a4d2125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_eca47f63-9344-4609-9d14-94c6d977ed79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_eca47f63-9344-4609-9d14-94c6d977ed79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_aff9caf7-93ce-4e40-8ef8-0262c0123511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_aff9caf7-93ce-4e40-8ef8-0262c0123511" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsChangeinBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6eeaef42-982f-4510-99ce-8a463ff20ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6eeaef42-982f-4510-99ce-8a463ff20ae4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_11360b22-54e8-4a7f-97b5-641d84f694b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_11360b22-54e8-4a7f-97b5-641d84f694b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf5b3d04-b4a6-439e-a15b-4eea48d0444d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf5b3d04-b4a6-439e-a15b-4eea48d0444d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf5b3d04-b4a6-439e-a15b-4eea48d0444d" xlink:to="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_e3929c85-283d-43ff-b4ee-ae98d5565a9b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:to="loc_country_GB_e3929c85-283d-43ff-b4ee-ae98d5565a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_20e401f6-18c4-4378-95c3-82975a2a32f5" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:to="loc_country_CH_20e401f6-18c4-4378-95c3-82975a2a32f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:to="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3f237d0d-e125-4a51-89c1-0bc502a23232_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3f237d0d-e125-4a51-89c1-0bc502a23232_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6123dbac-2b18-44cf-b0f6-f8bed43bdaa7" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6123dbac-2b18-44cf-b0f6-f8bed43bdaa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_e4906f64-7d3f-4ffe-96b5-925346fdfb05" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_e4906f64-7d3f-4ffe-96b5-925346fdfb05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_f167b053-03d4-47ba-942e-48b98615fcfa" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_f167b053-03d4-47ba-942e-48b98615fcfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6eeaef42-982f-4510-99ce-8a463ff20ae4" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9f02d1db-e00a-4a17-9954-409a400a41c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9f02d1db-e00a-4a17-9954-409a400a41c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f9d94a7b-b32a-4234-9574-613db861f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f9d94a7b-b32a-4234-9574-613db861f5f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8afb57da-cf0e-4676-8bbd-e519066d5354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8afb57da-cf0e-4676-8bbd-e519066d5354" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d051479e-415f-4025-bb1b-b5a3d69598e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d051479e-415f-4025-bb1b-b5a3d69598e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_9398b183-88e5-453a-b9ee-7607e2a35a47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_9398b183-88e5-453a-b9ee-7607e2a35a47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b0e9e7f0-0767-4cd8-be8c-9215cd9e465c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b0e9e7f0-0767-4cd8-be8c-9215cd9e465c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_f401499f-91e4-4d98-8dd2-6d84987c2da6" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_f401499f-91e4-4d98-8dd2-6d84987c2da6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_1dc229f6-e18b-4c21-bd14-1e828d333175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_1dc229f6-e18b-4c21-bd14-1e828d333175" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_380d6d7e-8921-4da1-a995-c01981aebf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_380d6d7e-8921-4da1-a995-c01981aebf9e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_63effc86-3bf0-4ca3-91b6-17a66ddedafe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_63effc86-3bf0-4ca3-91b6-17a66ddedafe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0af6cc51-38de-4af7-9070-042693ca0da5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsChangeinPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_694a657c-b3e7-4075-93fa-ba70ea4312ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_694a657c-b3e7-4075-93fa-ba70ea4312ff" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f89607f-1356-47c8-9ea5-3a94f424ac21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f89607f-1356-47c8-9ea5-3a94f424ac21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_168a205a-2160-4e89-a62b-9b94cb400973" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_168a205a-2160-4e89-a62b-9b94cb400973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_168a205a-2160-4e89-a62b-9b94cb400973" xlink:to="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_12700662-af18-409c-99b7-13ce6b73f4c9" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:to="loc_country_GB_12700662-af18-409c-99b7-13ce6b73f4c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_24f9f9a7-f9b8-4c53-a170-e104e1dbe6ff" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:to="loc_country_CH_24f9f9a7-f9b8-4c53-a170-e104e1dbe6ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:to="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_45db0a23-3cb0-4553-b9dd-8e302252e9c1" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_45db0a23-3cb0-4553-b9dd-8e302252e9c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_cdf2a2bd-d913-4532-814c-ec0dac1e95ec" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_cdf2a2bd-d913-4532-814c-ec0dac1e95ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_55985010-88a4-4948-a6f0-0b4780a91c63" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_55985010-88a4-4948-a6f0-0b4780a91c63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_694a657c-b3e7-4075-93fa-ba70ea4312ff" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8953525d-4d76-47f2-9c82-fd784721e110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8953525d-4d76-47f2-9c82-fd784721e110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_de8f70a9-95f3-4341-a5bf-9cabb54cb84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_de8f70a9-95f3-4341-a5bf-9cabb54cb84f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1b8a41f6-de88-42a2-b6c8-d7d4e4c40e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1b8a41f6-de88-42a2-b6c8-d7d4e4c40e2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions_3b21a232-8443-4298-8511-d14d37334393" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_iclr_DefinedBenefitPlanSchemeContributions_3b21a232-8443-4298-8511-d14d37334393" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_08cb3448-1dc9-4270-b4ed-0a3ce5fca135" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_08cb3448-1dc9-4270-b4ed-0a3ce5fca135" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_386ea169-f433-45a7-8ae8-e8c442110f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_386ea169-f433-45a7-8ae8-e8c442110f2a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_6e022fd6-688c-42cc-9023-bd5d487125d5" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_6e022fd6-688c-42cc-9023-bd5d487125d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_70d70f2f-578d-4641-8dd8-34f4ea2fa610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_70d70f2f-578d-4641-8dd8-34f4ea2fa610" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4ac24675-b6ac-4c33-b3cc-41623d5d5c01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4ac24675-b6ac-4c33-b3cc-41623d5d5c01" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_bd35d1b7-57e5-4d3a-aef3-cf5530dd9900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_bd35d1b7-57e5-4d3a-aef3-cf5530dd9900" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c9a6b46f-4e53-4b18-b34a-cd4d8cf0d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6ddec308-646a-4be8-9d26-62908da0fb07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6ddec308-646a-4be8-9d26-62908da0fb07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d5ee69dc-c535-4898-b4bc-4ab18c35ffd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d5ee69dc-c535-4898-b4bc-4ab18c35ffd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d5ee69dc-c535-4898-b4bc-4ab18c35ffd9" xlink:to="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_c0457d26-cf0b-4580-b59b-c9b4ef4bf2fe" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:to="loc_country_GB_c0457d26-cf0b-4580-b59b-c9b4ef4bf2fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_6d6977a6-855c-488d-9397-41af3962f25d" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:to="loc_country_CH_6d6977a6-855c-488d-9397-41af3962f25d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:to="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6c103d3b-a861-4607-85fd-6278749a21d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6c103d3b-a861-4607-85fd-6278749a21d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_ef7800de-cd6a-4296-9a79-2586a90e2d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:to="loc_us-gaap_RetirementPlanNameDomain_ef7800de-cd6a-4296-9a79-2586a90e2d59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1bce1b7d-2cc9-4801-bc29-ee7b5901f104" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ef7800de-cd6a-4296-9a79-2586a90e2d59" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1bce1b7d-2cc9-4801-bc29-ee7b5901f104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_fa2fcaa4-dd50-4b16-aedb-8b162a105452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_fa2fcaa4-dd50-4b16-aedb-8b162a105452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6757b1d3-c6da-47bb-93e2-7371537cf8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6757b1d3-c6da-47bb-93e2-7371537cf8d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7902e460-4941-4dee-a07e-0eb7aa69f279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7902e460-4941-4dee-a07e-0eb7aa69f279" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1f3b6625-78b6-441c-91ec-bbd320736d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1f3b6625-78b6-441c-91ec-bbd320736d8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35b79f7d-f5d2-4645-9572-97bd6e44b47e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35b79f7d-f5d2-4645-9572-97bd6e44b47e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b7fc2c1-84c1-4a17-84a0-9d4f6af1abc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b7fc2c1-84c1-4a17-84a0-9d4f6af1abc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b7fc2c1-84c1-4a17-84a0-9d4f6af1abc3" xlink:to="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_3196769a-210f-4566-a265-c19b5a896df3" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:to="loc_country_GB_3196769a-210f-4566-a265-c19b5a896df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_6e314ee9-3458-4995-8129-3df513fcf4fc" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:to="loc_country_CH_6e314ee9-3458-4995-8129-3df513fcf4fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:to="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_0b88e833-f5dc-474c-aace-cefe2717a5da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:to="loc_us-gaap_RetirementPlanNameDomain_0b88e833-f5dc-474c-aace-cefe2717a5da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_61017dae-fb2e-4377-b49a-436de3e6c1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:to="loc_us-gaap_RetirementPlanNameDomain_61017dae-fb2e-4377-b49a-436de3e6c1b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c5a8dbb8-a8f7-4309-9e65-f2b5b67fe8af" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_61017dae-fb2e-4377-b49a-436de3e6c1b5" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c5a8dbb8-a8f7-4309-9e65-f2b5b67fe8af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e72956b4-619c-4ebd-9e54-f37c96bce904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e72956b4-619c-4ebd-9e54-f37c96bce904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12d6bd17-b0ad-409e-9e0c-d6f4361622f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12d6bd17-b0ad-409e-9e0c-d6f4361622f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e3c62ae6-0414-4f94-9ca2-5ec3b17b9c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e3c62ae6-0414-4f94-9ca2-5ec3b17b9c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_1fe0f09a-b67a-415b-b039-b1a1249d00c6" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_1fe0f09a-b67a-415b-b039-b1a1249d00c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3b4527c5-758b-453d-9044-a3a53c5ed928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3b4527c5-758b-453d-9044-a3a53c5ed928" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_4cc2bf0d-2d49-4e85-a926-76786c5d8591" xlink:href="iclr-20231231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_4cc2bf0d-2d49-4e85-a926-76786c5d8591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_680ba077-a960-4c94-aa9f-4ff0504283e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_680ba077-a960-4c94-aa9f-4ff0504283e7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7184d710-0165-47e0-8a0f-6c38a232a54b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7184d710-0165-47e0-8a0f-6c38a232a54b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_08141c35-43fd-446f-aeba-e99eb2ebb449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_08141c35-43fd-446f-aeba-e99eb2ebb449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e1695f81-efca-4d16-9a72-34e2db268947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_08141c35-43fd-446f-aeba-e99eb2ebb449" xlink:to="loc_us-gaap_ForeignPlanMember_e1695f81-efca-4d16-9a72-34e2db268947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_04fc58d8-f92c-4506-9a23-427621496358" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_e1695f81-efca-4d16-9a72-34e2db268947" xlink:to="loc_country_GB_04fc58d8-f92c-4506-9a23-427621496358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:to="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_02908c0c-0c2b-40c6-af0a-0d9b2768d31b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_02908c0c-0c2b-40c6-af0a-0d9b2768d31b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d7d59717-0070-431f-a6a1-0dd90b95da26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d7d59717-0070-431f-a6a1-0dd90b95da26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e3d26567-e7bc-4468-96c5-d74fa92c305b" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_d7d59717-0070-431f-a6a1-0dd90b95da26" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e3d26567-e7bc-4468-96c5-d74fa92c305b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0397d0dc-2b8c-4381-821e-8bcaecfad5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0397d0dc-2b8c-4381-821e-8bcaecfad5e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_8b91f6c3-0ba1-4a3f-961f-420762562cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_8b91f6c3-0ba1-4a3f-961f-420762562cf9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_30fb9997-890c-479a-8f6a-4f7e0b3f69db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_30fb9997-890c-479a-8f6a-4f7e0b3f69db" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6c760ebe-a150-4b8d-b328-0192b11d45b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6c760ebe-a150-4b8d-b328-0192b11d45b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e8fbc025-79f9-4905-a07e-f2cea1bdf55a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e8fbc025-79f9-4905-a07e-f2cea1bdf55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8ba4f9eb-ddef-4d3d-b0c6-dd8585ebb8da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e8fbc025-79f9-4905-a07e-f2cea1bdf55a" xlink:to="loc_us-gaap_ForeignPlanMember_8ba4f9eb-ddef-4d3d-b0c6-dd8585ebb8da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_a061c5cc-4bb9-495b-b46a-d8665041f857" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_8ba4f9eb-ddef-4d3d-b0c6-dd8585ebb8da" xlink:to="loc_country_GB_a061c5cc-4bb9-495b-b46a-d8665041f857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_af573fb6-b264-4998-9d88-144ac3bb09de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_af573fb6-b264-4998-9d88-144ac3bb09de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_4d18d4dc-5040-4f25-9195-b340577435bd" xlink:href="iclr-20231231.xsd#iclr_GovernmentBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:to="loc_iclr_GovernmentBondsMember_4d18d4dc-5040-4f25-9195-b340577435bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_3e3a5fc9-f212-4d00-869f-60119e05d715" xlink:href="iclr-20231231.xsd#iclr_DiversifiedBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:to="loc_iclr_DiversifiedBondsMember_3e3a5fc9-f212-4d00-869f-60119e05d715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_40dfb7c0-7651-4f1c-b605-21b77e5efcd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:to="loc_us-gaap_RetirementPlanNameDomain_40dfb7c0-7651-4f1c-b605-21b77e5efcd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_62b93715-c60f-4238-b296-44527d2ad629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:to="loc_us-gaap_RetirementPlanNameDomain_62b93715-c60f-4238-b296-44527d2ad629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_41a4651b-251c-426e-8de9-53748661a3e7" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_62b93715-c60f-4238-b296-44527d2ad629" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_41a4651b-251c-426e-8de9-53748661a3e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_ed3b404b-2967-4121-9dbf-35b14cea804a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_30fb9997-890c-479a-8f6a-4f7e0b3f69db" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_ed3b404b-2967-4121-9dbf-35b14cea804a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_545d0bb2-300c-4567-8934-54c5c8a9de63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_545d0bb2-300c-4567-8934-54c5c8a9de63" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2ad8289-8a89-465f-95c6-e3cf380e92a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b2ad8289-8a89-465f-95c6-e3cf380e92a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f64d29f5-0b07-4fca-9165-cdfd5441f407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f64d29f5-0b07-4fca-9165-cdfd5441f407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_15b5ec86-fdf9-4cfe-a792-144d9856af3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f64d29f5-0b07-4fca-9165-cdfd5441f407" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_15b5ec86-fdf9-4cfe-a792-144d9856af3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d1022dda-f039-4852-8593-74755a963984_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d1022dda-f039-4852-8593-74755a963984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_535eb7bd-afe7-487f-9430-a9b399cd8f12" xlink:href="iclr-20231231.xsd#iclr_GovernmentBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:to="loc_iclr_GovernmentBondsMember_535eb7bd-afe7-487f-9430-a9b399cd8f12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_a30f261a-4038-4a45-ade1-57fe4a277244" xlink:href="iclr-20231231.xsd#iclr_DiversifiedBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:to="loc_iclr_DiversifiedBondsMember_a30f261a-4038-4a45-ade1-57fe4a277244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d11d3bd8-a02b-49f2-9811-35d1fff32ce2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d11d3bd8-a02b-49f2-9811-35d1fff32ce2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_516b86a7-9d66-4019-8412-89e3913168b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:to="loc_us-gaap_RetirementPlanNameDomain_516b86a7-9d66-4019-8412-89e3913168b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_37f56a6a-41e4-4fcd-9991-af69aef1c704" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_516b86a7-9d66-4019-8412-89e3913168b1" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_37f56a6a-41e4-4fcd-9991-af69aef1c704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9b14e983-ace6-413f-beba-8c694140deef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_545d0bb2-300c-4567-8934-54c5c8a9de63" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9b14e983-ace6-413f-beba-8c694140deef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsAnnualBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_420bbf67-cbf1-44b6-b1ae-eaf21b81074c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_420bbf67-cbf1-44b6-b1ae-eaf21b81074c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_420bbf67-cbf1-44b6-b1ae-eaf21b81074c" xlink:to="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_7fd47edd-69a0-4df1-84b9-068b6116ec52" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:to="loc_country_GB_7fd47edd-69a0-4df1-84b9-068b6116ec52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_4f54a433-6b7d-40ef-9e79-c4a46418d4ea" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:to="loc_country_CH_4f54a433-6b7d-40ef-9e79-c4a46418d4ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:to="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2e80d012-6d06-41a6-9576-38048714fd36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:to="loc_us-gaap_PlanNameDomain_2e80d012-6d06-41a6-9576-38048714fd36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f0d8e157-97cc-4ad7-a1c2-5b48593a8254" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:to="loc_us-gaap_PlanNameDomain_f0d8e157-97cc-4ad7-a1c2-5b48593a8254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_32e3df59-aef8-4f45-b076-f4d421c76bcf" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f0d8e157-97cc-4ad7-a1c2-5b48593a8254" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_32e3df59-aef8-4f45-b076-f4d421c76bcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_0b43bb54-3208-4a7f-a65d-8e149558e5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_0b43bb54-3208-4a7f-a65d-8e149558e5ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_899cd96a-9c67-4585-921b-f8583b9502f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_899cd96a-9c67-4585-921b-f8583b9502f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_723d14fb-7d07-4793-a1e3-9c3c97dca74d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_723d14fb-7d07-4793-a1e3-9c3c97dca74d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_5aa16b35-86dd-451a-9f86-4176e34a3d09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_5aa16b35-86dd-451a-9f86-4176e34a3d09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_afbac18c-81f8-4b02-9c47-520e3c237ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_afbac18c-81f8-4b02-9c47-520e3c237ca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a00fe0b9-281e-4556-89db-a6f5ffca5a12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a00fe0b9-281e-4556-89db-a6f5ffca5a12" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:href="iclr-20231231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:href="iclr-20231231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_35e228b4-541c-4ca3-882e-ff5d6e39721b" xlink:href="iclr-20231231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_35e228b4-541c-4ca3-882e-ff5d6e39721b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_5c9238cd-f2a9-4398-818d-8230c9d85878" xlink:href="iclr-20231231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_5c9238cd-f2a9-4398-818d-8230c9d85878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_a090fd12-94ac-45e1-afd6-be4e0f701556" xlink:href="iclr-20231231.xsd#iclr_OptionPlans2008Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_OptionPlans2008Member_a090fd12-94ac-45e1-afd6-be4e0f701556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a8708c13-f6e3-4d91-a8cc-601fc943770c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a8708c13-f6e3-4d91-a8cc-601fc943770c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_63d2436d-1f60-4cc6-a15c-dd5e259a1f2e" xlink:href="iclr-20231231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_63d2436d-1f60-4cc6-a15c-dd5e259a1f2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_110a8577-f9c3-429d-99e5-06fd976ecacb" xlink:href="iclr-20231231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_110a8577-f9c3-429d-99e5-06fd976ecacb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fc668233-f69f-4da2-b575-3b203e3178fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fc668233-f69f-4da2-b575-3b203e3178fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_58d81fd6-c979-4303-b104-68ad96c031ba" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_PerformanceShareUnitMember_58d81fd6-c979-4303-b104-68ad96c031ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_e6d3a52b-11d7-4c0b-be81-8a1ae6cecd7e" xlink:href="iclr-20231231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_PerformanceBasedGrantsMember_e6d3a52b-11d7-4c0b-be81-8a1ae6cecd7e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_ca6e7880-39c3-467a-b6f8-1d91b0203731_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:to="loc_us-gaap_AwardDateDomain_ca6e7880-39c3-467a-b6f8-1d91b0203731_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_0ac9133b-bc5f-4d16-bf75-34f323955f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:to="loc_us-gaap_AwardDateDomain_0ac9133b-bc5f-4d16-bf75-34f323955f70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_f5269549-e833-411f-bb55-e4009374aad5" xlink:href="iclr-20231231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_0ac9133b-bc5f-4d16-bf75-34f323955f70" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_f5269549-e833-411f-bb55-e4009374aad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fbe278a2-234a-4b23-a3f5-9ddc6954275b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:to="loc_srt_RangeMember_fbe278a2-234a-4b23-a3f5-9ddc6954275b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:to="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_adb77245-5305-43f1-bb90-53689109ab60" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:to="loc_srt_MinimumMember_adb77245-5305-43f1-bb90-53689109ab60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e2f1dfa-e68e-47f6-bdfe-f794f7347c11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:to="loc_srt_MaximumMember_9e2f1dfa-e68e-47f6-bdfe-f794f7347c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b0bf8a45-e689-45cc-8ce0-892ad5a90850_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:to="loc_us-gaap_PlanNameDomain_b0bf8a45-e689-45cc-8ce0-892ad5a90850_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:to="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_8f261626-2b42-4d05-a3f4-b9df8e1a701c" xlink:href="iclr-20231231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_8f261626-2b42-4d05-a3f4-b9df8e1a701c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_9160c91a-1ace-4efb-8e3e-306beabe30f0" xlink:href="iclr-20231231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_9160c91a-1ace-4efb-8e3e-306beabe30f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4d453100-0232-4287-a364-694f65582d2a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4d453100-0232-4287-a364-694f65582d2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ea403633-695b-4579-bcc4-efe93021cc33" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ea403633-695b-4579-bcc4-efe93021cc33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_0617d480-2c25-4c1b-bf67-8a6c132f5571" xlink:href="iclr-20231231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ea403633-695b-4579-bcc4-efe93021cc33" xlink:to="loc_iclr_NonexecutiveDirectorMember_0617d480-2c25-4c1b-bf67-8a6c132f5571" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_20821e73-56cb-45fe-b184-e169762b597c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_20821e73-56cb-45fe-b184-e169762b597c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_d57ac071-5877-44eb-b6d2-c9df37545aca" xlink:href="iclr-20231231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_d57ac071-5877-44eb-b6d2-c9df37545aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_9eca75b3-e675-49e6-8ed3-5b463519014e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_9eca75b3-e675-49e6-8ed3-5b463519014e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe9c4880-d109-4848-aa1e-f82b77665a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe9c4880-d109-4848-aa1e-f82b77665a7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e3131188-0262-4078-b7a7-5dc2349443aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e3131188-0262-4078-b7a7-5dc2349443aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e91c01cf-0748-43b3-baf6-9806285d786d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e91c01cf-0748-43b3-baf6-9806285d786d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e20d1afb-7858-49ed-9089-dd2eb479d62b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e20d1afb-7858-49ed-9089-dd2eb479d62b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8ccaebcd-df24-4fe2-985b-ccb0bf5ed705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8ccaebcd-df24-4fe2-985b-ccb0bf5ed705" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_95c0881f-67d0-4bed-8ae6-d4a34073763b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_95c0881f-67d0-4bed-8ae6-d4a34073763b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c3d50944-d120-4a3c-81eb-05d5328b2781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c3d50944-d120-4a3c-81eb-05d5328b2781" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_3b9e6010-4cec-4cff-b3aa-f8a6d02776cb" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_3b9e6010-4cec-4cff-b3aa-f8a6d02776cb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b9706594-7cd9-47e5-93cd-1f18c4c3a2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b9706594-7cd9-47e5-93cd-1f18c4c3a2e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_95079c51-ad95-408d-b49d-121f3f8b9343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensation_95079c51-ad95-408d-b49d-121f3f8b9343" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_59d99a2c-7054-4bb2-b7e9-f0e1f891f719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_59d99a2c-7054-4bb2-b7e9-f0e1f891f719" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e221901c-cfa5-4224-af40-d201d631b373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e221901c-cfa5-4224-af40-d201d631b373" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:to="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5bfe1090-64af-4542-b22d-06ba80f37fac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5bfe1090-64af-4542-b22d-06ba80f37fac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ce231e7-3298-461c-9d31-697bcbc5ec36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ce231e7-3298-461c-9d31-697bcbc5ec36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_7424f0e6-9792-4cc3-a5e5-8b12ec5dc44e" xlink:href="iclr-20231231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ce231e7-3298-461c-9d31-697bcbc5ec36" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_7424f0e6-9792-4cc3-a5e5-8b12ec5dc44e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a533ba1-56ed-4360-a183-bee208bf901c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a533ba1-56ed-4360-a183-bee208bf901c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_1238f6dc-4b09-490d-99ed-73eaaab374bc" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_1238f6dc-4b09-490d-99ed-73eaaab374bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee101c8d-b6dd-4fae-a517-836de5cac7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee101c8d-b6dd-4fae-a517-836de5cac7d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_33364271-2ff9-4512-80a1-1d63c3b5dda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_33364271-2ff9-4512-80a1-1d63c3b5dda4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ccee873-98f4-43dc-9f78-642960be6428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ccee873-98f4-43dc-9f78-642960be6428" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_417264e9-ed0e-4088-8288-881f6cb3b7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_3839c28d-d764-4f71-b56b-803df22a580d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_3839c28d-d764-4f71-b56b-803df22a580d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20348f9b-1553-44e5-98fd-6c9f42b25b83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20348f9b-1553-44e5-98fd-6c9f42b25b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_912163a7-8c57-494d-9559-21ecb8cfb22d" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_912163a7-8c57-494d-9559-21ecb8cfb22d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1dddbccf-f5d1-4b04-8ef4-593c6a2e0019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1dddbccf-f5d1-4b04-8ef4-593c6a2e0019" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f74f878b-5fb4-461c-a7b2-7bd90662fc13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f74f878b-5fb4-461c-a7b2-7bd90662fc13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_25366e6a-ad34-4ecf-abd6-400e3c14603a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_25366e6a-ad34-4ecf-abd6-400e3c14603a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ad9f4637-749c-499a-bc44-0c5a2a2d6205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c763b41a-60dd-4320-8d83-d4d3463f8756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c763b41a-60dd-4320-8d83-d4d3463f8756" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:to="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91e5de26-a8ec-4bf8-b0af-7b0b656678fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91e5de26-a8ec-4bf8-b0af-7b0b656678fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63c15a33-6b77-4487-8b25-cbae7912ebcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63c15a33-6b77-4487-8b25-cbae7912ebcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_a718045e-6e1b-4a52-8afc-c70d0be0de78" xlink:href="iclr-20231231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63c15a33-6b77-4487-8b25-cbae7912ebcb" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_a718045e-6e1b-4a52-8afc-c70d0be0de78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member_68aae7fd-a616-49ec-b3b2-16d6af0322fe" xlink:href="iclr-20231231.xsd#iclr_Range1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range1Member_68aae7fd-a616-49ec-b3b2-16d6af0322fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member_263c75ce-1753-48e1-ae11-0aa2462d93a6" xlink:href="iclr-20231231.xsd#iclr_Range2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range2Member_263c75ce-1753-48e1-ae11-0aa2462d93a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member_2b06e026-7a43-42d2-9fa9-2657c33549e0" xlink:href="iclr-20231231.xsd#iclr_Range3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range3Member_2b06e026-7a43-42d2-9fa9-2657c33549e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member_f9f13c63-4fd8-4210-996e-70bf88f1d076" xlink:href="iclr-20231231.xsd#iclr_Range4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range4Member_f9f13c63-4fd8-4210-996e-70bf88f1d076" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_e3bc6fee-888e-4163-909c-02dce0a1165f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_e3bc6fee-888e-4163-909c-02dce0a1165f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7eb6656c-3320-48ee-a3e2-a85ea10a13cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7eb6656c-3320-48ee-a3e2-a85ea10a13cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_e17dece7-edc7-43c4-9b90-bdd2f09ef78e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_e17dece7-edc7-43c4-9b90-bdd2f09ef78e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2fe8a2dc-241e-4fcb-88d3-084f4f9b7294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2fe8a2dc-241e-4fcb-88d3-084f4f9b7294" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d63d4161-d074-4598-be40-d05bcc357ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d63d4161-d074-4598-be40-d05bcc357ec7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_03ce0ce5-e73d-4549-b187-b3e20e9475d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_03ce0ce5-e73d-4549-b187-b3e20e9475d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_47dc56eb-5281-4b22-af5a-b778d453a952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_47dc56eb-5281-4b22-af5a-b778d453a952" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:to="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38a6fe44-19ee-4534-bf63-5e577515dae2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_38a6fe44-19ee-4534-bf63-5e577515dae2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6084b84a-e7e7-46b8-9fb6-e8f11fe74b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6084b84a-e7e7-46b8-9fb6-e8f11fe74b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f2f43bf4-ccb9-4e95-9abe-4d4e704af49a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6084b84a-e7e7-46b8-9fb6-e8f11fe74b7b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f2f43bf4-ccb9-4e95-9abe-4d4e704af49a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9103e7f4-91f2-42f9-9a19-6143f1485079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9103e7f4-91f2-42f9-9a19-6143f1485079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f7a471ec-19ae-435d-b136-40568ca78d63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f7a471ec-19ae-435d-b136-40568ca78d63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e343120d-98b5-492b-86fc-d4617b4e5aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e343120d-98b5-492b-86fc-d4617b4e5aae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d48260e7-0559-4e72-a596-88e40df706ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d48260e7-0559-4e72-a596-88e40df706ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd709e9c-d9f6-429a-965f-212aef6bb813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd709e9c-d9f6-429a-965f-212aef6bb813" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:to="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_261184d1-ce5e-4f6f-a780-5cc6201a7e39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_261184d1-ce5e-4f6f-a780-5cc6201a7e39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_d2ed4bb3-fb31-4e95-aed7-59842898b4b5" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:to="loc_iclr_PerformanceShareUnitMember_d2ed4bb3-fb31-4e95-aed7-59842898b4b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_59e488bc-cdc5-465e-8de5-f8c3ed90bb83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_59e488bc-cdc5-465e-8de5-f8c3ed90bb83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_241f8069-61ed-4fc9-bf74-b2d222b3ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_241f8069-61ed-4fc9-bf74-b2d222b3ded9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7bc368f9-304a-4958-bc29-064112564c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7bc368f9-304a-4958-bc29-064112564c4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c47d29c-6021-4f53-acb8-367bcce150f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c47d29c-6021-4f53-acb8-367bcce150f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e1ecfe3d-8f98-46cb-a4d5-a494c19e3567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e1ecfe3d-8f98-46cb-a4d5-a494c19e3567" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a86940ad-21ee-47ea-be61-0113d1edf6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3edd54c0-c40f-41ae-9737-472f16ad5767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3edd54c0-c40f-41ae-9737-472f16ad5767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2ee96e11-1b9c-4e11-821f-2e83290a418d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2ee96e11-1b9c-4e11-821f-2e83290a418d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_934efc97-158f-4989-99c0-88225436fa77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_934efc97-158f-4989-99c0-88225436fa77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7921078b-21b0-49d2-96fe-fa46cf94cc26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7921078b-21b0-49d2-96fe-fa46cf94cc26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d05853a0-1b71-4685-bb95-01bb060f24fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d4599b-d042-4f25-9f02-603bd73236c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d4599b-d042-4f25-9f02-603bd73236c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0c85c89c-0667-4f06-a597-ad68a87a87d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0c85c89c-0667-4f06-a597-ad68a87a87d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_fb2f367e-dc16-4241-ad43-697317da2d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:to="loc_us-gaap_CostOfSalesMember_fb2f367e-dc16-4241-ad43-697317da2d46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_922fc418-cd24-4885-908e-a47a009c760f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_922fc418-cd24-4885-908e-a47a009c760f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember_5661a1ba-1fb5-4625-a443-fbfb6444eff6" xlink:href="iclr-20231231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:to="loc_iclr_TransactionAndIntegrationExpenseMember_5661a1ba-1fb5-4625-a443-fbfb6444eff6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4793c4df-b04a-4140-9d17-0eb0860d7502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d4599b-d042-4f25-9f02-603bd73236c7" xlink:to="loc_us-gaap_ShareBasedCompensation_4793c4df-b04a-4140-9d17-0eb0860d7502" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c569b955-73a3-4462-86b0-5947bb118b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c569b955-73a3-4462-86b0-5947bb118b9d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:to="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4291d26c-1a57-4617-856b-5bf7809ea7d5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:to="loc_srt_SegmentGeographicalDomain_4291d26c-1a57-4617-856b-5bf7809ea7d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:to="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_87ae2c4d-f99e-45ed-a3c3-d7301a5a02eb" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_country_IE_87ae2c4d-f99e-45ed-a3c3-d7301a5a02eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_535bfb53-5d19-4483-9587-df1497a37c80" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_iclr_RestOfEuropeMember_535bfb53-5d19-4483-9587-df1497a37c80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5a2f7ce0-3a20-4a0c-b37c-7fe56a2506ca" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_country_US_5a2f7ce0-3a20-4a0c-b37c-7fe56a2506ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_b03724c9-96f3-49c4-b1f8-6a6672b68a21" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_iclr_OtherCountriesMember_b03724c9-96f3-49c4-b1f8-6a6672b68a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6c523cf-4997-453d-bc64-7e3525ecb2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c569b955-73a3-4462-86b0-5947bb118b9d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6c523cf-4997-453d-bc64-7e3525ecb2ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_022e1b1d-a21d-4167-ae36-4ab23a8cb37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_022e1b1d-a21d-4167-ae36-4ab23a8cb37e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:to="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:to="loc_srt_SegmentGeographicalDomain_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:to="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_967fb8dc-5baf-48d5-8d98-09650cb3b766" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_country_IE_967fb8dc-5baf-48d5-8d98-09650cb3b766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_2f8df56b-d498-4557-9449-751949b8e4c5" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_iclr_RestOfEuropeMember_2f8df56b-d498-4557-9449-751949b8e4c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f65f6494-4a0d-47fb-9fc7-d848176282bf" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_country_US_f65f6494-4a0d-47fb-9fc7-d848176282bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_ac6251fa-2735-48d6-9e8e-fe297385d070" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_iclr_OtherCountriesMember_ac6251fa-2735-48d6-9e8e-fe297385d070" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_ec199e0e-642d-4a4f-9b11-72ef9c34200a" xlink:href="iclr-20231231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_022e1b1d-a21d-4167-ae36-4ab23a8cb37e" xlink:to="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_ec199e0e-642d-4a4f-9b11-72ef9c34200a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_afa6a79e-cffb-4c64-b1ea-e53b063138ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afa6a79e-cffb-4c64-b1ea-e53b063138ae" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:to="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_015a022e-86db-4aca-96ef-bac3427c171b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:to="loc_srt_SegmentGeographicalDomain_015a022e-86db-4aca-96ef-bac3427c171b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:to="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_d69157b7-2cd9-4478-806a-e2240d7ccd01" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_country_IE_d69157b7-2cd9-4478-806a-e2240d7ccd01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_b3a01f64-8562-4cb5-9ae7-035d5c1e370e" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_iclr_RestOfEuropeMember_b3a01f64-8562-4cb5-9ae7-035d5c1e370e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6ea38f8c-1b98-48d6-8c45-0e4b9eea270f" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_country_US_6ea38f8c-1b98-48d6-8c45-0e4b9eea270f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_79b9511a-2119-48d7-bde6-f9b606883894" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_iclr_OtherCountriesMember_79b9511a-2119-48d7-bde6-f9b606883894" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_15bf9942-40ce-4956-b1e3-7089c15d3ace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afa6a79e-cffb-4c64-b1ea-e53b063138ae" xlink:to="loc_us-gaap_NoncurrentAssets_15bf9942-40ce-4956-b1e3-7089c15d3ace" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#RelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_19edca5f-0bf0-4e5b-89c6-863a170754ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_19edca5f-0bf0-4e5b-89c6-863a170754ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember_e934ab26-0dd0-4eeb-ac9c-cc35ac2865bb" xlink:href="iclr-20231231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:to="loc_iclr_CorvusPharmaceuticalsMember_e934ab26-0dd0-4eeb-ac9c-cc35ac2865bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_3a7291ef-85b6-40df-83b9-9989f9d560f2" xlink:href="iclr-20231231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:to="loc_iclr_AfimmuneLimitedMember_3a7291ef-85b6-40df-83b9-9989f9d560f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_8d0d0703-d0b0-47ce-9110-ce5a5bc2c16c" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:to="loc_iclr_OncacareMember_8d0d0703-d0b0-47ce-9110-ce5a5bc2c16c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fd387f12-835e-4e2d-a236-77f7cc741157_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:to="loc_us-gaap_RelatedPartyDomain_fd387f12-835e-4e2d-a236-77f7cc741157_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_439ee13e-db7c-4433-8754-0b8fbfa38c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:to="loc_us-gaap_RelatedPartyDomain_439ee13e-db7c-4433-8754-0b8fbfa38c9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_8be2ee44-a818-437f-bb8b-d517c14be20f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_439ee13e-db7c-4433-8754-0b8fbfa38c9e" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_8be2ee44-a818-437f-bb8b-d517c14be20f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9f53ab1a-1e50-4786-bbec-cd759f9a4db4_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9f53ab1a-1e50-4786-bbec-cd759f9a4db4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fa7c6e2b-4d53-463e-be73-04eeac91f3e2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fa7c6e2b-4d53-463e-be73-04eeac91f3e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_a39e893b-1863-4ef5-aefa-0904576b6173" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_fa7c6e2b-4d53-463e-be73-04eeac91f3e2" xlink:to="loc_iclr_OncacareMember_a39e893b-1863-4ef5-aefa-0904576b6173" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e5580f0-a926-4d95-bd30-61131d7d2de0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e5580f0-a926-4d95-bd30-61131d7d2de0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66fd8080-53b4-433a-9f6b-354bfcf17bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66fd8080-53b4-433a-9f6b-354bfcf17bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_924999eb-ce86-4fe9-88dd-5a86e81b2699" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66fd8080-53b4-433a-9f6b-354bfcf17bff" xlink:to="loc_iclr_OncacareMember_924999eb-ce86-4fe9-88dd-5a86e81b2699" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7a3b1503-df12-424b-96cd-0d711baa6308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_Revenues_7a3b1503-df12-424b-96cd-0d711baa6308" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_f69f7210-1cc2-4434-bbe6-879d3ba9c4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_OtherReceivables_f69f7210-1cc2-4434-bbe6-879d3ba9c4dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_75c89cc0-83c6-487f-a336-f0e880b20313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_EquityMethodInvestments_75c89cc0-83c6-487f-a336-f0e880b20313" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_803616f6-cd45-4e12-a036-3d66b2120c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_803616f6-cd45-4e12-a036-3d66b2120c4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_edb6e860-6a15-46b8-b02e-7d85e1d62a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_edb6e860-6a15-46b8-b02e-7d85e1d62a42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5fbe8093-c81b-497d-90f9-afa6d4b945d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5fbe8093-c81b-497d-90f9-afa6d4b945d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2c166bbd-d6de-4d0f-9296-97a119b8cc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2c166bbd-d6de-4d0f-9296-97a119b8cc9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2f1ba79f-e763-4a0b-af32-338f56ecdd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_Goodwill_2f1ba79f-e763-4a0b-af32-338f56ecdd8d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_bf32926e-7a04-4d00-94e6-5102f508b0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_bf32926e-7a04-4d00-94e6-5102f508b0e2" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_7c3453bb-6c3b-4258-bc58-93c2f194e931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_7c3453bb-6c3b-4258-bc58-93c2f194e931" xlink:to="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8c11a5ff-91db-4e55-b7bb-503ef69db7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8c11a5ff-91db-4e55-b7bb-503ef69db7fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_10530842-fba3-4ffc-80eb-8489dcf2cdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8c11a5ff-91db-4e55-b7bb-503ef69db7fc" xlink:to="loc_us-gaap_SubsequentEventMember_10530842-fba3-4ffc-80eb-8489dcf2cdd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4270e938-9805-4ba7-8e6c-461a52992989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4270e938-9805-4ba7-8e6c-461a52992989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_61ed8d93-fd3c-4899-b238-1dc2a24e09b6" xlink:href="iclr-20231231.xsd#iclr_BuybackProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4270e938-9805-4ba7-8e6c-461a52992989" xlink:to="loc_iclr_BuybackProgramMember_61ed8d93-fd3c-4899-b238-1dc2a24e09b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ccbd8f94-840b-4078-9f43-3e769f85773d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_7c3453bb-6c3b-4258-bc58-93c2f194e931" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ccbd8f94-840b-4078-9f43-3e769f85773d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_NontradeReceivablesCurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>iclr-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0c105b40-162f-4950-b2b2-c13f61a02230,g:35370e08-e85b-4be7-afdb-42ad7a0d101f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_09586563-aed5-4a34-9094-673a62f77287_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Information Concerning Outstanding and Exercisable Share Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_b2f5b23e-5b3d-4a25-a53f-df04033e8796_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of available for sale investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_25f2ab0b-7c63-439d-a1f3-fbd9c4a60cf4_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_359251bb-e5cc-4540-8295-2745a48f22e6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b07e2516-ff19-4c59-9dfc-850b388335da_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_bdd25ad1-4bd0-430f-8597-188a50e1d850_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0ad04c2f-8c8c-4ade-b852-9ab7d14c4ebd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ddb2cc0-721f-4638-8230-15b88276baac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_8aaa9bd3-e0e1-4107-bc4b-37544d7b53b9_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ba8bf8fe-d390-4cb2-b01f-bd0cfa9500b7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_4a6f1344-c485-403e-b86f-877409a3c4ae_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Costs</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1ef4d692-6dd5-4a29-8ed0-d509f7b09420_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_e23de313-16b2-4444-9df2-b9039834d0ee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of subsidiary undertakings (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_1b3f0f34-d6a1-4760-a7ac-5cc77c917f18_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_df26abe9-9431-44dd-9e49-702de63a5a61_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity-long term (Note 8b)</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_0ad69d22-95f4-4411-830c-eb2c7cff3d4a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability (Note 20)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b5c41d98-7cc7-4187-a866-ac02492bf3d2_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_be39e640-c426-4388-a4bf-7fca97986e8f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_c78e93d2-7af7-4d09-b86c-ad8af3122a81_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_33c091d5-212f-40e4-a3fa-2d9a5de7ecef_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_871b817b-8519-4e05-9a9a-359bc1652d6e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_914bfd90-73e5-46ca-b222-c362865731a9_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:to="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b5ce54cd-d5ec-491e-a742-7a179928bb5e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Capital</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_3444abbf-26e2-46c4-992b-55dc9b3c7d83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Net Revenue by Geographical Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_7b1a3fc0-b9e5-4b07-934f-d01076b7ce49_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a3676479-be43-4bcf-966a-1ab52625b900_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_96ce9837-a2b7-4839-923c-c5da45a011a2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_031cf6d9-53b2-4ac5-abb5-af5e4173fdd5_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_39b85b22-fc3c-470d-a61a-b81ba8302313_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assumptions Used in Calculating Pension Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4d721acf-1d05-491b-9b1b-ed4ec5472d43_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_95a04512-bf35-40ff-8ebb-8d5c1510b8de_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_f5cbab52-2716-4aca-a5e4-a05e82f655b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of change in tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6ee3dd70-faf4-470e-97a7-0a92ba8402c3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_43fa34b0-ac3b-48bc-952b-be9a127098c9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_4dea21be-619c-4e30-b7d3-3d217a906e76_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_label_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress" xlink:to="lab_dei_ContactPersonnelEmailAddress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_d3800894-477f-4f46-a6e0-69024805b936_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_26db544f-8fbc-4c86-9df3-3e644f24a61d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses (Note 4)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_103b8cd4-0974-49cb-b5f0-b455a8bfd252_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f096c94b-0164-44fd-b869-81a5060228c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_5685bf15-656e-4b52-9821-82443ddf24c0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_da9abf4a-7582-409b-b886-510b3f28176a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_4cddf4c9-bb5f-404a-ac46-2b9e709769f9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_6caa8e07-cc38-42a5-a483-db372be30279_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_c974c302-ff34-4e91-bf69-8a5b915f142b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2f077d53-a459-4c1a-ba7b-5f3713725304_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_11772164-d3a3-47a8-b365-e35cc7e52849_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_4704619d-456c-4cc9-a8ed-faffcc993e04_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_f26411f1-5657-4c7c-9a5f-5dd0c374dd90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_b3aa34a9-f3fd-452f-bfb9-44a83b5590f8_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cf2bb77f-7898-491e-bac5-3477012c3be6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_2b57bf9d-649c-4126-94d5-00b82bc795d0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_635606a8-7d23-4e47-a7f0-b7d22b981153_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill and long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_5eb4bf5c-2be2-496a-9c4d-2f63fc78f437_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_088db892-6b09-4d4c-b1ac-b6b49ad05571_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_ddb83f82-c619-479d-84d5-cc0359026611_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_27326305-26c9-4f5c-9153-8e50941bb60c_negatedNetLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0c10584f-0ef0-44e6-b2a1-41bb269983fd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_348797ce-02d3-46a1-88ed-39440f139c15_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_fe389970-e28d-43b0-a047-a22d9a11395e_terseLabel_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments resulting from foreign currency translations</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_label_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Disclosure [Table Text Block]</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:to="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2526f3af-03cd-456f-9e98-d410442c7e68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of number of shares used in computation of basic and diluted net income per ordinary share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_f070f1ca-488b-4a51-ba35-a0cb1f02c647_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c49a7148-3124-4005-aef0-3c8a37dca3ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding number of shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_1edcfe52-2a81-4fc8-8f42-0ee50fbea88d_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1a1fc052-4631-4816-96c0-59f74911d89d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise price of option per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_dda44bc6-a1cf-4221-bf5f-4d39c563152a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_50c76f4e-2aef-429e-b866-9f18c319329f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_68f244b5-fc94-4b45-be30-0009a6733354_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets recognized</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_6364b28e-8c7e-48ca-8088-18eabb323034_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fea360af-920d-418e-9e0e-7f876db1ec87_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b5c7ed0d-487b-4832-8aca-c04cba4581fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_172990fd-3636-47c3-b831-d530f18a038b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8f0bea6a-b606-4d47-8ff4-5db853de66c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dca7d9b5-9fb1-4fb3-8fea-25035019121b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_898f8215-b70f-471d-ab85-675042115271_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c1800de9-42fb-41f8-9899-2030769db472_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange movements</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d63afef5-c72e-4c60-a5ed-5992f26b31fc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_eb7d498e-f88f-4a41-ab3a-f7c3eccaa6b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_bd19123d-315b-4891-a3e6-82d4ae5bcfda_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0107f18e-f5fb-4f4a-9afc-db301a62541c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_721c4f3c-e1fa-4cc2-af9d-4f1c95028831_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_745f3433-ab84-4f59-a99a-e4d40937763a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_31954322-1188-4550-a241-597b144e1f8c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2a0e0adc-c58d-4aed-b402-817b174aed6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_673fd01a-03fc-4915-809c-b602d91ceda4_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_240c61d8-663c-4e82-8270-807c4a417c29_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments in equity - long term</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_a96e09f0-5c9f-4ce6-a64f-a5260ea99875_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_a9fe164b-3fd6-4374-8dee-f421c93d23b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_e5b4dbd5-6034-40fc-9a15-8a4641ce59af_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:href="iclr-20231231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_4c2f603a-1946-4aa7-a68e-1fbc86d7576c_terseLabel_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts provided during the year</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_label_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_documentation_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense" xlink:href="iclr-20231231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountsReceivableCreditLossExpense" xlink:to="lab_iclr_AccountsReceivableCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_c252b2c1-f2e1-4fb7-bf6d-0a2a899312f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e3b90dd0-8412-4b1f-9de8-74cdf3d54dce_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_29ad5702-20db-4c3c-8425-f1af906680bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_99af2a23-ebd7-42ee-b1f9-5ad95d0f4526_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on drawn facilities</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_604eb153-75dc-4299-8cc3-08bde18c22e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_da6c1101-63d8-4b47-8a17-0dbffd53557e_negatedLabel_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Share Repurchase Costs</link:label>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Share Repurchase Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts" xlink:href="iclr-20231231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PaymentsForShareRepurchaseCosts" xlink:to="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_96350907-35ef-4375-937b-460a04f03da3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f7add8a7-27da-4b1f-8571-c198f370262f_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_18205d1c-b432-4ba7-b144-c9876392136d_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_8aa7aa59-65f0-4edb-9c22-ec068b00070a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_dc8d0dfa-0296-4c2e-9f48-7eb257e07e45_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_74d5107e-c2c9-409c-ae87-502400c1fa3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_879139d1-6ca4-4ffe-a482-705a25dd369d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_a1f5396f-31dc-4f0e-9bde-e014b488c107_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f68e6a3-c0d1-4ec1-a4ed-64a9d0357538_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e830f71b-0a32-4857-8271-a523e13c718f_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_2e4848cc-439c-471e-8fd9-05c80f638c0c_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_e510518d-3555-4800-afd2-9629409206f1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3a1a2aad-acb1-4ec1-96ff-4fe0051bb602_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_58f9a4ac-592c-4a80-a7af-45563a91c1ca_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_67a6d2a2-bfd0-4dbe-b25f-b76d330723cc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6f53bbfe-f4de-428f-882f-0aa200e1fe2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_e7e947bf-1a49-4a57-be83-e81c514fa249_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_d02ef86c-03b9-4440-88a3-40815e810462_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_07e7e110-6a5c-45de-9324-40ef02b47515_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_88de5e63-f9cc-4094-a69c-08a4ceba0b76_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_255f72e3-f54f-4a01-ac27-fd3dc4d3bb1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_5141452b-362b-4030-9757-8fcf22f1c7af_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b7d2be12-7db9-4e46-a9d8-5067535409fc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_97e7f15e-b356-4420-af40-eaad6c59926f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableNet_625e2aa5-7a6e-4e9f-be5e-d4fdf24d51b5_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue, net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_label_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableNet" xlink:to="lab_iclr_ContractsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_c761220e-8d0c-48ed-9d0d-dbb1d37b065a_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_9dd69676-e95f-4840-9f9d-97bdaffa7dd0_negatedLabel_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_label_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_documentation_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:href="iclr-20231231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:to="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6edcad7c-e105-44b1-b620-64655f8993fc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_8bf98297-dbcd-4350-9de7-be6303b93125_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital [Member]</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember" xlink:href="iclr-20231231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapitalMember" xlink:to="lab_iclr_OtherUndenominatedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_76f8b73f-ca59-4472-a106-a7e7bf127c79_negatedLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_39e432c7-c114-4a13-b58a-ff8376c3f62f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea97f1e9-a38a-4d11-a8df-a2def6e25d40_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Recently Issued or Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b5f40e9e-e3fc-42d0-b102-ad604e97865e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net (Note 11)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9f2e05b9-f190-4e4d-905a-566fb7a4b102_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_ba96515e-a0b6-40bd-937c-c46a743bfdc0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to pension fund in the year ending December 31, 2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_f77785e8-c6ab-4cfc-84f7-ed5a48f96a6b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_183d82d8-2c46-4d7c-bfca-8f74bf4fe9a6_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1e893ac9-b517-48e7-b7b2-64c2f1d7bd97_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_ecc50067-1e14-4aae-ba82-f7e3da6b7660_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through business combination (in shares)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_1a29de8f-6605-4f4a-a8de-58d0ae6db12f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_7a0be6b3-2ad4-4f22-b9cf-d092bd89b7fa_terseLabel_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on cash flow hedge</link:label>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_label_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax</link:label>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_documentation_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:href="iclr-20231231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:to="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_62e08196-e11b-40ed-b8e3-a2564e90ced1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_28020dc4-de5c-454e-80c4-8e2872159e8b_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ff23c3a0-ad5a-4d59-9882-02cc172f2956_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue (Note 4)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_db2d79f3-8bc5-4a40-8e3b-87bc417030d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue (payments on account)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_99902837-4c3c-4766-aa34-8059222762cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted Average Fair Values and Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e0aacdc8-c0dd-4bc3-8ae7-3e99a71db3a7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f565c749-da44-4aa8-b7ad-451dda596609_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_c1a0a086-e8b0-4c29-9d52-31610890ab21_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4be7d75a-cb38-48c5-98fa-aaa660d4e07c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss (Note 25)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6f291b8d-990a-4cce-ae71-9c51612a7459_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_8aa2646f-16f8-4a15-9dba-7b40a7c43b2b_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_ed31d51c-e923-420d-b4d0-ae4ef7b933e1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9c654002-a254-473f-bfff-8f833d17c51d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_dccb20fd-4f88-4b3d-86e6-02ec716d28db_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_91715dfd-914f-4a86-b4d1-34b4449e960c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Debt, Equity and Other</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_9befe64b-83d5-42f8-91c9-378c9b2dff6a_terseLabel_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_label_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_documentation_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:href="iclr-20231231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:to="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_b45845f5-b7f9-4806-b47f-89fa0b3b3e25_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f6b51681-6a03-4bca-a795-03573f832d9b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_0c05cc56-7d4e-4188-8581-7938d1ef322c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c7a6b5df-aa15-44a0-acbf-b9a1f2284350_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_5cbf831f-77b9-42a1-8f4a-d80c88538664_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f9a2116a-5801-49d4-a29b-814d007f4c09_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year acquisitions (note 6)</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_caeedbcb-d5aa-4ddb-9320-575427daccc5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_b6f05894-6920-4244-8d45-2983f4ed5b59_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_c7339e20-2455-4f10-891b-2bde9c9b836c_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_4d132837-e5bd-4c5b-9820-f3bb1291d7ff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_1cad5444-8987-4afb-b4be-1b030818498c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_80469cbd-e664-43cf-a052-05c677c33c91_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, current</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range4Member_cde1538c-2870-4bd5-ba2f-c53f72bdf71a_terseLabel_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4</link:label>
    <link:label id="lab_iclr_Range4Member_label_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4 [Member]</link:label>
    <link:label id="lab_iclr_Range4Member_documentation_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member" xlink:href="iclr-20231231.xsd#iclr_Range4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range4Member" xlink:to="lab_iclr_Range4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_ac6006a8-385e-4f1b-9a85-7ac26fb0cd9c_verboseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid and transferred balances</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:to="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_900e2d95-4054-4f5b-8c52-ade320f787fd_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f3c7b2aa-b1e2-44c3-b239-f1ba1b7dd50a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Schemes and Stock Compensation Charges</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_c78f9565-5e58-49e7-bd83-7e6748430ba4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2d61a772-f7c6-4663-8ab7-828016744864_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of available for sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_c38b3660-48b5-4dad-b128-f5e83f31972b_terseLabel_en-US" xlink:label="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available for sale, cumulative amount advanced under subscription agreements</link:label>
    <link:label id="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_label_en-US" xlink:label="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements</link:label>
    <link:label id="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_documentation_en-US" xlink:label="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:href="iclr-20231231.xsd#iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:to="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_7d8ce060-9654-4877-974c-946baa866055_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_eed75769-fcfe-4fba-a2e8-ac84824efe1f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f8b33ea1-e544-4191-b6cb-08c6a78573d4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_a7aa955e-acb8-4def-9b0d-4b7ae06755aa_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e65010dc-bff0-415f-8e2a-42fa1630d972_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_869e0af3-1a59-4894-88ce-29cc1d07ef4a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_27a4dc4a-7d43-4eb1-bb5f-f08cb2e962c0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_594e9928-ecbf-4a83-b34d-6760f33f9deb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LeaseLiabilityMember_7ecf79f0-325b-43dc-9225-7a9726f8b60b_terseLabel_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability</link:label>
    <link:label id="lab_iclr_LeaseLiabilityMember_label_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability [Member]</link:label>
    <link:label id="lab_iclr_LeaseLiabilityMember_documentation_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember" xlink:href="iclr-20231231.xsd#iclr_LeaseLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LeaseLiabilityMember" xlink:to="lab_iclr_LeaseLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_af4aa525-7f58-4e63-91e9-757dbb208da0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_bf0e57e6-e7b4-4175-b706-f2a30711c1fa_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_913439cf-27d3-473c-bd23-0918022bbebd_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from sub-leases</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c233e731-1da2-4c99-958d-a2e7e8ae68e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_ee0088fd-197a-4d1f-b4dd-c7500616255b_terseLabel_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net balance</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20231231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_b25b5ef6-843d-4f4c-a1e0-04c7b1620ab7_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland subsidiaries additional tax credit carryforward for income tax</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:to="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b0cc7c72-81b2-4a54-ad32-f9d71c00259c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4fd33d90-0899-42a3-bcd3-5d2ec751454b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_c5f1263b-2ed8-4e05-8ed7-f17002a4bf2c_terseLabel_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan</link:label>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_label_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan [Member]</link:label>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_documentation_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember" xlink:href="iclr-20231231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_A2021RestructuringPlanMember" xlink:to="lab_iclr_A2021RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_3cc27d3b-2b0c-4373-91bc-79dfaa48c5e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_ec845e68-044e-4d91-a23c-89de082f4dc9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_b6f0f843-2f74-4a67-ad2d-39b539c7392e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated charge on repayments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_396ef255-47bb-4413-b8db-94272158bb91_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0bb82ab3-5f09-4624-af3b-05e767f60430_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange movement</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_33a3a1d7-4415-409d-9dad-240b4cad45e8_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_451e9d6c-2235-4369-a21f-21d445535f13_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_84aa0f16-a77e-4d7a-85b9-1b4134a76b36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4222268f-b374-4e1f-b405-bbbcec37a910_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_2775a10f-df2c-42c7-89cf-91e5221d4190_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_cb76fcf0-dcd1-43c2-a098-4291a676d589_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_003ee78b-6ac6-437d-9cb7-b4b3eea0f803_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Credit Lines and Loan Facilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_8408ac13-d067-44d3-931e-b707934e89d0_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Text Block]</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of the components of accumulated other comprehensive income (loss).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:href="iclr-20231231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:to="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_08e0fac6-f479-4168-957d-6d616e030887_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net prior service cost for defined benefit pension plan that will be amortized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d68ec783-05d7-4b07-b348-505003cfe841_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_134114cc-85e5-4c40-b139-0605ff09ddce_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share</link:label>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_7f5cd434-f6de-4830-a4c4-b533412fe396_terseLabel_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_label_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_documentation_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:href="iclr-20231231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:to="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_34bd654f-05de-4eb6-9ce0-ca933bb77893_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_887ecb0f-c28b-406d-8816-28cdf322833f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2ea2b5fe-a90c-47b4-8d63-c0979be62233_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c06e4ecf-655f-4719-bfeb-c7a7e977731c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VehiclesGross_d9c0f8f2-5faf-4642-ac57-1297e8e52e06_terseLabel_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_iclr_VehiclesGross_label_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:label id="lab_iclr_VehiclesGross_documentation_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross" xlink:href="iclr-20231231.xsd#iclr_VehiclesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VehiclesGross" xlink:to="lab_iclr_VehiclesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfVotes_d17bf9f7-8338-4e53-ab9c-ac0d179c02ad_terseLabel_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_label_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_documentation_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes" xlink:href="iclr-20231231.xsd#iclr_NumberOfVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfVotes" xlink:to="lab_iclr_NumberOfVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_23de9278-20e9-45e8-99a0-e27a1cc9115b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_b68a1665-bdb8-4900-a9f5-03e1b5f1cadd_terseLabel_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions pension plan</link:label>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_label_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AptivSolutionsPensionPlanMember" xlink:to="lab_iclr_AptivSolutionsPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_689d73aa-77b3-4b0d-b06c-c1b8d1333d18_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_ed1db1b5-c2d2-4f50-80cb-ff9a64e3db36_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_06a1646c-622e-4879-a3be-b8324b136d9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_cd9a7619-dc30-4b2e-a6b1-d4f2198b6a77_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan period</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:to="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ff39b5b9-4d0e-4d5d-9d07-427d13b27240_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_8c75cb4a-0d29-4203-b2fb-9a22a6aacb7b_terseLabel_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember" xlink:href="iclr-20231231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2018LegacyPRAPlanMember" xlink:to="lab_iclr_The2018LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d5469a75-fba7-479f-8a3c-5ea735392ddd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_a61236ca-4da7-4bef-b926-4d7108787aca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_9de574ad-2e91-4dac-9193-62c229120fce_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_87fc96a3-6fe6-40db-815e-91734c76ffbc_terseLabel_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments average maturity period</link:label>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_label_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Available For Sale Investments Average Remaining Maturity Period</link:label>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_documentation_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Available For Sale Investments Average Remaining Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:href="iclr-20231231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:to="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_e96c525d-24de-429c-b293-81c71fb751f2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_fd6e2743-9774-4dd2-88ae-af0f6bed6fea_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_8ba715c3-e64b-4e69-b4fb-0698c5c8f54f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_bd712c01-e100-4076-b698-bc393272ba89_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_192582f6-7ee3-4b04-89ed-e80aea4e719b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Replacement share-based awards issued to acquiree employees</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e9372f97-de28-43af-8460-e0976a36b36c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_85297898-1f45-47bf-8783-9ad5657afb2f_terseLabel_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, variable interest rate, reference rate in excess of</link:label>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_label_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate, Reference Rate In Excess Of</link:label>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_documentation_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate, Reference Rate In Excess Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:href="iclr-20231231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:to="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_793c3b58-914c-4765-a897-80a58dc44cdb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Annual Principal Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_4c925ef8-d6b0-4c7e-b014-e734019cab88_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (in EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_660d6b73-ca14-49c9-bf86-ba7f88acba8a_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient database</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a1c400fc-f731-466f-9899-7e17b559e01c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_9ce8eb4c-22c1-4173-bac5-b119551941fa_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of long-term investments in equity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8e5f682e-f7d9-4a6d-9e86-27e3f2f21cda_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_342e744e-9a7a-4b4f-bd99-4b646c351670_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_49804c40-dcf0-46b9-a7af-19d85908a369_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0b6250e7-25db-4708-9fd3-f219b18a9ad0_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_21010e17-6011-47ea-903d-b5219f13115c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares redeemed, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_d88b1f3e-c28f-48b4-b892-c42aa958ea20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_a39bb84f-b602-423c-ac58-02f628f347e3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5070b012-e8ff-43af-8cd7-2cb82c1c39e0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_c4a9bb7a-fb4e-4eec-b7dd-eb10e2476039_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_63b1f3e6-9822-4296-bb2e-30ddd552828a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9407501a-57d6-42d0-9589-a0ed5692923b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3d5dcfcb-20b7-4358-99d6-fb6e94e29234_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_d2691b8c-7e43-481d-b735-01f7b4a73199_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_87aef1d4-2571-426a-8d0f-d383f9068342_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_ce8157fa-5d01-472d-96d9-ab683c69f8b7_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_bffcb480-db45-46c4-8270-053ec8c4e42c_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_450d3966-9cd9-42cf-b92e-ad74ca69679b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2c1789c4-c588-4b20-8a1c-d4b694330dc9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_6066f610-afdf-4da2-afdd-6c0771340695_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_8ee18c33-fb59-4925-8e17-cb747a9334f2_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_b05d00f2-f829-4872-8b32-17067d69425a_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:href="iclr-20231231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_def49b6d-04bf-4e40-9a68-40a76e33de20_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_a689fd92-c679-4c87-9fd1-9866deaf4852_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7b085956-e1e5-4895-bef0-25f753276edc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_3fee9892-33b4-40e7-9537-5697547e273b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_6e24750a-67d3-4428-894e-732fdc8e23d1_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_7f60be0e-4fc1-4145-aa9a-5fa1c69f54f0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_bb43faa4-e482-46c8-8087-d204cf2481f0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from investments in equity - long term</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_a76dbf9c-87cf-4e73-a28a-bcbc574d3aee_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_06ac89d7-623c-4ebd-9fe3-60546e14eadc_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit (credit)/cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_72d37f1e-5cd5-415e-a3f8-86846ea537ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_ab8959b4-883a-42f7-9fd1-715da94eabfb_terseLabel_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corvus Pharmaceuticals</link:label>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_label_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corvus Pharmaceuticals [Member]</link:label>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_documentation_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corvus Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember" xlink:href="iclr-20231231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CorvusPharmaceuticalsMember" xlink:to="lab_iclr_CorvusPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_5c92c7a8-1659-4f19-9e23-3d18542e731e_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb35651a-65f7-41e5-88ce-07c84aabda3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OncacareMember_23517ee7-7425-4de2-8da6-963d0372fe16_terseLabel_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare</link:label>
    <link:label id="lab_iclr_OncacareMember_label_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare [Member]</link:label>
    <link:label id="lab_iclr_OncacareMember_documentation_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OncacareMember" xlink:to="lab_iclr_OncacareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_3c0b65aa-0b3d-4b47-b27a-cc61e65d53dc_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_0e9c127a-205e-4908-aa60-f0446574223a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_c0b7ef5e-599c-43b9-8b77-77826c8a8be6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_885ad4e8-9068-4ade-aa1f-0f116d00d8bc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Caps</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_8ed12fe7-565f-4ab4-a547-6205d26186bc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients1125Member_d14e85c1-fc55-46af-82fb-18ef0d07f823_terseLabel_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25</link:label>
    <link:label id="lab_iclr_Clients1125Member_label_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:label id="lab_iclr_Clients1125Member_documentation_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member" xlink:href="iclr-20231231.xsd#iclr_Clients1125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients1125Member" xlink:to="lab_iclr_Clients1125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableGross_7fe66022-48ab-434d-97bf-097b210eac55_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable (net)</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_label_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Gross</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableGross" xlink:to="lab_iclr_ContractsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_7ccc8b0e-c835-4a4d-b44c-b5a7413516ec_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of company revenue (in percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GovernmentBondsMember_bf2dc382-223c-4fe2-b315-0fb955a801a9_terseLabel_en-US" xlink:label="lab_iclr_GovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Bonds</link:label>
    <link:label id="lab_iclr_GovernmentBondsMember_label_en-US" xlink:label="lab_iclr_GovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Bonds [Member]</link:label>
    <link:label id="lab_iclr_GovernmentBondsMember_documentation_en-US" xlink:label="lab_iclr_GovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember" xlink:href="iclr-20231231.xsd#iclr_GovernmentBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GovernmentBondsMember" xlink:to="lab_iclr_GovernmentBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_6b7d43bd-589e-4fc7-8fe2-ad2ce01185ed_negatedLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_dd43937a-de4b-4f07-b32f-6ddbe80d1b16_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax (benefit)/expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c83c345c-829b-4690-9456-b05dd838cbb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cbec4e7e-5aa8-4d17-af7f-3726efb78915_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_86647078-c41d-4961-9068-6ab925f7b0ec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_00f8652a-c78c-4b03-af63-10f787ed649b_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_b54e4117-2850-46ff-8625-f2bf6fedf7a9_terseLabel_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to third parties for reimbursable expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_label_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_documentation_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:href="iclr-20231231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:to="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_41ad92ac-dfd7-4a80-8d12-b073294ceb7e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a829ae57-ef63-469f-bf2c-6877090d621a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AfimmuneLimitedMember_7024e6ca-cc3a-4ca4-b85a-ed293c7938e8_terseLabel_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_label_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited [Member]</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_documentation_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember" xlink:href="iclr-20231231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AfimmuneLimitedMember" xlink:to="lab_iclr_AfimmuneLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_0bf5169d-9da0-4d79-8ba8-c4d9789cdc86_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_b8871f80-21c3-4aad-96d2-02c05e1fd927_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current bank credit lines and loan facilities (Note 13)</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_77ed0ab3-2959-4b71-8828-284cad1c6a4a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_2c96b5c2-7018-41e3-a110-d5ad7633fb57_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_ec032826-cd20-4702-bda4-9d1247078326_terseLabel_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award date, prior to 2018</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_label_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, All Years Excluding 2018 [Member]</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_documentation_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, Prior to 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:href="iclr-20231231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:to="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_87ede9e6-cb41-4105-a8f9-3def979b6ac5_terseLabel_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investor tax expense on foreign subsidiary earnings</link:label>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_label_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount</link:label>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_documentation_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:href="iclr-20231231.xsd#iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:to="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_2781f233-6d41-40f8-8e6e-d93a92ba8d91_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ad643560-36a3-428b-8d67-9d7e9a293baf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityNumberOfEmployees_8b4a1b12-b2e9-4308-afed-cd576c8a9a13_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees" xlink:to="lab_dei_EntityNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_86951d7d-187d-43d8-bfc7-ed3601f3a14b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_00d90a6b-9715-456c-a242-e439947e5a72_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_923c21dd-87bb-4ca3-b57a-bde276daed7d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_24475568-c9b1-4e07-a75e-af21f4c88046_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_507a66c9-1843-4649-a9e0-5350b8e5b593_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_8d9e8dcd-58b6-4e17-aeb1-4d230f71ab5d_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_a988a8eb-be74-4e7a-b06e-e99fc90becbb_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured revolving loan facility</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:to="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_abf2870d-77f2-4b83-8c98-3e4b474409f3_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_1c61952f-fc7d-40e4-884c-6ea624805b1f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per ordinary share (Note 24):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_6f440849-9bd2-4a13-9486-7afef22b74f7_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0bbacafe-7495-4372-91ca-066714096d71_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_0b339a54-cd72-48f9-8541-7aa4808d1ad7_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_e25e0b08-9d76-4439-81c9-1ade9d3bc1a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8df58c02-1489-449a-8c43-2e38f96198f6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_196e7051-7801-4592-9338-d86581289ca9_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_02035d10-4f37-41b3-9165-7f9d501ecb45_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_473dc833-e945-4bad-a349-6866b6dbc37d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_81843b2e-91c3-467c-9099-1ff46c53fa35_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fd06721e-9168-46f3-a78e-6d18a5d362a1_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f2273157-04e9-45c4-b9ba-99682f0d7a49_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_301eb833-4eb5-43d2-8155-36f237887798_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1b6689db-f227-41bd-bfd9-40010e802011_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_7fdbac77-a2b0-498f-ba1a-f3c33d7ee649_terseLabel_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Cost</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_label_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost [Table Text Block]</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_documentation_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:to="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_11f61273-ca78-4caf-907f-c889f2824d22_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_a04c057d-e864-4751-a312-dbac863a50ab_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments (long-term)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2b888330-8a9d-42b1-b5fe-078f5e2aa514_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_471e9b2b-f9a3-4290-a750-839e365c5982_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_abbe1e0d-f04c-4f93-87b3-31b356a774d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_1e0ae752-3ba1-4277-9d6e-368066efd9e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement share-based awards issued to acquiree employees</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_06f6333f-274f-41a0-90af-b9a3609dd9ad_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, number of shares issued (in shares)</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_f12d2991-8f64-44ac-ac8f-8d86bb1a1656_terseLabel_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Income Before Provision for Income Taxes</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_label_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Tax [Table Text Block]</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_documentation_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Tax, Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:to="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_ef7d42d9-c132-43ce-9a23-0178ec357000_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and penalties recognized as an expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7a1daf67-4a20-446f-8180-d2c082c7f2da_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_60032fda-81dc-4b73-8b0d-8d79076f348b_terseLabel_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal net operating loss carry forwards currently available for offset</link:label>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_label_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, US Federal</link:label>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_documentation_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, US Federal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal" xlink:href="iclr-20231231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingLossCarryforwardsUSFederal" xlink:to="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5c63b60b-dfef-45ba-b138-72a9e6e80a28_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding (Note 24):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4d680f92-7b65-4284-8266-4231e7519ca9_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net (Note 9)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e22eae1a-3541-4602-8e52-e196d88939d8_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment (net)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_23e085c4-7533-4df5-b564-eee401f5331f_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_214f8078-cb1c-452c-9654-3e5bec3c1fc8_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_446ffa70-1a6c-441d-80dc-c4e918801340_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_226c08b3-9ca0-4d50-b935-e770dc783dc2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (note 16)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_dd975b2e-0063-48b4-b8f3-c28b5981ce67_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_336db9c3-e9d5-4a75-9f58-1cefd6a4fdbb_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_dcc61efe-525b-4198-b133-224e942dd871_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4c934b12-14f6-4a5c-8c14-5c960444b469_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0b187889-1456-4543-ac2d-cb0bf11e3a52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts charged/(credited)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_12155d83-e7df-42a4-8e39-06d693962c16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_371c69af-2399-4a5d-9d6f-6608cf54d536_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other Liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:to="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_c05b0a14-afcf-4384-b528-d16f3e29422a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BilledContractReceivables_a9d02fb2-4a63-46e1-9c51-4499b58cd673_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed services (accounts receivable)</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BilledContractReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables" xlink:to="lab_us-gaap_BilledContractReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_1394586e-1c3d-4f80-b086-84290fe12859_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a222347d-ba79-4e19-8fca-f9566383607a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5c0d258a-12d2-4beb-98a0-5d47becef10e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset (Note 20)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_85722991-c461-4979-a7ae-0b5ade55de8d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_acf9abdd-f312-4423-940c-e1dfe69e2cf3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5ca68b12-182a-42ef-8b5a-9e1c2dea390e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_525e3b33-edb5-4a19-baae-200342f4861c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital acquired (in percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_ff097af9-db18-4b00-8942-91d24fe97e66_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue (Note 4)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_facc069f-f399-4673-86d6-faffe74ee6e1_netLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_86defcba-0a36-4612-9f9e-54daee77779e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_5696dc0f-460e-49f8-b5dc-90f482be2ab6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss that will be amortized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_608f9e4a-53d0-48cd-b478-b898b022ac30_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_53ef2c70-e670-478d-af69-9373813855e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_22f304d8-b62f-4f48-9218-0a0205fe3c3e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_abad6006-9610-4a1f-a17c-1d2141630b83_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_7278c878-70fb-43a3-addf-4a8badaf75e3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_bf8b1213-de74-4eae-a7fd-56bc41d17f01_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (Note 19)</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_81e2790c-e380-4f99-812c-51262a0b00b9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_81b43c5a-7211-4ef9-af3c-e2ada0979a10_terseLabel_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG pension plan</link:label>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_label_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRASwitzerlandAGPensionPlanMember" xlink:to="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8692f02f-7d19-41d1-a73d-afbc7054b721_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_137c110b-d6f5-43c2-acc3-22fe74174ef6_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_241ea058-8838-49f1-933f-5c84bff6ded8_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_1f452912-f126-4710-95d2-8ef0798f13a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d31d5c6c-cb6b-4c47-9d08-3be73dec5d5f_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_4d698973-33f6-452f-bb1b-b5c8794ffb48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_d08c5562-279b-4ecf-9e97-7b9922f40047_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension obligations, net (note 21)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d259a7e3-7da9-434c-ab73-4f654e9d864d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_13b1cc2d-2139-4c3a-86d3-8d87f3fd9e3b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cd9e8fd3-4a87-40b6-953c-175f20417b06_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_c05925f7-b096-4499-b2a7-b1616e75affd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior period acquisition (note 6)</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_86b98445-6d2d-497e-9647-c8f01ac414d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_e01f41bb-b96a-4bd8-a787-8e66675d3659_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_7d020263-6bce-4b74-af49-e537b147895e_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units 2019</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_label_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:href="iclr-20231231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:to="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_406e7460-bb26-4cee-8915-09f293a72d98_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_5cc393a4-6ebd-45bb-9d7c-3be107e1215f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_aad35bd8-a4c8-427c-abdd-6ce3f023f127_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2024To2030Member_89d7dac0-1c01-486a-b2a3-3b690dbc87a0_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2024To2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax year 2024 to 2030</link:label>
    <link:label id="lab_iclr_TaxYear2024To2030Member_label_en-US" xlink:label="lab_iclr_TaxYear2024To2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2024 to 2030 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2024To2030Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2024To2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2024To2030Member" xlink:href="iclr-20231231.xsd#iclr_TaxYear2024To2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2024To2030Member" xlink:to="lab_iclr_TaxYear2024To2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceShareUnitMember_60e20fe8-89ae-4f1b-bd35-036ea365e1b5_terseLabel_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit (PSUs)</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_label_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_documentation_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceShareUnitMember" xlink:to="lab_iclr_PerformanceShareUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19759126-bd41-4e6d-955f-6f4089c576f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_bb621d54-4db4-400f-8e49-f9d84ab97816_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_62c0d6a1-3dec-434c-afd9-333db93095f6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_3e20b996-4558-417a-ae53-30884e27a11d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_98092a0c-8abc-489a-8496-79a18651fafe_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0335fe5b-b179-4172-8463-a507a276288b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in the total valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_689d362f-79be-4d44-8807-20f42d4437a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_26bdd22f-0455-4805-ac45-fd863b7f6021_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_df0b1fc7-599b-4939-9e67-fe01a4992015_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_e2f593ef-b241-4e33-9143-9deafc4988ab_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_7966595f-3d53-45dd-aaad-558ec8345eb8_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-cash Stock Compensation Expense</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:to="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_4a952f9b-d9b5-4db2-9442-7ed504aaa283_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_c1f3be36-5e6f-413d-9efb-f659cce48f80_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_aa37dd0c-e919-42bf-ac9f-259db3cb8290_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_16bec017-bf0a-4b97-a892-a320ecad1d3c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d0c81cca-a6b0-489f-ae47-8019c396c5cd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_d690a8ae-98cc-46bd-b454-f227dd6414e7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_58fb1e57-3132-4408-b3cb-11fd162047f1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of equity compensation</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a0d238d8-1a7e-4d5c-8898-2b2e71b912e8_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total proceeds from exercise of stock options by employees</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e1335a42-22d7-46ce-9529-2dde76ccc352_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_869926c2-642f-4639-af35-5de0843655c7_terseLabel_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order backlog</link:label>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_label_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_d0a7fb9d-1cb9-4c60-9428-ed18bf7dfef3_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeMember_a406d6b6-b36e-45ea-b8fd-cedd22e5ac78_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of Europe</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeMember" xlink:to="lab_iclr_RestOfEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestExpenseCreditOther_f4726b13-7f37-4f29-a3f7-b9333978fd16_terseLabel_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing costs</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_label_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_documentation_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther" xlink:href="iclr-20231231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestExpenseCreditOther" xlink:to="lab_iclr_InterestExpenseCreditOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e299649b-314b-4f3f-b24a-d3dc36ddb91c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_3501397a-f3bb-456a-9bee-7cd0667820d4_terseLabel_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liabilities</link:label>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve and Other Liabilities, Current</link:label>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:href="iclr-20231231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:to="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_d789fe36-b577-496a-99e2-a6a40fca6d66_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facility and senior secured notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_5321e34e-851b-4c3d-9483-2e7099733802_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses (note 5)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f10afa1f-8b4e-4a9d-85de-1cf7c61664a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_5a2068d8-2bd5-4101-b768-4f786369b94b_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_1edd6358-89d6-4624-bcf0-6ec3f1f6a69d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_dbd27eb2-8d0d-42b3-9db0-46619583f3fc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0f583f6-7fc4-4719-9ae6-05bed2be2c82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_42551bf1-a171-40ac-a096-a021d168142f_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_ccb6e64f-d531-4d71-92e0-e7a71e220b83_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_d6f384f2-4f34-4d19-a03b-d1f8f572a518_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of shares associated with a business combination (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_ff72a7fc-dc22-4dee-a417-a29e930ffc5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum range exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_baa4c424-0583-4e53-b3ce-9d29ad28974f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_cb6aa36a-2768-4a51-8b83-625d63a0baab_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0db3b012-8103-4e84-9e7b-3c8b2abd4be9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_aede06b4-6718-448d-9928-da6c54b6867d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8773831e-37f0-4f1a-a009-ad4cc384b34f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (Note 20)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6db0781f-55ab-4e81-b24b-d6d22842bfbb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense allocated to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_e584f70f-2604-4a95-90ca-390a30db4495_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_24a5da6c-9d63-4212-8e53-30516b583180_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts used during the year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b5203a0a-3aee-478e-9ca1-1d23c7587e30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_34226548-d1ef-40cf-b5e4-b99c47dc09f7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_29eda298-4d83-4f37-b866-7c7f0b81d5d0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_66ca3c42-dfd6-4629-a5e2-c0b61b1e4880_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_db6768bc-a46c-4463-a8f8-c936c165d71a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6b29a09c-91f6-4eac-8c31-4043033e30a9_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_3b2938ef-feda-4a95-ab01-3e047a50be78_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:href="iclr-20231231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_480ce653-ddb3-4a22-a1fd-feff35e57db5_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carry forward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9c20a649-569f-4b8d-a647-baae61d8d2cd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_688c096e-ea53-4690-94f8-df2f3643089d_negatedTerseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0835bff0-ad78-46fd-816d-b09a7841d519_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherRetirementPlansMember_e1b1351a-c46f-48f3-8bc3-c72bb008593c_terseLabel_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other retirement plans</link:label>
    <link:label id="lab_iclr_OtherRetirementPlansMember_label_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Retirement Plans [Member]</link:label>
    <link:label id="lab_iclr_OtherRetirementPlansMember_documentation_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Retirement Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember" xlink:href="iclr-20231231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherRetirementPlansMember" xlink:to="lab_iclr_OtherRetirementPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_90641e59-86b2-453d-b864-8f34d4f72b21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_3c8fdfd9-6865-45b8-bfc8-77da275b45a5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_e4e21936-678b-45cd-8e9b-a4834a7914e5_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_c10972ba-de9f-44e0-a930-3e4234c2140b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares redeemed (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0ae5c46e-0c98-49a9-adbd-cb3e43cd74fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_dcaaa905-f55f-48bb-bb34-bcd8ca1d9edf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_a4d4076c-fc42-48b4-856c-145b271f6675_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, share price (in USD per share)</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_00bdb7ee-b915-4c4b-9e7a-dffef79c5d5a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_35710d0b-ff3b-43b3-9242-64f2695fa3ab_terseLabel_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember" xlink:href="iclr-20231231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2020LegacyPRAPlanMember" xlink:to="lab_iclr_The2020LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_806df5db-679a-4e8f-ae53-3cf087c8d026_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:href="iclr-20231231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_8ca40fb5-8b4a-49a6-b53a-3e335b897a7e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_7688518f-c576-4bc0-8a76-7eaae3fe2f2b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contracts with Customers, Asset and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a53c1180-d92d-479e-a84c-485bd1568a87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_79a9bf89-99da-408d-b1e4-830141e9db16_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_98ff14a3-ef8e-4a37-a2d4-e58aa391d15d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_aa84c3a5-9f24-4f18-b7fa-ae337add75b0_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_102d84f2-24a4-45e4-9cf6-57bc541a5612_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_label_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:href="iclr-20231231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:to="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_6672b2b6-f1f6-49ce-af66-5d6f235363c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_fc3a1d81-b3df-4304-affd-aaaad71607b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_9f2390dd-7eb9-4827-a503-e437afcaf4c5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_978fd3e6-2f44-4aa9-bf39-5710643d3a05_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_01611b03-56ee-4d66-8a64-f975a5f8ca18_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_f916bd0c-4a87-4362-8d71-f20083fb63ec_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_1b5ea93b-69b2-44cf-805a-3eb3834a92f9_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2f05ca59-af00-4d88-8a00-8734a43c146c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of losses from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_00743725-c8e8-42e0-b651-d53a8f44e2d6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_dd87b1c4-165a-4647-bc3e-027ad3c7f55f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of losses from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DiversifiedBondsMember_9f7e519e-c9c2-49d9-b721-679c3d7f1b43_terseLabel_en-US" xlink:label="lab_iclr_DiversifiedBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Bonds</link:label>
    <link:label id="lab_iclr_DiversifiedBondsMember_label_en-US" xlink:label="lab_iclr_DiversifiedBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Bonds [Member]</link:label>
    <link:label id="lab_iclr_DiversifiedBondsMember_documentation_en-US" xlink:label="lab_iclr_DiversifiedBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember" xlink:href="iclr-20231231.xsd#iclr_DiversifiedBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DiversifiedBondsMember" xlink:to="lab_iclr_DiversifiedBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e52d8a93-de94-4425-9153-bbf46cfcf2da_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AptivSolutionsMember_0fc06a11-9254-4f70-b38b-50bd16efd3f1_terseLabel_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions</link:label>
    <link:label id="lab_iclr_AptivSolutionsMember_label_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions [Member]</link:label>
    <link:label id="lab_iclr_AptivSolutionsMember_documentation_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AptivSolutionsMember" xlink:to="lab_iclr_AptivSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_04d95937-250c-4f07-85aa-cef84c695ed2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_f8ac55c8-54ab-4e81-b3cf-d904121906c6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_e22413de-3931-4d91-bfc0-fbf6aad8c2f2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of financing costs and debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_3e5997f6-5108-4a50-b6bf-b1ab96684cc0_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_696f4deb-ef60-4021-be11-7b3a36a0485c_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1e9f9190-229d-4ef9-af9e-10c966e819ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (Note 16)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_12c4dd66-33dd-469b-87d3-6b6bd294f335_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1ba38082-1b12-4412-86a1-72a73d331130_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_a8dfb2ac-436c-4964-9d0c-06b67e41bc87_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_0289c642-7ed4-477f-8336-aea70edc4e8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_2b2fed8d-90ad-44d6-b382-e2e20e950278_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_24e9866d-74a3-4ebc-adf4-e5e3c0179ba8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment and Geographical Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84f63ab9-e679-4dc4-835b-6a9872911e34_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase/(decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_36e23a0b-9573-4a2b-8171-101be573445b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentDomain_c41f0fb5-ca47-4ab5-8dba-1db1e7d5e70f_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_label_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentDomain" xlink:to="lab_iclr_VariableRateComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_9e1b1856-8df6-478a-96ae-e8116060dcb1_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_ab8f1c21-34df-4b5c-9f6e-435cc1d07ca3_terseLabel_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related</link:label>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_label_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And Integration Expense [Member]</link:label>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_documentation_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And Integration Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember" xlink:href="iclr-20231231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TransactionAndIntegrationExpenseMember" xlink:to="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_699c7734-30d5-4f63-a577-887463c3eb9d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_571d70e5-a37b-4a24-b23d-4f0d5e12516f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of option price for fair value of ordinary share (in percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9a90b79a-f849-4d24-9973-3ff7cde5f16c_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State NOL's</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_4b1a4e99-5b7d-4228-9a66-f8a14ce9a19f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_a8ff6aad-dd57-4d52-966e-89457609be70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_2cea2d77-40ce-45f0-b922-23b258d9446c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_24c394b9-aad9-48c7-a4b1-094015525a59_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_6ab2e358-8b3c-48ce-9514-419a82e298fa_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2024To2037Member_f48ce182-fc39-4b57-be81-1b379f123db3_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2024To2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024-2037</link:label>
    <link:label id="lab_iclr_TaxYear2024To2037Member_label_en-US" xlink:label="lab_iclr_TaxYear2024To2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2024 to 2037 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2024To2037Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2024To2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2024 to 2037</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2024To2037Member" xlink:href="iclr-20231231.xsd#iclr_TaxYear2024To2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2024To2037Member" xlink:to="lab_iclr_TaxYear2024To2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_b8d0487c-ab89-4489-a5c2-7dc0552c176b_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:href="iclr-20231231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e710e15a-989e-4232-9625-b6b457c9d48a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_82ead579-cb00-44ed-9fe1-459a7c9609ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_34610857-6404-4b34-bc42-cc05595718c3_terseLabel_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive director</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_label_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_documentation_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember" xlink:href="iclr-20231231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NonexecutiveDirectorMember" xlink:to="lab_iclr_NonexecutiveDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_919493d1-3773-441a-b2af-c274da02fc53_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_6f9ba048-7acc-4676-a840-27c6a877b5d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate differential from amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_35cb7381-2a35-453d-8875-c200f0f3f3ee_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities recognized</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_4e4ceaf3-a63f-4e76-a85d-f9aae42a179e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_aa1dccdb-fe7b-4eca-bd62-e13c91fe1054_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants' contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_65fe7ee4-f8c2-4a1b-af1a-e5c6800416e9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3dddbb6e-db73-4e2a-a7d5-02a83dc0ead2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f773a863-a8b9-4483-9c24-5e79e80d9133_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income/(loss) &#160;</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0552fe4a-bf41-4337-9419-cf2f8e4241ff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss/(gain) - plan assets</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_39438a54-6198-4406-bcf7-7f14d0326e1a_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_d4292317-5075-4ad7-89c5-eb2ab3f87acf_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss and tax credits carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_f44fc0e6-13e2-4bf2-b65f-ba6d0655ac70_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_65c6e8fb-491a-49ec-8d9e-fcde3ef1497b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other restructuring costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_a8832e17-74a3-4f1d-9546-0ee7e7eaa91d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_01079361-c9d0-4cf0-8107-8bba2f85b043_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a9ab9143-d78f-4cd5-81a3-299736367eed_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_ad25351a-688a-4316-ada1-aa7843aec616_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unbilled receivables (in percent)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_b90e5fca-a89e-42fc-98c7-80b4a1abb319_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_5daee8f0-2026-4e27-8a9b-8867e23e96fb_terseLabel_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs Based on Service and EPS Targets</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_label_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_documentation_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember" xlink:href="iclr-20231231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceBasedGrantsMember" xlink:to="lab_iclr_PerformanceBasedGrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3dfd187d-5bab-434f-853b-4fb1b361856c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4ad93c3b-ca45-4625-88aa-903683963203_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3a7cbc6f-8ed9-4faf-9c57-10a8a221156e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range2Member_07f9b66a-353b-45a6-b1c4-1ffa1357178a_terseLabel_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2</link:label>
    <link:label id="lab_iclr_Range2Member_label_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2 [Member]</link:label>
    <link:label id="lab_iclr_Range2Member_documentation_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member" xlink:href="iclr-20231231.xsd#iclr_Range2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range2Member" xlink:to="lab_iclr_Range2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_cb3720ad-0434-42ad-88df-08b223e811bc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_6e05c1e6-5ac4-4efd-be30-78c6a5a62a9c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which company operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ac09c892-f8b0-42aa-b599-1ac010bafffe_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_620c2c1d-da52-46d0-a440-d5eabae9951c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_596d31d2-5a72-49d2-90c8-620a824f1c97_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate movements on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_5b7cfadc-8940-4188-bd7a-cb63282943a6_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentAxis_dbcd05b1-3fab-44d7-b8c4-9a89855ea190_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_label_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentAxis" xlink:to="lab_iclr_VariableRateComponentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6a1b7262-f20b-4c03-8840-8310c3aec968_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_488859e0-008a-40ef-ba20-cab79263f119_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_55dbdfc5-b8d3-4368-aa29-fc8459f676c1_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_48cba7d0-b93b-48c9-a881-f9622dc032bd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_9f59be5e-163a-4883-853b-3c51ee13b1a7_negatedTerseLabel_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Retained Earning Share Repurchase costs</link:label>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Retained Earning Share Repurchase costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:href="iclr-20231231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:to="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_9f5387a8-68e2-4d70-bb70-afa0c79bf034_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_460e0afe-f2c3-4122-9daa-62bb0b9c336e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_3862c9ef-8dfd-4788-bad5-d0433903c65f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_86b87717-f052-490d-9976-cfa799c90830_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_e5a790e7-7245-4628-a241-23a71c4dd9b9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_0e4e8984-1a7a-4eb3-b240-325820ebd786_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_b8609e9a-2bab-4a65-9441-40331c293175_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_28ab52ed-80c2-4bea-8106-4a6f38792b43_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_1ccb426a-3c24-442c-9779-25be39b41ae4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate derivatives held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_963f1beb-9466-4b8e-a50c-bf8ce649d0e2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_6eca5caf-cccb-46e0-9e0f-7a2ab2dfe036_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_6c2ee8c2-b9c5-4647-9ade-3d7d09d39ca4_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheme contributions</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Scheme Contributions</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Scheme Contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanSchemeContributions" xlink:to="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bc96cd2c-a2d3-4d6d-80f6-f6961e61d8c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_200592b0-8418-4755-ad6e-152b7eb0077c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_21881781-1cee-46b5-8786-63f02b6a9f25_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2f06d485-f473-4978-a5ac-09ce569d7f01_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c58641e8-4cb1-4034-b92f-bf4d27b32452_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_e7aa6229-d3e2-427f-b170-16aa9babbdba_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_1dfd7451-2715-4786-b625-07b1abd96ad9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_b59b823c-8fcc-46e3-9c2b-bacf958c2bfa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyAbstract" xlink:to="lab_us-gaap_ForeignCurrencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_05e1fca6-9476-4b74-8637-c36b53b2875a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Plan Asset Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c7e494df-7f1d-449e-95f0-aac2ab5e7ca1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_4c5b2823-de35-42fa-b4cb-adbb6055e42b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5b179da-9db6-4f06-8051-67a0e6e3e03a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_192c72fd-f62b-4c3b-a4da-50985216ab27_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TermLoanFacilityMember_288c47fe-11af-4afa-afd7-f9ec5776973e_terseLabel_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_label_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TermLoanFacilityMember" xlink:to="lab_iclr_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1b3d7fd1-1405-45c1-85db-d3b54453899b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8d4e66ca-86f9-404a-9706-1489fa32f1eb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_68e18cc4-9d5b-4def-bdbe-3a2075e38e93_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt at fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2f0a627a-3f32-47cb-b049-a6a9a46ebaf2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_13bdf271-7be5-420b-9610-7f29a407b0c9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_583bac96-2882-4ec4-ab3b-f0f308866185_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e12e8fc3-f6c9-4a11-a70f-695e063667c2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_001ce473-5a29-4ff8-91b6-b39af0f7f7ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Underlying Asset Split of Fund</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_88be4698-57df-41d8-bf0f-fd61ce31b823_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currencies and Translation of Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_595f1542-469b-42e5-af94-f98c5bdf24d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_edda6f5a-376e-44bd-8703-a1eedb6ca656_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_283a0b02-4e78-4427-92e1-6c4c58ef7546_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_acd0e006-5c7b-40ac-95d4-ccd41a6fc7e4_negatedTerseLabel_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of debt</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_a7495cb5-c64e-4685-a810-74e471144fee_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_b2f681dd-594f-453f-8bae-58afd643de85_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Income from Operations by Geographical Area</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_label_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income by Geography [Table Text Block]</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income by Geography.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:to="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_94e1237c-9404-4dae-881e-f2c4593dc171_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations, excluding restructuring and other items</link:label>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_label_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</link:label>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:href="iclr-20231231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:to="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_71bfa152-e793-475d-ab35-2add11ce82d5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1605d411-3aa4-41d5-9774-5f4d2c10b94e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7b66aba3-a6e1-410c-8687-301ee1c43d27_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by employees (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ffcb1a20-1324-4690-b0dc-37a919f27b25_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_672aa7d1-8882-40d2-b6f6-ad87e8ffb893_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_7a404d49-e532-4d18-ae22-bded7e07bc43_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net and Unbilled Revenue</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_1f0805cf-07c5-4050-a264-7e36e8536526_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs (excluding depreciation and amortization)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_fee202de-869d-4d97-b849-9adffcb71e09_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal NOL's</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6fa7cac9-984f-423e-b280-8cf7771ebddd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_315146ad-42c4-4f68-b6ad-09041d6c096d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_36f90228-c018-46cd-a85a-7664d849aad8_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_1f0cdd7e-c252-45a5-8f5b-98e4a62fc25f_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4a665844-740c-4de1-95d5-b77efbb5551c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c16f94be-cedd-4292-8478-8b101b6c9b9d_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 10)</link:label>
    <link:label id="lab_us-gaap_Goodwill_fc90990e-27e0-4f78-a311-1e7c17564449_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_22ffd16e-6f21-40c1-b3c7-17f9edb13b72_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_e9ea326d-123c-4e82-a876-15a7fd2ff902_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f33662db-880d-453e-a0fb-51f102ac240f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_4972cac4-45f9-4c5a-aeb2-1d83b9c1309d_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_03f8a5f2-dc9a-4591-8d20-8b8f51dcf931_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_d821b5f2-fb85-431c-9be1-5bf8badc37bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency impact on long term funding</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_575137b1-a49b-460b-a0d9-cc9b305e4440_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ca87a9b1-37a0-4953-b164-27a72f36fd8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities (Note 15)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8d1aaa79-b72f-429c-b93f-50aea306e080_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan to equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_1ce02fdd-2398-42a1-8261-78d9a1280ca0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_eca80510-1bbe-4c9b-8e1d-bb7f70ce4c61_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a7f55a35-568f-4d5d-9f1a-d3fbad594b5c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_55031089-f195-47b1-9134-22d5d2f32e80_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in advance payments netted against unbilled contracts receivable (in percent)</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_92dd1ced-de68-4e30-80e8-00d62d9d7224_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6074df69-738a-4aaa-b83e-0c9cac274526_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (note 16)</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a5eba0cb-6109-48b0-aa16-8a7ca4407d0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less debt issuance costs and debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c6cf6acd-aa3a-4905-9f5d-d8feecdee638_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_027926b7-b087-455c-ab79-c853b47ef1ec_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2071456a-eb60-4f2d-92d3-62fce09d566b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_9587f488-1af0-44d4-96fc-c7a69525b639_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_113d1e97-b3ce-47bc-9c4f-a45cb4e67fac_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_156534d1-e758-41d3-83e6-476a38c31eb6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_ab408b03-220f-4573-8715-a0018e834dbb_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_0dbc6b6e-ef5a-4141-a878-b652eba78fe2_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_b15e131d-499d-4f1a-9c1d-1e61cf58a082_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e496fc73-612b-41d6-94fe-ee4adbd4b76f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_5d74f497-d65a-4fd6-93e4-994f04d4b95a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_152849d9-4f18-4834-b29a-a5ac89e04005_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_fb634f48-e983-44a6-9ad7-c819079c3d96_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AuditInformationAbstract_label_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iclr_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract" xlink:href="iclr-20231231.xsd#iclr_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AuditInformationAbstract" xlink:to="lab_iclr_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_fac5b8bc-8f9e-4c0a-8c81-dd72cf8af3db_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (Note 13)</link:label>
    <link:label id="lab_us-gaap_InterestExpense_6307fecf-7df6-45d5-b534-e1f5c4401bd0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financing costs</link:label>
    <link:label id="lab_us-gaap_InterestExpense_36b12569-9905-486e-936b-650866491c01_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financing costs</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c9877bb4-9512-49ad-998f-1e20959d4068_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_075ca954-ad52-4518-a659-6c3bcbdfef50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ccd7ca58-1a1b-4630-84c6-fc7defd4434e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual term of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_cfa1a282-917b-4d7d-ac81-e6461e3e10da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfLocations_aec0f660-8891-42cb-b189-d5b500887607_terseLabel_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of locations in which company operates</link:label>
    <link:label id="lab_iclr_NumberOfLocations_label_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Locations</link:label>
    <link:label id="lab_iclr_NumberOfLocations_documentation_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations" xlink:href="iclr-20231231.xsd#iclr_NumberOfLocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfLocations" xlink:to="lab_iclr_NumberOfLocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_aafec6de-13f4-400e-aae3-13c6d348a8c9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_fc90b655-d59f-4915-8783-d4fe837f0934_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_03bc851c-8a72-452e-bea8-843a0e4b23ec_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_448b831d-98dd-4524-b2d3-b08e4c04f34f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e5eda19f-3caa-4892-96d8-7937b14194aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4f93dc54-193e-4246-b9b4-4abd7cc55495_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients610Member_76f06091-25a9-4462-9d29-f4f1771cafed_terseLabel_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10</link:label>
    <link:label id="lab_iclr_Clients610Member_label_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:label id="lab_iclr_Clients610Member_documentation_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member" xlink:href="iclr-20231231.xsd#iclr_Clients610Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients610Member" xlink:to="lab_iclr_Clients610Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ac410982-cc07-4906-8757-fa90b504d3e7_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_02e946f4-823b-4a80-a25b-739e519a69ed_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_ee68e073-cdec-434d-aadd-98d69547e55a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1212adfc-56a3-419e-9224-765e7bb1686b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_10a09e0e-6fef-4293-b799-f7bb5b01a287_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative minimum tax credit carry forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_b1049694-d4af-42d2-b1c7-5caf61668563_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_3a5997ee-ed70-4b1c-aeb9-5576408497a8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary of Common Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:to="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_cb3ca66d-0f4e-4c51-885f-af9a634fd9e8_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_de7fd1bc-0632-4ec1-9351-86dfbc474271_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d815dd54-086b-4fb8-8c29-8e3a385a461c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_cfa56078-eeb3-4af5-b8f4-55ad5b7245ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic principal payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fde7e14d-d319-4e08-a27f-407b2e45156e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_38cfd71b-3e66-4414-8252-5c7bc0980c09_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_b70dd48d-f4fd-4279-9e98-6ce973c3d987_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GainLossOnIssuanceOfDebt_da004b21-b535-4d31-87c8-616aed810b02_negatedTerseLabel_en-US" xlink:label="lab_iclr_GainLossOnIssuanceOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on issuance of debt</link:label>
    <link:label id="lab_iclr_GainLossOnIssuanceOfDebt_label_en-US" xlink:label="lab_iclr_GainLossOnIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Issuance Of Debt</link:label>
    <link:label id="lab_iclr_GainLossOnIssuanceOfDebt_documentation_en-US" xlink:label="lab_iclr_GainLossOnIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Issuance Of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GainLossOnIssuanceOfDebt" xlink:href="iclr-20231231.xsd#iclr_GainLossOnIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GainLossOnIssuanceOfDebt" xlink:to="lab_iclr_GainLossOnIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_34d9a0e9-d452-4066-b975-57169606640b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c71881ad-898a-4c2c-9a86-2aab0b1af151_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ed7f1583-3891-4a83-92a9-e635c875094f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_58f4c4ef-bd8b-477e-aefe-3f0b01c372ef_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9ded32a3-b78c-4633-b0a6-ec592e2af850_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_6b351d7d-82e4-4ee7-95af-6ab00f6acff7_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_3bb99a9e-f5d0-4220-831c-74ec7da200c2_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_dfde3e0a-ec8d-4100-8cff-079959b0a1ab_terseLabel_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grants</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants [Policy Text Block]</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:href="iclr-20231231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:to="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_49310a62-dc1c-4cc7-9d4a-c7098347eb86_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; development tax incentives</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a813e7fd-924e-4aef-8f71-9c780b3eebef_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_7deaec1e-b13c-4ceb-85bf-676852d813a1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_5fc254d5-6660-4c8d-9c38-0dfec07cc95f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3ab36f01-1b9d-4a99-802f-2d0d572f93f3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_632a6c2d-b38a-4b79-953e-9037ab145384_totalLabel_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before share of losses from equity method investments</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_label_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_documentation_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:href="iclr-20231231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:to="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2bd46ffe-53bb-4522-a9e0-2a5f0b49f07c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_70a9e775-55cb-4850-974f-36e5291b60af_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_e18cf81e-a8bc-4871-b5f2-2799875781c2_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_b3c47588-d4c9-445d-9d39-8ba0fe54a2b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_b2d34d88-5a8f-463c-8c83-8d0cc221122c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Benefit Payments which Reflect Expected Future Service</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3f148c24-fd50-4b3c-8d2b-178737a43adf_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Funded surplus</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_fc732c0e-70cd-4753-92bb-3da79563ea3f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c386c4ca-1e80-4b90-9da0-67b64fad258a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_9a1f7bf8-9e99-42eb-b116-0523e953ab6e_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2d7c55fb-ca1c-41aa-b07e-89b50137fcf1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_9826d85e-d7d8-48f1-9f47-965b4408b659_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_80dfa758-851e-46c7-aa1d-1d28fdc51a84_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dde5c5d-5094-45b1-b05d-040d2b6374d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_5a7aa8fb-1466-4033-b382-7c8da81174f4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation (in percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_d7999723-88c1-4255-9dd5-2e162e3590ca_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_48a295f5-5be4-42c1-84de-fcc0af7b2ab5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_33929c43-1bcd-4419-831d-ad37c00c3951_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_42f94446-af5b-4e49-9710-a8fd3d82563f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities (Note 12)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_4cce11e4-9e76-43c3-8a93-70aa401ce4b4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a167c954-d8f2-4083-9100-421005a3c9ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e0ca9a18-8301-4533-9ec1-0d974551d216_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_b00e35e5-59a5-4d0f-a8d0-02ccccbd46f3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_8fab417b-d482-4380-9ac0-30bfe4dd14d6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b2092773-7d41-47fc-b0f8-7e1ec9574e2c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_274ecd54-191e-4801-b163-b6baeeb7ebe0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_cc5d92f3-58b3-4ea5-a742-5cbaf85e4a5c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_717c5407-7766-448d-ae3c-be529b882ed0_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_dc1bf024-915d-48a9-b651-69fe8a0629e9_terseLabel_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized percentage (in percent)</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_label_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_documentation_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:href="iclr-20231231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:to="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a229d05f-01e6-47ae-a3f4-d7753fa489d3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of restricted share units / performance share units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c8a2ad5d-0ba3-486e-9fa9-f082c369bfcc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_271d1043-f2bf-44f1-8455-af7084978710_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_bf7aa833-c507-4e3c-b116-e3aa5f480e73_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense was allocated to the following components of other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_c4c737dc-ceb9-4f2a-a0b6-b88dd638560a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BiotelResearchLLCMember_e437e027-6c27-4d7d-852c-81ca471b461b_terseLabel_en-US" xlink:label="lab_iclr_BiotelResearchLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotel Research LLC</link:label>
    <link:label id="lab_iclr_BiotelResearchLLCMember_label_en-US" xlink:label="lab_iclr_BiotelResearchLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotel Research LLC [Member]</link:label>
    <link:label id="lab_iclr_BiotelResearchLLCMember_documentation_en-US" xlink:label="lab_iclr_BiotelResearchLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotel Research LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember" xlink:href="iclr-20231231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BiotelResearchLLCMember" xlink:to="lab_iclr_BiotelResearchLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_5fff9cd1-a494-4433-89d8-aed7340d72ac_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current bank credit lines and loan facilities (Note 13)</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_2f24aa99-aa9a-48e7-b865-eb1a0bb33f73_verboseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid and transferred balances</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:to="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_64e79e2b-ea85-4be4-9352-03cbd1942e32_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_74a8c487-0ca6-4e33-993f-a13e305fe3f5_terseLabel_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to acquire future long-term investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_label_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_documentation_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:href="iclr-20231231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:to="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2880a89a-6a24-4d91-b335-2bcd68ed423f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_a606b786-4a36-4d89-aa72-5a067751a677_terseLabel_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units 2013</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_label_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_documentation_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:href="iclr-20231231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:to="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_37fbc96b-2091-402c-a78f-27a93022557d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_6e686c98-9e2b-43ef-9545-1dbeef2e6802_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, potentially expire in 2021</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c00fbe36-0267-4d0a-9a7c-ccb1592eb42b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_3d19dac6-0537-4022-98bc-48c1dd529e27_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_16a43504-0843-4de4-93a8-226043df0492_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_c4121016-4d8e-4a9d-9ebd-b421960a76d3_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f3512e31-48bc-4782-a0ad-6c8fd010100e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0f314165-e31e-4668-aef4-16ada6da6851_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_03f57372-131e-4a04-b3ed-4d0f65bfe47a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_f9ba2d03-5d01-40be-94f9-20aed2018a1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0e600504-86c8-47ee-98c9-c37ce8ef516d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_f2268a46-7b00-4741-8cbe-d5cc21ecf641_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_6fbcb0fa-2edc-4eb4-bb10-b3fa178116a4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18702bcc-da22-4c02-9731-30fe41c79f8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97b90e99-f30a-41fa-88c4-803a41ba2334_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range3Member_225e4834-c7ac-4a40-99fa-9341a7a55060_terseLabel_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3</link:label>
    <link:label id="lab_iclr_Range3Member_label_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3 [Member]</link:label>
    <link:label id="lab_iclr_Range3Member_documentation_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member" xlink:href="iclr-20231231.xsd#iclr_Range3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range3Member" xlink:to="lab_iclr_Range3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_741e6749-9e7d-49c4-a3e6-c01b652e98c6_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate component two</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component Two [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentTwoMember" xlink:to="lab_iclr_VariableRateComponentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_ef984d0d-bf5e-4f98-9b78-b31aa654a25f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_e78e2bda-bfd5-415e-a60a-c0d65915391b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients25Member_42ea1a65-a028-495d-bcb1-37f6169da387_terseLabel_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5</link:label>
    <link:label id="lab_iclr_Clients25Member_label_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:label id="lab_iclr_Clients25Member_documentation_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member" xlink:href="iclr-20231231.xsd#iclr_Clients25Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients25Member" xlink:to="lab_iclr_Clients25Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_7ccb9502-1827-48c0-ad07-a53ea830ef03_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives of assets</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:to="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapital_ec8a1f75-e68b-4362-aa37-4a67bcfe59c2_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital (Note 18b)</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital" xlink:href="iclr-20231231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapital" xlink:to="lab_iclr_OtherUndenominatedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_97f3439e-ec74-41e8-91d4-670fec173183_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Subordinated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:to="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_065c1e65-c396-47d4-8b57-65d3324e75d3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participant's contributions percentage of annual compensation (in percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_dcdc4563-df76-40e2-887b-1be6e9076580_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_269ca9aa-f2da-45d8-9483-14d9cfcec195_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unbilled receivables</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_6857c0d5-13fd-49fe-9496-85d4bf1851d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_761eaa59-e76e-44e0-b82f-20aca5c3e8af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted Under Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_95cf7a0c-2678-4c29-8084-1b2406d6f4c6_terseLabel_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited pension plan</link:label>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_label_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:to="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_9c244a72-3172-4699-949f-dfe9243197fb_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:to="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f80b7aa3-6ba8-44ec-bb6a-7784b1703d2c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_a912a45a-8246-47eb-9781-147ebb72fb8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_54f5a795-ed16-4fa5-9ad2-4443de170011_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b42aeb47-7c16-4df6-bcc3-813b1340e6c6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_f63ff9f8-82e7-4a83-89b3-7249aa9cfded_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_fc37f749-88e4-4433-b5d9-409f89c1deed_terseLabel_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontrade Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontradeReceivablesCurrent" xlink:to="lab_us-gaap_NontradeReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_878a262f-41f1-4f14-82b5-57ed8c02fd22_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_label_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:to="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e6d0b9a1-ca02-4ea1-b527-8ab4b3867ea1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range1Member_f75611c4-a0ac-40db-a5e0-5a24b1fbd1d8_terseLabel_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1</link:label>
    <link:label id="lab_iclr_Range1Member_label_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1 [Member]</link:label>
    <link:label id="lab_iclr_Range1Member_documentation_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member" xlink:href="iclr-20231231.xsd#iclr_Range1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range1Member" xlink:to="lab_iclr_Range1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_dc602cff-decd-42d4-8256-165b3f618cd6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d2e29190-d9c0-4850-84ac-2c85b793f406_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit related to stock compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_b32742c4-2fff-4e58-ae34-4fa1e78a9f16_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per ordinary share (Note 24):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_62257010-4632-4b31-86a4-4f3eb13a2cb0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 82,495,086 shares issued and outstanding at December 31, 2023 and 81,723,555 shares issued and outstanding at December 31, 2022.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_447ff143-db9f-457f-ba4d-3bd2dd56a0a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Measured at Net Asset Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_263080b0-e1a7-430c-b6a0-5b379d0d78d6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_c16fc2df-f9db-4354-9afd-982c9bbceac3_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price of equity instruments other than options, vested in period (in USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_f3b345df-c10e-4044-9cec-73cb219e7505_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names &amp; brands</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_0c749826-9030-4d61-bb9c-dac9420c1551_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_21313341-4a57-467f-914e-35304467b619_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8f61955c-a6d6-472e-a9d2-bb46afd59dfa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in carrying value of operating right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_e7683534-7fbb-44bd-8174-52a0937b397b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_e4237e8b-0234-477c-bf23-ed575383b2ca_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_2d925605-c1ef-4b5f-aa5a-06d932b6a06c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e18719e7-acb6-441e-a2f8-732eca6ce48b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_820eb0be-ce08-45f9-a5ac-e3efd6169fb8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_5d51fe5e-923a-467e-8ee2-7facf5dd2dfa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_93e646ca-231b-410a-bf32-258ffe121a12_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filler Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_7bc53e90-0342-42cd-bc59-1997b2cafd64_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillFairValueDisclosure" xlink:to="lab_us-gaap_GoodwillFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_bb47134c-b763-4e0b-a7f7-e1d02fb6bf31_terseLabel_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedging instruments</link:label>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_label_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap And Interest Rate Swap [Member]</link:label>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_documentation_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap And Interest Rate Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestRateCapAndInterestRateSwapMember" xlink:to="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_98a42ca9-9f94-4bee-984e-062ab3e93678_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3ee23958-df0b-4b8f-a593-f7a3db0f4a86_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ad84338e-6036-405c-b9bd-503ee7f35c94_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_fe51b67a-eab3-491f-af96-a492c98bea5e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to acquired tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_908f4a95-f90a-490e-8f4f-f1f48c4c8eba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_0fa0c005-f4f4-46c1-aabd-8af2b595a6e0_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at start of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_87214bb0-d0c3-4f45-97bf-105aaeadad37_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_045ecf1d-2beb-476f-8a6b-afbda4ecefad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_88e11a1a-f562-4eef-b4ad-7eecdf332270_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_fbe18243-6dcb-418d-ab89-76b2894a9b5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General trade and overhead liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_1b1a059e-c6eb-4232-9d77-637160e81e48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_ea8d0bb9-1d11-4a8b-b208-545ce61c30cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_6abcc81e-7058-451d-a38e-5dd304caa961_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_6ef3a58a-9ad4-45fe-a1e0-2a4ba12ca999_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_e591e8a7-f15c-49d7-8426-03c1b33ebaf5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Years 2029 - 2033</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_73cb6dfd-24f6-4011-85cc-cd571b491b0b_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings &#160;</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b34587fa-2770-4361-aed5-b0ace638d003_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_29788811-a4de-4f70-b8f6-19622b506681_negatedLabel_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_label_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations" xlink:href="iclr-20231231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveUtilizations" xlink:to="lab_iclr_RestructuringReserveUtilizations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_9ac5f8fc-a057-4fd4-b427-79405db59240_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e9ded787-ec8b-456a-b244-bb34841186e1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments (Note 8a)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8c0ea9a9-4295-4a1b-acfa-f2abc7a235c0_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_63bb61d1-182f-4970-b961-fa80c3b0ff99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_bb61388e-0c42-475b-af4c-958b9bfd7222_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_411836c7-7b37-46c1-8788-34210c8719a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d12a00fe-af1b-4f10-b2fa-97764c286057_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_106da5e9-f99d-4ac8-8b72-661db2c17a78_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear20382042Member_3bf8bcc9-cfba-4058-a804-079bc5298528_terseLabel_en-US" xlink:label="lab_iclr_TaxYear20382042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2038-2042</link:label>
    <link:label id="lab_iclr_TaxYear20382042Member_label_en-US" xlink:label="lab_iclr_TaxYear20382042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2038-2042 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear20382042Member_documentation_en-US" xlink:label="lab_iclr_TaxYear20382042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2038-2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20382042Member" xlink:href="iclr-20231231.xsd#iclr_TaxYear20382042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear20382042Member" xlink:to="lab_iclr_TaxYear20382042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a0631afe-2712-4b2e-ba44-239c20422e53_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9763cbe3-220b-416f-a53e-2d1c43bd73c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_bc9af7ad-b23f-4679-b0d5-b8ed6b9d205a_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_e40690ca-31a0-4bc1-861f-0590b9a0d240_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized tax benefits net of potential benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e7dfa114-1488-4c15-aed8-d552cbb932ce_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tax benefit related to stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c142a093-bed4-4886-b7d2-6bc8ef1249ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_9a001a8d-430a-40cf-956c-a7415967e3e4_terseLabel_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_label_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc [Member]</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_documentation_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRAHealthSciencesIncMember" xlink:to="lab_iclr_PRAHealthSciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_966ea1ed-4927-4dfa-90ef-26d4629b351f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_23156a00-5eb5-4b35-9d90-e4d065f253af_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of measurement period adjustments</link:label>
    <link:label id="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Measurement Period Adjustments [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Measurement Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:to="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_de005a6e-85dc-4cc5-b347-29615392c15a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_2601ea5c-380e-4661-8bfc-4cc87c5256be_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_aa3893d1-3a8b-469f-96ad-5fffd3f465ab_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility related liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Utilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedUtilitiesCurrent" xlink:to="lab_us-gaap_AccruedUtilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_84e32de9-ca9d-4659-b34b-9edc8bc3b849_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_38c2d2bf-e022-4d38-b42b-3239d0994af0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_d76eb920-6587-46f8-85a1-f1d3ec6155d2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f21ccdd9-f001-4532-811d-cc1678993a88_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_7cd040a0-d387-4f42-87c3-85a4f7b05651_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCountriesMember_038cc5db-cdf9-40b1-9e9e-b176b25cfad3_terseLabel_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_label_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCountriesMember" xlink:to="lab_iclr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e973be29-216a-4d78-9c4b-87394091d4b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_fe18d250-59a4-4f3c-8a82-667baec32273_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease)/ increase in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3128f6b5-eabf-49b8-906a-a21132814430_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8a01cc9d-6d8f-470b-b07d-f368c9d3613c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_edce948a-59b7-4cbf-b55d-13ae8410e44d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1a9c2cdc-223c-4cf3-9e30-225eb570e8e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_03795721-3ca8-4a4c-a5d6-c5098ca3d88a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f7babe04-c21c-4a10-ad23-50fb1206f024_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_29335246-0a43-40ac-b5b6-8f9e5922e85b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9b353edb-4d8f-4d94-9701-89a3250b9f3e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_af7ad106-0832-40f7-874e-750f6c8608a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation costs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_5d138ec5-1719-4d59-9023-643663d278ee_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Net Revenue by Geographical Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_4ea97c8b-4cfe-4398-b175-6116e1830af5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Country</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_910c94e8-56fb-4832-8a24-d1da571bd6c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_abc9b3d6-9996-4d47-932b-c254ee82b508_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9d9958cc-0d9f-485c-a7f5-3e1c47f9bbc6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentOneMember_dc75d823-c854-4ebf-bf33-77525bc09695_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate component one</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component One [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentOneMember" xlink:to="lab_iclr_VariableRateComponentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_edc65568-79a3-44ed-988a-859fa9fb72d1_totalLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in advance payments netted against unbilled contracts receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_5c284438-c51f-4b2d-aa05-907ae42fc490_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in advance payments netted against unbilled contracts receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_46eb03c7-57cc-4da3-87cb-efb34600284a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_bbf5ac3d-f985-4901-86d9-5499cd1d54e1_verboseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4e0bd919-5403-4aad-9dae-27e2794a622f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b515c065-a5b0-4618-9012-d2d608793c4f_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1294ee7d-0354-4aa5-a774-dc0ead719cdf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable operating leases for facilities expiration period</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_8b8af9fa-a850-47a2-a702-47c8016a4edc_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursable expenses and Direct costs</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_ecee3308-1514-4a71-bce2-797f49ab9b3b_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to settle debt obligations that existed prior to acquisition date</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_352fa628-c26d-43f9-9ee2-e958f4e3e3e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_968c1595-e056-4e3e-bb6d-27f5ce3885e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum range exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_08413e3d-697f-451a-be2e-153ad3e934b5_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_label_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_documentation_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:to="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_690e02f0-d82d-4334-82c7-3a2a13bced10_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions for Company's Share Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c8716287-810a-46fb-b079-2959891b6c41_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_6b82ef6c-2d27-4c5b-b2de-d7621b9b4e6d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6dafa577-94e1-474b-9ba4-2d2b69a7a2c1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_e6ea0dd2-9871-4bd3-8cac-41ddcb04ee15_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_933f8131-a76f-47da-93bb-22f9602c4c5c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7c0c67c3-9afc-471a-a343-a8edb64a00ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes (net of refunds)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_242c19b4-dff8-4688-b1ea-980e0bb980c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_43464dd1-b57e-45e6-ad7f-520539835638_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through business combination (USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:to="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7cbd20a6-3805-4e44-b0e4-1170345b5b8d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_45abc7ef-1535-4bdc-8fa5-8fc25c9f2433_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_43454b9f-eba1-48bc-9da3-ee488f0259f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_14979c8b-0ef3-42c1-a030-9a4da96fd019_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-of-use assets (Note 15)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_224d0949-b1e9-4843-aa86-3ae052f303d2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202108Member_b36eb255-1b4b-4986-84c8-a77ad91df401_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202108Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202108Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate202108Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202108Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202108Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesTextBlock_a8942f68-83a9-4fe8-ac23-8dfad4309b47_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_b45a4ea7-d1f7-419b-bd0d-cf07ef2019f6_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_daac054a-c99e-4933-b1ed-d1f8005da47e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_f7bfcd54-a3cd-40d8-8c61-5f1870f1ebd9_terseLabel_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Award Plans</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_label_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_documentation_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember" xlink:href="iclr-20231231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockOptionAndAwardPlansMember" xlink:to="lab_iclr_StockOptionAndAwardPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_3c04e213-4a6b-4839-af4f-4042e5149ab5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_b22ceb7f-cd81-4322-a444-99cd52bf8c3f_terseLabel_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement period used as a basis to estimate expected cash flows</link:label>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_label_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Retirement period</link:label>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_documentation_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Retirement period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod" xlink:href="iclr-20231231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ExpectedRetirementPeriod" xlink:to="lab_iclr_ExpectedRetirementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_66190f41-17bc-45fa-a359-09362fa26f30_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_c039a828-c7f9-441f-aef4-f9a246e6e45e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants' contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_3d11fe9d-de29-4c25-b356-fdd00d5f1a8f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-U.S subsidiaries operating loss carryforwards for income tax</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_40e861c3-1d0d-4e1d-b35c-59aa7edfc459_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_fad3d7a1-35bb-4ed0-8aac-9ce21c7ab8c4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional provision in the year</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_2eda05bf-5229-4d9b-b877-7d07ae7c2964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_79b06296-6f6e-4113-87d3-32a811a05a90_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_d72c2f3b-ace0-4834-968f-266054b4b046_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_7a3f857a-3c0a-4b8a-98b7-5d8a2ecfbf48_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c48760ab-7ef1-4e48-b7ad-3343cf44ce9c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_51548301-de1d-484d-a671-506b958789cf_terseLabel_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_label_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_documentation_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember" xlink:href="iclr-20231231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeTaxBenefitMember" xlink:to="lab_iclr_IncomeTaxBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_7f8712a4-c00a-456d-b13e-6dada0b1a958_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_53671daf-2dab-46a7-9676-604ba2d1622b_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35c58279-014b-40f2-a8b9-91f876d85f02_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_4c34d6a8-2f57-498a-b64b-6eae970a2df2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_c2d7f0f2-f056-4462-ae03-72d50fbe7826_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_5a91c4fd-95b0-4b49-be16-b0214502777f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_c947366e-4f0a-4103-8f5d-164eca67465b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_21bf19ef-2597-4f66-9678-c025a8cfff9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock units vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_d12f56c1-4a99-4c6d-8e2d-f507b36d5722_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Payments on Debt Instrument</link:label>
    <link:label id="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Payments on Debt Instrument [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Payments on Debt Instrument</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:to="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_b877fe7c-6557-44ad-85f3-0dd62b598d0d_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_e926f46a-1fdf-45cb-80a1-8f62624c15c8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3c9914ba-7d3e-4c20-87bd-d8cc81eb09a0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan obligations and accrued interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCustomersMember_2108f7d2-c1af-4dd2-975e-f0636d614dd5_terseLabel_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_label_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_documentation_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember" xlink:href="iclr-20231231.xsd#iclr_OtherCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCustomersMember" xlink:to="lab_iclr_OtherCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_a9a022fa-f73b-4d02-ba4a-47202f1041a1_negatedLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain - benefit obligation</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:to="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ca784035-da74-4927-8676-db5afe57b29d_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_394e2040-54d2-4f34-9db9-21c26f45c129_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e6da386e-034e-4285-9c31-19b28195f43e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e7616da9-5202-4736-a25b-533011a1c2b6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a7a549f7-53ed-4270-aeaf-6b632565fbb2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a89c35ed-0c50-46d0-953b-e0472401b5d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of restricted share units / performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_a4bacd3e-d9fb-4f65-aca8-04404d34bc4f_terseLabel_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term government grants</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_label_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Current</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_documentation_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent" xlink:href="iclr-20231231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CapitalGovernmentGrantsCurrent" xlink:to="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_46a641c4-e341-4845-aad7-4a817e5c7866_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_b15e8393-fe0a-4631-b12f-03de943bf5cb_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:to="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_83757ddf-b641-493b-b1ba-c7b9d2892e80_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_43b53146-7c7d-43f1-a173-04f67bc67fbc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other net assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_bed78e4d-edc1-4646-a72f-5131455cc9ea_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_afa0aaad-68b1-44b4-bfb6-953345f54951_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_90b4c31a-9f23-4fcb-8b9c-cb6e1ce07230_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reductions</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_a7d83949-0973-405c-a82e-838e3fa38eb2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_db036a35-0126-4549-9cca-22caca58bf73_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_52943755-88cb-4cbe-afeb-e4a4418fd615_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drawdown of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_706d3387-c9e6-480c-b7ec-5b8258a5ff39_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and asset write offs</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_08fd3f15-11c8-40d5-85c8-db186889068d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TopClientMember_6d36db49-e800-4552-a196-8b606d095bf9_terseLabel_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top client</link:label>
    <link:label id="lab_iclr_TopClientMember_label_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Client [Member]</link:label>
    <link:label id="lab_iclr_TopClientMember_documentation_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember" xlink:href="iclr-20231231.xsd#iclr_TopClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TopClientMember" xlink:to="lab_iclr_TopClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_268412c4-e6ea-4088-a27d-5446102306ff_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_7a8e2e97-8307-4d63-802b-ef102ca6795b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_a8f0787b-b715-4684-8b53-1a1f3b1444f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Bargain Purchase, Gain Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_f7c23109-7127-4015-b433-cb468cc0e2eb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5fe67cf3-8034-4575-a37c-129f1cbcff19_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_e24da912-9a1a-41b7-b91a-74d06974c0f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_616ea8e9-fcac-48c4-86f8-76e489f40658_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personnel related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_ff940129-a29d-42f0-85dc-d8a6db90dd38_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Expiry Dates of NOL's</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_c882e6d3-1294-4fb3-a082-9966f5e263cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_9bbe1891-add6-49ee-a235-7606cfbb41f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related (Note 6)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_8f094dea-98d4-4689-ab11-b843ae976fe6_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_e7f55201-b6f9-4016-8bef-5f3693eba966_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_d7389ea3-dab7-48d8-a84f-3b027ef93a0f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_c7bbd866-4307-4ac7-bec7-5063245e6e3a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_902604bc-5366-402a-b9a1-e9c27da37140_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign and other income taxed at higher rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41235e87-6802-4a74-907f-fc12dfec2389_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_35697222-bd8a-4b83-9776-a5671eb7d870_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0f78c963-07a5-4f9b-83b5-607812fe428c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_72cd44b5-6d65-47a3-810d-ce55a632a1aa_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_91b26717-4bff-44ef-9cd6-c38fd806bd31_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_8dec0dc2-4e40-4d49-a76b-11ac0454ec14_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1e591ae3-ad4d-482b-82cf-4e23733df6b0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_590e8de4-c47a-42b8-b271-72013101f67f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_6dd52879-4789-4ef2-ac0b-bcab46c36ab1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_f1c58b99-ad7f-427d-9f33-21a70be7c44b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and Integration-related Expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_1f8bff48-4f56-4fb1-a347-a9d6ccefaeaf_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_ab5ff32b-cccf-4746-a4c8-e52314d1ae77_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BuybackProgramMember_2fba0d69-f6e8-4019-ba53-746f3401fb22_terseLabel_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback program</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_label_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_documentation_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember" xlink:href="iclr-20231231.xsd#iclr_BuybackProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BuybackProgramMember" xlink:to="lab_iclr_BuybackProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f1acfe02-f5b5-4c99-8f2f-a0b8bbb78db5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_ede1cc12-9fb4-4eef-bf44-498e605f355b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overall net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12796b3b-b8c3-4e56-a6cd-22809e992fa3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_027d2a03-9502-4eb2-81a1-d2b5f7ebb5c3_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_6a13b933-c295-4c5b-8826-16fac6e5df05_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_ef6c436f-f72e-4cc4-8d4c-62459db14a2e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_1007352e-7317-44fd-92a5-c917f0265f8c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1a6e77f4-0350-4a2d-9b06-f5710cc42ce9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3be5f4cd-b15d-4133-8b7a-61a4930cedc2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_73bca6e9-ee9f-498d-a84a-3f353b896fcb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4552659c-0280-43b1-8ad4-29a62259e51a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/expired (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6085acea-079a-4997-b11c-b6428d0afde0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_81f6d8e9-69bb-47ef-a0fd-85a3e0ab29ea_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_5e36c9ba-2aa0-476c-b881-f62cbbdf2847_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_61d6f2c8-0969-45d2-81dd-13d838cf0297_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment &#160;</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_a7dae7ed-77f2-4c34-811b-cf1a5cca7a10_terseLabel_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit of shares issued or to be issued pursuant to options granted (in shares)</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_label_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_documentation_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit of Shares Issued or To Be Issued Pursuant to Options Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:href="iclr-20231231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:to="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b3c2abf7-bb46-4c48-9348-c3cfc25f543f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable - weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_05608ded-8b6d-4f78-9fcf-865655c3d8c1_terseLabel_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_label_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_documentation_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember" xlink:href="iclr-20231231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherGeographicLocationsMember" xlink:to="lab_iclr_OtherGeographicLocationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c58b8f97-7d37-4adc-a522-8be736fec48f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_f4ac3c48-c2d0-4004-9797-ad4202ff4535_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_dfc78d4a-dfdc-4d7c-a203-9f2585425788_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e3df65b6-b4c1-4415-9ea9-e43618ef9bec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_6185d2da-29a4-494a-9567-98c00da7f771_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_200b6fd4-ad6c-4c29-9009-c9617bcecd60_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a893f00c-dcf4-4d1c-9325-0263a8f26e5a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_68cd6741-7ebf-4b3d-9708-073301e3f71a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_0bfb7c2f-c1a0-479d-875d-e0e3eedc98ff_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account) (in percent)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_51b2ef96-ab87-4c02-bd96-ea59e73d7db9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of ordinary shares issued to acquiree stockholders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_51f171ec-f8ea-4c3d-8a72-c9b5205d1af6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_bd6aa7ce-d611-4ee7-a6cc-e064916bb6ce_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7afde079-1712-4881-b68c-1d448a2c2bf3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a9e90af3-baeb-4d39-93e4-3fa231aa9ca0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5cf81df9-a0cd-4d17-94ba-92e14827cf9c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_cb4013f1-4841-4293-99d4-8f3efcc8d6de_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_43fdd8e8-4975-4e79-b2fb-1e2058b3da8b_terseLabel_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:href="iclr-20231231.xsd#iclr_ResearchandDevelopmentCreditsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:to="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_edb4244d-757c-4211-a0e2-0e1066375f25_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_c167afb0-d953-46f8-a420-21887b0452f6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_34403a2f-f7de-4b3a-a774-6f87e51e2e43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_a85c5007-d418-470e-bc9a-b40abc7945d9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_202c028f-5738-4aba-9442-c34f51509afd_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_c9a82029-39fd-406a-ac9b-cae00b309939_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_a915beba-5aea-48e9-8fd6-513c2951aa19_totalLabel_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_label_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_documentation_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:href="iclr-20231231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:to="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2e0a6e77-4e4a-4549-990d-335a1985d919_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OptionPlans2008Member_f1e9e5c8-9714-49f9-9af0-7d98996c8d0c_terseLabel_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_label_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_documentation_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member" xlink:href="iclr-20231231.xsd#iclr_OptionPlans2008Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OptionPlans2008Member" xlink:to="lab_iclr_OptionPlans2008Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_3f03c067-3f10-4a4a-94d3-f52ae4cc2d5a_terseLabel_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and one time financing costs</link:label>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_label_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And One Time Financing Costs</link:label>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_documentation_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And One Time Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts" xlink:href="iclr-20231231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TransactionAndOneTimeFinancingCosts" xlink:to="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>iclr-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:0c105b40-162f-4950-b2b2-c13f61a02230,g:35370e08-e85b-4be7-afdb-42ad7a0d101f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20231231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_75ac6f0a-8a28-4354-966c-f67c6a1857a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_75ac6f0a-8a28-4354-966c-f67c6a1857a7" xlink:to="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_8c538643-e31a-4083-a600-2d744e7676b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_8ea15efe-b9a0-4738-8846-469547d56f03" xlink:to="loc_dei_AddressTypeDomain_8c538643-e31a-4083-a600-2d744e7676b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_35aac587-72e5-4397-ac39-016556b20127" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_8c538643-e31a-4083-a600-2d744e7676b7" xlink:to="loc_dei_BusinessContactMember_35aac587-72e5-4397-ac39-016556b20127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4c8502de-635f-409b-83a8-7348aad2fbb9" xlink:to="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d92eb515-4aed-47cd-a279-818399b7b99c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentType_d92eb515-4aed-47cd-a279-818399b7b99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_c5268201-a046-438a-9f4e-4a8ab4b49b4f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentRegistrationStatement_c5268201-a046-438a-9f4e-4a8ab4b49b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_56a29018-f749-410d-957e-0312695a4cab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentAnnualReport_56a29018-f749-410d-957e-0312695a4cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a2f75f2a-ca79-42b6-81ce-d5c508af7581" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentPeriodEndDate_a2f75f2a-ca79-42b6-81ce-d5c508af7581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_39762b0d-24c7-4c2a-b9e6-b748425213c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_CurrentFiscalYearEndDate_39762b0d-24c7-4c2a-b9e6-b748425213c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a35caf83-d4bf-4fa0-b5e6-6581c0d4668a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentTransitionReport_a35caf83-d4bf-4fa0-b5e6-6581c0d4668a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_7514df55-5320-4f14-bdbe-7f02e2f896ec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentShellCompanyReport_7514df55-5320-4f14-bdbe-7f02e2f896ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d40f0ab5-ba58-4fe3-8150-ed5221a04bae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityFileNumber_d40f0ab5-ba58-4fe3-8150-ed5221a04bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ee4f62ff-5da2-4716-8c77-3650f271aad9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityRegistrantName_ee4f62ff-5da2-4716-8c77-3650f271aad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b87779e9-8c98-47bf-ac97-311774604572" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b87779e9-8c98-47bf-ac97-311774604572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_24b4d976-709c-4f89-884b-27662805c53b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressAddressLine1_24b4d976-709c-4f89-884b-27662805c53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_c8170c99-6aad-4db8-8e85-9741cd6a8149" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressAddressLine2_c8170c99-6aad-4db8-8e85-9741cd6a8149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1c8dafb5-49a6-40b2-935b-9801c56fc9ac" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressCityOrTown_1c8dafb5-49a6-40b2-935b-9801c56fc9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_82821e3f-e54c-4c1a-8801-74650b3322d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressPostalZipCode_82821e3f-e54c-4c1a-8801-74650b3322d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_bb5107d8-4222-4ba3-8836-49262880dd4d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityAddressCountry_bb5107d8-4222-4ba3-8836-49262880dd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_0384a538-d8b6-49a0-bbd4-d0ccdfcdc50f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_ContactPersonnelName_0384a538-d8b6-49a0-bbd4-d0ccdfcdc50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_015f75de-4bc3-4011-a519-99b91c0a57ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_ContactPersonnelEmailAddress_015f75de-4bc3-4011-a519-99b91c0a57ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_7873bea2-7d65-47d4-ac81-bafec1d97b52" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_CountryRegion_7873bea2-7d65-47d4-ac81-bafec1d97b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a87e8bb7-a224-4f3f-90fc-ffb82592df6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_CityAreaCode_a87e8bb7-a224-4f3f-90fc-ffb82592df6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e50093e-cab3-445a-a353-79f6f0f5f427" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_LocalPhoneNumber_1e50093e-cab3-445a-a353-79f6f0f5f427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7bfa2851-6770-4b16-8de4-6b7a39ed1c99" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_Security12bTitle_7bfa2851-6770-4b16-8de4-6b7a39ed1c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_69a13724-b085-44ee-bdb7-928074fe1886" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_TradingSymbol_69a13724-b085-44ee-bdb7-928074fe1886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b0f9bb12-cdcc-4669-97ff-ffb6fac4ea9b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_SecurityExchangeName_b0f9bb12-cdcc-4669-97ff-ffb6fac4ea9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_238395bd-2e32-42df-8749-49451bd6d510" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_238395bd-2e32-42df-8749-49451bd6d510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_c5d1fae6-cd42-4dbb-a9ef-45a3673d30f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_c5d1fae6-cd42-4dbb-a9ef-45a3673d30f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_5480a009-e8c3-4cfe-88b0-e2d37b826a56" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityVoluntaryFilers_5480a009-e8c3-4cfe-88b0-e2d37b826a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_1cb85514-1310-4d5b-aa9f-df18bd356a58" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityCurrentReportingStatus_1cb85514-1310-4d5b-aa9f-df18bd356a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_af4fca3d-fc5b-4dee-96ac-fd428f999a77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityInteractiveDataCurrent_af4fca3d-fc5b-4dee-96ac-fd428f999a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3a296d76-0779-4968-a6ea-bd562faba1f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityFilerCategory_3a296d76-0779-4968-a6ea-bd562faba1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_59157c08-f697-4010-b78a-e6d555c32d54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityEmergingGrowthCompany_59157c08-f697-4010-b78a-e6d555c32d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_9bc97748-ce51-4e91-8b2b-06efbefe5311" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_IcfrAuditorAttestationFlag_9bc97748-ce51-4e91-8b2b-06efbefe5311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_3f38db29-139b-49bf-a683-4a835f295117" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_3f38db29-139b-49bf-a683-4a835f295117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_50136012-eadc-4ac6-8562-6ca85db8f798" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentAccountingStandard_50136012-eadc-4ac6-8562-6ca85db8f798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e19376ae-211a-4b50-93c5-b19bbb0511c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityShellCompany_e19376ae-211a-4b50-93c5-b19bbb0511c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e9508b97-c408-4159-8844-22c96ccd08d4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_AmendmentFlag_e9508b97-c408-4159-8844-22c96ccd08d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f26be34e-9dcd-4ee0-8ba3-64271c850ab6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentFiscalYearFocus_f26be34e-9dcd-4ee0-8ba3-64271c850ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0d1d3b99-5327-407a-8ee0-2acba7e4c2f7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0d1d3b99-5327-407a-8ee0-2acba7e4c2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dec6cef8-69c5-4d05-8255-2e9d69fe9040" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9cca929-1079-4505-98d7-2ffb2665a348" xlink:to="loc_dei_EntityCentralIndexKey_dec6cef8-69c5-4d05-8255-2e9d69fe9040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AuditInformation" xlink:type="simple" xlink:href="iclr-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract_9fadf3f0-fe3d-4061-b95d-88afe68b51c2" xlink:href="iclr-20231231.xsd#iclr_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_b49a555f-2556-4093-ad31-a37bf134fae8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_9fadf3f0-fe3d-4061-b95d-88afe68b51c2" xlink:to="loc_dei_AuditorFirmId_b49a555f-2556-4093-ad31-a37bf134fae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_e127cefa-e75d-4d09-a2f2-4bb7802f62c3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_9fadf3f0-fe3d-4061-b95d-88afe68b51c2" xlink:to="loc_dei_AuditorName_e127cefa-e75d-4d09-a2f2-4bb7802f62c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_3ec3b218-49b1-4e6b-b5a4-4263015d9cd5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_9fadf3f0-fe3d-4061-b95d-88afe68b51c2" xlink:to="loc_dei_AuditorLocation_3ec3b218-49b1-4e6b-b5a4-4263015d9cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_94585291-1caf-4b08-9dcc-0fd68eb22e00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ab4f8aec-3b80-4f69-b8c7-5661bd6d38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_94585291-1caf-4b08-9dcc-0fd68eb22e00" xlink:to="loc_us-gaap_AssetsAbstract_ab4f8aec-3b80-4f69-b8c7-5661bd6d38b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ab4f8aec-3b80-4f69-b8c7-5661bd6d38b4" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8191f315-692e-4b0b-8ad7-7ddfd809ee35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8191f315-692e-4b0b-8ad7-7ddfd809ee35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_976d1f1d-e18d-42ed-a9dc-dc2bb908c43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_976d1f1d-e18d-42ed-a9dc-dc2bb908c43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_eaef5692-9b8b-4c4f-9e2b-99bd03a1fd62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_eaef5692-9b8b-4c4f-9e2b-99bd03a1fd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_721f371d-7398-45b0-89d7-7b7ef98312b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_721f371d-7398-45b0-89d7-7b7ef98312b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_8a7c24f2-85d7-4a4e-a2dd-5a02c358e10f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_8a7c24f2-85d7-4a4e-a2dd-5a02c358e10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1074851f-10c5-41df-bda6-4121fef9a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1074851f-10c5-41df-bda6-4121fef9a6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_1a9b22ed-c3b1-4995-b54a-533f2f8fd52d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_IncomeTaxesReceivable_1a9b22ed-c3b1-4995-b54a-533f2f8fd52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5c50b15a-cdfe-4790-9f7b-4cb29eeabea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d4f2bc2f-770c-4350-bd7b-f861a2e88273" xlink:to="loc_us-gaap_AssetsCurrent_5c50b15a-cdfe-4790-9f7b-4cb29eeabea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ab4f8aec-3b80-4f69-b8c7-5661bd6d38b4" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c30201b2-636c-4346-85df-e478ab8bf2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c30201b2-636c-4346-85df-e478ab8bf2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc3f52ae-3fc9-4a44-9610-5222788a7ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_Goodwill_cc3f52ae-3fc9-4a44-9610-5222788a7ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_062b2401-7042-4b7f-a078-4c007aa00295" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_062b2401-7042-4b7f-a078-4c007aa00295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9856a1fe-09b0-4490-ae58-b66fe0ab8187" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9856a1fe-09b0-4490-ae58-b66fe0ab8187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_28ff044e-f710-443b-95e8-7ae80934ee39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_28ff044e-f710-443b-95e8-7ae80934ee39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_e156fa44-e439-4f97-b139-24f3b355d63f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_e156fa44-e439-4f97-b139-24f3b355d63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c210dd60-f838-4b07-8046-72469391bd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c210dd60-f838-4b07-8046-72469391bd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_366008b8-73eb-41c8-ae56-37ad2fb85b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_e0fe5aeb-52b9-4d33-b521-b7d3336ac08a" xlink:to="loc_us-gaap_OtherLongTermInvestments_366008b8-73eb-41c8-ae56-37ad2fb85b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ebae67d4-2ad4-44d2-a5c4-5710941a4a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ab4f8aec-3b80-4f69-b8c7-5661bd6d38b4" xlink:to="loc_us-gaap_Assets_ebae67d4-2ad4-44d2-a5c4-5710941a4a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_94585291-1caf-4b08-9dcc-0fd68eb22e00" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_bca17432-695f-4cee-bd32-b1607fd07895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:to="loc_us-gaap_AccountsPayableCurrent_bca17432-695f-4cee-bd32-b1607fd07895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e73e9bb5-945f-41cd-863c-ee34ce1b25b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e73e9bb5-945f-41cd-863c-ee34ce1b25b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_54ad38eb-3b38-46e2-be7d-a8d74718a708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_54ad38eb-3b38-46e2-be7d-a8d74718a708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_878cc1d6-bd2f-433f-99e4-65e074c2efab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_878cc1d6-bd2f-433f-99e4-65e074c2efab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_06683ad7-ef26-47e2-8be0-514917517461" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:to="loc_us-gaap_LinesOfCreditCurrent_06683ad7-ef26-47e2-8be0-514917517461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5dc27d3c-c423-4890-a8c0-b922f5c787a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1f872e74-092b-468d-8ce4-f696c60efe7a" xlink:to="loc_us-gaap_LiabilitiesCurrent_5dc27d3c-c423-4890-a8c0-b922f5c787a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_fd4b7d74-7b6c-478b-add7-f2d4326d9029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:to="loc_us-gaap_LongTermLineOfCredit_fd4b7d74-7b6c-478b-add7-f2d4326d9029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_deb17297-83b9-4810-8036-ab9c83d0e6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_deb17297-83b9-4810-8036-ab9c83d0e6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_07c8514c-9faf-4ec7-9cd2-838ce5248491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_07c8514c-9faf-4ec7-9cd2-838ce5248491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_64bd332f-dd27-4cc3-9144-202e7bca976f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_64bd332f-dd27-4cc3-9144-202e7bca976f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2bebbb31-25c6-4268-9401-7e378d51b7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2bebbb31-25c6-4268-9401-7e378d51b7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b023d3f5-a5d1-41b4-8321-5432bdc23670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f90bc5f8-61a4-4a17-8915-d2aa09bde628" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b023d3f5-a5d1-41b4-8321-5432bdc23670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_adf38198-7e2f-4daf-a451-5ac65b91f8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:to="loc_us-gaap_Liabilities_adf38198-7e2f-4daf-a451-5ac65b91f8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:to="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_91bc7b78-9278-4893-ac0c-e110a3cf50f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:to="loc_us-gaap_CommonStockValue_91bc7b78-9278-4893-ac0c-e110a3cf50f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_555135f4-3ccc-4513-8974-8213171678df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_555135f4-3ccc-4513-8974-8213171678df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_c85b194e-fa62-44cb-a37e-e82784c67af6" xlink:href="iclr-20231231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:to="loc_iclr_OtherUndenominatedCapital_c85b194e-fa62-44cb-a37e-e82784c67af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c35cf39-5136-409a-9639-a44990bf13c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6c35cf39-5136-409a-9639-a44990bf13c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e378ed0b-61fe-4bba-9d86-66866af5ec98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e378ed0b-61fe-4bba-9d86-66866af5ec98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e304b728-504a-41ec-ae89-bd6f66840ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_820168c4-8db2-4a7f-ac89-5e812c598652" xlink:to="loc_us-gaap_StockholdersEquity_e304b728-504a-41ec-ae89-bd6f66840ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8a5a05ea-4766-407b-8bd0-49c3653e8536" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ea76734-c5f1-4bd7-bedd-fc2d992fdbb9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8a5a05ea-4766-407b-8bd0-49c3653e8536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_601fb946-1721-406b-81a0-cfa360cad5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a38f44cf-c716-4938-b5a2-f6aeb932313a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_601fb946-1721-406b-81a0-cfa360cad5f6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a38f44cf-c716-4938-b5a2-f6aeb932313a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_822ce6e1-e5a0-4d17-9e9d-42e7f407fc46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_601fb946-1721-406b-81a0-cfa360cad5f6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_822ce6e1-e5a0-4d17-9e9d-42e7f407fc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c0118eb3-2e49-4ff6-8f38-1732f4e7dfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_601fb946-1721-406b-81a0-cfa360cad5f6" xlink:to="loc_us-gaap_CommonStockSharesIssued_c0118eb3-2e49-4ff6-8f38-1732f4e7dfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a66c054e-4dad-415c-a15e-4b22972c6f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_601fb946-1721-406b-81a0-cfa360cad5f6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a66c054e-4dad-415c-a15e-4b22972c6f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_472eb27d-2e5a-40dd-a6d0-73d482c7e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_RevenuesAbstract_472eb27d-2e5a-40dd-a6d0-73d482c7e1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_af3615c8-0c01-4336-923f-b874edd19699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_472eb27d-2e5a-40dd-a6d0-73d482c7e1bf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_af3615c8-0c01-4336-923f-b874edd19699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_757d3089-3e3b-474b-aba0-dbaa5fa4a503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_757d3089-3e3b-474b-aba0-dbaa5fa4a503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5a292e69-5bb5-419f-92c4-72150d906021" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5a292e69-5bb5-419f-92c4-72150d906021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_539408e3-08fd-4952-b1e5-ad1bd81aa7da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:to="loc_us-gaap_DepreciationAndAmortization_539408e3-08fd-4952-b1e5-ad1bd81aa7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d97f1241-81af-42e6-9227-39edd27ae3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d97f1241-81af-42e6-9227-39edd27ae3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_c527edb8-d9d6-42aa-8e60-2a31f4ad0600" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:to="loc_us-gaap_RestructuringCosts_c527edb8-d9d6-42aa-8e60-2a31f4ad0600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_91111cf8-6cac-400d-a1e5-d2caa7f2a8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ee248928-8c39-4520-9d68-dbb352c7f36b" xlink:to="loc_us-gaap_CostsAndExpenses_91111cf8-6cac-400d-a1e5-d2caa7f2a8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d60e2fb8-bd54-4bc5-9eb6-20e1f33bf43a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_OperatingIncomeLoss_d60e2fb8-bd54-4bc5-9eb6-20e1f33bf43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8f172de3-1b91-4126-837d-9f99bb1d7f71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8f172de3-1b91-4126-837d-9f99bb1d7f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e0ef05b-76d0-4974-bb89-9efeed5028d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_InterestExpense_0e0ef05b-76d0-4974-bb89-9efeed5028d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_73b7e7d7-b564-45d0-b175-2aff740ed039" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_73b7e7d7-b564-45d0-b175-2aff740ed039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_904c4e0c-70a9-4619-a800-99afba5372f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_904c4e0c-70a9-4619-a800-99afba5372f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_d487571e-5bb8-4073-aab9-5c54741c24a8" xlink:href="iclr-20231231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_d487571e-5bb8-4073-aab9-5c54741c24a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16a90311-e59c-4a94-9b2d-14df54750b27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16a90311-e59c-4a94-9b2d-14df54750b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_68839771-c8eb-47c5-babd-0ba28bd6984d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_NetIncomeLoss_68839771-c8eb-47c5-babd-0ba28bd6984d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_201976e3-1742-4612-a492-79eb698891d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_EarningsPerShareAbstract_201976e3-1742-4612-a492-79eb698891d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fb258ab2-308e-4314-b054-af3ad95ee4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_201976e3-1742-4612-a492-79eb698891d7" xlink:to="loc_us-gaap_EarningsPerShareBasic_fb258ab2-308e-4314-b054-af3ad95ee4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_902de1a1-2dd2-4430-9a3c-d815b965c148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_201976e3-1742-4612-a492-79eb698891d7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_902de1a1-2dd2-4430-9a3c-d815b965c148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6cc22fce-d86b-4d79-96d3-ce60b1cfbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a2463d7c-4674-4e34-bfc1-f9bad23d2255" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6cc22fce-d86b-4d79-96d3-ce60b1cfbcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0c12376-cec1-40fe-abc2-7b34aa5e11ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6cc22fce-d86b-4d79-96d3-ce60b1cfbcd1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0c12376-cec1-40fe-abc2-7b34aa5e11ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3696f943-f100-4397-87cd-65a361d09ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6cc22fce-d86b-4d79-96d3-ce60b1cfbcd1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3696f943-f100-4397-87cd-65a361d09ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d2d69b98-c704-4595-87e0-0b21b6d0f6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1b0f793e-c4ed-4c7a-93bf-afe5aea587ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d2d69b98-c704-4595-87e0-0b21b6d0f6ec" xlink:to="loc_us-gaap_ProfitLoss_1b0f793e-c4ed-4c7a-93bf-afe5aea587ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f68435b7-053a-458a-b6dc-9c4bc2592d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d2d69b98-c704-4595-87e0-0b21b6d0f6ec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f68435b7-053a-458a-b6dc-9c4bc2592d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_01064ffc-6fd1-457f-acf6-abf62a513520" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f68435b7-053a-458a-b6dc-9c4bc2592d46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_01064ffc-6fd1-457f-acf6-abf62a513520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_27528c77-479e-4ec6-872b-2fec1c46525b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f68435b7-053a-458a-b6dc-9c4bc2592d46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_27528c77-479e-4ec6-872b-2fec1c46525b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b9936945-7602-4df3-8a27-80042db1e45b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f68435b7-053a-458a-b6dc-9c4bc2592d46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b9936945-7602-4df3-8a27-80042db1e45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0a1d833e-c083-4970-aece-b0cc12f9f70d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f68435b7-053a-458a-b6dc-9c4bc2592d46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0a1d833e-c083-4970-aece-b0cc12f9f70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6462c0de-4b3d-4a4e-8236-dcea77c5a29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d2d69b98-c704-4595-87e0-0b21b6d0f6ec" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6462c0de-4b3d-4a4e-8236-dcea77c5a29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_42d9f41a-b14a-462e-8ad9-722b83ad81cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_42d9f41a-b14a-462e-8ad9-722b83ad81cb" xlink:to="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_18e57360-4a3d-4fda-94e0-b362b416b828" xlink:to="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3884f93c-61f7-4882-b590-4258e3abc9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_CommonStockMember_3884f93c-61f7-4882-b590-4258e3abc9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f47d82c0-c920-40a3-8d71-79931b4137f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f47d82c0-c920-40a3-8d71-79931b4137f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_2bbe9838-cb20-472e-a7bd-fd0c82b96aaf" xlink:href="iclr-20231231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_2bbe9838-cb20-472e-a7bd-fd0c82b96aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c137b54d-eead-4d7b-a380-bde9673f3af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c137b54d-eead-4d7b-a380-bde9673f3af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9707ee15-3bac-48c7-a116-fd9a685f0533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4a074be7-4f8b-4635-be12-ff09d66c9436" xlink:to="loc_us-gaap_RetainedEarningsMember_9707ee15-3bac-48c7-a116-fd9a685f0533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a01c685-83e0-4138-8683-bb02b43592d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b6c31e41-ae01-4f54-94d7-937c67306dde" xlink:to="loc_us-gaap_StatementLineItems_4a01c685-83e0-4138-8683-bb02b43592d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a01c685-83e0-4138-8683-bb02b43592d2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f330ece9-5033-4fac-94cb-83a0873126f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_CommonStockSharesIssued_f330ece9-5033-4fac-94cb-83a0873126f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1ff0d58a-68ba-422b-bc9c-a4995748f8de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockholdersEquity_1ff0d58a-68ba-422b-bc9c-a4995748f8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ccb6766f-d451-41f2-bf9d-6a6c40d94786" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_NetIncomeLoss_ccb6766f-d451-41f2-bf9d-6a6c40d94786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0e5aa325-f87f-4308-9964-edcce3a55126" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0e5aa325-f87f-4308-9964-edcce3a55126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_94a7b296-af81-4a1b-8c2e-20ccf7c430bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_94a7b296-af81-4a1b-8c2e-20ccf7c430bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b76e34e3-3da3-491c-bed7-1c4b148e0292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b76e34e3-3da3-491c-bed7-1c4b148e0292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ecb850a8-87e3-49f6-844b-30ad0ecb7bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ecb850a8-87e3-49f6-844b-30ad0ecb7bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe6223f6-935b-470e-b01d-ac4009d538ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe6223f6-935b-470e-b01d-ac4009d538ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_af6875ef-432c-4ec0-b54e-e4d9edddc319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_af6875ef-432c-4ec0-b54e-e4d9edddc319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b18e4556-d82a-4552-86b1-140694f4a23e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b18e4556-d82a-4552-86b1-140694f4a23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c99bbb2e-e03a-4fbc-bcbc-b90d6fdac33b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c99bbb2e-e03a-4fbc-bcbc-b90d6fdac33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d07def32-ad85-4561-9493-e43505e1af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d07def32-ad85-4561-9493-e43505e1af5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a90fa19f-da45-403f-8016-cb81dcac7694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a90fa19f-da45-403f-8016-cb81dcac7694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_38bf6c22-f800-45e6-a5a4-249a8cf78de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_38bf6c22-f800-45e6-a5a4-249a8cf78de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_bbfe4776-f06d-4864-bde9-ab9fb0a42355" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_bbfe4776-f06d-4864-bde9-ab9fb0a42355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c186b1e8-7fe5-477e-89ba-5e2225c34608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c186b1e8-7fe5-477e-89ba-5e2225c34608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_3ec9af7a-865e-4f3c-b9b3-50f5f66ab4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_3ec9af7a-865e-4f3c-b9b3-50f5f66ab4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_dfa9af41-5f25-4f3e-bf38-43f6a32342a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_dfa9af41-5f25-4f3e-bf38-43f6a32342a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_55cff373-97d3-45ce-ad47-c5e9b9999e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_55cff373-97d3-45ce-ad47-c5e9b9999e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_2e8de659-4705-4baf-bd40-0d0da992d448" xlink:href="iclr-20231231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_2e8de659-4705-4baf-bd40-0d0da992d448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_15d9e4d5-13de-48ff-9dab-1b42d036ede4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_CommonStockSharesIssued_15d9e4d5-13de-48ff-9dab-1b42d036ede4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65bd80c2-cf46-41b2-a597-bce3e3b3c6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c68990c-9351-4b70-b81d-84fdf55582f4" xlink:to="loc_us-gaap_StockholdersEquity_65bd80c2-cf46-41b2-a597-bce3e3b3c6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea1441ac-93f1-4dd7-a0b8-c776cc1fc6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea1441ac-93f1-4dd7-a0b8-c776cc1fc6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_22bc87fd-a8f4-4292-8efa-cca77ff9eba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea1441ac-93f1-4dd7-a0b8-c776cc1fc6c0" xlink:to="loc_us-gaap_ProfitLoss_22bc87fd-a8f4-4292-8efa-cca77ff9eba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea1441ac-93f1-4dd7-a0b8-c776cc1fc6c0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_638bc57b-61d6-4036-8d71-85587b126746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_638bc57b-61d6-4036-8d71-85587b126746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b7f50281-cd3f-49dd-a230-83f73c30abee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b7f50281-cd3f-49dd-a230-83f73c30abee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_111ba7c6-758d-482e-bec5-3ead393aaf43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_111ba7c6-758d-482e-bec5-3ead393aaf43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ad419374-0b96-446c-b4d4-5fcf6e5829d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ad419374-0b96-446c-b4d4-5fcf6e5829d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_bfdd57ce-2d67-4f6a-a791-3f1e201ad310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_bfdd57ce-2d67-4f6a-a791-3f1e201ad310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_e935bbfe-daa6-4694-ba08-129a034e176e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_e935bbfe-daa6-4694-ba08-129a034e176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_37119989-5579-4c85-a3f8-1691a426342a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_37119989-5579-4c85-a3f8-1691a426342a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_074c52c7-c952-4227-ad7e-ca7195366df4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_ShareBasedCompensation_074c52c7-c952-4227-ad7e-ca7195366df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_df7121e1-e592-48bf-9ba8-adbb7fe96530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_df7121e1-e592-48bf-9ba8-adbb7fe96530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GainLossOnIssuanceOfDebt_b41e33bf-6dc7-4e23-8254-150dd9e908ee" xlink:href="iclr-20231231.xsd#iclr_GainLossOnIssuanceOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_iclr_GainLossOnIssuanceOfDebt_b41e33bf-6dc7-4e23-8254-150dd9e908ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b5c79df7-125e-4407-936a-60a48e24e5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_b5c79df7-125e-4407-936a-60a48e24e5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d96ef48b-48f5-40f9-a1e1-8220fc3809b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d96ef48b-48f5-40f9-a1e1-8220fc3809b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_29b8a141-e031-45c3-a0c7-346fd08751e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6216f80e-d0f0-4962-b729-b47eca93c2b0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_29b8a141-e031-45c3-a0c7-346fd08751e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5671dc73-fc28-4aa0-9735-89e27d40d165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea1441ac-93f1-4dd7-a0b8-c776cc1fc6c0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5671dc73-fc28-4aa0-9735-89e27d40d165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6a976360-1743-4b97-82be-67464b0658f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5671dc73-fc28-4aa0-9735-89e27d40d165" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6a976360-1743-4b97-82be-67464b0658f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d5a58996-9b96-434b-aaed-aa8ac51a6029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5671dc73-fc28-4aa0-9735-89e27d40d165" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d5a58996-9b96-434b-aaed-aa8ac51a6029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a261ea49-099a-4480-a431-0cadf2675119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5671dc73-fc28-4aa0-9735-89e27d40d165" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a261ea49-099a-4480-a431-0cadf2675119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_c3c83122-5e08-4b6a-b01c-13ce7a9a2a11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5671dc73-fc28-4aa0-9735-89e27d40d165" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_c3c83122-5e08-4b6a-b01c-13ce7a9a2a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b57a594b-cf1a-4676-87d2-6aad0a40594d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea1441ac-93f1-4dd7-a0b8-c776cc1fc6c0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b57a594b-cf1a-4676-87d2-6aad0a40594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b6dfc131-0f60-4ae9-8300-72e6d5a1d23d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b6dfc131-0f60-4ae9-8300-72e6d5a1d23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_b9ac99cf-654d-44c8-af41-ac0b0e361508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_b9ac99cf-654d-44c8-af41-ac0b0e361508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_02c58ac1-d0a3-48de-9d92-17514ee75327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_02c58ac1-d0a3-48de-9d92-17514ee75327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_928c00f3-8a83-472a-9219-01f09f6f6311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_928c00f3-8a83-472a-9219-01f09f6f6311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fa6396e9-eb1d-44a3-a982-ba84e4338581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fa6396e9-eb1d-44a3-a982-ba84e4338581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_e7d2a467-d7f0-425a-9af9-4683735f72a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_e7d2a467-d7f0-425a-9af9-4683735f72a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_3687ea96-67df-4858-a841-98ae5576922a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_3687ea96-67df-4858-a841-98ae5576922a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_0da13b07-5c72-40ee-a7ea-ede6e4e456c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_0da13b07-5c72-40ee-a7ea-ede6e4e456c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35b93127-0e9a-462c-9db0-4d5de3b7337e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1959bd12-dae1-4eae-b6a7-e23848b9a4a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35b93127-0e9a-462c-9db0-4d5de3b7337e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_98cc3460-d7a1-458f-8aaf-260c2554203c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_98cc3460-d7a1-458f-8aaf-260c2554203c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_32c04872-40a0-4efa-952d-e7aed169953a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_32c04872-40a0-4efa-952d-e7aed169953a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_c1a4d6d7-0d59-4537-9326-5c6ffe081a08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_c1a4d6d7-0d59-4537-9326-5c6ffe081a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_04e92608-ef44-445f-9a3a-b75e3602806f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_04e92608-ef44-445f-9a3a-b75e3602806f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_d4d949b1-218e-4ee3-a6eb-9687f8791b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_d4d949b1-218e-4ee3-a6eb-9687f8791b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1feb8dae-2c1e-4f48-87e4-79b78ca4419f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1feb8dae-2c1e-4f48-87e4-79b78ca4419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts_28750215-ade0-4dcf-baea-9b417cb42008" xlink:href="iclr-20231231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_iclr_PaymentsForShareRepurchaseCosts_28750215-ade0-4dcf-baea-9b417cb42008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_539d7ff9-0b32-4d08-82b3-0f47ff5cfa78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83206ff3-0e26-4276-a12e-24422895b7ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_539d7ff9-0b32-4d08-82b3-0f47ff5cfa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0d82651-a7a4-44b0-956e-9caa9f9f1db2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0d82651-a7a4-44b0-956e-9caa9f9f1db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c95fbf3-cb86-4f7f-90bb-e6105a562164" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c95fbf3-cb86-4f7f-90bb-e6105a562164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8f028052-9710-4c76-b1eb-2debe7e588cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8f028052-9710-4c76-b1eb-2debe7e588cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd285919-d3c3-40e0-90a9-c8b6abf4b153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_343ca23a-5511-414e-883f-dc6cfe226648" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd285919-d3c3-40e0-90a9-c8b6abf4b153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="simple" xlink:href="iclr-20231231.xsd#Descriptionofbusiness"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19bce621-a84a-45f6-b164-5866e5a371f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_ea6b189a-0000-4097-b0ea-67dc8eeea553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19bce621-a84a-45f6-b164-5866e5a371f3" xlink:to="loc_us-gaap_NatureOfOperations_ea6b189a-0000-4097-b0ea-67dc8eeea553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_36f352fa-7c39-4a6a-b2f5-98ba98a8729d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_31c9ce10-2994-4b8f-aef9-6719b740f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_36f352fa-7c39-4a6a-b2f5-98ba98a8729d" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_31c9ce10-2994-4b8f-aef9-6719b740f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="simple" xlink:href="iclr-20231231.xsd#DisaggregationofRevenue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c5ea4a0b-5626-48e0-9ee0-84c38c5d5653" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a7f9e29b-845e-4d90-b4e3-9dc0d2391c58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c5ea4a0b-5626-48e0-9ee0-84c38c5d5653" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a7f9e29b-845e-4d90-b4e3-9dc0d2391c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalances" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalances"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalances" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_881b4854-41bf-481f-8505-5763db5a9637" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_61ba6ead-9421-4a78-b395-b95946faaf12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_881b4854-41bf-481f-8505-5763db5a9637" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_61ba6ead-9421-4a78-b395-b95946faaf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLosses" xlink:type="simple" xlink:href="iclr-20231231.xsd#AllowancesforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_5ac38f17-a3d1-4140-a5e0-2904df86f688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesTextBlock_03ba0312-424d-4045-a2d1-472c01340c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5ac38f17-a3d1-4140-a5e0-2904df86f688" xlink:to="loc_us-gaap_AllowanceForCreditLossesTextBlock_03ba0312-424d-4045-a2d1-472c01340c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinations" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6eb949fd-dbf1-42d6-b129-73ddbca0bfa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4512573a-90b5-4eef-9382-5df333c4ec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6eb949fd-dbf1-42d6-b129-73ddbca0bfa0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4512573a-90b5-4eef-9382-5df333c4ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValue" xlink:type="simple" xlink:href="iclr-20231231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b2e6d526-0fdf-4c0a-9a48-c072a25abc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_10cf3688-51d8-4399-a3b0-f29696dc5ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b2e6d526-0fdf-4c0a-9a48-c072a25abc6f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_10cf3688-51d8-4399-a3b0-f29696dc5ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Investments" xlink:type="simple" xlink:href="iclr-20231231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eb6d8ecc-8172-48a4-b008-fa7d31ab3f63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_3be27780-d2dc-4125-9b24-65748fe4d47e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eb6d8ecc-8172-48a4-b008-fa7d31ab3f63" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_3be27780-d2dc-4125-9b24-65748fe4d47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="simple" xlink:href="iclr-20231231.xsd#PropertyPlantandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5ebfeffc-6af8-4ae4-b510-f6e2c307300d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7421a3ba-2819-4329-8df3-8b6d4d0bef62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5ebfeffc-6af8-4ae4-b510-f6e2c307300d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7421a3ba-2819-4329-8df3-8b6d4d0bef62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Goodwill" xlink:type="simple" xlink:href="iclr-20231231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9225c153-4bd7-441c-b013-6ace8a26356f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_3b8f43d1-e8d2-4e03-977f-833c9a5f2c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9225c153-4bd7-441c-b013-6ace8a26356f" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_3b8f43d1-e8d2-4e03-977f-833c9a5f2c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssets" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2cb97de0-15b6-4a1d-87cb-daa92b878837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_56b66a07-549e-469a-bdb0-6c5056c8d2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2cb97de0-15b6-4a1d-87cb-daa92b878837" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_56b66a07-549e-469a-bdb0-6c5056c8d2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilities" xlink:type="simple" xlink:href="iclr-20231231.xsd#OtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97e0cd85-9ab9-4ec8-be48-cd1130b884fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_62af5b7e-fc3a-415d-8a89-db5b897fd412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_97e0cd85-9ab9-4ec8-be48-cd1130b884fd" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_62af5b7e-fc3a-415d-8a89-db5b897fd412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilities" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b9aa594e-9386-4575-8955-d6ff843f231f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_29f753f1-04a7-4ff1-a8f9-9713337f410a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b9aa594e-9386-4575-8955-d6ff843f231f" xlink:to="loc_us-gaap_LongTermDebtTextBlock_29f753f1-04a7-4ff1-a8f9-9713337f410a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Derivatives" xlink:type="simple" xlink:href="iclr-20231231.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f174df55-60d8-45ce-b223-5024dd7bb3af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c8b7f5b0-e648-4ef8-8be8-7046842cdddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f174df55-60d8-45ce-b223-5024dd7bb3af" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c8b7f5b0-e648-4ef8-8be8-7046842cdddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeases" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8e36b5c5-707b-454d-853b-a6d229eed815" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f4997a53-dc7b-4b83-b27c-26ee0f2588e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8e36b5c5-707b-454d-853b-a6d229eed815" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f4997a53-dc7b-4b83-b27c-26ee0f2588e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Noncurrentotherliabilities" xlink:type="simple" xlink:href="iclr-20231231.xsd#Noncurrentotherliabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Noncurrentotherliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_33087467-94fb-4708-95bc-906d472baa59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_6cbf7c0d-cd7e-49f1-82ce-94be0be02713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_33087467-94fb-4708-95bc-906d472baa59" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_6cbf7c0d-cd7e-49f1-82ce-94be0be02713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="iclr-20231231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb66d277-5067-43c7-88bf-6f79e3263146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0488f38b-f6db-405c-be3d-cdba3eef073a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb66d277-5067-43c7-88bf-6f79e3263146" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0488f38b-f6db-405c-be3d-cdba3eef073a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapital" xlink:type="simple" xlink:href="iclr-20231231.xsd#ShareCapital"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapital" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b018505d-2139-4262-bcda-6184e55149ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_62854738-ded3-4e3e-a523-50c48bfb41de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b018505d-2139-4262-bcda-6184e55149ca" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_62854738-ded3-4e3e-a523-50c48bfb41de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringCharges" xlink:type="simple" xlink:href="iclr-20231231.xsd#RestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ae87cade-8072-477c-b019-0935e12b0b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1672c312-3f77-4603-b696-a2ba59264f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ae87cade-8072-477c-b019-0935e12b0b81" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1672c312-3f77-4603-b696-a2ba59264f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_71c23429-1acd-470c-8b1a-5a62cb2df962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_24099331-8779-4a8c-8f9f-cba47e884ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_71c23429-1acd-470c-8b1a-5a62cb2df962" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_24099331-8779-4a8c-8f9f-cba47e884ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_658590de-51b3-4bd1-a95b-b3e3b744742d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f569c3ff-2889-48f3-acd6-5c9bfc7756b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_658590de-51b3-4bd1-a95b-b3e3b744742d" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f569c3ff-2889-48f3-acd6-5c9bfc7756b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acf45cd1-2573-4d8a-be8e-8eea40b32c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e25c174b-5ad5-4ee4-a5b6-c4216922866b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acf45cd1-2573-4d8a-be8e-8eea40b32c0b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e25c174b-5ad5-4ee4-a5b6-c4216922866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0ef1d536-5290-4fe5-9bd7-938205e6b83c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_e29ecb96-39ed-4bac-9976-3fdad0b5af9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ef1d536-5290-4fe5-9bd7-938205e6b83c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_e29ecb96-39ed-4bac-9976-3fdad0b5af9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="simple" xlink:href="iclr-20231231.xsd#NetIncomePerOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ae4ad537-44b7-4998-af9e-e7eb43f51fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_38c1cf36-7085-4d05-863a-73e4e522d0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae4ad537-44b7-4998-af9e-e7eb43f51fd7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_38c1cf36-7085-4d05-863a-73e4e522d0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="iclr-20231231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_4c095aa5-6e15-4b68-8d0a-e9d52ef43cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_6e2586e6-d034-46c1-bd76-eb875f4eb9c8" xlink:href="iclr-20231231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_4c095aa5-6e15-4b68-8d0a-e9d52ef43cf7" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_6e2586e6-d034-46c1-bd76-eb875f4eb9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="simple" xlink:href="iclr-20231231.xsd#SupplementalDisclosureofCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_260df6bf-a53e-440b-81fe-428d7eca0ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_7603bf5f-f48c-41ce-bd6c-19325e87bba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_260df6bf-a53e-440b-81fe-428d7eca0ce1" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_7603bf5f-f48c-41ce-bd6c-19325e87bba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedParties" xlink:type="simple" xlink:href="iclr-20231231.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_2f9c565e-b1bf-45ed-a900-f18ebbd5daa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a860c25e-ffff-483b-b614-2bab524a26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_2f9c565e-b1bf-45ed-a900-f18ebbd5daa4" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a860c25e-ffff-483b-b614-2bab524a26c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEvents" xlink:type="simple" xlink:href="iclr-20231231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1fd17076-7a5c-450c-9bf9-b3b7fbb782f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_f9df144a-1010-4c52-b45b-50475b954036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1fd17076-7a5c-450c-9bf9-b3b7fbb782f4" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_f9df144a-1010-4c52-b45b-50475b954036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2d204e8d-e93d-4fed-80af-9d4a58549f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2d204e8d-e93d-4fed-80af-9d4a58549f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e507719c-b479-4356-8ce6-0621d17b219a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_UseOfEstimates_e507719c-b479-4356-8ce6-0621d17b219a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_862ae1bf-f184-4abe-a2f6-2ae4cc2a072d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_862ae1bf-f184-4abe-a2f6-2ae4cc2a072d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_e015acea-dd77-4f62-bbd0-9d6edca7ec6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_e015acea-dd77-4f62-bbd0-9d6edca7ec6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7bf41e3d-99ac-414a-b9ea-d917a02876b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7bf41e3d-99ac-414a-b9ea-d917a02876b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b204bcca-4a04-4f28-a5f2-1d204656b573" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b204bcca-4a04-4f28-a5f2-1d204656b573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_d6f1da8a-6166-462c-9bf7-4d31fa162705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_d6f1da8a-6166-462c-9bf7-4d31fa162705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_cda0e39a-2865-46d4-8d59-a459ec2897f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_cda0e39a-2865-46d4-8d59-a459ec2897f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_da6a9bac-9dac-43e1-a03c-5fe252c42a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_da6a9bac-9dac-43e1-a03c-5fe252c42a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_b4e7bc99-2742-4036-9521-09b3a04a9504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_b4e7bc99-2742-4036-9521-09b3a04a9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_49803807-a912-4fef-9357-3663af2ea610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_49803807-a912-4fef-9357-3663af2ea610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_27c03150-0681-4f26-a8ed-3741024cb636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_27c03150-0681-4f26-a8ed-3741024cb636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_85d357c1-4f4c-42c9-916f-78180d6af69b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_85d357c1-4f4c-42c9-916f-78180d6af69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_b5b2c164-59ec-47dd-a7a8-5839365378e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_b5b2c164-59ec-47dd-a7a8-5839365378e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_dff8d84e-f3fe-4ca7-95d5-074e6bed8fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_DebtPolicyTextBlock_dff8d84e-f3fe-4ca7-95d5-074e6bed8fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_dfc36e0d-c9e0-473a-8c70-b01c657fcf23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_dfc36e0d-c9e0-473a-8c70-b01c657fcf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_86d3caa0-2ee8-4fc4-b09b-6431ae993523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_86d3caa0-2ee8-4fc4-b09b-6431ae993523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock_68643935-4b85-4a25-9192-c87b33ec2ed2" xlink:href="iclr-20231231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_iclr_GovernmentGrantsPolicyTextBlock_68643935-4b85-4a25-9192-c87b33ec2ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_046711f5-59e9-4bae-b99e-5e6b7dbb141d" xlink:href="iclr-20231231.xsd#iclr_ResearchandDevelopmentCreditsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_046711f5-59e9-4bae-b99e-5e6b7dbb141d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_4142fc25-d305-490a-82ff-fe8034741c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_4142fc25-d305-490a-82ff-fe8034741c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_091df60b-d1e6-4044-896c-7fc9e3b9430d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_091df60b-d1e6-4044-896c-7fc9e3b9430d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_a154161d-c659-400d-a479-3b17b2d2d319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_a154161d-c659-400d-a479-3b17b2d2d319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_efc9ffaa-05c3-4a09-bbff-66a0818dcb68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_efc9ffaa-05c3-4a09-bbff-66a0818dcb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_6abbd44d-09eb-4218-b99d-18875b3685d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_6abbd44d-09eb-4218-b99d-18875b3685d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c9350dc6-14b3-4fc7-a5c1-95d2762dad3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8970fff0-5404-4697-91f9-411f98647add" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c9350dc6-14b3-4fc7-a5c1-95d2762dad3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_41f3d915-2f25-4256-b62e-3bafb6b123e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_c20e0538-a8e3-4560-971c-05624050f6af" xlink:href="iclr-20231231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_41f3d915-2f25-4256-b62e-3bafb6b123e0" xlink:to="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_c20e0538-a8e3-4560-971c-05624050f6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_69fb13cc-15cb-4d62-9ebf-6b22c958d05f" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_41f3d915-2f25-4256-b62e-3bafb6b123e0" xlink:to="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_69fb13cc-15cb-4d62-9ebf-6b22c958d05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a94a305c-3ced-4a71-8a6b-7fc53fb852a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_41f3d915-2f25-4256-b62e-3bafb6b123e0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a94a305c-3ced-4a71-8a6b-7fc53fb852a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#DisaggregationofRevenueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d22c3c68-fcfc-4cd1-a39c-79cf0444e336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a2804766-ffc2-490f-9578-0446698c0267" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d22c3c68-fcfc-4cd1-a39c-79cf0444e336" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a2804766-ffc2-490f-9578-0446698c0267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_316a3a9a-6378-4f12-97bc-d047a2223acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_7a2ca8cd-9b23-42eb-a5eb-7a93e7571cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_316a3a9a-6378-4f12-97bc-d047a2223acb" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_7a2ca8cd-9b23-42eb-a5eb-7a93e7571cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#AllowancesforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_6dc54a2a-668a-477d-91ff-a89160d006f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_bba1d271-dba7-41ed-9bf6-1f15b64e3c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_6dc54a2a-668a-477d-91ff-a89160d006f6" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_bba1d271-dba7-41ed-9bf6-1f15b64e3c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fc6ce7e8-360d-49f9-ace5-1c7b863270cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_99030b36-91cc-40a6-b8c7-6e078d7a3232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fc6ce7e8-360d-49f9-ace5-1c7b863270cc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_99030b36-91cc-40a6-b8c7-6e078d7a3232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_02f42482-e64a-41ec-8ab1-05ed73227a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fc6ce7e8-360d-49f9-ace5-1c7b863270cc" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_02f42482-e64a-41ec-8ab1-05ed73227a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_87fad4ee-d38f-4f0b-b76c-706c4861a8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fc6ce7e8-360d-49f9-ace5-1c7b863270cc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_87fad4ee-d38f-4f0b-b76c-706c4861a8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_5f3100c2-b43d-4546-9bea-0360731f07c3" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fc6ce7e8-360d-49f9-ace5-1c7b863270cc" xlink:to="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_5f3100c2-b43d-4546-9bea-0360731f07c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6652fc3a-24ae-4df4-bf49-caa10c772853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_5dc0aa42-f48d-4ea1-9781-00efed24dac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6652fc3a-24ae-4df4-bf49-caa10c772853" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_5dc0aa42-f48d-4ea1-9781-00efed24dac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1b9a13a9-3f3c-409a-bd04-6126109ba67d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6652fc3a-24ae-4df4-bf49-caa10c772853" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1b9a13a9-3f3c-409a-bd04-6126109ba67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#PropertyPlantandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cadfb1ce-eb03-441a-adfe-fa348fcbdb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_241ea9bc-17a8-424e-9b00-8f152c73c539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cadfb1ce-eb03-441a-adfe-fa348fcbdb5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_241ea9bc-17a8-424e-9b00-8f152c73c539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327deb86-0471-4ca9-9716-14d5dde71a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_a425282f-5cc2-4a30-9f02-aa41cd5a554d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_327deb86-0471-4ca9-9716-14d5dde71a2a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_a425282f-5cc2-4a30-9f02-aa41cd5a554d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f690a83b-c0c8-4649-ae55-015dab726a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7b09b497-7afa-4efe-b4a2-1d3032f34098" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f690a83b-c0c8-4649-ae55-015dab726a13" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7b09b497-7afa-4efe-b4a2-1d3032f34098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c666f80c-4c0f-421e-8444-416607448deb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f690a83b-c0c8-4649-ae55-015dab726a13" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c666f80c-4c0f-421e-8444-416607448deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#OtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c3afcb81-b6bc-4e66-b96a-69cfcae6f021" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_9e224d4c-2913-4f2c-899e-3a8041e9441e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c3afcb81-b6bc-4e66-b96a-69cfcae6f021" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_9e224d4c-2913-4f2c-899e-3a8041e9441e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1b70358d-1d1d-4302-8f72-9a6e13236b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c0c00e88-2677-4589-ae07-86ebcad6b3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b70358d-1d1d-4302-8f72-9a6e13236b2d" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c0c00e88-2677-4589-ae07-86ebcad6b3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_d7b1120a-3fd1-47ad-b0e0-95ebe5d51595" xlink:href="iclr-20231231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b70358d-1d1d-4302-8f72-9a6e13236b2d" xlink:to="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_d7b1120a-3fd1-47ad-b0e0-95ebe5d51595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_12013998-d2f0-43d9-9c1a-57cf4cbf341c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b70358d-1d1d-4302-8f72-9a6e13236b2d" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_12013998-d2f0-43d9-9c1a-57cf4cbf341c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_e49e517e-31ab-40f1-9bf8-6f85321683ef" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b70358d-1d1d-4302-8f72-9a6e13236b2d" xlink:to="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_e49e517e-31ab-40f1-9bf8-6f85321683ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4d62be90-50c1-497e-b7dc-c17cd4e935b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1eb68bfc-07f2-4479-8b76-f3c179fc9565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4d62be90-50c1-497e-b7dc-c17cd4e935b7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1eb68bfc-07f2-4479-8b76-f3c179fc9565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f434d1e9-71bd-42da-8c0d-9d112308c34c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_42cf334f-8fde-473d-b216-5a6d3f94aa26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f434d1e9-71bd-42da-8c0d-9d112308c34c" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_42cf334f-8fde-473d-b216-5a6d3f94aa26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e0b99508-c26f-444a-852e-c33095a1a281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f434d1e9-71bd-42da-8c0d-9d112308c34c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e0b99508-c26f-444a-852e-c33095a1a281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#NoncurrentotherliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7e250709-8dae-4977-bc72-c89e2b00d61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_e2abd9b9-ea72-4887-a30a-cd955d17e61c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7e250709-8dae-4977-bc72-c89e2b00d61b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_e2abd9b9-ea72-4887-a30a-cd955d17e61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#RestructuringchargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4647942b-3c93-46fa-b491-f391ca274f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_1aa882d2-0858-4667-a79a-603c5836b2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4647942b-3c93-46fa-b491-f391ca274f8f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_1aa882d2-0858-4667-a79a-603c5836b2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b6014e19-20d6-40b2-9ce7-3d3b022f6de1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4647942b-3c93-46fa-b491-f391ca274f8f" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b6014e19-20d6-40b2-9ce7-3d3b022f6de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_c8fbf809-7d62-4192-bb65-2e0e66135f6f" xlink:href="iclr-20231231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:to="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_c8fbf809-7d62-4192-bb65-2e0e66135f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_94fe4cd5-5d65-456e-849c-dac21ce0f83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_94fe4cd5-5d65-456e-849c-dac21ce0f83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_36730a52-c104-491d-8256-550822f29893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_36730a52-c104-491d-8256-550822f29893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8e731493-b8d7-4bad-a9d5-12eadb2ba18d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8e731493-b8d7-4bad-a9d5-12eadb2ba18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_8bd22829-619e-4bc5-9787-c8699727c137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_8bd22829-619e-4bc5-9787-c8699727c137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_32010058-9b55-42b1-8966-c847a5ae483b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb84ff06-3f02-4626-b42f-8a48e6564400" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_32010058-9b55-42b1-8966-c847a5ae483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_e75cf62c-cb4f-4407-9a69-8c3fa8af9ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_e75cf62c-cb4f-4407-9a69-8c3fa8af9ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_af1d992d-6d11-4776-b011-c9b06d9344df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_af1d992d-6d11-4776-b011-c9b06d9344df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_35d1c99c-e84a-4c15-9876-1db8ae989893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_35d1c99c-e84a-4c15-9876-1db8ae989893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_9c9193dc-6eb8-4bc8-abc6-f15d6728cb41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_9c9193dc-6eb8-4bc8-abc6-f15d6728cb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_d9891a48-9d44-4dcf-8714-9bc03dde4e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_d9891a48-9d44-4dcf-8714-9bc03dde4e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_3c344025-387c-4926-99b6-cf705caeacee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_3c344025-387c-4926-99b6-cf705caeacee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ddcbcabd-44e3-488a-93d2-8e80b316b176" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ddcbcabd-44e3-488a-93d2-8e80b316b176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d8e886a8-531e-4c40-8c75-534e170b5e99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_62d5c70c-1989-4f5c-a5fd-585b3f53bace" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_d8e886a8-531e-4c40-8c75-534e170b5e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69a8e793-8d19-432a-a902-d6d824626ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5ae242c8-282f-4aeb-9b6b-578e829222f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69a8e793-8d19-432a-a902-d6d824626ab3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5ae242c8-282f-4aeb-9b6b-578e829222f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0fecbddb-6342-43e5-a875-2facfdc68bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69a8e793-8d19-432a-a902-d6d824626ab3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0fecbddb-6342-43e5-a875-2facfdc68bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1b380b82-1026-46e2-b86e-f3b87e5e0efa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69a8e793-8d19-432a-a902-d6d824626ab3" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1b380b82-1026-46e2-b86e-f3b87e5e0efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_e8cd7070-3a4c-4321-898d-3367104577cf" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69a8e793-8d19-432a-a902-d6d824626ab3" xlink:to="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_e8cd7070-3a4c-4321-898d-3367104577cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_249c034a-775f-4d1d-a260-8a03d5f3ec88" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69a8e793-8d19-432a-a902-d6d824626ab3" xlink:to="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_249c034a-775f-4d1d-a260-8a03d5f3ec88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4f8317c3-32cd-45fd-bdfb-92faa7c7daf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_d0e71729-f2c2-4426-b119-8ecbda61cc16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4f8317c3-32cd-45fd-bdfb-92faa7c7daf0" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_d0e71729-f2c2-4426-b119-8ecbda61cc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock_1951c33a-0895-4b77-8215-627a573ba87c" xlink:href="iclr-20231231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4f8317c3-32cd-45fd-bdfb-92faa7c7daf0" xlink:to="loc_iclr_OperatingIncomeByGeographyTableTextBlock_1951c33a-0895-4b77-8215-627a573ba87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_6c647a98-5855-4b36-aba1-03b03d162ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4f8317c3-32cd-45fd-bdfb-92faa7c7daf0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_6c647a98-5855-4b36-aba1-03b03d162ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#NetIncomePerOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e30ec5ea-db8e-4e75-8880-09c6b71fed42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_141514aa-fa79-47ea-9adb-fbd7dc68fec3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e30ec5ea-db8e-4e75-8880-09c6b71fed42" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_141514aa-fa79-47ea-9adb-fbd7dc68fec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_3329dd3a-6587-4bc2-b4ed-d1d77ec7dabb" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e30ec5ea-db8e-4e75-8880-09c6b71fed42" xlink:to="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_3329dd3a-6587-4bc2-b4ed-d1d77ec7dabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c15e4b7a-61b6-4b68-ad12-f5f7573b4ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_13d42997-3885-4552-952c-07eba4ef3e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c15e4b7a-61b6-4b68-ad12-f5f7573b4ef9" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_13d42997-3885-4552-952c-07eba4ef3e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="simple" xlink:href="iclr-20231231.xsd#SupplementalDisclosureofCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_c1f97ebd-3919-48d3-bbcd-1c4644e97590" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_1e438aaf-9bbf-4677-8275-54d225cf4de8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_c1f97ebd-3919-48d3-bbcd-1c4644e97590" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_1e438aaf-9bbf-4677-8275-54d225cf4de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DescriptionofbusinessDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61453977-b1d5-46dc-88ef-b50f3771e712" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61453977-b1d5-46dc-88ef-b50f3771e712" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3fa43d3d-ea3b-40cc-80a9-9962db9f4415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a86d9476-2da9-42dd-9853-5af355e41383" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3fa43d3d-ea3b-40cc-80a9-9962db9f4415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_f74bac39-8a82-42c4-bbfc-c9620ff4594f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3fa43d3d-ea3b-40cc-80a9-9962db9f4415" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_f74bac39-8a82-42c4-bbfc-c9620ff4594f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4c7298fc-2cd0-480c-b3f6-739d90e7fd50" xlink:to="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e05f0b9d-e0c4-46ee-baf5-ea2443d6a357" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:to="loc_country_US_e05f0b9d-e0c4-46ee-baf5-ea2443d6a357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b86444fc-2a76-43a8-b474-bdcee482ae39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:to="loc_srt_EuropeMember_b86444fc-2a76-43a8-b474-bdcee482ae39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_fae3fa95-bda0-4d54-975a-591284031354" xlink:href="iclr-20231231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b120646f-7caa-4afe-96cf-9d7973bd8c3d" xlink:to="loc_iclr_OtherGeographicLocationsMember_fae3fa95-bda0-4d54-975a-591284031354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_35ce2d18-1621-4654-add7-92639cc303eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_77639bda-3642-4ed4-8d7b-84d6f331d42d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_35ce2d18-1621-4654-add7-92639cc303eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_7fe9cf4e-18bb-411a-8787-7f064674e0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_35ce2d18-1621-4654-add7-92639cc303eb" xlink:to="loc_us-gaap_SalesRevenueNetMember_7fe9cf4e-18bb-411a-8787-7f064674e0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_6bdd1812-aaf7-46ea-87ee-d0e0089b138a" xlink:to="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_5b8a5050-28af-4e57-849a-f1f38b595352" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_dei_EntityNumberOfEmployees_5b8a5050-28af-4e57-849a-f1f38b595352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_d7c69aa6-7ea1-4b2b-b447-767c91285de9" xlink:href="iclr-20231231.xsd#iclr_NumberOfLocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_iclr_NumberOfLocations_d7c69aa6-7ea1-4b2b-b447-767c91285de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_69082e68-da48-45d0-8ff6-c1565ac74363" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_69082e68-da48-45d0-8ff6-c1565ac74363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0c45fe37-48fb-43fd-80d5-008957489d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f8a5c2fb-ddfa-417f-9f60-6543a9eefb9f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0c45fe37-48fb-43fd-80d5-008957489d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_50257288-e1c5-41a7-a7cd-e343b0bea53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract_e45bcb88-76de-484f-91cf-7aced1fb011d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50257288-e1c5-41a7-a7cd-e343b0bea53e" xlink:to="loc_us-gaap_ForeignCurrencyAbstract_e45bcb88-76de-484f-91cf-7aced1fb011d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_554bb1e4-8b99-49e3-bdbc-02d10511d65a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyAbstract_e45bcb88-76de-484f-91cf-7aced1fb011d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_554bb1e4-8b99-49e3-bdbc-02d10511d65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7d719f37-bb21-4394-9a3d-3043367e9dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59b02a30-5aae-4f9a-b495-bdc9f44a354a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d719f37-bb21-4394-9a3d-3043367e9dd0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59b02a30-5aae-4f9a-b495-bdc9f44a354a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59b02a30-5aae-4f9a-b495-bdc9f44a354a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:to="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0c4b44d1-24a1-4d2d-b3cd-194201e2b62e" xlink:to="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5d82ccd9-0049-4f0d-88ce-3d1d37af12b4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:to="loc_srt_MinimumMember_5d82ccd9-0049-4f0d-88ce-3d1d37af12b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3819285d-f5a9-4087-8848-b09b0ab09873" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e983d8c7-e94c-4a2e-a60f-ece808793d85" xlink:to="loc_srt_MaximumMember_3819285d-f5a9-4087-8848-b09b0ab09873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c77ef560-9479-4c49-b098-d7ca3df46f67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_cc4afcd0-739e-402c-b09d-b92012cfb3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_BuildingMember_cc4afcd0-739e-402c-b09d-b92012cfb3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_8788f9b1-fcf7-49cf-9e21-ca86cbdfb2da" xlink:href="iclr-20231231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_8788f9b1-fcf7-49cf-9e21-ca86cbdfb2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_30fe88f3-e16d-430a-8025-457ac1a115f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_30fe88f3-e16d-430a-8025-457ac1a115f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_3339d533-0de5-4829-a6b5-a17f5241dbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_EquipmentMember_3339d533-0de5-4829-a6b5-a17f5241dbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_624e95f7-adb6-4b9e-aebe-2b60bc018130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f9baa8b8-64d3-4efb-b71d-34c8470f326f" xlink:to="loc_us-gaap_VehiclesMember_624e95f7-adb6-4b9e-aebe-2b60bc018130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3a364a9f-9e80-45d2-80da-a6ffcf2e0b88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a694560d-4c1a-4365-9bce-f6dcd0345636" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3a364a9f-9e80-45d2-80da-a6ffcf2e0b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bdd4c760-c9ff-4bc2-acd1-c343fd384dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3a364a9f-9e80-45d2-80da-a6ffcf2e0b88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bdd4c760-c9ff-4bc2-acd1-c343fd384dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0fec0472-d1bf-47af-ad70-5c49eb5c59af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0fec0472-d1bf-47af-ad70-5c49eb5c59af" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c7dbfbb-fea5-48fd-93fc-7e982f31147f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9ba7b250-c336-419a-899e-74eecf8ee42e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9ba7b250-c336-419a-899e-74eecf8ee42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_b79ffa5f-fe41-4caa-af4b-cd505c666afd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_b79ffa5f-fe41-4caa-af4b-cd505c666afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4ba08e71-e6fc-4aa3-8029-b4aed631a22b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_TradeNamesMember_4ba08e71-e6fc-4aa3-8029-b4aed631a22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_cf793eee-57c9-4afa-96dd-78601b87fcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_DatabasesMember_cf793eee-57c9-4afa-96dd-78601b87fcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0acb112d-f83e-4cd9-a0f1-efcedb43c04d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1115ae72-95a3-4d3e-ac36-e694eded28ae" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0acb112d-f83e-4cd9-a0f1-efcedb43c04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:to="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fdf248ba-3a48-4d5b-b3a7-970c09f73365" xlink:to="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8069fbcd-3542-4484-999f-7f174bab72ff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:to="loc_srt_MinimumMember_8069fbcd-3542-4484-999f-7f174bab72ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_422318d0-01ee-4963-97d8-e4ee4b3eeb98" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_418ddad7-2d38-4d72-8362-4cf97503e578" xlink:to="loc_srt_MaximumMember_422318d0-01ee-4963-97d8-e4ee4b3eeb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_eaf7f23d-86d6-445a-b6eb-487ff5b7c032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e8505328-d394-4c0c-a07f-d1c17ca5f88b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_eaf7f23d-86d6-445a-b6eb-487ff5b7c032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_19b5e9f8-375c-41ef-8837-723b30d5d6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_eaf7f23d-86d6-445a-b6eb-487ff5b7c032" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_19b5e9f8-375c-41ef-8837-723b30d5d6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4d171ca0-5908-46cf-9b85-4c38add10ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4d171ca0-5908-46cf-9b85-4c38add10ef9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:to="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_99d6ec4a-bd0c-41b9-a7b5-3c1b662472c8" xlink:to="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_3f75b4d3-0a8f-4402-9511-af3e8aa7d010" xlink:href="iclr-20231231.xsd#iclr_TopClientMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_TopClientMember_3f75b4d3-0a8f-4402-9511-af3e8aa7d010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_bccde3f0-27a6-4e8a-a060-604a62b1dff6" xlink:href="iclr-20231231.xsd#iclr_Clients25Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_Clients25Member_bccde3f0-27a6-4e8a-a060-604a62b1dff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_fe084083-e5d2-44a3-8723-62662c686017" xlink:href="iclr-20231231.xsd#iclr_Clients610Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_Clients610Member_fe084083-e5d2-44a3-8723-62662c686017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_39927b97-5c1b-4c8e-85f5-0f2750d19629" xlink:href="iclr-20231231.xsd#iclr_Clients1125Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_Clients1125Member_39927b97-5c1b-4c8e-85f5-0f2750d19629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_9e41db31-1287-44c6-bdfe-e864d116d6c9" xlink:href="iclr-20231231.xsd#iclr_OtherCustomersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b682d7a9-7c2f-4b91-838f-35945b275cbf" xlink:to="loc_iclr_OtherCustomersMember_9e41db31-1287-44c6-bdfe-e864d116d6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_178b6c1c-c750-42ed-9ae2-c88d211c7473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6c072494-ba16-44cf-a2b6-6569fcb4e88e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_178b6c1c-c750-42ed-9ae2-c88d211c7473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a412e063-df54-4317-bc60-16628b774a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_178b6c1c-c750-42ed-9ae2-c88d211c7473" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a412e063-df54-4317-bc60-16628b774a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesContractswithCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_45fd336e-b1f9-48b7-aefc-724e1b5cf999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_us-gaap_BilledContractReceivables_45fd336e-b1f9-48b7-aefc-724e1b5cf999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_860bda68-2697-472d-a753-6ff000cefdda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_860bda68-2697-472d-a753-6ff000cefdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_0a352e1d-467d-4225-b515-f4603fb24e24" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_ContractsReceivableGross_0a352e1d-467d-4225-b515-f4603fb24e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_f7488464-70d4-45f9-acd7-b59d00c3a2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_f7488464-70d4-45f9-acd7-b59d00c3a2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_f1988668-620e-43ea-a23f-bd6f34d2dd3e" xlink:href="iclr-20231231.xsd#iclr_ContractsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_ContractsReceivableNet_f1988668-620e-43ea-a23f-bd6f34d2dd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_30349319-ff71-4bde-862d-cb5b41816369" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_30349319-ff71-4bde-862d-cb5b41816369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_f4e0d304-8710-4a47-942c-a5a82ebb91a3" xlink:href="iclr-20231231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_f4e0d304-8710-4a47-942c-a5a82ebb91a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_dab9c92c-24d9-4ca4-a4a9-379aeb31a293" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_dab9c92c-24d9-4ca4-a4a9-379aeb31a293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_e88af8d6-c701-46df-851c-fa70bf4c0805" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_e88af8d6-c701-46df-851c-fa70bf4c0805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ed7ff5e8-7fef-4248-b41c-932c233b9ace" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ed7ff5e8-7fef-4248-b41c-932c233b9ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_0272fd81-516e-4a4c-8da5-3c7a923c815f" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_0272fd81-516e-4a4c-8da5-3c7a923c815f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_819b0318-dd53-4404-87b3-eb806baf4aea" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_819b0318-dd53-4404-87b3-eb806baf4aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_6ab7e9b2-57a8-4075-978d-b739c4e0225c" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_17132333-db80-4a2d-b6d9-91b5e3a49aef" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_6ab7e9b2-57a8-4075-978d-b739c4e0225c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c91998d-4663-4cb8-b453-60c814829bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c91998d-4663-4cb8-b453-60c814829bb9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_76cf3d98-3764-48dc-bd62-3a57cf4947b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_76cf3d98-3764-48dc-bd62-3a57cf4947b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c746d4d7-511e-4c3a-afea-319e70b4c47f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_5fe5b8ee-0e79-4faf-8f9e-c47a022b12eb" xlink:href="iclr-20231231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_5fe5b8ee-0e79-4faf-8f9e-c47a022b12eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5f442e71-22be-432d-b7ef-91f2cade5e20" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5f442e71-22be-432d-b7ef-91f2cade5e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f05d02de-506e-488f-9a86-fcc14447eaf1" xlink:href="iclr-20231231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f05d02de-506e-488f-9a86-fcc14447eaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_76a55ca7-f6ef-42fe-8eee-1fc335aada63" xlink:href="iclr-20231231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_76a55ca7-f6ef-42fe-8eee-1fc335aada63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4dc5d26b-2c88-4dbb-8149-083e6b82ed4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4dc5d26b-2c88-4dbb-8149-083e6b82ed4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_82f07692-f54a-4329-a957-5d525cdc67b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_82f07692-f54a-4329-a957-5d525cdc67b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_2765ba2b-969d-4a89-ad53-e3df4132074b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_2765ba2b-969d-4a89-ad53-e3df4132074b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b35712b9-432d-4670-857c-61990ba0b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_45bb9308-6755-4934-875b-e7b3efe9c284" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b35712b9-432d-4670-857c-61990ba0b6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20231231.xsd#ContractBalancesNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#AllowancesforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_a1b47479-7c42-4e47-be6d-3649abc84f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_a1b47479-7c42-4e47-be6d-3649abc84f5d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e1075ba8-953e-416d-a5ad-08d6a56ce004" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e1075ba8-953e-416d-a5ad-08d6a56ce004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_48f2e526-8a67-4758-a646-1635c0b30284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_48f2e526-8a67-4758-a646-1635c0b30284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense_0b56898b-b2c7-47c4-920d-ea59ec728473" xlink:href="iclr-20231231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:to="loc_iclr_AccountsReceivableCreditLossExpense_0b56898b-b2c7-47c4-920d-ea59ec728473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_d56bbdf1-460a-44c9-8f06-781b04ed14af" xlink:href="iclr-20231231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_d56bbdf1-460a-44c9-8f06-781b04ed14af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_151f020b-bc47-4f01-ba8b-89f428974ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_099be81c-e41f-4f63-8993-ad21ba33ea70" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_151f020b-bc47-4f01-ba8b-89f428974ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsNarrativeBiotelAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3a0cc504-003e-41e9-8452-60fbb4dcbfb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3a0cc504-003e-41e9-8452-60fbb4dcbfb0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3b4064f-63a9-42c4-a3e5-39e84f736310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14c03045-2e44-438d-afea-81624447debd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3b4064f-63a9-42c4-a3e5-39e84f736310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_f067873d-8493-4331-93c5-5faf614472ce" xlink:href="iclr-20231231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3b4064f-63a9-42c4-a3e5-39e84f736310" xlink:to="loc_iclr_BiotelResearchLLCMember_f067873d-8493-4331-93c5-5faf614472ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_876a222a-a2aa-45a2-a511-ec4589f2ae88" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_71ede171-d823-49b7-9eaf-138a610c9a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_71ede171-d823-49b7-9eaf-138a610c9a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_6e6fa75c-abef-4624-9db1-ec9be242f017" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_6e6fa75c-abef-4624-9db1-ec9be242f017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_868296df-dc3d-4287-9d34-0471f44a4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_868296df-dc3d-4287-9d34-0471f44a4d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac54c6b8-9b0d-4506-b151-079218975663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b70d832c-bc00-4b49-8ba8-22a86855b9e7" xlink:to="loc_us-gaap_Goodwill_ac54c6b8-9b0d-4506-b151-079218975663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsNarrativeOncacareAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2db0ae99-c6bf-420f-bed0-6489452fa5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2db0ae99-c6bf-420f-bed0-6489452fa5ee" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f4a8930-bd6f-45a2-9ef4-6fc0503e9330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91e999ec-f0b6-425b-af10-8d5b61a58853" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f4a8930-bd6f-45a2-9ef4-6fc0503e9330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_6a0696f6-0540-4206-a962-5ddc20e68883" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8f4a8930-bd6f-45a2-9ef4-6fc0503e9330" xlink:to="loc_iclr_OncacareMember_6a0696f6-0540-4206-a962-5ddc20e68883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_35fc1b6b-0c64-4449-8d2e-6a5e3025760d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2c609c69-039a-475f-a20b-1853b7953d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2c609c69-039a-475f-a20b-1853b7953d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_63faef61-426b-4183-847e-9ae32f19bd85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_63faef61-426b-4183-847e-9ae32f19bd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a0620f17-8871-4b09-a16d-ee519ff69d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_Goodwill_a0620f17-8871-4b09-a16d-ee519ff69d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_95dcf968-a5a2-497b-92de-cac75fbd2689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_932569db-c8ff-42c8-963b-3f79454378a1" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_95dcf968-a5a2-497b-92de-cac75fbd2689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsNarrativePRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_04c35b94-ddf5-418c-93f8-2b1ddd58e801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_04c35b94-ddf5-418c-93f8-2b1ddd58e801" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ea0264-9659-4302-8112-3ab247cf7950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4dce466d-ab21-44a5-820e-9e0f6b378754" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ea0264-9659-4302-8112-3ab247cf7950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_62e6b2a6-1a64-4313-84e3-54547427991d" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9ea0264-9659-4302-8112-3ab247cf7950" xlink:to="loc_iclr_PRAHealthSciencesIncMember_62e6b2a6-1a64-4313-84e3-54547427991d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5949a1ba-952e-4646-8f9f-e37dd1d7069a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_41e62ec0-091e-4409-8919-f8c51b024831" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_dei_EntityNumberOfEmployees_41e62ec0-091e-4409-8919-f8c51b024831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_a5ae4526-27a0-49ae-b004-6003d41ba05a" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_a5ae4526-27a0-49ae-b004-6003d41ba05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_028fadf5-c09e-49fb-b803-3e809b6ae4e1" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_028fadf5-c09e-49fb-b803-3e809b6ae4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_859e1d32-4ec0-411a-a523-64b506f697af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_859e1d32-4ec0-411a-a523-64b506f697af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0b364f3f-f4f9-4164-9082-db4f40c007cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1afc0847-b459-4828-bc6f-fa820fe37a2c" xlink:to="loc_us-gaap_InterestExpense_0b364f3f-f4f9-4164-9082-db4f40c007cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5395595c-c3c4-42a7-b49c-9a42d22c2448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5395595c-c3c4-42a7-b49c-9a42d22c2448" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_729ac040-0f42-4526-aa9d-3b135dcbd926" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_44ab7959-c336-406d-8bf5-8a062c32f27f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_729ac040-0f42-4526-aa9d-3b135dcbd926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_58dfa88c-5bf8-4e35-be68-a50d6862c94e" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_729ac040-0f42-4526-aa9d-3b135dcbd926" xlink:to="loc_iclr_PRAHealthSciencesIncMember_58dfa88c-5bf8-4e35-be68-a50d6862c94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5627dc48-be90-489e-860d-ba2890b43542" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_5e79eb32-1d76-4776-a873-b021dc634d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_5e79eb32-1d76-4776-a873-b021dc634d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_14188b2c-6590-4013-b82d-d8a81600523b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_14188b2c-6590-4013-b82d-d8a81600523b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f48186ab-686d-44c7-b64f-3af0cbfc9b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f48186ab-686d-44c7-b64f-3af0cbfc9b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_be3acbc4-8ea5-4216-bffc-34dee56870cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_be3acbc4-8ea5-4216-bffc-34dee56870cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e6f6864d-8ad7-4cd7-ad74-a15e433c6d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e6f6864d-8ad7-4cd7-ad74-a15e433c6d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_8b3f8d0c-ff45-414d-be46-ba646f7f5d39" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bdb6fdbe-96ae-48ca-aa45-71dccc0f19d5" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_8b3f8d0c-ff45-414d-be46-ba646f7f5d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_200dd8de-493a-4dcd-9703-e26ea0c20984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_200dd8de-493a-4dcd-9703-e26ea0c20984" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb12c56-1e4a-48ba-9383-1e4ec75dbda7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fac9540c-b175-4af0-bd0b-990032b56d65" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb12c56-1e4a-48ba-9383-1e4ec75dbda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_b3db0603-d42b-48c1-b463-bb3f6181ee56" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bb12c56-1e4a-48ba-9383-1e4ec75dbda7" xlink:to="loc_iclr_PRAHealthSciencesIncMember_b3db0603-d42b-48c1-b463-bb3f6181ee56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0607ca9d-08d8-4df1-a3dc-14e36216c73f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04e411af-284b-4da9-94d9-be39369e6b29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_04e411af-284b-4da9-94d9-be39369e6b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_542080d1-7bd8-4842-8398-5b9bf988fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_542080d1-7bd8-4842-8398-5b9bf988fc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_f709ba66-c4c1-470a-b1cf-33b1ca171e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_f709ba66-c4c1-470a-b1cf-33b1ca171e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac1f1939-c998-47f2-870c-07defb00bcce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac1f1939-c998-47f2-870c-07defb00bcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_78146e6c-282c-4de7-acea-0ac953b80fb2" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_78146e6c-282c-4de7-acea-0ac953b80fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b662c795-948b-45b8-bb5a-3115d35a448a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_Goodwill_b662c795-948b-45b8-bb5a-3115d35a448a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d96f6b21-50ac-4443-8e04-41ed15a0d9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d96f6b21-50ac-4443-8e04-41ed15a0d9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c2431226-72f5-4192-83ad-3bc629951921" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c2431226-72f5-4192-83ad-3bc629951921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e7e14173-27c5-46a6-b2bb-8e0ec85a30df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e7e14173-27c5-46a6-b2bb-8e0ec85a30df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3eedafed-23c3-4314-a6b6-10d98ea0ab14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3eedafed-23c3-4314-a6b6-10d98ea0ab14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c8954beb-1e31-40f0-9db5-44dabe9b16a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c8954beb-1e31-40f0-9db5-44dabe9b16a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_01de9e56-659b-493b-87fe-34e32eb79fea" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_01de9e56-659b-493b-87fe-34e32eb79fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_4f45494e-1383-4769-aded-99eeb8f65bf6" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_4f45494e-1383-4769-aded-99eeb8f65bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7fdf5203-6e14-4a7d-acb4-25331be3b502" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7fdf5203-6e14-4a7d-acb4-25331be3b502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a62afe84-de77-4d02-be4a-ecd0775ee8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a62afe84-de77-4d02-be4a-ecd0775ee8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_615f6d9e-5435-4c4b-9f4a-63ee681f0c26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_615f6d9e-5435-4c4b-9f4a-63ee681f0c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ecfbb95e-b515-446e-b055-450e2e7a04d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a57361c7-2672-4f13-9b0c-9b3888d932bd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ecfbb95e-b515-446e-b055-450e2e7a04d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_aaa82dbb-f1ba-4d5d-9b62-19b01f2a1af8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_aaa82dbb-f1ba-4d5d-9b62-19b01f2a1af8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ac97ccba-2f49-4804-bdbc-fe5b08bdca19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6a86d35-b976-4b58-89f0-6796ffdc3137" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ac97ccba-2f49-4804-bdbc-fe5b08bdca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_197d11ab-35c7-4daf-a5d2-2aa233c7bb70" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ac97ccba-2f49-4804-bdbc-fe5b08bdca19" xlink:to="loc_iclr_PRAHealthSciencesIncMember_197d11ab-35c7-4daf-a5d2-2aa233c7bb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b75e2118-70eb-4d9b-8589-e011413fe8cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cb49f1e8-48c7-4a0e-bb6c-f92c8039503c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cb49f1e8-48c7-4a0e-bb6c-f92c8039503c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_33e096cd-6fc0-4f00-8504-fd5d08594c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_33e096cd-6fc0-4f00-8504-fd5d08594c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_34a7a78c-ebb1-4e44-8a0a-a3d2754090ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_TradeNamesMember_34a7a78c-ebb1-4e44-8a0a-a3d2754090ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_6bb26bc9-f4ca-46bc-915f-eaadb49e4f26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_DatabasesMember_6bb26bc9-f4ca-46bc-915f-eaadb49e4f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_678683b9-4bdc-4799-a990-a15bd9837e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5c57a6ea-5609-4d5c-8a77-d1c71e20e170" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_678683b9-4bdc-4799-a990-a15bd9837e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_521cc2ad-e08e-4134-b149-c3688cc0ddb7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_325ab4d4-fdc5-4987-8b33-de58caa7924d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_325ab4d4-fdc5-4987-8b33-de58caa7924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44f73c9d-1077-4e27-994a-8a5a48399682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4830afbc-f3aa-4088-9ece-156577dc2864" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44f73c9d-1077-4e27-994a-8a5a48399682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3bb5ad9f-3f4c-4fb3-acb3-5a98654685f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3bb5ad9f-3f4c-4fb3-acb3-5a98654685f8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55292648-1218-4e9f-9db9-3de0a955246b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6217dbfb-bba8-438c-9302-319862e05011" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55292648-1218-4e9f-9db9-3de0a955246b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_3de015f3-d69f-4843-b841-fed6d0b9e5c2" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_55292648-1218-4e9f-9db9-3de0a955246b" xlink:to="loc_iclr_PRAHealthSciencesIncMember_3de015f3-d69f-4843-b841-fed6d0b9e5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_a376e2b9-0baa-4a39-8f60-68a9241d4642" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bbdf5a76-10b2-400f-b135-b5411fcae71a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_a376e2b9-0baa-4a39-8f60-68a9241d4642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202108Member_e0021944-7c3c-4eb9-9fb7-c5a625cf838a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate202108Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a376e2b9-0baa-4a39-8f60-68a9241d4642" xlink:to="loc_us-gaap_AccountingStandardsUpdate202108Member_e0021944-7c3c-4eb9-9fb7-c5a625cf838a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05cfd6f1-fa03-4445-90c2-d3a048874a40" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_71ad4330-c494-4b8d-8544-004ec5080013" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_71ad4330-c494-4b8d-8544-004ec5080013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_a6d2b999-b672-4a97-9213-a7c8df49b22f" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_a6d2b999-b672-4a97-9213-a7c8df49b22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_e28c33ce-39d6-4639-89b7-b350e2183c76" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_e28c33ce-39d6-4639-89b7-b350e2183c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_32ce7092-52d0-4830-adb6-8b2f73d9ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_32ce7092-52d0-4830-adb6-8b2f73d9ffd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_657b0f02-d2f1-41c6-b35b-57eea7164d3b" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_657b0f02-d2f1-41c6-b35b-57eea7164d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_91dff363-12ed-4884-a8a4-2b5399814e83" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_91dff363-12ed-4884-a8a4-2b5399814e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_6814cb1e-afd9-4dbe-b908-6359e471a599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_6814cb1e-afd9-4dbe-b908-6359e471a599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_f8a7ff0f-f0f7-40fd-84d0-9c22b2185649" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_f8a7ff0f-f0f7-40fd-84d0-9c22b2185649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_cea4f2f5-452f-4fbc-bef8-08313a34887b" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_cea4f2f5-452f-4fbc-bef8-08313a34887b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_a9658fd9-5705-42f0-9596-41af5b9df033" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_a9658fd9-5705-42f0-9596-41af5b9df033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_00a512ba-2bc4-425b-ad98-a687aed72329" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_00a512ba-2bc4-425b-ad98-a687aed72329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_38ddbb39-5fcd-4c72-bb9d-3e882ea6b2d5" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_38ddbb39-5fcd-4c72-bb9d-3e882ea6b2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_281f28a5-9d96-4b14-b3ee-ab6e9850c54e" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_281f28a5-9d96-4b14-b3ee-ab6e9850c54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_0e28e4cb-f7d6-43a4-9af5-aad77af13174" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_0e28e4cb-f7d6-43a4-9af5-aad77af13174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_9bb4b0b2-ed2c-4a92-9979-2eca05e53ec5" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_9bb4b0b2-ed2c-4a92-9979-2eca05e53ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_2a0ee6dc-5bb0-40e7-9d4d-82e2dc06cd80" xlink:href="iclr-20231231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_2a0ee6dc-5bb0-40e7-9d4d-82e2dc06cd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_b7f5b343-bb0e-4b75-b6bc-6387657f4aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a3bf6fd8-9dbb-4240-92e8-526f0c71de91" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_b7f5b343-bb0e-4b75-b6bc-6387657f4aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ed3f6072-106c-4218-8d5b-5e6dce4964fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ed3f6072-106c-4218-8d5b-5e6dce4964fa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34774a3a-3a5d-46e5-8a00-00ce3088ef52" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b64a0e67-92cf-4587-ad20-d2604f3c6a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b64a0e67-92cf-4587-ad20-d2604f3c6a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_287be85d-4dcc-4ed2-a3e0-649b1f7f18d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_287be85d-4dcc-4ed2-a3e0-649b1f7f18d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b9d8dd0e-09e4-4ee3-bac4-05c8c2699068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b9d8dd0e-09e4-4ee3-bac4-05c8c2699068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_adcc9af5-29e7-4dd2-bbb1-74172d4092ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_889c6ebc-f03e-4ef9-81c5-5a293552a904" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_adcc9af5-29e7-4dd2-bbb1-74172d4092ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f4b3cb98-f86f-4056-9573-76c01d427120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_294694fb-9b5e-49bc-9a1d-668eed2044f2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f4b3cb98-f86f-4056-9573-76c01d427120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_7b862f97-2f96-441e-8c3f-052cd7570e50" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f4b3cb98-f86f-4056-9573-76c01d427120" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_7b862f97-2f96-441e-8c3f-052cd7570e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5c7fb512-37fe-44f2-b1d5-4b1293f3b394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_99bfd841-d141-4551-b01b-55758197ebd0" xlink:to="loc_us-gaap_HedgingDesignationDomain_5c7fb512-37fe-44f2-b1d5-4b1293f3b394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6b53990c-4a66-4238-bc2c-2fa82a614b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5c7fb512-37fe-44f2-b1d5-4b1293f3b394" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6b53990c-4a66-4238-bc2c-2fa82a614b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7737bfd6-4b5c-42ba-9699-c9bbcfe75302" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:to="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2e3c0cd0-74e0-4c8a-9df4-6552c3ef3d67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2e3c0cd0-74e0-4c8a-9df4-6552c3ef3d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_35f9dd44-4496-4877-9bcc-7ae1e139cfac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_35f9dd44-4496-4877-9bcc-7ae1e139cfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_48c82fbb-1a80-4deb-9b51-f0168121a9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_DerivativeAssets_48c82fbb-1a80-4deb-9b51-f0168121a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_de217414-f10d-4690-95bc-6ca3d96363ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31a935f2-a1e2-413d-b6cc-aa41dd7019ea" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_de217414-f10d-4690-95bc-6ca3d96363ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c22ed24-9495-4553-8449-526de70fc0a4" xlink:to="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d84066a8-29d9-4117-b200-28d2cacbcdab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:to="loc_us-gaap_DerivativeLiabilities_d84066a8-29d9-4117-b200-28d2cacbcdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dd45864a-889b-4a9c-8967-a855a91b016c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_df962d1f-f119-4b10-bf54-6b72674c10fe" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_dd45864a-889b-4a9c-8967-a855a91b016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#FairvalueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1f60c46b-6762-4cc5-8424-dccf6c960a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1f60c46b-6762-4cc5-8424-dccf6c960a5a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e63959e-90d4-4c2d-ac10-d11f39f13bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3da25b-328b-4cdd-bebb-dbf424d11523" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e63959e-90d4-4c2d-ac10-d11f39f13bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5728e439-9c18-446f-9a49-be1a817a2b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1e63959e-90d4-4c2d-ac10-d11f39f13bea" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_5728e439-9c18-446f-9a49-be1a817a2b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11c69470-a866-4ac4-8a45-a3c1bd88d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa48f751-584f-4b84-be57-9b316de37d90" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11c69470-a866-4ac4-8a45-a3c1bd88d32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7672b207-658d-440f-ba8d-d570652265f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11c69470-a866-4ac4-8a45-a3c1bd88d32e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7672b207-658d-440f-ba8d-d570652265f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_424723eb-42cd-4657-a1b1-f975b05b2703" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0ef3015d-67a1-4dda-b3b3-746f79702ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_0ef3015d-67a1-4dda-b3b3-746f79702ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_45ff6ecd-7613-4664-8e1f-1ae90e96b563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_45ff6ecd-7613-4664-8e1f-1ae90e96b563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_e9810fca-9364-4a91-b6f0-bec129168f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_e9810fca-9364-4a91-b6f0-bec129168f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_1e71768b-54f0-4d96-bd3a-6a1c3bc1506b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ce0dab7d-8479-496b-be73-d22edacf8c63" xlink:to="loc_us-gaap_LongTermDebtFairValue_1e71768b-54f0-4d96-bd3a-6a1c3bc1506b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_684fb934-35c2-43bb-86e9-5ebf57fec097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_684fb934-35c2-43bb-86e9-5ebf57fec097" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d80305b5-99da-4d7b-874d-6d49b6803f07" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_45bf1e10-afc9-4825-983d-528bde5d9c4f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d80305b5-99da-4d7b-874d-6d49b6803f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_d3b9bb34-6387-44f6-9a44-3bf486fa88f0" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d80305b5-99da-4d7b-874d-6d49b6803f07" xlink:to="loc_iclr_OncacareMember_d3b9bb34-6387-44f6-9a44-3bf486fa88f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e21046d-80c6-429b-89a3-c35ce1e6ad83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd76cc2e-738d-4651-973e-8b7185c74998" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e21046d-80c6-429b-89a3-c35ce1e6ad83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_950a17f5-a1fe-4409-b663-b0cd2818d4df" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e21046d-80c6-429b-89a3-c35ce1e6ad83" xlink:to="loc_iclr_OncacareMember_950a17f5-a1fe-4409-b663-b0cd2818d4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_eac4172a-33dc-42cd-aa72-7e211ad4a08b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0ae27934-5388-45a0-bedf-78dd58bc6030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0ae27934-5388-45a0-bedf-78dd58bc6030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_28f58985-56a8-4c58-82ae-6b81c4f540ea" xlink:href="iclr-20231231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_28f58985-56a8-4c58-82ae-6b81c4f540ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_1a27d1f8-23a5-4bf8-aa6a-ad5cbbca681f" xlink:href="iclr-20231231.xsd#iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_1a27d1f8-23a5-4bf8-aa6a-ad5cbbca681f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_c88f67cf-9cba-448a-ba01-33bf7aa83bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_c88f67cf-9cba-448a-ba01-33bf7aa83bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_90f0415b-36e5-439a-8ae8-0e47bff70817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_90f0415b-36e5-439a-8ae8-0e47bff70817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_b9382d09-1dbc-4126-9754-ec5aec919eca" xlink:href="iclr-20231231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_b9382d09-1dbc-4126-9754-ec5aec919eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b7ee155-cdbe-4a43-ad17-248254562e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b7ee155-cdbe-4a43-ad17-248254562e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7bd750be-c637-4614-bff7-62a48ff519ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_EquityMethodInvestments_7bd750be-c637-4614-bff7-62a48ff519ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_95a47a00-fda5-4552-af9d-c21de381f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_95a47a00-fda5-4552-af9d-c21de381f58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_eb12a3ca-1655-4437-9523-0000c6683add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_7810960b-06ae-4d52-a498-67172da4bfe9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_eb12a3ca-1655-4437-9523-0000c6683add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e3304410-8e9e-4568-a655-ea9b19dcaaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_Land_e3304410-8e9e-4568-a655-ea9b19dcaaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_f5300bab-a7e1-4cdc-bf97-396ab2752656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_f5300bab-a7e1-4cdc-bf97-396ab2752656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_d2ed8387-b669-42d0-a953-64d191f39c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_d2ed8387-b669-42d0-a953-64d191f39c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_cf58a5fb-03e8-418d-b9fc-c85eaccfefa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_cf58a5fb-03e8-418d-b9fc-c85eaccfefa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_54e00b26-1916-48bd-9b17-37c9bcf63d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_54e00b26-1916-48bd-9b17-37c9bcf63d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_8c5b32dd-75b7-4444-ab17-6ab29d3ae1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_8c5b32dd-75b7-4444-ab17-6ab29d3ae1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_e0ebff61-1d43-424e-b057-5a3f07566bbd" xlink:href="iclr-20231231.xsd#iclr_VehiclesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_iclr_VehiclesGross_e0ebff61-1d43-424e-b057-5a3f07566bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_86867677-5656-4aa1-91f2-1b6ec3595c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_86867677-5656-4aa1-91f2-1b6ec3595c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4b929cc5-f437-43b5-b5e4-a3be1354e43b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4b929cc5-f437-43b5-b5e4-a3be1354e43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f3f47d95-fe0a-4229-b08f-dd09aa5a82e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a3b68667-a88a-43e9-ac8d-b2bafdda6285" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f3f47d95-fe0a-4229-b08f-dd09aa5a82e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#PropertyPlantandEquipmentnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7b083337-b2e3-435b-af36-04cab55310f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_44ca9302-dca3-4f2b-ba16-f337bd22e241" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7b083337-b2e3-435b-af36-04cab55310f2" xlink:to="loc_us-gaap_Depreciation_44ca9302-dca3-4f2b-ba16-f337bd22e241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#GoodwillScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7a8ca186-d497-4b30-8198-4a6424b1de80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7a8ca186-d497-4b30-8198-4a6424b1de80" xlink:to="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_85bfac6d-383e-4025-9003-3d21f87b1f37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:to="loc_us-gaap_Goodwill_85bfac6d-383e-4025-9003-3d21f87b1f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d66803aa-2371-4a85-9fda-532d01974c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d66803aa-2371-4a85-9fda-532d01974c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_30a1c4b4-4983-4fae-a576-3de99aef8d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_30a1c4b4-4983-4fae-a576-3de99aef8d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_f0ef9a67-abae-4c82-93b8-4113787669b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_f0ef9a67-abae-4c82-93b8-4113787669b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0d84b817-fa87-4748-ae5b-20d141f2f2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0ef6648b-5b02-4a81-a588-b1ce0959b832" xlink:to="loc_us-gaap_Goodwill_0d84b817-fa87-4748-ae5b-20d141f2f2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1779b6ce-c22c-44b5-8619-845f2e5a2d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8809453d-2d8e-4b58-985b-9263a5436b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1779b6ce-c22c-44b5-8619-845f2e5a2d5e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8809453d-2d8e-4b58-985b-9263a5436b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_034dc832-7339-4be6-93f9-c524e9b56aec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_034dc832-7339-4be6-93f9-c524e9b56aec" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ede95ab3-098e-4423-a3da-3cb261263717" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_901a1e21-d55e-4858-99fe-9d8061de23f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_901a1e21-d55e-4858-99fe-9d8061de23f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_3032c410-00ea-4198-9bb3-297392e88e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_3032c410-00ea-4198-9bb3-297392e88e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_d7b79c4c-036c-4f6b-abaa-2b68d38bb1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_TradeNamesMember_d7b79c4c-036c-4f6b-abaa-2b68d38bb1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_4217b1e5-bc3f-4392-ba87-61e7e64bf952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_DatabasesMember_4217b1e5-bc3f-4392-ba87-61e7e64bf952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d693fb7-0014-4b00-93a4-92ba60c1c30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5df21e26-16d8-4835-b4be-d22e74dc68a5" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d693fb7-0014-4b00-93a4-92ba60c1c30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_0910a415-3bb8-48f9-8d68-f41eb67c4920" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_760ac196-3352-40ed-9242-386cbad8338e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_760ac196-3352-40ed-9242-386cbad8338e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_57a9245d-561b-48c3-b2ef-84c2e309fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_57a9245d-561b-48c3-b2ef-84c2e309fa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b0f0f71-0119-4dc8-9c7f-63f4e2c78fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4727f3a6-2417-4aac-92c2-a15823303000" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9b0f0f71-0119-4dc8-9c7f-63f4e2c78fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66c6f654-4af4-4f2d-9764-a86a5cf40cee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66c6f654-4af4-4f2d-9764-a86a5cf40cee" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d3df537-8c8b-4cd7-896d-364acc252d35" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_f7ff76b1-233b-42e1-b188-3fb62efbb2b1" xlink:href="iclr-20231231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:to="loc_iclr_BiotelResearchLLCMember_f7ff76b1-233b-42e1-b188-3fb62efbb2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_e60b8a86-8753-4bf1-bc99-2de3accff053" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7325c82e-7aaa-43cf-8dc0-3344a2fd5962" xlink:to="loc_iclr_PRAHealthSciencesIncMember_e60b8a86-8753-4bf1-bc99-2de3accff053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56699ab6-f91f-4f29-b53d-11f15b318500" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_61baba69-31b9-4aae-986d-55c077a49bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_CustomerRelationshipsMember_61baba69-31b9-4aae-986d-55c077a49bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_98a0c2a1-4b7a-4f3d-a1e6-7b1ee4aba6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_98a0c2a1-4b7a-4f3d-a1e6-7b1ee4aba6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_212b7c9f-c0a7-4e12-b5b0-9ecf7b3eb8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_TradeNamesMember_212b7c9f-c0a7-4e12-b5b0-9ecf7b3eb8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_6d2cef16-f6d8-4950-b922-a3091ab79f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_DatabasesMember_6d2cef16-f6d8-4950-b922-a3091ab79f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_477210d7-7f8b-4023-aa8a-bccd234b68e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8e3cc72-65b7-49a9-9815-d5d080136976" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_477210d7-7f8b-4023-aa8a-bccd234b68e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc6f9e18-4eb9-4cd6-8d7e-35e1065ec143" xlink:to="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b7fcdd5e-7040-431f-8206-f1eec5a88cd3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:to="loc_srt_MinimumMember_b7fcdd5e-7040-431f-8206-f1eec5a88cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68fc0d88-144c-488d-95b0-025c513d3a59" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d18b7f0-89a2-4478-a6ad-b285bd74a0e1" xlink:to="loc_srt_MaximumMember_68fc0d88-144c-488d-95b0-025c513d3a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b8f29958-bd1b-4bfc-962d-7625a0628396" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1460cc11-32fe-4c0b-bb2f-9d9afbdffe55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1460cc11-32fe-4c0b-bb2f-9d9afbdffe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_228c9d26-c510-4f4a-bb1b-97f087a8318f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_228c9d26-c510-4f4a-bb1b-97f087a8318f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46042a22-8e81-4f7b-88bb-cd32fb2d93b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_46042a22-8e81-4f7b-88bb-cd32fb2d93b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bd68c820-4bf7-478a-90fb-0ae944fe23d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1649a392-8668-49ab-92a5-1f18a613f30f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bd68c820-4bf7-478a-90fb-0ae944fe23d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a1bf6ade-a57c-4d99-a994-da44fe8b3e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a1bf6ade-a57c-4d99-a994-da44fe8b3e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6e4e91a1-1ab5-403c-a027-26d7e1b833aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6e4e91a1-1ab5-403c-a027-26d7e1b833aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4ad72730-6540-441d-ad54-b46531b78a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4ad72730-6540-441d-ad54-b46531b78a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1c4ea62-8590-4bd5-9c85-70cf69bff4df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1c4ea62-8590-4bd5-9c85-70cf69bff4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7f768e92-67dd-4b11-afb7-092486c80c77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7f768e92-67dd-4b11-afb7-092486c80c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b23db5f4-1b65-4bde-9daf-e85f87cd26d5" xlink:href="iclr-20231231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d662a222-d29c-42b7-b776-f27251dd362f" xlink:to="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b23db5f4-1b65-4bde-9daf-e85f87cd26d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_4493eea2-3157-4ff3-b214-6e18f6743222" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_4493eea2-3157-4ff3-b214-6e18f6743222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7e961839-651c-42f9-b4b2-2f8ac85896c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7e961839-651c-42f9-b4b2-2f8ac85896c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_66604fba-900f-427c-a1fc-6c65591e854d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_66604fba-900f-427c-a1fc-6c65591e854d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_bcf9fe98-0181-4f82-899b-a51e2cf49193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_bcf9fe98-0181-4f82-899b-a51e2cf49193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_51e3b194-8dfe-46f6-928f-18b9c4e89d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_51e3b194-8dfe-46f6-928f-18b9c4e89d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_068fd91e-b7c6-4f12-b5ab-86510d164696" xlink:href="iclr-20231231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_068fd91e-b7c6-4f12-b5ab-86510d164696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent_92552fe9-8833-40bc-bd89-8b1785ca479a" xlink:href="iclr-20231231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_iclr_CapitalGovernmentGrantsCurrent_92552fe9-8833-40bc-bd89-8b1785ca479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_01138284-4cbf-46b9-8a5d-19f7a4cf3044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_01138284-4cbf-46b9-8a5d-19f7a4cf3044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_6f13fd5e-72a4-436b-a14e-b4d4c115b308" xlink:href="iclr-20231231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_11231a06-2477-4006-b34d-2a5f6668a1b9" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_6f13fd5e-72a4-436b-a14e-b4d4c115b308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_43b5fd7b-ef2e-43a1-9b87-51b7085f0c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_43b5fd7b-ef2e-43a1-9b87-51b7085f0c23" xlink:to="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_964449c8-a81b-48ee-a63c-54e3f0eb9864" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_98f6ac5c-6d49-47b6-97dd-38d47000aa81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:to="loc_us-gaap_SecuredDebtMember_98f6ac5c-6d49-47b6-97dd-38d47000aa81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_07445e18-157d-4c98-b837-7e7f156d6b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_07445e18-157d-4c98-b837-7e7f156d6b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d73d93cd-7e47-40b3-8264-40b600767574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728adc43-2c1e-433c-8fff-28676ed5e35c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d73d93cd-7e47-40b3-8264-40b600767574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:to="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_568f7183-096c-4fdb-972e-289c59fecd4b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_66f89207-3c03-4ce0-984b-69e73bbfd3b9" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:to="loc_iclr_TermLoanFacilityMember_66f89207-3c03-4ce0-984b-69e73bbfd3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_15b9831f-22c1-4b6d-9b9a-eafd1cd79540" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:to="loc_iclr_SeniorSecuredNotesMember_15b9831f-22c1-4b6d-9b9a-eafd1cd79540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c09c3b12-e185-47e5-b8c4-38f54df8bf90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_72645396-e398-4152-9d73-143b0ceb088b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c09c3b12-e185-47e5-b8c4-38f54df8bf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7b5a19d5-fdb7-41ee-86c6-02c8efae856c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d42c0102-07d6-43dd-a68d-c48d0882a0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d42c0102-07d6-43dd-a68d-c48d0882a0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_cce4f2ea-2262-476f-a316-b87ba4d080b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_cce4f2ea-2262-476f-a316-b87ba4d080b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_6bf68583-65bc-4991-8771-6e4b39c0eb0b" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_6bf68583-65bc-4991-8771-6e4b39c0eb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_f9671652-006c-4617-aa60-01ae71aa6996" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_f9671652-006c-4617-aa60-01ae71aa6996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a46db43b-e137-4706-8f7d-d43bbecc5499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a46db43b-e137-4706-8f7d-d43bbecc5499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c9c09d48-e786-4d3b-acf3-9ed2e75e2184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ed9ca65a-ed1c-4481-9fd8-4db4a215564f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c9c09d48-e786-4d3b-acf3-9ed2e75e2184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7db9feea-0f9d-4041-ae1c-d504cc358cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7db9feea-0f9d-4041-ae1c-d504cc358cd4" xlink:to="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9464e15-4ba6-4eea-aaf3-4c8ea66208f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_add8629d-3a96-4168-ab1b-0e8605452b2e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9464e15-4ba6-4eea-aaf3-4c8ea66208f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_efda2275-c855-40d4-b227-1c3c2f04571e" xlink:href="iclr-20231231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a9464e15-4ba6-4eea-aaf3-4c8ea66208f5" xlink:to="loc_iclr_PRAHealthSciencesIncMember_efda2275-c855-40d4-b227-1c3c2f04571e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07aeba5b-b13a-4182-ae1c-1ff392d30515" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e24a8889-1553-40c6-bb7f-4a905e9f8cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:to="loc_us-gaap_SecuredDebtMember_e24a8889-1553-40c6-bb7f-4a905e9f8cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0871c30b-ff87-4246-be80-a2b2e248419f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:to="loc_us-gaap_LineOfCreditMember_0871c30b-ff87-4246-be80-a2b2e248419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_2441a465-f0aa-49c5-b27d-fb76eb6fb7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7b6a8-091e-4955-a45f-91e551833239" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_2441a465-f0aa-49c5-b27d-fb76eb6fb7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_435a967d-074f-456e-ab90-5fbb8c0a31d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_b9c7c64b-6210-4ae5-a91b-7a72952b44a1" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_TermLoanFacilityMember_b9c7c64b-6210-4ae5-a91b-7a72952b44a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_bf407012-bfcc-418d-b038-68b94810739e" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_bf407012-bfcc-418d-b038-68b94810739e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_eb3f3caa-49c1-42f8-bb25-f947f65bef0d" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_eb3f3caa-49c1-42f8-bb25-f947f65bef0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_aaf752da-0695-4565-8063-5865d5a5b314" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f7e37116-046f-4fd8-8105-f194c70f728d" xlink:to="loc_iclr_SeniorSecuredNotesMember_aaf752da-0695-4565-8063-5865d5a5b314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f944f78f-85c4-4748-a20a-9132578e6f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ea1acb0b-82cd-469d-9e1f-7af83c82fde1" xlink:to="loc_us-gaap_CreditFacilityDomain_f944f78f-85c4-4748-a20a-9132578e6f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b02b12d4-cb3e-4439-887d-149039c2aa9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f944f78f-85c4-4748-a20a-9132578e6f11" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b02b12d4-cb3e-4439-887d-149039c2aa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentAxis_b53712af-2d06-45d0-bbbc-6dec06346e98" xlink:to="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_e74a1783-dc0f-455d-be85-5316b0fc7c80" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:to="loc_iclr_VariableRateComponentOneMember_e74a1783-dc0f-455d-be85-5316b0fc7c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_07565fde-dafc-49bf-9ead-b476d98db514" xlink:href="iclr-20231231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_5c6bd2e2-19d7-4a41-8c5b-28b759a5f253" xlink:to="loc_iclr_VariableRateComponentTwoMember_07565fde-dafc-49bf-9ead-b476d98db514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9d9d80d9-a9ed-469f-8c23-be7525a87fc7" xlink:to="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_81010f6a-9805-4c0b-98f1-9c614b52e7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_81010f6a-9805-4c0b-98f1-9c614b52e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_f99973e0-dc86-45a7-b149-51d7531b365f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8fafbfa6-671a-4bbd-93bb-a3b73c995310" xlink:to="loc_us-gaap_BaseRateMember_f99973e0-dc86-45a7-b149-51d7531b365f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1cace2cd-7925-4d5a-9124-d796deeb0c34" xlink:to="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08155e9f-a5c1-4031-9e1f-681a322d2802" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:to="loc_srt_MaximumMember_08155e9f-a5c1-4031-9e1f-681a322d2802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2073e6d7-c69c-4ad3-863f-e72c3adadbf9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc176199-cb98-4048-939d-7f2b21151d5b" xlink:to="loc_srt_MinimumMember_2073e6d7-c69c-4ad3-863f-e72c3adadbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_319a0305-2fdb-47a3-8098-68dfb92b23ee" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c5ae7cf0-db86-4e7e-952c-ed0faa8ba757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_InterestExpense_c5ae7cf0-db86-4e7e-952c-ed0faa8ba757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_683381c6-1892-491c-9dd2-f5b2c55d9b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_683381c6-1892-491c-9dd2-f5b2c55d9b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7db91a6b-99f4-429e-bbf4-acd74ae3102e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7db91a6b-99f4-429e-bbf4-acd74ae3102e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1f3f4e1e-9d15-4aa6-b5a1-fd89ac3cd431" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1f3f4e1e-9d15-4aa6-b5a1-fd89ac3cd431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_336899e8-c70e-4cae-8fde-24a7dbac4b56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_336899e8-c70e-4cae-8fde-24a7dbac4b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_753217c4-95b0-4f9c-b91a-739045ce203a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_753217c4-95b0-4f9c-b91a-739045ce203a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_47b26d18-bd79-4560-9bd4-05e7f88668e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_47b26d18-bd79-4560-9bd4-05e7f88668e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_4ff93188-04f2-403f-b3c5-c6c603428593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_4ff93188-04f2-403f-b3c5-c6c603428593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b096702a-1d7f-4da7-a3b3-e653a4b8e9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b096702a-1d7f-4da7-a3b3-e653a4b8e9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_69a3f89d-19ac-48f8-be3a-b6913b32eb04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_69a3f89d-19ac-48f8-be3a-b6913b32eb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_4ce2f5c5-1512-4b0d-810c-e3654f7ab004" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e7bd786-9d35-48a6-8d98-b1b914120e1e" xlink:to="loc_us-gaap_LongTermDebtFairValue_4ce2f5c5-1512-4b0d-810c-e3654f7ab004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_77cb3e60-f32a-4b5f-9f9e-a2c9bd3cca59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_5c3654c9-1cd4-47e6-897d-9a3a2a0fede2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77cb3e60-f32a-4b5f-9f9e-a2c9bd3cca59" xlink:to="loc_us-gaap_InterestExpenseDebt_5c3654c9-1cd4-47e6-897d-9a3a2a0fede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_770a0f73-a748-400e-a41b-e4d8414a6742" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77cb3e60-f32a-4b5f-9f9e-a2c9bd3cca59" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_770a0f73-a748-400e-a41b-e4d8414a6742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_8afb535f-dbeb-460d-b401-f4069a5244bb" xlink:href="iclr-20231231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77cb3e60-f32a-4b5f-9f9e-a2c9bd3cca59" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_8afb535f-dbeb-460d-b401-f4069a5244bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_6c34f1ce-59e8-4a4e-9b7c-b0a5e8a3c4a1" xlink:href="iclr-20231231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77cb3e60-f32a-4b5f-9f9e-a2c9bd3cca59" xlink:to="loc_iclr_InterestExpenseCreditOther_6c34f1ce-59e8-4a4e-9b7c-b0a5e8a3c4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_933012f9-6672-4f7c-bab6-ad5374a86d24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77cb3e60-f32a-4b5f-9f9e-a2c9bd3cca59" xlink:to="loc_us-gaap_InterestExpense_933012f9-6672-4f7c-bab6-ad5374a86d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_67110ec6-2f78-4285-8bfb-ac6ab0abff2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_67110ec6-2f78-4285-8bfb-ac6ab0abff2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ee0949a3-fa5d-438e-a6af-79fdbec7fad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ee0949a3-fa5d-438e-a6af-79fdbec7fad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_de130954-033e-45e1-871f-fa8b92884d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_de130954-033e-45e1-871f-fa8b92884d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_eacc2f85-de7a-4c8f-a877-eaf7068126d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_eacc2f85-de7a-4c8f-a877-eaf7068126d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_f3db99ac-c422-40c6-ba65-49eadabd2337" xlink:href="iclr-20231231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_f3db99ac-c422-40c6-ba65-49eadabd2337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d36a1fe8-e473-4535-9c7b-60b171560db5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70e39419-1b54-42ce-b1d0-29a98e36acf6" xlink:to="loc_us-gaap_LongTermDebt_d36a1fe8-e473-4535-9c7b-60b171560db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bcb2fee4-6acc-49fb-8f4a-af83f5f95666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bcb2fee4-6acc-49fb-8f4a-af83f5f95666" xlink:to="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_907691bb-62c7-46f2-b569-71bad94ac8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a605a4d3-2cd6-4250-8fe9-e2635b04caf7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_907691bb-62c7-46f2-b569-71bad94ac8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_20268733-6a0c-41eb-a8c6-74f9643f2832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_907691bb-62c7-46f2-b569-71bad94ac8e5" xlink:to="loc_us-gaap_SecuredDebtMember_20268733-6a0c-41eb-a8c6-74f9643f2832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:to="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e35547d-8c47-4ab9-a273-71e956bfd445" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e9b4f476-4100-42a1-8679-6adc05adf41e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e35547d-8c47-4ab9-a273-71e956bfd445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_a116559e-fd0a-4e52-971d-ec23346d8a78" xlink:href="iclr-20231231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7e35547d-8c47-4ab9-a273-71e956bfd445" xlink:to="loc_iclr_TermLoanFacilityMember_a116559e-fd0a-4e52-971d-ec23346d8a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3d9a97a7-0ac8-4b38-8b2c-6db10373c2af" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_fa094519-e997-4a7a-9de4-645f3b511c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_fa094519-e997-4a7a-9de4-645f3b511c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_b9375a6c-f8e6-44d0-8598-e5419305594e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c8de79d0-aeaa-44c6-b0f7-e4cca75d4d03" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_b9375a6c-f8e6-44d0-8598-e5419305594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e510fede-fcaa-4354-8c99-4ec84616aa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e510fede-fcaa-4354-8c99-4ec84616aa7d" xlink:to="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f1642c94-46ef-4900-8f4b-b6ff75f97642" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b6bebe11-3fe9-4247-a8c6-732d78b01fad" xlink:to="loc_us-gaap_CreditFacilityDomain_f1642c94-46ef-4900-8f4b-b6ff75f97642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5626a8a2-480c-4447-ba66-6615a6992d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f1642c94-46ef-4900-8f4b-b6ff75f97642" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5626a8a2-480c-4447-ba66-6615a6992d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a1aaf2db-3af3-463b-9ca0-fa51c273937d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d810816-9848-4457-a430-7bae71299a0f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a1aaf2db-3af3-463b-9ca0-fa51c273937d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_b3809de3-59fe-47ec-9165-85215b0f6e06" xlink:href="iclr-20231231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a1aaf2db-3af3-463b-9ca0-fa51c273937d" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_b3809de3-59fe-47ec-9165-85215b0f6e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8b40ed7-955b-4f55-8273-52d94073789c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64ccb12b-fe86-443f-8126-3134ec3420fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8b40ed7-955b-4f55-8273-52d94073789c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bf813122-2175-46e2-a877-d263cb4c85f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d8b40ed7-955b-4f55-8273-52d94073789c" xlink:to="loc_us-gaap_LineOfCreditMember_bf813122-2175-46e2-a877-d263cb4c85f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df940761-ed43-4bae-ae2a-788e54cc4124" xlink:to="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_3564b223-b45c-4ffd-973f-726a14a7616f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_3564b223-b45c-4ffd-973f-726a14a7616f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_f95177f5-7854-463d-be6e-09d83c09f5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_f95177f5-7854-463d-be6e-09d83c09f5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9059aee-fd33-4bed-9b67-6d80852a115b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71a34781-73b0-4fe8-ba07-82294ab25e1d" xlink:to="loc_us-gaap_LongTermDebt_b9059aee-fd33-4bed-9b67-6d80852a115b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DerivativesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d935ce2e-cd23-4bf2-9e20-0f86fa575891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d935ce2e-cd23-4bf2-9e20-0f86fa575891" xlink:to="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5d0d0211-1127-4a0e-b43a-8b5c76173efb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_ab06d769-fccd-4eaf-9a31-ccb0afd02f32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:to="loc_us-gaap_InterestRateCapMember_ab06d769-fccd-4eaf-9a31-ccb0afd02f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8c2c6d4e-75f9-4873-92a8-07430cf48476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:to="loc_us-gaap_InterestRateSwapMember_8c2c6d4e-75f9-4873-92a8-07430cf48476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_d8e53e30-549f-4046-a81e-5d2c601872dc" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f65534-23d5-4277-9bb1-278679c13877" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_d8e53e30-549f-4046-a81e-5d2c601872dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e0ff3d49-ab5d-4e00-a1bc-c52a14c9f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2b5b4cca-a081-4826-91bf-fbe8391c902b" xlink:to="loc_us-gaap_HedgingDesignationDomain_e0ff3d49-ab5d-4e00-a1bc-c52a14c9f91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_68b8f4f7-20ca-4e3e-95bc-cfdc6cfa5f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_e0ff3d49-ab5d-4e00-a1bc-c52a14c9f91c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_68b8f4f7-20ca-4e3e-95bc-cfdc6cfa5f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e9f27869-25c3-4c88-84f8-198ec988039f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_27206381-b527-4e2d-9d19-5d3130a60b71" xlink:to="loc_us-gaap_VariableRateDomain_e9f27869-25c3-4c88-84f8-198ec988039f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_773aabd0-52f0-4c77-94df-f4869ecfba52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e9f27869-25c3-4c88-84f8-198ec988039f" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_773aabd0-52f0-4c77-94df-f4869ecfba52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1af9d111-31b6-4fa1-8b0b-94812dda8ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e5437c8e-e94d-4902-bb27-4f0e657760fe" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1af9d111-31b6-4fa1-8b0b-94812dda8ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_935b02c1-fafc-455d-adc0-8919d04f2f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1af9d111-31b6-4fa1-8b0b-94812dda8ffa" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_935b02c1-fafc-455d-adc0-8919d04f2f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ff1429aa-32ae-4e55-91c9-716b1de39ddb" xlink:to="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_3ff44054-7ada-4161-89ae-53ff906912dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_3ff44054-7ada-4161-89ae-53ff906912dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_911e1c6a-e653-4ace-abba-f71f28c72e91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeNotionalAmount_911e1c6a-e653-4ace-abba-f71f28c72e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_1a9ea1c4-6285-4730-92f8-73d1ae68e793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_1a9ea1c4-6285-4730-92f8-73d1ae68e793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_c7d41aa1-350c-4a50-bd1b-f0a4ad787558" xlink:href="iclr-20231231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_c7d41aa1-350c-4a50-bd1b-f0a4ad787558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_d8100459-e093-456d-8f4c-eee78850a331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_d8100459-e093-456d-8f4c-eee78850a331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_b59fc658-6fac-40bb-bd28-e937c6653533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_b59fc658-6fac-40bb-bd28-e937c6653533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_84560b50-bc8d-496f-9588-bd012914c5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_84560b50-bc8d-496f-9588-bd012914c5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_d7d5506b-f461-4aae-bf26-e093106eee39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_d7d5506b-f461-4aae-bf26-e093106eee39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_5755468a-486e-496c-8620-e9c8a1921f00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_5755468a-486e-496c-8620-e9c8a1921f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_1c606a40-38ad-4062-9c17-92486284c899" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration_1c606a40-38ad-4062-9c17-92486284c899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b8fb9029-06e7-4ccb-9424-ee8a9f13d7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b8fb9029-06e7-4ccb-9424-ee8a9f13d7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cca45d8a-9bf4-4c85-bdd8-4861d427f979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cca45d8a-9bf4-4c85-bdd8-4861d427f979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_58141bda-a358-4d58-82eb-ed624b8f0e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a16e4a13-4a92-4e73-9d00-55883cf78397" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_58141bda-a358-4d58-82eb-ed624b8f0e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0497b88e-0589-4721-a627-2a8faaa8d2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0497b88e-0589-4721-a627-2a8faaa8d2e0" xlink:to="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b63924d-7617-42b4-8d5b-413382ba616d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_5e9b80ea-e1dc-48cd-a4b2-96952d67ab82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:to="loc_us-gaap_InterestRateCapMember_5e9b80ea-e1dc-48cd-a4b2-96952d67ab82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5d200dfe-b149-4f2c-80fa-0a3e0676cd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:to="loc_us-gaap_InterestRateSwapMember_5d200dfe-b149-4f2c-80fa-0a3e0676cd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_ee02a52e-5383-4b07-bf31-c3059630465f" xlink:href="iclr-20231231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_312b1cbc-69f6-48ee-a7a1-65901bff4c06" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_ee02a52e-5383-4b07-bf31-c3059630465f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f23747ec-4e5e-4575-99a1-96a74bac6515" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_f8ea5d41-1a29-49ef-aa8a-98c330e6b40e" xlink:to="loc_us-gaap_HedgingDesignationDomain_f23747ec-4e5e-4575-99a1-96a74bac6515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_562a0204-230e-4553-ae63-1c745aa74413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f23747ec-4e5e-4575-99a1-96a74bac6515" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_562a0204-230e-4553-ae63-1c745aa74413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d027132-0ebb-4fa7-a856-da7334851b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_561a57c5-9a1c-4331-bd39-09fe8912f998" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d027132-0ebb-4fa7-a856-da7334851b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_78d62c04-fa92-407e-8df8-0a1cfb2fe0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d027132-0ebb-4fa7-a856-da7334851b06" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_78d62c04-fa92-407e-8df8-0a1cfb2fe0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8034fd06-40d5-4e91-a011-f161191463e0" xlink:to="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c9e6f7a7-3def-4389-a876-fc8eb8933558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeAssets_c9e6f7a7-3def-4389-a876-fc8eb8933558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_50bdbc32-d7ce-4272-9dd5-b85b52a91aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeLiabilities_50bdbc32-d7ce-4272-9dd5-b85b52a91aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0b6f80f3-0427-4cac-ab27-f3d0b78da5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_21d58e91-6f82-4b3f-9533-f0ae16d335a4" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0b6f80f3-0427-4cac-ab27-f3d0b78da5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_54fbc4c7-712a-4da0-ab24-909bd5716165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_127bfe98-d7ce-442a-af2e-3e8cb719cd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54fbc4c7-712a-4da0-ab24-909bd5716165" xlink:to="loc_us-gaap_OperatingLeaseCost_127bfe98-d7ce-442a-af2e-3e8cb719cd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_9e43ccd6-78a4-4a7c-91ba-952f74291d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54fbc4c7-712a-4da0-ab24-909bd5716165" xlink:to="loc_us-gaap_SubleaseIncome_9e43ccd6-78a4-4a7c-91ba-952f74291d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5b864432-a47d-4b6f-bc0a-47ffd449ec31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_54fbc4c7-712a-4da0-ab24-909bd5716165" xlink:to="loc_us-gaap_LeaseCost_5b864432-a47d-4b6f-bc0a-47ffd449ec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_06b22af1-9db2-4653-986d-7a3e1a474523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06b22af1-9db2-4653-986d-7a3e1a474523" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f0e8f56e-cd16-4480-bee3-f3750af8e61f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_945abb91-78ab-4d7a-bb37-9f74e19a74aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_945abb91-78ab-4d7a-bb37-9f74e19a74aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_8e52be96-2a56-4088-9ba2-1b4ab4e992a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_af59f121-c875-47d0-b642-10a0177a945c" xlink:to="loc_us-gaap_CostOfSalesMember_8e52be96-2a56-4088-9ba2-1b4ab4e992a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a12f1453-c606-4112-9c0b-1ff4b874bcd5" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e78db12c-2647-43f4-ab05-d5c8835c6755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_LeaseCost_e78db12c-2647-43f4-ab05-d5c8835c6755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e6c22a9b-4bb1-4368-975d-9a339842eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e6c22a9b-4bb1-4368-975d-9a339842eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_0de2193c-0dc4-4d45-803a-c1f244989668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_0de2193c-0dc4-4d45-803a-c1f244989668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_64f187bb-038e-404b-8025-47eb9b3fd596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_64f187bb-038e-404b-8025-47eb9b3fd596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_37891cf0-5c5f-4346-ac7b-cc026502c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_37891cf0-5c5f-4346-ac7b-cc026502c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7603d019-3b87-4efb-853c-5b41bba169ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7603d019-3b87-4efb-853c-5b41bba169ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7594a552-a5f3-47a2-a289-f512ba884100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4f4ad75b-6801-4826-9f20-5891d7d02483" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7594a552-a5f3-47a2-a289-f512ba884100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f00b29fb-07c0-458d-be0f-f43761760ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f00b29fb-07c0-458d-be0f-f43761760ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_05b3223e-1f1e-4fa8-93f5-af937ddf5995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_05b3223e-1f1e-4fa8-93f5-af937ddf5995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_181fd003-7b22-418e-9056-b01f788da432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_181fd003-7b22-418e-9056-b01f788da432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cbf15967-e274-4af2-bbe2-a876d28bf58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cbf15967-e274-4af2-bbe2-a876d28bf58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4dae5196-07a3-45ee-b560-7304476419ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4dae5196-07a3-45ee-b560-7304476419ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_da529a57-49f2-4174-a8fa-916825c3245e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_da529a57-49f2-4174-a8fa-916825c3245e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f4e63225-b3b9-4831-ade1-9aa2ea4b1693" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f4e63225-b3b9-4831-ade1-9aa2ea4b1693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_32141a2b-dea1-4114-8d77-b83a9eb3413b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_32141a2b-dea1-4114-8d77-b83a9eb3413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ea9a8730-d57f-4f73-9cbc-01b64f8bc307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_39e3fbcc-127d-47fe-b975-029b08cac1b1" xlink:to="loc_us-gaap_OperatingLeaseLiability_ea9a8730-d57f-4f73-9cbc-01b64f8bc307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20231231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#NoncurrentotherliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e5b5e4be-35b7-457e-9812-a2bdc7f1443a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_31dc335d-1a69-4af0-aabe-cb4f4db41a58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e5b5e4be-35b7-457e-9812-a2bdc7f1443a" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_31dc335d-1a69-4af0-aabe-cb4f4db41a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_ea70e4a3-9894-4051-b1c4-0b64c95a00e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e5b5e4be-35b7-457e-9812-a2bdc7f1443a" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_ea70e4a3-9894-4051-b1c4-0b64c95a00e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9b938815-47c7-4424-8667-a3fc6872948e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e5b5e4be-35b7-457e-9812-a2bdc7f1443a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9b938815-47c7-4424-8667-a3fc6872948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4372abc8-67b6-486a-b59f-797ad03d9b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_034a967e-cfd8-48bd-a16c-ae5180a5c244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4372abc8-67b6-486a-b59f-797ad03d9b93" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_034a967e-cfd8-48bd-a16c-ae5180a5c244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#ShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_207043f0-0378-4f21-81ab-276ee0686f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_207043f0-0378-4f21-81ab-276ee0686f9b" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_09cfd171-7a92-4ff7-bdb6-c9b6eb17c2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_72a17f2c-236a-4ec3-afed-93eb3cb29ead" xlink:to="loc_us-gaap_EquityComponentDomain_09cfd171-7a92-4ff7-bdb6-c9b6eb17c2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_99637137-2b9b-4a18-a2aa-fb16b9262dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_09cfd171-7a92-4ff7-bdb6-c9b6eb17c2f3" xlink:to="loc_us-gaap_CommonStockMember_99637137-2b9b-4a18-a2aa-fb16b9262dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3dd7fe82-4dca-43c2-836d-0492623def4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_75c408f9-728a-48ae-ac57-7ff0ffd544d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:to="loc_us-gaap_EmployeeStockOptionMember_75c408f9-728a-48ae-ac57-7ff0ffd544d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bdc5a27e-a112-403e-8ca0-2e7ad5aec5df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bdc5a27e-a112-403e-8ca0-2e7ad5aec5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_04249a92-76b6-4109-bb70-ec8e6e0cef01" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_68e63954-3930-4362-b270-649e19f73a00" xlink:to="loc_iclr_PerformanceShareUnitMember_04249a92-76b6-4109-bb70-ec8e6e0cef01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_544ed05f-2a55-4a2e-8b61-67e6fa0211e4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e91426ce-1b32-448c-94f3-829b5a20cb9d" xlink:to="loc_srt_RangeMember_544ed05f-2a55-4a2e-8b61-67e6fa0211e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2db82115-6c37-45f3-9412-356df4fe0fad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_544ed05f-2a55-4a2e-8b61-67e6fa0211e4" xlink:to="loc_srt_MaximumMember_2db82115-6c37-45f3-9412-356df4fe0fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_af46050c-2bfa-4b8f-80e1-8107072eac29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5ec11783-9cf6-48b7-b6b6-2cc64106d17c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_af46050c-2bfa-4b8f-80e1-8107072eac29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_660a8a49-e00a-425a-b1ea-2723be2cf39d" xlink:href="iclr-20231231.xsd#iclr_BuybackProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_af46050c-2bfa-4b8f-80e1-8107072eac29" xlink:to="loc_iclr_BuybackProgramMember_660a8a49-e00a-425a-b1ea-2723be2cf39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ff446cee-ce27-4fb0-ba59-046d0ba93068" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_f7372930-6f30-4891-9733-d65008fedd90" xlink:href="iclr-20231231.xsd#iclr_NumberOfVotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_iclr_NumberOfVotes_f7372930-6f30-4891-9733-d65008fedd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8770fa4d-1f15-4e5a-89de-824f9df1795a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8770fa4d-1f15-4e5a-89de-824f9df1795a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cd6c556-b857-461e-9caf-b7d00bc3e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cd6c556-b857-461e-9caf-b7d00bc3e3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26285c73-17a8-4d54-a714-662edf501eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_26285c73-17a8-4d54-a714-662edf501eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_089d7604-f8f3-4b30-ba97-a597f951acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_089d7604-f8f3-4b30-ba97-a597f951acdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_94a4d396-48af-44b1-8837-bd925ccda39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_94a4d396-48af-44b1-8837-bd925ccda39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3ccd3d28-15b1-444b-bfdb-f13a5fed6336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3ccd3d28-15b1-444b-bfdb-f13a5fed6336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_738434a2-dd6b-44ef-a51e-1902b17ca5d3" xlink:href="iclr-20231231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_738434a2-dd6b-44ef-a51e-1902b17ca5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1c105d6a-f476-4b65-84a9-19875db65d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1c105d6a-f476-4b65-84a9-19875db65d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_70e25814-f0e5-4a6e-9e15-ac11b5f84fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3269224c-3896-42de-82ad-00df9d641834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_70e25814-f0e5-4a6e-9e15-ac11b5f84fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d8ce3f3c-3cf5-421c-9fd1-963895fb4b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d8ce3f3c-3cf5-421c-9fd1-963895fb4b7f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:to="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_962286da-f74b-4904-b4e2-d23132b305be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_7d1e449c-53bb-4069-84fb-50a226934963" xlink:to="loc_us-gaap_RestructuringPlanDomain_962286da-f74b-4904-b4e2-d23132b305be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_66e9ae24-9c41-429c-bcd3-16f30dff87ea" xlink:href="iclr-20231231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_962286da-f74b-4904-b4e2-d23132b305be" xlink:to="loc_iclr_A2021RestructuringPlanMember_66e9ae24-9c41-429c-bcd3-16f30dff87ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6daab919-399b-492d-8ef3-637ee764150d" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember_4255cd79-0723-4b43-9e1e-ce1ef60f83e4" xlink:href="iclr-20231231.xsd#iclr_LeaseLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:to="loc_iclr_LeaseLiabilityMember_4255cd79-0723-4b43-9e1e-ce1ef60f83e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_679b3882-8cfe-4889-a6a3-eee50f718850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_444893cb-57f2-4e35-8d06-ad3313f85e15" xlink:to="loc_us-gaap_EmployeeSeveranceMember_679b3882-8cfe-4889-a6a3-eee50f718850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_a7fa45be-8cc7-430a-a9f0-6eac26137c66" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_9b42a37e-4739-4414-a711-7fc964fad3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringCosts_9b42a37e-4739-4414-a711-7fc964fad3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c8b53fe3-9555-479f-a346-1d74bb8548b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_SeveranceCosts1_c8b53fe3-9555-479f-a346-1d74bb8548b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_f849b6e7-f391-4022-ac9b-4b028369f904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_OtherRestructuringCosts_f849b6e7-f391-4022-ac9b-4b028369f904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_888b74ed-ffb8-4617-a51c-cf1de6e608c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringReserve_888b74ed-ffb8-4617-a51c-cf1de6e608c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_b9158f97-15f4-42e4-b314-77b10164dd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringReserveCurrent_b9158f97-15f4-42e4-b314-77b10164dd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_8d44b4cf-6a82-4a63-9773-5873d057b76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_57381d49-b75d-4206-8415-8c4bdd430be2" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_8d44b4cf-6a82-4a63-9773-5873d057b76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#RestructuringchargesScheduleofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_baf949b3-be36-4042-b188-a172802a9011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_4c07f9dc-44e9-45e9-8250-57535936b654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_baf949b3-be36-4042-b188-a172802a9011" xlink:to="loc_us-gaap_RestructuringCosts_4c07f9dc-44e9-45e9-8250-57535936b654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1caf2d00-61c9-47ce-a65b-5f561476e1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_3ce2bf75-4787-45ea-a85b-b8034c1a1256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1caf2d00-61c9-47ce-a65b-5f561476e1ee" xlink:to="loc_us-gaap_RestructuringReserveRollForward_3ce2bf75-4787-45ea-a85b-b8034c1a1256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2a581968-e04f-4da9-91ba-4b5a93e9aafe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3ce2bf75-4787-45ea-a85b-b8034c1a1256" xlink:to="loc_us-gaap_RestructuringReserve_2a581968-e04f-4da9-91ba-4b5a93e9aafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_fdcd31be-280c-47fd-b36c-04801b18b520" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3ce2bf75-4787-45ea-a85b-b8034c1a1256" xlink:to="loc_us-gaap_RestructuringCharges_fdcd31be-280c-47fd-b36c-04801b18b520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations_4b2666ef-fa13-4c3b-95ab-8a8548821a2a" xlink:href="iclr-20231231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3ce2bf75-4787-45ea-a85b-b8034c1a1256" xlink:to="loc_iclr_RestructuringReserveUtilizations_4b2666ef-fa13-4c3b-95ab-8a8548821a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_0e195a34-8260-46e7-bd53-b208fe2858f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3ce2bf75-4787-45ea-a85b-b8034c1a1256" xlink:to="loc_us-gaap_RestructuringReserve_0e195a34-8260-46e7-bd53-b208fe2858f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8b64e446-3f48-42c4-b413-d0f5dbadd11a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8b64e446-3f48-42c4-b413-d0f5dbadd11a" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:to="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_68066ff9-6c65-4cbf-9452-5a8750b0afc2" xlink:to="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_834b030d-a7dd-47c3-959b-02239bdd6021" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:to="loc_country_IE_834b030d-a7dd-47c3-959b-02239bdd6021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b0409524-c50e-43c0-8087-1e0c3b489180" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:to="loc_country_US_b0409524-c50e-43c0-8087-1e0c3b489180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_ad999701-6bd5-4785-bd02-d20d2933d1fa" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_769731a2-5075-4ebb-9425-cca8f0d946f5" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_ad999701-6bd5-4785-bd02-d20d2933d1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_2d9d5d78-4682-44a1-bf14-b9b842127af0" xlink:href="iclr-20231231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_41d0ecec-3191-4f39-bc64-3749e455b63e" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_2d9d5d78-4682-44a1-bf14-b9b842127af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d14067d3-5f32-4330-9866-58fb091e4c10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_2d9d5d78-4682-44a1-bf14-b9b842127af0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d14067d3-5f32-4330-9866-58fb091e4c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_543ca6bf-3697-4519-a52a-f5d34aa58491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:href="iclr-20231231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_543ca6bf-3697-4519-a52a-f5d34aa58491" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:to="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_239a3ac6-191e-4b12-96b4-7eee9230c579" xlink:to="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_d4266006-bcc6-48a9-b445-e1dee2465750" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:to="loc_country_IE_d4266006-bcc6-48a9-b445-e1dee2465750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_68fa5197-353d-4575-a8fc-202828fa470a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:to="loc_country_US_68fa5197-353d-4575-a8fc-202828fa470a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_374f1629-3fba-4ee0-9e44-71b5d94a497e" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1ec3f48b-37ae-45a2-95c5-91316634a91b" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_374f1629-3fba-4ee0-9e44-71b5d94a497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:href="iclr-20231231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_50311b66-7deb-4cfa-a116-714643287403" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d336784c-7f87-4cc3-acab-d3444dd06b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d336784c-7f87-4cc3-acab-d3444dd06b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6db1f25a-ba9e-46ff-8ca1-f22fca0d794a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d336784c-7f87-4cc3-acab-d3444dd06b17" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6db1f25a-ba9e-46ff-8ca1-f22fca0d794a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f28ce530-ddd1-4451-ad01-21f736a31db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f28ce530-ddd1-4451-ad01-21f736a31db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2bada3d0-8014-4246-9737-20826f644907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_f28ce530-ddd1-4451-ad01-21f736a31db8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2bada3d0-8014-4246-9737-20826f644907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b0d69087-6482-4ec4-a2a4-e72ff8b4aaca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_1c277b9c-25eb-48eb-a2e9-849319f73746" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b0d69087-6482-4ec4-a2a4-e72ff8b4aaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2eecf868-0b61-41dd-92f6-f0eb78566c28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2eecf868-0b61-41dd-92f6-f0eb78566c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f175db23-2113-4387-8a91-f3473f2cbabf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_ffa76785-a9a5-4397-a160-af8ce84472aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f175db23-2113-4387-8a91-f3473f2cbabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_adf80966-f19e-435e-a025-f4e532ea12c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_94cb240d-03cd-4746-a970-b58d9045cfa1" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_adf80966-f19e-435e-a025-f4e532ea12c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_fd12aae7-7ff4-40d8-a326-073916f46708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_fd12aae7-7ff4-40d8-a326-073916f46708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_f89dcb16-cc38-4b57-8bcb-2a685314a7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_f89dcb16-cc38-4b57-8bcb-2a685314a7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_224660a4-7830-4f00-ba99-94e9e6b7b0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_224660a4-7830-4f00-ba99-94e9e6b7b0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_52fb086d-bfc4-447a-9ab2-c527a4c5cdc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_52fb086d-bfc4-447a-9ab2-c527a4c5cdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_00ae5dff-b6e3-4968-b2f8-257d8235b3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_00ae5dff-b6e3-4968-b2f8-257d8235b3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a98af733-c764-41fe-a707-3ff9dc4eb5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a98af733-c764-41fe-a707-3ff9dc4eb5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_11a05442-1592-4ff3-89ce-99d9ed1fccb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_11a05442-1592-4ff3-89ce-99d9ed1fccb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_3df30a05-8125-4c77-ae4b-f2c69d89673f" xlink:href="iclr-20231231.xsd#iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_3df30a05-8125-4c77-ae4b-f2c69d89673f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_5c73de69-3aff-4fbe-9181-92dc632ed7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_5c73de69-3aff-4fbe-9181-92dc632ed7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_bc7df8f7-6c95-47ad-9799-768c9115b1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_bc7df8f7-6c95-47ad-9799-768c9115b1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_07c11354-f205-48ab-80fc-bbfdc612e30e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5b576e92-4295-4c12-904c-ea980820a20c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_07c11354-f205-48ab-80fc-bbfdc612e30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_455f449d-cb23-4502-8a09-c39c532decbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_455f449d-cb23-4502-8a09-c39c532decbe" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9f38fe64-780c-49de-8625-511d49dcec0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9f38fe64-780c-49de-8625-511d49dcec0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d256a8e0-f515-4d1b-a515-2bc2ad79ffc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d256a8e0-f515-4d1b-a515-2bc2ad79ffc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_3651dc46-a057-4916-aca2-1d9e7e354162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_3651dc46-a057-4916-aca2-1d9e7e354162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_8163e8e1-51dd-451d-acc6-13a5967f7130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_8163e8e1-51dd-451d-acc6-13a5967f7130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_9a174dcb-5817-45cf-93f2-338ca58a80a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_9a174dcb-5817-45cf-93f2-338ca58a80a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_d8e5dd19-a45b-4b36-8f77-d484407feb32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_d8e5dd19-a45b-4b36-8f77-d484407feb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_01ce81fc-9757-4c01-bd67-64d05196ef1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_84045dbc-e97d-495e-8cbb-b047ecc39b7b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_01ce81fc-9757-4c01-bd67-64d05196ef1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_455f449d-cb23-4502-8a09-c39c532decbe" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_0533d0a5-f982-48a3-af45-2e0bbac9d9d0" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_0533d0a5-f982-48a3-af45-2e0bbac9d9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_a92d6ce0-fbcd-4215-a1a2-a71f5bd23ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_a92d6ce0-fbcd-4215-a1a2-a71f5bd23ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_cf750cc8-993f-470b-8c64-84b990c14975" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_cf750cc8-993f-470b-8c64-84b990c14975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fbf54fa3-1cdb-405a-a865-2ece1dbe190e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fbf54fa3-1cdb-405a-a865-2ece1dbe190e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_3129e22e-afbf-4ea6-8d78-98e714fba725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_3129e22e-afbf-4ea6-8d78-98e714fba725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_9f2541b7-e2e0-4c7a-add1-c1aefb719349" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_9f2541b7-e2e0-4c7a-add1-c1aefb719349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_6075f1ee-2cff-4d22-bb1b-4927a0586395" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_6075f1ee-2cff-4d22-bb1b-4927a0586395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_daf1644a-d4f8-4765-bee1-31e0ad99e0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_daf1644a-d4f8-4765-bee1-31e0ad99e0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_34436b1b-4c1d-4954-82b0-54a93219da12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_34436b1b-4c1d-4954-82b0-54a93219da12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cd31e9b8-bbe4-4e0f-b9e6-7631b3eba3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cd31e9b8-bbe4-4e0f-b9e6-7631b3eba3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_820fa521-304b-4533-a416-3a7a33ffc481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_820fa521-304b-4533-a416-3a7a33ffc481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_c870360d-e5dd-44df-accc-0541fe4b2106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_b98f2195-ffb3-4c78-91a4-08241fb0469c" xlink:to="loc_us-gaap_DeferredTaxLiabilities_c870360d-e5dd-44df-accc-0541fe4b2106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_58a75ebe-6703-49da-84f8-5d3779cc1a73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_58a75ebe-6703-49da-84f8-5d3779cc1a73" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_07d20e70-0e85-4945-b299-f243821b8d64" xlink:to="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_5ffb1e6c-b876-431c-a9c6-5603aca70643" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:to="loc_country_IE_5ffb1e6c-b876-431c-a9c6-5603aca70643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_129e748c-165b-48a4-aeea-96fb6600f3d1" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:to="loc_country_US_129e748c-165b-48a4-aeea-96fb6600f3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_43169638-1458-460c-ac58-9dee970b9500" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1998def-85fb-4e09-83ba-53a7589d3f92" xlink:to="loc_iclr_OtherCountriesMember_43169638-1458-460c-ac58-9dee970b9500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_21ce8081-2218-4a67-8690-54c496bff1ea" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_1967af3a-b4bd-4d2b-b0d1-69177e57c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:to="loc_us-gaap_ForeignCountryMember_1967af3a-b4bd-4d2b-b0d1-69177e57c78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f815bf98-aae1-45db-a9c4-2ef26c4cf46a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_328280ed-7711-422c-bc5b-a883984d4e66" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f815bf98-aae1-45db-a9c4-2ef26c4cf46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5ae0d10b-676a-410d-9cb5-f0bbe24ea17d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_3e244e4e-f9b8-4b50-b21f-c8b191e85300" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5ae0d10b-676a-410d-9cb5-f0bbe24ea17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_bb09b172-52bb-4ad4-97a6-ed2bfc90e71f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5ae0d10b-676a-410d-9cb5-f0bbe24ea17d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_bb09b172-52bb-4ad4-97a6-ed2bfc90e71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_785cf896-814f-4650-8b5f-6ded9bc67137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_50703469-ca33-4716-8fcd-eb65c5b0a0f6" xlink:to="loc_us-gaap_TaxPeriodDomain_785cf896-814f-4650-8b5f-6ded9bc67137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2024To2030Member_3722b086-383b-488e-9c3a-05a186ef83f8" xlink:href="iclr-20231231.xsd#iclr_TaxYear2024To2030Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_785cf896-814f-4650-8b5f-6ded9bc67137" xlink:to="loc_iclr_TaxYear2024To2030Member_3722b086-383b-488e-9c3a-05a186ef83f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_159a0855-767f-45ad-a05c-573c32881def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_70e1b7f3-953c-4f5b-9d82-60d01952c8ab" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_159a0855-767f-45ad-a05c-573c32881def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_2fb7299d-f963-4391-a4b3-5cb90296508d" xlink:href="iclr-20231231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a0855-767f-45ad-a05c-573c32881def" xlink:to="loc_iclr_IncomeTaxBenefitMember_2fb7299d-f963-4391-a4b3-5cb90296508d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_441a49d1-2635-4c39-918c-f762fd4054ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_ec1022cd-3a6c-4b16-95ac-403802bc6eff" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_441a49d1-2635-4c39-918c-f762fd4054ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_ca5c8f24-9268-4cce-b23b-f05c9c639182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_441a49d1-2635-4c39-918c-f762fd4054ff" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_ca5c8f24-9268-4cce-b23b-f05c9c639182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_14b1124b-32ef-4e3f-a7d7-d261648fbdb5" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_7886ac1b-527c-41b6-a033-5b263516a548" xlink:href="iclr-20231231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_7886ac1b-527c-41b6-a033-5b263516a548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5709cca2-3002-4001-acc9-1b1d51a655ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5709cca2-3002-4001-acc9-1b1d51a655ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal_4166b63e-e94e-48d5-a29c-1654e16a9782" xlink:href="iclr-20231231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_iclr_OperatingLossCarryforwardsUSFederal_4166b63e-e94e-48d5-a29c-1654e16a9782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_7d8875e4-1dca-4549-a196-94e3d19f73e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_7d8875e4-1dca-4549-a196-94e3d19f73e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_7d573f6d-128a-4518-801c-a4015d0e9dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_7d573f6d-128a-4518-801c-a4015d0e9dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5a88df40-dd2e-4507-8f31-aaef52f8372d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5a88df40-dd2e-4507-8f31-aaef52f8372d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5df6fbb8-2387-4c47-8bb0-0c2208d598ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5df6fbb8-2387-4c47-8bb0-0c2208d598ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fff2373f-e45d-41d1-8691-66f0ff20a9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fff2373f-e45d-41d1-8691-66f0ff20a9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e31b79b6-03b2-4643-bff6-f890d867553e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e31b79b6-03b2-4643-bff6-f890d867553e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_f45f38eb-145f-4898-a66e-9d6a5751f968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_f45f38eb-145f-4898-a66e-9d6a5751f968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_9510346c-ef07-4275-a00b-1940eeae6aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_9510346c-ef07-4275-a00b-1940eeae6aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_23ee2824-8521-4b0e-9d08-c86360a6930f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_23ee2824-8521-4b0e-9d08-c86360a6930f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_fec3e3c0-1899-47f0-8ace-5644afcbc033" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_fec3e3c0-1899-47f0-8ace-5644afcbc033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_5c3f1ccf-4256-4768-99c9-c111150e9346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_44091e32-67c8-4818-989d-b55b694e9dc7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_5c3f1ccf-4256-4768-99c9-c111150e9346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1fa2098e-7f29-4228-9f46-b16774c84df0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1fa2098e-7f29-4228-9f46-b16774c84df0" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c4ea3b6d-5148-4dc7-b067-f1db4bfb9a47" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c501be65-8e29-49b5-96b4-fbbfc5cf0ec2" xlink:to="loc_srt_SegmentGeographicalDomain_c4ea3b6d-5148-4dc7-b067-f1db4bfb9a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fbe4cfc5-27e5-4804-91f3-1026b1196b27" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c4ea3b6d-5148-4dc7-b067-f1db4bfb9a47" xlink:to="loc_country_US_fbe4cfc5-27e5-4804-91f3-1026b1196b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab335a21-01ed-4aea-8c83-b10d0c2ebb64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_c97f23fa-092e-40b1-b92f-0a15956adf21" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab335a21-01ed-4aea-8c83-b10d0c2ebb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_6650ef7d-bed9-45a0-ba28-f14439e02877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ab335a21-01ed-4aea-8c83-b10d0c2ebb64" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_6650ef7d-bed9-45a0-ba28-f14439e02877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_17ea7476-e0ad-4a7d-a700-dc39a6eb6285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_28dd172a-abab-42f7-a38c-282aab7cc0ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_17ea7476-e0ad-4a7d-a700-dc39a6eb6285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d24ef509-6adb-4987-af76-2b0d2024d63a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_17ea7476-e0ad-4a7d-a700-dc39a6eb6285" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d24ef509-6adb-4987-af76-2b0d2024d63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_0baf2bf2-8b9e-44f5-9c26-df53141fe0ad" xlink:to="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2024To2037Member_cca9628a-cda1-45d0-ba4f-709a04f66781" xlink:href="iclr-20231231.xsd#iclr_TaxYear2024To2037Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:to="loc_iclr_TaxYear2024To2037Member_cca9628a-cda1-45d0-ba4f-709a04f66781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20382042Member_c307acc5-069f-4155-b04b-75310e0266dd" xlink:href="iclr-20231231.xsd#iclr_TaxYear20382042Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_7c693ef9-022d-489e-8794-c71f18cd4013" xlink:to="loc_iclr_TaxYear20382042Member_c307acc5-069f-4155-b04b-75310e0266dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_93176150-d20b-4df9-90e4-1f47d1fe8ddd" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_01639094-7b96-4849-905c-b9f9fef53bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_01639094-7b96-4849-905c-b9f9fef53bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_dcd2160a-119f-4479-8650-4491c24d0a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_dcd2160a-119f-4479-8650-4491c24d0a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_05f660a8-0d92-4cde-8c39-f91922203fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1f687618-ce71-4b7d-94f0-0aa357f851f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_05f660a8-0d92-4cde-8c39-f91922203fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9c3661c0-2979-4ec3-bd4a-5a323024f1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c3661c0-2979-4ec3-bd4a-5a323024f1d0" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e3b41bbf-e580-446b-aed2-b5f48c7c9e79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e3b41bbf-e580-446b-aed2-b5f48c7c9e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_3d7fba4d-e2c0-4e90-9bc0-ab094563a20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_3d7fba4d-e2c0-4e90-9bc0-ab094563a20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_09b57117-6e62-4a65-ae29-e353ba6d134f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_09b57117-6e62-4a65-ae29-e353ba6d134f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_c7027b93-1acd-4fdd-912b-614bb9cc5ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_c7027b93-1acd-4fdd-912b-614bb9cc5ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_19afa1cb-55ee-4c42-9380-bc7461f499ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_19afa1cb-55ee-4c42-9380-bc7461f499ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_598d29ff-07d2-45ee-aa3c-19ee59c78781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_598d29ff-07d2-45ee-aa3c-19ee59c78781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_01fcad50-51b4-41a0-bfc2-42a7480ca214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_01fcad50-51b4-41a0-bfc2-42a7480ca214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b1e22f87-2725-4502-8ecf-4757b40ec2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_449edfdb-7e80-4db9-b34c-e780c9324ee9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b1e22f87-2725-4502-8ecf-4757b40ec2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1a8d5864-b099-48d7-8343-46ba976e9859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1a8d5864-b099-48d7-8343-46ba976e9859" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4bfc01ce-9eb3-46e7-94ee-cae9696314d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6658b97-b4d3-431e-bd1c-1dc04343fd4f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4bfc01ce-9eb3-46e7-94ee-cae9696314d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4bfc01ce-9eb3-46e7-94ee-cae9696314d9" xlink:to="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_71800169-9519-497a-bddb-2a677b95f20a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:to="loc_country_US_71800169-9519-497a-bddb-2a677b95f20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4844138b-0f6a-4886-b4e5-424de22e8698" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:to="loc_country_GB_4844138b-0f6a-4886-b4e5-424de22e8698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_298af1eb-2153-40e9-b2b4-b2e242a81da1" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_2c33b814-0521-4a2b-acdc-0376d3c77eb0" xlink:to="loc_country_CH_298af1eb-2153-40e9-b2b4-b2e242a81da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_597caf97-8c88-4c4b-b8ba-9e38c064c07a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember_eb2fe0c1-556f-455d-ada3-edcf1196a5dd" xlink:href="iclr-20231231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_OtherRetirementPlansMember_eb2fe0c1-556f-455d-ada3-edcf1196a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1b61174a-fe12-4a64-a6d9-87a44f861a65" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1b61174a-fe12-4a64-a6d9-87a44f861a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_527636ae-4e39-4190-9c49-d280607460f1" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_527636ae-4e39-4190-9c49-d280607460f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_91cc6af6-baf2-4c17-bda7-70f43a0e2406" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_090472e9-ca6f-4309-a54e-7bc37651b1f6" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_91cc6af6-baf2-4c17-bda7-70f43a0e2406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ac629be-73b6-4dfc-bec7-550d5dc4a146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0912605c-8bf4-4a9a-9d28-38e3fdd3643d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ac629be-73b6-4dfc-bec7-550d5dc4a146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember_d07828ae-fdc2-4373-8127-4e34d400f3ba" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3ac629be-73b6-4dfc-bec7-550d5dc4a146" xlink:to="loc_iclr_AptivSolutionsMember_d07828ae-fdc2-4373-8127-4e34d400f3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4d5e63b-5d1b-4e6e-8379-83381ef48c5d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_11acc42e-f8f9-46f1-9334-39ac4ba84621" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_11acc42e-f8f9-46f1-9334-39ac4ba84621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_a2402341-48cf-4fc8-9a01-4421cf23bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_a2402341-48cf-4fc8-9a01-4421cf23bdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ac31b9c5-64ce-406c-9d31-b142db70e192" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ac31b9c5-64ce-406c-9d31-b142db70e192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_bc29c60f-dc74-43c5-a75d-622469b169b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_bc29c60f-dc74-43c5-a75d-622469b169b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_cdedf32d-fd10-4732-8253-03351f4adcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_cdedf32d-fd10-4732-8253-03351f4adcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a6cd694c-3c7d-4fc7-840e-80866115ebb7" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a6cd694c-3c7d-4fc7-840e-80866115ebb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_6121339b-717a-41d5-a0c2-2750da6bd57d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_6121339b-717a-41d5-a0c2-2750da6bd57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_7f575dc0-e21b-43eb-a44e-679532eb024a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_7f575dc0-e21b-43eb-a44e-679532eb024a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod_63e1ad7a-aa72-4f83-85da-9f3682bcb819" xlink:href="iclr-20231231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_iclr_ExpectedRetirementPeriod_63e1ad7a-aa72-4f83-85da-9f3682bcb819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f56be1ca-7c17-4c42-b37f-c757c329842f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f56be1ca-7c17-4c42-b37f-c757c329842f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7dd89d54-474f-4d41-858d-28424ba5b8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2e218a57-06b9-4ade-95e6-919136e27eb5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7dd89d54-474f-4d41-858d-28424ba5b8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2b6b6976-d85e-4576-a924-9f30677b95f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2b6b6976-d85e-4576-a924-9f30677b95f4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a172abbb-a62f-4197-a446-ba63ea19bb12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1820346c-16a5-44ae-9a52-a091c7b36362" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a172abbb-a62f-4197-a446-ba63ea19bb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7dc062c5-1422-4403-ab46-4060489da155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a172abbb-a62f-4197-a446-ba63ea19bb12" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7dc062c5-1422-4403-ab46-4060489da155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ecd98b6c-0fe2-44a6-b5b7-63b2aad22cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ea12c6d-6260-448b-8f66-b5aaf31d29bd" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ecd98b6c-0fe2-44a6-b5b7-63b2aad22cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_6b87dd62-1fff-417f-88d7-ab7e07dc42a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ecd98b6c-0fe2-44a6-b5b7-63b2aad22cc5" xlink:to="loc_us-gaap_ForeignPlanMember_6b87dd62-1fff-417f-88d7-ab7e07dc42a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_85975f04-9e81-4ff2-bcbe-caf9ec2587cf" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_6b87dd62-1fff-417f-88d7-ab7e07dc42a6" xlink:to="loc_country_US_85975f04-9e81-4ff2-bcbe-caf9ec2587cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93de1073-a86d-4db1-9c27-4914c76d56c8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_e4ec3936-ece1-497e-b6b2-48ab8980dd11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_e4ec3936-ece1-497e-b6b2-48ab8980dd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_784ad9d2-234c-4734-adf7-e8242e8144ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_31e11134-380f-4636-84c7-787c1ef17f1f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_784ad9d2-234c-4734-adf7-e8242e8144ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c6f135e6-263a-4afa-8e21-3a50beed00ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c6f135e6-263a-4afa-8e21-3a50beed00ca" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8cb04b88-24be-4a06-9384-6770913b7dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_25169cc4-14cc-4c74-bd65-376f75ee8294" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8cb04b88-24be-4a06-9384-6770913b7dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8cb04b88-24be-4a06-9384-6770913b7dd8" xlink:to="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ab982119-4f91-4f61-938d-66f73e838a0d" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:to="loc_country_GB_ab982119-4f91-4f61-938d-66f73e838a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_dee403c3-929d-478a-b169-f3d15a97f588" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_56f9ea4a-b603-4cd1-b415-8d4226960a8c" xlink:to="loc_country_CH_dee403c3-929d-478a-b169-f3d15a97f588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:to="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_cf71c319-29fb-4c0b-8d86-ef785a6516fe" xlink:to="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_97707bb7-c91f-4a05-a5b9-811d39907b90" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_97707bb7-c91f-4a05-a5b9-811d39907b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_d99c5cbb-03e4-4923-8713-40b041c1acfe" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_d99c5cbb-03e4-4923-8713-40b041c1acfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_777662e0-f89a-4f05-b256-175ae36250f8" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_eb2d182e-66cb-4a6a-9190-d3b8d9fd7e0f" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_777662e0-f89a-4f05-b256-175ae36250f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b41d2a7d-83d1-4c29-8c37-b445b1a036b3" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_acf73eda-c2e1-4dad-978a-82a94a4d2125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_acf73eda-c2e1-4dad-978a-82a94a4d2125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_eca47f63-9344-4609-9d14-94c6d977ed79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_eca47f63-9344-4609-9d14-94c6d977ed79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_aff9caf7-93ce-4e40-8ef8-0262c0123511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53918fce-adbf-48ce-8768-2e332c4d0b08" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_aff9caf7-93ce-4e40-8ef8-0262c0123511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsChangeinBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266e2fc9-6687-48b3-9075-2fa8995a98f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266e2fc9-6687-48b3-9075-2fa8995a98f8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf5b3d04-b4a6-439e-a15b-4eea48d0444d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_11360b22-54e8-4a7f-97b5-641d84f694b9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf5b3d04-b4a6-439e-a15b-4eea48d0444d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf5b3d04-b4a6-439e-a15b-4eea48d0444d" xlink:to="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_e3929c85-283d-43ff-b4ee-ae98d5565a9b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:to="loc_country_GB_e3929c85-283d-43ff-b4ee-ae98d5565a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_20e401f6-18c4-4378-95c3-82975a2a32f5" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_c2a6fd7b-60ed-42e8-a079-965ca3956f99" xlink:to="loc_country_CH_20e401f6-18c4-4378-95c3-82975a2a32f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:to="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_3f237d0d-e125-4a51-89c1-0bc502a23232" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6123dbac-2b18-44cf-b0f6-f8bed43bdaa7" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6123dbac-2b18-44cf-b0f6-f8bed43bdaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_e4906f64-7d3f-4ffe-96b5-925346fdfb05" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_e4906f64-7d3f-4ffe-96b5-925346fdfb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_f167b053-03d4-47ba-942e-48b98615fcfa" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3d103ddf-46e9-4c05-acdd-3979a0641086" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_f167b053-03d4-47ba-942e-48b98615fcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6eeaef42-982f-4510-99ce-8a463ff20ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ecb549af-08b8-4e54-891d-c5687f9cdf99" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6eeaef42-982f-4510-99ce-8a463ff20ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6eeaef42-982f-4510-99ce-8a463ff20ae4" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9f02d1db-e00a-4a17-9954-409a400a41c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9f02d1db-e00a-4a17-9954-409a400a41c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f9d94a7b-b32a-4234-9574-613db861f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f9d94a7b-b32a-4234-9574-613db861f5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8afb57da-cf0e-4676-8bbd-e519066d5354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8afb57da-cf0e-4676-8bbd-e519066d5354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d051479e-415f-4025-bb1b-b5a3d69598e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d051479e-415f-4025-bb1b-b5a3d69598e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_9398b183-88e5-453a-b9ee-7607e2a35a47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_9398b183-88e5-453a-b9ee-7607e2a35a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b0e9e7f0-0767-4cd8-be8c-9215cd9e465c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b0e9e7f0-0767-4cd8-be8c-9215cd9e465c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_f401499f-91e4-4d98-8dd2-6d84987c2da6" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_f401499f-91e4-4d98-8dd2-6d84987c2da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_1dc229f6-e18b-4c21-bd14-1e828d333175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_1dc229f6-e18b-4c21-bd14-1e828d333175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_380d6d7e-8921-4da1-a995-c01981aebf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_380d6d7e-8921-4da1-a995-c01981aebf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_63effc86-3bf0-4ca3-91b6-17a66ddedafe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_63effc86-3bf0-4ca3-91b6-17a66ddedafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0af6cc51-38de-4af7-9070-042693ca0da5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_10d9531e-0e61-45a7-bb2f-fded7274e51d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0af6cc51-38de-4af7-9070-042693ca0da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsChangeinPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ccf064b-24a4-410b-86e5-5d902dccb519" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ccf064b-24a4-410b-86e5-5d902dccb519" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_168a205a-2160-4e89-a62b-9b94cb400973" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3f89607f-1356-47c8-9ea5-3a94f424ac21" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_168a205a-2160-4e89-a62b-9b94cb400973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_168a205a-2160-4e89-a62b-9b94cb400973" xlink:to="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_12700662-af18-409c-99b7-13ce6b73f4c9" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:to="loc_country_GB_12700662-af18-409c-99b7-13ce6b73f4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_24f9f9a7-f9b8-4c53-a170-e104e1dbe6ff" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_9cfc5350-617a-4aab-b814-dda90dc9baa7" xlink:to="loc_country_CH_24f9f9a7-f9b8-4c53-a170-e104e1dbe6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:to="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_da6c39cf-8d3f-4109-b92a-173bb9ffdb1a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_45db0a23-3cb0-4553-b9dd-8e302252e9c1" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_45db0a23-3cb0-4553-b9dd-8e302252e9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_cdf2a2bd-d913-4532-814c-ec0dac1e95ec" xlink:href="iclr-20231231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_cdf2a2bd-d913-4532-814c-ec0dac1e95ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_55985010-88a4-4948-a6f0-0b4780a91c63" xlink:href="iclr-20231231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4e119d48-aae9-49bb-ac73-676901b589da" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_55985010-88a4-4948-a6f0-0b4780a91c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_694a657c-b3e7-4075-93fa-ba70ea4312ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d81f9565-b6f6-4819-a70e-3ea54e1bc9e0" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_694a657c-b3e7-4075-93fa-ba70ea4312ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_694a657c-b3e7-4075-93fa-ba70ea4312ff" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8953525d-4d76-47f2-9c82-fd784721e110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8953525d-4d76-47f2-9c82-fd784721e110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_de8f70a9-95f3-4341-a5bf-9cabb54cb84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_de8f70a9-95f3-4341-a5bf-9cabb54cb84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1b8a41f6-de88-42a2-b6c8-d7d4e4c40e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1b8a41f6-de88-42a2-b6c8-d7d4e4c40e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions_3b21a232-8443-4298-8511-d14d37334393" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_iclr_DefinedBenefitPlanSchemeContributions_3b21a232-8443-4298-8511-d14d37334393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_08cb3448-1dc9-4270-b4ed-0a3ce5fca135" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_08cb3448-1dc9-4270-b4ed-0a3ce5fca135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_386ea169-f433-45a7-8ae8-e8c442110f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_386ea169-f433-45a7-8ae8-e8c442110f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_6e022fd6-688c-42cc-9023-bd5d487125d5" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_6e022fd6-688c-42cc-9023-bd5d487125d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_70d70f2f-578d-4641-8dd8-34f4ea2fa610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_70d70f2f-578d-4641-8dd8-34f4ea2fa610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4ac24675-b6ac-4c33-b3cc-41623d5d5c01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4ac24675-b6ac-4c33-b3cc-41623d5d5c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_bd35d1b7-57e5-4d3a-aef3-cf5530dd9900" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_bd35d1b7-57e5-4d3a-aef3-cf5530dd9900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c9a6b46f-4e53-4b18-b34a-cd4d8cf0d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f48048ec-4d96-4638-8d6e-3a60ce1bb315" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c9a6b46f-4e53-4b18-b34a-cd4d8cf0d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_56cbd48e-a94e-498a-a939-47dc5a4bc4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_56cbd48e-a94e-498a-a939-47dc5a4bc4ef" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d5ee69dc-c535-4898-b4bc-4ab18c35ffd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6ddec308-646a-4be8-9d26-62908da0fb07" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d5ee69dc-c535-4898-b4bc-4ab18c35ffd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_d5ee69dc-c535-4898-b4bc-4ab18c35ffd9" xlink:to="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_c0457d26-cf0b-4580-b59b-c9b4ef4bf2fe" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:to="loc_country_GB_c0457d26-cf0b-4580-b59b-c9b4ef4bf2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_6d6977a6-855c-488d-9397-41af3962f25d" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b694ba0f-1526-47bd-a7c1-752fadbf46c3" xlink:to="loc_country_CH_6d6977a6-855c-488d-9397-41af3962f25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:to="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_ef7800de-cd6a-4296-9a79-2586a90e2d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6c103d3b-a861-4607-85fd-6278749a21d9" xlink:to="loc_us-gaap_RetirementPlanNameDomain_ef7800de-cd6a-4296-9a79-2586a90e2d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1bce1b7d-2cc9-4801-bc29-ee7b5901f104" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_ef7800de-cd6a-4296-9a79-2586a90e2d59" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_1bce1b7d-2cc9-4801-bc29-ee7b5901f104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0e6189b-104a-495a-a7fe-f5ab600c75b0" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_fa2fcaa4-dd50-4b16-aedb-8b162a105452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_fa2fcaa4-dd50-4b16-aedb-8b162a105452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6757b1d3-c6da-47bb-93e2-7371537cf8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6757b1d3-c6da-47bb-93e2-7371537cf8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7902e460-4941-4dee-a07e-0eb7aa69f279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7902e460-4941-4dee-a07e-0eb7aa69f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1f3b6625-78b6-441c-91ec-bbd320736d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_1f3b6625-78b6-441c-91ec-bbd320736d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35b79f7d-f5d2-4645-9572-97bd6e44b47e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d7ea9a00-4f1c-42dc-bb31-e9c42f3184e0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35b79f7d-f5d2-4645-9572-97bd6e44b47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_df367518-3a2c-4523-916c-75aad9c7cfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_df367518-3a2c-4523-916c-75aad9c7cfb6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b7fc2c1-84c1-4a17-84a0-9d4f6af1abc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9d5ca5f7-d28d-4869-8782-4c8a73a9ae95" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b7fc2c1-84c1-4a17-84a0-9d4f6af1abc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b7fc2c1-84c1-4a17-84a0-9d4f6af1abc3" xlink:to="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_3196769a-210f-4566-a265-c19b5a896df3" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:to="loc_country_GB_3196769a-210f-4566-a265-c19b5a896df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_6e314ee9-3458-4995-8129-3df513fcf4fc" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_dff34828-78f7-4785-93d7-7115b23a2e92" xlink:to="loc_country_CH_6e314ee9-3458-4995-8129-3df513fcf4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:to="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_61017dae-fb2e-4377-b49a-436de3e6c1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_0b88e833-f5dc-474c-aace-cefe2717a5da" xlink:to="loc_us-gaap_RetirementPlanNameDomain_61017dae-fb2e-4377-b49a-436de3e6c1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c5a8dbb8-a8f7-4309-9e65-f2b5b67fe8af" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_61017dae-fb2e-4377-b49a-436de3e6c1b5" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c5a8dbb8-a8f7-4309-9e65-f2b5b67fe8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e4d917bb-26a2-4092-9356-71296a80ad50" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e72956b4-619c-4ebd-9e54-f37c96bce904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e72956b4-619c-4ebd-9e54-f37c96bce904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12d6bd17-b0ad-409e-9e0c-d6f4361622f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_12d6bd17-b0ad-409e-9e0c-d6f4361622f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e3c62ae6-0414-4f94-9ca2-5ec3b17b9c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e3c62ae6-0414-4f94-9ca2-5ec3b17b9c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2bf3410-ac89-47ca-a6b3-c60eb5654902" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_1fe0f09a-b67a-415b-b039-b1a1249d00c6" xlink:href="iclr-20231231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_1fe0f09a-b67a-415b-b039-b1a1249d00c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3b4527c5-758b-453d-9044-a3a53c5ed928" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3b4527c5-758b-453d-9044-a3a53c5ed928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_4cc2bf0d-2d49-4e85-a926-76786c5d8591" xlink:href="iclr-20231231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_4cc2bf0d-2d49-4e85-a926-76786c5d8591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_680ba077-a960-4c94-aa9f-4ff0504283e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_edfaf9da-b6e2-4917-9a06-2c55ba69b0a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_680ba077-a960-4c94-aa9f-4ff0504283e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f92c054-c662-4f15-bc98-484335e4b092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f92c054-c662-4f15-bc98-484335e4b092" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_08141c35-43fd-446f-aeba-e99eb2ebb449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_7184d710-0165-47e0-8a0f-6c38a232a54b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_08141c35-43fd-446f-aeba-e99eb2ebb449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e1695f81-efca-4d16-9a72-34e2db268947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_08141c35-43fd-446f-aeba-e99eb2ebb449" xlink:to="loc_us-gaap_ForeignPlanMember_e1695f81-efca-4d16-9a72-34e2db268947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_04fc58d8-f92c-4506-9a23-427621496358" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_e1695f81-efca-4d16-9a72-34e2db268947" xlink:to="loc_country_GB_04fc58d8-f92c-4506-9a23-427621496358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:to="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d7d59717-0070-431f-a6a1-0dd90b95da26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_02908c0c-0c2b-40c6-af0a-0d9b2768d31b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d7d59717-0070-431f-a6a1-0dd90b95da26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e3d26567-e7bc-4468-96c5-d74fa92c305b" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_d7d59717-0070-431f-a6a1-0dd90b95da26" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e3d26567-e7bc-4468-96c5-d74fa92c305b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00c2f6cf-63b9-46a3-8e43-b4f8c6217225" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0397d0dc-2b8c-4381-821e-8bcaecfad5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0397d0dc-2b8c-4381-821e-8bcaecfad5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_8b91f6c3-0ba1-4a3f-961f-420762562cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3847629-2094-4c7a-8c36-dffb77043f72" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_8b91f6c3-0ba1-4a3f-961f-420762562cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_463abd40-3e33-44d5-a0b4-f05ffd621a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_463abd40-3e33-44d5-a0b4-f05ffd621a89" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e8fbc025-79f9-4905-a07e-f2cea1bdf55a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6c760ebe-a150-4b8d-b328-0192b11d45b6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e8fbc025-79f9-4905-a07e-f2cea1bdf55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8ba4f9eb-ddef-4d3d-b0c6-dd8585ebb8da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e8fbc025-79f9-4905-a07e-f2cea1bdf55a" xlink:to="loc_us-gaap_ForeignPlanMember_8ba4f9eb-ddef-4d3d-b0c6-dd8585ebb8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_a061c5cc-4bb9-495b-b46a-d8665041f857" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_8ba4f9eb-ddef-4d3d-b0c6-dd8585ebb8da" xlink:to="loc_country_GB_a061c5cc-4bb9-495b-b46a-d8665041f857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_af573fb6-b264-4998-9d88-144ac3bb09de" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_4d18d4dc-5040-4f25-9195-b340577435bd" xlink:href="iclr-20231231.xsd#iclr_GovernmentBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:to="loc_iclr_GovernmentBondsMember_4d18d4dc-5040-4f25-9195-b340577435bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_3e3a5fc9-f212-4d00-869f-60119e05d715" xlink:href="iclr-20231231.xsd#iclr_DiversifiedBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_582d7dd4-673a-4dac-bb01-9640999507d4" xlink:to="loc_iclr_DiversifiedBondsMember_3e3a5fc9-f212-4d00-869f-60119e05d715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_62b93715-c60f-4238-b296-44527d2ad629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_40dfb7c0-7651-4f1c-b605-21b77e5efcd3" xlink:to="loc_us-gaap_RetirementPlanNameDomain_62b93715-c60f-4238-b296-44527d2ad629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_41a4651b-251c-426e-8de9-53748661a3e7" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_62b93715-c60f-4238-b296-44527d2ad629" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_41a4651b-251c-426e-8de9-53748661a3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_30fb9997-890c-479a-8f6a-4f7e0b3f69db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_61741f03-b43b-4c8b-a7ea-1a51e9e70fed" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_30fb9997-890c-479a-8f6a-4f7e0b3f69db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_ed3b404b-2967-4121-9dbf-35b14cea804a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_30fb9997-890c-479a-8f6a-4f7e0b3f69db" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_ed3b404b-2967-4121-9dbf-35b14cea804a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c62914f2-8ed6-4cb5-8582-3ce6f82df348" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c62914f2-8ed6-4cb5-8582-3ce6f82df348" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f64d29f5-0b07-4fca-9165-cdfd5441f407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b2ad8289-8a89-465f-95c6-e3cf380e92a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f64d29f5-0b07-4fca-9165-cdfd5441f407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_15b5ec86-fdf9-4cfe-a792-144d9856af3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f64d29f5-0b07-4fca-9165-cdfd5441f407" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_15b5ec86-fdf9-4cfe-a792-144d9856af3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d1022dda-f039-4852-8593-74755a963984" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_535eb7bd-afe7-487f-9430-a9b399cd8f12" xlink:href="iclr-20231231.xsd#iclr_GovernmentBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:to="loc_iclr_GovernmentBondsMember_535eb7bd-afe7-487f-9430-a9b399cd8f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_a30f261a-4038-4a45-ade1-57fe4a277244" xlink:href="iclr-20231231.xsd#iclr_DiversifiedBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fd969063-8834-4360-b7c3-15d1a8d5b8b0" xlink:to="loc_iclr_DiversifiedBondsMember_a30f261a-4038-4a45-ade1-57fe4a277244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_516b86a7-9d66-4019-8412-89e3913168b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d11d3bd8-a02b-49f2-9811-35d1fff32ce2" xlink:to="loc_us-gaap_RetirementPlanNameDomain_516b86a7-9d66-4019-8412-89e3913168b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_37f56a6a-41e4-4fcd-9991-af69aef1c704" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_516b86a7-9d66-4019-8412-89e3913168b1" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_37f56a6a-41e4-4fcd-9991-af69aef1c704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_545d0bb2-300c-4567-8934-54c5c8a9de63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06c03b9c-940e-4c9e-9b86-73c4768110f4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_545d0bb2-300c-4567-8934-54c5c8a9de63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9b14e983-ace6-413f-beba-8c694140deef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_545d0bb2-300c-4567-8934-54c5c8a9de63" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9b14e983-ace6-413f-beba-8c694140deef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EmployeeBenefitsAnnualBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2774c0c6-0a32-470f-9170-5b28255b2bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2774c0c6-0a32-470f-9170-5b28255b2bf0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_420bbf67-cbf1-44b6-b1ae-eaf21b81074c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c11e6111-d2d3-4d2e-aee8-b0fad8de4e88" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_420bbf67-cbf1-44b6-b1ae-eaf21b81074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_420bbf67-cbf1-44b6-b1ae-eaf21b81074c" xlink:to="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_7fd47edd-69a0-4df1-84b9-068b6116ec52" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:to="loc_country_GB_7fd47edd-69a0-4df1-84b9-068b6116ec52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_4f54a433-6b7d-40ef-9e79-c4a46418d4ea" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_22c7be40-240c-4d2b-9bad-30384d920ced" xlink:to="loc_country_CH_4f54a433-6b7d-40ef-9e79-c4a46418d4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:to="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f0d8e157-97cc-4ad7-a1c2-5b48593a8254" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2e80d012-6d06-41a6-9576-38048714fd36" xlink:to="loc_us-gaap_PlanNameDomain_f0d8e157-97cc-4ad7-a1c2-5b48593a8254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_32e3df59-aef8-4f45-b076-f4d421c76bcf" xlink:href="iclr-20231231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f0d8e157-97cc-4ad7-a1c2-5b48593a8254" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_32e3df59-aef8-4f45-b076-f4d421c76bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_113d4a7c-451c-4b2c-a3ae-0dbd2ba99812" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_0b43bb54-3208-4a7f-a65d-8e149558e5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_0b43bb54-3208-4a7f-a65d-8e149558e5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_899cd96a-9c67-4585-921b-f8583b9502f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_899cd96a-9c67-4585-921b-f8583b9502f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_723d14fb-7d07-4793-a1e3-9c3c97dca74d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_723d14fb-7d07-4793-a1e3-9c3c97dca74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_5aa16b35-86dd-451a-9f86-4176e34a3d09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_5aa16b35-86dd-451a-9f86-4176e34a3d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_afbac18c-81f8-4b02-9c47-520e3c237ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_afbac18c-81f8-4b02-9c47-520e3c237ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a00fe0b9-281e-4556-89db-a6f5ffca5a12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_98feaa41-21c5-49eb-abf6-02db308095b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a00fe0b9-281e-4556-89db-a6f5ffca5a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af7fe180-4938-4e62-bf16-968b032bb684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:href="iclr-20231231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af7fe180-4938-4e62-bf16-968b032bb684" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_580dd0ef-ddcd-4d79-b47f-b7a4b94dab63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_35e228b4-541c-4ca3-882e-ff5d6e39721b" xlink:href="iclr-20231231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_35e228b4-541c-4ca3-882e-ff5d6e39721b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_5c9238cd-f2a9-4398-818d-8230c9d85878" xlink:href="iclr-20231231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_5c9238cd-f2a9-4398-818d-8230c9d85878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_a090fd12-94ac-45e1-afd6-be4e0f701556" xlink:href="iclr-20231231.xsd#iclr_OptionPlans2008Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_OptionPlans2008Member_a090fd12-94ac-45e1-afd6-be4e0f701556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a8708c13-f6e3-4d91-a8cc-601fc943770c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a8708c13-f6e3-4d91-a8cc-601fc943770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_63d2436d-1f60-4cc6-a15c-dd5e259a1f2e" xlink:href="iclr-20231231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_63d2436d-1f60-4cc6-a15c-dd5e259a1f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_110a8577-f9c3-429d-99e5-06fd976ecacb" xlink:href="iclr-20231231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_110a8577-f9c3-429d-99e5-06fd976ecacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fc668233-f69f-4da2-b575-3b203e3178fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fc668233-f69f-4da2-b575-3b203e3178fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_58d81fd6-c979-4303-b104-68ad96c031ba" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_PerformanceShareUnitMember_58d81fd6-c979-4303-b104-68ad96c031ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_e6d3a52b-11d7-4c0b-be81-8a1ae6cecd7e" xlink:href="iclr-20231231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa83de9-5032-419c-9b6b-929c96b7a547" xlink:to="loc_iclr_PerformanceBasedGrantsMember_e6d3a52b-11d7-4c0b-be81-8a1ae6cecd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_0ac9133b-bc5f-4d16-bf75-34f323955f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_ca6e7880-39c3-467a-b6f8-1d91b0203731" xlink:to="loc_us-gaap_AwardDateDomain_0ac9133b-bc5f-4d16-bf75-34f323955f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_f5269549-e833-411f-bb55-e4009374aad5" xlink:href="iclr-20231231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_0ac9133b-bc5f-4d16-bf75-34f323955f70" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_f5269549-e833-411f-bb55-e4009374aad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fbe278a2-234a-4b23-a3f5-9ddc6954275b" xlink:to="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_adb77245-5305-43f1-bb90-53689109ab60" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:to="loc_srt_MinimumMember_adb77245-5305-43f1-bb90-53689109ab60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e2f1dfa-e68e-47f6-bdfe-f794f7347c11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a8523e56-219c-437e-a27a-12f7f7cf6ce3" xlink:to="loc_srt_MaximumMember_9e2f1dfa-e68e-47f6-bdfe-f794f7347c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b0bf8a45-e689-45cc-8ce0-892ad5a90850" xlink:to="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_8f261626-2b42-4d05-a3f4-b9df8e1a701c" xlink:href="iclr-20231231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_8f261626-2b42-4d05-a3f4-b9df8e1a701c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_9160c91a-1ace-4efb-8e3e-306beabe30f0" xlink:href="iclr-20231231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a16517e9-a03f-404e-8715-5bf94d9e894a" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_9160c91a-1ace-4efb-8e3e-306beabe30f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ea403633-695b-4579-bcc4-efe93021cc33" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4d453100-0232-4287-a364-694f65582d2a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ea403633-695b-4579-bcc4-efe93021cc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_0617d480-2c25-4c1b-bf67-8a6c132f5571" xlink:href="iclr-20231231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ea403633-695b-4579-bcc4-efe93021cc33" xlink:to="loc_iclr_NonexecutiveDirectorMember_0617d480-2c25-4c1b-bf67-8a6c132f5571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:href="iclr-20231231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_aa0c02ee-5dd5-4297-81ac-187cf9e0a7d6" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_20821e73-56cb-45fe-b184-e169762b597c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_20821e73-56cb-45fe-b184-e169762b597c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_d57ac071-5877-44eb-b6d2-c9df37545aca" xlink:href="iclr-20231231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_d57ac071-5877-44eb-b6d2-c9df37545aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_9eca75b3-e675-49e6-8ed3-5b463519014e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_9eca75b3-e675-49e6-8ed3-5b463519014e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe9c4880-d109-4848-aa1e-f82b77665a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe9c4880-d109-4848-aa1e-f82b77665a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e3131188-0262-4078-b7a7-5dc2349443aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e3131188-0262-4078-b7a7-5dc2349443aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e91c01cf-0748-43b3-baf6-9806285d786d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e91c01cf-0748-43b3-baf6-9806285d786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e20d1afb-7858-49ed-9089-dd2eb479d62b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e20d1afb-7858-49ed-9089-dd2eb479d62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8ccaebcd-df24-4fe2-985b-ccb0bf5ed705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8ccaebcd-df24-4fe2-985b-ccb0bf5ed705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_95c0881f-67d0-4bed-8ae6-d4a34073763b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_95c0881f-67d0-4bed-8ae6-d4a34073763b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c3d50944-d120-4a3c-81eb-05d5328b2781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c3d50944-d120-4a3c-81eb-05d5328b2781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_3b9e6010-4cec-4cff-b3aa-f8a6d02776cb" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_3b9e6010-4cec-4cff-b3aa-f8a6d02776cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b9706594-7cd9-47e5-93cd-1f18c4c3a2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b9706594-7cd9-47e5-93cd-1f18c4c3a2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_95079c51-ad95-408d-b49d-121f3f8b9343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_ShareBasedCompensation_95079c51-ad95-408d-b49d-121f3f8b9343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_59d99a2c-7054-4bb2-b7e9-f0e1f891f719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_59d99a2c-7054-4bb2-b7e9-f0e1f891f719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e221901c-cfa5-4224-af40-d201d631b373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9b03d8ab-70e9-4807-ae55-e7c5960c7ff9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_e221901c-cfa5-4224-af40-d201d631b373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e8d7358-e29d-46b4-b9f7-3442b8d9dc11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5e8d7358-e29d-46b4-b9f7-3442b8d9dc11" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:to="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ce231e7-3298-461c-9d31-697bcbc5ec36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5bfe1090-64af-4542-b22d-06ba80f37fac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ce231e7-3298-461c-9d31-697bcbc5ec36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_7424f0e6-9792-4cc3-a5e5-8b12ec5dc44e" xlink:href="iclr-20231231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ce231e7-3298-461c-9d31-697bcbc5ec36" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_7424f0e6-9792-4cc3-a5e5-8b12ec5dc44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf9ce2ca-42d6-4b86-b1f5-eb32a16b9bdd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a533ba1-56ed-4360-a183-bee208bf901c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a533ba1-56ed-4360-a183-bee208bf901c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_1238f6dc-4b09-490d-99ed-73eaaab374bc" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_1238f6dc-4b09-490d-99ed-73eaaab374bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee101c8d-b6dd-4fae-a517-836de5cac7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee101c8d-b6dd-4fae-a517-836de5cac7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_33364271-2ff9-4512-80a1-1d63c3b5dda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_33364271-2ff9-4512-80a1-1d63c3b5dda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ccee873-98f4-43dc-9f78-642960be6428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ccee873-98f4-43dc-9f78-642960be6428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_417264e9-ed0e-4088-8288-881f6cb3b7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ff409142-10fb-4cf4-bb86-096accd9a913" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_417264e9-ed0e-4088-8288-881f6cb3b7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_3839c28d-d764-4f71-b56b-803df22a580d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_3839c28d-d764-4f71-b56b-803df22a580d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20348f9b-1553-44e5-98fd-6c9f42b25b83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20348f9b-1553-44e5-98fd-6c9f42b25b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_912163a7-8c57-494d-9559-21ecb8cfb22d" xlink:href="iclr-20231231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_912163a7-8c57-494d-9559-21ecb8cfb22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1dddbccf-f5d1-4b04-8ef4-593c6a2e0019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1dddbccf-f5d1-4b04-8ef4-593c6a2e0019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f74f878b-5fb4-461c-a7b2-7bd90662fc13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f74f878b-5fb4-461c-a7b2-7bd90662fc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_25366e6a-ad34-4ecf-abd6-400e3c14603a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_25366e6a-ad34-4ecf-abd6-400e3c14603a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ad9f4637-749c-499a-bc44-0c5a2a2d6205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a1124ec-0aed-4b92-825d-84fbe3fe5f8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ad9f4637-749c-499a-bc44-0c5a2a2d6205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c763b41a-60dd-4320-8d83-d4d3463f8756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d82c97d8-f17b-4459-83e9-997616ba14b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c763b41a-60dd-4320-8d83-d4d3463f8756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_069a3700-ae1f-4f19-a5cc-4cd99d003234" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2d4ba590-77fd-48f6-9322-bbc2c4edc149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_069a3700-ae1f-4f19-a5cc-4cd99d003234" xlink:to="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2d4ba590-77fd-48f6-9322-bbc2c4edc149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2d4ba590-77fd-48f6-9322-bbc2c4edc149" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:to="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63c15a33-6b77-4487-8b25-cbae7912ebcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_91e5de26-a8ec-4bf8-b0af-7b0b656678fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63c15a33-6b77-4487-8b25-cbae7912ebcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_a718045e-6e1b-4a52-8afc-c70d0be0de78" xlink:href="iclr-20231231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63c15a33-6b77-4487-8b25-cbae7912ebcb" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_a718045e-6e1b-4a52-8afc-c70d0be0de78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ac1d0bb5-9f0c-4526-a45a-43bee2b1eae6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member_68aae7fd-a616-49ec-b3b2-16d6af0322fe" xlink:href="iclr-20231231.xsd#iclr_Range1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range1Member_68aae7fd-a616-49ec-b3b2-16d6af0322fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member_263c75ce-1753-48e1-ae11-0aa2462d93a6" xlink:href="iclr-20231231.xsd#iclr_Range2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range2Member_263c75ce-1753-48e1-ae11-0aa2462d93a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member_2b06e026-7a43-42d2-9fa9-2657c33549e0" xlink:href="iclr-20231231.xsd#iclr_Range3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range3Member_2b06e026-7a43-42d2-9fa9-2657c33549e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member_f9f13c63-4fd8-4210-996e-70bf88f1d076" xlink:href="iclr-20231231.xsd#iclr_Range4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1d8bd041-5579-4e60-9432-a8d983e3061a" xlink:to="loc_iclr_Range4Member_f9f13c63-4fd8-4210-996e-70bf88f1d076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_360de6dd-ffb6-453a-ad9a-c56492a2af81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_e3bc6fee-888e-4163-909c-02dce0a1165f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_e3bc6fee-888e-4163-909c-02dce0a1165f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7eb6656c-3320-48ee-a3e2-a85ea10a13cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7eb6656c-3320-48ee-a3e2-a85ea10a13cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_e17dece7-edc7-43c4-9b90-bdd2f09ef78e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_e17dece7-edc7-43c4-9b90-bdd2f09ef78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2fe8a2dc-241e-4fcb-88d3-084f4f9b7294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2fe8a2dc-241e-4fcb-88d3-084f4f9b7294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d63d4161-d074-4598-be40-d05bcc357ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d63d4161-d074-4598-be40-d05bcc357ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_03ce0ce5-e73d-4549-b187-b3e20e9475d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_03ce0ce5-e73d-4549-b187-b3e20e9475d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_47dc56eb-5281-4b22-af5a-b778d453a952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cac8abb-7743-4192-827c-f734e8b66f01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_47dc56eb-5281-4b22-af5a-b778d453a952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a024ab37-0c72-4aa7-9de4-0ed3aa6bc9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a024ab37-0c72-4aa7-9de4-0ed3aa6bc9bf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:to="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6084b84a-e7e7-46b8-9fb6-e8f11fe74b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_38a6fe44-19ee-4534-bf63-5e577515dae2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6084b84a-e7e7-46b8-9fb6-e8f11fe74b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f2f43bf4-ccb9-4e95-9abe-4d4e704af49a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6084b84a-e7e7-46b8-9fb6-e8f11fe74b7b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f2f43bf4-ccb9-4e95-9abe-4d4e704af49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_186387b3-55b7-4514-8c4d-a7fd9e98df18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9103e7f4-91f2-42f9-9a19-6143f1485079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9103e7f4-91f2-42f9-9a19-6143f1485079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0894b288-3903-43bd-9c79-c3173ac40488" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f7a471ec-19ae-435d-b136-40568ca78d63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f7a471ec-19ae-435d-b136-40568ca78d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e343120d-98b5-492b-86fc-d4617b4e5aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e343120d-98b5-492b-86fc-d4617b4e5aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d48260e7-0559-4e72-a596-88e40df706ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d48260e7-0559-4e72-a596-88e40df706ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd709e9c-d9f6-429a-965f-212aef6bb813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_073832d1-45e3-4149-93cc-114440e4aa0a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd709e9c-d9f6-429a-965f-212aef6bb813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e90059e5-91be-4b22-bce6-ffed60545576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e90059e5-91be-4b22-bce6-ffed60545576" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:to="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_261184d1-ce5e-4f6f-a780-5cc6201a7e39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_d2ed4bb3-fb31-4e95-aed7-59842898b4b5" xlink:href="iclr-20231231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:to="loc_iclr_PerformanceShareUnitMember_d2ed4bb3-fb31-4e95-aed7-59842898b4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_59e488bc-cdc5-465e-8de5-f8c3ed90bb83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_485f51ac-2492-407c-ab3b-43b71893e0cc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_59e488bc-cdc5-465e-8de5-f8c3ed90bb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d88c6df9-0bf6-4e2b-85f0-88ab733f9941" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_241f8069-61ed-4fc9-bf74-b2d222b3ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_241f8069-61ed-4fc9-bf74-b2d222b3ded9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7bc368f9-304a-4958-bc29-064112564c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7bc368f9-304a-4958-bc29-064112564c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c47d29c-6021-4f53-acb8-367bcce150f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c47d29c-6021-4f53-acb8-367bcce150f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e1ecfe3d-8f98-46cb-a4d5-a494c19e3567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e1ecfe3d-8f98-46cb-a4d5-a494c19e3567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a86940ad-21ee-47ea-be61-0113d1edf6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_264d88ce-76a1-4ddc-8448-11c53277f2d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a86940ad-21ee-47ea-be61-0113d1edf6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf45d3a1-25fe-4932-a44a-2e27087855c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3edd54c0-c40f-41ae-9737-472f16ad5767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3edd54c0-c40f-41ae-9737-472f16ad5767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2ee96e11-1b9c-4e11-821f-2e83290a418d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2ee96e11-1b9c-4e11-821f-2e83290a418d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_934efc97-158f-4989-99c0-88225436fa77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_934efc97-158f-4989-99c0-88225436fa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7921078b-21b0-49d2-96fe-fa46cf94cc26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7921078b-21b0-49d2-96fe-fa46cf94cc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d05853a0-1b71-4685-bb95-01bb060f24fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f96d480-ebef-4489-b4b3-83b0f086c849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d05853a0-1b71-4685-bb95-01bb060f24fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a051e88-afc3-48a2-b3a0-528e02688970" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a051e88-afc3-48a2-b3a0-528e02688970" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c85c89c-0667-4f06-a597-ad68a87a87d5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_fb2f367e-dc16-4241-ad43-697317da2d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:to="loc_us-gaap_CostOfSalesMember_fb2f367e-dc16-4241-ad43-697317da2d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_922fc418-cd24-4885-908e-a47a009c760f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_922fc418-cd24-4885-908e-a47a009c760f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember_5661a1ba-1fb5-4625-a443-fbfb6444eff6" xlink:href="iclr-20231231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e7b7f1ef-e2a2-4a59-81ec-744451e94b11" xlink:to="loc_iclr_TransactionAndIntegrationExpenseMember_5661a1ba-1fb5-4625-a443-fbfb6444eff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d4599b-d042-4f25-9f02-603bd73236c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ea22cd0-f37c-4527-a5b6-556029f8f39a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d4599b-d042-4f25-9f02-603bd73236c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4793c4df-b04a-4140-9d17-0eb0860d7502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d4599b-d042-4f25-9f02-603bd73236c7" xlink:to="loc_us-gaap_ShareBasedCompensation_4793c4df-b04a-4140-9d17-0eb0860d7502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_77f7adbd-15fa-4baf-91c7-be2ae71ed3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_d32b30de-454d-4310-861b-f750b7c41270" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_77f7adbd-15fa-4baf-91c7-be2ae71ed3f1" xlink:to="loc_us-gaap_NumberOfOperatingSegments_d32b30de-454d-4310-861b-f750b7c41270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c42577fb-71d2-48ed-8843-46ef068e331f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c42577fb-71d2-48ed-8843-46ef068e331f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:to="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4291d26c-1a57-4617-856b-5bf7809ea7d5" xlink:to="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_87ae2c4d-f99e-45ed-a3c3-d7301a5a02eb" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_country_IE_87ae2c4d-f99e-45ed-a3c3-d7301a5a02eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_535bfb53-5d19-4483-9587-df1497a37c80" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_iclr_RestOfEuropeMember_535bfb53-5d19-4483-9587-df1497a37c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5a2f7ce0-3a20-4a0c-b37c-7fe56a2506ca" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_country_US_5a2f7ce0-3a20-4a0c-b37c-7fe56a2506ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_b03724c9-96f3-49c4-b1f8-6a6672b68a21" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_29ed1076-fc18-458b-8d6c-0debd99788a6" xlink:to="loc_iclr_OtherCountriesMember_b03724c9-96f3-49c4-b1f8-6a6672b68a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c569b955-73a3-4462-86b0-5947bb118b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdac174e-c09b-4eab-bd64-c8feafdd0fe5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c569b955-73a3-4462-86b0-5947bb118b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6c523cf-4997-453d-bc64-7e3525ecb2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c569b955-73a3-4462-86b0-5947bb118b9d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6c523cf-4997-453d-bc64-7e3525ecb2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1137f38d-c17c-466d-bae1-4a5fc97385b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1137f38d-c17c-466d-bae1-4a5fc97385b8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:to="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ea7b8fe8-cbf3-4c82-ad73-f95d5901ec9c" xlink:to="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_967fb8dc-5baf-48d5-8d98-09650cb3b766" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_country_IE_967fb8dc-5baf-48d5-8d98-09650cb3b766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_2f8df56b-d498-4557-9449-751949b8e4c5" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_iclr_RestOfEuropeMember_2f8df56b-d498-4557-9449-751949b8e4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f65f6494-4a0d-47fb-9fc7-d848176282bf" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_country_US_f65f6494-4a0d-47fb-9fc7-d848176282bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_ac6251fa-2735-48d6-9e8e-fe297385d070" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a3f8256b-c4ad-4f4f-a93e-dab65c8d378a" xlink:to="loc_iclr_OtherCountriesMember_ac6251fa-2735-48d6-9e8e-fe297385d070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_022e1b1d-a21d-4167-ae36-4ab23a8cb37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bcde0978-2381-462b-b68a-8ef077e7c528" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_022e1b1d-a21d-4167-ae36-4ab23a8cb37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_ec199e0e-642d-4a4f-9b11-72ef9c34200a" xlink:href="iclr-20231231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_022e1b1d-a21d-4167-ae36-4ab23a8cb37e" xlink:to="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_ec199e0e-642d-4a4f-9b11-72ef9c34200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c3fcebf6-05bc-4fbc-915e-cdbb99a52fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c3fcebf6-05bc-4fbc-915e-cdbb99a52fcd" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:to="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_015a022e-86db-4aca-96ef-bac3427c171b" xlink:to="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_d69157b7-2cd9-4478-806a-e2240d7ccd01" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_country_IE_d69157b7-2cd9-4478-806a-e2240d7ccd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_b3a01f64-8562-4cb5-9ae7-035d5c1e370e" xlink:href="iclr-20231231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_iclr_RestOfEuropeMember_b3a01f64-8562-4cb5-9ae7-035d5c1e370e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6ea38f8c-1b98-48d6-8c45-0e4b9eea270f" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_country_US_6ea38f8c-1b98-48d6-8c45-0e4b9eea270f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_79b9511a-2119-48d7-bde6-f9b606883894" xlink:href="iclr-20231231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_456db8b3-4397-425a-b38c-0779aeb36727" xlink:to="loc_iclr_OtherCountriesMember_79b9511a-2119-48d7-bde6-f9b606883894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_afa6a79e-cffb-4c64-b1ea-e53b063138ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_f0be7a51-d452-4635-b5f8-13bf0c35ea6b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_afa6a79e-cffb-4c64-b1ea-e53b063138ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_15bf9942-40ce-4956-b1e3-7089c15d3ace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_afa6a79e-cffb-4c64-b1ea-e53b063138ae" xlink:to="loc_us-gaap_NoncurrentAssets_15bf9942-40ce-4956-b1e3-7089c15d3ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9bdb6ff6-3a7e-470e-ad14-ba315d0d5f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fabce3f7-37a1-4f0b-bae7-654e8b70279d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9bdb6ff6-3a7e-470e-ad14-ba315d0d5f93" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fabce3f7-37a1-4f0b-bae7-654e8b70279d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_926d7406-40fc-48b7-9afe-34966f4810bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9bdb6ff6-3a7e-470e-ad14-ba315d0d5f93" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_926d7406-40fc-48b7-9afe-34966f4810bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6971a7b9-24ce-4bea-b196-4c8ff684f37c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9bdb6ff6-3a7e-470e-ad14-ba315d0d5f93" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6971a7b9-24ce-4bea-b196-4c8ff684f37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8d881ced-3c88-4897-9bf6-458848d42f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_ebcdd7cb-0dbd-46a4-bdd1-9d62b359d7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d881ced-3c88-4897-9bf6-458848d42f4d" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_ebcdd7cb-0dbd-46a4-bdd1-9d62b359d7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4c6d83af-54fb-4af6-9a12-2d9248450725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_ebcdd7cb-0dbd-46a4-bdd1-9d62b359d7d3" xlink:to="loc_us-gaap_EarningsPerShareBasic_4c6d83af-54fb-4af6-9a12-2d9248450725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a898d38a-a0ff-4a68-ba53-6423e667e00d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_ebcdd7cb-0dbd-46a4-bdd1-9d62b359d7d3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a898d38a-a0ff-4a68-ba53-6423e667e00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_54a224d8-ae00-4511-be3e-676217aebc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1de9ee66-a396-4060-8443-451117c76d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_54a224d8-ae00-4511-be3e-676217aebc3a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1de9ee66-a396-4060-8443-451117c76d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_484f900d-9e7c-485f-85c1-31e2f1dfd916" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_54a224d8-ae00-4511-be3e-676217aebc3a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_484f900d-9e7c-485f-85c1-31e2f1dfd916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_b9d55db0-d866-4324-ad63-bec3ca69626c" xlink:href="iclr-20231231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_54a224d8-ae00-4511-be3e-676217aebc3a" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_b9d55db0-d866-4324-ad63-bec3ca69626c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c13e1e5e-9ecd-4c3b-9a61-3270b26a89df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_54a224d8-ae00-4511-be3e-676217aebc3a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c13e1e5e-9ecd-4c3b-9a61-3270b26a89df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SupplementalDisclosureofCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_c37f9b9a-8a1d-4005-b5d3-faf87b800c13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b2d0b1ba-8a93-43c0-a3e1-d3e3755d53df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_c37f9b9a-8a1d-4005-b5d3-faf87b800c13" xlink:to="loc_us-gaap_InterestPaidNet_b2d0b1ba-8a93-43c0-a3e1-d3e3755d53df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ac613414-9c34-4cce-b316-a8b3402686db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_c37f9b9a-8a1d-4005-b5d3-faf87b800c13" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ac613414-9c34-4cce-b316-a8b3402686db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#RelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_45c607cd-fcf7-485b-a40e-a43a04317cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_45c607cd-fcf7-485b-a40e-a43a04317cf2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_19edca5f-0bf0-4e5b-89c6-863a170754ad" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember_e934ab26-0dd0-4eeb-ac9c-cc35ac2865bb" xlink:href="iclr-20231231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:to="loc_iclr_CorvusPharmaceuticalsMember_e934ab26-0dd0-4eeb-ac9c-cc35ac2865bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_3a7291ef-85b6-40df-83b9-9989f9d560f2" xlink:href="iclr-20231231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:to="loc_iclr_AfimmuneLimitedMember_3a7291ef-85b6-40df-83b9-9989f9d560f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_8d0d0703-d0b0-47ce-9110-ce5a5bc2c16c" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_cd69f87a-a50c-432b-ab0a-69bfae170a86" xlink:to="loc_iclr_OncacareMember_8d0d0703-d0b0-47ce-9110-ce5a5bc2c16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_439ee13e-db7c-4433-8754-0b8fbfa38c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fd387f12-835e-4e2d-a236-77f7cc741157" xlink:to="loc_us-gaap_RelatedPartyDomain_439ee13e-db7c-4433-8754-0b8fbfa38c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_8be2ee44-a818-437f-bb8b-d517c14be20f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_439ee13e-db7c-4433-8754-0b8fbfa38c9e" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_8be2ee44-a818-437f-bb8b-d517c14be20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fa7c6e2b-4d53-463e-be73-04eeac91f3e2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9f53ab1a-1e50-4786-bbec-cd759f9a4db4" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fa7c6e2b-4d53-463e-be73-04eeac91f3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_a39e893b-1863-4ef5-aefa-0904576b6173" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_fa7c6e2b-4d53-463e-be73-04eeac91f3e2" xlink:to="loc_iclr_OncacareMember_a39e893b-1863-4ef5-aefa-0904576b6173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66fd8080-53b4-433a-9f6b-354bfcf17bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e5580f0-a926-4d95-bd30-61131d7d2de0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66fd8080-53b4-433a-9f6b-354bfcf17bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_924999eb-ce86-4fe9-88dd-5a86e81b2699" xlink:href="iclr-20231231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66fd8080-53b4-433a-9f6b-354bfcf17bff" xlink:to="loc_iclr_OncacareMember_924999eb-ce86-4fe9-88dd-5a86e81b2699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_63bd6127-b767-4f12-8cbd-672c4595354d" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7a3b1503-df12-424b-96cd-0d711baa6308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_Revenues_7a3b1503-df12-424b-96cd-0d711baa6308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_f69f7210-1cc2-4434-bbe6-879d3ba9c4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_OtherReceivables_f69f7210-1cc2-4434-bbe6-879d3ba9c4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_75c89cc0-83c6-487f-a336-f0e880b20313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_EquityMethodInvestments_75c89cc0-83c6-487f-a336-f0e880b20313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_803616f6-cd45-4e12-a036-3d66b2120c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_803616f6-cd45-4e12-a036-3d66b2120c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_edb6e860-6a15-46b8-b02e-7d85e1d62a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_edb6e860-6a15-46b8-b02e-7d85e1d62a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5fbe8093-c81b-497d-90f9-afa6d4b945d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5fbe8093-c81b-497d-90f9-afa6d4b945d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2c166bbd-d6de-4d0f-9296-97a119b8cc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2c166bbd-d6de-4d0f-9296-97a119b8cc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2f1ba79f-e763-4a0b-af32-338f56ecdd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_Goodwill_2f1ba79f-e763-4a0b-af32-338f56ecdd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_bf32926e-7a04-4d00-94e6-5102f508b0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_34d619a8-8d4c-4f68-b1a9-22e53468bf50" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_bf32926e-7a04-4d00-94e6-5102f508b0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="iclr-20231231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_593ca7b9-5378-4201-8c0c-3ba4f11e920d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_593ca7b9-5378-4201-8c0c-3ba4f11e920d" xlink:to="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8c11a5ff-91db-4e55-b7bb-503ef69db7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d4e69001-02cc-4a2f-acd7-a4f9cb9c11e9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8c11a5ff-91db-4e55-b7bb-503ef69db7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_10530842-fba3-4ffc-80eb-8489dcf2cdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8c11a5ff-91db-4e55-b7bb-503ef69db7fc" xlink:to="loc_us-gaap_SubsequentEventMember_10530842-fba3-4ffc-80eb-8489dcf2cdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4270e938-9805-4ba7-8e6c-461a52992989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_93dcbf6a-6b35-4751-ac00-ee2e99f1a7db" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4270e938-9805-4ba7-8e6c-461a52992989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_61ed8d93-fd3c-4899-b238-1dc2a24e09b6" xlink:href="iclr-20231231.xsd#iclr_BuybackProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4270e938-9805-4ba7-8e6c-461a52992989" xlink:to="loc_iclr_BuybackProgramMember_61ed8d93-fd3c-4899-b238-1dc2a24e09b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_7c3453bb-6c3b-4258-bc58-93c2f194e931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c9f66c88-a653-41ec-963a-9154da06a73d" xlink:to="loc_us-gaap_SubsequentEventLineItems_7c3453bb-6c3b-4258-bc58-93c2f194e931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ccbd8f94-840b-4078-9f43-3e769f85773d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_7c3453bb-6c3b-4258-bc58-93c2f194e931" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ccbd8f94-840b-4078-9f43-3e769f85773d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>iclr-20231231_g1.gif
<TEXT>
begin 644 iclr-20231231_g1.gif
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M]PVRB6XY#AZ+R/3KL,<NNTZ!&6#IOZ'P=[65FYJWN[T%15S$$T5  /]!%CH
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M1U@@/0"@!&1E ,0S(>#3 F$#)S?0!.F#!!]@3%F07 ! 3<EC1GM@ #U05P"
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M*'5QJ*Y7G782KBI&<7YIK?;Z%J#5K6&7.S)IDXVFIR<1K2L6$34P UKP!#T
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MT1E&)PM*/6()IM13#-O@K2\>0)!NHP4;D)\V4#X:"B_I;=[XA@3=PSSGR3)
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M:U@7-D7BJ>!(MM'.CX*:48ZLH (XF$S>KAG4M,3@..H,RU@P"I.N9C%N#.$
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M?]3H;"6EU;GI31L"%:MX8%2;]'*D2K".-A_>)XRCD#>/L(Y&-,()LJ" !DH
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M;O3&J.B(.LQ%R1&_U[K KZH\&),@%Y&C8E$!'?@"76F>@]D]$E!'WN,(=-"
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MR\B4S BS"I7<2D8I1Y6+2E&TPG#)+\QY@"+@ )?Y-)\;%#VY@1>X%2FI@#>
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MP\((-=(C-0UQ]!ZXBSVXRSX(2$\,A92+"<Q6:P$&B#<M>($#L(&O:?^"!>
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M Y(K;$]X8(P%6 '%2Z'C<;O-66*CVRBV*F?,O6:@:,@5ZHS^D=(U5?],+ G
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M E8AWR3K%]W= LKVB7EI,V(S40M B"SP 6^'E2+H@06XMZ,-F?-J%\9Z&PO
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MS9NLI\0E,K&)$[%6##0C"X]DIS 4T!T$>?>W@7 @"T40"!.R8(.#V.1"-7C
M Y" E9B@ 7(W28!4LH6>$6C!,Q[00@],H(0M6,  2B$'Y!Y 0:4 X"=Z^\G0
M%&) )SIDD14A& FY< 9X6 TD,> -"QPE+/(E$4@MT (&]E.#HC3A"20@P1.:
ML( *F* '*N@!![#P!!H\80(,T,)8%C "6$+ !BUX@0T6,(,:V. )&TBD:/\6
M\(19(L0 -+#$"/ZV-IS5 &I>JR8 'F #'$00-80QS$<> 0<EG $Y$.#-$/ID
MH.)8AP)](<B9]F [((&&,(\(A1,<Y)MFR7->TB$8<>YY'5&!)@1<Z"<C$ZK0
MA3I1G8H#@BSFPC+#/*Q;1$K1$9!0A"-8I0@+.  )-K  '>B- S;0 !(R4(,7
MS!(+.*!!)+3"/EIN $%:@)<%MM <"]Q FQS8P ,V4)8^ZF # ,"!#;0R 1K0
MX(&>42=#51(#W\#+.01Y@"3+L:00E(,%6$37MV0&50*5@ D]: (-*D#+&OQG
M!$](P @6D ,DW,,"2%E #;" 2R14X 91F8 6'J'_A1]LP00>^,(#M#""%V#!
MGX$A2#%U\(2CP6,+3(@* #Q@ 0[@( 8MR  '+(">!X06#0:P@ DLL((6>"$+
M"XA':[R6,A:D( 4LR($!<DN00P%A?$,RP!7=A! 6#D%-%EQ7L@P0JP^ J5V:
MTU(GO:-<)]B!6@11' B3):ZH<K>[WAW2@&0[D'L\X0QV<((?[A&"1L#AG3,#
M4V24$(5EYH )3UC )Y_P CYF] TO0 (#<GH$&S ! EO @0ZBT *P'"$+2U""
M%@C2A C7P )'8  $7)N!"9N  UOHY0( 8 $D?" +(VCE EYRW._*+30K9AI6
M3[B.Y#P!:UL$ZZI:$ 6&_[6@!38 (!:T.8$$3, &-XB" 4PPWR>04 L:V$(-
M,H#DG#ZB!Q#@:\Y:D ,Z(N^ .$/IA[?UDB\4 0M;@-@3MG#?%JA S39H'U(4
M^TD;C& +&\BH#9#9&DEQX0%G H*\(N29#^S!;XZ%X4"$L(XAK*,"GO&,I0"-
M(8*EY %28H%P(V. $&#@##\ZUD$8Y)%3">4!ZY!T<UFLZE6S^E$X;I8?KC@$
M('Q,0&,-5$%>H(4/] "6&K#!#Y" @1S80 <8Z$&[BI"!)[#A"!K0P@,6H($>
MK,  1[AV$2Q@@3H.! A;"$$)5("$+90#"8V-P@0&TH,)E!( ?C6P?8Z V;>U
M>K5GA][NUW#V!])I()/S6M%SO!9##!VD!#TXJ0HR< ,;#-@$2!WP#:0<$B;<
M8 $6V$ 3_$H?+=3@"$SI00N:T 0=T. !&>^*:/QR R?_>,@$,>L#YFN Y]U
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MW@F]+80!W(-O)!V!B,>V'4"1B46(W0 -C  -8!\-],"3,4 +8!P-E(V./0$
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M!\ !!OQ!7=QB!#;33L+!.M@!8J :J!FC5$XE0PV'":Q 391D(5V< @& %VR
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M?>W@M]J ;\0$.=Q#&TECR1P ![Q :!6-6^*J1O9J0OPD#8K'N!K%"*P'N@'
M!%1JG?V 6\U22+S !&0!!!CA V2!?N%2@HTD^WF<#@S$ =  $UR5=SX Z(W
M1FW %L! F4I'=F) GOT%#IQ9>7S8%UA 06; ",BE8LZI4EC "$PB#-R9#F3
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M?<#(O0 /BD?I88'Q"@1[Y \ Q,,# .A.D(, W<3-X&X 'H&@ML=Y>  6P "
M0$X%8('.Q)9"Y 9L+)HMOHG1(A=!D, (]%$A"6@++XV6D(!H[:9H1(8)S-("
MA*F1(H134&;:7+"57"L$]0@%_PLQ-$<S2^A5,6E!$[1+$N+#P6U+I_*A$F7G
M$9C !D" Z=7 6I@ !/SL W#D8D+DHJ*'C[U0MVYH)+R!KR39T+!5+X]DS+3
M?YC /9! F.+ "CQ0_Z2$"=2!H\" %ZC6#6Q?-=ES(;U!+\_+,P]%$4(%' ,
MXYT88-E>4FD!!Q@8 Q19!7Q!^=G SHX I?J843&O%^0<9Y$S#<S;N=Q:#V@Q
M )  &GC !ACJ!CC3CXET#1BJ%6=G-*V %GR2!CP!$@#5&189!F@!5@S8!FB!
M44%&VRQMR<9)RP# /9@===Q*M:9Q0F2 )6!67#I>Q"RC" & Z^*K6UC%FQFJ
MX^:$4O\\@%U.KE*0@)::6S="CCS61%[>Q%TC\T1$UW/8!'X$"!H\  S(HZ[D
MQ$5+LV5?M@T>!&EMP!*XH1?4LJ^DUOSJ<M.TP *8P,V@EN(= 6JI  !]@+QJ
MTPUX 4EEE@W(M=Q:"V#4X1/YR$&@$@U,P!,0<P48-5L4A0:<]CW8P/C]-!:'
MS=A4\FW/J9B^P0<7X3L&*@>D;3$;@.E>%ZA"6^HM&[31D8&!Y 8L130E6 B<
MV>*9&5KH5#!9Q0O @)H-!#EHF[;A +*VQ([@8%E#AU"\!.JJT=!E@0=OUA+$
M!&J9GV995&EX0!$T007@ $T;  G8 %H(]Q.6!1H%\@*D]P?_;($2T( B^_0L
M\7<2QQ46<, U%T4;Q?(%%74P,=Q*:8&A#O- ))918;:/_[C?+6<QD\R"^0IK
M"RPB_L\&])5:/8#ZC.@$^1*0_RZ?;";UW*\_*?.3SBKD:.H!$!)^VZ5@#HU,
M7-6%W 1?3A.8A_6;6%!*[%X+)$!B-6RX&@#S+L UFX 6P,.6W5<(V, UZ\ E
MGEE.&8!]0\"S <"TW4,1\#>@UP2X0H^6D\]+8),K(F=F=G5I]$@&L %2M  3
M+$ 4/ "==O 1!%L2\Y&7AE!E?\9 L%X4,($%0,4#R)O'/L&6/@$#1 $6C]Z6
M7E@)=_ #Z$ /(%BF%H&&(\7P-"''_]TDGAS$ 2 !CG  @.&#LN% #T3!35![
MWC+GE'\[N'^+;ML@1$SZITDTWY(L#E3 &ZQ :MW#"JP -SW "G" .H*JN>O=
MM58&\+DAA!N$^C93OBU*KHZ[ "M1#'+W ,*UFM&I@BV!%C# D56 ,HE86^I
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M";PF-@X D#B18D6+%S%FU+B18T>/'T&&%#F29$F3)U&F5+F29<O_DS7><."
M(P9&#QXNHK% ,0& GA)_NOP8E"> &#^)"E6ZE&G3DC5KT.B!H8<-G !J],0Q
MHH;$KEZQ4LPZL<97KST-)'7JL@4.'!5(U$39@L1$N3XGJM5X=^+5OBV\=CT
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MO TF")*##;P8838=FI!R PZ"A'>HD>1*U^"%5Z*0K VB6&"""@Y@[@D;5K!
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MHRRCDE:I!/H;J.>B#\C9KR[: F&[U.:UM_WM0;+QBM0 6!:)1WR;JVIV2=<
M/V !"QHA!"'\0 AG<,(1?(B2$L 7]S_'"CDD,]6KD670J>)+5^A,3[)7\W]/
M:5@G4:4I#RQAJTF$0?\%[D&"7Z'A'CN321I[9R2WY*=G?5F!"MY@W_@,\J@F
M 4@ S"H@3,P.[&#((CP@'E+J^Y:"+^+GL< D<0"@KE(&3$[$,$QNY\8/(QBB
MZBK(W<9)6]H, )Z "8Z@!^[A-7"%\B8 "Y0 "63O/F3K T-"!78"*$9@?3*
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M3,KE!%A +#>VI#153J'U"=QG!-[ !WY@L[Q@93U@ XYP 1@ 7U3@'K8'F#C
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M[-[DRYL_CSZ]^O7LV[M_#S^^_*,M6*";'QFR3 A 9'U@@0<$@J'74PD8/ !
M8/@MR.""11V1 PT&8#%!0G@!4%(-&]QA@0%/',$!  ^,\(() '!PQ!$0-#%!
M!FV9D,$17V!QQ U/D #1!# ,V.""0-FA@8*]#5543WX55:1*22(EY$M-KG</
M56Z9T-$7$-B0P0@A)B0C!QDH] 06-N!PVD 6>#&""3!LX -#H(694@5-/$ #
M#A:L90-C*NV5GG()ON1G3SMA]U=03Q[UQ!,I+=%##?\VZE#2E2]LT$0((VR
M*4=/W*#%!%\AB,,"^-C 00U;)*:%%_C5$)8%5O4(:ZRRSDIKK;;>BFM[187
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M @-,M#H3O&"J'-B)"<+8M I  &I?E-WW+( %H4D<!L^]P9R]<(."QLH ?Z!
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M 7>2D.,&,NCA7CU2/ZD&'Y ! 2[G4<+)H1V*G(7!2*TY*S^ ,IVQH+JS$B3
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M -4S+AR0<D)5<(!6DO?^AVU[3+Y+YN#'HKHYYE2]W3ZFN!,@4 <P&B9 =!R
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M&'# 5V&$B2,F:)AX<F/# 1,<'ICP#&!#!;E<2[!X0-GW;\!?OUX&"KB"DKG
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M@P1$I@8<2!&[S%(#MUC3FC3Q  >T]) 6;,$"7UA>##C@S0WPYT0)6E!P:&(
MI*PCD38QV\O<"8!9$?^P1V[!005B0 (;3. )GIG !I!&@PG X ;<\4 +'M"$
M$0CH!APH*"65DTF;E(-_GC3=.H_5)U&&5*0C):E@I#(!)]A!"",, 04@$(,)
M\*8#14'7%CDX,8_BU),(E.*B;%I2#HJP;+]3%8,V!(' 5,">T6J!$X80@J>$
M( 5':$$%\'""4?F-@7BD#@OR5!,/T  - "#'F!9@ @NT[ ;W^)(%6F  ''@!
M!VFY@5M[F%8J?8$F.'">#69R3@C@(S(-V:I/A!"ROUS&#M9BV^*D"+PH89(N
M(LIIC[" CS+)A@.@P4'0*D(# - F ^>4X7S:NH0-'.A'7_D!"SBJOAW]$:C_
MLZ5M;459OYK<XQ$&@\,YF,*6$-F.-^]\K8X,92>:["9OMMU9V,96-E[V+@'<
M>RL 0N"$2OT%6;8$&Y&,= 8_K$,6ZYB 5$Z AP^<@6&".0$+TF>""=CD 3U
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M*&QYV&..UE&Z4E(*%JB6.Y"8G:N*FZFL'1% U\&M-Z,YFZB.!<RY9#$^#=S
MH).46?N /UB'#/ * UBIER.].OD '[C N\ R#N2+WI$@%C !?(L2LW$^NDF0
MI?*)JPL,GC" #J 0=% *T'FGQ;H#J8,^]W) 9WF G! 6V*NLZ6B,58F*#! W
M)\,.3HI"H: L%#21!R(Y%C*]8G*1'@2,PVJ]:+&1O5"]%WQ#."PD S !/+"#
MQ3H9/G$"_KDY'K$D + ##4@,Y?(:%@0;M_@?.S@'%@"F_["IEL+BB^@#0!/Y
MJII( 2X  EF@@!.,@0QPJC:\O*TX 9_SE1W+BI&31+^HKM3+-3Z4%N,IQ%(4
MGWDY0]_@L3W<FNV*0UW<Q=FR,)LX 2[8K3WX@,5J.GV)%D"LP<(P@ 6"'UHD
MGVE)N:=@Q!)XBA,$C-?3FM[A@C.P \R!JE#0@.>SBPGC/E:<$2R2EG.<P J3
MQ7<JM4SREP\IF@2('>0IFNN8"W_QB0.(A!+QDYE;QWSAMU6DDQ_@@LAP0QW!
M&EYL2(><G[JYC.HX R-))9@K$67L$9[ />2R+CEY%N&0EQIPJ ?@%X6\)RZ,
MB<S[@T: @Y:!)R=0@O:QFW7+P%S5.A$:J1T*014GT  GZQ >3,F>$$6<"DD]
MRXV3=)W_\P@:6(& F0GWVXP9R)J!$:,14 $@ZHD':#"?J*J2F %)28X&_,*M
M6*+B>+?(&K7IH!$(O)/203;Y&L6MB?_$AZQ+N^0:/\23=XJ)!_""<8R4C 1%
M/[+)PG!!P70WGR@!"#@#7AJ"1X DH90VXIF;9EN':D$D:[2B3PP_=KR:SWO&
M!F%%A^$92&H!(#@#*Y*2)'H+B(%%=*0,)QP>';"$+6"+:FJ!H# !+?" !_ .
M=DD1J-0"&[  &] " O. R'B +* XVV2D&]""%J,F%$%. #B %.&7HBF_FPD5
MU3,]C)(.JG!+TO%.@526$CD7I-R)>GP6D.+,P!#/NXQ/^9P16[%.8"NY%M&Q
MUDE*]EK"P\"V1S3/W" *#'@$(?B!1Z  %O@!$/H):O.!1V@$/ B%!$Q/4IR*
MO:#+MZ03)&/_PM<$ &0Z#+Y1C.K@B0.( B:( OZ@CR-H @8(@07(@@G @H>X
MC8H ->74 )8Q/ ]X@2:8@/';@@J8* ,@ 1IX ";(@OWXCP?0 81JJ UPC?1H
M@1?8 !WH%2\4#&/!2,!P%QC8(/Y,C+7D03]D%@V=3S1-TQXQ  MX 0XX BPP
MBXQ!BQ7H#1(P$!\J3R#Y@Q6,S!9L1M \C&FI' ,(@3,C&"X G3#UF+=0%0C(
M  ([/:WXBL91PQXY  ^  2SP@$U% ]6RF[)[K1)U3W*D'\YI1;X0@B?(4"2
M@ 4@B0G( @[0@"U@ %H%#23X@8GH '&JB0F( BUX AH< 2T@SB> _P A)=8Y
MS(('T( B0 TD>*;A7( %^($BL $.*(+]0(()H % PZ<1(<NL*!'Q%+)D^X%)
M6IQ '8P\P9%%)8P_N$9V55-ZK5>M"*=KU0(M.#"@0)R>D(@*: &.H%$.0!S)
M ANH(Y\.6(?E LF@^)\?,("\\ &J,@"*=<VA(Q&S.%B= 114]8DS!9*>T5=]
M]9(92!]QC0M'V;9 (1OR^3\,*((/>((M" $EV(*84 F3F,,M* \;> 2&Z#>6
M>0$;0((;V((;\ B5V()RV("., $D:(&4 ( CV+2>!0 LV((,V (0>X(F@  M
M8#3>B8'1ZR.: #:D2=FLF!N&',CN4]LZX?^3.LM8U=S8FGB.L\LZ>]W;#32
M+:"(/U#2&%NP XDABNNAJ<D"<:P W&B!&WN =PT,.[C%PFQ&JWD$O?"=1M"C
M2E&0+-21LG@ T+@!BCM;$B!=U9J-#("!=:D +\ Q4M6*;-1+'IG#&[A6[%&+
M_B@:R'B _/-=(F(:#_!%/]DS_^Q!MR@!+L@QPW!"*/& *(B")XC1#'B!GOV(
M(Z@ 75"(+>#-*& #QBL)!:N!<LB".^@!<=S:K84 B[B'(\@"02D">%@(!M@"
M$Q 4+8" (G@# %B )G#?(V "X\2GX_%3# V4$\B $#B< R@!!&6+.P(,ZW.Z
MR!62H,2C"CZ,;!3_L@?Z$(_E6Q#>12K<@DEB@"(X AQPB.F5VAYX"0Z !Y6(
MU06R@2:X%&K-#'G)X*THBQ ]C)XZS!PI.P 8@C-@G'6 $B,!@'MP@K_T#;WD
M "3H@11-UR/H@>)\ EVI !OH 2YVCQM@@B?0 I"KO? +,NF+W5JLB;"]CPEH
M@3FB@1&P !IH M\=(QJH%-;0'ON8Q;?@2,1H@75(-\,8N92H,2Q@@G0  B30
M@06P@:K:@LWJ7@!X B1P#ZBT 1O  !MX O:8"!OX@H_X 0B( H/8@A(PB3=E
M"!6P 0W UGNPWTF^#1MX@2>@@0/8SM!TK()!%:?(@$90/AQ$1:[@4XE9_]<"
MNK"1[$I;6T.Y[%)4T[U("<EC#+T0KN:@4[HH(.'BG(T9'8%HU8(%B 'XP@(D
MR #EQ(T>P( ;0(* W0#W4!9 1$O!J!<TKA/-46(6>(3@JS7G[:X7B-864(%*
M_@C[>H!@;8@>(#,:<&0!=B@;Z!6S",RJD"UF,0 MH(A)MH&/> (+0 )\2 G9
M."N:A8<>6)ZBM2@6FMW"7-ZT'(Q5::<*X%^:B*&;12L"PX$Q>8/(P!4^@JL5
M, &>J  41I$W*!<<L  8,+S0RFFIP &Z0YHWT(Q^ @ 2^((;B(QF"U>]A9,8
M: 0,0 =O1!4@4 )SMITV\S[B:=:S?EME*8$$??^ $NB %,D+I(*7K0Z2O/A<
MO_#@"Y878[9FP XD@=T#\(E3UF#D+4#62C$ WC1:B( DC=@ +6 Q2]V1'C8,
M0&[86E%'$.6"#($8#&AC # 2C!V^FN" +1BL+9"XVJ2)H_T )&" =]*,$2!E
M<[9'2946,RYMWZ@!+= !FJB/<#*!>S!:S-#1B*-9"(A6 +C9C@K+FFBOQ #D
M /6+QEC*GK (P^!MH<CJSK293ARJ,Y")#*$)5#(A=Q("'T =9AF8L9FB1HCO
M,^ "Y:ON9<G%P3 6I7N PH('R'S;OPYL 2?$+< 'N>B!*)B::&WDWM0[)+"
M<P8 ]$@)[+$!=0+BW["H@S[]S^$"R4 I4*&-)!8HX!^9@"+ ZHN>@![8R"W(
M@2RHH9$\@'O@ !O8@H?.8;A0JB9.8P:,@B:@":<- 7%J >/N 1W0 23@LR+
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M,(()";!4PQ,UW&##%S2TP($.-%3PQ ,TC,!!5$G%%-QB(<"QSA\: G $%P^
M2-A3!OR 5G/(T=5;70"@R (%%(1BQSK$ ?  %V<TPD)J+"KV1USC*;;4/4X
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M'P\ E@:RT"@M&* #2#AG 1F !)-M02 G ](L4::N&-C1*O%$GB6?:QD2/ %
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M!*27:B&&G;A,KQW&[S#<0'  < ' "B!!<: !Y0# Y"Q !9Q3#<# Q6&$9-'
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M=3''77I*YZV%W#77J%!F$V8D4JA !KR A(!,?G:=X4D? TQ #FG$U53@#6Q
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M  SPC>$)2(5L@)0DV0W@PT-\V-M$X_:8D]QPP -\@<#5P K(DTO4X50TTPM
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MLW",QR@6(GU %.!?.<S9E0[$K]UQEK0 &ZBP =P $F3!\)  L%A6JU!IUG[
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M'S:,P OFNL<3_T;PB"@\841?.8E+6* + , #"4<X A+@PI$),.%F3QC@JVH
M@V,QH6&@*6M'Z5M?^]ZWJH21Y5F9-+RSVK9*(65E3*QJ5IG$R01.^( 8]C"=
M![#@"4*@25,G;$06J!:"3*)*2]#0E:L< $09/!(<61D#@R4 A2J@<( $G)A9
M*D:<>X3>'5M,)Q)8  8MIDKM>GL3)2T&3R.*P1FX\( 4K.,($/@!.K8#4PT8
MJ<""*<<(HBR8&'@XI290P96-&(,7A[4Q:TKF?S,WQ:$=!ZI0J^70_&,!#8P
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M-FR !+"Q,?B$>DS2)$5Q#EO2)5\RVJXD"L[DR?#A!71 J<K# GX&M7Z ,UZ
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MQ8=4# 8\H$$+"\7(V@,KF! ##BV8<"+_ ":$@ , )*R @P$X</2A!R%6T"0
M#WC1@A<60/G %TO@@""5%GAPCP5O@#G=B*VY5X)\?/;IYY^ OF8A #4\PH(/
M%-S!PAT/!!7HHY!Z%4-+,&SPQ0RRJ=!<!1O44 -(H)J@PA<TV%4!<2LLH0*<
M./2GA9VBP9CB QP]4%=(,%00T4LQD(-#C_/A "M"1[7 @JV1.F; "7<(F>Q1
M.AE 00:=1<280,X^6U!B'#S@ 0< J/" @9;FQ0$3%<Q@PA( <""A"A/8X).2
M$!ET @LW4;F%#3;T<(1.)N!S $PX/,&O"L &^= #%G!) [T\_5$4D)_%H,$?
M^88&!(T4A[:A_T*[=>P0>T+X<!V>VE)'KV@&8$MLC99EEFS"*==L<Z _&= (
M%Q^40&0(0' !P<U$UQP)#B@2BD-X'D34- Q08DF"!PE0[8X''M0 IIP5?*'8
ML*U%U%$/6O1000M;G*#8P ?!L$ ->/:P08KU/E0"!K:B7'1!$/B0\=X/3>N:
M>]WI?5X+6%NXM:=3/U#!$5\T@8:<)7+]16V&-^3@RR8@L<0#(VR!8 V.FV"A
MXW:V0,(#"1BP0!059*!%!1X\D&N/-;@Y< PDG/TI$FZ^@6&)WIHH[&0&8($!
MS392P%3F5AEP1P8GPS2H0S^-6!,'-=3T,DP_R:)!B="S-B*O(I?_=_^RD&U6
M0P9V>I !\V0^X&E23A;TJU.M]P3##16@'^ &2$"K? P ?W!"HQ[PB RTP !G
M>%$!)^@Q^>#@"&F*U??J$H4%(,@&&T#;"1P7(0\@[58&2  )W.0T'%2 '#70
M KB:\I(0L" \%(Q)LW*X$ ,HA7K5^4S+!K*3";;% DE32*LL@,,@-D4F"KG!
M%K(FQ8[H@ 8O>%M?;$"<%DS 8#B(01.T\((*,* &\1J!#710@Q:,X DTV)(%
M;/ $?)3#!EF8P UL\ "YU, C#Z !'.ER$(EEJS-*X5AK<.25 R#H'B6LVNH2
M@*$*18@$6L,"UBA4@P4L38"C < /-+ G[*P^[#S=X= &G<@0[HBL3RY;B >*
M<(2"-($-):J!42QT&!@@29?S(A03C/($9/5(,SKI$0GN41!@L:V9&M# "$#_
MR<-J\E [&JCE'YY  18\R  88(HUQ^F8KA#),VVLD6>Z8H(L&-,#(=C"1WKP
M "T\X0GRQ,(4,\ O&TQM 4_HP1,,8(,)%$1(([H;LLA9GE42T";2HE;=.%,!
M"I3R9H:+R/T:LM%3:HX%US%!$18P BV,X %%Z,$%HP /+6S@ 1LP@10ST(0M
MM,!(6MC"$T) @R)@@0'RY$ 4&/"$V6W! EAH0@4>$05TO,"F-M  !+: !8!"
M@%\)J\#RQ"-$Y^E(B(Q4YU$V0(./;& #G'(.PU2P@0S@0 ?X.,(>CZ "M3Y!
M!2.HBD<9HA4D >YZZZ.,DE*Y$/5QQCWT\\ 3IGD2_R9H34*>DA &O( %2#)
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M\)\C?%$))% S$X" Q">\N5M/. (&TDNH";#!M:^LKZ2U50,N- H(0 C! [B
ML0R\=](3O)Y16KP@E,GJJX2]DWQ(4(05&. D- A!%$R@@1[ 8PMT 2@6B@ !
M)-#E ?"HP @X\ 0DA, &X+(6<NEV4"[@,,;)^L $C +M9%$@1T(TB$#(5S1S
MK@A]ZSGN93;'7YL:I 4"!H 4X=&#$53@"63VUQ%>T((%V."S43A"Z$P X@HH
MH0?_%E#"#:A[!!S(Q01;@( %D$"Z+2"A*O>\@1),()D62; UTE)DM9,"!" &
MUD<;F)H-FG-9_UB@"?.FB)]I<(0VJ4!UBL70DVEXD =0P*\KZO)K?G(]F[0
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M86< T%D;D#5/H&Y*4!$W@ %D!CH8A';?0FOCTG9^%AU-<$Q_EX-6%H#,$1D
M@ Y'< (/= _.IH.O5UC?YQ2\ @$XEU]#QQD_81?VUC 9 0-PP5-8T"XO8'FD
M\T:= @_X,&RZ$1Q7H5#-14%VH/\"_E= TN)WH4$X"K&&S\(3CK-Q,.$@":,U
M/>(TN60GP^,36+!0O%-: - $/7!3S[1,!C&!!G$/#T8UA (KO ,L+Q&!LR4C
M-Q8:-Q(5KJ1E!@%#(:*(O(,D,0 #X6%:6I,U(0(#E4,HW(: XM.$9S@>"%@0
M+I(PM0@IB,40-5 5108 2I [(Z !/X!&# 8!M -3&B!>;Y9Z$] 2%E #9G(
M2@  $N)G;^8!+_!%!<<PGB):)3$";6>,9,9]=FB$Z"AC=8$'F6@Q,Y&.*<,V
M.L$>T#:/ ! "&,!,39&+/5%W+/)Q^B=[AU1</6$LH\=#!%%Z ,F&\14:+Z&
M!204]^+_>I)B+^_8&BI  X)'>"UA2$_8&!9C![/(&=-S'1YUCI?Q$Z-T408(
M.'_ !;4%D9 2)6ZD>B0"/Q-02_"XDX%R NN0 @?Q 4Z@CSSY*$IB7(:5,P71
M NMPD'W"&'HC(DF8) OY,B5P0P%83=(FAP0T+=7C&=OFA(!S+US9& [RE5 F
M7&JYD93T8$BA2A]9$%H%+/P(%#.RD9QQ(S;9%'2I-S0#;L2B7.+#DA-D$R]6
MED4#AUD9*&BD 2;10Q.@ QH -D59F9^A&3>A 414&G<' *1FF3M((BT0,E3)
M&2&P#D0YAU&694[4B4*A(@[!E$[)0[1731"E 7N9DO/5>J59_S0Z(1.(>14R
MD64O40-U4A?S8Q#B-8NW@4'V\P";<756,2D'<9BNH13BM$A^9S@)(&>$4A4P
MX2%XV9L[8A"*&9<VXR H&2B0$9PW=8F7V$QN62,;!9KV^2?H@ =#(RW3=I^'
M=Q EP$!G,*!"B)[E^1*R.3/N@ 5[6!U: YL%@344"9>OQ!A7V43C] %J:* W
M$U&#LU^T]0%^LYY 8@<:P!@\08:G@CA9XP,X0 ZN" "3TR,FL #<@@6^5P,S
M*J$K "YZF")8@SA ^G$6!YB@<9<M>1F;J%X&6!L @ .E@C63@C6Y] !H0"NI
M"*-:HZ42NE==,66RJ&Q':(OK\)DY=!F>/<%U;S:;)");LK@0!U 2;*$0:)2%
MYQ:?__Z9IXWQ :CY ?DXDGHJ&C7Q"!@P+1D !(O"3*=V&08)*#K1 CK +S20
M1 8Q1PTJEW0Q RL J.$&$4K2J"'Z:>,D/;E9D:P7G,\BD1?)&B; F]ECC1M@
M %]@ F3!%G<Q-S)%&R!1$%Z #Q7PJQ80!22@&!GP!ASP4@NP '-2&_=@K"J@
M BLP&YNZF-TG&74Y'Q?S&N2GA&1" _7'$3/P'*+" 3AP#RLP Q;P?AO K!/Q
M!>."KGB:E1'1?[3ED:,JDQR% ;^B9(B32Y[2(0^ #PQ3%ZJH-41I LM#%35P
M !ZP&S<P I,"21DA6OX:J!8[&@29E0;@ RRP#JI'HA<+%/\GX 1 9P E8  A
M0 $:,##7JFK?P:;C\1(6D 4%IP4:*:/V0V V5;"C:6^Y0Q=5D[-M]*,X"Z/5
M08\+888@VR<*2:TYY)7CZ1B[Z+2 \Q)V %*N06Y.U!('@ ]@886<L@%W  $:
M.1@H=QR_%!A'< \T4 -L!6%7115?<"IF<:PMD 'KVA9O !.6>)T:\#P<BA1Z
M:9)(00,,, $,PP Z, &^QX&*$2'VQP$Q,&PT  'KBGG=(GM.B [CTYH#9!-8
MP +Q2C13VQ.!9A _X '8V(M'<%EPU@0/,#]^=@3O,P$<D#0@2#M@4@%O1@(8
M\ 0>0&MEQ 08D $#9@)V&K(7RW/_0!$1]^ $=["TRHN$ /"\0_, 0S $'Q #
M(< S41M*.F%#J0DH3W4$#P !)! #)G!/.F 76L!35<%@%5 $6R!M+Q #-R!(
MX%6C1[!&+5 !38 /.D"9LM<2-H2AU60 'R"J%!0MN(EQ^$JUD,(@C["JZV21
M/<%XW:)'PP823W  &(0/&F ;UO@&16(#4/HIOJ4I]V8!1\"_'/ %)O$1,#4"
M;\HB1(&JUJ$!(ND:#<FAZQLG(T!3&M $,4 Z_4$Z$^$##- N;Z089D01%.L5
M4T:8U#E!+QF3/G@4;'=N5%$!Z/(?[Q8E^@IUM IO*&8"',,[1Z !+S G>2%7
M!9=H&& !_QC  &&6$3<\O97)E<XRG[L$%-]CIGS<$*6'LBR@!&=P=Q4<R :T
M$ 8IO4X!J67S!&X2!1MP RYU!%$03^"R %H@$O1D;SBP8&^P8#-KN]Z%3TJ
MPDM9 4AS/ YQE3 [01I*;>0D.*U1482IE5O,&NH),P=! EH@+",  1Q05Z!S
M _A@ @R0K@S@-$UP \;J1C]PN[P! 9B' R\U%I_# 1D ' !P5YIKBQ";I"EI
M8U79&(.[CR^!>Z*U?8=F 2]0)^H2PQ,Q-"#Q!0K',,A,)TFC/GV50T)1 >M
ME]4D$+W<$"L!)FXD(5C@! !L "3  :^&5B<U(6J6;#2*(@F +O\3$EL2D@%,
M< ,%IP%7LHW@6<CW>4#V:%S4^S=7[(\L[8DA<@>U9 =.0!"-X#="L ZS !JB
M!RB\TCNTT@.TM 4EH@0R]+XR-,X+8 !/,#<+@ $;("\ H /^4@0UT 'U>W(,
M-F!/*JDVL+<;:8:TQ2PZ3%RZG&U\PYL*\U %\0$6'!JU^1 !! !0@R#0&258
M@"2PC'/WT"41L4RJ:$(J@2$QT )($P-MI@+1Z'L]89V<ZA4&\+?:ZH;0@TD
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M*&>!)^H/TP2B\ .G/*!<"]A""-@P 0#T#'YJ>4 1SN4^!K4-5&8I30) @Q@
M_& =7#@"O/QF&/(HACQQ,11D,D:O!&2  PWSP @JAZ$F8,$&+WC""\I%@^QY
M@3X6T +MT#7"E)0  VIAGOL^H ++))%]!J  WD(CF0JPBVT4_!L+&-0I>@FJ
M)"30W03(I[L8K( J%GA BF T PNPB@,Q,L$*2& 0'*R(0S8 E@A5\@ ,=$"/
MD#K6@IC_=8+L"$^$[GB!"9IP! [$(2Y@O(<%$D".WWRA<29H&' D])4'6#%0
M[F+> R#0 C.UP 3M,B$%Y_6@"CP@"@E0PK?$J /J/21;%B !+760@?R9JH$X
M,%&J*C !"(Q@<UA$9C)IP@&;82 +3PA!3C"P!0C #PM,L,'* #4"+91C"Y?3
M @,PH(L0:(&!&4!"!IQR#_CEZ2V&5&9-IJ:7EV P SY87J+@99;_K*0N%Q,>
MVDR@@B.\X91'R( -0D#+^!SA"//16N< L ! ><500XMG:RJ349/<[4"B<5!)
M+ //C!'N0";UCU1&DD>%%.@@[3I(#6)P ,'(E#I.PT'G..#$_R%" #N"G,#J
M^(F9SLS$A JYAP<BT5'!C$0A+9"I357Z%2'@TWV((8L!?H"'=2CM!Q#XPQ"<
M, 28HBYC$'B>5Q*"$  \ %@X.$)72' 0JSP@!J?TP!$D1 Y@>: %'&EK DQP
M! TPD*.'S6A<++"%%FSE!@;(R02T(#&//6$!4 J3#K0 )1?V (<)[(%P&+ %
M^FAA PB<*V(Q8TC##/4D3AOB)R_XQR&^285UBP'!/) !%5C 1#0@F1M-\,(-
M>  '8E3!/6PPP9D@[;8<_4"C.!J72#DK+*6I(EEXVK</L,"L7^G4=VWD@3=\
M(8^Q7<D/,- F>F(FD!]MUO&P&)<8R/]" RU=S';)-!<#/*"K2W,"!5B@ 0IT
MRI.C@]MHV!L3\7[E'B]X0(14.^%X5F %';% #0Z 1@.\P6!O>  .3FG>\MP@
MDG'J' [>T((ES)5%0XGC#RQ$'?U2V"5.+*%)2-I>'K?7I29)H?L>,(,9F @&
M,[0/#-Y @B6," =?B,0<2[ !R6*4)B7@ F1JC#&R?& UM,6B1\62KKW%,S5?
MOLS@C,>:+=?D.OD\30PT\ <&A0>]\7R 575L,0N:Y %<J,P'N%".$(2@!6\)
MP1,>,: VSTDT&Z5)HV52 8+9V-*73G./,2V6'2^&@WK1KG]4$K6^D5"E2^W(
M1T"MP00L#P96#>/ >:]\J DOL<'LHX#K#C2:Z2BS-)FZ]4PZI4_9>N76G=:J
M$]XI:99L1Z@(!@NS)!69UMX96C,AG@9@VKZLHD,#0Y ;%^B\$-')P@D2ZC/[
M*M6F3F__VMWOA@FS92)O>*^M6/WTL:CG39)_<MNB%OB"E6D29-5ZF<)0W&3>
M3%)FE+1[OR9!Z6DB+ID<%QO;(X$=O5DBY^XLJ'4$4KA(0TU"FIP0 .O"M\5R
MO!TGA" %H3"!:$KP!PS0V0!VX ($DHG68 O.B_5^-WE$TFL^+X0J5+%I%TDN
M0N1IW-T_=A2KX3(7Q5C00$+7BT(JGFZ5V!;H=S&BE@_[@0DT$;$:F#9K5EEP
M[V(F+ER\S*=;,,\]#RHFINPY@]\+9F,#0=?$CO8!:N#P>I*DO]IN^)QZ#9H8
M<&8='VA$RQ^!AT,?@05"^,,Z\.;T&JT=1P9H5VE2_G72S\E _QS F0VT4*T;
MHY>^2Z]VZ=E6@\X-J ;#O0<)<# =7YH%!Q6@_=Q!SJ(74"NU^4V638MU#Q8\
M5YD8I"?G@T7JPQK@!&7GJ&*@*$4 Y/VUZ0FIF4DR\<N<0(M\_TH+I#0FPKO$
M $&M,_?IW9CR( O:8EDWR/LFFG6$(A3KP( ?>(LS"04G<(MD BGO,RJR8!%^
M:C_9RSZ3(+H#2;DGR((F& &K.8A6ZP@#2#6X@"JG2C7%Z(BUD3[$,HP'Z D)
M:8$BL 036()M(8DFB )'L8'IR8+4$@FSN($LT((?9#VH:Z]3F<!":;ZK2I:Z
MNS:[DXF+TC1E@@ ?N#]DBB*W"XT?./\P_:,@8%L0$E% ER@!IF&S)#R0O3O!
MT(BO=T$)&;&NR^BD;9M"14D0<X,#"A"[,W$"(5#"OH& .X!#"B2)"/M#"+2T
M,XPS 'B"+2@)W' ('0 Q'6"DQM*!<6D@2-R7>S@ $YC$<QD]",R.!T ")-B<
M#,")#S NT%L"\["!A3 !!F""V\@"M3"5"E ,"RB"!^B 0TL 4SFEAS !$[ *
M&T""38H] *B++V0->.(OISHOKA.+$GB;@H,TCAK HAHSE& XB^,RB N_T^@N
MP/L*LW@3T3'$!\0V#= YC_L[)I2GT'B$.]C#2!N4XDD70[RB)5R;-^&"#Y 3
M WB$(^0I9+S_BVR\D3]@ 6<D1(XB.M#+BA#LOA[3H!PA(0U  B#0'0^H@"RH
M@ ,H AKX@"RP@0TX@BU0@:"I  W( AW8F EPI0G8 "WHBGA,2)* AR)@ BWX
MD3W@&2!J@0VP 6Y:@ Z@@1[0 )]9DA%9@";H 9T8"712 B]X@]P+21O@FB;X
MR1I: "1XHY3P.M4:)@9Q0G;$(K(SNV2B+@WX.T/TO+$[OTP;B4RQ1Y+ ,N=;
MP,-X)_E*E%9KKR)T/PIXMB>,-B @)+R4QY,X B 0R.JP+SCL(LEXFF4D3)1X
M #CHKC/8MJP: A: *>AKB;U(S)A8.W.,FSP;Q)F<L!8X@3O0EUS;_\Q' 8V:
MP0 ,A($*0(*-U (-8  D8  #6 #9,( M**PM^!2E#!H&&$D:B4O$6A(EZ($<
MT +F-)\H@!(8L:P/N,5((,H?R (;>H*$L@&S0"<C60 3@($)Z(TM@(>4.8(7
M: $!:DV38#ZZ5*8,\)$%<2[5LC[LPT]K##F2& W0^,P< 9P%(3_)>)/S$LW6
M8XWWL[\#X<^0RZI'^(*X.XD'.,@:Z:()_ ]#"@$N> 19:(L%8PO-_(Z](+D?
M2]!HXSD;48QRT#/3/+@6 ()U ((_@(!_M,/VDI,4-1J4:((BZ "G,0 LT,@.
M\!GK;)>4\4 M& 'W!( 18(*:>8(J\8*H@_]1OX$2F2D"Z=0"7M(""-B"KL
M&\@!QN+-$5B9<N@!-A@!+N":D;@!TC( FKJ!!5"")R@"4]* !=@L)Q4I(Y3/
M9/J )XC(!<4 @<NH*+2Q* K0DZB41E64;SS$!M*BY)Q+"NVO'SBTAVR!/VB7
M/J.W&/#+R!0+:2NDRW@$Q/P.IXN+XOE#>TR03P/,.]NJ#Q""=7@$F'J ,V""
M=(Q#]+.1*EHP&R'-*SVLJ@."YC. 0BN!$M  %F OU[*1UT0"'="!$;@!*-D
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MEL@+^YK=2C8J/7J6J(6V9RF!31T4L\U94!O_DTH9Y-.PT#U.8RP"@C-HJW6
M %G  YT3 A)%7VC#B(/PJ\5;0M%;C!*$8]-,X);X0*:30 V%7;LCBXN%KHH]
M$&K.J-3\PKM484&JPFO4&Q+N9I@@8%(M4-YMC2\[0\-H 2XP9)E C+%-DQ2
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MY/WO\D""+) 0*+$$IM0,)YF-DI@.,]D))  6#S2\DFC!+*B6%F "2^A7+5@
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MP6[D '! "S!L<$\"*A!6%EL$BCCB:S@T1D*$0B7P0 V$1>+! 9QMQ!1^1SU
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MHO>,H"MF=" <K9( ON2M+T(*#1[3QY8X)4E_<4Q)7.@"L+9(48]?[(L9><3
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MQ6')N@"!BV%%,B':"R#! LS&"T  $FA!#UA/#S2!B2'!#6#!!#R!#1P!:&C
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M/?A,BZB(1U))VCGN17LE%]2A:V"5#2!PQ-C C;3 $Q#& ^S= ]  !S!( GB
MR;6(B5WA@SP K@% /#S JA9U J0<@C$F!YRT5YPO<[;7DLF"\0H+'GB7F2J0
M"7L$FEK3MY7/_DCQ?M  RI'-"T#%/6R #0S(J1FGM\J*V?#?!E3$$4S_@'%&
M6 N,P N<C-280 8< 7"\0$),A)61R+,VM&F(<)QRZ6.554\\! %W< T A8VQ
M;0N\08F90$4TA@7 P'8\@)_5U2+;C;Z(;.2>Q1$(HQ)YP62D %9C4V7HEPR+
M!./QD^5BA!"< >D80 M@@"RV%"0AVD=-UFUN1>7)[TB3$Q^=D$L9LV:0[.5X
M $R8F EDRU8G"0Y\"'&GA#F>Q$TO  T8X@-@2E3_(4>0 PY(D?"9*W"X1 S0
M &&TP"F_A@VT !K(FEZ;P P<L FH   (Q-AMP!O0P/6Y<@68P )80%%$V!>,
MG1:(K&A,0&9,LMEMJ5<S)71=4#0ZP:.BGA\5_S1J&^2->D07>2>):(T)O '0
M&"<)3, +/ 2T+8VH<8!"/.8MSP .J(#45( *&*==QT4%,!_8T< 1D#7;-.QB
M@P1T+TE--C,)<\0!,,B"G=[6>L M(TT+J( %O$!VUT!0\G1V'P ,S(0$5P .
M9(H%'#@)A(U/+.NR%M@7@/-@(:63<]-T22\%#0'%!M4##4'-%".;_A'*\C8+
M# 'TTHGS<" \YJYPGY>W9M994%AOR5A3L""?&^M!TUQM^<IJG.Y'8"%&=,<*
MR"YL;@%1+M,1H@06($$/T,"%\0R%&,"JFABJ'E.,J$B/NE-C>,$65,3R*.:K
MGL83J!K4-$%,-P%A>/^ HQ@X_.G #<3 "%3 $SP V+W $20TU5R8$D"B;G"$
MKLFWW95K5D!U1"-V^KC1!\+#O8T@\NZ1N<],'IK?_<JYB#AR3M\$B9E TY K
MFX =.[V  )LYHFJ$I3Z=#C0-80, A)$ ![\!! @$M6C+K[R/#X!CG>-0:FN
M!MS!EUVX1Z2Y!7Q!31P!V E87GU 3AQ-3L1:V)E @V> _#'\V )%!GS!#P0S
MM7LSP%( NUX\2&2 ^.E8T/<=*/_+^>"'O\+15W3%&<3>):%4:AO =-&[4N 8
M9!5%#3P"!GV ?*7)F]#G^**$<=/H:AX;S3Z+0D>9:?]:,H,B2Y B5%@ $K#_
MR$\T!D%XR\F1'-*H7"%7-$ITMV)50!9XP;%R0*;<  >'P&,R#18L?@T<P?_"
MA!=HN7GAP+A6 (5F@:<HY%%0%'[4P!.@AU",P!),]@BD7'U/Q@/@@]DTQP9X
M@ 7@PPU4P!>0? U8@ 8(LJC= $(X!EFW #[(=]#:#Q4UL5((2S4Z=59?C %8
M ,UH6%V@WVIJ2V-Q "M76,^8^X?[76V2"&&-@*'Z?"JA,PN< #K(@L_](%^X
M$2:ZLJBU0)S?0_W=,@0 A>T#0,U#QUM9@ X(!4"8X& !  D+%BI $'B/0PL
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M+3@1(DP,(F@ ![3C%Y//"VA.(&K !BKG"&8@HF[1*0^B0%;@!NX!P@P 'Q@
M.5Y@ W2@ B;@%_]-P 8@8#]@@ ;XAP0^TS0M(+AZT#TI5)#2)NGZRT76R+"L
M\^FB+@?#AK#,LFW* 2'?<]6RPBG8*Y'L0E(PTBQ: *@P$I32#45(Q0-Q<B^,
MB@8_#M0J%6;NU#W<LNURI@:PX/8H8G:4\"ILK>^0CD(PL2)ORR4Q<JXF# A8
M0!8:@8?,[@^X@ M2@$>TARVF;D3T3GDR-"(HX'V0A#L+HP;H+")8Y@'B IP>
M]29J  :BYK+N8>'8) $. !_PY2QX,R\\0('(Z48XR0.T\@$<PE/L@ 5(\I/4
MPR%DQ )N  +,Z2!:  9:Q0)6@%T/@C^^P*] ;>^X8+,, B+> $XJ@ /_OH #
M;F %8H $;B &.* &2.!;5N +9J %WF &+" &<& &J 8 ."!EXJ %CL#%Y ET
M#N(Q<Z--8N!C0S:>OB ZB&@N*[3M#@1).C!/9(&-YC2TVN(!UD%N8-4#)25I
M/4)9# M2'@#1XJY0%2L&-&!97&WLC 3/"K6I/&P1,<ONX+-(RB54(X($K&,&
M/(G5JJ2%OA-/T(($) PDV L]([4BPK"'_ Q"KH-O(RF.[G8_(;&_.L!6\\H)
M:.L#G"!Z_@I%)+199 N?.*J.R ,&'F!Z^DS(C&9/Y6U2>61#LV3<G,@"9JP%
MM. )5#%E*F#$<E,XP(ATFV!&HB!<5)8&FH#&_SB@"28@ T:  0*F"49@":1/
M%#=@L_[B! +UAS0W1'" Q4S" B1-24W -#. !LS$!-Z@8;_@"6[ TJSP(G3,
M+>GO0R9D5-)(;J)F4\NB3;S +]-(EI;WE!ZI/2GW+'?$".U';"WL1/*N0NQ1
MZ= HC7X@L< SZHX55[*S+G)4OU;T3P_R@*FV;<3'(3_@/%73 WU"56!"[9BV
M2 B%$%\2=PIC $DG0CS *4RWVNH) -#@5^KB!ZJH<#B)9<;IR,1U0LS5 TH6
MR-B"-X$/ %"U/GU"<(DV*BS -ZE3-LGC8M/S)ZBB0($(*-SF4BA@<<]A<:.C
M?W<DG]1B) ;":'+#?\$! ,+&E$GM!VGM3(O=!K]NR>P>@CO3Z #0+$O\Y0G@
MK >XQ3-"(+L8@*1"( MLP (\  ,70 O@ 0/ RPNJA5JZ# DV %R00PM4X#:,
M#AV+E"(JV'XP<6-NC#K?X @R0$!F( ;<Q 1&S&T,(@,4S (V:+3LER)T3,GL
M"$DJ8/MT:"3ESWYKP@!PP'*R#PO@TE6)3U@K="Z:F$2FJ'Z%:[>$]GXQ#2V<
M0SL_DB4>@36:I 8ZZ!$<8CI_N"<&8YC")FJW_SF",4TFU^%M]^)_W[.I0+A8
M.-6)8N"=]**#[\<LGN5&8 )I(,R<D, WG(\=:8 #7/G)F(#%Y/8(:*![ SHN
M2!<Y.,,"'I/FC#&@+PLQ\0%%,T"WR X2<:VQ%FVT/  )K,@N%J"E_HH$)D"2
MGDB:*<+6E&?"NADN@"\&/B #0N (\$ #0N".ZD+M/H A7_HA-*!'#X!C2*!#
MJ1.=[((S:-#_3+,"'@0'&$"!O@6;,Q:=Y>U"(7CX(*+J^*H%],]P[M".3:J^
M%# #N"Q@M@!<-*(%AK.D#4 '"FI;'N(X4,YMZ# 'D&"H\_()1H!<*$*CKD(8
M*T!M+2"4,V &$N @(/]@ N3I($;@-FT@!^Y$9QGNDP1.;T>)9<Z732"5?S/)
MAT4$J"Z;8)53 _X ))P5S$[7 T[9160Z".E/*/)3(O**I1?+'[>Z8#F4 M;!
M*TY@-1YA'9Q "?HL:0]QMY?0.92;G/T$)H*")I&D$=#S)#]8/D%";&.@=1[A
M$4[@ 5+K;C\" M9:2 -Y"V@ 'OIECS?@!+(@0+HI2[9@ JBE!3X@"R9@H'1@
M KHI!^9;"YJC"(XC![+@P0(YD,WL".YE0AXB X9@;/<BLYL[;+AM-V#.!GY@
M7T(G Z+Z""S *2H@8+M9) X/4NXAB_?(4S!*V8Y5![PW$K;C"7[C"RH PJK_
M#0 .(':-<0)L *$S  (VX E40,;4% OP(3PDU[3=9I_$>R*4I<\ZX'0KH%6Z
MQ024 +P W .ZT:0VP -0+CD*YPV0X!$T( I:8 +,_ 5Z  OZ, .:H* ,H A>
M<PM>8*;0A '>3/E&*</J)SN*\"GPR  ^MG"P  MPH,<F%@9L1H=#%@;D*72*
MINYV-B+"E[=%!#%OA"/*!3Q,8)-C!#$WX V&J#;5QT@Q&"@21-+'4B^L$0/.
M!PF.H#$> *H=A 2\KZW8E3=Y\\=F/2\R#VVC\YKL\4>:?$&"-G-1\.J<\ZY*
M %92P Z8H-=8*0,>("Q4"$;6IMCI5IQ/W;E+9[0"_T/;[:<1[,JZZ3>$):(#
M1B,*@0 LM-E/"^.[(KT"7N 1=L, >H @'H->2L :2YBBE(";/J!;:H"\6T <
M&X8)'@$#>J "Z!P &* (L* ("L<#R$0)M"5<(2*(BZ117#(\=8:D'L$8UJH(
M>@ "HJ!?[D5ET3N0WT.\HL!L21Q4/ *IZ.(N2 U')%*(L<D,CU4H 0 >[O43
MD8,#GN #:&!EEF,@<  ? F8$>EG!'X$#<@ "1F $JC<Z,&H0\P1TW>8]W+$'
M:  +;" 4FZ.%)I @RK0Q@*>\\?(";<  ;N"@QDR&FL  -D#Y$J"\XMJOBS?O
M\QM%,TH2.^U3E[W;]V[@B/_J)MZ# \;C(2S@"03P^.*AQZQC7+\%J$B78U3@
M42/'S#2"<VI P;# .BY73YR*+K6@VN)+ XQ#KJ<H\F5(5]:, _P/Y1KP,PX
MH9F/1C0D525B6B#\"E6&4YSYHR4" @AX+VI )A^@)10EUJ0"'<10;B+5Z_T$
M @C5VTG)F.V7GB&"NB<<E-@8MJ6"5^>C20AK':9$W'F;7K[ \@_#WA?  +2@
M"3K !AZ38JSQ- %BP98%"Y \R9"EA8DM(5IL,8$A"H<-+SP@\0( X0,M'#P<
M,?%ERXT115H .&D@ Y 8)UNV3. RILR9+5NP>$ SI\Z=/&?"!/  B88;2(X
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MG0)2=$HTB$)QLH"#$6RA!!9 @@H2CN!'#*'A2+Q#M[/I+R!P"5 L&((&X &
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M,\$!".,!!Q )3I1N 45A"0!N,4 .<#1M4])6;;@D%:!G.@$L\B$@JG=<+;4
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M%@]P;Q8,@>(4J/&H%FSQ "RP#@-& 4YP!Q&:SSL!H?>W</X<)S#Q;R'P+S[
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M *E\\@''_&I[ZYH-MGAUH92<\B=_LP"IWO0%(;9 =@!0006^\)\,<" F&^C
M4U6 !2G]YPA'L,!;GOH&M0WQ"S8X_XH=$K05@9:K!$\(H*6V6:UVUL0C-3"
M!=X@4QRTH 45P$$%'F""-.( !UC@JQ^)9T"^/J &.*C!7\OX@,'Z:S]8P&L+
M\&JE!U2 C>MZQ!<4I$ZN/. J"<4+%DQW',OI(@-1T  3<E $!C#A"5CX5P6*
M4 X1-J$"6< "QM@Z 0C\JP4),X$2*I"P#$P +I5,)4WH8B30:L9#U"-MN7#R
M "X$;CB**Z5B?V6 ^57W+C*DX25-$R8CX<0#*S@=*P$ $0ZXB+J"LYU8_&,[
MRJDL40_ "F[^(DHOG"%FBY-038:#2/%NI0732>M42H#0X]F(!"3HRW-6Y=>4
M0%9L,HU)#/\H>^$.>_=A*,%"_O:*.0,EZ:>5\C#UHJLII&#K5].D5 TNAY68
MD*,&]TB C9T3 YD^B2W366QQBOP<S29EPC*IP#V>PX$5\I0F8_P<3^[Q S])
M>7#K$%N#)2?('R3%RT2)@0;^4$X5U:8%%HB1!$6Z@!19#1]'0 B6)N !'*3I
M9_C P@A@ +@5<. )Q_W"5MW$@2\\H ?_:<$&-J""_(*7E$"MB1 FY;D$Y\25
ML%S/"%9' B0LK <G@H M:\"P"B#A 0EX GIZ0)\$,D @\]&:,X=XE%KAT+IY
M^8$U,WTNP; @!#+4 "I?J(%HX@J=OYZ* 89 0P(#P 19V,*>W@G_ !@TP4CS
MI,D15H>!*(P +:?;B0=H$*<M?&0&8-2G:,;<E9D8P ?)CC9@G!*M%WM%D !D
M]E00Q-Q2CL9>Y0SCNW&%TVJUP <(AI!F* 1MXU2  O/UYU;^W%Z>=,V%#,H<
M4UJH9=#$1ITMX$+A7";N[U+@,T;A&TKBI"4H?<$Q@Z[ $3K2 AKXT (Z: $#
M5/ ""SW!!#0XPA!;$#4&:*$"%B!!>S8@QP64 Q]$),$1OO""F%2FL]NJ<E[
M$E""]YLF#SCM^(SB 21 8+<OP )Y<E"2CK!Z 5\(=ZJ;P($HF, "6Z"S%EK
M@1'<( J0S)D6W@1RFD"@V"IK'O4,+O8(_QGEP6?X !?$YDW0-JLE'5C'F5F<
M$LQ GBB=^0S(M5.$&ZQ*=K1[@ 7D>0,.H#$EX^D  'S9 N'U5J90MK$%6K"
M+!RA!8!=+'H'7"W4" K3]AX"\U)RT+:*GL!V8$&U0C#P,*9L)F+!4%YJTL:X
M&'N<'_<5](^_LAD"M3*Y%O/YS7>G]&VF9!Y7$F0B9Y,35)]6^<[)2QA>J3_
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MG[" +$B>(FB!-] "4O@""/@ )" '$SB"!Y H(_&V!2#$O (N(% U&V"=O\J
M63*!+8B!%B@"7$*9"KB!2_2+RC@ ,W/(!0&-#, >?;._E+B?6Q0]K;BAA&,!
MAPJ[]:F)5(.+5#L)<D #E/" -<,/'GN8=T*#+:$!FP*-2UI)G$I(!?,!=!@-
M&XP0EIDQ7=,WG*B!+XH5 ,! NBH5L6B)EH 5<+ZB3%8"OQZ;2.50L=$#10B9
MB1LBE_M#'Z7(D_RJ'Y0(0,%LM@+D"0] )!\#,GE:"5@!LE5)BAHX@!@X +30
MS1^;C)@0BR=!B[Y@%3HB,/ Z@M/$"Z,0 A]8GZH$GTT+N\V  7QH2(>CL>I$
M*P/(PL/_5,G37,M5ZHGUHP#<&L^:>(24]#[R=+8OW(E:RH[@>X 7D \=N($M
M@ <=>((CL $F,)(<0()'Z"0F?((-\*6>?(($\( *"*;6B\D6V()'T ('U*.1
MM!8*63E?.8&4C+]VP9_77*=F?$:&BCY@(3&!J:N2>H"G:;(T\1&3RC,.^ $<
MB \82#/S)(H34)Y?L9["A"MH*]'W Q4*X$[!B8$1L*D'>(,,D*DG(*0$F*(W
M6+"%\*0/&H$%:*Q]K("J(14\XXJNX1-VP1>>, ']DXU$@:>C\+]JJ0 ,N*9*
M"0H/I472TCH@_16KP,@M-*V&S,U],DW-G!>C8"Y7L:SCX;:&_^L)H5(9L/!3
M\L1.\HF*?%F-1T'3J6@!"C!)[AD-[VE4Z=NF"?A"E."/-KF!H[P!A#C*#$ "
M>.@!H9,HYAH/4TDU#E"/OXJ"@=F 8+*=+3"6+6  )9@/#%T^7/F3K/R5^3%2
M<DJ)$."W247&-<65_V$PGMB>2R(!'R$!'= B$WF!*/$]%7@:17P &(  +_""
M@<@:43V*P!1-O#BP9W4X#3# 2K%"]-2)#<"R,A&T&Z@ .E01#K"Z@NV!<IR
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M&AWPD*P!&IVY ZE*$7RD 1C0(POP@D<3$EE./0# !YW)(A5X.A69 !V8@7O
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M,&<V_,&B94X (WTB3:KTY1\-*I="76G@ 8N;4:]B_[V:\X"6$0TS(#'!Q N
M)T^P;'D X$B4&TA"V.  H<B]"FE=%N598MV?K#IGGASB=S!A Q,^Q 2*MR3)
M&A8>D,1A8K*)B#@<9WB\PL0&@6\>O%F94S%AI8IG^N@KL[3+#$">L@8 M 4+
MM;%O(_U 835N "5J1\U)PX0'$A4\X/!@(!X.& DKD"!Q[\8#XQX >*AP7'9>
MI 8^W(%=.F\('R%Z2]60P:5XTT9=0J#0/FF-)Q9@<&A1(WJ,XML]/(!##%@D
M]]Q$V9' D&SOZ=3=";NAU]"#Z.74PCKW1-@0!!C,%YL!&MBQ8(,98I63 4<
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M%=30ZA,&<9 5>"#[Q>MYN 'U9H;QS8=Y0DRND"H-+WSQZA(>C%"!#@^,\#@
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M+UM&Y4,FR)=BD%4!-,"$!,[928$2^;Z9Q$ #1NM>0Q[Q&O209&_ C$JX8 D
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MD,7G5!&FC( A'J**D6*FG5>:*<8]$%IOZ);8756T$2(Y8H6J_6!A1*&; (%
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MCQ[A +NX'M @UUF9?N@'7P>#>S#N@RY=-#QCE1O\0++<Y.M#3IL<J$W(@9K
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ME& ^)$BQ:' P5[O/")R9ESL\13 C^=4K#S*\QG0&F1!1)F H5QSH)"=!S:$
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M?RCYDW/16U_JVK>7&[WO?O7J,T/1E[_1U8@2:--'^!ZX+Q_PKD'0:Q'=G3;
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M1 (54 /H)?LH, ._[78<T/WT;^"DS37NH8OR+_R*!..L+?T*D +5X@//[_L
M8.8:\ 6W)B9*$ ?O#X5V;@:_K4+<H?]Z< ('X@^>@+V,$/VD307LP/I@< $]
M4".2A/Y&$/^B3W(<3N5P4 ICX&^V(OZ"D ES4 I%(JX^T/RTY.S(L  !  *7
MT V+L :1J SOD 1IL/\@(L$!^M /_Q 0 _$/[^$+[N >!!$1$Q$1(\$=6, +
MI$$:%%$2)3$2SB 8(G$2,U$3-Y$39X$"O@ 3.7$3[^$(@N$011$54Y$3I8$"
MO$ 5-?$>^H "0O$5$1$*[L$%\. /:I$7>[$/9\$+\" 2H< 7!=$=G( 1BE$0
MI<$3OV 6E#$09^$1+K$/B1$:'6 6T $?=I$6KU$W0/$:_1 8J;$:H?$6B4 7
MP_$/@5$8U;$/8Y$%NA$:9^$8?\ ='4 :(H$1G  2[_$>@L$5W9$9[P <[_$,
M[D 0K;$8_P /W.$>'U(<38 ?[W$6"O$4U7$63B 8'!(B_9 93: A._(:EX+_
M"&0@""[@)%,2)5=2)4]2'P@@"&)2 H(@&""!#X( )EE2)UMR)UE2'X+@)6.R
M#R!!$F(R)WD2*7N2)V$R)O$@&(* 'I)2*I62*F.R*EER*J4R"(:R**TR*Z\2
M*0F #VH2!:R2*7<R);]2*\&2+;V2)0F *V,R)NLA".A2+7<R*"\ )F$R&/#
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M5)0>:-ATMY:@8?<"Z$$O071]W9, ]!*-(==(WU6B:5ATMS9F(1>0ZYE'$SH
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M':H(H&00!-Y)GC\*G^*IH19&/AR#$3'X'L'A99;1/C<T,C]JG5! A0 J MP
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M8GPYP^0^ M&R\]S)1, -PRJZW%"E4# +4/!%%S*)E1$!$MVAJ)JGD1#.>:K
M]K#7LY"%56,;7;*PWX$]LN4Z/8I@^-P1$0"[7^K8O#O5P\K&VPF7HWA,J18
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M*$%0S"(CC8BT61$N'"3@1H!#ABD#H/0HDLXL?4$<2'/ QV:D&+-<."""4&$
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MBKDOQOQ$9C%Z$K>$=Z$ ?H@H"Y(FHBXI,;-9)2>9<=HJHZ(96U7'4"FI$VW
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MC#SE2*@4Q1.NFMA46V/@CX&A#1;]V) )RU*4T7-P&GG,(%0<$O"0QS-!Q9R
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M;%<Q)H&I![>P2P/*.("&/)GA,R(Y"$#0"Q! 8  ! @1>&"A (<&! MT$("!
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MF/8C2*;?=DK+0 -9 RTSDHX22L&38J+-H+9H*FFHAAK##+G'YLH+I>E0LPQ
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M/TXGB)B(8A;1H%C_ ZDP@@[NZM*$Z"08)P0'1R)^*Y> *$ RD4XZIR^ C*.
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MS,*(P_^@^_\3P:1$@* 78""!@0()N"$X4(",  1D('0H((" @@4%7)A(8*(
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(M4G7=4   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>iclr-20231231_g10.jpg
<TEXT>
begin 644 iclr-20231231_g10.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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3;E'8^DR^G4A14:J2?9._YG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iclr-20231231_g11.jpg
<TEXT>
begin 644 iclr-20231231_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!F17AI9@  34T *@    @ !@$2  ,
M   !  $   ,!  4    !    5@,#  $    !     %$0  $    ! 0   %$1
M  0    !   7$5$2  0    !   7$0       8:@  "QC__; $,  @$! @$!
M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,
M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $T
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /W\I&;;2TUOO?A2>P'-_$?Q_8^ M FN+JXAAF9&\A)#_K7 R!@<
MUYKHOQRUZP?3[>2WM=<FURW^V6+QD6\:J 2\9/.2,<5V'QLT;%I8ZWY?G?V/
M(WG1[<AX'&V3CV&#^%>50:)+X>M5M;=9+A_">J17UGL&YI;&<X('L,FOS_/L
M=CH8SDI/E26ENIRU)24[(]O\%?$;2_&MA!);7,/VB2$2R6_F R0^H(]CQ63X
MW^+L&D216>CK:ZMJDDC*T N BPA!EV<\XQC'UKS>TTL^#=5N)+&!8[FPUB:
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M@UJGP/\ A,VFZQ)"M]?7T^HO;0N9(;'S6R($;NJ=,]Z]<5N:\RI2@IM1/T?
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MQDY&WJ,=QP:^TD_9'\"KIL5G_9=UY,-RT\0^W39BD9=K%3NXR.,=*CN/V/\
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0<]23F^8];#4?8TU#];G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>iclr-20231231_g2.gif
<TEXT>
begin 644 iclr-20231231_g2.gif
M1TE&.#EA*@X(!W   "'Y! 4  /\ +      J#@@'AP"4U@     Z2JW.6M[6
MQ6,IA/___UJEWCJ<UG.MY@",>T*$C "<E&.4I0"4C !:6C&MI0!::P![<QEK
M>P!*4@!"2@!C8V.UK0!S:P"$>P!K:P!24A"UWB&]WCJ]WD*]W@!26EK%U@"U
MYBF]WC&]W@!K8TJM:WN]8TJUW@"$<PBUYH2]8VNU:T*E<R&4<YS%8Q"4>RF4
M<UJM:Y3%8TK%UJ7.6AFUWC&4<QF]WE+%W@B$>SJE<QF4>P"UWF.U:W.U:TK%
MWF.]UDJE:XS%8TJE<P!K<XRU8P!"4@ Z .;W]V.E:P!*0K76[][O[[7>UA"4
M<VN]8\7F[][>[Y3.YKW%Q93%Q6NU8P"4>Z7.8V.]YL[>C,5S<XR$Q2'%,=[F
MQ0!28W.4A)2,G%)24G/6*8PIUM89.H09.LZ$SM;6*=XIUJ6]8Z5S(2$QWB$Q
ME#%S.N9S(3J4<U)*UG-K,6.]M;49E&-SA&O.Q2E::R'6E(36A  Z.I2MO2'6
MO5K>A"$9$"&$[R%*$"$9.C&EUB&$,1#>[QF$Q>__]SIK<R%2.@A[E"$A4G.E
M,5+FO0"$Q3K>[R'.>Z76*5+F[^;%M=;66C%SC"'6<R$I:Q"EE%*UM2FM[SJ,
ME._%SDJMC"&<E !""&/>8U*UYC&EE!E24CI[Q=;%Q3&$A"$ $%*EO0BMQ5JU
MC(2UC%*M,5*E,6.<G!"4A%*UWE*E[R%S:P 9.FO>K5*EC#JEI6,0E"%S8Q!S
M<PB4UAE*4F.EWI3F8Q"4G&-CG!EC8R&$<P"4O0B][P 94AFMQ2F$>VNMQ6,Q
ME#J][U+%[___[VNUK4*,A$*<U@!C:P"M]PBM]SJ<O4JEWAFE<Z7F6JWF6FNM
M]];6UA!K<P  &5JMWC&4>XRU:P Z&2F][R&][TJUU@"EWJV]6@"<I0!".J6]
M6@B]WE*U:V,QA A[<P!C4@!S8P"<A#&EI1"EWEJUU@"EY@BEYAFEW@![:P"<
MU@!*6M;6Q6NMYC&MK4*$A&.4G "4A !:4@![>QEK<P    C_ /\)'$BPH,&#
M"!,J7,BPH4 !$"-*G$BQHL6+&"U6@+A10,>/'$-Z% ERI$F0&U..5,ERI<N6
M,%^N3$G38\T*-W/:W(F3)\Z?0(,*'4JTJ-&C2),J7<JTJ=.G3H_@E%J!JM6I
M6*MFO:JU*]>O6\-ZU2JU+-FS9M.B7:NV+=NW1\K*K3HW+MV[=O/6W8N7KUZZ
M<0,+'DRXL.'#A3?$57R$L>/%D!M'?BRY,N7+DS-;UHQYL^+/DD&+#DUZM.G2
MJ$^K3LUZM>O6L$U_GMV8]@;;N&OKOKT;]^W?P(,+'TZ\N/'CR),K7\Z\N?/G
MT*-+GTZ]^O,OM[%OT,X]N_?MW[N#_Q\OOGSX\^31FT_/?KUX"[?A;Y!//[[]
M^=O588?_13_^_OOE%R" __G'GX$"%C@@@@0>"*!^$#XH88043FAAA1A>J&&&
M'&[H88<@6@B?!0!:H)^)7Z"HXHDLIMCBBB[&"*.))*ICP8@KDDBCBSK:R../
M.P9IXXU#TDCDC48F6>222#;IY)-01BGEE%16:>656&:IY99<=NGEEV"&*>:8
M8JZ#I)DWHFF!FFR>Z6::;Z[Y)IITPBGGG77B:6>>=9KIIYQ_!@KHH((62NBA
MAB:*Z***-LHHH$7X&>F:DZX3J9D22+H.IIIR2NFF%F3ZJ:>6@IHIIYZ*JFJJ
MK(;:ZJJNQO\*ZZROKB-!J*[>JJNMN?::Z:[ ^LKKK\(&^ZNMR!ZK;++,+NML
ML] ^*VVTU$YK;;782OOKMK9R*X&WX'8K[K?CADONN>:BN^VZW;+[K;OJMBOO
MN_.J^^Z]^.:K[[[\]NOOOP '+/# !!=L\,$(2Z# MPLKS/###D?<\,004RSQ
MPQ1GC/'&#FO<\<8+A_RQR"2/;'+)*)^L<LHLK^QRRS"_W''(-"M<LP(WYVSS
MSCCSW#/.- =ML]! #VUTT4@#K?323#?M]--01RWUU%17;?756$_MT-9<=^WU
MUPU1%-/8,I%M=MDOG:TVVFNWS?;;8^O4T]QRU^V336[G#3?>4/7_[???1;DE
M.%R$#V[X684G?OCBBI^U055+- :YY$=$_GCEE%L^^>6:8\ZY8DN +GKEHX=.
M^NF/EZ[ZZ::'GOKK%=P6.^RRUT[[[;/'[OKNM_&^@>_ ]R[\[\,'S_KJIO,F
M6VJJY::\\]#W)OWSTT=/_?706Z?]]MQW;_WWU5?O/7#NJ6=^>^>7GQYV[(/7
M_OONQP___/+73__][.>_G?Y?\.___@#L7P#_)\ "\H\_".P?B5*DP 8R\($+
MC* #)<A '57P@A:L48KP,R(.>K"#()P/A$8T0A'VAX0G-*&-5(C"%:)H2# \
MDI%B.$,9TI"&\QE1B>:S0PWJ,$1 ?% +_X?(PB*^<(@R8N")E'C!)?J0B19T
M8HF4>*,4&<F*0[(BDK1812=Q44=D\E*1B,3%$R')C&1L$AI5=,8R;C%)77P2
MCYHTQS>.L4=OO%$.P8@C/NY1BW\4$AYEJ*0S&I*03$+D(0L9QD8Z\I%3:I.=
M[D1)258R3FURE"8?M<E.<I)1M]K4I7 E2E.MJ528.N4H0XE*4O(JE; DI2QU
MA2M:VK*6N+RE+G/)RUWZLI? _*4P@TE,6T9* I$J@JZ2N4Q+-5.9H3JF-&TU
M3612\YK6S&8UBUFJ9 XKE]TLE2_#><Q:6LI514#GL)@9JF?JRIWMC*8SNQ7/
M;]7SG??,I[%\I?_.3!U3G #]IT"1-5!_$O2;UH0F,I?)T&@V=*$.C2A$OR7-
M=U:TG1>EZ$*5R=&->E2C(%UH2)4YTG>15*0H/:F]WDDO?+6SI?=ZZ4K;-5-\
MT=2F^KKI2G>ZKGOIM*<^A2F\AEHOH@JUJ$5-F%*7JJ^&1>RI3HWJNZ0*,:A.
M568QRZK)F%HPIS[UJUX-Z[W$>E5\>?6K:#VK6LUZ5:VZ%:MP?:M<XTK7F.WL
MKCW#Z\3VRC"^ZO5B@+688"M&V(O-]; GT]G/:N8 AS5V88^50&0GZ]BA9>VR
M4 .;9C?+6<U.I )ZV(@>/#): 9 #(J$5P&A!"Y'3JE:TI&TM:F'+6M/_SE:U
MMUUM:4_+6M"JQ"4R 6Y+A+LWO;6-)G:CV]V4RUSD\@UP3WGNWQA'W<95URT_
MH4I7MJO=[F;WNUGA+GC%&]ZW($XM9%E"[-;[._:J-W6Z<R][XYNZ][HW+I;#
M;V7RZSG],H:_^8T=Y00\F:HXQL"+07!E"-R9!D-&P!!63(2E(N$*4_C"$R;-
M9C;L8 YS)C/8VTUL1BP:\(7XQ-8+'XI5;&(2N_@US6.QC%>,O=G8N#8W_@V.
M=ZSC'C_/./>SGY"#3.0A&QE]2%:?DM-WOO$X63M/_@V4IRSE*G\GRE>F,I:5
MK [\0,C+_0%SE^'S93*'V<QCWD"9[^.?+JOY_S9NCC.<Y_SF.LN9SG;^C9OK
MS&?^J)E]_B&0H /-( 49VD&'3A"B$2UH(Q?YT0(*8H=T2.D-9I"'.LHA%#?]
MQ$Y/L=,\'.&01$A&&XUZAB<\-0Q3K4<CJ=#2)WIU"5LH1 Y*^D.XGC04VZC&
M,OJZU\!&DJ8)6:,:UK&+=SSV()UT1V(O4HV0C+:TI_TE2UH;D]B>Y+6UG>U+
M<GN28DKGC<1M 7*;&TV3*C>ZUSUN=JN[W?!^-Z[&C:1TFNG<-[H5O>]=;S3I
MN]QRPK>\TTUP-8$[3DTR^)X6KJ>&\VGAXM:WQ/--\7E/W.(5O_C%)Q5*CG\*
MX^^>E,CO3?)W:_SC'?*'I<=+14J/#_/EQ8SYKKQI4(,J5%:UPKG.3\7QG--*
M5NCTI]"=>4^BVY-<RC3Z.^>IT*4G_>G;*KK3B85TJ@]]ZL/"9]2/3D^NORM7
MV1J6V(TU]F*9G>IB)VDMN:YVE@;=EFP_^DNS;O6Z@]2A&G7FW7/*]WS]]*;E
MXJK@^_73P1O^\(-/*N+'"K*ZTK6L504KXR$O^<9_;*LBP[QA PMYJEJUJIX/
M?5L=C]C2D_[T/Y-L92&[>M6SWO4]>VSLC29[UA>M]K!7?6-WK_O>\_[WO@\^
M\!W0C]O3_OB+E;WR;;;\I;G^^92U/?1;3]GA2[;X2O_KK/:WS_U_1,2W) E)
M27Z+DO"/_R3B3S]QR[]^\Q,7;LF-_W*3.Q/D.A<H>.-;_O$_-^E"]_\ &( "
M"!1F,19@<8!A\161LX"8PX .Z#GS]8 ,^#@2N&!DD1=X<8$:F!8<B!:7\X%V
M\8$*MEZ4PQ@D>#ED 5^DLSF0\U^8DSD@>((?ME^K SJ2D3S]A8/YI8,W^!@P
M]F) ^(/*$X1$*(1%:&)(.&,^EF,_QF--N(1..#[!03_U$#]5"#]7:(7UDX7M
MPX7@X87T(X4X)H57-H7$ 65F.!QH2#YGJ(;H8QYP>![O(68>M&9H)F9G]F=I
M]F5AMF1)QF1O&&@!Q!\'-$#_VT&( $0BA\A#C*B(&@0@#Z)HB;9HB=8@DFB)
MF,@@FK@?L79$.?2)GMAJ1"2*LF9I&O)#(O)!JAA"K,@AM$8AKUAK;+1$G3A%
MM4B+4!1JN?A$671J.!)(8*1%PAA'5O1%U,9LA#1L/E(DREALHO@C2Z)%,:1L
MTFA'7@1'RX9LQMALV.AL-G2,X!B.D*1P"%>.!W>.E)1P4$*.Z6B.WO9)CO)O
M?S)O;$)N:B*/2(*/%4=)^CAOE>0G^A8H]I@F]@8GY[0G!0DI=.)OAQ)*,O>0
MR?20,'=+O )R)V>1&9>1&'E.+)=R+2=.$AF2$PE,YS22)BF2#XE0\'1T[,22
M1E=-_UH7D_JD2RT)D_)T=,V435IGDRZI3=B4=2_E*UX7E'4GE,#2+?^T+4F)
ME.*T4=0T41TE4SUU3$%E4H!W+U0I5(L',"H54EX)=ODBE3J)4W[7=V09,%VY
ME6JYEFS9EAR#5FX9EYDWEYMW>73I,:+W>9SW>7F)EQSCEY?76)6E>H,IF(-U
MF(2%F)LG?91%F(TIF-'GF-\2F8N5>RT3F9C),\\G?9RYF9X96:E',HHUFCY3
MFI4Y>\:7FJEIFJRI -'GFLP7FSC3?+ YF[)9FSM3>T"S>T#3?;[YFPSQ?2&1
M6L0)6[9UG+H56Z^UG+LE6[C56\UYG*Z56KQ%G:0E6AOA6O_5F9W.N9W2*5L5
MX)V\)9X>09[A>9TSP3;]]Q,\L7\LP5SM23?L:5S%55P!J%T#F)_X.1;@A9]<
M(1;A518QZ((EN)^ H1ETP1B2,3D"YH -VH 4]J /R%X0&CDXX8(,BJ&80V 6
MNJ$2)CDJ** 79F$CVA@6>F"I QDGRH"Z<V$(^AD"9F$I*J,Q.J+\980X6H1'
M6!JVP:,BYCP^.H0E]J.A,:0TEH0G%H5*"H5,^H1"2J0YBJ,_5F-+2*53ZAM.
M6F5^N*6 R*7KPX;MHZ5.5C]BBH;P4Z9@.J;B@1YLRAYMNJ9NZJ7J4Q_X4:=T
M>J?W@:<*TF6 EH?@L69_ZJ=YZ!__=:H=>HH=;=8^C&9H"Z*HX-%!F=BHE;B)
M%>)!&W2I#() EZBIF(B*%>*I/=1#F,9!EC:JE!8AQ:9IJ)I"5;2J+J1!MU@B
MRXA%EJ8B.82JL[HC+ *KQ2:K,C**L&A$HI9KQ'IKEP9M7+1'02)LT$9':&1&
M7'1")\1&<R0C690C>#2M,O1'ONB,W-JJ<92M@J1(Y,I(YII(YRJ.X<B.[8B.
M[/BN3S*/;J)P\FJ03E*O<U*.]%IO]QIO3?)O=Y)N 2M) NMN _LF(N>/_!:0
ME$*/%%<I#<NP)6F0Z91N"YN/\29N#/FO_&@G#LEO]^@F":FP !>R(>=S*+MS
MK;)R(V=R_R?KLBS'LB77LAY9LRCW<2Z72N-43C.'4"#9L[;TL^ 4M#S+LRBY
ML[S"LS^[M$K;=N!DM&A'M&4'M/Q4<^8$=;_"3'JGM23%M13%=%^;=")53VTG
M=,"2=V:;*UXG=Q/5+K6D4&[[4''K3%P[M79+=GAK3M>B+$"%4C353C35=5^'
MDS@I4_>$DT!9=>E2+HR++HV[N(X;N7*Y#@I N5-%N9;+,)@;59O;>6P%>IX+
MNJ(+6),W>8.UEZ>KF*E;6*N[EY47>60%N_L"F+3+NG^9F(VG,;H+6()9EXN)
M>G#ENX@YO&6UNR(#FA%#F<%;,IX9FLXKFJ(Y,[DG>Y9)FJ=IO?\W0[VU&3+1
M]WN099O>RWJXES1$LUCE>[Z\IS35VYO V;[ ^7VCY5HE@7[G5[_N1[_A9Q+H
MEW[D5Y]ZDYXP$3=E(\!QLY[WYQ/OZ9[PB13>%:#CU<#D%<$0/,$/;%T6?%V$
M4P$3B!,;7*&2H\$0Z,&/0X(6NET_(6'AA8(16L+:5<(<S($=2AD*5F$I6&!I
M\1@D&*,Z/*([K,.@,3ES 5\B&*$4^*$[N*$)UE\*"AJ0D:(G:#H+!AK\M<,F
MR,3_98-"/%]9O,5:W,5<_,5>7*/+XQIC7,;-TZ.^$:1(NL8J-CU'@!UOK!A?
MT!ASO!V-485XO %YG,?=$<=_^,=K:(;_.):%Y%.DMT'(4F;(>CRF=FP<T@/'
MO ')<DP;DAS'.+:&F)R&5K;)8FJ&@1RF:>K)P@'*8BIG!)*H=FH??<BGJ(P@
MA?J&<F@^D+:H?C8@CQH_M?P?M^RHWP&I[A,AN*S+?2H_P.S+#E+,D8:H 4*)
MS)S,J_C,K C-EZ@?Q5K-&2+-T9S-J0BJG=B))@1"VZR+J$JJWKQ%G0A"J&BK
MK5JKH99IO?J+:=0B/I)'PQB,Q,A'ZMJ-RCK/S&I(R0I&RII&1T)#R#@FQD@F
MW)C/"LTE#^=P#-?0>9*OZIB.$=UP#&>.!REN]J;1&AEQ]%:R' UP\^9Q+ENR
M<J)OY$9Q!]FP_PJ[T6?BT@3)T@V[T@?9C[@RLK1T)SD=< Y[TQYKTJF4D <I
M*2<M2^5TL0_+D Y)2SI;U$L]2[B$2QG]T2%=U51]U2"M<K#DD0AUM%XM3!TI
MU>ETDF3]U=RD2VGGLS17M5>;UONT=0A%E;V4M5U]+E +N-E4+$6;+$JK=7P]
MM4>9UWP[=CP;M"*5=4TGV$)5V.K"V.OBV'.'EOZ2EOM"V?PR+B2%E/UR4I8=
MEY[]+V?5EH!7N39%VCYEV@ 3VI]=NFN)VFQI,:\;V[&[5:+;,+U+F(1I,8;Y
M+KMM5<1KEQ#3VX!5?+_[>J^WVY#Y,,E=F)/9W*V'FA^CO<_=F3<SW3DFH[RO
M.7U"TYB=B;S*RYF,-;W(AYKD;7O0K;ZJB=[1FS/0ZWO?^]Z2%7OR#=\.,-^P
M!YN\N9NZAS/_[MO?VY>_O06>RSG@J47@'5'@"'[@"NZ< 2Z_J[6<X&=;9X._
M_6N? WSA 6SA]J? ]S>?"]SA_I>?(C[B)(X5=G&@!*B!*/Y=<\%=)<PY^ GC
M4\&B@7&B">JB6N'$G ,4(WS"7='CD)/C"QCDE4,7'9K#$;H71Z[",:HY*NRA
M.>P8 28:$_;#*0JB'LK#2]RB6+P81XS%-AZE.BKF,(;&8VZDS/.C:"ZD1LK&
M1\IBP3&&5=JD:LX\;_[F<)SGLP'*M5&%6NK'L^'GWC''4-;G5>;GZ\'(F<R&
MC,[)BJ[)9?CH9AH_:%KI@ZZFE'[IF1RFW1&'7_KIG?YGHM[*B)JG_VR6'ZB^
MRNPA'X;:RZX^'JQ^'ZW^RZ]<J<LLS+9NZ[A^Z\/<07O:J)O(J)8:[)08J9/X
M0:<HSA+"S3M4JN <J^5,SKNX[*'*03ZD[*0(J];J[*S*J_#LSC-RSB_2S;VZ
M:C."(ZPJK*PZK*9FS>Z>(>ZLK)A&(_(.1J\JBJWVK  =1Z^*13U2K=AJK<"F
M[W!$T#7T) :_T J_\%;"KF%B</):T0P=KQ.-)?NJTQ3?KQ&]\1;-\1P?U?-8
ML/[*TWF"CR4W*!9;U'\R<?\VUOR:;DRM;@3GCSM=\R;M\AA?<"J[\S^W*J]$
MLS=+3C.;2A_YLAXILT5OLV$=3N DUDT=UO\V&_4W.RL[5[5U7=='.[42:70.
M-4]P)R]K#5-7RRYA7[A6QY13%W>%C7?K=+::[?5BJY5/IW=G^W96I[;G4D^!
MZ]<QM769#75@*RZ '_=@"[AQ/Y/WI%)7B76(.[C<0OB.+_B/?Y:%M]IGJ96"
MU[F6O]J5ZU69V[J@'[K%#;R2^;G [9>HGR]T2;JX?5:][52WG=O S9><1U72
M5_J]W;NKO_NU7[S!'=V-A[S/+?O'_3*7"?S,&UG-NYE!<[S2"YK.[[R]5YGU
MG9OA3=[BK0#$K=_@#=W+Y[W35]_-?[ZT9[[QO=W4S_SEO33^W?Y?,YSS&^ B
MP5OSO[_T;Q+WWQ'_^<_@\&O_ "% 0(6! BOH*9B0X$*%!@LR?/B0886)$R5&
M/$A1 #F,"SU*K'CQH\:1 SV6I)@2XTJ++5F^3!E3YDR:*8]4N%E3YTZ>/77F
MW"#SYI*;12L0Q6GSJ-&A1BGF+'H$*4ZB4H_DK!"4Z8:B1+DFQ9HT*]BG57%R
M17HDJ%:*;-%>9:OV:E6Z<K5*?8M7[Q*N>=>.O:HV*=J^5M<:QBE8L5>J7PW#
M!5R8ZUZ[D047YBO7JUW.BSD?_AQ:LFC2HR7W/:W7=&FUJS>D1MU:=FS3KF?#
MIIW[]N[7O%'3MMO[=.V^7W+_?OV[=7+FS9T_=[Y\PY?;TU$;CVY]0[W>_]B9
MJ\7.G;9QZ<F]&S^OW7IZ]MW5HS?_7GY[YM[KJX]O_S7\YOSOZU\//^WLPX[
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M3_ (9*ZU6O1D#_=@#[#1HZ;9HZO9FO-,CT9BY$8*3SL6&['=#TA.&P>-9/?
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MZL?,_.T?&Y\R]:C,.:I1B1H=SO%_/455!1B  *A_!JB 4:6 ^>%47[558,6
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M4B3'DC$]RHRIL69+G"YIYF19<B!-@BMWKBP",:;#=0^%&@S:U.%3BD8-0I4
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M\_,.H8H_]R,KM%H.!D$1!^R_K$(1Z*A ^>!2L() +/U2 DS $IE G5*1"?3
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MOT%6)ZR1@7"UJ>MQ5H;JJ:5QJ=0Q@8]Z5\+1J2K8@>T!';31'L8A'V@E'?]
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M3UC*&@N#!:,RVFPT1@NX]**V%,S-%G8XZI>[A&.Z+&,U]FPO<B.*>9BM=-C
M#"W0RA@]2BW#*&W%<(QHXQC3KF.,,2W44B1I4YF526T^CBW)R(P^IFW7(IG7
MQK;8SN.3F2U"(MG9[@S;>B25^4R6C9F_A)K1-$QQ/TV:8=E%.N21M0U 2MI2
M[N2A63?4 $Z0(679V*3:P$V:;>X%* VB81KF<B11Q@UYTTU/H@V@9;?J#D[F
M:JXAH(U13DXK;&[AQ&Y3MN7KBHZK!?BLT2[I7.6 \W>YN?]EZZ;:8,HEKF7E
M["IX^I(E\9(.N24OM^5.^W"F9**EN%TE^I1/8]*-9OXELK7O_&Y/\NYN\O(/
MN9&/!MU;BQ?F^J(O:K9/NV$FOP7F^70XANM/_ER0C%<0D5-.D1MPNW&<:5)F
MPI5FS*6;;&X<!]50!<?1:TK1Q26P!#^Y=EXGR7V<;VI=F(]P!P,G$2$1;[H1
MRPDQ&MGFE;/1RZF1$*6=V8VGE7L=RRV$T34=T[61>9J=$5&=GA^=T]FYUQV=
M%%?=E9\GH]<G%)_G?%9=%G,2>.+GH!<=0O#GI!L$WNE=*6DZ%H>QIRNH2)0Q
M*B%>*\7Q&[L2++7Q%_LQ)FF>A-K_4H7:\>?]W8E^Z$N@:*VC*#/]71X_$^;]
M,;'3\3*)7HO2\3?E<8TV<NK9:%/<'BD[%+3+7B3S\>X)*28;:3AI,D"=1>>U
M<D=@:4+MA"LCQ?+A'CB9<KG+!3\]!;ES^T$H:2_7^Y<ZAF/4^_6!'[]_G[\[
MAC&;WTN9J9S27\''Z?T1H#,GO#4SO%!Q,S;?Z<,7(/\1U3E?X#D?ZE-MO*):
M%<:'E:,VJE?EU:8&M#DW-*;RL\;+<PCZZEY5EH@X-&0-],R[1V0E=*=2"$<+
MEGJ\ZJ9J%HXD(5DI=*Z*%A@F"+,N%DQ3=+4J]*NF2$('"8.DM$$W(9#LZA,B
M/6JUEM$?_\D6=E88@KW7-WVWTC1.T]9-VS28G.%.*_661,E1ISUM(2)NQ3VD
M(,BZ>HJ*Y#U02S4BPCTC\B$E>M>22)<C.BP=2I<A3HJ?$'5V_7VE+*(C>HF\
MHLI7FPJI9+Y9/ZPNKN+!IA=;MV*H>.Q<6ZQ<;S7)"C9>5U?J/W;&9EB!Q4FY
M[.+-=N*!"8O)8AC&+AAD3W:[D"SL.QAE7^/ $*TV.B.\'#]G RW%+.V,22UI
MM^,7O%AG*QF/17_4 IG52C]I9ZT[8BWXTQA *C?:PK9LVS9LI_] [C;[4RUM
M'V1PH[^9H9D\4JW>7J0X7AF;64RB]2- J+,PT,(&"U\&"D1HD/_@0H(/OZB+
M>-""Q(H%&UZLB' @1X$%#804:8C*0RHB4:9T0E#=R90&'FYP\M) 28T/"6Z@
M:7-@ YHK<<9L]?-CP28OFTC\6'1I1*=%!\Y\N2QHU0T76KFDB?)"50OK!H+U
M2E"L6+(/S8X-6A:G!()%P!89*-=LVK!G\;(%N_?KVKQWY\;EVQ?M0+<6#O>%
M^W4Q70MR$1L&#/FQX,IW%R<&>S@NX;V.(T?>C%.N6\Z23T<^['8Q:L1F6X]N
M;5ITW]%N;[M>;+GT9-FC0Z^^3!LW8[:9%>=>AUP";\%PE]^._AHY7.N6HS-_
M'5G[=-:YF[\FKIH[>/#DQZ<7CYY]>M/_R].OB_]>_?S*S8N8UD\=__O\Z]T3
M#Z[])&BN/_G@DP_  @U,4(+_PNL/,>L,S,\T"@F<4+X#\X-O0@/]8Y"Z#:/3
MS\$&Z6-0P?X8Q&_#%.%+L4#$5&R11@L1M+! '6E<L44$9VQ1R!=?I%%(&X/<
MD442]6O2R0)]W)#'%G6L\,@C>U3RQ1^OY++++\$,\TH%UE& 03+%; [-,],T
MLT4W"X233#C'C+/,-%6D,\XP]<1S3S:/[-/,05MTH$L%^I% 3S<));3.185T
M],]& ?U3T3\-+3#3-R?=4U)''36440DRI3/42T%%555*1X535$]7W?/56 F=
ME51:;VU5TTM?_ZU54599Y1775T4-=E!*>\U56 7,[+594H^]M=AGF<V5V6:K
M-9387Y6-]MIL?V56VW#)=>!;!;:M%MMOESU6W%_'G?9:1<=U=U!SKQ457WVO
M_<???P$.6."!"2[88(,%$("<A"M@F.&#(8Y88H$=%J!A/2[.6 ^+$^9XX88;
MYAADCD7VV.*-0P898Y)'/GGDCU4&N0*,7W9YY IN+OEFF466&6>?+>89YYZ#
M+GKHGY%.NH(CE&Y::9&/,#KJHYU>^F>F<<:ZZJVYKF )K+_&.>RKLVY:ZZN7
M*-MJKX_ VFVRPX[[B*_!9KKMI>UFV^JOQUZ:;KJ/V(!IP0>_NFV^\_^V6W"R
M R]\@[+G;KQQO^T.>_*Y'[=\<<H7C[R"QR./_/'1/_\\\-)!!]UJT %777#6
M%V?]],,E3[WVTP6G>W31&W_=]"5RKQWUX7GO?7#C7P_\Z^271[YWTY./WGGI
M-_"=>NJG#QS[ZWOG_O7OM0\??.^K%__[ZE__HGOSUR^_^GK<'Q]][:-'_WS[
MVQ^_'NV_L!__^],7O?[1SW\$_%__YH? ^!G0?]]#H/G0IT %PF\#\%.@_Q#8
M/PW2;X#NZZ#],@C"!FX@A!&LW@512$(1GE"$$6%A"%-HPA1*4(4J=*$&65A#
M!$ID ^H@H0]+J,,<AI"'-2SB#7N(0X-4KR#_-?SA#_O71!CZL"!'Y&$3H7A"
M(%Y1ASY<HA23R$*E?'&)4"RB%*FH0C1&,8E 7"(2>1C'_ITQBP5Y"AN=\L8W
M*N6.?+QC'<V(1Q[V\0M.L2,7,4)&IQ"2C'8\)"'Y:!&#/.4@DDSD)0WY18=0
M<B*3M*0E[[@1C"#DDYD<"$-0><I*<B25HU3(*TGI$%&VTB*UC*4H,9++6V)$
M*12QB"\[>1&&%&4B%C$D1QK2E%[BQ"!0H<@N-8),5=ZDE6/Y94(@@I./(/,G
MAKS 5E#"$(1()24,(4@W'\*4@7SS)3P9R$Y8@DV"D!,E5)#F45(B!6>JQ2M:
M04DK^!D4=6#%GREQ_Z=7*..9L=@E+6Q1*& >4QBUP&8NDEF.9")ZT8AN%#(=
M9<Q'0^-1D)+FH\"IBF8V2IC4//0S>%'I73A#F8NV5*.=<2ADIC.8CY[FHHE1
MJ'4P8]'*@,:DP2$/06@#TM',U#9#]8YKC)K3WFB4-B4Z:E6+@QO'1"<[3ZTJ
M77IS'>B(=1T>ZFI[OJ+5KM8'K?11S8K2BE:XU@>N5JW07%<T5_3HU4#MP:M;
M 0L@#5%(0!O24)*(,R : 4BQ#UK1@ :4G0=)R$I]3=)ALY2B+,EG0":"DF7U
MTZ'.,FBT6ZILAY0D'BZI1D14 I&1$'NAS]9(2I]5;6MQ"UO#OI:TILTMB+6.
M-%K@#JE+NRTNEF;KIROY%DRP76Z-E!M=YO+I3M&U;J1>U*<W51=0H[(4@TH%
M)N]"ZE+?]6ZG L6I\'9*3H]2%9M.9:KRMO>]FYK5IBR5K/*B-U6ZJM1\;_5>
M-_7#5ZHB\*YP52U8$>K REK6KIX5JP?/BEH!-E:"E96N":LJ4].RUH?5M2IO
M=2M8Q4)5A9.58F[-R\3G@E:[@/4L#U>8Q=+R%;K"Q:X9VRO#X=*6C-U%KFRY
M_VMB13:RD5.6L(4I+&%'=K*34X:RBB7991WCV,IF9K(J)SEG2^:RDHE&-9V-
M.6<SJ]G.R.PSH1G-:$+[69OA+&8YN]EB4^/9V;AF9SQW;<]O6YN? ;TV02<N
M;4A[G-7<EC:M[1G18SNTVQ*'-ZR!KG*4HYO?)(VXOQUN:WDSG=TB-[;CB1K1
M&PC;YL@6.]K]K'/!P]GN''>YX,4.;Y<^'MY65[KCF=IQ92/<Y**WO$U+#G7'
M>U[T=)VZI1'.>I\.GO&4E[WM.:]YS#,>]' G[<]1;]O8GO:WD5>_<+=O>N)>
MH/OR%SCXM0W=Y?M@NML-P?H!\ CK1K?Z*/B^')Z[<?_VYI^^\]U  _:;A?5V
M=P$O> 0:DE![%@S< X580_XU?-\<S&' 5QCQ@@?1B2\<X05'V/%]QS#C(H=A
M T%.<I,S<8@>CS@"P?AR+=JPY1TOX<F5J$$W@A&',<<CRXT(\SWFW(V*I#D;
M[:A&I>M\Z7I$.B#S^$A%<C&/@BSD(*D^=*U?LI&!1*32N<[UA3BDD4]?9=@]
M&<JN/Y*/HW2EVC%IR52VO9D3@;LFC0G+7*;2D+:<Y333_O>WB]+O>P=\1Q2"
M2[MW!)=UQPE"2$F19E+D)@*)I"JE:<IG$OXFT;1\)3.2RYA@7B#F3,@M/W\1
M:8*DG3$!ITAP4M"0R%,G2,'_)C(Y\@79&Z K.:%)$]12^Y08 B@$V7U ^?D%
M>HJ$*LC/YD"&8GO V"6@./6+\Z^_T(=N'_L-K0KUOT^8IA;G(3*]3&LPRA?T
MO[2BH6FJ49$:?YIB]#2.8<UE=/J=VK"?+T^-S?D[XS1H S*2RJ9<0RRR:O\&
M<#K@C_S4BCR@PZ(:@SL4L"^$XP''HS%^PZD@\#RZ0S3(:C@X,#O:B@,CY*U*
MD*W>8T2\(Z\::Z^*0+&N@SCJ@S4L*T%0ZZU$RT50BT)\1+!X\ :)8Z[\PT,R
MQ+:LQ 4;) <GB[<.A 8/*[2>$ =9!$1\)$@$1+;X(T10)+6JD :%$$=B:TLX
MZ[,L_T0,D4NWKL2YD@NX\@.UKJ0'AVNYJH2TYO"YB$M,C(M)]/!(I@NZKBL0
MI6M-!#%2HDN[^ 1/$-&\Q&01T>N[#/&_#B42%^Q+'!%6#/&\Z,M2/N5(PHM2
M *R]="5:',Q-UJO#X O"0K&\/E'"DN7"3!$36TP6,:Q11DS#;LP5.:P6NV7%
MN$7#G$5:0"Q:G$5=:NP5:0S%5LP8[07'C%$8M^7'A.Q<[D58S*5<U@5:UL49
MK>5;XB5?W@7'S.7)R+$<_07,6.9AS'$="08=,\8=!6!EP,S,QJP>Z;%DL*QD
M/H;,F"QFSLQFV S-CB8@XRS.D"9HZ"PAW:QK!,ULGF;.VO^,(?-,(AERT90F
MTIS&TP;MSU*M;.1&;TCM9RP'U"@'USZM<FAG=G1-TT)G)=NF<!)'=$KR=%Y-
M)B>-<V9R=3#2UORFU4AR=TBGUU2GUUY2V7+G*%]M)G_-VF#-=%SR;HCM*-D-
M<VPR*)LM>6:G>7XGVV:-VKRR?*J-=Y8'VX"'*KD-W-"2W/BMW>1'+=E'?]XR
M?LY-<!0H+NF'@KJ'+?-2X0#HVRQHWTQH+M5-?N(GX"R.+U_G+]$GX/ R,!E(
M,"5N?C"HX/0M@AX.,%&NY&QNY5).B)3HZ$;.,S7.AKR(AH@NY]"GB$"SBS1.
MZ,KHYH#.YWIHYN9(Z%SHB:(.Z/+_B#1I,XT$J8:2KNIT,X>D[BG ;HD&B>42
MJ>JPCNF>CHWV".JR+C=S4^JH+I*LKNNH<^L"23LEPI0(:?#PSNHDB>Q6"3M+
MB>["[IA "3OCSCS-\Y(,K^XL23Q/S_!<"?3L[B/X[I5(#_5VJ97$R3\'5)<2
M#_2^Z/,B[YD2;Y(H#_'B:?(@8BF>[Y@>+YDZ[XMRXODHM"IR3YX^XB=2Z?4,
MH DDE H,X26" I\,2BW8Z25,SP)8%"4:8)_6:2MLXB->M)[&P@F:H FHP F<
MH/=P8OE" J >X@*6(4A_%";4XO=L]/K,[_J\3_SJ J+.0B_>8DO#[TKO@OJ\
M;S#ZKZET_XJB'F*E- HO?$HL9 JL"D-,/8JAIC2C*LJABB--S>+^R(_^CJJG
MW"^F^E2H*/!+[:\V"G"H2@JJ@(,$A<-/9VJK@ H#$_4YE",!SVJMR(.KQ"JN
MA$,T<.-"ZBHSRDJQ].H\U(JO4I ]\BH^>L,_1B0]7O (@3!6B; ]5/"Q!@L*
M'2M(<H1 =JNS"@M%9E!7@U6V(&NN@-4,BV2VLB1+Q+"S'JM)6,L+^7!7B62R
M1 M(6HL,G22RE"1)Y+"R5G57A0NW9"1)MD0-W7!+ZC!=9ZNTH.M%X'6XRG4-
MHZL.=]4.OX0-"[%?_=42V^1?&Y&[R&L2.06\&#%5*%' #I83 _]L4SJQ3UY1
M5G"E4-X+P"J1OD!14O9K%"M1PC:1%1$68PNL8BE,%0^LP116Q71%O[:%%Y41
M%H?EP7(Q%V<17' 6%G4V5TQL%G&QQICQPWJV7'K,QI8Q&T-,7C)LR)KQQ8#6
M:7DV7X[V:>7%3-CQ:B6&RI9LR;"V:_^!RL V'K_,849F9;RL9-"V9=2V'O=Q
MS1129V2&9N VS!;RS092(8%FSMX6(H>&:0PR:/",T1R2(I,FT#CR<"T2:027
M;$I'<0L-T]!F;A@7*DGR)?D&T6!2T2P'<K,&<5IR)@%GV3SM)VO-<PBG)ALW
M<5A'UYSRUD9G<TF'UII2)8-2=4^M='?_!]=XC769K2AW#7>V$MJ:1W=Z9WBY
M,MIZMWG$\G:*+2V1;7N\K7?3LBS'!WFC=]ST,GO%9WNUU]S>$GOIAR_!%S+M
M,MXHDX (J#$93H P4]K"[808Z-\FKC([*'PC,S$=L^)J""\7#N16Z(/^MX(
MD^+^$N)0B(#\ES,U$S-#,S #&(N<*($[T^4N:(MJ#C:%Z(C"*.)X3HQLDX5B
MSC.+#HEPZ.2&4S71R.G"2#5K$X2!TX633H6L"#?UB.>VJ(4/"3<MN#B;LXZR
MD^T8"8C7;NBN\^K,<Y*&F#K1,Y,@J8_0[NS&<_#<4Y,(;Y,2;XK_KN^L6//Z
M\S\-#SSKLS]E_^F7!/3P]/- =VD_>6GU-B_O5(\_+Z+T5,_M&'0B* _R4H_V
M<BF/)2\H3*^8[GB:EJGS<N\E2"+V7L^=E(\FKM@"HN\EB)2:9E0D#LH"=@_X
MJD(=I& KBN^4?L\K?((FM&GWFJ\BMB*2M0F>3@I+PT_\*..5N=3]7AG\).JG
M+".E8#DP,.HR4BHQ<KF7!56G") T;ADX=F/[>$.7O_0L>&JJA$HNH-E,E^K_
MVB\UTN*8WP(!E;D\*DH N9FGZ#137PK]K@.C8D,#,_4#D0,$<Z,Z^/2K-A"=
MV6HZRGF>F<-4V9FPO"I559"??V,(&\L\^IE#9O"M;A6P@ 0(#9JU#..ZL1HK
ML595-2#+!E6+H<W0"7LU1E"D1R $H$T$#A?K"7U06M/P1RPD"Z>P27!$N+:0
M5^U06]M0HS5:7VO+N)X$N-Q51>JP2E K6K]53/C52X2D#D.Z"84Z3&RZN'3D
M#W$:$ 7VJ071$<?+8*<Z$:U:JJ_KO/:+NSK68NMD82\6K"=14#!VO1 V%B,1
M%"ULOTXVP%816;J:8?MKK2.VJX.E%]&:&.M+%^&:QF)E8F-V%_TZ9FVV779Q
MQH81Q!*[9VU1:'_QQGALQ[R%6IP1LJ4V&_%E&HE%KUV,&N':7!B;&NO% ?^\
MMK0IALG2T6),FQW1<6NG#!VQ#&7RL69TQFQK.VVEK,P4YLQBQF3HL<QT6R"!
M&R&)FV_Y-B()ER'IMLZ0^R(9MR&3FVO&QG)"TL\*%W(2]VU&%R29YB-?4F_^
MC-!"IW!$EVT\!R6[^[Q9<G/QIG-8#=%ZTG-$-]):,B8SA[Y++;Z#=W@H[7+*
M$B9K%W;(^[[+DG( O"63!WKFVWJ$IWBDAWIY9R4)9RQYARFI;7HMW'G'=\,U
M_-O,K7I!W"U!_'S\#3+;4M^^MX#.1^$&3N"D1WW^Y^!$*"_7K2Y##H(@+GYH
MB,7UMX$HR,87:(  &(%=O.,4,X0LSC(#$X,9.#/_-_,S%VXU59/F9+CI7,[D
MW @U7[B,9),U96[+8SB((+B%D8CF@K.-LHB/2+/G7IB(V!PZA6Z-NM/K=$Z)
M:;B*E/B'I3//B_B-I.[/NU.(DT[0IRZ(-6F(1PF)S[.)Q7.+E]@^_3SPUBZ8
MW-/OT@Z+_<X_]W.,;ZF,JS@_U5B+/SW3<X] JQB-&>_R%#2:;B^9/E0C+,^.
M4SV.,V+Q")GRA@E#D2F/(\^9,@]#60*=*&)'7P(3<GWW%G0@)EDD &KUEGWV
MY.F=?L^</N+90\*>$%GZ<.+9*]E(#0!)HV(K6@'\O+V3NP_[T'VBK(^56UE+
MM0\GJE1,V3W^UCU/Q<^E_^[]_AY5H>R=JMPO4-V/J?I]I#:J44$JJ7!#FQ6D
M+" U-!Q5,JS/^L;#3Q4C4*M*J-0*K(!#JRC047L#!!/U3ANU4/>943N>GP\P
MGSV^I.K9 E$>JS@UKO[*KS[UY2,UHNGJH!7:15B5L[1UH8_05SVKJ)N5YW]P
MZ.\*5'G^6$'UI//5N9(UZ>F#Z:4^I*<U6J\0M)IPM\H0"X5D6H=02["56VLD
MH*$+#I&D29:U[)5UMIA:M7P^[=,>IG>$Z]OPJ+_D#._P[ID:[Z'Z[Q51O+ +
M$K\Z\#'V8+4Z$O'KJSTVO?X+$;5+3_2+8^&:O<):PAXQ%LGK9>D+8D>68DD6
MO?_P:V4QY6,C#!=]$10]7UA %F9W461G%K(Q[&11'UA.+/8;&Q@W[!F'EAE9
MEEYN/[*7$1O#\5H.3!S#I1^<9;-S3!N;'UVHT<9D3!M_S%WJ!5&JME]6>[6U
M%AVWWQS#]LK>$1_3=AYK.V?XL6':]OR'.[C=OQ\)4K@7,B#W-F^I9F_M#,[\
MMF\14FT HH+ @0*/##1(,*'""@@/%GS($"+"B1$A5CRXQ&'$A@H;'LE(\"/#
M)4<,EF1H\B+*DADGDFRI<N3!(QM&?KQI\Z3!#25IGJRYTR'0B!M>ZJQ9<R#2
MECPS(JV0U"=4@4^'\L1YM:C.J5H99H6:TJI7ECO+?N7_B=2LSZ<^2;8M2U;K
MVIM=T9:TBQ8LWKEGYY),N_<OV+]\F[X%S)?FDKP;D.Y]G/@QVLDT\4I>:[FR
MYLEHZS7>G/FS:,JBOQ0^XIGSW"^-1XO>[).UZ]:H:=NVW'KV$=D\34].39KU
M[MRS<P_?()QU:M#)&_-N+9NW;)J^63\_CIRS<[3*<S_W#CZ\]>S$R7^7OKT\
M^N_0RY/?KBX[>O'QHZ>W;WX[_NCUTV]0QU]Z%N2WW8!?Q/?>?LCUU]B # Z8
M'8#F2<B:A!.R9J!S]5&878;C'6A=?Q@N"*)\$DH(88HD_A?B> 9R^.*(!Y((
M8(TR4FBCC1L,R...*_8(8HXC_UHPI(]?&,ACD$K:J.222_:8I(U0.LDCE#X2
M222 4VH)8I1'7KECE4%F^261.W899IID6J"EEFH>F*4%59ZISIIM'GDGFWCN
M6>>><AXIIIP[UE@EFU@>B6><7-9):)QT(BJGG9 "&F:=D?:IIZ&% @JGG(P>
MBJ6E@+:IJ:5A7DJD :JN:@ 5A@+8"JNR&G JD4[,:D"DD6X0*ZX&.-'G!53X
M:L %NEXJA:]-./'G!<2JRNRQ%B@;K06M-.&KL<<..^LRNFY +!7&KL.F$]CB
M*BVYTLJI;J1%L NO!>K.*V^\[=H;*;GW'ONN!1+4JV^]NNX;,,#IPMMNPO$*
M3*^T___Z>^R_Y#[\;Q'J6KSNP@];@/' !^?+<<@3PXOQP^2^JR_&%[<KL< <
MJUOQO1)W7'&]%J,LY[\F0]PRQ9&VG/+(]>ILL,\^0XQQR3G;//+(/2^]SLU1
MGQRUOQ,[+:_26$O0-,\O?YWTU4H3/?/6/)M-MM=IZ[S.VFI;K3;6[W)=<MM6
MV\TVV5'?K+?;;!=!-]EYMXVWU8 ;3G?A.NM\N 2+X_TWUQ5+[N_?45,>..&
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M[A-P__:^ [>9I"F_H(F_)7>:)#>:I#ERPM-RR7F<(81Q)L>;N^F:#D1S%;?
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MZNNMY\@0]5!NT7N[GGN-W.LQ*J815<H7T5%G44[^A%$']5 IM1)?X5%@2E$
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MO-8ES]72 Y^O@;V\YM7Z?;T3'_)ZZ+T+^JY[S?8A]_@'OOVAK]K3/A_YWI=
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M8N^I\",_@:J^YVN+2P8JV2"_3.YD;._D4@;3*]6-*\4J^"LK4::-5U;34'9
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MIORR7/YF.&=R_Q$9T:^)_Z]JNOAG:G@!_^_045+4*9V) V?\#EW./='4!;!
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M 0H0@ 1$H/^<9T#^,9"!Z/M? >\G00@.T(*A*T("I_? "@8P@P-4B 8'Z)
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MA*"HO/"HUT.-AW)1Y(.^X@,H&L51D&*^[XL^VGLIC.I1\?N^BGHHZ_,-C@)
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MX'8?O^U<I?PUEW2U]Z]M4IN;Y7DU8[.UR$TU67L?JX0TP04(=1:^6!A8<*!
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M?WSVQZ^?//?8PP]_[_.[;_X&W?/?O_6\%[WM 5" WB.@ 8E'0 3>CWL%=.
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M)6!*\1-'\5M <<-*T6)6$5W*Y5]4S,((AL4L#,;8,,0^9EQ(S&2H!69XT</
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MXZQ*4 +-RCPX(T/T[Z[,"@+9Z@/[@SC2%$/JM#TXY*W8JD $A$_+*D0$1*S
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M\&N^[LN^ZEN_\6N_\ON^[:N__YN_ 4R_ ^R_ ES !(R_"#R_!\S "=S "^S
M$0S!$]R_$ES!%'R_&,R_&7S!'<S!'RR_&#D\UR,_^) _L*II!/21!E1^E8(H
MA6< FX(0E\  -&S#-8S#-ZS#.<S#.^S#/0S$/RS$04S$0VS$18S$1ZS$2<S$
M2^S$30S%3RS%44S%4VS%58S%5ZS%6<S%6^S%70S&7RS&84S&8VS&98S&-&P0
M[&#"1O0KMF9K(#23&J%_+4$1+?2M">N61QF9X=;'=W5;P*59,13(@3S(,/]4
MR(>YQ[60R'^,R+:ER(0,R8Y,6(H<R8\LR)+)R)-\R)L,7(8<69;<QZ*L69=,
M5Z0<RFD)+JH,F:7LR*G<R<0U6CY)RZ,LR"\DF;<UE>6ZQSC!+DO(ETCQEA0[
MK=,J0["LR:OLRH<,RS[Y0K6\Q\VLRM#\S,%FS<N\F+ZLRFC9RU)8S%[HL.#"
MR]T&F+ZF;+_LKS<1A=U,$T:XE\*V;/&\S>K,D^$F;ME\@/]:%OD379P)<':1
M*:"!&*;9LB^+M57+M6"+T$>[T%W;T JMM0\-M1%-T0D]T19]T!7-T!KMT!P-
MT1@=MAT-TA*=T2/MT1>]T7=HT"<73LN@'HT+8@P"]AK_<BM?^6FW-%TREL1S
M-2,=_(4</NU?G>@=Y* +F9)("N9-$5:YBQ1VIPC3,)VX3CV?B1L;P91>B>@>
M$MI-3OW25OW272W5BP363"W6[@%,9(W67FW68\W69JW698W6;1W7;AW69_W5
M=)W6=?W6=KW6>"W7=SW7@0W8@]W7@EW8A W7B,W7B7W8C<W8C[W8D;W7DZW7
M=1VXB"L?WQ1.[%0DG/,%0&8DTCMD0/(+F0*G2$-YHK=E#I6FV=O:UJAYKAW;
ML)V](KS:KVW;LEW;@ZK;UXC;O$W;OCW;N1W<MSW<P$W<R8W<R\VFO6W<N]W<
MQ>W<TRW=U:W<T7W=OXW=S*W=_]U]W-L-WMX-W>(MW./]W>3]W.6MWNG-WM2=
MW:-G):B]4/43I^'TD2NLPI!B5)<FJQ^1*09QP\ JX -.X 5NX =N*FI<$"GW
M5?\B0B*Q$A".K"LA,-6Z+3\9S/<*L.CL;3]1;AZ.;N0FK;XL;^&JSR">A2+.
MX2I>STRAX6Z%SD]9S_%&KN;BKG,9;O9FAD^8$SM^ACF!@(QI@Y@UF/D\F!"0
MXB]NF$^YE-(6+NHFET^^@X+Y+0:8F!>;QQV.@^+FSD.!@SKAXU(1YF,>K3KA
M$S\!K>=JYCN(@S/XX0^;@RDGA\ZE  *CGICPM=?5T:-)MGSNYWK^YZ()Z(,N
MZ(5NM?^$?NB&+HB*CK.+GNB/[NB1WNB3OK227NF47G*6GNF8WN>(KNF=SNB7
M+NJ;/NJ@#NF<SD5C&^A\H>IX3M%>VT9\T9X0AJ$2BM3L99\X+8G7 8FZ/E]V
MVW.C9+<V[1TT4V"56*#440<NT0F,NV,0DDM5^J =)HN$6]584^W+FUYBH[C3
M?C;=KNT+=C3(*[B4>]7>;NY/;;CI3NZ1*XOJ7N[OWNXO-^[<[NX0-N_B_C3Y
M#KKGON[R;N_TON\!K^_7KN_]#N_W7N\'S[G^'N_X3O (S^\-G_ ";_";*_$1
M3_$3S^X:W_$,__%ALUY(%XQ>1QL.U@DNH0]%=DY#IJ6ELP#_S$X\L]V]]/-D
MW%MY%IGS%:SSL7V_/8]E/\_S0R_T19^^0,\[-T_T1[_TYXCT3]_T2F_T3A_U
M.S_U4L_T5V_U6<_U5*_U/M_U6._U8;_U8V_V8H_V99_V8'_V:N_V;+_V04_V
M</_V<@_<K^T]UL@.*4\1K<#"+CPI@4\H?R]^&_")$R'# J'@",[XC>_XCP_Y
MO7H)+D$+P&+Y^5="*#&2$H$)]*K(OM;'](R%>%7F4PX4\PSFWYS/7SZ%PRRO
MSMR6H8_A0W[ZW9SZ_7K[BXGF^TJOLI_/NR^PDP5LJM_*DO660AB"KK\3+[3Z
MX=RO:AC\L*R6X2)#5][\[/P3;9[/_\$OY,;_E)>YR'J9;G%%_5[NS4[^F$N(
MST:8+@08_NR\SC88_'\)@0)[S(L,RKQ,__OO^8X,$/@TX6O'"5^M4/@2+E38
MT&!"A 0-1HR8T&##=@PM*HR(R<#'CY@DC"1)4H')DB-/CFP%\N.R"S%EQL0T
MTV;-"SAOTK0I4^?.GCF#"@WZ<Z91GT.1\BRJU&E3J#V7$I7ZM&I4H%>U9N5Z
MU&K7I%B]B@V[=:S9LF"9HEVKEJK;J7&_GE7;2NY5G%-GVHTYQZ4!3 XDG"3L
M0,%)PX<5'Y:0>+&"?Y$E3Z9<V?)ES)DS"Q! CG.%SY\UCR9=NC)GSP) JPZM
M6@]K/:L]@_^>S=HV:-RL5X.NXK**XL:#%0M^_-CQ\.# B2-NS)BXX>:%!PMW
M/AAZ8NO3F2^&7ITX=07+PQ-.SKAP=>7@M6,77]Z\=?3QWX_?+I\\???N[[.G
MKG^]?/_.JV_ _0 4K\ ! X0OP0/_8U ] ?-K,,+V)EQ00@@OK#!#_#9<S$$,
M/Z2P/PL[))%#_M(34<,35S111>!&A'&^[H1+[KL#/SS.0 5Z ZF*(S8(4L@-
MB#32R'J&#%+)(H?<@ K?V&'' 2JG-,Q**K-4 ,LLJ=RRRRZY!%/,,,$LT\PJ
MT4Q333*S;'----]T0$XZU9S3SCK9Q'-//?N,D\\__30SST +'13_T$,%'1/1
M114]T]!&(7TT44G=9'322"G5-%-.,?744D=!_?/++K\DU50KP[NS3%*K]/&C
M*C:P0)TO9JV55@MDU=767"WH]0M::7W5@"H88(>!2QA05MEDFT7V66>CA79:
M::NE]EIKL\5V6VV[Y?9;;\,%=UQQRR7W7'/317====ME]UUWXX5W7GGKI?=>
M>_/%=U]]^^7W7VFG79:!*5RBH@@+UK% @H01ED!AAAE>N.%UBH XX6&=Z 2?
MASANIZ%0$(H(Y%HX@HBAAAH:2&2.\5&HG8Q*'NBACQ-:.>267XY9H)9#J9EG
MD%.VV62A@]:(HY0?*CFAC'CN6*.2+[J(_^FA0]Z(Z)-9AMHAI(]6.NB/9S:Z
M:Y<[=IGIG*DF"&6?,X*Y;;C?EMOMIGTV>FF\21Y[H[:+1GLAO!FJ6R&<.Q[(
M:I.73OILQ?GF.O&[2<9Y:\%W1AQPL+NN*/">D7X:(Z@AN%QQ3FH>N>F*#K+H
MYXL.YYKRM_6>'&S,U9Z]=M89/_IRV147>W"<@6^Y9MY=_WDA)PQ>9Z654BJI
M^9(RGJ.MHUJAOJM4TLJ^K>W?ZOZG[V<*7Z;Q8RK_@O/3UWY][MGW/BWKW[H@
M?J/HM\G^O:C'7Z;]8^I_?OT%4'[_(Z  ZV? ^R$P?P-4(/\:Z+\' I"!$SP@
M!1-(P>[1I7IDN12>5?22/)!0X3""P<X(I[.<?G2G/O^F86$+6[@;U,10 "ZD
M(0UA&!L95N U,+S-#G6#0QWF!HBAT4,27%(+Q"#'/"2,3G(:TX\8%<>$C@&/
M<Z2#'!(^ICG9X0YWUA.=X82G/ Z (G5V-$+S2-&$722,&L7(QBH:!SPE=..!
MZ*A&.Z81CW/4HQ3SV,8]PM&-;PPC(/W(1T,6YX]Q]*(@ZXA(1BJQD)%<XR0'
MN<A+0C*3C@RD)1_)R4."4I&:_*0G.XE&,X(QE-M9CGYTQ(F_$(E)1EK2%VA)
M)%O.\@@5,")(:J$E+X5I/*M2%3N&*<PYJ<HPR61F,(W9S&4^\YG.#,\THUE-
M96(3FMJT)C>SR<QN@O.;TAS_IS:IN4UQ I.<ZC3G-=&YSG.&$Y[NE&<[O<G.
M=]HSG?$L9S[]6<]_]A.@ Q5H0?%)T(,:E)\)9>A"'4I/A4*TH1)]Z#TKND^*
M9A298%*FG=RY48^X1%; (FFP@&4!DO8*5R-51Z\V8 B78&)@RTK63&UZ4YSF
M5*<[Y6E/??I3H 95J$,E:E&->E2D)E6I2V5J4YWZ5*A&5:I3I6I5K5I5=H3T
M(X:8&,,JMHZ*=56L#+.86&$*DCD4[7B*(]SB&#(1JT7D<PG96]"P9M?=X94B
MCN/;7CMWM8YMCFVJHQUA"X*1NAV6(:D[FLA0]KF_-H2Q9VM9103WV-<=+Z]S
M5=U _^KZV;P"CJY*>RO77$?7S1*VKZ7=R&'KRC3.AD*TA54L98_6,[F.3;"I
MZUQNXPJUT=ZU:5.3;-42MUC>'4]UR.V<R81GMJR%MFR2Z^UL3Q8TSA)-<HV3
M"-8F"]NV'C8BQ*-LYSH&5WSX!22&<-YTVOO>L\**@UE)A5%J,CWRX02_YM.O
M^/J;W[[X-\  OL!^T?=?_@XXP046,(,);&"^.-A_")X?A2-L8/CE92\:YA^'
M)]R6"/\DQ!L&L8<K7&(4OV7$'4ZQB$V\X@^K^,4S;C&)95QC%M]8QR[&<8QY
MO..9[!<I)B:*?:\WA_J&12\_P<2PV#N@Y;!'.5,\3 VM?/_ER.2P-17 <I<Q
ML^76I 8T.'2-;F*8&S.G.3>'<(DA=)2=,RZH."GTCG\2TTK'G'%%SY$S$Z&L
MQ>](43AW/F%P<"1&)N)Y.\U)='FV>.A&*]J)RS2THZ]S0D17VHJ3SK2?D\CI
M2-OHTDD,]:8A76E)G[K1IL9TJ3^M:DV_NM6H%O6B*;UJ69.:UJS6-:X?/6M?
MCYK1N\[UL(-MZTY;&MFN_G6O8]UL8S];V+>6=GUV!.=8(SJ3B79.+S]R""3=
M4MQ.6E*3S+V -HOI5*(JU9J.R=$WM0K>:I)WJ>)];WKC&TWUUI*^S<1O+_E[
MWOL6N+WS?7""(_S?!>^WP@>^<(?_&SSA$X<XQ1]^<8E77.,8;[C%,\[Q@$>\
MXQO_>,E'#O(KB3SD'@?FNU&5IF&:*N4&SR8[XFN 4J14YR;EU:YV5:L-H'N]
MQWK658U^=*0G7>E+9WK3G?YTJ$==ZE.G^E!K>O69WCP4%$-86+W:=8<E+&*^
MDH FVKR[VD7-<]BU[=C6+ENGW17NN 59X3XV5]82)&:H?1Q#3@LSO1$W%$]3
M>UYC)[BU_;5QCBTN8Y?F-=FU=6N$?ZW*-+<0P",.N@:YN^E6U[7273YM+Z/N
MS^K&>)S-3+F#';W:,L+:PA,D[GQ?[=X*=]>B'7?MEI_[;5&KM;/]C&QU9_O5
M@EM\PC'>_V-XM6OH9T>\D=G][7U/O/%C[_S$B\UNG[]=U#ZVUM=97JT:23W(
M3!_:OX3BO8-9GO.:!\OU<A@3X]/)_&UB8$S$CRK&2 O_V^+_MP# GQ# F2!
MF3# F$# "U! !DP+#7) "&2*O#B?")2?"KP+MK# #M) #L1 N)B+"P3!#?3
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MN%O+[J,ME!W.VLNKZ1O,JMV[G)F:\;*=J=7:GPE)E9#.]0M)##0Q)EN+ XW
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M3I;ES5P>3+*T=5)F];L:+^IBKN$)K^;$YYZA9<PK9]F$S%+V*^#*K2I_*XV
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M#O5@W@">Y\3O#&WM1-A<$E]ATIY]*4]=3B?S25 '?2;X.&U!5!#M(1!B*I\
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M-HT)3FRNTYSM5&:(SNG.=)*3GO*$IS/5:<M9HDF4/>I1,8VI3A:A4J \6I-
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M4B1( K,E"]#ZK<$@JU\:.] ,*HL1XD$*RJ ? V A!. 46K3$V(U3*]'I*,1
M+*3#R->9K0L0!44$1L-62XQBU2$-'L,M7=,O=3&@&"(6U$)78S,Y=+(#SB(<
M_?\A&UHUG>!@&:4RY3"-%(ZT%88U/*)0&_XS'!XS'=X+'@8S*<KAG-!52"HT
M07(Q$D6/R'"".2@T#7;1.$)BXYC")7:B3@2/"N7B(G)A&S6S*C5#X5BR#:E$
M&>6R$E:,6OO32DK%/RW%3R(H@?2GA)36@"JW;EO'99)@?5V&?C*V5JP4+JG%
M0:Z20HXH6!3&1*:F%9D#(6W(42K66E5D7V1D=MI6/4%DA*KD5^+D0_Z0#OW4
M32XW4M9D0;[D8X-&!YAD5/YD3#;D0&;E2@5&$.E05RYE7#YEB#JE?J)%;0O&
M8/+E9)2E8K9D38TVA;(F3LWD/%;&9K6)3?$X4?DXBAS_E7FU*(SDR)'*6*S[
M.0:(X$F5656U V\VYZM#YZ2;!2:X!'9(YZ5;E6)EAZR3YW.VYYUCE8F]9YY;
M%7V.E7I^9YP"Z'U^NGCF4">8YZ?KUY*"YVU!6(;&.G ^Z(0FZ(K>R*SKE4PQ
MJJ#JJ8Z>29B\2<V$KGC)S+.MJ] 4+>9*3;.:G*3LXYHP!-J*K,VJERBH KCM
M*J8J/==CZ><[JZI)/=E:3+]D+>7#A]]55:!^R[4E:<!:&*2N6N32JZ).+*%N
M:KSK::_9/-4$K>C*%\?4*\X*2]\CO+\,RZAT2[[+V@Y-+="32LGLR:ERVL*"
M&9NN&:1V@K86+*'$2Z'FN[RQHEO06CV>SJW:*B["*2W:DDK#2=R&R4F1?ERO
MJANZSKO6?,WSB\WB5,_O1$\+VVP!:P)E4$K>G0.D-H#S!(F6""#UNB_8G3_T
MPAZ&(+#IZ=#1-9_03I!K"(G\VLX.=,_>!B 2XTT B@FD;@):",_SJDWG9,""
MP(0F<(+:P>T)I@67:$X/:^[:C$#O5+&8L*_YI,T#O# *_!_;G0@ETZ$8S4]-
M=/^ _.5/_YP@]Y:Q$AI@^$8R#Y(+(TO0(T/O06)B,89!2VS@1%)@S@ 0"0CG
M/@;1,,M"_*2A4T/P@PX,5C[HX6#O%U0TX8 B4+11S8 T!B+B.1JC25O"'Q:/
M8BWB!Q80(X)0)#73!E<@%K<C-,LB&*_A%9GQ(*YQR,!2'"\C&C^T[H"D.:B)
M97#328:QV8#!$-;1%R]A')5?#(5R#*4-.N4B,=1AG3AP[L#P&^W@HAA%!ID0
M3'KC5*P0)2NW<C5(:EO44?61B>.00UUF+'EI25V&&ZD3;S2XA%N4/;>V8<M6
M/@=T1_GSUVT"1:%P%$W4;QMT1QV41N_61R?T//<E1S?_DEL.DT2!=$I/)3\G
M-U;J5B@QU$1GT5C>=$&WUDDA<@.X\TK'"4S7]$E'=4]OMD$?DVE[MG^+<U "
MR#])5"#I5"K)5D7&$E#?=3])$':%UXKJJ(K$9FRN5UJQUYA*< GV5XLER==-
M@H\LUH5%46RO%7UN*7$WZ&]WV(,.6'0?%G:P@YHH9V0A=V7I=G"_V&V^Z'ZN
MBW'QV)KD%)#MEHYEE[I(*[PS&>8:V[_CO8D9KK>E+9>N\YJH@KM]ERJ >.*[
MZH%/O,;AJL#<F^0#&(>YS,,4>;N%ZK2*F<L#/(]_F5! :J7%Z>#2&).%6]I3
M&,;&V\M]VJ:1&9)%G,2+W+1I_QO%35S*>3S$H[OHD^FU#86Y9;[1 ^S8*VG6
MTQ>*-X"(1R[GI5K8"AN]]-FO1<O(Y+RV!7JH55S2XBV\P_BZ5)O+>>RO>:K'
M0_BLL:[4N>SK6AWQ55_FL=X&!&_R0>HD6$^L%UW\&<'K3<[JW=WC:9^\-]T+
M&)[$UWOO]0CA@6H-W'O@+-W[B7P _ CA>5VJ13#+1]_8%9X3K0*0H/SGC5X.
M''WR;GSSSEX!$_W8)V_U+4Z^I[_J'8F# !Y,6,'O:$$E-PS(D&\<O%\**GX,
M F#_U<$->HL,,K*Y,+(%3;*ZR,,:0N,9(B,"_T(EJC*^J/:9;0(.M_$Y1*.A
MD&*\X/]@0A2T[S=_!X^/-.,TPX#P,%L/(O9P,T;",2Z*& 8(!Q(4$!RH0.!!
M@@<E.%!H,"%#@Q$5-D0HL2%#BADQ*AC8L"-"D \K#KP(4F/%CBH_3A1)<:'*
MDR -T*QIH.#+EBT36BR(\>/"BG.2U)SSTZ #)S9I.BD9TB=*ASE#[B09,Z//
MC1FQ*G1)$*C L!&!=BW+$F'*LC%Q=OTHUNU#F64GDORX],B&#7CWZNW;%Z]?
MP(+S;EC*KN'A@PX..VCL6$'BQ8T3)F;\V')*RY G8W;LF:=BSY<=+"UMNK0=
MT:I'AUZM>G-KUY\CRWY-N_;LADII-G%<N?%NFTX0^R;^V#C_;M;)<\?&#5OV
MP=^-38\6_7PYYXK8B2MN?GNS=N"EG6B^O?RZ=P=#:Z9N3KHT>,K;KV/G:3T\
M\L:,&3_OWSFT>_(A)]UDQ7VVVG[Y 0B=?@<NM8$%$$IHP1?J1$BA.E]<>&&&
M%E:X% ,ABGA)B"2.6"**#)AHHH@MNO@BC#'"R,1I-9KFA(PYZK@CCSWZ^".0
M.T914Q/L!'EDCRS2N!2.*HJXI'!(2CFECBPR8!J568:(I8M0UM2DECEZR528
M9;JHY'A3VD$43788&2:79K8XI@%@RGEGC"NF:*6/2UFP3A'K_%G$H(.N(X$%
MB!(*Z#J,+H5/*+5$&@JDE7)2:3N1_U8Z::60UE*I)IM*VBFEE%[:CJB>@EHI
MFS;6F(2JFE(:*B=5M%I%J:I>&HJLL<Y:J:2?[IKKIOAD^FDH[61J+*7+-JMJ
MJ*9NJNFP^-"*3Q3*+!6%J:@V2RPGWGHJ+::4;IHMD^/B4VRHEJZ;:ZG>>OLI
MJ<CBLRNDXCYK;JGV]DINKKL*JZ^[L8K:+<'JDAONO<7N6RR^_5(ZZJ\26XN/
M:9B*"['#%!O<K\-5&%)3%>Z6.N12UY#J<,.0)KOJI2Q+R^_%(.<[KL<"6YSK
MLB:GJO.H,?=*J[,^!\QRQ,PJ*R^\*R\E =10=U02U5%;+<%2F%RP]05:;^WU
MUG-PC4DK7/^;/7;98W^]MME@DWTVVUZ#/4<3I25!2]ML=UUW:7#[?3;8?\-M
M&B:IB"UWVH!S+;;>7?\]]P6$)RZXX"C;U$3@@5.N]N.;*]ZYYVO/<4UI3=#"
MN-R":YXWY52TZD3AC'-M.9%NA][XYJFCS?G;MCO^.^> 3[XZZ**'GGG;D^^.
MN^=+M5725\^SE-!)_UA_/?;9:[\]]]U[[WT% @@0O@#DB&^^ -^KOS[[VE>@
MQ_CPDX\^^7J\/[[XY(>_?_[QX\___\3G/+5\!2MT,6!8I-(6 L;E(EP9RUP$
M$AQ7U:@)!11+5A+XE7ZH!8,:F2!3CI*4\0"%*RY!H$/0$A>1A.3_+1XQ(0LC
MB)0'/D6#05')1ABHP+B010(@K)-46GC"IT"0+3<,"O0N*,.NC 0J1\3@2&"X
MD[6<18E(I"(*L58:&T81+CVQ8@H?,@<J+&497,'(#YM"%@WNI(A8]&(2C[@6
M!8;1AC#9B@Y9.!;HF= I7GD+3+S"ECT&4I!T',B#^.*7+Q &,(')RV#^LA35
ML*,[*5F-8OY3$?YH1S.NJ>0F>7*8_8@R.I.A( 67 <I51L<^]RGE8EQY(%B"
M,D"79"5^CD-+5SJ!;[RII6C2.$M=-NB2N\QE@8YI2V5B\I;-- TH?2-+8K8R
MEL@TIC6!*4W/1+,UG#R.,*/YRE!:TSW9_SS('$"XC'*FA#J=I.8YKPF:>)HR
MGIB)33<+=)Y.A@:7F.%D;#*YH&@",Y_$M*8]ZZG/PRPE0Q; $$0K5"$,:0A"
M$KU086S2(CZE*$E.(A%(/RK2D))TI"-EQP]1B1H4E;2E)G4I3%\JTYC2=*8V
MK2E.&>"$5ADB"1N]*5!SZM(2H;0T3/CI#X\:U*4*E:E =5&<FBI5FVZI-!LM
MZE*4ZE2I8M4F2ITJ6+<ZHJ[61*M-98<=0&B'GX:UJB Z45A;2E::?%6L<;6K
M27>D)R?QU4I^0A2C A6H1%E@L(-%E*($]2B:S>Q='6M:O/ UJH9)2EE)FQG%
M/%8%E;Y*896J O_M#%"RQH(+'YEUE\=RE3.6W0RR^;JLL2Z5VF)!ZH<J>QFG
M)L8K<25-9I(*16@-P*UI&0Q?+ O5;#E1*G,9%[*9Y95G)0NO=C179I@Z6&RO
MVS3JLBQ3\D(5;&7+V,DF3;JF+95IFG:I:!6+NZ-"KL6XRRG0+@57*PM%&I%6
MLU5Y%F?@O6_!=)9=QA:+O.<EKGK?M3%X/5>[!U8697D6,=Y:%V>30J]-KJ9A
MJTUM:EJLB>>(IS?BB?AX9DN%W[2&"=(M)0FR\]L<4A%< \2M<;H#GM9:X3NM
MF>9V/F8=\7K,N^"M#A.^K,DUX)8*W=T8>)\#LHV+-^3?92ZXUS@<W'0WS#JX
M:2YU.G9":)T Y"/3),F?\YV3:XSC$/\X>&5K\HE''+S<J7G+7+Z EMF\9L=-
MLBH9?,@+Y?_2OD$3FM#GZQ_^QE?H12\:T?K+G_S$AS_["8#2]WM?^,S'OTWW
MKP+.V^-3Y,+$'M9%(A>$H1V+Z,"/I)2S!FC""@LX%[:$A(/2,T@:5YCKZ,4P
M>H$FH$:HQT1@7X6-3ARVJ-=BZI?@L(XO2>!$()AK:',$V%Q40#^F-TAFG\0D
M$90U'J]BEA066RU8L4BUE\WM<'?%-*M6MA%+F&ZR%*15-5FGN!60QF)[6XX#
MR;81U2WO-W81AO F-\+M..ZS/%#8<YPA 17>%8"?VH8"N4LC(:D7OASA"X,1
M#",'X[S,5$<R M+GR?%#F_@0J)B2R8W+6^/JT\RA,Z(!Z&]L7DS_^6Q&YR_G
M^2@_F<R<"[TA<R@=<T;()./PYYXW?SDEATX<G^-\ZD4'.M2[<QMWJESJ/;\Z
M=X*.('TVJ#7QL8UCA*E+HH^=Y.#Q#)D-4/-B,L:=GG1YU-TN]KR3?>UE1R9L
M?H-UJ.?G.+EL.LS?GAVT@^>;R1&08I8B48=."$(8M4"')J^A#+WUIWS=$^@_
MCZ<8T6GF-9G%Z%.O>BW-PFYO6GV0HC RX;P^1&FL/>Q3[U>KYEY'<7K2>-C!
M43G1B3R]IY+LF23\(-F[3;B?TN_O5/SG'S]+>]TKD/S$*,("BON$0JSW'643
MS&J76O_5%:K8:S36'JU>NL+8C:I0A4Y _W>GIPF8N&9OD]$:BV,,+MC.[!?#
MS,N]'$L!7HS :%>PE,NZ, RUG,MXZ!>!\0NR3$JP: JDH(M-#%?,"$W++-<"
MEM?&^(IC:4JT(,MD/6##X-9L,8NEZ$L(+HL'GLIQ%>"S.&#1\$SZ':!SJ0L!
M.E>NI-=^X5][@0QII6##Z!_)$->E!-=P <QCK2!QM9>W6*!U\8RZ.*"P;(JS
M? I\K0H0#DRJ-!;1%*%UL5>SR* !AH('&LS3;!@<:MA24-F;I=B<;5GFI$WA
MC)@>L@[J&,[9!%<2C!B*_4X3:$O6%&*;/8[R")F3,9F:]<X=#EF/E=C7Z&$=
MMH(&UD04:,Z+V?^AXG29(H)BWHABF\5=%#S9)*J8CS6?:!$/BVV@[HQBVXSB
M'CZ.+3*/G.V9*MZ9X[P8B=59URC/)%ZB+E)9,:[.T^A1MP4;O3T$HT6C-%K/
MHY7/H:7/-&8C]\R/^-A/I/E/->*/I@50 .T/I6D:_ R06;21(3U<PCV<!QE1
M$$G1#\$:3I@:/HY:OT6%$T$11?3#OB'1M,71MJF0"U%%3T 0PQGDL%&;M\F;
M5MR0 ]B:'\E1,ZY0'R4DMID;$KD0'5713RA119Z; UT1'5&/!XTD7&2%2<HC
M'-UC%062::RCKWD1#L4D0F9$W"V#3/@CU#"DN1$1L^70&;&D01:</O;_HU8L
MY$GJA$8B6[79VAH57*BUD;;%6DM@W,=EG,;U1<AUI6 81LQQ4R:1)4+]DT!=
M4S-94C4%U$(EA&G,P3Q9$N"Q$UU2W3R]$X+D95GNY27I)26UI6\<W5+TACC5
M1]\15#5MDWWT96#^I6/>'%_BW38AE#111SW=Y2=-)N&996/JAWUHDV):)BBI
M761ZIG:<9H%4TDX>"#V!YENN)F?B)62&AS:9G,I5D\]UYD$E$SFQ4WA,DUFB
MIFMXDV NIF0VE.91'D5=R$5MB(1TGNB=B$<=7TH9"78R %JEE8U4GW=^)P/8
MP5+TE.>!9T<EE4BU2'9VE'G>2?29Y^^92'92_U_JS2=UMJ>,L$@:(4G<K=5]
MXLGP3<E^!BA^ALGUA9Y;T43X$1;X24"C&-;V(<IB8=>OF*%KP5:"+4MEY>!L
M;59I\!]CQ9UPC8J^Q!V(_LJRR*!GE=:HD*C+<*%U]4QNS=9R$0R\.&&NM MS
M2<L)JA;-3$MH*4,46"C+^(O/R%?[!2"^+*EC.9AN15C%P. $$FEE]5:\W(QX
M#>&52@R)>F"R),T%-B"D""%IE:  =I>7;HJ) @N_+-=R65?06%>6BE>22J&/
MSI:-HBEK7=8"NE9CG2&['!@0:@P7BDN?CFF&#<0Z>)C4+&H<SB'H(,_9Y!F=
M78 Q2)G@7.KBR)C=L/^.IGY-+-J$I3[9C5$JG,D-X?3B(NZBXF@9I5Y C'G-
MJZ88F2E#$]A9K&[-K"Y9G)V-[,BJYO JU] BK+*-J]K.'-""$^+.Z@CKWPBK
ML":K*XK9FJF8EA'/)T*.V7PBI7[BF55J,?*BB5$.\LRJX[RJB%EB,>J8.M*D
MK.EC6FBCO++/-59C!<PKOOZ#HTG:I4&:-?ZK_E":I=5KI^'/TU#%.J9%1RXL
MN'4;O<%$J?F:4?I0Z42/6Z D2I[15G@D,U*1$>W:0P0D]63;N1%;!Y7LL/W:
MNQI<PBY;"7$DL^7DK,$1PRU06M"%R2[01@+:2F!D3+K$M5E12DK/L1W0RPK_
MK4X0K5P<T$QZ4%76D#P:+4[$G5RR)!C)D,2U9+,A[,;.T4D6TJE9K=>J)$E>
M[!5IF[%-T10AW!&A[-H2A%;ZQ5^ I<9MI5],4M?A!UN^AF_^4W;PG&TNGG5(
MA^)-1VFH$B;=$]4MGM;]Y<L1+G<$KLE5G2LER-GUQ]@IQC)4[-_-)<D9B#D9
M'MT9!^#V4]E1KN1"+GV0W75PG8"L7&28[N1Z7>I2YFIV9G.TAMJA7.P:B.J:
M1V/T)^-&'8#\AV58+NK*;H+D!X$@7G'V[MXVGN#:7%\J7O)V[L[%KN6V75F>
MW(,\E.5!2.99B$6-[T5!B'0B:%^I+TOA54[IU'N&_\B;B.>-P)7[WN]=Y>_]
MM@C]VD02X)[^WE6+[.>/!##^XI7H1=4!3U6"UD0!+W!>50D$&["+$'!3A8@K
M^B=;.96/&#")$/ $AW!,K2\)9Y]-&(KW%4KW,4KW(4JB+$62AFFXP" / EBW
MQ,J\A.''!)<3^"FBMMB;[HHKSM\'RDR>EBF\Y*@4.J"=]JF])(V.#B$$;@L2
M]Q^!R;"%(0L/#RJ7EFG10!@:'LO1T,P1O^FU]""#R0J-VJFZN.";*O'_6:%K
M*8P8K\NRH*&@_K!-2. .6BF-4A?!#/$5FNF_L-\3$W*GX"",FF 1,TS$>"',
M*& AJV"9GC$3^A\;,\RU-(9,'=^PDE;*&UZ- AR*AGG8*&=-'?K8J>Y.EQEC
M*T]9X1@#V,3=(+[R[%1BE*GB+6Z.(_HBFNV9):KK,9)B*L3=-; BYV@JMOHJ
M,@YSV# SG-W.(18FWDB9M\;.,V=SV SQ[2BB+?NBVJ3KV!#KE(&SN)+J.:>S
MZA!CI$*9,9KSP28MV*KM2O_DJSV[#Z*A#_K<LS8"[#?6C[T2[*8-+*<!D#JR
MD5"J6]1"K0JQ)!XU41.E4#W")!\U&[_)(S]VT#Q*T'AD[$#"8T5[A3Q3]$IJ
M;1V5I+,E43S*K%Q@4+HA6]O>) VA-"$AQ1,%)52\;<*A]$Z3FTXKI=@"M1/%
M&MS"1Q1ET//T[,/246N:$!%Q++(14L7QVDGTD+ I9#.:=%)/=4A&=5!#!<+R
M&B"=="%9945V)"+9A-QZG-Q&DB(Y4F",G.&E939))M1Y$ET:R'"ZY6'V72B9
MQCK%4V4>AVC:M6$;IVP8%&QN9F*&KF_&1O\2B6M2)EK&)BX)9FXF=EY;YF-F
M]F/_TK5H8.98+O9>#Z=?IF;?FE,_B1)LAA-H5R9BVW4M[:0YW:9=NZ5MAJY!
M;39GH_8PB9/L/B[*N:8_B2Y"*13?CK9>IR4P(3?A'83D.:=#351%192',&=&
M.?!_;C>,A%3UI92.H-5I%"AY6Y_\1K8!D"=W?Z>)@#"!EC>>Q.]WQB=\U[=>
MV9Y1'0D[]&=YRHEWEPEZVK=_AQ[V78E-;-]A,:B")Y:"PS #-E<5[E?1[ IW
MJ1\>'TV+$MBN_!"(CLNRI-27NO&:6HQX558B2W@:Q^D:NU9R=4J8-E:)\TJ0
M#FF*0Q>&D[$-_Q"-GU>&'QB10E8 /BF"*4R/M[@1<G*:_[[7@\&Q_T'RBV.R
M#\XI(O\6Q\R6$.++TMP+L5QH'N<PI(QXA VY$E]@EU+A&+N,C:[X(H,AFS(@
M=*V@FN-6EV,*#?KPDR:,CTJQ?+%Q*(1R'/XYI)9S,Q.S)9(S*?JJ-X>J 2C#
M("I/(7K-C%V H7M.MK)-C)6&,GB9, OSL>KR,.\8X"BZ< G.K-Y8-+<SJ!>/
MJ8_-C/\JLVZKL"ISYTQK+WK-I_JALQ:9ZL"8Z#@KH@OSL)ZZK@:.N<[9+_/B
ML?\-NAI[Y-C$.^H16/3D0/ SM1-LHMTKM4OCOE(:.7+C_PAL0?</_53:_GS:
MJ(U;VV;M5ULD5>-L50Q$/:*:6/^[$56+],2B&PR!+$*(K%78[,FF4STVP7"4
M9*@%13H=61,(O$:36[5]12]]2=5"A$N^$+U59<:>.S_V$L([@5SRK$R+A<9?
M#L=/$4(&I0$I!,"7CL"_^[&E4#H5)L<SO%0WK:E9-:TU),F#!&T[]%*C1%&^
MO,AW?+P1)$=H$-#SQL!C[42D?&$V 174[,5CK<=>40-QV[O:T3-B-'3;!,<1
MQMP^$MU^'-ZR7'+_[> N'N*A!X&0_2N5!W*81FHD+FM0[]^ZO2TQ!_ FQ9%Q
MO. U4]HE?- O+W=L;F&^G>#!+LQYQM$C_=Q-=MTCT^(+?-CY_<&K/'EP$\G-
MI.+VW>K_)L7#P[Q1%*[;8\;G?\EP8'XN[2[IYGTN=;Y^"*_;83[@9J]ND)D3
M#$?@'5YUV$?IUTGCY_YLW'[<";Q1))[C$3=R*-[@K;[9DR[?S;[,J36'+"?U
M.U2'0%3ZEC )!^A[E\D'RW<%PSV/1$$2V%L2. 'JQ5[Y^R_Z PGYFW_[(Y^]
M.8$&QPAZOUJ0M!Y-G+^,O#] &! X,(F360P0)E3(P,G @4X67EJ84"*#B@EG
M16GHT$"2@A-!+LR8Q*%'B"%19BP)L2)'@2AAAAQ9\F-,EP9B4LRY, K)AW9"
M7@194:C"F01K[F1PE.9)G4(W.CQ9-&C")(8XVF&GU.I/KB![__I<>1!FU(<(
MJ3+0*):@P:]O<Q)%.]<B7 8<+:PKLDZO!0EYBP 6_/=OWW4<VX7"IUAQN\6U
M&./CM/BQXL>+'5N.K'AR*,BU*">N+'DTXR@NG5#V3)F3XRHW0T=F*["*:MN6
M.85UF>1:;<:@*6/FC \S94T]'4;Q#7HS;M7(!RJG'$491R>1)P?/[7%W[\6>
M5W?&=YKCM<WX($L6O9UCE&O&+V<?3OJ\9.@"I6,G'AE?.]?W.TJ"B5 Z2V\U
MSM9CK;3^\*DB"O)H>F^SSQ9L+!0'.4I".O%48VXQV$+)3+3&5 O/,?E$T^0V
MYF8SP([S#F0.M (AX ^\!B$4B#??,O\#3C$56XOO1,HP)$C"R@STD),IKLE1
M1PT/) V^X<X;4;W;2J,22_%@Q%(QCB0(,TP%Q"1S3#'1E( C3"YHT\T+6KF
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M2FBJM2UTEZ/8X787N!$*L7O&"Y[WG':WB"UCM7Q$',.BQND]2J%L45/<%IM
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MW4]TK1A@2I"G.N'1K'6=NT9*GO]G.DPD@6QRVAT%;V>Z#[YN=0&LWPB_=\(
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M:H9@$K8;F__('-+E*PT+M3_;CFM[C0YK /AH+/2X8LX2MW-;+1+1;%(3+A#
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M;<:VGY*]7?G;AX[8P&VW-Y#["[C?EKONN/.66^Z''/";87;\%GQP!0+_F_#
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M0N>5^/"A9V:)#Z#X$65SD:5-GB.84N+$)KT$IE.L Q%;WL1)L;&*,X7YL&M
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M=R$7GDE(JBXQ?<G$'=M#;Q'K_AK82"OL%\,6Q-Z:!R,7C$1&\O^21L .#2H
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MTW+49/)**F#CC"0>KZ2M6,L*SF'K/8PF+SGS#3HJ_W$8%HT>?W%&MS@7IV%
M/XCFW.&4H$[HW&'I1(F).J4_=J576N(_;C[4,+L:[8VP,]&MB(ZOD">J2$_2
M<%$DW8HF<$^@8-/C<"4V-8^W**BB@'58*M!YNB@Y_N*BR'5U0J<X/D]2"@7)
M<J=/OHPI3B=D%PM:C[[W6+[Z'(I%5H\C[N6_R(K0N 9U(@KA<SML;V)A/R5_
M8CW! \_S'">/TX+UM&-3 &UUB'"[M*N.'>7V$P6G;)<FH((E;Z\"7 H-71=/
M,/[0ZF!UT[N/G%@^I<#V.F8I[0/F4'D($=%3+.W!\V.4+Y7!!TD%8_#X-04J
M]9L2LCJ4/ZW!K;B22!WIK:""'OPKC)\J3_W3T:)FFD<JD[X M\*2:.YY!?E2
M+J9G W@0'Y)Y'Y$3R5+Z1I4+D9<33!# ?(ZKET^4G<\1E+]ZOXHJIV=4R3HK
M)C'H(;P J!(+H8=G*G "1+V&T5K D593DC=5H<IGG,<_A'AJM$8NNM;_Q)G^
M^U,)UMF2%<"'0MS:K>$RUBEL%IYFEIU&%M^*67,1%7 9%XG%UO[",!T;ZNR:
MKY6ULWI%6&W%,7.MF/W2%O J,';=,1DKE^:R9I+UF%OD>VUE1EO,-.920G]U
M"(6-KH$96'C56H,=685Q@F601$TA'B0T;$[96''%L;5I6(BUGH7I+@#/6/%B
MV9Q1?G!I&J$V5X"!?8=8AJTF,Y>]_J"5?=RO%E[,EK;M?.E?5QZA?34D;:B>
M,;[71!K;54>L&8!P(,&!@H$2%"!48&#APB,;'#[<4&]#Q(H.(5ZDF/$APX4.
M"#I@]_&C@I ?V95$27*E2) G2XXT&;(DS)DV_T>JI FRY4F<-1UT9+@L)M&B
M*F,Z"6K B=&/2@T4=9 T*-.8.9LHG;-2JM*A.)$::.+$R3*M5I4VX4ET:D<G
M.H$J?4FT)%N&56L^M0J3W3*T*4MB#>KU*$&_>O/^=1DU\<^?'^<$#NJS[D*F
M*G.:S N2KM*J8*GNK*DPKD^N0>V4IHGX).6E,A4[54K8=%N8B1U$9FBV=,R4
M,2$_O6S3=E3A<^6R]+UW<7*]QUWB[6CABX4-%M1]45?=PG3LWJECOPY^0U &
MYAE<.J\^O?KV[-N;3_\>/GWZ[.>;;VU@??S^#/0[T1X[3]57H'JMV<'?>4F)
M%<4L"9HWH%(&4OA?9__NG1>%4A"J)V%'26!H85!,G'??>78H!2)]"++37FL!
MNJ@4B15V*.*(!UY((WT$AL@ BA/J.%]0AJCH7X0&))&$$TS,@IYZ/#IIHUWP
MO5ABE.SDMA"'"\K8X9!%FLC @$THR21[["2Q87U?KMAE?6'&>-J:0%(()3L_
M?E@?B_Y5J6.+8MJ1Y4(*ZEBH?5&&F:A_0G8DP3H62 "I!44\2JFDZU@:J:;<
M!85/*/APXJFGM7Q:JJBA?GHJ/IK@TXZIK(IJZJ>NXD.JJ+?*ZFF:0YIJ:ZFI
M5O%4KJ&T5L6GJ.(3;%!)#(M/L;&2VEH4S88BJ+&B=G*-4M."6JNLAFR+K++_
M'S9;[*>DUI+MMJ6ZVMHUT,Z*JK"Q.ML9O:E6JU05W1*[[KV>_DJOK;C^&V_!
ML>H7!3[8SENJK>V$ZNZ]3WG:3JP4'SMJ**%H&!2WLWY*F2'[9ERJM+=V,B^R
M%I?*A%+ORJKRPJ:.NY R28C*JJ\';ZP?S*V:&NK.H4)\[\/(4MLJP**2FBNZ
M^.(3E 134UTUU059/750%W!]P1Q=@XT)V!>D(C;79G>-]MAK7V#,V&JGS74K
M:*.=2L<,W1PWUV6#?7='9X_]]05^5T:X(7 #_E05>I,M]E-A7_#XVG _1;>V
M'2D3!=MG9ZE,$YL#WG4JH5\ M]I5[+JUV9A<WI'F_Z&7[38FE7<]A]U!>5ZZ
MVUQ+3CKKVT[>NEULW^[QV,(O]+K:JRNE#":M<#T'+8)>L[;MF*0^_.3;E_X[
M\*6#/O?F=&\./>2@ARX^^EU+71!" [D?/T("$6100@C]D[_^^_/?O___ S"
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M=FP A]&K'2)F%KU$S"VD?:JS,TL66F@L9"0E(0K72'*.RPRO"G.B"E6( A/
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M<1WMGFL,$4(8J/R!TB!GQ0GIL4(!GB0_CAOIWB,=A!2\*"(Y0%E,<IJ><F<
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MFH#"!J:Z.$Q[%JQBCN8(3\4/E>8"[A#_;5(&9I#BO,J%!)WF"AEL$54"PQ0
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MO9/] YS%W=W;G2V&R=WCW3_T&)O=O9-E^9R.CIZQN9.!+D1):>$[+]LQPS4
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MP$M^Z-M<W5<U!9I]OJ==P$M<P^=^5T,RQ 6^P,6]RJ6\].> Q*M],J._7!/
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MP(>5R)%-)R,S'0"QQSK(>4]X!%0=CF\FX?\63VDDCG#>>,<X^8E.Q\,S&>$
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MM9GP(PWBH%<[H12"1*;X(6L[-$K#(7%#(V)SH1S2(GA;M32JHJG@HFFS(P7
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M2S:EC6<T3!TUF<>CI&=/4BH1D^ $_YOIS)*6M&P.=[Y3@5KN<I>WS*4OL2,
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M3?9TE%8REVPGE2"EE8<G)297=S1)(QXU=X.ID8%G=\$$:PI1!8V'4YSI>$?
M4V)2)GM0$7,@>FBU6Z)56;JE67OE*9 U>IKE6VO%6;7G5X%%*7O55;TE6ZW'
M5_=RF[;W>FWU6?^M:5:C$EG)V9JV^56"Q569ERJXU9N252C'^57?0IM5-5O"
M27N=!9V\E9M.59SBAUICA5ND]9IZ59W0&5>4-UNC59R115FR"9Q,M5J.A9V]
MZ9R%=57K65N\TEJP!9NXN9_YF9Y^-0<5407,]2_]YZ  Z* -N@$R:0",P%W@
MQ8$5R(-A V$#EH!FXU\[>(,G"(/J93$@NH(<VJ$(!H$C&H,UN& K^F ?6J(D
M6#8MN( I"E\N*J,Z6H/>-:,;NC$YNH$.AJ-'&EX)JID85C<:UF%ZTV$;YC<4
M6@61=HF[ T%JZ&5&!CHFY&=E*&0EA&1K9FEDICM-QFA@VFA2Z#[@TT+_6Q:F
M;JIF,49 [6.()S2+=@:&C)-B;<IJ?/IDC-:F658]X2-G568YQ=-JWP-H %1H
M9&9GC'@[PF-D:PII9:9H'!1"??IIID9!.O:G=_ID@/IF\I-I-]8\H@IC?-BE
M;?9FGB9DZP.G#D0Y!9&FK"B(X_.F;&B&_/-H3$9G(B2)@,JE9D:E,Z0 R3AK
M#$&E)2$5Y=:.:H&/#\E'U/I$%_"LSK:..-$45I2M0B2/]8ANO :.8Q2MQG:M
MRK:0;52N^29O>]06"2FN)?&NO3:03(1M1*$5J6 ,P@82[2:M^V:/Z#JN,;%(
M)S%M[WINV$IL.P$7"/M':3$'5!IWXJ0G.'EW_R.IL:/Q21FWL0[W2A+7&::D
M&JVQ&BHILK&!<;01!C_(=(9)F#'BEH*I3FE)E7L)LW494@1"( )U=W*7=UJW
MDTY7DU/Y<R5UE46)F&SW33?22_6D4'"733>7DU>)=64WE"97F% G<_C$E56"
M=6PI=.UAL0@EM ?"E%_)L\^4LV-K($([<PFB3?51=1O%3RM%ER!7E2E74O*!
M=$LYM>S13P 2'4*B'5 K3QJEN)3Y&\NX!Q7@4Z*Y4SH%>6="FL18*NTG>YPW
M?OB269NWFMQW*)^G?KZ25[.'*)6'>\:">?#B+GDR*^JB>W?E5J+U>>AB+YP"
M?O1WFLL"?IVK>>;'GO_WQWF>VWZQ"WJW!YWOR2>MZWZU1RW+UWOXXKK4>RZV
M.7RY%2UTA9S5-RZK^[FRJRGUXKVATEN:DGWCDKE#I;[8^;VHR;KG!RW*IRJ.
MNUP"(Z']-X !J# $<[GZ=V#SQ8 ]2L _*J0V>J'_I:$S^( XHX'JE8%(>L!(
M2J(W"E]"6C0J2#940\$\:*-8@\ 8K, ;**(JRJ/H=<$T>H$A+,(JLXQ5,#!Z
MLPYY(X1-N@Y%Z#=_4P04Z@3WXX?%&CJ;J*@=M(@BU*E3.(7]PV)[VHG XXF4
M&L1V6*9<>HNF"JEP"*GP8Z<&\4"ZV*LPMJ<(I(NH6CUQ:(LD1*>LRF44%*?_
M:?@[\\,[9PJ%]]-GE]ADJ4,Y=GB'ID@]NX/$AK,YSR.%"J2%M$.&<PQ">3K&
M(=2%8JH_GUACGI.GDJQJE5/%F!,_:"RIE_B'>6R*^(.)4)BKGZAFIO,\K_-I
MH?QD#]1DT[- +ZRLRVJ,S$IA!(MN9!2- 2FPVOH16T04$<FM)@%LU4IOOG85
M(N&-.[03TWA$"HE%PQRQ9N&-3@3,T*AO$SE%>91N[K@1T(Q%;[2P<U 5VZI&
MUQS,6R%(S*S+T7:NU)R-VWP7ZGP14:"@ZJ26XX1R&_FQ&_N1"B< ^XQP_=RQ
M_OR2K[2RL[2R$E<!AR WAXDB4E*7@&E2>=E/2HF1_T-7255[T84I<P27F&?'
M4FSKT>QAL=$D=@P%E&=7&#_)N!QB)6EI42\+T8/[L@Y%M1<E("M=E1Y%M2,]
M=,KQ32N7MBFW=3+M(V-)T3R)(EPIEP55LX,WTT7K=B3"DX-73B "ERP">%H)
MET'+3O!1F7O7U':I=VV9=VCK&[FA$(=@4Y7[>%\0N6*R 0RM$(;PN:C%FOE9
M6I,5G)CEUZ<5G/V)5?[)O@-*64FUGJKIOO396H[EV(R]G)L%6Z;5G@0**. 9
MGJ#75FHU5<'YV+U)G_B968N%V,8YF^A+VHH=G:BWV/,YGJ&=5K:E>K^%UZ"=
M*L6Y5Y*]G[G-U_YIVY(E5O^R3=NKW7VK25JFC9OC&=P'JE;/>=O:Z0 W5 H-
M.H#)A;_Z^W_^]R^E(#<YF*$DW,(4*((=?%\:B*(E7, O:*(/O(-N$Z,G/,'I
MC=XGBM[P7=X+K(,LO-[D':(C;-_V?6 1O*(>7*0,ML 2^-_DK=8)H0E(6(1,
MFL,/OF'<;4M')J9QZLIR6F;@0V4M1$&6EFJ;:D%#?#L=KL:*DZMB^J6@",B.
MN.%L;! 0T$!FF$&JMHEE5D)-5N.(BCA;RHJL3*N&'(E6YF5R]D"H-HAWO&2L
M:.-6_#U+7C]J5HLMCN,DQFJ1JCL-1&4LAN*I2F@7#HH"%.8<+F6OBCWR$XR1
MJL:<4CZ*ONB$APK%JF- ;9S* ?1F*=8\LB/G:LZI4DRF<3JH7PQH/<8X-Z0)
MLDQ#B<X0P64 RC"1$!FPTD:-#7O.]+K,73%$]3H2XXSI<L1OR":N%Q&NP<SI
M+?&MQ\;.77'I"_D2U6RNW+:N!2L3_II#I?[J\&;+"!GI^FJON?QK!WNOMB[I
M!KNNY29LZT;.Q ZP]:83RF!+:X?6-_<C_P"]L02-&M1N<!!G&JSD2:<1&RX)
M2Z=DLAAW0T*ED39RTFTW<G_Y3G87EW2'(R,2[W5+45B=E63]=H]IU6<YF&ZW
M[^9A(W\GN$^]3#9'=DBYN'I)=G8)N"V5E18+3&%WUEB+=TMI24IY[ND!4S_K
M(G#YMSD;E&#Y[O=>'322U>M^L])AM1FE<R"?F)?T4AK_EFC)F#L=(!X/N -7
M22QOF%!+MR2]&)JP)3AU4W!M)IWI4T9/N1MP0YQ0?]P[>LA;>YH[?[""FYH7
MOLV+]8$E?$_5VIM-NM2B]>>KN:OW?G ENK,]O=%I+UV/NM];NK-G5U-_>6:O
MO7,??ZRWN;Z;+__V&7WHNWW"=WIZ#[R6A_;;VYU@O_?#I[R:1[[$N]BY"_7L
M.=JG>W[M^RBWZ_B7?W[*>WW9:WK""YQWDG\&8 CWBUP,:@'*E3#WZR\W=( Q
MN,'W+=\ GL HR,(?C-_J[8#CS:)0,S4!WM\;FN#Z[=W3=?OAK<$&3-X5;,$Y
MR/SAG<&[[X)1D^ =.($J;#/&W\(^6-='*(2 (_XU'(1'^#<2L. &, =^W(8<
MGHO#VC]PC$"3N#PD1&.(,XN;.#E"'F- #!#MVN$+-3!4+7R<!K8+A8_@P80+
M"3J$V)#3Q(,9"2*\V-#BPXT>$U*LU1"CQH[X#"(4J5!DR9(3%48\*1/_(T:&
M!"_>%"F2YL>< C5.!-DRIT>8&6.&:JB)XDVG*9WZ3)D2XDRG*DVV)-DPIU:5
M/#=.-#AR*\:8*8_>=&EV;$&"4V_>9)A4[,RF$466+>OS(]*Q.WN:9:DU+<F)
M4>_:1/GTZM.C+ M7M-B79DZK@8NRY2D9GURE@Y%67F; M %#$A1(8-V:]6K7
ML5L;.FV@"J8+%W#KSKW;=RO>P7/W3C6<N/'ANY$O9RX<N?+<<XQ#3PZ<.?7<
MQC"EDKX<>_/FWYWWG@Y>=_'DZ:^K'U]>N&_CW=MCLNY]_7O[YNE?KV_<V'/T
MW'M.O_[P8\^\"U*!#\$%V\OO//(>5 ZW ,=K_S!"!#%L3C[YH/M.//#$PZZ*
MV@Q1H!\'5%LM105:E(#%%5]4L<75%/CG1AQSU'%''GOT\<<?*Q!  "$%(&?(
M(P4 <DDFF]Q12#TJT(/(*8NT$DDBAZPR2R&OE-)+ :+,<H_:JJ#110?ZH3%%
M-E\\\TP9'6A1SC/I1-/-.^64<<XW%6@SSQEAO+-/-@<U]$\_XUS314;[Y%/%
M&6N,4<Y"^:03TC75K'-.3-MDL5)$:<0T44/W-%722P6-L50Z*WVS547_U)/1
M65_=4U1 !U4-3T<=Q3-57GO%%4Y.[9QT5%Y5\Y3790U-M%!9@U7VUAG=='52
M4H7M]=95(84Q3A4+Y?^6VV=QG=7-4455%=%DU=UUVU++=5;11L,-U]DY23R-
MB@TV..((?_L%.. -O@!XX(,%5GC@"O0UK0H'(O8S8@?8\7-B2BVFF!V*.]:8
MTHXE#OEBD$6.F..3,:Z8Y(U5=KGCB5%&F6*,-?938YM3IGGDD'?>6&>51<:9
M99-CCKGGCU>F5.6/9\:89**3UEGJEI66NNF)GU::Z9NYKAKEH*DNV621@PY:
M:;2A#EELJL5&>^>9K<YZ[;5K[EKGMWN^V^FE8:[:9[SO]EAMD/?^V^.J[?:[
MXJWA?MGLJ15OO/"T(V>\[HP?/SSSLN%VV! J+/A"'0LVL*!TT=7Y(O7552?_
M?7384=_ 80.F8.!VW&^_A('=<_>]]]]]%WYXXHLWWGC@@^===^:7=[YWZ)MO
M/OKG<Z>>>N6OGW[[ZIT__GOPK>=>>^]QQSY\\<E7?WSNT7=__>[)9]]\XN&W
M?_[DSR]>?O>_OS_^]@&P?/L3X/\,B#_IB:][P3O@ /M'P.1E3X$13" !"XC
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M0"*+*:((:!PU3 *+@E-&.])'C*2+0M(B41,-8$PUBL0'5#2 UVB-B'LXUU
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M$=$+=:(H'E&A#=N@76(5N<2PD1'_=! C(A 0C2*?\5 ,*2(8A00736(*&5H
MA:(D>E"?+5">62(7+>*:H:(5,9$T-B-#;-$:*9$#66(/05$G N,&.>(IBN*M
M;:("X(/Y044#; !3W-&T$04\VM$<N:.SU=$R)" ?L,/"!1P_DH8A'5R\*1)9
MO)O!^>,KP9LCF5M"'D8_KE)#@ELF@49 $B3"Z9M$,MQ#[EM%,@9%,F1$?J1
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M@_Y2S(JG>(J]SXI10T=- P%K5(IWM,<>S(8#,(F9V/_06$))+/[^#__>.,4
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M0=,9P9$T%2L"=*S VL$O+2S)<D KF<#$2I%^(!3&4JL+]*M"W<$3I"P_5=1
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M+;/1WKHKM-/N:FJSW69[+;;1<OLGL]_B2NVDUUJKIP/@1ENNN^!J^ZZZYRK
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MWQP[*?$%Q_#-7O$!QVJD'O<-'UD\GWF4<8GB:/5)7_01W_817QE7*?@AWW5
MJ7Q\Q_RI!R0[1W:0WR/''R8#('#X7Y;&QRA/%9JF!YV>J99*2 =FU0+&AWY
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M#%=K-<Y8H\N,K)51(\O*K%B#(\RJXSN*(\RZXUMC#>2OF3SFK)])ON3/F=+
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M>(B"^"H8G='A&O0E#8E"/](@W=$IMM&6.(P#AHG[2C$4TU\(-K O_2Q+/['
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M+'H;Q@@'-R,5*6]VHYO>H-0V( 7I$4X*'>:8-#JQ(4Y)DW-3Y&C'.-II#G^
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M[!-2^9BJ\E,JH2J_(66JLH(II7K2I#*K#I&KMII2JI(_J^(JL H0L/(0+?W
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MR[5BT[2V)317 [51BQZ['<E1NQ^QK;:&)+;HJ9[I:;5J>]MH^S7N 4I5JYX
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M?.FWBP\]^.4S'_[RPH-O/O6QWQY_^*0W+__YX-M_O_[[GT\^__\#$(#KT-\
MBU?  (*O@ HT( .;-\ %(O"!RSO@ ?<GP>85@8 6;* %*EC!"78PA,O+X$%$
M"#Z$3,2!)ERA 3,X0(244((+A* "1V(!%V80(3BL80%A*,(4^A"&.BRA2H:8
MPQO&4(0H3&();=B0XA6QA%(,H0VEN$25_X00BRV4X@-M>,4.DI"$*,0A&*F8
MPB>.D8<Q=*$5P7A&,KIDC7*,XQC+&$6%H)&(251)'H&HQR@"TB5HQ",@_VC(
M0@XDCQ)!)!%'@DA&BF20CHS(1D!"1(D8)"B8;(@C,T*313:D)#<)Y4)&^12E
M5&0AHN2(*96"$4MJ\B67+.4JEP*4D3B2)3:ARDJ"HLI)SF0AP-1D4PABS*G\
MTI0RV0A0?JE)GQS3*Z<\2E6 LDJK@(4DVGP*,;OB3&M24RQ#X>54.MG-HV!3
M+NI<)SO;&1B]L&4R[EQ,9/ZBF<#$!I^,64QH*&.;QE@FG_(LS&@$VIK6Y-.>
MP2FH/"DCFM-4!O\ZOP$H:2+*4.5(H!_-@0YLH*-1T<B&HQU]CGA2XQC3J"8X
MQC$.<<#CTO6\5*7,D4YWIM.>C8ZG/C:E3D[Q8Q_P.$<WA'E/>KQC'P5H5#U'
M[<=[U ,?I1XUJ/?1*7WH$Q_JX&<^^8D05[OJ( :!-:QB-9!7RVK6"WVH1BNJ
M$8HHE%:W>HBM.+(17>=J5PVUE4=ZM6M=@;37(/GHKWL=[(\":U@**2E-1Q*L
MDPBKV,>624I>(A.@H+0$,%7ILJ#24F7#A"9 7990:PI3DPY5VM-**E5;"JV8
MH-1:.;UH4X,*U)_R%%O)&NI3L4I4D7@;J-Q*2U&VY5*D2&NH0>U*57K_\NVK
MC(7<8Q4*38:*+IV:%-Q/Z?92UJ75=J^U7>G^]K>SVFUUIZNK5D%K5^82U[8<
ME5YDM8N]YEKOP>;+WFAYBUSDLB_$,):N^O*)8O6M6+FZ-2^ Q8M/]^HO@.5U
M! $#V%OGNA>[\+LOBGUA8 #.\,$<AJ\/1_C#"UX9O( F,)FA+&(:[EG.1&8R
M$Z/8PRXC&<VPEN*5S3AF,'98SKCF-;3Y+&Q"SAJ1.W:TJ/$L9T[+VM6^5;FU
MF<UD1JM:Y.+&L2,G.6PI@YK8P!8W+J_M;5C.6^6\7.8SZZUO74:SY=J<YBJW
M^7C'ZS*9&Y>Y-,OY=82[<_2JW.?-Y=E[>M8S_^PTI[GD^=G0@#8TY8CG+^8A
M>GN2YISU!BUHY5$:TM';':=]=^G2):]WT MU]9;7NO:A3\^F&]_OUB=J4WOO
M><KCWOU(7;^VQ?I[GCYUJ8$GZ?O![];"5M_]>%?J89NZ?[\67_80Z&S_,=MY
MY(.VLZMM;0J"D(,1_)\'LZW"^UT0@@W$MKA#6&YM?_#<-RRW$UDHPC .$-Y3
M1"(+Q4AO(1:OBM[6]A1]&.\S9AN&%TR@N;/M13,N;XE-;-X229AO-[+1AE44
M.!3[K4<)8A&&5?3B"RM.QXN[D8$''\BZ2U[$%_Y[C1W7X<<9B4N72+SE(1^Y
M(5N.\D/B')(YS[E+%O^Y<X:8A)(7^6,J3XY)GP\])$(G8DUPN<E,>O+DP(1Z
MT7N>D$QRTI@4P;HN.RE,BV2RE%3/Y,N3 A.3./WJKSS[3Y#2<V2FA)59L>5+
M8L+TN$>EF.=4)=S[_G62\#TJ*"&+)W.2$[+HDIQE465-N!D4PH]EFE[ABCO+
M OG*5SZ>9C%,5S@?%X0"IBR>[SQ$_5)Z?9K>H7;I!UCN25#:0";VH(=]0RTZ
MT=)O%/:>6>CN+QI1W_RSH"D=#.M=6M'=(^<Z"T6-3)<#G)@BWZ0MW>A*94I]
MZ^O>^4"M#E5Y"GWX<'2G/ZW^^)G#TZ,FISM1G6ES/C.;IK+F/$[UCONWKU3_
MK.*_J Y(*E2S8];__]]8">  -@@ &N"#","%5 !:P55>P55=9<A;0:").*!@
MB8B-X B)X,@&$I8%^M4'@B"3" ED&0EC:4B7D.!CH6 *4A8)MJ"92!9G85>:
M6,F<F!:AQ$F?Y. .4LF@G%:?")=P48JLH,J+W IT-4H0=I9O69:LJ%9Q&>&6
M;$IPJ8IJV6"SV,FI)(IZJ=9J,<MJF9>O?.$6'HNIE%89=LH3^@D98@L6HB&G
MT,JK3 MP(0JIC*$=RB&QS,I[.0L6[HH>FLN>T)=\Z5>$W=> (6*[@(LB*F*W
M/%B! =@A'AB(59C'\$NW+ S$E$LF?HN+%8RZ4!C)_SSB)#8,BGUBPFS,*;Z+
MNHRB@'%8OVCBR81,AY'8B:TBB]68C9U,+NJBS>QBCET-DYV-DQ7-S>R,,!Y-
MR42-C4V9T!39+R99EGE9UI#--!+-,#I-E$%9S%A-E'$9EU'C,:9-QZC-V;C9
M-UI9,39.ECF..@:.-K[-FGFCE;TCFPW.FY59G=79YR1:GOW-Z\190!9:H#D.
M/QIDY!1DH<W.\)2.]@S/[UB:\10.[H0.[?Q:[1#/Z31:[& D\\1:1AX;0\I.
MZX":]"0.]LQ:M*FDZ$ /Y^":^]#/^5C:JSE/YN@/],1:]ES/L>%/2QZ;3Z9/
ML,6D\PP;M"5/L.T/31;E^O\PI4HBI;6!V[Y=&U2ZF[4YG,-IT IU&_]\$%=>
MI<@]'!*E$+W9&UF&I<:5$<!Q4%>2T%@.D59&I03M$%R>3P$='!/)41G9D0,=
M$1NUT<?]I0OU$ -UW&#RD,-]41WM91:U$<4M$<;IT18I1%ZFT1SM);Z)4AL=
MW!M)YDA\'!X=$<REY1'-T0[=T<L!T\5M)A_ATL^YIL[!YFNB46I&TA%Y4LY)
MG=4Q!")E723YIB/9Q-8IDT; DM<EW=O=W4'DDE6,DG$6$2B=1'%BDU(HIREU
M4CJMDG,:73 M4M(!1329DBH%GG>"A#G%G7)R9RA!Q3;5TG&"$RE=!2KA'4Y
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MO?X:[+#%%MN LLTNVQ,DTO8D;3>04%OMML\NFPJWWU[;D[GU'IOOOOWV>H#
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M9GB&97X&2)=-K[^MVZCT2K%4L;/4W9"FW:KFL=DM:^*4LK_&30V 3/VMWW[
MX,I4;BZ[;"J;LN>T!CAN3AUN<@1G3N_T3T<NY/_^U% !%>4(U7)^SN1NFW)H
MA^4LU;8)IW! QU*!.U(C5;BGIW!F=70B=5+!Q^H@M>HZ!WR"NU*+;NF"QUBW
M9^@L-59Q3NARQ^BP+KK5A^A8=5A-]7V<1U>EU7RDE;V-I[W/AUF'X%61-7[
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M;ILLI]KJ>BVXW(9K+K+:OKK"M:::*VVYNYXK+[KT:FNOO?'6*^^]^:Z+KK\
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MLY2F-,/IS7&6<YKF_.8WBWE.=4J3G>ILISCG*<]VEM,%]-P!/NWI3GS.TY\
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M:BB&4^B](A1 :4A"?3A$2!2_-'1$/\1#5O1#,[2_5Z1"@RB_:13 3C1%6Q3
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MQWY_*SE^FSAI4^H,2#I&TSL >#*>4X";R[>8"X*_SK>8XSG& [G$;CH(*('
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M*4U]NI.?^ 2G/P$J4('>LZ#\U.</\IG0$YQ@H0F5ID,A*M$5/'2A]J0H1HW
MT!]L5*$-S:=&$YK0D"H4HU;(:$<I&M*&-I2C(EVI2ZWP48X:P:4KJ"E+7=K2
MD'+4"CP]Z0]>VM*& K6H0_V!466*5)42%:D_@"E'E9#3$TC5!RRU*D=]$-2M
M;E6I'&4H51DJU:@R% I</8%6?R!5AEI5JFMU:UC5BE:TDE4)6;5K6'U0U;"Z
M-:MMS>L/M&I6L]K5JCXP+%7;VE8HV!4*6J5J_V!_P%BZNG6Q@CVL6@.K5[TF
MUK&1W:L2],K8MD:6L8R5K!)&.]K#AG:SKFTM; ^[V= FMK.A36UL?:#:VVI5
MMJ]E+7!G*UO>!A>VY_CM;Y5P#M[RE@A0<&YHG2O=T2K7!]#5ZW(W>UWH*J&[
MV(WN<QEKW-L>5[G@E>YYS?O<U*)7"<Z5@0S6NUSTAI<(RH6O$F1@WOFZ=[_V
MM>]RS_%?Y?X7OD0P,((;HN #RX#!]FTP@H7@X @?N" RL#"$(2SA##]$P1T^
M\(8SS&"%9)C$).ZP0C:L8A"S&+X*P?")X=OAAUBXQ@9A\89I7.$#2Z0A/>[Q
M1!K2DA?3&"$W*?)"?O_<D)L8N20ZD8%%>.SCD,#$(0?VB$)0$I$D.R0B+^FR
M1A[B%(%0)2-.J0A5E)*0B#!9)FL^LT]F<F:GQ&3-:[;(G$/B$[ITI<]4L8F?
MZ<(5J*QD+5(Y]*'K8I="3V4K+9B+5\ 2Z$<_>BM\!HQKZC*8O_C%,H49S*<)
M0VC(-*;2C)%T8CP#FU5[AM21<36K80,9T,B:,[%63FALPQG0, ?7VO&,<6!#
M'?'8.C>_48ZMRY,;8F\'/'U9SF>6G1UD^UK:U'9!*+P#GO8PV]C1_@URF&,=
MZWQ&/_I)D'"V<8,-P6<[!^).< 24'PG)QSWX4<^"Y@.?:;1'../)D(/B/9W_
M]4P&X!G:3[CG _" &\A &2I1A$Y4H0:)B-\"DGB+! 1Q'V6<11VOD<=]9*,.
M@?Q'-&K1R'FD<AV!R4L^ GF.MD3R.&UI1ZX@TY:(U"4HT;Q,8?J2EOH4)C.%
M2>9=LM//]W0F,^F<3&;2TY.B1"@LZ8!0@1H4HAJE=44Y"E"'*I29OEXG6:$*
M!JN*5)4H]2>RISWL5;H4V3,5]SF=G5BE*A6N2E4K5BG@[(R2U17F[BQ;58KP
M>*<5X'MUK&,%/O'#XI7BD54I!^!B6]YJEKBF-2QL98M9F9?7LS2O+7.IR_/H
M,OVXR)7Y=>&+7?.RE[[\%3" S7Y@"!/8P0Z6,-RO_RQBOO\]\!&6,8T)O_<0
M<YGQ8Q8SE]W,8;VOU\1R!OWI2_]E-Y/^SFS6^^PWK&G+MUG+A!:TF>UL:$$+
MVM'0;WZBI7]J2UL:UA[&?JHMS6M.(]O6MO:UKF%-:UWCVM:HC=D\S?[M']K,
MC=[8C0*23>%,3>.4C=NPS=WLC0/J3=KX#0;FC>0LCN LS@7VC056C@AZ3@A.
MC@AV#ND\X.6D8.:,3NRPX.F 3NJXX 983N(X3NK,X.FH0_#D8 ZV#NX<3P_.
M(/$83_#H3CWPSA=(S^D@8>[@#A,*(?$P(?%XSQ(TC_(,#_@XS_ILC_M<3_J4
MSQ:BS_2,3Q>^3_Y4@/:\#QWWT$_^M*'^Q&']','_U&$ _0\ V>$!W2$!]>$>
M,O^0"@6B($:0"6F0,E !&""!(BJB)R!!(SZB(SKB(WH")5:B)X!!(1K (&[B
M"AV1#-5 #@U1$&%!$5D1$JE!#?"0%#'1#*VB%6G1%4W1*S:1&541+=YB'L$0
M(1%2%]%B%YV1'^E1(^D1,6I1)!$2&ZF1$V71)!&C(SE1,VH2%44C,PKC'J62
M*^&2,8:1-HX2+EG2,(;2,\*2''5C+E7C'C4C+^%2(\'1,ZF1.L82.X(C-D[2
M*?72,DG2,3'2(;&C+ 63,@W!/2:3,453,U53-1UD,UG3.'73-B$31%J31';3
M-#DD12[D.SUD.W'31+*31J[31_[3.WT329Y 29(D10W_@3VMI$FV)$N^I$NZ
M)$7%)$RN)$:9)$09 4:!U#Y]$T[N9$7ETT4!)43=$T<5Y5,QU4SJI$YIU$P>
MI4@QE%-^E4BM@%)]U$D!U53A%%-:95/:E!6XE$V)Y0G@5%"594*%Y5"%I5=2
ME%AZY5 905@&54V%I5J:Y5:%%4N-54Z-E4Z=95#9Y5G"U5N)E61!%E^1U0D0
MUEF2%A2(54,]IES!E6 %E6%%EF3)55J15FEI)F2YU6/:55\=%F2956]-IFZ-
M)FAJ56I-9F8Y%E^AU6F*IF/-%F/:YFUI%FL%EFAJIF%5%7 2EG"JE6/E5FOI
M%6]25W -%W(99W(QIW']5G8U_R=KU9=HD1=N7>=TL1=V;=9R/==L$8$/G -X
MFM=LF9=X[I=YIJ=>.==WJ2=Z0=<YX->!J:=^P1=^RL!\/5> N5=]R1=Z+I=_
MXM=\YJ>!'JB!*H$0("A^*BA\+6A^0BA^0JB$YN>$B1B"*<&'R9B+)1B*=2B&
M<EB"$0%#&$2#,82),<2"+:B)DAB+GBB$!1F)3AF,9AE&($1*!%F0 5F.+BB.
MZIA%I(28,01%""E!V"B/=@1)B%E+R,1"8)E&=(29K5E&*"F;N1E1J(2;K<24
MVL1,[,22#L50G,1)B.E/C,5)3 6<1051%(6:ID6C$5I)3 68_@2G)9J?R85;
M#!JE\?\II''%4ZS%70@J7V#%8*0:J&&:J,E:8"@&9!P&6?"%JZ7:JWE:7CBJ
M960&;%@;JQU'9X"&I]H:981JKBV;J$+;K4%;L&U&L)EJ7S2;K15'MNG:ISZ;
MK4[;=D3'@2C'9KS'>[@;=^0&N?7'KH(;N"U(KHJ'=L2;?,1;<P K?7P&<:P'
MM"I(MA4<A:!'@K@ P=E'PP5KOME'Q6'(A2S(PEG(N19(N<J;QWG(N;:'Q,F(
MR4F(CJCKB:2(C.3KC*3(-.@KC\ KRLT(C*R<R=4<D-2KR*V<R)E(G!!LCL3<
MSPW)T9F(SC4LT<E)PVY)R_G<G"C)DRP)G3P*#/3)SKF)GG#_+,F&[-(!"LF"
MG9Z\;-5)7<S^"<W2+*< BJB4W9_<R=>I"J3P+)[4W:G<;*Z RJ;L"JGD"JFL
M2JST7:7<G*X,;:W@"M,Z+=,&"ZY8[:PL2^$]"ZQ GJ]T'J\(R^:%2[BH'K=8
M7N=UR[F GN:Q+;A\B^F]'MV^2]WR"[G,G@+T0[W02^O)7NSUK>SQWK[H'N#>
MGNT%G^*FS,I4#/(YG\*,S/-%#,BD3/<U;L=4KO4YS/$YG_)I+LI@KO?!C/;=
MC-)\'].L#/?53-%(#?F1S-'X3.O^S-6TW].,W]>X[M+(+M?0[MB0G]><30""
M#?$&[_\)(/*NS0'FC=G(C>14H.1<_R#D2&_@(([D7.\')B (*@[D="_C0(X*
M@N_VAB\.FJ#FF.#K',[J\. .C@[HR* .KJ_JU X.ON#L^.#KO$X1*J'H#$\0
M[N_^2B'S"*$ "_#R4*'OZ X90H_SI$_S+##WA&'Y;(#V6 _\)+#OS,_W2/ 2
MQ$\9YH\88D\'AW (RZ$)WX\= A ?)A !*1 #&9  #)  <"(-6U F&@ 5N$$D
M3N(.]S /1^(.8V(AUC 1Y] -Q= 0J>(0B6(+B2(HQI 0(3$4JP$2M>(LOJ(J
MOD 6;[$2\9 M8O$3\6(?U2(9(V,PYM$9H3$8[:(7.6,D+6,:QY$<?Q(6U=$P
M9A(:<1$J_?^B,&KC/[X2#*'Q%WU2-FJC,NK2&QW2.$I2+N&Q(-'2+CF2+NE2
M+M$C/PXD0O[1']$2/BKD/Q(3+5E3)W<R0BYD*4]D*9^R*8=31%)D0U;D19*3
M.B5D+&\D/K7R+8OD18+3-WF3/P74$)Q ,(>3,-_3,.<3,A=4,B^S,N\3,^>3
M00$40SGS37V4-;=D2_JR-D>44!IE2:%41\U42<$42+&41LV4.$?44YV 3Y4E
M5E*45HYE-?]E.L.S/2/56L942'E52]US4<%S2_644A654UF!0>/S41V53L$5
M5ZFE4P&F7DJ561GF8GY5:-(51UWT8(858>757#T67O757.$52-/_U44WUF2.
MM&:IM%EIIF?V%F2E)EVEIF2)%F>U566-%G%6%6M&%FO*]&RB%FO*9E6MEFCZ
MUG(*%W.95G:FUG4>%E.GIFLM9VNIU50[)W!AM59GUW6QEW*N9VB)EU[A5G9E
M%V]-9W=AIW6!)UIS-6.Y-70!6'6IIU?+M7[6]7XQ:'_VYX"A%U_7%X ]V(4.
M]H@6=H@1]F%#V86F&(.]:(@R6(F!J(DEV&0+68N%F(XI-H>F!(8AF86IV$#<
M6(/EV(5)V8N9-I2EV(OI:&ICA(6M-I?I*),]Z87)MD>DA!!0A)V-V9;9:$20
MJ)>2J)*5!'#K66]3J9.Q&9<Z&5%4A)A=_ZE P!D<"'>=S5F:^<12J-E=[#:A
MY?::(<15*$6=2@6AE?=VFP6@I7=Y.UJEM3=Z/QI>H+>CV45\/QJAG05ZST5[
M-ZJB]<6C\7>B@AIC",:HMAI^1P:F%CBKT9J!([AD./BMJ=H.6!N#GRJP23A9
M4#BM\MJK<BIF[-IE:+BN8D9^@#AU8,>K2NNG"@=T4-MY^)JQZENO35M]D'B,
M[\"][:J^ =RZ!>NVRANU]EMVL*MWF >#^-NZ[?A\$%R$$,A["#ER_'C#*7F$
M))RZ.HB(2,C#D>N57YR%2-PE$#F^TBN(0%S$G9S*_<? IKF-[ C"HOG &JS#
MDIS.)9V;KUR/T/]<F.A<Q>ZYE6A)U+5<Q3(LU=4)T/F<*Q#ZQ#+LSU'=H2.=
MST$ZV!UZS,XLF1#*U&T=V %*H7Q=V'E=H>SLW>DLVZV=T=Z=I;S=VQV>T<Z*
MJL]*J<!ZJM>=K*AZK[!*J3@MV;+*V?W*JHQMW;E*XFTMTCY>L2B>K*BMKE1>
MLG0>M;C"M$P>YNE*/ZCMVWY+ZK&>LF0[YYGMZL5+N?"+O)R>M(A[N1=NOM +
MP0AN[?%>XM*>PJ#[XLY[Y-8[\$ENO52?Y#+?])%NYHY,Y69,S%1?Z*),Y\*,
M](TNS71?R&@?ZI;N^KV?^TU\^0'-Q+?N_4E\UM2?S03@[9+-[I9- ?+_W]@8
MX/$F+\HC8,HS+]SXC?:Z_/-:(-XD(//*/,W73>& X/:6X.-XH A2COJ:+PIZ
MSA<PSN*T8,^[(-"_(.@8O?T"80V:S@UB#OO*3NOLSOWVH/VB3A(&SQ)F/?%<
M_==_?>C4P_(0L/$@\ $7S_8HSQ56#_6(#_58,-Q+#_@X\/0D\ :?CQKN?1>2
M3P6+X1JF#_ZXX0G+X1[F81\JOA\J/@,MD L34 ,1,>4[4"$>(B/N,"12HB1V
M/@]#(A(80296/B?*$ Z]T !0\1'%D NE/A+!D!+'$"JF_A.OX@Y9L1%E,2[B
M8A1U<1MWT1<[D1?+XO"S,1@%<B#+\>\38QN=_['R.[\Y)N,ABS$>)Z/RRQ$F
M51$FV2,>X9$A8>,W3O(WMI$Z-C(BWR,_ZA$U_M(U>M(B>5(<;?\C!Y,\AK(K
MC=(I/1-!=I(L*3) K'@Q9."*<@0%&DQ8(^&*(>420GR1<&)%BBLN6KR8,>&0
MA@TG;@S)$61)C",];BPYD5M(;AA7O'0H<PA-FQAK)I09$^9.GSV!SL1Y$^/.
M%2=RGC *\RA3IT^A1H5YPBG5IABMGE"*\0?7%5V/&CG*C>J/LEK)?J6Z56W;
MKUC5FB5[0FQ7NUK-OC5+]X1=O6576%%KQ$K?N'3MUC7\PRSCOH^--'YL5JR5
MKI:_7FZ\&7%@S9[I8O]F[-GSC\B6"6M&W)>Q624G7K<VZV/R8\L_+.=V#;LO
ME,>O7_,&[GBW$L:TC2/O:_R$\N$_H,S^X8-Q]-?4KT^'/?U']NS4L2^/[@,X
M;?*PK4.YCAQZ=^O-LZ=7X@/*>>SUIP^G7WX[>?7^?3AO/OO("]"]_?+[#[X%
M U2OO@'G6P_"_R D+[\" ZQPP (KY!!##J$@(D/_B @Q1 R5H)##<^9CT<04
MB5#B'/)89-%#&7T0<;X21<R11A@CK''' D4L40D>8?R111Y#5,))(9>4X4@3
M>902R25]9!))'I=LD@@I:Y1!S#')+--,,H5 DTPETCS3S#;+_%*&%L2D4P;_
M.><44TX[OU0"CCH!S5/0/^],<T\]Q2244"),$+2%1NU4--%&B6CSSR_MI%-3
M&?ZDDU%.[S2!SC_A@#3/4CEMM%,A3"!U4%%-,.'3456=$U914Z5U5% 9;4$(
M344MM85-2R6BUSF%;355(H2=\]=420TV6%L?%399:V%]M(5DM>56VV]%[?97
M.,;]M84;1$5WV!O,U59==L_]5=UT3;AA77IW.#=<=/-%U]YWZ[U7WX'SW2%@
M@\\MN-YZ\RWUWQT,5K??A6^(&.*+_S5A!W8AKMCCCCNF&&.($TX8Y)$W/MGD
MCUE.N>*488:Y8A=.?OECFEF>1N8=<.89Y)Q3[KEE_YQ#F=GG&Z:Y.>BC-TZ:
M::-[IEGJHZ>N.FB/I]DF::UON*&3HY'V.FRI71 ;YZ23[J3KI,D.I>RRO[X!
M9[)Y=L&%K^UVF^NLD=X&:;N[AKONM>7VN6RV_V[ZAKT/M]N%::0N_/%M'(_\
M;KD!=QQSM;.&W.S*.ZE<Z\;OIMQQR._6'/7'[0X]=;M1[P1R&!RGO?+6;Y_&
M%;MI=]T%VRO?'707A.?]=\=WA\%UVXLWGGB[A;>=]N2/KW[ZXVG/_GGMJ==>
M>QVP=P%\5X"A70?S82!_]_/%7]]N]L&'(?OOY9?_=_G+G__^^O&7/W[[Z0=
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M"M6R?I6M8C4K6L6Z5KC*M:UUG2M9EV#7"K1UKT?(:P4V1=#7)>P5L'\]0@4
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MZ(/?[",VR)5;PS5%W(/?(F1!T!4X&,XZS",Y(FXXVO5!IN-!*(3C+B1= \1
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M]=[B3=U>0\BKU3SLK3@,#CSZK=^L=3OP0\H#I,D1)..4O.'BS=_< ^&\W-_
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M%@I0H0#_?/\(8H@BCDABB28:@&**!KB!A"<MMDB%BC+.2&.-,IJ(8XXX#C#
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M!&4L>J;+6+2<%S_?)2U-F4M=#*V7NP0:+XE&3%\:O1E'9^4P?Z$,8!:SF,E
MQC.><4UA(IV9SX@ZU/^C^;2F&^.9T8C&,ZEAM:I9 ^O5H.8RO2D.K8_#F=H0
M)SJXWO5L9(WKY?QF.1NHQW:";6SLH";9U.%.<YQM'.TD>SK0]HYWCJT=\CA'
M/N'I=GW@<YYPAT?;Z1E/?O(S'W/3QS_/6<)]WG/N L6'/?U!4'_B32![)^A
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M*9[T&5M)O5W_U'E<7KU?QI6?X>6>^8F?[$6=]KE?Z05?<$V?\%77;EW7$NH
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MOEV[B^;$M8_?[@H8C.GI?3-'[_VWCO7PV\\_#T.^>OOQLZ-'+W_]?!?@NR]
MW^!SQ3X$\U.0OP 3Y$\'_OJ#X0D(^UN/0@8KE/ )!2O$$#T.=< 0P@\K-%%"
M!"'4,$$5T5,@1005@%!&&%YLD48;:YRQ1AYWQ'%&('F4\8H8=1@22!QK_%$'
M5X9T4H<KDE1 1BBKO,+((76TTLC_*J>4\<LIL83RR3 =\/)+!W Q4TT)C'1
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MHJ_Q6L[FTB_UBFL2N\_](E"ZQJ\ RRX#H^NYKK#U]*^SIJ__RFLX\"T"TS
MFS %BU &.S$%_:\&L[ 1JVL"([$,,S$>VS "HS#$1FP-G3$6>['LFK'LPJ\:
M2^P9*^P1_3'41C"#..T=6VP=F^TH>[(MJ^T9[5")F&T1H[$DX]$BBP@6RS+:
M[@@C"S.2(.XY^[(E90DH?=(YDPDF-;,VRS+KWC,\TS,]L[.H( HIU;.VX%*D
M>(M%<U*PN-*V@#2U"(LU76]0P]/S)F](&V^<\(M>6S:/F M;.PQH*XO+6#6/
M\-1&_Z6-.46U1.V)3&/491N,6CMPT]@,Q4 VU-@+5R,V0:WP_CZ-5K/P42-5
M"<>V9ONUU\@V4YT-5\6-9DNWX#".:8 !>WN-$/>VYY!QT=@W=1M6<4N.%Z<.
M&Q\/8+ W=R/67276?@.&(*^.($^/(Z>/WT X7B4/:TT/@UN0_; 0EK/7B^./
MYAC7"%D1":G7]U!7<?U6$6'7+G^0*]^0"7$0$:G7#_ERGMN1&'$0%GD1FC.Z
M@MVY'?$1'N$YG<L1H2LZF;,10L\Y5Z"Z+FD2& "ZIIL2/T=8A.42I-O8,*&Z
MKNL2K;OT,(%9L,,27%A9.0&[,^&3N O:4D^4F(T[L>-9/?]9.[TC6D/9.Z:M
M%%J7E%I/O*(UVDJ9]:7%=5(Y/,6+VL-+VJDM=DN)/*U-%60OO:V=/&&I6E^I
MVLYCO<M+O;9MEFBI=F<16[E%EFV'6W"W%^);EV^QE7'G%M@SE]\#7'6)%W8O
MW-T#&'UQ/GS!E^*;=^A+OH")/GXOF(]Q&(/I/HN9%]*=%Y'I/NW;W(,)/]1%
M/Y)Q7?"#7=5]/_)3O]EUO]E5O_:3FOKKF>(=FX_'W>#M/]P]F>&=F@$,P*PA
M>:297I1_7K)IW@*L0+0A&^RMW@JDP+39WL3!WO%5FPP\WZKA^<8YWQE,G,>!
MG/IU0::OP<QQ>AQ\>LS10<T)'?[_!4+_%4+1&6 "=AT(_GK9*1YN6,+?<4('
M/OOC ?LJ],+MP8+I\4*WS\(N_)[J,1\U'  RS)X+%F&^)\,W_)_V49_[&7P6
MQL/]\1\(NL-!1* 8;GP?QB <WB =?L0!<GPD=J$>#J ;6J('BD1/Y,1&].'-
M%Z%!M.%$A"),I$4?$F+-)T4?LB(O_D1%#*,A L4UUF-))*(G_J12_$10+*-9
M'")'EN,GRB)7Q*)9;$4[UF/FI\8\;GXZ4F1!SF/G_\8]FOYJA*-%AF1P'&1Y
MG&3NCT?PET=T=$=TC"5$>D="VJ5-,B5.:G]66B57DO]5HF58.N6#S&5-DJ9M
MJB6 .'&"_]N)%3]6&%Q!,.&)@P(=0EQAY,1$@@<G_J!8\&#&B!DG-EP1,B3'
M$U8,DFRHLF3'E1([&CSYT>4/*Q@QRNRHLZ%,F3@;=K2RTF9-(S6M_$A:4VE2
MI$)W*CD1]024'U&; GVZM&%4* *I)E4)MJ4/J6;#^L@8M>R/JB?**E'[MFW2
MJFFETOV1=JW:NGJM2BT+MZV/P87Q0BELU>Y>*'$%QU6B6(ECP)(/^ZCLV$?D
MO6\%ZTV[V:K>RY(O2]7\F'-AUE'C;J8L&R[KS9P=VSZ=6?)HUY,+FV[->KAN
MXL1C^SAG6KD/(K%SGW9\6K)S)92K,P_>W'=S*$2L-U=RSK?S[__>NY<'7QZ]
M>._>KU]_KWR^DN\RE-Q7+D.&_?3?_XL7('_UB3?@=^<0<0Y_^Q'!H(,RM+"?
M$/L]V* 0#2Z8H848PK%?A!2": *%'V+8X(85>O@@B2E"R"(1$W;8HHPQTBB#
M"1A^&.&%-LH8H8@-WKA@@SH".62+.T;880LF*-GBDD0P>62$2RJYHQ!).AGD
ME"W"88()2]YXI8U+8MG"E%\*H2234,(!)9E?WOBEFU'"026;5#()IYEP=DGE
MFWTRB6>'759)Z)Y[UFEF"X9^Z2>:=9IPPY*2]GDHI)+>$*FEC0::J:1">-I"
MJ#MH.JF9H6I:Z@Z2BMK"#JZ.^JJD.X#_"JNHFI***:ZASMIKI#NLZBJNJP+K
M*;#'WE#LK\06VRRQR3J;K+'1(DLMM,Q"*RVQ+CS;+;/<:@LMM]\VRRVX.YQ[
M0RC)FHONMNNZJ^VY[<KKKKGLLKMJOO>B"V^[_]IK[S0WW#!PO 2[8/"^^.[0
M2<$$HVNP"_NB>R_! T_,[L0N)'PQP0[?"S*Z-W1B[L WN+"-"R4__' G \,\
M,<PDP[S-P"5/8^[**)/,,<<H8YQSPCZ7S/',.5<L<\\H^]QTPBJ#7'31*QM-
MM-5-3TTU#$Y7W<D3/KO"<=9-AUWUUCZ??3;7'&]==MH<EQWVUEMWHG;:P+CP
MMMYYP\VWW'RW_PTXX#  X\K<>1\.0^*$&^Z"#HB[T+CBDSL>.0R/4X[YY8C/
M3?CDF"...3!SCZYYY9=/KGC>H&_>>N<P/*&#ZIK+CGKJM-MNN^RQQ[XZZD_D
MK@/PLF-.?/"*&X^Z\0K4K@#JSC./O/3.RWY%\S!$'[WLV6._???/8_]]]MN3
MW[WUY5O?/?/0,W_^%>OKH$/Z"LQOO?ORX]\^_M;KOW[[_NM  0!4@ ,$*,
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M3=]<8 ,*3N+PC05N8-QTH.#\C0=Z8-@\CN/(S>@XS@EVH.HL#@LNSNF<SNL
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M"\&P2_2QB\*(G\9,W\@XS,ELP\ATS#3L'_=MS,@TC.9B3,M<[OSU']#PS,R
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M)8 SH-@,J$+I200?$)272EBH1,UI4(=2U <!54)##;K/CFJTH_PDPD05RL^
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MW7_QF.53789!/HS1O8EAEX+YE^R3W=V;OH>!W>'S/G.! >KS/HFO^.USOB<
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MCN= #N\<(?NPSA3Z3A#RCOGT[QB*8?E,SQ1B3P/##P63C_T8#_<DSO+XS^W
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M!9UQA9\-6E$<&GJG-Z+Y:9^R-U\0:EU$6GS7A:$^JGT?1J/F]Z+>MZ>AAFN
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MA 71CG[T7+[RE*C(12R.)HRBMQ(4O?S%TX%!C%T @QA3?V4VDR&+8L8R&<+
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M:_YV>]>R#<#ER4_]WB_^:H!D #!Y\6\ R@%Z@6;H^6_I]Z_IEUX LY=[EX8
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M?R,W89-_?Z,U5Z U@X,X"XB C8. B]. 8>,X1#,X@_,Z%0@Z6D,Y@J.!.N
M'!B"E7.!'8B"# @Z&P@[(7@%AM,Z"U@Z"O Z#E ZKX,[F/,Z"G YH=.#R).#
M/9B#TP,\PO,\SM,]OH,\VG.$OT,]3NB$U;,]QI.$YQ,[5EB%4:@ _8"%Z;,[
M\(,^7'@^U!,^\;,^\A,^[*.&[F,_:(B&]@.'<2B']X- (%1!!>0]_)- =^A
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MN]A'-$(3,Z>;NNE7NV:#-O].0W^W6[LE7[Q?DS?]9[PS;[UH4[O-6_-=$S<
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M_A9\;W_]$Z#U3'"#ZPD!@0<<X.\6N ,'[N\&#*2@^138@@E",'H3Q. !*2A
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MK&!UEA&0@ 1/(($;_%*KL:A0UK/^@%]AE>M<PSH -0S@!7@= !8&H%>]\G4
M-<"". ";5\,.0!QZ/>P+Q%&#NRYVKW]5[&07*XX7U,"PF+4L9O'*6<9F]K*?
M52QFRP':TFHVM)@E;6A+&UK7XM6U+VBM:E^0_]K:8M:VLG4M;FG+VQ<,H0;
ME2UPA:O;&JS@N*RM;6O+,03=UO:YRX6N<Z&[@M@F%[C6K6UVJTM:[AXWN)==
M06ME.]XAE!:YUFUN.;2;WN2NU[K.3>]VU2O?WS9WN+_E+GM?8%WK)C>^]O4O
M?^L[WP$;)+G]';! ?MM? !NXOQ'V[PM"(F$+3QC#&%;PA3?,8 ]O."3^]?!
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M,ADS,1F3,HDJJJ+J")BJJ2X3JJ2*,RM #SRSJI)* $)3 )[_BJY24S6[REG
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MVR DHLE^H+BOC"&>]$FCS,JH#+J?V\:T#"=F(DW##+O)[$S+#"42@B2PNRC
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M(&#Z>O;PX\=_OWX]N?K@!=R'7[^_G@IZK/?/@ 06:."!"":8H $,-L@-$IY
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M04=L0DPL0T D014TQ2AT0M8X0R240DMD0E?T1$%$0C%T_XM?_$-2A$1>C$)
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M2-_HC-ZX0]#X0MVO0\Q80WZ<2,U(R=:(R)0<QTW4Q@ !QT2+%@()MA "I\5
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MU9::K*?,]IILN'"$VP*KP:+**K+FLFHM$2W8RRN[]KJKK[7X@LLNLS=8:X+
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MSXL%<92WO ,X[WOC>][YUB"^\B7O?>>;W_WJ]P7B($A__\O?]]: O@;_%C"
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M>O-]F'YZ):YW7PGJJ9_?_<?/SQ_^[&7HG__[XP>_^IWC>MDK8/<,V#TB]*^
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M_\P5J>0$SF>Q,US8DI:PI 70:JE+70P]%D3+12]FV<NA&V,7ON"ET8F1BV,
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MK'K5H>Y^]T/5'5F%CY:W#D^M:5T+\<BZ5K:Z]2O$+XL;S((7MBYOK<L/H?+
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M)BE+)FOG=I0R)I2^Z7%2=8KB<9_^=CK+*&JR**0.*&-7ZH?WZ7RW*( 2*.Q
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MSV0J)SG)E%TBY8= I25.;DE43M(4H/3D*5/QLEV^C!(K.'DN*U"SF?F"%*7
MI"L8B;.3G9SFNO DSC#9<UWH?!>G0"7-51DTH(VP%T)#I28O@4M0$$WHNN1%
M)K%AS6 LTQ>]5.8RL]%T72J]:;A IM':P32F"].9RFC&-9,VM6PBHYC?\$8S
MGOD-9'ZC:M_D>C2<R4UI5$T8T_PE,:Z9]:N1 Y=;]SK7M;ZU;6Y=_^M3TT8Z
MSLZ-;=;CG/$(ASG.R0ZVNZ.<\80[.;GYSWC4(Q_SZ(?;_)&/?=RM'.#<^C_J
M47>[*W0A"Y&[/.<Q4+_Q\QTHR. \# (X@@;>H8.?1T/LN7>##-Z@<R"H1@PO
M49%J=/$CX4CB+#+1DWJ$(Q'EJ.,9YS@<2O0CCZ-<2"HGD@P Y?$@J3Q&=W+Y
MB5ZN)1K17$LO?_F,7AZGGM,H432?^8E\'J<S$5WH9SJ4I13E)J*;P$V*"A.?
MP@3T%B#)1E7WDZ+D9*=+:9WF<&@4I[X>]:Y?2E"N8M.ET(2I*;VJ4J_B%*7\
M)(14.:I6KC+!#D+%*DKE7?"S(CRRA.#W.O\A/E6L6E:Q"I]X6^4J5=2"5:HF
M;ZUK9<M/D\>[XRD/KFE]ZUCABEBQ\/4LO*/>7-=:5]]93_IPC8M?UEI][>DE
M^WG52V,@D]?N>R^OCV5,^.P:V+H^)C'>]^M@$^,]Q0@&+^C_W@6A(-G!(#:Q
MF8TM8M 7F/9'!C!X#0U@UU]^U790-*C-#&SJ+]O#D'9]JG7,9!L[?]+&7S&6
M[>S^^6]_VI"6-OGK&/GCF: 1&__KOY]!F0%$0+>1/Z$Q&Z%)FP@L&[])&[WI
M!+K1FB=P&["I0)290 S4F\5)G+Y1G,L!G$M8G!"D'!4\'<"Q&Q:T'!F<F]#!
M&V!P!="!'-GY&\W_P<'+V<'9H4'1"1W'\1W.*1W: <+0,<+2V4#O29[7P1R\
M>4+BB<+7@4+@2<(GK)VY>9X@O$+RR4(L#)[@:<+L@9XS]!XO=)WTT1[RN9_H
M^1WS@<, BL,Z9!\W_![U21TZ5!\8Z,/O<0#UR1]7N$/[T8$%\I]"#*!%7" W
MA)_4$43XD<0!>L1#1" =8 <(@I\ @L0*(B!!Q* (4@!<L"!<N" *6J$34J$7
M6D47TJ 5TJ$1@B%91"$2PB$;RJ%<3*$>(B(<@B(?:J)=!$9@_*$B<J(@RD4M
MLB(LNB(MBB(%**-EG,8VRJ(],B(\JJ,XRD8QRJ)NW,8JPB,XXJ)KQ$8^_^K&
M;Z0C0*I&."(D,R)'06JC.=JC18I'3:)'-/*C>]2D,,K'0KK'34*E?DPE3AI(
M0@JE5GHC6>K'A-1'?4RD5SHEB)Q(5;*E67(EB\Q(7WJE8QJE71*F9*JE:+*
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M<J=U9==U0E=W59=]A2=ZIM=JO1=[^M=[TF=\IE=XC==[XB=[QB>#R6>"S:>
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M2(,DW+P:7 7H@80(R,CI*X9(W(=07(F P<:A2+^"",$:+,;]*\CMZ\)6B),
MB9($R9"@W,PY;,VYG)*4 \5^"<W=G)<('=#]7)D,W9D8W<?RR9NL29F<;,D&
MW=7)G=&];)[ K-C5":5PRIO,R=?1;)MHBJ&X+)TL2J]$BLLR2IJD"=[=":[
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M;K+5)IONMM&V&V^XX;Y;;[WY;KOOMNMI^PC X2[<\,$)QQOQ([XH'.W"'=]
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MHN+)G!3J)W72H7QRIOKI)A5*H1;*"F[R*,-IG@Z*IC8J*8^*IL()*:V2H'Z
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MK,= +$$3(D('["$*@D$EE,0R+$$Y3"<PU$(Y B(V0LD@8KF,;",P%"(\@LF
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M@@TUO"W>I.TYHN,VI@,X7"#:Z&W=*",ZH'59X8W=RH-:JS4]VJ,^^@T]X$-
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M?OHZF _^]],;KT#\Q,^_//TP*"#]_-%W7___M=/!%>K7O?GI#P8#S%_^HD=
M 0(0@/ICQ_\ ., $'E!_.M"! O2W00'J;X 8!*$&.4A"#7IPA"4$80D[V$$'
MX,(!&XRA!!P@ 12R$(8;I*$.-SA#"2C ASD$H@)VB,,?[I"',@RB$7W(Q!\.
MT8<TY&$4F3A%&O;0B1)HX@^SN$4K8K&+7&2B_QBM*,8F9E&,6Z1B&,MXQC:Z
M\8UPC*,<W;B.+!;AC'7$(QW;: $]GK$(=;RC!/HH@3SVL8YYS&,A%TG(12[R
MCH0D9"(7&<@Z]A&0$L"D!=:AR4$RTI-]#"4H!\E)3FZR"*(,I2E-2<I.;I*5
M%CCE)E6)REF:,I;K2.4M=QE+6ZK2E[/L)2Z%2<Q@%C.8N43F,(\I3'7$TIG%
M_$(LI3E-:'X!FA:@9C:=>4T+.%,=W?2F.*'Y37%NH)H6..<YP>E-:9XSG=MT
M)SR[^<YS7E.>]P2G/O/Y!77"<P/\W*<Z[SE0@!:TG]<T*$#5H5!P;D"A_83H
M0Q4J481.]*(1Q2A%-_]0CXMB] @*[2A()PK2+XS4HR=]Z$A/"M*6JG0#+HTI
M3&<JTPK0= ,V/4)+<YK3FQZ!ISB5Z4]UN@205L"H12WJ48]:5)Q6H )%/4)4
MEWI4G5+UJC]]ZE"U^M2N:E4 7@WK4\$ZUK)6 *QH/6M9]:#6M*95#V"%:P7^
M0=>ZVO6N>,VK7O5J@+[Z]:^ #:Q@!TM8P.[UL(C=*Q8&(([%OF  :AC 8P?@
MV &48[%8$ =E)3L SD[VLXVM@6='^]C*5O:QJ!4':B5;@]6ZEK2L?4%K/3O;
M%Y0#M;6];6MO&]O6[E:VP/7M"W ;7. "][:V'6YK@;N"Y;9V"+H=;G%K %W_
MV5:7NL"][G"1>]GF)@2[R<7N<I4KW1<,P;SC->]M5U#<]4K7O<O5;75ER]X:
MU)>]UUT!<NEKW];JM[K-G:]ZAW!>  \7OP>F[W?Q6P[V?O>\#HZP?1><D 0G
M9+T3;BY^]<M>#E=X!03NL'T-7) /?[C##NDPBDN\X@V;6,4IAC&+9?R0%U>D
M(0:Y2(X_S(V']/@@%WD(D%6,8XS,&,0ZCHB2EQP1@M2D) :)"4Z&P!$G._DB
M&DD)EK>LY8+PI"A9#C.7B4*4+ -%)U7IR44(4Y4V1X7,2O$)1XQ E*/0^01/
MP?,*T(+FI=2YSATIBZ#Q3)>@]&7/> :+5?9LZ*70_QDR=.Y+HB'=:#PGI2V,
M!@I4C'#H3FNET5XY@:=%W>A,%[HQEL$*:!#CF+3893#$B0MN7@,9UW!&-$O!
M3&LB8QCG<,8SI;$-<7S=%N'8IC67<4YF9E.9RNB:-[-I#69X@^S(''L^QS[.
M9W:C'=48AS;&:0]O^I,;U13'-M]637C*HQYL7V8^Y+&-=>2#GO5<1]S3&8]\
M^K.>W;R'W,<Y![GY(QPES,=#^"'/A.(C< A9*.'M.9##\X.@@ =<. ^RD,(3
MOA\1">A"*VI1BTRT'Q=I:$C'2=%^!$2$$[5\Y3=B$8"(1/.:VYSF0B#2I"24
M<R+T/$I'6M*7F*0$-0$=2O]+@A+2?]XEH/N<YU"/E(2,%"80*1WJ2$_3T2DU
M*";]:>J#,I+4VZ3U0&%]2T+HE)Y\WBI$A3U.4_JZW+E>*3ZERE%WCQ01&G6G
M/^V]542 0Y[ZGBN\&PI7@2?5K'+5*UXM*D^-YY3C6W"KQ5.>\;0Z5K$H/_C+
M>QY6L_H\KIXE!&S!85K;>E2Q&+5Z97E+]=ERE[=>CZTR8>M:WKH]N8SU+'S-
M7EZ[]]>]KN4Q@@UL^ <;&+Z*O["%_2OYS>^7R#(F_>H;C/K0CQC'\H6Q[K?L
M82>3F,NX);2'@7_\0%/;^!7V-FXUS&)8(W_*.H$TDL6_9EA[?_Y'EG[R[PQG
M[=?_,"\#,V2S?CA3?S< -EU3?V0S,V^S#3]#?W-S@ -(-$WC.#03-5F3-3MC
M-6E3-FWS-V'S@&TC.%>S-2"(@H&3-"LS-C1S.'-3@B'8.'N3.'[3"3-H.#6(
M.3?8-I.#@YPS.'1S.J,C.J)S.9\3.[Z3.;WC.:P3A$]8.E$8A;P3.\03.Y,#
M.LC#.J6C.L63A2YPA6(X/+KC/5N(.V%(AL.#.>TC/;]3A5<( ZFC.V*H/&MX
M/]6#/]/C/NF3AO?3/^U#/NR#/_TS/N!C/X?H/PI4._S3B(H(B%=00 HD0)(H
MB1K$B),8B9?H0)IH0)CH0(X(B@BD0:X 0K6C0I<(0JZP_XG\HT*G"(JNL$&,
M:$"@:$(<Y  CA$*Y&$.\.$0DE$,O)$,P)$1.Q(LZ!$0X)$1:A$0]=(Q3Q(P.
MT ^\:$;/>$76"(U U$/96(W7>$8TU ]HU$9D1$9EE$9I=$;G6([HN$9LM(YS
M](YMI$AQ)(]NU$AW)(^3Y$:"=$F/E$EX=(^0Y$B2%) $R4F?=$C[.$JIY$F6
MI) .N0ZE1$L0"4BE!$@68)&#1)$7&9&#%$JIA)$;V4L=J4RHE)$7V4O)5$LA
MN9*YE$S+A$HMN4S,-),T69//1$S8)$XZ&4V]1$W2A$_9%)1!R4[/)$WL=)1&
M&4OVQ$W.M)3XQ$Y.^4_I=$]3Z8Q0_T10!%65!G65&Z!/"[50%C65!N507YE0
M%D51&351%I51$966!L661]!/*?52_=11'>51/O52);52,T52?<F7?WE3/=52
M0I672H530968/P532G54&]!41#54,&54-L530Q693Q542=55FGE58B566156
M9#6:946::F56<=56:L56 B  Y-":9X56 O^06+19FW=56+B9FWY%!6"@!&Y
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MLQ6 W_WH;W_Z069^HIU__@)3O_J!UK*L&<UMZ6^:LVF9L'F: (2;M)D:N#'
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M\QF>49JFV9G739K695VM:1L!_PP:V(69UO6_?JF<%(3 K1&9P/'=RMF;WY7
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M)=9XXX4THK@BBR8J\*$$*SJ BP,7#NGBCT$&J0"12TK@P))0\L@CE$C_/JG
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MG_:M'[RPG^XVS.[&'^_:'\&D3/WU'_[)7_N-#,?,C,P8[_XQH/W!# *:#,^
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M$390CW:V\YW>Q.<]Z;F!?P[4GP4E*#X/*M""+@&A"D4H0QT:T88>@:'_%=B
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M8\AX*QQ9XKARX".6(UMN_'G#9\ZB08N^? 0UY\\5.I-N_?EQZ]6T9\.^C5O
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M*YDB2!XRDA?29(P@Y"(4(;*-$S*0C0BY(U4FB)<7DI&.3&0C8+;(1$AR9I%
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MT2MK.FL7%'A6?9:=+?UM<UG6E/8T2S,T3",U0<,S0J,S2=,T!\@T8L,N8R.
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M/M@ZZ_N#[2LXYY"^I",ZEQ._;A,\87@\]LN#OC,Z5^@UP_._5/@Y6/B%O /
M!WPZ:5B%S-.&V0.(R",#OD,\UF,^^BN&S6/!P!.(]/.'XJ,$[ .(I*A"[M-!
M_Y[HP29L/O;CB(L(/@\TB06DPO&#/XEH12P\0AQ4PAET0+#X0QV$03X\0Z^H
MBQ\T03$T0T<\0#[D03N4C XD0Q^$Q%#DBMGH07E(B\A(!%YDC$A$C$>D1&C$
M0T%D0EI$1BAT14ODBEIT1VYT1=@8QN58CF:T1FG$1FF,C_*(0OJ81WN\QSB$
M1RB4D.@HCXW41YETR'WT1P0Y28(DCY&D2)QTQY0$2=Q8D9<\2A")2;0$D9K,
M2A:YD!HI2A4IRI\\3,2$R@[ID"*YRK*43"RI2R4I3.=D3;(T3<A$3S*Y3;H<
MD^BT TM9RR89D[:4RSGIE!R%DY_T2FF)E.?DS$B)3O_Q)$_%K$[YE,L5Y5#6
M7%']I)5'^93]1)?6_$YL&5%BB<UTN5(6]96%.5$&]9=\.5)DJ5*=\,X4A5,&
M%5,P-9A_.0U"9<\H!5(T553_?%5--9B0B="4Z5,)/9F1*56165=X:51.954]
M-5>9V=!T!0-WI9JHV5=L==$:C5B7Y0*0)5B1952LU5BTZ5:,)5FLZ5F.Y9JV
M>5DFS5C 25DY?9N>I=,Q/5DKW9Q;E9RGA5>NY9W+Z5FI95E!;5K;^9RZ]5I-
M'9]%/5M&+5R8Y0"HY0K5!5[ 15SQF5UA'5T*,)^^-9_295W^>5SI)0&N$-98
MK9\%RE[\2:  ^J#Y5:#X%:#_=@U?^16@$MJA$GK7@8W7@IU?Y=4/'"IA%[I@
M(IJA%:9ACEVA&8:BE>UA)MIA)F9BF(UB+JJB06:C)DIB-)9B-!JD*QICJ/VC
M0#IB/YJC0[JD2R;;4;:D5<:C"E$06;9FN<UD5#9E(W:E2OIE$@%FQ5UE8)9F
M'J%E9SH29HJF<49G>182;0K=<G84TVUG@.H2=YIGA_9G?RJG4-&GBR9I?DH6
MAEJHY8VHH$;>99$6DO:HC7H6[AUJC=II;0%JENIIKO871W"I7[%J_@T8LE85
MLJ9KIZH8N.89NM:KR989P*9LSK89LH&KD\&KQ98:CY'ANU$:K'%LS39M(7X;
MUK:L_]JFK"/.;=@&K>"6'./VK2\.'>M!!6# #6  !MV*X]P*X_2&'^,*( 0W
M  %7 _O6;P B(/C1( H"Y/IF(4T^K_O:(/=:<09"<0[G(53N< );(OEQ(RB2
M<4Y2)S9B<C;R)$*"Y3)W)SPB<CD'<@HK)F^^(BEWLT5W<R8')W">)DI7=5/2
ML#97)U_7YBQ+L2Q+YUYW)722)G&")C&'(X "LC.7=8?G=2L[*7X2)6)W*I+.
M>"N;M%Y2=TO;Z8)R>)>2=VQ7*Z4.*G='*JC^>*T>>*L2=U K*U4;M; >M6'+
M=Z_R*L:">;T.+HQ'>;_N*Z9'[*$'>LGB><*>[-]2ML>G>_^[[GK.DB[ULK>Y
MER_/OGK"1^WPXBS.[C =H^V]]WR]U[C,E^WN<GS[<GP!XWT!D^[3\N[91WSS
M;G[+YWWD%WWPES'Y7G[31R\N [LI,S/<ON\";S.R6W\!N"]9<P)G _"R"_!=
M0X(.[S908X*_F[L/J/$2'[U20X$9'S5H\X$;.#2(,S<9&(&'<X Y.#<".#;9
M^[IK8S0S?X,7^']X,S67XX)]<S<MS[\H;S@FOX,T6/&3 [_]B_3X>_1#*#FV
MDX3)LX-*N#AB2/4%/+]2+X1NX_2W0SJ.PSF[,SL(++^W(SQBV, <C#IM>/8C
MK(80W/9T^,!P.#R_4SV(>#]"X(?_AV@^ K3"'7R'Y%.+=9CW_-/",6SXC,C"
MD+B'>]^(F$B,"=2)C1_Y(P2++0Q%2UR*^S/YI A$Q,A"M?CY11SYKDB,GI_$
MF6\"TBB(7%S$S+B+7RR*7I2+533&S[B,J:B,7RQ%8A1&P!A%:01%<&Q'8@S\
M9[Q&WTC'LWB-CK2/<S1&S^^-T;^/TW^0D)3(^IB/[WB/@%2/D>3(D?Q'AO1)
MDU20E1Q)>\1*FNQ'FF1)NN1) *G^F#Q*H$S*(PG*$PG*U 3+&8E++PD0-W:X
MV"%P8,&!H00*G":0($&'!1LB?!C1X$.$%@?>F.C"842(!PEVNO%P6T.%'4<N
M)-GPX\$;_]LPCGS8L>'#FB5=W!S8J>+-4#]+W@AZHV30G2>W#27IT471G"YP
M2J6ZT>/-FT.?2KW15*=3GUFSNCBIT^=7K%^U3I,9ENHTGU1WQMWYE:Y<J7#S
M2KTKUR<,O"X S^4[F"]>PU('QQW<6*HKQ9$%4W4,V05DP)DC ^ZDX_%DS9I!
M X,!@[1F5Z0% \,\V55FTZ5#>X9]FK9LV+=QN]!1^O1JV+QA/($-V+.KWL!A
MW.8M6+?QW()+/Z']O#?NY<Z7E^[=G7CW[=3#@[\.'K>"W@JV7X>!?OO[\C"N
M@)\O'[Q[]_7SIT_?GK^.^O3CS[_Z'$C/P/8(= 4]_=!3 +_^'/_4 4 *!9SO
MB@73D_!"!SMDL$,='@S1PQ$?-/'$$R5P0((2'W3@Q!5C5%$"%!58T445%:!1
M1Q-GU/'&'6>\D<<?=^311R2//!+(%6ET4DD)HM3122JGE++**ZW,,LI^HJ32
M2S#!U'&=,,LT\TPTTRR33"\MB)+,(MXLTTTPBX#32S+I))/-*-VTLT\)XOQ3
M C?S)%2"=>(T%,Y$#?V33C\-==."/"4EU$Y,UYDT44KMW-2"22_M5--#+2B"
MTDY1!?540B=-%=14->445E@U!=564U'%%5=:3[WU5UJ#%9978=4!U5A:C?U"
M6&8W@-59"Z!=%EED+?A"G66MC9;69;/_O=9:9:E=UMEOK_766&C3!7?<=;'=
MUEQRL<76V0W@C?8+>LV=5U]\\:VWWGTW^'?@:P7>5QV!_57XWWX1'ICAA 66
M6. C'I;X"'\?KN?B>BN>N&*/*\Z88I(Y#MGD#4!.>>6355:Y I93AAGFEX]8
M N29979YB0UHKJ#BF8_XN><C;"[Z9J%__OGF"I1F6NF@FTYZZJ:KKCIIJZT6
MH.FMM^:::Z^WUN/KKBOHFIRNQQ:@ZW_:=OMMN..6>^ZY#;#[;KSSUGMOOOO.
MFV[  Z=[ "S$&> %PA/'8H##$T=\<<3%0?R%&@BO0?+&$5>C\L</Q[SSR3,7
M_85RL*@A=-1'_S_]\-4IG[SUP\MQG?7727?]=-QM/WWV%UQW77;?@<\]^-Z%
M]WWXW0=88??2EW]AB')V/WWY(7)W7O<A>O?]^7*RS_[WWK,_7?85>G>^AO*U
MOY[R\K.7??K=GW]A^?31G]]^ZLF?'GKV^5_A^_9]3W[M*P?]!C@_[CUO"-#+
M7OGH!T#T0<^!"%Q! >TW! <:<((/+.#]-KB"#5)0A"$$X?P<B,'YH;"$)'2@
M$2B801>N4(8FS" -9PC"\G$#@4/@!@Y7T$,;XC"(&/Q?#XOH0QP:\8<93&(0
MEWA$*/(0A%($X0F(:,45G""+6[1B#T_@Q2%T,8M>).,8S?A%$/X@C?]G+",:
MW5A&-:[@!R<P0A;KJ,4YXG&->XQC'_F(0S6JD8YRM.,)3A!(0LY1CH=<9".M
M0$A&JM$*=)0D)5?PR$ >TI)6R.0</;E(3WJ2DH?DY"$E&<I+HI*3<CPE*U.I
MR566T@B2?&0I?]!*3G+REG-4@B%W>4M2_B"7M]2E*4O9RUX"TP<G6"8O3X!,
M93YSEU#@Y2VIN4PEW+*9R#RD$J[936;^ )NF[*4/RLE-'XCS!\G,IC?7^<QP
MFI.9Z'RG/.M)S7/"TP<^@$([^ZG.?.Y3GN84)Q3VF4US&M2@2L#F.@UJSH/^
M$Z(,3>A EUE1;V:TGPN-*$,IZDV,$O2@(_W_J#@_"M&)CA2E)TVI.<_QT8T2
MH9\3A8),7YI0FRK!HRG]Z#E\0 27[A2H#!VJ#VXZ5)DFM:8O58)/7UK3ID;U
MI3)5 A%DH%,9!/6E4ZUJ3:$P5:A.508R "M2JWI6KI;UJU$=*UG'VM2VQC6N
M5JUJ7(4@5[S>5:\R:,%8^RH#.(S5JC(8+&$%>]BQ!M:P@$7L7P?[5\CZ5;!W
M)0)E$RM9OF+6L2;(;&"%0 3.@A:PG&T!:3N;V<CV5;2B#6Q@^]K7P(+6JG#@
M+&UAR]?:=M8$MP5M:4=+6!/LU@2T96QI;3M:X<86MKM%+7-;<%S;[E:UT7VN
M"7I+6]NZ=K0M*.UK_YW;73@(P;C#%6YWI4M>\ ZWNMS=K6W9N][T<O<&NYWO
M<UL@7OMFE[[)[6Y]_;O?%OPWP";807\)K-X )[@%!18(?;DK7R$4N" 1'O!\
M"PR'">^ P03> 7TC?(, :UC#!AEQA4=L H,8!<4H/C&)23QB&"-$QC!>R(QK
M+.,:7R0C(KYQCS5,$!S#."0UAL@T@IQBF.S8*#O81D8ZXN2(4$0B"YD)2*3,
M$2MC>293OC)&M *33ARD)65QR4UP4I"GE&0@%5&SFJ\R%+;,I"(_$0J6.7)F
M.GND)55Y"%+F F>S3.7.;[FSED_R%A?$I=!UF<9AN-+H1!\&TH&A2E_ZXO_H
M2E/:+W))3%P8PVE0 P8REG$-929SF<^<&@9QL4RK2^V8R+@:,*H!3:U#$YK1
M8"8SNI:.=%A3:^8$!P:MR8QJDF.<R01[.-B!3FFT(YS=L*?7[)%-?*HMG?5
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MMXKUK,U;H%K.&OVVT"7Z;&WK7JHOE[OHI:W7QXM?\L+7ME[?L-H#+/>VAQ?
M(!9[A.$K^/.*UKP@YK"%$6QB$9/8R)K/?.=O;&0A\]?&/D8RY[ML93$[&?>W
MW[*5W8QEXJ?9^(6VLJ&5'V3B/W_44E:TI0E-_D$S6OV;1K0E*&UJ[<]:__TO
MM:H)&[+Y&K,A0 $LFP+L"9JR44"S61NT$?\ P8E "80;OZE "[Q O)E #9P;
MQD&<Q"F= 0#!QOG Q5F<&E #PBF'QJD!$S1!T!D=&$2=S\F<UCD=R:G!R9$=
MVMG!VZF=W,'!]]$=WSD<(3R>WD&>X@&?&J@>RF'"XJF>\OE![5E"(TR@("0=
M]V$?*GP? T)"_-%"!/H= =)"YW&@[G$=[SE##QH?]RD?+@2>].E"$;(?]*E#
M-\2@,^R>]C&?,S0@%-JA/C2?+Z0@_$$?!RI$,[S#"<(@0YR?#GJA$8I$$I+$
M%#(A&H+$%7JA&MI$3M3$2T0B(3HA$.*&!GH!)3)%(L*A5$Q%)P)%)VI%'UI%
M)")%;M B4D0C4GS_(BV:HEW<HO^QHE[<16&L(E"L(BT:QF/,HF1,QA4P@F,4
MI#CZH2^R13TB)&NT1C]B)$)R1D7J)$)Z)&?DQBR2I#42QT_*)"O@QA-(1SJ*
M)%!J1V&2(W/$)%$")F#BQDGZ 7P\I'VT1WJ4(TP*2&*:)6$J2(),QX(DIEL"
MR& R)5/Z)834I6%*R$DZ 2C0I&3:I5YB)DW")WCRR&2"IW(R)&[Z@6^Z)6@*
M)VGZIV]*)Y-$*)%DIHNJ)W&*R72:*7VZ*'XB*)"J)WG*)H,2R9D2J7(RJ7FJ
M)V1*)X1:IYWT)XKJ*)E\II6:RITBJ:%DJ)=4J:=$*96:2JZL2J\\J9L2_ZBM
MI"BJ@BBJNBF=\BHBR*A]2DMO4JJJ!*J@JLNH:BF=^JF\;"IS2JJ>NLNV?"J_
MW"JIBDLE("S##"NH(JNN:DNV#*NF\DO$/(>D0DS"@JK!RDR\0BS-9*S%LBK0
M;"O.VLS1[$S--$W,@H/#C"S/["OKDH'/.JS8C,W,>DW;M*K7C,W0NJS,6BS%
M4JS7D@'G$L[;"L[@#*S71$ZK.D[4:D[M$J_A.BWC*B[<FD[K$@+FTJ[IY"[
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M#>VJC\+:U#) @2MT4$"!%EMT,4897:0Q1AT<D*#&'7GD_S'''Q7(,45]&FB
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M^@?<N @]/X[?]@XE(L+OWHWIONCDVJ[>GJZ&5G.'P,U];DXC?@+K>DZ 0LZ
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M^-V7A(]^0DW/4:2<)2\50:@A9'-2^ N '"MU:6WDS]+;V+\"_T/E/W.<XP8
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M5]XT_T.>^5V?JGXJDMX?]GW?HY9I,ZLI#FDS-H?S_'6>)TW1$UD +:'2[6T
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M1BR4H4%@AF&3113VH 8F O&NSQY$-DE4AA@C=B;2;%3GAER A%Y$A5JO8E4
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M*0M +KLRC8*!&R !$GC"Q7N"$KA%Q=NRUT$\UMF/,!<S_QRS,"?0  D0 ;U
M+[] RA]0 @W W7DS#)UII]K?%5EJ^H%I!!$1F)HS*TU>Y7&?X*&JFK8I+:$S
MK)*ST#MS-:\20J=I)1'2F[Y1EWX!3E)IQW==(EU>!&@]^X!2USD!*MURC3K!
MEG91B!_*T\/J.#/]WVUJW+/I&7$ID^*=U3/1^ 6]*_6\+&DTFO^BO>@1D:C6
M$-]'?>"+JBQMWN#WO:R:Q4T'JT\CTS#UTN3OZ@\804\78#)-?@&Z!5T4M6/9
M-CUIM;$^-SD5A#FUZT"%DQ."4UW0DP^R+ ZFOA_:T^I7%62-!@S.A&%5K$JH
M8%/(TT0T%&3E_E</(21N4[["DPY*%%)UZP821A%L5'C ODH1KQ2L80C6*5:I
M?<:L81F^*S9@>\9JX@3\PJ8WP=-*5BPG@5DS!6K3Q= 6OUEYA^T/_PDVA6G@
MMEH !+98$PCBPH8M$3:""Q--&+AP0D)*#B/&$K@0%\&&%"<H++CP(L2/#R$^
M3(AM8L:.E% NC/5K(ZXB+$EN;*APH$G_@C4+*MRH\2#'E@P9HKS8D"1'HM@,
M-&UJHH4,."9DM!!25:H,J%NA8FUA DY6(EV_AHW:XFN+J5''JJUJU6G3!7/I
MTJ4T]V[=O'GKXO7%MZ^F!7O[VOU+MQ3>PG87-UYP6"_DPI0D]P6<>'$=P(8W
M\]6$V?%@RTGB-DW"N*\OO8[O\LU;&G;LIGLL7X-]371MV*<54R(M&W@5RPML
M R]MUPEL*<9+T\Z]@'ETZ0:N0:9\=\_TXW0A*]>>!+!V[IM#T\TN74IHU9-7
M(X^MV._>)N_A%X^+>S&E]X=?:X_MO"_[G,*O+OH>:VV!W_SC[3G4X/LLN=(8
M[*L4_B+<;K'E__PS $#%!/3/P0L'I$N[ZP;;4,(&"_-%L/)4A*_!%LFKXS,7
M&2.OL1H7JQ"PSAP4#<'AA)R+Q]YL+(^OTA30X0H=EE1  5>:;!)**I^\$LHL
M';A2ARV=5  7!R1P10(HQ51  C%+TZ<!?=ADLP%-6FD@3C?;O//-.^?4!$XY
MV=2D@3W[O!-0006ED\\_V]0GBMWTF2^N//6IHK0H]('-$"K>W!12_S0E=-%.
M4:1NTS8_I&Y1/"E%L0HV]VS@U.D"1=3-4Z^954\ZY\33U39CLY375#=5T*DD
M>GU35.DR+?548'?=M-'2FK#SS=CN5'74*G2%LX%DHUMVUCQSM7/<5'U7C<Y8
M.W>]]EA<UQ64S=B8H!;/.D.%;5IF;^N5SEBE"Q1.9$=URMD[3R66.6WAG)--
M?YDS5E<\!TX"7NV$C8W;-\_UK]4W:W$XX5GY?/70.$4FM$]]]MP5T#]5-KE4
M:L5E&,]6JHVK @$JR'EGG7G660!R@/Y9:*#U %J ?_^47IKIIIU^&FJHI:/"
M#220\.3JK#T!H[2LD:!"NZC%'COJ =08X(4!L% ;;;7%J6%MN,6).VXU:FB[
MG+733KN&M-<N[8LBOK @@L"_,-QPP14?O/#%!2\\\<@;-SP""QXGW'#,'8\\
M<L$U[_QPP4%_?''0"7^<<L0]CT#TS2.8?'/.5T=]<\P_1QQVRC=O/?3>:Y]\
M<L839SUSX',W7$2G?$^]"&\-:*+WUY./2XH-#K] P]*H.#XV*@Z_/ONX&%]<
MNWI>MP X*1KXWGFGJ%C_B^D-D&+Y(KK__@OL8QM?=<F!!SUWIV,>Z#H7O-V-
MCG*V>UWN'F? _L5N<95[W0'_#_@YUPF/=E]@H 9)A\'>$8YX&5Q=_R1'P!%F
M4( 47-[K E>:'YS@!RN(X0MIN (KR%"&1H A#6=(0ROLT(8R_.$/9GC#TGAD
M BSYR4 V$HLF1N0@$[D)29A8$HV(1"E0-,H5$1*4G=C$(]C(2$P(0I.%*-$E
M$1')3T[B1"L.Q"=67*)16((0+IJ1C -1R1=W A$Q6O&,1OF)&@GYD"X>925V
MI"(2)V"0G&BQBA#YB6R4X9\F!,4F"YF>$]9X'M@XH0$=<4+XG'))DVA'D+&B
MPD&P80SG%20G"I&?$XS!2N=Q\HH3,,XR6"D_ _@$B2S9(T3&V,="EJ0A36P(
M&GO"_Y*10,2,SE1*+/;HS"<Z,R=LI A)BEE&.U(D$;] XT"B*9 F9L2-=C0G
M1^9(2(.\DR+.9 DEBL#$7R0EB7%LI#?#"<=!9I$2W70D1[A)2#7J,9])T4]<
MA$ 6L%1E*U\A@@R$$!:+/A0M51$"6C":%JB,92QP2 M$IP*'X[AF/9:I#'QP
M=*26MH@]/VI/?F9Z)" AZ3F4T(1F8*12&YGH1Z0T@!-Z5%.6]O0Y0IW?-;#C
MRPXMP)-QB4Q>$&: S<2*J=A1:D]!=A^^,"%]>\!.5:G3H["VAJP#$BMQ8M,$
MT!1(.6NE!%;S AKC[&&M_K)+'<1#I)WBJ*CFB0Y3C^H@'_\M)E9WJ4-CR)J>
M 'V2,' M#7F,0UA*[(&LIR',7"'K"\PL%$.E:!%6U[H I1(6J8[IZH;P E.V
MWB8OF#609+TJ&MG"9CBG(NI<Q&-7X,A5K_&!T5MS2E/6T'0OKEV-:Q8;&J!2
MHKDO@BEE/AL9P]@TL#;-#8*"1![0-@5*3'+2E[C$I2LLZ;Q?^A(N%+"E++WW
MO6=*TWO79#*;98Q.>&J9L&86L(@MK%<T\^^V\CLGAIU*"OI 6*ON%"WW70HV
M"FL3H!Q\'S=-2JB&R%6;*FQA-U&A?0:PU+' 6BEUW4Q"U[CPQN)2KP;$1L4K
M)JNX M5A$=\W7/1BV'[U88A]"6O_P@ S%<;4U0 ;D\I-52 KKUC<E N_3&#U
ME1F1P_7BW<1X4K+)D\V.C&4E6^M-#+-9O1@6,W,-5F9M&O.8TTPM-N<7PJ6Y
M1IE3]2P.8ZQ>-AZQNF#\Y"_#9E,,:W)3;I7DM"(93T<V3<?^+&<UGQG&';N&
M\]*UJ"Q+BPH=PS">Z13GZ$P9T$7V="D+?6G8"*NJU]!T%< &FQ'#N=/7&K.L
MW07K3AN87=N*&<GH=6%>E<9GP>99!?3P,Z(-30#%UMG1*D V9S^[:=&IFM:N
MAC5/;*UKUD:"&Z8#;6]#C6UN:YO9[H:%&LP-;>46Q][:QNZVH?L%-2A':2PP
MO'H?L'(F_[2W!N]=PB*PD(+YYAT ]2WPP.4;@/TNW<(-'D& )S!QA.LW A=.
M<=DE_.(6A[@*%7<^R(E0WU^8POXB&+@&^'*HG!NYM>Y=N TH]7*%VV3$#R=4
M8T <.$XX7#TNH$'#R09Z$P=. TK7ZM(8/ )&=]_F7@Z;FX-\@QP?G.04[G/:
M-9SJ_7-@U#>><==5_=]>CU[AL)Y!KDO]X!:ON,/W'?8(UOOL!.?=^;HN.!?:
ML(8SA"'>8;AW*\3P[S8,/!%/8 3"&Q[O>"\-10R2QCT.4IM1-.82U;C'BUCD
MH'U$IQ\G$DEN#H4H!D%*(QD)>:6H9"B/).1&0D)Y*&9DF$ AY/]0;&*0B1!%
MCRVQB#4M L\T<@0FQLPE%#$"E,Y#\?:F=PA*#,F2@<7ED@0EB$<V&<>7"%4*
MM:0$'+&Q#!C/_B#>JF50&L\4IW\3&[_PUAXR.0%CQ*:6'9F^TIVRS^D#G9$3
ML')I<+F3@S1DC!Z))QZ/G4HBC%#O(1I/(HSOCX@/H8[)][A()5P/]^QO^H;I
M)PA0 1MP]8P)]"S0)#P"CN9)]A)" 5>"(?Q)(8:B\3(O!7TB]T20]G+I 7?B
M%U;/^BS"?N+"+!KJ+'PP*^!@HR#J++P"+$R "(2 "$:*"(0P*J9B"8/0H4JC
M2'J*/"1CI8Y+N.:"/^JB"E4$I2(KIG[_ZD7RHPO+D QU!*C0\$5@;$4Z@Z=V
M9*6B:D2"Q+1F:S#6#S $X[M,PTABHPIZI*KVH HIP9>20*Y*ZR[\Y:DHP7D*
M0S; 0R^"@Q+V0GXFXV!ZA [G9S$B,3=*X;)@+"\TH36$BC;$<$B,BK/2)Q ;
MHZ6>PSKPXA(;Y+(<!C\L$3:8@*;P\$1B(SUZ1*D 9#VFAT!(!#8V8Q,-(!!=
M(U9B"A7O N5&)3\ $1AAHT-6L;;TPA3KXB^F1Q<98QMQ)!(UT0U=RKA2$19=
MP[EN:C5(T:CH@A1I!+!<I$AT9 'LT4BV:SS*XPP=(Z5"0TF<Q$K&2P&HQ $&
M,KRRQ!7,)$O8_^M)R*N]RJ2]LB1-)*"^ZD5E7.5E=@77$D5/) 7(<,S,CF7-
MA Q:'.5#2DW!2J-5NH=?1JTI).S"JDHFW82L&"Q/!@U5#,564F8E)412W 3&
M'NU4YH57]$&H% ;*>C)88F9A[D1>JNQE8LU-CDQF8#)3^,32DE)<O 4G?PTH
M4V;_(H57O"7!@O)7-@4KJ4 K+RPI@<PIX=)>&L8XI. K0;+-\#)7[NM77J77
M-B56ZDP?;(57; R4CO(M):6JLE)FVB<*CC)6DD!3G@PIP8Q7JBH)M(5=!@U8
MWL3&G/(GX\)8V,Q-O)(R[07/AL51CC(M%^4VJ+)-!@TGQ:Q<H$PDP_\,-S$R
M7-X,)'53U%"L*7IF9X8-V7H&:7(&V00 :;Z-.:.&.:9-VZS-VK@A+J@@.K=-
M.II3.P=@W-*F.\UFW/2&.]=FW-J-.]WM!;  <$"N?T#(@7CG@/0M@QY(=^IG
M@&;G@8B'/B6(?[@.@2S(YQ:HXA+HX4:(<OSSA.@S00&T@8I'Z^KS@A)T<>AO
M8.C'@RC4 *A @ SG D@N<B[@Y*@@"BQT<Z:G%1AG@F3#>PX4=63C@RK'>;SG
M<R+ 0RFG 2Z "IQ@1%\T<"CT1#?T=T@(/OWMXB#(ZOC'2-?N2#<H[@"4/R6'
M=U)([BS.@1STXJH4Y#"GA$!H2"MH<FY'ZKS_] M*XX9TJ(B$"(=H"(A^X(:(
M: 7,M$U?Z.]V"(;:](@V0IAH\/>$+R.^:8_PB2;:3R=R:?3Z=)#T":$V#XN>
M"//\K_C(Z2(:<(I$(I+Z:)"L:?GPB?&VR/&$ D^+8(QP(I?R%$\5B8N2@HKB
M*8P.E?(,28N$28R>KRFDP(O(R)DV29*2\1=64"2F)_K\J*J6852Q87I6Z??,
M[XA*XE2,U2&2"1N\!9>82#9*SR&J*EH-:HV&SYMX(HT48I[TB9DP(B2*R2-*
M]2&D:%M#XELME8]H<)TR]?>4SYNPB"/J:/.>B/*<M8OV5)H0:@1%<)^>J +G
ME8[4Z22PJ)NJJ%^S_]4A2L,$'BHL(-8K2(JDH,(JSB()GU J',HL(BHMK&(J
M,&0,O9!"9*J[/*LN8$JT7"H+V<,.)Z,R#HNE_M$,4^L560-ECZL_Y,P.B6LX
M]L*SIFLNK!6P_@,P-K$8Z<)6 &-I.Q&W^J+$CC$TZ*HPDG$S9(,\3HNRI+8O
M8@-'FE8QL+8P2B'5%F,0782Z9O:S&DTV2DNF;H1F?78!HE96I8 \Z);0]-$8
M179GFZ,Q1+$^/FDUZ(,OP%8O4LV[_A$P\%96K0HU&!>UGL-K]0*OKF&4FN!K
MK9$O1,M6&N1LIW%R"P-:?:2E7E9O4VL!0(,R#$LS:/85U9$\7.ME47$P<O_6
MI][6+Q#CKX:DJ)X1;M512=!+O*AD(1,2O<H+2BI22^(+2Y(73<3$O=;D6(+R
M*%V,SDZL*9M2(^&2>FO%448-8H2RO@"Q9FRLT/@K-8'SP?@+5N1EUNA$S\C%
M5T*MUS T5UA-1Y,@7:YR68,R?GOMT? R7F[CO@I%S=0R5B1%SV#MPL!LQ5SM
M*HWL->6W%=)W?J47R#"46N*7*L57RLSL>K>LT]C6);67S$QX),=R0)[R+^\L
MU/;K?RV-U9A@TL*75Y8U6,@7SMZ$K&(,3QA7Q/Y2@TMET)Y,6 [&UT*S*?*%
MORZE":XA"E@-@)6X*=YGP +%@F'2 ))X48:X 9HJ3"F%A0GT%XHG$X7C4H Q
M$HWKI5!R4RU-V,><0MB&1MEV1MF$QMB0IFAR_T8[^WAIC ,ZJTV0L08)N,8I
MP&"0K<:0C<./OXUMSF9MQ),\O9/=UNW<]B9OT$8<VL;<-+D&CL[?RDX^!RAW
ML&YX" [CZ)-(4:=W#DYSCN??^@V6^:V4[0WADE3C!K1+[],^1_GJP&Z J'3B
MHE$[+J#JXF=_"O1P8@/N4@=_JB[?*%3G2L=%52@VG$#A7@=#GRYR8J/G' =R
MON> -LGM'A2<@9F7R_GM"@A,%=0^XQ/JCIGCY@Z=D6Z6#4YVN$Z4<3GN='GL
M+ A!6QGJNCDN9*CO$&^&9$CO &^&C&"(W-1- T^B7\CPK&#QC,)4]33S)E I
M!#:9+.*;>**@+- %&?_O]@BU)48O$;A5I<$I!+\) *?O]NZUCR+I(B+0!5<Z
MCD[0GZZHH))BD&#O]!AI!'W:_C+ICQ8)G\#HI/_/*!KW>:[AGQ*"(*2YC["!
M0HT!G P*&X3*"7*/)4R1F Y"J"JB\B*"0O= J'4)-A+!]OPH.9K ":A@#[1Z
M]JY9_GXB HA1G[;)K"DU4@5VJYFHBU2B]])H]QC0K_>I3V&5\1AP7Q\P)$)"
MC4XZDP;5(AXBEM#I*'KZK;%UJNEU^:3)!%': 8=/)UPU]\XZ]N@HLS^0]02"
M4U=Z H*/K9W"+(@0HC86+*[B*X8P"M>B!\^B*Z!0HBY*8]%""$1V,5JV,?K_
MT3%V=V13%S)@RKD?PQE=$1WQ@D9\]@MO]@R_<!V;F[::PA"2MBZ243;PHT)Z
MD7I"(QDA$;<$D6OI0J@ ZU2$PT/*T17EIV@C;!)O Q/_PVG]UBZ0-C_ZT  F
MA+<$?,!39#,^]Z8(0[DR9#IFRD1D%C%B<;6D0[\9HW/WT;VE2KXEI*7B6R^\
M$49"%R]87"]L0PHL=P]:<;M8A+CXH\/["C#N.S].Y13UHG3G@A@+8\CA8QL+
MB[]?/!?).Q^Q>PLWO'<+ Q^K&Q]3@W:Y\&:Q7,07H\*)Q HAP\:U.\NM'&WW
M%KP*\DL6DKS4*[S<2[T<@"#?*TS0A"&9][TLDBQ'_[)[ZTPN?],WL[?-X-+&
MTB59-*8TYD6+<=(F3VTD\SM/#J9ES*S/+*T5F/)E>K)[YR<)H#B,@_(T-S@7
M,=+2V1>-M?A\??--@)@RJ\J('SW"_(O*5#,N#$%2^+(T:/TDY8R+&U@*DB *
MKF$R9S+4=#._ 1V ;_/0/AAET)AFKO=B7 U@/!U/$OB_,!TC0UA8; S1#68W
M.GA1!LTHU26!1Y)\<[U8S#C-N@6"%T6H;/@J[83'MC+"ZN3$M+A>K+W7-/T:
M5(U:,%31+8TR WV-NW?/12TD108D2U(KYQ+8AFTXBS,Y>4;9E"UHE+.1^Q@X
M MG:W, -P.#:KF:1,_3CH_^3"BH)."X>VL(M;=#-/#EYD_TF/ >@!LZ&;VA>
MYM-F/4<Y<@!4@3IHEQ>GG0.(@4)H/P5(<RRGE,TNX?13A9A40-UYZ]1NYY5Y
M2&L9/Z=TX"(H2LENEHGY7^S35Q'(6[Z9EO\M24>I>W*GK98'@ZS%08M ?C8
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MK*#!"92P[5F84 JV@@<3.9R RZ#&C 0/8HNHD>-&AQ$/3B@)TN1%CB]9KIR
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MB>JKNZ$0*:M[X@D8S/W NNI(N,ZBZ;SW;CH6 X@#_ !8U## "^(,<#SQRK_
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M2%Y? AH<6#;#U2<K0@H:$F'LI2:C86%2$(H* EJ]$7G^%8JO>"4@LAMD$AZ
M EV#I2+3D8P+T(+BH5IO HF<T8ODQ8V+ EORE2!2HAE#DB!&)%R;$2-^U8YU
M,%YBLF+XF(^]:(Y)TH^?55JGF(OP%"2P,2_D19"?$2/!X20+X%PTYEJQP5#H
M00D,:6+ 05WQH6)RPAK*.%AU (FA2(JG__A:(LF1E$4)^F!8JC$;(VF*LI%9
M=J*)ND$1D"(I/U:35X"3.@ED#J IG&(J-5DJE5)DGZ( $@ I1ZDJ*Z-H5!9E
M66,SNS(Q^B"55 DKK6 QK8*54YDK@@9N"2%N7ID0V#(@L<**!C P.[,S5 ,K
M<:,TBM, %@9LX:)E7V9F2JEKGU9EP1(%?I8=Q48PNK)O@FDS%C,=7W9O :,P
M94E>:JDMLJ();?,JOK80,I-K/].8"[.582F6KV(QFIF7^F"6S(&9U?$S@SEH
MBB-MT0*7U($V<9DX3%8UAB.9K2)9_*9HAZ-EF1DK*P)H4#DKRW:0E[:9NWDS
M%F8O=T,QRP(R9/\VFUJ&+.>V*VU):^1E-@ZCE;55,^B&F?CR-M.YE8A#:J$9
M3UN&-L R,I^99%&YGJOBF5B),.#I,$@CE=$9EI-SGY!##OAI.0WG<)'#GR87
MH*8S'6"0<9X0:<I !;&#!+0#<K$S.[LCH ):/<]3/"AWH<X#/12:H1Q:/35@
MH2^@/0NQ>U>D=78$0__C=3YG>6C71RN:HF2T>'.D>1941S$*1)_G=4@G>[?'
MHG"D/U\413R'1V 40517=O\#1O4P<C$C!7HS= !$1:;F!#O4/2F81GUG0UHT
M'1=0>6%$2,SA/?8SF0K1!#TZ/D94>!@D/EGZ1&D414M7=06DHSP:I#?_FD5T
M%*5*]Z9?"D2L=T9RQ'-FQ'M9E*)"ZD<4Q#Y2%WM_NGA>U$5V.G8M&J,(=*+P
M4TA&X$B+M$B4M$G,]ZF6M *4U*G1)TFB"DH+04UO^$\BE7_"1']KD55K@0M%
M,%4TP83W)U)FH1.X\%/AU%)T>!2V)%!'F$^C=$M"H4Q=883?E*L0>*L!>$UL
MF(#I9Q*RI(35E%'&E%)CD4[;Y!3EI!9TN*VBA%'C1$H<11UQ.!-3RA;VJ%%4
M=5',,88T08OYM%'\Y%_D45+8\*[(A%*Z.JWR2A'_1%+I>AYKT54HU4Q:Z$M3
M$5,,V*H<D5)*054T<4L[!4[>2DXFE7] $:MS_X@3)9%*X%I4)^$53T%+[R>Q
MPQ14+E5+W/H1X)03ZZ=3U/1,)L$5T,047/51,)M19.A+NT01:K47@U@9@9&T
M@B%6;H57@PA7@IBT+<"T>$49CI@<*K9> )*UV:B2E84C'*:)YY@; &8G&ND;
M*B:.:%N)*@D:1O1@$7F0\K&.NK4B"X8B!,8SFC$LL"&0(R1;SQ%;A^)@>-*0
M64(H4D(H;*(,1P)AS,@9?3E"SY4F"Z$HRA4GQ"B*D<5;NN&-].)>FDM:U2D%
M34"0'X8:A*N)=+L ZX@CSJ4<X\4$&\:Z].4+FL6W;O):H>N/3[(0C M8_04;
MHOFWN.&,+ *WG!&["__PD9N1N:'1(Q2)BZ>E6;H;DI 5MH[5MH%%O4RB8I6E
MN:*A7]0E8X$%(+"8C9FAMHLUN[988S99D^SP8YURDS:&*:Y0DT7)*3YIE/P[
M*IU"$3DS</A695H9F(D3F :\.+QFE6^9:KWH!-*I*I4F;JUB1->29OI:'UW#
M'/%V+\?I,%U9FQS,P-2&;*[2IM.6;W/V*BS#P,E)G#VS*DR69R'3+=.I"4Q*
M7A2L*U-Z.+VYP+(2-[/I-:=Y;QB<P>$&+_@F*_TR'3L\GEM#+^YB,&J#.+W2
M*],Q:?%V9=*R(HU6P\_9G?.6P8 6,%Z3:BYC:M!I,UWV:^>6;M8R*[UIQ 7_
M-\+MHJ]) )UW8S#HD@3<IBNN)L1F;,>S>3=*%IT-0#9Y8YX$%YN"Z<AO&<F7
M=CBFB6MZQF1N9C(&AY\,QW".\W#\"7&;(Z&D##K3X08+JCL<ASL-NC4=)SL1
M6LH4ISS @W,# ',#4 [#DZ' XW(?NCRXO#R[7',OL'.+IWJ+YS][>JA5%Z>;
M]W7,K$7[<Z0I*GIRFGITND3HXT4(U'E'!\W8/,T)M'MW5Z1;YT=8%Z>ME\Y>
MVE]B^L[O;*G?3'=59Z*-9W3&@,+.TD73X7A<5P3]O,Y-EZ\,DGJ-!S_GD\](
M/ 7>0\T.M,XONLQQMWMHYT4^.D9TZGF.)W32_'F)_XIV3:=Z/:<_9?>G&=U[
MFF<^2'IU;]K2"91!P-=\C01]Q[<"CX1(S_=\S7=(-VT%/5U\/Q!*8,B#*J&S
MV:2S_H02(U$$1?&%4]A]\^1]NRI4^5> .R&RJ#07TR10)2M2YA<14^A]4YBQ
MLG053%A16574V\2##/@+W3<4644)3.VQ.0@1,F51->L0$C47<UT7S*&"XI1*
M$V ,9>(E)T@0=%=2$V"/]><6<G&##H$-] +8#.BW46(1.,'80[C9.2C7W5<2
MD-T5+Z%:JTJ&*>M*72U*\8=_0[U167'8COT0J+T3S+2N&4M,N\1^)[%*)7O7
M686 !K%-8&T60.5]1J6$/_^5LSX8UKT=K5X]%*K4V6KX@$VM2F(QW;>D3!%!
M$7N(&(@85T9[5H7!M(,1M2U &9"!5G#P%VK5%Q I6,4QB7RB*)7UM2]VO9YU
MDHY5B9W16))H8'KR&2XIDQWY)G52N-K87GRR&99]+,K1'?_M(SK"(='XN;71
MX"RR7+V[$&+2D0G.X1[NO-$X&I>;) SYNL]AO/#4'G,"X7 BD0L)N8>;W[JU
MCX<P&HI\'B09B1O^'[S[XRNFD)3EBJ5E'GKU)L[;B\@[DT7.&5IVC[:1N_AU
MX**;75JB,.F!X1]B(0P>N:V8',-"C84=7#O2XDW>MYR+WY0UDH-UMJ0XX!'N
M5VK_#KY2OKND$1J:(-^'M;5V#M_:&[TT>6,W1K_[*RF1P@Z9(I2>0K\_>;^@
M<I1(>9=KLY5/-C%/AL90V<(%,S14IF<U_,/, B0<&,-SHVM40)K5*2O<F<E'
MO"]ZUHO@<C$<;#>3'#APZ>6V2>D-H&7 %F\F,\B .<!(0VRP,KQ14IGO0L12
MW#?KTI8#]YTAHV\&8^Q0@NR_DI?C)055K##T\L0N?&?>Z9>)IBN*.2V@/C.X
M[I=!/.OON6\65I>P$L99N2W-Z2IA')^UP#"S3F=X#&KO.)O#*<2O\IW]XLCM
M^3:N0NUF\L:LSL4.CR]+]C4%CVWW I]NII:<C)_Z>3D;"-\YDI,Y$.<Y_[(L
MH=.!<1W'' G:<4CP<1^RH$B0PR-/<2S'/+U,/1VJ!L;C<L/<<M.#/<WS<@.P
M/7FZTK.'12=-SD,*I_+LT7E4I!8-I'?$HD??0=WC]%%_S4ZO/[''125MIXXJ
M=',Z0%E$HO4P!=/A/A90!&G_/18@]K('2%]@]EXRI^)C1"_D/WUW#5- !5-:
M16!JS$DZ'5D$2*U 'E5_1VF:1#G.9WSO+'JT1D^/IQD=>TP/]30:>I/ZJ%4:
M^?P#J4H_10[M]4GO^3^WS<SLHJ-/^E>?I%(?I/M32#/-2)L*2<@7JIYJJIV*
M?*;JJ4: J@JA4=<4"[_ %,QDL$)QW&)A3+1*4O]2P1,@$:[I1[(O-4Y1+1,3
MI1%%D4LP,5)%V%3G6G\^]8-.U1:M&DZ-':[EKU/CE*RSG=<]<1-#4;/ W['$
M9$Y)<4KI/[ +T1 9@?\ 4832A G8I!A F# )05S8"CI)F) )P8<1$3IQ."$6
MP40<"UI$2'!C+(,@]TSH2!#;,I M72),DB@C1(M."@X429&CPXX;5;94B1+;
MP)4@D_A,J7$"KIM+,VY,V9%ITX8H-S:429324&Q,D0[=F1';UZTXF5;UN;3I
M59U01Z)4"55MW)PBL8%%NI-I5[P,-795B3/E7<%@I\*EF/:M3IE@$^L<.S=R
MRJMX 7O,2-&KQ["-+<K_:&$B= LAH(68(")DM D9<%J#A@T'=8O6HD&[EDT[
MM^T6N5L+L;B@E"]*"XP?1YY<N29*=325.E[\^//CI9@[A[Y\N/0%E(@;Y\Y=
M^?;DXK\KERY>^7KV[=$G)V_<%_7PZ&E:W(,\>W3PX%M&2:XE][J[!J1KT"L0
M/^.,ZN^X/5Z",*(DR*/DOH0.=*]"D)@HKX[BDC"I/TH$Y*^[!RU*XCCGI$LP
MHBJ2 S'""/.+CD3YN#M1P@56/.X@!4MD3[PZ8HP(P^@H:4)& S"4+K[HODO/
MPH0&I/(X*0W@< 'J:@2IN/!L-,[#_HA,Z,7N"#10.3 7N/+ \X)$3KSZRKLR
M_\4STQ/Q2@/4RU')ENQ<@#@R09+"B6NNY#"^-I7S,2(:U1NQR_4HJ<(B99+
MLT3OBM.D/"@'5._&*H5[DU0GO1SUS#A53754[[9D];Q-557O4U2-NXZY!2Q2
MX H=%-"!G5]]!58!8(EUX-=BEW5  @>6-=8!7!20-EH)%+B66F,5B,@0?1KX
M5I]PP6V@W'#U::5<<L5M(%U-V(5WW7/7I7?<>.^-PD!V6X0)I"K U6=0 ZI@
MMX%*_72IB7%; K@!3=(=]^ BQ0VW%7X1NJ9A?5J:MUYTR6WEW( A;.*:*"XV
M((IOS=4'Y6OFO=?>=5MZ66.;O_UO7"H0=BD)F!M F?_@C2V28MQZ&5YY:(LT
M3EI>>C79F6>C[*7Z9H%5ECE)&5^.N=YVY54Z(JQKD3E>0T!2V6& \[4H8WL%
MCJCD:U".0EZ.RTTWW88EOO!>E)GX5N]S!S6$BG/I7AE@F$$RQ.EOKVE429]A
M%MAPQ6<&26/&?[[W:Y;)-1CE"(6^F>FRO2X;9HA1!UG=BAT.UZ(**A!@=MIO
MKUT <G#G/7=R! #^=P'^(;YXXX]'/GGEE0>)"D\\0<(3-UIR/GHDP( 0C.>A
MIT(9EY8'/_SE!\!B@ %>&$ <],D_GWQQVL>BG/;15W^ <M!?'XOZ\;?HBR+\
M_T($_@=   [0 A&(   /2,#_ ?[O?PM\8 (=^ 4 2K" %)R@!1D8P U6,(,!
M/*  +ZC!"#:P@A;\GP@G.,$-+E""(D3A!5=(P0.:<(81J*$,6RC"$(ZP@B.\
MX1<@"$(2*M""4>O? "T8P@GF<(860&)"J%"/(A9!:Q%IA1 3: $]28$*#:#A
M%YQPMHB T80MP: 6*WA -.J0)433H14SE\8B=/&+%*3@&)>6PCCVD8 AA*$1
MZ:C&)5HPAC-$) <3.<0<"M*&%QQB(I^HPC1>L(,?-"$D1;C!1\[0@VD$I!]O
M.,0M(I"%BS2D!2QBA17\@)4_.,$/6OG*5\+2E;"T@A%B*4M7SG*6NOR!+6UI
M$<"4_P4;'=G*7R:PE8X<<YF744HS\_),M5"&,QXAB5T0LY>Z](0BWBS(-7GR
M"X(D4S-<:4Q2-*).IR@F,W+9R3HYDTUKLM.:Y70(3QR2EJULY"Z<\:8Q91)-
MO\ S%IM1BCFOJ9B$9B01+=E#9M12EB),16!2X E%4$8%Q%S))M]\#$%:XDRX
M"&P93R%(GQ!"A;NTU*4O=2E%KL31@C!E((GX15H8D]"1;F0K=^F(2@V T;E,
MLRKWU E!B^E0G30$*X0A*4.XHI186),O3$E*5)2:DGY.]9I*T4D_EPD7KL@E
MJG41*% I<E.E.#4Q6^&F4\":DWIB,S-NK:I(LEH7D#X3J__:+.=F;'K6D#XT
M(JIY36A<0QHA$.$UOAF-8D%C@L76AC:2;8%NB$!9T*P&#L&!$ZW XPOH= I4
MK0K5:5.5VOTT:+39\5*I7MN>V.(IME6"U)-P1+/4MH>W_6E):KF#,B>PRCA"
MO08EV!81.9&6;QB[E6WOM!XF&"@]LEU ==O6GL@AA$;'(5%SD//<H6;*. )[
ME'&ZNR?13C>Z 9*4<5HK5"F$:KV/JD.#S$LK@5&BM<>YXDMZZUKJKNFT^]5N
MD;HCIM&"R3N[DE1Z-)%?]88(.<2MCX#2@^'0/K@\M.V.+Q;@,O0PV#@)CHAK
MD?M>]T[W3**3PC7VL&$+(P?%%ZG_#WI]"Q)-'9=0GH+/A*FTWU7IQ[1QPNYZ
M.F4=X]**M!_6;: F5>3WB-8[_UT/DS/T9.M0F$J\.M:OQ.RK*QS+6,I"<YF5
M!:UMM=G-SVH6MIJU-(I]C6(A\QB>?X8WIMFYSS"SU^H@UC*TA>NY 48(O-#+
MLBAB#%Z/IEBD-0<2=@GN7,M-2!0@IHER(6Y<9(S(MSC]:,?1"\;7(!C @B8N
M/6,:(4S ,Z<AMKJNM036HO;SHT'=-W*1EVN1!G:PJT9>E;G: '5^-*?OQBZ.
MC2MDYZ)UXJ@PJ%\+V]HW S3 !$9JBL%M:6#[LSYD#;I=.]IQ,J/9RB#FZ;6U
MI&2I+M>-_PU@N$]3VF/MMDC:ZMPF/>M9'X@>V+J,S34].ZW93ENWM^TM,H']
MJVIA0XBW,$?G=0V::06O,[BJ(+J<M8[;YPZWS?S=9UE3#5TRPQO$:]>[V>6N
M=R[/'<QK)SZ:U_QX( &#]3R!/4M5[WD\;XDR?+[SE]C<Z,HKGSC*Q[[VJ<%\
M^#-?^=:'OQJP;^KMJSKZ+,+'!N*0DR-$H==/V4=)#K(($K0 V=4>=@2F78=K
M'V':,_E(_QTR@3HT)"?;[D-/8I*."%1[V2UY]K*G,)()U!,=Y0[X1XH]@(A'
MD1,<F'>4+>."[M:B!08X!9!<((9H["0 6^)X #8 )$T X0]1UO\ %F*>])RW
MB.7]_D/#AWWLB'2\ R,Y^$H:GO:\MWO@4UEWTOM^[E^O.^]O__93.E[L.'2^
MW+\^^0-*'^^![WWV$VD17I[ "+#\OO=CV<KQ@U^8*[""^=%ORUUZWPJQM()%
MXGF8C-8TJ06I*S;/B1C]AY2NCD$,N? )E/JFH7 GK3@HGF"+N6B+R.B_K.J+
MI$B+P^BKG<J)"2S AL )NSHJJ^ KJ8 FQ'",@1(*G* GAT HL)J*9AHH?VJ)
M98 +#72*J2")]4H""IP C\H,8R 4OR@(G]@('D21NL &E#D)$;P H_ (7"B+
M%12+H, &(900Q&@,L$@$DE@,KB@"H!#_"L<H"A2YI\$8B+2(BK>0P'@Z0 !$
MPZX8"%P0B/HKP:^2)HJ0*+4X*L#0*2JLC!C,B YLJFCBBK,@0KAR*,=@"WUJ
M0RL$*W6Z)\+X"\'H*T/TB"NTB[-"IK_@II0XC*L@B0W$!HOPC<4R =N @],(
M#=,@Q=E #5',K,EJQ=[@#='0#=&0#=#B#_,8,! [#ED)+0*;,E%ILMZ:%2I[
MDR/#E?8P+19K#Q$SKEQ,%9?H1?CJ%B.IL!\1+H"CD3=!$A[K+BD8CP40JB9H
M%>6XF"2@QE4I#A*[%>,X!!TCC^#2$O%0J4MAC_M:L ^IL7%<$!Z;%/("E#&Q
M,%U!#WT81O#B_T?V #@% Q+W( _1<3$B@Q-*(#$M@0\#BY0?*;)VY,<H21-6
M61.A^D<@P8Z%+$C[8)![/,;^<,CD("]QU,?G<+?N:*TK^2[P^!M&R4?QT+#U
M ,GH&,E?;+(AHS)?/+!E%$;DD"U8(;"C'$>(U(\D$TA264>#3(@PLTHT.[.L
M)!9C<86L],I$<#-C<99K(<MG,1:+$+5Q>1>/2QUG:Q?.N9R?&;EL6TM]&#AX
MD9%S6:\O8A=_3!W0>;A_\Y>' Q>7*9A6:(6['!Q_,9=<TYMWP;5O*3<#2 ):
M Q=CX\MU,4S/^<O%T1?.?)UO(:^ $[5&HTR4:YK3>;3UTH?N:@+'$9Z<S3D7
M1"N<43L=V)D7?VQ,P&Q,F1FWW_R:NFPV;FM-",$:MU2=W@28_P"YC]&'T?P7
M?[M+Q7$WJK$8BZC-Q;0(A^,<PW1.NRPT;&NX<S%-GVG.EB07R#RWC5NOB  <
M>^FNPJFXB2NCV61,]82=/BLUHX&:C8L02>N<?ONS>X/+><F;<E'/U*R8V(D(
MEVNYV=&#WOF=V]&#VJE0VKE0X/\YN@U='I#X 22('D^0!.IYGNCA!@CQ.23X
M@:+C4 ZUNOEYNO9YT1IP.OV!'_F!NG*0.JSK'R?ZI BJ(@YB(BU*H;S+I"%:
MHP0RI"*Z)!HZI+\+/1<RHB9"($KJN^LSH=U+I!\=)$,*O>4K)-Y3HP@2)",U
M.T7RG\3+H"=]T@FZDBF@(AT2&#,*H"2$(QTR33I=(-#[/0GB4R-ZH[C1(A0"
M.,L#("E,""D8U C*4^8CTC--HS#END@]H4#2TD?-(,USI$=E4K^[5.73H1R*
MH4;:TK'[O4D=4K\+/>"KU$W55#.M/5%"4]&+B/*+I5MEOUZRI??3U5JR)6#2
M56&*)6+_ZJL%?":X:BO_FRNX\"D"!"D!Y#_[JT!LTD2P @QO:@PR? QKP@5X
MLJ<&](LSM":Q4@QP(BAFC=;*R"O.4"C,2 MTFJM#!"R2$M=NPJ=[38H7#*N*
MPJ=FNJA]$@J/2JJ1>B9OG0![:!ZFRD&0."G-$"F0^">_^"NZNM<)()0Z]*=/
M3((D< (GB"@6M%B(/:>,0"Z'8*N<<"8'5 JN(,"DF-AF$L21R(R?&@QV4HE-
MG%EGBH5^2@ICZM>_8*AH+:N*70QU2EESTL2R$@NM0E:G^"F%!:QJ D2A:(O'
MJ(IHG8LSO%G$\-G\0XE?\*;/X"S10 W$T@W+>BS8&(W.0BS9_UBLT-@L., L
MWF@-BW!&ZT@R.8&R_YJ3T<JM]N#;V0I*8X2/*GN/4&'&A0RR7OS;DE05T<D/
M5*F/6VD))Q /EYD3[H!'X6!)?[$N\/ 0T]I<IWPOB=P0*B&N]F@X^=I'6^0/
M^F*/U:7($?O<]CJMG2P1V"7'?-2O)Q,.37@3B%I*<'R))J"$QD7=-6F.R07=
MZSH.#EL/>-1)"TLM TM=_L#=[O@QHJ1,<Y2Q)]$RHJ1=HJD2T9&NS0W**M/=
MV3TQWAU?!<.3H&G&UDTQ$1$3\O+&:$2RUKHNZ?+;9$Q<IMRRZDC&7\1;+)O?
M6YQ?QQ7*]-7'\@ S,PN6,"NSKI1@K_]D%F=I,S0SRVA9,PU>&KU9'3M3S5RS
M%^!TE^#$FU%3FW8!3M!$''))R MIF(:CEX/KG!PF%W8+''$#EZOIX<+<D(+;
M*,+,ER2(L2KXHG;!7V2CF%6;%WG3M-#$M4TCX<F<8G"Q.!9VB7@Q/>P$%TX+
MX](Y%S$.%RHH-]-TF[))%Z398<:\-XA XBA08BZF--MD81T.'(_SL^5DS-,9
M380HFG!A810&&5S[XK9!-K6QN"Z&&1YNR8<SMG\1N$++MI')-ZK9S#+^X>9)
MST0.-<($S[8!G?T$&]&Y!HLCM.ULF))K@,F,EXU2%SS#F^IJ@I.I H<SG5)F
MF2IH3S8F8[;_?$LM/N3FU,]AKK32L8B58^;;<6:8FU"9PU#::=%J+AZ<TSG3
M%#KKN9Z7$#KH@1Z@ PEK/KJD6SIS9KH74+H8Q8*LB]&I4[JJFY]RL(@J=;OC
M*[SD*]+<PZ#<HR3L.SOI"^BUJSX?&B2R8[RW*[XUFCZ\LS[C,U-^'B6&7K[)
MD^@^LM("BJ&-K@?3-(!3I>C?JR#3I(*)-K9EF"!0OHA*3;M"_3R0$&A^;HE$
M4NFAHCZO6R_6\[I6:![>*]2*3NA)+8(O/=-2U>B'WJ"-EJ$V!=6@?CRU ^G!
MVSL6XN>Z$VCLNVBGCCY]QFJGKFA072&OLXCUP]6R_KY6(K_P"[\?_S "5DJ_
M74+KMW[KMI8_2BS ,>0+>NT+=.7K .1#2I@*KRHLPV H'*1"KL")?,*,;^VK
M>\+" <P+8YVG>)(*SD"I.4PJ+-R)#<3 S="I%92,<\76OE#9:ZILO9"K'_P(
MD] ,@8@G@D#4A+ )=5)C%"R(];J&@:K6U;8(8V! ;*#)P%")]3*&,22K"4@2
MCKT&8]@#?VJF]4I6N8CMD*##X'):L/C"*6R(NU(+Q+;LK#A7OM+6$:383:1#
M,]QK2KS:@H@JDC@FJ*) ; TGJJ+:&!3MQ"CMTU[$<@*K=Q7#C+)KS;8*-<1L
M#Z3!^E.G3C1$L!T*&;P)H,KOQXB,?+((NO\MQ=B(1<M*1=Q(1=H@@K6%+!D@
M@MTHQ=  K?YU8))48/B0+2>!LMX5#Q=?C_.8,,D-2N[X%,95W!T7$2!Q1O1P
MB9H,%.&B&5D1*@.@+90)R3A1$O$X,DK0L?4XB!B3,2%GD\]MW$4)L5NQ1^0(
MK^3HR4RAA"X'CW!DCP=!8D.9,==R,.28QW_T$IHD2J7$R>VB,M-U"3-Q7%NA
M$^E]X/W0<OU:26G4D4E1\OZ]DOKRR(,$,$;_E"/'+>1(]"KC2) PL6IT%%:1
MCBE7\YKTM=1:KRJPK4"W$@MS<?3E$>(EWP3V15CY<8;,D!*)#[T%QJ&LDE))
M,@>F=10W7!Y/7\K_C8@S(Q8Q Y8.WI8UPTIC3W8-SI8XHQ8-QA:TE)FY5)N/
MR^.F$;36H>4];AC0$5"[++=? QH(235QB4_+"1?:I(*ZQ,TD, 1SI.-R%\W3
MVS-PH1FFF<Z^W)!SPV2Q^18U1DT;=C:7&=!9<QURN?< -9?1K!G[9&5S$1QW
MA_=<+AB;41*;L4U[7[AYS[?6J<N+TC;LS,S>E'B3H?C K!>( 3A]ZS..&YC#
MY$SEC)>081RW:1UZ&4U]JQAYRQAW4>.X%)?*$1F_#+=TTQACR^**+\[MM!>
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MEBV5ZZ7)AL.0QK*(CX9B%;OLQD2;DK&[]+(R$?M+S?:9L]<UXC['6$MP/O;
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M%7IAU505AEIA"",J5VC<QX)459R)!(+]"(N80$?>"(RP2) 4"891&(792(O
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MDD4C=T0R2!YI5%+'**>4T<D<DUQ1DU+V>,VT)+(\<H$]7/-R#R+%E+$TPY)
M\L7_'<GTTH VK:R3DC4)NP9-'!TKC(DEZSPD"<.J8%$32@ZK<\DN"Y-"T1K+
MW*C0*'?LTTQ %ZCCT$3=E)%1PAQ5=,5(#=-3R@7$I.13.:LHY9 J2)VT2DSY
MY#1+%M-<8,LW5ZWLFEX-6 #('$L%]K SIZ3$THW^I#11+%LD]3-D3X5Q1CPU
M4B8)3=S,<MF-9E556L3HS%)5,['52,=O#3#5Q7$W<G>!PVZ5L0HV5QR6TFJK
M35+?6??ME\IZDR3X323UH>3(?ZD$N,<G^:WW8!D+4T 'BZ^X6 %7,E; 8@<T
M#MECD3V6P $)-O9890=*9MGCDU4NK %]&FAE9IMIUB?G_YUGOKD!37+NF6>:
M@>ZY:*)]UF1FHFFV66A]HC"DL"J6;F!FQ)YN(%T#J#ZZ9RK@95-GH:O6.6S"
MJ&BBL&MRQCF*4L<.6N=[Y4Q"9[D;H-NT*K9^NI6WU[Z;;*N=)EMG.2MK0O#"
MAP:[[J%KSEIKR\H>FW%]##,D[J>-)??NH?5QW$LI/N?9ZK%/_YEL32A#G&N=
MJ1@4;<%WKD5NIY7&W'6QXZ99=9VC#ISLUO?N>_.[SS; $"KTCO=XP F+0NZ=
M92>,:M!;V;HRNX\W.G;7V>Y=:+5]K?HP?7#F'''NI]='^^V[YAGGILLVG.SY
M#4]?:9N!;MOJW-MVO)P5I@(5$/]  0V8P ,>4($-7. !]?# ?TR0@A6TX 4Q
MF,$,'H8*GO $$C[HAL)T\(.>X 8'/5A"3YA&@RUTH08'H(8!#. %,ZQA#0>
M!1K.4(<U%$</<[C#&LBP'%@0QPZ+.(#"?*$(7X@ $Z'8Q"A^P0(1:&(3GWC%
M*4I1BUC<(A2KV,4O1B"+4(1B&;E(Q0A4<8IK1.,8VZC%+XHQC6D\8Q/#^ 4U
MFE&+9;3 ')T(R#2ZD8]J+.,9K0C&-]*QD&QL8Q3998 ]^C&1>11C'MGE!#W2
MD7R$:< =]7B!STB!BL8PS 4VJ<?#*'*/5URE!:Z8R&48)@I?_$(G-]***5K
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M9FN:%8:!"TR@ <GAP >20P 07* >#/_X0KWOW8*'40882@A")+1.&500/!+
M8!@W!#Z$+.3[XS&HPR#*4/(WM.$.=XB%&L1P\S540PUJH'G,OZ &Y2@,(],I
MQR@>LH[J-*<7B[!,+/X1]J\O)!V5.4;:!]*:SLRF[*$9^]TC<HU,)*,XBQ]+
MXP=?FZD$)"&W^?SAMYZ,:ZS]%>MQUHV<LY!\7&8$M&^ *?C^B5M;QNR=^,<O
MF!M4FH3B!E8Y^\.LTYSQY[T>?7D:*J;RCUM=QNZK[X_8;R.DP/V>"/X,H_OZ
MR/:,[YNJCY%L3XQN+Y6@CYEVKXX2"9J*C_G0*/G2S_A0#P"GCP)=3P$_\/J>
M[YJ4#P4Y< +_6X_\F$\"W4DA#H(@Y(DB'B(B$H(A!.*>=! C(J(P D0T_ .V
M0BI K$*PVB.SMJ*QR ,JYN,NN"(NE - \&.PSL.Q_H*BVF.T!@LS4 H^9DHI
MQ$.Q,D,VN",L#FL_I.H*O\,^KF(O1,H^_&(OFL,GAN(*!P.IFJ  TXJICJ(E
M6()=KD&D?N*EB@!L<*D)_I YDD,P8 (;&J /N2JM1@L;?L$8G.[,"M"RD@,_
MDJ,KL,$)KH&JG. /9:HZ]E (J5 V\F\CDB"@1J*CR.,_Q/ [5 ,XP"(4S^,V
M ,,L[D,N1.,K $0_Q@,-Z>.QEA EJB(0J= -&0,XNF(6FS ^AC$L_V1*KVAB
M""L*KNQ0.)9"&\DB,JZJ.!RK"7&QH,RCIZIP*XJ@,$I$1'9K0WSK0VX+N3)D
M0R3D0QXD0R#$'NTQ10A#2FX,R[0D1Z[K2M(K2?ZL6\ L8LJK(%N$81CF4>S$
M%W9%SW:D(0=M3&2L49S@(0U254H15)K@&B3FQI2E4:IDP$J!)".E#^5EQ]3D
M,:YL29IL(H>$PZBDQ+)L17I%6QSRZ*R,$NJ@26BD%&/R5SJRPH2E18"%3G %
M3J0 ETBQPT22N?; ":BJ*E&R2,C$5*0LO9(R48[28<I+1[;R-)C24^KL14J%
M1O8 6\;-QVZ$$']R7NIL+&7D3JIR;9P *__#BR]7DB5?;&%6))*0Y"PG$B9/
M8]SLA#%W;"[9$DFB;,KB<C _+%*N(0ILS%8\S##P3-"JY<_N:R%?;+W>Y$@*
M$BEODE]Z)+_X4DL.S5I$<D4T9;YFI&(Z)F4N1F0NIC<OAAU"!F1(S=-(#65"
M+3E+YCA7C7"$AG'NC>P.[NIN+NK0)VAH;==V9FL SM>.CN:6)M@T@N.RYF[X
M9L6D( F@C>F:9GKXABT_AZJBH'!F)GCRA.'\K239LCW+;6SB$Q;Y37=D9F?(
MLUVP,^"69G>2( KJ+77P!G?P)F^N(5+6T^K.<V> +EVX1]8,YWQ^)MZ.AV](
MY20'5$%]AV]P*0G_I$ \RPU%*R=N2+11V#/J\H8]Z^=HBH[6#L=U6O1!24Z
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MWD:=7<$+>]0YG.W\!9<U4>4HY5D5Z+@2F[(TYCFCHI>.K"<YS S/5:#CS+Z
MA"P#]6=SLN-*;AK'*.^9"3YW8L^B*!0W6T%/2*ZCSO?_5&68BO&H1/D9DHV
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M8O]>SH7W*?V"D']<SEJQ<\+XI"J!Z9HI.2CW;S70AJ^Q'3OZ-N@F.OU7A:T
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M <.V9="YCWY4!C/8KL<^U%4YRE[^W>FZMS[P@6_*<-8; N$79C8/K@Z:X'(
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M('<;H783H0Y2-Q)*H;=T@'BS-Q#*2WQC(:&X.*^0B)@0/+4PI#AJ!8;+I*(
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M&(5 ];M %N6]&NG1&DVHY5,/X&M1BJ*.&34K'M4]%16^CPJIZ7!1&+4J^@/
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MK),Z#MZ[^A6*MX@+ [6+S*N+SLL+S/,\"C6]T:,")7 #)&AC-W8#-P #"36
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M[KXA#)/>.9\74'EGK$L5M/C_1"U>88E4K[H2K6A%K5== E,<HQ>EF,6R*]H
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MH1,#/@==1(;W;=6I-M.CMD((ML:C*BE$I9^=$B!&& /E44<2'()W'.%X)*$
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MA[B&._E@ [F*7SF2O[B&-SEU6$=9?7EWH!59*2%X2"M65_] 7#\A<*?YN0Y
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MF@_\@42(&9(A8RW6NPZ 7L.APU__R,+[]8)L%A;80Z#7N\9O/,=WO,<OMA9
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ML'[URU\S):6_5GE*@RM0%:A@12MVLO!8,G-A#>O)+HGZBZ(*4Q?#L&4M>QF
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MYW(&%>Q21W92YT^);N=,1W)(YQP<]75<9U)AQW7&[E+5+E.1)WG&#N\\U>Y
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MJ;*5J<(6*H1E+&?ILEBZ'):RH 4,;BDS6ZZ,YJL AB]UJ4%=( -GT[C9-.7
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M/]@^4NB\[2,_OS,].P@'WK,_U5N$_9.%#+2$YW.%+[2$[#,_ I1 Y^N% &1
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MJ 3PD6^!%X0" 3MX0! &$(,<Q" &U== $:+P@B@<80E3Z$(1GJ.%(M2?#*%
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M==LK!!F\M[KQE>]TXVM?$\B (/F=KG[+2X3WGO>_[#4(>]6KWOY.U\#\33"
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ML\L\Y[R3B#OC=/3/%AP5DU))U83#3$P==9303<4LU$Q//87#4DQ)->&&36]
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M[-\%_!M/OKSY\^C3CT?BR1-[) :4&9A/O[[]^_CMNWGOR4U^ ^H%**!Z PR
MQ0#B8"'."P4JR*""-3"XX  ,4FBAA0Q*>&"&%JJ!X8<<A@@BB!.*F&&$%$:(
MXHDO+!AA.2^LJ&*,-,(X8X09THCCCC2^8.,+/;X()(]!UCB$BBO4L$*,2_H(
M9#E'#IFDE$3R."7_D"]<.626/389)901#O&"F%!"R:620":I9I8XKE#.DC"Z
MZ:.88S*9YHM-KBGFD4N^**:;>XZ))I=FFKDFH7]"N>00<#**IIM+ LIHFEQ&
M>J>E:@[A**:5=LKIIZ!F&2FFI'HJZJDKE)JJJ*FVNFJHKI(::ZN>ONHJJ[3.
M&BNNH^JJ*S<K<#/$"<)R<T*PQP*+[++&,IOLL\NN<*RTJ4+;[+702GOL"=RV
M2NRT/U ;KK'<AOOMMRN$FVZJZJI;[KH_E'N"$2>$2V^X^,*[;KWU2ANN%?ZN
M '"\^>)+KQ7WWDMPN@/S^\/"/PS<,,'U$DRPQ J?@'"]5E3,\<,,A_S#_[T=
M1RPPP@^CG/+*#[?\,+\^\*N$QQ&[7+,5\9XPL\4_0!&O#S_LK/,)0#\\\\X_
MQWMTO3[[K'//04/]0\Q 0U'UPTXK$3314&L-Q=!>1VWUTS%K7?;4/AQ==M->
M*U$VU3W/[,/<4+A=-]!J3VTVT&GK73?:>?^MA-5XXWVWUFZW/??<;B\^>.)U
MWWVWSFD?'GGBC*>=^>:-=[YYYIX/3H3EF*=]CNF)GV-WZ9B/[CH41*#.N.J:
MNTT[$8DK0;O;H_,..^JPPR[Z[ZZ+[K8,P1>O^_*J-\^\$C+(H+KP,KR.^SFX
M*X%[]-I7KWOQUWL?_?CDCT]$]"U$?[[WN+=?_?_[Y\</__CIK[]^^>KG_[X,
MZ>_//_H _-_^X*"__A'P?T(XGPG6=T # C"!T6N@#""XP F>CX $K!\ ,R@#
M#+ZO@B!,GPD\F+[TD;"#*&S!"%&8P04*00@B5*$)66@"$ZB0@R:L(1%6F$$9
M7O"&*=PA$&7(/QO*<(1(;&$)C=A!&SH1#D>\H123:$0AP.&)4VR!%HTHPQ;
M\(I0-*(1P]@"*-[ !#<HHQBO>$8M3C&-(SQB&H70QAT(80=>W,$5MWA&.*:Q
M!7AT8PO2&$@XJG ': 0D(0FY@S^>48^)W $B^SA(/#:RD8F\@231: ))WK&/
MDM2D*"\Y2E*&$HV7#*7_*DF)RE)J,I6O=.4J7VE*3;J@EK!4I2TO><M1^G('
MO30E,'%YRV(.\Y?!-*8Q=[G,8SKS!C>8!C*'V4QE1G.7MKSF,X%IRV(J$YBA
MN&8QLTG-'73"!=><QC;2>0-OME.:TNR$--L9S75"4YWS[ 0[O2E-%VS#!?I$
MYSGI"<]H!K2@!46G"Q+:3W'VTP40'2A$;WG.A;83H KMYS0".E&(3J.CZL3H
M1"L*TFU4]*0PZ&A*7;#2CKJTHZ[8Z$A7^M&4;K2E+G"%2TDJTI7Z%*(Z9:E0
M(?K3E!HUIT/5Z5&7*E2E"C6E3F4J4YWZ5!A %1A+U0%+L9I3K,) JU]E*5A9
M_VI5%X UK##P*EG/:E6T&M6J8&5K6^-:UKJV%:YS_>I=S>K6)^@ !D_0*UO_
MJE>]^K6M@;7J81?[U\8&5@>'Q6M;%2!8JU*VL7C%+&9A< 7-PN"RG_VK D2+
M6=".5J^G/6UG/\M:':PVM:&] FM3ZPH%C/:UI/VL;750V]W^%;? =:T#?'N%
MX;I6![<]+F5W>]O1,M>VT$4N<IWK7%Q ][K8=8 $AHO=ZVI7N]#]KFTET%T%
M;->\X/WN=LE+7O2R%[SN-:]\Y?O>]=(7O.QEKWOS2U_ZZE<"_ 6P>0%,X 'W
ME\#Y1;!_!QS@! L8P1".L(0G3."!%&3"!R$(@#.,8/^(:+@@ UF(AQ%<D(4P
M!, 0";$$/#SB#(/XQ2N^<(ECG&(-'V3&.&Z(CF]<D8X(Y",;27%,-$(3DW0D
M)2QA"4Y,@F2'#'DF*\%)3J9\$YM0&2A2EK*5>U(4G70Y*5[QLE L4)0ND]DK
M4TG*3[K2$J1\F<Q5V0I3X!SFI:CE*51!,UC(TI:OV#DM?=8+FM$B%;:4Y="&
M!@QBZG(7R#3Z+XF)3%X0+>G()$8PC_D+9>9BF,Y@YC.9/DQC' /JSIBZ-8ZY
MC&56LVI5ZZ8VBJ'-:)8 FMG,)C?'T8VMC3,;7=LZ-A50C7"*HYSC$'LYQ>8.
M=JZC;.=\YSK;\8YULM,=YS#_9T#8QG9[^/.?;GO;/F!PCWO@DY]LFSM %!*'
M@=9MH0,5Z$$7VE"!/-2B=&.H!NW^$+T'L&\3D8A&*<H0C"CTHX!CR$4 UY'"
M!^ZD&]6(13\J4L.Q-*.(5XE&0X 1C:;$HQM-*4ED&I/%/UXF)V5\XTBB.*&,
ME"8;@5SD/6(3EIH4IPA-Z>27.CFD[+2F-S%I4*-"TY\>E:4X_4E3<6)3I#*N
M*3IEBE-_&M.BWN3S3%6]Z);*^*A,]2FNPXKKJ$+5K6PE=K*_RE-&8)6R@K6J
MM0,K2]S(TA"4-?=4U3U5;V<[WEOE=K[[?>^ O_O<1;5V:E6K6HSREMVGI7C#
M3XOQ_\22%K"^1:[#;XM:E]^7LN(U^7FU:F3:BCRZXK6NTK>+7>DZ5KR,D/I[
ML:M?^?(\ON:E>GT)S/3<,L+J2[8NWD],]KO75\$6AC.!_6OW%C-^Q=*%_-X?
M_V,U,P+.1O8RG&EL]?$JOO4I)C2ME0MGTH\8SJ:O-)B![6D4F]K0UE\V]*M_
M9N>7V] (MK/ZU^MH4U/_UL+F,[/UGVA/,SA0<S8^X#,#2#1I\S1_LX!F,S@)
M&#3_)X!S@X!$@W]UPS4%*#=\ SF,,SF=0X$.F("5DX .V#BU$S2U SJ$HSF.
M@S8LR(*> X.@TX&],X,I&#J<HSK+\SL[J 2/4SO),SNF(_\[LB,ZJ*.#LE,\
M/-@[L:,]R:,]/F@]3^@\5.B$X1,]JA,[N.,#SD,$6;B$UE,^]I,_]X,_9GB&
M:$@^)E! $50]0B! 8SA ;+@__=,_.R1 =OB&#-2&U;.&=WB'!N2':WA A+B&
M?:@^@WB(?WB(.)1"_[-$351$)?2(;PB),Y1#5]1$.V1#_]-"'20$G$A 1-!%
M-*1%CTA$>Z2)5T0$J0A%U7-$8&1#&+1 >[1'M A#.92+-P1#(\2+9<0_L:A%
M</!%<21&@T2,*F1(QMA&<(!(:G1&S=A)7@1(LCA)6M1&-P!#CS1(B42-?J2-
MD<1)VYA&Y&A#DR2-?61#CC1)C53_29M4CI+$C;[42JB42N(HCI*$2:#T2JTT
M2_DH2O7X2[&42P(Y3))T2[E$3,ZT3<&$38TT#:0D3;QT3.%D2LLDD=4TD=C4
M2]_42Q+93@\)DB(Y3OUT3->T#26931\%3-[42!X)D@K52-%$DN)T42XID_-$
MDRF)3C-I3O=43PI5DRW)DP@UDP8E4$'Y4?04E.@43Q?%40#U4#.IE!_U41Z5
M42_%4Q UDR,541W%E1-EE2\EEB]5EC @3UYYEB^%4T'54>>T4N<454^%5$,%
M540%4W5YEW1I5F])ERNE WU95'-Y5$&U5$ZE54H5575%53"@5&TUF%6U564U
M5G>552X0_UA"15AN-5=FU9F-F9F5U9E_15:D"5B2!5=\Q5=WI560-9FFJ9F>
M55B$U9J5)5G(59NU25B4E5>LE9NRY5F[65I?95JM-5N"=5G+-9S#>9O2=5F=
M-5K,:5NZ%5K(J0.WJ0 .\)P*X K3Y0J=U5G,"9[.J5S:J0#:.5VC95S.-5T.
M@%S<%5ZVY0K;-5WV-5[P59_M95OP99_095_[.5[S%5\!*J#M95\&VE_^A5_Q
M!6 *RJ -=E\.^E\&]F %YF 66J$4%F$,EJ$<"F RUJ$9:F$2=F$>BF(((1 0
MQF$GNF$LBA N*A$V=J(JEF$\]A H>F,UMA 901 W]A UD6)!MO^C$I$1/<JC
M0/H1.&$0&0$2)$$3-Y$22_9D'C$34'9E699E-K%E.Z&E6!841B%F<Q:F=@84
M8"866#$661%G=-85=K9F7\%G<G9G>T9HA@:G9D&G=W874A%H=F$7C'9IZO!H
M@EIHB#9IE89I<N%IFT9JE99IBU$6BRIJJ%9JDNIJF^%JKR$9F7H:KV8:PA9K
MH.H;O28;L,$:K]%KI6%KP+$:O/8;NW9KQ:9KR:8<L-ILT*%LS!8=UL$=T]8=
MW!%MX1$>YS:LY<$?[.$)WY:LWK9M[D$%Y4:LT/H/ZU8A^58#6% .!P(A&Z)N
M'&*M'_(A-: &X3HB_F8B)4*N]\8B 5?_<"$2(0@7< [W(S]R<1W7(_(J)3HR
M)2XW<1(7<3X")ULRKT#"=!IG<70R*!O'<C82=5&"(W0R)W4"*&V")#4@)F@R
M*'LR* B+)F8"L45')B!+*1W;* -K)T(')Y8B=9>"*/_Z*(\")4V'=7*W<RN0
M*(PR*5T'*UNG*F+7LV97*Y6RLSY;L[ZBL[VB*XE'M'9'M$EK=F-7M%"KM+_"
M*,)"+%2;+%0[+-@R!#^0M5:++LUB>(>'=V!K+=G2+=YR+/32+]IB+.9"+LUR
M>J:'>G2;,Z[7+_0RMPMS+[!W>_DB?/PR,'[K>@7#M[.'+Q,#+\OW, K#?"*S
M,1'#,<PGN2#S_S(FDW[/%S&ZQS(M,WWDES,QDS-(T[F;BS+;)S04<P(1Z# 7
M^#< .'])(W]+4S5F\S1D<X#M-X%APW]&0SEP@S<*N'\,^#.T&S?&>X&*0SD(
MB(+,ZS8N.(,HJ#8(V#: \S<I^((QB#F60S>KDX'>^X.'\SF((X/DRSJ@<SHF
M:#MS4X/GF[V5HSM)F#QUTSJ:P[[+<X2IDSH^T#N[L[_#XX2^TS[RZX,R$(4^
M6(5?6#S.0SY/:#W+<SW%XSW8(SYH*#_[4X;D\X83M,%OJ(<R $)Q^,'X$X=V
M&$#K T$H1(<F'$ EC,)U:$$/=#XN#,-XV(85)(J/Z(B<.(DQE,.<6/]!D[A"
M/]R(!"3$C3B)10Q$/%1$+<1!J7B)0[3#/K1 H;A"6X1!2Z1$.[Q&3/Q$3B1%
M_(.+2-1%7.2+;Y2,9 Q%4D1'7A1&;MQ%?.1%<U2.:H3&UBB/B22.=@Q%EL3&
M> 2/;D2.BI1'9N2-@QR. !E*W-B.UCB0^MB/J61' TE+I920E2Q+NN2/JT20
M_AA,!EE*GNS("/E*HVS)%:E)&,F0"OF2(>E,R;0-W#21&5E,%>D"M5S+LJQ-
MZ!3+0ZE,RC1/P 3,N\Q/-W!.W!10W)1-QCQ.$ 5,R Q0W.1-7KE0_[24,/F3
MTEQ/'R5/7'E1%N512_G-"C51WAS.[U3,8_G_3R=5EOU$4O$TS0OE4MO<E1B%
M4WKI4C9USTCU4Q-EST/5S_7<S]ML5 /=5$!UT!"E50;M4UR54U,%F6'E"ER5
M5J[P5EQ%F4^%F!:]5%!U5EYE5VLEF6PE5F1E5!_M5R5=F73U5F*UFKF9FF$%
MFXJU6;P9TS.]5H\E5H\%5XEU6)LUFY:EF;MY6L?%6:6EFYN5G+DE6Z>%6JB5
M6ZD%U:)EG*[%G9]56U/]G;RU6[HE6LD56M;Y6M0%G=^Y6^7I6LFUGL?%#NMY
M!6/-7-/%GOWYG^U97CH@7MAY7@.*7O:9G_.U7GB=G_BIH @JH0;:H .&7_]E
MV ^F7>NE8!@ZH0GF_]B07=D;&J$-!J*:W:$C)J(M>F$J^J((IJ(%<6$BRF$;
M8:(NUJ(T6J*K7:,L>J,?QA! 6MLS1A$U41%*>F0_JA$^=A$Q\6/"W=LI =Q-
MRF0YH:0N(1-86F53]F/,K617VA)<VJ5 869$X:57<1-=UMUI2A9TUF9SQF9J
MFF?FG11MBMXGD=YZ!A>)-A9X:J=QP:=ZP6AR46B"EAAHYA>.=FF09FG_C6F*
MAAB1]JB,D:B*41F6-FJN!N"G-JF*BFJ6:JF\D1JK-A>C$:JH01JND1J\0:K
MIJJK=AO"X:HBKAJI&FRU2N(L?FS)L>*XRJNW:JO,$6W+1FW69FT5H ?1.O^L
MXO8>_Z"L0HX?_.$)8/"L/7YN!3*M"3)O\89O\L;D'0+E%^)O\L8A5WYP[:JN
M7)YN-'*N+.)P%2=P8:YP1$(A_*IQ]9KF3[(E,1(E13(C/^?F/Z)S#C?G/W=R
M6* E7?+F7/)PBS(G-8?G*]<D7*)U3T*P*VMU;#)T'Z<D@6+H42<G-7MU*>LE
M2F?GD4)TKU)U/C<IB+[IBR+J.$LI.1MV.1LJH"ZT*Y!VO8+J3OOJ9Y?JN6(K
MLSZT1\LJO/*TM8XKNQZUL0)YP3ZVTM*TCB>VD#=YRKXME]?LF"=Y=?MZDT<O
ME3=ZM3>WV/ZWIS=[A%M[@LLOGB>XK0=[N2<P\V+_,/PB?>=.,[!WN*V7?NE>
M,LBWN!:S[M7W?.%G? PS,N/'[S63?<^G?<_G?NO7N=,'?2\#?TN#?_!'-;8;
MNC^C@& 3\3L3NMU7+P7X?ER#?UNS-<#+\#Z3\:L[@23X?R*X\'I#-G*S\B'_
M-@+X\OT7@5U3@14(.C5OO1UX\C1?.1[_@RN?-NYKOIB#@M?K.)QC@SBH@K$#
MA#OH.D9OA$4(/#Y8-]9S]%I8O[7C/*B3.$WX.@#<]51_.4PHOZ.#P%8(/<^3
MA5EHA<)S/6P/A=4#!=PCA@4<PF<H/W@_/Q8\/AJLP2*\/B5\P7Q(PG/XPH?H
M0&YXP8(HARE\AXV_AH&H_XB+GXGUDXA$4(F=>/B@>(DH=/E(7,61*(H[W(F#
M6$,YM,4J5$0IQ$0E!(N<R(JRV$0SM$=I_,6Q?\5CC$&\:(O3*(MQU$2Q^,9@
M5,=J3$:UZ/MJK(Z^3_S*C\?<^/QMQ$GLR$G1B,;4:$;5"$/GJ$F#=(U&!$K4
MN,B,E$F+7$GTV/WI2$NIA,>3?$K[N,F75$F5!$KK_TNXY,@.N4N<_,D6>?\
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M\ ]\PQ![XQ!V]8\(^9#_$ _\0) !49  V583D9#W<#C]<#@'P;@-T;@4 1
M,1$!(;GT&#D=2!*&4P!<\)$2$9*2N[D2N9&APQ*+-9*8*Q*-?1$C43F<:Q*,
MG9(Q89*<ZSF@4UDU\;FG_W,Z,;D2IFO9IBL3I:O9J,-9/#&3.J$Z-IDZ/_G9
M0 &418F[H164J1.[N",[N4N4KB-:3<&ZNDN4J*T4J>641AF55<E:4G&\4=E:
M7\D4R5.56?D[P^,55[D56"&65[&5MKT\RSN\MZ4\N*7;R@,7< F]5GF79HF6
MT?.6;9D]TQN7<6F];3'<P=V6=LF]<_D6U\N]?(F7W<N7=,$7VT.8@BD^@TF^
MD4D^?G$^AX$8WLL8XZN8>K&8>HB8Z\N^[],8U&V^E&F9U8U=[QL_DQ$:\[/=
MH F9FRF9GH$:\RN:X+48_2,:I]$9^ZN9_F.:X]V9J>F_YQ5   S LOD: R3
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MT$ !"5PAP0D7K&^(&O*3L$ 'Z].0P0T1E'"(_88HI\017Y!00P+U8W' $5<
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M"Z#9S5M^DY7,Y.8YX<G,>,)SF>BD)SG/Z8I;,A,&\X1G,O7I3W+VLY_W9&9
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M$1S!4Z,T0N,U&EP ;#7"_R'8=F-67?7"?^/84A4)B$W";74 [@,ZV(/<T&,
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M@"O,$VWGW*8]X]9/>C(3G/=DQML%.G=UQ&.>[- 'W/Y!#SL*A![_X.<_^W8
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MR#_VPS[L(S_QLSU4Z(44Q(5D6#]IV(5JF$#[TS\$%$ 5-$%Q^(8+-(<6-(<
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M ;PRF,&LP#"%6<QCZ@&9 C"F /[Q3&A&_U.:TZ1F-:TY34]X @G91$(WW6
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M=[_[VO.>=[PG^ %Y!V*$\(+WO> U+WO'"U[[_N"]]C6"%9#KW_M:@;W?G>^
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MXTT:!]R:NMF:IX%>M5& MA&:MLD:I[G>$$2;ZHW LO'>OM&<NOF;$\0;'?C
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MPW=\R_=\TW=]V_=]XW=^Z_=^\W=_^_=_ WB S[>>[?:;T=F!@P&6CL5P:ZF
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M;LZ/_"@\D:X\U5,YNU,]R1.,_.B,W).-ZG.-XI,&YI,\!\D^^S,$Q"@'P A
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M%]<S*!=U(%<S+U=O'Z<T+W<_.D=S5QIR1_IM3;IR*X>E/'=S6P-U-0>EV29
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ME3^")T(2(PY")5>")O\Q9?\!YL$C=B5M,L1I\F(%/\16DL-WTF,&/\4>K/!
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MO1RP[GGC^][W\H:^&8KO??,;X :Y-\#VX6]VKPLA_O*(.^F%,( CW-T941C
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M35(KS9V@8YSP\1[A0=+W85+90;H%BCKQV1\RW;OI\1XS!=/FV3PGW9^NRSH
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M)F!JV9I=F:3I916#\9<1YF.*&622Y9\LF9C%V9356:*E\9O]25>""IDUVIE
MR98XIJ( 2YB%BJ.1VJ45<K%TYJ989FA"6K.<B; 1_]N98-JKH69OYMJF3?*Y
M"-NF$9LE@QNP+5NHR<NM[8JL?1JX"2>RO9IO*F>L(1LJMTNXV$$"= HL*ULM
M+Z=W8IMR5HPM.XMR[G(L2YO!**?#$+.ZN(MR1MMSIF=\KN=[/G-[-K-Z-AS
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MF(F+5-%Z%+O,E6ABU:M=V9IQHQOM+WM]:L:5/A?%4!VMBEWZ76O&&*P^S6B
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MZ)5][,W['=S?CCW<Y;UZ:U<>]OS^=\ '7O"!_W>@^+('P0,F<'N+9_SV!CA
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M>[JGBXI"+I39E]I9."Q#B.*G1"3$G7U#F6+$G**D1$RIF2*I.$S:E=*I>OJ
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M;$NHM<BY6/,Y\^>X].BC $Q\BAN"TO.A&6@Q.^BHR9JXR6B\4&BO&5N *JC
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MRK=??B[]U7'EO[<+_VW<.'+FW,';Z4Y W0[Z]>.SLZ=/'?T4 _OY]_?_'\
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MH%M]<[>CV\^CQW4[B"[KTOM:Z(A'P>AIK^P4O*#9+UB^Z.4M>V9'9Y\=WL[
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MDI?#U.4EBVE-9^I2E[B<YBQ?&<YO?O*4K/SD+$6YS&8V\YK(5"8X0B!/>=)
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M0!+B0S+*#+L\D00R7^RRS#6Q%%-,+N$T,\HMHW13RCC/1%+/+YE,DT\JS^Q
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MO?HQ[WW5HU_J$_C  &[O>_A[G^OCA_K9UV]^ZBN?ZO$W019^[H?S.R '%FA
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MF \(:&M.3^ZW%]?/?K#Q%N\$&#!4:#X SHZA?F1Y-^+79X @T<$ P8(&HI
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M+*=3%0E1K'JSIIC]+.H=(?I46RX4J @U:4%A2E.L]A2C4#6J4AF,UK5FE+X
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MU+P<_\V]S9S2W)RZ:=4 #9[J#:!B3I^NG<U-7=($#LS%S>($'=S=3=_8C=)
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M%"143%L-=4U/6R4!U5])A?584@5%%=E._S^%E5=D0<7T5&H_/=5590_E]55
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MT8UD#"0?]0A&<,SQCVRTXQO7V$@5OH*0!U1C&X$ 1DL"X8QUS,$6$<G(1])
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M![6>1>UI3DO:W"K><:/QVVJG^W?-Z_8WKMEMX6 +_]S&>3XSO^GN=K+C@]N
MU[OJ88YQQO.8TUN..9E?[G2]VQW3XY8XVAFNZJS[G^VT7KO;^>YT4C?[\T[7
MNK>YC7@ 3-[IOOX_T170[52?N]V/U_?U34_N_S,>_@AXO]OM_7WJ@Q[]"DC
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M1F,XRNLO;@,U_#>] G(BRVN]JN-_#7@YZ N A:,Z</\C.V0R@MGC)5NR@@5
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M,MJC^!,_[2,C[R._/3HC;@W!*](C,SJ_#Q)!+1)!/6(^^@.F=PW!+UHC&5Q
M&_+8^BNB^GO DN6_''2F*,K #HQ X$M $ PF%:0_FD59"L3!!5K!F%W9$VQ
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M@RR<8 I;*$,38E"&(3Q@\" HPQGV4(8OE.$-@]C#& KQB"+\X0U/^,,B-K&
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M]1TWX'\%QK==8/T5UU^"]3487GP77GC4AMD-=V$: J8AX7LU!H=CBMW%F-Z
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MWN$0_N$2'N(4/N(6?AT87N(:GN(<?N(>WN(@KDIAM;$*:A\"@$-@=1 YNR%
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M<9FHN(@*J0Q:U*.IQQ4@THO"\-2E@4@YOZ]8,U86U=PUWO]U[EH%,("Z(HH
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MO/]#;R"5*]V!IA>W@C3O=FL[7_+6%[[ E6]^E[M?]D:W5- -[WKM-V#\_M?
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M3I2C2;H4S(; D9=&F56OAH0F5^FADC.J2#$ETZQR'JPIQ;N/^[J7.RZ5#S"
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M#[O6O,8BKE>DZV,7.]F^7C:P]2+L9Q/[U[0.MJVKW>QK&SO;R&XTM'LC;?"
MV\2._W5VN)LE7$&KV\[QE9GQ*B"]KVS7@)?C2H<*F+R$M$)O@-7,Z#0"V(/
MJCXJ@=4UNNM=C5PC,8(C7U<2;AI_NW*5"R0<  W>BJ@DG)W:,N;ROCQRC?QU
M2?.T'N"F7:C):05_FF/0OG5+D(J'[RU:B:O#-^?*_^1'(^75.6AR&Q7YQ(4*
MDO-?88O#U_"UPCYT&2EL8GN2]Q V)".126%CYW&BGR=W<9'<QPM>6(Z+'"0*
M/R("6R7SU=9\?E!/N4NN01:WYT1(\SX[S%[%0-R(\'SHWCAZO ,3 FDP(\G9
MG6J7Y#RT^WN0\E6JV'(:J""W=MR6A^.?+(WN0K.0A^YFK?^[0;\KT4_>\T\:
MO8Y*_TX9K1[EIY]1ZB'D^LY/^_.FMSWJ<5_NV.]^EKIGO81N'WS8@];WG#>2
M[%L__-?GOO?$=[[QH<][Z3>?^LD__K:5+WS@6__WS_<^\I&2?=KK.?K8G_[W
MJU_[ZX\__7;!L=:BN<J/I>V)['7O:PY!"I)G1%;G]Q!5Z#^)2*6FR9,,>[2X
M228+.R=QJ@ Y@T!H$:8(I$!A:1F2LBEMLC,^H[\-').?>C<E&:=1HA)0 A+1
M^1YRJ:4-6<!IZI,..:%XV205=$%UZ9D6M#SJTA4<["<%[+,<O,$?[,&NB;Q/
MDB4B[, 2/,+TXD%G\D$2=$(D;,+_)'E"%8Q")A3"*TS!+*1"*>1"4?%"*.Q"
M+!1#,"1#*QS#+2S#)51#-#3#-ER5-]S!+V3#.5Q#\0E#-ZQ#%J1#/#S#.-Q#
M$]1#/X1#&0Q$$01$0K3#0?2Z0C1"1>3#.RR32&3$0&(1:=H7F, ;U)"[QV(X
MB6"WJQI C9 "=!L[PBDBIQK%B,"7E3 E+'N/A5C%SE@1ZP*+632 E[FQY\)%
M+ N*(&G KUN*1BR9KEL2ZGB;"6$.7 0>&&L(5<1%S#!&:,3%M^FBJ<.R9DR@
M;$RT",FMD<.97B1&Y3"EU;JY5J'& 1R4R"*,5^3&VTK'5:R)@XDLK#,[LK*=
MNYB@%^G%T<?JN.M9$:8#B=4BO&_4,B:SP\M3PI!*K(7L/!1,2 0\P]9",PX$
M&W>J2(@\"XQ\LH4,1>+3R(]\O9"DR(YT09%\R$=$23TC28X\094LR9?TR)@<
MLI.D27*R29>L28_129SDR8@<F8L$RGC3K*&\&J&,Q)TLFIX,RJ),2I]<2J-T
MLJ=A2J)$BZH\2J<T0:6D2JF\I:Y\RJ:\2J^T2*T$29C$RJE,PAH42P^TON]A
MN652IH0XA+@@!2?PB;AP@@54RU9:Q5LPGHK!LUL*LS>C,7CA_TL=J<#%+!;#
M9,P(U!I=2\PFBZ$A8Z)%>Z$_VS./ L$5#+3-U,R$ 4V+5*,]4[/P&QM.NA5P
ML4R%=)?6C*63@<W U)G9E++"Z+'8K,W<I$VYL<W5Q$U! <ZT$DZ3E,EHV\G?
M-$[EE$D_L[#A=$XP@<[C=$W9Y,W;),ZXG$[F3,[KW$[O7$[P;$[JU$W?%,_N
M+,[QY$Z?7,_7/$_V?$_W3$^NI,S-'+U!1*.W&0_-,;CRP;CW69&D6T7@<4&!
M.[R3LS=70I]C'%!;H0NK&TB34)&]BZ .2=#CB)W;PLS ZL5_\\3S<PBJ"+CJ
M9">D8!Y2B1&'@-"X0+NR@AYL/+O;Z/^YKFB"\AJY4Y%.P^N_6+P(=_R.'NF5
M'NT_'&4TXQC%!?5#O5D  QG,"Q6@D\.[AE,.^5A1N5N,J^S%B&A&PD"@,]'1
MD#@Y ]T?S3'2 <Q0A?A2 UC0MU$\(7'2,\4FD\',2*NP78%+1'O!%1Q-UHQ/
MZYQ/^/Q3^=3.\ Q4/QU4]>S3W2Q413U4]&Q40'U40=VO[UQ4\ZS4J6E/0YU4
M0HU4355-3MU41+U4LLE41@U51SU52$U52?U44>U44VU55(U558TRA3Q-T%3#
MD#O*2.(7T20(>S")!C@$(3D$+XN5JK"2N!O 844:*QG,CMRV.'VTK32*QWS,
M";36-L.3RO/_%F!Y5E2KR-[<E@2TR31BR\KD,\V[T_Q:U]!$J,FT5)KQ5N-$
MH:]4(8295^1<UVI*S-3D5QNL,UTLPC/95S-3QH EF7R]O(*-O(-%0GD=V"5A
M6/IS6 _\5S_R5X.]MHE56((-*(W5UX]MV(T568HEV8("V84MV8Z5V)6-V)J!
M&9:%68A-PI9%V9$-V9LUV9P-4IQ569V5V8SU68\%VI<5VIW]V9Y%6J)5VJ!%
MV(O]E0LS)C3;T(J!C7B,Q:SCK*ZX1]D2)7<$"67XCEC:1]:$T>OAB\H8Q;>R
MQEO\,GTX+4S=QR(Z6U3TQR'R5M*2QS*5B%+L2G*)":IPBS(;*::(_RRD)(YE
M[+^W&BWY<-*(X C5@:JF(CFXS;?/4-S*-4;S<:7,B<L3 UOWB-LSX= !) ^K
M&A!7%-R=Z)^Z_:Z'F8WS@(G0+;GSZ Z0: +:%9 !@:[R$3R5*TJO@K_'_2[6
MG-O/""_GXL3C.%W\R@[-JSQJA;]'(LSY8\B';9<1=%KL35BC?=J495H. 5^;
M;5KOY5ZH/=GRK=F9%=CU/=KMM=CQ9=_N==_O'5KR%=_[G5_TY=G\75K\Q5?S
MC5_]?5\!YE@#=MGZ/5_Y+6 %'N#_W5\&ME\(;N!^G6#X/6 'SF +[AI\>EEN
M+<P#%!25<D0?],N,^,7<J #.U0A5L$RMZ/\R7+0'PYS>X&M7;D5$(HRT<16
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M%.\B%7_'&L[MMB&Z8;Z&TY6XR&@J'4P@=C:)1AE,B\;_W?9U[&[F<9Y#.HO
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MV$[=E&]$'Y<D%V<E(4Q*FCR=7*>P4_>EW%.6!^B)5*>X7O"HFS@ZS_S%AH&
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M.Y+K?J<ADOGF5[ <P:N*_PF9TV"W+/0<Z9&T^2(4P8B7X""P2DH,I>H6F)L
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M)+(POMQVF&;[)<7FXJO'O];;6PEW*RQ;R[N!F1 A'4U;I_TIUMXV+Z.%.C5
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M*3^\$\_RD^OR(]_R(L^W6UOP'I]%W'OP#J_R.?^Z\([N1FGFR'7SS4S@*IF
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M,_#%\-+#CT+8"*2QJ [[0Q%#QIX2DJBJY/NM10N]:_$O"!-#;JKX<KHL2*^
MK.]#"N>SJL<0GWS1LIZXFY'!'[5,;DH3DWS0NIK<1*O)Q^0$B4[,['2/3/WN
MA!,C&-]<+<Y Y_RSSST) _0_/P==-#T\8],S4BTG/=121Q&EE#),N7S4L48]
MU?320D/EL]-32TW41U05'3735EE5==/08CW1UKLLK3#7BH*44S@-]3LTRQ03
M-#9-%[]K4L8/V=1H/)TJR[)19J,U;] WP1P3_]NUZ NSK@H8$G=<<LMMB%8
M5R561*QL!-,_QJ1LZL C5W4635-_/59"JNC,D30&;RRKL*?X/1.J*/>LLM#S
M!C2X30^-O.X^U%:<%LWV(M8-JR"K33#,\ C^N,20][62Y"1%W@_DE$W>B&48
M56X)9J=D/MGAEC5^&>687>88X"]]IMDGFW?&N6>=?W[7Z()OOACIIHU^NF:A
M>:8ZZ:&#QMIJHJL^^NJHE1:1Z7VS9JEHL0$\V^NIN][Z:[?#-OMFN;G6VLB=
MT,9V0H6113C$9=7:>ULH,P1ZW@Z5[#=C4^>[;TJ/7VOXZJ7757/$A/VVB'#[
MQBSS2<5K[%S?'_%>DO_Q$DDW?7'L="9<Y%Y+'QORUS]W5T=K*V:8+CAW"STW
M"Q?UE6_-?9VX-")/'WCY'3%.*U-B#SO^8'!!=YXYUJ.3V+V9@XW>IH"3!QQ'
M)X5=R4B,+>;>V$V_7_=G=0&S>.'7UW>][8CLCQKN_".7F'[1^0\U^)/=_0#8
M/[U%Y( %W!\!R6? PSVP@0N4X+'XQT +.E!_&:3@!CUTP0I^4(,"9,T($PA"
M#_XO@BD<8 =)R!X7GM"$/JM1#&FHP!6^L(8YE*$-D[9#;;&PA N$R.>2E38'
ME8YU2/R5X^HR'D:%3SO,LAR?#.>^(#EQ*T9L5TIFMYTK8BZ$&?L;O)1WHYT%
M9.Y;U]K_B+G<^$8X'B1_S7O<=PYGKV211GT,LUT>S5<X*IV.B!$JW^#P"*#?
MM85P][H<DWJ'2#N>9D)DU,N,\D:]T?F-D=^Z9/U )*#X?3)=Z.K16T+Y1U.2
MLD%>5"4DD=3*MZ3RD;%DY2R==$K5U9);M'RE+8&&2X:!$I:W'.8OB]DC8!I.
MEKLDIB^1>4QA.C.:S#2F-$=IS65R:96]7(Z\F,)%2D(,-H&;RM3R9L3FJ<F'
MZ,,@J)Q'3FU2L77O2AB;_J4RU $,7>S<S?A$U\AP-N5A_XI1L1941A,]T).>
MW.0\,VE/9=$E=]93FZOPB1%"&NIS\YNCY7+7119Y-)(>%%_G_\*(/3->"8?*
MW%CEJG(]A:)/8,1C)T.S%YR06,M+5Y1F'?5((RK>M)#- J.+/J6@>>%KI, +
M)R/?>5*E/'6H44663QLCU3MVJZI0]>)6I]K5;5FUDE[-*E7#RE4DD=6E:3WK
M5]F:*+&.!JMK)4E;RPI6N**UKGEUZUZ)1U?/_'5L9N7K7=\JV(IJU:Z I61<
M!:?6P>(5L4Z%;&()^]>%DJY V%PJ5_0D3MW1JYOHG.@BEUK30]8.1UR5IU<G
MFS-%&E)->RW@ZRP21]SFUHTEM-OJ%O:P/WI33,9S26D/L\U'TI.,')T<\S@)
M,=3",UKWS*+LI-M$%%6W?E2,E_S@\O_1*J(SGZ;I4GUD=-V.VH^\WDTO=Q-K
M+>B&AKH1&6]W?]I>E<X7O[K3;WREQ5[_KO>^ ;:O2O>+G_[6][W^(?""D]+@
M!"OUOP-6<(1K6^#00AB[!Y[NAC7,1_I*6, &_G!Y.2Q?#U<XQ2+&\([:Y*^,
M-+21J+6LH R;I8,!UXZEC>B@8JM.?2H4=T65W!'%]RT+]A6<OXI1*+L78/9Y
M+KWII$SH^"8P@!91<T;6T7/7-$4K%GB+[N1MFG8JQB1SB;75^[%0]TL\*5K6
M>.$%ZGA%^T%N(>Z"7W3=/Y&<+FT&N<MI5I7RAN3GY9&3(^IK916=J]TQFX>
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M:0^-[A-@3XSPRQ__^_/?;W_\^.^O?_WT\^]_^0.@_P)HP (BD( *'" #^[=
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M"[GC"[_IZ[[SJ[H]N[CWB[OU*[Z'R[_MZ[^I"\#YJ[G_"[./J[__!WRW\KO
MV=O  XS E#NU$<S "DRTJ8J-L#H9:V0E6)($PCINC.+!6$) =$3"3)($I@(F
M+F6J6+(E.5FL4^LI+3H45A1@GFH5D2(E)18IONJ3NSHHY# HA?+#XM5@6-E
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M!]7E3#$*TI<F,Z8Y[>9.:XK.BE+3HRV5*%$Y:E26TC2I\!PI4Q.*5%\J-:H
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ME$#< 8<30N79)&" "JD$WGG_$/US(889:K@AAQUZ^"&' @A CH@D"E"!B!6
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M,ELMN=Z:ZVZXQ:I;\+SZOFLJ>8\RG*^RZ(J[<*;?(FRQP@1G?'# M78L\<<
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M!WRN\_F@ WR>WWN<]SG%_[G%^SO&%SS$,[K$K_O"RSN^TSN'%WK$._R35[S
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MNL]Q[W0&1*#J'K? _QU0=A"DG03E1T'AV<]_&71@!9?70?U]<(/]P^ (\_?
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M'=)245PR(BOCJTL.>B*B(TX04JG6SG@2*4;%>2**%3B*TG(!\D<>>__1=YN
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M<\%I=7Q')8? -R=!<FVR!#LU/0>A>E<Y(NGR*(Y&E1@U,'MP+.?R3(J"-WN
M/,_4(4@R7R&1)SCG-RX'!FN24 6%(:#B3.ZDI(G93.E$'MMB+;:2)43R+$?
M5JZG%UG5HZXV6'NJ>23'+8 'M2CR=B&A*UMW!'H:.82G)R'"/1214$.'5828
M4#)"N(Z*$9&2EP26)FVW 4RE(;D$59#GMA>A*X#"=5^2J)G74H+_N[E?02LD
M97)_YB)5FU#PPIEZ8BE""09UT"*/,S G)F49:[//BK/GJK,KB[T<F[,PN[/^
M6K NF[+;.[#K.KX8&ZX4N['I*['K6[(WZ[W:"[[<*[X7^[XJ>[X+Z[XT6[_[
M:[&E^KVH:K\$B[_^2\  +*PHNZ\">Z\!'*T'F\ /O,#DV\ /*[/S*\'\2L$A
M:\$.R[X9W+\#S,$56\'JJ[\=W+(H;+XJG+T;[, F[,$L_+\NK,$O.\$RO,+Y
MV\(Z_,(X7,+M>\ D',-"W*DW6;1^\YE>V$?4VX4"9ZF?&"$J:C<RN&J/&A4R
M@7*Q8\4480BDDP1*DGD;02%)P*5G#(6U_UAS!$"%H>-@>ZA2?0JT4"Q"! 1T
M[NB.=JK'OG.&,":G>_RF9*H^),-#LQ$YAY:I)>8W$2>(X^L@W68^(FIC?CIE
M]96G+(D_]C.<08N2C?/(0W9'CM2N-(E#G=C(Q"7*R>I?I7RDH Q)J0RMJWQ%
MINS*N@IEJLP5K)R(L!/*MQS+N3S+K<S+K^S+-B;+=43+PVS+3_'+Q13,NXS'
MP5K,L06+R1S-FSK-;ZC+.WK-MI3-O+3-QYBTV,S,Q@S,R"S,W>P_WTS*S\S-
MX^S-Y4S-X<Q3\+S.\JS-[BS.=I4W[.RG]'S*O8S/X*S/]<S/$^'/QRQ![WS0
M2CG0[8S.T&S/_?_\T/]<T %-S!6MT&A:R]*LT>>\T/N,R@D-TARMS!Y]Q_-\
MT1U-SBF=SQ'-T"/]T<X,TR(=1ED\R7SD%$F8E#GYEZC(B&\$Q\Z\/IP;EPPB
MQGOP>"=RNBY5 <QPAPR!EB2E*3];/SG"=M=DO%SX3B^BE3"WM7OG(49IEU\=
M+GB7RQ!"4:WRF&UX$MU$4B$B+<D4UXXI:O'#(489(F4]8%(W(E5=$%SY39:;
MIL&!KQL$AX288U?8.6 @4D\;>G&]N<7TNU0=I9BH>4W)(X\9$<H4(K?0* 2P
MFA\"V/4%(P-%)@A& (+-ML;3UET'5=P2><7$DZV-=2H%*[7;+M'D>H#_PB5O
M4BR=PY,TM27:=!.FN2OGY+Q9"6*$&)>??-(M/<H67=,&+=,N3=#5C='+C-T0
M'=+6+=#=3=W?O=TH/=T;;<T3C= S[8C:S=+Q+-[HG<[J[=#Q7=+IW=!G=-[W
M/=_Y#<OF3-/D_=[W;-\!;M+J3-$%WMX"'MWPO=\&CM_7_> +?N#TK=^X#.']
M+>$83N$1'MX37I(>GM$*'N(:_N$<7N(2[=\DG>$JON'-W.$F/N(@7LTRSMTT
M#M #GN XOM(-3N \WDL]!D=R.#[0>H@R0:HR@<S741HS>3ZYQ&'C&LQU*#]?
M+#I)\"BU6<6%<L9;>J7&!&K3) EA.CHN(>7-_R6'+YF$3QYBQO2DGPG(@!RG
MQV.&<:Z&L(+$BET[>-QC34;&J19E?NYI8$8>>DJD4T$X=L,HVV8O4S6$90;)
MM0%T0K1 ;HBDQM0Z93;%>9@[$7)RB@T_E<IJ5AU#Y/;I#J2'HJ[I]1)"IF[I
MD8/I,4CJK1YKIWYH.ZWJ4+;II5[KKYZD9"SKNT[K7V;KEP[LJA9K2=;IDQX7
MJ([KF:[KK"X_O=[LMQ[KR#[KTT[LOA[JT-ZC-B3%S(YZUG[L?I?MX3YJ7 CK
MY3[JPJ[MGL[MJ>[MR<[IKE[MQK[HP2[MZ!YLZO[K^8[M[L[OQ;[N &_N K_L
MZ0[J\J[O0?ONXN[OW?_>\.">\/V^\,\^\<IN[^..[[9Q\/M>\03_[Q[?[B"_
M\1'/\ %O\M3.\05/\JON\ ,?[QBO\C$?\C-_[1]O\R>_\#Y!DSWKB9?\M3C)
M8PG?$8?7Z?T>;$I!(7"&:B['*$V[3&PRO$6%Q9&R<A6 M6%N#ZIW<R.BF<&]
M))LV477K+GOW<6=;3-2B3&[K](^7(F<OUB8RN2#2*\:"]B>R+. K)O*T!#G'
M9,'YV3+8]Y.B+(-\ATG[2_@1NF[5:.]TU;] )<RT<4'R:*#G(7RBQ!/2]W&]
M+%-1+2=R>77&=R*"M7Z:N4/7(7;X*P*@NY&W"1-)$*J7+(<_%&OW3*/OW(__
M BQL*RCDP[:T,OI+W%+!N02OQE4U%2Y5(I2/7V1PT?@M/_)@H?,4S_/.GO,E
MO_,LC_(T7_T:S_T7G_TP;_WAC_WL3O[@O^WW[O+4K_WEO_[2+_$U#__PSO[3
MG^O?KO[V+_\I#Q"2[-DC98\ P8/V!!HLB-"AP86D"!2<.'#@08$"264<2/'A
MPHH.)5Z,6#'D184I-Z8D:/#CQ88C1T+L:+(A2HXK([J<"3+FP9D$2E*\Z3(G
MQY9 $_JL^5!H3:(6C:I$ZK$GS*9!AS*4BI$J2ZM+L8I,^!1A5(M>-5;E*98K
M69)0W^+\NE/I0*9P:9Z=.W4MV+9XQ\HLN_6D7X)LD^^R#$DX+M_#:A,#7IS7
M\5Z):.G^M?OR[66SF?M*UMDQ,..?3@T7):W8<^/%H6UV3<G9=.7!L5?3/DK9
M\\*2#C4*9HG48FF$P5>J?-HP(DB1"U\*/+E5)7&IU*.C+*H]HR%E!L2/%R]%
M4G.O%#EB!$_>_7OX\<F;9YER(@&O0H4VD8^?>M2R:CL.J>&*JT\CLUHB3O\R
MA/YQ\$$((Y1P0@HKM'#""@00(,,--21'PPM#%'%$"<^SR$3ISI,(*)B\X@JZ
MF++C[<"FKA-,$IGL.XY!A98JB",33S0M2!Q9=/%'P.S[T447<62(2><J<O)$
MI9RK"2,L:TO((RIUG!*X+*O"KT<R,]K2I2Z]L[),!E=D4\O;LLM/H351;'-,
M.^%,2DXOZPP3+#S_#))+O.;\LM R 0U3K3,30E1-XO(4<U$]"4T4(S\3+8E2
M,^-,TZA,453TS4[W_!332 6]DE0R37T4U%0U75725BT5%=7B5$6(TUK1?!57
M,&7=E=5!?;V4SEA%W9381OF$-%=AW:2U6$>//93_V%D%;?949*%5-EM-M_VU
MVV"_'79:<:T-]4Y>J7465F_99=;3<:^=%EQET[V5W$?E19=>=9/U5UN ][57
M5VD)=C7@> 4\5V%;#5W7X9$Z+95%XJS<J24@A<SX,$1_E;;%^P!-<DDOE=RR
MHA4E.F\/,"K8X B:CYBY9E6H)."0"FQ>@N9?@'M2J)AGOKF"!6S*$DM25%F@
MYII[-OJ(GF6V&6F;5.GYB)^/$$"5_S %H^:?-^CZ9K2YMIGJHS&2).:K:?XZ
M))^$4D7MFX\ 0S_[9I:ZYT/2&[MLG-<SE,4@#<SHID,!].B@^_ #XY -JKZY
MZU_RH]ELJI$6>FB7M:8Z_VZPT21@[:-_H2SOS@/G:]=#UD;=+DGVB+KF,!*U
M;^RM_58%R]/SKIR9^Z1UKG::"?^:*/RN-KH"U<,^BW*UU]X4>:LKG_KOT:G.
M?,V'<ORX77TE%ICB0,,MV/R&)YUW88,G=O]?^-DO=V#UZ^_S_/DA-C9^_HV*
M?A';7_L$Z+]J =" RQK@_^S7+_21;WT%O%\$WT? 9U6P?_G#(+PT>$ ..I""
M$-Q@OB:801*"T(3Z0R&V'A;"!#[0A0F#X;N E4(&(M"&_)IA^E;8P1OV4((L
M]" .\<6H$Q91B!<480OO]<(?-E&)3Z1A%&,XPB4V\(J0HMN)*N:1SW5'3[NJ
M$_]VAH,?YG%+./5Y4\48HS@R(4D[B+$7?^+S%.@\JT<_DD\?_3@>920!C9%Z
MD6D@(H7X& )R%9-,BM@8$B@-"25P,I$;=48B3&9R1![B9(<VI$E0@K)DM!,2
M=?Z2'D>:DB;JL5%FE,*D!-%%*:J4T>=X,B #(2XN$Q%:=3 S1UOF$5#_61 >
M=VF2,-JR-!WC6%H,I"#&K9*0'>D86Z33)$-&LSG3G$PU)4F7DPEIF\_LIH!V
M<LUGQD@PXU2F-\_IS# :TCX%:J<Y 8/.>"IHG@JJIS>;"<Z-:9.>V%DFQ>J#
M36B*<Z#U*:@UX9DQ>:JRC-2TYSL!FDV%\I.@[OSF5,+_N<Z%2J>A]WSH1_<Y
MT7(R$TD732A(-<I0CO[3HP'-*$I':M&98M2E-HWI2G/:TI-R\Z8=1:@Z@TK.
MH<JTJ!&5)E)[>M!T,I6=&ZTH4:.J3XD*]:GXA"A6F]I/>RKUJ@)]J4BW6E*:
M[E2K515K/LG*4[;Z=*E>==%#;B3-I\!&E8Z:)2'SFI.[)B6,9JF*<=9CR *I
MC#KXN4_8!'*WN!$.#,N1",]Z=X1;^(>0"ZC:VBH !E$9B"*J$( NH$8XRWEV
M=*#U#P'",+7*'6$/BYT),Z0&M=C*K&=G&UUL?Z:*D7"VMS2;+:!:M@?N_6P!
MGY,$WFA6@4/XQ+;/55MQF?,Z_^VXK$9I >9%C;FB\YCI%YY]WA',0H"MH6ZR
M*W,C?I!KM:T5ER.=[5K@(B>0"NC6;]%UR5_M85GJ5D"S3[F;U<JFBDUT51*<
M+>\1$.P<MNE6;][9TT(@F[;9CC*]6\ML?E9$@%_<=FL#7A%D;R?BM74-NJ5S
MZ7K.F$RJ^E.N8ZWI6F4,5;?6V*EQQ7%7WVKCL,XXQVK=\8VY:M*L%CG(/4;R
M5V.\Y".G]:A@52F3I9QD*ALTRCJ=\I.KO&6@8MG+6D8KE\4,4QZ#V:AG-FN:
MRQQF)Z/9R&]><YS;/&>6UGFJ<H8RG:4:4ESB^:=Z!C1%!3W7'ROYRWZF:Z%3
M2N8\__^YK('N<Z0;/6E#5WK0DH;KH6E,Y"P[U-*)#C5)9<E*CR:HER*M)4UF
M(TZ:4)B8N63UGN<HF*L@UE?,1$F3FA">]PB2L6?Y7%U-\D=DQT<2TK.26(Q)
M "_$ASZLEDKX8GWMY+@ZVU*1B9@($TIP@YM#X^YDN,U](5SM$3O=\E&O12/:
M]-2KB!K#)G,=INL5:C1QCIP+@5:E8#B"TUI8U29:J/U&;GNL-IJQ&,;8\L]J
M>?5&#&]C8&,$G82;$5F^S)/&,(KQXRA\<?VNN$$A7NUH3ISD';?X-R.>\H6O
M/$L>3RC(F:IRCL^\Y2?/.(V<E/,X[GRE+Q?YQJ/)<I,/'>7_1?_YT76>=(2'
M7.--+^73'Z[TGJ>2XDB_>M1O'G.@5U+H7I<XV)T>=*C;O.PC#[O#PZEVF+/]
M[&)/^R2E[O.M6_WM=O^ZW*N.]J[#G>EY!_S>C;5VH_^=[H'G.^*I?B.]TU3P
M4R?\X@U/=,K+O/"2;WS<$P_YS7^\\X-?N<,JV4@C-620;WK+C9-$SWC'G(=L
M3-RZ>1U:&K6W9?>)W?:.< <T8N00J#T"?W-)"KCYC68YBZJ*QA8UWVMO=-G#
MFDF0VSVJ_:YDO.2=\]*;MMC&S;-[R$S1XE8!%D>N1Y(0G=5HMC>3&&1SR3M"
MYFK#NZG-#34I4]*3H(PXQ]F1DMD5_P*P'17#F4)QKOQ*FDX9)%X2';;)OD9Q
MKID)&B9YKM0Q/;S@&>DSFSJYOOF;&[IA+.3+K;4) ^"1G>=:  VDF^N3,!'L
M&Y^YFL#II1Z)G0BLG+*HF$W8&<Z1/@.K&<Z!'H22D8MXM8.;/+S3/,OCO,/S
MO,>C)+=S0LQ;PK;3-]%[0M*[0IJ[N-'+/"X<.R74.B:<PBRL0C(,P[K30C"<
M.S.LN2^T0C?$0CAD0SE4O#?T0CM,PSGL0I=;NC;$0SK40S0LI<K+PS_,.D,L
MPT%,Q+OC0T'T0YY[Q$540\;;PTKL0S&,0T@$O28\0T"\0T]$Q$GLN\^3PD8L
M1<<[Q%3$.F)*Q#E-7,-"A,5(W$1,I,51;$6R@T(_O*:)&D$M43W&H90?N0F?
M,KDO28^E8CLZ09QZ*XIF<I*2B(\D""\!.1-$*4:,0*1DZT8#<+8O*A2&NX_W
M" ^QX"@4*8KNV,%"DJ,YJ?^E)3DW>1213OH03ZJ ><S'!SDO1^(1XS F_@.?
MNH*QJ=L1VU-$6MH3CSL)[8(,5>*WAO0WACP3!)F,[7B,P-HK5@)(;R*L'HNE
M7.J*O;HV%PNLJ0!)&^0N;3.FDKRW_) .OQ+)E>Q(H>$JE%PGF<PKDMPGE^1)
MC[DU5],.EN3)?_3)F%1)G1Q*6BK*A#S*71)*FC3)EZRVE'S*_HK*GFS*D$1*
MJ+0GC[1)F-Q*JX0<K&3*O?A)8_$OLO3*FGRHF]01KKQ*MI1*HQ3+H)3+COE*
MMPS+JKS+M<S+MI0EOL3)N/S+:PS,DQQ,N!S+G5S*CU1,H%3+QMP+LWS+R!Q)
MI:3_S,>D2L)DS,S42\'DS,7TR\D$S<04S<N<R;G,RK-T2M+\3,2<2B-,S:0L
MR\V<S;3$3-L$RVH+C.5@M97PK^4@B^ T*J(\2U4;BSSK(I#P-YAL$WM0A3I@
M!C#XA5NH@W@;)8@@ ,CJG9[!DX$8+^>JP:R0G-2:F0SSC($@+;*A+N4# U5X
M+^7[+%42'>WIF0<[+.'Z/@F3,.>A/[4!&\D1@.Y!S_40#??*+P!=+P&1,*,Q
M/OS8S[RQKL-ZMU43"9[(+NI0!>FDSA![-E<R):'@0/&;K(7@GIFQKYJ0'@)X
MOJ[YF=E:K.::SPUP':&!+ZZI4;=KB1"['?,ZQP(+/]FB_R57FJZ9.; $NP@%
M78+]&A.'\"^X$4('VP3"4%#/,C[F"K'Y-"\$&26BF8"MZ1K4D=()VP[9L UD
MPK;=W$O4S$W5!$RZU,J^E$S8C-/6M$LZ7=/0Q,UJR=/5K$S(=-/:_-/;1,L^
MU4U"Y4T^S<FNA%/6M$Q!;=3#M%-(/=0WG=1'#51+'51'!=0VW51);4E/7=3"
M+,W8K,LY1=1.+537]--5551#952\Q-11C=52K=-,_519-4Q1954\555:]=54
MO=1>A=56!=9B95-2]4P]/<UE?<UFE4U;9=9$5=9IA=9J%;CN8K:^8AE'&2EH
M2LF$O+5QK9&2(8SGI)&5P8ZAY/^K=?HU^%"1D/.OYS =2? "0_#&;FP"*9!-
M)GE(@Q"*)  V\E"&L(2J&O$F*_E-<%HI7D,32=!'B8T0<O,D>YS8>?2B;#R)
M ;RW5@D.,GRF[#I'9QE!>@LZI4$6>7TE]+DW:.0WAKH+B]FC.6FO?RJ5E])
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M,#J<WILP:>5\(K;.QE993)F/N:ITNL90-RDIJD6A.>"($K1SV'AN"CLQ>KQ
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MER.DAC2D.(1KMI*:Z9",%,PX24EJHXI-[$UD#UG 7.0"K(= #($EP0H8=$:
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M!<4M.)$JA($IL456.%%A2 (9_40R,@:AQ1I@1) +E=IG#,0>M&,N$=_5# ?
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M71E%_;8=J-1!+M/)YUM572Q</;=#?=-O7=;5D=91O==C_==9_=A+Q]9]'4F
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M"WF/.-3 2I:R0;F"!%PK!ES!PJ3 $L/ &[R0'9R\"SS!(6RZ(YQZI@'"1^3
M%NS!*VS"+<S!VP3#$ES ,RS"-4S"'RS#-DG#(6'#&8PJ/ZS#0<S#,8S#18S"
M.ZS"-ZS!.<S$1^S$0[PI- 7$."'$U$3$5VS$68S$3\S%P2G%7TS%6VS%8XPH
M*5S!88S&8.C%"0S&5>R#.>*]4\S&<TS!< S!IMO&=/Q-$O.@N!1-XG0NI8)1
MRL2*(Y9N&?]9;++B<MURQJO*OTYG<?FH3/$AH#2TE#?H,![3(3WI0OFC?_8&
M4WP<+FW831HJ8MM(8)=,1.NH0<Q('B?GA4E50 KYP02P!P;WKM$BD/Q(+<8"
M!N]D%1.$,8W2$KF,7EE(<0S8;"L8LEJX@Y*14;>I(TS7P^ ;/ZLAC[F<CAKI
M7E53/?5TO>5K0!X+8N[4CG$\4R:T@2R&4C7TB^W6E]-E;"75:]1\Q@ISN\C,
MS+5ICM!W;=@!%@$\ODD,Q4NLQDV,Q_RLQV0<QV;,P@O-'0T=P7E\P@Q]QQC]
MT!IMT1S=QQD=Q1M=Q@Y-T5T<T7R,P1Y-TB!MTAV-TFG\TA)]TC[_G-(E7=,Q
M?=,S;<<P+=(M7=$^K=- +=-OK-(7G"@C+=0(O-)*'=0X3=-.C1I+'=5#/=4E
MK,16W=1)3=50W=-<K<5&7<=A+<=??=0YC=4]K-5@_<!=G=4*O=4&M$/NK%1H
M_9-:I(U!!<+FVXSOC!\<=$'(-TU5(Q!!V1K0848Q03L#UFB (;R0'=F_*PDY
MJ8Y"J$WQ?(/S\U1=0;WGJ9YVP9Z>;6"(@V//3$R'YZ^&UEPJG%$S\I\P=A_I
M;*"" B2=!,VS\S$-&A7M B+3QKOZ:F7RII'PT]=714(2*U4DMBVJ,VVH,R3C
MPG( :K(V]6P 6]O2K;[4_9[/77.CC-C:_TU#T\:DSQW.Q;.Z(?%-UQW=U#/=
MXJW>T/W=#YQ,X G?WAU.\XW7VV3?,X;?*4O?*&G=\>W?Y[W=_T+>.\I !?[>
M G[?YNW>>S3>"IO@V:V($<[?J2+?_ZW?Z=W@_?W@X7WA'I[A! [A]3WBY:W@
M)A[@).[@*A[B)][B'_[B%A[CW3WC%1Z$(B[C) [B-<[B-][C#%13J8HH![O)
M$ZMM$NHTO(AN4G=CW:.Q+IS>0;.L36)?JIMLS/IEW-HZ]2P:"2,F2UJ4GT*M
M8[HO]9)DCSPAB;'EO^K:E*(ZE'A\B T^JC)CZ4RF->$O2">OA^"N [4!!#=0
MR0(&JB"O9IIZ-_]!KX&J@R8KH2?;L+*$,"0N,O/#;Y>BB@ ZL\,MJPN(SL9S
M0"D[L*M4SR#VS"*SY-U5YSCGID9('*_G=FU>K/J$.:4!WFY<GP>N,FG6UQA&
M@V9*.[4>C/>'XA3>WC .Y$#GXCD>7C:^[#B.[#^^W\;^*S2NX\^.X-;>[ !.
M[3R>XMS.X=7][<=>&RON[4$.[M*.[<JN[=B][L[>[A.^[?#>[1U.[O1N[LF.
M[M NY.&.WN.>[N6.Z^S.[^[.WOH^[?<N\/E.\/%N\//^[@E?\ O?[^H^\0]?
M\0>OX0N^XPPO\0YO[P%O\0.?WP#/W23?\"9OX!)>HA</7FV63NZ%JODVV[)/
M8J/OMNS-*$(Z=C&25B'?**XXI;(*]&'VLRYB8K\7MGV2W?1.'SU-\*4 [V^6
MPK%$B6\:_U,1HXV T6N 6^\^Y A4K<I\FDW85U5L":W8PV+<]T2^RM2P1C^&
M]KA5FI1B)"@;$L5 .+CVLAG!!]QT8 [/=DV+O#V3$@5>;8B]_*MRR)<X" D1
MS)V%ZVL\+_/X#--CZBB?E)\AEA_F]#OYS,3YZGSY4<?XGD(VG1_YF:^3D^[<
M[NOYDJ_YH1\BJ8_YIFB^1O0O\4SZ+,**N/^^* *KL+_Z-0_\!4V,JG_[UI7[
MK@\;O+_XC3S)E3_ZPZ_\C7\TM5_ZT;_YM$_]R>_[RV_\-X_\M@_^UX_ZWE_^
MIB_]HK_[U6_^IS_][O_]Z\_]NO_Z]+_]LW__SO_^ "')GCV!!/\'&A18D!2!
M@P,%DG)X<"%$@P02(AQ(<:$]B@(9<C08\N-% ATQ<F1(ZF)$B_9:*O38$.3)
M@@-;-B3I42%+B 5CUGQ94>''@P1:EBP8-"=.H2%GJLQ8D:/.AA!+&J08,2I)
MF@>I7B394V+-J5['2CS;TJK5F!E3MEWI-N/#E#>-+KQJLR)4ACYGTC5* ,R"
M0X<J5#AR9,.10V!4D8)\5^M#EQMOKNP;$FK4NDYO%F6K5:Y&S6:'8HT8NBE*
MDT'O9LZJ%&/<S$3GVH3)4^M"CQ-E5I7KMZ11RGM9#C7I$JS$JTB96S5^$BI9
MU9J'AU5>.>+RDTZAPPW96WC9ORY!!F7_.K/RQZRY,7;.3CP\QNDLU0\G[W?[
M_)IB5VZT*:_U\A.-N[C\LZXH ?';3+_9]MM*.J(DLVFC!@OLJK\'45(P-@OU
MJ\E [S8$T*4%/YS,-/[0XJY$"@>\T"D1-6QQPA/?2G$_OVB4L$/0<)Q/1PA!
MJM''"H%T<$86>PS00R0Q7.E $FUTDD 9,USR/RI_M#)$+"/4TD@8051QQRP3
M;)++&+V,<L0BTSRRRS*'1/ T.,?,<4,IWS2QRC7G[*Y.N>YDD$PA YU2S$+S
M5!),-/M4TU ]W602TCC_/+1$F:[BR[KE+FKOM^S(.BHYLGHL]3BIS,+1-JJ.
M E5#V;([#\)._WL;*3WT6&*(  -^!39888<EMEACCT4V666754:2H=@<[;:O
MHLN*MZ) C4^@?[;EMEMOOP4W7'''!;<" 00P%]USR3F77'??A??;(27)R\S^
M4BHMR*0((HI>C8RRSL,5FRM1K,Q$"M)"@E6<E-^KO"3R87XWQ4LO?X,SB5XB
M)S8I*];,8E6[TC8Z33^2S9,IU! ]!DHO5D_F#K34\-UI8@WWDOA3BF?>^*^#
MRQM.T+@JY%DLGT?$66BGB,:*YJAL1BOI!X<6F:Z>._JY-=]T/K5>#HW&&FE<
ME>ZZ8Z>/OGGLJ9>N^NM\-4Y[/;)W;OIJA[+F*><-9:X;[+O%EGOMLO^+?AMO
MJ;FFVVJ_H7Y:;<0;\MK"P@$/6O#$W:X9[J@=7QMRL^UF'.BM.^=;\<GCKOSQ
MTC%OW'#.=?:<\,Q=#UQUIDV?G?+185]=\MQ1WWWOQOON"T$L#]XI+Y)?$VDB
M@,_KR56"2.-0X]B5#UG'%Z'=&_O03;ZR1(@30AYE2: ##J%^G_[>?/-4!OA\
M\\C?CBBCOUXX?5,GOKM7WTT[6%[PLY/EY(I'7%%?A*02E_%9;&'DHU=@)!@9
MYIDL?N'!5Z ^,IR@U69ZCI*?U^#6%_9<4'0!JM[P%IBOC0D0-BX35<QD2)%<
M]2]L(?L4"?7E$!KB;'(4NME[^ <[!ZTJ@0W_+!YS=B@J 97F)_.RC_C<@KPD
M8FP]Y8-;<M0C*!ZF!V72&Z#PVO8_M&VN=J2['>O*.+S4H7&,9PL;\/06LS22
M,8YF;"/OZ@C'O\EQ;K'KV^GP&#PZOA%TFF,C(;NSQT/2+H]BC!P?0Z>U.2[2
MD(M#I.@J2;5(-E)WFV1;)S'I2$5R\G.C_.0?>R?)3%)2E8Q$I1\M!TC<M2Z5
MLURE)V5INTL*,I&@'%P@?S=(8%[.CGTDYBM[.<Q?*C-C^/M@#J72G*51[V1N
M3$C&,FB\ZM6K?-H;$,,RY['UU6PWF;$>2L[FDU!U49P.D\*RY#E/>M;3GK]*
M0DD@@A<:5JN"S].._P"7=Y*#?8=H!(A70A4*KW4U5%WH6FA$(TH6S)P&.M;B
M8%F\YY=G9BN%5 &0Q^I3P"OUJ#Z]>I7=I-<SZYQM3FJ)"5]:1IK>2$M%L H2
M2G %(>$DKZ8Z0\_]U%(9G6D-9=?"2D7?9T*8!923FXJ52&+*5'0Z-9103:I4
MEUK0JC;GJ9"+:E*FRM7WA*9K6'V(4NM"5NSL"H:XR:I8MYJ@MGX5J6G5ZEKI
M:ARW'A6N>)6K7DO&5[O^M2R!5>=>:]I7VXSJL' 5;' (>U6PQA6RB1WL8@OK
MV/K$![.2U2QE[_I8SU8LLU8]:V4!>UG3@A:UFT(K:8_RV8^^%G*Q[>QL6_];
M6Z^*UK"Y':MB;5L4W*J5MDWM;6I'"]RYGC:YL%6M;(/K7+-"=[2?@:QE.!,;
MT%@0,#7=852S-C2<]J> T\I-\C2JL(L^S5HGW1_^W-,=RGQF,ZT1DGW)H\XV
M:88R8<D@Q-Y'':I\5C9+^8QY=V@7 @O)2QG,$U]$BEV-[I>BQ,W<3%)EHO(Z
MS"+RF8]SHF)4G7JT*U<ZU:$X%&+?I(J#@$'11IF"4U7)%7$>LV2OH$CB_URX
M5@K3<'5)*^']]':HJ1&-3!IX&_;D",A]PJYJ@&K<^]K/:YVSX(JY4]7J;.:Y
MLU6@8TN\'*,V-BC,C2QOA4S<Z*+YN%U=\ULY2V7:JI95S&Q>+IW9.EGE_E;/
MPGWN;=O\9^K>6<YG)K1K XUG/^?US79F;'$=O5ODQMFO<YYTG>OJ6TPCEM)P
M-O2E$9WI/8>VSYUFK:;Y;-U&>UK5IF8UJDO[ZN$>.JRI+G6M17WK6>=ZT;:V
M;*\!;6DS\UJWM/[UKH-];%\36]*N;G:HB[T:I.*GR4\QD[4]@M.;2*ZV+;M7
M@4.#'^]T)J0*E"&3#3NT:?EP8TO)T67,XU:%?5B"!)""4?*-;PGN6QGW!'C
MSS=PE12<X -W%EZN8UEYO]NCFUEQ5Q+_S%^)5KSBZ<*X0RV^<7)5%60PDQ@
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M#7A"_QM>1(4R[. .7=C#&\80B%5)XA"76$0<5O"))FP>$4%B1"<Z,(H)].$
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MCI:IF6_Q?L[N7J1FY*K[^AXE71,*SF_[)M3[WB]R&J#^PAK_VJ_M]HCUL:\
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MV&3WBB@V$]ORU;:A1A*6([!T@LTUEX!\-3#="/A'W'')+=?<<]%-5]US!1"
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M5 =__]EEC':MU<UD(Y/&E38L/0(K,3=IQ1LV53>?48SH/3JRG;9\[<PS=J5
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M^.*'G_WZ[K?/_?ORQV]]_>6SO[W]^N,//__GYP]\_TM? -5W/P#Z3X *-.
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M?OCMG__^^O'?7__^\_^??P#T7P )Z+\L,"$)!E"@ 9*0!";HJH"W.R "%ZC
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M?([C,FGS!"_P5G!:)JLF6.UU&% XZ(R5TDB2-J,#:S";S Z30(,%P0-5.C
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M91JQD1FI,1NKD1NW41NA\1O%,1RE$1R]L1RO$1TGA!T?(P [+@D![R+F"8L
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M-,/EHTR^<TF%_X)>JDR7Y^G<?[?: 4.7'B;WE^9]Z&&,!REWJ@LB@1R(JH+
M=$4: 'X>SDTNZWM^[(6>,7Y^!)%4R15]Z2^#ZO-<8(I^KBQG-!(I".9^L8[#
M[N\>BEZ2-&I>D9"<59#0($+T\TK,Q<;.\0B_62>#U!'B["U(7ZT%\H62:XE^
M//$\JC*)=U.MN;Y\S6B74=-V.LC^Y=N;L35_<E0R3TV0S8:=,D(T/I7^Q/:S
MP;:<[&>[._C^\UL<XX=?XS/>^(G_^(L?^9=?^9L?CWZM"%]964>1G2/5>A.,
M\="+S09>-O![%O]=ZE*T1*;_85&9('DQGW1FOENM7Z2__=^?_>-?Q?_DG[WG
MW_[K'_\'D_[U__[Y'R#H-1((8&"C@@4%$C2(T.#"A0D92HSX\*!%A1<M4LS8
M$&/$CA(A.N28L2)(DR5);OR8DN7*B2-=QH3ID69(C3-%UM1Y\Z3*G#AW!NW9
MTB;*ESR/ O4I4RA3HS^=%DT:E2C2H4JE7GU*M:G5I5.Q5LWZ52O8K6&YBO5*
MMNW8MVSA0HWK,F%# !WO@OQHH*_?OA?Q#A1,+^+?OUD8(@20Y+!CQXD)#WQL
M@*#>@XP=)_E8L#%ERED68[;X.(IDR9X_/TX2>#0 )HZ99%%].(%EB8\ST^X;
M.C7MQ+<7^]YMP/9@UP >TQNNVGAAXGZ9'"?_++HP3LG+#:VF+-UC=8J7!0N>
M_5AQ2;MWK\LD#]UO%LMV#^9F#KH1_<>AQ1>$?5@V],WLT;99?(4E=-]G^8UF
M'7[:4::0@>VYAU&!C93&V4$!ML<:@?(Y9AIG_!WVWG2Z16A :,=95UB&_PV6
M7'M,>&<A2]8=^-F ! H68G0LWH@9>D0]:-!]23 AGD,^":G?0#WN%EEZ@LTX
MG84N!D:?1A%VE]".$FID5Y._/41=A8[9UYYS$H&IVH IWE31FV'!>96<0-$I
ME)UNQJGGG'O6V>>=?^;)YZ!^$@JHH8(6JNBABR;*Z*..1HKGI(%2BJBEC6(*
MJ::25NKII9]F&NJF,J-V"NJIHJ)*JJJFINKJJJ^V"NNLLM;*J9Q GK:1BF-Z
M=Z1HO5;)&9 0Y8I<E;Q.-] __\PVZ^RST$8K[;344EN!  )<FRVVY&!;[;?@
MA@NM>+<15&R>3EEV%+ TC@11<.8>!*^\] (0+[GUSFMOO0C=J^^]_>;KFK\#
M"XSOO@@'C/"__!K,<,(.%[RPQ !'?'#%$T.<\<,<4]SPQAYK3/#%'X^L,,8F
M6WQRR0:O+'++*L<,,LDO9^QRQS3C?'/(.LN<\LP[Y\SST$(7'?31/L,,=-(V
M,XVRTC]'#?7432]MM=158_UTUE1O[37+7(?]=<(IO\N0V1ZI2Z9C6E'$95\Q
M*MC(V\09AY= =(>F]D*/27?W0'0[Z:5#JWU<HHD;[OHV$S9"]I%"VVD8(<!X
MF]A7$/]'\AU;A!L*E.6$QQY\H9J:";QNPSO1W?G9KJEGN+FD-W>NYYIQ'F$C
M(;W=^&&[_]5=ZZ]97MRQ]" .4>_XM5Z\9A +A#SS9A<>,#UY:^2\\+PM*=CS
MO),&8^NK*8P0]W^Q)M*6FT<8V41D_Z@8W0T:4&2Y_-+_4 +8%_<X0^'+W?_^
M (A">?:5)?W0S6[WRU]D9M<WSK&.'K'ST<@F:#$*SLR"&*R@!B^XP0QR\(,>
M#&$'1PA"$HJPA"@\H0I-R,(4MG"%+HPA#&?XPAK*T(8TO*$.<\A#'/IPAS_L
M(1"'*,0B!O&(1$2B=WHR+. M!F$<V=?I.(.2>[&O)J<)'4'_Q,7%+G:16V#<
M5K:\2$8R,C%%3:10LBCTJ^^<T3IX(9:"V#7'T-$1CG>DXYBT%Q\^DHAX>NQC
M'NWXQR7A$9"$/*0A UE(-_I1D8X<Y",9"<DZ3C*1E,PD)C=YR4Y*\I.(]&0H
M0;E(3I(RDJ-,92E%N<I36M*5>X2E(%6)RE;2\I6WC&4N9VG+7M;RE[CT93"!
MJ4MA%I.8O$1F(X?)S&,V,YG/7*8SIPE-:@ZN7+FZT"$5.9GRJ'%7.@H?12)8
MN(?TR&_F*0S=?D5.S4S(+O_K2.#^,\MYWDY%@\D?]HS$D79VCSH)T:=[,/,Y
M#NU*;DM"WH< R:'@H!%P?</F0PMT_\?KK U[*"J70"T7H_C8<Z.Y 4\C_%D^
M.)E(2R/5)_VDYU%](O1%O(OC1?(FH_QM*"8?I4U 822DY?VS=3E=$T '$U0!
MR3$]8FK(?V33QVOV2J C6N-CI&#(>)J'/I;YG$/H%H+,%02J>^DF5-M45-#X
M\:R,1"LAU<K6M+IUK6]M*USG*M>ZQO6N=,6K7?/*U[WZ5:^ [6M@_RK8PA+V
ML(--K&$5B]C%.K:QD&6L9!\[V<A2]K*6S6QE-XM9SF9QJ/C4)DG6Z*6C&G2B
MWZF+LK*XQ#*Z]K7,TI9LPPC;VDY+;1ICG6H5YB[KO91^4-S+8(,C/BVNE;@2
MTR-R16?<L_\NM[C:>Z[ADMM<Y1[WNL[%KG6SR]WM>K>ZX(VN=L,++.EJK+SC
M%6]WR4M=]7[7O>QE+GSGB][UTK>]]7UO?N,+W?W>5[[^#3!^!PQ@ O?7P-,M
ML((/O. $,_C!#H[P>1$\X097&,(7EK!Y-YS>ZNB67J<S+XA'0QDHP6>FTJ,7
M99*POL#%38IT<^CVF#>2%;>8.\']*N\2QQ P,?4@3!!@WZYISR(A) B?X>=M
M5!,%=,8.G8%;'0%7<^.^M8O)3OY,% Q2P.N4S7!"5DU4.7*NO^D*.?3QVUL%
MY9W[--DB69AGO0BJY2S3!LHKGIX]96.1QK&X(%FX#W 49&.+N!C)8"9*T.%\
M!^? C1DOXB1TW]:7A3 ?IKA3O4OE'&.W_4RZ(7$VJ]JX0VE+_V7*T'DQETLG
M128E&46O,75TV#<WU?"Y,Y^!H@5/4M:^% DS,G:-FYTL9T->U"_F\Q)+S;/H
MOF@NU?$ZH&Z'W>C/X)9VE'DSH)/\+BJO+];]H]6M2C5N5I4[5N<6-[G7;6YV
MH]O=ZFZWO-\][WC3^][VSK>MX+WO>O<;W__6=[H#3O"!&YS?!_=WP@&^<#,#
M%]@0QYA+K$BS$=<59AY<_Y9M-PZN,'9+C!7@N,C_<2'P:'.6$OUF*D-+K,P5
M/"6@.RB@8M[;F?N)YJ"SN<[1=?.>[QQ..*\YS'W.\Y\/W>@R+[K2@4YTIB-=
MZ$Y?^M&EGO2H6WWJ5Z\ZUK>N]:Y#G>M?]WK.J1[VLH\]ZV87NMC5GO:QK]WM
M;>_MV^4>]Z##_>Q@Q_O<[4YWO=>]Z7EGN]\'+_C"Y_S,V\2.L&(B6DA[DY=5
M:E)+/212^K 3/\"M'H5D;0#3M.E*6;3J]9(GIOO@4YU:OM!]%G^CTZAIT(5!
M<FY<0S?/>^1*WX0I\T"2;7RFU#&8<U>P2OFF0 LH^,-OE[%70I\Q'ZI7HFT2
MCO\<TJ2XP?'8Y9.I0%X?GR:99Y[ :<B!;DJ0-+,Q>)1'EN6!92(4IQ^?WF<C
ME1;3H_ ?I_DDH1(<J?>8KMJ%.;\S(;+7'ZU3?SW5; : .:#V&,'W3OE$>4]D
M)J2G&/>A>/Q'&4$ .HXF36ZD1N3C:W54$]*G?:X64>DT(WR1?G$D&DG '&T"
M  /X%PW(>#2E&".('=4G)AT2:<\64W81@WX!<XP1/T&X2#F"6DBX1D>HA$FX
MA$[8A%#(A%+XA%,8A51XA5:8A56XA5C(A5K8A6#XA6+HA608AF4XAF:8AFBX
MAF?8AFKHAFSXAG(8AW0(AW8XAW=8AWBXAWK8AWGXAWS_"(AC&#H(16L]%8)R
MPQ.(UQ+@-%HOB'(),7*2""VS)48?-XFV)6/Z4E&YU49@83:L168D%#1CTS-7
MTS5@4XI$@S2G*#:I^(HUHXI&XS2P:(I:4XNK2(NQB(NSV(JRR(JWN(O":(NH
M.(RYZ(N\"(S%2(RN:(R]&(S,^(NZ&(W).(W'"(W7N(S9V(S4Z(S*R(W;^(O"
M13Q>HHD0USPD%E+D:$Z4(6EE@HY#%B_EQ#K,D6P(T8ZB8V7GF&E>TB2PYQJ<
MIV8&$65+I&.0P1$KYEL&>9#!X2 9T8ZXA7V=9U$)N1@$T2.;<3;U9S!.-!,.
M]WMKPB;LDC;*4S\ B1\UPUL__X,7])&1%GD00%B$*<AJOH4@*Z4<(+:!WA%E
M%T(W2N8][W@N)F@829:!<_-KY8>3^'*!(O*0K(81BV,X0XDPX:.!CY$ N$&$
M!M!J9A9D1<)G;[(X#Z>/"A&3)\)XZ1A3:2)JS!:0+\F4(D(YG/=MA (EG$<<
M26 2"-.2H@B#)=8P*?8WXB00$V%YK+.1! .7 W4;? E 9FD Z221\D-%()E]
M&B&6YWB/328;3_)AT+6)8/.9[06:*1F:IEF:J$F:JCF:K"E?J^F:K2F:L#F;
MLEF;I_F:MIF:L7F;NZF;M,F;O^F;N8F;P#F<O4F<PEF<RIF<S(F<SGF<T!F<
MSRF=T?]IG-1YG=:9G<LYG=K9G-6YG=]9F@\',$T#7,0%BA(G/GN#.IF)81&!
MB?#I<=@B6_ )6R)U/H)2<HW7<D=H2^?'5Y7$2LH4H-54H!QXH 2*H)HDH-&4
MH ZZH+*DH*:T2Q+*H-;TH!-J3 :*H1:ZH1!*H1P:H2$*HA^JH14JHB4ZH"G:
MH"MZH2WJH1FJHC'*HC/JHC4*HQUZHB1ZHSIJHBWG)DV5%\"#2#YU&(SX4)*'
M&?5W1_4H4P4QEWMD95^"DD/1;/;X@#[($#486G2FEBH2."]5@OV1+#CV4'RI
M1@>!>PFQI"&!:X<1!5)%E@BIC@2!/YR&7"GG8?'Q//:'1??\"7F\0A\SZ)_A
M$1/SUQ.:1Y2Q(:3+D6(/@H!H!*:*U"2PH"P0%(^#P:995(]HQ&US]""8>DBS
MT8),(!M*HGO(]AU!4*I)($ CLA)2&AC+9AU;NI#(%J:GAT9KRJJNFDZV"C?Q
M8:>U\:@DPH-/.H%LU*7EPSY@JCVU%AL.J'W0IRP?Z!Y-]1P0F!/HUY3%$FY8
MXAA4Y3X4HJ:+(:Q_@2:90U-'(B4TLJV(87+<X3[P]'A AGE1L1(GYSJ:U5G\
MNJ_^ZED VZ\!^Z\"6[ $>[ #F[ &J[ (N[ .V[ 0R[ 2^[ 3&[$4>[$6NWS]
M:1"FQ!5JA44P 2R^6I(N=Q)X_U&?DUB)VG*)*%M&YX5;'[F(Z!B*G#@15N2G
M\65>%;NS&,NS&>NS0-NS0ONS0QNT1'NT1INT1;NT2,NT2MNT4!NP.%LUE&F!
M(W:3;).9Q&.N?[$0,>:1 - C)7%.P+).$D$WNC4>(;5D._:2?ZD?C#E _:(Z
M+O.K?<%^LZ<];KD_Z[087VMF"-$C'H:/!/.V"A$"R"J*YX,QY)-1(S6S(JN7
MHT$?6"EQ"'6>].*3BJ$V9/M$;QM< ?EA?>M^8VIQCRFY0[EIEQ83%ZF.4?*7
M.(NV)'BSS/:K+6A'\4*>$OF3KUL^(HD^!RD>KU:(,R-WN>L:0T88/=)5BBB1
MX2J\WO]4I04A!6N[5288ELE[,"%[O''4:W'I6SZI%[=Q3E:D&8F#$=Z*')QG
M$H@;O%RINHB!.PH1OIL[&N0+/KF!NK,WORMF)#!;OS.[G@J'< 0\P ;,< 6,
MP <L< G,P O\<@^\< ZLP!0\P18,P16,P1<LP1K<P1S\P0WLP2',P0&<MF&%
MGU5#72;SOX [%ZS8""T[<O()<C%L1B4;5I>4J]BQA.?Q4/EJM2 <P2,\Q$)<
MQ!D<Q$=,Q$ELQ!NLQ$W,Q"(,Q4C\Q$M<Q51\Q5%LQ5F,Q1]<LJW!<FU*(FGD
MCD8JN9D3?Y[VCL-'>N*!>Q?!J=IGMEQJM^M#$(%9F;,6;-O_!JU:JH_MHIB
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M19A!MY)K/\3+^X8\,<</?!#AWZ(QNDL"X/U>&R&[NU!BMPL?W,(CD  !P,!
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M"RR(-H$L7^FO.[$H!=,*TD,(R"J((%"5/^L]S4$)1^FSH!$:2YDV;+*EQ7A
MUSBX"@N;U<J1U3J9IQ,6 F0(#_08^YLI]W,1=(N9N!B7T<HB:MDBQ8B*W=(N
ME(":E6",B-O_P;0 0@^SM+#( ITSP"S<)?$BK?X[*Z.!$-["P+"JP833#,9(
MBMG:D_8JL?.S*DI9MM>R"*Q[B1M\08_[*AQ!K4=A/TG!E]CR"0AS/V4)0Z=
M(?SC& FD*0F+"B1LO^"",[R+(C'$L6NB*]X+OU,$OU04/U1<155DQ5=TQ5AL
MQ5F$15J4Q5K$Q5O415ODQ5Q,&]&:FJGA,&KJO;UZ0KOK-PV<J%_3/3CSC-J#
M1D.#'9(2 &@,J7NSJM02G@1JD>+0EV_<LV*3HIO;NY0;GG+$1G0D1V!+1W9<
M1W-4QW-T1WF$QWF,QWNTQWRLQWUL1WY\QWX$R'\42'H,2((<2'ST_T>#5$B$
M+$B&/$A];$B(?,B$=,B%E$B+I,B+K,B-U,B.S,B/C$B0G,B0),F1-$F,+$F4
M/,F*7,:Z@Z,D:K3 4,A@60AD2[AD([N0N$$EZ@MF5 VGH3^"4,8>)**^X$DD
M*A:P S":DZA.BL!*C!I-NBO<$;L <:&>?$HQ8@B(X\<)F@@RZK>Y XP]"2-Q
M\R6-2AX3/+JHU BSNRR,XJALI(B\<Q3A<3?S4DN=R(Q^:XG*J$HP%"LZ<<J\
M- "C^")0\B/2XD STAVCE,FTTJ ^J@B]TA:Q-!@&,YAE<Z1NF33VRSHN[(RK
MP+C1B9:9@AA)*2_.%!#/_!&A2Z"5H\'TNO^HKD,EU4I#AW++M:RSWED[*VJ[
ML-#"-;HLE_S*T$P+0RH,N_H(9S(68@$-H3.=IB-*@M@)XH3#3=+!S-S+D"BF
M0#(XAQ(XR6)+SQM#<72BJ*(J]%3/J5K/]&3/]W3/^&S/^81/^I3/^L3/^]1/
M^^3/_.Q/)"*EEAR>NN*JX: W!4+'=9NTQW2@U H-:X0]V2LI$X'0VDFD^ZLL
M#WLO],L<=>%!SGHI _+/$=U/$OW/$S71%"W1%451%E71%H71%Y51%Z71&'7/
MSPA1]]*S/RN=& -.">0JR]RC'"$9U,BKCZB6+2(_!@2**$ =%T% \MP_*MRB
M.4NND<@O'@D)IU'_+RWTT(LXS0,QPE(<E]2A+@2<L2E-4D8*)/)ROZ6!"L,(
MP1G;T5^C!^<JB#P+#3SM"'Z[T 6ZE;8(KFF)P1M9N-S3B"R-DS$-0A3"#9MS
M.P/X*RT]0\,(,#1<.@U4TVIATP-*Q"?$5-Q"/SO$%IIK"(HK/SYUN1G#PKR"
MQ)&1KRDU@ T=B<!"51Y156LA0S>D-\6\D2S5LU EHM(H+$\JT@S5TZ- )F\)
M%E<UFE.ZH:T1TJ-CU>$ZE8:P)6A201;I&?%R5DEZQ :LK/SZ-2=D%C@M2L%(
M@)+8/Y<+P$B%FE.IC1DT+NNLT1FUT7S%UWV]UW[55W_EUW\5V( E6( U&MB!
M92>M@A80Y<WJ0AWAHZS?JZO7 #XX^TT9_ZG01)/&UQ&1C+4=QPA0^S*V<?0\
M'OF/:)')9D([>UVE$G3)'JTS9'S9EI59F'59FZU9FIW9F-W9F]59G.W9G.59
MH"7:GS7:H3U:GT7:I57:IA5:IPW:J"U:IGW:JI7:I+7:J85:K<U:K+U:JOW:
MK?5:K@W;K@5;LD7;L57;LUU;L67;MW7;N#5;N2W;NIW:WSG0&NK&DHW*<NRJ
MXHQ6VRB)EHNL4"DZFEBX\YR([5*KEMU V4A<;6,AZ7*:B@%9?,O4L7 6M^ /
M8'VKLKK<,MT(M8NVT'(,IX$N>U.A'-0WQ*1'72N+0KTH0FT4>O-*M$S-EA *
M,KRNR&H1T(I++O]M(/+R#,8D'D2*5,.TM%ZBU 8[SLZH#"X="M?JJ+ @K<*E
MDVS]W$VRI+&,D/Q2C6%Z$*=<"G-#D"XDS(F:5K4:BO8B,.I-BLKER<\R0.&,
MC,#(3;5RN T-GNNJ3LG(RFA=">"%IL2ERM"$$8%#NM.(HN?T+EWJ")A+$ *F
M$^%5%%HR$,?JWCU"'D($EGMCQNB!2<KC/!+>O!/&O!1^/!1>814V81?6/!@N
MX1ANX1I^81NFX1O6X1RNC\^XN9%]1VZTN_-<4--AJ=,3MI6=7SKQV$&3T&FD
MT"96$8<AT+,$&Y^9U_'<*QX5V4GRQ2_>13#NQ3 FXS$V8S%&XS).XS/_5N,V
M9N,W7N,X5L661%2+3<P$\[$9[*WXJPT_A$!R74:M@XH1W,I/3=1*M1--Q%S5
MW!-D\K#KJDN6<4ZBR1=H@;A2G$Z_&A0_;A/PY8HK?38*^\"JT<.<05D1ZSDP
ME:]720(V_=+.P[]$#4JRBI5?<9H_)!24D)BC&;#-X<H# 9IO+8CPNJ_Z51=S
MW<S)I2M/EL/)/<::J%S6"%-+[>4-5F870:;<XJ%:L:I,+DPW<197+@RLZQ<_
M!I5L)N4'5I4 8]((IC='3B%(G0T]E)I8=I-Y$8KX[5UF_238M BG*1EJAJL>
M :USQ2ZK@BS] A5(98A;%AZ 3LPK'1!1%LKM_^5>4(F@X+J<JF*H'(5C-Y;C
MCQ;ID"9ID#;ID3[IDD;IE5;IED[IER:P$KR6%^Q1*M;HL\Q&;X7 "WUE9]3&
MTI-BE-K80POJ%/&/C%IBCF[,) :.)+H-I^:U@RU8A*7JJ;9JJ<;JJL[JJ];J
MKN;JK]YJIPK9VS7'B]K?N-0]?=GC39K-&%Q@VKU?$.[=NH1+NZ(Z:OGG964@
ML(P+4 B*?_;?6^K=PF0D3T%GN4"MLR!,)TI>GKQ>O!Z993U*Q4S9N_Q 2$()
MQ8@O+K*Z$;[>M28D [TJD^LMU/0,0ZP*+FK7ON0X>P,-KX,ZAB;,!%!?<#M@
M[70HM\YK+_5"[7RA ZOZ;"7%5ET>7C]).[<VEM[=+*)#8'@MC:#8"79#)E1!
M;NU2;LPFE76MSMZ4H\KP:UWN"O^5-,*,[D9+:/)4V?X8;'GI1F1J99Y8;1]:
M8N+U9H\@)#/,2:0H2T/9[!:Z31AQ;T8Z#/?^O$4,E85!N+R\Z^7&[ZK#L\8L
M'236P+H.:Z^N<+"V\ S'\ V_\ [7< _G\ _W:N0QGV##398*/>6YW+)6[!H)
M1V#+XLK_*.J0>F+:F_$3X;J9OIT.T](]>YN8IM/+L3,S<S,R0S,V,_(B)W(D
M7_(V8_(C=_(H3_(G5W(HGW(I;_(KU_(LYW(K[_(J!W,J%W,L]_(R#W,R/_,M
M-_,Q5_,T%[*%K3N<ML2<Z5 .';D]EB[Q6N^@&#^KVBX+"Z0]!V\.<]-#IJ.#
M.9?2?I"D,%<9(408">8 EI>!T9'$)AA.?):8:91E.="L$701XD ]!?02HV@,
MZE0/8US.8,'FW39ZTQA,$4(7B730G,-L-,([?"2+:73*$M97<5+/@]_8!/7W
M B[;E E+276@6*L?/2S0X0Q# '9PJ2["W?3?P\.,*%*%Q>02_Z1V1A'GBDCV
MG'@%QL+@FNRME=GT<N;5726K<7^I6P<0="4VP^AVH& IEY(SAOV:>V?S+^_W
M-4?S?W=S@&]S@3?X@$?X@D]X?U]X@F=XA8?XAY=XAZ?X@;?X@X_XBL?XB;_X
M)0/'\7PVVXVFH=MV;WT_/'ZQGO;$8'78H[CQCQIJ:GQY#AE0=23QI&Y0(@:K
M<32]I2Y/')[AH&?A'19Z&1YZ'BYZH#_ZI"?ZI7=ZHX=ZI8_ZII]ZI,<.)2JY
M<C30H;33SKZEZ^PAICAUOJUW!#9Q0;8VDZVHLM>[S4'FC,B[VFVC3\>)G0B[
M2*'K!*RP!5([#@+U90KVW\G6C%CD1/]</6V*>\Z( @+_Z0*/IL2?%[L8QW"O
MS05!SK3D2I#%.-KLTZ3S3'84NP'^>Y5SWLI6B-Q]%36Z(PYF.;)*^^Q49HP8
MS/5E%$3'25J.BL(WU6%;SCP_",AO"]^_B*9KC&PGXK^#OT'*^8-0U4 I;V&R
MUE-F>Y?#Q$:&E8LK"H*C?)F 2>0J_3?)UI78?NXG:Y\W*VP<^0)/1JJ7^O9G
M__>W^JIG^OAW?_J'__G'_Z>O__R7?_T'"'J-! (8:+"@0((&%29LA/#@0H<1
M'S*$V)"BQ(L3(Q($H!$ 2(P>'8XD:)(DRHX0"XX$F1(ERX,76Y;,>#"F0I8X
M':IT21.FP'__0H<2+6KT*-*D2I4*$$"NZ5,!%9I66&KU*E:C*1'ZG/C0Y]>!
M7,5F'#L3YE>1+NFEE;B3+5FX;,W2C5M7[MV\=O?BY:NW+^"_@OT2#EQXL.'$
MB!<?;JS8,>/'DB-3AFQY\N7*F#=K[ISY,V?0GD.3'FU:-.K2J4^K;LWZ]>K8
MKB^7Y6K6IDZQ>6^KG+M5]V]Z!H83+V[\>/$D96L?3)($.70#4=8N[YT%.A/J
MN=,ZCXY\.EJ)W]>"!?#<^W>W89D@9X^>>)"8Y)%+(;_0O?&T+O$7#Q&79'?O
M$0=>;G"-)Y]/4B"G'W_(*6=?5V<]=)Z R3E$87&@+"323?]MUZ" \TR\%*%!
MUU587'PV^48?6"B!:$"'!+T80E<SRE56>PWE=.!O21ARHG0ZX<3CC;T5A&&%
M623TU7CJ-8)D=$G LN!6#FY'SXM*X@9EA2GVQ*6#4QYW$P O%@=>1RPZ"1>8
MWDV'$T59+AF1B<:)V-N(8X&519LASJDG '4"&1^@XAV')FXG9B$H<2&1529Z
M25 W(TEP!@$D? 4R>:A]'7&IZ:68#J<<;GK"%&.A-W8:GI%VP38;K*_**MNL
ML=)ZJZVYUKHKKKSJVBNPOPKK*['!%CNLL<DBN^RQ!:H7UEUKQKCAAJ96Y%NG
MSLI7*7!&J@4<=3GMI/]35N6::^Y44E$%55/GNNMN32W==!)(&G6TK7;CXEF1
M3_2&]Q6]VHK[[W8%$WQPBPD;K##""SO<,,0,2_SPQ!%3?+'%&5>\,<8<:]PQ
MR!^+[#')(9<\LLDIH[SRR2VK[#+++\L<,\TPVSSSS37CO+/./>>\,4_<0JM3
M1WC*YR]81F^DW4NB%F?(@P7S>^2)201\D4;0 0Q4T%17^"!N!#GHUDJ-F(E=
M2%@/E&6HZ&71=6Y6<HTE<EUG]&("$CY9]=8^R?T1 %'4+:] [^$6=M !"P[D
MV_L9%U]/-"G]DT),+(X>$XT+V;= ?%:=1;YN_<W1BSTEA'><R"4@$THYPEW_
M^'&2VNU2G\9)JF\C<K>EG4!G(_>VN+#;_E.@ I+JND*Q/WA2EAT6Y+ON>#(*
MW?'',5&1X?*.+2]8T-OI5DZG_[Y20M,;D%V\]/84D4.78PJZ5V0#$$3MR8%N
ML-BQ5ZJ2^<?%UW9Q&D&^W*&':'B;FD,\]S7@J2AHVY.0^X@SL$#5SSB-6U^_
M&MB5FGS$7B.*G/-\QK.?C;"$(CPA"5%HPA2R<(4N5"$,6QC#%\JPAC2\X0QS
M:$,=XG"'/C3AU=0C(:*AQ72G(E$0F7:2X'6-7R3IX!-GEQ:CM20H[[HB%O_!
M+J>L2RI9_&)2\N2A<=GF4;RA"(3\0B)M44MB;7P)_PA_R,,YRK&./;PC'?%H
MQSSR<8]^U",@^QC(/PJRD(0\Y" QMCZX,&T[U.I+BQ#(2$U5IT"B2D(4F) =
M)[4%6P51H'<TE#"AC05$47/D$$$9'5"0IRTLBJ1-O)<YB00'4L>!7YO0Q"$
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MB DQ'N3(T*/%AR Q+E0(D23&BPT15HSH4"/+E"-= OA7T^9-G#EU[N39LZ<
M >2 "A50 6@%GTF5+LTYT*/&A1M3TB-)=:+&F1RA=HQZ,FI6B4ZS?K0:<^97
MA%C#HNU*,&Q(KUI/NMWZM:Q=O&[UWMV;E^]?OX'[#@9,6'!AQ(<5&V:<N/%B
MQY$A3WY<6;)ERI<U9__FC-GSYL^=08\673KT:=*H3:=FO=JU:MBM8YM>&]<D
M794/TXZ-B]6J;ZT*MY:5J[)N1]V$]W*=F/QW<:IV=0.?ZQ3MU;8RK^^&V+>W
M\>!5UX*=^]9L=;TRB=^.SK7N<;+#X2YOWYMMV_IJAX^O&E[Z^-_DJVTZ\/A2
M*SWDWMK(/.C>\PXW\80C$+WVIK+MP/[64\^O]!1D3BP/V7(I0>R@(]%"X (D
M;\4!-4Q11!"=DT]%J>S#[:D3.9PJM^PRA LO&&%L<,681 S200V#(PY)\/3C
MT487(:2N./5^'!&Q^:I##\ @Y8)/0BZ7"ZRK%SF4*K<8+XI0Q1UI!&NPO,[_
MS(_(_ZY$$SD<K6/QP#R[7/+"_?[KL<,2+930T!T![##%.Y^K\<WGSGM--DHG
MM70V3"O-]%)-.^7TTTU#]5144$<UM514257UU%539;4P_KIT<CLQ=Q/0MB:I
MRS#6&Z=DL\07:\632N<2_#)1II)55EFCBCIJ**"6E5;:C-(<MDH%7Q+I(HA8
M$NG)$:MU2<VQ1"I/6^T$M',DLV*2=,]<XTU77@?GM;=>?.G5]]Y]\^7W7W\#
M[G=@@ D6N&"$#U;88(83;GAAAR.&>.*'*Y;88HHOUCACCC'V>../.P9YY)-@
M^K:EE9KTKR%SFU,P4990[B\BL=@K266:52H2I)V]_[790VZW+?!F/A,TZ:.<
M6RK2VI1MA0MFHZ\5UZ 8I][R7)W-O5IH=(7^>=WYD [7W9;SK9G($\,5\+R@
M,RJWZ?/>O+KHM8E&MZZ?V[X;[)+#YIK<BG9..B-=9XIY7:BQG5GMMWO6RMMY
MVS3V9K&;]DKP<8T#,>ZD05270293-NG<F:D[VTF34<I:=+FJ#MSEH&]S&FBN
MNW9;9K8;;WUUP?'6_-I$P_T=VQ'+'EIUJLUMF\783W;YN]MG#IYU?-M&^NY$
MCP-=;[^U/SQ$*CUG_'O';<<5Y>#)/CS[MZ%BG^20XX=_?I'KE]]^^N_7/W_^
M\?=____U#X #%& ! WA  B(BT(#ZLQ[OA/8XW;G-6ME#W<DN=R<)9FY[&LQ@
MN@!GK*4U_V):(R1A3: 5E&<5I80KY,F3\$.[.?4.35ACGZ$PI!T(X:P\=D(4
MD";W%T@!RV5#G."UB,A#(Q9Q<4H\(EF2B,0E0K&)3W1B%*LX12M248M9Y"(6
MO<A$,$HQC%<<XQ:_*$8TDC&-9BQC%]MX1C7&D8UK=",=X3A'.=8QCW?4(Q[]
MV$= \E&0;R0D#V_X0V%%2CKDXI)OD/0=\<VI16(RY,H*5R4V"2E;A-J/E9[B
M)P0-B(:@BQ,4*;0A]^2P.V$Z$RO]AKF[R DJMRH6*R\$)U[AT#J,:E$K7P@G
M8)42DITL7(5DE,C/?0E#SSN+,K7WPEG%B6Y2NDISEG2E3M+(D?_,W*1XMEDA
MKT336*#L86-6MIYSI@V<4H.4C12EJ'6B[INI_"1OSG(C*\E2;B$R4BD1)<;K
MH%-/IT3;)@V4'$R:$D% ?-0ZJS;.!Q%OE^QLEY<4"I_:/*J;A9JAVB@4GLHL
MZ)7>#*(C\8/0+.DH;.>;I@UO&<,"29.3YLEF%&'XQT':L9![W"E.>QK(G^:4
MISHEZE"-ZM.B(O6H0$TJ4Y<J5*5&U:E2A>I4K5I5K 95JTW-*E>91J)P6I*;
ML[1GI! Z2:!%** --=*A%D6H[OQSF)2\'@OMNI1FY?6$=^7K/Y+W-:N!4'C7
MLQMY4J>\[D5M<W^SVT.1M\_A7?!EC.W_'&53=UG+9K:RF\4L9S7;6=!^5K2>
M)6UH2SM:TZ86M:L];6M5ZUK6OE:VL:4M;&T[V]O6%K>[U6UO<_M;W@+7M\$E
M;FW=]Z-(=J]><06IY,IS.L@=T7R!)9QD%\<=*DFO=OFDY>U6UQNQ<0]ILNL;
MX1#+3Z*M:V_@ZQ988F8RPDJ$@UDB+[Q4)\,K=M"77'M:2H\G)Q-U,+Z4G:]V
M9"=>#NJ-?0I=K-)V5]]L,7*^$@[L5[4KKJ--F+\;31ZZ('S!_"XW5\@[KN4J
M)ZD&.[>_T-.P[YRVO.\YV'RK_.!C4W?=NIGNO#<V''+=2LJ]T=B(W>0>CG_L
MLP(OKVM,RYU^_]V[.\MQ<$KGH^"#:]?>J7'.5X;]L7Y<!R:U0:[!Y2W;ZP9W
MY28E=\KHY1?3L+;>$)*XS-^=LYQO1S8[XQG.=+XSG_5<YSWGV<^#%G2A WUH
M0">ZSX96])\7C>A'-YK0D'9TI2<M:49'6M.6SC2G*7WI38/:TYC^=*=%?6I3
MI[K4JR9UJT.MZCJ_=\-F;M[6%&=A#Q>V2)#T)"*Q&[KU:3"^)<Y@7XV=DQ,2
M):_'9F&QTI>C\?W2S73]+[0=FDWEM+)7/WRG\$2)S02&>X'C5F"YQ6UN<I];
MW>EF-[K=O>YWMQO>\Y9WO?'W-C"]5# ^!&>@MIW+(]$'*QC<2BKU_?RA,M%Q
M2[54Z_AB2FV TXE')<WG,?44'VAR=W*H-.N?\*3)8#9JD<>$)UW?F4QG#^N:
M6)+D2P7>(%Z&KIAU6G@LMQT=EA*HGA6MCY+JM5!=ZKR7C".KS61GHIYGDIE5
M)-W-[<F@^AY]=-1$;]1IRAM_EU-\P@PHT<_798NNZ5B"LK@[L_MPB1H<XED_
M:UDGCJ6&PMR^^ Q3R^$%Q&=_W88O;Q<O)RY2S-6=W]VN9]4Q^CEJRI77 6KI
MVRGZR[3B:H(13Q+9(QEOS-,[\_;6?.<Y__G-A][SH@?]Z$U?>M23'J/MJS@\
MH=YVAQ*K?"9%J2(7R:=3/C(DL!KB-Q/_PFS@Z]59*!0 \$MH9MPU-K(:+'"0
MO>8E\%H09YP;<S3+E]GQNG74KV8U]UV]??"CNOOAA[7WS4_^\8O_^^H_/_O1
MO_[RO[_]\7=__>E___3C'_[YY__^_3___C._"\.SYE,9PJJ<FCN[R-FP)[,5
M,W,+(5M  WL21LHRHE$SE@JAK3LO%SLNJ>,9'\,PKP,S\Z(A*R,S'.HP#6R9
M+_,NZ/HOQT(^!Z(E+,.QS2JL[NJ]I*&SO,N@[.L@"#(Q' 0K9Z(<L$(Q#8LQ
MV*$X(*R<\[*@73-")WO ;"FO&T/ "^P]]5DQ82/")8PPOI$SP.JPJ'FLR4*T
M8&L:UENO"WN/_[-9I:(3K! CPN]IP.M+P^D9,QYY'^\J,6L:F^-1(] 9K",#
M-"J,PBGL,7:903[<O;31L1W$,L>I018\P2PDL:LI,EF3&9 :G&+ZK@IBNDKD
ML [\/_D[1?L+0%34/P TQ51T159<155\Q5:L15F$Q5F,15J\15O<15_416#,
M16%4-&UYGY]Q)QDCGF5*0TB4O"#T0S5+'*/+KD-B)"6D!^,[MF1+(:3(QFFY
MI[P#MP.L/5ZS%6S+-G7!P E9O(7B-GW1)GKJJJ?:JGGT*GNL1WRD*GK4QWOD
MQWR\JGT$R'X4R'^41W\\2()$2(-,2(9<2(<,R"F"1[5BDN2"%3-Y$/]T\KN!
MDCN/V[KM*)T_O*FTVZ&YBI*.'++;:RZ*<KMKVZ:M,:;]6KF3:[HD4<>],T?C
M,#N+A"@SR<&-5!/?,R>S\;5; I]NFA%_DA$ 0ZLM*\J2C+:N2RL=M"*9PZ6W
MXHZV6KF-PR9LT[V)2LEI.CE+ZJ?=VS=LFZB.S+H=^B>8G Y:N3B@(R8:#+BU
M$CEV#)21DS;8@Q+F\+<%1$M]JIE!D1R8<A22*[M9J::,BZ%>DI4ZZ9FF=,=X
M>D1\@\OK@;R3BIRL+*M@&4.2]#NLC,R-U!&R8RMT[,M>(2N7Y+B&A$C7',B'
MA,W7+,C95,C:;$W9S$W:U$W;Y$W<W$W@[,WIX/Q-X2Q.JW*YJ\,[;INYQ2P[
MN JEJ,2Z-;0\G8O+RDQ,Z_#&OA*^9B$*[:063LPU,9Q!M8":J9"&*6 ")D@"
M VA/]WQ/^(Q/^9Q/^JQ/^[Q/_,Q/_=Q/_NQ/__Q/  U0 1U0 BU0 SU0!$U0
M!5U0!FU0!WU0"(U0"9U0"JU0"[U0#,U0#=U0#NU0#_U0$ U1$1W1_4R"*&""
M*="&\ H/YEI$(=3#%B3#!F,]!<L5/1S$:8,/6$C/]211'_U1( U2(1U2(BU2
M(SU2)$U2)5U2)FU2)WU2*(U2*9W2#351%-4&;&E1FQ)/$'3_F^^\JVT<OF[\
M4J90$F%ILT;1.,9KA"Q@ BI]4SB-4SF=4SJM4SN]4SS-4SW=4S[M4S_]4P5E
M E"PN3]Y3 RR2F+RN<Q<*[DT4SA4N9N3-M]H4T"M5$N]5$S-5$W=5$[M5$_]
M5% -55'E4$']2K+L-VNB0;D@4Q;BSKUBU:4X,^IQQ%GRG+M9N(3( D,855[M
M55_]56 -5F$=5F(M5F,]UC<UA 0@+V;=0^-10<J:E28+RRZ,,C5Y%R33#UU%
M5F[M5F_]5G -5W$=5W(M5W/M4&5]L^EYQM(IL8& U1(*TV6#UZ0P0&=3E,1"
M$;IX!?8\5W_]5X -6($=6((M6(,]-5@?30)0:"<BHCE51=.J\4E)M=?QJ#:U
M; 10Z%>$W5B.[5B/_5B0#5F1'=D^55CZV,M]2D"$_Z#7$7)5XF-9GX!6E&&^
M*E0^&6N(*2!9G=U9GNU9G_U9H U:H36 *>A2ZRK#\HK#&9DS6ZW60]V@D1C
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M$W(\B->I89B$928$_+:PR<-C(T^<_#:D8X^(!5_^V)3K9[B*$5=^Z'GD:,E
M55O_7GR6-.6_FV5+7>C9K^V2%1GKI@VY<=_>L8'[QCV<Y&[1<XFS%32%290H
M!JA7C\)D2A9IQ9LC_0GR,5[-K8,2Y=BH.O6!E<-'?-QU?-./XUWK/EZ?)7X
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MM0[[-*%W!EILL*E.6V>TRU9Z[;>GQOKKMI%F^^>[Y1X[;I'G=MMOONG&^VK
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M*5"G@Y@_751\\?]'T>"H8P,ZXC$XVQ&Y2H-4B_O WK$(K#LOT".]K#Q(F@1
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M#KH6VTK(A U7TL1(:"4N5(UC <*.()? TWO->.:1:!BO%LI(8*(EN';<O0M
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M]-%F+ T4T5&BZ$X93D%]%(&4 )4O+$Y5#7120*-(0IFSHH!5T$0!E>A6B:)
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M!Q9>:@>5.(B*Q2Y<5DSUSI<B*R\\S,/P_HE>^NFIK][ZZZ]/"0Q/D.#>$T_
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MR]Z&A,A^HY^&K" /R,]JZ8#D9$(:KEF3M9=<[2!I \EXA$:M54?^ \ED3DP
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MF\Z U'?7NUQP$@]!?Z(Q1%=4'O)B]U!8FV1^5 8#H'_Z7]&:*(["&1L9V2Z
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M#WZTWSQ'RG6W*Q/;VT"EPEUZN]J238\T%F72]]WK1HIWY'A/+FWN2J>]_S(
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M=6J7-%9O=EU[USV73ECI,V=S9WU];VKK=GQE-58%=7<7[4"\GS15$:J!VGW
M:C1\Z71P4438-TK(IWRRZB-"R7WG:@+-*7RKZJD^2*KRMRW^=UYD(9Q)J#?7
M'Y]6$X!3B"-5"9N]#"R;&A>2H"*FZJ$%B!;?=XXP4E4T.!LZ$E0H13#2LJ3N
M&GHD<DB8&:VIN'P",W[KFGVKN)__;5):.+&"[?'])O$8,^Y'9+ :VFF OXB-
MT\B<^O>-T+BPU5\&GS*3ZIJ H[B):[)^0Q.K1FJI9:&DB=*< 5J74UM[R*^8
MFSFA\M*8_RF(G/F:ISF9XTB<MSF;VZF;J[EJV+F7T_F=[WFK]CF?UUB>E_F@
MRSE]]EB=!SJ@&[JB-[J?+SJ:/[J@)SJD3SJB@;$PNQ^CT5\A_QF"LWB2QUH:
M&0F28/H-3IN$&T>I;R']JL0OZCDMY8@K.EJV">QA=Z-B36L]FQ.A4($2N'.P
M(X$G( $W,(0[N\$\$PJO'TK?Q1[J]([SB"O8?E[=6;?DFBYTP=3W+56W@S39
M*J;(72OW_W$[ZB8L0I\*O/++YGF[N#.MYV9NZE4ON6M>\$)N] ;U[KT[]9(C
M=J4?YH[<R$V,Y,TEY$J>\PB7ZA7.[*:?\,1[YEXNX(VL3-L[MF=[]G6EZSJ>
M-"K7\C@N[)4[MT_\IZC[WT%L5+=>\4K/R??>ZI4=O <\ZP0>\(5KN--\2U\T
MN%9\][X\SPM\Y$D?2??.YN9[Y ;\MGN[Y7AO\D5UZ#'\\++3XXWV\AU]X*FF
M;&J3W,FN]'7\\9KW8FJ]6$\KP^>F>;=\00\NO8$]XTR]9V4]VY_W8L)TN /O
MMQZO?!DT=RXO4=?>]K+>/A^\SQM7QJ=]]B)>]3E]Z<1/F;SFPO^)'_;RH^RP
M1LJ?G^\I_<:G;6NM/>IF*]5?9M<T=L1[?$3.'OG=N]B-%"3[Z7L;DA_B;R2"
MLZ )0J2I(C-VLS-7.9KO]Y5%N:DB\Z$5&92_7Z;=_JA^$OZ>Z8*6*6;P*(T#
MN8BO9PHS*8=@^:>UVO 3?[0U?YC#^0C!<+2->J<O&*.UGQ;N6*K-IZV=NJFZ
M>B%;OS?3<*C5*OA7/WTNR9/[V33-6>S'/A8#! *! PDB:(9@U,&#"!<.7'AP
M5$&)#0U6M$B1XL2+ C%*)*B08TB''D<^%'G2(\B-(TE6-&D1I<:7'5NJ?!FS
MH$V4&7.NI$E2)TRA,D7^3.GS8TN719/_UD3*$NA3G$EG-HU:%>I1K%-+,LU*
M="77D%N']B3+DVK$AA%[#E3+-J3:I D%TF4+4:'<L"WI&M3+$>[2JH''(DA@
M +&!*%[[#I22V$ 0L@0/)Y92=^G*QXD39'9*D##)P) --*('P'1J *A1TU/=
MNM%JT[)/H_YW&W=NW;MY]^Y-&K@!*FZ0%/>$Q-/QXV!(*T?BADKPX+ZI5_?-
M&C8 U[)7;]<>FWOLU^)=;V]$FKMWU=O9@Q=/^_UZ\.K+QZ[/_7OW^?OU]V=-
MG[_\LB///O?@\\] [ #T[C[L&LDBN-8.+#"_]M(CL$+^WLN.0??J:]##U-3[
M#D3S1OR/0@L=_P0010%-E._ ^T:D$#8553/P10%#))'&&SM$T#S\P&,-PQU_
M)-+")#>$<< @L^,1._QB)-#))?L+TL8)3Z0P/A1E#%'%#VETTKL+M7PP.!&-
MW#' $</L\<O^QH.OS/%.W'*U%CF4S\T 4RP01/W>U%%,'0<,C\5"6X1S/R7S
M'%-#(1O,,,\G$[030P6'_!%3!)L<\CT\5\2QQSPM3%#4.36UE%)6\9O1P5?]
M-%1,3@V]DM'[(,U2UO!B79564A6-LTQ':[S1Q5!I!+;+7X]TM- ^6[T3V1GK
M=)54("%-UM1L'SUU3RE]_)-275O=T%9J$5UR4BX)E8^T+!SMU%MR^_^, CTB
MA3PP2D"YC%/-/8\$4]78\KTT/QAU?=%&8R^5UM4<$>Y26>Y(4RHTI39BZRW!
M LLXIU&BH>@NA)1"RRF3&FKFKHQ7+H@PE0##+"J3-8:+Y)_ ":UCSVH">2^;
M9^ZI+[18CLFHDP-K1I!1I@AN*)5+SBQFH2"">22]BOY,YI-I;HIDH/0ZNBV&
M:):9;)0M>CJ)*-R>8@JL.=H,,J]>[JOEFK_.F"VVW8X"[IKH3@RSM/_Z>F6@
M)<K[Z)?K6BMDEEB6NJVQEX9);;=8@HLPCK>:O*N;4W:Y<(W!/@IUT# O:R/#
M'U==<YAP/OSCDV87JG;9':(==LAG#CMVW_V.PKWWV(<'_FSC&X<]><1Y#U[Y
MYYL7>GGC;1:^^J^OCYYXZ)WO?OK;D=_^^_&GIEYZ\M$'7WWQF6]_=_;/=]_Z
M^>,WW_;[W[?_=X_HRFMU5K-*68S&%XVTSFMRTUXTF+(0M>P",HM1FD#PQ9FE
M-6UG%X%@8B3(O,!4$#&[L%G)\&*0IB%E>6D;'GJ8-"MZF?_(.C&4H6ZDDQ@J
M% <Y.72.)YAC0QTBAPK*J&%B9EC$WHCH4T$J4FUFLR()F88T\3G-CE@U&P\]
M<8I(^A45BX2D)9(GB>O"(FWX]; OYLB)6@P8 (+#!!\]<5^Q0J*! M;$3GEQ
MBDQDXI.P^!HXCI%*V%K7'JV(IX?U,8MQ+-BC)'4L.GVJC$HDHQ<MM; W%K*2
M4@3C(O%(Q_)(")&^FA!L0 5**]8(E6:4E)V^-<<\PM&.6;RB',GHR2HZTI3T
M:.,GYX2L)LDQ4.S"9+,*B<1?CBJ3YK(E%PW)L$/6<8^4-*8=&\G'2O:+EV6L
MY38]V<UC?8B1F]17,2>E1EE*,E/_L3S4+$_)14=.4XWK'%65#M5'4=ISGI0<
M)SZ]6<QM M*>R+)2*O5(1S'VTD2"E.(UK]C.40ITE:^LXCG3.<X\3DQBVO0G
M)(&9SHO2YY?C:J8_(=K%+8(QC>TLT1\-RLH[CJM?8@2H2S.)J"?"@C320.-&
M50I-3=:(":01A$;KI$Q&YC*E%ST3*A%)GBB^DY>)9*<>&SE0-8$44[)T(I5
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MQ4E]A$$S:]@DFSGM981GFNOMT:)06>#$#6F'<S'15-(Y!4:][*4+"^@ S^$
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MZ0=[[#5A[X=>RH=<NL-IW76!DL9B+EA!O2&6&/9@J &")J8='%8^SB-) 8*
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M7-TI=IM-]NO_679DISMC9]U?=Z)F9_1CK_9HS[)![]AI?W9E[W9F_W9G']M
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M3C>OS+1X(5KL+I+Z<)4LES:_BC'[UIX[QZO^2#-Z[J24T4XQX-\ $P T0L^
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M*'"#"1Q@ #D(0@F*D((>A. !+=C!$'[0A"Q$805_<L$7SI"$+=0@#6$7';L
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M2FC4R&=ZJEN(TA/"'2)"\5NN#17;<%J?E!O6$10G$HO+W4HT+8N $ML::LO
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MU']X0N+)$Q7JW+M[[R[I>G8PWZ='/X\^NO#?P=D/Y_T;N6W>NMD+I\\;?WP
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M;^TUV6&;/7;9:I^]=MILO^UVW&C/W3;=<-LM=]UZW[UWWGS_[7?@> _>-^&
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M/*JD-$N9#H?!=RN;+VK$HL;"4OR;6'R06*B=+&J?KRE,^O7#3*?%)D>V^RF
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MX<BM;1=ANZ3<!O>[_93NL%X[VQF-M[[;W2U^LWO6\_96P/%=;KVEM=\'A[?
M$X[P@J,;3>9^^+?[Z?"&,]S@]NYVOPD>\'\/_&8;WR;%&Q[RBE=;WMFN][XE
MSO*7G\N?$%]YRMU]<YG7/.(MSSG.1Q[S<_.<<T /)]&_K7.5^_OG0J?WNAF^
M<(XS_>@^+[K4Q>5T[)WE,9%=JU@5VM-KMBS55 ;FR\&=472J5.F0^]J7A?=V
MJ)I.ZR%L_RK()S14I1[R+AQ6"CK#SFF<L<W(>$H/F\7Z25XFTBA(-??C\F=D
MF]RX?_PFFPM]*DNU /0F@V0I*G_X]EFJ7:03#8E?^NG0GY9:GUIQ);.'B<RR
MTK'OQ)%+N^?)'K_S5)4%;EWE)Q+5G\KMHCO1#8.Q^E[*YEN#% QDX6N*GM@;
M=)R9[_A*G'_2T[3R\[N,9=UCYO1[YC*N^<:F,T6_]FX2A?NI_W1@*EVU^Z9S
MITYN*U9>:=-"?]C^\H>^G?5O2&GJO/S[+P",J:,"/%T"B_N;OP%\K +<J0/D
M,C8['@/$/JJXP/CC(!!YBEAR/^;@JCM2.%<*O^9(*(FJ/K: I_^@42N@ZXWT
M$[A-4B-_>3\VHD#,"Y^W2C9>.[;^  /V>9\$ 0-2X$%DT\'RD1[A@1Y TYHD
M[#+E 9TQ.S"8@:P_BS&B42_%BD( \YTIM,(.6[!1ZT+NN<(M#!E+B3$N=!8>
M$S$LI$(QO#0R!$/?218TI$(D\T)8JT,_"YLY!)F%N4(^=$,_S,(S;,,&*\,P
M5$-"9!$Y%$0F7$0V1,3N"40_0\0T?,0 ^R\\9,0SNT0E7$,=^\-FT</NL40[
M5,1,?*Q-]*].=$1?@<-1-,0X;,5*;,1:I$5 ),5#L<593#%/-,1?I,1>))I#
MU,5"]$57M#51/,95?,,UI$-9_,)H9$;_]<K%:0RSSQFUP8,S8K2U@DD;3>RJ
M_,*Q4*F78LD4.4G$\)*=3S2;-[LT4:N=#],U%S,>$!2TM[F=8C0P%/,TQ F<
M!7O$W!L9$/N2P[&^W!F8^4H9V4E ALS H)FO+V$U* S$UNNN?S0S:#2^)YF;
M+ELUZ1HTJP$N<@P=U0F>*Z.O0V0>;-0H^A,+CE0<?SPP1Y-#'ZDR,^PQ_FJU
MJDDEH%&R;UP1C2R<@;,>D>N9PWHT]JBQIUJ=D!&<!B,S6KLR(0N80:1(*_,8
M>_R:3?,>1>,['B,>50S)$&/#<'S%%=Q#!=N5W:%'GRRQ.5S+Q4F<EXS+F_1&
MA51*.Y1+@^R;_PO;R[N<2[^$2\!D2<%$2$6S2\/L2\0LM50TPYU4F=+Q-"AQ
M1R9AS-:!Q7I,NW=,2/S"-[79RH)\2(Z<P(/QQ EKKXDQM$E;2$WS/($PPKLB
M0@:A BH  VX  S#X =O<#V6@30>1S0A106:;P&7#06N*N\48#8CD'XJ*((/3
MN]I(R"HRL(_\.G'1J>FLMB*"P>X$S>_LO? <NBM"-^D$H!@<3ZLJ3_!D3_&$
MH>B,([A,R=(S3_F,SQ'"SQ.RN_'(N/.T.>_8SM;K)/NL3N]T3Z*43X_[3V]+
MR?#3.@5-R@ ]SIW+SP.=(/XTT/:LP0V%S@+=H@O%3O)\H:GZ)A%=3_\2[=#L
M4]&URLX(9='I1-$3'= ;3$\05='% S<&K;1"JM$$'<\ 8M %[<^%TT[T_-']
M_- 432S6XPRX&INW4J?&$XB#\L#=HU"#DD$M_:.<NL'M8,$5;3_7F+K*,B=W
MNZ*W.R7(H\"F(JC_<3;B>[_8FZH69:7IDRF G#7?N">$P2F>*#NJNE,2):E>
MPDKXA",.-%(%I;?)@-/U2S5G2Z!8NKEY-)1G,M+/2[ME(B<2;";+(2:Y&3\7
MU"7)K*7)."K4F[T@%57]7+[UK-)](CY5Q;L974[&FR8'M%6J-(_ZT[ZM4XV&
M6:OD!-8F!:CC(R IDS#6:]/BY*CLR(U=!;MT3[J^XBO4'[(FKB*]3"(F48(I
M6$H]$_2]:G)26-4F:?/6S0-7<_U =(T^2]U6L&*+V-@J;E6^4_U6>(57"<H[
M3E54 <0F=4M+/_6H566_=06@U?2@I6JC!9R(1*4JC J^U4S!5)*KA.I7:;53
M@?+3+/T:$TO_*N&L'^#DC]\<V6,+60A)S8CKQQ5$M#UCRYFA-.-T'$V,,+>S
M3.;$,-*L/TSC69OUV9W5OYX5VI\E6H8LKN+1,C#+Q!]KEP1#6@ DLK$\VIO=
M3.!Z-9@Q6J6MVJ&MV:#UVJT%VK#56JEUVJ^=VK$%V[*-G+1%V[75V;8UV[AE
MV[=-VKK%VJ:EV[*1VZQ56YF$V[ME6K*SV[P%W,(EW,'%V\05W)Q%W,95W,=E
MW*M5P+/EV\.%7 )SW,G-LLW%V<ZUVJ7E7*B5W-#UW-(%7:YUKRLI,C4S%#H,
MGVZ$M*?41F^<6^TBKEP3RS+-/ UYVH6"E$:D/NYRW38C->L4N4+4_\AWJ1ZS
M?2:-V9Y:4\2QS1_8X9V)1)J>M#&ON1L!([4]F<?CG;.<E<CO'<T48TH]'!1B
MG+B:9%NA+%]C93!L>TSFC;6 _,?(I,?!=$/NM<Z3)#O!4T9[I#2=#,4^%#6N
M-=)0<UE.2CC7U$JW&42X41Y5;$D;=4SJ5)=3H[5XE#7AX!JD/-Z.9"?\?<VW
MY-_VU=/65#7%N$"VBS//Z4H((]B@72;CW. 95J1W520(WC!W\K(?[F'=O<Y2
M!3P4\V$=AC\>YEXDAM/2-.+-&5H;=EQRTQZQBZ\)[LN\;%L-?BN;C)H!O4/"
M^R;C:RPP^=\T=6!M'+O_PYR.#%)-*Y40;O]@E#T?D[UC'JSC_$@.X1-'?_%4
M4U/56@)8Y*NF<VUCC:U/,P:.KFN\@)W6]:M3<RHIE?0*3WI.1=ZZ'OU5_Y/2
M2UYD3NZ?%_SDZ\QD+-W4B!76V5-C1V[E29Y25VY*!Z;D:*5EONFX<NLI4K[E
M9=NZE.3DL?+D[:CE5'Y.5<YE8:8_77Y48M[E68[E-VUE9P+FJ_H[TT1E-AYE
M649E5I[F7J;09'UD:C[F)+9D9C914Q;E:&;E9]YE;[;E=R8_3!YG8Z;G2GY4
M7X;F1$[F7-WG9:-D<;[G=*YF#Y1D;M[F959DJ\)5_U,_D]F^=9K?^U*]:"WE
M.46YDS,YJ(-0%-7_G-BST8[Z9\OSHIFSP>J\UCV=V&+-YR).UQ<[IJPZNL@J
MKX,=WY<PC5R]O94ZOS5"G8<RJN?8CJ_B'++2'VY3NY:8Z7J&6&LV8\DBY)1N
M+%EM)QY%J:%QSI>F#>6;F/XCP* FU?VA&G7&HY(N:09:P(^5TK+=SOG=IEP&
MODQ&O%RF.U>*6 0%.[*Y"X:V(%4.(DJ*YK-*T*OKI:$>JS755<Z14XQE(0\5
M:2-R89CF5L.F*WB1JB=R*TVN#:W2J-?#4.S<[/;H; (-4]#&;*CR;-+6#=,6
MZ\Q&S]*^;"22JA+,/MBV4-I6Z?!TU.FH4VUEOJ!:I\A#JP'2Z7CM;8?\_VV3
M2E5P-C]$56 )1,^\QM:;_E=?$M*&#28]+A\\WNZ\RN[[(,DX$T4R2]]@@KU@
M]E_+')(]9%T!9N?G56%D+$G^*N&=I,1&L33Y;K0XD6!3N4,!?EEXM!O_7LD!
M+\4*KL0J_&\8AD?USK,!'LD Y\KX%C0(Q]^QBW"-HD5\_%LA2_ MA-[8!<OT
MRF+VQMY$(V_3M/ %I^^S!$0/#T@OQL(+1\,9;\,3!T8 K\,;Q_"W3B]$*G$#
M+_ .2W "YV\*!_(A]^\RW''ZCO$/3W$;3V$,SW%+J^_TI7($K_#V9G(%CW$3
M7\(I7W$Z"]X$+"\8L53F'?*%^)#_^5G(E.I8E/_$7;S&#'S'&:%?J%1')KO;
M"3[("&[(+RO(8"X=  M-)=PT) _PVE5*^F3'#%OAP;VW\18[F)U$T%RRP)1Q
M)(1C,"1'@NQ>F@.RP*3Q$<U@1V<(B>$164FN?IGOR&3SJ-44-E4ZHXS>5XM(
M%A[A1?O,Q3*G+O0XC&3C")-QV!P<"\?#3U??(TO"G :728?P-#]-DD&>R=2U
M+_?=PG27-O_"[-G>I\2R9:S+C>R;M#K-S0S?IX5=%_YB!HZ;EPW-159J+1M'
MXY':)!-+>N]>>Y=WJ]3T?==3;&_O9'4L[DJZ)_]W8YUW@5Q&FFSQ=03)P"O*
M^'*L$H7"X86Q' OQS^P57)J5+S1K%,JY\SXSW[>$2J*T7B"6_PCOAA#N;ODB
M7'GY*.L6IF3(+EPBDZ>($N[YE+NE]KRCBU*<EZBH\Y_<B6B?SSH'9%2@7P^A
MA[FFS[FE1WJPEOJC=[>HQT"BA_JD%^RKW^VMI_H&M?JO%_NI)_NJ]_JR1_NS
M_R834_JQ5_NPA_L,A5B[,_JXQ[VW9_N\W\"]3[RUM_NZ]_N[Y_NTQ_O"!_P#
ME6RGS_J@8WRW+WO)RWO$?SK%U_K")_R_%_S I_LVT?O+U_S$?_K&[WK#SWS.
MIWS11^;3E>X?%VKQ"\!1$B=>E9E FM!0M_V,;E*88FB^X>D)/5+(=^S!RSU-
M96K^ WW:7_.(?N:BIN:[=JJ&<IWI\_]UL-*)EGM6G2%JRF;.*]4]L:-!-;5K
MY(&J@YU2^U/87-).1UK7<3T\?\8AMA)4 :R@A.3^">G21:53M?:H81HJ@&@$
M@%XC@@ $'@2@4"#"@@@-#FRHT"#"A P)0IPHT6'"A!@?,HSXT:+&A28Y@HQH
MLB-)B10A<K0(<R'$F1U#'C1(425/CC4OIKPIT^'(G!)[KD0YTF9,GP)_TD3I
ML>'+BB&?!E7J="=+H$6=]IR9$NM-KF1%GK5*4F5,J$;?4L79%"W)D6K!PHVJ
M,RU=ME'_EL6;=:_&JE.1MCP,<N=9NSL)"[WJEV[(GX;),DW,U>YARH_Y)B:[
M6+)EH(<SD\;_R;FQUM-'7RM6R?2KV:2%QSK&/+:SU,DQC;J%FK%WW).$Q<X4
M&UBO:9@VDY]E_K;C;-: U_YV+K<DT;G=>6J_?9SUO_+FSZ-/KW[]>@/NW\./
M+W\^_?KQV>//S_YB3N!4C?]7$$W]32>@5P .:" ],L$U6X(+$FB@;7$MV%2%
M$ K8E6']9=@AAALJ.*"&IG'XX4H-!FCBB 5>**)5(+88X8>2E>BB0B@^:.-?
M%LIX8FLU1GCCCR$&N6-9/<I((Y$="@FCABXREF.1.'+8I(].OG@EB1+J2.62
M&#:Y98Q,[N@<DB\J.::*0ZJI)8MGAOFFAV[R.&>2V+6Y8IUKQKDG_Y1EIOBG
MEWEZ*":<@$I)YJ!GSBBGE7J::2>:<J[9J)]3LGGHHI+V&6FEB *I:*:<@OHE
MG35*:JFG78[*9ZD5/EHHI8*V2BN6KFZ*:ZV88AEKIX&62*%68 :+7;&A&I=7
M<2QFJ>!KQ,KJ7WA"O7DGM3S"V1VL(<X5+&T'\O>=A5=!VZ)<R'D)Z$>P-H@J
M8%)5="1P#SX;8& 872?A=\N).RNY]";X)+=#F<M8P>-N:B510[7TE;N1504F
MMEX5UZRZ#,+&Y9P57X9:QU06FRG$&VUXI'?SDCOLO%46R"RJ$GM<Y;,ARYPC
MO.QRNZZ]$"=UX; <4QP>F0:>ZVZXD4+I'?^^-+=V]+4^;VONRJ:)N^Y:D=DX
M<<A2'YL8PT[+[#"353,ZL[Z-,OQRBDJY*:1M+CNKE[HXC0QPD$HFC?3#<1\[
M-+TFIBSTMSY/'771VP4:KK1_X\GRX5$3O#&^CV-MM.%+.[NMS2=M?O;"WC:N
ML<F0!\TXY1MU;CB*Y69L;>89$^XXZ0P:>S?4R3JN+*5^BHXQ<@-7Z[F1).OK
M>]C$2_=?Y$;Z3O+H.3=L^[L( J"?]=>C9Y_VVW,/'_;?KY?6>"9E]!G6H_'6
M,FS458:\85&V#Z+;D*6<U_@-4RT;7U2;CQK^KDWH?[KI&?_:AYBF]:]U]1O@
M^2ZC/Z04$(#\<B#__3C7M <JYX(5%& "PR(9J6QP@1T47/[NAT #TJ]C*-P?
MC@:800J"YH021-T'9VC!KSVP@25DH A7&, :NA!H]N/AUT98L=#DD(9(-*$#
M?<@O'(80?AU\8@V9^,$I"A&$,50A %^XPP-RD8@MQ.(-OUC!"(H1B&0<HQ.S
M6)<M7K&-%H1A$J4H1R2F)HE%]*$7AWC /7:1AG1,(1HQJ,26&9)Z8%F*#R/X
M1CW^I3;B^UDD\?(6SL"-<YSYEN[VY4#VU8:02,D,88C8K6Z9CS5% 8]+!(,@
MA/WD@K[Q377(ASH 06:3UH'D_CB)&QEFYI++"F))A.D?6Q;3+2<[)F26^;<<
MX>S&C]/+326/R<#-_ @ZB3R*%>^U+*C4"S#3TF97I(4PO]1R,'-I8L2L@Y4H
M*7.::KG6NPS62NZXC96:%(UM=";,$#YM2^D35C*SDCP?\4:4T.1)0L4DT%L:
M\)D&U,WX2BG.HZ2-A;W!Y#WY,ARAU/)W!;J9:@0SK8BR3Z+'5%842\J<#"Z'
MGI3$Z+F(F$O0@/.1[QLF 5?R45?N-*,]32F"M D6@<8T* PSJD5/.3V&-J>C
M30TF*N]2P: B=9CQ[",S[QE3:E9ND=PL#D=/:DU<6B>H#L,A(AGYRI*T4W\*
M'2M5/6A7N[KS1O)#2VW4M\\YUN^D!/\!'V'-@P1/'/:P8(@/&)#@V,="-K*2
MG6QD%TN?PF+68!.2I.S6]C?E-0(44V!"%)+0O=.B-K6J72UK6^O:U\(VMK*=
M+6UK:]O;XC:WNMTM;WOKV]\"-[C"'2YQBVO<XR(WN<I=+G.;Z]SG0C>ZRDT"
M$Y@P!62 ZV"$B]O"R&:RT#G2LY^3W&9[Q+;L%HH>VAAM::7KWO?"-[[RG2]]
MZVO?^^(WO_K=+W_[Z]__ CC  AYP;*EK7>Q";9Y[ E:&"/8@S!(6L1+VA&7?
M P9/8/BP$]8PAS/LX0U+6+'U@3!A]<E3?\+3J=_DR"N80. 7PSC&,IXQC6ML
MXQOC.,<ZWC&SCWOLXQ]SCPE96%]5?:J6,UHTF#>E(UO,XN2C2F<ZQBP(*%P,
MY"MC.<M:WC*7N^SE+X,YS&(>,YES*V1PMK2:#8EH;TC\O<1*F!OQX<9C00SG
M#M_9PQVFL#(NZV;L"3)Q<>J;U1 FH 08HLR*7C2C&^WH1T,ZTI*>-*4K?5]#
M#+ED>%,:D2$W,ODICV:,"UX]D\6?FV3!TJI>-:M;[>I7PSK6LIXUK7^;A 2\
MA%F8XYR4E?;_EC]?#\\5=D]C[1QB/1_[V'=&@IS]#&S]^'.6>9$K67FJ$FV8
MMM;:WC:WN^WM;X,[W.(>]W&3 (H''K648EOK\KH)EWO:<Y]]C#=+0YMM<N,[
MW_K>-[_[[>]_ US&YJ9K+]$7[:H^6S_*'K8!+JSLA\,9XLA& L.]E_#\N Y=
M\$I4SQHTA8"#/.0B'SG)2V[RDP=\"@L&G)HTUBMZ8DQ$_S.OJ2<7.^@%[.,H
MWSG/>^[SGP,]Z$(/\!0XVJ[>T&YK"+DX?I)-A?C\0 YNF#K5JV[UJV.]ZD]W
M-M/5@\ZH:M-_56N?.ZPL'^I.80J[. #;V^[VM\,][G*?.]WK;O>[O^,][WK?
M.]_[[O>_ S[P@A\\X0MO^,,C/O&*7SSC&^_XQT,^\I*?/.4K;_G+8S[SFM\\
MYSOO^<^#/O2BS[LV$I" T=X[/E%PQ]MP"%&Z6'0JN5$W\O Z5%AJ54GNB )]
MDA"%M$_!],(?/O&+;_SC(S_YRE\^\YOO_.=#/_K2GS[UJV_]ZV,_^]K?/O>[
M[_WO@S_\XA\_^<MO_O.C/_WJ7S_[V^_^]\,__O*?/_WK;__[1Y^]B9[/ZA&S
MT":O&39%_T7778]R$6#XE%K,&1KF?(I#9$+JO0<3)( VN-TIL)T%'@ &:N %
M<F &=N &>F (@N (?F )BJ )DN )JF *LB *NN *OF +PN ,RF -QN -TB .
MVF .\N .^J . F$/!N$/"F$1$N$1#F$2&J$2(N$2.F$30B$32N$33F$44N$5
M6F$65N$68B$7:F$7@N$7BJ$7DF$8EN$8FF$:HN$:GF$;JJ$;LN$;RF$<BN$N
M4"#;C=9\) $"B$SF3!OT[,O&=)RV*%*"<1PB_8:V-,(#\E_P$9\QF!XD)H D
M4F(D6N(D7F(E8N(F:F(G9N(G<B(H>F(HDN(HFJ(HHF(IIN(IJO]B*[+B*ZYB
M++JB+,+B+-IB+>(B+>KB+>YB+O+B+_IB,/;B, (C,0IC,2+C,2JC,3)C,C;C
M,CIC-$+C-#YC-4JC-5+C-6IC-G(C-GKC-GYC-X+C.(IC.8;C.9(C.IIC.K+C
M.F8C\4T![YT='X(:SW )H>7$ >J' >HC>K@5C.S&3[&50[@#!!I %$S@VG&@
M0C(DVS7D 3QD1#KD1$(D14ID16+D16JD17)D1G;D1GID2(+D2'YD28JD29+D
M2:ID2K(D2KKD2KYD2\+D3,ID3<;D3=(D3MID3O+D3OJD3@)E3P;E3PIE41+E
M40YE4AJE4B+E4CIE4T(E4TKE4TYE5%+_Y55:9596Y59B)5=J95>"Y5>*I5>2
M95B6Y5@NY=KM@@6N)=LE@#S"1Q*P'NT9$U$I$6SL%).9U':LQEI@TH801$'*
MQ^\5GR3BWV$B9F(JYF(R9F,ZYF-"9F1*YF129F5:YF5B9F9JYF9R9OOMP26>
M'ER^AUQ"D,,\F4R-1#_B!S^J9GGD3I&PC3VR2\N(IGM, 42>PMKE9@4J9 ;V
MIF_R9G"VW6X.YV\2YP4J)'$J9W(R)W(Z)W!"YW(^IW1&9W-6YW1:)W5J9W9R
M)W9ZYW6"YW9^IWB&9W>6YWB:)WFJ9WJR)WJZYWG"YWJ^IWS&9WO6YWS:)WWJ
M9W[R)W[ZYWT"_^A^_J> !FA_%NB &BB!*FB",BB".NB!0NB"/JB$1FB#5NB$
M6BB%:FB&<BB&>NB%@NB&?JB(AFB'ENB(FBB)4BAT/F>+4J1SZAQ\,('9\)I#
M,2#*($V6J _.C$G'X:AGW0T U*8!2* E?J;P'6F2FIZ2)@"3.NF20FF31NF3
M2FF54NF53FF66JF68NF6>FF7@BF7BNF7CFF8DNF9FFF:ENF:HBF;JFF;PNF;
MRJF;TFF<BND40.)GXJF4[FD"5 &?YNGI!6J?_JF>#NJAFEZA"BJ@,JJ?,JJA
M-NJ<-JJB[BFD0JJC6NJB7BJE(NJF/JJF+BJF@FJEABJG?BJAGBJBBG4JJ;*J
M))IJIJ(JK*KJI4JJI/[II*8JKLJJKHZJJKYJKR9JKGIJK=8IL=IIF[8JKR;K
ML(+JL1KKLQ9KM#JKM$+KM%IKM6(KM6KKM6XKM";KJG9JJ0JKN.XJLRXKN0*K
MN88KM[)KMK;KMAJ?89I=! )+F?QHH>'_3&NV1W+I:WD@#T$I!R<%58R^1P*T
M74/N0C,X9,(:0T4RK,,V0\.J9<1"K,1"),5.K,4^;&]R[,%Z[(MV+,A^+$:2
M;,B6[,B:;,JB[,J*;,N>K,NJ+,RR[,O2;,S6[,S:;,[B[,[*;,_>K,_J+-#R
M[,\2;= 6[= :;=(B[=(*;=,>K=,J+=0R[=-2;=16[=1:;=9B[=9*;==>K==J
M+=AR[=>2;=B6[=B:;=JB[=J*;=N>K=NJ+=RR[=O2;=S6[=S:;=[B[<%N[,5J
M+,8Z),5^9 ) X!2D#TOLJ%7%$+6$4NZI$!>%51D9!,$:0!(XHO$=J>GM0O!M
M;@)T[N=R;NAZ_Z[H@N[HFF[IHB[IJN[IKF[JLN[KNF[LMN[LPB[MRF[MXN[M
MZJ[M\F[N]N[N^F[P N_P_F[Q"J_Q$N_QOF[S92[S0E_S,A_T-E_R=N[P2:_R
M76_R92_R;>_Q=2_F/F_X/M_W%A_Y,A_U(N_E>J_X.I_Y6B_[.J_FIJ_RHB_]
M]F[\MN_QU>_^SB__VN__^F\ ]^\  S !"W !(_ ! R_WPF_T-O#RN2^2GJ\!
M4W "5W#R"M^?2J+T3D'ARI1'K=C;%$2_I@=KMN:J.,TYJ3"QO$)\W%K#LF@S
M[,(N&(,,7ZQ"UG#"JJ4.LUT.V_ ,V_ !^/ .!_$0\W#$RO 1Y_ -Y_]F$MLP
M$@/QVD$Q$^NP$CNQ%"^Q#C=Q%!\ %%OQQ*YE%3]Q#G\Q%5]Q%Y/Q&/^P#&_Q
M%Y>Q%HLQ%I_Q%,/Q'*>Q'(-Q&ZLQ%],Q&\<Q&MOQ&H=Q(/-Q%OLQ(;_Q(1<R
M(9OQ(CMR([OQ'D/R'B?R(#MR)>LQ'F/R'WNQ)-?Q)7NR(D<R'D^R)H>R)8\R
M(.<Q)]^Q*I>R*F\R(I]R)L/R++,R(W]R*O<Q*E.R+<LR*>=R+P.S* NS*P>S
M*0\S+R.S,1/S,N\R+7=R,D-S*S_S+3_R,=>R-%MS+(.R-O\R,RMS-H/S-.-R
M,XMS-7\S.G?S.&^S+Z^S.NNR(8=S-+-S.LO_,SE?LSG3,SP7,S\[\SVWLS>_
M,T#;LR#C,S?'LT$'=#US\0WWL S_, _O9BX#YRXD@'R 0EPY!"!Z&J=MUUFI
M<*P43-Z\CLW0 RBXL"-R0966K_"YHSK"=#O&]$O+=$W3]$W/=$[_8N;R=&%&
M*4M+[P9+\$^[]$_W]",:]5!GKF$:YB:V(E(#]5 /GU G-50?-4L7=503]25>
M=5!7-59SM51[M5:#]29VM4]KM9)2J5,[=5,S]51G-6@&:I4VM5F+-5J?M57?
MM5Y_=5;G=;SJ-$ZWXE_[]5[#-58+=F(']F+;-&,K=F-#]C$N-5^3=6'W=5A?
MMEUG-E57-F:#M5O'_W5;'S9;OW5<@S9HBK9IC_9IDW9HE[8FKF^5=G!\9'3I
M')'M4,Q"D'#VQ <55!QOD?!:G9)1P54X-0($&JS',FP41W$"7+%%>S%SSS##
M-H-S,[=SD[%T S%V3W?"<O=T1VQWTW!UAS=X?S<0&X-XU_!Y>W=YH[=ZDW=Z
MF[=[+W=WKS=]QW=WT_=XLW=^@[=\3_=] WA[#_A^"[A^]_> \S=^)SA\]W>#
MV[=_;S=^*_B!SW>!5[B$$[A^9_B#4[B#,_B'1[B'8SB(%SB$![B&JWB'AWB)
MCWB+<[B)([B(ISB)Q_B+GSB-S["%3[B+USB,_[>,7_B-_WB.^_B.JSB*(_^Y
MC0<YCL_XD2^XD1/YD@/Y>SOYD#=YD3_YE$?YEF<YE4OYEW<YEENYEI-Y?9MY
MCW,YCV^XF+/YB@NYFKMYDNOXF,MYF8.YE^.YG;?YGK^YDO,YG%_YG:-YGI^Y
M@=,YE/]YG2^ZHB?ZFC_ZG#.YGT<ZI4]ZH0<ZH#<ZI%\ZHG<ZBX>YI5<YIN<F
M=LNP=5>QJ>MW&,=X$ OQ1<=E(%$;%<5)V*7$_=!EM5$)&34$!&[O9QKF/41P
M9Q)[L1O[L6MO:&\U2]=U64\V\4GOL[_O\0E[2Q/U58.OLRN[MJ/VLDN[5$MU
MLT?[MH][MW,[6WL[N5L[NI=ULV/OM&,UMLL[N#-6,+2KN[V;>[FSN[Z+^[I+
M8K4;*;+C^[[[^[K#N\ C?,(KO/1!+[\;_$_W^\!'/+Q/?+@_/+HW[[Q?.[AK
M?+QS_,=O?,A[O,C_NI8:'^4FP3J]DT8%QSO_[?9YR(<2.)8;_#9ND7 ]]0[?
M# F+I!I\J!T,$Z=T)W$:>VX2SW ;5[%X;W?2H[(.KW<4RS" 0S1XZ[#10ST-
M4[W13[W55SW67_W5<_W42WW2;[UXBWW6HWW8.SW:@[W9K_W7=[W:1SW;Q[W;
MSSW<E_VJWWW7M[W>>SW?U[W?C[W6 _[5#W[:V_W?3WW?H_WA,[[ATWW>-W[D
M%W[7.W[@3S[>5_[9:_[B9S[@2S[D=S[36S[E>[[H@_[FOWWJGW[IC[[<*S[9
MJ_[>>W[HNS[KDS[GXS[L7[[MZW[MSW[L$W[K_[[L$__J __QT[[QYS[R,S_O
MFW[S+__P2[_P([[@_T<_]+]^XO=^\'>_\EO_X]]^\E?_]Y=_]G,_^F/_]J__
M[J<_^W\^^6N_^[>__+\__<?_\]^__=>__@/$+H&[FA'<96Q@P8("%1H<:+ @
M0H8.(5*<&#$AQ88+,V*\V-%B18D5/QZ F("AQ&8H.>XZI7'7 8X<7QZP.<5
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M4KCCISWR*"*$%S9J:9F6.LCGH\9$RBF8*7I)*JP0RLKAII422:NE(/IYHJV
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M6P_J^QT&&JV,4(8<B9RY:ARB\SF=_YNR"+P2,U(&,1FD"SRD,D&"1.H_BI!
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MM(JC4[L1*XF>E(Z/#![XBA&YC(R0U#_OH4O#L$OSVLNY)*WFRLN_Z,NZ#$S
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M*(U3.YU3/*W3+M50)WU3/>52/_520/U3/JW1+2U40>U31&V&/2"C!%2&2$U
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MF6:.V6:;NS1P )J[<%EGG&S*F::<>?9)IIA_\@FFF&K2N2:<<_8I9Z&[''H
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MN8=-;6Q_.]OG+C>XWTUL9D-[W/)>M[?1'6]U7SO?\'8WO[5-[GE7F]OI;K;
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MU2P)UI<<P!3TH;[)DF/9&B^EDBI)E".V4YP0%C(QXF5A%H-\%E2>R*3-G8E
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M+=;88Y%--MF2P/#$$R0\H<*QDZBM]B1EL<U6V:!^)8J>7KOZEEMND2K7VZ6
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M]0,HL=U0_E"/V32_)189&4$E(:&L&O7:GQ$W!HS1D,Q1K=T9U.IB!!1)<7-
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MDIT)\"D)UM/_C3P\W"2$[0,G7U[#93<>>;[QMY84S*F771/$V6=<@FI),1R
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M%H*Z^5;/=,UCX_M:=SB6K&>+L%BEIK 7EOV%DW]<D H<"X([O>P.=VV5'5,
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M<F72V(P5;8V2,26>8U&6W(G+S<Q,?)"3/966 32!$]!'1*$)V 54=:Q=2R9
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M)S!4N'NZC@1,1##9K5L/3]V =/7KI1NGY]LX?.+ ?<L'WIO^_=\1F^WR_Q]
M /OKSS]C_C.F&0,#3## 71+L3\$"'?Q/BHND.."  !$LL)F6$&IPEYL&_.^
MBY(@<!<%FQ%Q0A0?G- _%&.<$40/#;B00 @GK%"U*?X;, $99QQQ%PQYY _$
M'&F$\3\;I2@RPU.@/!*A*9J)BL$0(WI2R@P/%!'+7:@\2(H79\30RQQ53."F
M)0WLT,(#I.P/0YLB\G'!%B,4<$P#3H111@)M-,#+"=O$L$48^V0BQ0&-87%$
M)S'<TS]E+E*20!,+)9+_12BUC$C.&3=TL,\H8#004@ 1M#$)1"4<D<X)T1S4
M5! =5'%#%RE=$%<B;[4UQEZ9S-+6+%_4%=A?;_65V"2%11988W/]<5<!GZ4V
M66F9K1;;98?E-MA@M\WVVG"C+5?98M%MMD%MOR57W'?/C1=:=>GMUEYOZW7V
M7G/S/19??O4-N-UUP5468'\%3CC=A:=5N.!^&XYX8(AYE9C=BRN>6&.&,[86
MXX/=W9=BA@'$\&./.8ZVT1:C6O9E:X&,B E',<4R0F;_NU/9BP),P%*$!+IT
MPD>1]#!66'\,6&F;!W91SU<C.@Z^]XX;CC[BA+-O.*WCF\_J][S>.K?BP@:[
M_SCYMAX[:ZH!P"DGJ%#CB2_9JLI,*).4@BH!'R>K2&_ &>K3 "8HLNLG)VZ2
MXAZ^;KJ;HB8L?.WQNYT$ZR;##PLZ(; 4W](VH"_2G*'* YN+(:-Q$FONR1\#
M.@EEI$B"=(8X%QHH0T;?Q;;;_:0(*M]7 ZG4C/CFBG>*G$CB\84^3V@BK22G
MF38V.ZK^)+CW,EVOA8JG'*73"6(5MLNVRGPS@IXW,?2ZN[_M>L2T&E0*PT1?
M?:OI$ZJ_M 3T1\AP5%D4]OSGIR1(@0E.H$B?^/<:O' O 0QL7&&81[VJD \O
M# 0*ZF#3P04N;H)[>1U!=-<1JA0E>>JK7$P>-\+_D?_I=,W#RPMOU+B?L#!\
M56&?8 @B/!WF<""M24 %$Q*%U&6O<YZ;W&9BLH<4CH^(2>0@ ?OBE+S@K7S=
M\]L4CY@ N06.@POY(A4AYT6?D!$Q9A0(&%$GQC-J!3-T6^/>'!@6)J8Q+:()
M8F$6 L>9B 8RZ5M*%MOXFLJDY2=SV^)I E>%"2YF)T($)/#:)\C4,86+DWRC
M X_'Q8>H9BM"W& =&<*WH&"R+)896D)T@S6R56UM92O;V'[#'EO>TCFJ 4-Y
MKN,&*AA &<J@0G:T<Q,WD.<ZZ$D/+ID)G:I=[3Y?PT_:B),<Y,2')$^;%KM@
M%:0A"<A;,F/2*0Y N%W,Z6'_@KI)E)8E/ #-R4)+(]"B(F0,+U5("OF< J/.
M630"(6B;@SK GE!4(M5(853.RE@S#F"G;#K-F][\49!R-86+1 %-13IG.4>7
M4 =I"E&PNDE"+;HE<#H((K/3Y](^>I%-P:BDT-.H?Z1D(R<ZC5(V,Y Y><>@
M-!GH (-R4*'H*:1&96Y8;8H01R."T40E:% 2_5$\YW2@%:'D04:*)]3\8U":
MR;-->9)*/%NTSWR2Z5?LW(5#$?(DIW%558'Z)ERM>E*E+:FN++TKD_)*H[T:
MU:.8&E:# CM7EL;5KHG"*X<2JS,-R?6IA^TKH!3+5\;JM;* A>Q?";O9S':V
ML8-]_VQHZ7I9OWYVM)AU+&)5*UK6GG:UDQ5L:5O66MH6-K*+K2UL72M;P^H6
MMYQ-+6]OZ]G8FI:RQ]UM<GN+W-E*UKF_M>QRGPM<XS:W90/*$(,$RU<IV76;
M#YNND)RV()JA2*HQ\B9YLQL1*@SI4ALZ14PQ\JD/334B7(!30F@J(=,&RJ/)
M4A7$M&M? [A2:PAN)=6@Z1O\+-ALU^0-@[TVS?D\4SX6S@^$78F?B!Q%,W:L
M(ARW<CR'V"TV4_R(:A1(P$$-#R11A.%F!H*^U,GP-5%5945D7+B2(!$A0;P,
MJW@8P=$=L<=,6$S0\LF$:XP2@HCIL5D^F4.'M) @]YBR(?^K#+WJ7>0E&V3K
M09I D5TPH0E-8%Z8\3(3,%/D<IP9XI$SP@7K)83-:KQR1,(<DQXCE)1W3DCM
M5JF]JOPR?H3Q2]\6\N>\$(1P!VEQ:S2YEQX;( IB&64"UC?HS4"0+ 8F\U;&
M;  J(";.AW%(C\O,DBA_Y!Y]BM[@V->WUR3YQ(SN,D(F N<=7A"8!FB"%)Z<
M$28P(0E-L%29W9> 4C,[T(<;".$\:!1GOSG&)I)*&FT,/Y?8FB&E[C55:&B
M&VXO?E_F<YOG'!%H-P5]E<$VWQ8253@?, G,(^0*FVV^TZ&XD\8+I"<=\IA<
M6]N.?60WPJFL\!0S_(I\.7BT4US_FST",M<6MW6EK:AI#Y(RDG1<8Q=%PQ:H
MH%*-/<D,RI$"1DA*_(P?%\IHNF@8E@\<XU06.$@0'A.W%$2(#A](K@-^&KT$
MO.9J%)_Y@J@:H8\RYUO9MF'D-G+"3,W!](%P?-Q&X0HW$^S2N<DPR>,&]WK'
M.MQ0C1MX"1[TA!WNLE2;++=^-KI?F&WT0)* J>4H@4WWFWFBDU=E>B4-&6IW
MV_5FJG;6$4]UE:G[.X#2"(\0\H8I28M#6<Y>/.BF(>AE."55IPA:VP?%[#_T
M/8BI0D6@RA_$2ER04Z8ZLMT4 4A$LD=3YOZISBW)2'4)@9#A)^0D**%H4862
MYX94!'G-_]M^L$A]4Y%X.K!!<355""*<\F.D&N[BOO9U[4^G&K7]_LY(]0=I
MAI!$E"L5L8JHFI)5AC!D(Z?NRECAY"LWFV^F_>>T_Q(*P#I&_P809/2$KOAO
M2 3P +NEO/Z/ /W/ !VP !O07!YP B^P @DF_R30 A%F PDL !,0 !>0!".0
M 3EP!"5+ 1&0!4O0!?&J!3'P SLP!470!%\0!4_P &E0!7-0!F'0!W$P!B&P
M!T-P8FR0!RG0 W^P"#,0!)N0"(<P"5?0OT#O5YIE0]!D\L+E8TZJ  ,L7AH/
M@!8P:L1JHOSCO,"/OV9$T,SM]<R$:)!&ND"05]Y*7]RO"(\*-_\6K.X:C&S.
M!N_NCNZ^AA!A23_TXY6HB1##!IJL)B(>Z>.&;C/(XH^TJ'JTXB,PJ34HT39$
M0C5JYS1>;-;4B'!F8WPJQ\UR:(,PJ"J2K&ZB+!73[7CBC=;232FPK'10PA/[
M1]:P1WB,: \F"(*VK"I^,19Y,7(N"BBZ[151XB-2#22<T79 AY1\B"M*#<9&
MJ=,P0BYPS!-=480J:0^TD0G\[7ZHH]?D:.DV(]((33!(D3;VS-VJIQLQ3<YH
M2'.(HMO8PMYDXB:@K2[:;7]HKL>,2"N$AU&JHALG(B@4LI0J@H;JAR!H:!T!
MHQN-J,2Z:!77#8^ ;,;ZB-KBAB'N,2>F%L*'E&(D >/24J0J?(<B;2TSHHS:
M'N,?O0UW-@/1O&PAJ#%UC+&*+(GGL <=H<XI,L[HE.XC(>=U;LXPFK*0H'(N
M//$HG/*(I/)OY.*0- F%6BZ%' +IDJZ2:B..?.*)F%*.B*+E@"XHEU+7VO(2
MWP?FR%+(WH*-WG*2BA(L4(GC+FDHWT*04+%O4FB+^@*4N B+(O(O/)&#< @A
M!K%KV@;"(LP/&_\![BZ3.6[B![##.OALF,KC/(R)F,R..C"SF:@&P8(C,C4,
MPR(,/B)BKMQ/2<3*5P9+:?HO7;2*K)J&"0C'1]C/9_JO3;Z/G%[O1AKDS_I.
MJC!EIV[B@&)D"B)M<6ZO79+$/[11GK*0HOQCO5ID4!C%]0[@TI@@H[HOON9J
MG="DIGC/08+D.[_OJF"3LHP!%O9 VXREH2P$8(QJ6,CITI+@NXH&I0@'/&D*
M0_XL0%/O)J9"0..S#=%O04=$2B)-O\#*I2I+U!0B1NCOS](D1K[S51 DK$XJ
M_2ZDGQRTK5YEHQ;EJ4;%_Y9&O,+I146E-LUD1OWI_]3$J(8O1\<0G&+_U$;%
MD$<!3$>K$TA=5$BS2YST#T9K%$EW5$G[SD>;M$>9E$:K]$:'=$FS-$K'D$N/
MM$CS!$RG]$J)E$QQU$RM%$VW-$G'5$VU5$K?M$MEM$V=-$Q_U$[/%$Z]M$ZQ
MM$_3]$OS5$[=-%#]%$H)]4_9]% %E4N)9$>G9?I:9CGST.^H5/P";$!XAD#2
M*[( JAG(J4)1E)\>Q&=01/6"Q&?PB[_VZ[ZNI%G@Z@'Y#@P/)%$B(L%4$U?M
M8^ZXINMV%<.T;L,D3&O )C\F+#5;TY4,#3#_AN"$DN0^[I 8XM+(I,6,C#K*
MZ-*4DM,RYQ)'ZBUGT<MFCB 1HEIW$<]&:2#$_]'2+J)<0?)WP&T/>NPB0?(E
MG++&F'&.=@V IM$C><Q;\>+%ZLATH*)/H$W+;D*!+K$A?>W(C&X\<X(LN$?A
ML$TI>HS-9F)0VI5>#X=AO>S$6"XI]14AFH!T9D>9!JTO1VE:'=(KF*+SRI4I
MY-4P7BPF/\@:V;%/PJQB_Q5<4=8P9!8D2HTB'6Z 9NXFIPUA0>([&2)#^RS;
MJ.=C7V./GK8C%O,AQG-J"<)BMR)C.?8-,>*(OO,HA =L%TT5?P@GS*?'#*$I
MEK9;+Z)_&,)&\JS<6FS(V <J'"(N0N+<1FX>(=9^-'$NIJXJ/(/2T(AI_R+C
M!E=Q$=<K&I?$0&)ON?\L<LT,<@O)S,C"+FR.*E"NZJ0V?3QN+N,R<)UUTP@(
MQ= Q,;G,DUIWA.K(,QPNC?IH<TOCY\!R+_JVV9!R(Z.UYO2VB43V7?.6-=R(
MYTCLY[),*]EM@R)BZ[(N;8;#FNICPC+,-"_S)I! >Z]C)Q&"[,P#/=KN[:[W
MEB93[MHFEE+3[JQF/Q(B0T0F /$%11I@H(KE"F6E2Z03@0Q/)#KO]HZ%\=1P
M=/KCV* D/TVD9HJ"0+NP9)JO\TX6/<[QKQZF_LAO04(/\%IJ@/VC\QBE/#.T
M9L2D9EXF/1$E0P[JGC2/K\C/53F8K!CXS,CJV*)BF\ PJ*CCV%KXV*BCH*#_
M)/U6;T!Z<SJQ+[X*ZJ!"V&2][_PJ98/W]U8LN()OHE9$@G#*Q&7&CV@D$/YL
MCW!HISV9(#HMF%P")6;X<TG5"[H*AHS3^ X%I(P%[$6)+X/C%(UUJXW3T([/
MN#W96(_EV(SI>(_S&)#]&(X#ZXW'V(WY>) /^5S66)"GE) 1&8_G&)(965T<
MF9*9-)(;.9$?69,M6:$Z.9/C&)356)3_N)(5.94]F915^9-=N959V9!A>99E
M&9-164W5RU%1S[6^C^\<JS;)]';XZ5OXLQED#_+J=PV;Q/,D]4Y $8!DI"7(
M$YHM#YP>Y$UPI3IAI8:WI9O(\""*M<$:$7W)^5C)_QF6!C%MY&X1RSDRUUGO
M.@=OQN@UZ'GI7*XL5([B*K>#(%B9ZF<Q7TPCM]4YSX<5<Z(;:Q8H8'$G<(PB
MNE<BKI'.<JV+6VQY;(P238<J*6):-4>(:ZV/'+J+&V(CIA7&'+-S@F(B<X)F
M2>>CK1$EN\VD8[(C$Z+%: <GP59I50/:+KK6WD@794-=]9(N&L>D_=DY TC7
M%.-;9>*!<5I]D(TZ8G)QRTUV&D*J#PKH%L(BU:=F7\P)-"??;,S/DIHARJUP
M"N(CO@<F8!'88#JG0_(__?8_8S*LR3:,3D<ZO5ANI3/I:+8B[O%=DU(7S;6I
M-$?-KC5NDS:"E/IK5P.3JO^Y'J&HH#>->Y@ZSEQM<5RZBLLBLLLH=)-GT4('
M;QB.Z<"-B4+H+<T'Z3K7X40W=#9WYY92MF&[>FJ;'>VG+U*7*:SR=-'5<5'[
MMX<[CYPU*>=FTPRNN*WH;P%C>?/UN0$3Q'2.D%H7<\=2YRH7-![-6JF'GZ\2
MC[[;LW.Q#W\5$1FQ.*XF;<@W["Z""K:W,SV3F$+3F'@)HA."O6T)5Q^,ZZ9I
MO]&WPG8#-O%PM8"40VQ/IZ!&9]#DJ/VY0&EU1)?EG_NC.*53'3\58UB*G"P<
MJ;]JN*PE\E:UAG4+8"2[PV]DNW)%F218@]UWH_KIAT^6//MNI!JF&=*O50IE
MPY7_:404Y&& RC\:'(+QI*K(24Q.7")>RCSE$_)B&,D_Q%4R-8)5M0T'I,*?
M_$*X3X"9G*5PG$G$\\D+YUZ.!5,/O &6+U9/A:'./ =GM/<.@,U=T,W-',VM
M],WC_*W*O%'@O,[G?,_QG%+%"D'XO,WU?- !G<S9Z\_[W-#7G-$5_= ?7= =
MO= AG=+EO-$)'=,M7=/SG-,1738GO=,#_:0BO=)%'=33_,XEO=0OW=-1G=59
MRM0W'=9/O=5'/=%KG=9O/=7MG,YM7=9=G=2#'==#G==CG49F_=5[RMCK:L25
M!4,JU/1:%$7$D+',%$5_<\\1C5$\]9PX@CPS2E3EB2/P_Z1HWA!+RIU>P)VA
M6/4@+LM 8$':]X])#^9_L^44;'5ZIW>=J]=\=_4/?;6:W(;# %Q8@55Z&\R:
MX*9R[T&4DC>OQ56X)9YO+[&3!-N?Y_49D7P='2)BK:QCOVW3W#JNG>(F,Z)/
M3FWC.SP)(/ZQ;YN"GOP<!^GE43O,#V(AMBWX#B+/!N+9S.R!R3:B51(]A'[U
M>$B9F(T>$V(PM/;).YY?E=78>#:4T/&!PUSCT^)XKC[8E"GKT2W,WRW<E"EL
MBUXUYC5=S3X4M4+<.@@6+W%N44WFNTC(0Y$V2@.0A-SH):TI!J+N?QHIL.V(
M+'SO\RPG_OF!X-8V3-KHDZ H-8<:Z+G'R3G^6<D27F4.+8,R+$D7,/FY<T$[
M:V$^O(7[\T?_L[U6MT._]%.?]$<)DXR.$B_#Q+"[XC)N<D'L+O4L+;6U[_]R
M+FF>,70?-CPCM\="O*>RJ4\7*@?2+Y\[>/VV<8W2Z$2)*60CLGT[QHL-N"V_
M@RHCD=2H+BG>L T [_C]X/E=5W7_([^;R;UYB;Z]ESS4CCK&(SO 0.C7?STL
M+'W3MUA?"2 :T1/8"   @@82)CRPJZ'#APV;&8L(<5<SAQ<E[F*X:R)$B<T2
M?'1XZH!)A2A3JDPIY<!%BS";K03Y4,I*A4DH[F)RLV>2D TY/GQIT>/+ TEZ
M*IUB4^64C,8R8H09-6+3E \]5L6XM6(SGDJ5MCP%\>K*G Z5J3SZ4F98IQ?)
M/IQ)$62"*2J3F"1Z<NE4HG5WD77[MJ>4C8"/)BVLL.4!N54GTH7ZE;$!L"@?
M%W5H-B_,770]PD1J.>%AS91!KZU*M#)+DALQEY;2#/!0D4,W2]WH4G3%F!-W
M[_7M5??G_^&__P8_WCMYW>5'FSN'&C.H].34A5__G9VYQNG&HW_''M[Z>.[E
M>9\OKE'[^I'MO1.'#]W\_-SQQ=]77EW]_N?](0=>?O8Y!UR V[%7GW\&=J=?
M@^D)2!Z!# ZXH(3H48BA@@B^A]^%"=+7X7\'ND>B@P5:."*$&H;XX8K@<;=5
M,UR85!QP)C'4VG]V%265;;8UE!(5';TD&Q. '5F22ZHIA.1F_?&50$H)L(91
M A=9291L!F2$Y6@V?A=D1%KZ:.9?9PJ)4D$'&<3FFV[2X^:< K5)T$!ROIEG
MG@?A61!!<?YI4)M]_NEGH7+:R2>;?=II$)4)1+J'I)1&:JDQDO_>8^FD"511
M*:>6ACI%I)B2.D6IH4YZ:JB1>LHJJDPL5IH!29!Z5ZF@)B K8U)4&JI:*:%*
M*9>T)I!KI+LFQ$25EZYD+*L)$-LKL[^JM&REQA ;5JVB8NJLK[A:JFU8UQJ[
M2Z3 HD0MILF65BZSWX;:A$I18-MN8>5R.FYAW++:64K])I"N0II"J^NL =L:
MJ;/"6NJ$2M-RRFFI#8?Z\*P&2*$MMQ,_^VFJ#F,,L*V@@GKO6<G6ZS&GY()J
MS,D^*7SIOCV]"^J\+'D<Z12[M#NJKQ>C5*NJE\)\T[6H[D%SS)N*RFK'EHJ,
M4L0&'UP:M^%&K1*SKB80]%M1;*VSL6'_]V1(M9 VC2S"!AMSJK/'1DILK:B^
M+/*RI?[<MLRLKJISW'Q3"SBEJT)]J<Y=KWPNM98FWK#$BS?L^-.21L[JY"";
M&SCF:N]A>:B<0TMQU:27+K&O.Y\[:L5N&SQXU12/&O<>FF;]JL*GGTYZXI2'
MZK;D'^OL=^L5=^IZVZO?/G;IK8I>NM[,5YF\QWXSJW>IGK;.[+B+Y_KS[#)#
M?WCT=WUL3$IW"FHHH(2R+VBC OTC__STUV___?CCGY(R8'B"A">>H()*E$$%
M__D/#$HAA0$]@<";Y.^!$,P?FP;2/@K"B8( P. %"Z+!0:7D1ZR)2E=VE*5F
M'* !0]%1=8!D_R6C1 0O4FO)<B"R$J_ L"=",2%3>'6N'YUIA"0QR;_$8L)=
ME*TQR>D*13AR1)3XD(0-*1-1;J@4)A!K(W6A8@U!4L//8&1I*.$9F@B#$N=H
M,2'?6=(!AM@8)1;)C18!HT^@5$3K'*")V[)13+Y$1H4XQ#=G7(D55:+'F 2R
MC,'IHG;N:!F]<.0\?4P(1+:RA[SD*$P[M$P4& (=UO#1BZ 43'E\.)6'#*8^
MI-0); B4RE"><H7]465#7OE$4-J&EK!,#$1P6<M2KA*5L73E*(-YRV'N1I:B
M9"4Q=VE,6S)3F<<4)C2=:<IFZK*:T[SF+W-)S6W64INSM&9NL G,:/\6,YOC
M]"8W?1E.=+(SF>7L9COC"4YX<K.>O(3E._/9RG/2,YWSO"= [?G-@?)SF:;D
M9$%;DZ8OA2F$Z[ED%!EJ)HW @@MMD5%(:)*1E#PI(BHA4R3)U*2$B!&9'8')
M*;2(FXDZY$N3C"-6?K,DT900.&.:#AQ]=("4%*J"@ IJH(::03C]]% =U" %
M+6A!@RR5@Q-<7Z":VB8+4NEU@B,?Z515JEVXK'>\6QFT<E4J/+YE65AEEEE[
MH@S834ELOIK;6!/P+RJH;8"-LQ6QVFHJ9K4+;]!B AL9-KZWI@14]\"JT5+B
MA+E^*U>++1;$?+62K/TK"7$;[$JDT-C;R9'_"69M&J:6YC&&_6QT:[T)QQA'
M*KPV#U;Q<AKH1"NW65U+L!XE'>M\5UNIY>1UG(IL$G K-, 9K0F!;:17>Q>M
MR"JDL\O[U[3&]]>XR35S=+4,$Y;+JITXMS%JPQ;J3NLUJ16+N<S2[,@ -ZG8
MADJ.&E,)X):&*M?JK%3J%5KG0F5?2DWJNCK+K]"84#?<H6YGXKT<=H^%*?%9
MKWC'NUYXC_>W_59-=Q5>7N9*9F$*<SAX'@ZO[@"7M.:I#7N5"NO>#%8]$%.*
M> EV\.H<?#B_T3AZ#6Z8[0)7V-)!V,6_,UA8=YQ@J+'W5=^+U')SO&'2Z8W!
M;HW6T?HVNFY%V57@_WL6DUFK-85@\*E%=:I0B^JG0Q4D@FA.<_U4TC\#4F%@
M"2F@ 1MX$SG_CQL]4;.>\=?4H.Y)?4Q=7P<1U8A&!,M 4W%CEBHTT98&$Z!R
M:<9W4;+)O6#)2I/IRB'16"28II;2O(GBC4C*G ,0EUP<<0EQ'<E1G=!DB6N]
M#R1CJI--9TS53J&*0RK9$Z"45"$O"6%#,FF8)P'&(S,ITR[.>!CAD 5FVQ6I
M16I4)"]>1, >=0@G*4(6)I$F+#R[B%!HN!I2TDQCIB9D6T3#ZYL0A2[8A$ED
MGQ+J_IQO+9^AD4FDE4PL;N334WL2DU**Z/&\FBLZY0H+$R[MH?#(IHI^N/_"
M/R+QAB,<.Q!?.,8G[G"&IXG4,N+XQ4-N<9![)>,4]_C!39[RDD.)Y!]_^<E%
MSO*.N]Q#(%^YS%L><YR_7.<^-WC$53[TC=^\XCU'.M"57G28+YWH&G=ZTV=^
M=*CSG.I)MWHH/1Z8CN0H0U71S,!)/>L<144D'"71+@;VT8[@VR%OMXA'V\)'
M*[TP)5,83+[#8R4J*B/MXK&VHY63&IW'7$T*893[$E6GGSK>SX)V%*+@!]2I
M/GY.DH<?XP]5P;3=MVI=PQ348B>]L1:,?!CF+78=)F"56;C%:R/7N3H&*KA!
MZVL)P5KU! DM]X9L9 ;C_82S&Q;7C^W>*3D]=C'_A5^P(:WW<*V4T?"6K(09
M5ET\LQ3.*%VP7,6J,-.-6[:4PBW<7T9T-&L67"$<V7?MU_?/DFO61*\\: EX
M6JBZ"F US&.#3=I)O:,]MA(6TY(R!5-@,*,RN>($ZI4$TW5@GB-EV])CI;)]
M"J& K")\.B- P%<\WT=^[I=9X/=\ES(%RJ=Z#?-_IM%C&M9^ 9A]MC<V-#-<
M.Z$2W7<KO743E!*#RN.""< %>_-8MY<75?.!!*A5%I8WP]=_D_)5_%=Z)79@
MY1. )A8]T ,J*L9BV)6%T'*%>44^7EB%S.-@J9=E]8=D#R:&NE-BQ>,VB\,\
M$5AE-49D!M8I;]A70>8\/\C39)D#8],C5GESA\L#8QVVA AVB.-S+&05/2I&
M?_&G+*MG.)'R:1X#8>(G.W XA>0C+.A#576B/H,R9IK7*/][5HKYHQ+<L$ <
MB!($M$!T-D %]#](\(HI88JV6%51-2=@EE10-56]"  ?5%%ELA5V%Q$YY$D@
M]"%'L7<-$0789D4/!1%8TD7CU S..#7.F&\3H2.@918.6&DJ5'CIE!@F41+>
MU1D:$VZO9!)A(W,[]1D3H2T@Q%!0=$P9,4@XP00FD4@A51<,<4?>*%A\5$,S
MY$NQ$I#;112H1(T5<49H@1&/- 4.&'#1!AA?]Q)?TFU&]%U6U$X' A,P98T3
MV1A2$&XNU6J19 !;9T*C@(^Y!XT'  OMYD>7!I'_%I"' 5(JX1&1)FHZ$@4C
M:1I6!!CF^!%=Y% ZXI#^%AR7I#'_0?F24_!U8Z0E,Q)**D1X56D;5_D<KQ9-
M6*1+()&5$+&5."66#T&6E&&6VN9,89E16LF6(N268PF776F5=*F607&7<GF6
M>MEU:PF6<>F7>0F8=?F6A(F77ZF,B(F6/K*8??EHC-F6@IF86+F7?ZF8ECF8
MF#F9D1F8D/F87MF9A3F7AYF9E,F5CEF:G F:=JF:G^F:H<F:AKF9L013(@51
M8GEL&?%07NEJ+J1*Q[0D[W1/49%M,1%2K-&/,.%1[UA*UV< 7P(62&(,!X!1
M#2&=#L$EOT&6(Z1LB(93?_0C/842@19F[R,HN]B+7V948%9Y&$14<&)4Z=,^
MDL>+ T$E_\+28'VUB.(#90I3,;F#@UQ6?RV&83LA!=7GC*JG/*>#*;N H,G"
M!-!5.OVE5WEA7-92B<^9$%7V7Q?Z,?_268JH9(+EC0XX?"PC-GFH9(G#*0^*
MH"GAC"&H,)4EA3!Z@>_R+\@U,;&%*6;U@./3C=5WHG.E,P<J-/BW,/MS8 ^Z
M*TD E/4E7Q2&7TG@I)R5B$JF-S$(*C6XI,RCA EVH$,*I-1RD)9(.";FB$ X
M6M_5*S\VH D E)3V@,D"I-YWHPDAH_4G6 E*IJM'HGA**T1:-3]C5LA%.2%J
M,',SHHP#H4(3!>7R.#+CC%4*,!H3/J&26&E*AI82J$H!J:C#._\=TZ16VI]5
M4Z%:)A*@A:3012RETZ1(>JA*ZGE+Z*@X<:5P6GL[680?:CR,(Z0 ,ZCFDSRP
M!RW<M3.CHS?%>F',8H8"R"S,%S@TICU1R%JL0U[@LJ E*#-.R&/4&E[Y*3K8
MJJ&^VH6]LVS52ELK)H4^)H8&AF*Z]80N1F7E6J1DA8GH]:?:&J\\1F(L%JY8
MMBYIJ(D"6BE/IJYU"'U.XGI'QH ],:%\F%4KEGIR.&*SA3YA5GGF&6:>B'F-
M8(L@.S]L)HN>H 0K$8O^@V<]@;*SF&<AJV>$=GGT.;-Z0I]W,E/?J6],LB#-
M27%!<G <H9$ V2Y2 *E2T9.ID4O"9A'_(K$7H59(.C%PWO:/HG0 ^W%P8G)V
M8,(;3 ).VJ%/PGB2"= ;Q^0;/WL?#3!NK31PM207VO:/71L4!@>>&P6/<6$?
MXF:.>N=K@3&/7==+;BL4ES2X-R5N7Z=W=L0D!PDQ1BL8.:60)=2T@^NT* 4?
M=%DE.7(*N[$DW2:.=HM%3GL4FEMMO42/9^FTCU1M_[BW8V0FU*E'/I0CNQ%V
M<!NZVJ9W6ON=]$%1NINT6V<AO)NS:9)38!>\!3>\NLN5PPF\RSLA0)2\ODN\
M"F*\+/*\O8N\T(N]UXNUR0N>E>N\U,N\WUN\S4N^XSN]Y8N^Y[N[Z<N^ZZN,
M[0N_[TMX\4N___.KO/?KO;\+OO6+O_N;(6C7L[3&42*Q4ZWF$8_TFZ&D'_F1
MN\DQ=W,1C' 7C/SH)/JFN50Y43,)G1*H+%R[;"CQ)%KDN<7XNU392_!1P!N%
ML92G>9]X>7?B*$(EGXI")P/1>*.8/GCBBSRLPY]()3/&@GR#*GHCJD6*A-12
M..63*UR(8\>'Q/OJB!PFAZ;RIKV35OL*Q:^J9$*6Q7K8KBS8Q%\LQ.5#Q<X3
M@>N*A 4&87=(B/V7QE^*Q.E*QEG8/?5*QEX\Q*7#.Y(JL:DBB'C,6VDU,<LJ
M+#?6J7+*$J *,EO6.8"<QU(XR.S:KDVHAU@<K8K#96_8R&!LQ4]HQ?_",CB>
M3(5Q[)^18JM(ZGX3)L93.EL"*ZY:3,6.2(=P7&#2$\IO#"VNXH;@ZC1!)BR/
MG*]P^J;^&8$4NWR,P\MB)3V"2,N3+*#S)V%52,29$WK(6EAA:,T%2\UJH\W5
MP\TI-C[+BH>58RJ/W#6%DP41>V!9DRO^"CAAF'KS2LJ[1<M'QEJ<PL=_&#RM
MX\YE3&&< \Y('(?B:CD_QBFFJE9'PP1%'"E.0&R;58B=+*^LM<\*9BD#8[,[
MK"CN0VB#]K(@.[)S!HL&U+(]H02JZ+(@C689R['SZ=%096;M>1 I$8YT^[HY
M]$? J;1TUVH-D9'Y-K@5%8XVI=/=2Q% +1C_-J*W%A&TLR04:I2Z?AN>X[B-
M2BU*=%34#A<D!OP9(8D?'\F]-'$*L%#"$\40I_ E-;D>=UM$<SN9OU&06-23
MKK;5.Y<58Y+7W#8:%G%*=9M06$T@;ONV??U(@JM2UL:TK;'4:.U2]*MS+91"
MXS:8<%M*9ONV;NM"MED1MCG8*J5'Y>A+Z]9#/1L79/E.+R&</7G9OOE$$'5X
MA7O"L$VZLFUXL>VWMDW;N U'MWW3/ZO;OET<KUUXO W<Q/W;PRV,R"V.@"?<
MS/W:(Y'<S1W=S^V[B5;=LRW=T)T;VFW=%-'=V8W=N0W>XRW>Q4W>YVW>RUU1
MRNW<[#W=W*W>[HV2_]M]W>]=W]\MW]1]W]Y-%?H=W_Q])E\2' 2^VT#"OKB-
M'O[[TZ7K4D8A0EL)4]MHG<W=1Z/2%OW(13/U$AXEE=*X&\^9=X04VOVHG>31
M0W2):*(!W7QT:2GQ5!U+54JE>+@H9N:)5'KRBP<Q9H#20;FXGC:>L06!G\QJ
M/1.&R89X+ &+I=_*KPLZ>GX<7DN>89+X.EF(Y*4'A- *I__YRO6*R?W<Y5@.
MY8QC.+AL*T0V*7FXB'_:H"!6L0FF/+L\K;[2,=$*K]UZ8EU^Q'LNAVON7URF
MIEL.IHR,I;R%R9PZB%O>AZBSB)P<.(;L._@J8N-SYP/JYCYFT9."KN(URL?'
M6N1S1<5DWN9*IN:F(^92N&REMV*6CGI[7J31>JS2;,9 AN8_.&'5XY]@SJYD
M;H:Y?#O,!SUGOH:++L?%SC>F3NN!3%N[/H5.>,@H^,J7/,:5CNS9:JW<.L\(
M33J:NNSZ"L62*-&@'J^8PLI[4^Y:O.7F[CSHKE7A<M"PGL4W)GZ(Z,HFEF5V
M?NINM<M@G%8 RF5T?L>Z ^VB7+ +=N@):[&63*A?R,?])T<98QD6_<HPECC"
M#LT'JV/L_)Q-Y>,NK8LT7F8?_[O2I:@2=N8);G"R /0_M)@22$"R;^9 )!]!
M\>FQ?[9YC[<G'MLG*0$9X/$8.YM*/B>\0!$DW18FCKU$K5OA)1P?=@1*5<D;
MB(NX&.<@:!>U3_OTLQNY$T>/4^<C@V=R>NVSB5UM$?%)%'5V=+?  5ZW0NU+
MJ4L<:6E."UP5@:L3I8W52)\52]1M-64=<B%17WGU<I]2&35V8#\@3$NZ7K2W
M2F2[?3L5-BUN9W_<CGVWI82XFD%V+=[U2A1LJ;&-W/O!2*NUT@N]Q"B]?-MP
MI3UXK];Z9&_VV.'ZJ=\@M _ZMA_[L&_7LL\=MY_TOJ_[JO_[O>\5Q+_['(?\
MK#_\PO^?^[RO_#_$_,\O_<E/_<OO_-6/_=<_'<=O_=&O_=_/_<TO_M,/_J_O
M_>=O_K5/_MG/_CM]]L)-<U)Q'VI/;8Z?42ZD)2UE4[9)'0"Q2V"S7<8($ARX
MB^"! \8$/H2HS,!$ TP>-C-&D2)"@1HGGDKHD<E"D!@/0MQU8(K'!+L\&EB8
M\B5!*AY/'C38DJ-"@RAYXKRI4*C/G0,]-@* %$!2>DF9*FU$#^K2J$BC4L5Z
M52M5J5FQ.M7:M&I3IV#%/D4+5JU5>BP3)-CS-NY;NF^-U96+=R[=N7OM3MF%
M]RY>PG#I#AYL5R]AOX4=YWW,M^[>Q'2K0)X<.7."RI']-M;_O#CTGGN/+TMV
M#%HT9L6 0Z]^W'=RZ<.H7]\VG."T9]:-5>.&_%MO8,Y37G>NBYBU;=ATC3/_
M/3>Q=-3(ZU8A+CRR]=RR"_]VS5CQ7>6;O1\VSCWW:F//%2?7&\3R>N:.*P\^
M_SUX?=':J^M_#SOQ7O-M,P#_&Y P]QI3CCS.'NM,O=3VNTLV]S*;;L+NECN-
MNM&(8RPPV?(+[:[+*AR0L@.7B\W [01#[\$$-Z1QON)DC*O#&.M*CS[4J"O0
M0^$<](Y$&%&D43LB]_/QR"1;;%+&%<=[KS+IGMN#N-,D3."Y]FBSK\<+A2QL
MBL$N$\Z[W<S$S$NX1'P/1OO>VK(P__SL9&U,O"Z4DK [^:2QO!WS2J_'EPY%
M-%&_V.S2.2BY[)/%.-\Z2BRINDH+JDNK8JJLJ_X!-5111R6U5%--/=03)%1%
MXB5EJ%#5$T_ 2)2*56--U(!3=^7U5*[8LNJKKH+%E%A@B_5(**"4=8BA WQZ
MJ*>!>C*)6FJ9)<@AC!(J:5J..#KEV8&>W19:<P,S*:&+U$UIJ&_9'8JGG^)-
MB8NBLEVW&7)WZ1:D:-U-J"AZ!=(6X'0)7A:ADR#"*6!I&8;X89_\53>!;!$R
M2&*('$+)8FF#*KC<95%"R.)X&PAXW7TI%NK9?0\>E]Z@$F(H97TOZJE;>;%=
MMUV2!TX86O^!_2W*Y&XYUK@@C(N&^5R &69Y)X5[CG9A?)LQ^=V?RX579X'E
M31>H:X-JFJ.Q'QZ9W;/?+;MJGAV6VNVTTXYW[7PE-OLFM.>EVFZX(4;X;<'K
MUIMMO.7F>_"\!:=[\;D3)YQQR!U/O''$8;8\\,?;UKSRR2_?FW.E)1?=;\5!
M-SSNSC'_?/70#W<]=<!'WQQVVCTOO?"[5;^=]=Q)M]WTS'M__6*J-R>Y)XYU
MS];9@3T^_M^P@29*(9-G3ZGFH)OQB(J#+'XIX/"MYUXC)HP15^"< _-HC_(U
M*HC<\)MA0B-E4.)8J(R+NM;I?VW.5T<TLI1A;0H 72D66C!E%D[_#<M3!&P@
MI\:"% .J)5.82B"G#DA!#K8/2I0QSF?D5)C=U*915ZK1/52S%S3-B$*Z04T)
M89B;.Q%&A6]A%'= <Q<V[:4Q6&*2"'_TH"*Q!C$A9%%[#.,?#QG(2K 9#)O$
M5,,=,@DO)11B7JB(&=F<25(C8E&!S,,D'F9H3C.DCU^VF,:_1&F(7 20H"8$
MJ0]."D!%C))_:H0C*1D).(21X1A7<\/:+$@S.HPC&MWX) C=L2Z[8!0>4W0;
MT(#01UPBD83$&!<'&2A-ZQ&CGOBX2-[<B$>VT2-_^)-)).(&CWYTD8;$**/=
MY(=!4S1B+!FE2$"=\3:[D&$3<2BI1IEP_S2JK",Q98G,92H3D)**I(V46,G,
MN&>7OIRD'/N81"E!DB[>U*)C=$1*]4BHE68<ISC;V)]APB=2'DJ,(67$IS+>
MIC/::4*N]'FH"R7F3KN09'):>9X=(E&)2TR 1Q2H*88BD(,;M& C>C51BH[J
M4&ZX%1+<\!)8K0H)W$ 4K&*%A!_DJJ(G-558.J7!8/V**Q?T5%,\(JYS$:1?
MDO-?3K46+ZQ%+WLY(=^\$C:VEOR,:!XSWD,HECZ(,#5Y"]%>QE*&M)YJ;6$,
M:XFUC#>SY14U@$(K:M.&DC^'>:MGZ?*:TG1RD>M!I $'()NRK#<M@E&->OV#
MU_1FIS6*B35Q'_\3FLH"2]:EM34ATKK6T>XFM/U]%2%,O2K6KBK4X^%5JY3]
M&4UC(I!3? NI*3/73IH5U+;A2ZX/@>S <NH_MM64K-[*FFN)DI/))F^VDE4M
MSFX;V]"^]B>\9>QN:\LPWYH$N+,5;F[I^M3CVI:YP]7M<Y6[,^+B]FO+K6YS
MB9O<ZU(79]:5K72[R[7O:C>ZV84N=LN;7N_"EKWD=>]TX?O;]Q:7MO*U+WA[
MR]WPHA>__-VO>/N[WO\*.," $UEP08N]T&9O=0%;ZX(W)K;3UM6L9@4)37TB
MDH(\I'X4&4G^/CR1D738)>9K1MQ8EU"-3.$ ,QD*C$<\D>E)C0O/ZI;_U,9&
MV8:YS6U'B>E*SZ)28*W4I4*6X*_(<I4+,O3($K34 \-B%8_0IH:W<8\2ZWDC
M?]*'CD+T#W+TV!X01>I%9A9-"8&H(<5DZ8_M[%*97]-+9M8FG2Z,"Z!D6,(N
M'S,RT9P2'4G)(^2$)\[K'":7 $5/@=I(GGYZ\R0))$@%/4A'? )CH-SXZ/;$
M\S&NZ>%FM/Q%; 9Q/R>JTC61%)U#&I-02$JTJQ'*9L-<$TKK\9*MZPRC3]*P
M1[&LXG7H-$H7,:J%[@FD"RD-&P85ASATAJ<\N3,=.>.)D0_2=5Q^8QT5A>>@
MP-D+F_C<(S^&.=)E,J.L!40E+G?IB+7!(W(0<ADI+TI)WDBT-6EPF)AQ?GLV
M^[81"AE#FUWVNY?Z=G? [0AP-,<2AMN6"YA&S4;#J,>'SHEG=DCH:C$O_)D/
M>F*[;3-Q5[8YXNY,MG( Q>H<?H<XTS8U?SHYERG,>)^)D@*=<7/EVR0[,I7Z
MRI1?^L @C_\%I4<_U:' ,-)9V:^CJJ+519'@4234)%%(QWI+I[)! SY4+1GD
M.I4UHC#3V15=.]O>9?4Z$.@E)&L<Z^O35NN3RT;MM7$C5\'0-SF).8]E,I.[
M9@F[M[E7>.TA(_QW(5;;>S789-?;Z7?S;N'_Y559GUUPR=+5V(TECF)Q5ZU?
MOU4PQ5Z-7T(A6H4!OU/>P2RV?GU8V[=EVN795W_+)6_(_)=8S@X%QS+SK8F%
MBMB9-7CQ^9L\[0-88X,< &75 AE'('^M'0ML^B>IOD^NK[^X=HSLV.\^1+:_
M5=4+9/R]4^WYL^]]LY)_N.H/_T/@+U?K?Y_[]->^_=V??OVCO_[_[?>__ /
M]1.__B- ^3/ ^#._!,0_]J.L US  53 LWO "9R_XD- "6S  M1 #(S "MS
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MBI6FHPB16I6HTP@J4,N1TJ>S1*D**K).R10CBRE-28IDD9B[ [[O@;#">RK
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MB>9K+F 7$H[0/%ZW= \7*-CYH)7T=:<?MHU6"5[RA%ZTL%7GB55S=DQF%5D
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M<G):QZT&;/'X"B];1NFV<RM7!Q9NKBAYBJ;.:O\64#(-S_V(I:>.1K%&I>K
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M)9>C^WX66F"A\S+'J[R).U]F^YG 556I4X (DRO4>9GLPC887;YCDS8'B+P
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M"": _]O?*?[7G^])9WFN(6!0HK<0Z$W&>.7S3O76PY7W4.\GNVC  9A3O]X
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MWE0UM>TS92L]6$9_%K1_YBUANT+:2>D$MKEM-*4[%=M%.YJU>@ZT;WGJUJ=
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M'4J?'-K,RLZS@TO!72ZZ?=RL6QN-X4PTT94IL%<$F0*!;%CU.M^";3@'&=
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MK5#^;+UB;Q/#&=3@!4[6!E[3&P/# ZYF4(3"+&8T$LZS)!2@%"Y1@-BUJYG
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MMO" H6V><,-UC49=M\$MNN+=6H 0Q"!ASC)J 8I/@Q;4GBET=VSQG:]\E6$
M^__B][Y&LZ]X\JO?\?"7OO456X#]^]_YYM? _ TP@ \LX/ D^,$#9O!U*4QA
M!^]7OQ>6<-K\NV .]S?$%<8PB"%<X@=O.,,B/K&$/WQA!J=XQ&J#,8L)'.("
M'U@9+B:Q?'M<XP9/&,0Q%C*/_SMD%;/XR-U5<GR9/.,?.[G#4$[RE$\<Y2=;
MN<HEOK*4LUQC+OO8RUO6,I$1_&,-%SG,5(ZPC)$\XA3C>&SXG;.!@9QF#H,9
MSVA>\9AQ;&$=Y]C$=/9SGXU\9S-'&-!Y[NX4&N&T!#E(:O8YD(.:UM[V"BB]
MQV0:<_MCWD<OB+W"Y/1_X'MF'G_8QH=V<ZH];&(4OQJKR'76LX-3?6H^MWG6
M:+9UD^^\Z%5+>=:_'O.>AZWJ7F=8U[*.=:+-'&L2.YG77;XUE9^=Y0T;6\RP
M=O.-<:UF0A>[UJ^V<+6I[6QS-QC;X;;VN:7-;G0?>\@OWO.:O8UL>&<[V*=6
MMJ[C;.]D8]G.Y2ZSE_G=8OJ26\!1IK&UY6WH5@=\R;D>MX_A?.8KNYOB.X8W
ML8&]<(D#G-9,;K2C'\3>]3[H;Y56&H/0_S/>EUO-;%X#6WS/YK6W"9BZGJ!"
M>&'N\U#;;9C%!/HLA?Y*^&BC:!Q?.M.;[O2G0SWJ4I\ZU:MN]:MC/>M:WSK7
MN^[UKX,][&(?.]G+;O:SHSWM:L]Z$[0Q'UD"".YWFX^D :=+E/.2F,T=NLF/
M&TR_\QU [K5;TM=N^,,C/O&*7SSC&^_XQT,^\I*?/.4K;_G+8S[S8V_[?LH;
MH*#7,FJN#+K/83[SZ5I7;530.1)X3M^R49<**2Z]SUGNZ0+5I]*<9H_*'XW[
M($A(\\(?/O&+;_SC(S_YRE\^\YOO_.=#/_KFED(07KG[44_ZO+B__7OJ[EX#
M*4B6>\^^]6=Y\JSN3UKNMJ<'\*7O_O?#/_[RGS_]ZV__^^,___I7?A)V(>K.
M=U_O7=KW]1WYT=[+:5?J$5AV:=>#@<'I><)U'>#+?1_< 5.F =[1_8<%:IHV
M$-?^@6 (BN (DF )FN )HF *JN *LA@3[ (&ZA(LW1UZV1+OW<W_Z5+>86#?
MU4T%^B ,_EUY$2#4"*$'LN 1(F$2*N$2,F$3.N$30N$3NJ#=61HNJ9_?B!\.
M+@A\_TR@>'U7!%Z7&WS7#SR8S'V-!'9A='4:T[2< )H?I($:@41-(TC#<#5!
M%.)A'NKA'O)A'_KA'P)B(!J-%#!!A32#$,)A[FT?Z*T7I@&@(O[?>6$:]S7B
MTYP<[@F>(FI@RJ$??SA:'19B\ GB*))B*9KB*:)B*JKB*EY=$Q3B%$B#J 6=
M')(?]\UB^J&<>J0A=&D7$ES7ZK5-ZR$<,,X<SJ7-+D*7#CH7!H9:X&T@#<I=
MIN5->CA:-5KC-6*C-:)'-G)C-WKC-X)C.(KC.))C.9KC.:)C.JKC.K)C.[KC
M.\)C/,KC/-)C/=KC/>)C/NKC/O)C/_KC/P)D0 KD0!)D0?]^XS9NHT$J9#XF
M)$ VY$)"9$2&H^"A'##%H X>%R-NVH&,'C']'WI1(7+UTC.*9"76("-Z'CU,
MXT/&1TM6(WPX&DS*9$S29$O.I$N"XTW>)$YBHT[6)$R^Y$\*I4T.)5'RY%&:
MHT\:I5*Z)% "Y5 ^95 B9<E9HU):94TV93;N)#=>Y5(6I5-"95%R95CB9%=.
M95:295>"I5>RI5JFI5CV)%F>Y5I*94[695MB(TO&)5:6HUNB953>Y5Z:I5\R
MI5;"Y342YEL:Y5A696!Z8V+B)58")F)*YEY&)F!"YC=N)3<F9$(RY63:Y3AN
M(V0^Y6?6)5WZI6!^Y6DJYF:VYF'_:N9KJN9B/F9EVJ9APN9L9J9L@F8WDB9?
M2J59AN-O7J9<UF9QZN9M]J9<8F9P4N9BKJ5P/F=J+F=C^J9S6F9U)F=D'J<L
M1B(N69\Q 1X!OATQ(:/<0"!XI0T#GMZ#?:'L]=QY:@TG)B)X(F(%"B$;2J(<
MTAWO^>=_ JA_ZDV $FB!&N@M&6B"*NB",FB#.NB#0FB!#FB$4JB$VJ --DB%
M:NB&<FB''NB"(JB#AFA_>JB 7FB)HFB*JNB*FFC*T=V(LFB,RNB,TFB-VNB-
MXFB.ZNB.\FB/^NB'DNB/"BF.3JB.%NF0(FF21JA[86)Z/2)]WN ,0AJI26-R
M#> LJM?<_V5?B&)?[EEA^B$H^B6(2DJB2K)7%J+I(GJG2I)IF_K2FI[IF:Y'
MF\(IFIHIFM9IG4JB>K I@[#IGP)JH))IGN*I^(D??1AJH?(IF\IBF\XIHBIJ
MI,;I^@%JHSHJHTIJIC;JFNZIH&(JH09.IB;JI]XIGQ(JJ)ZJIJHJH3IJJHYJ
MJ<)JK 9JJ.Z'H<HB[KGIH@IJRRTJK3IJJ/YIJDZJG/8IL19KI"*JL!;JKT;J
MI8:?LBJKLPK(H%)JGS)KIT*KK=KIHU+KF4)J^*EJL*ZJIQZKG (KG3XJGW;J
MJY)KMUKKG/YIX#3IN(YK^K$<O8KK^8VIOM;KO3XJMC8KO/IJOF'B*ZRN*;.2
M*J>:JM)8Z[3BJL"B:[9::K:2Z[GVJZ7*:[0B;+E>;,=:+,%JK,$6:K+"ZZSJ
M::]JJWTD[*$NK*O&*\5^J[.R:ZQB;/C%;+M*+,-"[)SJJ[X*H.[18,]V&G/E
M_X=\QHUV[=Q^E8UV&6-\N8'-@6%\&NW5:-\R!E[>12,S<N)XFEP,4B0N4>/7
MBBUXDNW8FB15ABW9IJW9EFW;LNW;@BU"4B7<TJW;?JG<JBW>ZJW=PNT:AEK:
M F[="F[>SFW<\BW:[FW@(N[BKNW<>N+>^FWC#N[A#NX,*N[E[JW@82[C)F[G
MVNWF2B[E&J[B]NT;FN[@9N[G>J[H?BWHKB[JCN[K<B[KQN[L;B[LRJ[KTN[C
MVJ[LXF[O N_NUJ[NAN[DYJ[GPB[Q(J_P'B_P)F_S,J_;_J[R.F_T_N[U6B_A
MZN[U8B_O9F_W?J_H4B_IAB]%SN N>>3YDB3>*5<SSO]A#VJMWTFI<PUM^FX:
MW,%O>6I?ENZI2.9IE4JJXO8-GGK>W6IJ_];KFV:AW(HG[1[P &OA&GZ>WMWM
M2&8B2>(O!?,=_1IP,W8PWX5D"!<=-'JD^09A P\= :^D_>:@#'+P F>P N?L
M,HKP>+[PJ5*C+'VDT)'M&E*A^L[A!;^IYJ;N!*?P#G]D>/:P!@_Q#(]DVBJJ
MV$*PI!YQ#+=M"S>QV8IP G/DWXYF^UYD"=<P54ZQ"\L=Z:*P?9[N%1;@V*:Q
MV )L!+OPU5+P_&:D&8,MUE8AX)4Q 7_M#__OX5)Q2#XC(4,N#>.Q!9_N1H;M
M('/P2$8Q!,NM&PNK,RHQ"'O_\!][)R9G<!\C,B7+,!67G"-'8]EN<2/3( -K
M, R?J@G+L#-ZK2FC\0A[HB%?KB0[,BB'Y/Z29T?*+Q,W(SU,K=:DIR>  8,1
MHQFZGM,BP1AVUS!GS=/TW:=)L,_ZWG="::0E%T5BJ'GE(O@"8#?CXI?"(?;Z
MK3F+\[.R\1ZS<RQGXO51\[R"[Z4Q(SV/LY>"\Q4#[3[WL#S?LS\G(C4'X#\_
M*9A>)"W:<SX/8#H#=)-*S?4%]#]+-#[;)T0[=/1&-$6[,4)S=.6.,R5G-#^+
M<DA/-#_',:^2-$E?<!27=$MK-/AMLC6G]$5K( &[=$-?,9RB-$Y']$KK]$VW
MM";;__3Z\31-P_10%[5$"W5,$S50ES,Y__1,?[3P-G40VVU32W5&'W7VEG(^
M\^]7WQ+1 C58;VT0=R\;EF]:PS$!\JU%C[5:;VF5\FHZ?[0WBRG1<> D@EXU
MVRQ^WG0!GRV65B&6RO5.VZ);V_.4=BF5GA]]=K0TRS0F(B)'V^(B#ZV )O;1
MH34];U]97Z*5MJ&6[MW[WN>+=FTC\K)G>S8DJG-GGVW7WC4'TJ(T8NBHJ2FI
M96@XUR)F/S9G&S1Y@E_G2?94*W:&0G9"'[5K^_4M:J0C.G5LXZ=D5Z)S5[59
MZ\>38O<U%S=N=^)G!W1^.G35KI^86N0F@W5(+^)])C;0J?]W:MLU=;<A;=^S
M#];O<&OUTK0S2A]37_OV0FNS; <U6PLV5B]V'/J><$_W;6>W.N]P-U^T[2EW
M7A/T-<]V4<>WJ?9V*A\X9>_U=!>XS>I>/).UFHJU<3^K8PLM/)=W>^/B@JO<
M(]KV1HXV>7>I-)_W>]OW;V.V@'OX9(,I;L-X-D^TAG\W2-YJ8R^WEIKD<*]V
M@4!SUD#M=H'!E#<STA[S?(GA=_GB,S^YU9RS!;<P2K+UUEXA1L8A[ZVD_I[P
MFM?@';=Y^:GV<8ED_M(YF[OYG>=OF]-RGLLYGMMYGF]S28YX$+9YG=<@>(IG
MW&TAH?MYH?_YHLLYFQ,A<,?Y#YK_]9Q;:29_LINS<\H9>J-S;37S,:279)I3
M^J#'.1$^<:5[^H :^J3OH'*I.OPZ\*-'>JN?))>FNJW#^J#7,*CS$JJ/^*<'
M^ZF3,!T[>JZ?J+'O>K('GK!_,K'_7:\S^U=+^ZW[^BK;^K-7^ZE?.[57^J]_
MNZY#.ZXW.KAGJ2\#>Q!J^)O?.:9C<KSSTK6ON[/3^Z=W.Q:'.ZEWN_?5.Z>7
MNJL+O'_.^L"CN<&[NZI;NJ'WN[5O^Z>7Y*:'GF@OXPV^LB4S,:R+.:L'\=U9
MWYV;G[-OVA&O=LBG.P8';:('4W,9D]_Z\+$G>LO3LA;:^]^9?"J?KP579!1_
M?"WQ-1CK^;0>'WJL*[R>5W$EZV]%*I?1"_TOZWR4SC'-_Y(0@UH8B]XBXSK/
M?S,WMWLNOOP%8CO02[A<![M[\[O1.WW.IU=STW<A$]W5P_TNE["LI[*_>WP,
M+W"?S[L:)WS;SWC.=[(8KSPPUS:4RKP1#Q."RGT,@[S:QWK?MZBBZSG;[WS4
MY[I&7N!> _VRF[DM[3TDH_+DTSWHJQ>^FR3CSUVQC_'!9^W$;ZW]/OYKQWOA
MW_S4C_ZRDWVF#[&'^W$7MR@M7WQ8E_#5,_[&![;NGR\/XWOO2[+- [#K/[W_
M,J+7UO8NO[JV$ST6AMZ,*[O0V?&MB[EX:C[(M_&*+_](EU_-%\Z<V9@A=<47
M%2A!,[]G?*%_U?PWD;\H?K/L92_V^P)$(WH   @L.+!1HX,$"Q)4*!#BP8?T
M)E:4>#%BQH$+(5)T^%&CPH8-0V+T6!+E294662(<*9(E1I,M:<[T^!+D39@?
M29Z<^5,DQXL2$>KD&3-ES:1'<[;\V3,B3J@ZC3JL6I&B2X-"I3I=R#&KTI5
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M)SW9G4SWUK9.2:(A/92+C@H@UYY6LRF9**)8$]-#LA:VLTT0:;4U+6MEM;?
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MT.YNJHW\%LC(U.;I?.V&_.SG%@?8J,F[4@Q^A$^1;JN32L_;%E" 5LT$ <8
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MLV=J^R=4@X1%>[<=P5=+\V%[HT<?]K(9HZ)$LY1M9X5=0C1:QY4:)=A'0&.
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M?.6\:RF0[KASJZ9W<'9P88=N\&EFC*.5,D=VY4:1^_DL8CJ=>#._4[=Q[UG
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M+5#\&H11%B8RE$;(2-=@VTQ'NS+: ;!.NS? 9X>_G+0X^!^;:HOOA(*J'*6
MZI+,AY""BD-<$;C_5;5,'^6 K3<LADB[&TMTL'1'FLV5XT1,[SJ X-13U;3
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MI8HJ6&ETA*EB$O_)W+++.\29/WF@A\.BSF;+D%D\6@R<4%J>IJQO[^[KR;M
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M4Z$TI;$.>^%< S\U DTQ_6(R*U%"DK<ZMM4PM3O7D=%#S=+("STM'CQ>6XX
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M\_-+]$9W]$>']$B7]$FG]$JW]$O'],5>]&#*]$[W]$\']5 7]5$G]5(W]5-
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MI%-Z)%"")%(:95-FY5/Z9$Y>I4HN95)NI5AJI50:(U5R)3X2EE%AS_'_<"!
M41JFS:5<PF7R+)5$-9-CD*"#<<9,^12LZ99$548-@!5@'IM@^E1A_F5H>$9B
M=L9B"M5A.J9M#:8#,N9F4"9X669D_D9C,IM)<:9A?J9JB29F!MQC$N9H9B9H
M>J%BKB9J5N9KGF9@RB9DPF9M;N9L2B9IIN9E\B9KEN9N>F9P^F9GED9OVJ9J
MTB9B*N=O$F=LZN9M,J=F.I=I F=T6N=P(F=Q.N=Q=E1W2N=R8F=N:N=TDF=S
MBN=S<F=V%M5U0F=YNN=V@F=[AN9\6F9\VN=YPF=ZFN=X\F=URN=^LF=^NN:
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M]W?^ZJT=^5G?]^]>[G??^8W+(2)/***G2K# MEK<"Y3!"[P "V)+_,7?"[0
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M0FB#1#B"1FB%2(B%4KB$6]B$B/.$"KB!4TB"+-B%5SB 8*B";UB%<4B&<\B
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M2[13V[0@^[339;9@6[14J[96R[98>[9:"[='F[)"J[1OF[9X&[1)V[!H6ZU
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M2S]<=/_MH']DZTDOCO]4E?^UKS9$@/]LB'_? \2+ 0.P$"0H3J":@0H+)AR
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M--?[3?M&N)3D)+% '5SC$*<8R"LN<(N)_&()'UG&RAPR+FW\7AP'F<51;B^
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MS/MDD8(VO_'=%G?3J-KZIC:QW:*<>[./X COS%GZ[5&2U%O=5&3WPZ$#[\M
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MYFI&9A=6YFS.7ESFYO)E9W.^7'2FYG&69\#%9G"V9W&._V=6-N5E[N??Q6>
M+I*,?.=N,8W'T+-I&3J7C5U^!(ZFC1NL#9*_]5KZB8R_^ PW8LED!EA@[5OH
MD.#V>Y_ (:4FDA-]+MX7^-\$D@SGF[S-8D+(V@S:DTFF!.'2K*B5M(OF:!J;
MM5F:+:$2$FI;R\,(/4E&8D#%^HLCDB$?RL,-7:9\G:^(.K6(2A.HHJT72@P.
M;:T,)5Q"W1M/@<NZ6&JBO&HD8MDB@J.:I-MQ,PFH\HPW$R.OA2MZ;5RT0I_
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M).=-)7//):NQZR7R?U(R(Q,R'V/R&O]K\BAS<BE;\BF#<B0#LFV^L1ZC,:7
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MES/_) E[)<8:7)MF5!EY9FL#>%]B":M6]&B"+X&[[CF7>$?&5:__0EPYT/"
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M:/;PU3\A1P3 DI&X<M8V /72&HR[2IL%3Q7_W4AS:RF32)'.$H%68ITT=U5
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MBB^U515O*,/3QNTBM[L;^FYM$5O9YUJIL9S3ZH;4^R3VWM:]EH5O;&Z5'?>
M1*J/HFP1X0;6@<D67?Q5K'0NXR2(+95S)>R.MF12&)/JBE)P.I;K? D=!LJ%
MIX$%(4'OI&*Y)4M=-O%*<FUBK*#V16*[\ANA!B6=&^\$=L,E\>TJ!4)V<N_"
M:HF(%Q@*(WO,,$=-B!$ NS/@>MWXF_@JX Q! \($6J=BBB/DXI UR8U]BL
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MP-JF#T2R#_D0::'#@L$M%93')DR2K727&C ( W@RA=*"C:@![5'$"-*HB?)
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M)_(PKTS+D I,,1UQO3 ECMRL,[1P2@VJ3_F"G455T:^!,$Q:,IX))5PC1K5
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M?:DV1QF4D$\)[#Q.F%-TX0P:S02Z/O?XU%>J82.'](-Y;0C6Z^@Q1H!X,6
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MEW8HBF8D1":VY5Z8DZ\D$=5-8:=I-;S_@!:L:1][D]@-0!/LX*+.Y6[]Z&N
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MO[OGQX#6(@IB$R;-S*E_'DG(%R4QFU;B)U<\]QI_O0NW\8NKV6Y$%YEYQ38
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MU^X$/VPN+<PN<NIU@ T\9\S[]++$%.V'ON]%X*O/H,L;/2MY8.HP"O+)$J.
M,I2>5O+V_,4-@6T9BT(.XQ.+4$<<1:7#O/"+:"M"*]&YG"UGD HV(,MT"LRM
MXJ(KB]'[N+1\ "XP,? JP\B@1$)!H0MHLH69(%0T"ZS)E,6<"HG#'/1%-X:/
MW ]&F_^SY.BK"*D*^GBTUQH++R&+)4/(;X3I+N=DRO:&+\_++X%0-S44XUZ1
M-9%S,W\SNZI3J&BS.'7L_MSF-"N3-T$/C* 3R*3S_-!G,:VS3JTR/Y4S57=S
M4S$3,3TU.*=35F5S5*_356\5-Y=357?U.6W5-5UU.)&C.$FU6)/S6'-54U63
M4WO5,'\U5N%'*Z*56)GU-AG,6B4+6WF5,Z.S4T/#,[^55LE$R<)D_7K34'6S
MQ<[*G3)+!!\LL@)F*WSKM>J/6H,,3'GC7LY$](!J3SL#_5KR#XVIZG)JN9BT
M6\EMVK9JZD[5H'HKQ@ N;YX+M#22.EZ@&C@)E$+R/+1 /FS_RV;F\P\!+J^>
MY6!#]$;%TIHD["9S-D%H$D,P1&=C<HGFD2BRT)2<K],,C$PRAQ/]9UO")@Q[
MYU2SCP3U2SG?Z(N\-?.$".1R\K52KDJM#FT<QHQ$#FFN0L@"5D2']E0Q8D7Z
MAJ^V#G]P+%1FB%W7Y/[L=M@0A^7.Y\":J([6J4_EL G_2#M)S,T4230,2K!.
MYQ2[UI&@BG:>L.7"UA)/#LPXY\;8$XGFJ_NJ9W(;-^D&!7(K$G^R4.10T7)#
M[D0#1GH<B00A)4],E]9"%ST;, 4Q)^:4,=E4]P99%X7NM'#J)'8'\3W]!RD!
M(W)K+ CE;QLG[7E(*W-AXW<Y-W@]_W=Y,8]VV<QV)?=Z PEU4XYW8>:0A 0O
MSRC_:&I+3:;#9(4?V:P:A<].ZZ-M5\9.5K""(I)\:K38@D4ULO  AS0(T[9O
M^;?W]F@(SQ;<U$1?BD]S=8NR,F_G8H<&GQ>.&.MKFP_Y9F^<&K1Y&6Q#A\?9
M'*(415!Q"J?4L';_9M *);65ZD-I8>2+\G>_ '4)95<?>8[]I-=X4R@>8\24
M"O"!CBY&AFN>/(R+ L5")24B\:@B=0(/&Y8I(I)=E^@_M'9W_$U=_HX-Y;3X
MZ&CUTE=_+!@1@W=SE\8="U!$;4R)TBP\S^:?9BY*((XC#,J WXI\E&7Q.,X(
MPZ_ORN= _?\+5/),N4QH_^PV?)[GUBSRV&@PF.1L]5*/4*3PD 86<9/,04D0
M;ELU:$77YDC7:6RX%G<W@<47!:<7$/OJ<+KWBRW&5T8W(#\Y=YNWIYZW<-3"
M=T4H-EEH>)VL>'6.DY'7DVL%E'4W=4?9EDL9EU\W?G99WPJR6[0W>?UEF&6Y
M7VAY_!JU3*0EEV'W<[&7E8_7A8,YG"LJE(OYBWH7F<MXFY>YFV?WFW]YG&^W
MG5&)RTKNG$EY@1]1BQXHN[JO?\\XK0ZRHP1O"XLQ1+HP?MF+P?B0! .)'=VX
M!(]VE:@G#=7&@(A8 PMS(:,7#!$G?#!S_CIX^TRDDFK@(U%6&9K_H&WA+@/E
M.$P,"2JZ[%M4I4_?<@!^]F=G$I=P":<;3KP&%#"UB4MC<[!JIV1B6#?G.'@
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M:++,1 >VXO=;K?:TZOO*(U>=G&2(7WV 12/^Z;?7M.JJ #% S8 7 [ 8)#C
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M;OP83Z*>=SR5M[HA:K%44O], _>?T[)R)[0PZ794@8BGKO(SQY2O>P)9GFG
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M1[K,HD@C(#^MN6F'3K;,@BVJ&H[3CD6:)I*PJ1B9O@T^V3U/J#%W;/7=C'&
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MWR;V4:Q!6F5HV\&W$9NMRBM4IO,57D.U,]/X*:&MODGMRTCWKJTIMRPCF>5
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M-GX=.G"R6G4BN=[B[NDZQU6[VZ?[]N_&/>UPK[O<[4[WN^L][WS7[]S]CG?
M[UWP?6][X T_>,07_K.'9WSB';]X,T6>CHHGO.4KCWG(7U[SF9?\YCW?><IS
M?O2@)[WH2X_ZTZN>U*EG_>K9;GK7RQ[VK:?]Z]>.^[^'?O:Y;WSM>__XW^L^
M]K;G_?"%[_O;'U_YR3=^\XL/?>!/WOG!9W[UJ3_]Z"\?^Y^W?O:EWWWN[U[[
MSP?_^,U/?/0C__KD9[_ZO1_^]G]_^_*/__O%GW[ZW[_^Y]>__\O_?^X7@/,'
M@ 4H@ 9(@ >H@ G(@/8W@ Z(@!"X@!+8_X#]%X$6.($86('Y=X$<F($>N('K
M%X+PIX$4:((EB((@>((J6'D%4'58!X,K]W(CB'\B2%\_@C5 4G,G,G8JHG._
MU8/#45YQ-"0Q 1NC<82G(1NQ41JLD82381I0Z(1+B(14J(1-R(2N4858N(5:
M>(5>*(59&(6J,8:M489/2(93R(5?>(96&(9=V(9K^(9LJ(9@F(9B6(=Q:(=F
MF(=]B(=_"(=^&(B 2(>$.(>'>(>#J(B%N(B(R(>&F(B,*(F.B(:/V(B12(EN
MB(F;:(F3R(F5"(J:V(F9*(>?*(JA6(JC:(JIB(I[V(IZ"(N"Z(FJ2(NO*(ND
MZ(JGJ(NLN(NYR&Z+O^B+P1B+D%B+O3B,EUB,P'B,LVB+Q-B,R/B,S&B,M[B*
MPL@09Q"#V6AU+Q=$RDB-K7$2V5%&HU0C09@B8;<SYB@<5R)K4^>.[PB/\2B/
M\TB/]6B/]XB/^:B/^\B/_3@B>Z"- :ER9Q".'C)),O_#=>JX(JV60Q6@D--!
MCETRCH_B7FC')A4)8!8))1BY8!II)1P)DM+ED>;U7"-IDAF)DAV9DB&)72>I
MDB_)DB6YDB(YDRU9DS()DS29DS:YDS@9D\)UDT#9DT+YDQ>IDT6YD4>IE#R)
ME!^YE#[YE$09E4;)E%.9E%6)E5"9E5*YE52IE5_)E6#IE6%)EF-IEE<IEFA9
MEFIYED[9E6P)EVZ9EG*YEG39EB19EWAYER[9E'H9EWYIEW_)EU89F(4)F(<Y
MF&]IF(DYEX@9E'OYF((9F8LYF8XYE)!YF9*9F92YF9;9EXR9EZ")F9]9F:*I
MF:39F:;)F:C)FH3IF:ZIFJ__J9BRV9BQ:9NEB9NIF9NM.9NWJ9N_R9NUN9NP
M.9R]69S""9S$F9S&N9S(&9RA>9S0V9S2^9RCJ9S5>9K7J9W,B9VKN9W.^9W4
M:94%@(T"*9 S6%S=29O0I9&3U8W0]9#0@8ZN%I^]07OM2'(PIY_YR9\EMY_^
MV9__*: !2J  :J #>J %BJ +JJ -FJ /RJ 0ZJ 12J$3:J$2BJ$5FJ$7JJ$=
MRJ$?NJ$AZJ$B"J(C:J(EBJ(DJJ(GNJ(IRJ(OZJ+S!I QN F^D!MGP 792)!$
MTJ*SEAU%6!+U21P_J$-"VD/4,31<YX]+RJ1-ZJ1/"J51*J532J55:J57BJ59
M6IY8$L<%!&$+49(06WIU-KJ#&');#_]A648:'/.IIKMQ&V7*-$JJ>>5UGZSW
MH]NAI'F*IWNJ'7K:IWQZIW\JJ(%*J'9JJ'6*J$]2J(G*CH>JJ([:J(P:)(OZ
MJ))*IY6*J9&:J9,*J9QJJ7,*JIYWJ9I*JIZZJ:-JJJ6*JJL:JGY*J:K:JH#:
MJ:PJJK$ZJ+-JJZ^:JKM*JZZ*J[4*K+[ZJ<$JJ\,JK*>:J[]ZK+!*K+=JK,6*
MK,VJJ[T*K<RZK+R:K,_JK-%ZK=2ZK=9:K=@JK<H:KMXZK=G*K>6*KN#ZK>+:
MK>OJKNHZKMIZKO.:KNUJKN2*K_":K_2JK_7ZKO;*K@ KKP%KL 6+L/LJL/&J
ML ?;L E+L __*[$12['_:K'^BK'W6K$9.[ 7J[$>V[$<R[ ;^[$BVZ\EB[(A
MF[(C"[(L:[+\^EDP2 I=.J>^< TP6*<BMET(.:HZ*V$_4S0^:R-M"AQ$ZI!M
M6I"(1Q.H5A+5!$Q#X;0+];0C$;48-;6@Q!A5ZTQ7V[19Z[6.H;5A^[50.[94
M6[98"[9GV[5IR[9DV[9F^[9HZ[9S"[=T*[=UB[=WJ[=K:[=\F[=^N[?N&;>
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MM9V6VVJA!9=:<L<U-S5OL46W6W;#W79==[^%M]QYSSTV7G7OI5=?>ZW%-UV
MV]W7WX'%K?=@?A$FN%^#$W9X884;AOAAB2M^E^*+)];88GDQ[GCCC#G.%^2/
M10[X7X$9#GGEDED>V>24(W;YY()GCMGCEVU&>>>:6_8YYY]I5CGHFTD&^FBA
M92::YZ&1+AIFII5V.FJ<DZ[Z:9U[GEIKJXWN&FJNL5XZ;*J]%GOKIK_..NVS
MU1Z;[;+!AIMLNN>V6VJWT<:[;;[C7O][;[_?!KSNP>^^.G"]#R=<<</-1CQO
MR/M>W/')Y2[\<L8QI[QQRS._VB'%7*V1KMKJ*HBQOFKDT5^?]72LX^9.-U:Q
M7FLO+5=<.[-]]\@6\Y;U'H75,M;062L^V"&)-^CXUY(_WGGDE6]>>M>@GY[Y
MZJDW7MCLL=\>MNZY_UYYZ\,'?_SGM5]>_/7/;Y]\]<M'/WKOWT^_?OGMIY_]
M_/N/_W_\ 9!_ G2?_P)XP $BL( $A)\"&YA ""[0@?>+X ,E6$$*7E"#%N1@
M!CNXOPUZ4(0@_.#U,$C"$9HPA"ADH0I+:+X7SL^%*80A#658PQ;B<(8YO&$/
M];=#(.I0B#[V-. )@TA$!MKPAT-<(A(GR,,F1K&(*SRB%),(Q2G&T(I/K&(6
ME>A%+%ZQBV)D(AC'R,4RDM&)1DPC&M=(Q3:R\8U:-&,<X3C'+ZIQBW+<XQW[
M2$<]UA&/873C'_-82$$:DI!\3&0C _E(1$*2D9+THR,C><E)8K*2E 2D)CN9
M25!NTI.'#.4G15E*4IY2E5HLS*G6]*JS- :!0YI+D&BYO5NN+W_@.Q-@>/?+
MR>1.-*(!INU8!ZS<S&Y6I&)F,YWY3&A&4YK3I&8UK7E-;&93F]OD9C>]^4UP
MAE.<XR1G.<UY3G2F4YWK?*8KB34R5JDN5IFZR+MD_U>08A83=U*24CY[M9HP
MA>Y8KS,(EX;5D7>VJIX(9>A!';K0AY:EH1"EJ$0C6I&$AJNB&)VH13=JT(\J
MU*,CY>A%04K2DY8TI!I%J4A5VE*6OE2F*:6I2VL:TYL.9J4ZA2E/9VI3H.(T
MJ#[-Z4"':E2A)I6H1[5649O*U(PN5:E(E6I5J7K5ITXUJU;=*E:CZM6._E2K
M7^UJ6<EZUK Z%:T/X<(UF""%&B5!"J18G5G3"M6[CC6O7%WK3L%: ":00@I)
MB"LIV/(0@JIUKW_UJUU-BM?'ZO6Q;R6L6I)@6,$XMK$#H>RI+GO8(T%VLXO5
M;$\9:]K2LO4:<+7L7 _;5__4PE:LZ&@K:^\B5U((=+21Y2MI9:M8WIYVML(%
M[FZ-&UO?)C>XJ2TN<I?[6]$Z][C#96YTJ0M=R4ZWN==5KG:MNUWP?E>\V95N
M>;G[W.Z:-[SD/:]WV;O>WJ)7ONZ-;V.3-Q!W A0XR7N5JK@5VO^VQJ 971>2
M$E*_'PK4+/[\I3!SQ6!;;6EZ[@*,CXAT82!A6$@:UDV1:.-AV8 8=1PV$HD_
M;.(0HWC$&6;QAEO<817'1<0RCK'I:GR,&=OXQ27>\8E[G.(?K]C%0X9QD&EL
M9!T3F<=*]C&3@>QD(1<9RD>><I*E?.4E8[G)6GXREZ.<93!O.<Q='O.7Q7QF
M,J/_V<QI9O.:W4QE+\.YS')6,YW;;.<W6WG.>JXSG^_LYR@7@ M,.%6ATY($
M+N0X=(0^%5N0C&,.%SH),1*.I/L,Z>-4UM!W<71P %OH3L?&TAP:-::K;.HX
M QK.DNZ/;3?]VMC5F NNWK0!KG'8/*-ZSY!FM8PN)!!+$X<4M39 HD475U4G
M6]>7%O&PB9V6N3Y:T=,^]FV536UIZ\;9->+"KK%]ZF^G>ME_'G>NP^WM&Y^;
MV>EF=[;=#>YVP_O=XE8WN>MM[GC3.]_HGC>_Y?UO??=[W0*W][X'#G!_!QSA
M!U=XPQ/^<(9#O. $S[5^\VMC:;5&=0 N-YX]?NWN)$G!D%Z"\.[VV9E^EOQ*
MP[LOO$*W3';&7.8SIWG-;7YSG.?<3]=X=J&E *9-@%I//E\4T=^DZ9ZGY;4Y
M"GJC$6/T/$%]4E)7$Q>2;H DW GI2<\MGZBNJ;9VZ>MGH;70JZV6GRO*ZE>'
M]M*]?JJT^XD+7<\1H[FM<[SG7>][YWO?_?[W1JGFX@(&U]EAI2D LRI?MO\L
M@,IKYV!=C<;Q3@(>0W0]& 4;&/";YWSG/?]YT(<>\&MG^]WO51<J%/H, X;3
MV"6BKK^0%?9E&?N99EWZM>C+%JD_U1F*!?78F^0D#*F]HUQ/&(Z0/NEQARB!
M[Z7\TL<]ZG!WUNP+^E7K Q@CV;\8%P@K_<, /Y;;KK6.:@3^0FV=[6X?.O7[
MY'T#H%\OMB!_[I/$^I(Z/ZL%)GR\\F]1_0M  !S _RM _#O C$- _U- Q4M
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M#Q;A$O;@$$;A"Z9@"VYA# ;<@SQ>#I77+T'>0?/<NT"Q6T4CD1U%TK;(V],
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M^<)%2G$1E))!H?UTQFZI)>A>9!*1F%N$)7+TCXHKLMBB_XLOPABCC"]6((
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M.$G"A6O@20I2N,:)2H)"! )6=L8DVZM^6:O3MH4B+"'?LLXGS6 =L"60?9^
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M]92^GV>_[_ML\[N^)_=6_[M/]=N^D17I )R_#SQ8$[S  UQM%=R_'5R^%US
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MR5-F4*)#<18%BC*I3Z5.CT)%2G6JU:<V)Q+<2M" UZ]@PXH=2]9 @6MAF11
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MZD0I_;>]S;7:M]*33&;(K:,.'-!F"-DD_=(G_UUL#SQDAGQ](^H_+^W3\6S
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MEW__^/\__7,_ :R_ #3  3S  D3 !53 !O0_!GQ !T0_ HS "IS !+3 ]I-
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M-%SL/0)II29:(L/21)\SG@,ZI4J;*LE[K7[TQW\$R( 4R($DR%C)Q$LCQXK
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M^O*NC7*GR7(<VW([ADLGYW*N+',C!_ K%_,A#W,F5_,]3W,E1_+F[7,\YW-
M1_,D/W,O1_0[+]8 ?UH 5TZIT\V)IMG)-3P>1DW+9&_0%%R(P;V8K92GBL./
M)3T%[IOI*G7 I&-N:Y?HK"Z<M=7.O#Q&HIU)%U4]64I+#^ZT:O$JHVDJ4FB
MY<SA@VE((9SPN^Y.U$SX]7'9M30=QSG=T6\WI.SB!/4CG=0AJ_\<?YNZW_MH
M(;TP$CZ8% _OP"9W<S=A=!=,PQSW=&_W=2_W=Q?W<Y=W=J?W>W=W?(=W=9_W
M?/?W?:_W>-?W?@?X@;?W?R?XA#_X@D?XA5=X@6]XB&?XB7]X?G?XBY?XB@]X
MB\]XC.?XC]_XD#?XCB=YD!]YK11R>P8NUL$<ZR/PAID^2C=@F6^;OQVI&1>7
M0DZIQH;2Y4+8LSU5_74T[VXS@(W&;0VB+:TF'.Z@/G5P31TAIW=ZI-<@J8_Z
MJX?Z"IKZI>?ZK&_Z"-IZ;07[L==ZK%^@L$\FI@=ALZ]ZLO_ZLO?ZMH?[LV=[
M>G5[N7][NI][O%_[O;?[N/_[O.][P0___,'G^\+'1[]7^\0G_,6G>L1W_*[7
M^\:7_+N?)/T.6Z#?HR>ZTIN1U)#%V]3,;FH]"NC6]+E1ETB?=:O =CIZ^NT2
M/.<CH5@U9?2E5M&DG8")W&@*09M&-%R\H\$>,^5D//.D]P%BSO0-U4V_QE8=
MFPWNB?:]8(F1;WM1S=[/IDRCY\W:8!3A]%+QZ>'>83J[LNF*,(JFD_I^=^].
M8*->3G>%_WB-_WF5__JG__N?__RW?_W'__T'B (%C@DD.+ @PH,*#3),V'"A
MPX@0)SZL*-$BQ8L:,W+$Z''CQXX@1XHL&?(D28_H3#I<27#E2H$R"\2D.9-A
MS&,Y:PKD.?,G_]"@/H,F5&@TJ$&B-W,J)9I4)]%_4J=2K6KU*M:L6K=2%:"G
M@@ !8+^&%6LV+->T:J<6!9JT*="A3>4J?0OW+MZ\>O?R[>OW+^# @@<3+FSX
M,.+$BA<S;NSX,>3(DB=3KFSY,N;,FC=S_FOW85&[Z)[VY&CSM-S1,GU^5-W6
MK4R,KM_:%6J9+MRA+^?^9)V0)T^#KDO#-CS[]5#@IRMCQ!OS^=&9T$U_?GW8
M)^[8ME>3QEL[+^B0=Y\+5YI=.G&%QP\.=YJWYMOSVI??[?YS]W?>BJ<'#RUQ
MO7W;3==3><3!1"!"+BT'GW4VY7<32='IE]QJYJ6W$6\*TF<@AQL^^#!@9R&*
M."*))9IX(HHIJK@BBRVZ^"*,,1Y6X'P@$M6>AJ4EQ9^.Z4$G7UP"\C7@AMO_
M%; 6DDDJ65589)TU%I1E+3GE/\5!52%J2#5(I%Y7HG<AEO0-".2&RGU9Y(T=
M<FEFF&3RF.6998:9FYI@LNGC>W7*.>>"><*Y9IQ].J<G=H'6Y":AO1G*IX5_
MVKDHF(V^62B?A_HYJ:*5,IJFHWL^&BFGF,9)*9I"=CHGJ8AV2JJGJHJ*:J:E
M!KEJK*U>JB>L9[J*ZX6IWGIJK['N"JR8PO[Z9JYM'MMALG@.6BRT@F)IIJ6!
MZB>K7^$QY129T!ZX::/3(O5MI@<262V%1E%*)$[E2C01;J#5)6YI.[%W;ZWZ
MQ3<ONL[2>R>7X]9;G(3IR?L7M>)6:QI%Y-['%*L0_\*9H,#&Q5K=Q ,MO%R
MX!'G9:<=?W:GQ)8>#.[#LZ;VJ;):PLN87"=+W%Q3[;J\+ZB Q>Q?CJ0-B+.I
MWMV7DID@SWHTKQM?*RV=+8^GJY_^-BWUTDJ'RW35*-=J-:=47\VUD5A_K?6H
M9">KJM==BZTVV$BWO;79P>;L=MS1HKUVV&^7/3?<?.^-[=]WZWUVU'C3[3?A
MSZ:==]UL"MXXU(H;WC?@B0^I::GY&<VLM=;M[)^5VO5[VI48&P75NJ>WU.R1
M5+K^>E5@>24[.6')?KN4L*LU-X 4"R7<0\<)7_!PW14_G^H4 X^@\LPG?^_R
M--DWO8/.4Z^A:\>##KWUR/_CQ[SVSW\OO?>BJQ>]^.:C?_WYW6\_?O@^MT_^
M^^J[KSKVZY??//WIYW\_^_3'L_G%KWS_J]\!"SA  >*/@-1;( #M1S\%-I"!
M\HL>!2\80?YE[X$5W"#W)NA!#?8O@. ;H00S6#T1[N^#)32@ UM(0A4F$(4<
M1&$-99A"',:P?C?480Y]&$(:]G!^Z8.@$,>7I4*)9H4<:F+E?C<A\\@K8G&B
MC00AI"&4<&0]W.%?QT*G-G>A*5T2&YISC%>;>-7(/3[47G=DP[DV]F]L9+3)
MCZ85'@S9"''JB>+ ,*8Y)^(KCY%K3A^W]YL=V;%;,T,:)-?#QJ#],5_C\]D>
ML9?_O)<D4F7^2AC#T.-(A"&N(3GBW+=Z1DB]]*<M)"M*!W_3.5;F!R;&2YX"
MM1=+5;Z0A;S4Y?)^J48$"7,^N\3E,,E7S$42$YG&#*8SF:G,:,9PF=6D)@:5
M*,!C)O.:W<RF$[<)S6^>,)SNX^8STSE-<OH2F^6T)CCA^4YWMI.=Z)2F-]69
M3WS&DY[W-&(_[3E.?0:4H/,4:#,1NDZ#UI.A_Q1G0ATZ4'X>5*(1I6A#,8K.
M P+4F$%JSQ-%1[-Y9>QJ))69*.OS+H^QYR&Z>^GKP!*EL]1. +5S4NY@:I4O
MC7(W@-S+*)>V'\T$%3%%O0Y1DYJ9HUILJ4K%#%,+$U7"]4QU,%45S%4#DU6=
M/?4R6R6E4\,*5<=,M:=G'.3-9O445@$J-ML*(8@LLD6(S5*L0)5;RK#U0 9I
M[&58@J++^!;'RG7RIT)KX*^\!)I6=N2M@;G2S^@E(:")!UQFC0@O33JQS1V6
M<^PCG:5VMC+'U@P^_>+K=Z""4L$4UE^7W-]:5^K)BXR)IPM1T.?*8\BZO+5T
MK@Q;QAS66246C& %.5?=BOO;QI05J\[5ZG.Y"MWI2K>Z8+6N7YI+W>MR-[O1
M[6Y?M(O=\'[7N]LU[W@O=U[RKE>]Z;UK>^'[7E:6]S(^+5@8ZS.=^R+O5?PE
MDY<8FTJ5+JXI_SH]<)+*0E/;,=@L.%4PA",LX0E#V!);=!Y[IZ:GQ0[,6T("
MI6T9-> 0A_A511JQ9/^5M(]^*EVB>B6*YTBKX+)X3RY.E(A+&K 7X[5";;WQ
MC",5XY+.&+F*^O%L34PA))-1R35.79-7?.06)UG**;5QE8&U9"I'6<M/OJ.*
MO3QE+'<962?6L9!Q#&,TG[G(UAKRCM7\9C8#V<ECAG*)K>QC+N=9S%?&\Z:V
MO$1(<LB,_5M9R=($4C26!'FLM6HEBP;<<-&%L:%Z9(/..L'"D72Y[3O/*TTU
M)MV"BF1FIN_63I;:Y%ZKME'T3<LL/2C'H2_%ZL5-[R+9QY'"19";,O_E=TX)
MR/Q6"$39 12HJ:C(Q""KD\G<-88UK:Y\%>:U&3&D+9\+'(SE,CZU823EB&5H
MQE$[W'Y;<];*_3>RH=N.=>WQN>><[G='B]WR=K>]<SSO?*=YW_'6-[[_W>^
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MTA_]!C!LNF^>Y6_[6B3^QN\!\V("Z^\"WV\!*[!D(G $._ $,W %]^_[=J\
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LCI&,933C&=&81C6ND8UM=.,;X1A'.<Z1CG6TXQWQF$<][I&/??1C'@," #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>iclr-20231231_g3.gif
<TEXT>
begin 644 iclr-20231231_g3.gif
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M2P!(30 S,P!'4P^#<Q&#<Q&$=!*$=+?9U-WMZWBYL!.)=0
M
M
M
M              ?<@$R"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@
MH:*CI*6FIY\$JJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;'R,G*R\S-
MSL_0T=+3U-76U]C9VMO<W=[?X.'BX^3EYN?HZ>KK[.WN[_#Q\O/T]<"H^/GZ
M^_S]_O\  PH<2+"@P8.8["E<R+"APX<0(TJ<2+&BQ8L8,VK<R+&CQX\@0XH<
M2;*DR9,HI0E R+*ERY<P8\J<2;.FS9N.4NK<R;.GSY] @PH=2K2HT:-(DRI=
MRK2ITZ=0D67BG$JUJM6K6+-JW<IU4-2O8,.*'4NVK-FS:-.J7<NVK=NW<./*
M[=6UKMV[>//JW<NWY=R_@ ,+'DRXL.'#B!,K7LRXL>/')?M*GDRYLN7+F*E"
MWLRYL^?/H$.+'DVZM.G3J%,?7DZ9N;7KU[!CRYY-2+7MV[ASZ][-N[?OW\"#
M"Q_ND[;QX\B3*U\ND+CSY]"C2Y].O;KUZ]BS:]_)O+OW[^##A]].OKSY\^C3
MJU_/OKW[]VU+Q<N?3[^^?:[P\^O?S[^___\ !BC@@.FQ=M^!"":HX(*H"$#@
M@Q!&*.&$%%9HX8489M@0@QQVZ.&'(-:FX8@DEFCBB2BFJ.**+#IG16"(,,8H
MXXRS.=CBC3CFJ...//;HXX] 1D3CD$06:61702:IY)),-NGDDU!&J>&+1U9I
MY958!F2CE%QVZ>678(8IYIADSCV5Y9EHIJGF)F6VZ>:;<,8IYYQTUDG.FGCF
MJ>>>3-CIYY^ !BKHH(06"B2?B":JZ(R&-NKHHY!&*NFDE/)&.N6BF&:J:7A;
M5NKIIZ"&*NJHI);:TZ:HIJHJ;::VZNJKL,8JZZRT-K/JK;CFRE>GM?;JZZ_
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M8>76B;'TC_QX5K88==.DC+QH"YG8"T<)E.[(DK*0DV,(E9<G>SFY5^@FA:M
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M65?GR5.Q-)[/-I[E>5GSF9_VV9J@5)S7>9+)Z)P!"J&4F6'G.69=&80@&GG
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MY$C2HAEJHHO7Y/N:"PU5G@W4GAR;([K5ERR6FE77@MW!>HI,N9W7P&3;K+?
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M\KU0&%=:R^^MN!^+S5VOE31\,M$XL>83=PHNS/;K[+]2R.D6W5O?HT8T/]O
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M%J9Q1Q2'+/)C^([LRL.&*F7G+6V:#,O I@%<[L%0-:FPRYM$["?*W@:'\\]
M;_KQT$07;71@UFEY]$5!-^UT324_30K/@^KC[[]+2BV:M@1;:_"^G=S<H-A!
MZ[PGU<A\J_7:;.__N/3;<,<M]T77%3(W)6WGK?<K]V2*P(F8B">9L^(BD&DZ
M4X/-&L*:$ 00@H"GTG<P?XOR,,SV&$"FX9$3,/A.5S=N>#"([^=SX*-WL[+F
MI*\,BN:'NZ[)MUBI[LGDE'?^*>&TX.YL3RW/?GKM4&%V.=>WLYY;5(Z'XKNS
ME1\(>S1_EPZ*VL^D_KOL1FE/VE"8N_)\])<$'\KTR\M^&O<\UARXS)F@O[WD
MRD.O>S[>'_ W^XE_?OJ=VC) _?1G/27YXG&D$X7\",@_LY$'?N4;(/DNT3PC
M!5""!7Q%?K"WP/TI4''CF^ I0MBY]9E"3_<8H/ZJ]SK_*<Y&!(C:![.F_PD2
MOBI_'AR']W)HNM8H"'NWXXW@)#,4&(+"AJ2H8 3]=C_1;2Z#>XNB%$MQMRI:
M\8IQ4TFPL B)*7KQBSES(0$-*,;0C9!,DH&B!7TH"LPU[S3(2\40@[&RXS&.
M$W"4# +L)$;>=8)XGU.C\/PXQP-N HUT+ 4@!W<_6B'2:P3((^ADM\?>N9 L
MYL.$(S_7OJR$(GP/]%\EGZ$X>_1QE+5XY"2Q=3H5[H1_N_/?-$"I"DGZ+)-X
M5.4=_[3+%K[(B+D48Q-)>4E8ZK*7JNBC_@;I/E?*ZHV!_.,QOW<^(/X1?K9T
MUC24V$EV.+.4K=A@*X_IN@K>XY*G*.3OU!%',O^6Z9K*/)$ZV4A!(4)0D^VL
M9S$QU<=A1G*:@NRD:QR("?/-TY#OHV$8+ZD[<ZK3C)J8YGC 2-&*$H"+&,VH
M1M5E&+MM-!$6#6G;LKG*A9[R%1)%)C,]N3CW-:Y.V80E/..I%7!V I0I]>-*
M/Q>ZG$Z4G;R3*#X6.3CV^51V 5*EIGP*T50JLP"X]%QPE"K0K:F4%T\E)D(Y
MP51:^-2E8?-92IM:/F4*@Y:H2"E49794=Y9"AL",J#+UI[ZY+M-Y=F5I,D_:
MS1B:=4AK_9QK?!HY@I95H5CMHS*XB<\>C346X@SJ7\FH#)+:%(]V1>5+$7M(
M:T8RKW3]H6+C5Q^%F1 CLW,EZPCS:E2[=@Y'AOWL+[.:T(*AUJSE!)1EZ3E3
MVHKTMVS_^ZAPATM<*\&K8\4U!'"7"[2O;K6V96S%;D%WO<MV%IF.$V4KG'LU
M.X(U$]SE)3I-"5J()G6NE;6KZZ:K)]+)$KSEC9EKY>1>P5:UC?GT*WH9F]C,
MRL*YWV7F6?W;TE.B59%YC>MA$]S;G[+2M@J6+6L_P=V5L=>Z_1MO8Z'2U=VT
M1KLU!.U=/:S33T2UOXKEKU2[T>&3M?.\J:7LA?7*51&[YC1-E-.,LW90EAJ1
M3$EL9X5CL6,:ASB^0'TN=%5K4-]J%9)R!>WJ8#KA!CN9N5AV67*WS.4N0Z>C
MATENEL<\L4<*4("/Q Q4UTR]-4-5NH.KG@#CG&0CUQB[@42S_Y+3R<@S(](V
MWG4PBKMQ9F<^R\UM7O-MJ5=H.M<4>HR>LV16;#])XTF2<AXBX'AZ9IW^N="(
M5*TK0NUG%X95CYT>,0!Y2^%\DEK/U+/IITM-792BNM%%??0*(VWI3N61<[U.
MX\MN_4W;%C3.N)Z,>*%\YQ(_^9W+7EZJ=^(),].:VE8F8++15D,VTU'1.^7U
M$,LS1UJK&=G3IAX9F1RM5[MR-*YA:+HQ7(K([IIT\V8U=,4#:CT6N#;7QA&V
M/VE-21;ZF_Y:,YG<C!DCFD@4IXTR3P+.602#[N"YSK:V@_V_->[YR>Q>DL+_
MX>;-&GO0A(;U*\G(;XH[>\'XSO?'R?],\XIY^>8XS[E>X*4T,=?\Y^42CV:A
MJV\4B[J'<21JZ )M&\$-W9_DQ1$:.</TJ&OSI@-?MNN$;0\T+IV15B\I?-&$
M1ML0E8]<+RA 3C-TE&]#V1+/>B=W^>;[$ERE_.;,'#G#]O*@\17\_F/@3PUW
MTJK;RFVW)=2Q/AM55KOP!9WZHNV\TM(HV.N35_6QVRQ:SY(I/G!</.$I3^G#
M'UE.3F^XQY&I=!)K/H@*S;M)5[[Z@D_:Q2J-YNQ?_NS<\%WRKK_Z[O<<\3H#
MFO,*^ONZAP1MH\_0V'!L>^^/WNIVAE[7K,?\Z ?JV; OWZW!#^WP[3S$Q ,_
M[H+>?'Z!SGX!8__I_/WPC_]'P(P=G[?__K>*_K][VOVTTM[*Y5%UPT=]2,=[
ML=1QI==:O>1 GX=]*W-^F1> M99Y!MB S6: ,,=LI3=S2_9OHF=QUB5)H\>!
M=E=@9O=_8:=O#$@V%TAZ$G9R&\B!<.1WIM>" 88*,PA[<C=H$ 5'H]<YP!17
MXF$G.1A*]&:!*V5A.[A71;=A(8B"1/=Z-JB$L-5_1LAL14B!1I9Q$8A[-QB#
ME)>%AE>#UX6 &2B%8V>&JP),;'=W5V4V00@_L"&&+?B!)9B"C(=A=.B$W&>&
MD_=]P8=X^Q=^:'B +^=K2XA_BE@K\M>(COB(D\!S859<BUB)GK(Y^"7_9%8(
M@DUXA<PF@";7B3JQB4"6A%858,PB0W?HB2[X@I\(A>%F7B^VB:X8'Q/H@&Y8
MB,-&;WDT@JH%BF-(@JZX9ZE(B[YT5<%H9T1TC!_7AO^6?O['B[>W>F2%8YVG
M@<ZW>R.X7F#1(O\V>TU5? 6"8<O(?'U(;\-85S026U'EC=D6;[ 8BJUH.;/X
M3%5(ALMV-9B8B^D788;H+XE(C8!XC<WGA)$CCL_&/:6X"@2%D'N(AUIWC2$'
M@W H)_OH@02IBZOF; W);9;XD6$"B2(YDB.I)1U3?Y0(DBKI)\Z(5YYGC)DH
MBFGX<< 8A;00D)5GBC&9?LRB8&07:%NH)^*1H8O^LI#51$.0%Y',6)"R8(W\
MR)0;V$CH:(BET9+,1V,]>4^/5W$9*('K5XLM"'%)N5I?J5]98Y1+.7E;%T=Q
M6)8VXI3TN$N&Q8)*.8*Z,QM#R8\*J(+&B$M6Z4Y!699TF9/15D)XB9.#-GD3
MZ6P(29B>>#^JV('@5X8::41P^6!?&&1^Z)B#MI<T:5/L>"H5F35_J8,OEY??
M&(ID-9@KV9IN_T.2L!F;.@=F-;!EKGF;8>*.&$F9!(A]HN:#J^>93<>:#0:9
MV%.3I7>7U8-VG8B/I@EEB.F*3=4PIB5P<BB8RXDD#Y.(T<F'I]B/0$EUV"E
M,K5L.799W9F<^5@BQ)F0!<B4U6E3>"*$-(*6SXE 7)F-1*= P 8+-(.-G>0O
M#X>9&LF*X#@*N*2;6UETZ>F<J5*/,,B91-=0ZX@R2&B0S$>0FFF HWER_@@;
M_AAWO9F,_,E" HF@2WB/&.B) ZF-N\<_%ZI/R+B?\EBB H2;..HFLKFC/)I<
M6I02MIFC0KHM6JF>O EX-P-,R.F>$/,P8T&>.IF+I;%P&G19 \J>6?_CH(]Y
ME!!6I+.AI3,YC\-@GPOZBIL9G-]9&@JCH%1J&GK&/_96H/\8=O=SF:E IGD(
M22$JH3**C9'Y;.NY'_V)H1OJ-:6Y"_^I6I&IH+LW3 [7ES2RIM9YIC,YHGRZ
MD7)JEE+(J&$GGOE)J"1:IE>#9H93J% )<AGZ@_>Y>HY:I&%GJ7T*C9.YBJ@J
MEK'7?TKJI<C#J:>G9(<ZI,"Z)STZK,2*45JB14$:K,H*(F(3F7_*9Y_:E6BZ
MD\,9K:9:I3*)8I9W<>%DI46*D& JK6E9HPQC3:TB='8(6649JZI:@,+)JO4&
M3NC*#W&JJ$"TIZ#*A)GIHJ%:J F')J(9J>M::GPG5$II5)ZLD*A8>IKP@Z_J
MIV2AF:4#FX"!RJ696EVY9XR+&B[@.K&:>F@ :ZT6>ZH=JH'/2A#'-Z/3JJ^V
M@P[?JB(JFJDG5K+PZ;&JR*N>Z*FU@;#+VK,A_U*L0!NT<;,E0&I_/GNTZ=&8
MU6=LSZHF,)F!:CJ5FEJM$<JRZ>J=U!IMZ9,*1]*TDQ>U*JNT_3IH!U>V94NF
MW,)I/"L^/$-? UN38EN7<[>UXJ!R7\@MJNBUH9BN<;MZE$D:9ANX*M2N!QJ(
MY+H*;">X@=N-@51W^B**W-(P>ZJWO2IH$6M;?1NE??5\%TNPYOF= @I!XIBY
MZ/>Y$LDW'->BA\NO*_NP&Z>XVR:KIKJSQO2T8*FYDNF2%(FK]4&Z8<JZ)J8B
MY>:X2%N\*"*TR)N\'Y,2). Q1FN\T'L<ODNC(FIKE&JZM'J!5 N@7.NQN)BU
M?XMJ!=N$E,NGJY*Y/_\F8IP$KSN);-4BIIA*N 3ZKBSZ5K)61E=+/PL4I\:)
M@.7;IWS;MDL"8.OK?=H[J^S*"D6F>Z[+2&L;ER08N=8TN;9KI+E[1+U;I/"&
MO<P(J_FZN42IH;;*:M.;P)6;IZ('578;D#2[M-#HE^H+=HC;3PI9P; 1LXM)
MLKPK<E3SJ/GID#0<O4+L(,I;Q$;,+D3+)<\[Q$P,&@Y+O96*K?LJOYA*OZIY
MD]Z[?6F:IZ(DE4U(-C?\E>A;6C$\C=EK@^X++5(;OW*+L<*HK:N[DS1X2OD[
M$/OK0K:XKGG[M"BKP )L6V5LQKC+QH8[MG(4R',X5P'%LG6TKI)+BV#,-9="
MJZ<:+)^.7,$<#,(%%KH_;"!/;,*#7'JDD$)?I;J&?,6SM[V(?+7L%5"1W$LX
MC**W>J8^7+4B?,H-=F.*_,!-W,N,_W'$P!S,NY(TDTA<OGS,E/')KL@9_^O&
MLBNJK>O"V^O!5,S(6TR(G.;,7CG%%_@LYYN52X+(,+O&O=?%N?#);INM6"NE
M<9R+=M)CZ_1?,9S'*CNGE\IRK(#.X2S.3=C'J%S(4'S(_"R%1.4_BSR^$7S)
M9CB7W@M7D+HDG[S![&NQU&S!]WRDP+NJN(S!H+FKM+C &MC"==;&L1K(%5W0
MC9O).^G-'7V]&6C* 0VHIB".^*JT*.W R)S3L2',/-W3B!(L19N2.CW4<J',
M"-G,GFN_"+BDL870SQROZCRUKY-39G0D9*.*WXR.1C30T$G.%$35VFFMZ?S&
MZVR"[5Q@Y?\$UDB:6E=ZT=7KUJF<S[H*R%S]G)0).+7,O2,;R"=R3NCEG^2H
MT SKTE?-00_=I=8JT7!]P59;S7G*R;8LKC&MN\U8'VAUTVF$I[4*T =<O^,W
MS[#@UU=FT: ;S7V:PS -RJH]PA KNKX&S_!+U+)M%3Y=V[;M(753S,,UV[P=
M%LH,3$B-?5 7QE'M1IA,H'6\I,G'5R2-J<.-/%F=K5N=Q=JL0\Q-"_I\<BA3
MDQ$MM<5VW.B';A\\WH\]T9R;KMD-2>WYO2^=JAM=KB([0CW&RV5MWD,"V7+Z
MRM\UR079W0PJV)TKW([=S;?,T:SVVZ=R'R=VAGVV30%+RP #*^$AH\Q7,=^+
M;=\46[B4K<,0#M&NFM>G6KG<(]HN1-^]?>(._W';*K[BVF&206W,*![C.8&S
M!:Z?"6O#T"VUQNW2#UK/$"RF!U9#WTW/,Q>N*AW=;SS=/ [59'U$0VX+)3S6
M\,O=E1S5!?7D#(ENVRRK> M$S>S/M?3'Z@W>%ML37@OBK4#CH4WB@FS- LZY
M^+V:."Z7ATW)B6W)/M[427WA'UOC&DUT,J5@8-[G=09PQ#O9I^W>V)>SP6?B
MO</F<F?D&![+K,WA& CB@5X?-<TS*FQJ,O[I1<'BHC[JS2&)M;G$H)[J#&&G
M(TO@H^:JQ-WDA[GD3![@[.W,'_@\VGU9FOWFFIS+K5ZZLN"1@H=(MW S4@ZG
M4@L64>[5Y.%,-YY(R/\]X!C]WM=XM<@^P*XZRFUACQ[N[)5;QXH$Z4_MKGM^
MWZ?+CSV^W\9HF6(>F-R<Z-V:L3Z^L9U<2JP^KG]8W_)8[C*=[IS=V9M-I_S0
MZ877Z]5,Z<$.\'Z>[XJ^VL".@^0N[JI>\=E ZAB?\7]!?\EJ\1Z/$&+CG,$=
M\$NILV(ZZRMZIT^[0C=ZQGQ^E?#8ST6JH$C>BI@^[."^UXZNTG;=W%K\XV ;
M[Y(]BCG_;#E,Y/Y.Z-9^U_,N]*[XHK8@T03E[FO\I*4CZ;6P2!7]G_?SR"[]
MR;H96[GJX\O,\PS?V&9?[4OONB;O3V J]588CV'I>F84HIZA&PIK$%J_]O(7
M:/+GF*F"OL/&%O+WZMI%7SX7^?&*KQ#_&M_XCO\2/,<2J+[XE"\.S9SO(Z^6
M2CWX99GO>GZMLLQ;K6*G*MP+7?^EEU7":"O&X(S85NY7V6G:]C YIT_=*PWZ
MLD_M6_K6E:YFM+^P3O^WIHKT_<N8VVW[-J[O@&Z_L6^:['!@8^_T)8/U936H
M5SXZ&:;7\WONIFQ8JJ_I$$2F_]N8$DSKOL[G]A[99<_[E0XXGO'\^>7PT9;:
M_^["[>V;"&;]](/][\GH@$ @.$A8B'" B%@HF(A8L$A@T'@ "7G86!G9B)"I
MB;EXB<C965@P:; H^4E*8-KX2%A@@'#(.CA)::N[R]OK^PL<+#Q,7&Q\C)RL
MO,S<[/P,'2W=_\E4;7V-G:V]S=WM_0T>+CY.7FY^CIZNOL[>[OX.'R\_3U]O
M;UU3TY.??^__+V^:P($$"QH\B#"APH4,&SI<IBH1+%L1'5G:=&S2*%T:(9VB
M^#$51F6N$J$"N8I1HY.D*AY@*2C4@8VL0A::-'%1QUT[;ZYD5=)BRTF+@BK2
M993FK5>L9"KM9%.9RYQ0B7IDRO$G*Y<P!;G<)?, 5:<\M?[JV30J(;69R.H<
MN96MKZE94PHRFLM6TIJ?K ZU&],O7Y.#PG;M%':B4:J9OA+#694P2E&0*CZM
MA'8PY4*.-1_E+)A4XJN2XR:Z[$LN =6@X!+J3&JQ2*R3A6:R&GJV1/^DN!J[
MUOVY4T54PT6S;DW;E^S:>56>YI79N>W7N3%7]_H;-&!/NW71U9Z(=_+EIL,_
M/(\^O?KU[-N[?P__&<#Y].O;OX\_O_[]_/O[W[]/#3+LT\-_!OH37X(*+LA@
M@PX^"*%ZT56"5R5N%?-=6F:MM>%M<EG&S(6DJ'7<4AW"U@EY''97&62V&$8:
M(H<5Y:)PU8WVHEPU^K8=)"HJ,R&-U^TX8H?6&;E:=C[B0A6*F?P(G9)+JE9B
M84IFB%B5M@192F_(L6@<DN")!6)YP0T"98LI[:67ER;*J(N(P1#I4VE_;38F
M:L")%2=;3JK9(Y>Q,!GC2]Y)V0N58GXY$Z!+9SY)9Y+/M7D==1*5R2.865:*
MJ:/-1=9HI(,BVF6E=<&9XZ2#8+FIG6_RN2=SGUJ*IZ='UIJBF[0^2B&16A(@
M9X3"#DMLL<8>BZQZ_P<NRVRSSCX+;;323KM?/@'V0VVVWR3+;;?>?@MNN,F&
MI2<A,%ZD*C%X,29DCSBVA<N,G2+C4KG8)0>LJ%:R)>BJD;*V+E"ZKHAJKOC:
MVJZFGLXJ':Q%IIOI=,J0&QLN#$LJ<:L9&Q(ON@J_16>_]WY\*J\>N_KJC"=?
M%K#&!0M#L<'5M6RCJ6BN))/*8UY,Z,.XQNSSR]QM##*NP!SWZ[PC-TKIP0GS
MRB:D ^]+,L$?)TUJ62@WK#/'$"]]\=/L NURUW?AO"C89I\]M;\]@MVG1#8'
MEG7#A@K#ZJU,WZPOWX$Z'76O;<,=\<5DPXODGU-JFG>A]HH+>>223TYYY?_&
M:(MYYIIOSGGGGG]N38 $U@ ZYI:?CGKJJJ_N+5[E%A!6V,'"W',E+MV]9[FQ
MX[[KXW,*6N'.NEM\V.%/HW9<[.RZ+6:5:>YL8>V+;XVQPR[;&S@SN.B)E\E]
M"^^RT&P[?=?NC!E?ZM=1DF\N\7JO3;?18%OO]:^>[?VT>8P2/3[U10\>JX4M
M+WY"<UV8 $.SZ+%O?>*S&OR&=AFE(6Z!MU.9]-)WG026PGR%>J $4].\M+5/
M?8H3V_3DAZ;8E6QN]1*8Q0I7,_W=J6,NS)H*AZ'!_9WO@COCG=66QT._<<I4
MBC/@DVX8P!I*+(?UXQ_KG@C%*$IQB@8IG16OB,7_+&IQBUFT5@U(H \N/HN*
M9"RC&<^(QE1M0EX6&^#L@M$] S &=MN3VB88,PN+^7!IO@.&Z^9XNSEN#X^[
MV^,?;1?$?+$OCG.,G9Z<][VA78R1)T-A]08XJCLB,I+$N!T"\*A'GBT0@Z(@
MI!Y5YL@3'NR0 L1;(B490O\U\9$TC$4A'VBF4NZI1Y3<'_YF6#?"57*/D4"?
M(V?4O;'5<H,BBUO5L$;"8/;/)(VLHP*-)(M03E!]W=L8-"W)0&)6[X&S*R$I
MEW?,A=&O<.K[WR]MJ4W!M5.26GME$T6!S#86(W8JHZ.2>@E/+HF*GT6YG0Q)
MJ:<2IG.7ZQ1FQ0Y&4!^A"\]NF$RC12^*T8P*_TN,'.VH1S\*TI"N0W3\$*E_
M-(K2E*ITI0\J) (, --"8O*-< PE3&>Q.WL9]"4QC5?BI D,@]+BIJ?<9+QZ
M>@HDY?2E-\TI.[_639[BU&+E@N0HZ2G/HR(5@)=TYB:8NE6@#B.G-]WI05]5
MT1[***PR6A19B1K*ABZUK$X=QBD+@%=9%))ZOZ)I-^D:5UQJ2"-EC6O8H@K8
M%^ZBFVEUJ#OQR=:S4HVP<%UF)BD;4PYB*)1*^>8[(<@+Q&:6JD$[365/(Y/P
MS:2P<6679_L8- N*<+(1G-LTW:A'L,ITL7ILK%#EF%>S2O95.S+G/<'I2\C"
MM*C%Z"98IYI(T4)74/_ZRNUI19%:#_5V5V%3Y/::NEVCFLR$I#1M4S5;J(:R
M=+WL;:][CV'2^,IWOO2MK[;TX<4"V=<^[^VO?_\+8-H95I\:@RUO!VS- R(8
MKS^=IS'VREG5AI+!U(-PA.VHV/(BV%Y6K1KSQML*!!-8;XTEH(@_VPP+:V1(
M5SUN:X/2-16_8J G%BN&3YS-=O:55%'-[6QY(>/3F*K'K>U%*@_UMA#7V(E!
M!MZ2/=R+'M>I@8ZJK8-5N6$E#I@3V=WF@-/TVF(H2I8CE)]QA:A>$XNXQ)-%
M;IE/S E][14F9T:S$X>9Y6,0><(RJS&'%^EG[W9WSMQ5,(YC".++-G3/X=7:
M6YH##.E(2QJ-^ZVTI2^-Z4RO@Q_7TC2")@WJ4(M:H\(=Y&!1C,,FBQ//^H1Q
ME:'!:"@+NLBNOJ:(U[97=OGSUIY9V_,*G2)5/XZ3;1ZP8(U1ZN>P6-;);;4(
M@_P(.2_YV'W>\C3?YU7L0;LX]!)QG)/<"F'_ B^X/'.3?9?L2,;Z-&SVZH["
M#!P#EZ_&#XSU*+KL93[_Z\>@?4PLJ<PH*P^7O$_E;+NGN6I6AS=G-W9-G8O]
MBW2W.,I+_B105+VVOMF;@-5V. O]7-&'/V_=N@35G4>-\I2KW%C_GFZYRU\.
M\_B.SEHQ#\C*;X[SG(M+QB6FJ;KRS(M2;Z36>9*&BN6(Y LK&>#A1C#2U:@O
M1O>QPR>OL]0;2^P4.OW@R+ P+)9]<G7"A>B-@?!)?MUT8W,]-BJV.%H[F.VF
MY79IU(8Z@6U[]=^!&WI:IJI@92S8=+\T1(T>9](_^\&^DS:T7I\L1<Q^6[C7
M1M[8EORI!9YH-#>6YWH?>,&CDOBEH^7A:@L&X)TA>,%*O605W76C\8UE_#V<
M\[D4CX=3OZ6LZWSWO.\]06H._. +?_C3XL> L$5\=?A^^<QO/GNFB\]V^[RY
M>?QJW=%DF<%?EHU73@;T><KU'&.W*V0O^3NYGA[:"L:F^J@5+-4?[=@4+=?Z
MX5Q[,<]O?ZD8)B=@A[_\Z;]]WL%^JZ48G/1]+Y5_>C& ,Z%]?#=E"?=FL"5^
M^+0KU_=XI\!_>X=]]=* P1!Z2004"\A4026"Z!=E(MB!S#"!+P-O10='*&B!
MQ;1&8Z&!7C& "*AYEC=#E*>##A1W(%AM;': )AAQ-K8JM$!8KB5""]@<I-<P
M"1@))0B%BP6#+T@N*1@T)7:#1 A[MH-$6.4=2#B#NR!RZE:%]11VSJ>&:\B&
MK)!\;PB'<2B']#!S832'Y="&>:B'>\B'?>B':604?RB(@\@0@4B(AXB(B:B(
MB\B( H=QAX\(B9$HB?C@1<@WB=W0B)FHB9O(B9W8B(;HB:$HBJ HBJ5HBJ>(
MBJG(7I?(BJWHBBV'7R1 (*^X#:IHB[>(B[FHBQ&"4S 5=$:XB\&H4KT8>, H
MC,>(C,FHC,M8#+3HC,\(C1Y5B98(C<QHC=>(C=DHC!_H@]KHC6C$C2GSC>-(
MCN5HCIZ &(WIJ([KR#GXA5_ZE8[G*(_S2(_U*&IH]V'^9X_[6"SX"#93R(\!
M*9 #29"KPXX'B9 )N2S32#KJ6) /"9$1*9')(C+9,Y$7^1X5V4P8R9$=Z9$?
MZ1 **9(C29( X8ZSZ) @J9(KR9(M"0P1513*XY(S61 PR4RZ1Y,YJ9,["9)P
M)>F3/PF4ZF M8+0/Z\B31XF42;F/U@5>[J.43^EOW]64E@6556F55SF.0:F5
M6\F5VD!2U/B,6"F68TF6GDAR_%:657F69):6;>F6;XF(72F7<_F3)VF'\0B7
M>:F7>YESKK=@?%F6?OEE@$F8A6F8.E]'EXFIF ?)D$9YF(\)F9%I44SHE))9
ME91)E9:IF9O)F66TF)\)FK1X+2B)EYUIFJ>)FL>B5_B7FDJYFDG8FK$IF[.9
M+*%IF[<)B4,9((Y)F[WIF[\)G,$IG,-)G,49DDRXB9S).7S7@E^\:9S/"9W1
M*9W329W5:9UMJ9S9J9TNEU]@Z8S7"9[A*9[C29[E:9[GF8K;J9[KN5_,690I
MB9[Q*9_S29_U:9_WB9]D6<2>^\F?(?6.- >?^2F@ TJ@!6J@!XJ@"7HY_<F@
M6=0 #PJA$2JA#QJ:QM>< :J@&:JA&\JA'>JA'RJ;#2JBGS.A)6JB%*J8_^F=
MM BB+>JB+PJC,2JC,XJ15R-JHYASHCF:HW3)#^_HG#0*I$$JI$-*I$5JI()X
MHTDJ+3K*I"<JEP0B R6%H4=*I55JI5>*I5FJI5&DI%W*+$T*IB;:E3U*FM&X
MI6>*IFFJIFO*IFUZ$%A>"J?^$:9S6J);.3J[J8X"X*9[RJ=]ZJ=_"JA6&J>#
MFA]T:J@2JI7\0)0-69J!ZJB/"JF1*JF3&IX"0*B72A^'JJD0&I0J"H_1J*>4
M*JJC2JJE:JJG"I>64XJIJVH/F^JJ#0"47\FH9HJJM6JKMXJKN:JK^Q@ K.JK
M\O"JKUJ7)/6IM+JKQXJLR:JLR\JL<?FKS]H.P1JL/LEI8#2KQMJLV:JMV\JM
MW>JM*Z6J5- JKN<@K->PJ3Y9A\4*C:'ZK>WJKN\*K_$JKQLUKO5*#H<*#H9:
MDIQVH5,ZK_\*L $KL -+L,$0KO:*L-U I^7@ '-*DG5XK=A:L!-+L15KL1?;
MK%0)J['<L+#FX+ CR:_O^:,82[(E:[(GB[)K>K ;R[),\+'DVK!-.I($8JWJ
M"HT!D+(YJ[,[R[,]ZZ$M"[0OBPX/&K,[*I+\NJ)AZ;-+R[1-Z[1/*YUU0!NT
M.>H ,1NM55NT=>J@6NLL=FFS-PNU82NV8TNV9<N7*RNU"&NB6%NUL.H.#="V
M1LNQ.CH.,CNW<NNR=-LLC8F09NNW?PNX@2NX'IFV+'NB6,NI;\NV3JJP>AL.
M=KL-3&H-8<HL7IN0.#NXF:NYF\NYG7N,>VA;N..ZMHCKMN\ MW'+M9'KN/DJ
MN7?+N)1;N?I@K1'KKYYKN[>+N[FKNVH(NJ$KKJ-;M/%PNJ0[H8V+M]\ N=H@
MN4)K()9[N;L+O=$KO=-+O?WENQI;HHM;NJ8[O%D;H<;+N(_;NJHKK2BZD.Z8
MM*!:O>O+ONWKON\;.7B]>[V_"KQ6"ZQLB[J)2[[AR[JKFPWE:[X+2:PCR:[P
M:\ 'C, )K, ,,;\)F[W:.P]$J[W?Z[IB*@[)^[\ W+7H2[LCN\ ?#,(A+,(C
M3 J]VL#V^L"H&\'=Z[T!C WCV[_'^\(:O+?[((MWJ9 %3,([S,,][,/2*[]P
M)\RJ$XJ_^@L/$DR\%*R\_NL-&#S#TOHLE2BR(JG#/VS%5XS%6?RT02S$JTK$
M$+S"^-O"%9RZR O#&0S%SB*K/EG%6NS&;PS'<0RP7-S%F/K%I$L/$%K$B+J_
M%BR^3&RNY1O% \S&<FS(AXS(B8RL='I<QY=ZQW&;QTB<ORX<R#(,OOR+QK";
MMT8<N\P)E&VLR*$LRJ-,RFK*R(U,J!(JQI3\MI(\QGW\RG]LR9.KRIA,R] 2
M(#?\M3E<RKWLR[\,S#1ZRJ@\J*J\QY',PMY;P9-<MV?\Q'H\R=N+.=W9P50<
MS->,S=FLS?<YS'[$'*?&#,; ZLK*#,OD+,NV7,G0',N9XY[5+)($$ "@O,WS
M3,_U;,^Q*0 F[,WU"LYXO,+)S,=+#,T!'<-$6[QDO,K2/,TJVI7R?,\/#=$1
M+=%MV<W[_,T1FM#(S,($_<RGR]%-7,L?G<[CS,K9TLYR*0 ./=$KS=(M[=(=
MF<][%NW &'W,_[S12IS)'HW39HS1!]W'-ZW0]S5SN_R3*OW21XW42:W4V)C/
M!"#3V$O3X2R\ZLS,Y2S2".W3 DW5]MN.^1"E4XS22RW68TW69:V*,?W44+W5
MP2O.KGS5FRS!;ZW5!BW7C\S5FZ.B[JR5\6S6?>W7?PW8;=C4@FEMN%%-O#:]
MQYP\TE5]SG";U3E]TYY#ICB\F"EMU(&-V9FMV9N=42FMSX2]L?VLPFT-U"4-
MUSJMV)?LV'4MVJ9-+5 JI;@9SY;-V;5MV[>-VY-CV3@+VH4KVFQ]Q(:=M9?,
MV 6]VCO=T9'=.9--U+WMW,\-W=$MW=--W=5MW=>-W=F K=V.O-:IO0ZM[=W5
M8,QR#=GK7-Z'W3EWFK[;S=[M[=[O#=_Q+=_S3=_U;=_WC=_BW=WA/;3[[=KC
MC=RJ;=[)/<&2G0^+FM\)KN +SN -[N /#N$1+N$33N'U)=S#S;W^'=2T/- !
MCM6L;=C\77Q#7>$E;N(GCN(IKN(KSN(M[N)X+^Z[%T[>][K6P&W5'O[3 S[2
MW2OBTK+&, [D02[D0T[D16[D1X[D2:[D5E3C.%X.OVWC<UW</*W'CTW@Z-V.
MA+SD6\[E7>[E7P[F82[F8T[FU=WD3M[,XSS:RVS.QJWC'$[5/1XMU;K>96[G
M=X[G>:[G>\[G?>[G<W_^AFK>YN1ZX5$NY6\^U\?-WX\LY[B,OLT-Z)$NZ9-.
MZ95NZ9>.Z9F.Z8)NY6G.Z:ZMWQV.YHN-Z*?-XZ N+2&KUYK.ZJWNZJ\.Z[$N
MZ[-.ZS(MZ*4NX&)\UVS>Z8D>S;F^YIL#L;5.[,5N[,>.[,FN[,MQSNP*^>F]
M_M/)[,\@+>J-_L70;NH%OMS=V>S=[NW?#N[A+N[C3N[EOA_2'LVH;NHUONN\
M/N/K_NL(C>7"+KL :N[WCN_YKN_[SN_][N][_NR8S*2Z#LD%G>[4'M78SNCJ
M#BU(N^K_#O$1+_$33_$5;_%I%^_-Z-["KJKKC7[:21S>P*OP_>SQ7:OE&(_R
M*:_R*\_R+>_R+S^7Z [ !,_P< [R 4VU-P_LAK[0G@SS/P_T02_T0T_T16_T
M7$3PZ6ZH';_AX#O!A_KT_TWR-6_R^77T5X_U6:_U6\_U8UWO]>9*\QQ/\QX;
MYYJ:V(L^]4U/+4,9VU_O]F\/]W$O]W-/]Z^>]!L/IDS?WZ4]IV<O]2%.]35L
M]75/^(5O^(>/^(FO^!0N\TL_]GOO]S(KR2,/^&I??!R\^)FO^9O/^9WO^5Z?
MG[8:3Z<=SPXD#;N3#^)E;_FI?O*@[_JO#_NQ+_NS3_L^:?I-^OBEC_J0J\Z4
MK_H&[O.U+_S#3_S%;_S'C_PF)>VX/^_1RO=^O,DZ+^_!KCFQ6*;)C_W9K_W;
MS_W=H>_]P7WSX%T/U5[&T1_O.=[\F2/%#__][>_^[P__\2__B:_FY3_^J#WJ
MFO;C\\___0\(3(*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.D
MI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3%JS4]-<C(QLW.S]#1
MTM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CIZNOL[>[O9O#Q\O/T];_*R<HU]OS]
M_O\  PH<2+"@P8,($RI<R+"APX<0(TJ<2+&BQ8L8B^4CD:Q'QH\@0XH<2;*D
MR9,H4ZI<R;*ERY<P8\J<2;.F34?XENV[R;.GSY] @PH=2K2HT:-(DRI=RD:T
MJ=.G(O/EA$JUJM6K6+-JW<JUJ]>O8,.*'4NV+,&<^<RJ7<NVK=NW<./*G4NW
MKMV[>/.NE;I,K]^_@ ,+'DRXL.'#B!,K/%[,&.:R?!X;2YY,N;+ERY@S:][,
MN;/GSR[UR>@+NK3ITZA3JU[-NK7KU[!CAWVL3[;MV[ASZ][-N[?OWS; @PL_
MI._Q\./(DRM?SKRY\^?0HTN/UW&TLNG8LVO?SKV[]^_@PXN_7+SC^//HTZM?
MS[Z]^_<S\..SZZA3OOW[^//KW\^_O___S.E# FD %FC@@0@FJ.""##;HH$VT
M,?/@A!16:.&%&&:H-.&&'+H"66T=ABCBB"26:.*)**:XG$[FJ>CBBS#&*..,
M--9H(U3Z]##@3C?VZ../0 8IY) M1!;9#7WX&*GDDDPVZ>234$9)9(X$2FGE
ME5AFJ>667':)'9+7>2GFF&26:>:9+FBF21>5R:CIYIMPQBGGG'3665%'.T9F
MYYY\]NGGGX &*N@M5(8YZ*&()JKHHHPI-JHFBQ(Z*NFDE%9JZ:686I@3B)EV
MZNFGH(8JZJC"0:HGJ:BFJNJJK+8HZNI<^.S(XZNTUFKKK;CFJFM*IN[JZZ_
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MN,=-;L,Q4:"L+?=>OLWN=KO[W?".M[SI.>*]VGK:\\[WGI$A:WT/RJT%]K?
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M8</$X@&T\-O$UT.M]&(Q4NS$>WF^7.9C=J;"'4R_("+!Z2O&+W9B=\MJ_&7
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M^%'SV$S10T/^WL$;)5&024/)+EX362HA1V 9#4X,!;)?Q(8PE_D;>=)AS$Q
M"2YBIL__WJZCG%HV_08Q(*>E0$D2I=DSVK=JIF3.[(@2+-1#":MR-&JV;+N-
MF,+RS!H5+D9\8E5JO$F@Y#R+6)E^'7=5Z2[!<C\R=,1WH%2=8X-*JELUF4*
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M=7<32($5:($7:($1J($;V%_+!GT*]W41ASV)53C__U=M>G9O^K54.O=\TZ"
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M2]^U+N?F++MV7.%@KL\J;..[3.Y>*\Z*CMD/NO.@/,R./;] ;]&(WMR*6_2
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M"T.5_E9I-01/^3E]X1D]^A.7ZQ2="/I6T86#_U2!/,E.U>EAUUEX#IJ:=D9
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M?^S)GWP+O9N*DCLA5NB]V3FTFB1\^-6,S[DF\2>B65<UP:A\[C1'NX.^)H;
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M3&*RT[1)";%FW,;FL,Y QZ)H^3U(Y+4G/$@?:*<--[]$B3P.F95Q6X.B)HT
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MM0ZPME5K!FG_M10)2'9J5H-DJ!,P)X(!6$Z8MWDY^("'U'T!EFEZDT2C%8+
M%%+R)0J0HV4817HYT@]-571<M1C^@'JU!4)P(84>IT:*D4Q5Q0GN W:Y48:4
M:!-<:!;@DX?9YFO\9%_.U6L@%A8L)5!'F"ZNA(#-LV#\46?V(G_F-%?\!T)$
MR%Q*=7E!%3+^=7C2QDJ]<W= 9Q65&(PRT64IU3I"%XNO1Q31(TA[=VN?N I[
MZ$@)5CK#U'T49WYE-43_['-,(G:"CG0]T@=+0K8-I6@N%%@V%H=;*W=YPMB.
M[OB.>:6&7U1\?99L+J9FG1:%T%AIYC)LI85P C)KNN=#<%0;XI=\296&96)$
M\<>,R/1%._-.G<0FBS93\R5U'JA%S',*\-B1UA WU484I68]3[%VM-=QU*8B
M?J=QMU-7675^N'%Z^P4]G]A56O-+GP9G\A9%P:9&L=)3$\E:C%9VW-4[IU=C
M  E?%6.25N:13BD-'X(DCB%&"TAS:29R70@ZO0>*';.5JH5^^2:5S:1/7DEZ
M'0-2;AAO->6"-JE\!SDN*W:%4[=C2V9*A-@>@MA_3[F7S1 <9_:6,-F'-3=6
M_V0&--EQ1R(U-+N500WX)9'V7;GGAQ7)2$SVC7$IB1B#@VPI3"W#D]XS@4"A
M;]U($@5(1X]I: -I#GRYFJS9FL)#$4#%5L3GASR"1: 8<"<D'RB3+T]X=(0X
MDYND4HB2B9;#>7M"0K!X;AM7:]@6'H)'>Q_V%Q5TB/4V(,OX8#7U)\#W-0&A
M1*[YG<!@.Z- %ZOXF].7'BVRAZ["7L:E/L*YA+35<JOP?0ZH=$ T;G.3549G
MD2.EGQ-6+LMI<;8%AL62.=B#% /Z/LO"F24!G@[*!$X8.6W8=&Q9F9 50)V7
M<$4!F90C4OB#-B?YC_HX<,TIET_5DJ58>1XJ."\X5E<ZLH5*>(5!E73OPW2
M<XLIV!0/ZJ!;MFM/^)?R*7"D>)R.!2'Q8&[7Z5>&.%]-1IM.V&4&QH/LUSF
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M$QOA#F+)CM+E9<ZG/HO"6Z,S<QZV*CSG@<^7/;OU=D_T<?@V?]C49)AH=_R
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M*Y&WO7$ZE\NBA%;/J(/BLJ%<%9TN>UU[#5QR7 -/>@ W@ ,O'82#T,5-ZDG
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M6_):/PN/WO5=;X-MNLXRIW4GEE"L[9IFV%:A9;^MB&^EUQ;["M0;.+%+-Z[
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MZ/ 2IX:E*&KB@]2*#CB7#WDJ8GVIF=.8MH\58FQ3X$HAK4;ELJ: #WS^Z@D
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M,C&1ETKC<(E! U#C)6C_3<5FLHAQAW=$Z88L&_B"O4@GR4*10-@@>D>+)UB
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ML+KJ-7)0MYS'M[&02;I>*K1%>(*#]Y,ADPO_"%#?P;:2&E%1:@NG^:FB%7Y
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M?U9)Y]^/&7]YFT<5(*GR/-D'G.AN^[R/N\Z)+WEU<GZO_OHC]MD6>]V8HXJ
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MD'0)M!:I$&R+VSK6@0.VW= TQUSK7CW05Y,LDQ-S/>)*3?9)G:F.=,0+$7N
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M$99'X313.+B'A5*&!"@]\6)IT29?NN$FY#8Y)!AWM0)WD55$_X.'X*9]?BB
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M53&K(3.4DXAM3U>]\O9-E&2?J4*-7:2*S2DZQGFC UL\JV)0R_NMF-%#;F>
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M>NJ]ONR=O_2:+Y,FKG1TUF:"19GQ.BHUP$_K=Z/Z/*85U?YL=1MK$7P][(R
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MZS&TQ1C!93]Y6VC'L<ARC<UN;*(U)]"\>D=,*!16374B@P^-]T;.V<L RZ6
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MR@N:%XP:RKV'<_=:J9F;THK8W.2]#2NM&?K$Q]UHU[S3BHF)WF./7>??RN:
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M^UE:=W6(R&>*.*A823QQQS+4,(/E>D7&?+"NL,H5.;EAU&:M*"-8RD*8LK*
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M9+^.DVL6%V/K.N9(+OK"?(GV,"YS:ISH,=MFT]O+'O3;X<TR6_0<:!VS_3Y
MAHN$:A$:IK#9+3B:>_]Z[>3U0D4EE]M5+I!P;J!=98SFNN14>Y'\YRU%Q,09
M+E$JRFZXUDQ+,JRF$>"')2.E0;A-6=\0)74N-9.ZQ5J#7S@VZ'GDO&-]N;!R
MES] I*NK)6IL2*ZHN,)B;)5E^+SBZNOE^'1&A+TM&P.+ES4BY\@'9UY#4Y?"
MX;@M,I!;A=(AL]3I3*\Z$W1E=22S^:&"_*.G"":Y BD2=!'N](1]Y595TZS5
M^,($]I DC&150N6"D"=<;) $E=O@0ON^SMCPKG<38@.=K "\+_;.1=$M8^Z^
MJ+M]A7&N67MBW(JXT">8RSQ/)Z6];NXNHO/IU6(I2=\*IZP<*Y*3K*L^5=/_
MZ3BQ(RYC0JKMUGRN5\PK_-J\!)=DIOIUV-@IPZ9E?-"A](AZT'972A9>%/(,
M4)B"6GJ./O[&N&PE7>T[3&@+^HT,-7V.'TQX*]FE:>[5?2-6C_XH,309C .T
MQWI7N*Y7VXT_(_,4?]G\S,DM7\0F%800GR&T%%B7YW;0!@V&MUV(=U[\\B"5
M5V*RA'?;Y7C;QFZ5EQ.,ERU($"*.4 D2^':?4PT8F F"(&D\LEV0@ -A!8#G
M$6%;UV1F,V,>9VE_$1TR(W[IU&8M<@WIQX/T 5_]D4J=1W*G #">)6?;I#HX
MIG3<1'W/0B\V U@$YWS\=&BD@S)*B%$V]6$":"#,_V5Y3HA7SB2%S/-]HC=H
M!_)^&+13GO1I4.AS,99ET0<DPR%8<K8C"/<5/?A- >$ #@ 1 T1U_2-U)16(
M>MAC"62([L!5X25HB5,($--1K-1OM]=>-P)K81-B9W,=@G54CZ!R8K8R#/@@
M22!X!/,-*=B 1<%U88&*J5@+9U8*S)6*1D%_E."*VS56S0)]/4> '68(S+4*
MUM=4C14G9$A\Q32$[<)M!T-[:C>&9Q<.B2B-%Z-QU/-N#,8,0])6OO-G7D<=
M)4AQL;=:539]X=@3!H5-1\=IHV:.XRA1?S%$IP551F>&\5=*Q[98%]<]U=5Y
MXH)_]+5Y$G>'(&%VT*-4P<NTB'9D)]/(D$L&3^K63V;&CA)42MX%2K&V1_*2
M/D;C")B'(23V15GR94FB@O"W?[>8")QP':+8@+FHD<2!D@%5<<5Q(:V8BMS%
M@2C)"34!=",2DZ084MM5"+*H"%/TD&<E@P1G@Y)5A]-#:^W1/$S2D%,9$6-'
MD0"G'1-'6PI5<([H%.J()2$E:9)DC^+1DTQ8/96F?;234,87/6#Y:51!>9F0
MBZ; @$&4E.6&=' W7F+Y1W_)BS!'61^46=PG8EY2).""F.GU5T_9-O_V0Y4'
MY ]]> _S@ ]^Z ]1AQ S58B1^5(RY9FR8U]T5&9S""\XXI798TA =65%]U@\
M$I<^,9<N&0NJ*#YQ,9<Z>4Z]&).+\(4PTY&]Z8 :$PRYB9+6,A(@0Y2NR%WL
M\W@KDYO<!8R.-6F/A99%@SY2*'R?%VG !6O8QEZ3Y&$C%9KE*0^#]QFY<TB7
M)3I52&5O]6*A1FE35IVMI(SX!4;#:)TN.#J>%W>=DEB&8WML!Y7_.%3E@C-8
M"%<Q5YAB@DS#)W\*@IW$J$)+DIQ&*'L+MHIPZ#WFZ:'PT)_H63\3-R_J.6S?
M-PGQ\RPF.GCL:9BW$37@AECM:6J3P(4WHH+_OV&<MX@#\<.2%H(9.WJ3=4E8
M-&F+/YF+/WJ"(2>D#6A6<>,([;:<BX")@*%O3Y17[8*,Q2:1Z[B:)SHO>$@:
M'TJF[.!@9Q=_D!<Q9;=OV;=6D*@-X E16<I1,$)4[L%'+9$XV?57IJE+7@(G
M0.=:(,.2EF )>9>*F3@\&8=]9@F-6.I"<\J+448^F":'K+!?1ZF+\V=;(C9P
MDGI^9<HU_-"'E/F'@-@ F-D/0K:9)L4/J IU]-"9*M6J%U&K$Q.KKH.('GII
M"9>6D#6IR(.G8&%KSA1C2P*67)(IB=8L/.,);9<MT;!FS#"ES%E,AM"DKCA6
M.).ML[A'W=J2,E:M_S<9&Q#3EX+!@(+0DMEX9G181#EC.- (I]U3G8")ILX&
M4C!X(*+*K^:P3;=#&*OQ:@$7?D*S+(;&EI)$FD@3D=NYC'/U9-;F)AP'C=>:
M:U"34];E;!^Q64@TEFID8^O3#29W40GKC63V>Q8V46%':FO5C?A9BU[7DV59
M;6^Y;OV*L^( BK8'AB+S0'I!D36(K%<5;!H99\S8?49H)?P2C!"ICW[ABQL;
MG+4 %^#Z2IZ@I)CPA9$PKJEH0HM$DU:["+\HG%2Z55T[BH*W)&JAI*5(:3U7
MCQ$[;%M9-ZBFM).67H8"COF1LS@KD8DG32%9C4*X9;HF=@FG"_.J).KAC__D
M='K,RIB3FI'JY(Y7V66.%$=H^R WH+;W!URS)TS(IYV:D1_;6+(*"6_;V'LD
MD;"@ZE['4K'CV:NF&9=]6S&D:JJG&@^7F;OZ< [^DYGV<*N#Z&/ ^S_J8+RO
M"A#^TQ!!)HC!ZQ"WNKO&RS58QZMX\9"DIG.-*I^)9UZ9EX--B1YL"EM>5H#,
M %V]IEFS:*C0E9*_<9.&RI+1MZ.;8*C>6F9'>GCRZ[5:0I3R&X&CR%;\=B,>
MX+Z;.U8I EH(PZ*9YEC$Z9^/N*"\H:+V"88K5D2W1D>VRZ]$-']M"GQ-^'+Z
M";[=$'XL$G:NU[/.HZ:S%X>!0[Z_<X[.8*(8*EOS]5E895-C(A1FTG>$+B9Y
M2D-:+0M7?N9^B[.HXG@--8Q79OAZ2I61:=F@G 4R!N8('"RJH[>?P\I>]B;%
M]DI>OH9TX^7 M;>%;F<U3-RIDB" )W0]B&&<@L"_X3H2.&#'7FC'=@P4RRF_
MR_F;I5 <#-B^#=@+"7BH#1A*?&RHRTFCH1"_A8R3Y<=YBAI\]FBW9<8^"QMW
M(5I;<H'%9=JR$&PUX-55,&I];EHY%WI/+F.)KSLMZL7"J%<[-^Q6A!52YQ)Z
M*UR&#%2$@5&;90LAN-?"TD8]=:2,SLBH5<'$Z_9:FG-[)BQORP-TKAMR181M
M(-?+_S#RR;NR#Z6JJKJ[O*G:N\?;4I-Y4L(;$.5,=<FKO-%KSK/*!.P,SO5
MO>J\JL@KO;3*S@\G+F0:LP1G>RC!IZ&[F)O"CZ<EK$MYD"=Z<Z?K2EJK7>=;
MRC-GG-;R*-=RM9X@BVN1)_I+;E4AB\ @"399>?_!7(.0)]B*-R8QEZ3H)X4
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M"Z@1^ODR-["(3\2:5DQIA1M@:50]C)H6!^[!4PI1RRPEN0NDO3Q4WQ.D/1K
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MFZ1@HKUUU^$=Y &P#51T]]H0*RNQ75E) "M3Z#@PULHW+%(SW LPCH>#*A^
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MNE1C@B*FGT5:\YK85*(J/;:\3#4H:E-)WE%>%#3;H,^9KI'%J>3SC+Y)(W$
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M='1[P4D#QQ#^$X+,0V-\QV"KY7B&=EM(!3%45F=($QH:Z'0>(S]=]QI:%D@
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MC0Q)T*K'Y+6.W1M?&T<<ZZX.^TU1!BY!)LM<O#>\C'LR##9MC4TCV<B(^[>
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M40\U[=9/UYMWG'P$);4FJKB"Z4C#A(B_F$M_6Z\CO9U@,M":&V1-7+03*]+
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MY5H9Q\TAK'W'F.[!L8&>2VEQ2,_/@^C%ZH0E'M2"XY:T T06OFOB6&GDUL"
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M4EA[L$=>(P0@[1=E5)=WT$55V8->Y\&!=Z@3LX9U V)VF]& ;_AHR()IK*9
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M2_&-J>CI+:F2>LT:Y/2YZXCNX(YXKUH%4TY*(RB?N,C95%;"M/"=867!,=N
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M?&$RF(AKO$>;*52G<J1E#QE!0>$Y,HD>/N6<DU"9E\D44.28)($#^\D.CE1
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MQHSB6&GO6)ONLXL@IJ;9Z)YG24S+='GR!UC,>:65:A#OM9S>A97MMYX1HJG
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M];7._PTN9 :A44H+&G)HZ#NPP\+$B?69V<EA22,BOS+8(\MZ>QD:JYD]BF/
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M@[XE'!=PB:,R&R<4!\+@ZYDMJJ=)6DMY^EUP$G:30T29.(*B2*$HH;,Z2EC
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M=K&JN7D_)^-[^>SGAHB$0M0H5Z_,G7)O#:6)+&JKK\"#"Q].O+CQJPV2*W?
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M>"YBO]0H7Q:;C&$!);,W5&WY,^39Q;;7N*1+5W83OD;_>+U1.(WODI9=UF"
M++6 1Y6%RL# :Q0G0DYP^"%JG,GU4$FG>V#+-&)@3(V\V9^<8XM3M<1F+"V1
MNU5FJ7*&/,5-S!",2Z/X0HS+*2S^P*RKXX)C]JDL"Y^;)K[I5K'LBZ'%]2\Q
MHE=/J(>DH,G.' \1-%!/^8C,N;)9R*"ONZ.&IX,-^KQJVL=R*'3ARLEBBJ]J
M6,Q]F;;JB:Y>O!^43,[U2XRX)\GK^I6RZ3]L$89S\<S\/ \<W,%$VL)&*34D
MZ+,"#:5(BX$";= 9>*0+_<(V.R3.T,_>0$(/DL<R@LJ^N"^(J1_3U+LBZYA*
M]&FK1[_\VZD'N'2G%\6#MDG-_U9? K:6E+6%B8,0EV>_]0M2%\UR;17..I2C
M(M1L0&RF[YJZD/7#-@TLST#13)T..<PJX)FMDP-.X])R<=F]7^E#="F5]9JO
M$YRN%9P8)9*#0+T0HC/2L;H1Q0?+>QHQ)AJZ[4R-Q/MWBP?!;=I55G6F3^VZ
M]=EG[4*#\VQ\33W8XS#/VAIC[=B]E6NYV:*_:U+#X1G'O-PKGO!UO9=.C!RX
M[[B[9,&=E^W8/!2G*4?,42U0C"PM89W9! :_9B?9Y0J[>[DSA#W;X7"^6HB5
M4LFH?2U[K%V+80VH\QNMD)R]*TNNMVI<F&6W=UG/QEW&=ZV6,(K "BM\G_6B
MD1V'P!& -%:MNE#903R-H%K%TLY)5O^T7=Y<\V\B?&\#_<$N',+6 =$'S;14
MZG#Q;9-8:H'6E<(X&TOS\@N##9DRE(8_I'K,BE74^PS"2+K82W5F)J=4W)5_
M3&JU=M74S3<PHL!@]MGV:I5Z0]I>=:B7?'L0.VOSA,-9R::E-EA.3,#-N7O1
M/1$Z%ICF;=ZV6L]R[; #O)&GVH.M6MV<&KI<: R*DQ]"?#![17JGJLC^NVC-
M>[L6=K7O9&!#?'-I^+\.6L76'(OXV:P^N&.)^$'>G*\I,>/FG=B+_5BWK(2T
MT2I<.VDM<N8>[N4?#HU?6FZ6Y=F[DWOD"*@"N.00'KE#;'J"NM$4?&/LB+6.
MG%D&*[D@+KC_^'QAGTKFY3V>OB?FC,:]KOUNX3F?F^/&ANZW7IK9->RFA%R_
M+4KE0!Y#2%[<>AU@@+V[J$=X85N*'G98W0R2Z)EF!XOD-]+@J@XODC[C_TP<
M,SF4^\T<[W"E]0W#Y\W026O?\CW")*S"^YW>1?(9@SV<PXG-&EO5V-E3$ZS(
M$402C L4N6F]\53JBQ:ML?;2LJ'=LBK*9#O*4^O<MZNR9A*$ /C8;AL[O([A
M08?*O[PW_7+6X0(EPY55<-DS'78@P3[;$K'%X[S7N4B\J6VVC"[E&D*W$WOC
M$269X_<_8(2_C.W%-ZI3HP+GNBZ>TZL\0_[CX%W6%>;B=9RRLDC4_X@>\?+Y
M\54'=(?S\(2-0AH]ZFQ)?:.(SK@7N\DKQ][,= 3BR_O"+W=;K].ZV/LP<S>_
MW6]:-*F-P!T!4'GYF(HIU^=RTT;O+@(OA5Q"\R7.[==9+;$3V9H-]-EN(&0F
MTVIRHQ/.X^NJ>:[9]NNH]4:(NI3MB6PMTQN2Q5+LOYKZUMNX[V9)9')\8;$W
MM]K.JC,*#(S9<YT'U :[VYQ"][0][,2^W@_G@ \(#_!]T-@U[3P)[<RN@<>^
M<!#-5,]$V"O-FAEAS5<+V0^;L#_-P/#9G.Z5SC"'.I2A4Z"\8WX*TVEJ/+6:
M=)/OBV1-IM>\9#0->@:L(_@<FA]KVWQ<O?^!?L8?ZQ(F8:B/(/IU_Y90W.Z+
M*6GKEN5@W:FX4O".I>G96Z:IRU>L1KZ 4--34T,R.$B(F"BX:,A(R*CX> BI
M2+DXN6CYF,E)Z8@8"ND962B*2>J(>;G:"HIZRDE:6IFHFDFBJ2O*:]JJ^WLJ
MW-F3*WMXRZ2\S-SL_ P=+3U-76U]C9VMO<W=[?T-'B[N'*RKJBK36MQ)NTDK
M>,MK//C:DUY+7'/?7CG_RW@+EBR B.+ERT1ODT)VH>ZMR_?JW:A:PQ#:LN6.
ME:A;JA"E:SBJ%SZ1^/@M;"1IXZ63^RR6Y >/8*>(OA[2@SFRIJ]''7/VZEEC
MG-"A1(L:/8HTJ=)6I<T\.:28*^'$7HJ :D3ET)\DERM=SK(4L&4H1P%C59Q5
MRV YB:<^[NR*2B"P24#9\3,FUVO&8W'W[D5+R2RA?2(+^G45."ZQJ(JOSOUK
M$2XRC"4EYX3_Q32SYLV<.WO^++2!Z-$.2I<6#9J):-.F1[LFS;HUN-6G7]NV
M77L;[=JW;R_;[>"U-=BL>Q./W2!UMY"$E#M_+NY=K(MP.65E?E:1C,",\[F#
M=*^EV+4I[>H#"S!FXIWMNIL46/?[=Y/=KY;7>Y&K>HJU"!^TV1=S>:'UWS&,
M153>39'@M9)[8^4EGSJ,35;*= I6=Q* @ $#78<>?@ABB$K]4PPEUZ6'6( +
MVN68=71Y,F$_?6G5&'F5O<@?0X7P1=5:WMU8E87[Q63@@X,12>1-]E$WX'WN
MX 4C0O4! Y9')/JT2HPX49AA8WBII2$GYPB&8Y;Y#2-8#R*NR6:;_VZ^:9:#
M5!)8T90")>@>@8]--9<^<S(YY(JL;.>GCI"Q5QU/ H)Y(XO\K6<GCB3=)Y>%
M<CY&XY63;14F386IN)!&6FD9*9E+YN@D3*G^F!ZEH;P):ZRRSKJ4D::&A. \
M>:Y3Y9$EZH7@2Y)<=VNH/*7ZEY* 2D?95V<ZFQV69VFRZ[,#/86AI.@$J&&V
M\$7(%RG56:4M8 =:9B8K.+4'Z%;D"NLHDU.^0FN]]MZ+[S6X%9><<@W$QMMK
MR/4;#G#&&>?-O_P>3+ R!KN&C<( #PQ<;O6VDV_&0^U53Z7B[K*CE<SR*9,O
MNE9883U/7;9B9(3$]X]+Y 8IX$'.EN*I@/\I!:1CLQ6)O IA!BD+\\>)^(=2
MH+_Z\A2#$.:HZK'?XN-6.2HQYY]4ZO0IS)B791N5QF*/3;:(6_.))I*QJ 7M
MR_K=6N"G&;UKJ2#[#*WSC3D;5+1YO-Z-(=(P'W82@5ZC$NQ/::/[4,]/#W(B
MF8?/YVJ\;^/RZ9^8WXGHGS9I67;HHH^^F6&-4EJI,=BFF&#-A7G:T]J)-?[S
MV45ZCB*OE%$^9U=7VV[TBUW&/)U>*Z=M47<Y:Z[UY>^4>KHY$\5>\Y93NQXN
MNB6S1;S./3E">OCBCQ_.8E9CPNC(/$Z4_4C4PV-9L.Y#DCCZ7='-M8J; WGD
M/UE))2=L(0UGP^C_F& B4A:TA2QK^)C9E0C(,GN,PFMG29_-M@>97ME/3+4#
M65K>TXB1P2THY"NA"4\HC7VUIF&I.<[$BE,4TC!,AN*0&,.>\;#1:*-B+QP8
MOMR!0O%A8H#' Y(_OB8+4&C)9AAR&N+.]CTRQ2TNA)*BH3#E+/G-#3\#X8[C
M@G$N$:(M4ZT+%'WB=2K?30EYL&/B [NF'B@A3UT'Y%;W<!>5/)XBB'SL8_@B
M1"$TKB]J:?*2C+(3*;9);7]8<AXM'&B=9$DH2ME"%N[@URCLH,J#AWE)$946
MP:E)17?,>IWCTJ2KXDG12JO:RB.J)B5'@:M]&_*C+6^I,>LE#QD>61S5GZZ5
MQKI0$E?"(YD8S3@8DH0K>*Y$7I*:! OE81)QF[IC@R ($RV-$#WK^@3-WD*E
M([;+9A\)8^?6,RS?-;)8[,%BDBY5QF+N*1BXK*<]966U/&TH6@^BXQE/418G
M@NN;W>)>S JU15M!LE!(\Z;;O"@33MUI0DX3DH\&&*8NI1%&ICJ9/%K5K/ \
M"E2]2Q?GBMG/>982B:!<F;#$>4EE,?_BGC2MJ4T3)C&*+66&J"&*PGJS&1XN
MC(7V&LE-?^A!Z81Q/-32EF.TYDQH'1&= KV2.2WZ/$#BRE5%V^;UYI48C"8M
MD%;,JD3VB40)OJR594(+_G+B1#N9CI$%Y&?G%+,8N7E4)\<\J""."MC =D9[
ME?R@/\&YUF9Q-*9?(Z,F/AFG@1K3;IMDE"07F30W:DY1JT2H3M0:O4+IAS\J
MPQ[?)(G518C%B6",FD'3%KLP*JMR:GR@4_*&RD;.5+"\[>U1<.O9T,YGC4E-
MK#BU,\4I9O25V&L1!)?+OTT([7=TF>.>)B7*#7J,5?$0IQ;;9\G-=E*RC)7/
M<;LH6JU%L6?_ZYEF<I4)U::Z=A"^K:]]RT>G31HT?Z1P:7K/5EOT%+) 4/-E
M!R_;NO9V,F^C/:ST&FS'^#HSLLQAK>+@6KGU.13 F2S0\F;"L7:,YZWK?4_F
M>)E85M'WOBQNL8M?/+YJPCA$ VD9X]BUW3?FYZ2%O9GV7#M(+L4RGNL:LBLP
MZ+%HA?.@3Z66Z0@GEVJIC8M0IC*32*G.FQ&XH%L.X9/?)8M/?I&@/UKQC,_\
M8OJ);&>,8" '&;)$A<CU=-!;)NV@^5'::?.9#$Y%FTT*X=:*RKWCU:]GE_8Y
M]7FEQNI+*9#EYC)Q396DSXR3N;HG9Z5*VHUYQFVF*FT(-(NZQ8,6_]0IB6LD
MS\8H<YCL8)22'$*4 0,H56PN<6U\99)UVEH;4K..HVDT=X@4K:_<BG]+O31F
MSO/.JM(C@X<'EXXMFV5#0JZ?AA?KDBGQ*S!]]5]'#6[?#GAIPA35D].Z:BWG
M=[[8FW(Z$=LX2?D(RTA2H+F\-4M"Y6^N():O-5DK4HV"DJ6C7;1FXXBF2;=;
MRX?Z[PA['2:&AM) L@RWQ2^.\8Q'!Q\:_\S1*-ONXG$XV 1W;H:YK=W9/C3)
M)^-OE@K"ECW/[\2WWD0"8TW=^$VK?6S3ZR!SMQ,P1US)S\YD73-[0<V>N)T]
MFC=IO=6)CDN]GC<NY*0+O7 E'U:FD'[@A\X#G2%(7C;'< .*PN_BRD>2?.2>
MBEQL6?&^LS0-<BF?7]#ZS+%,9W'I>V(J8GDN$IY98MB54>34#^]'Q=Z'>F N
M\ZPM:NG.7M(G7]HH1X#W9WC]0MI89>?(#U*U"9>TFCC3%*Y+=BJ^'&B<S4.R
MSQI5[CY-\[MXNR+O5NIC:T:T%HCO/0K5X_<KIO@[5G'BW3+[7<@/'_50BQK>
M+ @W!DH0M+HC.D"QR[T,N93?EAFP6QS353Y;UW;(;=[8,2MOFU?]?(F!9S_&
MOWLOHO;(E__PO?WOCW_>:B3_2(&R(G]%>JRR+!543>'Q%]LV+4(28EH%'EE6
M..?!7O\7<I1F9,?T'=M74;M4,X2B%I!4/W!F1#AF8N01?EMV=9IG.7,D1V_%
M@0'2<Y7 ?S$X-C-750 "2%+F4%:T-/N@;Q"V>NR"?8UV2$QG)J-@@, &-LFB
M<.B$/G#V";W3<K?W;K\628+$?+8U<-T72A:D2\IG9R"T8'#T,;8B:Q+%"S*(
MAOE21DU$(I>"7OIU8S,B>E)22&P&:W7H9$MFA7Q';E#!#CU(9O6V>-^D:YK4
M+G)4;2<%@?*C2[%T00QX@.71@V\($2;5$MU48!.WAG]7?VGHB;3_PF/>X5B?
MQTY6-&Q:)R/GDTS_Y2.+5E!1Q66T5%V'V(#L X$1-TQSF(NUZ#;,\SA^-7!@
MB!7Q)48(IC^0YQX-M62N]D7-95NR0T*?*(W32(VPPA_5" []MGDMHH3&E'/\
M=17ODURSF%; HRZB-8X:J%N$M8005W28Q'GBM4[%=V H.'\T@5E;UXNZ<W,[
M6#VG1AD(&'2$M7SG>%J;='12@8T+&2*>)U%IX6"_,RP0J6'+1Y'K2&VCY(TV
M4CNS\W(OP6[I<WVA14C5PVI:.$UP<X[5-X':*!F*M"U24X)FU3<=Z1#'US;H
M^(6E1W[2XFO1R)!!Z1QFU9,^=CP".4O$_[A8OS1S1*A[?+=(\T%HIE<2(JE)
M>9<*/Q:.6499&_%:6Y-!(/DDV-=D)9=7!=D_8Z%\93EY@0$XS4(6IJ9NU/<T
MD""4=ZD<1^=7KY@Z]7B'V/0WUO*2D[5A\/<>AQ-DL/9,_<AC2O203$B!A2E,
M+G,AF05^%-8UIM-R1:27<]*.,W.*3A-[I#=7UE>.B 92C/DQ>,F:K>F:WJ N
MKVD-::F8@+D]"\*'<T:&1,=$@],_JS5(CIDRYH-KM[:4'&E.<KD?J=5,P(:)
MQ]AGA]:6 R*,O%A[!R=KQ6B.Y4B;REEE]":%*B*;XSDBI-0V)TF.'6D]S>EH
M:R<U*14+M2:7J,^S?:GXBZ]P7'/&7L*UD>; C7ED6K1$FB&SGH5'8%^(77R(
M9UX7>3LRAO"Q"^*H@"\EAH5!GA=J%)D8BCZ&@X4'-(YV*K5FGO'D%W)R7LLI
M+PJ6B)Q5>P+V)Z$73:NT1/KVD.SV=%0HBMZ9=2LW?D)R<V&V)3+WF[J8:JMS
MH.E"CV2W'QC*I$)QA2[*A@9W$&)'/_T)?X?Q?0)U=H'WF TTH"M:<Y16H\:R
MF'/(;,BBFF7Y.0W::\)HAV_8I1]:A(;8A3H9EK>SB%OD-Q[ZFYC_T:1_"JC4
M:(3?%JC*4))VFI&XXQ]%(U9U!TZ65F.#@C(#ME\=EGJYE41DN$R99R.LJ$[F
M]V L28JVYZ#?-'<^J7D.Z(I-I2X(= E,M8EZ<@B$IR,S61[X.6Z%JJO8P)7J
ME92E:I8MX8;"R5+<R%?KQESH**>MYGHH=E><PXB]"7:?-4G0Z3)QEZR7R'!P
M"7)^B9KSX6;M9)F5\#^:2%?N@Y4/Q@Z^R:I9::E N:OQ"@U;1Q:MU!$UF%V&
MV'"H\XL4N:PD%WNGA'=<<Y#NN*D9!HE)59IKI(QEFB.TJF+;.E=@(EL<II$(
MFV(IB7-:.JJYEX 9JW[+)J\C"PU6A8HA_TNM]]J*-JBQJM22'RNC\K).C-4H
M#5N;=+@U5OD/[#IV&R:@)NET7V=G+UBBCE>1YW97\K"5V[B3H!IIQJB1)"NU
M4RMJZR&O!CJI2>MG8:BO*2FD%0JRD0:!@GAD4RD*@)A84SAYU6EMO;JMKU"?
MATBIVM%ZQ8,MB-A+(R5/NZ=I!TNGE"*?<_%]:,F=*ZF=2N>+0\A[5$NU=G26
M*(H38N:1?&ME^2BPIM0C5*%/DS1_STE^5U42IQBZW>FFD2)F#]I^!(E%W&0Y
MS_5(G]J43F=&=QJK$PJ?R[)?XP4ZC#NU\OBZ)%6CLO2V5-5T"9HG@9LH(RJF
M&$FT+_M2Z0FY+O_:,O6VHBO;9;/GD5I9B^A 6]"T8[=GA/BF4ET7L]=TI\)'
MMT6X";S;N_LY@ 2*BA?5LM:;>=7$CRFU/"BIH-LZGX1T*7%&</+FDGL+O?9X
MHQ8+O*'8=;00<. 1@3_9MV:(A(687P(GK>^HIY+ OAO,P8#%65>KD7$A="O'
M=MM)P=O5N3MK=0N&PN9SJ0Y\;2V9G483$3:KHRFHB@M1K]G97HLVPC/R>BW[
M:4*6?9=X"8QX/V-*$V=78NAB61])J!VLJR?1-S-QGFF)F.!KKU#\Q%590?\H
M9YV7J#/KA?N9NJA[HD!3D2 EE?T#>.MV&,]'Q%5AP+4:OVI)LSR)*%^9*UP<
M8;Y6F A2'*_OY)GJ2VP^ZQC$LC^,<D0CYDQ[([Y=V#3E %D$=J^2UU$[1Z:P
MZ,#\9KUI)U918;,+C+[C&VD5BPMWL4P-&VT(ML-6%BT1(<B[ZE5<9,=FB3J2
M4YIP7)>WZ;(DN$@=>"C=@5%&NFUO1K,BT:B(7!,4)6+1^:N2-ZXM%V$'[$\-
MPE;ZV)C<]I!^K*2%>3T(_S'+XTS.)L0A(*Q)^9MKSQF.IM9D7EDG\$S(JNNQ
MSAF+4FDLG88GO@90-?+.[V@H<E558(87L"1[JRA)'[@JSP)S\78_9P51$M5=
MMV.>*-J>Q"E/ ?@7Y5RH5RB )XF(.UF=A*+(.*Q0><LZKNMJWRI*C$%X]T'2
M.O:# <T^#WVQ?DAM><JLK<P_CZ9;[LB$3OLS_C Y)).?PGLHDF578SS'H<;1
M@,K.<[D?,0D7Y12$!RJJ562K%'?(JY=H$3MRM-NIW"3/BBFI>YN#-X*VS8=B
MSBJJR3:]!OV$=3M1[@52R%HWJMILS_BLF@JAYZ<F3_VG[[6AA%TF;EMP+.NW
MY?^U5PE%H'"(N+!KHR4U92GRH+Q<E^$U2O_+)<Y6;-'C<^$;H-K<O^L<'_II
MN\:IO(>=HB,GV*\-V_AR#"3K<DELK<<<A.-&N!VK2U1*+N6JI+-XOU6JK%,Q
M'FTQ>@X*;TO8CN>;U".E$--EU\U:81"6H,6%S]0=A\D[;0*H>L]-'K'=I+F7
M0)ELS3FJ-_N+V(C;J8^MBXD-EOX)V9<C@3W,C!M5A@."K9Q:U%/)66"=V;X<
MX"2GI@#\([A*3?9&2/6YON*-H5A7Q*?IKU,1TF_%W59*K@@Y5N;Z.R_XW7#U
MI*T%WX+&T,#+6MWJ@M>\E_JS4DA[J. ;UN%DF+O<.%;_.=3JB<K>U@L.CJ%8
M_-^)Q50E?:LT3J$[H8QC2=E+N[P>_8 CR153]24#T<6@/6_=]KAD6=?CA&'N
MN3U&"MCO *->BL-1V;4'1W?8M*?[PVKT&]@\[N9OWB'G+*\T U_YA!_RW* ,
MXH;)!N&)G8ROYK+(#80<F;6X=S4GF]%>UH9 /#<]2N$DJK<.:71UW.BMP(&F
MF>B%;=O"Y].#3@IP+ILZZ&^B_JL:YH;\"<0VJMZR>EY$\\ _.27W(-!M&H")
M6,EC.Z.C6[,F%]_#A#L+';U11HY@38PH&Y9#O;P:I'@P5=&T .JO.>#-MR$6
M=I5)OG!&YL14#.Q$SK^DZ=F);([LBKN6[3V28GRVC:6 U'ZX1\QHDNHD'H6M
MK5>]1FS6]@F9LXM7G:7;C?;LK@F9A26J*,>AJ\K#AI91(8WM@*:>W5W&Q8O$
MU>Y6J:;#;GU'DVV!V G+$U1'(<R25^I8]3CD3+O.,:Z2&YG"9O_6[RFO\K^5
M$E);J2 7[2Q>ZMW7ZF=7<%.JUS<-ENW(WA0ID+0^KE2(BLG7R[[T?L"5-XZP
M,A*JN.PFU+*+LAR^HTG_A(IVQ'_A'RO/FJ\SH2I+E'/L*X6(QT-W@D+H66])
M3!^CSEU:SPI*B"D\6DW<T[L@??)84#S#U\^*3>\BY%B=[R)OC!_')XPIZ*H(
M18N#%UJ/E\M(K1GNM*X+T4A7.*RDI$]<]M#FO+5<#H('P<;:4%5%W3%7>M^I
MM1+6R ;?M<ZJH6ON=Y,?W\US;-;.YC0BS=[F4@:A^'<Y\Y$Z]3V+<W;Q=;"E
MM#%,B6S%9,!:8FZALZ>T.OVMO]TN)TC_CGIO-<%/6W0/;_:2< NP.A=Q6:SN
M+?EV__?D\CT@9%NJD/OIK_[;@-)2FVF0X_KNRM/2#W789FH__[[F\;.+CH(5
M#P@]-34R@H(UAX>#BHF+@R2&)(B.DY65C)2,DHV6BHB2EX.?AS*/AZ ]FY:3
MG(N0HJ&LJHZ;K[&&IKFPL9^9L)B$K;B9M:*1HZZ.P)BGK)3&EZC*E4S5UM?8
MV=K;W-W>W^#AXN/DY>;GZ.GJZ^SMZ\G/C9Z<P\ZKQX*OB;:]O/BQI6KP&U0J
MWZEZ"/7Y2@5M6K]4P^C!6];0GT6&PJ(UC/@,V;U^O_C9DF9/V:Q]"./%DY9O
M(3%[&3?.ZH5K_YY#C"O]Z2/)<2-,8RP[]F08JH>[HTB3*EW*M*G3IU#5*;(%
MC)#'6S.%/BI)T2I1B"H[^?QY\Y=#JA6KJ@5:-*P\:!+%.L-I*6# 4/QL:FTT
M<V9<N1(%!3R9"QC:N: JW=5;LZU83:MN/2:I%;"C@'\QTRS[]JV]J*!#BQY-
MNK1ITA.A^57H\9\OR\E2!EM52*#LKG(W9ZP*F/70UVT'UH,I[3#DM97E&K=-
M,&9,JJKH8GWIVOEALH[G2F[>5OKKKJU":>Y._?O+UK4\&SW-OKW[]_#CRY]/
MO[[]^?'NZ]^?S>W9B'[MXME/@J7%'&\#(M<:+;L]Q&!#F*$ESV*3H/]B2T',
MZ<),>26-]<IR!IDG&4X2L0;7-.'5DY=+%64W#V&4R0-B>6]=]T]<PR''%WAB
M[411*YOP)^201!8IY(D/'AB6@0[EQF)@ OK$T6_S4!C373!1"!PG'ZH58%U,
MWJ;+DV8]5F9*8'E"WDA<5;9C62[R8I%*A#&&UD@]G:FA:@TJAXM(2V(2W5BW
M&&GHH8@F"E6'4XH(I7J==/G@@%9MYEN&E7Q9E%UZQA9AB'3^1HF-A8T58G@C
M:I>J,QBVV6:!]/#D7V)4 H4C06:EB8B6J.(YC:RN/+=KF9>6&!AATV#))6.B
M""<0(HI&*^VTU'[S*Z2P*9OA<[<"!^>;6THXZ=:'Q*"$J8*PZ67/H&2*B]6/
M[?ZE9HZ=(BABA0IJ*PRM9BVGD2XK$FHN7:#>"JHL;(&TG;&F=M3_2;401RSQ
MQ!17;'%4YEZLL3@'3]6DO\> -(RS&YHY280JQ70OP4AVJVYD(:/IKIS.G8C;
M5,T(&FMD'^766*!- KBSJQ]A:[3 G2:<T\O^SE;SRDO"UC,N&U=M]=5(X;R=
M@^82U[))*4:)XKF)\7Q14$C3FW*XZ2[,79X./LEO;)F"ZYK/<*[JIML/(8LK
MO'33_1?14 K>=MO,[CU,;62-_*(_6$<N^>3@($F+3'S_:]/-96KW%\AU[7MB
MJ_*>>>'>C><=*7!VB5EVF,^*G.1:ZKKL7TJ:LOWS+B'M_#-DJ:LL,Z.)C:?U
M6 4%=5RP;#4Z">701T]YTIO=OMWI7OL^_RA1>)7N&/?[K!UUC7WB2^97]U 6
M)^::D#(F^H?KREW0YE'4=(,Y!IA@X"S_^&7MCJ*5A5A$(/K!#&JK.H3T%LC
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MLIFYDJ C:F*CVJQJ0B,GT0B(._Q:/ZI*V,(RPJPGVN"05'30868Q2=[+YN(
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MY8=8V3O6[]SS:1?M9EY1C(FV9O.;56MR._^7TT=^>+")N+&7G;G3\IPHM=?
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MO_G/C_[TJW_][&^_^]\A#__XRW_^]*^__>^/__SK?__\[[___P^  2B  TB
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MZBDW)/*(Z:BDEFKJJ:BFJJJ@AW[JZJNPQOJ+HZO6:NNMN.:JZZZ\HD!'IZS
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MW*C [,WIK,X>J!5.F3<&839OU?S#T69,L5S-]]@I]QS+.U+(JJ'/F[S/F#G
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M*0+6?"(6H402G5SDB#WP^&;CC3CFJ...//;HHS\XP2;DD$06:>212":I)&I
M+>GD-1/]*.645%9IY9589CD94_I!1^)^TT44TX98(;;>*>6!(AV XWWW'YMP
M3G=B?O\,!>:4@";9IZ9W Z+XWI]8R87?F\M]B9*=B[2(9YPITH<4HHR^-"B
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M<,D@<B":/RGN1S,HM(4B[\G2EKKTI0*))#QG2M.:VA1)VKJI\AH*TY[Z]*=
MS4R;UNB=A86P7]_<*$2?,#HVZ_1#*K<$H&-LN3-#\E2B)!OH52N34FXZ42%D
M$Y%R ')(IC)S5D15Z=P4:DU.LA&1F/G7'E?WNJ#:]:YXS6O>EJRAT[[Z]:^
M5<<[ ZN-N>KUL(A-K&(S.E*UPJE[1\TEN80YQUBF+( QR<U$IP=2Y_13GYMM
MJEGQD;O1TA6@DC'ME0A:V:(6<:N+C:UL9]M"X1'VMKC-K6Z9D<G=4F.;M VN
M<(?K4W"J]I5V8BEPB<M<+(G/8Y']*<<RZL_F6O>ZV$4:#'W+W>YZ]Y(X_&XT
MY)G=\IKWO"J,*'K7R]XI*?.X[6VK>N-+W_K:-ZZ?<A&O?O?+7^+UEK]NO:^
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M_>1?_N8/+=L?@<P9_<2/^QZH^^<?__(__ZVLOMR?JNX?-?G/SQ>[_H#0(-C
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MOW]S_*C#/[_\]-]O?_[U[X\___KW#\#_"=!_! Q@ 0=HP 0B<($';* "'<C
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MKTG'B_,*HL,ZH>C*K\K*=(;Z#,S:%ZK6+@R+LSFKLSO+LSWKLS]+C:FS6-^
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M67#8S3PL/<5G:/H#AIY';>V<JTV)^<>]*FRHYTDHY()IOL\R3 D?*X+_:!;
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MJ6]AI8N,E)IF>9ASM 2&Z6*Q694OPBMM\Y]0YG+19TZ%I)0""BK5=PJ&B7P
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MNW /LIF0U:;NL_FGWXYZ),SC''+\\L]/?_WVWQ_R,O\5[\]___[_#\  "G"
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MJURIM7VK8@T5N>ZK7GV87OH:OD'ZE4<J)@?<KN J4N(:EXC$4C>I)LO*1O.
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M'NL6KKGE,8)_2]WL&OG(2$ZRRY0JW28[^<E0CK*4HWM9)5OYREC.,H/XF]^
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M>-?O>?-TU'O9U\_^]O<0F5^/O_SG3__Z/_/:[L^__O>OPH+#O=7A5WX(IUJ
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MD+">,Q-%R+)5JI2@**;BVJJ66I&@Q4T4F*;1^DDRJV]M]V9;FF>PN1EC.:N
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M>NNNOPY[[++/3GOMMM^.>^ZZ[\Y[[[X5_PY\\,(/3WSQQA^/?/+*+\^\G($
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>iclr-20231231_g4.jpg
<TEXT>
begin 644 iclr-20231231_g4.jpg
M_]C_X0" 17AI9@  24DJ  @    % !(! P !     0   !H!!0 !    2@
M !L!!0 !    4@   "@! P !     @   &F'!  !    6@        !(
M 0   $@    !     @ "H 0  0   + )   #H 0  0   +0-        _]L
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M5W6$E? E)H,G1&/C\2@X161E9K1&A:7$\D=VADCS_\0 &P$!  ,! 0$!
M          $" P0%!@?_Q  ^$0 " 0($! ,%!P,% 0 #  ,  0(#$002(5$3
M%#%2%4%A!2(R,W$6(S2!D:&Q)$+!0U-BT>'P!C5R\8(E_]H # ,!  (1 Q$
M/P#JD
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MXC66@3[3)OOM_P 339B<1S35G8^CPU5UJ2J/S*@ J;@
M                           #(UUIS^T.;V^/XS8I@,7X>@Q-:%M]5)+'
M&KVOUHU1'9H6@[2NSGQ=.52C*$>K1R7D#??25LW*5=^1X)7I*V;E*N_(\$Z^
M/ ^1\$Q6QH(&_>DK9^4:[\CP1TE;/RC7?D>"3QXD>"8K8T$#?O25LW*5=^1X
M(Z2MFY2KOR/!(X\"?!,5L:"!OWI*V?E&N_(\$=)6S\HUWY'@D\>)'@F*V-!
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M;O*Z/K<'2E2HQA+JBH *'2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                               ,QF
M                   !F           ,P  ,P
M          ,P
M                          ,P         H
M    S
M
M
M
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M95%GFCA\^R=KW?BY)\9M&QW>COENBK;?*DD$B;R_J4.#6I%'&T:[RTY79E
M5.H
M
M
M                                          %'<14H[B!#Z')F/OMW
MOOWU)\9[J+2'B>AI(*6DN>RIH6-BCCV$7!:F\GF.P>''WV[WW[ZD^,Z3P,UO
M098ER3^HP?-M.R<E&*NCY#"8>=?$5%";C]#0'3/Q=RRG>\7@DSYHKJL/>M/^
MZ-U:K4ZR>\:6YHSR3#_K5'[HRC)2FK(]#%X6IA\)4SS<KVZ_4S',^KGA*O\
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MI&@E4ZD)TSI_V;W?_I?.L-%Z.L.LQ/B6*BJ=^D8QTL^JN6;4XOA5#>FF=/\
MLWN__2^=8:NT!U,<6+JF!Z^.3TKM7W'(IM2=J;L>3[1A&ICZ<9=+&SKQHWP[
M76E]/34$-'*K/&YH6Y.8N7'VS1&$[A-AG&%*]<XUIYMSU#<L^#K9/0ZN<O!5
M3D>\KSUQA7+2;^ZZZ1(>WKOWA2;=[D^UJ4*,J<Z:LS:FGZ]RQ4M#9H7:D<_C
M\JKYMK>)OXV7P'AT/X%MUTMLEXN\*5*/D<V&*3?:B)O*Y4ZZJOQ'CYH"F>S$
MEMJ?,RTNS7\%ZK^V3_0G41S:/Z2)G54\DD;_ %]=7?M!^[3T*TXJO[0:JZV,
M%I1P!:8[!47&TTK*.>E;KN;$F37LZ^:>Z1_0-?9J>]RV>156FJHW3,;YU[>/
MWT^(VMI&J&4N!;X^1<D?221HOW3DU4^%R&CM"],Z?2!0N;Q01R2O_$5G[0@\
MU-W)Q4(T,;#A*USXZ7\NF1>?6B^:82C1WHU@OEKBNU^EE<R=,XH6<'@]954B
MVF'+ICWCUHOFF'0.!$RP78OO&#YMI-23C%6,L'AH5\94SZV9BX]'F'4MD5'/
M0[>"!SWQ;1ZYM5W'Q*ASGAB!E7B.SP3QI)#/50Q/8O$YJO1%.O7[S'>L<CX+
M7_G"Q_?T'SC2M)N29I[6H4X5*2BO_M#I"' N'(J.HI8[:Q(*C5VK-=^3]7?3
MK]8Y^TE6^EM>-[G14,:4]+$D2-8G$F<;%.J6=2AS%IB\L6\I[5\TP49.[N:>
MV*,(4(N*MJ;;P7AZQ6K#-LQ VACCK([>V=TR.<J[\2:W7[!I*G95XSQA$R>1
M4J:Z;AO1.I;VO60WY;:9];HDIJ:+R2>S-C;ZZPY&C-%E3'2:0++--O,VCHD]
M=S%:WXRT-;LY\;&*=&DE:+-[0Z.\,Q4&Y5MD+][?D>F;_P ;C-$8VLTF$<7R
M4]#+*C8]2H@?GF[+K>\J'5**F69SCIUJV5&-U9&O"@IHXG>RUG/3X'(5I2;=
MF=/M:A2I45*"LT3[&URY]:%):_+)]1# ]R?=;1F?PYD(T +_ ,YUOWD_Y<9(
M*NF?2\SPUCTR<YK)D_"J4>GP*A'] 'VYUOWD[Y<9:/P,YYR<L71;ZM(II_W\
M9T*__(L^7(3C!%S6S:%8Z]$X<$,[VI]UM7Y?#D0C3_\ ;E1K_P#),^7(9^BI
MWU7,[ZD:<)K7S+^#4J]WP(I#7NQ)A)QQ=9KJDS7N![(_%V+XZ>LEE6.77J)Y
M/-/;U]_MJIOB;1WAF6WK3);(8^#EM&)D_P#&-1Z"JID..&L>N6WI98F>RUFO
M7X&J=&KDB$59-.QO[(P]*K1<IJ[9R?4MJL&8RE93R?TBAFX+E\VW^:&X])6%
MJW'-)8ZFTR4S&1,?)_2'N;GKHS+B1>P:ETI5+*K2!>9H%X&U;$J^P8C7?$IT
M)99Z6QX9M%-<JJ&FDCI8X_'GHS-6L3/C)J.UF88"E&<JM"3]PP.BC"%PPG25
MS+G)2R+.]JLW.]SMY,^/-$[)L+K'BH;A1UK5W'5T]1J\>RD1V7O'MZQA)MN[
M/H</2A2IJ-/H8?%?VM77[UE^2IR915$])44T],_4G@D;+$Y4WFJF^AUIBK[6
MKM]ZR_)4Y<P7ET86//BW=!\XTWH=&>![;6:M3BG8S73.Q;UKRG>\7@E>F=B[
MEK]'B\$Z;39Y)U)7QOK(TCB+M-X^S:W7CO\ ^_,QM:VJJK'(VBE;#5S0+LWN
M3/4>K=Y34]@T1U%)>::HO5725-#'ORP-UN&OO)U]\VAC&[I8<-5]R1J.="S-
MJ?=*NJWX50YYM,-]TB7]*6HKY))-1TKG3>1Q-1=[)J=MQ%-.S9;VA.DIPA*.
M:7DC:FD2#"-/A:OA=#:XZS8OW.R%C-IM/,ZJ)O\ 'QFL=#,KXM(-J8G4R;1C
MNY/7]DE]VT3T%GP_<Z^KN-14RP4TDK$U&L;KHQ<EZ_70ANA[RR+,OMOS+S2-
MLKL>?7=3FZ3G%1U7\F8T_P"71K1?>3/ER%-&> &XHIGW"Z3RLH&/6*)C%R<[
M5^Z\Z7<T O\ SK1?>3/ER&S]#29:.;5_U?G7D.3C35C2EAX5_:$XSZ(P..\*
MVW#.C&^0VQLB,FDA>_7?K;^U80[0$F>,JW[R?\N,VAIF\KB[?]+YUAJ[0#]N
M5=]Y/^7&1!W@S3$TXPQ].,596,3I=LRVC&M6K(_&*O\ I+<NWU7Y6L;SP+>F
MW3!%!<)I$560JV=R^>9FURK[V9%M/=EW9AZGN<:<.ADR=[!_!7X=4USAC%/.
MW &(;4LN3Y]1(,^OM.#)[R(+<2**J:P.*FGT:N89J3XPQOOYH^XU7XC%7]33
MJNE@CIH8H(FHUC&HC6IUD0T3H"LVZ+W57:7)8J2/91Y^?=Q_!\HW\A2L]<IU
M^Q:34)5I=9,H[?13D?&?VX7W[^G^6IUR[J5.2<5R;+&MX?Z'<9W_ )Q2V'ZL
MS]O:PA]3>>$]&]DH+-$RYT4%96R,3;R2IK+K==$[2&IM*N%X<,X@AW#O4-2S
M:1,\ZJ<;?6ZYTE2RQU%/%-$Y'L>Q'-<G7132G-$5#'UMGIT7A,CDD=^$K,OD
M*13DW.P]HX:C#"9H*S5B?Z*;N^\8'HY:ARNG@UJ=Z\6>JN\OXNJ<UVZEDN%P
MI:-BIM:B=L+<_NER-^:!X'18)FD?_;U4DB>MJM3]1I3!6_B^Q_?L'RVFD%9R
M.+&MU:=#/Y_^&_HM&>&6VIM*ZAUWZO\ 6%>NU5<N/6_VASW(U]@Q)(V)<YJ"
MJWO9,?\ 5.O?,>X<CXS^W*^_?LWSCB*+;NF;^UJ$*,:;@K:G1.D:PU^),/);
MK;50TZR2M?(LN>3V)OZN]]UJD7P1HUI,/U%768@6BK%X.RUTS9'V5X77,EI?
MQ158=LE+';I$CK*MZL;(J;[6HB:V7;WVFL,%X-N6/-K7U5SFCA8_9NEFSDD>
MJ9*N6:^L5BG:[>AKB9TWB(QC#-/]C.::%PPVEI.<^X>>6V\<W)JY[/5W]?5[
M>J9#F=I7+#?85ZEFP<WW=?Z#!:1\!6_".'Z6IIJFIJ*J2J;"JR*W+5U'KU.7
M:0S/,[/;&W$3GKDQJ0+\X6E;)H<M)3\0696OM]#5CI59B)9[U%+*NZM>KB\T
M[A\-IO)E1@#%%JDHZ=ULIY'LU&-=&V"2->MJ\2Y^LI;?K%@G&5P_HUSI8[G,
MG5TE0W7E]=OFB'7_ $07.ABDGM55'7ZF_LE9LG^YQH,REUT$:%;#N3C%3BR4
M8#T<5N',04UR9=*:2G1CF/C9&J;1JIO=?L[Y!M,]\FNF+):1'KN*B\::U.N[
MS;OU?@GPT6XHKK3B*AHMM*^@JIVT[H5ZE-?>:Y.QOF%Q]3OI\:7QC]]%JI'_
M ([M9/E$QC[^IE7KQ>%4:2LKZFY\+8*PG;K3''7;AK*M[$VLDTC79NZ^6:[W
MN&JM)5DI,/XE3G-+_19X]K%J/SV;N+)%SXB84VA9E53Q2QXA39O8CF_T3K*F
M]YL^-;H@I+>C=V8KIJ=7=3M:=&Y^_(0I*^K-:]"M4I*,:25O.Z-HZ/+U)?<*
M4%;49I4*S4FS\^U<E7W>,DZD2T<V1E@P^E%#<8[A#KN>V6-J-1,UXMY5)=UC
MGG;-H?1X;-PHY^I!M(N'+56V*[72JHHI*^GHI=E*N>;=5CE3K]DT9HUM]+=,
M;VRBKHVSTDNT1S%XERC>OT'1N.,EP;??O*;YMQS[H=3+2/9_6E^:>;TF\K/"
M]ITX+%T].K-A:5&TN$,'I;;!3I1I<IUVNSSZE&\+W\FM]8BVAW!U+?Y:JONL
M:24<#VL9"OFGIQY^MO>^2+FB*9706.K3?;&^2%?P]1?V#U\SU4QOL5TI<LGL
MJ4E]QS$1/D*$VJ=T)0C4QZIS7NKH9'&FCFSUUDG?;:&*CKX6.?"^%-765$ZE
M4ZZ+D:PT.WR>U8PI*;>2CKEV$K<L\G>8=[^][IT9=*N.AM]14S;T4,;I'+VD
M3,Y9P#3R5>-K)$WB6JBE_$777Y(IO-%W)Q].%#$TY4E9G61YJVH92TLU3(OC
M<3'.=[B9GI3B0P^+('U.&;M!'U<M+*QOKJQ4.==3WZC:@VMCF:!M7C/&,;*B
M3^D5TW">GF6_R:;];HYPTVW;D2VQ<7DO]IGV=;LFC-%E5'2Z0+-+-O,VKHD_
M"8K6_*.ILTRS-ZLG%I(\'V30IUH3G4U=SG*#1]BZSX@2JM5 LT=--KT\NVB;
MKM1=[/AYIFB[Y*-/U\GBI*"SP*L;9DV]1VVMXD]U?B))=-*E@MMQJ:.H2K?-
M3O=%)LXT5NLWCZY =/T#NB.WU2)XW-1ZB^NUZK^V3&\I+,4Q%.EA\/-4)7W/
M;H?P-;[I;'WB[PMJ4?(K88I.IR3>5RIUU53*Z4< 6F+#]3<K331T<](W7<V)
M,FO9UT5#/:$ZB.; %)$SJJ>22-_KZZN_:,QI'J(Z7 ][>_>1]*^-/9.353X5
M0K*;SV.FGA*+P69KRN:IT"WV:GODMGDWZ:J8Z9B><>G'[Z?$1W3!Y8UY_P"E
M\RP^^A>G=/I!H'IQ0,DE?^(YG[1\=,/EC7G_ *7S+#5)*9Y$Y2G@$GY2-DX
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M IEA*A^_V?(D,-S.:<+$'^7_ '@;O2+JG&E[248*RL;L !S'T8
M
M
M
M                             *+Q*5 !R_C7#U[J<87>:GM%REIY*ESV
M/92O<U^_VDXCH+!D,E/A*S0S,='*RCA8]CDR5JHQ$5%,[DG8*Y%Y3S*QP87
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M9L*RCK9KS.:+CC_%5_I9+:S?5_ EW)3KM'?<]<EFBK1[5TEPAO%]BV"P9I!
M_JM;?X3NQVD-U:K>PA5$R)=6ZLE8RI>R[5%4JS<FC3^GFUW"Y26/G=1556L>
MW1^PA=)JHNSX\N+B,MH/M]7;L*U<-;2U%)(M:YZ,FC5CM56,W\E-EY(,D*YW
M;*=$<#&.(>(3U9K/3C05=PPK20T-+45<J5K7K'#&KW:J,>F>2>N8K0-;*^VO
MO?/*BJJ17[!&)/"Z/61-IQ9\?&;@R0JB)UD&=VL'@8O$+$7U0 !0[@
M
M
M
M
M                        %  /%<*2GKZ5]-64\513R)DZ*9B.:[UT7C/)
M;[!:+;+M;=;**DERU=>&!C'9=C-$XC,9!4S%RCA%O,UJ$XAF"@+E0
M                                            H !B*ZP6BOEVM=;*
M*ID\_-3L>[WU0]E'20T<214T,4,:<38VHU$]Q#UH@R)NRBIQ3NEJ.L ""Y13
M!U&%[!-,^:HLUMDE>[6<]],QSG+V554WU,Z,B;M%90C+XD$3> !4L  2
M
M
M
M
M
M
M
M
M
M
M
M
M
M                  "F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S
M *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@
MIF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,
MP"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H
M*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C
M, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J
M"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8
MS *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *
M@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF
M,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"
MH*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9
MC, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C,
MJ"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F
M8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S
M*@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@IF,P"H*9C, J"F8S *@
M                                         'SD=D 5<[5/FY^LF61:
M"I4  @D
M
M
M
M
M
M
M N:[53B/HUV?$?$!,'I!\V.0^A<D
M    M<Y&IOGP+GNUE[1:5*@ $$@
M
M
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MMH,VNA/0 06     %B+@  D  @  $@
M
M
M                                    'W:N9\"YCLE"8/N "Y(
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MIN'OQW@#Q2-7ZFX>_'> .!/8<S3W.CP<X>*1J_4W#WX[P!XI&K]3</?CO '
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M6>IN'OQW@#Q259ZFX>_'> .!/8<U3W.D <W^*2K/4W#WX[P!XI*L]3</?CO
M' GL.:I[G2 .;_%)5GJ;A[\=X \4E6>IN'OQW@#@3V'-4]SI '-_BDJSU-P]
M^.\ >*2K/4W#WX[P!P)[#FJ>YT@#F_Q259ZFX>_'> /%)5GJ;A[\=X X$]AS
M5/<Z0!S?XI*L]3</?CO 'BDJSU-P]^.\ <">PYJGN=( YO\ %)5GJ;A[\=X
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MQ<>IM&49?"P ""P  !Z$WRI8SR(O+D@
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M+D#],G_B#I*8"Y _3)_XAL4#/+<<*&QKKI*8"Y _3)_X@Z2F N0/TR?^(;%
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M"AL:[Z2F ^0$[\G_ (@Z2F ^0$[\G_B&Q ,\MQPH;&N^DI@/D!._)_X@Z2F
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M_)_XAL0#/+<<*&QKOI*8#Y 3OR?^(.DI@/D!._)_XAL0#/+<<*&QKOI*8#Y
M3OR?^(.DI@/D!._)_P"(;$ SRW'"AL:[Z2F ^0$[\G_B#I*8#Y 3OR?^(;$
MSRW'"AL:[Z2F ^0$[\G_ (@Z2F ^0$[\G_B&Q ,\MQPH;&N^DI@/D!._)_X@
MZ2F ^0$[\G_B&Q ,\MQPH;&N^DI@/D!._)_X@Z2F ^0$[\G_ (AL0#/+<<*&
MQKOI*8#Y 3OR?^(.DI@/D!._)_XAL0#/+<<*&QKOI*8#Y 3OR?\ B#I*8#Y
M3OR?^(;$ SRW'"AL:[Z2F ^0$[\G_B#I*8#Y 3OR?^(;$ SRW'"AL:[Z2F ^
M0$[\G_B#I*8#Y 3OR?\ B&Q ,\MQPH;&N^DI@/D!._)_X@Z2F ^0$[\G_B&Q
M ,\MQPH;&N^DI@/D!._)_P"(.DI@/D!._)_XAL0#/+<<*&QKOI*8#Y 3OR?^
M(.DI@/D!._)_XAL0#/+<<*&QKOI*8#Y 3OR?^(.DI@/D!._)_P"(;$ SRW'"
MAL:[Z2F ^0$[\G_B#I*8#Y 3OR?^(;$ SRW'"AL:[Z2F ^0$[\G_ (@Z2F ^
M0$[\G_B&Q ,\MQPH;&N^DI@/D!._)_X@Z2F ^0$[\G_B&Q ,\MQPH;&N^DI@
M/D!._)_X@Z2F ^0$[\G_ (AL0#/+<<*&QKOI*8#Y 3OR?^(.DI@/D!._)_XA
ML0#/+<<*&QKOI*8#Y 3OR?\ B#I*8#Y 3OR?^(;$ SRW'"AL:[Z2F ^0$[\G
M_B#I*8#Y 3OR?^(;$ SRW'"AL:[Z2F ^0$[\G_B#I*8#Y 3OR?\ B&Q ,\MQ
MPH;&N^DI@/D!._)_X@Z2F ^0$[\G_B&Q ,\MQPH;&N^DI@/D!._)_P"(.DI@
M/D!._)_XAL0#/+<<*&QKOI*8#Y 3OR?^(.DI@/D!._)_XAL0#/+<<*&QKOI*
M8#Y 3OR?^(8:\: <)UD;EH%KK<_K)'/M&I[C\_C-NEV0522\R'1@_(Y!QUH7
MQ%AB.:MH/^+6]G"UZ=FK(WV4?T9F5T6Z;*^R2QV[%4LM=:UX+*GJIH/7\^WX
M>QV#JA31.G+1/!<:6IQ#AJFV=Q9PZJE9U-0WKN1/1/C]?CVC44_=D<\Z,J7O
MTS=M#607"CBJJ.6.HIYF:\3V=2YJGH.7.9XTA/M-VCPW=9,[=6/_ *(]W_=Y
ME\SZSOE>R4ZC,IP<'8Z*5555<  H:GVCZA"\MBZA"XLB0 "0
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M89O5O7_N]6R;NC?J'1+WJ=WY'%"/#K-;F\0 <YVGWBZA"XMBZA"XLB0 "0
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MA-D3F94% +(C,RH* 60;>Y4M*E!9$9F7 H!9#,]RI<6%R"R(S/<J "+(9GN
M44(39#,]RH (LAF>Y3(J44(2TAF>Y4J4*D61#DP@" 60S/<  FR(S,  FR&9
M@JA0JA&@S,N0! 19"[W  )LA=[@ $616[  "2&9EP* M9"[*@!"+(C,]RH S
M%D,S  060S,#W2J@FR&9E G&%!#2&9EZ<10JTHHLB,SW!<6%Q%D&V 5!-D1=
M[E 5!;*A=[E"H!5I"[* J!9"[!4H5(LB')@ $V1.9[@ $61&9[@ "R)S/<
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MNGMD'SJ$#YD;J<4_Y7]\3SFC-[13=/;(/G4(%S(R\'%7^5_?'0OE'//YZ.B
M <QV'WBZA"XMBZA"XLB0 "0                           "R3R-2\LD\
MC4A@^( *D XKT&>6M8/9R_,O.U#BO09Y:U@]G+\R\Z*7PLXL3\R!VH8C%M:E
MMPO>:YO5T]#/-^*Q5,N1W21Y7>*?\*JOFG&$5[QU3=HMHX1*@'JI:'@2Z@
MJ   "XM+@&  ""H  !4H5 8  (   !<6EP   !<  "X  @      %$*E$)1#
M+BA4H&05 !(!0J4(8+T*E$*D@         J  0P  4   *@    $ N+2X
M %Q:7!D,%"I0(A  $DEX !       *E"H(8        !4  @         N
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MDS0NJD;V.9X>HEF:T,$ #4Q  (D0  0 7(6ER AE  "      @  2"H ((
M +@        "XM+@        "2H     !<      5*%2&0P           "H
M !4      %R%I<@!4  %$*E$*@      @  A! J4*DH,  D@O !4@
M  %2A4(A@  D%Q:7 A@  @            %2A4      AD  $   E J "0
M0P  0    7%I<"&  " 7%I< P  0      ;FYGFI>K+S3+U'C<K/A1QN1#2G
M,\_UN]>UP_'(;K0\ZO\ &S[KV0[X6)K3FC/*INGMD'SJ$#YD;J<5?Y7]\3SF
MC/*INGMD'SJ$#YD;J<5?Y7]\77RF:S^>CH@ '.=Q]XNH0N+8NH0N+(D  D
M                          LD\C4O+)/(U(8/B "I .*]!GEK6#V<OS+S
MM0XKT&>6M8/9R_,O.BE\+.+$_,@=J$=TC^5WBG_"JKYIQ(B.Z1_*[Q3_ (55
M?-.,8=3IG\+.$0 >H> RH !    +BTN 8  (*@  %2A4!@  @   %Q:7
M%P  +@ "       40J40E$,N*%2@9!4 $@%"I0A@O0J40J2         "H !
M#  !0   J     0"XM+@    7%I<&0P4*E B$  227@ $       J4*@A@
M      %0 "         "X  J"XM+@B4  22"J%"J A]"A0J4"(14  @%Q:7
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MER AE  "      @  2"H ((   +@        "XM+@        "2H     !<
M     5*%2&0P           "H !4      %R%I<@!4  %$*E$*@      @
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MI\\@J!#H2.!N[NP  ^I4  @ N0M+D!#*  $     !   D%0 00   7
M   %Q:7         $E0     "X      J4*D,A@           %0 "H
M +D+2Y "H  *(5*(5      !  !""!4H5)08 !)!> "I          *E"H1#
M  !(+BTN!#  !             *E"H     !#(  (  !*!4 $@  A@  @
M N+2X$,  $ N+2X!@  @      W!S/'];O7M</QR&ZS2G,\?UN]>UP_'(;K/
M.K_&S[GV/^%B:SYHSRJ;I[9!\ZA ^9'ZG%7K4O[\GG-&>53=/;(/G4('S(_4
MXJ]:E_?EU\IF\OGHZ( !SG:?>+J$+BV+J$+BR)  )
M         +)/(U+RR3R-2&#X@ J0#BO09Y:U@]G+\R\[4.*]!GEK6#V<OS+S
MHI?"SBQ/S(':A'=(_E=XI_PJJ^:<2(CND?RN\4_X55?-.,8=3IG\+.$0 >HC
MP&5  ( !4 H7%,E[!7)>P  ,E[ R7L @J!DO8&2]@ %2F2]@J   "    7%I
M<    7 %0"H* $%04&8!4%,QF 5*(,PA*(9<4*E R"H ) *%2A#!>A4H@S)!
M4        %0 "&  "@  !4     @%Q:7     N+2X,A@H5*!$(  DDO  (
M    !4H5!#         *@ $         %P !4%Q:7!$H  DD%4*%4!#*%"HR
M"(  ! +BTN *@ @@  (  !   , J4*A!A $    (  )   !<A4HA4A@
M%0  @5 !(  (8+@ 20   5 !(!0J6D,%Q4H5"!0O+"[,@AE04S (*@IF,RX*
M@ JP  0 7(6ER AE  "      @  2"H ((   +@        "XM+@
M"2H!4 %   7 % "H*  J5+2[,@@ 9C,  9C,  9C,  9C, J!F,P0 !F  !F
M "Y"TN0$%0  40J40J      "  "$$"I0J2@  207@ J0         "I0J$0
MP  2"XM+@0P  0            "I0J      0R  "   2@5 !(  (8  (
M +BTN!   (!<6EP#  !  '6    -P<SQ_6[U[7#\<ANLTIS/'];O7M</QR&Z
MSSZ_QL^Y]C_A8FL^:,\JFZ^V0?.H0/F1^IQ5ZU+^_)YS1GE4W7VR#YU"!\R/
MU.*O6I?WY;_2-Y?/1T0 #G.T^\74(7%L74(7%D2  2
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MTMQQZ?9_)7I;T'JJMW<W_2.EO0>JJW=S?](R&0M+<<>GV?R.EO0>JJV]S?\
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MI?WY=?*9O+YZ.B  <YVGWBZA"XMBZA"XLB0 "0
M     "R3R-2\LD\C4A@^( *D XKT&>6M8/9R_,O.U#BO09Y:U@]G+\R\Z*7P
MLXL3\R!VH1W2/Y7>*?\ "JKYIQ(B.Z1_*[Q3_A55\TXQAU.F?PLX1 "'J(\
MO:Q7Y-C3A*;VQO&W#]JLV#Z5R(RW0,EJMG_:5+TS5WT>R-18*9')C/#[)=]C
MZ^#/NB&S-(LCI<<7Q'<25*HGN&?61SXR;A0=O-V(X,@#0^=           4$
M@%#H7#&CS"U?ANV5U9:T=43TL<TKTJ)4S<K$55ZLI.HH=3MP>!EBVU!VL<]@
MZ.Z!, Y?U:G[^?X9%=(F%,*6K"=54V2.G95QOCU')5/D\VW/>5R]8JJR;M8Z
MJOLBI3BY.2T--@ U/*L #>6D7 V';+@NON-MMZQ5C-DC7NGE=EG*Q.NXI*:C
M8ZL/@Y8B$IQ?PFC ;AT0X.L>(<-U51=J+;U$54Z)LB32-X.HQ>LJ>>-9XFIH
M*+$EVIJ:)L<$%3)%$QO$UJ/5$"FF[(5L'.C2C5?1F+ !<X[ #( 6   L
M,@!8J@"$MT9TEDKL0U,.)Y*:.AW,Y[=M/LFZ^NS+)VLF>]F5D[*YK1I.K-07
MF1($NTF4EEHL0TT6&9*9]"M,U[MC/M4U]=^>:ZRY;VJ1$1=U<5J3I3<'K8H
M"QDU8  !)L  $          * H)*H>BWU<]OKH:RDDV=1 _68X\Z!4S*LM"3
MA*Z,CIGH:=]VHL06]B,I[Y2[J>Q/,3)O2)\*>Z:Z0VECSQS1%A=\B>.05M1$
MSV+LU^@U:*?0^@J/-:6X)KHCL\-XQK3+5Y;AH8WU\^?G(\OVM4A1L_0\BLLF
M-I$3QSG=JY^NJYDSZ"F[.Y3$%VFO=YJJZI3QR=^]]PWK-]PQJ)D40JN^6BK:
M'S=63G)R90%2A8S         !4H "H)-H[MU/=L84-ON46UI)=HCV:[F\4;U
MZRFZ)M'>#*9,YZ%D?LJN1O[9C.JHNQZ>$]E5,53XD6DO4YQ!T1T#X$]+T_?T
MGAFIM)]LM5HQ'#2V:.-E'L&/X+W29NUG==541JJ3M88KV7/#0SRDG]"'@J#6
MYYA0 $@ J4 :L  !8J@!M/&>C6DL.&*NYP5U1+)#J:K'M:O5/1/UE)3478Z:
M&$J5XRG#I'J:L!+-'%)9*R^U,>))*:.A2G<Y-M/LD1^LS+)=9.MK%=(])9*.
M_4[,-R4KZ'<[7+L9MLFOK/SS767+>U1F]ZQ/*/A<6ZM^Y$2H!8Y;,H "0 5*
M 6 !4"S !NS1[@BPWO!U#<+G;UDK'[5'/2HD;Q2O3K.*3FH*[.O!X.>+DXQ\
MC20*E"Z.1JSL               3#1Y51/N,UEN"?\,O#-S2LZR2>8<GW69J
MVYT4ELN%51SKG44=0^%_LFKD3&RS)3W>@F9QQSQ/]YQY-+L6RTBWQG9F1_OM
M:IFM):'MX:;G0L_)D/ !H2;6P1%T.Z.ZZ[1_U^\S.HX'^=@;U;D]=V:?BF"0
MDE]RBP3@V!B>-[BEE3V3GHJD;0BFM+G![3J-U%#R213K% #0\UZ@     #,J
M4-KZ*L*6:_V&JJ+M1I//'5.B21)'M56ZC'=94\\4J34%=G7@\)/%U.'!ZFJ0
M= RX&P3')E)2P,D[#JMZ?M'ENNBRQUD&=N=)1O\ ,JQZR-]Y5_69+$Q?5'I3
M]@5TKQDFS1 ,E?K35V:Z2T-?&K)X]]%\R]OGD,=D=$9)JZ/%G"5.3C)6:+05
MR* IJ "N0)LR@ ! !7(H  "H!0%39.$M'E)?L,4UTDKJF*1S9$5C&-WE:]R?
MLE)S4>IOAL+4Q,G&GY&M054H7.=IIV  0$V!4=<D& [?373%5%15T6TIY7/U
MF;[47@KV"LG97-*5)U9JFNK(^#8NEO#=KP]SL2U4VYTJ-IM7+(]V>6IEQJOG
ME/6RU8-7 ^Z7347/C<2NRW9P]MJ*O4:V6>?6R,U632:1W2]F3525-R5XFKBH
M!J>=8H "2 "N10#4 %02HW91"O6-Q8YP;8[5@FIKZ&AV=6QD>H]9GNRS>U%Z
MIV7$II[(SA44^AU8S!3P<E&;ZJY: #0Y    50H$ *H26_,Z(]&R5,N_7X?>
MQNOYZ"3>3WE^!I&B5X176P[C"-?(^=;W?A-1<C.ITN>A[-FU4</)IFJ  2=!
M]Z6"2IJ88(/)))&,9[)3<N,-2W)0V&DWZ2UPLCXNJE7A/?\ [ZZJ:WT>,:['
M-B1W6K(E^$G&)'(_$5S<_K5<J?E&4OB1TWRT6UYNQC@ 7.0  @
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M]Y6H[(G Q4JJOY&4K*I]95RU,J9/D?KN0^)7(9&)W2=W<  L0
M           ;%PIAJU5^'J:JJZ;7G>C]9VT>F?#<G64U_6,V-7(R-/&HWN*1
M=S>IAW2BI/S/D"7X L]#=>>&[H=IL]FK.&K<D5'=A3&8UHJ>WWJ2FHXT9&K&
MKJ<)WQC-K8F6'DJ:J^1@P 6N8 &>P1;J2Z7MT-=%M&;!SNK5O7;V#Z8[MU):
M[M%!0P[-CX6NZMSN%K.[*E<RO8WX$N%Q/(CH +G. #[6]D;[E2LJ/ZOM&:Z?
M<ZQ!*5V?$$OQ=16"GM<<EFEI%GVR:RLG63>U79[V:D00A.ZN7JTW3=F #8>)
ML.VJBPU/4TM,C)V,9D])'[V;FIV2&[%Z>'=2+DO(UX "Z,
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MT0[^CFV^M+\Z\S;<H:[G=3I0I8UJ"M>)S84*E#M1\5/XF  6*@
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MA_5C2A3_ (WN9-OU>6KFG9X/G>(^FD-<.95'//[,;E=N?R7MZO4[W&1S0_\
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MR[HPB[4E8ET^)1J<1+1:6\C$Z&OL)7;W_>E^2TA+[/->L<5U%!G'KU4SG/\
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MJ]:E_?EU\IF\OGHZ( !SG:?>+J$+BV+J$+BR)  )
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M'\HF6(OL_<_ON7Y1#=&_V]6+[ZC^43+$7V?N?WW+\HS_ +C>7R/S/" "3E
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M5E54U")UIGJ[XRO":OJ;2Q].<8N<-4;8TP-U\,0HWS-4U?R7'MA5$T6+O_\
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M[/+W7M-655PJJOQNKJJJ6+L/D<X\XRM]25BX1BXPCU  -#SP "0
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ML;'WV[7S[YD^,US@;[=+!_B,'SB&QL??;M?/OF3XS/\ N.3VA\C\S   T/
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M_<_ON7Y1#=&_V]6+[ZC^43+$7V?N?WW+\HS_ +C>7R/S/" "3E
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MHBEC?YQ_ *(F8N,K3L4![G62[*S6YUU^IV=SO^@\+F:F;)$%T2X2CJT  25
M                 /KI'^TS!_\ G?G6&O.P;#TC_:9@_P#SOSK#7G8%/X3;
M&?&OHOX1<G6-EZ*_M7QAZU)\X\UHG6-EZ*_M7QAZU)\X\K5Z%O9_S?R?\'N
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MKSX='_EU_8W-S0+43"5!DB?UYGS<A@M!^$H*B.2^5T6TV<FSIF2>9U>-_O\
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MP%-(>#+-<<,55ZM-/'33L@6I9)3HC6S,1N>^GK$1T:N7K7K4YNE)26S\C02
M ZSY(  $               DSV-/*AP[_B,WQ&K3:6-/*AP[_B,WQ&K2(=#Z
M!_#'Z(JG&ALS0_\ 83&O^'-^6IK-.,V;H>^PF-?\/;\M1/H6I^?T?\&.*%5*
M%SY=]0 "0               = Z%K12T^%8KBR-FZZI[U?)EOZJ.U=7\DP]'
MI.N5/B+<F(;9%0TJN5CO&W[2/L+U]9/<0C> [_B'#=%JT]GK:RTR>.(FP?JL
M3KJU^1L"S8^PWBJ2*W5=-J25'!;#5QM<U[E\SUT53CFK2;>I]?AZT)4:<(2R
M2]5U-=:6*FP7"X4U;8ZF&2I?K)4M8UR9[R9.7>)KH@PU2V^R,OU=%'NN9'.8
M]W]E&F:;WKD<TPX/H;)#2W*U1MIHYY=E+$G4YZN:9?BJ;"MC'UNB6&*D5-L^
MT[-OL]EE\8G+W$D4P]"V+G*HE=*Y$UTQQI=E;SM7G9KZNTU_'-7SVKE\![=+
MV&*2XV22^4,<:5D*->Y[?[6/_:FBUWSI.Z,?1:))8JI4VS+3LG>SV67QB4<C
M5C+"5Y8VG5A7Z):>@T0^5Q;/^K\Z\UIH(1.C&IS](O\ G(S9>B'RN;9_U?G7
MFM=!'VY5/WB_YR,B'29TU%[V&_\ O)%-.Z(F,:7+TDSYR0S7,](BOON:(N]!
M^\,1IZ3_ )MHW=;<;?EO,US/43FLODWF7K Q/<U_I+R?W1R4XKQ6W_W0]E1B
MSG%I+N=IW%MVW"KIV[7::NRUHHF=3DN?9)=C_$_0K9X:Y:1*K:3)"C%DU.-%
M7//)>P:HQ;Y>$?W]2?)B)CI\W\(T7WZWYN0HXJ\3NAB*BI5[/X7H>?0W7I=[
M[BJO=%L]NZ"79ZVMJY[0@>E2-TND>Z01;SY)(6M]?9,)=S/*\._?]#]X8#&K
MV1::%DE7)C*RD<Y?N=6(NM*C2.&JE4]GTW+SE_V;(IZ6V:-\&R3I'M*B-C=H
M]$X4\B\2>MG[R&*P;I-;?KU';:^A93K4)XTYC]=/67MGHTZ0R28.@DCXHJJ-
MS_8Y.3XW(:?P)%)-B^RM@\DW5$]?8H[-WP%8Q4HN3.C%8F>&Q$*%-6CH2C3'
MA:&RUT-=0,U*.KUM>).I;)EUO7-RXG=04]@GJKK$DE) B2O9EGK999;WKY$)
MT^21IAN@CS\<=5:R)VDC?G\9G=+WE<7+UHOG6%<SDE<Z(TX4)UW!>29@,,:4
MXKO>J6@J+9N9E2_91/2?7X7614R3C/%IZM-.VEH+K%&UD[IM@]W7<FJJI\DU
MA@_[;[']_0_+0W%IZ^U*B^_6_-R%W'+-6.*E7EB\%4=76QE,!6^.SZ/J>IMM
M.R>KFI=U9)U4LCFZR(J_ 1O#>D^HDN\M%BJFIK?&C'</9O:K7)YER.S,+A'%
MV(<+VYD%QLM=46J-,VS/IWQ[)J_=ZNKJDZLF*\-XUD2@GI<YW,SW/60-7/UE
MWT4JU9MO4ZJ56,X0C3EE:\GYFH](_.>2_I4V"6&2GG8KY&1\%K9,]]2)$\TM
M85I<-W>EFMGC=)5,?XRGF'-X_P ')4("AT4W>)\SCX2A7DI*S]  #4XP
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M;8HZ>:-S-=K$X+VJY$XO=$=)*XQ&:I2FX24E_!K  '6?.
M   'UTC_ &F8/_SOSK#7G8-AZ1OM-P?_ )WYUAKQ!3^$VQGQKZ+^$7)UC9>B
MO[5\8>M2?./-:)UC9>BS[5\8>M2?./*5>A;V?\W\G_![@ 9G6  2
M      " #<<L3[%A]$M-(E3)$UO 3C?V7=M33C6Y\!F\3NV8JN-II&1WBW5.
MQCR8DSF.9\:;YG-'?@IQAFS?J>NRXS94/E@OL4=/P,^H=EZSDWR-NM=)<L8;
MFMLG]#>_75S%ZA-7-2=4-RLV)TDBV<<KT;OLFCX61AK+;:>R8[2FC3*.6!7Q
M)V,__P"5Q5.USIJ0<\MW=7ZF4OUXH\*V^&"CIVK(_J(FKJIZZJ6X:Q)!B%9:
M*KIF,E5F>IGK-<TCNE*-[;O3/SX$D&HOKHJ^$>#1[$^3%%*]OF&.<_WLB<ON
MW$J\HXA4UTZ%]WM3+/C"C;#O0R3Q31)^%OM)/I23_@-+]\M^0\\V.7-7$UA9
M_:+*U4_':>G2CFEAI?OEOR'D7O8MD4(U4CV8 3/"L'LG?&IJ4VU@#/H6I_9/
M^-34J)YGKEH]6<^+7N4S;>-T_P"3JKV,7RVEN"[ZMXAF@2!(MRLC;GKZVMGG
MO\2>=+\<IE@ZK3L-C^6TP>BCCNG_ $OVRG]IV.3CB(Q7FCYXZQ)K+6V7<V>\
MSQ[:>L_BR,\S+I=KO_\ PY?FR XW7_F>X>V-^2TGT6_H[7_#E^;)Z)&5*;G5
MJ7V(?@"R,N5=-/5Y20P>9ZSG+OYJ2+$>,([37[BI8&2JQ.%UFIVCYZ+',YWU
M[4ZK;[_O$+Q2Q\6(;FQ_H[G^_P )"?BE9F3DZ%!2AU9L>BFH\8V63;PK&[J7
M)YJ-W912,8#I74>,*RFERUHXY4WO9-/?HKB>D%?-EP'O:SWL_I+K$YC](]SU
M?0W?&TCI=&RM4X=1K6YD,57Z"P5,3V4NWK)V9Y(N63&\9[[)<Z;$EID>^)NJ
MN<<D2KK9$)TH9+B*'+TLWY;S/:+4_P"#57M_[+2&O=N6A5E+$.GY$=PC:*>7
M&%533>.,I=HB-=YK)VKF2C%U^N-EJXV4=!%+3JWR9Z.WE[&\0U[[C#BFNJ;3
M#)+*RIE149'K>;=QDJBQRR.7972@J*>1$X7_ *+D3+5HQHRC&,H='?J?*Z7N
MS7RP:M9-#'5*W@L7/-DF1KHVO<;-:L0VE:FA9%KR,58IHDRW^WD:H+P>QSXU
M236;]0 #0X0              #UV7[+T/MT/RB!X^^W2^??,OQD\LGV7H?;H
MOE$#Q]]NM\^^9/C)A\1EB_D_F;!YGC^MWKVN'XY#=9I3F>/ZW>O:X?CD-UG)
M7^-GO^Q_PL36?-&>53=?;(/G4('S(_4XJ]:E_?D\YHSRJ;K[9!\ZA ^9'ZG%
M7K4O[\M_I&\OGHZ( !SG:?>+J$+BV+J$+BR)  )
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MF5JJZ+8%VJJ_GI^IG 7U,4E//+#.FSDC?J.+#([6K.S  )(
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MRM71LVNQ):+%;]S69899/,,8O!]=5(K@ZZ04>()JVYRHS:,<NOONS<KNTA'
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MF>P\,EWHP(,]T58#Y!O'?*#HJP'R#>.^4&9[#PR7<C  S_15@/D&\=\H.BK
M?(-X[Y09GL/#)=R, #/]%6 ^0;QWR@Z*L!\@WCOE!G>P\,EW(P.0R,_T4X#Y
M!O'?*?2.BG O(%X[Y0C.]B/#9=R,!D,C/]%.!>0+QWR@Z*<"\@7COE"<SV'A
MLNY$?!(.BC O(%W[Z0IT48%Y!N_?2#,]AX;+O1@"J&>Z*,"\@W?OI!T48$Y!
MN_?2#,]AX;+O1@3*X=L5QQ!5)36R+77S;_[.+MJIZNC+!M+F^DPI55$O$FZJ
MU43X,S"XDTA7F\4JT$&YK7:\LMR4+-FUWK]=>+UB&V^B-:6 A%WJ2NO0R^.[
M_0VJR="F&Y=T,U]:Y5S/[>1O]FGW"?J]?/6R%$4J6C&QTSGFZ*R  +HS,_@C
M$=1A>]QW"!-I&OC51"O%+&O&AL6\6"GKJ7GWA)=VVB7??"SR2F=YQ[?=_P!\
M:Z<0RN'[]<L/7#=5GJI*>==Y4;OM?[)O$XSDK.Z+2C"K'AU.G\$A!F&:1;3<
M%3HFPK2R5'FJBAD=3N_%XW>^5Z*\#\A7COI/I)XCV.&7LQ_VS1A@9GHKP/R%
M>.^D^D=%>!^0KQWTGTD\3T*^&2[T88&9Z*\#\A7COI/I'17@?D*\=\I](XGH
M/#)=Z,,#-=%6!>0[QWRGTCHJP+R'>.^4^DCB>@\,EWHPH,UT58%Y#O'?*?2.
MBK O(=X[Y3Z1Q/0>&2[T84&:Z*L"\AWCOE/I'15@?D*[]])](XGH/#)=Z,*#
M-=%6!^0KOWTGTCHJP/R%=^^D^D<3T'ADN]&%!FDQ5@?D*\=])])7HHP/R%>.
M^D^D<3T'ADN]&$!G.BC W(5X[Z3Z1T48&Y"O'?2?2.)Z#PR7>C!C,S713@;D
M*\=])](Z*<#<A7COI/I'$]!X9+O1A09KHIP-R%>.^D^D=%.!N0KQWTGTCB>@
M\,?>C"@S713@;D*\=])](Z*<#<A7COI/I)XGH/#'WHPN8,UT4X&Y"O'?2?2.
MBC _(5X[Y3Z2.)Z#PQ]Z,*#.=%&!^0[OWRGTCHGP/R'>.^4^D<3T(\-EWHP8
M,YT48'Y#N_?*?2.B? _(=X[Y3Z1Q/0>&OO1@P9SHGP/R'>.^4^D=$^!^0[QW
MRGTD\3T'AK[T8,9F<Z)\#\AWCOE/I'1/@?D.\=\I])'$]!X:^]&#&9G.B? _
M(=X[Y3Z1T3X'Y"O'?*?23Q/0>&OO7[F#!G.B7 W(5X[Y3Z1T2X&Y"O'?*?21
MQ/0>&/O7[F#S!G.B7 W(5X[Y3Z1T2X&Y"N_?*?2.)Z#PU]Z_<P8,YT2X&Y"N
M_?*?2.B7 W(=W[Y3Z1Q/0CPZ7>OW,&#.=$N!N0[OWRGTCHEP-R'=^^4^D<3T
M'ATN]?N8,&<Z)<#<AW?OE/I'1+@;D*[]\I])/$]!X=+O7[F#0J9OHEP-R%=^
M^4^DJ[']GM[G+8,*4T<ZIP*BNG=-^1]89V_(E>SNZ:/?8<.L;1\^<1R)062/
M)=9V\Z?[AC>WD0S'&)),37I*G9;"CIV)#34_H;$/'B'$5UQ#6;HNU7).Y.HC
M1,F,]BWK&(4JDV[R.R\*4.'2_-[E "I<Q*FQ-'V):%U N&\1O6.@>_6I*OKT
MTB];V"_K]U-=@I*-S6E5=-W-MWVRU5FJM2JC39N\BE9Y')O9[RF,S,)AK'=X
ML5,E(NRK+9Q;DJV;1F78;V"2-QUABHU75F&:JFD_^7JM[WEXBFJT:-'2I3UA
M*WU/,BYE3U=&6#%_^ W/NR#HQP9R#<^[(3F>Q'+Q[T>,'LZ,\&<@W+NR#HSP
M7R#<N[(,SV'+Q[U^YXP>SHSP7R#<N[(.C/!?(-R[LA&9[$<O'O7[GC![.C'!
M?(-R[L@Z,<%\@W+NR#,]AR\>]?N>,'LZ,<%\@W+NR#HQP7R%<N[(,SV'+Q[T
M>3+MC(]71A@OD*Y]V0=&&#.0KEW9/I)S/8<!=Z/+EVQEVSU=&&#.0KEW9/I'
M1A@SD*Y=V3Z1F>Q'+Q[T>8'IZ,,&<A7+NR?25Z,<&<@W+NR#,]AP(]Z/*#U]
M&.#.0KEW9!T8X,Y"N7=D(S/8<"/>OW/'EVQEVSU]&&#.0KGW9!T88,Y"N?=D
M&9[#@1[U^YY,AEVSU]&&#.0KEW9!T88,Y"N7=D&9[$\"/>CR9=L9=L]?1A@S
MD*Y=V0=&&#.0KEW9!F>PX$>]?N>3(9=L]?1A@SD*Y]V0=&&#.0KGW9!F>PX$
M>]?N>3+MC+MGKZ,,&<A7+NR#HPP9R%<N[(,SV' CWK]SR9=L9=L]?1A@SD*Y
M]V0=&&#.0KGW9!F>Q' CWK]SR9=L9=L]?1A@SD*Y=V0=&&#.0KEW9!F>Q/ C
MWK]SR9#+MGKZ,,&<A7/NR%>C#!G(5S[L@S/8C@1[U^YX@>[HOP9R%<^[(.B_
M!G(5S[L@S/8<"/>CP@]W1?@SD*Y]V0=%^#.0KGW9!F>PX$>]'A![NB_!G(5S
M[L@Z+\&<A7/NR#,]AP(]Z/"#W=%^#.0KGW9!T7X,Y"N?=D&9[$\"/>OW/"#W
M=%^#.0KGW9!T78,Y"N7=D^D9GL1P(]Z/"53KGMZ+L&<A7+NR?2$Q;A%F_P X
MKF]?.OJ_YC,]AP(=Z_<\T$$M5/%#3QRR2R=2R,D%;64V K?M9]E+B6=G]'I\
M]?<[5_M']E2.5VDJJCC6'#ELIK/%)U4C/')?QW?00:6:2>HDGGEEEEDZI[^$
MKAE<NI93IT4\NKW+97R2SRR22;623A.<6=8)OE<C3H<,I9G=E2^"66">.>"3
M9RQ/UV/\ZXL*@1DXNZ-UVFYT^.J!D\"Q1XB@;X_3]1MT3S;#'2QO@GV<L6R?
M'QL>:HIYI*>:.6GEDBECZA[%U7-)];M)=7)$D-_MM+>(X][:O\;E_'3Z#!P:
MZ'JT\33J_'H]S+@^/1SA-?\ X#6QK]Q4?S*='&$^1KGW=HM+8O>GWH^X/AT<
M83Y&N?=FCHXPGR-<^[-%I;"]/O1]P?#HWPGR-<^[-*]&V$^1KGW9HM+8F]/O
M1]@?+HVPGR-<^[-^D=&V$^1KGW9OTBTMA>GWH^H/ET;83Y'N?=FCHVPGR/<^
M[-%I;"]/O1]0?+HVPGR/<^[-'1MA/D>Y]V:+2V%Z?>CZ@^71MA/D>Y]V:.C;
M"?(]S[LT6EL+T^]'U!\NC;"?(]S[LT=&V$^1[GW9HM+87I]Z/J#Y=&V$^1[G
MW9HZ-L)\CW/NS19["]/O1]0?+HVPGR/<^[-'1MA/D>Y]V:+2V%Z?>CZ@^71M
MA/D>Y]V:.C7"?(]S[LT6>PO3[T?4%G1KA3D:Y]V;](Z-<*<CW/NS?I%I;$7I
M]Z+P6=&N%.1[GW9OTCHUPIR/<^[-^D6>Q-Z?>B\%G1KA3D>Y]V;](Z-<*<CW
M/NS?I(UV%Z?>B\%G1KA3D>Y]V;](Z-<*<C7/NS?I%GL1>GWHO!\^C3"?(]S[
MLWZ1T:83Y'N?=F_2/>V%Z?>CZ ^?1IA3D>Y]V;](Z-,)\CW/NS?I%GL3>GWH
M^@/GT:84Y'N?=F_2.C3"G(]S[LWZ2==A>GWH^@/GT:83Y'N?=F_2.C3"?(]S
M[LWZ2-=B+T^]'T!\^C3"G(]S[LWZ1T:83Y'N?=F_23KL+T^]'T!\^C3"?(]S
M[LWZ1T:83Y'N?=F_21KL+T^]'T!\^C3"G(]S[LWZ2[HRPIR/<^[-^DG787I]
MZ+@6]&6$^1[GW9OTCHRPGR1<^[-^D:["]/O1<>ZT6FJNLNI3Q^-LZN9_4M]=
M3%RX[L$#5=1X>EG?UMT56][R$=Q'C6ZWN):9\D='0\6Y:9FHS\+LC+)^11UZ
M,%=N_P!#+Z0,34KZ:*Q6*19*"-^O/4^F9/H0@!7(9&D8Y3RJ]9UI9F;?YGC^
MMWKVN'XY#=9I3F>/ZW>O:X?CD-UG#7^-GV/L?\+$UGS1GE4W7VR#YU"!\R/U
M.*O6I?WY/.:,\JFZ^V0?.H0/F1^IQ5ZU+^_+?Z1O+YZ.B  <YVGWBZA"XMBZ
MA"XLB0 "0                           "R3R-2\LD\C4A@^( *D XKT&
M>6M8/9R_,O.U#BO09Y:U@]G+\R\Z*7PLXL3\R!VH8^_T//.RW"A1?ZU2RP?C
MMR,@4R.=.S.QJZ/SSE9)'-LY$6.1F\Y$+#;?-!8(DP[B:6\T4>=JN<BO]JFX
MW-]WC3^1J0].F\RN>#5@X2LRH -#(  @ N*%<B0P!D,@05 R&0 *E,BH   (
M   !<6EP   !<!F,P"X%,QF" !F,P"H*9C, J40J40(AEQ0J4!!4 $@%"I0@
M%P&]V1O=DD%P        *@ $   H   5     (!<6EP    0N0M0N3B)9#!0
MJ4(00 !(+P "       5*%00         5!49 @H"HR!!0%1D 4!49 DJ ,@
M0"XM+@  "2050H50$,H' ."(  ! +BTN *@ @@  (  ! %2A4, %1D$&40!
M   "  "0   7  A@   J  5  "!4 $@  A@N !)   !4 $@%"I0A@N  (*%Q
M:7$    J "Y *%058* J" 4+T+2Y 0R@ !      0  )!<@R"%2""T  %P&0
MR  &0R  &0R !<6Y%P        !)4      N &0  R&0 *E,BI!
M   !4  J      "Y"TN0$E0 ""K.N4*LZY0      $  $( J4*DA@ $D%X *
MD          J4*A$,  $@N+2X$,  $             J4*@     $$  $
ME J "0  0  "    "XM+@0   "XM+@0  "   "XIF5/1;Z*:XUT-%21[2HG?
MJM:0W8O"#F\J-Q<SY12-H;Q6NWHY)(HF?@:RK\HV^83!]BCP[AZEMD:)XW'P
MGIYIZ]4IFSS:DLTKGW^!H\&A&#ZFL^:,\JFZ>V0?.H0/F1^IQ5ZU+^_)YS1G
ME4W3VR#YU"!\R/U.*O6I?WYJOE,K/YZ.B  <YVGWBZA"XMBZA"XLB0 "0
M                        "R3R-2\LD\C4A@^( *D XKT&>6M8/9R_,O.U
M#BO09Y:U@]G+\R\Z*7PLXL3\R!VH #G.T\%ZM%#>K?+;[G31U%%-U<;^)3FW
M'.@:Z4$DM5A.7GC1^EYGY3M_4[X%[1U""\*CAT,:E&-3J<&5>%,0T,FI5V"Z
MQO5.-U))]!Y^<-VY)N/>\G@G?8-EB'L<W(+<X$YP7;DJX][R>".<%VY*N/>\
MG@G?8+<P]BO(K<X%YP7;DFX=[R>".<-WY)N'>TG@G?:E".8>Q/(+<X%YQ7?D
MFX=[2>".<5WY)N'>TG@G?0',/8CD5N<#\XKOR57][2>".<5WY*K^]I/!.^ .
M8>Q/(+<X&YPW?DJO[VD\$NYP7?DJO[VD\$[W YA[$>'K<X(YQ7?DFX=[2>".
M<5WY)N'>TG@G>X',/8>'K<X(YQ7?DFX=[2>".<5WY)N'>TG@G>X',/8>'K<X
M(YPW?DJO[VD\$NYP7?DJX=[2>"=Z@<P]AX>MS@KG!=^2KAWM)X(YP7?DJX=[
M2>"=Z@<P]AX>MS@KG!=^2KAWM)X(YP7?DJX=[2>"=Z@<P]AX>MS@KG#=^2;A
MWM)X(YPW?DFX=[2>"=Z@GF'L1X>MS@KG#=^2;AWM)X(YPW?DFX=[2>"=Z@<P
M]AX>MS@OG#=^2;AWM)X(YPW?DFX=[2>"=Z CF'L/#UN<%\X;OR3<.]I/!'.&
M[\DW#O:3P3O0#F7L1X>MS@WG#=N2;AWM)X(YPW;DFX=[2>"=Y <T]AX<MS@W
MG#=N2;AWM)X(YPW;DFX=[2>"=Y <T]B/#EN<&\X;MR3<.]I/!*\X;OR3<.]I
M/!.\0.:>P\.6YP=SAN_)-P[VD\$<X;OR3<.]I/!.\0.:>P\-6YP=SAN_)-P[
MVD\$KSBNW)-P[VD\$[P YI[#PU;G!W.&[\DW#O:3P1SAN_)-P[VD\$[Q YI[
M#PU=QP?SBN_)-P[VD\$JVQ7?DJX=[2>"=W@<T]B/#5W'"'.*[\DW#O:3P1SB
MN_)-P[VD\$[O YI[$^&K<X0YQ7?DFX=[2>"7<XKMR5<.]I/!.[0.:>Q'AJW.
M$N<5VY*N'>TG@CG%=N2KAWM)X)W:!S3V'ABW.$^<-WY)N'>TG@CG#=^2;AWM
M)X)W8!S3V'ABW.$^<-WY)N'>TG@CG#=^2;AWM)X)W8!S3V'ABW.$^<-WY)N'
M>TG@CG#=^2;AWM)X)W8!S3V'ABW.$^<=VY)N'>\G@CG'=N2;AWO)X)W8!S3V
M'ABW.%><=VY)N'>TG@CG'=N2;AWM)X)W4">:>P\+7<<*\X[MR3<.]I/!*<X[
MMR3<.]Y/!.ZP%BGL/"X]QPISCNW)-P[WD\$<X[MR3<.]I/!.ZP3S3V'A<>XX
M6YQW;DFX=[2>".<=VY)N'>TG@G=('-/8CPM=QPMSCNW)-P[VD\$<X[MR3<.]
MI/!.Z0.:>P\*7<<+<X[MR3<.]I/!*\XKOR37][2>"=T <T]AX4NXX8YQ7?DF
MO[VD\$<XKOR3<.]I/!.YP.:>P\*7<<,<XKOR3<.]I/!'.*[\DW#O:3P3N<#F
MGL/"EW'#'.*[\DW#O:3P1SBN_)-P[VD\$[G YI[#PI=QPQSBN_)-P[VD\$)8
MKOR5<.]I/!.YP.:>P\*7<<-<XKMR9<.]I/!'..[<F7#O:3P3N4#FGL1X5'N.
M&N<5VY,N'>S_  1SCNW)EP[V?X)W*!S3V'A4>XX:YQW;DRX=[/\ !'..[<F7
M#O9_@G<H'-/8>%1[CAKG'=N3+AWL_P $<X[MR9<.]G^"=R@<T]AX5'N.&^<5
MVY,N'>TG@E><5VY,N'>TG@G<8'-/8>%1[CASG%=N3+AWM)X(YQW?DRX=[R?0
M=Q@<T]AX5'N.'N<=WY,N'>[_ *!SCN_)EP[W?]!W"!S3V'A4>XX>YQW?DRX=
M[O\ H'..[\F7#O=_T'<('-/8>%1[CA[G'=^3+AWN_P"@<X[OR9<.]Y/H.X0.
M:>P\*CW'#W..[\F7#O=_T#G'=^3+AWN_Z#N$#FGL/"H]QP]SCN_)EP[W?]!=
MSCNW)=?WL_Z#M\KF.:>Q#]DQ[CA[G)=N2Z_O9_T#G)=N2Z_O9_T'< '-/8CP
MF/<</\Y+MR77][/^@<Y+MR77][/^@[@ YI[#PF/<</\ .2[<EU_>S_H'.2[<
MEU_>S_H.X .:>P\)CW'#_.2[<EU_>S_H+N<EVY+K^]G_ $';P'-/8>$Q[CB'
MG+=N2J_O=_T#G+=N2J_O=_T';P'-/8>$Q[CB+G)=N2Z_O9_T#G)=N2Z_O9_T
M';H'-/8>$Q[CB+G'=N2[AWN_Z!SCNW)=P[W?]!VZ!S3V'A"[CB+G'=N3+AWN
M_P"@ISCNW)EP[W?]!V\!S3V'A"[CB'G'=N3+AWN_Z"O..[<F7#O=_P!!VZ!S
M3V'A"[CB+G'=N2[AWN_Z"[G'<^3+AWN[Z#ML#FGL/!X]QQ)SDN?)EP[W=] Y
MR7/DRX=[N^@[; YI[#PA=QQ)SEN?)=P[W=] YRW/DNX=[N^@[; YI[#PA=QQ
M)SDN?)EP[W=] YR7/DRX][N^@[; YM[#PA=QQ)SEN?)=P[W=]!=SDN?)=P[W
M=]!VR!S3V'A"[CB;G)<^2[AWN[Z!SDN?)=P[W=]!VR!S;V(\'7<<3<YKGR7<
M.]W?0.<USY+N'>[OH.V0.:>P\&CW'$W.2Y\EW#O=WT#G)<^2[AWN[Z#MD$<T
M]AX/'N.)N<ESY+N'>[OH'.2Y\EW#O=WT';()YI[#P:/<<2I9+GR7<.]W?07)
M9+GR7<.]W?0=L <V]AX-'N.*.<MSY+N'>[OH'.:Y\EW#N#OH.UP.:>Q'@T>X
MXIYRW/DNX=[N^@<YKGR97][N.U@1S3V'@T>XXIYR7/DVO[W<.<ESY-K^]W':
MP)YI[#P:/<<5<Y;GR;7][N'.6Y\FU_>[CM4#FWL/!X]QQ5SFN?)E?WNX<YKG
MR97][N.U0.;>P\&CW'%7.:Y\F5_>[ASFN?)E?WNX[5 YI[#P:/<<5\YKGR97
M][N'.:Y\FU_>[CM0#FGL/!H]QQ7SFN?)E?WNXISFN?)E?WNX[5!'-/8GP6/<
M<5<YKGR97][N'.:Y\F5_>[CM4$\T]AX+'N.*N<USY,K^]W#G-<^3*_O=QVJ!
MS;V(\&CW'%7.:Y\F5_>[BJ6:Y\FU_>[CM0#FGL/!8]QQ:EEN?)]=WNX<YKGZ
M0KN]W':0(YI[#P6/<<6<YKGZ0KN]W%Z6>XY?U&M[W<=H <UZ$>"1[CB_G/<?
M2-;WNX<Y[CZ1K>]W': )YI[#P2'<<7\Y[CZ1K>]W#G/<?2-;WNX[0 YI[#P2
M'<<7\Y[CZ1K>]W#G/<?2-;WNX[0 YI[#P2'<<7\Y[CZ1K>]W#G-<^3Z_O=QV
M@!S3V'@D.XXPYRW/D^O[V<.<MSY/K^]G'9X'-/8>"0[CC#G+<^3Z_O9PYRW/
MD^O[V<=G@<T]AX)#N.,.<MSY/K^]G#G+<^3Z_O9QV>!S3V'@D.XXPYRW/D^O
M[V<.<MSY/K^]G'9X'-/8>"0[CC#G+<^3Z_O9PYRW/D^O[W<=G@<T]AX)#N.,
M^<]SY/KN]W#G/<^3Z[O=QV8!S3V(\#AW'&?.>Y\GUW>[BG.>Y\GUW>[CLT#F
MGL/!(=QQGSGN?)]=WNX<Y[GR?7=[N.S .:>Q'@D.XXTYRW/+['UW>[BWG-<^
M3Z[O=QV:!S3V'@<>XXSYS7/D^N[W<.<USY/KN]W'9@(YKT'@<>XXSYS7/D^N
M[W<.<USY/KN]W'9@)YI[#P2/<<9\YKGR?7=[N*I9KGZ0J^X..RP1S7H/ X=Q
MQKSFN?)]5WNX<YKGR?5=[N.R@3S3V'@<.XXUYS7/D^J[W<.<USY/JN]W'90(
MYKT'@<.XXUYS7/D^J[W<.<USY/J>]W'90)YI[#P.'<<:\Z+EZ0J>]W#G3<O2
M%3WNX[* YI[#P2/<<;<Z+EZ0JN]W#G1<O2%5WNX[) YI[$>!Q[OV.-^<]R](
M5/>[ASGN7I"I[W<=D <T]AX''O\ V.-^<]R](5/>[BG.>Y>D*KO=QV2".:]!
MX''N.-N<]R](57>[ASGN7I"J[W<=D@CFGL/ X]W['&W.BY>D*KO=Q7G/<O2%
M3WNX[(!/->@\"CW?L<<<Y[EZ0J>]W#G/<O2%3WNX['!/-/8>!1[OV...<]R]
M(5/>[ASGN7I"I[W<=C@CFO0>!1[OV..4M%RS_J%5WNXN2T7+TA5=[N.Q 1S3
MV(\!CW?L<=\Z+EZ0JN]W#G1<O2%5WNX[$ YI[$> Q[OV..^=%R](57>[ASHN
M7I"J[W<=B <T]AX#'N_8X[YT7+TA5=[N'.BY>D*KO=QV(!S3V'@,>[]CCOG1
M<O2%5WNX<Z+EZ0J>]W'8@)YI[#P&/=^QQWSHN7I"J[W<.=%R](57>[CL0$<T
M]AX#'N_8X\YT7+TA5=[N'.BY>D*KO=QV&">:>Q/@,>[]CCSG/<O2-7WNX<Y[
MEZ1J^]W'88'-/8CP&/=^QQYSGN7I&K[W<.<]R](U?>[CL,#FGL/ 8]W[''G.
M>Y>D:OO=PYSW+TC5][N.PP.:>P\!CW?L<><Y[EZ1J^]W#G/<O2-7WNX[# YI
M[#P&/=^QQ]SGN7I&K[W<.<]R](U?>[CL$$<T]B/ (]_[''W.>Y>D:OO=Q=SG
MN7I"J[W<=?@<T]AX!'O_ &.0.<]R](57>[ASGN7I"J[W<=?@<T]AX!'O_8Y
MYSW+TA5=[N'.>Y>D*KO=QU^!S3V'@$>_]CC_ )SW+TA5=[N'.>Y>D*KO=QV
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M/;(/G4('S(_4XJ]:E_?G0OE,XI_/1T0 #G.T^\74(7%L74(7%D2  2
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ML?UBCBK^L4<:(QD?,J_C*%7$F):  6RO8  L0   "A4H   2  ""0 "2
M "4 6J7%JDDHH  2      4  +   %H        "EI<I:2B4  22
M       "TN+0  "460 !*ZE0  6!0J4)08 !) *%2@      )     ))0
M+"\L!**@ D@   M*%2T%BI:5*%B0' . 10  DM"@*"Q0  %A3,J4)+#,M+BP
M$@* H)10  DM4H54H22"TN+2&2@6EQ:"2@ !(*%2@)!87E@+(H "22TH5*$$
ME%+2Y2T%@  24*J4*J ?,H5*!ED4+2XM!*!0J4!8%"I0 L*%2@+H.+2YQ:02
MBT  L@?,^A\P6*E"I0ADH'S/H?,@LBT. <"44)IHST@W3 UUUZ=9:BU2/_I%
M)YEWW3>PXA90B45)69>$W!W1^@-FN-)=K92W&@D22CJ(VRPO3KM<>Q>,T5S+
M5^DJ[)=;+4/_ *A*V:'>XHY,\V^^W/\ "-ZGFU(Y96/>I3SQ3-9\T9Y5-U]L
M@^=0@?,C]3BKUJ7]^3SFC/*INOMD'SJ$#YD?J<5>M2_OS7_2.:?ST=$  YSM
M/O%U"%Q;%U"%Q9$@ $@                           %DGD:EY9)Y&I#!
M\0 5(!Q7H,\M:P>SE^9>=J'%>@SRUK![.7YEYT4OA9Q8GYD#M0ME\@E+BV7R
M"4Y9?"SM-3E"I3KGQSZLYWU*%2A4(J4?UBA5_6*$H . <2"TH5*$$,  N4
M")18 "22TN0M+D!670%I<6DHJBH + L !(!0J4)1  !(+"XM+@0P6EQ:"I:H
M"@L0RT %B 4*E &"CBI1Q*(   +0 2"T  @(5*(5+(A@^9]#YD@. <"Q0H "
M0P6EQ:" 6N+BUQ*(+0 "2XHI4HI)4M !)#** H+   %9%@ )14%%*E%)#  )
M(8+2XM#(+4 0!!EH +$  %D48+2XM) +2XM)15@ $D%I4H5"(*%I<6E@4 !)
M4H  B&6  E$,%%*E%)*LL+RPO!#!:_K%Q:_K%B"TM+BT$%  25*%I<6ER@
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M"BYET[GEXB@Z%1TV[V*  DP      *  %@  "T        !0%!*)  )
M           /F?0^8)0 !,>I9  $KJ0@  2"A4H2@P "2 4*E       2
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M:S2,WVZV62-1>SPE-6(:03MJ>#[4C2CB&J70H "QYP     !0  L   6@
M     * H)1( !(               !\SZ'S!*  )CU+(  E=2$  "04*E"4&
M  20"A4H      "0    "24   "PO+ 2BH )(   +2TN+060*%2A8D!P#@$4
M  )+0H"@L4  !84*E"660+"\L!("@*"44  )+5*%5*$D@M+BTADH%I<6@DH
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M  21<  @G,P ";$-M]0 "!<  M8*370H6EQ:6L2  0      "@ !8   M
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M+Y3,Y_/1T0 #G.T^\74(7%L74(7%D2  2
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MI_\ #9_?)R2(X-3M9@?<*&?Z$+_R;/[Y;T(7_DV?WQEEL1P*G:S  S_0??\
MDV?WRWH/O_)E2649;$<O4[68$M)!T'W_ )-J"G0=B#DRH]]"<LBKP]7M9@ 9
M_H.Q!R94>^@Z#L0<F5'OH,LBO+5>UD?4^:DBZ#<0<F5'OH6]!N(.3*GX"V5E
M>6J]K,"6DAZ#,0<F5'P#H,Q!R94>^A*3#PU7M9'2CR0]!>(.3:CX!T&8@R^Q
ME0OO$J+*/#5NUD<!(5P;?^2:CWT'0=B#+[$3^^@LRKPU;M9'5+7$A7!N(NM:
M)_?*+@W$7)$_ODV97E:S_M9'BTD707B+DB?WQT%XBY(G]\DH\)6[61EY1W$2
M1V"L1\D3^^A:N",2<D5'Y)HC&6#KO3(R.%JDDZ!\2<D5/OM"X'Q'R35>^PDI
MR5?L9&02?H'Q'R34^^P= ^(^2:GWV$:#E*W:R, DO0-B/DFJ]]@Z!L1\DU7O
ML+CDZW:_T(T"2] V(^2:KWV'BK\-WFW,5]7;*F-B<;TC56^^1<B6$K15W%F'
M*%2A-SGL  20  02 $0SU-A"_P!5&CX+36ZB]9\>I\9-S6%"=3X5<P()-T#8
MDY(JO?;](Z!L2<D57OM^DBYIR5?L?Z$9!)N@;$G)%5[[?I'0/B3DBJ]]OTDW
M0Y*OV/\ 0C.1;D2?H&Q)R15>^WZ2WH%Q'R14^^TG,B>3K]C(R"3= N)>M9ZC
MWVCH%Q-R/4>^T9D3R5?L9&02;H%Q-R/4>^T= N)N1ZCWVC,AR5?L9&02;H%Q
M-R/4>^T= N)N1ZCWVC,AR5?L9& 2?H%Q-R/4>^T= N)N1ZCWVC,BW)5^Q_H1
M@$GZ!<3<CU'OM'0+B;D>H]]HS(<E7[&18N)-T"XFY'J/R2O0+B;D>H]]HNAR
M5?L9& 2?H%Q/R14>^WZ1T"XGY(J/?;](S#DJ_8R+ E'0+BCDBH]]OTE.@7%'
M)%1^3](S(<E7[61@9DHZ!<3\D5'OM^DIT"8FY'J/?;]).8<G6[61C,9DFZ!,
M3<CU'OM^D= F)N1ZCWV_2,R')UNU_H1G,*2?H$Q-R/4>^WZ1T"8FY'J/?;](
MS#DZW:_T(N"4= F)N1ZCWV_24Z!,3<CU'OM^DFXY2MVO]",YA23] F)N1ZCW
MV_2.@3$W(]1[[?I)T')UNU_H1<$GZ!,3<CU'OM^D= F)N1ZCWV_21<<G6[7^
MA&0I)^@/$W)%3[[?I*= F)N2*GWV_23H3R=;M?Z$7+25= >)N2*GWVE.@/$W
M(]3[[?I(NARE;M?Z$6!*>@/$W(]3[[?I'0'B;D>I]]OTDIK<E82MVO\ 0BP)
M3T"8FY'J??:.@/$W(]3[[?I)35^H6$K=K_0BP)3T!XFY'J??;](Z \3<CU/O
MM^DFZW)Y2MVO]"+ E/0'B;D>I]]OTCH#Q-R/4^^T76XY2MVO]"+ D_0%B?D>
MI]]HZ L3\CU/XS1>.XY2MVO]",9C,D_0%B?D>I_&:.@+$_(]3^,T7CN.4K=K
M_0BX)1T!8GY'J?QFCH"Q/R/4_C-&9;D<G6[7^A%@2GH"Q/R/4_C-'0%B?D>I
M_&:+QW)Y2MVO]"+ E/0%B?D>I_&:.@+$_(]3^,WZ1=;CE*W:_P!"+ E'0#B?
MD>I]]HZ <3\CU/OM)S+<<I6[6192A*N@'%'(]3[[3SU>#L24D:NGL]9J]?9Q
MZ_Q$YEN2\+676+(\6EZID6$F%FNI4 $E0% 4$EI:7%8XWR3;.+QQ_:(O8M%-
MZ(L*$DIL%XDJF:T%EK=3K;2/4^,^W2_Q1R-5>^T9EN="PE9ZJ+(J"5]+_$W(
MM7[[1TO\3<BU7OM&=;D\I6[61-2F?;)6[1]B?D6I]]I3I?8HY%J?R1G6XY2M
MVLBA125KH^Q3R-4?DE$P#BOD2I_)&=;EN4K=K(J4525= .*^1*G\D= &*N0Z
MGWVC.MR>4K=K(F4)7TO\5\AU/OM^D=+W%?(E3[[?I)S+<E86MVLBA;F2SI?8
MJY#J??;](71]BOD.I_)^D9H[EN5K=K(D4)9TO<6<AU/Y/TE.E[BWD*I_)^D9
MH[CE:W:R* E?2]Q;R%4_D_2.E[BWD*I]]OA#-'<GE:W:R)J"6=+W%O(-3[[?
M"*=+S%O(55[[?I&:.XY:MVLB9:J$MZ7F+.0JKWV_24Z7>+>0ZKWV_2,T=R>5
MJ]K(D6DOZ7>+>0ZKWV_26]+K%O(=5^3](S1W)Y:KVLB68S);TN<6\AU7Y/TC
MI<XMY#JOR?I&9;D\M5[61$H2[I<XMY#JOR?I*=+G%_(53^3](S1W)Y:IVLB(
M4EO2YQ?R#4^^WPATN<7\@U/OM\(9H[D\O4[60]>,H3#I;XOY!J?R?""Z-\7\
M@U/Y/A$YX[D\M5[2'%"7KHWQ?R#5_D_2.EMC#D&K]]OTD9H[EEAJO:R'J"7K
MHUQAR#5^^WZ2G2VQAR!5^^SZ1FCN3R]7M9#BI+^EKC#D"K]]OTCI:XPY J_?
M;](S1W)Y>IVLAR+D%)@FC7&'(%7[[?I'2TQAR#6>^WPAFCN.!4[60Q03/I:8
MPY!J_?;X0Z6>,>0*O\GPAFCN65"IVLA9:KB:=+/&'(-7^3X13I98PY!J_P G
MPAFCN6X%3M9#<RF9,>EEC#D&L_)\(=++&/6L-9^3X0S1W' J;$-+?<)DNC'&
M?(-7^1X0Z6.,^0*O\GPB,\=R>!4V(7[A0FG2PQGR#5_D^$4Z66-/4[5?D^$.
M)'<G@U-F0QQ:33I98T]3M5^1X13I98S]3M=[[/I&>.Y*HU-B%E":=+#&?J>K
MO?9])3I88S]3U=^1](SQW+<&IL0PL)ITL,:>IZN]]OTE.EAC7U.UWOL^D9UN
M6X-38A>2E$)ITK\:^IVN]]OTE.E?C7U.UWOM^D9UN3P9[$,4L)JNB[&OJ=KO
M?;])\:S1OC&E9KOP]7ZO_AQ[3Y.9&9;D\*>Q#@X^]1!)2SR0U$4L<D?5,>FJ
MX^*KQ%BMK%I87E@)1O#F5/MNO7WBGRVG3YS!S*GVW7K[Q3Y;3I\\^O\ &>UA
M/EHUGS1GE4W7VR#YU"!\R/U.*O6I?WY/.:,\JFZ^V0?.H0/F1^IQ5ZU+^_+?
MZ12?ST=$  YSM/O%U"%Q;%U"%Q9$@ $@                           %
MDGD:EY9)Y&I#!\0 5(!Q7H,\M:P>SE^9>=J'%>@SRUK![.7YEYT4OA9Q8GYD
M#M0LE_J\I>62_P!7E.67PL[35*EJ\9<I8O&?'/JSGEU!]J^>V6"T\]<0R[.D
MR_HU.SJYW=H^UHI655<YDNJR&--K(_/BC;QFA=(&)Y\68@EK5X%''XU21>AQ
M)Q>_USV_8_L]8F7$GT1RXFNJ$;KJS/8CTKWVY+)3VF3G/;^)L5(B;3\)_'G[
M'(A\N(+M)XY)=+@^1>ONA_TF+*'V$*,(*T4>'/$5)N[9DN?EWY5N'?,GTE.?
M=WY6N'?,GTF.*%LJ*<66YDN?EWY5N'?,GTCGY=^5;AWS)])C@,J'%EN9'GY=
M^5;AWS)](Y^7?E6X=\R?28X#*AQ9;F1Y^7?E6X=\R?2.?EWY5N'?,GTF. RH
M<66YD>?EWY5N'?,GTCGY=^5;AWS)])C@,J'%EN9'GY=^5;AWS)](Y^7?E6X=
M\R?28X#*AQ9;F1Y^7?E6X=\R?2.?EWY5N'?,GTF. RH<66YD>?EWY5N'?,GT
MCGY=^5;AWS)])C@,J'%EN9'GY=^5;AWS)](Y^7?E6X=\R?28X#*AQ9[F1Y^7
M?E6X=\R?2.?EWY5N'?,GTF. RH<66YD>?EWY5N'?,GTCGY=^5;AWS)])C@,J
M'%EN9'GY=^5;AWS)](Y^7?E6X=\R?28X#*AQ9;F1Y^7?E6X=\R?2.?EWY5N'
M?,GTF. RH<66YD>?EWY5N'?,GTCGY=^5;AWS)])C@,J'%EN9'GY=^5;AWS)]
M(Y^7?E6X=\R?28X#*AQ);F1Y^7?E6X=\R?2.?EWY5N'?,GTF. RH<66YD>?E
MWY5N'?,GTCGY=^5;AWS)])C@,J'%EN9'GY=^5;AWS)](Y^7?E6X=\R?28X#*
MAQ9;F2Y^7?E6X=\R?2.?EWY5N'?,GTF- RH<66YDN?EWY5N'?,GTCGY=^5;A
MWS)])C0,J'%EN9+GY=^5;AWS)](Y^7?E6X=\R?28T#*AQ9;F2Y^7?E6X=\R?
M2.?EWY5N'?,GTF- RH<66YDN?EWY5N'?,GTCGY=^5;AWS)])C0,J'%EN9+GY
M=^5;AWS)](Y^7?E6X=\R?28T$Y4.++<R7/R[\JW#OF3Z1S\N_*MP[YD^DQH(
MRH<66YDN?EWY5N'?,GTE.?EWY5N'?,GTF.!.5#BRW,CS\N_*MP[YD^DKS\N_
M*MP[YD^DQH&5#BRW,ES\N_*MP[YD^D<_+ORK<.^9/I,:",J'%EN9+GY=^5;A
MWS)](Y^7?E6X=\O^DQH&5#B2W,CS]NW*M?WR_P"DD5CTD8HLST6.Z25L'$^G
MK/'F.]_A>\I# A#IQ:U1,:TXNZ9OZQ7*U8WI97VJ+G?>XX]>:W\39<DZJ/Z/
M_4\"IEQFF[3<*NV7&EK;?+LJB!^LUQOBY5,-[M%MQ'2LV<=>W^D,3^RG;O/_
M %^]F>)C\&J?OPZ'="IQHW\S$@ \M%092UVN.>&JK[E5)1VVD\EJ%WO<3MG@
MI('U=7%30*FTD>UK<^V8;2S>MK<8L/4#_P#AMJ1&]N67S;U7M9JW\8[<'AN-
M*[Z%U:$<\B^]Z29H72TV$J6*UT>66Z5CUIY?77K$/J,17JJEVE1=*Z1_W=0_
MZ3%E3WX4H05HHY)UYR\SW<^+GZ?N'?"CGS<U_P"_W#OA3PYKV1[I>R,^++<]
M_/FY^G[AWPHY\W/T_<.^%/!FO9&:]D60XLMSW\^;GZ?N'?"CGS<_3]P[X4\&
M:]D9KV19#BRW/?SYN?I^X=\*.?-S]/W#OA3P9KV1FO9%D.++<]_/FY^G[AWP
MHY\W/T_<.^%/!FO9&:]D60XLMSW\^;GZ?N'?"CGS<_3]P[X4\&:]D9KV19#B
MRW/?SYN?I^X=\*.?-S]/W#OA3P9KV1FO9%D.++<]_/FY^G[AWPHY\W/T_<.^
M%/!FO9&:]D60XLMSW\^;GZ?N'?"CGS<_3]P[X4\&:]D9KV19#BRW/?SYN?I^
MX=\*.?-S]/W#OA3P9KV1FO9%D.++<]_/FY^G[AWPHY\W/T_<.^%/!FO9&:]D
M60XLMSW\^;GZ?N'?"CGS<_3]P[X4\&:]D9KV19#BRW/?SYN?I^X=\*.?-S]/
MW#OA3P9KV1FO9%D.++<]_/FY^G[AWPHY\W/T_<.^%/!FO9&:]D60XLMSW\^;
MGZ?N'?"CGS<_3]P[X4\&:]D9KV19#BRW/?SYN?I^X=\*.?-S]/W#OA3P9KV1
MFO9%D.++<]_/FY^G[AWPHY\W/T_<.^%/!FO9&:]D60XLMSW\^;GZ?N'?"CGS
M<_3]P[X4\&:]D9KV19#BRW/?SYN?I^X=\*.?-S]/W#OA3P9KV1FO9%D.++<]
M_/FY^G[AWPHY\W/T_<.^%/!FO9&:]D60XLMSW\^;GZ?N'?"CGS<_3]P[X4\&
M:]D9KV19#BRW/?SYN?I^X=\*.?-S]/W#OA3P9KV1FO9%D.++<]_/FY^G[AWP
MHY\W/T_<.^%/!FO9&:]D60XDMSW\^;GZ?N'?"CGS<_3]P[X4\&:]D9KV19#B
M2W/?SYN?I^X=\*.?-S]/W#OA3P9KV1FO9%D.++<]_/FY^G[AWPHY\W/T_<.^
M%/!FO9&:]D60XDMSW\^;GZ?N'?"CGS<_3]P[X4\&:]D9KV19#B2W/?SYN?I^
MX=\*.?-S]/W#OA3P9KV1FO9%D.)+<]_/FY^G[AWPHY\W/T_<.^%/!FO9&:]D
M60XDMSW\^;GRA<.^%,E:L:8AM<FM2WFKXLM2:3:,3\%V:$>S7L@.,7U"J27F
M;0MU?9<=)N6KBIK/B-WD53%O053O.JG65??^216XT,]NKI:.NCU)X79/:G%[
MA&FKD;.KJCHMP'%>'\.[VI[::K<G]K$O42+[_P HY:E/+JC#$T(UX.<5[R_<
MA8 *'@ S&&K#5X@N.Y:/QN-G"EE?O-C9V5,.3V^2]#&%*&QP^-UE<QM37O\
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M%7^4^>:<]'W'L1?TJ9XOM-^_%>@ ![!Y@
M
M   -QZ+9=T:-[U2R)G'25T4S/PFY?J-.&WM$GVB8H]OIOC4Y,;\EG7@_C_)G
MN !\PC8D&!=1N((II.H@9))[S%0T?4S2U$\L\GDDDFN]?7-W8-^R-7]Y3?)-
M&'N^S%[C9&(^7$J #TSA8  (                             !(  (
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M)E])%N9<\*U,C41\E+G(W\'>=\&9EQ+3L=BPZ=/.:11"3= >).3E[M%X1\<
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MY2U2(:#VW>T5]HJ]C<(D8_L\>O[$NLEEK[U5[&@CVB>;\ZSUW"ZM<C)*]CP
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MJ^'65O";GUT0PA:+NKHSE%P=F $!)4
M                  &WM$7VBXI]OIOC4U";>T0_:)BGV^F^-3DQORI'5@_F
M?DSW  ^81T&?P;]D:O[QF^(T8;SP;]D:O[QF^(T8>][,^6RN(^"( !Z1P@
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M2H9M6;F>YWFLNNB$>0E--71,HRA*T@  4
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MAU-\3"]2*5D8X><I9FWY$1T8XLO-9C.DHZ^NEJ:>L;)P)DZA4:KN#^*9/2+
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M.W0M5,I9DJ*5E##LIG;^U;FS5=[J&:JR36IK+"TY1E[MK'*  .T\4
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MHQ^%OMGM/WW'\MID,=?;E>/OIWRC2E\1]![*^1+ZF"3B*E$XBIL=X
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M#+M;?524[UX.O#(K7? 7UUQK[CLG5]555"1]1MY%D^,\:ID!9$YG:Q<5 !4
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M>M2_ORW^D4G\]'1  .<[3[Q=0A<6Q=0A<61( !(
M      !9)Y&I>62>1J0P?$ %2 <5Z#/+6L'LY?F7G:AQ7H,\M:P>SE^9>=%+
MX6<6)^9 [4+)?ZO*7EDO]7E.67PL[352EB\9>I8O&?&OJSG?4Q^-?*OQ5_E/
MGFG/1T+C7RK\5?Y3YYIST?<>Q?PL3Q/:?S%]  #V#S0
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MT+5K+-*V:A901[!R+GG&S5_4AR@"O >EWT+\_%9K1Z@ '2>:
M                  #;VB'[1,4^WTWQJ:A-O:(?M$Q3[?3?&IR8WY4CJP?S
M/R9[@ ?,(Z#/X-^R-7]XS?$:,-YX-^R-7]XS?$:,/>]F?+97$?!$  ](X0
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M>/OIWRC'X6^V>T_?<?RVF0QS]N5X^^G?*+T_B/H/97R)?4P2<14HG$5-SO
M                   !O"711AV"#6GK[@QB>:?-&GPJPT>=%:7/*]N>7_A?
M.L,*K::29VX2,7&3DKV(_'HLP[4HJT-TJ7O3K[2*3XFFM,:85J\*W".&>57T
M[]Z*7SWUBF 8J]^+;8MLBD1\<S=?4\RW6X6M]SD;.T\N9T/6]O\ ;K5<'V.H
M[6_9(3<9)-W+N$*M-R2LT:3!MO2?@^Q6/"^Z[90I!/MF-U]H]RY;_952+:*K
M+07[$5327:FW1 VE=(C5>YO"UV)YE4[*FBJ)K,<SH24U#S(S8:..OOE!1U"R
M[.HJHHGZJY.U57(F&DW!U!A:"@?;YJJ5:B1VOMGMZR-[#4*WFUTEFTKVJCML
M6Q@CJJ7@;17<:M[)LS2'9[5<(:*JOU7N>@I5=K[^2O5V62? IG*I:2.FG062
M2\SG7,SF";1!?,2T5KJYI8X)]?62)<G;T:NXUS\Z;/AP/@_$MKD?AR58Y&<'
M;,>]^3ONF/7Z"%Z.:*>WZ3J"BJTU9X))VN[?C3R[J*2=C)8=QG&^J9],6X0M
MUDQ;9K9#4524E8L>U?+*W6:BR9*O4IVCYZ1<+V;#\-#)::Z6HEGD=K:\C'9Z
MJ)V$0D^E.G96:0L.TU1&DU//LXGM^Y=+DIB]+F&K5A^DMCK32[GEFD=K+M9'
M<6JO753.,G=79I5I)*=ET-:Y9%38VCW $=XMW/:]S214*]1&Q=37:G&JKYW>
M^ D%%A[1Y?)7V^U2952)QMEEUO<U]Y?<-'52=C&.%DU>YIDH9_&6')\,W1*2
M2598Y.'%-YYI'LC1.ZNC"47&65FUTT<VA,#<^]TU^Z.=VZ]7:,U=;9:V74<6
M9JE%.DK;2/KM&E+10ZNUGM#(6:W%FZ')/C-:=*&^^FK9^._P#GIU>MSNK8=^
M[D1[TT<VGH(Y];JK]T<[MU:NT9J:VRU\NHXLS5**=)7*C?0Z,ZNBER66GM+X
MG*WBS;"J+E[QI+ N%:C%%PV3)-E34ZHZ6;]GUU+4YZ-LKB*%G&,%J1P&XY;'
MHZH*I+95U7],7@J]]1)GGVW)P47UR*:1\#]#>RK;?+))02/U5UNJA5>N755-
MV,IX:45?J0<&T\-8"M%)AOGWBF618WQ[96,X#6-7BSU=]RGMLU@P#BALE-:8
MZF"H8S67AR(Y&^>X>;2'52)CA9-=35=@HXZ^^4%'4+)LZBJBA?J;SM579$QT
MF8-H,+0T#Z&6JD6HD=K[:1.MJ]A$,=%9GV#2=;Z"219-2N@5KU\TU9$5"=Z<
M]DL5A2I_J^Z';3UN"5E-YU8M"FN'*_5$1P9H^?B6T\\(Z^.GR>Z+4V6OEJ^Z
M8#!5I@OF)**V5<LL<$Z/UDB7)V]&KN-<_.F^< OLTMB5^&HGQ4"RNX+];>=O
M9\:J:^P]+A>32#AQ,*4\L2_TG;J_7]"75ZI5^Z*\23N:O#Q64C>DG#5)ABZT
MM+02U,D;X%E7:JU4WG9=9$(@AO['MCLE5=:2Y8DKT@HXV)"R!5\E=FJ]C6]X
MQEPT>X;O-BDJ,,\"74<D4C)W2-<Y/,NULRT*J2U*U,*W)Y32H*)URIN<(  (
M                  **9W OVX6?[Z;\HP2F=P+]N%G^^F_*(ET9:G\2,'BW
M[:;U]]2_..,29;%OVTWK[ZE^<<8D1Z'S=?YDOJ"3Z,/MZLWMZ_)4C!)]&'V]
M6;V]?DJ)=&:8/YT?J9>Z_9>K^^'_ "CSGHNOV7J_OA_RCSE?(^HEU  (*@
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MU"!\R/U.*O6I?WY9?*9G/YZ.B  <YVGWBZA"XMBZA"XLB0 "0
M                "R3R-2\LD\C4A@^( *D XKT&>6M8/9R_,O.U#BO09Y:U
M@]G+\R\Z*7PLXL3\R!VH62_U>4O+)?ZO*<LOA9VFJE+.N7J6+QGQKZLYWU,?
MC7RK\5?Y3YYIST=#8T36T68K1G'_ $;Y]#GGK9GW'L7\+$\3VG\Q?0  ]@\T
M
M                              &WM$/VB8I]OIOC4U";>T0_:)BCV^F^
M-3DQORI'5@_F?DSW  ^81N9_!WV1JOO&;XC1AO+!F]<*IB>224LVI^*:-/=]
MF?+9&(^"( !Z9P@  @
M                                             $ZT2?9N\_X/4?&T
M@I.M$GV;O/\ @]1\;2E3X&;4?B,  #D/F9=693"WVSVG[[C^6TR&.OMRO'WT
M[Y1C\+_;/:OON/Y;3(8Z^W*\??3OE&E+XCZ#V5\B7U,$G$5*)Q%38[P
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M9%[!#3X=B(5(\=N^AK*O_KE5[8X^"=<^M6[:5<TD?D<CW'S.H\^74  $
M              %%,[@7[<+1]]-^48)3.X&^W&S_ 'TWY1$NC+4_B1@\6_;3
M>OOJ7YQQB5,MBW[:;U]]2_..,2I$>A\W7^9+ZE"4:,/MZLWMZ_)4BY)]&2Y8
MYL_MXET9IA/G1^J,Q=?LO5_?#_E'GR/3=TRN]?\ ?#_E'FS*^1]1+J  "H
M                  !.=#WVS5/WF_Y;!I@^V6F^]&_+>>#1O=J*RWN6JN,V
MR9)3.9KZBN3/6C[!/:O$^#*Z37K9*6H?U.M-2.=\;3"5XSO8[:>65'*W8A&B
MNA?4XGAJF^1TK'N<_MN;JZOP_ 933'5LDKZ"FRWX6.>OX6]^R9FMQW8K91(R
MS1ME\XR&/9Q_J-576NGN-PDK:J1))WIUD+13E+,R)RC"&1,VW=_*FB^\:?\
M8(?H_P -5%X2:>2KDIZ.-ZM\:7A.<9:XXFM,VC^.V1U?],6EBBU-F_JFZN>_
MJY&+T>XKI['!)0W%)%@D>LC9&IFC'+UBJ3RNQ9RBYQN>JHJ,$VRLDU*.IN$\
M;^/C;K>^GQ$ETN?:BOM[/B4P%578(HJK=])%+6U.OKLB\<U5=^$F1]<?8HM%
MYPUL:.I5:C78[9+&_P"C(C*[HMFBH25T9O"6<VC-(Z#R=8)V,]LX61J&@AGE
MN$4=/GNG:-U/9$RT?72]6R*1(+755EKD>O49<!>OEVC)5F.;8Z?7LEG_ .*3
M\!LSXV-=K+ZV;E)5XME7::BV[6,KIB3_ )8IOOMOR'GWP:[5T90O;QL@G5/Q
MGGFTQ/RP[2-:O#W6W+N;S%X<Q-::/ 2V^HJMG5["=NILWY;[GY<+5RZY5*\$
M7<DJCOL0?"BY8HM:?_-1?+:3_3/_ %6U^SD^)IKNPSQTM]H*JH39QQU43W/^
MY1Q+])>(;;>Z>WLMM1MU8]^NFS<W+J>RB&C7OHPA)<*29*,*Y]+%-S)X[N6?
M+V?"_6:@I-JM9%N?R3:-U/9$JP+B]+!M:6KBEDH7O5R:O51*O6R))#=\"TU6
MMQA8B5:\+)L<G'ZW49D:Q;T+^[447>UCVZ8=3H:IM?JMU,U?7U7&+L>+I**R
M14>(K/5)3L:D2S;/@N;ULT7M$6QGB=^(JN/*-8J.'?B8J_E.))9\8VFOLL=L
MQ-%(B,8UNOEP7Y<2\%=9'$9;1Z#B)U&T[&2IK)@[%$4O.MNSJ(^JV*N8YGX*
M[WP&L[];9+1=*F@?+M&P/SU_A:;#H+_A##4,LEG66HF?V$=GZV;\C75WKW72
MZU-9,FJZ9^LB=A"U.]_0I6<;+<VSB[RKO^A3?*8131!]L]5]Z.^6PSMGQE8J
MO#T=OO:[-61MBE9)&KFNR3M(8;#MXL5IQK7U-/,E/:I*?4B\:DWW<#M9^9<5
MLU%JQK)QS1E<Q^D[43',NUZC4BS]XF^EG:-PI'N?J-NW7]CJNR_*U37./;E2
M7;$TM30R[2%\;.'LW-\SVT)-AK&] ^U);<1Q[2/9ZFNK-9'M^Z)RNR>Q2-2.
M:46^I#<.QW:2X*VR;5*M(]_92:O!/36I?J/$-,ZO262YQZKV:_CKM[BXB=08
MEPAA^.1UFC62=_H;'[_X3C7TM]JI,0)>'[U6CMKEYG)OF2=9:V*2BH)*YL.;
M%]IKHHZ;%5GFII>--O!K-]=.OE[A\JW!=BO5LW9AR5(Y.-NH]SHW+V%1=]"V
MKQ+A/$E-&M[CEIYV=9=;-GX33Y5>,K+9[-)0X8CD>F3M5W"U6*OFN%OJ4RM=
M#?-&SS-,UH #H//                       !*ZD+YH'RWK_\ ]#_\>(UT
MAL7F@?+>O_\ T/\ \>(UT33^%%:_S&;OYE+[;KW]XI\MIT^<P<RE]MU[^\4^
M6TZ?.*O\9ZF$^6C6?-&>53=?;(/G4('S(_4XJ]:E_?D\YHSRJ;K[9!\ZA ^9
M'ZG%7K4O[\M_I%)_/1T0 #G.T^\74(7%L74(7%D2  2
M           62>1J7EDGD:D,'Q !4@'%>@SRUK![.7YEYVH<5Z#/+6L'LY?F
M7G12^%G%B?F0.U"R7^KREY9+_5Y3EE\+.TU4I8O&7J?->-3XU]6<[ZGH2A6\
M6*]69BY/KZ5S8O9M3-#F1S=3@.XSIBDGDI9HIXO)&$ TN8,5\LF*;#'M*2?A
MUL+5\@DZ[O8J?5>P<7')P6SSO:%#B14H]4:E !],>&
M       !F
M             #=F!J1]JT6QO>OCMUKG2M3_ ,*/@_'\9 ]'>#)\47';3KN>
MRTJZU55O7+>\ZG;4VC?K@RNJH4I8D@H:>-M/!%EEJL;Q'E^T:Z4,BZL[\/3R
M)SEY]#%  \%%C,80JVT>):%[NID?LES[+]XU-B>UOLF(J^@D7^KSN:GL>L[W
M6FP3VXRL:XTM,5SMBMDOU S4JH>)U1&G4O3[I/U^L>I[.KJ#R,M*'$AE75&G
M@55,BA[AYP  (                    !(     (
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M62.>)8I(^KC>46Q]7&:JQ4X]&4  )  R  &0R         R
M      )/@W%\^']I#)%NFCD?K:B=4UR]@D*8RPO#6;LI['+NQ/-I$QN_[^?P
M&MT09%7"+9K&M**L9G%>(ZO$55'+,FRIXUSBA\ZO97MF%09%<B5&VA24G)W8
M R!-BH    &0  R&0  R49+V  !DO8&0     *9@%0
M4&8!4% H ,IA>@YYXBH:;K2/:K_8MWU^ QC6;1-6/?D/9C*[LT?89J84E_YH
MNT.R:S>UJ.!W&KNVO6[:=HK)^2+P7F^B-2:3KLR]Z0;_ '"!VTCDJ7,B>GFF
MLX"? TBR &L59&$Y9G<W=S*7VW7O[Q3Y;3I\Y@YE+[;KW]XI\MIT^<%?XSV,
M+\M&L^:,\JFZ>V0?.H0/F1^IQ5ZU+^_)YS1GE4W3VR#YU"!\R/U.*O6I?WY9
M?*9G/YZ.B  <YVGWBZA"XMBZA"XLB0 "0
M"R3R-2\LD\C4A@^( *D XKT&>6M8/9R_,O.U#BO09Y:U@]G+\R\Z*7PLXL3\
MR!VH6R^02EQ;+Y!*<LOA9VFJ5+%XRY2U>,^-?5G.^H0]-OKI[?+M()/9,7J7
M>N>9 B%H2E!YHO4JV8R^X(PG?Y=NV&:Q5K]]SJ;A0O\ P/HR(P_0[&J>,8LH
M-3[N!S?VB<.3B![%+VUB(*SU,)8:E-W:()TG5]4]!^(\KTG5]4]!W-Y.@XU\
M=K[(IR5'8@G2=;ZIJ#N;QTG6^J:V=S<3DM)\>K[(CDZ/:0KI.M]4UL[FHZ3K
M?5-;.YJ34#QROLARE'8A72=;ZIK9W-1TG6^J:V=S4FH)\=K[(<I2V(0NA]OJ
MEMGXC_I'2?;ZI;9^(_Z2:@>.5]D.3H[$*Z3S?5+;/Q'_ $CI/M]4ML_$?])-
M5 \=K[(AX2CL0KI/-]4ML_$?](Z3S?5+;/Q'_234H2O;M=^2(Y6CL0OI/-]4
MML_$?](Z3[?5+;/Q'_23,%O'*_H3RM'8A?2@;ZIK9^(\=*%OJFMGXCR9 >-U
M_0<K1V(;TGV^J>V?B.'2?;ZI[9W-Q,BTGQNMLB.5H]I#^D^WU3VSN;ATGV^J
M>V?B.)@"?&ZVR(Y6CVD0Z4#?5-;/Q'#I0-]4UL[FXEV8S(\:K;(<M1[2(=*!
MGJFM?<W_ $E.E"SU56W\1_TDO+2?&JVR(Y:EVD2Z4+/55;?Q'_2.E"SU56W\
M1_TDM \:K;(<M1V(ETH6>JJV_B/^D=*%GJJMOXC_ *26@GQFMLARU'8B/2A9
MZJK;^(_Z2G2B9ZJ;;W-_TDN+1XS6V17@4EY$3Z43/53;>YO^D=*-OJJMO<W_
M $DL*$^,5MD.!2V(ITI&^JJV]S?](Z4C?55;>YO^DE8'B]8<"EL13I21=?%5
ML[F[Z1TI(O55;.YN^DE()\8K#@4>TB_2CB]5=L[F[Z1THXO57;.YN^DDPS'C
M%78<"EVD8Z4D7JKMG<W?2.E)%ZJ[9W-WTDG*CQ>L5X-+M(OTI(O55;.YN^DN
MZ4D7JJMG<W?228L)\7JC@TNTC72DB]5=L[F[Z1TI(O57;.YN^DD@)\6K$<*E
MVD;Z4D7JJMG<W?2.E)%ZJ[9W-WTDC!/BM4<*EVD<Z4D7JKMG<W?24Z4T/JKM
MO<W?220M'BM4<*EVD>Z4T'JKMO<W?2.E-#ZJ[;W-_P!)(2@\5JE>'3[2/]*:
M#U5VWN;_ *1TIH/57;>YO^DD 7B)\4JCAT^TC_2F@]55L[F_Z1TIH/57;.Y/
M^DSJ\8WQXI5&2FO[3!=*:#U56ON3_I*+HF@]5=K[F_Z3/Y=LM'BE49:?:8+I
M30>JNU_B/^DR=!@+"%J=M[G<ZJ\O]"B9N://MKQY>LIZRW(B7M*K)6"4(ZJ)
MD;E=I*JDBHX(HJ.@@R2.DITU8VY>M[IC4"@XI3E-WDR)MR=V6@ A% ?6FJ)Z
M2JCFI)4C<Q,FN8?(M7>)3L[HE.W0RMVCP_BARR7ZBEHZ_P!/4/FO9M,&_1S;
M7KKT>+*79_\ C0/C<>@H=L,=5@K$N47K*-SR=+:E]5=L_$4=+6E]5=K_ !%/
M7D4+^)52/N^T\O2TI?59;/Q%'2TI?59:_P 13T!2R]I565?#[3S]+2E]5EL_
M$4=+2E]5EL_$4^P)\0J$?=]I\NEK2^JNV?B*4Z6U+ZK;9^(I]B@Y^H/N^T^?
M2VI?5;;/Q%*=+>E]5ML_$4^I0GGZ@^[[3Y=+>D]5MK_$4=+BD]5MK_$4^Q:.
M?JE6Z?:?/I;TGJMM?XBE.EO2>JVU_B*?0#GZHS4^TLZ6])ZK;7^(HZ6])ZK;
M7^(I=QE%0E8^H.)#M+>EQ1=?%ML_$4=+BB]5ML_$4*N0S+<[4(SP[1TN*+U6
MVS\11TN*+U6VS\12@(YZH1GAVEW2YHO5;;/Q%'2YH?59;/Q%+"BD\]4(XD.T
MOZ7-#ZK;9^(HZ7-#ZK;9^(I\E YVH.)#M/KTN:'U6VS\11TN:'U6VS\13Y%%
M)YVH0ZL.T^O2ZH/5=;/Q%'2ZH/5=;/Q%/D!SM0CC0[#Z]+J@]5UL_$4=+J@]
M5UL_$4^18_>)YRH.-#M/1TNJ#U76S\11TNJ#U76S\13S%!SE0CCP[#U=+R@]
M5ML_$4MZ7E!ZK;7^(IY066,J$<>/:>KI>4'JMMGXBCI>4'JMMGXBGD+2><J$
M/$1[3W=+R@]5ML_$4=+R@]5ML_$4\('-5-RO,Q[3W=+V@]5ML_$4=+VV^JVV
M?B*>!>(^8YJIN1S4>PR?2]MOJMMGXBCI>VWU6VS\13& GFI[CFH]B,GTO[;Z
MK;9^(I9T 6WU8VM/^FICD#NL.9F5YR*_L1D>E_;?5C;.YK](Z7]M3CQC;.YK
M])BP3S$]P\;'L1E4P#;/5C;.YK](Z ;9ZL;9W-?I,2I:I/,3W*\['L1E^@&V
M>K&V=S7Z1T VWU8VSN:_288M)YB>Y7GH]B,WT!VWU8VSN:_2.@*V>K&V=S7Z
M3!*6N)5>>YG+VBE_8C/= 5L]6-K[FOTCH#M7JQMG<U^DCH)XT]RGB:[%^Y(N
M@2T^K&U_B*.@2T^K&U_B*1W(9$\6>X\478OW)'T"6GU86SN:_2.@2T^K"V=S
M7Z2-@<66X\378B1] EI]6%L[FOTGTAPOA*WN<ZY8AFN&7_=Z&#5_+=O?$1D$
M<26Y#]J;01*+GBEC+;+:L/T$5KMC]Y[6)K2SKEYM_O\ OD5R+BA4XJV(G7=Y
MLH "3G!=&]6<)F\_LEI1"OF6C)K5$VI\6T5UI(J;&-!NQ(^ VNI^#.WU^R7.
ML&&JG)U#BN./[BL@5KF^Z0@(7N_(].E[5JQ5I*_U)KT*VGU6VSX1T*VGU6VS
MX2%9#(G/(U\7?8B:]"MI]5ML^$="MI]5ML^$A0&>0\7?8B;="MI]5ML^$="M
MI]5ML^$A):3=[D^+OL1-^A:T^JVV?".A:T^JVV?"0A0@N]QXM+L1-^A:T^JV
MV?".A:T^JVV?"0@"[W'BTNQ$WZ%K3ZK;9\(Z%;3ZK;9\)"%*"[W'BTNQ$XZ%
M;3ZK;9\(Z%;3ZK;9\)!@+O<GQ9]B)ST*VGU6VSX1T*VGU6VSX2# 7>X\6?8B
M<]"MI]5ML^$="MI]5ML^$@P%WN/%GV(G/0K:?5;;/A'0K:?5;;/A(,!=[CQ9
M]B)ST*VGU6VSX1T+6CKXMMGPD$ N]QXL^Q$[Z%K+ZK;9\(Z%K+ZK;9\)!"T7
M>X\6?8B>]"UE]5ML^$="UE]5ML^$@0)UW)\6EV(GO0M9?5;;/A'0M9?5;;/A
M($!KN/%I=B)]T+V7U6VSWU'0O9?5;;/?4@68S&NX\6EV(GO0O9?5;;/?4="]
ME]5ML]]2!9C,:[CQ:78B>]"]E]5ML]]1T+V7U6VSWU(%F,QKN/%I=B)[T+V7
MU6VSWU'0O9?5;;/?4@68S&NX\6EV(GO0O9?5;;/?4="]E]5ML]]2!%!KN/%I
M=B)]T+V7U6VSWU'0O9?5;;/?4U^!=[D^*OL1L#H7LOJMMGOJ.A>R^JVV>^IK
M\"[W'BK[$; Z%[+ZK;9[ZCH7LWJMMGOJ:_!-GN/%9=B-@="]F]5MK]]2WH7L
MWJNM:>ZI 2A.NX\5EV(GW0Q9?5E;$]U?I'0Q9/5E;/?7Z2  BSW'BS[$3_H8
MLGJRMGOK](Z&+)ZLK9[Z_20 "TMQXL^Q$_Z&+)ZLK9[ZCH8LGJRMGOJ0 "SW
M'BLNQ$_Z&+)ZL;;[ZCH9LGJQMOPD  L]QXJ^Q$_Z&;)ZL;;\(Z&+)ZL;;\/T
MD  L]QXJ^Q&P.ABR>K&V^^OTCH9LGJRMOOK])K\ID6M+<GQ1]B-@=#%D]65M
M^'Z2J63#%*FO7XLCE3SE' Y[G>Z:]R"#*]P_:;M\")[68SI+52RTN#*"2DVG
M!?75/"J'^MV""2.UTUG[[RF\4)4;'%6Q,Z[]X  L<P  )+X99:>HCFIY)8Y8
M^$Q[.J8; H\=4%TCBAQ?0R2S,X++A1HULR>S3B7_ 'O&NE0*F95PN=5#%3H/
MW3:24N%ZE$=1XKIHXU\S40.C<GOY%W.RPI_^K;7\/TFJLBU2N1[G=XK+M1M?
MG78O5;:OA'.NQ>JRU_":H R/<GQ67:C;'.NQ^JRU_"%MEB3CQ;:_A-3*449'
MN/%7VHVSSML/JMM7PCG;8?5;:OA-2*"<CW++VH^U&V^=MA]5MJ^$<[;#ZK;5
M\)J0#(]R?%'VHVUSML/JNM7PCG;8?5=:OA-1EHX;W'BC[4;>YVV'U76KX1SM
ML/JNM7PFH2P<-[D^)OM1N'G;8?5=:OA'.VP^JZU?":>!/#>X\3?:C</.ZP^J
MVU?".=UA]5MK^$TZ!PWN/$WVHW%SNL/JMM?PE.=V'_5;:_A-/%HX;W)\2?:C
M<?.[#WJNMGOJ.=V'O5=;/?4TX6#AO<E>T7VHW-SNP]ZKK9[ZE.=^'?5?;/A-
M-;Q:.&]R?$/^*-S[@P[ZL+9\(W!AWU8VSX32X&3U'B'_ !1NG<&'?5C;/A*;
M@P[ZL;9\)I<HJ$Y'N2O:'_%&Z=P8=]6-K^$;AP[ZL;9\)I3-0,CW)Y__ (HW
M7N+#OJPMGPENXL/>K*U_":4 R/<<]_Q1NK<.'O5E;/A&X\/>K&U_":3*9#(]
MQSW_ !-W;BP]ZL;7[RC<6'O5C:_>4TBY.(MR&1[D\[_Q-X;BP]ZL;7\(2DPY
MZL[7\)H_(MS[ R/<E8U]IO+<F'/5G:_A+=R8<3_]9VOWE-';XWQD>Y/._P#$
MWCN7#/7QG;/A&Y<,^K.U^[F:,&0R/<GG/^)O):?#7JRM'NYC<^&O5E9_A-%J
M6Y$9'N3S?_$WON?#7JRL_P (W/AKU96?X31 &1[CFUVF]]SX:]65G^$;GPUZ
MLK/\)H<HHX;W+<TNTWQL,->K*S?"-AAKU96;X30J\9:.&]R>97:;\V&&O5E9
M_A&PPUZLK/\ ":#**.&]QS*[3?NPPUZLK-^4-AAKU96;\HT I8.&]R5B5VG0
M6PPUZLK-^4-CAGU9V;X3G[(M5!D>Y/,+M.@MEACU9V;X1L\+>K.S_"<]C>(R
M/<<==IT)L\+>K.S?"622X-I%UZO&5 L?G::!\B_ <_*6$9/4LJR[3<]UTJVF
MR1R08&M<KZS+?N5R3-S?81_[]933]QKJJY7"6MN%3)4U4[]9TSUUG.//UPY,
M\B5%(B55RT*+Q%BEQ:I<R-W\RE]MU[^\4^6TZ?.8.91^VZ]+_P#(_O&G3YY]
M?XSVL)\M&L^:,\JFZ^V0?.H0/F1^IQ5ZU+^_)YS1GE4W7VR#YU"!\R/U.*O6
MI?WY;_2*3^>CH@ '.=I]XNH0N+8NH0N+(D  D
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MF  ,QF  ,QF  ,QF  ,QF #YGTS/F"4  2BR  )1"  !(*%2A*#  )(!0J4
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MZG%7K4O[\V7RF<T_GHZ( !SG:?>+J$+BV+J$+BR)  )
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MPC"]O\FFND@O+Z=Y_P#F%O2/[.(/T/\ \PW.!QY;CP?"]IICI'__ %_]#_\
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MJE3O!?X@Z0Z^J1.\/_,-X <Q/<GPS#]IH_I#.]4B=X?^8.D*OJD_0/\ S#>
M',3W'AF'[31W2%7U2IWA_P"84Z0J^J1.\%_B&\@.8GN/#,/VFC>D)_\ <GZ!
M_P"85Z0G_P!R?H'_ )AO$9CF)[CPS#]IHSI!_P#W)^@+_$'2#_\ N3] 7^(;
MS YBIN/#,/VFC.D$OJD_0?\ S N@)?5)^@_^8;S YB>Y/AN'[31:Z <__P!2
M_H'_ )A3I ?_ '+^@+_$-ZC,GF)[D^'8?M-%=(#_ .Y4[P7^(4Z0'_W+^@?^
M8;VS YB>X\.P_::)70!_]R_H'_F%/$_?_<WZ!_YAO<$<>IN/#L/VFA_$_?\
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M'SJ$#YD?J<5>M2_OSH_TCBG\]'1  .<[3[Q=0A<6Q=0A<61( !(
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M-/7^ZS7FYRUDZ^2=0SSC>LTQJH$!]M""A%1B?D=:K*K-SEU94 &AD  2  "
M  0P  0         4                        *@ @@
M                   !H :)1> "IN      7%S2TN:5++J7  &@      :7
M%K2X@E  $$@   O0L+T(9>)4 $%P      A4HA4       %2A4A@  $@
M !"\L0N:0RT2H (+   %   5:?0^;3Z (  $@     % 4 !4 $$@ $ %Q:7
M  $D@ $   D!0%!5EO(  @      %P !<   %I<6A@JA>6(7A!   D
M  H   2@  2"XM+@          5*%02@ ""X  )            !5"@ /H "
M"H        )0  )      * HA4$@     %2I0J"4  "0       "A(
M+FEI<TA@J  2                  #Z'S/H&&  00               44!
M027B6@ %@     "]I4HTJ4            +  ]DMMJH:;=3Z:5('^:]<AR2Z
MEHP<NB/& .(71%F 71QOEE1D:;660]%;;ZJ@V6ZX]3:=2')72"C*V:VAY7'J
MME=)05<53"B*C>L><H)14E9DQDX24D;DHYV55)%/&G D9K'V(_@>;:X?C^X>
MYAGT/"J1RR:/L*,^)3C+<UIS1GE4W7VR#YU"!\R/U.*O6I?WY/.:,\JFZ^V0
M?.H0/F1^IQ5ZU+^_-?\ 2.>?ST=$  YSM/O%U"%Q;%U"%Q9$@ $@
M                   %DGD:EY9)Y&I#!\0 5(!Q7H,\M:P>SE^9>=J'%>@S
MRUK![.7YEYT4OA9Q8GYD#M0B&E/[4Y?;&_&2\B&E/[4Y?;&_&6P?SH_4I[5_
M!U/H:5 !]J?DP !(        *L  $         %         68  *@
M     %0 00                                   "47@(5:5-T4
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MF(         *E"H)0!4H063N  "P              !]  05        !*
M!(      *%2@"  !(  !4J4*@E   D        H2      "YI:7- *@ @D
M                'T+&=<O((                  ** H)+QZ%H !8
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M,C]3BKUJ7]^77RF9S^>CH@ '.=I]XNH0N+8NH0N+(D  D
M             LD\C4O+)/(U(8/B "I .*]!GEK6#V<OS+SM0XKT&>6M8/9R
M_,O.BE\+.+$_,@=J$0TJ?:I-[8PEY$-*GVJ3>V,+8+YT?J4]J_@ZGT-*@ ^U
M/R8  D           %         "&  "H     +,  %0            A4HA
M4,,  @@                                $H^B%2Q"\HS>/0M !(
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M>D?/@         J4*@E%2A4H03'J  "X              !]  05
M!*  !(      *%2@"  !(   +BTN!*  !(       !0D      %S2T %X ()
M                  !]#YGT##  ((               ** H)+KH6@ %@
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MV"^='ZE/:OX.I]#2H /M3\F  )           !0         A@  J
M              $*E$*AA@ $$                                 E%
MS"YQ:SKESBC-H]"@ ))   !5"A5 #Z@ J;       JA0J@)74J "I(   +D+
M2Y RR+@ 5-         !F,P !F,P "H  *@ @D      %6<10H0RR/H ""P
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M?^&R//W44B%[NTUXK]T3\%.I8SSC3'(!3P\*;S+J*V.JUXY9/0J5+0;G(7
M       %2A4$HJ4*E""8@  N               ?0%"I!4        $H  $@
M      H5* (  $@   J4*@%0 "P       !0D         O !!(
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M-T]L@^=0@?,C]3BKUJ7]^3SFC/*INGMD'SJ$#YD?J<5>M2_OS1?*9G/YZ.B
M <YVGWBZA"XMBZA"XLB0 "0                           "R3R-2\LD\
MC4A@^( *D XKT&>6M8/9R_,O.U#BO09Y:U@]G+\R\Z*7PLXL3\R!VH1#2G]J
M<OMC"7D0TI_:G+[8PM@OG1^I3VK^#J?0TJ #[4_)@ "0     0  "0  4
M    " ("&  "H                 )   "%2B%00  00           "0
M0                  7,ZY52U"XJ;0Z   L      ?1I<6IQ%Q4U0  )
M ;O)D A 74N !!8   %R%I<@!<"A4J;  H 5!09@%04*H 5        !4 $$
M@      H5*$,E'T !!<   %"I0 %6E"K0#Z #,$@#,  #,  H5*   $!   D
M   N  )       0 ADH  J2      "XM+@2@  6   +2HR! +P 22
M 0V  "H  !8   N         *M*%0  "&60  +   D            'T/F?0
MAD,  $         L      "A4H @  2   "I0J 5  +        %"0
M  #Z,ZY0HTJ02                  #Z'S/H&  ""       "B%0
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M(33K<1NZ*5L-PDM;ZM?H >]UHN,;->2AJV,Z[MBNJ>#C-(SC+1,PG2G#XE8
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MZ,EPE'XE8J#UNM5R;%K;@JM7L[!3R=81DI:)B5.4=6K%2A4H6*  $,(  $@
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MN5#Z+3SMI5J7QR[!^^R74X/ODMI%5%ZGQ !(  !(      /H?,^A#(8  (
M      !8       %$   !(   *E"H!4  L        0P  5) &8  !-E?2V_
M"%!6K;:*=\CM1VTC;EYK?XNT9U:F2UEU-Z%#BWN[6U(4A<2.+$5!QSV*BV?F
MM5C57XBW%EK@H9:>:A\AJFYM9_OV12-5YLLE8TEAUD<X2O8CP/O!1U=4F<--
M)(GW,:N*5%//32ZD\4L;_NV:IKFC>USGRRM>Q\0?5T$[8HIEBE5DG4NV?!<5
MGIYZ=-2HBEBDD\_'JD9D'"6Q\0>I]NJ8HEEEI:J./SVH[5/*2I7Z,B4)1^)
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MG%7K4O[\T7RF9S^>CH@ '.=I]XNH0N+8NH0N+(D  D
M          LD\C4O+)/(U(8/B "I .*]!GEK6#V<OS+SM0XKT&>6M8/9R_,O
M.BE\+.+$_,@=J$0TI_:G+[8PEY$-*?VIR^V,+8+YT?J4]J_@ZGT-*@ ^U/R8
M%\3))IHXHX]I))P6M:6%\;WLFBDCD6-\?"8]A$K^1,;7U,BEBNN7V*K.XJ46
MPW9.*W5G<5+.?5UY4K.[O^DIS[NR_P#Q2L[N_P"DYK8CT.[^CM_<> F^B9C7
M7ZH<J9R-IG(B]K60A!G,&W?G-?HJA_D*^-R^Q7K_  $XR$IT9)#V94C2Q,93
MZ&'GDDEJIGS[\DDCG/\ 9%(%D;+E#M-KYG4XR:XCPE5555)7V/95=#5+M&I&
M_+5SW\T[)],*X;EM55SWORI24U,FNQCGYJKNVAAS=-4M.NQTOV96>(L]([^F
MYB<*75;;<*V>2GJ*RY2,U($V>MJKV^N2/#4F,)KS3NJTGW(YZ;5)V,8FKU\D
MXT+\/54MWIL1UUJV4=WF<U(\\M9L>2:OP9^Z8^RV>^R7FFJ;W-)3TD$K7N=4
M3YZSFKP43?ZYPUFIYFTD_7K^1ZV'INGPU%N2OY:+KYGWHX6T^EQ(HX]5FT?\
M,*J>/%F))(:BNM%J;##0QZT4GC>LZ15ZKXU,J^FE@TMQ32LU8IM98W>>RAR4
M@6(,EOMS^^I?E%Z$(U:B<M;11ABZTJ%&48Z7F_TT)C?KD["EIMUKM64$\L39
MYI<N$N>\ONYGWP%B:IKKRRANCDJ%76?!(YF3F.R7]6L?*^V]V+;-176UY354
M4.QFBSR<N76]?//WSZ8"PS4T%X96W2-(%8CF0-<_-SW*B[_XNL4EPN!+/\?[
MF\'B.;AP_EZ?2Q\L$(BZ0;M_U_G$/%@F&&@M5SOM1"R62EU60([K/7_^9I[<
M$;VD&[?]?YQ#Q8&FAKK5<[!/(R.2IX<#E\^GT:K5)G?WK=+1O]"E'+[M^MYV
M^NECQPXVO;*_=$U0DL7FH4C1(T[6?&>G'5!$^Y4=1;HEV5PA;(UC>N]=[]II
MYZ?!-[?7;":G2*+/A3)(BL]?+C/ICVN@YY45';7ZL5NB2-DC.LY.LGK:K3>/
M#=:/ V..?%Y:?-[JU^OY'@Z%+SR=-[Z'KP#%)3XVH89H]F]CY6/3[I(WF'Y]
M7;E6L[N_Z3+X!FDDQI0R32+(]ZR.<]W&[@.-JW%X4^);H^ASX5X=8FGP;WNN
MIFY$2\63$-O<OCU%52U,'L=9V?[?XQC-'T#*>6MO4V6Y[?$Y&JOGE_E\9;9K
MBZVZ0)G.3QJ>IE@?GV'/\(R>.*>'#F'8K51KDE54NG>B><1V:-^3^*<5I1^X
M725O_3U+PJ?U4NM.Z_Z/+>IGU&C6WS/WYI:U[WKVU63,R5KH;A:\)TLMDI]I
M<:[A23JQ,XV=9.%_OX#$W++I86O?_P"^/^.0R5&^LON$Z&&RULD=;0*K)(H9
MMGKMXD^)./ME&G&%ETS/Z%X3C*KFEK+(K;_D>W#S;]6RR6_$=$^:AG8Y=>5C
M> [W#QZ.ZBLI\25-I?4O6EI8Y$2+),LT>B9_">>TVJ_N=))>KA<:&@B8YTDC
MJM4=[F^N\?'1O(DF,JEZ2R/22"1==_&[A-ZKMB4;PG:UK>1>%5QJ45JG?SZV
M,)37N2IO5%57R22JIX>-O7S[/OY$CJ+CBVXW!\MOIJRG@UUV;'1M:FKUNJ/A
M@FUR6W%<#;O!L)%8[8:Z]4[M>YF6U]JQ=7U\T=2LZ,63JFSZD2-];/B-:DH2
ME96T7G_@Y:$*T:;E*]W+HNOYL^ND^"1DMHFFCCW5)$NW1G7<FK_,R^D#$,UK
M=34UN1(ZF:)KY)59F[4S7)/7ZHQFD6A?%9;(M/X_2TL.S?.U4RXFHGOF2Q_A
MZ:ZU%/4V[925<,+62Q*_)VHJKDOOZQC"4'P\_34ZZT:J==T5J\IC<(WN6^S2
M6:]*E535+'+&]R<)%;OY+_OK'QPI20V>EO5VJHXYY[>]8(E7SZ+E^MJ'UPC8
MIK'4R7J]_P!%@IF.1K'=4Y7;V?\ OLGRPI507FFO=IJY&0R7!ZU$2.7C>N_^
MIJFE2UY\+X=+_P"3GHYK4^8^9K:_7II?\S'0XUO<=>E1+4))%YJ'9IL_6SXS
M)8BHJ6+%-BKJ2/4BK98IM7BX6;?Y&-@P3>WUZ024Z1QKU4VT16>OEQF1Q%6T
MLN*;'0T<FO#12Q0*Y-_)V;?U9&DN'G7!Z6=[&=/C\-\UNK7WOY'LD3_MA3V2
M?,*8NT6QEUTA5L4^3J>.HFE<Q?-9/7]HR<BITX47/S2?,*8ZS7..V:0JR2HR
M;3RSS1.>O6S>N7PF4<UO=ZY36>1R]_IQ&?&YXUNDM=(^WU.PI8W91QMC:J*W
MMJ>;%=ZI+['13QP2Q7!C=69VS35D[7'Z_OGHN>"KG%<96T-,L]/(_..1)&HB
M-[?8/CBZVT%FBH:.!->XHS6J':^]EEQ'32=#-'A]?_NIQ8AXO)4XOP^O^",D
M^TE?8G#?M#_BC("ALO&]JK;I9; M# ^9(XEUT9ULVM^@OB9*-:G)]-3'V=!U
M,+7C%7;2_DUH;+Q"_:Q8(DEWYWNC7U\]GF8"SX*N=55HE=&E)2L7QQ\BHJY?
M<GLQ#=X;EB^SQ47]5I9XXFOZSN&W/XC'$5(UJBR>5[_H=.!HSPM&7&5LS22_
M,K?5IFZ3UW?J[DUF:VMU/D:99F6Q W%[+E)46Q^THM;.)(]14U>MFB[ZF Q5
M!2U.D:IBK9=G32.C:Y_%EXTF1Z9[%B>SUSHK7+424?'$Z.1-5$^Z;GQF66+4
M-5T\^AUQE)3JI)VS/6/4^%R='B'%-N@GH):6J<C6U.TCU5=VS,WY^)XJ]:6R
M4;Z6W0<"/9,:NLB=?UNT7WVYNMS<.2W=8^><+]>HU$S74WT54R]P\>([;B*:
MXRUEGK:JHMU1XY'L:I4U,^LB9\1FI.3C=*UGUZ&SC&"G9MRNKVZ]"[%-%4W'
M":W&Z4Z4URI7ZKG(S+78N][W"^ \-'>+ASEHZ/"]'4Q2,_K,K8,T5^]GO[_;
M++]1UUNP_$EXNU;)73/_ *JM1FW4^Z,WB.FO$M!;FX863G:E.B)N>1&/S[?P
M?"63M%)VM?\ (S<6ZDIPNFDKV^)_]'T9!>)\'WE,11K)J,5T&MJZZY(J[^KV
MT0\>%&U4N#GLP])''==LBSJY$ULO=_7VSUV"SW"##]^BK9TFKZJ'@P+(CGM3
M)VKK=M<R.VG#<E9:-T6JIE2ZP2.9/#KHWL\7^^R53BU*+?FOH7GGC*$U%N\7
M]>O\F2=<KU0T593XJHZFKI)6ZJ.1C>"OKH>7 % ]MON%WAI]UU4'!IHE\^O7
M^%/A,QA)N)*:I5+V^1+4UCMHM2]KNMV5X7OF-PG5MJ(KW:Z"HW&ZI>LE&]'Y
M+FG6^!I+D\DXQ2\NG0I&$75ISJ-^=D^MS[T%;C2*O22JI9IX%54?&YC4;J]H
M^\=MMUHTC1LGV;89F++3L7+5;(O^W9>N8J"RXO?7)$^IKXXDWG2NJUU<NRF^
M?*:@MU?C'G=4W.KJ(]GLVS2R:R[1/,YKUOUC+=NS5K>0E-I1O%MYE;,_X,Q6
M+C2@N&WR=5TZ/ZF)&N:K?6ZHAV*ZR&OO,M1%3RTJO3AL>F2J[LF=I;9C&V5:
M0TCI]1J<#5D1S,OPMXII,EC?74+7+'SP9#G4*SL];]9MAFHU4E9_3_)S8^,I
MX>3=U9]'_AD+ !ZY\L#Z(?,^C2&:PZE  07      +CZ'S/H59I'H  "P
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M_"WBFD*1CJJA9(L*UK(<ZA&=G)/YFM"5JBM;\O\ )CBTYT9-W5GT?^"*IQ
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MEB<M*FYQ_O/, #M/+  !(      /H?,^A#(8  (        !8      %$*@
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M35<CNN9FUNN,=!6KB#+<*0_VO59]?,MHG?KK^91.4E9Z:?D010@"G<>1Y@
MD         V-@#["_P#6=^HDI&L ?87_ *SOU$E/#K?,9]=@_D1^AK/FC/*I
MNOMD'SJ$#YD?J<5>M2_OR><T9Y5-U]L@^=0@?,C]3BKUJ7]^7_TC.?ST=$
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MF?0AD,  $         L         4  )      +@ "P       !#  !4D
M'VDJIY*6*%TDNP9U+=?@^\?$KD0U<)M= AZ)*F:6.-D]3)(QG4L<_@M/.7H'
M%,E2DNC/3%<:N*)(6553&U/,LD75+(JN>+:;"62/7ZO4?U1\ 1D1;//<^BSS
M.BCBDDEV#.I9M-YOX)\T"@BR1#DWK<],ERK71K$^IJ9&*F66NN1YN( F,4N@
M<Y2T;!Z:>X5<$&I!55+&>=9(YIYBHDD^I*DX_"R]D\K)MM'+*DGG\^$*F6>>
M37GEED?V72:Q8B;Y4**6H<F^K+>,]%/755.W9PU53'V-61S3XE%0-*741G*/
M1ET\TD\NO/+)))]V705$]-)KP22Q2+P. _5/FHR&56L')WO<KD2?$TCVV;#[
MXW;-Z0.Z_%O,(R@4SG"[3V-:=;AQDMS[U%;5U/C<]3+)']V]7'SBJ)H4D9!)
M)%&_>=JOZKURP%E%=#//*]VQ&_9NUV;SRZ::2HEUIY)7R>>?OEF15"UD1F9Z
M.>%=L]ENFIU/.:ZZI8RIJ(X=C'++L).K9M."?(*5R1V)XLWYGTEGGGC8R226
M2-G4,>_J/6*0U$\.T9#))%&_@NU7]5ZY84095:PSN][E43K'UIZF>ES=!)+'
M)]Q)JGR*$M75F53:=TSVNNUS7_OU5W=3R/>]RH^7QQY0%5"*Z(NZDY:-GU;/
M.R*2&.638/ZINTX/O%L4\D$VO!-)')V6%B(5&5!-GWFK:JH3*>JDD3[J15/@
MCUC36CXRF\-XE125D2YR>K9Z9JZJJ(M6>JJI8_./D<[,\\<CV3;2-=G("F1"
MBET0<Y/6YZ*BMJZE-G45,LC/NY'/+):F>:*..HEEDC9U+'R=2?+(=<9%Y(ES
MD^K/7%<*N&)&05-3'&GF&/4^#WR/S?+U91.(H$DO(ASDU9L^]+4STJ94\LL:
M?^&_5+9ZA\TNO42S22>>=PBP$95>XSRM:Y?35$\&;X998Y/N)-4NJ:NHJLMT
M22R>SDUCXY!!E5[DYY6M<H "Q4  %@        #8V /L+_UG?J)*1K 'V%_Z
MSOU$E/"K_,9]=@_D1^AK/FC/*INGMD'SJ$#YD?J<5>M2_OR><T9Y5-T]L@^=
M0@?,C]3BKUJ7]^:+Y3,Y_/1T0 #G.T^\74(7%L74(7%D2  2
M                62>1J7EDGD:D,'Q !4@'%>@SRUK![.7YEYVH<5Z#/+6L
M'LY?F7G12^%G%B?F0.U"(:4_M3E]L82\B&E/[4Y?;&%L%\Z/U*>U?P=3Z&E0
M ?:GY,  2  "" "A(L#6^ENF(XJ:MCVD+HG<#7<WK=HSJU%3@YOR-\/1=>HJ
M<>K(\";7.HPI1U]13R6*K>^%SHU>E4_)<ER\^8ZY7##<M%(RBLTL%5EP)%F5
MR-7L]4<\,6YVM!Z_0[*OL^-.]ZL;KRU_Z(T"A4ZW)'GY7L "A5R4>HC!R=D5
M*$GQ]:Z6TWQE/1QZD"P-?J:RNS=FO94C!2E552"GN:XC#2HU'3>K14% :774
MQL[V*@%"+HKE?2Q<#T46P2KIMU_U?:-VGL>N>B^NH5N50ZT-U:3@[-KD<G63
M/JNV4XBS93;@/)G,< "]UY&65KJ  +HC*[7!4DN%K=35MIOTU3'M'TM.DL?"
M5-5=5_8]8C2&<:JE)QV-ZF'E3A&;_N*  U33,'%KJ  1=$Y'L "A-T1E=[%0
M ""H (*@                                 N9URTN0AFD.I4 $&@
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M40J0R2@ !<  $@            ^A\R\AD,J  0        "P        !0
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M?J<5>M2_OR_^D9S^>CH@ '.=I]XNH0N+8NH0N+(D  D
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M'S(_4XJ]:E_?FB^4S.?ST=$  YSM/O%U"%Q;%U"%Q9$@ $@
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MJTNY]TU"TW%L]==G^*>13>G1EQ74G_\ (XZV*BZ"H4[VZN^X !U'G%0 00
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M(R9TJRJ14T;5\-*C4=-ZM%  :Z=3#*[V*@ K=$9);  $D68  (
M                   !*+P7,ZX*7.CR+0 20   7%6\:E 0674^@ (-
M   7%I<0R4  02  &[(E*[L$+R>XUPC345M2LM$:L2'?FCVCES;V<ESWR!=<
MYZ->-:.:)V8G"5,-/AS\P"18ZMU+:KLE/11ZC=@URMUE=UW=E2.EZ=15(J:\
MRE6A*E4=-]45!0%]"EF5!0#069<T%$*D70ROI8 HI470L[V&_P!D "Z&5WL%
M4%5,I:'6Q*2L2XQR23I#_1LT<O#R=Q:I2<\JN:4Z3G*ST,6I0J";HJHOR  )
MNB,K  )NA9MV!5I0N:5;)2?0J "+E\KZ  "Y#374H "0&GU/D?4   $@
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M5-G4T[-S*GGW\?PHB^Z:I0Z<+-UY\1^2M_V>=[0IK!T> NLFW^7D5 !Z)X(
M                            )1]$*EB%Y1F\>A: "0   7  @F/4^@ (
M-0      7%I<0RT2N0U7&;IL5WJFIHXH*M&,C;JMSC8N\F]V#Z]&E_R_KOYA
MGT',YUKZ17Z_^':H86WO2=_I_P"D>R*Y'UK:R:NJGU%5(CYW;SG)Q)^*?%#6
M[<=>ISJW$67H;-Q%>^<^-X-JJ;DGI&MF1>QK.X7N?K(EB^R+9K@NQ5-R3\*!
MW83SON?K,AI2^V.FR]+M^4X]&'*F/$%DEL57*FVCX=))VDW\O<^+UCRZ<72I
MJK'IYGT-6:Q%>6'F];^[_P!%^.*1UPQK24C<D2:*)JKV.$X^MQN]79JJ6@L%
MM5D$&372O@<Y9'=?)3[8JJV6_2%05#UR;'$U'+VG:S2S$MRQ3;[I,E/)))22
M.1T#HX&.1&^=7>XS.+;4$]5;S-YY(2J25\U_)79X<1T[;I8([TVBW)6,?LYF
M*S5UNV?+&:(F'<+JF6_3N^2POOE1?G896:\5JQI,Y&-IGP,1SLM_/BWN(^N)
M:2:X83L%31Q/D;3QJCDCX2M3@I^R:4VTXMO2YA7BIQJ*"=W%?R>;!N7./$O%
M_5%^2\].CV&GGMF(&UJ(R!&1[3M(FNKCZX7ME10X9Q!45D>Q2HIUV;'=5JM8
MN:^^X\6#%_Y;Q5][M^2\BH\V>S\T,/%TG24EY2_R4J+IT15=#:*:C91T"2MU
M5;U67"3XCWWG$?.&KDMUCIJ=C(."]SV*Y7.]PC&&*N.@O]#4N758Q^3E^Y=O
M&3QE8JJ&\U4\,<LM/5OVC7Q\++/?-94H1J*#^&W[F,:]65"56GK*]OHCWW#<
MF),-55R93QP7.B\DV/4R)V.VA[Z9*JUX6H*FP43)ZB?A3R:NN].WVSQT5+)8
M<%W&6N\;J:W5BCB>O"[&7K\)RGCIZ.[VJV4UPLM1))!4<*5D4?D:Y==N^8-)
MK*GI?2_0Z8R<)*4H^\XZVZK7J?2Y7F&Y6RIBOM-N:Y,\@E;'JN]T^E"Z'#.&
MZ6Y)!'/<J[R/:=3&G8,I:*RNO5!6PXBID;2MB5S:A\>SR7_T^(QEQI9+Y@VT
MS4,2R2T6M%+"SJLDZWOM:H4E\#T5]=BTHNSJQUE;2ZUZE*/$]+=V2TN)(X=@
MYG F1F^B]C>XCXX01$LV)58J/_HBY>\\\F'\-RUTDDUSVM)0P-<JR]1G[Y[L
M'ZB6;$^Q\CW.NK[SS6HJ<825-['/1E6G4A*LO)_7H?#!U!"ZEKKK51;ICI=]
ML7GGK_M#(08EN<TJ0W*UQOH)."^)('9M;Q;W9+<"5D[K'<J*VR(RM\D@5<N%
MV>,^<=WQA+5[!-U(Y.-5IF(B?DF<TY3DG;3=G12<(4X9;Z[*_P"I]J.V1VK2
M)2PP>02(LL:=;)6NS+;SB9UINU53V:EIHXVO<LKG-UEDDSW\\CZ4ZU'3"HH*
M^OW7/"U6Z[8VLRX+ER7+UR+8@^S]Q^^)/EJ6A#/-9]=#*M5="DW25O>,_C6E
M@JEM%=21,CDN#,W-:G&[@^$>N[71F$U9;;3#%MFL:^>:1F^Y5^D^&(JC<UNP
M?+YR-'^]LCYX[M=1/=$N%)%)44M5&U5='OY<'+B];(K3M++&?34O6O'/.DO>
MT_='SNEWH+[8Y9*YD5/=V.RB<R->&G:/1;(5L=@IJZ.A6LN=5Y&JLUDC:AC>
MA_<^&ZJXW)):>HUE;!#GQ]C>[9(8+A<Y<(4$UCD\=IM:*HA8Q'.7+BXT_P!Z
MQ-2RCE@]+_D104IS<JRM*VENI;;*Z;$4RVV^T'5QN6.=85:K53XCX81H5IZ2
M[S04\51=J5^RBB>J<'M?[[!?9:_%-RJE9)/+3PM3-TLD$:-3M<1C+30UU>^Y
MW2VULV[HYLG,C3563/K_ ,BC3M*-TEH:YTY0EE;>O5:__(R,>(:ETCJ;%-!_
M19.+.%6ZI"IFQI-+L]^/:< G6'KS?ZJOBI+C2K-3O>K9MI!EJ-_WV2*8DAAI
MK]60TR91,>F2=A3HPUHS<;?]')CEFI*=].FJU,8X '<>.#ZGR/J"4  "0
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M94XSG-:6//7)_P @6_>_[S^MYF*UU=9Z"D3#U#%+3NA:Y\K69JY?]_&8BO\
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M@ %@     "Y"XM0N*R  !         !*  !(     !L; 'V%_P"L[]1)2-8
M^PO_ %G?J)*>'6^8SZ[!_(C]#6?-&>53=?;(/G4('S(_4XJ]:E_?D\YHSRJ;
MK[9!\ZA ^9'ZG%7K4O[\O_I&<_GHZ( !SG:?>+J$+BV+J$+BR)  )
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M39.&J=4KEW^MYTP2KF4IU%4CF1I5I2I3<)=45&_V0"YD -_KH!=$V95H (
M     *%0"4R\ %2P  )!0J4 !5I0JT ^@ !(      *%2@  !#"  !(  !<
M 2       @!#)0 !4D      %Q:7 E   L   6@ @(^@ ))        (?0
M%0  "P  !<         5:4*M   (99=0  7  !   )         +RI0J05
M      !*  !(      *%2@"  !(   *E"H!4  L        4)         +P
M4:5()                  !]#YGT##  ((       *(5       "E"JE"2\
M2T  L      #Z-/F?1"L@  0         2@  2      ;&P!]A?^L[]1)2-8
M ^PO_6=^HDIX=;YC/KL'\B/T-9\T9Y5-U]L@^=0@?,C]3BKUJ7]^3SFC/*IN
MOMD'SJ$#YD?J<5>M2_OR_P#I&<_GHZ( !SG:?>+J$+BV+J$+BR)  )
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MVIDGP+^2:YN%4^LN%54.ZJ9[G(A>C)UIIOR7[G/B:*PU*2[GI]#X  ] \@
M    O!1I4J7  !(*%2@ *M*%6@'T  )      !0J4   (80  )   +@ "0
M    4*@@  %2P      +BTN!*  !8   M ! /H "20       "'T  !4   L
M   7         %2@ *@ AEEU  !<               JA>?,^A#(8  (
M    !8      %"I0!   D   %2A4 J  6        *M6)  (      !<TJ4:
M5()                     /H ""                  "P $FH      /
MHA\SZ(5D  "         "4  "0     #8V /L+_UG?J)*1K 'V%_ZSOU$E/"
MK_,9]=@_D1^AK/FC/*INGMD'SJ$#YD?J<5>M2_OR><T9Y5-T]L@^=0@?,C]3
MBKUJ7]^:+Y3,Y_/1T0 #G.T^\74(7%L74(7%D2  2
M         62>1J7EDGD:D,'Q !4@'%>@SRUK![.7YEYVH<5Z#/+6L'LY?F7G
M12^%G%B?F0.U"(:4_M3E]L82\B&E/[4YO;&%L%\^/U*>U?P=3Z&E0 ?:GY,
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M0I.";EU;-L7755I1Z)60/JG$?(^J<1JSFIEH (+@     'T9URXL12\JS1=
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MB@ .@XP     "YI4HTJ5+H  $@H5*  - : ?4  D         H "&$  "0
M"X $((  DD        H6        :"47  %@  "T $ ^@ ))        #5P
M 4   +   %P           *@ AED  "X               /H?,^A#(8  (
M       !8      %$*@ H  2   "I0J 5  +        $,  %20     "YI4
MHTJ02                   "K.N 7@ @@                  L !)J
M   #Z(?,O0AD,J "I(        )0  )      -C8 ^PO_6=^HDI&L ?87_K.
M_424\.O\QGUV#^1'Z&L^:,\JFZ^V0?.H0/F1^IQ5ZU+^_)YS1GE4W7VR#YU"
M!\R/U.*O6I?WY?\ TC.?ST=$  YSM/O%U"%Q;%U"%Q9$@ $@
M               %DGD:EY9)Y&I#!\0 5(!Q7H,\M:P>SE^9>=J'%>@SRUK!
M[.7YEYT4OA9Q8GYD#M0B&E/[5)O;&$O(YC^D=5X4KF,\D:S:_BKK?J&$EEK1
M;W*^TH.6%J16QHD 'VY^2OK8  D           $,  %04*@$I   @      H
M     "R  !   (            *@ @@
M    'T0^9<A#-(=2H (-      "].N7EJ=<N*LO$  %P "   2"X $%@
M "K2Y"UI<A0T14  L    @" %0        4S+BTN0@(  $@     %S>(J4;Q
M%2I=   D%'%2C@   #Z@ $@       9@%     02   7  A!  $D@
M%"P     )L  !8N  +    M+BT,'T  )           *   %@  "X
M    %2I0J0R2@ !<  $@HA4H@!4         ^A\SZ$,A@  @        %@
M      "@&0R!( R&0 *E,@ 7  %@       "&  "I(     !<TJ6-XB\!  $
M$@                 'T *9D$%0   "F8!4           %@ )-   2   "
MY"TN +@ 4            +      &QL _85?;G?J)*8+!E/N?#T>T3A/UGF=
M/"K.\V?7816HQ3V-9\T9Y5-T]L@^=0@?,C]3BKUJ7]^3SFC/*INGMD'SJ$#Y
MD?J<5>M2_OS1?*9G/YZ.B  <YVGWBZA"XMBZA"XLB0 "0
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M:P>SE^9>=J'%>@SRUK![.7YEYT4OA9Q8GYD#M0 '.=H     NR,J  %V,JV
M %V,J  %V,JV  %V,J  %V,JV  %V,J  %V,JV  %V,J  %V,JV  %V,JV
M%V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,J
MV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %
MV,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,JV  %V,J
M %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J
M %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J
M %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J
M %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J  %V,J
M %V,J  %V,J  %V+(  78L@ !=BR  %V+(  78L@ !=BR  %V+(  78L@ !=
MBR  %V+(  78L@ !=BR  %V+(  78L@ !=BR  %V+(  78L@ !=BR  %V+(
M 78L@ !=BR  %V+(  78L@ !=BR  %V+(  78L@ !=BR  %V+(  78L@ !=B
MR  %V+(  78L@ !<60  N+(  7%D  +BR  %Q9  "XL@ !<60  N+(  7%D
M +BR  %Q9   60  %D  !9   60  %D  !9   60  )L  !8  "P  %@  +
M  6      -9\T9Y5-T]L@^=0@?,C]3BKUJ7]^3SFC/*INGMD'SJ$#YD?J<5>
MM2_OSH7RF<4_GHZ( !SG:?>+J$+BV+J$+BR)  )
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MKUJ7]^='^D<4_GHZ( !SG:?>+J$+BV+J$+BR)  )
M        +)/(U+RR3R-2&#X@ J0#BO09Y:U@]G+\R\[4.+-!GEK6#V<OS+SH
MI?"SBQ/S(':9$M*]Z?A[ -YN%._9U$<&RBD1.*1W!1?<5<R6FK>:3?EHQJE3
MS<\"9_A&5-7DCIJNT&<@E<@@/3/ ?4H  0
M
M                                                   "0#-T6$\0
MUU,RIH+#>:FG?OLEAHY'L?ZRHAY+M:+G9I8X;O0U-#(]FNQM3 L;G-_"(S(T
MX;M<QX*Y$BBP5BF2-5CPQ?'L>G!?N"7P2')(K&+ET(X#UW&BJ[=5R4MPI9:2
MK9DKH9HW1O;GO]2X\N19.X<;% 5R/M2P2U4\4%-%))42/:QC(V:SGN=Q-1 W
M8A(^ ,M<\.WFT0I/=K-<Z*G>[+:5-(^)N?8S<ABD(3N2XM%  24    "
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MA8LCW9;_ !-#99*YY 9.[V.[679+=[976[:JY(MTP/CU\N/+-/6,:$[AJQ0
M J     "  9.TV2[7K;<Z+977'8JFUW- ^74SXL\D]<ANQ=1;,8#U7"BJ[=5
MR4MPI9:.K9DKH9HW1O;GO]2X\V1*=PU8H  4     !(  (  !(         !
M7,H!8  $
M
M               JA0   DNC_#C\6XOH+-&]8XIWJLKTXVQM;K+[N32LGEU+
MQBY.R(T#I:[7?1-A.[IA6HP['4*Q=E4U>YVR[%V7FGN77]?5XC66F_ ]+@R_
MTW.IV=KKF;6!FNKMDJ<;<UXV]="D:EV;3P[BKW-;%4/7:+;5W>ZTMOMT:SU<
M[]6-B&XW<SOB%MN66.ZVM]9J^0*C]7UD?E^R6<TG9E(TI2U2-)%,CTW.@JK9
M<*FBN,,E/60/U)8G>94\Q9.Y1IQ=F=KZ&;T^_P"C:RU4[T?41Q[GE7[J-VI\
M*(A.#4?,PKGHU<G_ ,]+\EAMP\R:M)GNT7>"-9\T9Y5-T]L@^=0@?,C]3BKU
MJ7]^3SFC/*INGMD'SJ$#YD?J<5>M2_OS9?*9S3^>CH@ '.=I]XNH0N+8NH0N
M+(D  D                            LD\C4O+)/(U(8/B "I .+-!GEK
M6#V<OS+SM,XLT&>6M8/9R_,O.BE\,CBQ/S(G:9JSFE=_1=5??<7RC:9JSFE/
M*NJ_ON+Y1E3^)&]?Y;.0@ >F>$  "
M
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MAJ\?N&VZKF@;G#?M6BM= N'XY-FV)&.25\*?=:V35U>MD;UTB7>GPYA:JO\
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M-[>/+JLW.[!6DY9F:8F,5")!@ =1YH  (
M
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MU]L@^=0@?,C]3BKUJ7]^3SFC/*INOMD'SJ$#YD?J<5>M2_OS7_2.>?ST=$
MYSM/O%U"%Q;%U"%Q9$@ $@                           %DGD:EY9)Y&
MI#!\0 5(!Q9H,\M:P>SE^9>=IG%F@SRUK![.7YEYT4OA9Q8GYD#M,U9S2GE7
M5?WW%\HVF:LYI3RKJO[[B^49TOB1O7^6SD)0%!Z1X0  (
M
M
M  !)VWH-\J?#OM#OEN-4<RGB!8ZN\X?E<J))_38.PJIP'_L>\?31UILP_AG!
M%KM%;07>:II(W,>Z&*+45=95WE61.LIIK1[B*3"N,+7>/')(J>3QYK.-T;MY
M_P !R*F_>N>G*M%9+/H=CW"*VX$P[B*[4L21,>^:Y3?=3.3]:HGOFK^95J9*
MNDQ155+EDGJ*J*1[EZZKKD8TPZ8;;C#"G.>R4M?3I).Q]0^J8QOC;>%DF3UW
M];5,5H/TDVC =%=(;O2U\LE9)&YBTS(W<6MQJKF]D<.65EG6CQ%KH22XUD=#
MS6K9I]Z+;Q0?A24:,;\+C*<UM;II[9ARXQIXS3S30O\ 7D:Q4^;4TSI+Q+3X
MFQ_7W^SK504]1LGQ;5&MD8K(F,ZRKUV]DW)A;3=AZ]6);;CVE7:*S4FDW/MH
M)DRXU:U,T7M:OK$N+C:1G&I"2E!OJS7G,W6^HJ]*E!4L\CHX9Y9?=8K/C>;1
MTXUC'Z5=&E&B^.0U[)G^Q?/$C?D./HW2OHYP;;9&X1H]T22;ZPT=(Z'7=]V]
M[4]_?-$38RJ;II%H<47U==8:Z"I<V%,T8R-Z.U&(O:0G+*<KV&:-."A>YO[F
ML/*\MO\ BL?S4I,-'MQ<[1#9JVV0[HF@M3-2+KRR1QZN7NN::/TTZ5++CK"]
M);+32W.*IBK6U"[HC8U-5K'IQM<OGC%Z&M*[\%12VNZ125-F>_7CV/DE.Y>J
MRUNJ1>QQ]?LE<CR%^-!5;WT)6O-)5GJ8B[[7P#TZ0M(.*[E@2XLNF"I;?:ZR
MG:S=;ZCJ==4RX.6?7,T['&AR2K2\OAI.>/59K;9-?6[/4:NMV\_=-6:9=*;\
M;NCM]LCEIK/ _71'[SYW=97)UF]A!&-WT(E/+%WE<WAS-]5'/HKM\+,]I3SS
MPR^RVCG?$YIR3>K?/9[O5VZKX%123OB=[A-=$FD:HP'<Y=I&M1:ZM6+40^:U
MD\VS[K+WS<U3I T1WBKBNUUCIEN#,^%4V][I-[LY,5J^^3K3;T*WA5@DW9HU
M:FAB\-P=T1U=?0T]/N7=KX9DDVC&ZNMDO!XS?',\KGH>L/\ F/GY#3>F33"S
M%%OEL6'8Y*:UO_K$\W!=+EYE&]9,T]WM%V@_2Q0X2M4EFQ"R9*'766"HB9K;
M/6ZIJMZR9]CMB492CJ6A.G"=DS3-332TM7+2U$?](C>YCV<?"0[/N%'-;]!%
M50U*:M13X<=#(WL.;2JB_"0N_:2=%M-5/O%%;Z2Z7G/78YEOV<FOYY7R-3?[
M>^IB[YIWLMXP5<[746ZY1W2LH9:=ZLC8L+9',5O'M,\LU3K"6:=M"(*%)2]X
MS_,H9KH\N.?*LOS41YM"%9&W2KI,I'9+/)7OE8GW+)Y6N^6TA&A?2K9<"X7J
MK9=J6Y2U4M:ZH_HT;'-R<QB==R>=('38TJ+5I*KL4V;>6>MGJ&Q2IU<4DBNU
M'Y+V H-W"K1BH>AOO2=IBK\%8KEM#\/Q5$&S;+%.^H5JR-<G8U5\TCD]P\>'
M-,N)\2PRS67 R5L4*ZCW15F>J[\0^CM*NC;&%NBZ+J%*>>/B964CIM1WW#XT
M7W]XQF*]-&&[%87VK1_3(DJ)J,E93[&&+[I$7)57W/7*J-]+:FCGJY*6AH['
MURJ+OC&\UM;2[CJ9)W;:F5^MLG)P53/W#PX=@@J\06NEK/ZM/5Q1R^Q5Z9GA
MEDDEE5\BK)(_JG*?/(ZDM+'FN5Y79V+I\NERP_HWD?A_:0*^:*GEDAWE@A5%
M153L;Z-;^$:_YF7&]=)6+A6LVM33[-TU/-U6PRX3FJO87X_7,A@'3E:JBRLH
M,<12,J&,V;ZE8]K%.F67":F:YY<::JF6J=,&CO#%OE7"M'%+))QPT%"M,USN
MMK*K6^_DIRY6EEL>EQ(N2GF)9I4JGX8T9WF>P42)(]C_ "!GD:RNX<N7X2N]
M<XJZQTAAWFAK;/;IH<4VFI6>1[DRHXV21NC7K.1SD];KYFB<836.IQ!4SX9A
MJJ:V2\-D-3&UKHEZ[=YSM[L&E%.+LSGQ<HU+2BS"]<[KTF7.LLN [S<;9)LJ
MVGI]:)^HU^J[UEWE.%#HO'FF_#F(L'W2T4M!>(ZBLIUB:Z6*+515[*I(I-:+
MDU8KAJBA&5V:V733I 5-Z_IWG!_#(=?+Y<K[5)57FOJJVH3B?,_6U?8IUC&H
M55-XT4$C"563T;.S>9Y\I^P^O4?_ )$AQBJZZ*Y_&;_T7:9</82P);++7TMT
MEK*;:[1T$4;H\WRO=QK(GGCG_M&=)-29T5ZB<(I'8G,WU<=3HJH(&9ZU'//"
M_/SRR.?\3T.2+S;Y[5=ZNW5:[.II)WPN_!4FNB32+48"N4FTC6IME6K5J(,^
M$F6]KL^ZW_=-SU6/]$5[J([M=XJ7G@B?]ZM[W2)EV<FJU??4JLU.3=C2\*M-
M*]FB4Z)HGX;T-6I]QX&PI9:M^OUFN<^7XG'BYFZL94Z*Z*%F6O2SSPO[:K(Y
M_P"V:GTP:9&XFMD]DPXR:"WR[T]3-P72M\ZU.LGPK\<9T/:29L!W"5E7'+/9
MZK)98F=4QWGT_P![Y7AMILNJ\(R4?)$'OEMFLUVK[;5KJ5%+,Z)_N'8>@6WS
M6[199V3IJ22))/J]AKY'.;\"H16^:0=$EVF9<[K##6U\:;S)*"1TBY=9V;=5
M?=4^%NYHG#Z4[MW6JZMEUG:K:>.-S=3-=5559$W\N,3<I*UB*2ITY-YB"\RF
MO_:+7[W_ ,*D^>B/MS5\,B8YM<RIE&^W-8UWW399,_E--<Z.L5R8-Q737>.+
M;11HYDL:<;HUX\CHVY:5=&.(;?%S]V53J<-M-66]\KF._%5N?NEI74LUC.#C
M.DX-VU([S)%%41V_$5=(S*GGD@A8[LN8CU=\MICKC61T?-:[:=?&]O%"GLGT
M:,;\+C+6W3OABV5<U%1V:JIK+ W4I=Q0,367S2JS6:C4[''U\\C2^DK$T&(M
M(5??[/NN"*?9/BVJ(V1CFQ,9UE7KM[(47*39:4X0A%)WLS<_-96ZHGM>'+@S
M+8T\TT+_ /J:FK\A32>CO!5?CB]S6^W311[.#:OFFSU6[_:-VX7TW8?O=DYV
MX]I4CEU-69ZP;:&=.SJHF:+VM7UCW]-C1UA"W21X3I$GED3-8:6D=!KN^[>]
MJ>_OD1<HK*D3-4ZDL]]#0ND?!=1@:^16RLKZ6HJ)(&U'C*.35S<Y/->Q.I.:
M$:K]$-^1./\ H_S\9R/BR_UV)\0U5VNG]8G?Q)U+&]9J>L;\PWS0UM9:(H<1
M6JO6KC9J2NIM21LF]U7"<WC]TF<9:,K2J06:+Z,YLR)WH/JV46E+#DS]YFW=
M#[LD;V-^4>32KB2@Q7C"IN]III*>EDCB8UDL;6NX+<NLJH1.GFEIYHYJ>39R
M,?K,?YUR&ULT3FC:$[KHCI/FL[9//:+!=(]ZGHYI(I5[&TU,OA8:RYGJ@GK]
M*EKDC3QNC26HE=V&ZBMR_&<TVKA73=AN]X?6AQU%N>IU-2=)*99H9^VC6M7C
M["H>9FEO .$:F*'"-GUX)WYU4]+3[+@IV-?55WNY(ASI22RV.R2@YJI<]?-#
MU<5#C/1Q5U&6Q@K9)7^Q;)3JIL+2CBNJP;AE;O1V[GBV.9C)H]IJ:C79\+/)
M>OJI[ISEIQTB6K'_ #FYT4U?3[@6=)=U1L;U>IEEJN=YPEVCG3;0,L;+/CJG
MED8QFRW3L]HV5G%XXSK;V]U\QPW9%E6CFDK]3[6OF@[K<Z^*AH,)15%7._5B
MB95KK._((OIWQ5?KW06RBQ)AQ;+LY'31*Z?7VO!U53B[9L&DTB:)L+;2LP]2
M1OJW[V5);WLD7M:TC6Y>MF:(TC8RK,;8BEN59G'''XU34_6BC\+LEH1N[V,J
MDVHV<KG3=BEZ8^A!(9<GU-50OIW*J\51'FB._':CCQZ6*EN!-"O.RD5%D?!'
M;(LEZK-N3E_%:]34FA+2G0X%M%PM]ZIKA44\T[9J=*:-C]5VKD_6UG-[#3PZ
M;=)%-CV:V0VF*J@H*1KGO;4-:USI%]BJ]9/C*Y'FMY%W7CP[_P!QM'F3ZJ-V
M#[S2K_6(Z_:O]B^-B)\AQYL8Z=*_#6)[G:JG#<3UHYG,;)NI6:[?,NZA>-#2
M6C;&U?@?$:7"CB6HIY&;*HIE7+:MS^4G6-[U>D?13BML=5B.E9'6,1$3=E ]
M\J=K6C:[>]T2@U*]B*=3-344[,672YBR^6_=]HP%)4T?";MF5G!S3C\P8_F6
M*G=UQQO5JFSV\\$NKV-9TR_K,1I*TSVR3#TEAP-32T].^/8NJ=38-B9Q91-[
M/O$8T&Z0[5@'GSSVIJZHW>L"1;EC8[J-?/6UG-\^@R-Q=D3Q4IK,[V/OI0JX
MZ#FD=VSKXW3UU#*_V+8X5-M\TY;IZ[1NR:G;K-HJV*HD3[G5>S]M#G+2AB&C
MQ5CNZ7JWQ2LI*O9*UDR-9)P8F,ZRKV#;.C?3;;XK''9L;12RQQLW.RI;'M&R
MQY*W5D9ZV]U\^N6<6K/8B%2#<HM]35.B*WSW+21AR"G_ +.NBJ7^QC777Y)O
M7FL*R-F$;-1JOCLM?MF^LR-[5^6A?2Z2-%6%(YJO#M-%NN1,G,HK>^.1_:UG
MM;O>Z:%TD8SKL<8@6OK(]E!%G'3TS=_9LX_?[(:E4E=HI>-*FXWNV=3Z>K?4
M7'1;>64;->6-(YM7LHR1KG? BG'%HM\]VN]);Z3QRHJYV0M_"4[ATBXBZ$\'
M5UY6FW0VG="CXDRX372L8[X'*:VL6D#1#;94N]#2Q6^X/W]7G>_:,SZR:J*U
M/<4I3FTFDC:O3C*:;=B1<T=4QTVB:Z1O7*2HD@B9VU25KOB:X]',]9]*"Q9_
M_,?_ )$ASUIBTE28\N,<%)'-3V>D55B8_>=*[S[T^)";Z+M,N'L)X$MEFKZ2
MYRU=-M==T$4;H\W2O=QK(GG@X/+8A5H<2[>AS\=H<T+Y4%]_R_\ ^1&<7G0&
ME'3+A[%F!;G9:&DNL=74[)6.GCC;'FV5CN-)%\Z:U$W),PH3BHR3,1S*?EB5
MO^%2_.PDYQS61T7-.X-DF\C6@;$GLGK4,;\+D-/:%,9V_ V)ZJZW>.JDIWT3
MJ?*FC:YVLZ2->NJ>=+],6.:3&.,K?>;)%74T=/2MA3;:K)$>R1[T<FJKO/%9
M0;F6A4BJ27G<Z/TO8]J\ 6Z@K8+2VX4\\CHGO=+L]D[+-OF5XTUOQ37]CT]7
MJ^W!:*T8-6MJT17ZD-6O4IU^H+L-:;,/7RR<[,>T*[5&ZLKU@VT,O6SRRS1?
M</:W2CHVPA0ROPC0I45$G&RFI'0:WLGR-3>]\IDMI8VE4S/,I:$,Q9B*\7W2
MY@EE_L3K+605U-XRLB2:S5G3?WDWB?<U?O:/+;_BL?S4QH%^,:BY:1Z'%-Z5
M[UCKH*A[(DS1C(WM=J,15[#2?Z:=*MEQWA:EMEHI+G%4Q5K*C.IC8UN36/1>
M)R^>+N#NC)5(N$[OJ1;F?$_[7K!_F/\ \>4V+S7J[^$_6J_W)J'1=B"DPMCJ
MUWNX1ROHZ3:ZS8D1S^%$]G75//$KTXZ0[5C[G-SJIJZGYWK.DNZF,;U>IEEJ
MN=YQ2SBW-,I"I%47'S-\<SSOZ'K%_F/_ ,B4XS>U(^ _JS<^B'3)38/P^EHO
M5!55%) ]SHIJ;55S4<JN5JM54ZZKUS':;-(MGQU1VMEDH:^G?3R2.D=4QL;K
M9HWSKU(@I1DRU64*E-:ZHU, #H//
M
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MU9S2GE75?WW%\HRI_$C>O\MG(0 /3/"  !
M
M
M          )     !   )           !   )     !         )     !
M     )        !   )        !   )      .@-*.F7#V+,"72RV^END57
M4[+4?-'&V/-LK'<:2+YTT!D4*E(Q4.AI5JNH[LH H+F0     )        !
M
M
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M;(/G4('S(_4XJ]:E_?FO^D<\_GHZ( !SG:?>+J$+BV+J$+BR)  )
M                    +)/(U+RR3R-2&#X@ J0#BS09Y:U@]G+\R\[3.+-!
MGEK6#V<OS+SHI?"SBQ/S(':9JSFE/*NJ_ON+Y1M,U9S2GE75?WW%\HSI?$C>
MO\MG(2@*#TCP@  0                      "H)LR@*YC,"S*  $ %<AF+
MDE  "   2 "N8!0     @ %<@"@
M          %R4K@     @    %024!7,H!8  $         D        $  J
M"2@       !                                        !7,#0FS*
MJ,QH+%  "     5S!-B@    ! !7,#0FQ0  @  $@        @
M                                    #,$@ KF!8H  0     "0 5S
ML4  (  !(  (                                               !
M-@  +7 '6 (  !(       !)  !!(    *C0FS*  $   @ %<P38H"I0$
M   D #($      D   9@ $   DZTYF#RMI?O^7Y+#;AJ/F8/*VE^_P"7Y+#;
MAYE3XV>]0^6C6?-&>53=/;(/G4('S(_4XJ]:E_?D\YHSRJ;I[9!\ZA ^9'ZG
M%7K4O[\U7RF<\_GHZ( !SG:?>+J$+BV+J$+BR)  )
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MK=*:368Z35R7>\SK;^]O&CD0O3>9'/6@H2LBT &AB
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MD)C.6:S*NDLCD0JKP#B2CPMT15%LV=FV;)MT[>+J7N:UO!UM;S7G3?&#D_\
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M5-SZQJ VA+,KG'5BHNR*  N9
MDZLYE#RO+E_BLOS41A:CFCHX*V6%^&%V<<BL63=Z=9<N+9F9YE#RN[E_BLOS
M41%9[CH0BN,SY[95;I8_A*_=#FZV?8U\N,X]')W1ZL6U3C9V)'IWM%EOVBQN
M+:.FBCJ=G!403;-&R/CE<W@KW3/W"+:#KWB6W8&N<%DPES[HWUDKI*E;G%3Z
MCMDS-NHY,^+)?PB9:;;;/BS1G#<\-7"'G)2P;L6E9'JI*QG71?,HU$7>R/-S
M,"HFBV\\?V1G^9B"?N$2A][^1S-;+?676LBH[;2S557)U,,+-9RDPJ=$V.::
ME6HDPY4JQ/.2,E=^(BJ[X#<N@*BH\-Z++IBI8DDJY(YYG.ZZLA1>![BM<0+
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MK\;5U5=K1SIKI$9MZ;//?U>JSZ^9$SHB[JYQ5%9V10 $F8
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M#HM'.@"6^T$46[ZBG;5*]_$Z21S6,S^Y36::ZP-IROMIN%2_$T\MUI)&;S.
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MJ]:E_?FO^D<\_GHZ( !SG:?>+J$+BV+J$+BR)  )
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MC:M<Z1V74YZOK\(YDZY3(KURU.&70SK574=V6@ N8
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M>]FL;_YG_&UF;AVNPAB&2."*=7) Z9=1LS9$R>S/K+G\HR^&M#%MPOB*EO\
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M,CFJKE<GXVK^":WXP5-(K*K&%2;G*[+0 6,P
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MDS[!Q^ 6A#*4JUG426P !H<X
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MNN'Q>X<[Z4KY28EQ_>;O1?U2HD9L>MK-:Q&:WNZN9$@J$PIY7=LK4Q&>.5(
M U.4           $G6G,P>5M+]_R_)8;<-1\S!Y6TOW_ "_)8;</,J?&SWJ'
MRT:SYHSRJ;I[9!\ZA ^9'ZG%7K4O[\GG-&>53=/;(/G4('S(_4XJ]:E_?FJ^
M4SGG\]'1  .<[3[Q=0A<6Q=0A<61( !(                           !
M9)Y&I>62>1J0P?$ %2 <6:#/+6L'LY?F7G:9Q9H,\M:P>SE^9>=%+X9'%B?F
M1.TS5G-*>5=5_?<7RC:9JSFE/*NJ_ON+Y1E3^)&]?Y;.0@ >F>$  "
M                              "N90 6)     !   )     !
M                                   )           !
M
M            )  !   )  !            )  !
M                                       )              !   )
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M;(/G4('S(_4XJ]:E_?FJ^4SGG\]'1  .<[3[Q=0A<6Q=0A<61( !(
M                    !9)Y&I>62>1J0P?$ %2 <6:#/+6L'LY?F7G:9Q9H
M,\M:P>SE^9>=%+X9'%B?F1.TS5G-*>5=5_?<7RC:9JSFE/*NJ_ON+Y1E3^)&
M]?Y;.0@"J'IGA VK9G]">AVIN,"[.ZXDG?2Q/\TVFCZO+UUWE]<U4;0TB.5N
M!]'L*>1\[I7_ (2OWS.6K2-(/+&31KX &QQ@ $D
M
M
M                       F.C_ -UQPEPYSU-!&M'L]HE2][-Y^MEEDQWG"
MLI*.K+P@YNT2' W#XG[%76KK)W>7^&0W&NCZ_P"$(V37:FB?2/75;44[]:-'
M=CM>Z556#Z,UEAJD5=HB  -+F      ( ,WA+#]5BC$-+9J":&*IJ-=&23*N
MKP6*_K(OG3[XWPI78-O:6VYRTTE2L+94=3.<K=5<_/(GG2N97L:<-Y<WD1T
M%B@ZP)U=]&EXM6"(\435=!);IX8)FLCD?M,I,LM[5R\TG7(*N^5C)/H6E!PZ
M@ %BH        (  !(    )S>-&5YM>"(L4SU5!);9H89FLCD?M,I,M7>U<O
M-)URKDHVN7A3<^A!@3F\Z-+Q:\$18HFJJ"6W300S-9'(_:9299;VKEYI.N08
M1DI=!*#CU !)<"80KL:W6:WVR:FBJ(X'5'])>YK=5'-;YE%\\2W8K&+D[(C0
M,MBFQU>&L055HKY8I:FDU6N?"KM7?:CNNB>>,2$[DRBXNS  )*@     @
M
M
M                                             ]MDN=39KK37&A>C
M)Z5[9&Y]?M$FTUVVFBQ-27VVQI'07ZD;<6-\[(_JT]_?_"(7D3S'Z[319HYD
M?U>I<6>XV=J(8S5I)G71=XR1K0 %RIUIS,'E;2_?\OR6&W#4?,P>5M+]_P O
MR6&W#S*GQL]ZA\M&L^:,\JFZ^V0?.H0/F1^IQ5ZU+^_)YS1GE4W7VR#YU"!\
MR/U.*O6I?WYK_I'//YZ.B  <YVGWBZA"XMBZA"XLB0 "0
M            "R3R-2\LD\C4A@^( *D XLT&>6M8/9R_,O.TSBS09Y:U@]G+
M\R\Z*7PLXL3\R!VF:LYI3RKJO[[B^4;3-6<TIY5U7]]Q?*,Z7Q(WK_+9R$H"
M@](\(&T=(WVG:/?\*=\M#5QM'2-]IVCW_"G?+0J_B1>/P2-?  U.,
M
M
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M  7,
M
M                                               3G'OE3Z./7N?S
M[2#$YQYY4^C?U[G\^TSGU1TX?^[Z&M@ 2#K3F8/*VE^_Y?DL-N&H^9@\K:7[
M_E^2PVX>94^-GO4/EHUGS1GE4W3VR#YU"!\R/U.*O6I?WY/.:,\JFZ>V0?.H
M0/F1^IQ5ZU+^_-5\IG//YZ.B  <YVGWBZA"XMBZA"XLB0 "0
M               "R3R-2\LD\C4A@^( *D XLT&>6M8/9R_,O.TSBS09Y:U@
M]G+\R\Z*7PR.+$_,B=IFK.:4\JZK^^XOE&TS5G-*>5=5_?<7RC*G\2-Z_P M
MG(15"A5#T_(\(*;0TC?:=H]_PIWRT-7J;0TC?:=H]_PIWRT*?W(O'X)&O@ ;
M'&
M
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MTMZ5['C+":6RV4ESBJ-NR;7J(V-:B-S[#U-* %H1459&=6JZKNP "YB
M
M
M                                     "<X\\J?1OZ]S^?:08G.//*G
MT;^O<_GVF<^J.G#_ -WT-;  D'6G,P>5M+]_R_)8;<-1\S!Y6TOW_+\EAMP\
MRI\;/>H?+1K/FC/*INOMD'SJ$#YD?J<5>M2_OR><T9Y5-U]L@^=0@?,C]3BK
MUJ7]^:_Z1SS^>CH@ '.=I]XNH0N+8NH0N+(D  D
M       LD\C4O+)/(U(8/B "I .+-!GEK6#V<OS+SM,XLT&>6M8/9R_,O.BE
M\+.+$_,@=IFK.:4\JZK^^XOE&TS5G-*>5=5_?<7RC.E\2-Z_RV<A* H/2/"!
MM'2-]IVCW_"G?+0U<;1TC?:=H]_PIWRT*OXD7C\$C7P -3C
M                               !(  (        !(  (
M                                                         !(
M (
M          !(  (
M
M
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M??UT^(UGC_ -YP7.SGG'%+1O\BK(4X#ON5\ZO^T,U5B]#>>%J05Y(AX -3G
M                  -F6G18MPT:28OY\[)(Z>>;<>Y?0WO3+7U^OJ^=ZYK,
MJI)]"\Z;A:_F  6*       $AP!AQ,5XJH+*M5N-:O:93;/::NJQ7\6:>=,U
MBK1\N'\?VO#+[INC=SX&[I2#5U-H_4ZC67B]<JYJ]C14I..9="" GFE/1\N
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M<5TD8F>Q6+8/=ZW"5/?5#34D<D4TL<L>SDCX#V.\R(S4NA-2C.G\2+0 7,@
M       0 371MH^KL>.K^=]52TRT&RUMLCEUM?7\[[ PM)8GRXRBP]++LWON
M*6YTVIK?VNIK:N\4SJ]C;@RLGN80$]TJ:/EP#):XUNG/#=;'N_J^RU49J_=.
M\\0(F,E)712<'!Y9  %BH          )_HJT=IC]+HB73G>M#LO^[[77U]?[
MIOG"LI**NRT(.;LB  ]MZHDMMXKZ!)=KN2HDAU^+6U79'B)3N0XV8 !)
M  (                               -HZ+]%'1W8*FY)>DHEBJG4^IN3
M:\3&+GGKM\^3!>9R7U4I_IZ_Q3)UHIV9U0PE624DCGX&Q-)6BVY8*I8KANJ.
MOM[GHQ\K8]1S'=;-#TZ-]%G1GAFINC;TM%L)WPK%N7:YY,8_CUT\\2JD6KE7
MAYJ67S-9  T,             #VV2B6Y7>@H$EV6ZZB.'7RSU=9V1--*VCKH
M!2UHMSYX+7;7^PV6IJ:GW3O/E'-)V-%2DXN7DC7P +F8           (
M                  )AHPP9T<X@J;7N]:%64KJA)-AM>I>QN6KK-\^>;2+A
M7H.Q-+9MU[MU(VOVVSV?5-SXM92F=9LIKPI9<_D1@ %S,
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MK>K+G55M)6,=L=U2:\D6KEK-1>NG"::S.BF[QN<%>&2=K6  -#
M         V-H%LD-\TATV[(TDAH8W5:-7LLR1OY3FDSYHO'%SIK_ !X?MM9-
M1TT<#9:A87JUTJOSR;FG6R(;H!O4%DTD4NZI$9'7P.I-9?/.5JM_*;D3'FB<
M$7*HQ#'B"VT<U;3S0M94;%NNZ-6\2Y=C(YI?,5STZ=^7]SK<Q>BW$N-L.3[>
M>QXBO%GJH]=K-SRN:F>^CV.R7^:$-TJ5,USQA55S[%7V9]6QLNYJF-6.<[J=
M??1./+WS<FA7$F,[G/;[366:GI;!0TK875+Z>6.16M9JL:BN=DKMY,][LF!T
MXOAATX82DJ51((V4CI,_.[I?F5B[39:<'*BG=V+J'1OA#!>&:>YZ1997UE1J
MIN9KU:B/R1=1NHN;E[*YY'PQ5HUPW?<&R8FT=RRJR!'/?3N>YVNC.J:FOPVO
M3)>OOD^TUU&$Z.&US8TLMQN4.<C8'TKW(V)V29YY2,XTR_%,7@3&6&+=8ZMN
M$<'8FYV;1SYG,@21FLC455S=*O6R*J<NJ9K*E37N-+_)%M". ,/XMP37U=VM
MZ2U\57)!%/NB5NKXW&J;S7(G&Y3(83PKHKN5PDP[3RU5QO#-9'5$DDT>T<WJ
MM14R9_OKF:YF]T;='%Y=3HNSYX3:G9\BC--:#/+3L'LW_-/)UEF=S/W8*"RK
M4KI$P-)A['L5@MBR5*5>R?2*[JN&NKDONFQJK FCW =NIF8ZJIJVOJ/,L?(Q
M/P6QY+EZZF8QG)#%S2>$G5.6SW#JIGYY5J$;^5JGWTPU6!Z'$5(_&F'KG75$
ME/XU502+LU:CEX.]*W?3//B\T'-V2+1HPCFEIU(+I+T:6JFPI%BK!53+/:M1
MCY(7KK\%<DUVZV_U]]%--(=)IBVQ,T75]!8\*XDI\/R4D[63/@:Z)FLB\+7=
M*JY:SL^N<V&M&3:=SDQ<8QDG'S.IN9YGPW+9JIEAII8KI'!3<\Y'ZV4C\GZN
M6;E^[XD1" 8BJ<(S:4\/QX9H:JGN<=_8EP?-KY/=MTXM9RIU6MQ(AF^9/_\
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MT=G&K.HRS;EO'.1M1EF1R8N&62L  ;'&
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M\-Q*C*RK8RF=[G#E=^-\HYN4VI-RO)G'BHQA:"6I4 &YQ
M G.//*GT;^O<_GVD&)SCWRI]&_KW/Y]IG/JCIP_]WT-;  D'6G,P>5M+]_R_
M)8;<-1\S!Y6TOW_+\EAMP\RI\;/>H?+1K/FC/*INGMD'SJ$#YD?J<5>M2_OR
M><T9Y5-T]L@^=0@?,C]3BKUJ7]^:KY3.>?ST=$  YSM/O%U"%Q;%U"%Q9$@
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M1'ZO;1J,:F?OFF@'2BR5BJB65,NEDD?*KY5VDC^J<6@&AS-W  )(
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M53Q[FHH&:M/39ZVIV55>RI#@#2,5%61E.;J/-(  L9@
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MII:&FM5K>B(^*%^NY[?.YY(FKZR&L0"T8J/0SJ595'>0 !8S
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MJ]:E_?FO^D<\_GHZ( !SG:?>+J$+BV+J$+BR)  )
M        +)/(U+RR3R-2&#X@ J0#BS09Y:U@]G+\R\[3.+-!GEK6#V<OS+SH
MI?"SBQ/S(':9JSFE/*NJ_ON+Y1M,U9S2GE75?WW%\HRI_$C>O\MG(2A #TSP
M@;55BXET)4$]/XY6X9JY896>:W/.[61WOY)^"XU42W1SBQ^$KZL\\:5-LJV;
MGK:9>*6)W'[J%)*^J-:;6L7T9@@3C'&"N=L2WW#TW/'#%7PX*F%=?8_<2]A4
MXOY[Q!S2,E(Y:E-P=F  6*
M
M
M                                                       D  $
M
M
M                                                       NC8^2
M5&1IM)']2WCS("39?2T\M54Q001[6HDD:R-C?-.7B)MILF@H[A8<,4\J2QV&
MA;3RN9Q;=^^_XFF:LMNI]&%NZ(\211KB.6/_ (5:GKPHE7>VLO8RW][]?4ZC
MJZN>NK):NLEVM342.FF>[S3G<9E?,[G;&/#CKU9Y@54H7,CK/F8/*VE^_P"7
MY+#;IJ+F8/*VE^_Y?DL-NGF5/C9[U#Y:-9\T9Y5-T]L@^=0@?,C]3BKUJ7]^
M3SFC/*INGMD'SJ$#YD?J<5>M2_OS5?*9SS^>CH@ '.=I]XNH0N+8NH0N+(D
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M9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W
MRO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](
M:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM
M[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%7
M8QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!M
MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?
MI!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&
M-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MH
MJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R
M-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/
MZ&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5
M[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6
MX&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?
MI#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&
M-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MH
MJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](
M-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM
M[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%7
M8QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1M
MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0
MV1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<
M9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W
MRO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](
M:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM
M[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%7
M8QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!M
MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?
MI!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&
M-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MH
MJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R
M-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/
MZ&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5
M[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6
MX&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?
MI#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&
M-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MH
MJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](
M-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM
M[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%7
M8QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1M
MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0
MV1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<
M9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W
MRO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](
M:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM
M[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%7
M8QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!M
MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?
MI!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&
M-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MH
MJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R
M-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5[C/
MZ&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6X&5
M[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?I#6
MX&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&-O?
MI#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MHJ[&
M-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](-MH
MJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM[](
M-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%78QM
M[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1MM%7
M8QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0V1M
MM%78QM[](-MHJ[&-O?I#6X&5[C/Z&R-MHJ[&-O?I!MM%78QM[](:W RO<9_0
MV1MM%78QM[](5VVBO_[V]^E-; 97N,_H;+CJM%<?#='C63[EZTOZE/LNDBU6
M)BMP%AFEMTZ[W/&M?NFH_!UMYB^^G:-7!",GJ2JENB/9<Z^LNMQDK+G4RU%7
M)U4TK]9QX\BI4LD9MM]2T%Q]Z.DJ*ZKBI*.+:U,[VPQ,;YIS@W815V=8\S/"
M^+1A&]_]O5RO;V^)O[)M9# X&L4>&,)6RTQK_58$8[[J3C>[W5S4SQYDW>39
M[U)98)&L^:,\JFZ^V0?.H0/F1^IQ5ZU+^_)YS1GE4W3VR#YU"!\R/U.*O6I?
MWQO_ *1S3^>CH@ ',=I]XNH0N+8NH0N+(D  D
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M8]G45FO6R^N]>#^0C#=^[3L_,XU[]>Z\C88 .<[3[Q=0A<6Q=0A<61( !(
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M4[%.+Z,^@ %B;H  BS&9  "S&9  $V&9  $6%T  +"Z  %A=  "PN@ !870
M L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !87
M0  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !
M870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@
M !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %A=  "P
MN@ !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %A=
M"PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %A=
M  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z  %
MA=  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"Z
M %A=  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T  +"
MZ  %A=  "PN@ !870  L+H  6%T  +"Z  %A=  "PN@ !870  L+H  6%T
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M62>1J0P?$ %2
M
M
M                                 1<  $@
M
M
M
M                    'WBZA"XMBZA"XLB0 "0
M      "R3R-2\LD\C4A@^( *D
M
M
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MZJ\1NW,JXV+1GF  (+@
M
M
M                                 'WBZA"XMBZA"XLB0 "0
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M#X>)VP]RM=O?9X(\3MA[E:[>^SP1]R/ZCT/OXHG"7I"_][Q?Q!XHG"7I"_\
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MQ!XHG"?)]_[WB_B'P\3KAWE:Z_F_ 'B=<.\K77\WX ^Y']3Z'W\43A/D^_\
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MU/H??Q1.$^3[_P![Q?Q!XHG"?)]_[WB_B'P\3KAWE:Z_F_ 'B=<.\K77\WX
M^Y']3Z'W\43A/D^_][Q?Q!XHG"?)]_[WB_B'P\3KAWE:Z_F_ 'B=<.\K77\W
MX ^Y']3Z'W\43A/D^_\ >\7\0>*)PGR??^]XOXA\/$ZX=Y6NOYOP!XG7#O*U
MU_-^ /N1_4^A]_%$X3Y/O_>\7\0>*)PGR??^]XOXA\/$ZX=Y6NOYOP!XG7#O
M*UU_-^ /N1_4^A]_%$X3Y/O_ 'O%_$'BB<)\GW_O>+^(?#Q.N'>5KK^;\ >)
MUP[RM=?S?@#[D?U/H??Q1.$^3[_WO%_$'BB<)\GW_O>+^(?#Q.N'>5KK^;\
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MK%94=+QU-(8F[RST9O\  !B=(  !]XNH0N+8NH0N+(D  D
M              LD\C4O+)/(U(8/B "I ,%C+$E'A7#U7=[@OC5/'O,3JI7=
M9J>NIG3ESFGL3OK\3TN'Z:1=S6]FVF^ZF>W]3/E*7IPS2L8UZG#C<A#4Q!I8
MQQOYR5M0OK1TD*?$U/A]=3JK1W@&TX(MR0V^+:UDF_/5R)XY+]"=HP&@?!S,
M+X/BK)X_^*7.-M1._P TUO\ 9L][X<S:"%ZM3R70SH4;+/+JR@ ,3J  (
M
M
M                                                        !(
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M0+#6BW#5CN$=P;%4W&X,3@U5=+MGZWGNQGV\B>%<AD')OJ%%+H4 !!8
M@
M
M
M$@^51#%50R0SQ1R1R<%S'\)''-.FW1)'98YK]AB/*W=74T:?]W^[9]QV>QZW
M%TUD6R1LDB5DB(]C]YS2\*CB[F56DJBLSGOF<])#W[/"M\E7)?L?,]?S/@^]
MV#H<XPTKX9DP!CQ4M>TCIY'MK*%_G-_J?P5_4=88%O\ %BC"EKNT:[]1!PT\
M[(F\]/?S]XTJQ7Q+S,</-ZPEY&? !@=9]XNH0N+8NH0N+(D  D
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MXMBZA"XLB0 "0                           "R3R-2\LD\C4A@^( *D
MXLT%>6O8/9R_,O.TSBS05Y:]@]G+\R\WI?#(XL5\<3M, \]P=J4<J_<'.SM1
M'KC4[JK-=/(_,*>?(HN^5,),WOI8  $@
M
M
M                  H+$7*@ $@                         H 5    *
M"Q%RH !(    * %0"@!4         %"H
M
M
M                          !3>*QOU,GQJ $P2NCFW1212'V,7AY?Z)*G
MW9E#9=#"74UIS1GE477VR#YUI N9%7?Q1_E?WY/N:,\JBZ^V0?.M(!S(O_ZH
M_P K^_.J/RF<$OQ".B0 <YW'WBZA"XMBZA"XLB0 "0
M         "R3R-2\LD\C4A@^( *D XLT%>6O8/9R_,O.TSBS05Y:]@]G+\T\
MWI?!(XL5\<3M,\MU^Q\WL#U'ENOV/F]@<[Z'=$C  ,#<
M
M
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M  *EP
M
M                                                 #-X>\@F]F98
MQ.'O()O9F6-H]#&?4UKS1GE477VR#YUI .9%X\4?Y7]^3_FC/*HNOMD'SK2
M<R+QXH_RO[\ZH_*//E^(1T2 #G.X^\74(7%L74(7%D2  2
M              62>1J7EDGD:D,'Q !4@'%F@KRU[![.7YIYVF<6:"O+7L'L
MY?FGF]+X)'%BOCB=IGENOV/F]@>H\MU_J$WL#G?0[HD8 !@;@
M
M
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M^KB-GZ7,-UF)L);FM_#K*>=M0QGGM5KDU?RA.:XD;LK2I2=*>FCZ&"YG5?\
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MGDJ(]C#"].$C>-SG=CS)MXYJULWNG=ALS@LP !D;@
M
M
M                         &;P]Y!-[,RQB</>03>S,L;1Z&,NIK7FC/*H
MNOMD'SK2 <R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ1_E?WYU1^4>?+\0CHD
M'.=Q]XNH0N+8NH0N+(D  D                            LD\C4O+)/(
MU(8/B "I .+-!7EKV#V<OS3SM,XLT%>6O8/9R_-/-Z7P2.+%?'$[3/-<4UJ.
M5/N#TE')F<[Z':B'@^E7%L)Y62GS,&C=   D
M
M
M                       7%@           18  $@  @&@M(EMQ9AC%$MW
MME5=:FU23[HA\<?)'%YK4>SL?J-^ TIU,AG5I<16O8Y\Q!I4NV*+)+:+99MG
M45$>RF?#(Z=VJ[C:UN77]TFVA;!59AJCJKC>(4BN%7JL9#Z%&G9[:FS07E66
M7+%6,HX=J2G-W94 &)U  $7%@     18  $@ "X     !%@  2     +BR
M      %V
M
M                                                           #
M.8?3*"7V9E3RVZGW-1QL7J_-'J-UT,)/4UKS1GE477VR#YUI .9%X\4?Y7]^
M3_FC/*HNOMD'SK2 <R+QXH_RO[\Z8_*."7XA'1( .<[C[Q=0A<6Q=0A<61(
M!(                           !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY
M?FGG:9Q9H*\M>P>SE^:>;TO@D<6*^.)VF #G.T\=QH4K(ON^L1V>)\$NI)QD
MN+9(XY4U)41Z%7&Y93L1 $D=;*15\C*<ZZ3T,KD9?,B. D?.ND]#'.ND]#&1
MDYD1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R,9D1P$CYUTGH8YUTGH8R
M,9D1P$CYUTGH97G52)QQ?EC(QF1&T0S5LMJ,\>J.+S+,C)0T\4/D3$9ZQ]BR
MAN4<R@ +F;-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/
M\K^_.B/RCBE^(1T2 #G.X^\74(7%L74(7%D2  2
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M=0A<6Q=0A<61( !(                           !9)Y&I>62>1J0P?$
M%2 <6:"O+7L'LY?FGG:9Q9H*\M>P>SE^:>;TO@D<6*^.)VF >6Z5D=OME762
M>101NE=[B9F"69I'7*2C%R?D:YTI8XEMN=IM+]2KD9X[-Z$B]9/NC2[EUUS=
MQGVKJR6MJYJN9=I43O<]_NGP0^VP>%CAZ:2Z^9^=^T<;/%56V]"B[RE #M/.
M
M
M
M
M
M
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M'7WL?J:8OY$OH<R@ ^]1^9/J  "
M
M                                                       "N10
M          %0"@!4 H               "I0
M              J4
M
M
M                    -U:"/L5=/;V?)-IFK-!'V*NGMS?DFTCXGVC^(D?H
MOLC\) UIS1GE477VR#YUI .9%X\4?Y7]^3_FC/*HNOMD'SK2 <R+QXH_RO[\
MRC\HTE^(1T2 #G.X^\74(7%L74(7%D2  2
M  62>1J7EDGD:D,'Q !4@'%F@KRU[![.7YIYVF<6:"O+7L'LY?FGF]+X)'%B
MOCB=ID=TA_:;>?:'DB([I#^TV\^T/(PWS8_5&F+^1+Z',ZE"JE#[Q=#\R?4
M D@
M
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M8:=*FJBBDIF;[I8'YZOQ*9QQM"4LJDKFC]GXB,<[B[$3 !UG$
M
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M8;YL?JC3%_(E]#F<H5*'WD>A^9/J  20
M
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M0 "YF
M
M  ;JT$?8JZ>W-^2;1-7:"/L5=/;F_)-HGQ/M'\1(_1?9'X2!K7FC/*HNOMD'
MSK2 <R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ1_E?WYE'Y1I+\0CHD '.=Q]X
MNH0N+8NH0N+(D  D                            LD\C4O+)/(U(8/B
M"I .+-!7EKV#V<OS3SM,XLT%>6O8/9R_-/-Z7P2.+%?'$[3([I#^TV\^T/)$
M1W2']IMY]H>1AOFQ^J-,7\B7T.9RA4H?>(_,GU  )(
M
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M#7/U6I'ZS$-4A#G7LRBI7M^1U^,8EQM?\_,N54?PG\9:"AZ"5CRFVW=@ $D
M
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M;>?:'D8;YL?JC3%_(E]#F<H5*'WB/S)]0 "2
M
M
M
M
M
M
M                     #=6@C[%73VYOR3:)J[01]BKI[<WY)M$^)]H_B)'
MZ+[(_"0-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/\K^
M_,H_*-)?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
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M((#W7BFCI+M74T2>-T\SH6ZWW+LCQ9&D)J2NC*I!PEE90 KF3<I8H 5S%P4
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M%7$1I6S>;L;T</*M?+Y:D( !O<P:  !   NB;   @
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MY,_-(? [$[ZHX'%Q=F ;(T<8&M^)[+/5UL]7#+%4/B1(7MU<M5B^::O9,HW
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MZA"XMBZA"XLB0 "0                           "R3R-2\LD\C4A@^(
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M ,'IJC#WJ4TM%Y+_ ":_T&;V+9_O)_RXS!Z4%_Y^O'LF?-M,WH,^VV?[R?\
M+C,'I/\ M_O/LV?-M/3I?C9?0\BK_P#KH_\ ]$5 !ZZ/!  )      !O;07]
MJE;]]N^;C-*7#/=U3[-WRC=>@M/^5*W[[=\W&:TKL%XB?5S.CM%3JJ]<M]#P
M\)5C3Q-7,['T>-HSJ8.BH*Y%F-5[]5O&;9EJ,#X7M-/L*:DO=4_CRU95[;ES
MSU4($W#=PI;U;:.ZTTM(E7,V+6=UVJY$<OPFU,924N":6A;8</4]1+*CO'G,
MUM3++?<O5+GGV2^.JQG*$8N]]G;]S/V=0E3C.<DE;=79Y+O8[%B+ LU[HK8E
MLJ(X))X]5B-7@HO'EO*BY'GYG[JK]ZT'[PE#JNXUNBZY5-VBV%6^CJ'+'J:J
MM;JNU=[ULB+<S\O"OWK0?O#S\\I8:I%OHU_)ZBIQCC*,HKJG_!]:BZX*MV)*
MJVS6Q*B669VWJYHTD:V15W^J[':,!I7PC2V*2EKK;&D='.NHZ).)C^MEZYB\
M081O#\75=&VFJ)%GG<^*;4X+FN7JM;XR<Z=ZED5@ME BIMGS[5$[36.1?E(=
M%-\.K3X<KWZG+5CQJ-5U8VR]&8K V$[5!AF7$6(X]K D;I60JF;4:F?"RZZK
MUC(V"KP5BVIDML=CCI)]3./QML3G9=A6\2GNI(78BT-I1VY4?4L@;'J=ET:H
MNK[NJGOD-T5X>N:8NI:N>EJ:>&DU]JZ>-6;^JK=7?]<K*7$52<Y-23T+QAPI
M4H4X)QDM=#&U&'N<>D*AM=0NVI]V0*Q7,3QR-[TXT^!39^*+'A.S5$-TNM/3
M04[&[-D$<.6T>J^=3JB)XZJX:K2Y9V1+FM//312>RVFM^T>K3\[QVRLRX"ME
MW_Q"6YUZE)2=KK4K&-/#4ZTHQ3L]+D?I8,-7S'-;+/-3T%@8QKF1+E!K+JHF
MKULM_67>)+%?,))?XK118>I:F.29L*5+(V+Q]C>SR]TP.AW#U#?+A72W*/;Q
MTS&:D4F^UVOK;_N:OPDC@Q-=4Q<EGLU@IJ2ECJMD^38JBK&B\)W61-[UR<3\
MQTXMO*M[#!I\-59)+,]KD;TNX;H;#<*&6VQ+%'5H[6B1>"U6ZN2I^,;+T>7:
MAN>'*FIM]MCH88WN8Z)B)D]R-3?WD1"(<T%U=AS[$_[LR6A#A8+N+.NM5(GY
MMAC6O5P<)R>M_P#)M0RT?:$Z<%96_P $(D;1XXQ514=GML-KA5B[18FMZE-]
M5WD0E]\J,&X,GBMTUGW7.L>N]SXVR.R[*N=U_6(GHH?):,:4K+A%-3[:-\+-
MK'J\+L?DGHTM6"Y=%\U93TM3405;8]5T,;GY.1$;JKEUURS.F<8NM&C*5HI;
MG+#-&A*O&*<V]C*8UPE:*[#'1#AN/9L1FU?"B9-<WK\'K.0^&A.UT-S2\)<*
M.GJTC2%6)+&U^KGK]DD<<+L/:'9*>Y*C*B2EE9J.7B?+GJM]]QB>9^WEOV78
M@_>&4JLWA:BOHGHS>-&GSE-VU:NUZV+<118.P[;KE;$BCJ+N^.3)^QUMF]6K
MEEO9,RWN+B/3A&T6O$NCF9L=#1<](XWP+.V%NNDC=]BYY9^=4U;B=R28FO3G
M\>ZY?EJ3G0A=5IK[56Q^2,JX]=OLV\:>]\1K5P[IX?B)MO1G-0Q4*N+=)Q2C
MJCRZ'+'#=+W535]/%/!2P(NK+&CDUW*F2[_:1Q'L<RTLN*Z]+;314]+%)LF-
MBC:UJZF\KM[MFY9*1F"<-XCKV.:LD\\D\2=M^2,;[YST[?-L#4>(K2K>71&/
MM&E'"4(4+:ZM_P"#Z0125$T<,$6TEDX+&-.BJ_#T>+L.VYE_CEI*N-&O<D;V
MZR.R3-,]],E-6Z&$IUQHFZ-76V#]CGY_>_9UB1XI?C*FQ\E10TM544C=Z!D2
M^-/9O9HY>)%]<Q]HS=6LH)VMK<Z/94(TJ#J2692=K(\&E>\LN+HL/6>FEE90
MO\>1&*J(K6Y(U/6-7N16Y-?U9U'4T[*:GJ[I!0M=<I*;A-3JGN:W-K#F"I?)
M+52R3^2R/=K^R-?9==2@X)=/Y,?;>'<)JI)WN9+"7VUV7[]@^6AL_3]_4K/[
M9)\E#6&$LNBNR??L'RT-GZ?OZE9_;)/B08K\;3^@P?\ ^OJGUP99+'5Z,H:R
MZ4M/U$KI*E84VFHDKNOEGQ(7X/DP9B=:FW4MDCA6*/7\=C1'/9Q:VLF_\)?A
MWRC)OO2I^4\BF@S>Q;4?>3_EQG#*+E&K/,[Q>AZ$9QC.A345:2UT,_!'@W#N
M(H</26M*N>1[6.J*B-LFJYW4MW_U(1O2[AJBL-?12VYFRIZIC_&4XFN;JY*G
MXQ\\6;VE[_/T_P"P2'F@%W["O7RG_=F])RIUJ;4G[RU,*^6K0JIQ7NO3]3S6
MM,&X?PQ%5U:TMWN<C6ZT22-EX2^91O$C4];K&>M%GP_C?#U5+3VB*V2)(^-K
MXHVM76RZI%3C*WR@H,$X:I9K59(*^H5[(WRO9KKU*\-R^X9W1[<[K>+'+67:
MFCI]H_QAC&*S)F7;[>9R5:KLZL6^O6_^#LH4(IJE-+IT2_R::T=X:9B6\I!.
MCF4E.S:S:GFNMJ^Z3B_W3 ]JN$MIJ+''(D::LLT4;=9G:SSUC%:":MD-[KJ9
MR^.5,#9&^LW_ /F,9C+!]\DQA6[EHJFHCJYW2PRM9XWP]_)R];+MG;5EQ,0X
MU9626FMC@HQX6%4Z,;MO72Y+-(MBM5LT?Q2V^EIUD8D+6U+(&[1S>SGEUT^,
M^-EL]MET125\E#3R5:4LZI4;%-IO/?EOY:QD])M'SOT74U&Y=HZGV$6?K9)F
M?/#^2Z#)=[_NM3\MYRQFW1B[_P!QVSI16(E>/]A']"ELH;ISX2X4=/5(Q(59
MMHTDU<]?LH9"GK<%4&)%L*6B.>5\^P=42QM<U)'+Q;_$F:Y;Q9S/^\M^]:#]
MX0?CTD__ +5_>G1*#JUZB;=DO\''":HX6BU%7;V]3-Z7,.4E@N5)+;XTC@JX
MW^-)U+',RXO?)+9<.6/"^$&7C$%-NRH?&URMD9K9:R<%C6\1Y^: ZJP^M/\
MNS.8VHY\6Z.Z.:THDTGC=0V-GF]Y6JWW-;X#/C2G1I*<M&]6;<O3CB*SA&[2
M5D>/!D>$\45\L]+:8:>>&'4EI)8F+'ONWG(B9IO:O&GGC66/*:"EQ;<X8(XX
MX(YLFL8Q&M;O&P-#.';E07.KN5SI):5FQ6G8R5FJYV^BYY>X032+OXWNZ_\
MC_0=.#:6*E&$KJQR8^+>"C.<;2;VL1D 'MGSH
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M-(:@-WW]?^PN+[UIOEL-'IOG5[+FW"46^C./VQ3C&I"45:Z3  /3/'
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MJZU-?5QQ1U$Z(C]EGJ[S<NV8U"N1O&A!3XEM3!XB;APV]  #5'.  2
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MHM*^(&-1KXZ"3[MT2Y_ Y$-?C+>*U<-1JZS5V7I8RM166$FD9S$>*KKB)?\
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M2 <R+QXH_P K^_,H_*-)?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M                %DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[
M![.7YIYO2^"1Q8KXXG:9'=(?VFWGVAY(B.Z0_M-O/M#R,-\V/U1IB_D2^AS.
M4*E#[Q'YD^I7KGIM]'-<:Z*DI8]I43/U6MZQYC/X&ND-FQ505]7GN>-[M?\
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MVC1^KGK]E"'I##T>I3;.+<_/'9[+9\'5VO4ZIUQQ:<YT[?"<$L"U3A5O\3,
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M;%8/E[6E=,^8 .LX0
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M  "0                    18 J4!(     (L  "0
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M6"3$=S2AIIF1/2-TBO<F?%O?K)G4C36:70BG"522C%:F$!4H24Z:  %B
M  "JA"05>'UI\'4%]2H7*HJ-AL-GU.6OPM;/[GL=<CW&9TZL:E[>1K4I2IVS
M>>H !H9
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MI .9%X\4?Y7]^91^4:2_$(Z) !SG<?>+J$+BV+J$+BR)  )
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MG7C&,-6NK  /51XP
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M62MUMY_D==7VC1=&4<SE?HFNGYF 0NR+4+D/;/FF4 !<
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MJ?>,*<Y9\CTBY/7_  =52G#A<2.LU%:;(UL6C,'NH^9  +
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M>51=?;(/G6D YD7CQ1_E?WYE'Y1I+\0CHD '.=Q]XNH0N+8NH0N+(D  D
M                         LD\C4O+)/(U(8/B "I .+-!7EKV#V<OS3SM
M,XLT%>6O8/9R_-/-Z7P2.+%?'$[3([I#^TV\^T/)$1W2']IMY]H>1AOFQ^J-
M,7\B7T.9RA4H?>(_,GU  )(  (L"A4 6)N4*E2@(*Y% !8% 5 L3<  6(  %
M@  + #( 6!0%2HL24 !)
M *Y %                              4!4$6)N"A4"Q R&0 )N4!=UB@
ML+E"H*BQ R*9%2@L"A4 6   L  !8FX !)     *@% "H!0
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MZ(JR.5N[N  6(
M       !0J"+ H5 %B;@ "PN4!=D4 N"A4"PN4*@"P&0 %B!D4*@$W   N"I
M0"Q   L"@*@6)N4*@"Q  !(* J 3<%"H(L0,AD ";E 5*@7+2H L0  + H"H
M!-P !8@  6)N  20                        ;JT$?8JZ>W-^2;1-7:"/
ML5=/;F_)-HGQ/M'\1(_1?9'X2!K7FC/*HNOMD'SK2 <R+QXH_P K^_)_S1GE
M477VR#YUI .9%X\4?Y7]^91^4:2_$(Z) !SG<?>+J$+BV+J$+BR)  )
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MM%AJ,.1WO#LLE.B/2*6FE?OM]S/>(4BG91K*JKHX,1AY4)97J6@ V,
M                        "I*\/8+KKG0+<*NKIJ"V\:3S^:[:=HP=BHTN
M5ZH:-RY-GE;&ONJ3#3!<'R7^.T4^3*2A8QK8D3@ZSFY_$<5>I-U(T:;LWK]#
MT,-1@J4J]75+2WJ6QX#H:Y-E9L2T%95<>Q<S4UO6X2D,N=!4VRNDHZZ-(ZF/
M?<Q%WCXQ2R03QSP2;.6/A,<2+$=ZJ<972A1*...KX,'!7/:YNWOC4B/%HS]]
MYHB3HUH6A&TOY(TG$#85=28/PQ+N&XTM5=J]F_,]DBQLB7+B3)4R,9BRPV^.
MUT]]PY)+);9G[)\,G'"\0QL)22::3Z,3]GSC%NZ;75$0'6-BVK#EBDP-0WNZ
M;:G5DS]LZ)ZZ\W"5J,1.+L'TMELPKBN&II+-05-ON,,.UB625S]?+\)>U[Y#
MQ\=?==EYEU[-FTO>5WJD:_H*62KKZ6FCWI)Y&Q?C.R/3B.TR6.]U5NFE9))!
MJ<)J*B;[4=^LRVCZIM<-[ACNE#+5S231)3O8]6[)VMU7'ZQG]+559W7FOIV6
MV5+MKQ:]5M%U7-U$ZV>7%DG$1/%36(4+:6)AA(/#.HVKW-< VC)A3#])8K3>
M;LZ6"@DHHW21L>YTD\SFZW6[6?%D1RV6>V8FQG)36K;4%JV>U\<\D:U$;GQJ
MO&I:&/A--V=EYE)^SYPLFU=^1$3TVVEW;<*6FVFSV\S84=[)V1-TK]'[:A*?
MG16['7U=U;=V7LLM?]1Y+M868=TB6VBIY->GW1!-&CUS5$5^2I[Y"QBDG%II
MV?4MR+A:5TU=)V,!BNT.L5]J+:M1MUI]3.34U=;-B+Q9KV3$9$NTK_;_ '3_
M *7S3")&^%G*=&,I=;'-BH1IUI0CT3)+<\,;AP;0WW=6T6KDV6QV?4]5YK/[
MA.L1G(V5BCRG,.)_\RGR936R(9X*I*I&69]&S7'4HTI14?-(ID,C/X,L;,0W
MF.CGEV-/&QTLKD["$B2OT?MJ4IN=%9L=?5W5MW99^>RUA5Q7#ED2;^A6A@G5
MCG<DEZD(ME+NROIJ7:;/=$[8M;UW9'NQ59EL-]J;:M1MU@U,Y=35ULV(O%FO
M9,]=[$S#ND2VT<$FO!MX)8T<N;LEDR5/?0D^D"FPS;,15-9?(ZJX5E5JR-IX
MGZC8V(QK-]<TX\NR83QGWL7'5-=#KA@%PIYW9I]3460R-A5EALE_L51<\*I+
M3ST?"FHYGZW!RZW'V%,-@?#3+Y-4S5]3L;90LVD\OOKJ^\BG0L9!P<GI;JCE
ME@9J:A'6_GY$6R*Y&P(ZG -35[D2W5U/')P4K=LOOJFLN7XI',98?DPY>=R:
M^TIGLVK)>NY@IXN,WE::?J*N"E".:,DUZ&!R&1MO$6%L+8=KY:V[+,RAE1K8
M***1RND=YMW'G\*$4PU9K9>;E=JR>26ELM)K3ZB=6D>LNJSC7K%(8^$XN:3M
M_P#:&E3V=.$E!R5R'Y%<C8ULFP'=KC#;H;36T[YW[&*=T[NJ7BWM=3"2T=KP
MWBZMHKU2RW"CITU&-8_9NX6JY';RIUA'&9KQRM2M>P> RY99DTW8Q^*\/RX=
MN--25$T<DLL+9E5O%PE<G[)@S;FENKL4=1'#56Z2:Y24B;"HUUU8TS7+-,^S
MF8.AL%DL%C@NN*DEGGK6:T-%$]6\')%W^+M&5#&MTE*:=W^YKB/9ZXSC3>B_
M8U^#8]/9,-XMI:IN&X:FW76!FNVGFDUFO]]5,/HXLE->[Y645=3(](Z*22-%
M>YN3]9B)Q9=DVYV"A*35G'JO,P\.FYQC%IJ71D/,_?+&RV6NUUC*V*=U>QTJ
MP[/R%,FKEQKY[M&5Q)2X7LULJ+;3R5%7?&:K'U#<]E$_6373C[&:9;Y;C*S4
M-LPYAFII(DCJ*Z!TD[M=7:SM5G9]DI3FN)*+5U?]]"_)NG&:=FTOTU(;D5)W
M162QV&S4]SQ/%4U%16\."BA>K>!V7+O=93ZU5EP_B.S5M9AB*IHZZC9M9*65
MZNUV9+Q<)>QQE^=C?H[=+E5[.FXWNK[>9K\$RP98+94V:XWJ^+424-%JL2*#
MJGN7K_E(96VP8,Q'+)0TE-46FJ>SQJ5\VLBY=C-5$\;&,G&S=NHA[/E**DY)
M7Z(UP4/O40O@J)H9/)(Y',]X^!V)W5T>>XM.P !)
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M1J1DW%>1I*G**3?F6@ N9@
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MK2 <R+QXH_RO[\RC\HTE^(1T2 #G.X^\74(7%L74(7%D2  2
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MNV2VZTVRFM=#(N<K(>JD]=<D(B=>#ISA%J?Y>9Q^T*M.I)9/SMH@ #M/.
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M$\TVUK^5BL:-*=/+3BGI]'<UD"J<84]JY\\^I0 $@
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M9Y5%U]L@^=:0#F1>/%'^5_?F4?E&DOQ".B0 <YW'WBZA"XMBZA"XLB0 "0
M                         "R3R-2\LD\C4A@^( *D XLT%>6O8/9R_-/.
MTSBS05Y:]@]G+\T\WI?!(XL5\<3M,CND/[3;S[0\D1'=(?VFWGVAY&&^;'ZH
MTQ?R)?0YG*%2A]XC\R?4  D@       J4   *V!7(9% 6  !%@  + H"H%B;
ME 5*BPN4  L0  + H"H%B;E 5 !0%0!<H"H%A<H"H%A<H7% +$  "P  %@
M2 4*@BP  !-P !8@H"H!-RA4 6%P "2
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M2@*@FP* J"!<H"H)%P "+$% 5 L3<H"H%A<  FQ
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MOOD4<;"K+*O,FM@:E*.9V=NOH1P '8<(
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M  L4 *E
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M)C"A4C4486<5H:W !ZQX@
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MG35**C'H5JU95)9I=2T &ID
M        ;JT$?8JZ>W-^2;1-7:"/L5=/;F_)-HGQ/M'\1(_1?9'X2!K7FC/*
MHNOMD'SK2 <R+QXH_P K^_)_S1GE477VR#YUI .9%X\4?Y7]^91^4:2_$(Z)
M !SG<?>+J$+BV+J$+BR)  )                            +)/(U+RR3
MR-2&#X@ J0#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7QQ.TR.Z0_M
M-O/M#R1$=TA_:;>?:'D8;YL?JC3%_(E]#F<H5*'WB/S)]0 "2        5R
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M3 %0@4D@M!4 % 5!%B;E 5 %R@*@FPN  0R 4*@D7* J"+$W*%4 %A<  BQ
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MSJ="<YPNGIN>K4Q4(4YZJ\MB,E2A4]H^>8 !8@
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M#55VRZG?:B]?+LE'4BI9/,UX<G'/Y&, !<R
M        -U:"/L5=/;F_)-HFKM!'V*NGMS?DFT3XGVC^(D?HOLC\) UKS1GE
M477VR#YUI .9%X\4?Y7]^3_FC/*HNOMD'SK2 <R+QXH_RO[\RC\HTE^(1T2
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MC(7VU55ENLU%7L3;LW\_,O3SR&/-XRC..:+T.><'"6675%H +&8
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M5=FQ%XLU[)B,CHA.-2*G'HSGJTW3DX2ZHH "QF
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MR#YUI .9%X\4?Y7]^91^4:2_$(Z) !SG<?>+J$+BV+J$+BR)  )
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M9+1/J_4B=EBJIKK1,MW];VS5B]<FEZLEIBNDDF*L2NJ+GDW:QT].JY;V]O\
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M3/2#=/\ I?-,(@2[2LY7:0KIJ=?9_!$PB2'HX+Y$/HCRL?\ B)OU90 '4<@
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MN"L50T%XBNDJTFM*V%B[.+@OR5./C_9$\74C*ZEY]/\ TB&"I3C;*[VO>_\
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MR,YY%@[6UNS$Y&V*Z>;">CJSSV"-&5%=J/GJ=FCG)K)K9+\1JC/,F5DQ=?\
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M1)\6XFCN])16^W4.X[32IXW%U3E<O77X2+C(&U*E&E'+'H<]>O*M+/,  V,
M              #=6@C[%73VYOR3:)J[01]BKI[<WY)M$^)]H_B)'Z+[(_"0
M-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_P":,\JBZ^V0?.M(!S(O'BC_ "O[\RC\
MHTE^(1T2 #G.X^\74(7%L74(7%D2  2                            6
M2>1J7EDGD:D,'Q !4@'%F@KRU[![.7YIYVF<6:"O+7L'LY?FGF]+X)'%BOCB
M=ID=TA_:;>?:'DB([I#^TV\^T/(PWS8_5&F+^1+Z',Y0J4/O$?F3Z@ $D
M      % 5!%B;@H5!(N4!4$6%R@*@6%P !87* J!87,G87VUE?')>XJJ6AV;
MM9E/U6?6ZZ&7QCB.&ZPT-#:Z>2EM5$SQN)R9*]R]=?\ ?74BP,)8>,JBJ/R.
MB.)G&FZ<?,M*@&QS  $V *%0";E 5!-A<H5 (L0  2"@*@BQ-R@*@6%R@*@6
M%R@*@6%RA4 6(!0J!8FY0%0+"Y0%0+"X  L0"A4"Q-PB!0!8@H5 %@  2
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MH;"T.W&EMUYN#Z^IIJ>-]/FUTKVQY\).R:]0J8XBCQJ;A?J;X;$/#U%42N6
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M(?VFWGVAY(B.Z0_M-O/M#R,-\V/U1IB_D2^AS.4*E#[Q'YD^H !)
M
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MWOCZV.&-]&]CV.>V=)5=%O=;61,_@(0A%*O3J_ [DU<-4H?,5KE  ;'.
M                  "I#=NI*5^A0%2A&9;DY9+J@"I0G,B,K  (5GT8::Z@
M "\=R<DM@  [(A)O0 J";IAIK0H 509EN3EEL4!4H+I!1;Z( J!=$.+6EB@*
MY@K=#*]B@*YC,9EN3DEL4 !<J
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MHK7AY\WCNO'K;1_!XDX^LG7,]H]I\*TF*J%ENKJRNN#]IL7K!LXTX"ZW'O\
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MG_-&>51=?;(/G6D YD7CQ1_E?WYE'Y1I+\0CHD '.=Q]XNH0N+8NH0N+(D
MD                            LD\C4O+)/(U(8/B "I .+-!7EKV#V<O
MS3SM,XLT%>6O8/9R_-/-Z7P2.+%?'$[3([I#^TV\^T/)$1W2']IMY]H>1AOF
MQ^J-,7\B7T.9RA4H?>(_,GU  )(
M
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MJ
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M;S[0\C#?-C]4:8OY$OH<SE"I0^\1^9/J  20
M
M                          0P4!4%2;E 5!-B<S* J 1<H"H)L+E 5! N
M4!4$BY0%00+L%2@)ZD%<BTJ"";LH"H!.9E 5 (N4!4 9BB[Y,\&+AFAV-RO-
M;5;OADUVTK(U<UV7%OZNK\)#2Y#*M256.6]C>A7=*>>US(8ANDMYO5575&\^
M=^LC<^I;YEOO&-+EWRF1>$5"*BNB,ZE1SEFEU90 %C.Y0%0";E 5!:PN4!4$
M"Y0%0387* J"HN4!4 9F4!4 7!3(J"6A<J3BDK\,WFR45'>-K;*ZE9J-JX(,
MV2-[:(G^^R0<&-:@JJ2O8Z*&(=)MVO?<G\5[L6%[/6Q8=JJBON52S9.JW,6-
ML:=I')]) "A4K0H*E?6[9-?$RK635DB@ .A'*  2             5R*%0Q=
MKH 4!"BMBV:6Y4V7H-5$O]PS]*_M(:S+C'$T./3=.]KF^$Q'+U54M>Q:>FW_
M -?I?;&?*/,#1Q]VQDIVEF-BZ;U1V*J947_N3/ER'VTM*BV'!^2Y_P!%?\B(
MUJ#AIX+)DU^$[ZGM#/Q-/CM^5CV66?<MXH9N+9S,?GZSD)CIHIGQXO;,F6SJ
M(&.1R?<[Q BAO/#YJJJ)]-#&GBLE)TFKW:9NG&F%Z_$M@PUSL=%XQ2\/7?J]
M4UF7Q*0_I78B3S%+W?\ D0<&%+#5J,<L)JWT_P#3IK8RA6EGG!W^O_A([#75
M.#<6:\[-I)3/=#,V/S;>OD2J^80IL45<MUPK6TS]TKKRT[Y-5S7=?UC60-)X
M:3DIQ=I?R8T\7&,'3G&\;W^AL^P8>I,%U7/C$M93[HA:[<]+$_6>YRIQ^]]*
MJ1RP7!]UTD45=/P735C7IVM_B(D5(CA'[SG*[:L2\:KQ5.-DG<ENE;?Q_=%S
MZ\7S3#V:&ID@QI$Q5WIX)&>]DO[)!@6Y6]#@W\K%%B[8CCV\[V-BX"@=2:69
MX7Y-5CYV^NG"+[]HZOU=?KC4P-I=SSU,DK,YLE5'/5=].MQFMRG&9O"5%452
M,];6Z?\ ILL;3E#ASA=7OU)=><!7NU4,E=5-I=A FLY&2[^1F[7SNQCA&@M4
M]9%27:@UF0[7J9$R^+BXO.FMLAD6EAYS2S2U71HI'%4X2>2&CZHGB:-+NR9S
MZZIH(*1-]9WS[Q;I+O5#5QVBTVJ5:BDMT.R69/-+DU$^3\9!<AD(X:3J*I5E
M>W02Q<%3=.E&U^I+M%"Y:0+5GV9?FGGBQ]OXRN_WTXCV0-%0^_=6_E8Q>)O0
MX%O.X !THY  "0                                  5R*
M                    N/K10354R1TL,LTOG6,UCU55HN%%$LE=0UT$?GYH
M'-^,HZD%+*WJ:*C-JZ1C@54H7,P         "^..62:*../:22+JM:T^M53S
M4DSXJF*2"=B;[)F:J^\I7,KV+Y&U?R/. "Q0    %<@"@!5"M@$:4R+D17+J
MMXST5=#4T4J1UM-4PO5NOJRQN8[5]T72=F]2ZBVKGE0'U@C?-+%#!$^221VH
MQC>J<XOJZ:>BDV5732T\W'J2LU7?",ROE\PHRM?R/. "Q0    ]3*.JDI9*M
ME++)2LX+ID8NS9ZZGRBCE>BJR+/4ZK>*YD^C+N#2/FN^$7(]-)1U5;,L5%2R
MSR(FLK(6*Y4]X\X4DW:^I#BTKLM !8J
M          ;JT$?8JZ>W-^2;1-7:"/L5=/;F_)-HGQ/M'\1(_1?9'X2!K7FC
M/*HNOMD'SK2 <R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ1_E?WYE'Y1I+\0CH
MD '.=Q]XNH0N+8NH0N+(D  D                            LD\C4O+)
M/(U(8/B "I .+-!7EKV#V<OS3SM,XLT%>6O8/9R_-/-Z7P2.+%?'$[3([I#^
MTV\^T/)$1W2']IMY]H>1AOFQ^J-,7\B7T.9RA4H?>(_,GU  )(
M
M
M
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M)ZZL:+ZVNJ9GGOF'[I9%9STHI*='+DUZ<-J>ZW>(6(IN612U)>&JJ.=Q=C$
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M<;-K52:C7.V3.+)%/IC-&55_P5=]FD=17-A?)^,Q<ORE,'I?KYZG&553RO\
M&:1C61M]=B.5?A,(U*E>K"4'9M,Z)4:6'I3C.[5U_!A,389N6'9HF7*.-8Y-
MYDL7"8OK]@^V'L(72_0R5%-'%'2MXIZA^JQ>R9V\R/DT.6-S^'(RL?&B]KQU
M#[:5:B2WTUDL-.JQT45&V14;O)([BW_6R_*-HXNK.U-?%=J_T,I82C&]5_"D
MG;ZF#O6![O:;?NQZTU72LWWR4K]=&)ZRHAC,.6.JQ!7R4M)+%'+'"LN<V>6J
MGK(I)=$-?-#B5MM7QRCKV2-EA\RBHS/6^#5/?HJA92:1KA31)DRGCGA3\&1J
M"6(JTHSA/5I71$,+1JRA.-TI.S1B+?HYO-73Q/>^CIY)&:[(JB;5D=[B-4QE
M#A6XU>(Y+*](J6M:CE3;O75>B==N2*8NNN555W.6OGDD2L>_::_8R['K&P-)
MUP?;,>6JX0HBS0TT,CD\\FN\2JXB$E%M>\G^0C1PTTVDTHM?F:YKZ62BJ:NF
MF3*>G>Z)R)UG(96X8=JZ&Q4=VEEIMS57D<6:[3U^++X23:1+.M=BZAJ+>J;G
MOC(UBDXDUER:OP:BGCTK5T<M^BM=)FE);(&PL3C1'=?]E/P2]/$RJNG&/GU,
MJN$C1524NBT1$[<F5?3^S9\HG6FU,L6TOWDSY<A!:#[(4_LV?*-NZ3;[:[;?
MZ>&X8?AN4ZTK7I+)+J9-UW)J\2]C/W2N*DXXBFTKZ,TP<(SPM12=M4:NPG]M
MED^_8?G&D@TO?;U5>U1_),E8L4V&6^6V*FPC34\LE3&QDJ3)G&Y7(FMEJ];C
M]P]>)J6&OTSTU/.W-CG1JY/8QZR?$9.O+F,\HVM%FT</%X7)"5[R1';3H^O-
M=3,J7K34C)/(TJI-5SO<R4PV(L/W'#]5L;C%J;3?8]BZS7>LI.\8V"*\7ZHJ
M:K%=JCX2MCAEE3QIJ;VKQ^_VRS$+*)FCV6@GOEMN=92SM?2[&9KGHU7(W5X\
MUWE=_M!3QTW*+;O?RMT%;V?349)*S7G?J0_#>%;IB!99*&*..G9U4LS]5AD;
MEH_O-'025C)*&KACX3DI9U=J^^B'JM-!>[M@Z*CDEH+=8V3:^Z:A^HLJYN]_
M?]\D^C2T6^VW&O93WR&X5$E,Y7Q0,74U<TX6>_FO6]T5<94@VU+H^EO\C#X&
ME-*+B]?._P#@CMC3_L>Q#]]1_*B,[H\PS.F%KZ]:BC<ERHT;$B/\BS8_??O<
M'JO@,%8URT.XB^^X_CB+=&V]AC&OWA^Q(955)TJC3_N_Z-:62%6FI*_NO_)E
M-&EGDLV/IJ.HJ::IEW$Z36@?K-WW-[2&!H-'-YJX(GNDHZ>61FLV*HF5LCO<
M1JGLT)+_ ,W3?>K_ )32%U]RJZVZ2U\\DJ5CW[5')ULNQZQK&%;C2RRU21A.
M5%T(.<?-Z?H+K;:FTUSZ.M9J5#$S5.T>+C)_IH578GHW\3G6^-7?CO(">CAJ
MSJTE-]3S,725&JX1Z%  =!R@                                   &
MZM!'V*NGMS?DFT35V@C[%73VYOR3:)\3[1_$2/T7V1^$@:UYHSRJ+K[9!\ZT
M@',B\>*/\K^_)_S1GE477VR#YUI .9%X\4?Y7]^91^4:2_$(Z) !SG<?>+J$
M+BV+J$+BR)  )                            +)/(U+RR3R-2&#X@ J0
M#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7QQ.TR.Z0_M-O/M#R1$=T
MA_:;>?:'D8;YL?JC3%_(E]#F<H5*'WB/S)]0 "2
M
M
M
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M*M\;6U%+,_5<U4/E24L. ;%<Y*^IIY+[60;&*"'A;-O;_P!]8X+P=%4TO?\
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M04-LT37"DH:F*KEAJ6;HEBZG:ZS,\O635-2&WLZS4\O2YS^U,RE!3=WE1+\
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M^T/(PWS8_5&F+^1+Z',Y0J4/O$?F3Z@ $D
M
M
M
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M  !(        (L  !8  "P  )
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M%W5S\QE%Q;3  +%0
M
M
M
M
M
M
M#=6@C[$W3VYOR3:*$!T,6]]'A/;R*G]+G?+^#Q?LD^/B,?)2KR:/T?V5!PPD
M$S6O-&>51=?;(/G6D YD7CQ1_E?WY/\ FC/*HNOMD'SK2 <R+QXH_P K^_,X
M_*+2_$(Z) !SG<?>+J$+BV+J$+BR)  )
M+)/(U+RR3R-2&#X@ J0#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7Q
MQ.TP 8'8:3TMX0DI:V:]T,2K33[]0Q/[)WGO67XS6*'7#FI(S4DWT-;XET64
M-=+MK1*MOD3^QRUHE]9/,_[WCZ# >U8PBJ=;]3Y;VI[$E4FZM#S\C1P-@2Z*
ML11R>-[AE_ZGTM+.E;B+T&F[N>NL?AW_ 'H\%^S,4O[&0($]Z5N(O0:;NXZ5
MN(O0:;NY//X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2
MMQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\
M,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#
M3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#
M3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R
M! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/
MX?O0\,Q78R! GO2MQ%Z#3=W'2MQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W'2
MMQ%Z#3=W'/X?O0\,Q78R! GO2MQ%Z#3=W*)HMQ!V*;NXY_#]Z'AF*[&0,DF"
M\,SXDNS(8D5E+%Y/+YQOA$YL>B!R/U[S7HC/0J?PG?0;2M5NI+521TM!%%!3
MQ\3&'FXWVO",7&CJV>M[/]AU)24ZVB/K14\5'1QP01[.&)FJUG81.(^X!\TW
M=W9]A%**LC6O-&>51=?;(/G6D YD7CQ1_E?WY/\ FC/*HNOMD'SK2 <R+QXH
M_P K^_-X_*..7XA'1( .<[C[Q=0A<6Q=0A<61( !(
M        !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY?FGG:9Q9H*\M>P>SE^:>;
MTO@D<6*^.)VF # [0
M
M
M
M
M
M
M          #6O-&>51=?;(/G6D YD7CQ1_E?WY/^:,\JBZ^V0?.M(!S(O'BC
M_*_OSHC\HX9?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
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M:Q]#QW?[$5WM+_DG+4=HMG;Y&LY9)))I)).K?OE$XBA5I\=-WDVSG8 !
M
M
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MZ&M:BJ3M>Y+5@ 5,K,@H 5"5P4 '7( !4H2TT  "
M
M
M     3' M0CZ6JA3^SDS]\E*$.P$F<]5^!^T3%#ZC 2S4(FT>AK3FC/*HNOM
MD'SK2 <R+QXH_P K^_)_S1GE477VR#YUI .9%X\4?Y7]^>K'Y1QR_$(Z) !S
MG<?>+J$+BV+J$+BR)  )                            +)/(U+RR3R-2
M&#X@ J0#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7QQ.TSQW?[$U_M
M+_DGL/'=_L17^TO^2<E;X&=GD:S*%2A\>^I@P "
M
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M:GWH7<!?N1BHSE2;TDMT3*]C   \4R
M
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MY;.SR-9E"I0^/?4P8 !
M
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M<;]=J;WQF/QC=J>J2"EIY$?J/1SW)Q(1D%IXV]-TZ<;)EG+2R*  X#,
M
M
M                   E. _)ZK\#]HF!#\!^3U7X'[1,#Z?V?\A&T>AK7FC/
M*HNOMD'SK2 <R+QXH_RO[\G_ #1GE477VR#YUI .9%X\4?Y7]^>M'Y1QR_$(
MZ) !SG<?>+J$+BV+J$+BR)  )                            +)/(U+R
MR3R-2&#X@ J0#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7QQ.TSQW?
M[$5_M+_DGL/'=_L17^TO^2<E;Y;.SR-9E"I0^/?4P8 !
M
M
M                                            )3:Z   @
M
M
M   9         9
M                            #(       $IP'Y/5?@?M$P(?@/R>J_ _
M:)@?3^S_ )"-H]#6O-&>51=?;(/G6D YD7CQ1_E?WY/^:,\JBZ^V0?.M(!S(
MO'BC_*_OSUH_*..7XA'1( .<[C[Q=0A<6Q=0A<61( !(
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M<EZYY"91<'9H  %0
M                             @ !4&5M5DJKG2K-!+#J:^KP];K>X>OH
M0N"?VM-^.[P3HCA*LEF4="<K9'NN5,C=+'5VV+:3JDL?GV&-0RG3E3=I(AJP
M !0     ( "I6FC?/510LZN1[6K[I[;M::BUMB;/+'(LGG4R+JG)Q<TM$+>9
MX  4 *GVH**:X2;&D5)':FOQ[Q95TLE+5RP3Y:[.P7X<E'/;0FQ\P$!0@
M    #( %3+VW#M77T4=3%+$QKTS1'9Y_$8J>.2"66&7JXUU#6=&<(J4EHR;,
ML"'HM]#/<)5BI(T;EV5/1=K//:]G)/LEUURX)"I3E'.EH,KM<\!0S-%AJNJ8
M=NNRCU]_)W&89_!X/7$Z,X).2M<BS0 1#[6^D?6U,=- L*/<F:H_WRL8N3L@
M?$'JNM ^WU*13[)7ZFOP#RH)1<79AJP !4
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MXT[ZB"6%&->K$U];K>YVS&H3*FX)-KJ  "@
M                             !4'WH[=5UR*M+322(O97)GXQ:,)3=HJ
MY*5SSC(ST>%+D],Y$IV>R<OZB]<(U^6>UIW?AK]!T<G6M?*3E9'@>ZLL];2;
MT]+)L_/LX7Q'A,)PE!VDK%6FNH!0J4   !*<!^3U7X'[1,"'X#\GJOP/VB8'
MT_L_Y"-H]#6O-&>51=?;(/G6D YD7CQ1_E?WY/\ FC/*HNOMD'SK2 <R+QXH
M_P K^_/6C\HXY?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M         %DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIY
MO2^"1Q8KXXG:9X[O]B*_VE_R3V'CN_V(K_:7_).2M\MG9Y&LRA4H?'OJ8,!
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M](/DM%[!_P"R1%.(Y_:,KUK6(GU/H #@*
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MN:MWT7LGG13(8AHGT->D+YED1&:S7O\ .F,13RZT,DVC-EX ,R
M
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MKTB=+M.!K->[SIC$4\NM#)-HS?4O !F0
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MO !B                 ,@
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M3QE2G%)>1"DT>RZU[[C4R5$^\B;VIYUIXP#"4G-N4B'J7@ J
M
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MM7SK3QH <TI.;<I=2K=R\ %0
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MOZJOX[/I-(4Y3^%7)2N8HH>ZLM%;2QZ\]-)LT_#^(\*%90E%V:L18  J
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MJ:EFJHY7P,1[(6:SL^NA*3>B!\0 0
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MR+1@VKH'ER&1ZH+=5354U/!%E.Q7(]NT;UMX\Q#@UU!0 $
M
M        %3[T-%/72:E(S:21\?4_M'GG9)%-+"[R1C]5Q+C)+-;0  $ ! $
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MH8XWU<>SUER;XXT\J;Q$HRB[20&0R!ZKA;ZJWZFZXD9K[S,Y$_42HMJZ!Y0
M5                                        );@ZK944LUMJLE7)R-[
M;5XT(D5CDDAGVD:;.5F_F;X>MP9YO(F+L>Z]VR2V56K)Y&O4.\\>%LDL>>RE
M5A.++61X@H9::O@1Z-ZMV7!7^9$KU2QT=PEAIY-HR/?R[!OB*"@E5IO1EI*V
MJ/CNRH]%F[H-V5'HLW="L%#63PI)#3221KYV-7'TCM5?(F;:"I1.VPQ2K/I<
MC4\[ZB21?')9I"ZCI9ZNICA@C1SW)GFO6,[084JYL]U[."/M<)QE9ZNW8=BW
M/2L22J5/=7V2F\,))^_6=D2HOS+;S*RQ6%*2G\G>F7O\;B$J?:LJIJNKDFFE
M1[W<62<2'R0QQ-?BR]W1+H1)Z@!0<Q4E. _)ZK\#]HF!#\!^3U7X'[1,#Z?V
M?\A&T>AK7FC/*HNOMD'SK2 <R+QXH_RO[\G_ #1GE477VR#YUI .9%X\4?Y7
M]^>M'Y1QR_$(Z) !SG<?>+J$+BV+J$+BR)  )
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M,JEVDV6\_P \>)#@J1RR:*O0N !0@
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M_/'D0S][JJ)]IIJ6DJ&SR4[TZMCF\'WB/H<U>FH3M'H4DK,N !@0
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MUH_*..7XA'1( .<[C[Q=0A<6Q=0A<61( !(
M  !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY?FGG:9Q9H*\M>P>SE^:>;TO@D<6
M*^.)VF>.[_8BO]I?\D]AX[O]B*_VE_R3DK?+9V>1K,H5*'Q[ZF#  (
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M1F9E+W70U$-+2T,>I1P>?XW&,"H$,IS=1W9'4J "@     R         R
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MMEL]IYEIYT*H,CF<G)W92^I< ,BI(
M                !*<!^3U7X'[1,"'X#\GJOP/VB8'T_L_Y"-H]#6O-&>51
M=?;(/G6D YD7CQ1_E?WY/^:,\JBZ^V0?.M(!S(O'BC_*_OSUH_*..7XA'1(
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M"H+<@79  M!> "U"OOGTAA?/)J012R2?<\(^?KDV8+07@@%@+G)D@R +2\
M   M!<        6%X + 7@ H6JA]9X):==2HBECS\]O%BAIKJ"W(J5R&0!0H
M79%<@"PO0  9#+MET,#YDD='%+*D?5ZGF2A-K H " 6%X     "#( %05AAD
MGDU((I9'_<[Y:A-F  "  @ !4%RPO9#MI(I=G)U#_,YEB*+6       *E"Z&
M&2>34@BED?\ <[X2OT!: H  '6              "@(F9*  !
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MNSCZM_F24K@M !  4!$S)0 **F14@
M        $IP'Y/5?@?M$P(?@/R>J_ _:)@?3^S_D(VCT-:\T9Y5%U]L@^=:0
M#F1>/%'^5_?D_P":,\JBZ^V0?.M(!S(O'BC_ "O[\]:/RCCE^(1T2 #G.X^\
M74(7%L74(7%D2  2                            62>1J7EDGD:D,'Q
M!4@'%F@KRU[![.7YIYVF<6:"O+7L'LY?FGF]+X)'%BOCB=IGCN_V(K_:7_)/
M8>.[_8BO]I?\DY*WRV=GD:S*%2A\>^I@P "  #)06G:1QNYY44>O'U+Y^$7A
M!S=D2DV8X&46R[WV3MO=S'5,.YY9(DEBDU/-MX32:E*4%=AJQ;3>2Q>S)5BZ
MOJJ2XQLIZA\3%A15RZZYJ16G\EB]F2#'>_<X_:&_*4ZJ,G&A)KT)3T9\[5?I
MW2QPUV4U))P'N>A\KG9TCOK:&!41)$VD6LN?KF&B;KS1,CZLFMS<G1G;4_\
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MPQ:5,W5O!0V#90O ,B
M   "L"Y2Q>S,UC&HBJ+G&Z&6.1B0MSU'(OFE,(A:IM&K:#AN3>R/=8IHZ>[T
MKW^-L5_7,A4UK*+$[ZR*6.=BNR74DUE1KD, N^"8UY1CE6]Q<D,]KMU7*L]+
M<J:-CTZF7)KF^L>2ZS4,&YH;=E(M/U51YYQB40%I8G,K)6N3F)-6[BONSJ=V
M14=7J:DD<JH>V@2EIK)<Z2CE2HEC@<Z27/@JYR+DABWS6:YQ1/GEW'.QFJ_4
M9O.]XMK*^AI;5)06W:2;?R29QVJ<8WF[?4M="P5%+-;JJV5<NYUGX;7'LM-/
M;;77Q32UT=1)EJ,U.)O;52+KOE#DAB<J5XW:*YB362H@BQ17S.EC;&_:<+:)
MJ[SCX6.HI7VNMH*NIW/M^IE, "%BFFG;?]R+DBI*.VVRICJ:NOBGU'\!D7"]
M\^=]?"W$,-4RHCG8^1K\F^9U=4P2#(/$^[E4?49C/XCCA?5R7&EKJ:371J;)
MLB:RGVJUHK\V.;=,=+6:FHZ.7B<1OC*(3S2;;<=&+DC=/0V6@J(:2JV]7,S+
M6;Q-3B//2SQMPA50I(S:;;J=IPNL84ID0\2_):6L+E,NP3+#]3$ZS;:=/'+<
MCG-]UJD3I61NJX65$NRI_-O,M<:VE@M.X+;)(]CWZTLSERUNR3A9\-.;9*T,
M+-(^::627+7D76+H%V4\+\MKJ/ZCLGS7?!S9FWF()%54-KKWK4T5=34NNG#B
MER;E[G9*5]12TEFYVP5.['O=K.?UFD>!TO$V3RQLV3F)"LE%>Z"F;/5;DJX&
M:NL[B<TMW/;K52R2.J8[A5O9JQL;D]$[9@4 YMOK'7<9C.4TT;<(54*2LVFV
MZE5X76,&%09&-2IGMZ$-W)78ZZD?:J5U7(S=%$CD:UR\?!(M-))-++++EKR+
MKEF603>+U:\JB4=B6R18AN,;+[155))&_4B;EJR)O[[MX^E?26Z[2;N@KXH%
MDZMLI&07YJ[>:-TQF,[=JFEIZ"*VT$VTX>M++YX^NTHKW;Z=L]5N2K@9JHY_
M$YI'@A"Q+S.ZTV&8SNPMUKI)'OJ8J^K>S5C:W)[4[9;;DMU7:TIJN6*DJXW\
M&7SQA<BF1',Z_"K$7)+;8:*SU*U<ES9-J1KXS%PM8CE3)MII9/1'ZY;D,BM2
MMG2BE9!LS>'IF0V^\,DDCCVD/ UO-<%Q6BGC3"=;#)+'KR/;JLVG"XT,(40M
M'$.,4K>5A<R.')&0WNFDDDU(\EX3NOP3SW-[)+G7/8N;=L[/WSRJA5.N9<1N
M&0B^ECV6>N2@KXZA5WF[S_8F3GM=OJI%GI;E31L>G4RY-<WUC (,M\O3KY8Y
M9*Z)3LC,7&HH:>>AAH&;1*>37EER\D,C=J:BNE6E7'<:9FNC>#)EFWX2+IO
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MGZS!9#(F&(<<NG0)GHN-,RFJ6Q1SQSYIGK199'G0KQ%#";3E=$%P *@
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M\        %"H    !0J                                       @
M R!+30!87@BP+ 7@ L!> "P%X + 7@ L!> "PO!3K@%0  6E<BH    + 7@
ML+P          "P%X + 7@          L!> "P)QEX *(54  M4ID7Y%,@"H
M  !87%0"P%X    !87@ %%XBH +2F1<,@"W(%X       + 7@
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M(M??,?<;9/0LIGU"1)MM[57JFY=DL\/4BLS0LSQ%,B\ID8D%I>
M       6 O !87@    %@+P
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M4>NW^9976R_5-6Z5)=FWS*-FZDTY6/5)M7L,I&)X7P3[.HBV;XS.8S^R=/\
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MGKE<9E4_=(DM="X '(5
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ME0
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M=GD_UOH(LG7*%4%:JJC3M8BY< #$@
M                 %I< "P%^11=X M "<8 !=D,@"T%Q:        ,BH!0%
MV13K@%!D7(A7( L!=D,@"W(%^0R + 7C( L!> "W?/;9ZR.BJ5DFCV[%X#FG
MCR&1:$G&2:!F]SV#:Z^[I]GZ#J+K>_D>6^7%;E5(]C-2"-FK$WLF-R&1M4Q#
ME'*E8ERN4+RPOR.<@          #(                    9      9#(
M                                 E. _)ZK\#]HF!#\!^3U7X'[1,#Z
M?V?\A&T>AK7FC/*HNOMD'SK2 <R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ1_E
M?WYZT?E''+\0CHD '.=Q]XNH0N+8NH0N+(D  D
M      LD\C4O+)/(U(8/B "I .+-!7EKV#V<OS3SM,XLT%>6O8/9R_-/-Z7P
M2.+%?'$[3/'=_L17^TO^2>P\=W^Q%?[2_P"2<E7Y;.SR-9E"I0^/?4P8 !
M&0R     "E18% 5*  !         4*@    %2A-K"P !    + 7@ L+P  !D
M "PO      &0)M8  $     #(          L!> "PO  !87@          L!
M>  44J "TID7#( M+P       "PO                              &0
MR                      + 7@          L!>     44J "P%P +2I49
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M969EEBMS+E7:DS5;!''KN5%R,G0FI*.Y.4QN0+Y]1)9MAU'F"PS:L5  (
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M)
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MCSIG7HQIJZN&CX@H5.4J
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M+7[F9EJ0=CSSM]3.,UP<[ZK1$7T(^A5"U.,N0\UNY0J
M      "4X#\GJOP/VB8$/P'Y/5?@?M$P/I_9_P A&T>AK7FC/*HNOMD'SK2
M<R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ1_E?WYZT?E''+\0CHD '.=Q]XNH0
MN+8NH0N+(D  D                            LD\C4O+)/(U(8/B "I
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M
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M(S?A\;:B]4Y=\IA+NI?R\Q'K<\&*:B-]PW/&B-AI6;-N79,,A5\FUFUW[[Y
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M:HG#]D>%U=5OBU)*JJU?.[13R9YD5<1&4,D?W(;*E4+4+D.0@J
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M<D^639G=<QL\[YY99Y/)).$XL09%)592BHOH1?2Q0O+"\S
M          !*<!^3U7X'[1,"'X#\GJOP/VB8'T_L_P"0C:/0UKS1GE477VR#
MYUI .9%X\4?Y7]^3_FC/*HNOMD'SK2 <R+QXH_RO[\]:/RCCE^(1T2 #G.X^
M\74(7%L74(7%D2  2                            62>1J7EDGD:D,'Q
M !4@'%F@KRU[![.7YIYVF<6:"O+7L'LY?FGF]+X)'%BOCB=IGCN_V(K_ &E_
MR3V'CN_V(K_:7_).2M\MG9Y&LRA4H?'OJ8,  @       HI4 %,BTO !8"\
M%N^"N0)NP6C(KURN6\5!:,B_(9$V!9D7(,BH!0%0 "A4  L+RF0!;D,B[(9
M%N0R+P 69#(O !9D5*Y#( J        "P%X + 7@ LR&1=D,@"T%X
M
M    &0R    !12H +5*9%^13( M!> "P%X +,AD7@ LR&1> "TH79 F[!: I
M<0"T(7@ H,BH *%I>4R *%"X$W8+0"X@%N0R+L@ 6@O !9D"\ %@+P 69%2[
M(9"[!85+LAD 4ZQ:7E,@"W(9%X +,AD79#( (6J7E,@"T9%^13( M!> "S(9
M%^0 +,AD79%<@ "I06
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M3DJ_+9V>1K,H5*'Q[ZF#  (
M
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M &:1HG%ZW7-GA5)R;?Z$-:D2CB?+-J1QROD\YYHS=XM,D5#;'4]-)KHQVZ.
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MNJY*ZI?43;))'IEXW^*<_$7"</.Y%SSY[Y5"B%4.<@J
M                     "4X#\GJOP/VB8$/P'Y/5?@?M$P/I_9_R$;1Z&M>
M:,\JBZ^V0?.M(!S(O'BC_*_OR?\ -&>51=?;(/G6D YD7CQ1_E?WYZT?E''+
M\0CHD '.=Q]XNH0N+8NH0N+(D  D                            LD\C
M4O+)/(U(8/B "I .+-!7EKV#V<OS3SM,XLT%>6O8/9R_-/-Z7P2.+%?'$[3/
M'=_L17^TO^2>P\=W^Q%?[2_Y)R5OEL[/(UF4*E#X]]3!@ $
M
M
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M5R + 79%<@"P%X +,@79%<@"P%X + 7@ L!> "P(7@ HA4
M                           E. _)ZK\#]HF!#\!^3U7X'[1,#Z?V?\A&
MT>AK7FC/*HNOMD'SK2 <R+QXH_RO[\G_ #1GE477VR#YUI .9%X\4?Y7]^>M
M'Y1QR_$(Z) !SG<?>+J$+BV+J$+BR)  )
M +)/(U+RR3R-2&#X@ J0#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7
MQQ.TSQW?[$5_M+_DGL/'=_L17^TO^2<E7Y;.SR-9E"I0^/?4P8 !
M
M
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M:5E52S1U4?5/?'JZQ%;#1IQ>NH:,.H+>N50XBA4
M                       $IP'Y/5?@?M$P(?@/R>J_ _:)@?3^S_D(VCT-
M:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/\K^_/6C\HXY
M?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@                           %DGD
M:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO2^"1Q8KXXG:9
MX[O]B*_VE_R3V'CN_P!B*_VE_P DY*WRV=GD:S*%2A\>^I@P "
M
M
M
M
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M6GSE?)+PY95DD^[#Q,,K23U)N6)QER%J%R'$4*@
M                       E. _)ZK\#]HF!#\!^3U7X'[1,#Z?V?\A&T>AK
M7FC/*HNOMD'SK2 <R+QXH_RO[\G_ #1GE477VR#YUI .9%X\4?Y7]^>M'Y1Q
MR_$(Z) !SG<?>+J$+BV+J$+BR)  )                            +)/
M(U+RR3R-2&#X@ J0#BS05Y:]@]G+\T\[3.+-!7EKV#V<OS3S>E\$CBQ7QQ.T
MSQW?[$5_M+_DGL/'=_L17^TO^2<E7Y;.SR-9E"I0^/?4P8 !
M
M
M
M
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MR+L@5(+07@ L"<9> "G6"E0 6J4R+BH!9D,B\ %A>
M                            2G ?D]5^!^T3 A^ _)ZK\#]HF!]/[/\
MD(VCT-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/\K^_/
M6C\HXY?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M  %DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO2^"1Q8
MKXXG:9X[O]B*_P!I?\D]AX[O]B*_VE_R3DK?+9V>1K,H5*'Q[ZF#  (
M
M
M
M
M                               !*\ ^35WL&?M%F+HV55-17*/S;=1R
M]I=\OP#Y-7^P9^T5P^Y+IA^JH'KXY'U"9_B_"A[-.T\-&EO<U\K'AP;2+-=%
MF?Y'!'G^$IEL8RQU5BI)F+FQ\S7(ON*>6).=6#Y'[T=15[_NK_(8@RZ$;5O^
M:9\AQ:$5"@Z?G8CHC%VNQSUT*U+Y(Z>#SSB^OL$D%*VII*J.K@9U36_R4S]\
MI(7VBDIG5Z4<&JG&S6UN+MGGP^ZW6U)?^+13LD\RK$:4Y2G'W&OSN,J(U:[=
M/<JO909(B=6_SIEI\,HQRQT]=3/JO0LD:J_E&0P[LX+;>)J-$UVJ[5_!;O$/
MCED9+KL7QSJ]<PX=.C&+DKMBR1*\>IE';/POV3P8JI*BEEI%K*U:C75V7C:-
MR[>\>_2!DL=MXTS5W[)],9,CEN%LCEZAZ_M(=&(@I.I^1+6K,51X?DEI5J*N
MIBI()$XG?S4I76!\%+NBDJ8ZN!F^YS<L_@S/5CZ1^[Z2%.HU-9??,5:ZVNIH
MI&T#9)8W;[O&]<YJD:,).EE_,J[7L7V:SS7-TKF+LF,7)7OZYD&X:9*FI2W.
MFGD3S/\ MREEEI*F:UOD?6[CMN_K)DF^G7]8]F'J>UQ76+<]2^>HX6JNIJMX
MM\TI4(6BI+KZDJ*L8[#<+Z?%$,$F])&KM9/P''PQ,N=^J,_/_LF7CW](/X;O
MFC#XH^V"IW_-_LE:L5##N*[B&K(LL-"E?=(H7^1HFNY.RTS>);TZDFW!;O&&
M1]5(U.(\."9&QWG4=_:1N;\.9Y<34[X;S4J[B>_73W2(-T\-FAHVPG[NA[[-
MB2>*L1M?(DD+^J7SACKPRDJ;JG.G*1LG&R./S1XZ*E?5U<5-'DCI.R22P6O<
M&)(X9I8Y'M@UN"F7:(@ZE>*C/I?J0KRT/@S#.SB5*ZOIJ>1_F.LOPH8^\V:>
MV9R/7:T[EX+F=8IB&:26]U6NN]KO9^"TSMN<M1@JJ;-Q1HY$]9,E3X2W#I5'
M*G&-K>9-DS'4>'7UEIBJX)D19$S1BLZGA=93Z/PT]U+)+0US*M6\3&I^M''M
M:]S-'S%CX\_WI3 "^.7#\#]HUC0HYHTVNJ)LKV/'3X:UU2&>Y4\=6O\ 9)PG
M)[BN,;/;'076.@G55?(]K=HG;\T?.W2/=>*5_&]9V_&2'$6:8PMGK1_+4R5*
ME4AFBK6821YY<,+ ]-T5T<<&6:RNX.MVLM;(LGPO5QRZFUBW.G"VN6KJE,=/
M=SVB8G4,A53W7V1Z8/MZIU3]DB^ZU325*A>:4?AU%EJ>*3#2K2OGHJZ.L5O6
M:GZ\U/'8K2EU;4>.[-T.KEP-;CS^@R^ %S=</P/VBF!D\:N?L&_MD1H4YN$D
MNMQ9.Q&*6+;U4,/HCVM,G<;,M'=::C6I5^Z-7A[/BS=EV3PVO>N%)[>WY1(\
M1[V,+9ZT7RU,:-&,J;;W15*YYIL,+#)G45T<<'7E?P=;M=4>6\6&2VP)-')'
M-3^?7C/3CJ1[KM$SS#(57X3U<>C]R^O\X:RHT7*<(K5:EK+H>'<U0N%(ZG=K
MMS>@;/>7A]G/,\MGLLMS=(YB[.!JY:S^N9=^2Z/X_;/WI=<EW/@JF9!O(_5U
MOPLW?&3*A!M-]%&XL>1V&=I')N&MIZB1OF,MY/A4Q-#03UM7N9D?CB=7K^8+
M;=/54U4KJ!,YUWEWM;,REG9=*VZ5+X94IY^*5[H_U&$52JM98OZ$61]5PU R
M1(GW.GCJ%3J$3)?>53Q267<U?N>OJ8Z>/4UV2^9_4>BHIK/%++)67.2I?YO9
M,^@]N/U\>H?8/_9.AT:>1SR]/4LDCW8KHH*F.EW171P:C7ZNO_:<7;_WF8.V
M4U1)8*V5E:L=.S7UH]FG"X*'MQYO16SV#_V!84_Y0NOLG_(::5%&==QMY?X#
MZF(L]EGN:M>Q=G WJG/ZY[WX9VL2-H:^FJ)&>8RWD^%3UW'.GP72L@XI-76]
M9<U,%AZ:2*]TVIY]K/P5.=TZ5.4:<E>_F5LD6V^WOJKK%1RHM._AYY>9R0R7
M0SJ2R,JJZ."-79,5W&_W,S*5"-9CJFU..1BZR>LQV1@L5/>[$%3K]2Q&Y?BD
MRHTZ,&VKN]B6DCY7NS36K9K)+M8WKDU_;/;2X<>ZE9/7U4=(UW$CN/\ 4>W$
M#L\'VI>RD7S:EJ7:UW2EB@NVTC>SS2[WPDK#T5-I[:"R3,;=+%)14NZ8Y8YX
M>/6:8A"2W"V/CMLDMJN4U12Q]5#KYY]K,BYRXJDJ;5E8K)%X .4J
M                                           2G ?D]5^!^T3 A^ _
M)ZK\#]HF!]/[/^0C:/0UKS1GE477VR#YUI .9%X\4?Y7]^3_ )HSRJ+K[9!\
MZT@',B\>*/\ *_OSUH_*..7XA'1( .<[C[Q=0A<6Q=0A<61( !(
M                  !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY?FGG:9Q9H*\
MM>P>SE^:>;TO@D<6*^.)VF>.[_8BO]I?\D]AX[O]B*_VE_R3DJ_+9V>1K,H5
M*'Q[ZF#  (
M
M
M
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M7)0VI9)%FSUI7;Y'"XID8UJ\JSNPW<H7EA>8D     9               9
M                              $IP'Y/5?@?M$P(?@/R>J_ _:)@?3^S
M_D(VCT-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/\K^_
M/6C\HXY?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M   %DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO2^"1Q
M8KXXG:9X[O\ 8BO]I?\ )/8>.[_8BO\ :7_).2M\MG9Y&LRA4H?'OJ8,  @
M
M
M
M
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MQ%?[2_Y)[#QW?[$5_M+_ ))R5?EL[/(UF4*E#X]]3!@ $
M
M
M
M
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M/*HNOMD'SK2 <R+QXH_RO[\]:/RCCE^(1T2 #G.X^\74(7%L74(7%D2  2
M                          62>1J7EDGD:D,'Q !4@'%F@KRU[![.7YIY
MVF<6:"O+7L'LY?FGF]+X)'%BOCB=IGCN_P!B*_VE_P D]AX[O]B*_P!I?\DY
M*WRV=GD:S*%2A\>^I@P "
M
M
M
M
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M#[K+6/EB6N@JYJ6"G59(X6:NU\\8?(9$3KWBXQ5KAL=<JA:A<AS$%0
M        2G ?D]5^!^T3 A^ _)ZK\#]HF!]/[/\ D(VCT-:\T9Y5%U]L@^=:
M0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/\K^_/6C\HXY?B$=$@ YSN/O%U
M"%Q;%U"%Q9$@ $@                           %DGD:EY9)Y&I#!\0 5
M(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO2^"1Q8KXXG:9X[O]B*_P!I?\D]
MAX[O]B*_VE_R3DJ_+9V>1K,H5*'Q[ZF#  (
M
M
M
M
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M>           6%X + 7@ L!> "PO     !87@ L!> "P%X
M     )3@/R>J_ _:)@0_ ?D]5^!^T3 ^G]G_ "$;1Z&M>:,\JBZ^V0?.M(!S
M(O'BC_*_OR?\T9Y5%U]L@^=:0#F1>/%'^5_?GK1^4<<OQ".B0 <YW'WBZA"X
MMBZA"XLB0 "0                           "R3R-2\LD\C4A@^( *D X
MLT%>6O8/9R_-/.TSBS05Y:]@]G+\T\WI?!(XL5\<3M,\=W^Q%?[2_P"2>P\=
MW^Q%=[2_Y)R5OEL[/(UF4&8/CWU,  "
M
M
M
M
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M;8]M45_O'BO<M++/&R@CU*=C-77RZKMDUG:F]%KZAO0QY5"WKER'FE"H
M
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MS  ,2
M
M
M
M                                                6EQ0 M&1=D,@
M"T%Y10"T!0  $+D0 REIJZ%*22BN,?C;^IE;QH>VC6SVM^Z653ZR1B<%B,U<
MO@([D%0Z88EP25EH3<^M9.^IJI)WHB/>_60^* '/*3;NR  $( !<,@"T%X +
M 7@ LR+D&14
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MN9M4#PB/<,AJK<U1Z%-W,;FJ/0INYFU0/"(]PR&JMS5'H4W<QN:H]"F[F;5
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MBD  =I8UKS1GE477VR#YUI .9%X\4?Y7]^3_ )HSRJ+K[9!\ZT@',B\>*/\
M*_OSIC\HX9?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M      %DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO2^
M"1Q8KXXG:8 ,#L*@&O\ %FE?#>'I98&S27&LCZN"D36U?77B+PA*;M%%XQ<N
MAL &AJC3^J)E3X;X'9?5_4/EXH"?D"+OOZAT\C6V-.7GL;]!H'Q0$_($7??U
M!XH"?D"+OOZ@Y"ML.7GL;^!H'Q0$_($7??U!XH"?D"+OOZ@Y"ML3R\]C?P-
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MMB.7GL;^!H'Q0$_($7??U!XH"?D"+OOZ@Y"ML3R\]C?P- ^* GY B[[^H/%
M3\@1=]_4'(5MB.7GL;^!H'Q0$_($7??U!XH"?D"+OOZ@Y"ML3R\]C?P- ^*
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M1=]_4'(5MB.7GL;^!H'Q0$_($7??U!XH"?D"+OOZ@Y"ML3R\]C?P- ^* GY
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M/% 3\@1=]_4'(5MB.7GL;^!H'Q0$_($7??U!XH"?D"+OOZ@Y"ML3R\]C?P-
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MMB>7GL;X!KK"NES#5]DCBDDEMU0_B95IJM=[%_%[^1L7,PG3E3=I*QC*#CU
M ,R#6O-&>51=?;(/G6D YD7CQ1_E?WY/^:,\JBZ^V0?.M(!S(O'BC_*_OSHC
M\HX9?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M%DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^9>=IG%F@KRU[![.7YIYO2^"1Q8KX
MXG:8!'L?WE</8.NMT9Y+!"NR]FO!;\*H91BY-)'=%7:1I_3=I'GDJZK#MDEV
M5/'P*NI9U3W=>-.UV>SQ<7'I1!([757R*$/I:%%4HV1ZE.FH*P*9%0;&@
M
M
M
M
M
M
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MXB^45P_S8GH4?B1RX #Z='K
M
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MEGM9%;$C_8J]4UCQ8APS>L.S1LO5#)1Z^\U[^H<O816[QFJL6\M]2JG&]C$
M!30L (V[1=2/?D)=;]&F,*^%):>PU.KV)ECB7\5[D*RJ1A\3L5<DNI$09J_8
M6OMA\<N]LJ:>+S[F<'WV\$PHC)2U3)33Z  %B0#[4=)5UU5'3T--+45#^IAA
MC<YSO-<2'WN=GN=J2+GG;*^CU^I2H@='K:O'EF5SI/+?4BZO8\0 +$@
M  "Z%P#)UN'+[04<M17V>YP4\:9OEEI7HUO6ZI4,80I*6J9%P#)KAZ^I3)5K
M9[EN5C-=TNY'ZFKY[/+(K1X<OE?115-#9[G402)FR:&ED<UWF>J1I5U(KS&9
M&+ !<D    'IMMMK[I5)36REEJ9W[^I$S6<0Y*.K(;2ZGF!-DT58T6+:<X9-
M3+/R>+6][6S(K=K37VBJ2GN=#4T<R^9ECU=XSC6A)VB[D*<7HF>, &I8
M             70 ,G6X<OE!22U%?9[G!3QIF^:6E>UK>MU3D,81&2EJF0G<
M  DD
M
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M8_*/-E^(1T2 #G.X^\74(7%L74(7%D2  2
M  62>1J7EDGD:D,'Q !4@'%F@KRU[![.7YIYVF<6:"O+7L'LY?FGF]+X)'%B
MOCB=IFMN:"\KF;[XB^4;)-;<T%Y7,WWQ%\H8;YL3T*7QHY< !],CU@
M
M
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M((Y96>OJ:O[1/.:@K7LM]BH47QJ>265_X",1/EG+B;U*T:-]#.K[TU Q\G-
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M:3 !Z)T@
M
M    $CT:[^D/#RN].QY>^;&YJ#>OM@]HE^-#7>C)?^T+#WW['\9L7FG]^^V3
MVA_QGGU/Q,3GG\U&E$-J<S=]OTWWC)\J,U8;3YF[[?IOO&3Y49T8KY3-*OP,
MPVG-=72K>D[<'S#""(=*8]L>CF'$]3=,6U_].GU5?3;=V;<F(U,F1IK\34,'
M#8=$5_DV5MN2T=0].#G/+&ON),AST<4HP2:?0SA62BE8T0#86D/19=L)QRUE
M-E<;9Q[9C.''[-/U\7K&O4.RG5C45XLVC)25T  :%CISF<_M F^_I?DL-H&K
M^9S^T"7[^E^2PV@?,8CYLCRJWQLUKS1GE477VR#YUI .9%X\4?Y7]^3_ )HS
MRJ+K[9!\ZT@',B\>*/\ *_ORT?E'FR_$(Z) !SG<?>+J$+BV+J$+BR)  )
M                          +)/(U+RR3R-2&#X@ J0#BS05Y:]@]G+\T\
M[3.+-!7EKV#V<OS3S>E\$CBQ7QQ.TS6W-!>5U-]\1?*-DFMN:"\KJ;[XB^4,
M-\V)Z%+XT<N  ^F1ZP
M
M                             !L70->F6C'L,%1(C8Z]BTF7W6\K/A;E
M^$;)YH?"=5>+=1WFVQ[2:A1S9F,ZI8W>:3UM_P!\YQ:[4X<:F]<!:;FPTL='
MBJ.222--3=D*:^LO9>GZT]X\_$TIQJ*M31SU82S9XFH+#<KY3RI16"NNC)9Y
M-Z*CG>W:.]BTZ[P10U]MPG;*:[U,M3<&0YSR2R+([77?5-9>/+B(C/I:P+11
M255++M*E$WV04CFO=[JHB?"1JQZ=Z59ZYU[H*ID;Y,Z5M.QCM6/+S;G.;OG+
M6XE?50L95%*IKE(SS-6_I K?\.E^=B'-+K_S_1_X=%\[*1S1)BVAP;B>JN-R
MAJI(7TKJ=-SL1SM9TC%Z[D[!32WBVAQEBBEN-NAJHH&TK8%W1&C7:R/>O65?
M/'3PI<QFMI8UROB7]#H#2@Q^(-$ESDM_CFVIHZIFKUVM<V3Y*'*MJH:BYW*D
MH:=<JFHD;$SW3:>BS2Q'AZ@ALU^CDDM\:9030IK.C3SKDZZ=LF<&-]%]GJ9;
MG:HX>>&62[FH7MDW^QFU$3X#*"GA\T,M[]"D<U.\;=3,\T!4Q4^C.OBE\EJ'
MQ11^R1Z/3Y![J*BDN>A6DHH,MM/8XV,]DL"9?"<_:3L?3XUN47C:P6N!<X(5
MZOV2]OXC85CTT66TX.H;=#05\EPHZ**G368Q(W/;&B<>MGJY]K/M&;PTX0C9
M:W*.E)16YHAL;WS;&.+.7J=3+A:QUIB)G.30M4TE8OCE/9MRO7[O9;/XR*VW
M'FC.>MY\U%+%1W=4UGK)2.<]'=G-J*F?;(1I>TG,Q53<ZK-')';&/UI97<<V
MKQ(C?.YFT\^(E%9;6+RS5&M.AL/1GA&QX:P'%B&Y4T514R4G/":9S$DU&:NO
MDS/L(1"OTZ7:JG2FL-GI:=9.#%MM:1WP9(>W1GI7M-+AF&QXIUXEIV;G;,L>
MTCECRXE1N_O=3Q%)\2Z*L.U7/.Q6Q*RZ1YNCX$K6L=VEDWF^XAEDDI/B1;97
M*[O.KFP-.F_HLO/_ $/GXRF@K?T5V;_K_//-<X^TM6+$^":^TLI+E'5SL9DJ
MQL5FLUR/\]GEP>P-'.EFQX7P;;[36TESEJ8-KKOBB9JYNE>[C5Z=DIP*G!RV
MUN1PY9+6\S21D<,W/G/B*UW-4S;23ME_!1>$8X'M.-X69VVNK'7>DNR]&6 I
MH;;+%)+(QE32N7?:_+A)[Z+\)R354]123RPU$,L51'P',?P7,-E:,=*M7A:D
MBMMXCEK+9'EJZGDD"=AOGF]HVNS2K@*HRJ9JK*=G4[6CD<]/=U5^,\RFZN&O
M'+='+'/2T2N1S0UHWHIL-2UF*;5%+454FO&RIC368Q.+WR,X22W-YHF%EEBA
MBH(YYH8VP]3P*=Z.^',RND#36RIH9J'";)8Y'\!U9-P-3V"=?US6&CF^4F&<
M8T%VN$<DD%.LFLV'55V_$]O7<GGBT859QG.7GY$J,VFV;4YJ1>'AG_,_NB>+
MY1'_ /CG_P##&E=,N.[9C9;-SL@K8EI$GUTJ&-:JZ^IEEDY?.DD72S9.EMT/
M;EN.ZUM>X-ILF:FTV.IY_/+/M&+H5.'!6*\.62*)/S,_VB7#_$I/FXC0^/4_
MYZQ%_B-3\ZI/M$6DNSX+PU56^Y4M=+425+JC^CQL<W55C$XU>GG36N):Z.Z8
MENEPI]I'35=5+4,UDR=JO>J[Z'1AZ<XUI2L:4HM3;.H]!GE56?UY_GGD$YEO
M>DQ-_EOWIY-'.EFQX7P906FMI+G+50K+KNBB9JYNE>[C5Z=DC6AO'5MP4MXY
MYP5LRU>PU$IV-<J:NOGGFY//'.Z,[5-.K,G3E:1Z=(]5'1Z>UJ9URB@KJ*5Z
M_<M9&IL[FBK?-6Z/TJ*9-?<=5'4/3LMU7,7Y9H32+?J3$V,:^[4$<D<%1LE:
MV9&H[>B8WK.7SIL[ &F&WQV6*U8NCED8R/9;IV>T9*SJ<GI\'7S-:E&<8PFE
MJBTH22C+8U'A2P5>)L04UIH=Y\^OXX_J6-:F>LI.9-%%1;L98=M-SK:61;D]
M^MN?-'-9&W7?OJGO$_I](&C;#,,E38*>+;R)U-+2.8Y_:S<B;QJ>ZZ1;E7X\
MI<3;+4W(_*"F5Z:K8\LM57?=:SLW&F>M5>BLBZE.;>EC=N-+[8]%=IH66RR1
M.GGUFPQQIJ=3EK*Y^2KYI./?4\&BG2+=L:8IJJ:KI:6GH(*1TJ['6UM?78B(
MJJO8UCY772!HYQ?:HX\2[5$9PTAF@E1S'=I\:?$IB;1I1P/A6J2BP]9JF.@?
MORU+$\<<[K=6NL[W5S[1R<*3@TXMR,<C<;6U+-+2+T]<'[WI/_\ )>9_FF5_
MY#H/\1C^;D-:XXQW:;_I!P[?Z2*MBIZ%\&V9+''K*V.77WLGKYX]^E[299\9
MX9I*"VTE?%41U3:C^DQL:U6HQZ<:/7SQ>%&>:F[="T82O$U*=!\S'2PI:[Q4
MZJ;JV[8E7L,U45$^%3GPE^C3&\^";M+-'$M1;YUU:B!/N>)S>VAWXN$ITW&)
MO6BY1T,QI"Q;B&@TIU5;)))%);9W-I8/,[+K;WW:<?LCHG#M52XHL5KO$]"D
M;E_I$;9X^%$[)6ZR?J7L*0F;2/HVNSHJRY[FDJX^HW3;722,]U&NR]\P5ZT[
MPLNU,RT4$DEM9)E/),FK)(W+S#>MO]GX#S)TYU$HQA9HYI1<DDE8A.GZYUM;
MCR2EJHI*>"D8V.#67JDZI7^ZOR36Z&W=)^/<(XTM.HV@N=/<X/ZO4/@BWE["
M^.<7Q&HT/3PMU32:M8Z:5\MFC<FC7199,6X2I;I-7US*B1SVRLA5B-:]'>MV
M-4UE=*:YX4O]51-FJJ.L@DU4DC>L3M3S+M9IGM&>D"LP362-V>Z+7,N<M.G!
MR=YYJ]GXS<DFD_1Y?J>-]\BCXMYE;0[96^\CCFG*K3FW)9DS-N<6]+H\6@+%
MM]O^[Z6[2OJZ.G8W4JGIPT<O&QR]=?A/-BB:EHN:,L$V<:)) UDO9VCVRL;^
MR>RZZ:,+VBW)#AVDDG>B91LC@V,3?7WM[WC05YOE?>+])=ZR7^F2/VJO;P=3
ML9>MUBE&C.I.4K6316$)2;E:QN[FG*":6W6&MC\@IY)8I/P]3+Y"FHL"X1KL
M976:@H98HTB9M7S3:VJWM;QMW#FF&PWBR;@QM3+KZNK,]8-I!*G9U<M9/=:>
MWIG8!PK;Y&84HTJ)7+GJ4U.Z'7=]V]Z)[^^(3JTH<)1U$93A'*D1'!&$I\':
M:;!05M535%0^&67QG6X.M%*G7]B2W3M41TF+='U3.N44-<Z5Z]I'PJ:JP]CK
M5TFQ8IQ!M)$VDNNRF\RBQ.8C4S5.+6[)DM,F.[9C;G/SL@KHEI-OK[HC:Q5U
MM3++)R]@LZ-256+DO(EPDYJYOS21B6?"6'.>U-0)7-CE:R5FOJ:K79IK9Y+U
M]4UC0:<[C<*N*DM^%XZFIF=J,8VH=POR#SX!TPT#;)':<94\TC&1[+=.SVK)
M6=F1.MO>OF9Z#'6C##C9:VPTT,E7EDJ4U&]K_?<B9'.J3A>$H79GDRZ-7(-I
MGQ->;O2VVFO^'><[F2.FCUZE'ZW67B3M_";@TY^57>/^A\\PYMQ[BRKQA>9*
M^J\:B3@TT/7BC[/TFS-(^EFQXGP77VBBI;E%43+%J/EC9JYME8[C:]>LAM.C
M).G9="[@_=L:MP%]OF'/\1IOG4-\\TQ]H=O_ ,1C^;D.>L-5T=KQ+;;A4[22
MGI*J*=^HF;M5CT7>0V7I>TE6?&F&J2@MM)7QSQU3*C^DQL:W51CT7?1Z]DUK
MTY.O"21><6ZB9.>9E^T6O_Q%_P U$:)Q^F6/<1Z_*,^7=5)3HETD]!45527"
MEEJ*"9ZRHL.^K';R<2]DR^E7278\7X;W%;Z&NBK-LR5'5,;&Y(F?71RE(PJ4
MZS>71E4I1FW;J;5TZ>55>/\ H?/,-2<S7OZ0:W_#I?G8C+:1]+-CQ1@VOM-%
M2W**IG6+4=+&S5S25CN-'KUD(-HDQ;0X-Q-5W*Y0U4D+Z1U.B4[&N<KE>Q>N
MY/.E*5&:H2BUJ1"$E3:9).:67_G^C_PZ+YV4VUH,\JNS?]?YYYH'2YBRAQCB
M>EN5NBJ8X&4C:==T1HUVLCWKUE7SQ.='.EFQ87P;06FMI+G+4P++KNBC9JYN
ME>[C5Z=914HS>'C%+43@W32*<R]5Q17"_P!*Y<II8XI&I]RUS\_EM(MI_H)Z
M32/73O\ (ZR.*:+UVL:Q?A:1'">(*O#-[IKG0IPX$ZC/@N;YIJF^':2\ 8KM
MT;,4TJ1OCWUCJ:=TNH[[ES$7]1I.,Z-;BI73):E">8U9@31E=L8VJ2X4=534
MT+)%B3;:W#RXU350A]WH>=EWJJ':Q5&PG=#KLZE^J[+>-Y8KTP66V67G=@FE
MREU-6*5(4A@@WN-$5,\^UJF@7KM%UY%S4WP\JDVY2T1I3<I.\B5Z++VRPX^M
ME9/(D=/KK#*Y>)6O;EG[G5&^M.N%JC$N$X9;9$LU90R;5L+$X4K%3)S4[?$[
M\$Y:R-R:.M,LEGI(K;B.*6LIV<&*IB3.1K>PY%X_C]<RQ-&>95:?5%:D'=3B
M:=<R2.74DA\<SU5C.F.9_P *55AL=37W2)]-65ZMU89%X3(V(N6?KY^\B'NZ
M:N '+NM:G*H[=!)K^_J?K(+C_35NVEDM^%8I:=C^ ZLFX#LNOJ)UO9+[QE5G
M5Q"R9;%).=59;&(Q=>F7S3S:WT[T?!27&FI&*G99*FLGXVN;"YH^BJ*G!%--
M!ELZ6K9)+[%6JW/WW(:#P'OXZP[_ (E2_.H=1Z3\3TV%K-2U-=1+6T-14MI9
MX\D7@.8]5WEWEZGB*5UP:D$O(BJLDHI',VB^WU%RTA6*.GZEE7%42;_F8W:Z
M_)-^:;+C!0IA'=*L1([W3U'K,9GK?*,?9\>:,</0R5-F9'!4/ZML%(])%7L9
MJF7PFE](^-*O&M[W3)&M/10<&GA5-]K?NNVIIEEB:JDXV2)<74FFT=-:2,2U
M&$L.I=J:WI7-CE:V5FOJ:K79IK9Y+U]4UE0:<[C<:N*CM^%XZFIF=J,:VI=P
MOR#SX"TPT+;'':<8TTTD;&;+=*LVK96?^(G6WO7S,_!CG1AAULM;8:6*2KRW
MTIJ-[7^^YJ9&"HNFG&4+LSR..C1 ],^)KS=Z6V4U_P .\YU9(Z6-9*E'ZW67
MB3M_";ATY[VBJ\+[1\\PYNQ[BRKQC>I+A5>-1)P*:%>.-G9^DV9I'TM6+%&"
MZ^TT5+<HJF?9*QTL;-7-LK'<;7KUD-9T)+AV70T<'[MC2!U/1V"P:,\$R7.>
M@AJ*BGA:ZHFV;722O7),D<O$FLIRR=#8<TL8:N^&%MN,5='-L]E4))"Z2.7M
M\'-=\Z,;";2:Z>9>LI.UC&V33)>+_BFUVZDME+34U551Q.SSDD2-5X6_O)Q=
MHD7-,[^ K?\ XC'\W(1N/&.C;"59NK"5GEK:]47QY-?@IU]^5<_>0Q6EK278
M\:89AM]#2W*.ICJ6SLVL3-7>1R>9>OGCD5-NK&48V1DH/.FD3CF9OM%K_P#$
M7_-1&A\?IECO$6ORC/EW525Z)])'07%5TE?22U%!,]946'C8[>3B7LF6TJZ2
M['C##J4-NH:Z*LVS)4=4QL;DC<^PY3:,*E.M)Y=&:)2C-NW4VKIT\JN\?]#Y
MYAY>9_J8I]&E#''U=.^6*3V6NK_VR":2-+-BQ1@VOM-%2W.*IG6+4=+$S5S;
M*QW&CUZR$'T7X_J,$W&77C6>V3;\\2=5GYY.ROQF,</-T6FM;F:IR<+$3NM#
M46RY55%4?UFG>Z)_X)U5HQ8[#^B2VR7#@;"FDJGY]9KG.D^)2-3XWT77BKBN
M=SAAW?EDFZ:%[I-[LY-5%(9I3TL1XAH);188Y([=)Y/--P72?<M3K)VS2:J8
MC+#+:W4M+-5M&QF^9:ZK$_\ EOWI ].?EIWKUX/F6'MT.8[MN">?'/."MF6K
MV&HE.QKE35U\\\W)YXC6D6^TN)L95UUM\<L=/4;)6MF1J*N43&]9R]@UI4I+
M$.36A>,9*HV;RYF7?P'</\1D^;C-<4=LQA+I&Q-<L%1;62FND[)52>-N><CE
MU7-<J9H>W1%I,LV#,-55ON=+725,E4ZH_HT;'-U58Q.N]/.F'POI'7#V.KQ=
M8*>66V7.JDEFA<FK)JJ]7,=EQ:R:WO&7#J*<VEU*J,LTFD3>FTUW*TW&2VXO
ML4:3T\FRJ'TLO4N]COHON*2S2=8K-BO -3>FPQ;>.B6MIZA$1K]74UT15[:?
M&1VY8GT38CK6W*[Q_P!.3>S=!.USO7U-Y?=,%I0TKTETLTMCPO'+%3R1ZDM0
MZ/5X'%J,;V<C.-.3G')%I^9FHMM.*L:8 ![)W
M
M                                  $DT9^6%AW[]C^,Z7T@:.K;C2JI
M:BOJ:J"2F8YC%A5O7]=%.:-&GEA8>^_8_C.T.L>/CYRA53CU.+$R<9)HTWT@
M[%RI=/?C\ D&!]%UMP?>G7*AKJZHDV+H=2=S5;OZN_O(GG38F17B..6(JS5G
M(P=63ZLY&TZ>6G>O7@^988; >#Z_&-VW%;_&J>/>J*GS,3?"["$\QM@^OQCI
MIO-'0>-4[-ANBIRWHF[%GY780S^-\66[1O9DPM@Y&I<O[27JUB5WFG>>>OP>
M\AZ<:KX<:=/K8ZU/W5&/4E4.*,-X4N%GP*CWU.NQ8)'/DVC8LTX+9%=UW=CK
M>L:)TM859A/%DM- F5OJ/'Z=/.M7S/N*0]T\BU>V667=&TU]=.JUO/&\.:/3
M=%IPO6/R29\<N>7;:Q2(4WAZD5?J(QX<TMS1H /2.DZ<YG/[0)?OZ7Y+#:!J
M_F<_M E^_I?DL-H'R^(^;(\JM\;-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSR
MJ+K[9!\ZT@',B\>*/\K^_+Q^4>;+\0CHD '.=Q]XNH0N+8NH0N+(D  D
M                        LD\C4O+)/(U(8/B "I .+-!7EKV#V<OS3SM,
MXLT%>6O8/9R_-/-Z7P2.+%?'$[3-;<T%Y7,WWQ%\HV2:VYH+RN9OOB+Y0PWS
M8GH4OC1RX #Z9'K
M
M                           %,AD5 !0J           "F14 %  0"I3(
MJ"0      "F14          %  0"H )                4  %,AD5 !3(J
M                                   >_#5>RVXGM=?4K+)3TE5'._43
M-VJQZ+O(;+TO:2[-C3#5)06VEKXZB.J;4?TF-C6ZJ,>G&CU\\:E!A.A&<U)^
M1G*"E+,  ;F@
M
M                                         !G]'D[*?'EBED7)F[HT
MS_#.U&\2'!:+J<.-=\ZKT5:0Z+%=MAI:R>.*]QLREB<NIM?NV=E-[K<1Y7M"
ME)VFCCQ,&]398S*(J9$:Q%C*Q8?JJ:FNURAIYZAV3&+OJB=E<NI;VU/+47+1
M(Y%%L@&EW2-3X:6KMN'DA=>I^%43-_L$R1,U[+]5N\G6R.<)9))YY9))=K))
MPWO?YHWAB;0O47BJFNF'K[2U;*M[I4W4F]PM_P D9GK>\>&U:!;O)-_Q>ZT%
M/!EPMAK2.^%&H>MAZE&E'KJ=U.4(1]2 :.\-3XJQ92T#(TW-M-K4/\[$F\J?
MLDVYHR]0UN)Z&UPJFSML*J[+S[\EU?>1I(KOBS#6C2R26;!VSK+P_>EJ,]KP
MNNYZ^:=V&I\!H:IGDJJN6:>5):B1^N][^J>YQM3BZU3B/HNA:'ORSE@ .TW.
MG.9S^T"7[^E^2PV@:OYG/[0)?OZ7Y+#:!\Q7^;(\JM\;-:\T9Y5%U]L@^=:0
M#F1>/%'^5_?D_P":,\JBZ^V0?.M(!S(O'BC_ "O[\M'Y1YLOQ".B0 <YW'WB
MZA"XMBZA"XLB0 "0                           "R3R-2\LD\C4A@^(
M*D XLT%>6O8/9R_-/.TSBS05Y:]@]G+\T\WI?!(XL5\<3M,UMS07E=3??$7R
MC9)K;F@O*ZF^^(OE##?-B>A2^-'+@ /ID>L
M
M
M
M
M
M
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MK[=?ON7XS'IQ'=%YDF;IW*@ DD
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MTZF=7L5 !T&@
M                          !TYS.?V@2_?TOR6&T#5_,Y_:!+]_2_)8;0
M/F*_S9'E5OC9K7FC/*HNOMD'SK2 <R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ
M1_E?WY:/RCS9?B$=$@ YSN/O%U"%Q;%U"%Q9$@ $@
M        %DGD:EY9)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO
M2^"1Q8KXXG:9K;F@O*ZF^^(OE&R36W-!>5U-]\1?*&&^;$]"E\:.7  ?3(]8
M   Z5YF?[0[A_B4GS49JNMT38TGK9I([,NS>]V_NJ'L^S,%AK&^(<,V^6CLM
M<M+3O?M7-2")V_JM;YIJ^=,LFEW''+2]Z0>">;P*T:DI0MJ<KIS4FUYF[I:5
M^&-"<]%B:=DDT5#)$_A;VL_-&1IZVLUJ>L0WF6=]V)O6IOWII[$>)[SB26)U
M[KY:Q&+FR-R9-:O9R3>/KAC%MYPMNI+!7[GW1J[7QMDFMJYY=4U?/$\I/ARC
M?5CA/(UYLVMHAO,%NTM8JMT\B,2OJ)5BS\^R5R*W\I3#8_T7XCJL;U\]JHDJ
M:.OG=.V99$U6*]V:YY]3D:MJJJ>LJY:NHDRJ)'OE>[BX3M\E5'I.QA1TR4\5
M]J=5.NZ-DCOQGM52TL/.,LT&6<&I7B;:TOU-/AK1+;\-2R1R5DL4%,G8X&JJ
MOR[&;?A(KHTPK?IL*2WS">*)*:L76UK<R!%:Z5J\%KE5VKOMRWU;YHU5<[E5
MW:KDJ;G52U$[][6E?K./M8;_ '6P5>WLM?)1R2;[T;)P7^R;U*A8>4:>6^HX
M;4+'2FC*]8WN594TN+K0V&CCCWJE\6S<]W8RXE3W#3MWBMM/IXIH[0D3*5EW
MIMYB[S7:[-=/Q]8QMPTFXQKJ98Y[])J+Q[&-D?Y3412'(N7#_M"M+#2BVY:7
M$:33?J=#\T5A^ZWE+346RB?44]+'.L[V+Y&F35S_ "3[Z&*"*CT6SW2Q4T<]
M^EBGZOC61NMJ1Y]CJ?QC4#M)6,'6^2@DO$CX)&+$_6CC<[)=[/-6ZWPF*PSB
MN^X925;+7RT^LO"9DU[7+V<G9H56'J</(V0Z4LMC?^BVIQ[<<0U-5BQ):>UM
M@=J1.@;%XXJMXDRULMYW&:ATZJB:5+UZ\'S##Q+I*Q:^OAK7WJ;;QZR,X#,N
M%]QEJ_ 1_$%YKK_<9:^[2;IJWHU'NV;6=3[!$+4</.-3,]O(0IM2NSI+3W8K
MEB'#%OBLU*ZLDCJDD<QGG=1R9_"1?F8&215&*(Y>K9N9%_/&M+7I)Q;::"*B
MH[Q)N=C-5C7QLDU6]MST5QX,-XOON'):I]DK]SR5FIMEU&2J[+6U>K1>RXA8
M:IPG3"I2R921V2Q+B'2U=J2*[I:JW=51-3S,CUG[1K^I;PF^9UE_!-B/K-*6
M&[XM!'#T0T&NW9U$T#6:R=??:[@KZZF@Y:ZHFN$M:^65*V23;;9G ?M%=GK;
MQ*Z;2GC2"-(H[]+J=E\3)'>^K%4O5P\Y6M9H3I-]#9O-+0T'.:TS/9$RZR3H
MQ,NJV6J[6]Y5897 5)+<^9Z6BH6(^HFI:R*.-5\TLLJ(GOG.MVNM?>*K=-SJ
M9:RH\],_60R6&\9XAPW#+#9+I+!&_A:BHU[=;UGHI5X67"44]4PZ+RI$IT16
MJNLNEZS4=UI9::>/:KJ/[<#S+:=ZQ*#2U:JW5U]SP02Y>QD<IK]V+[Z[$L>(
M%KD6[,3+=.SC\[J=3EJ\7:/+B._W+$=QW9>JK=%1J;+6V;6<%/8(AIP)NHIR
MV+9)9KLZ TR8?J,=89L]VPRJ5NYT<]L;>-\<FJF:=E4U>(A^'=$E+38:K;MC
MV2JMZ0YO;%#(S>C3SR.1V:JO$F?8-=8;QA?L-^-V2Z24T;^'J<%T?XJYH6XB
MQ??L2*K+W<Y:F)G#U.HC_%;DA2.'JQ62+T_<JH2C[J>A-]#V%*Z]TE=<+#BB
M2U5]/)J+3,CU]9NKFFMPDX*KVO,FQ-'][TBRXA908GM35M^3MK6/C2/4R\ZJ
M+D[WCG2T72NL]4M3;*F2CG\_"_50E%1I3QI-#L7WZ347SD<+%]]K,R*N&G-N
MUG<2I2=[&1T^0VZFT@/9;F0L78-?4-8G]MO_ +.J0O#53!1XCM=55KE24]5%
M++[6UZ9G@FFDGGEGJ99999.&][^J<?-3JA#+3R7-5&T;'3.F["E\Q926R7#<
MNZ((M9SJ=LR-1RKU,B:RHU<M_C7UB8X+I;I#ANV18NW-)=X=YDFMK.SU5W]9
M>-^6MGD<O6+'^*;#2;EMMXECITZECXVR-9ZVNBY'FN&+\0W"ZTMRK+I425=)
M)K1.R\B=VF]2<+P=1K)I9&#H2:M<S&F>*ZLT@7.2\1ZCI'_T9?,[%-YBM_7V
MR%&>Q+C&^8GBCAOUPCJ8X5VC<X(FJQ?9-:BH1\[Z47&FHLZ(1<8V9U5I[KZV
MVX$2>UU-325&ZHV;2FE6-^KD[-,T.:ZO$=]K(5AKKQ<ZB)>-DU4]S?RG&1Q%
MCO$F(K<E%>;INFCU];46")JYM[;6H1<PPV'X2]]792E2RK4SN /M]P[_ (C3
M?.H;7YJ1?Z7ASV$_[LTI0U<]!<*6MI9$CGIWMEB=YUR+FG5&4Q+BJ\XGDI7W
MZOW1)!K;)=1D6KK>P1"TZ,G6C/R0<+S4B?<SC?(:#%=5;ZJ1&;O@:V)%Z\C.
M-OO.*8^T88DJ<;U\UKH4J:.OJ'3MF61$:Q7NS7//BR-3M=J\+(F-)I.QA2TR
M4]/?JE6)Y^..5WXSVJI6=&:J.=-D.$E+-$VSI?J:?#6B2@PU+)')621T].GK
M1Y*K\NQFTIH-JJ3$&C:YX;DEV<S-M"]B]4C)45=;WW.- 72X5=UK)*FY54M1
M._>UYGZSC8^A?"]NQ"E5)#>ZZV7JG>NS2FE:W6CR3?1,L^//,QG04*-I=>I2
M5/+#4R."-$U^MF,K?67N&FIZ"@G;*DS:A';5R+P$:G'OKJ\>1]^:>3_CEG^]
M7_*,U9\%8\K,54,V*;MNBU4%4VH14J.#+J.S;P$_60GF@,0TMYQ7'!02QRLH
M(=D][5X*2:V_[QG!RJ5D[W*QO*:-A<TTJ]!]J^_D^;>:TT#VRV73'D;+G'')
ML('RPM=U+I$<G%V=[64CN)L;8BQ-21TM[KMT01OVC6[!C5UN+S*(8.AK*B@J
MXZJCEEIZF+A-D9P7,.FG0E&CD\S6,'&&4Z'T@UVD>7%LMLPU2R4]K=JMAJ8X
MFY+FW-5<]<\LEWNL?3FE6JF +8QZ:ZI<8^+L[*0T_6Z3,85E*M--?:I&KUV1
M,C=^,U$4\%ZQOB*^6B*UW.OW1;F*U6,W.SS&\F^B9F4,)44HMVT*1HRNGL;L
MYG5?^S>\_?LOS$1JS05Y:=E]>?YAYA\.XWQ#AR@EM]IKTIJ221TKV;GC=PE1
M$Z[5\Z8FQ7>NL5VAN%LEW/5T^MJ/V:.XVZJ\%<V\3C18>24_^1;AOWO4V+S2
M/EA1?>,?RWD]YHORN;+]_1?,2F@\1W^YXFN.[+W5;HJ-39:VS:S@I[!$/?B/
M&^(L1T$5!>*[=-)'(R5C-SQMX34<G6:GGARTFH?\2.&_=]#=>%%RYFBH^\:S
MYR0A7,U?;_7?X=+\[$0FCQMB&DPQS@@N&SL^H^+8["/J7*KG;^6?FNR>+#>(
MKMABX2UEEJMS3R1[%[]1CN#K(OFD7L$<O+)..[)5)V:W)OCGR_D_Q&E_=$KY
MJ7JL+_YGXHC359?;E6WSGS5U6TNNNR;;;-O5,ZG@Y:OF3UXGQ;>L4[EY_P!?
MNC<^MLN!''JZVKK=2B>=+*A+-![#ANZ>QO''?_N[V[[QH?W8YG+RN;S]_2_,
M1&E*_&V(+AAV*Q5=?M+6QD438=SLZEO4;[4S\SV1AW&V(<.4$MOM%>E-22/=
M*]NYV.X2M1O71?.F?*S=/)ZW(X,LMC):&/+0L/LW_(D);I_J^=VE"S5OI>EI
MYO7U9I%-4V:ZU=EN$=QM<NYJR#J7[)KON>OFT]6),0W/$UPBK+U5+45$;-BQ
MZQLCX.LY?,HGGC:5%RJJ3Z6+2IO/<Z#TO86FT@X;M%PPS)'4RP:SXF[35VL<
MB-SR5=[/@MX^V??0=@^JPC;:];KLX[A5[-SZ=CT=LF)K:N>7;<[WB/T&"JZ'
M"D=?HRQ/7RMFX6YYZANS5%RSRWLFO0S>!*&NP+9;Y?,<U^O65.HKE?.LKD:Q
M':J9\6:ZW$AY\FU!TXO2_3S.=WRY4SG/$._?+K]]2_&>!O$?6OJ=UUDM2_?V
M[W/]\^*)D>S#2*.V/0N !<L
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M4,8N;6(FK&OX*9(1RM1M-V^I'"E?4WGS.:Y:.KSO?]^E^9B(3S-/V_UV]_\
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M)@*"MJ[=61U5!524\[-YLL,FJYI182<HR4GJRJHNS3\S8/2@Q*F)]P+2_P!
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MU$;-](TU6M5>SJIDAG1HU*M.,6_=*0C*44O(P2+Q%Z%B%Z'J1T.Q  %B0
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MC?5Q;"-R*N^V.-F6LY.MF:$-L#=0=S3#IY2H .XW
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M.NN4B/N==55C^Q4RND^,\>14IPXWO8A15[EA< 6)*@ D
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M-))+/KR+M)).K>\HA7(9$I)!*Q4 $D@
M                                             '3G,Y_:!+]_2_)8
M;0-7\SG]H$OW]+\EAM ^8K_-D>56^-FM>:,\JBZ^V0?.M(!S(O'BC_*_OR?\
MT9Y5%U]L@^=:0#F1>/%'^5_?EH_*/-E^(1T2 #G.X^\74(7%L74(7%D2  2
M                           62>1J7EDGD:D,'Q !4@'%F@KRU[![.7YI
MYVF<6:"O+7L'LY?FGF]+X)'%BOCB=IFMN:"\KJ;[XB^4;)-;<T%Y74WWQ%\H
M8;YL3T*7QHY< !],CU@   #/X+PI<<777<=NC1J1\*69_4Q)V%-RQ:$,-T<#
M&7>^U:3OZ['Q0-7UFJU5^$YZN)A3=F92JQB[,Y[!M#2+HDJ\,6^6Y6RIW901
MIX[KQZLD7;^Z3_>1A-$N$Z'&.)JJW7&>JCA;2NG1:=[6NUD>Q.NU?/$K$P<'
M-=$2JD6KD*!.ZC"MCH]*\F'+A7R4UDC<]KZJ:9D3F+L==.$Y-7JN#Q&*TC6B
MRV2_I389K^>%(M.U^VV[)N%PN#FW)"8UXRDHK:Y*FF[$9 0&Q< E.CBRV.^W
MI]-B:Y\[Z..E=*V;;LARDS8F6;D5.)SC'8RH;;;,35]%9:K=E Q[=G+M$E1R
MZK?--WC)54YY/,KF3>4PX -2P   !D,,T,=TQ/;*"HVD=/5U4<#]5<G:KWHF
M\373)@>VX+JK6VUS5,BU;)7/W3(CNIU>+)J>>,I58QFH/JRCDE+*:Z 0W9HY
MT3V/$N"J"\W*LN<=1.DB/2&1C6-U9'MZ[%[!%:M&BKR(J5%!79I,'1,>A7"%
M2JLI;[7RSY;V51"[X$8:PTDZ-J[!>RJFRI76Q[]5LNIJN:O61Z=@SIXRG-Y4
M5C6BW8@H .HV !LO2CHR@P5:::N@N4M6L\^QU)&(WS*KUE[1G.K&,E%^95S2
M:3-:  T+    &P]&>C2KQE&^LJ:AU':V2:FLWA.E5.-4]_C)Q'HCP/<974EI
MQ1))7)OZC:N"94R[+$:BG+/%TX.S,I5HQ=C0@))CO"%=@Z[;DKME+')'K13-
MS1)6HORB-(=$)QFKQ-$TU=%0"4Z.;-8[Y>I*;$USYWT<=*Z9LVW9#E)FQ,LW
MHJ<3G$3FH+,PW97(L#,XQH;;:\2U]'9JK=E QS-E+M$E1RZK?--WC#$QDI)-
M!.ZN  6)
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M=:Z^[&_I!*]*'=D3>$U51C=35UM]&L-="G54[V\@I7  -"P
M
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MXIH];M[-$R-'W:@J+5<*JWU\:,J('NB<WK*Y":6(A5T74F%52T1Y@ ;F@
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M4?Y7]^7C\H\V7XA'1( .<[C[Q=0A<6Q=0A<61( !(
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M7XT1SF/_ &B8\U#_ %W#_M<_QQF'QODG-%4V_P#_ !*W_)A,SS466[</[_\
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MYL_!=DG61,N(U,AWX64I4TY'12;<=2H .@T
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MD%I<>R=I4 $@
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MZQS=+%)#/J3Q+')'YAY.!45=^9-!6N6H5 /2.D
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M7*KDJ*MZ<)SCRE"XTBDE9$I6T14 %B0
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MFKY8XJ1>'N:F9JM=Z_&J^^1#(ID0L/!/-89(IWL4+@#8N5 !(
M
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MYUI .9%X\4?Y7]^7C\H\V7XA'1( .<[C[Q=0A<6Q=0A<61( !(
M                 !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY?FGG:9Q9H*\M
M>P>SE^:>;TO@D<6*^.)VF:VYH+RN9OOB+Y1LDUMS07E<S??$7RAAOFQ/0I?&
MCEP 'TR/6                     !3(J "F0R*@ ID5  !3(J "F0R*@ I
MD,BH          !3(J "F14     %,BH          *9#(J
M
M         "F0R*@ ID,BH *9%0          "F0R*@    %,BH *9%0
M
M                                               "F0R*@ ID5
M     *9#(J                      "F0R*@ ID5
M  *9#(J "@ (    *E"I*
M   !TYS.?V@2_?TOR6&T#5_,Y_:!+]_2_)8;0/F*_P V1Y5;XV:UYHSRJ+K[
M9!\ZT@',B\>*/\K^_)_S1GE477VR#YUI .9%X\4?Y7]^6C\H\V7XA'1( .<[
MC[Q=0A<6Q=0A<61( !(                           !9)Y&I>62>1J0P
M?$ %2 <6:"O+7L'LY?FGG:9Q9H*\M>P>SE^:>;TO@D<6*^.)VF:VYH+RNIOO
MB+Y1LDUMS07E=3??$7RAAOFQ/0I?&CEP 'TR/6   /1;Z*LN59'2T$4E14/X
M+&,X3C9%'H/Q=44R/D?;*=_H4LZZR?B-5/A)SS/EDI+7A.JQ'59;>HUO'5\S
M#'Q_E:WP&ML0:6L47"[2S4=?+14VOXS!$C> W[KSQP2K5:DW&EY&#G*4FH>1
M@<88+ON$IV)=:9&4[EX-0Q=:-R]A5^DLP5A2OQA=9K?;)::.>.%U1_27N:W5
M1S6^91?/&TJ;2M9+[@J2U8QBJGUE0QT3WPP)J[^>H_JN"IA^9IW\?UO^'2_.
MQ$NM5C2DY*S1&>65M^1#X\$7)^/.A-TM+N_A,U]=VRWH]IQZN?%]R>/&6&*[
M"-U2VW.6GDGV;9?Z,]SFZJY^>1/.FP[G;N>_-%U=%NFMHUD>Y-TTDNRE;E39
MY([_ 'O$<TUV9+%C*&E2X7.X_P!$:])J^?;R=4O!SWMXF%>3FDWU5RT:EY)/
M8@0-\XCT+6*V00U*WJII*%G]:EJWQNS;O9(F36[ZGDN.A^RU^&);E@Z[RUKF
M,<YFOJ2LE<B=3FC4R+1QM-CC19K#!6%:[&%UFM]LFIHIXX'5'])>YK=5'-;Y
ME%\\>/$UFGP[>ZJTU<L4E13\%SX5X/4ZW7:A+="5E3$&*ZJD6Z7.WZM"Z7:V
M^?8R=6Q-7/)<TWS$:1+0^WX[N5NBJ:ZX/UF,;+42;2:1RM;O*[KDJJ^,XMZ6
M)S>_8BR W12Z(K-:+5%6XZOJT+W_ -G%(QB-7SJ.5%UO<0Q>/=%#+7A]+[AJ
MYK<+:R/7?OM5=3S[7)O.)CBZ;E8*K%NQJL&PM%^C>3&,=37UE4M);()-5')U
M3W9(KLO.Y9IODMMVC3 F()):/#N)JI]PC9K<<;][LZNHW63W29XJ$)68E5C%
MV9IFTT,ESN]#00+%'45<[:=FNW-NL]=7?)!CO ]RP7+2MN4M-)NO7<U*=[G=
M3J\>LB>>/O:K'-AW2O:[15\*>ENE*W7;Q/378J.]XV!S3_\ 7L/\7D<_QQE'
M7?%C%=&0Y^^DNAH\]UDM%=>[A'26FEDJ:A_F&<2>R\Z>$Z8T:4=+@C11)B"H
MCVD]1!NV7SSM[QMF?N^^Y2^)K<*.G5DU9N"T-=P:"\4R1H]\MJC?YU]0_-/>
M:J?"0K%F#;UA2:-EWI=2.1<F3QKK1N7US-7'2OC"KN$E3'<Y:>+6R9#%&BQL
M]W+XS=> +U%I.P%7T=_BC2HWZ:I2->/-N;7IV%_6U3FE5KT4I5.AE*I4AK(Y
M:0J3_1O@:EQ#C>Z6.]2U,6XX)<UII$:NNR5C%7?:O9)A+HIPG:KK+3W[$TM,
ML[_Z+"M0QDFIUE>KD_4AO+%0B\K-75BC2 )]I0T<3X,DBJZ>IW9;)WZC72,1
M7,<O6=VC[Z-]&<F*J22[7.K2W6=FME+GPG9<?5;S6IDN^7YB&3/?0GB1M<UT
M#=DFB;#5\MU4[!>(]V5E/U3)9&2LUO<1-7/L[YJJSVA:C%M#9;DDU.Y];'23
MIQ.;K2:BIGYX4\1":;7D3&HI7,0#?=PT&6Z.Z1+!<JJGM,<*NGEJ)&.=GGO(
MW>1$3+C52#/T?1W+297X<P_5(Z@A8R5U9,K9-5FHQ5RU-7/-5R*1QE.70JJL
M6:]!O!VC; %-=><]9B>KY[*]K4C62//-W4MR5B_&0S'> 68-Q-:Z:X5^O9Z^
M3):A> YC6N377K\)&J3'%0D\H5:,G8Q5'@2^5F%%Q'3TL2VQ(WRJ_:-UM5JJ
MB\'\$Q>%+%5XFQ!2VFAFBBJ*C6U9)L]7@L5_61?.G3UFH,.1Z)9**BN4S\.+
M3SM=69YO2-7OUUZGC15=UNL:3P]8;-4Z6J"UX:N]SYV2,?J5\%1LZC6V,BJJ
M.U4];BXC"&+<U/TN459ROZ$6QGABOPC=$MMSEII)UC;+_1GN<W576[*)YTP1
M/--5FYQXP@I4K[G<?Z(UZ35\^WDZIW!SWMXD>']$5)!A^.[8UO'.N!Z-?LF9
M1JQ5XM9STX^UJF\<0HTXREYEU42BFS4 -Q7O1%0UEEENV!KQSS8S^Q?D_7U>
M-J.;EDO:R(EHDPE08QQ/4VZY3543&4KJA%IY$:[61[$ZZ+YXE8F#BY;$JI%J
MY"@;L?HHPG;;S-17W$<M.L[_ .BTVT8Q^IQ(KU5JIO\ K(1;2QHYZ"MRU5'4
MS5%OG?JKKKPF.['K%8XJG-J.Y$:L6[(UX#:N#-&%%4X5=B+%MSEMU ]-=C(\
MM;9YY-<KE1>/K)D95^BG#U_M-34X(O\ )63P<3:G)R([+/57)&JW/UB7BZ:=
MAQHWL:5!=(Q[)5CE7QQG&6G2:@
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M1>/%'^5_?EX_*/-E^(1T2 #G.X^\74(7%L74(7%D2  2
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M">6*5Z==S%R4\A?4U,E75R551)M:FHD<][_/.=QGS0]2%TK,ZXE0 6+
M
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M"\KJ;[XB^4;)-;<T%Y74WWQ%\H8;YL3T*7QHY< !],CU@   %  +>N7( +
M  H6EP(!3(9%V0R)L+%"TN! +<AD7Y#(BP+,AD7Y#(6%B@0J"; H6EP )7HV
MQ@N";W+<TH=V;2E=3ZFW2/C<Q<\\E\Z8[&=]7$N)J^ZNI=S[K>Q^Q636U<FH
MWCR3SIA045**DYKJ4R*^8M"%P)+%N2A$+\AD38DL+@"04R&1=D,A8%A5"H!%
MBJ!0 26C(N&0L"PN  !:7  M+@ "H )
M                                           !0 $    ID,B[(9"P
M+<AD79#(FP+<AD7 JT#YE4+@""TN )))UH_TE77!['TD<4=90/>KDBE54U'+
MV%)/4:;9*>&1EBPQ16^H?U4NTUD]Y&-S-/E,C"6%IR>9HS=*+=S[UU947&JE
MK:N662HJ'Z[W/\TX\W7*Y%4-5%+1&EBW)1D7Y#(G*"PN )!3(ID7Y#(- L+A
MD,A8%0 2!D  "W(^M-)L*J&;T-[7E@(:(:-T7?3U7U5O?#;;-%15#DWIGU&U
M1O;U=1II>5[W2Z\B[660ID51#*E0C2^$K&FH]"Q 7 TL: M+@206@N L"W(K
MD79#(6%BA:7  M+@ "F0R+LAD+ H6EP +2J<94 %4"@$@M5"F1>,B+ L+@ "
MT%P!%BT*7 (6!:7 $@  %2Q4+P&@69#(OR&1%@69*,B_(9"P+4/I"Z6*>.2/
MQJ2-==CRS(9#*#;MOTV5<EM92X@L5#>%;DFT<_9:V775JL<F?O&%QSI3N6)K
M2MMIZ2.U6Q4R?%"O#?\ <ZV]DWUFFO2W(P6%IQ=[&:I1109%4*F]C4MR*Y%V
M0R)L49\T*EP)9):"X$ (5*(5))             4  M4H7 BP+2X  %I<
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MA4WRXV44E9%[6+"I<"+$EI<@"%D 6EP +<AD7Y#(6(L6 N %BTJA4 D%0"0
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MFI(Y:FHDZB&"/6<[W$/?7X?O=!2K4UUGN=/3Q]7+-2/B:GNN0AS2=KD-V,8
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M %@
M            4R*@                       'MMEGN5VVO.RV5];L\];<
MT#I-76XL\CW]!^*/4[>>\)?H*.I%:-E7.*T;,&#[5U#64$VQN%)-2R>AS1N8
M[\H]=OL5UN5-)46RV5U;"W@NEA@?*UKDX\E1"<\;7;)NC'  L2
M                H !D+E8KK:HHI[I;*ZCCDX+75$#XFZWNH8_,A24M40G?
MH #Z4\$M3/%!!%++42/U&QLX;GN=YE!<D^8/7=+3<[4L;+G055%M.HW3 Z/6
M];,^L]BNM/;UKI[97QT$FJ]M1)!(V/57BW\LM_>(SQW(S(QX +(D
M                                        %,BH *9#(J "F14
M                     Z<YG/[0)?OZ7Y+#:!J_F<_M E^_I?DL-H'S%?YL
MCRJWQLUKS1GE477VR#YUI .9%X\4?Y7]^3_FC/*HNOMD'SK2 <R+QXH_RO[\
MM'Y1YLOQ".B0 <YW'WBZA"XMBZA"XLB0 "0
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M"3V]]PI;U98X]2:1[%2H:W//7W\\\LO/&AD.G#595(W;-*4G)&\N9>7.OO\
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M(^/JK&ZV]:NWQ4VY-IJ:CU=KZ^I]!#$+54N0]*G!066)UQBHJR*@ T)
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M33LU.MOM<G6WLB:&)G*:4F(5)2>IJL#,'I'2
M
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M61.)>(YEC97S>6QEQY=3DL%98Y(II&3>21\$M;Q'K)W1UE0
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M*:=DCLME+OY(IS\$)G0XDXSOT$J>9I[%F1>@R*FZ1<  D
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M
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MVHU0 !)(
M          !TYS.?V@2_?TOR6&T#5_,Y_:!+]_2_)8;0/F*_S9'E5OC9K7FC
M/*HNOMD'SK2 <R+QXH_RO[\G_-&>51=?;(/G6D YD7CQ1_E?WY:/RCS9?B$=
M$@ YSN/O%U"%Q;%U"%Q9$@ $@                           %DGD:EY9
M)Y&I#!\0 5(!Q9H*\M>P>SE^:>=IG%F@KRU[![.7YIYO2^"1Q8KXXG:9K;F@
MO*ZF^^(OE&R36W-!>5U-]\1?*&&^;$]"E\:.7  ?3(]8
M     ID,BH *9#(J    "F0R*@ ID,BH    *9%0 "F0R*@ ID,BH *9#(J
M"F0R*@ ID,BH *9#(J "F0R*@ ID,BH *9#(J "F0R*@ ID,BH *%I<" 6EP
M                    *E"I*       *9%0 4R*H
M                   "F14 %,AD5 !3(9%0 4R&14 %,AD5 !3(9%0
M  4R&14 %,AD5 !3(9%0 4R&14 %,AD5 !3(9%0
M
M             "F14 %,AD5 !3(9%0                       H !:I0N
M!!%@  2               "I0J2@
M                                  =.<SG]H$OW]+\EAM U?S.?V@2_
M?TOR6&T#Y?$?-D>56^-FM>:,\JBZ^V0?.M(!S(O'BC_*_OR?\T9Y5%U]L@^=
M:0#F1>/%'^5_?EX_*/-E^(1T2 #G.X^\74(7%L74(7%D2  2
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M,:#Z5E+/254M-5Q2TU0SJX9H]5S?P5/F63OJB0 "0
M
M
M
M
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MS0B^IE.__P#RSEJYJU66572T,9WG)V5S#\TA84HL3TEYBC18Z^+4E[;V=?\
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M:6<NF1?OOI")GKT/EH[(?"@ #4N
M
M
M
M
M=.<SG]H$OW]+\EAM U?S.?V@2_?TOR6&T#Y?$?-D>56^-FM>:,\JBZ^V0?.M
M(!S(O'BC_*_OR?\ -&>51=?;(/G6D YD7CQ1_E?WY>/RCS9?B$=$@ YSN/O%
MU"%Q;%U"%Q9$@ $@                           %DGD:EY9)Y&I#!\0
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MZ-_,RF*KJM]Q#<[GLUCW9.Z757C:WK&*0*#JC&R2-TK*Q< "X
M
M
M
M
M                      .G.9S^T"7[^E^2PV@:OYG/[0)?OZ7Y+#:!\Q7^
M;(\JM\;-:\T9Y5%U]L@^=:0#F1>/%'^5_?D_YHSRJ+K[9!\ZT@',B\>*/\K^
M_+1^4>;+\0CHD '.=Q]XNH0N+8NH0N+(D  D
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M<O6<6H8B51V:$*KD[,A( R.PW!4ID5)
M
M
M
M
M
M                               !TYS.?V@2_?TOR6&T#5_,Y_:!+]_2
M_)8;0/E\1\V1Y5;XV:UYHSRJ+K[9!\ZT@',B\>*/\K^_)_S1GE477VR#YUI
M.9%X\4?Y7]^7C\H\V7XA'1( .<[C[Q=0A<6Q=0A<61( !(
M             !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY?FGG:9Q9H*\M>P>S
ME^:>;TO@D<6*^.)VF:VYH+RN9OOB+Y1LDUMS07E=3??$7RAAOFQ/0I?&CEP
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M[,PZKF*>&E&:E)D1I.,KL%R%J%R'>=
M
M
M
M
M
M                                 !TYS.?V@2_?TOR6&T#5_,Y_:!+]
M_2_)8;0/F*_S9'E5OC9K7FC/*HNOMD'SK2 <R+QXH_RO[\G_ #1GE477VR#Y
MUI .9%X\4?Y7]^6C\H\V7XA'1( .<[C[Q=0A<6Q=0A<61( !(
M                !9)Y&I>62>1J0P?$ %2 <6:"O+7L'LY?FGG:9Q9H*\M>
MP>SE^:>;TO@D<6*^.)VF:\T]P)/HUKW+_9R1._+:GZS89C,16J.]V.NMDZY1
M5<+XE[+=;>S*4I*$U)G?3=I)G$P/3<Z&>V7"JHJN+9U$$CHG-]B>5#Z>,LRN
MCUD[JY4 %B0  "F0R*@ H " 5 !(   *  @%0 2          $  *%,BH(!4
M $@ID5
M
M
M
M
M
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M&.E)@CD;],G\,>)4]F.9B<H ZOZ4F".1OTR?PQTI,$<C?ID_ACQ*GLQS,3E
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MQTI,$<C?ID_ACQ*GLQS,3E '5_2DP1R-^F3^&.E)@CD;],G\,>)4]F.9B<H
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M#ZG\A&'2_=IV?F<7QU[KR-B@ YSM/O%U"%Q;%U"%Q9$@ $@
M              %DGD:EY:_B /@ H*$ U9I_P._%.&$KK='M+K;-::)G7EC\
MW'^M/6RZYM,$QEE=RDXJ:RLY-T"Z1VX5N"VB[RZEFK'Y[3TO)Y[V*]?W^R=8
M-?KKKLWXSGS3;H@EFEJ<085IMH^1=:KH(^N[S[/UM]X@^C/2W=\&[*WW"*2X
MV9G!V+]Z2#V"_J7X#HE&-19HG)"HZ#R5.AUZ"$X9TG84Q%%'N*[Q4\^7]6K%
MV,J]K)>J]S,FC7:Z:[#G<6NJ.Q34NC+@ 18FZ  %F+H  68N@ ";"Z  (%T
M !=   70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=   70
M  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=
M   70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=   70  %
MT  !=   70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=
M70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=   70  %T
M!=   70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=   70
M %T  !=   70  %T  !=   70  %T  !=   70  %T  !=   70  %T  !=
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M<*6;S4LGGG$CR*599GH:4*7#CKU  ,S<^\74(7%D?4(7ER0
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MDFZ]T_F.E]I$Y)NO=/YG:(',/8<I'=G%W2^TB<DW7NG\QTOM(G)-U[I_,[1
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M?%16NEAIJ./J(86:K4/850RE-R-Z=*-/H4 !4T !](DW@@?0J 7)
M                         *.3,^#DR/06N3,A@^ +G-5/6+2I
M      &1   )
M
M
M
M
M
M                                                     +FMS3C
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M\9//N!E%CX9/&3S[@918\Z-<7;-Q]@38DL1B(7%02
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
F                                               #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>iclr-20231231_g5.jpg
<TEXT>
begin 644 iclr-20231231_g5.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BH[JZCLK:2::2.&&%2\DCL%5% R22>  .]?G[^W5_P<%?#7]G
M26^\/_#F&+XE^+H-T336\VS1[&09'SSCF4@]5BR/]H5V8'+\1C*GL\/%R?X+
MU>R-\/AJM>7+25V??/B+Q)IWA#1;C4M6O[+2].LT,D]U=SK##"HZLSL0JCW)
MK/\ AI\3- ^,?@?3_$WA?5;37- U9&DL[ZU;=#<J&*%E/<;E(ST.*_F:_:S_
M &]_BK^VSXA:\^('BFZOK%7W6^CVN;;2[3TV0*<$C^\^YCZU^\W_  1E&/\
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M,RW$2R1LLD<@#*RG(8'H0:=7P!^G!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1139IDMH6DD98XXP69F.%4#J2:
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M,6M/)=QJTS9Y@$YE)QGY2O%>'_L]?MU>!_AA^W=\4/B1J:ZU_P ([XP@N8[
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MGR04+MV25WN[=7YOJ?SY7J^TJRJ64>9MV6B5W>R71+H%%%%:&04444 %%%%
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M\V]?TD?\$9O^47WP9_[ 7_M>6OAN/?\ <J?^/]&?.\2?P(^OZ,^4_P#@O/\
M\E_\!_\ 8OS?^E-?"]?='_!>?_DO_@/_ +%^;_TIKX7K].X'_P"1#AO\+_\
M2F?Y]^)'_)38O_$O_28A1117U9\2%%%% !1110 4444 %%%% !1110 4444
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M_P#CM?:7_#P7X,_]% T/_P B?_$T?\/!?@S_ -% T/\ \B?_ !-'_$0N(O\
MGY_Y)'_Y$/\ B7/#_P#0JK_=6/BW_AP?XH_Z*3H/_@GE_P#CM'_#@_Q1_P!%
M)T'_ ,$\O_QVOM+_ (>"_!G_ **!H?\ Y$_^)H_X>"_!G_HH&A_^1/\ XFC_
M (B%Q%_S\_\ )(__ "(?\2YX?_H55_NK'Q;_ ,.#_%'_ $4G0?\ P3R__':/
M^'!_BC_HI.@_^">7_P".U]I?\/!?@S_T4#0__(G_ ,31_P /!?@S_P!% T/_
M ,B?_$T?\1"XB_Y^?^21_P#D0_XESP__ $*J_P!U8^+?^'!_BC_HI.@_^">7
M_P".T?\ #@_Q1_T4G0?_  3R_P#QVOM+_AX+\&?^B@:'_P"1/_B:/^'@OP9_
MZ*!H?_D3_P")H_XB%Q%_S\_\DC_\B'_$N>'_ .A57^ZL?%O_  X/\4?]%)T'
M_P $\O\ \=H_X<'^*/\ HI.@_P#@GE_^.U]I?\/!?@S_ -% T/\ \B?_ !-'
M_#P7X,_]% T/_P B?_$T?\1"XB_Y^?\ DD?_ )$/^)<\/_T*J_W5CXM_X<'^
M*/\ HI.@_P#@GE_^.T?\.#_%'_12=!_\$\O_ ,=K[2_X>"_!G_HH&A_^1/\
MXFC_ (>"_!G_ **!H?\ Y$_^)H_XB%Q%_P _/_)(_P#R(?\ $N>'_P"A57^Z
ML?%O_#@_Q1_T4G0?_!/+_P#':/\ AP?XH_Z*3H/_ ()Y?_CM?:7_  \%^#/_
M $4#0_\ R)_\31_P\%^#/_10-#_\B?\ Q-'_ !$+B+_GY_Y)'_Y$/^)<\/\
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MS?\ I37PO7Z=P/\ \B'#?X7_ .E,_P ^_$C_ )*;%_XE_P"DQ"@G H_,YX
MR2:_0[_@G5_P2676+;3_ !W\5K%O)DVW&F>')AC>.JRW0_(B+_OK^[7I9YGV
M$RG#_6,6_1+>3[)?F]EU/*X;X9QV>8M87!1\Y2?PQ7=O\EN^AX+^Q7_P3+\9
M_M:2P:O>>9X6\%;@3J=Q%F:]&>1;1G&[O\YPH_VNE?J=^S=^Q_X!_95\/K9^
M$=$AM[J10MSJ4_[Z^O#ZO*><?[*X4>E>E6EK%86L<$$<<,,*A(XXU"JB@8
M'  '85)7\[<2<98_-Y.,WR4ND$]/F_M/UT[)']7<)\ 99D4%.G'GK=9R6O\
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M*KTC4VC)]I+:,GW7NOM'K\,T4 YHKUC^E@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /TX_X(_?&S_A.O@%>>$[J;??>#;GRX0Q^9K27+Q_]\MY
MB_@/6OKBOR3_ ."87Q?_ .%4_M9Z/;S3>7I_BJ-M'N 3A2[_ #0D_P#;10/^
M!5^ME?-X^ER5G;KJ?P#XY<-K*>*:M2FK0Q"55>LKJ:_\"3?HT%%%%<9^.A7
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M^=*#)'N..^U%&?:OA&OHLOQ?UK#0Q%K<R3L>IA:WMJ,:MK705_21_P $9O\
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M%=WV.T1E5YW_ -A2Z@D=-PKEEA<.I^VE%<W>ROM;?TT_ QE1I<WM&E?O^'_
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M1_P1F_Y1??!G_L!?^UY:_FWK^DC_ ((S?\HOO@S_ -@+_P!KRU\5Q[_N5/\
MQ_HSY_B3^!'U_1G@W_!6+X':M^T?^W%\)_!NCJRW6L:-,DDX7<MI +@F69O9
M5!/N<#O7WE\)/A9H_P $_AMH_A70+9;72=$MEMH$'5L=78]V9LL3W)-(_P *
M])E^+:>-9(6DUR'2?[&BD;E88#+YK;?0LVW)]%%=)7Q&:9[4Q.!PV CI"E'[
MY-MM_).R^?<_)<GX;I8/,<7F<M:E>2U[1222^;3;^78****^?/J HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "N;^+OPLTGXU_#C5O"^N0B;3M7
M@:%^/FB/\,B^C*V&!]17244)M.Z-L-B*N'JQKT).,XM--;IIW37FF?AM\9OA
M-JGP,^*.M>$]87%]H]P8MX&%N(SS'*O^RZD$?6N8K]$O^"QO[.RZ[X,TSXD:
M?;_Z9HK+8:H47F2V<_NY#_N.<9])/:OSMKZC"UO:TU+KU/\ 2/P[XNAQ)D5'
M,M.?X9I=)Q^+Y/22\F@HHHKH/MPHHHH [3Q;^T-XN\<?"G1_ ^I:HLWA?061
M[*R2!(UC90P4L0,L1N;KGDDU8^%7[1_BKX0^$]4\-Z7?*/#/B"0'5=.>%'6\
M0C9(H8@E"R?+N7GH>U<GX<\*:EXONIX-+LKB^FM;:6\E2%=S)#&NZ1R/[JKR
M?:I+#P5J^J>$+[Q!;Z;=3:)ILT=O=7JI^Y@DD^XK'U.*R<*=N5I?\$\6KEN4
MJC+"5*=-0<E)QM%+GE*ZE;^:4M4]W+;4^ZO"_P"V=\*=$E\.ZU;_ !.^)%OH
MOAZW#?\ "&7<3W374RJ0@:X8%F5>,*TA!*@\=*^8_B'^VYXU\6:SXL33K[^R
M_#_BC7#KC:>88Y&BD5XVCRY&<KY4><<$K7E>I>&-1T;2--U"ZLY[>RU='DLI
MG7"W2HVQF3U 8$9]15&LJ>%IQ=]_4^9R+PZR3 U98F*]LWHG/DER\LG+2T5>
M2GO*7-.Z2<M#UC5/VW_B;K-YXBN+CQ$KR^*[--/U0BSB'VB%%=57&/EPLCC(
MYYJU\./VK_$5YX)L/AGXK\2WL/PONMMGJ,5O:12W=O:9W;8G92PP0,#GBO':
M*T^KT[621]!4X4RB5+V4,-".J:<813C**Y82CII*"TB[:6TT/IS]MK]K;PO\
M2OA%X+^&_@&XURZ\->%T1KB[U-=LMVT<?EQ ]VV@L2< 9(P.*^8Z**JE25./
M+$TX>X?PF38)8'!WY;RDW)WE*4FW*4G97;;[+2RZ!1116A[@5]H?\$6O'YTG
MXP^*O#<DC"+6-,2]B7/'F0/M/XE9#_WS7Q?7M'_!/+QFW@;]LKP/<<>7?7;Z
M=(2< +-&R9_/%<^+AS49+R/B/$G*UF/"^.PMKOV<I+UA[Z_&*/V(HHHKY<_S
M6*VLZK#H6CW=]<-M@LX7GD/HJJ6/Z"OY/OB1XLG\>_$?Q%KMU)YUQK6J75])
M)_?,DSOG]:_IZ_;<\;)\./V._BCKDC;5TWPMJ,V?0_9G _4U_+/:1>1:QQ_W
M$"_D*_2_#^C[M:K_ (5^;_R/J^&H:5)^B_,DHHHK]%/J0KW+_@G#XXM/"?[7
M/AW3-5D6/0?'<%UX.U4N?D$&HP-;AF'?9*T3@>J"O#&8(I9B%51DD]JZ/4_
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MS,#A>.>:+,7,GHC3HKS/0OVTO@_XG\7R>'].^*7P]OM<B;8UA!X@M9+@-Z;
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MW@/11KGQ2CT^Z;X33_#B#Q'HUDUT^[^VKD_8$L#*#N)BOUGD([I& >.:X/\
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MX\#Z*T_PET?3KJ.2!WTB&VF1EVO&3"JL"#T(YKHJ**N*=3"PPLEI%)>ME8C
M9/'"XVMC82;=1MV[7;?ZG\TWQ>_X)6?M2_L&?M,3:[X)\%^,-4D\.ZH]WX?\
M2^&+,ZBLB%F\M]B!F5BIPR.F.2.1S7[*_P#!%3XC?'CXH_LS:UJG[0-MXBM?
M%;:](EC'K.DKILWV,0Q;2(@B?+OW\D9SFOL2BMJF83J4?95$F[6OUW7XNVIS
MX/AVEA,4\10G)1;;<;^ZVTU]ROI^84445YY]"%>*?\%%K=;G]BSQ\'!^2P5Q
M@]Q*A%>UUXO_ ,%#_P#DRWX@?]@X?^C$K2C_ !(^J_,^FX+;7$. :_Y_4O\
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M.:ZP^#O!?PP^$/Q(T^3P[J&H7DGA;P[JK73ZGL*O=^6X"KL.T+*2YP?F4A>
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M%%_WU7R?&E!U,L<E]EI_I^IXN?T^;"-]FG^GZGZQ4445^-GPH4444 %?(O\
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M*\'Z?^W+_P '#?Q U?X@6MIK4/A_5=:U2"RNV$D3O93K:VB;&SO6)=K;>@*
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M[B# N%3ZQ#9[^O\ P3WJBBBO@CYP**** "BBB@ HHHH **** "BBB@ HHHH
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MW]IU/J&"?[B+U?\ .UU_PKIW>O8_1S_@W0_Y*S\3/^P39_\ HZ2OOC_@H?\
M\F6_$#_L'#_T8E? _P#P;H?\E9^)G_8)L_\ T=)7WQ_P4/\ ^3+?B!_V#A_Z
M,2N/$_[U\U^A^\> .V5?]?X_^GC\=Z***^@/]> HHHH **** "BBB@ HHHH
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M'BC_ ,@?_&Z/[,J=T'_$8,L_Y\U/_)?_ )(_H%HK^?K_ (>>_M!?]%8\4?\
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MPHHHH **** "J'BGPQ8>-?#6H:/JEK%>Z;JEO):74$B[DFB=2K*1Z$$BK]%
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M/W<Z=4FC/='7# ^A]0:Y.OHU)-71_)]:C.E4=*JK2B[-/=-;H****9F%%%%
M!1110 4444 %%%% !1110 444RX0R6\BK]YE(% 'V+^RW_P3 T7QM^SJOQ;^
M+WQ B^&G@>^.--(C1KB\4DJLA+Y #$':JJS, 3P,50_;"_X)JZ7\(?@18_%K
MX6^.(_B1\-[AUBN[KRU6XL"S; [;< KO(5@55D)&0>M>\_\ !0/P/K7[1_\
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MI_AF?P?J>IS>'++5',EKJ5C?6T!^SSN"QMY5G'+ABI+C)(%=;K/P-\,_%_\
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M*S\3/^P39_\ HZ2OOC_@H?\ \F6_$#_L'#_T8E? _P#P;H?\E9^)G_8)L_\
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M&?\ !0?5O"&M^$_$4O@GP7K'CKP9:1Z=I_B._CG>86J,Q"&!7$._:[KYH4,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>iclr-20231231_g6.jpg
<TEXT>
begin 644 iclr-20231231_g6.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHKQ3W HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'&-S,QPJ@=234>G:E;:Q91W-G<0W5O+RDL+AT?Z$<&@":BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BKUAX=NM0Y6/RT_O/Q6K;>"(U'[
MV9F;N%'%%S6-&<MD>:?'/_DA?CG_ +%S4O\ TEEK^7S2SG3+?_KDO\A7]8OB
M/X3Z3XLT2ZT^^^U26M]!);3HD[1B6-U*LIQV*DC\:^3_ !#_ ,&_'[,NOW$D
MJ^$]8T]W4*HM-:N(TCP,<)NV_I7UW"_$&&RZ-2-=/WK6LD]K^:[GU.0XZG@H
MSC5O[UMO*_H?SXT5^T/QF_X-C/ ^N1W%QX%\>:]X?N-I\BTU")+NV#8XW/\
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M\(^-M6^'D/Q-^#M_;62>)+XFPT6^AN0#',\8Z2C/^K7J>*3]JS]DWQ9\=?\
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MD,IP5/J/>OWX_P""._[8<G[6O[(NGKJMQYWBKP85TC5"?O3*H_<S8_VE&/\
M@!K\WXVR=1:Q]);Z2]>C_1_(^(XJRU1:Q=-;Z2_1_I]Q]64445^>GQ@4444
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M6<G^7+'RTU3OIW?5WREK-6TC^M_77NM;>EDE^<'[0O\ P4,^*7PN.O>+M/\
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M 6LK93<W*YZ91,D9]ZX7_@IS^U;JW[.7P@L-+\*AG\9>-;K^S-,V+N>#/WY
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M8*TLDWW5Y(PIY(Z4VK)-_P!67,U\HZORUV%:[LO+\79?>]%YZ'>45XO\&_\
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M%H_*Z379GYS?L^?!:3XE?';X7[?#7[2DEYX+N!>ZC<>/M8N8])T&1(2A%KN
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M"&C_ +4GQ9^ >@^)=0UBY\,GX87>HW6G07\D,>JLFH3&(38.60'G:>M?8_\
MP63M+?0O^"8_CRUCFFT^QM;>T@\R&0QO;0B:-258<C:N>?:G6BZ<4WNY-?=-
MPN^VJO\ J%.*G4Y(O2R=_6*EIWT>_P#2^JHYXYF98YK>1E^\J2JS+]0#Q1Y\
M/G>7Y]OYO_//SEW_ /?.<U^=?CSP-\+?V8?&7P"\4? W5@WBSQ'J\$&K+IVI
M->S>(]*: O=3729.XJ &W$##&OGG]H'4-"?X%6_QB\*V&A:/JVI>,HIK3Q5K
MGB>2;Q;<9O=A1(8FV1IMROEN!M4#/-5&G>HJ?][E?DVXI/T][R=TU;0F,>:'
M,NL5)?=+?L_=Z7T:9^J6F_M1Z#XC\>_$7PKHMM>:OXD^&MO%-?V,3(AO&ECW
MI'"S'!8@@9/ /6NR\$>*I/%7@?2=8U#3Y?#MQJ5M'/+87T\?G63LH)B=@=K,
MN<$J<<5^=/ASX&_#SP9^U#^V9JFDZ3I=CK5AX86XTR6*4B5!<V0DN'CYY#L<
MDCUKSK0-&\4_'#Q5\*?!^LV/PY\0>%;/X5:3J&B:7XZUB]L=/NIF7$\\9@/[
MV=0!G>?E&".M9T[R@GU:@WVU51NW_@'7\+.]2C'XEMKZ_P#+NWXS_P"'T/UQ
M:6-%RTL*J1D$R* 1Z@YZ5ROQN^-.A_ 'X0Z]XWUZ?=H?AVV-U=-;,)'9=P7"
M@'DY(XK\P_AI\++CXL?%#]G_ ,#>+_$]GXB\*Q^*_$-I!!H&H79LS9)!$38&
M>7#SPJ^5SR,*!VK4^/?P-\)^&/A+^VE\-[32H_\ A"? ::;K6@:5)*\D.CW4
MD<1=XLG*@Y)QTY-36]VFYQ[-KT3C>_G:72ZNK7MJ;8>BI5HTY=TG\Y..GS75
M)I/:ZL?J%X8\6V'BWPGIFM6MQ MCJUK'=V[2RJN4D4,N<GK@\BM-!YC+AEPW
M0@_+^=?F%\3?V=/"6N:C\)M!\)?\*X\2:3IO@2&Z/P^\2ZE/I^GRM*-TE_:7
M*'RS<;RP8.?EP#7UE_P2]\9:+\4/V0[.QT_3M<LM-TB_O-"GLM6OA?M'LD9'
MCCN 2)H "51@?NX':NBI37-44/LMV7DI.-[^J6U][.S5CAC)^SISE]I*_JX\
MVWI?1VVTNM3U#X*?M$^&_CYJ7BZT\/S2O-X*UA]$U$2 #]^J*Y*?WEPPYZ5W
M$<\4Y81S6\K+]X1RJY7Z@'BOR=\+^!=(_9R_9X_:XU?X;V,/A[Q-IOC0:0]W
MISG[=IFCM]G\YHQG("J[G=CC)KUSQ3\,_A=^S3\;/V?=0^ &I0_\)-XNUZ&S
MU:WT[4VN_P#A(-*>)FGGNUR02IVMO.,%C448J:IO^94__ IQ4KVZ1UWZ>\M>
M6[Z,1'DE42^RZEO2#[]^R]'I?3]""P52S,JJO)9F"@?4FFI-')'O6:!X^F]9
M59?S!Q7QM_P6)UGQ0NF_"?P_I<FAQ^$O$WB;[%K_ /;-]<6.FW/R9@@N9H/G
M6%VW9'0D 5\L?%'P+KWPB^!O[0_ARUU3X>^']!D\)V5Q/X;\#ZG?7EKI-RUX
MBI=)+,<0R.."BG^$&L8RYDWV;7S23?X/3?I>R=S2-"\H1O\ %;Y)RY?S5];:
M;.^A^N"31R.RI-!(R_>5)59E^H!R*#<PJY4W%L'7DJ9E#+]1G(K\ZOB?\%]-
M_8R^-_P%UKX6VE]9^*O&GA_58=7F>[DGE\0RIIZ2QM,&)#R>9R#UR:\<^,OP
MR^#]U_P3&\-_$B3Q%-)\9?$>J:<=1U)M6?\ M/4-0>]3S[.:/=D1JP9=A  "
M"MXTTZG)?[2B_5R<59=5I=[/5*QE3CSQC+^9<R]+7=^S[;WU=]#]>)+B&!E6
M2>WB9N@DE5"WT!-$LL<"[I)(85_O22!%_,FORQ_;$@\*?'/5OCQXEAT30-3U
M+P3 =..L>-?$4EJ=&GBM5<#3;6%@ZC)!#$89SZ5TOP0?P[^UE\4_A!X=^-VK
M_P!K>#8_A99:KHUKJ-^8;'6M1.5N996! DFC54X)R,DUG33FM-]'\G&<D_NA
MVZK6VH2BHQYGM9^MTX1:^^>NNB3TOH?I4)$92RR0LJ\EA("J_4YP/QI(IHYT
MW1RPS+TW1R!Q^8)K\<?[7N/"OPH\>^'_ (;Z];ZA\.=4^-J:/J%[K&JW"6+6
M7V5 MO/<Q_O$MO,&S*]E4=Z^H/\ @GM\.]:^#7[9VM:#9W'PNT#P_>>'?M>H
M>%?!6I7VHV<<P?$5T6GRD+M\P(!RP ]*NG%3L^C2:_\ !<:EG\I6TOKJ[+4*
M\'3NGNG;_P G</S5];=KMZ'WA1114$!1110!L>"Y=NI.O]Y/Y5U%<5H=U]DU
M2%S]W=@_C7:U,CT,++W+!7XS?M&^%)O^"F?_  7?B^'^KS--X-^'I6.:V#G9
M);P*LLNT= SRNJMZJ,5^S-?AO\>_&_Q2_P"";?\ P5X^(WQ(T7X;WGBJ/7/.
M33S<0S+:74$Z1$R*\8/*E2N/K7TW"T6ZM;V32J<CY;M+5M+2_6Q[V4)N<^3X
MN5VZ:Z'[?Z;IUIX=TB"TM88;.QL8EBBBC4)'#&HP !T  'Z5^%7_  69_P""
MM_B#]H_XG:Q\-_ NJW6D_#K09WLKR2V?9)K\Z$K(78<^2&! 7OC/I7<?%O\
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M2968?4 YK\T;;P?\,_@?^VG^T9XXO]-;3=2T;P#IFM07.F/MU))[FTE-S-;
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M ,B5X3_[_P '^-?<]%+_ %FI?] 5'_P&7_R0_P#5*M_T,,1_X%#_ .0/A_\
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M\/-2\(Z/\/?">F^%]88-?Z5!8*MK>D$$>8O\6" >?2O0**-KVZ[AS/3RV\C
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ML::K>QPA9]16,%4$K?Q!02!GH":VJ*;;>_G^._W]>XEIHNEOPV^[IV.!U_\
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MX5O+A[N?27LE-I+.[;GE*?WV;DGJ37:JZO\ =9&QP=K X/OZ4M.7O;_UK?\
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MH*^//%5KL\4:M#BPMI%^;38&ZD^DCCKZ"MN)N(*.48)XB>LGI&/=_P"2W?\
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M\5_MC_%CXV6GQ*N_A9\/_"FM?#SP7+>:+<WNJZG-;ZIK,\,?[_[(B_NU5<@
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M_)$]'+HM_P CWJBN#\8?M2_#+X>>.[?PMK_Q"\'Z+XFNBHBTN\U..*ZD+?=
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M*^5Q>.Q&*ESXB;D_/].B^1\_B,56KRYJTG)^84445RG.%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !114]OIEQ=?ZN&1AZA>*!I-[&5XJ_Y%/5O^O&?_ -%M7XR:I_R%+K_KL_\
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M['\;^+?@-]0ISSGAN+=)7<Z6[BNLH=7%=8N[6ZNM%]D44$;317FG\KA1110
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MDTI?>FFN^J=MW^I6]#C][#\W3]XO/TYHW*20'C8KU <$K]1VK\*K#X.V;?\
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M:ZQ4N52\E+5K?IWTC5>[)>\FDUV;3;5^K5EZW>W*T_=J***R **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ H)"@EB%51DDG  H)"J68A549)/0"
MO/-,T_4/VGO$4UK:32V/P\T^3R[N[C)677)%/,49ZB('AF'7H*3=C2G3<W9$
M\OQ$UKXF:O-I/P_L[>\\AO+NM<N\_P!GVA[A,<RN/0<>M=1X6_92T6*]CU+Q
M3=77C'6%.[S=0.;>$_\ 3.$?*N/SKTCP]X=L?"FC6^GZ;:PV5E:H$BAB7:J
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MHJG+9+2R45;LK67HK+\]Q7;;;ZN[]==?Q:\EIL%%%%2 4444 %%%% !1110
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M*_;"U:/0=)TB[\*Z/ IEN))]\:R$?=WM_)1]:BGD>(O>O:$>K;6GR3-J_&N
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M;>SN[:XU:;6[@:B9(9VC:6R1!]WY1@R8R2:^X_V=-7\<ZK^R[X;O->M?#O\
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MK#'&[,L<2-)R[*@5G^I')_&AH8WD5VCB:2/[CL@+)]#U'X5R'P[_ &B?A_\
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M71_@_P"-O!_B?PYJFD-JNIZEI)M-*\/)8E?-FM[H@),6VD*(R20U>E_\$_\
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M (_? ;7--N/&G@VXU*UMGNM-F34H7GAG0%EV8;.6QMQWS1S+V_-RNVWX6O\
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MYR/"69X6DL#@<3^YDTY-Z2CK[W)96M)?9>B.0_9*_9-L_@_HMKK&M6<3>+)
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M]6T#Q0_Q&U716UUY(WU*".%GC ,@.QI]J[2XX)R17J7[1OQV^('_  38\?\
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ME?*_CW_@F3XP^*_G>$6^%U]X5M[[7EOIM:B\:BY\)V$:S^<;FSTLMYL=PV.
M5V@LQK],**J,G&HJG5._S33OWW6O?J-3:BTNO7Y->G5V[' ^#_V:/"7@3Q/X
MYUC3K>^6_P#B,B1ZX\EVSK.$@$ \M>D?[L8X[\UI?!3X)^'?V??A-I/@CPU;
M7$7AW186M[:"ZG-P^QB2P9VY;.3U[5UE%3TMY)?)7LOE=V]2?Z_K[D?/>B?\
M$N_A!H'CRWUR'3_$<EK9ZB=7M?#\VMS2>'[6[+%O.CLC^[5@Q+#T)S5SXO\
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M)R?\ .PJC117O;:(_LZG",(J$%9+1);)+9(=;V\EW<1PPQM+-,P2-%&6=B<
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MIO$G_!-KX6^*];\<WEW#XI6'XC7L6I:W80ZY+'8RW4<L<HFCA VQN6B3)'4
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MEUK;?6%%[>3YUY.+6[=_6M%_X*?Z/J-[I.IWGP[\<:3\.=>ODT_3O&UTUO\
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>iclr-20231231_g7.jpg
<TEXT>
begin 644 iclr-20231231_g7.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M*I4[U.&5E/((]#63X=_;.^'/BK]IG5_A#8>(K:?Q_H=HMY>:: <QQD \-T+
M$$@<C-?F/_P3N_:,M_\ @DA^T1^T1\$_&EXEOX8T2WN/&'A9YFVK<J%W+''Z
M^8A3&.I4U\E_"RX^*'P+\7>!OVY-6GFETWQGXYGCU"+:=QM9'*L6/_/-ERH[
M?NZ:P*N]?3S)EGS4(.UW?WO)+<_?+]IS]K[P!^Q[X5TS6?B#KT>AV.L:A'IE
MHS(7::=S@  <X'<]!5?X5_MJ_#;XS?&OQ-\._#WB:UO_ !=X05&U*PP4>-6
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ME$*O!!A?)3D_=9LGG^5=!^R7^RQX/^ /[:'QJ^+#?$[P[K4'Q.E4/IA:./\
ML\J0Y4L6_>9!].]?0=U^Q[\-M3\+6NAW7A33[K3+25YH892[>4[D%B"3D9/O
M58_L4?"^.:W;_A$=/:2S4K"Y+[H^,9!SU]_6E[;FN[N["& 4(QC&*Y8ZK<^=
M/V1/^";7PO\ @5_P49\9?%KX>^,K&9-<TMX9?"UIL>/3WG=6DD1U.=A*9"X^
M4DBON,=*X;P!^SSX-^&&O+J>@Z#9Z9J"P&T\^+.]HBV\HQ)Y&XD\]Z[BLJDW
0.5[W.["T%2ARI6N[Z'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>iclr-20231231_g8.jpg
<TEXT>
begin 644 iclr-20231231_g8.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MBEMHC.)V>60L0[;A@8 P*\Q\7_L:_%QHOB3HOAOQ_P""['PE\1-4O-0E@OM
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5\H 8[>E.HH :(U4<#%'EK3J* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>iclr-20231231_g9.jpg
<TEXT>
begin 644 iclr-20231231_g9.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M 1ONUE>+_$4?A30+B_E5F6W7A%ZNQX ^I)Q6JQP*P_'WA[_A*O#%S9"3R9)
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KFQZ7 P>/*D,.Q!XI]9_AO0+7POH]OI]C%Y-I9H(XDR3M'U/-:%<IZQ__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !V ;(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]^***"<=J
M "L/XA_$GP#\)_"MSXW^)?C#3M#TFT7-QJ&IW2Q1K[98\D]@,D]A7B/[>W_!
M1WX0_L.^%%AU3R]=\87T>=)\+6MP%?'_ #VG;GRHAZX+,>%!Y*_BW^T[^U_\
M>_VN_&#>+/C1XVGO(XY&;3='MV:.QT]2?NPPY(7C +G+L -S-BO3P.65<7[S
MTCW[^A^9<;>)N5<*2>%HKVN)_E3]V/\ C??^ZM>]KIGZ-?M*_P#!P'\+O".H
M77AO]F;X=3>*YH6*1^(-;9[6Q=L?>CB'[Z10?[WE$\XXP3\3_%O_ (*S?MX_
M%Z_FGO?CA=Z%:RL3'IOA>%;&&%3_  JRYE8#U=V/O7S?17T='+L'0^&-WW>I
M_.6=>(G%V>2?ML3*$7]FF^2*\M-6O\39N>,/B=\2OB'/]I\??$'7-<DSGS-8
MU::Y;\Y&-8>:**[.5)61\94J5*LG.;;;ZO5G:>!?VD/V@OADT?\ PK[XV^*M
M'6-LK#I^O7$<?XH'VG\17T;\"O\ @MU^VQ\);R.#QKX@T_QWI:X$EGXBLPLX
M7/.RXAV.&/J_F ?W:^/J*RJ87#UOCBG\CU\MXDS[)YJ6#Q4X6Z*3M\X[->33
M1^VW[*?_  6I_97_ &A)X?#'Q!NI/A_X@DVJEOKTP:RN6/:.Z&%7Z2B/KQNY
MK[$@GAN85N+>59(Y%#1R(V593T(/<5_,+7U5^P?_ ,%6OCE^Q[?V?@[Q!=3>
M*O 2GRYO#]],6EL8\_>LY"?W9!_Y9MF,C(PI(8>)B\E5G*@_D_T?^?WG[7PG
MXU5/:1PV>Q33T]K%6:\YQ6C7=QM;^5[G[I45Q/[/_P"T'\*_VFOAC8_%CX0>
M)$U+2[Y<.O"S6LV 6@F3)\N1<@%>1W!(()[:OGY1E"3C)6:/Z%P^(H8JA&M1
MDI0DDTT[II[-,**"<=J\I_:Z_;$^#O[&7PS?XA_%?5F\R?='HVBVN&NM3F&/
MDB4D<#(+.2%4=3D@$A"522C%7;(QF,PN7X6>)Q,U"G!7<F[)+^MN[T1Z9K6M
MZ/X<TFYUWQ!JMO8V-G"TUU>7DRQQ0QJ,EV9B H ZDG%?#_[4?_!=C]G/X07\
MWA7X&:)<?$#5(01)?P2_9M,B?^Z)6!>4COL39@\.3D#\Z_VU?^"B_P ?OVU=
M?FA\7:RVD>%$N-^F^$--F86T04_(TIX,\O<NW&?NJHXKP&OH\+DL(KFKN[[+
M;[S^=.*O&K&5JDJ&1QY(_P#/R2O)^<8O2*_Q)OR3/JKXU?\ !9?]NSXOZA(^
ME_$>#P?I[<1Z9X3LEA"CWFDWS,<=?G ST4=*^??&WQP^-'Q*9C\0_BUXDUP-
MU75M<GN%^@#N0![#BN7HKV:>'HT?@BE\C\9S#/L[S:3EC,3.I?\ FDVODKV2
M\DK!73>"?C1\8/AHX;X=_%/Q%H7S;MND:U/;@GW$; 'CUKF:*T<8R5F>;3K5
M:,U.G)Q?=.S^]'U)\&/^"QG[=WP?U"&2[^**>+-/C;]YI?BRS6X60=/]:NR9
M>.F'QGJ#7W-^R]_P7B_9[^*E[!X6^/GAVX\ ZE,H5=4,ANM-=^!M+J/,ASZL
MI0#JX[_CK17%7RW!UUK&S[K0^XR/Q*XNR.:Y,0ZD/Y:EYKTNWS+Y-']-WAWQ
M'H'BS1+7Q'X7UNUU+3[R(26E]8W"RQ3(>C*RDAA]#5ZOY]_V-?\ @H1^T'^Q
M;XCAD\!>(9-0\-R7&_5/".I3,UG<J?O%!R8)#U\Q,'(&X,/E/[5?L=_MJ_!O
M]M/X<IXX^&6J>3?6ZJ-:\/74B_:]-E/\+J/O(<';(/E8>AR!\UC<MK8/7>/?
M_,_I'@OQ&R?B^/L;>RQ"5W!O?NX/[2\M)+M;4]>HH!R,XH->>?H84A8+UK ^
M)OQ1\ _!OP1?_$;XF^*+31]%TV'S+R^O)-JH.P'=F)X"C)). ":_'?\ ;\_X
M+&_%S]I6]O/AY\#KN^\'^!_GAD:";R]0U9#QNFD4YBC('^J0\ACO+< =F#P-
M;&2M'1=6?'\7<;9-P?A5/%/FJ2^&G'XI>;_ECW;^2;T/O_\ :R_X*[_LG_LN
MR7'ANTUZ3QIXFAD,;:'X;D61;=AG_7W!_=Q\\%5+N#_!CFO@#X^?\%T_VPOB
ME-)I_P ,#I?@'2VR%72[<7-XZG^_/." ?0QHA'J:^*\<YHKZ;#Y5A:&K7,^[
M_P MC^:.(/%3BS/).-.K["F]HT]'\Y_$_.S2?8[[Q[^U5^TM\4#*OQ ^/7B[
M58Y@1+;W6O3F%@>H\L,$_2N"=WD<R2.69CEF8Y)I**]",(Q5HJQ^>8C%8G%5
M.>O-S?>3;?WLUO"WCSQSX%NQJ'@CQGJVCW ;(GTO49;=P?7,; U[3\+?^"HG
M[=OPDNH)=!_:%UG4((2,V?B%EU"*1>ZMYX9N?4,&]"*\ HJ9T:53XXI^J.K
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MG;M.U#\_C<IJ8=.=+6/XK_,_H'@OQ<R_/JL<'F451KO1-?!)]E?6+?1-M/\
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M@U\/[/PK^Q*WBU+8+<^)?%-Y<S2[1N9(MD"#/7 \ML#L6;UK[78@<D5\L?\
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M\>V>CZ>K*S>'?#=Q]HNYAW62<KY<7_ /,R#U4UZE3,,'3C=S3]'=_@?E^7\
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M!/C)KM]\2OV8=?L?".MWA,MUX?OHV_LNYE_B9"@9K8GJ0JLF>BKDFOAWQ/\
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MJI'K^'D<O$F0XSAK.*N Q"UB]'TE%_#)>37W.ZW05]X?\$JO^"K\W[-OV;X
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M /P6@_X*'?#G]I^[T?X!_!/4FU/P_P"&]4:_U37%4""^O1&T2"#NT:))(-Y
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M\,85(HU&%55&     !P!1I>DZ9HFFV^C:-IT%I9V<*PVMK:PK''#&H 5$50
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MRZD$=O:VL+222N>BJJ@DD^@H!)R=D5Z^E/\ @G=_P3F^(O[;WCR.]NX;C2/
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M^";7_!/#PC^PY\.FNM8-KJGCK6X5.OZW'#Q"G!%I 3R(E(R3QO8 D<*!]-
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<510,!0!P !P *DHHKR3]8VT04444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416989072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-08704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICON PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICLR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock, shares outstanding (in shares)</a></td>
<td class="nump">82,495,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filler Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001060955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Brendan Brennan<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">Brendan.Brennan@iconplc.com<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">291-2000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415554208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor firm ID</a></td>
<td class="text">1116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor name</a></td>
<td class="text">KPMG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor location</a></td>
<td class="text">Dublin, Ireland<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415964624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 378,102<span></span>
</td>
<td class="nump">$ 288,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">1,954<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses (Note 4)</a></td>
<td class="nump">1,790,322<span></span>
</td>
<td class="nump">1,731,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled revenue (Note 4)</a></td>
<td class="nump">951,936<span></span>
</td>
<td class="nump">957,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Other receivables</a></td>
<td class="nump">65,797<span></span>
</td>
<td class="nump">63,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">132,105<span></span>
</td>
<td class="nump">137,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">91,254<span></span>
</td>
<td class="nump">48,790<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,411,470<span></span>
</td>
<td class="nump">3,229,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (Note 9)</a></td>
<td class="nump">361,184<span></span>
</td>
<td class="nump">350,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 10)</a></td>
<td class="nump">9,022,075<span></span>
</td>
<td class="nump">8,971,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net (Note 11)</a></td>
<td class="nump">3,855,865<span></span>
</td>
<td class="nump">4,278,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets (Note 15)</a></td>
<td class="nump">140,333<span></span>
</td>
<td class="nump">153,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other receivables</a></td>
<td class="nump">78,470<span></span>
</td>
<td class="nump">70,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset (Note 20)</a></td>
<td class="nump">73,662<span></span>
</td>
<td class="nump">76,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investments in equity-long term (Note 8b)</a></td>
<td class="nump">46,804<span></span>
</td>
<td class="nump">32,631<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">16,989,863<span></span>
</td>
<td class="nump">17,185,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">131,584<span></span>
</td>
<td class="nump">81,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (Note 4)</a></td>
<td class="nump">1,654,507<span></span>
</td>
<td class="nump">1,507,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities (Note 12)</a></td>
<td class="nump">915,399<span></span>
</td>
<td class="nump">1,005,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">13,968<span></span>
</td>
<td class="nump">41,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Current bank credit lines and loan facilities (Note 13)</a></td>
<td class="nump">110,150<span></span>
</td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,825,608<span></span>
</td>
<td class="nump">2,690,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Non-current bank credit lines and loan facilities (Note 13)</a></td>
<td class="nump">3,665,439<span></span>
</td>
<td class="nump">4,599,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities (Note 15)</a></td>
<td class="nump">126,321<span></span>
</td>
<td class="nump">131,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Non-current other liabilities (Note 16)</a></td>
<td class="nump">45,998<span></span>
</td>
<td class="nump">38,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Non-current income taxes payable</a></td>
<td class="nump">186,654<span></span>
</td>
<td class="nump">239,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability (Note 20)</a></td>
<td class="nump">899,100<span></span>
</td>
<td class="nump">988,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">7,749,120<span></span>
</td>
<td class="nump">8,687,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 82,495,086 shares issued and outstanding at December 31, 2023 and 81,723,555 shares issued and outstanding at December 31, 2022.</a></td>
<td class="nump">6,699<span></span>
</td>
<td class="nump">6,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">6,942,669<span></span>
</td>
<td class="nump">6,840,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherUndenominatedCapital', window );">Other undenominated capital (Note 18b)</a></td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss (Note 25)</a></td>
<td class="num">(143,506)<span></span>
</td>
<td class="num">(171,538)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">2,433,719<span></span>
</td>
<td class="nump">1,821,384<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">9,240,743<span></span>
</td>
<td class="nump">8,497,963<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 16,989,863<span></span>
</td>
<td class="nump">$ 17,185,278<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherUndenominatedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other undenominated capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherUndenominatedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418512352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8364; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in EUR per share)</a></td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">82,495,086<span></span>
</td>
<td class="nump">81,723,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">82,495,086<span></span>
</td>
<td class="nump">81,723,555<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415920752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,120,176<span></span>
</td>
<td class="nump">$ 7,741,386<span></span>
</td>
<td class="nump">$ 5,480,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Direct costs (excluding depreciation and amortization)</a></td>
<td class="nump">5,719,949<span></span>
</td>
<td class="nump">5,527,045<span></span>
</td>
<td class="nump">3,972,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">768,559<span></span>
</td>
<td class="nump">778,753<span></span>
</td>
<td class="nump">585,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">585,950<span></span>
</td>
<td class="nump">569,513<span></span>
</td>
<td class="nump">314,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="nump">44,176<span></span>
</td>
<td class="nump">39,695<span></span>
</td>
<td class="nump">198,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring (Note 19)</a></td>
<td class="nump">45,390<span></span>
</td>
<td class="nump">31,143<span></span>
</td>
<td class="nump">31,105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">7,164,024<span></span>
</td>
<td class="nump">6,946,149<span></span>
</td>
<td class="nump">5,102,297<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">956,152<span></span>
</td>
<td class="nump">795,237<span></span>
</td>
<td class="nump">378,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">5,014<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (Note 13)</a></td>
<td class="num">(336,699)<span></span>
</td>
<td class="num">(229,731)<span></span>
</td>
<td class="num">(182,423)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Income before income tax expense</a></td>
<td class="nump">624,467<span></span>
</td>
<td class="nump">567,851<span></span>
</td>
<td class="nump">196,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (Note 20)</a></td>
<td class="num">(11,749)<span></span>
</td>
<td class="num">(59,411)<span></span>
</td>
<td class="num">(41,334)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest', window );">Income before share of losses from equity method investments</a></td>
<td class="nump">612,718<span></span>
</td>
<td class="nump">508,440<span></span>
</td>
<td class="nump">155,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of losses from equity method investments</a></td>
<td class="num">(383)<span></span>
</td>
<td class="num">(3,136)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per ordinary share (Note 24):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 7.46<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 7.40<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of ordinary shares outstanding (Note 24):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">82,101,813<span></span>
</td>
<td class="nump">81,532,320<span></span>
</td>
<td class="nump">67,110,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">82,717,640<span></span>
</td>
<td class="nump">82,468,363<span></span>
</td>
<td class="nump">68,068,311<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411795728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">26,221<span></span>
</td>
<td class="num">(89,530)<span></span>
</td>
<td class="num">(60,617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain on defined benefit pension plan</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">12,657<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain/(loss) on cash flow hedge</a></td>
<td class="nump">1,567<span></span>
</td>
<td class="num">(3,728)<span></span>
</td>
<td class="nump">778<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">$ 640,367<span></span>
</td>
<td class="nump">$ 424,703<span></span>
</td>
<td class="nump">$ 97,725<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414938272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Undenominated Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,788,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,850,236<span></span>
</td>
<td class="nump">$ 4,580<span></span>
</td>
<td class="nump">$ 617,104<span></span>
</td>
<td class="nump">$ 1,134<span></span>
</td>
<td class="num">$ (35,477)<span></span>
</td>
<td class="nump">$ 1,262,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">153,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(60,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain on defined benefit pension plan</a></td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain on cash flow hedge</a></td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">97,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">118,589<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">118,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">133,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issue of shares associated with a business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Repurchase of ordinary shares</a></td>
<td class="nump">5,658,155<span></span>
</td>
<td class="nump">$ 1,960<span></span>
</td>
<td class="nump">5,656,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Replacement share-based awards issued to acquiree employees</a></td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,554,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">8,066,827<span></span>
</td>
<td class="nump">$ 6,640<span></span>
</td>
<td class="nump">6,733,910<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="num">(90,937)<span></span>
</td>
<td class="nump">1,416,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">505,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(89,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain on defined benefit pension plan</a></td>
<td class="nump">12,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain on cash flow hedge</a></td>
<td class="num">(3,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">424,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">35,828<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">35,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">70,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(420,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(99,983)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">81,723,555<span></span>
</td>
<td class="nump">81,723,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 8,497,963<span></span>
</td>
<td class="nump">$ 6,649<span></span>
</td>
<td class="nump">6,840,306<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="num">(171,538)<span></span>
</td>
<td class="nump">1,821,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">612,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">26,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain on defined benefit pension plan</a></td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain on cash flow hedge</a></td>
<td class="nump">1,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">640,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">50,958<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">50,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">51,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">82,495,086<span></span>
</td>
<td class="nump">82,495,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 9,240,743<span></span>
</td>
<td class="nump">$ 6,699<span></span>
</td>
<td class="nump">$ 6,942,669<span></span>
</td>
<td class="nump">$ 1,162<span></span>
</td>
<td class="num">$ (143,506)<span></span>
</td>
<td class="nump">$ 2,433,719<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Retained Earning Share Repurchase costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdjustmentToRetainedEarningShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415353456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">585,950<span></span>
</td>
<td class="nump">569,513<span></span>
</td>
<td class="nump">314,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived assets</a></td>
<td class="nump">8,686<span></span>
</td>
<td class="nump">28,767<span></span>
</td>
<td class="nump">20,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Reduction in carrying value of operating right-of-use assets</a></td>
<td class="nump">41,546<span></span>
</td>
<td class="nump">45,215<span></span>
</td>
<td class="nump">45,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
<td class="nump">2,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition-related gain</a></td>
<td class="num">(6,160)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Charge on cash flow hedge</a></td>
<td class="nump">2,407<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">17,749<span></span>
</td>
<td class="nump">12,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">55,667<span></span>
</td>
<td class="nump">70,523<span></span>
</td>
<td class="nump">133,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_GainLossOnIssuanceOfDebt', window );">Loss on issuance of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">59,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax benefit</a></td>
<td class="num">(85,403)<span></span>
</td>
<td class="num">(124,985)<span></span>
</td>
<td class="num">(60,616)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange movements</a></td>
<td class="nump">19,706<span></span>
</td>
<td class="num">(13,009)<span></span>
</td>
<td class="num">(6,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">24,332<span></span>
</td>
<td class="nump">11,324<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(83,296)<span></span>
</td>
<td class="num">(420,695)<span></span>
</td>
<td class="nump">113,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Unbilled revenue</a></td>
<td class="nump">4,716<span></span>
</td>
<td class="num">(332,592)<span></span>
</td>
<td class="num">(17,656)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">134,566<span></span>
</td>
<td class="nump">192,944<span></span>
</td>
<td class="num">(69,121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other net assets</a></td>
<td class="num">(170,810)<span></span>
</td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">108,259<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,161,027<span></span>
</td>
<td class="nump">563,315<span></span>
</td>
<td class="nump">829,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(140,692)<span></span>
</td>
<td class="num">(142,160)<span></span>
</td>
<td class="num">(93,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="num">(71,766)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,914,475)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment in equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Loan to equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sale of available for sale investments</a></td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of available for sale investments</a></td>
<td class="num">(2,857)<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Proceeds from investments in equity - long term</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchase of investments in equity - long term</a></td>
<td class="num">(13,954)<span></span>
</td>
<td class="num">(5,612)<span></span>
</td>
<td class="num">(4,077)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(226,653)<span></span>
</td>
<td class="num">(145,867)<span></span>
</td>
<td class="num">(6,024,235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,328)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">5,905,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and facilities</a></td>
<td class="num">(1,265,000)<span></span>
</td>
<td class="num">(875,000)<span></span>
</td>
<td class="num">(877,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of equity compensation</a></td>
<td class="nump">50,973<span></span>
</td>
<td class="nump">35,844<span></span>
</td>
<td class="nump">118,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(853)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(99,983)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_PaymentsForShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in)/provided by financing activities</a></td>
<td class="num">(844,043)<span></span>
</td>
<td class="num">(864,173)<span></span>
</td>
<td class="nump">5,114,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate movements on cash</a></td>
<td class="num">(997)<span></span>
</td>
<td class="num">(16,720)<span></span>
</td>
<td class="num">(7,727)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase/(decrease) in cash and cash equivalents</a></td>
<td class="nump">89,334<span></span>
</td>
<td class="num">(463,445)<span></span>
</td>
<td class="num">(88,092)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">288,768<span></span>
</td>
<td class="nump">752,213<span></span>
</td>
<td class="nump">840,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">$ 378,102<span></span>
</td>
<td class="nump">$ 288,768<span></span>
</td>
<td class="nump">$ 752,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_GainLossOnIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_GainLossOnIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_PaymentsForShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Share Repurchase Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_PaymentsForShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631502054928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of business</a></td>
<td class="text">Description of Business <div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development serv</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ices on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2023 we had approximately 41,100 employees, in 106 locations in 53 countries. During the year ended December&#160;31, 2023, we derived approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ly 40.4%, 48.7% and 10.9% </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419340352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant accounting policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination and income taxation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short-term debt or equity as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by Level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The changes in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses, other than temporary, which reduce the carrying amount below cost are recognized in the Consolidated Statement of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts charged/(credited)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value Measurements ("ASC 820")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Any increases or decreases in fair value are recognized in earnings in the period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 - 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2023 and December&#160;31, 2022, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for these plans in accordance with ASC Subtopic 715-30, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans &#8211; Pension</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 718")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounting pronouncements, effective for the year ended December 31, 2023, did not have any significant impact on the Company&#8217;s consolidated financial statements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following accounting pronouncements have been issued, but not yet adopted, as of December 31, 2023:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting &#8211; Improvements to Reportable Segment Disclosures </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(&#8220;ASU 2023-07&#8221;), which amends the guidance in ASC Topic 280,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis. Furthermore, all disclosures about a reportable segment&#8217;s profit or loss, which are currently required annually, will be mandated for interim periods. The additional disclosures required by ASU 2023-07 apply to entities with a single reportable segment. The amended guidance is effective for fiscal periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with retrospective application required. The Company is currently evaluating the impact of this ASU on disclosures within its consolidated financial statements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">which requires disaggregated information about an entity&#8217;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418455264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,453,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,012,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,120,176</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,742,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:44.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(702,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152,777)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and December&#160;31, 2022 were $333.0&#160;million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$406.3&#160;million (see</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2023 decreased by $5.7 million as compared to December&#160;31, 2022. Unearned revenue increased by $147.1 million over the same period resulting in an increase of $152.8 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2022 and December&#160;31, 2023. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Company's receivables and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">unbilled services was $24.6&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and $17.8&#160;million for the year ended December&#160;31, 2023 and 2022, respectively.</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$14.8 billion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.7&#160;billion as of December&#160;31, 2022. As of December&#160;31, 2023 the Company expects to recognize revenue on approximately 52% </span>of the unsatisfied performance obligation over the next twelve months compared to 52% as of December&#160;31, 2022, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419297344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Contract Balances</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,453,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,012,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,120,176</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,742,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:44.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(702,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152,777)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and December&#160;31, 2022 were $333.0&#160;million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$406.3&#160;million (see</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2023 decreased by $5.7 million as compared to December&#160;31, 2022. Unearned revenue increased by $147.1 million over the same period resulting in an increase of $152.8 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2022 and December&#160;31, 2023. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Company's receivables and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">unbilled services was $24.6&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and $17.8&#160;million for the year ended December&#160;31, 2023 and 2022, respectively.</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$14.8 billion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.7&#160;billion as of December&#160;31, 2022. As of December&#160;31, 2023 the Company expects to recognize revenue on approximately 52% </span>of the unsatisfied performance obligation over the next twelve months compared to 52% as of December&#160;31, 2022, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419464480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesTextBlock', window );">Allowance for Credit Losses</a></td>
<td class="text">Allowance for Credit Losses<div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December&#160;31, 2022 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,533&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//310/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419216320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">BioTel Research LLC Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#8220;BioTel&#8221;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$68.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Cash acquired amounted to $1.4&#160;million. The purchase price allocation, as of the date of acquisition, was based on a preliminary valuation and may be subject to revision. Preliminarily, the BioTel acquisition resulted in the initial recognition of intangible assets of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$36.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> and goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$23.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Preliminary g</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">oodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of BioTel and the expected synergies of the acquisition. The goodwill recognized is deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Oncacare Limited Acquisition</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare") for $5.1&#160;million, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$13.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and also gave rise to an acquisition-related gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$6.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The combined company has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">ASC Topic 805</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The combined company has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received, per share, $80 in cash and 0.4125 shares of ICON stock. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Company incurred Merger-related expenses of $44.2 million, $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 the Company incurred approximate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ly $16.4 million, $17.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> and $86.7 million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:84.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, <br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,048)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(204,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151,098)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December&#160;31, 2022, the Company incurred a $2.2&#160;million amortization expense which related to the year ended December&#160;31, 2021 due to the timing of the measurement period adjustment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419307104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short maturities of these instruments. </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of the interest rate caps and the interest rate swap. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2023, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $12,878.0 million (December&#160;31, 2022:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $13,250.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and are identified as Level 3 assets. These assets are comprised of goodwill of $9,022.1 million (December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$8,971.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and intangible assets of $3,855.9 million (December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$4,278.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $3,793.5&#160;million at December&#160;31, 2023 (December 31, 2022: $4,650.3&#160;million). The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value, due to the short term duration.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419137264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Available for sale investments (short-term)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at December&#160;31, 2023, the Company held $2.0 million of available for sale investments (December&#160;31, 2022: $1.7 million). Short-term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. The Company classifies its short- term investments as available for sale.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short term investments at December&#160;31, 2023 have an average maturity of 3.6 years compared to 2.8 years at December&#160;31, 2022. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company's practice and intention in respect of these investments. The Company recognizes the unrealized losses in equity as these unrealized losses on short-term investments have been considered as temporary.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Available for sale investments (long-term)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. During the year ended December&#160;31, 2023, capital totaling $14.0 million (December&#160;31, 2022: $3.7 million) had been advanced under the terms of the subscription agreements. The Company determined that the interest in funds meets the definition of equity securities without readily determinable fair values. The Company therefore concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820. </span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was an increase in fair value of $0.2 million (December&#160;31, 2022: $6.3 million) recognized in net income during the year bringing the carrying value of the subscriptions to $46.8 million at December&#160;31, 2023 (December&#160;31, 2022: $32.6 million).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span>December&#160;31, 2023, the Company had committed to future investments of $66.4 million in respect of these funds.<div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160; Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 24, 2020, the Company obtained a 49% interest in the voting share capital of Oncacare in exchange for consideration of $4.9&#160;million. At that time, the Company&#8217;s investment in Oncacare was accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare. The Company recorded its pro rata share of the earnings/losses of this investment in 'Share of losses in equity investments' in the Consolidated Statement of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded losses of $0.4 million, $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of </span></div>Oncacare, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419262064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, net</a></td>
<td class="text">Property, Plant and Equipment, net<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">781,067&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,493&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(419,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,184&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The depreciation expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$126.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$106.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and $75.5 million for the twelve months ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2023 and the year ended December&#160;31, 2022, certain fully depreciated assets were written off as they were no longer used by the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419435936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,022,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no goodwill impairment losses for the years ended December&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419257344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,090,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,147,971&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,855,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The amortization expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$459.9 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$463.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and $239.5 million for the twelve months ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#8220;BioTel&#8221;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$68.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> The acquisition resulted in the recognition of intangible assets of $36.4 million, comprising  customer relationships of $12.5 million, order backlog of $3.9 million and technology assets of $20.0 million. These assets will be amortized over their expected useful lives of between 3 and 16 years. In total, $1.5 million has been amortized in the period since the date of acquisition.&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0&#160;million, Order backlog of $500.0&#160;million, Trade names of $202.0&#160;million, Patient database of $168.0&#160;million and Technology assets of $111.0&#160;million. These assets are being amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets was finalized in June 30, 2022. In total, $1,128.5&#160;million has been amortized in the period since the date of acquisition, $451.4&#160;million has been amortized in the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2024 to December 31, 2028 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419186752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities</a></td>
<td class="text">Other Liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">915,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f $333.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> at December&#160;31, 2023 and $406.3 million at December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419122176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Bank Credit Lines and Loan Facilities</a></td>
<td class="text">Bank Credit Lines and Loan Facilities<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2023 and 2022:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,251,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,696,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,665,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2023,  December&#160;31, 2022 and December&#160;31, 2021 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Company expensed $16.4 million, $17.7 million and $86.7 million of transaction related financing costs, inclusive of the amortization of financing fees which were previously capitalized, associated with the debt facilities used to finance the Merger. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of merger related financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Includes costs associated with the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,030,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger").  In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million (the "Senior Secured Credit Facilities"). The Senior Secured Credit Facility and Senior Secured Notes were issued at a discount of $27.6&#160;million. On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the applicable margin is 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. As at December&#160;31, 2023, $445.0&#160;million remained undrawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2023 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $7.9&#160;million (December&#160;31, 2022: $7.8&#160;million)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">drew down $370.0&#160;million (December&#160;31, 2022: $75.0&#160;million) of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility and repaid $315.0&#160;million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2022: $75.0&#160;million) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as shown below. As at December&#160;31, 2023, $55.0&#160;million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$nil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">was drawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div>The estimated fair value of the Company&#8217;s debt was $3,793.5&#160;million and $4,650.3&#160;million at December&#160;31, 2023 and December&#160;31, 2022, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value due to the short term duration.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419518016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as cash flow hedges.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps expire on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%. </span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap begins accruing on December 31, 2024 and the interest rate swap expires on September 30, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2022 Caps and the 2022 Swap are designated as cash flow hedges. G</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ains and losses are initially reported as a component of other comprehensive income/loss and subsequently recognized in net income.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">      The fair values of the Company&#8217;s derivative financial instruments, on a gross basis, are summarized in the following table:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,100,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,201,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the Company recognized a current derivative liability of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.9 million within <span style="-sec-ix-hidden:f-957">other liabilities</span> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3.3 million within <span style="-sec-ix-hidden:f-959">other liabilities</span> and $0.01 million within <span style="-sec-ix-hidden:f-961">other receivables</span></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and a non current derivative liability of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$0.5 million (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December 31, 2022: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$0.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">within <span style="-sec-ix-hidden:f-964"><span style="-sec-ix-hidden:f-965">non-current other liabilities</span></span>. </span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> the year ended December&#160;31, 2023, the Company recognized a gain of $1.6 million within other comprehensive income/loss (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: $3.7 million loss) after a reclassification of $2.4&#160;million from other comprehensive income/loss to the income statement (December 31, 2022: $0.1&#160;million).</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> the next 12 months, the Company estimates that an additional $3.2 million will be reflected as interest expense in the consolidated statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419177344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating Leases<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $45.7 million incurred in the year ended December&#160;31, 2023, $37.9 million is recorded within selling, general and administration costs and $7.8 million is recorded within direct costs. Of the total cost of $52.7 million incurred in the year ended December&#160;31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9&#160;million incurred in the year ended December&#160;31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, during the years ended December&#160;31, 2023 and December&#160;31, 2022 totaled $37.7 million and $28.7 million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $8.7 million, $24.8 million, and $15.4 million, respectively, as part of an office consolidation program (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 19 - Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2023 were 6.72 years and 3.29%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2022 were 6.90 years and 2.45%, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2023 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental <br/>payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,926&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $36.4&#160;million and $43.7 million have been included in <span style="-sec-ix-hidden:f-1012"><span style="-sec-ix-hidden:f-1013">other liabilities</span></span> as at December&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419232256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current other liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock', window );">Non-current other liabilities</a></td>
<td class="text">Non-current other liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419110080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next sixteen years. These leases g</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">enerally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Operating leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2023, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and 2021 and future minimum rental commitments as of December&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419150928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Capital</a></td>
<td class="text">Share Capital<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Employee share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, 535,705 options were exercised by employees at an average exercise price of $95.12 per share for total proceeds of $51.0 million. During the year ended December&#160;31, 2023, 188,800 ordinary shares were issued in respect of certain RSUs and 47,026 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December&#160;31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December&#160;31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This resolution has been renewed annually thereafter.&#160;On February 18, 2022, the Company commenced a share buyback program which was fully complete at&#160;March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418624384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text">Restructuring Charges<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended, December 31, 2023, a restructuring charge of $45.4&#160;million was recognized in the Consolidated Statements of Operations under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected a workforce reduction of $34.1&#160;million and an office consolidation program to optimize the Company's office footprint of  $11.3&#160;million.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023, a total liability of $7.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $3.0 million of facilities related liabilities of which $1.0 million is included within other liabilities and $2.0 million is included within non-current other liabilities. The remaining provision of $4.0 million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.106%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//420/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419296528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(352,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,152&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,403)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory trading income tax rate, the rate of our country of domicile, is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease)/ increase in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investor tax expense on foreign subsidiary earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in foreign subsidiaries </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,073,114&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158,693&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,643&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,417&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,676&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,038&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(825,438)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911,655)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.9 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $1.7 million and $331.4 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $1.7 million U.S. federal NOLs, approximately $1.2 million is currently available for offset against future U.S. federal taxable income. The subsidiaries' ability to use the remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. All $1.7 million of the U.S. federal NOLs are limited by Section 382 and expire between 2024 - 2037. As of December&#160;31, 2023, U.S subsidiaries also had disallowed interest carryforwards of $204&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024-2037</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2038-2042</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2023 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $42.9 million. At December&#160;31, 2023 those subsidiaries also had additional operating loss carryforwards of $12.9 million which are due to expire between 2024 and 2030. In addition, at December&#160;31, 2023 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.3 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2023 was approximately $43.0 million. The valuation allowance for deferred tax assets as of December&#160;31, 2022 and December&#160;31, 2021 was $43.4 million and $45.5 million respectively. The net change in the total valuation allowance was a decrease of $0.4 million during 2023 and a decrease of $2.1 million during 2022. Of the total decrease of $0.4 million in 2023, $1.1 million was recognized within income tax expense and a increase of $0.7 million was recognized in Other Comprehensive Income. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expenses and $1.3 million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2023 and December&#160;31, 2022 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and tax planning strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has recognized a deferred tax liability of $52.4 million (2022: $1.6 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. Given changes in various tax laws during 2023, the group has taken the decision to repatriate certain excess earnings which will not be permanently reinvested and consequently have provided for the relevant tax in the current year. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $65.0 million could potentially expire during 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2023 were potential benefits of $160.0 million, which if recognized, would affect the effective rate on income from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2022 and December&#160;31, 2021 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $217.6 million and $202.1 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2023 amounted to a net charge of $4.2 million (2022: $7.1 million, 2021: $1.9 million) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2023 and December&#160;31, 2022 were $27.1 million and $22.6 million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. In the United States, tax periods open to audit include the years ended December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419435936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">Employee Benefits<div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were $40.4 million, $45.8 million and $23.7 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pension and Postretirement Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,738)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,033)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the specific defined benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $12.3&#160;million and $11.6&#160;million recorded to non-current other liabilities as of December&#160;31, 2023 and December&#160;31, 2022, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Development Solutions Limited, a subsidiary of ICON Plc, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 and December&#160;31, 2022  consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded surplus</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December&#160;31, 2023 and December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,320&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit (credit)/cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net (gain)/loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit)/cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit (credit)/cost for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income/(loss)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) - plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,559)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income/(loss) into net periodic benefit cost over the next year are $0.2 million and $nil respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2023 resulted from changes in the assumptions compared to those adopted at December 2022. Changes in the assumptions reflect the changes in market conditions from December 2022 to December 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company&#8217;s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December&#160;31, 2023 and December&#160;31, 2022, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of assets held by the plan are represented by quoted prices in active markets for identical assets and are therefore classified as level 1 investments.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2024. The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2029 - 2033</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 and December&#160;31, 2022 consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded deficit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 were 1.5% and 2.3%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded deficit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 was 1.5% and 2.3%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,747&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (loss)/gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419213888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Schemes and Stock Compensation Charges</a></td>
<td class="text">Equity Incentive Schemes and Stock Compensation Charges<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#8221;), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan")  were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2.0&#160;million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,472&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.48&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(535,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,806&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.96&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.67&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2023, was 4.42 years and 3.89 years respectively (2022: 4.69 years and 4.25 years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outstanding and exercisable share options:</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$20.83 - 96.15</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.29</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$103.81 - 121.68</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.54</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.45</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33 - 233.88</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.69</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$20.83 - 233.88</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">902,806</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.42</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">142.96</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">654,386</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">119.67</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December&#160;31, 2023. Options exercisable represent options which have vested at December&#160;31, 2023. From the date of grant, substantially all options vest over a five year period.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.  No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors vest over twelve months. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(188,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2023 totaled $35.4 million (2022: $34.1 million). The share price range for the year was $159.33 - $265.96 (2022: $137.47 - $265.96).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2023 totaled $7.5 million (2022: $6.5 million). The share price range for the year was $159.33 - $166.51 (2022: $137.47 - $166.51).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period  2021 &#8211; 2023, 2022 &#8211; 2024, and 2023 - 2025. Depending on the actual amount of EPS from 2021 to 2025, up to an additional 49,340 PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2023 is stated after charging $55.7 million in respect of stock compensation expense (inclusive of employer related taxes). Stock compensation expense has been allocated as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,667&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2023 reflects a net income tax benefit of $20.0 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2023 was $10.9 million. The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2021 was $23.9 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419182160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographical Information</a></td>
<td class="text">Business Segment and Geographical Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#8216;CODM&#8217;) in accordance with ASC 280, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as one reportable segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the Group on the basis of an arm&#8217;s length return for the services they perform in each of their local territories. The arm&#8217;s length return for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The arm&#8217;s length return  is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model has been completed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the arm&#8217;s length revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the arm&#8217;s length revenues attributable to the activities performed outside Ireland. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the overall basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December&#160;31, 2023 and December&#160;31, 2022 and for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,574,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,283,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">884,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,176&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations (including Restructuring) by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span id="ib1b5cc593b5a4d838e37be253e511406_6-1-1-1-225727"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419110080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Ordinary Share</a></td>
<td class="text">Net Income Per Ordinary Share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,101,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,717,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419297344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,506)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419232256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text">Supplemental Disclosure of Cash Flow Information<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419297344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related Parties <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $243,000 (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$428,000) from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder</span><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">of Corvus Pharmaceuticals. $101,000 (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2022: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$231,000) was noted as due from Corvus Pharmaceuticals at December&#160;31, 2023. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $45,000 (December&#160;31, 2022: $235,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $47,000 was noted as due from Afimmune Limited at December&#160;31, 2023 (December&#160;31, 2022: $263,000).&#160;</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), a specialized oncology site network in the US and EMEA regions, with a third party. The Company invested $4.9&#160;million to obtain a 49% interest in the voting share capital of Oncacare. On April 20, 2023, the Company completed the purchase of the majority investor&#8217;s 51% majority voting share capital of Oncacare. The consideration paid by ICON to purchase the 51% majority voting share capital was $5.1&#160;million. As a result of this transaction (the "Oncacare acquisition"), Oncacare and its subsidiaries became wholly owned subsidiaries of the ICON Group. Prior to the Oncacare acquisition, the Company recorded losses of $0.4&#160;million and $3.1 million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023 and December&#160;31, 2022, respectively. The Oncacare acquisition also resulted in goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$13.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and gave rise to an acquisition-related gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$6.2 million</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419518016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Subsequent Events</span><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has evaluated subsequent events from the Balance Sheet date through February&#160;23, 2024, the date at which the consolidated financial statements were available to be issued. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">n February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $500&#160;million of the outstanding ordinary shares of the Company. All ordinary shares that are redeemed under the buyback program will be </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has determined that there are no other items to disclose.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631417028176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination and income taxation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Disclosure of Fair Value of Financial Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short-term debt or equity as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by Level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The changes in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses, other than temporary, which reduce the carrying amount below cost are recognized in the Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies and Translation of Subsidiaries</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts charged/(credited)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Reimbursable expenses and Direct costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in Debt, Equity and Other</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value Measurements ("ASC 820")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Any increases or decreases in fair value are recognized in earnings in the period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, Net and Unbilled Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing </span>("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 - 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2023 and December&#160;31, 2022, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of goodwill and long-lived assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_GovernmentGrantsPolicyTextBlock', window );">Government grants</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ResearchandDevelopmentCreditsPolicyTextBlock', window );">Research and development credits</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Costs</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for these plans in accordance with ASC Subtopic 715-30, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans &#8211; Pension</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 718")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Transaction and Integration-related Expenses</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Restructuring</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income per Ordinary Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Impact of Recently Issued or Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounting pronouncements, effective for the year ended December 31, 2023, did not have any significant impact on the Company&#8217;s consolidated financial statements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following accounting pronouncements have been issued, but not yet adopted, as of December 31, 2023:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting &#8211; Improvements to Reportable Segment Disclosures </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(&#8220;ASU 2023-07&#8221;), which amends the guidance in ASC Topic 280,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis. Furthermore, all disclosures about a reportable segment&#8217;s profit or loss, which are currently required annually, will be mandated for interim periods. The additional disclosures required by ASU 2023-07 apply to entities with a single reportable segment. The amended guidance is effective for fiscal periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with retrospective application required. The Company is currently evaluating the impact of this ASU on disclosures within its consolidated financial statements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">which requires disaggregated information about an entity&#8217;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_GovernmentGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grants, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_GovernmentGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ResearchandDevelopmentCreditsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Credits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ResearchandDevelopmentCreditsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3,4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481097/715-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 60<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 80<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419199040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ForeignCurrencyDisclosureTableTextBlock', window );">Adjustments resulting from foreign currency translations</a></td>
<td class="text">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts charged/(credited)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock', window );">Estimated useful lives of assets</a></td>
<td class="text">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 - 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,090,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,147,971&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,855,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ForeignCurrencyDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ForeignCurrencyDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Useful Lives For Property Plant Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419216320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,453,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,012,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,120,176</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419512560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contracts with Customers, Asset and Liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.676%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,742,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:44.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(702,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152,777)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631502016144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Provision for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December&#160;31, 2022 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,533&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416943360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:84.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, <br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,048)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(204,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock', window );">Schedule of measurement period adjustments</a></td>
<td class="text">In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151,098)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December&#160;31, 2022, the Company incurred a $2.2&#160;million amortization expense which related to the year ended December&#160;31, 2021 due to the timing of the measurement period adjustment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Measurement Period Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631420511344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.</span></div>(c) Represents the fair value of the interest rate caps and the interest rate swap.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.</span></div>(c) Represents the fair value of the interest rate caps and the interest rate swap.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419420080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment, Net</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">781,067&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,493&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(419,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,184&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416165504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,022,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631420521888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,090,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,147,971&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,855,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2024 to December 31, 2028 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415568512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">915,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f $333.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> at December&#160;31, 2023 and $406.3 million at December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419378560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2023 and 2022:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,251,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan Facility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,696,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,665,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock', window );">Schedule of Financing Cost</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of merger related financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Includes costs associated with the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,030,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock', window );">Schedule of Principal Payments on Debt Instrument</a></td>
<td class="text"><div style="text-align:justify;text-indent:14.25pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2023 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Financing Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Principal Payments on Debt Instrument</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631502009904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text">The fair values of the Company&#8217;s derivative financial instruments, on a gross basis, are summarized in the following table:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,100,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,201,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631420528848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Cost</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2023 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental <br/>payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,926&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419393008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current other liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Non-current other liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419180032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring Charges</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.106%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416058224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncomeBeforeIncomeTaxTableTextBlock', window );">Summary of Components of Income Before Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(352,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Components of Provision for Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,152&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,403)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</a></td>
<td class="text">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease)/ increase in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investor tax expense on foreign subsidiary earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</a></td>
<td class="text">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in foreign subsidiaries </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,073,114&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158,693&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,643&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,417&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,676&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,038&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(825,438)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911,655)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Expected Expiry Dates of NOL's</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024-2037</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2038-2042</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeBeforeIncomeTaxTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Before Income Tax, Table</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeBeforeIncomeTaxTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416078000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in Balance Sheet</a></td>
<td class="text">The balances recorded to the balance sheet are as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,738)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,033)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded surplus</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,321&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December&#160;31, 2023 and December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,320&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded deficit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 were 1.5% and 2.3%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, <span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Plans - General</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded deficit</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 was 1.5% and 2.3%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,747&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (loss)/gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit (credit)/cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net (gain)/loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit)/cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Summary of Assumptions Used in Calculating Pension Benefit Obligations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit (credit)/cost for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income/(loss)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) - plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,559)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Underlying Asset Split of Fund</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Plan Asset Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Annual Benefit Payments which Reflect Expected Future Service</a></td>
<td class="text">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2029 - 2033</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (a)(b)(c)<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (d)(5)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (f)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (h)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419707520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Transactions for Company's Share Option Plans</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,472&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.48&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(535,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,806&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.96&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.67&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Information Concerning Outstanding and Exercisable Share Options</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$20.83 - 96.15</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.29</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$103.81 - 121.68</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.54</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.45</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33 - 233.88</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.69</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$20.83 - 233.88</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">902,806</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.42</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">142.96</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">654,386</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">119.67</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Fair Values and Assumptions Used</a></td>
<td class="text">The weighted average fair values and assumptions were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2023:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(188,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621,011&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock', window );">Schedule of Non-cash Stock Compensation Expense</a></td>
<td class="text">Stock compensation expense has been allocated as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,667&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Non Cash Stock Compensation Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415300688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Distribution of Net Revenue by Geographical Area</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December&#160;31, 2023 and December&#160;31, 2022 and for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,574,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,283,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">884,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,176&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeByGeographyTableTextBlock', window );">Schedule of Distribution of Income from Operations by Geographical Area</a></td>
<td class="text">The distribution of income from operations (including Restructuring) by geographical area was as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Distribution of Net Revenue by Geographical Area</a></td>
<td class="text">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span id="ib1b5cc593b5a4d838e37be253e511406_6-1-1-1-225727"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeByGeographyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income by Geography.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeByGeographyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418539680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of number of shares used in computation of basic and diluted net income per ordinary share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,101,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,717,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409564144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,506)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419354880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416718256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Employee </div>
<div>Country </div>
<div>Location</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>Employee</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">41,100<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_NumberOfLocations', window );">Number of locations in which company operates | Location</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which company operates | Country</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | United States | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">40.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Europe | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">48.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Rest of World | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">10.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Locations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414704576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyAbstract', window );"><strong>Foreign Currency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Amounts charged/(credited)</a></td>
<td class="nump">$ 12,916<span></span>
</td>
<td class="num">$ (25,997)<span></span>
</td>
<td class="num">$ (14,316)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415946960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Motor vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411307104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414787120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,120,176<span></span>
</td>
<td class="nump">$ 7,741,386<span></span>
</td>
<td class="nump">$ 5,480,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_TopClientMember', window );">Top client</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">721,309<span></span>
</td>
<td class="nump">683,546<span></span>
</td>
<td class="nump">441,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients25Member', window );">Clients 2-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,453,508<span></span>
</td>
<td class="nump">1,506,087<span></span>
</td>
<td class="nump">1,291,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients610Member', window );">Clients 6-10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,188,943<span></span>
</td>
<td class="nump">1,112,636<span></span>
</td>
<td class="nump">752,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients1125Member', window );">Clients 11-25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,743,539<span></span>
</td>
<td class="nump">1,585,739<span></span>
</td>
<td class="nump">1,077,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 3,012,877<span></span>
</td>
<td class="nump">$ 2,853,378<span></span>
</td>
<td class="nump">$ 1,918,309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_TopClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_TopClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients610Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients610Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients1125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients1125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_OtherCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415119184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances - Contracts with Customers (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed services (accounts receivable)</a></td>
<td class="nump">$ 1,821,855<span></span>
</td>
<td class="nump">$ 1,751,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses (note 5)</a></td>
<td class="num">(31,533)<span></span>
</td>
<td class="num">(20,562)<span></span>
</td>
<td class="num">$ (7,081)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractsReceivableGross', window );">Accounts receivable (net)</a></td>
<td class="nump">1,790,322<span></span>
</td>
<td class="nump">1,731,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled services (unbilled revenue)</a></td>
<td class="nump">951,936<span></span>
</td>
<td class="nump">957,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractsReceivableNet', window );">Accounts receivable and unbilled revenue, net</a></td>
<td class="nump">2,742,258<span></span>
</td>
<td class="nump">2,689,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (payments on account)</a></td>
<td class="num">(1,654,507)<span></span>
</td>
<td class="num">(1,507,449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Net balance</a></td>
<td class="num">(702,571)<span></span>
</td>
<td class="num">$ (549,794)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent', window );">Change in unbilled receivables</a></td>
<td class="num">(5,719)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="num">(147,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Change in advance payments netted against unbilled contracts receivable</a></td>
<td class="num">$ (152,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent', window );">Change in unbilled receivables (in percent)</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent', window );">Change in unearned revenue (payments on account) (in percent)</a></td>
<td class="nump">9.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent', window );">Change in advance payments netted against unbilled contracts receivable (in percent)</a></td>
<td class="nump">27.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414750848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 333,000<span></span>
</td>
<td class="nump">$ 406,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent', window );">Change in unbilled receivables</a></td>
<td class="num">(5,719)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="num">(147,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Increase in advance payments netted against unbilled contracts receivable</a></td>
<td class="num">(152,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Bad debt expense</a></td>
<td class="nump">24,600<span></span>
</td>
<td class="nump">17,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="nump">$ 13,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="nump">52.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416831344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Opening provision</a></td>
<td class="nump">$ 20,562<span></span>
</td>
<td class="nump">$ 7,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Amounts used during the year</a></td>
<td class="num">(13,358)<span></span>
</td>
<td class="num">(3,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccountsReceivableCreditLossExpense', window );">Amounts provided during the year</a></td>
<td class="nump">24,550<span></span>
</td>
<td class="nump">17,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments', window );">Foreign exchange</a></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(406)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Closing provision</a></td>
<td class="nump">$ 31,533<span></span>
</td>
<td class="nump">$ 20,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccountsReceivableCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccountsReceivableCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415949280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, Biotel Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 02, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,766<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,914,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
<td class="nump">$ 9,037,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">$ 68,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">36,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 23,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415336112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, Oncacare Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 20, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
<td class="nump">$ 9,037,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,160<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition related costs</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414750080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, PRA Acquisition (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>Employee </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">41,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,176<span></span>
</td>
<td class="nump">$ 39,695<span></span>
</td>
<td class="nump">$ 198,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336,699<span></span>
</td>
<td class="nump">229,731<span></span>
</td>
<td class="nump">182,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld', window );">Business acquisition, share price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld', window );">Business acquisition, number of shares issued (in shares) | shares</a></td>
<td class="nump">0.4125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,400<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="nump">$ 86,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409532832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,766<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,914,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">$ 5,308,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of ordinary shares issued to acquiree stockholders</a></td>
<td class="nump">5,658,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Fair value of replacement share-based awards issued to acquiree employees</a></td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Repayment of term loan obligations and accrued interest</a></td>
<td class="nump">865,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">12,041,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate', window );">Payments to settle debt obligations that existed prior to acquisition date</a></td>
<td class="nump">$ 401,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414997408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
<td class="nump">$ 9,037,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable and unbilled revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,084,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,919,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(380,048)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(739,278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability', window );">Non-current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,119,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204,291)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,041,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414882448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) - PRA Health Sciences, Inc<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,919,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 3,938,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 168,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 111,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416766704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) - PRA Health Sciences, Inc - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue', window );">Accounts receivable and unbilled revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,039)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities', window );">Non-current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities', window );">Non-current deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (151,098)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Amortization adjustment</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Accounting Standards Update 2021-08</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue', window );">Unearned revenue</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202108Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202108Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416312576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">$ 1,954<span></span>
</td>
<td class="nump">$ 1,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term)</a></td>
<td class="nump">46,804<span></span>
</td>
<td class="nump">32,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">48,758<span></span>
</td>
<td class="nump">34,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="nump">3,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="nump">3,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">1,954<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">1,954<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="nump">3,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="nump">3,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Investments Measured at Net Asset Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term)</a></td>
<td class="nump">46,804<span></span>
</td>
<td class="nump">32,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">46,804<span></span>
</td>
<td class="nump">32,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Investments Measured at Net Asset Value | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415948704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 48,758<span></span>
</td>
<td class="nump">$ 34,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="nump">3,793,500<span></span>
</td>
<td class="nump">4,650,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">12,878,000<span></span>
</td>
<td class="nump">13,250,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">9,022,100<span></span>
</td>
<td class="nump">8,971,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Identifiable intangible assets, net</a></td>
<td class="nump">$ 3,855,900<span></span>
</td>
<td class="nump">$ 4,278,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411575872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 20, 2023</div></th>
<th class="th"><div>Jul. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments</a></td>
<td class="nump">$ 1,954<span></span>
</td>
<td class="nump">$ 1,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod', window );">Short term investments average maturity period</a></td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements', window );">Debt securities, available for sale, cumulative amount advanced under subscription agreements</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Increase (decrease) in equity securities, FV-NI</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of long-term investments in equity</a></td>
<td class="nump">46,800<span></span>
</td>
<td class="nump">32,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CommitmentToAcquireLongTermInvestments', window );">Commitment to acquire future long-term investments</a></td>
<td class="nump">66,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
<td class="nump">$ 2,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CommitmentToAcquireLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment To Acquire Long-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CommitmentToAcquireLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short Term Available For Sale Investments Average Remaining Maturity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479567/321-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416203232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 3,724<span></span>
</td>
<td class="nump">$ 3,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">70,072<span></span>
</td>
<td class="nump">70,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Computer equipment and software</a></td>
<td class="nump">550,119<span></span>
</td>
<td class="nump">500,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Office furniture and fixtures</a></td>
<td class="nump">45,856<span></span>
</td>
<td class="nump">50,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Laboratory equipment</a></td>
<td class="nump">56,217<span></span>
</td>
<td class="nump">59,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">65,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_VehiclesGross', window );">Motor vehicles</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">781,067<span></span>
</td>
<td class="nump">750,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and asset write offs</a></td>
<td class="num">(419,883)<span></span>
</td>
<td class="num">(400,173)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment (net)</a></td>
<td class="nump">$ 361,184<span></span>
</td>
<td class="nump">$ 350,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VehiclesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vehicles, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VehiclesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418544272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 126.1<span></span>
</td>
<td class="nump">$ 106.4<span></span>
</td>
<td class="nump">$ 75.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411397184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Opening goodwill</a></td>
<td class="nump">$ 8,971,670<span></span>
</td>
<td class="nump">$ 9,037,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Current year acquisitions (note 6)</a></td>
<td class="nump">36,750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Prior period acquisition (note 6)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(35,692)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange movement</a></td>
<td class="nump">13,655<span></span>
</td>
<td class="num">(30,569)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Closing goodwill</a></td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416634096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414981344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 5,147,971<span></span>
</td>
<td class="nump">$ 5,109,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,292,106)<span></span>
</td>
<td class="num">(830,553)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">&#160; Net book value</a></td>
<td class="nump">3,855,865<span></span>
</td>
<td class="nump">4,278,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">4,090,393<span></span>
</td>
<td class="nump">4,076,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">541,302<span></span>
</td>
<td class="nump">536,934<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">204,653<span></span>
</td>
<td class="nump">204,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">170,366<span></span>
</td>
<td class="nump">170,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 141,257<span></span>
</td>
<td class="nump">$ 120,984<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631410068064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">30 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 02, 2023</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 459,900<span></span>
</td>
<td class="nump">$ 463,100<span></span>
</td>
<td class="nump">$ 239,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,766<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,914,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">$ 68,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 36,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 451,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,128,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,308,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415319872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Future Intangible Asset Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 344,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">229,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">214,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">202,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">189,539<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet', window );">Total</a></td>
<td class="nump">$ 1,180,571<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Amortization Expense, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414787312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">General trade and overhead liabilities</a></td>
<td class="nump">$ 463,882<span></span>
</td>
<td class="nump">$ 530,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Personnel related liabilities</a></td>
<td class="nump">385,499<span></span>
</td>
<td class="nump">395,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">36,414<span></span>
</td>
<td class="nump">43,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Facility related liabilities</a></td>
<td class="nump">11,078<span></span>
</td>
<td class="nump">16,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">13,532<span></span>
</td>
<td class="nump">12,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RestructuringReserveandOtherLiabilitiesCurrent', window );">Restructuring liabilities</a></td>
<td class="nump">4,951<span></span>
</td>
<td class="nump">5,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CapitalGovernmentGrantsCurrent', window );">Short term government grants</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">915,399<span></span>
</td>
<td class="nump">1,005,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 333,000<span></span>
</td>
<td class="nump">$ 406,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CapitalGovernmentGrantsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Government Grants Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CapitalGovernmentGrantsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveandOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveandOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416157152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 3,806,213<span></span>
</td>
<td class="nump">$ 4,701,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtCurrentMaturitiesGross', window );">Less current portion of debt</a></td>
<td class="num">(110,150)<span></span>
</td>
<td class="num">(55,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross', window );">Total long-term debt</a></td>
<td class="nump">3,696,063<span></span>
</td>
<td class="nump">4,646,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less debt issuance costs and debt discount</a></td>
<td class="num">(30,624)<span></span>
</td>
<td class="num">(47,026)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net</a></td>
<td class="nump">$ 3,665,439<span></span>
</td>
<td class="nump">$ 4,599,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Term Loan | Senior Secured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">7.86%<span></span>
</td>
<td class="nump">7.092%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 3,251,213<span></span>
</td>
<td class="nump">$ 4,201,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes | Senior Secured Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Senior Secured Revolving Loan Facility | Senior Secured Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">6.72%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Excluding Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtExcludingCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409320528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,699<span></span>
</td>
<td class="nump">$ 229,731<span></span>
</td>
<td class="nump">$ 182,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">5,905,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Closing Balance</a></td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="nump">3,793,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,793,500<span></span>
</td>
<td class="nump">$ 4,650,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Senior Secured Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Closing Balance</a></td>
<td class="nump">$ 445,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 445,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Senior Secured Term Loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Senior Secured Term Loan | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Term Loan | Senior Secured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,515,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">7.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.86%<span></span>
</td>
<td class="nump">7.092%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Accelerated charge on repayments</a></td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Term Loan | Senior secured credit facility and senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Senior secured revolving loan facility | Senior Secured Revolving Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes | Senior Secured Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,400<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="nump">$ 86,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414801520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on drawn facilities</a></td>
<td class="nump">$ 311,019<span></span>
</td>
<td class="nump">$ 209,189<span></span>
</td>
<td class="nump">$ 93,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">17,749<span></span>
</td>
<td class="nump">12,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_InterestExpenseCreditOther', window );">Other financing costs</a></td>
<td class="nump">9,278<span></span>
</td>
<td class="nump">2,793<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="nump">$ 336,699<span></span>
</td>
<td class="nump">$ 229,731<span></span>
</td>
<td class="nump">$ 182,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_InterestExpenseCreditOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense (Credit), Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_InterestExpenseCreditOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TransactionAndOneTimeFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction And One Time Financing Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TransactionAndOneTimeFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415060448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 110,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">555,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtMaturityYearFiveAndThereafter', window );">2028 and thereafter</a></td>
<td class="nump">3,030,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt, net</a></td>
<td class="nump">$ 3,806,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtMaturityYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, Year Five And Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtMaturityYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631420324864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities - Schedule of Principal payments (Details) - Senior Secured Term Loan - Senior Secured Term Loan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic principal payment</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Total</a></td>
<td class="nump">$ 950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631410003088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines and Loan Facilities - Schedule of Movement on Debt Instrument (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 5,905,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,265,000<span></span>
</td>
<td class="nump">875,000<span></span>
</td>
<td class="nump">$ 877,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt, net</a></td>
<td class="nump">$ 3,806,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,806,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Senior Secured Revolving Loan Facility | Senior secured revolving loan facility | Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and facilities</a></td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt, net</a></td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416512704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 29, 2022 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other receivables<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Non-current other liabilities (Note 16)<span></span>
</td>
<td class="text">Non-current other liabilities (Note 16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain/(loss) on cash flow hedge</a></td>
<td class="num">$ (1,567)<span></span>
</td>
<td class="nump">$ 3,728<span></span>
</td>
<td class="num">$ (778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate derivatives held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,101,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.42%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps | Total derivatives designated as hedging instruments | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf', window );">Derivative, variable interest rate, reference rate in excess of</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,101,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liability, current</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative asset, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative liability, noncurrent</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Variable Interest Rate, Reference Rate In Excess Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DerivativeVariableInterestRateReferenceRateInExcessOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411156352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) - Total derivatives designated as hedging instruments - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,871,000<span></span>
</td>
<td class="nump">3,363,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">1,600,606,000<span></span>
</td>
<td class="nump">2,100,606,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">540,000<span></span>
</td>
<td class="nump">307,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">1,100,606,000<span></span>
</td>
<td class="nump">1,100,606,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">2,411,000<span></span>
</td>
<td class="nump">3,670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">2,701,212,000<span></span>
</td>
<td class="nump">3,201,212,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">$ 2,411,000<span></span>
</td>
<td class="nump">$ 3,670,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418618368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 46,820<span></span>
</td>
<td class="nump">$ 53,880<span></span>
</td>
<td class="nump">$ 51,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Income from sub-leases</a></td>
<td class="num">(1,103)<span></span>
</td>
<td class="num">(1,165)<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 45,717<span></span>
</td>
<td class="nump">$ 52,715<span></span>
</td>
<td class="nump">$ 49,862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631417013360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 45,717<span></span>
</td>
<td class="nump">$ 52,715<span></span>
</td>
<td class="nump">$ 49,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">37,700<span></span>
</td>
<td class="nump">28,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of long lived assets</a></td>
<td class="nump">$ 8,700<span></span>
</td>
<td class="nump">$ 24,800<span></span>
</td>
<td class="nump">15,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">6 years 8 months 19 days<span></span>
</td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">3.29%<span></span>
</td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">$ 36,414<span></span>
</td>
<td class="nump">$ 43,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 37,900<span></span>
</td>
<td class="nump">$ 48,300<span></span>
</td>
<td class="nump">47,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-6<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414972096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Operating Lease Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 40,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">34,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">29,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">23,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">15,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">33,998<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">176,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lease imputed interest</a></td>
<td class="num">(14,191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 162,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419414112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current other liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Defined benefit pension obligations, net (note 21)</a></td>
<td class="nump">$ 14,738<span></span>
</td>
<td class="nump">$ 13,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">31,260<span></span>
</td>
<td class="nump">25,227<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="nump">$ 45,998<span></span>
</td>
<td class="nump">$ 38,260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419332192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Non-cancelable operating leases for facilities expiration period</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411090256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 18, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 22, 2016</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_NumberOfVotes', window );">Number of votes | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,973<span></span>
</td>
<td class="nump">$ 35,844<span></span>
</td>
<td class="nump">$ 118,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember', window );">Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares)</a></td>
<td class="nump">420,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_StockRepurchaseProgramAuthorizedPercentage', window );">Stock repurchase program, authorized percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535,705<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Average exercise price of option per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.12<span></span>
</td>
<td class="nump">$ 102.87<span></span>
</td>
<td class="nump">$ 111.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
<td class="nump">$ 35,800<span></span>
</td>
<td class="nump">$ 118,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,800<span></span>
</td>
<td class="nump">195,029<span></span>
</td>
<td class="nump">446,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,026<span></span>
</td>
<td class="nump">46,087<span></span>
</td>
<td class="nump">44,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535,705<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issue of shares associated with a business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_StockRepurchaseProgramAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program Authorized Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_StockRepurchaseProgramAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415027168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 45,390<span></span>
</td>
<td class="nump">$ 31,143<span></span>
</td>
<td class="nump">$ 31,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">6,999<span></span>
</td>
<td class="nump">$ 6,022<span></span>
</td>
<td class="nump">$ 10,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember', window );">Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring reserve, current</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring reserve, noncurrent</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember', window );">2021 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">45,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">34,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other restructuring costs</a></td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418455264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Schedule of Restructuring Charges (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 45,390<span></span>
</td>
<td class="nump">$ 31,143<span></span>
</td>
<td class="nump">$ 31,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414976448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Opening provision</a></td>
<td class="nump">$ 6,022<span></span>
</td>
<td class="nump">$ 10,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional provision in the year</a></td>
<td class="nump">36,704<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RestructuringReserveUtilizations', window );">Utilization</a></td>
<td class="num">(35,727)<span></span>
</td>
<td class="num">(8,653)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending provision</a></td>
<td class="nump">$ 6,999<span></span>
</td>
<td class="nump">$ 6,022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveUtilizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve Utilizations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveUtilizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409152592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">$ 624,467<span></span>
</td>
<td class="nump">$ 567,851<span></span>
</td>
<td class="nump">$ 196,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">624,642<span></span>
</td>
<td class="nump">432,963<span></span>
</td>
<td class="nump">231,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="num">(352,532)<span></span>
</td>
<td class="num">(270,440)<span></span>
</td>
<td class="num">(278,413)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">$ 352,357<span></span>
</td>
<td class="nump">$ 405,328<span></span>
</td>
<td class="nump">$ 243,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631410840128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">$ 97,152<span></span>
</td>
<td class="nump">$ 184,396<span></span>
</td>
<td class="nump">$ 101,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(85,403)<span></span>
</td>
<td class="num">(124,985)<span></span>
</td>
<td class="num">(60,616)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense allocated to continuing operations</a></td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">59,411<span></span>
</td>
<td class="nump">41,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax expense was allocated to the following components of other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Currency impact on long term funding</a></td>
<td class="num">(3,903)<span></span>
</td>
<td class="nump">7,211<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Fair value of cash flow hedge</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity', window );">Total</a></td>
<td class="nump">8,147<span></span>
</td>
<td class="nump">66,622<span></span>
</td>
<td class="nump">43,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">80,427<span></span>
</td>
<td class="nump">53,248<span></span>
</td>
<td class="nump">18,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="nump">45,253<span></span>
</td>
<td class="num">(6,166)<span></span>
</td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="num">(42,428)<span></span>
</td>
<td class="nump">60,753<span></span>
</td>
<td class="nump">35,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(143,323)<span></span>
</td>
<td class="num">(118,475)<span></span>
</td>
<td class="num">(52,717)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">59,153<span></span>
</td>
<td class="nump">70,395<span></span>
</td>
<td class="nump">48,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="nump">$ 12,667<span></span>
</td>
<td class="num">$ (344)<span></span>
</td>
<td class="num">$ (8,452)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631418212720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)</a></td>
<td class="nump">$ 78,058<span></span>
</td>
<td class="nump">$ 70,980<span></span>
</td>
<td class="nump">$ 24,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization', window );">Rate differential from amortization of intangible assets</a></td>
<td class="num">(71,223)<span></span>
</td>
<td class="num">(59,330)<span></span>
</td>
<td class="num">(31,228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign and other income taxed at higher rates</a></td>
<td class="nump">35,778<span></span>
</td>
<td class="nump">52,464<span></span>
</td>
<td class="nump">51,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research &amp; development tax incentives</a></td>
<td class="num">(3,868)<span></span>
</td>
<td class="num">(2,608)<span></span>
</td>
<td class="num">(3,120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Movement in valuation allowance</a></td>
<td class="num">(1,068)<span></span>
</td>
<td class="num">(777)<span></span>
</td>
<td class="nump">3,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Effects of change in tax rates</a></td>
<td class="nump">3,154<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">(Decrease)/ increase in unrecognized tax benefits</a></td>
<td class="num">(54,347)<span></span>
</td>
<td class="nump">8,392<span></span>
</td>
<td class="nump">5,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount', window );">Investor tax expense on foreign subsidiary earnings</a></td>
<td class="nump">39,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Impact of stock compensation</a></td>
<td class="num">(11,487)<span></span>
</td>
<td class="num">(8,756)<span></span>
</td>
<td class="num">(9,083)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="num">(2,413)<span></span>
</td>
<td class="num">(654)<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense allocated to continuing operations</a></td>
<td class="nump">$ 11,749<span></span>
</td>
<td class="nump">$ 59,411<span></span>
</td>
<td class="nump">$ 41,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411695344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 7,547<span></span>
</td>
<td class="nump">$ 10,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating right-of-use-assets</a></td>
<td class="nump">16,108<span></span>
</td>
<td class="nump">23,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="nump">39,014<span></span>
</td>
<td class="nump">37,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Intangible assets</a></td>
<td class="nump">950,055<span></span>
</td>
<td class="nump">1,078,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Investments in foreign subsidiaries</a></td>
<td class="nump">52,408<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">7,982<span></span>
</td>
<td class="nump">7,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities recognized</a></td>
<td class="nump">1,073,114<span></span>
</td>
<td class="nump">1,158,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards', window );">Operating loss and tax credits carryforwards</a></td>
<td class="nump">124,150<span></span>
</td>
<td class="nump">88,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">9,082<span></span>
</td>
<td class="nump">6,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">20,190<span></span>
</td>
<td class="nump">27,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">2,166<span></span>
</td>
<td class="nump">3,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Stock compensation</a></td>
<td class="nump">17,605<span></span>
</td>
<td class="nump">21,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">84,928<span></span>
</td>
<td class="nump">66,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">23,748<span></span>
</td>
<td class="nump">66,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">8,774<span></span>
</td>
<td class="nump">9,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">290,643<span></span>
</td>
<td class="nump">290,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(42,967)<span></span>
</td>
<td class="num">(43,379)<span></span>
</td>
<td class="num">$ (45,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets recognized</a></td>
<td class="nump">247,676<span></span>
</td>
<td class="nump">247,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Overall net deferred tax liability</a></td>
<td class="num">$ (825,438)<span></span>
</td>
<td class="num">$ (911,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Contract With Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411183376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="nump">$ 42,967,000<span></span>
</td>
<td class="nump">$ 43,379,000<span></span>
</td>
<td class="nump">$ 45,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Investments in foreign subsidiaries</a></td>
<td class="nump">52,408,000<span></span>
</td>
<td class="nump">1,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Unrecognized tax benefit, potentially expire in 2021</a></td>
<td class="nump">65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Total unrecognized tax benefits net of potential benefits</a></td>
<td class="nump">160,000,000<span></span>
</td>
<td class="nump">217,600,000<span></span>
</td>
<td class="nump">202,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties recognized as an expense</a></td>
<td class="nump">4,200,000<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Total accrued interest and penalties</a></td>
<td class="nump">27,100,000<span></span>
</td>
<td class="nump">22,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember', window );">Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="num">$ (1,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">42,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country | Tax year 2024 to 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingLossCarryforwardsUSFederal', window );">U.S. Federal net operating loss carry forwards currently available for offset</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax', window );">Alternative minimum tax credit carry forwards</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">1,744,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forward</a></td>
<td class="nump">204,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">331,370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">9,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingLossCarryforwardsUSFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, US Federal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingLossCarryforwardsUSFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2024To2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2024To2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411208048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Expected Expiry Dates of NOL's (Details) - United States<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">$ 9,251<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">331,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2024-2037</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">271,434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2038-2042</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">50,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">1,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2024-2037</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">1,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2038-2042</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2024To2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2024To2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear20382042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear20382042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416491664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at start of year</a></td>
<td class="nump">$ 217,584<span></span>
</td>
<td class="nump">$ 202,065<span></span>
</td>
<td class="nump">$ 19,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Increase related to acquired tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">170,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase related to prior year tax positions</a></td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">16,098<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year tax positions</a></td>
<td class="num">(918)<span></span>
</td>
<td class="num">(5,442)<span></span>
</td>
<td class="num">(1,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">4,552<span></span>
</td>
<td class="nump">5,701<span></span>
</td>
<td class="nump">18,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(844)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of statute of limitations</a></td>
<td class="num">(62,363)<span></span>
</td>
<td class="num">(838)<span></span>
</td>
<td class="num">(3,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of year</a></td>
<td class="nump">$ 160,016<span></span>
</td>
<td class="nump">$ 217,584<span></span>
</td>
<td class="nump">$ 202,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411585552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 07, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember', window );">Other retirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="nump">$ 11,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember', window );">PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Participant's contributions percentage of annual compensation (in percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost</a></td>
<td class="nump">$ 40,400,000<span></span>
</td>
<td class="nump">$ 45,800,000<span></span>
</td>
<td class="nump">$ 23,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">20,999,000<span></span>
</td>
<td class="nump">$ 19,558,000<span></span>
</td>
<td class="nump">$ 41,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Net loss that will be amortized</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear', window );">Net prior service cost for defined benefit pension plan that will be amortized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod', window );">Pension plan period</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contribution to pension fund in the year ending December 31, 2021</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ExpectedRetirementPeriod', window );">Retirement period used as a basis to estimate expected cash flows</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">$ 6,441,000<span></span>
</td>
<td class="nump">$ 5,806,000<span></span>
</td>
<td class="nump">$ 7,643,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan | Aptiv Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">$ 7,747,000<span></span>
</td>
<td class="nump">$ 5,345,000<span></span>
</td>
<td class="nump">$ 4,990,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ExpectedRetirementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Retirement period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ExpectedRetirementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_AptivSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_AptivSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411412464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Schedule of Amounts Recognized in Balance Sheet (Details) - Pension Plan - United States - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other receivables</a></td>
<td class="nump">$ 6,321<span></span>
</td>
<td class="nump">$ 6,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Non-current other liabilities (note 16)</a></td>
<td class="num">$ (14,738)<span></span>
</td>
<td class="num">$ (13,033)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416775632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Funded Status (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">$ (20,999)<span></span>
</td>
<td class="num">$ (19,558)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">27,320<span></span>
</td>
<td class="nump">26,050<span></span>
</td>
<td class="nump">$ 36,198<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded surplus</a></td>
<td class="nump">6,321<span></span>
</td>
<td class="nump">6,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">(6,441)<span></span>
</td>
<td class="num">(5,806)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6,261<span></span>
</td>
<td class="nump">5,681<span></span>
</td>
<td class="nump">6,964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded surplus</a></td>
<td class="num">(180)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">(7,747)<span></span>
</td>
<td class="num">(5,345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5,529<span></span>
</td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">$ 3,017<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded surplus</a></td>
<td class="num">$ (2,218)<span></span>
</td>
<td class="num">$ (1,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411192512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Change in Benefit Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">$ 19,558<span></span>
</td>
<td class="nump">$ 41,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">672<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(318)<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(335)<span></span>
</td>
<td class="num">(18,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="num">(3,913)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">20,999<span></span>
</td>
<td class="nump">19,558<span></span>
</td>
<td class="nump">41,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">5,806<span></span>
</td>
<td class="nump">7,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement</a></td>
<td class="num">(645)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers', window );">Benefits paid and transferred balances</a></td>
<td class="num">(134)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="nump">511<span></span>
</td>
<td class="num">(1,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="nump">578<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">6,441<span></span>
</td>
<td class="nump">5,806<span></span>
</td>
<td class="nump">7,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">5,345<span></span>
</td>
<td class="nump">4,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">417<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement</a></td>
<td class="num">(753)<span></span>
</td>
<td class="num">(844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers', window );">Benefits paid and transferred balances</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">1,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="nump">711<span></span>
</td>
<td class="num">(627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="nump">644<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">$ 7,747<span></span>
</td>
<td class="nump">$ 5,345<span></span>
</td>
<td class="nump">$ 4,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409184800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Change in Plan Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">$ 26,050<span></span>
</td>
<td class="nump">$ 36,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actuarial loss</a></td>
<td class="num">(910)<span></span>
</td>
<td class="num">(7,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(318)<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="nump">1,394<span></span>
</td>
<td class="num">(3,676)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">27,320<span></span>
</td>
<td class="nump">26,050<span></span>
</td>
<td class="nump">36,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">5,681<span></span>
</td>
<td class="nump">6,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actuarial loss</a></td>
<td class="nump">356<span></span>
</td>
<td class="num">(987)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanSchemeContributions', window );">Scheme contributions</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers', window );">Benefits paid and transferred balances</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement</a></td>
<td class="num">(645)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="nump">562<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">6,261<span></span>
</td>
<td class="nump">5,681<span></span>
</td>
<td class="nump">6,964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actuarial loss</a></td>
<td class="num">(52)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanSchemeContributions', window );">Scheme contributions</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers', window );">Benefits paid and transferred balances</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">1,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement</a></td>
<td class="num">(753)<span></span>
</td>
<td class="num">(844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="nump">467<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">$ 5,529<span></span>
</td>
<td class="nump">$ 4,059<span></span>
</td>
<td class="nump">$ 3,017<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanSchemeContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Scheme Contributions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanSchemeContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416817888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Components of Net Periodic Benefit Cost (Details) - United Kingdom - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">672<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(1,258)<span></span>
</td>
<td class="num">(1,171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net (gain)/loss</a></td>
<td class="num">(274)<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (credit)/cost</a></td>
<td class="num">$ (272)<span></span>
</td>
<td class="num">$ (241)<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416762192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income/(loss) &#160;</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost', window );">Actuarial gain - benefit obligation</a></td>
<td class="num">$ (335)<span></span>
</td>
<td class="num">$ (18,636)<span></span>
</td>
<td class="num">$ (2,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Actuarial loss/(gain) - plan assets</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">7,305<span></span>
</td>
<td class="num">(1,176)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax', window );">Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost</a></td>
<td class="nump">274<span></span>
</td>
<td class="num">(228)<span></span>
</td>
<td class="num">(625)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax', window );">&#160;Total</a></td>
<td class="nump">$ 849<span></span>
</td>
<td class="num">$ (11,559)<span></span>
</td>
<td class="num">$ (3,898)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415552384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) - United Kingdom - ICON Development Solutions Limited pension plan<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416925552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) - ICON Development Solutions Limited pension plan<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember', window );">Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember', window );">Diversified Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411397056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Plan Asset Fair Value Measurements (Details) - Level 1 - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 27,320<span></span>
</td>
<td class="nump">$ 26,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">21,312<span></span>
</td>
<td class="nump">22,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Diversified Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 6,008<span></span>
</td>
<td class="nump">$ 3,163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631415914480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Annual Benefit Payments (Details) - United Kingdom - ICON Development Solutions Limited pension plan<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2025</a></td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2026</a></td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2027</a></td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2028</a></td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Years 2029 - 2033</a></td>
<td class="nump">$ 4,028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631408252080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">252 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 14, 2017</div></th>
<th class="th"><div>May 11, 2015</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 18, 2020</div></th>
<th class="th"><div>May 16, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 13, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 5 months 1 day<span></span>
</td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable - weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 10 months 20 days<span></span>
</td>
<td class="text">4 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,667<span></span>
</td>
<td class="nump">$ 70,523<span></span>
</td>
<td class="nump">$ 133,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit related to stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
<td class="nump">22,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Cash tax benefit related to stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="nump">$ 23,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember', window );">The 2020 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember', window );">The 2018 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember', window );">Consultants Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted', window );">Limit of shares issued or to be issued pursuant to options granted (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember', window );">Employee Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member', window );">Option Plans 2008 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of option price for fair value of ordinary share (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, prior to 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Shares expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember', window );">Restricted Stock Units 2013</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019 | Non-executive director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,400<span></span>
</td>
<td class="nump">$ 34,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159.33<span></span>
</td>
<td class="nump">$ 137.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265.96<span></span>
</td>
<td class="nump">$ 265.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159.33<span></span>
</td>
<td class="nump">$ 137.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166.51<span></span>
</td>
<td class="nump">$ 166.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember', window );">PSUs Based on Service and EPS Targets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock units to be granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation Related Costs Share Based Payments Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limit of Shares Issued or To Be Issued Pursuant to Options Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631410002688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) - Stock Option and Award Plans - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Granted Under Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,378,119<span></span>
</td>
<td class="nump">1,695,460<span></span>
</td>
<td class="nump">553,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination', window );">Assumed through business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,177,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">82,472<span></span>
</td>
<td class="nump">108,643<span></span>
</td>
<td class="nump">100,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(535,705)<span></span>
</td>
<td class="num">(348,286)<span></span>
</td>
<td class="num">(1,065,529)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/expired (in shares)</a></td>
<td class="num">(22,080)<span></span>
</td>
<td class="num">(77,698)<span></span>
</td>
<td class="num">(70,186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">902,806<span></span>
</td>
<td class="nump">1,378,119<span></span>
</td>
<td class="nump">1,695,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and exercisable at end of period (in shares)</a></td>
<td class="nump">654,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (USD per share)</a></td>
<td class="nump">$ 119.86<span></span>
</td>
<td class="nump">$ 110.38<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice', window );">Assumed through business combination (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">232.48<span></span>
</td>
<td class="nump">229.94<span></span>
</td>
<td class="nump">177.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">95.12<span></span>
</td>
<td class="nump">102.87<span></span>
</td>
<td class="nump">111.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled/expired (USD per share)</a></td>
<td class="nump">196.20<span></span>
</td>
<td class="nump">143.08<span></span>
</td>
<td class="nump">128.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (USD per share)</a></td>
<td class="nump">142.96<span></span>
</td>
<td class="nump">$ 119.86<span></span>
</td>
<td class="nump">$ 110.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 119.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416302208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum range exercise price (USD per share)</a></td>
<td class="nump">$ 20.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum range exercise price (USD per share)</a></td>
<td class="nump">233.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member', window );">Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum range exercise price (USD per share)</a></td>
<td class="nump">20.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum range exercise price (USD per share)</a></td>
<td class="nump">96.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member', window );">Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum range exercise price (USD per share)</a></td>
<td class="nump">103.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum range exercise price (USD per share)</a></td>
<td class="nump">121.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member', window );">Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum range exercise price (USD per share)</a></td>
<td class="nump">125.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum range exercise price (USD per share)</a></td>
<td class="nump">147.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member', window );">Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum range exercise price (USD per share)</a></td>
<td class="nump">159.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum range exercise price (USD per share)</a></td>
<td class="nump">$ 233.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">902,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 5 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 142.96<span></span>
</td>
<td class="nump">$ 119.86<span></span>
</td>
<td class="nump">$ 110.38<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">654,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 119.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">201,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">2 years 3 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">201,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">132,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 6 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">132,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">249,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">233,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">319,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of shares (in shares)</a></td>
<td class="nump">86,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631411297232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) - Employee Stock Option - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (USD per share)</a></td>
<td class="nump">$ 107.21<span></span>
</td>
<td class="nump">$ 85.12<span></span>
</td>
<td class="nump">$ 68.42<span></span>
</td>
<td class="nump">$ 49.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (in percent)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (in percent)</a></td>
<td class="nump">0.56%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
<td class="nump">1.86%<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631408241360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">152,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">60,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares) | shares</a></td>
<td class="num">(47,026)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(60,512)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares) | shares</a></td>
<td class="nump">105,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 192.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">232.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share) | $ / shares</a></td>
<td class="nump">159.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">198.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 226.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">582,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">308,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares) | shares</a></td>
<td class="num">(188,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(81,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares) | shares</a></td>
<td class="nump">621,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 207.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">218.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share) | $ / shares</a></td>
<td class="nump">187.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">216.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 218.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414828256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">$ 55,667<span></span>
</td>
<td class="nump">$ 70,523<span></span>
</td>
<td class="nump">$ 133,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">26,595<span></span>
</td>
<td class="nump">22,854<span></span>
</td>
<td class="nump">18,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">29,072<span></span>
</td>
<td class="nump">47,669<span></span>
</td>
<td class="nump">41,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember', window );">Transaction and integration related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 73,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631502032976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of reporting segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416759248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,120,176<span></span>
</td>
<td class="nump">$ 7,741,386<span></span>
</td>
<td class="nump">$ 5,480,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,377,104<span></span>
</td>
<td class="nump">1,984,567<span></span>
</td>
<td class="nump">1,365,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,574,783<span></span>
</td>
<td class="nump">1,618,350<span></span>
</td>
<td class="nump">1,175,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,283,790<span></span>
</td>
<td class="nump">3,574,610<span></span>
</td>
<td class="nump">2,581,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 884,499<span></span>
</td>
<td class="nump">$ 563,859<span></span>
</td>
<td class="nump">$ 358,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414992464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">$ 956,152<span></span>
</td>
<td class="nump">$ 795,237<span></span>
</td>
<td class="nump">$ 378,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">432,026<span></span>
</td>
<td class="nump">218,088<span></span>
</td>
<td class="nump">131,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">153,450<span></span>
</td>
<td class="nump">253,799<span></span>
</td>
<td class="nump">177,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">310,343<span></span>
</td>
<td class="nump">254,849<span></span>
</td>
<td class="nump">39,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">$ 60,333<span></span>
</td>
<td class="nump">$ 68,501<span></span>
</td>
<td class="nump">$ 29,573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631417933536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 501,517<span></span>
</td>
<td class="nump">$ 504,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">199,051<span></span>
</td>
<td class="nump">143,025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">94,046<span></span>
</td>
<td class="nump">99,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">159,245<span></span>
</td>
<td class="nump">213,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 49,175<span></span>
</td>
<td class="nump">$ 48,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631501751216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</a></td>
<td class="nump">82,101,813<span></span>
</td>
<td class="nump">81,532,320<span></span>
</td>
<td class="nump">67,110,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)</a></td>
<td class="nump">615,827<span></span>
</td>
<td class="nump">936,043<span></span>
</td>
<td class="nump">958,125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</a></td>
<td class="nump">82,717,640<span></span>
</td>
<td class="nump">82,468,363<span></span>
</td>
<td class="nump">68,068,311<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409478880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net income per ordinary share (Note 24):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 7.46<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 7.40<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631419318656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
<td class="num">$ (149,148)<span></span>
</td>
<td class="num">$ (175,369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Actuarial gain on defined benefit pension plan</a></td>
<td class="nump">7,803<span></span>
</td>
<td class="nump">7,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax', window );">Loss on cash flow hedge</a></td>
<td class="num">(2,161)<span></span>
</td>
<td class="num">(3,728)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">&#160;Total</a></td>
<td class="num">$ (143,506)<span></span>
</td>
<td class="num">$ (171,538)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631416720432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 317,975<span></span>
</td>
<td class="nump">$ 210,918<span></span>
</td>
<td class="nump">$ 106,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes (net of refunds)</a></td>
<td class="nump">$ 163,778<span></span>
</td>
<td class="nump">$ 116,322<span></span>
</td>
<td class="nump">$ 55,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631409454704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 20, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of losses from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
<td class="nump">$ 2,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,022,075<span></span>
</td>
<td class="nump">8,971,670<span></span>
</td>
<td class="nump">9,037,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,160<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition related costs</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of losses from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember', window );">Corvus Pharmaceuticals | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember', window );">Afimmune Limited | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139631414716432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 20, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>162
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( />$5U@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #WA%=8S+HI%NX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)OITU%,'1S43PI""XHWL)D=C?8M"$9:??M;>-N%]$'\)B9/]]\
M ]-B4#A$>HY#H,B.TM7DNSXI#!MQ8 X*(.&!O$GEG.CGYFZ(WO#\C'L(!C_,
MGD!6U0UX8F,-&UB 15B)0K<6%48R/,03WN**#Y^QRS"+0!UYZCE!7=8@]#(Q
M'*>NA0M@@3%%G[X+9%=BKOZ)S1T0I^24W)H:Q[$<FYR;=ZCA[>GQ):];N#ZQ
MZ9'F7\DI/@;:B//DU^;N?OL@M*SD=5')0C9;6:OF5LGZ?7']X7<1]H-U._>/
MC<^"NH5?=Z&_ %!+ P04    " #WA%=8F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M />$5UBQ.!7TH08  %<?   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9EK<]HX%(;_BH;.=-J9!GR#D#;)K$.@94I3%M)VLYW]H-@*>&)+K"R'Y-_O
MD0V(MN+8FYW]@B]8KQ_K<EX=Z70MY'V^9$R1QRSE^5EKJ=3J;:>31TN6T;PM
M5HS#/W="9E3!I5QT\I5D-"X+96G'<YQ>)Z,);YV?EO>F\OQ4%"I-.)M*DA=9
M1N73!4O%^JSEMK8W9LEBJ?2-SOGIBB[8G*DOJZF$J\Y.)4XRQO-$<"+9W5DK
M=-]>!'U=H'SB:\+6^=XYT9]R*\2]OAC'9RU'$[&414I+4#@\L %+4ZT$'']O
M1%N[=^J"^^=;]5'Y\? QMS1G Y%^2V*U/&OU6R1F=[1(U4RL/[#-!W6U7B32
MO/PEZ^K9KM\B49$KD6T* T&6\.I('S<5L5? [Q\HX&T*>"5W]:*2\I(J>GXJ
MQ9I(_32HZ9/R4\O2 )=PW2IS)>'?!,JI\X%X8/*THT!*W^A$FV(753'O0#'7
M(Y\$5\N<#'G,XA\%.L"P _&V(!<>JGC)HC;QW3?$<SR?Y$LJ68[(^KOO\TM9
M_Y"LB KH1(J,>=6%=5?X/H&GR%BQ+/_+]NV59&"7U./D;;ZB$3MKP4#(F7Q@
MK?.7+]R>\PX!#G;  :9N@*^?5LP&AQ?WG*,10M'=472;4<S8(LF5K.IMKBC4
M&=RV<>&"=S3-&0+6VX'UFH&%G!<T!;Z5D%8>7$?) L,YWN$<-\.9,IF(6(\&
M N/0VG U2MO^7PX !*V_0^NC@H-"2DTV2O((*NJ&48GBX6I'1ZYWY+L(U\F.
MZZ1A!Y<4@GO9L0ZW(JY5UZM<QX1!IQG5? D.008B6U'^A(#5Z-62[05H%U4:
M<I6H)VC&E)&K(KL]$*YQ$=_WCYS^L1-@2)Y!\IH@;6,#U-H5S:R=JD9H//A\
M1::3 49E(KV+QN4MU9A'0D*KE2'K316SB)#0I 57\@F.L1T55Y]X&*2)[BX>
MGS>081R#=>1OMB>D=*3/W$Z&2\YALK6L/N^)7!0Y_ V"4RKO,6+C!"X>N5'B
MZ[6P$N.2$R965,8PN5ESC-&8@HM'\Y\9!_H*VOSZEQ=L^&I,IKB%6\3M8W#&
M(EP\LO\,-Q6Y@H#\9[(ZW!=KO,+MDS^Z,\PE7&,3+A[9?ZF[:IQ8L7"E\1 #
M,O[@XD'].E$0ZL0=<;U7MZ_)G$6%!$(K$*[T>78YO@IG-V3^(9P-YU#UX8Q\
M#2=?AN3EB[[?"]XY;:='AN'@ S:#-2;BX4$?'"U.^(+,G[);D=J :P3&@\D,
M(S&FX>'Q?EMI9/@8+2E?L(,1ND;H*IQ?AK]C3,8UO$:N$8DL \N'P1_=O]E,
M] F$,!@4O*R]5S#TJMNOK<#56[KE6W32^7#>]X*3KM/OG78>;(3&0;Q&#O)-
MSP ^<H@=T/EH+CB+R3C/"[OSUFC>H&F,9XS#:V0<7T4*PQ/RYW)"(',K$:YT
M)3 @XPM>(U_83C.KF5+9^\%Q"SL8KEA35<8-O$9N,.:*R2KKUY->ND6UDN&*
M-63&"KQ&5@!-!VU'!C S60A[J*T1FE )8SJ,(@9"(!-7W0&#-(;@-3*$8<;D
M0K?G>U H)QCEE-@*BPO6S84]8PT>'M#'@]&,A$6<*##W4"D&0:-,($8I75C)
M<+V:+- WD=]OF#Z,$DYYE("_[Y)E,I2RG']"[ZN6HKYK7/O*PW_+*GQC$#X>
MUTT>'47:\#<#E\<P+[."X7)?VO,V>1^&4PS..(7?R"E^2,6L4+A,;6WM+2+A
M03R$JHJK]CW0T6H$:E&,#_@-UX?V\_H1W+1&W!JQFJ4&WYB!WW"]:$.U60XY
MS(7+C6XP*F,$?B,C& "8!*@QC]DC^<CL?0F7<AS'=7K.2;>+D1DC\/'XO4O3
M!@+</+)Z$B[QS&5(W]B W_\?5DY1)W@NL_$''X_GS\FN:R2?E5T'QC@"/*(_
M)[NND6R870?&*X)&*U"-L^L:N2;9=6"\(FCD%?\FNZY1;)!=!\8Y@D8I19/L
MND8)S:Z#O>T%/.1O HZ.T)#9<)8>S QKA"Y@+AU33O01YCP8G+&1 (_[O\(-
M,YJDV^JS4N**&\KVAO*W)!)\E49MR$(Q8F,Q >X+VU5%O18J[*,!%_"[:$<S
MCA+@CE(.RE R>KC;XP+8VGY@7"/ Y_H34=K_$I)F9+6Z1L0[<8\\<%P;46=O
MKU-G*.6.;D[*26RU[;F[N]LU#JN]4O-XM>7\B>H$)R<INX.B3OL8NI*L=G&K
M"R56Y<[IK5!*9.7IDM&82?T _'\GA-I>Z!?L]M+/_P%02P,$%     @ ]X17
M6 L4S](K @  J 4  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX;6R-E-N.
MVC 0AE_%2J5>K<@!2%N:1(*E!U0AH5VUO:AZ89()L=:'U':6W;>O#R&E$D3<
MQ!Y[YO<WCF>RHY!/J@'0Z(51KO*@T;I=A*$J&V!8340+W.S40C*LC2D/H6HE
MX,H%,1HF492&#!,>%)E;V\DB$YVFA,-.(M4QAN7K"J@XYD$<G!8>R*'1=B$L
MLA8?X!'T]W8GC14.*A5AP!41'$FH\V 9+U:I]7<./P@<U=D<V4SV0CQ98U/E
M062!@$*IK0(VPS/< Z56R&#\Z36#X4@;>#X_J7]VN9M<]EC!O: _2:6;/'@?
MH IJW%']((Y?H<]G;O5*097[HJ/W33X$J.R4%JP/-@2,<#_BE_X>S@+B]$I
MT@<DCML?Y"C76.,BD^*(I/4V:G;B4G71!HYP^U,>M32[Q,3I8ME51*,-][_7
MW%,6:B-K-\.REUAYB>2*1)R@K>"Z4>@3KZ#Z7R T/ -4<H):):.*:R@G:!K?
MH21*IB-ZTR')J=.;WIHD^K7<*RW-D_A]*5^O-KNL9LMDH5I<0AZ8.E @GR$H
MWKZ)T^CC".ML8)V-J7M6(5%-)$.;]26\<8$XCM,1COG ,;^)@V,&ER#&H[_M
MME]&(-(!(KT)@HKRZN,<5UAW>[-TAS82*.87'V=X5CT,Y,'U"(5*T7'M"VE8
M'=K0TE??/W??P[98'@A7B$)M0J/).W-+TO<%;VC1NEK<"VTJVTT;TTI!6@>S
M7PNA3X8]8&C.Q5]02P,$%     @ ]X176 \2LR_W!P  P2(  !@   !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6RMFFMOV[@2AO\*X5WLV0))+)*Z4&T2($VR
MNP5RVJ)IS_G,R$PL5!*]$NTT^^MW*-F6+(Z8%,B'-K(]I-[A99X92J>/NO[>
M+)4RY$=95,W9;&G,ZNU\WF1+5<KF1*]4!;_<Z[J4!C[6#_-F52NY:!N5Q9P%
M03PO95[-SD_;[S[7YZ=Z;8J\4I]KTJS+4M9/[U6A'\]F=+;[XDO^L#3VB_GY
MZ4H^J%MEOJT^U_!ION]ED9>J:G)=D5K=G\TNZ-O+D-L&K<7_<O78#*Z)=>5.
MZ^_VPX?%V2RPBE2A,F.[D/!GHRY54=B>0,??VTYG^WO:AL/K7>]_M,Z#,W>R
M49>Z^'^^,,NSF9B1A;J7Z\)\T8]_J:U#D>TOTT73_D\>M[;!C&3KQNARVQ@4
ME'G5_94_M@,Q:$##B09LVX"]M '?-FA';MXI:]VZDD:>G];ZD=36&GJS%^W8
MM*W!F[RRTWAK:O@UAW;F_/+3Q]M/-Q^N+KY>7Y'W%S<7'R^OR>U?U]=?;\DQ
M^79[17[_]0WYE>05^;K4ZT96B^9T;N#.MOT\V][E?7<7-G&7*Y6=$$Z/" L8
M1YI?OKPY.VP^!W_W3K.]TZSMCT\YO:YK51ERT33*-&\Q?[H.0KP#N[?>-BN9
MJ;,9;)Y&U1LU.__M%QH'[S#O7JFS U_YWE?NZ_W\4C9+ K-&,GNA_E[G&UF
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M &D!'M=B(^-B(<^F2H^A\C1-VN==-L]# \^#"'P1A5I+<%TL^&+?P50/OF.
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M).> ^8%/L<'-AM& 8NRYJ04=M6 \EV,Y<Y$*7,,(J6>0<L!82*%)RH9A2,+
M=Y,*.U+A**G',BYDG'2<TD+Q5=EP+'D6*[X 1[="<<"<91E:HR+$;F$V"H>:
MH\'01L%0MR_L9@B]7D1XO^C!NO0VB=J4U=1KV,#02:?UM,>'XM!,F0.&(21F
MRMPPCPX0VE%%<#QI0NF9E5B-V<D(VG,&,N(A8G*R@2PD#)H=)G( *=3R)!PH
M18AZ7FB4UTV1B)R#92ERH/<.31FZ62%K#"%ED"*3E(WS0XJP;W*R<=@/* H'
M*/6""8ZJ"TU)<;VL*#VQ*FY.+MB.IP>M]-@HA*VN[O+EDP$2O8:!XR*F(]$6
MVML<PNXY1*PQ'&/,6&AV<Q>P*B,,358.( P004.MH=<V<'3U?ZNX)Z[WJ+S-
M$5#QZQM3)S]J3Q1$"/-->C:.,EU4%CL;!T/&@H'E"O;: XZ+CQN+3ILXY+D3
M9VN"8PA]2V*X<#0DT"+FP&GABH?JL=<8<%QD[&=-KF/]*98@$U(WP:9]\!^;
M5/T$.5=K4:UJ6UV^.2^4NYO8@D$+(1\&)G&'L/ "0CR3N(V#E&(RH,1AKT#@
MN 29_W^JMHPXQ@$VB;I0$)L[#A<,008':/::!(Z+DEL^VB]#:Z.CLX4Q-4G8
M..I1[!&3A8V#%,-@8)E&O>Y WNC.J:<!]&(&1*FE?US^; NVG8KDHW,[A48E
MS7_=3QW46W0H;_MA[=4/&E<_E[%,$W!4G?E48:VCZ>QGK9]@=_$_(:8V=:#8
MB:$C(@<(G:!@H$)ZP8/&!4^49IM:8;^##'*1,;G8('9B[20<*$UFJ-Q[J8/&
M#X>^U:>8FDV\U=)MQ4&QR9^JNE\:I2^!V"BIM'+M]?C@/#CHL=)!O46'\K8?
M[UZ5H7%5ULZ#M&BCZBX;6SH%"'HP,*OBRH74?1!A9"YO#B3S8>5T8(%#O1Y#
MXWJLFQ"_8&5+ID"OUSXSE^(K)Y*P #-K5CAD7>!I)#37L^G.@7;.RU7]8D#J
M_=BF4,W)<'>W>_EP41^Y&_<OX6G4O$+HW31O-+[$Y2HM),CX4KOT3GP]K+)Y
M2=!<*/%<'YL_":5$7O]<\WC!RPJ@_U\*/:O:B^H!W:N:V;]02P,$%     @
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M7/!TSLNF@/C\L2CJ'V^:GS[:_US7Y?\!4$L#!!0    ( />$5UAW ]&QJ0D
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MR*Z\6(Q.0A( ,L>>^@=3HH/RH6[E<\N+SC?YCN>%UCUZ(X :_?;$5%%;NY#
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M2.'(N1*3G;Z_HF 'PT%QAT?GBBQY(79AZ_2B]"=<_PL@56)Y-A:*@[3\#9Q
M^/=Q:R# :*$4/=1O?''Y^=F3QS@LGH_Y2H[YCM[6L@W%^FA3S,#A[Z;WY&DJ
M#CJ'OU'(H]!IE;SH6LG-_0# VF-\AJ6H'2T@OP2S/A <:H$+9X9)(%R;OO8$
MDXN H%\AYMZOO4@JD"J ;'(>N"OL9\K"GIZ\O_[98V4J0/F=:1I/'WK'#\T
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ME4P6HC12E4R+S>WH/OCP,*?U=L%_I-B;P9A1)&NE?J,O/V2W(Y\<$KE(:[+
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M+2I['4B(;9!<V-:6L@%VL0JBPR%49L5UOM(6W?8&X#$>2$A)_G^-J=,AU:E
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M-1V>BBU)6_E%6L9L1#0\JV=[%$:5'3',YPPH9;:G,2;K4=SW8"D=""^ >6E
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M&AX/4P]4V^-:P\C:]96%--2EW+2@WP(JZT#[2TE)WACV@.Y',_L#4$L#!!0
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MSB\[#B5KL"AMZ;L(),NU]$IR%3@G'4(].48HA.K6YH%J@N.Y0IP*2'0%3D0
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M%P,?'P*^"=S: QM\)YG6#_[PL9A&B2\()>;.,W!Z/>(U2NF)J(Q?+6?4I?3
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MZK&>"(E#\#](R<&T'0K"D6T+AE_+ZDB^\#Y=.5A#U! ?I,."GV%-!X$KJLC
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M!1E%B-1307,+&&A<FP[%<</)SY7&= 3(^UV=I1Z3D95=DC&A]]5L+X\J'.-
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M_UYSS:AQ#31H79]8JB7#ILY53;I;)7&\N,RBV"-- \10/<88_D!S P X VA
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M!>@,G2B-Q4>B8+4"CX4]C=Q;R*/_SFYK4*R5Y;U>%20PY$50)9[C<TS!FX.
M(#:@-X"$'VQZHN TSGFT!%0".3:HZ_"ZYO $="2 #@1D&(<B I$D$!]1!<@Z
MVXAOY';W"C4A\E^UV_;0 8+$[@.CO9/&*2&\$[OT"^?SP<Z/U8/B\=#E@RPZ
M(PM%U5YB-H+:<7E>D@ &, D>_CWTD)FHRC806'%^MC[:T* HQ *NRYA DV$[
MU.V-NKTCGOB1YG1EK;+JOM1_M_AEX0OL1D"Y$"NF #M? +O"&!  26#1B:^"
MV[-$?Q#02@F'!#, V3@Z"\H/-M#7<),J^\*X ')&>N"?$Z8)0UP2 <9NEHZ;
M#DD1*N04>1-'@,$X3>:PZ;I'L>L>QZY[)*.@Y*%'-;8*4%43X[V39;; R61=
M'R#@7M9Y8^+OGJ ++JX(\AH(KM<ZDS A!30#**'!."U89R1ZD_>%EBM=Z+8O
MC+BJ+ D4;(@^)RY/HO#]A05>BI]KPOCVX(A=0>P2.^JW3AM_1= Y$0.DA^!#
M;OW)) 2@2DW]S8MJ_:)KU LKBX<\YJ(@0?J-7?&'JLKWNBC(W*X7BH!R)94I
MI_&(C(D0CP#?+H(]<'WK5%M.$WK&ET@W%'18S ,6)-8)$@"$C_^IQ#$(?U&S
M(Q^G90GU0SQY4>K$RV"J,,/FRY'PZ!N,Y>@S0B>G\)AZ!>5=$C<E@LD3>B97
M]D4,-;GC53@DQUS[KN,M7>'#*F#R7),^U1&(]1@Z_'0>0UZ"+Y'P47G&OM79
MF#RJF"4*2B3#94"5" 4L9Z4'57:*[)J$_#E"])KI",8D%%0T17,J[_E:HO8(
M _X-O43\>0;4H+G9N52N+6,*?"J%DN7MG''&]O1#B(DZ@'[= (7= Q0*-RR1
MZV;]X0#_ODE]5$Q!2AGG9@F8B"/43-^V,]'6%V\3;]S(L3.<^ *)-LKHNZ[>
M58VRR+&5!T0VS]"4W<TDC >OFHK! DXC'Z0N)%F::%7K-25N>2]UV2"!=VUG
M.JBQ-5%RK.%FF SDN?;BQ5)L$8U0^F)>KL^+3XMSH?CM6N6D0_9:2N&*E5E-
MX^'FZK]_^M/5[8GL6!R52%U]U5O3UUU[BZ3GA E>!X&W"/M7SDG;"&!&$("R
M0<-G*H)'6)5SG +>D04T@;GI4S&NV53[LF]C6Y["$(M>E9O-*:L311 _SKE@
M_C :Y9[M%_#E.4Q/R$\E,"7CV#*_%[WG(MMTE'2H!%6TZT;FN& S,'UB''!9
MZ"TW'&P,_"L[S%G)!I_RCK.9+2>HN-V7JFXV>D=*\X'IY#D %5X#3TN':DKV
M6TI7!_');K8%0#?3P!-HJ;K$&A\MJKRK<E,(+M.8Y\LMUY_P4@3MQ 26Q)DE
MV)J]("?+,M"2Y<FX[5XIXMP/Q0O\! D681<]BP:'5CG9I2B:BD,BUPW#%M?I
MD :IZMSIKWUW\&D3Z"@'G@KTWMVGU/Y!O[>.36JV38)5WFF0/U!LH+:A%(8*
MC-S*():5#<;H,E/$4#(VBQV0'.R^"Y57&:E^$F&]L3Z-@G>T<_"#M1\WNJ?U
M"EGH!=F'*@\DG9"J?E3M(2HUO$[Q+?2'NA'E0YQ&\*Q>D<.7)=IK;T0#2(,4
M0C6(D#EPFO%FKWK30A'W*':)K577P(FADHN@?@YL[B*=6GQJ.(1239I4LR%_
M#--1QV$5_ A31K%E5;ZH%37%O!+1HM<V@$_<GZS"UB,UQZ3F]$)&,!T01&'C
M-(-+,>.CG3[6(47&24;XUV5!2/6<&)CDP!-KA?Z3&=$(/0\"O?_ +(]*S<EW
MM)38;S1ZP\OF870R@!JXBZFKRF=R^6^K1AZSP^5B)%P$1\V3@\\UN;.R\N[2
MB1V#A?LTM4O5I9R%?Y,VSC<W:'E:,)P6,&&TB(8W9^4+UTJCGIR*#:Z4Y_AD
M <&I[<=)6^YHN;RKR<]8%QSETZ'^PIL9Z@\%36LK] O4.:M3[D/6/1(BED;E
M]5ZW&UW.;@XS0\->@J&>7*(#&J:%>#?9_OM@2Y[+'(^%-!S[SA1\G\NQZ>$@
M;/ /,GG!VYIYYYWS*1_0R4T^_+G6\&="5+MS.L45-=]QCJ.4(MCI?>S7+K_G
MYA(ZV\I2WO.6DF/S!2*]XJ+I"P410SR]Q*HKJB1E0>(;]*&EFWXCT7SJJ\_Y
M/0UGM![O;VJDN ; I\R.6DMUY_SR!$$-6<ENFPB$+?5NMIB8BV#>8J#)$\;)
M,EW1,DKT3/<[@G-4J-Q5.RH\P7.WJXP.3>+MY\V763;.:#CLI:N<JR2#\@::
MYS>25LI,-\45""[$CW-J(\)T^)YWA>W%ZT869W),P);S4-?J7FH'#E;]:HJT
M1YHDR@;(Y]Q#T(%HJ^XIFT"<K?QBA-2-=0CBDOW#XMTEQ9)ED)MH<?(N.1<O
M%QR&O>$I;VFY8+[H&".G$-:HIKGI)X-N/[#IUFN=:6*B5_/YMMUD>\XH[:3H
MM@JVSC#9[T=BGL"+O+0A03@7^2-H-AODA%5Q_^[69O*GM\KV+&8[XB.OE#%-
MKVW3*O0;M 8&QDD?7)N5*+C^  PL;4IKS"8U9.U,7<JGM:,\9<Y'[NNJV['X
MK?QBBU"@NN;;'%P9[V1;:XK63-4M:HF^)QF8,B$U#G>H&(YC>NPC?V:+%G*I
MWSKSC2M[1,"#S@U:6B@KU(,<=N7Y77_&1_7Q@DX#SF'G:"3B8IHK1K$P'_0C
M='^>X?I:L;>3F7O9.(X-&.)M1U<:=-87:IDLLHZ6M[LAM-<^V>R?%],1&[2Z
M#P-P$^6AXS.\$,C6=  #\_:[8QS<5,N,ZM"IAM!&P^*KSG26?'8S?SO -*ZC
M@SA[JG',=+5N<IWU.-V.=TL.R"<FV,OJR.C4D.;P;*4F<DG>S<<2O40G_33!
MSM$W*<!82;7:ZK;M<^>QR40-LJD*/D!LS9G8;E<<C6.FF>+ALBH,H];[+QGA
MGJ/3<LV=</+*A&8+*"2_1:=1U5^&C;'O/XN=9+<?:2U'3\)5+'HC]O(R@[+D
M6,<KI >3+'B3Q9S(VD-)&L*EV^7C)$XEQPV!?\IQX^>+JU%AT<J:.:/HIAT%
M+W&BE/<67-]QXXAO0] A!!5XIN <!:S,?NMT'QYHF;1QW--3+"]Q'3=,9DF@
MS .D\/)3(I[CQ1Z=G[C+5-#.47\X]ZS9-TN/#O0B)PSI[-]SXF5T.\O &-].
MB(1.%-&A7N)Z=&\B]@+Q2;5MH0Q$G8IYD])]@S_)G:G*373R(V_$V5L#-['O
M!#&=RZ6!.> ,Z/=1,RDZ>QV,Y,50IQ?/FNN7,8I?X(#0_K(/LH^2VU['T;&-
MI!-\Q-FN:LW!,A#6-NG'O!92@&=%EZL!&5:RX![N&;X_W]QR)] O>AQL]N_=
M(W^.30SHJ8\+.!8=))]@&JCB1SZ9Y-/VH0=BA)F]YV'*E?^?))>Z9]WK:T9&
M%LCY/TLTN:1T62K3-WK)L7@RG1_8&C63T\[]0[_]22/1&<CB].!P5/D?'KLV
M82#1@DB_&U";+?7K<'1HT!=YR9$IHSHN_);'PJ_?X!LT:EM<8N6\S5W8DSF9
M974WWK2>2C:_%?)HVWKMCUBU*O5'2AYK])QI,$PW,*=W:L#(3A[,-F9K&RC>
M4%Z(G[H:6>Y7>]=@G/7-+NA0>MB\-KE*M1!_4;R[-8YJ+OI7OPYIE+N'CGMK
M,+>JV@U?Z#&+3A;D]#YL?S*2VN:/+DBSI3M3\K"PHTW762^AHY-3';OGK[SS
M5_/!%C!_9TKXS^3TO8FCIJ-:E[5/'6QFRS39P0EJTW"1_1 [1:%H,XU;[B%_
MF;YB=1 =&X_L-KJMNIB[C'LWNBB]58A(N@[>F/M;YL[T\':X<?ZMN6A]'&ZN
MJ_^(@-;@HE!K3'47271EKDCT?[35CJ]=PZG::LN/&R51T=, ?%]7\$O[!RTP
MW,-_^[]02P,$%     @ ]X176&.N:>EB#P  [C4  !D   !X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL[5O[;]M&$OY7%JK3R@ C\Z57F@1PG":7NTMCQ&T/
MA\/]0)$K:2\4J>Z2=MR__KZ9Y5.6;#DMK@6N@*$'R9V=]WPS:SV_R?4GLY:R
M$)\W:69>#-9%L7UV=F;BM=Q$9I1O988[RUQOH@)?]>K,;+6,$EZT2<]\UYV<
M;2*5#5X^YVN7^N7SO"Q2E<E++4RYV43Z]I5,\YL7 V]07_BH5NN"+IR]?+Z-
M5O)*%C]N+S6^G354$K61F5%Y)K1<OAB<>\]>A?0\/_"3DC>F\UF0)(L\_T1?
MWB4O!BXQ)%,9%T0APMNUO)!I2H3 QL\5S4&S)2WL?JZIOV'9(<LB,O(B3_^A
MDF+]8C ;B$0NHS(M/N8W?Y&5/&.B%^>IX5=Q8Y\-L&-<FB+?5(OQ?:,R^QY]
MKO3063!S#RSPJP4^\VTW8BY?1T7T\KG.;X2FIT&-/K"HO!K,J8R,<E5HW%58
M5[S\;K--\ULIQ2N9R:4JS/.S F3IYEE<D7AE2?@'2'B^>)]GQ=J([[)$)GT"
M9^"G8<JOF7KEWTOQM8Q'(O <X;M^< ^]H!$R8'K! 7H?9:&TA"L5C9CB7^<+
M4V@XQ;_W26SIA?OI4: \,]LHEB\&B 0C];4<O/SZ*V_B?GL/MV'#;7@?]>-,
M\D@2XC7>,IF("UA*JT7)(7&91EE[*^[>RK78ZAQ+A5E'6F4K88K;5(HM+QD.
MBK6TRP>G(M)2Y,NEU""B$&@B*S<+J7$--$LB*LU(O,N$R3=2Q(@AXP@0,#4Y
M(J#ESZ4B"HM;D>9QE(HTNC'$AY:K,HV(*U"YD+I JA&RDM NEJE:J078*W*Q
MC72A8K6-"DG<-(R**$O:FQETTKN[B6X%YPJB@; &_Y'8YMIJ8TE/*M*)?%I$
MGX6,= :E$ T\C@>K-$7R..)FK>*U4$;H,B-YH@S/)1(/)>2#Q,3M2/R O2_R
M#7BYQ>X%TJWI\O>-Z5G$B')+K,65 E)Y+5-3<;:S+LJR$@J,01Q\L>IZV^&1
M'S-50-E7!=0$*ENIK88%)7+>0+=!4QF=-AK\.+H:-98OUE$A?L9>:@DIL;'5
M')G11"F2/*RCHVQER9007XNK*A^'KC?\=%H+\"XKI,[ ]$?(E97$:B*QT1Y[
MM1P<:;3:6$ZEPKW[72&*52Q;W76"(54;53S>8-#--71 P1-M*!# @2D7_ZGX
MC2B/JTVY(4[#T?C)(XQYT=N(98*[-9JI(BK.-1*R4RON%HIH6:0;9#+$TF>B
MW$0+:)L\54G4. A;#\Q]:-QDEP.@@V8+(\C/$^256'(>J#.Y<^>2ST&Y>]43
M-\@EXB1T1R%J7IIB"P=?QZ-9_977G?C!:-I<02+>2J[Q*8+KL@I(>NXR1Z:_
M4P(J%^H;U?J^(;NIO#1W@R"*=6X,R_I6Y^76P2*LA')LT.]/939;,1G*:M:5
M%HB0+):F,53MF]4-85$948Q(PRD E'EV5ZU[M#ID4T( B&].Q0=0I3P:2W4=
M(4T:<2(F3@!%TWLX]\7W>?8T+A&X9&A^.E710J6J0.X6PRQ',O4FIV+HA<XT
MF-&'P'&#X)32>I0DBN.DXI_LH)8JIHCDRK*H-,Z0$O3,.K]!-9!P='A7>HL'
M()M3>=^N+0PB5$.)>27%CD6LWM?1-=0$Q+3A6G%-I:# H@P:S!<H#U&=$TX\
M?Q3T_<CS1I..'[76R.Y52\3I]ZX]]OFT[^PXZ+N+#]_C*7S)MRS-59Y6P?1W
M2C=@H%M4CG@>X4SIQ:A$4>8%:[SF,HV=*L'+*D/WC-+;I4ZQMCK\#:DKR3<<
MW00BFJ)K'=BNH"R< ;\GR",VIZ:WK (BI&4:=46)$8JV$O<4R2X.6& J!!&3
M"3@&;E2Q9DI1PND94D6,3/ P"/)FM@ IK 6<*R%[G01!K^ T?*2-*#D:93C7
ME1E)O)8I<]0IWR1= B2.YQCQ+%'63)MP6"F),G&:FU)7PC%*S HK'4ECHYDJ
M0V$#\H#452HA@[.SG5]=B*DW?NJ[3H/;^OGLJ7B+[Q0O'2.MX:H+*:%_<%6Y
M-AHF4-5<67D_"0B'RK34L/A?2XC)6G&#D7A3<D*'/-NT-%^2@2YU3F6OXW:=
MH#P10\@SG\]/Z:,W=\9C9)@W$4KW=926;/1MQZ#^%+G+%?[$<<?N+G.[F8UT
ML*P>02TK.6P?X1**;!.G96*-5V6!/%L]A?DWO:2:[ZF?KZI<?D6Y'%5S36B(
M".W1PQ?H]=5=*I!M(5<J(\A#FN.J?R*L6O$A])R9%S1XAR)2A+[PO*D%11+?
M^>)\.A:3J6]CJ0N<O]G!.=Z<_II68QNI1 P#CZK$V M/Q3E'I8)+K@A8#H-@
M3 5DYDP"E!0TUVB=X9J<9V, NL^QU1)E+&$_8Q,8>X:USMP+#LF- .U(;'VJ
M%;W5?=>9OD#IASWS@.XK3ST1P<3QYC/QW>>M#084LU)G(N^S!%&],5Y],-WJ
M+B7<,9Q[+G2' '"APZK-TSOVF+KT]ZO-=K1A@GE(AIE,)P_H9L<^-HP;]7"D
M-LN;UJ9>OLA1U!.JR44=D:*"7D6OM2%L@<R(L".U 4$4NN0$ZE#A0"$LL"B.
MRZUBB.90CVG#NMJJ--6-#EV;3-NT70%ZBU0;R/ (!$UIB#!]GM6YG5827,$C
M*D\ G^H4,8Q19U1Q>D9A>1P O NI=WRX%_XGE !.. 7@-0@/)(+)9/R0ZP[9
M=RFZR7OYW9MZ2 $;:LI^:4 8R3FD;'!Z9OW:G\+C?'\F)OY8?/^@%KAF3'TN
M&'[HT;L_#G9M9$RYV5IMLYW8L/!#TC1T#Z/$C66:!@EZ2B3E=L51?,<J-939
MS]=OVPA]J;%? W^0?]I(#4=S\41XZ)[H=8S7CW29QS-M4TE!I66$/C  &GXB
MJ+>BUQ"OK=6KA?NM'_ 6]2LMM)T';:/EFA1W30D8W^79D Q_^MMX\TZ%>7H
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MT/;71?9+D6_Y%SV+O"CR#7]<RRB1FA[ _66>%_47VJ#YB=?+_P)02P,$%
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MB6RV5:R P/%/%-SE?B;V\+!+_V_W"/"8)92 CEF42#,-)NB1AA+.P7DQY@&
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M_Z-N8 FX/+Q_J#)X2& 2ZQ3:&YDF5Y4:<(S$#NFU);Q(*@/%2, ,-%=G.EO
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M6R5QN:$->+\VN&'V#Z1@_-I\_1]02P,$%     @ ]X176- O^%S* P  ,@H
M !D   !X;"]W;W)K<VAE971S+W-H965T,S(N>&ULK59M<]LV#/XK.*VW3SKK
MS995S_9=TF2W?FB;:[;U=KM]H"78XDJ1&DG9S;\?2,F*DR:^9MT7B2_ @P<
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MP[L)C3]\J-Z:R$G%2;EUAE8EV;G)#>;"80K7PCB)]GC@")27!DD#<%H#Q"\
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M'Q*Q"."\]#X>%F)@_.=:_0M02P,$%     @ ]X176/IS@@8S,   @ZL  !D
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M;:]#(P,YM*6K+WA]$5=[5^R;ZO=!)N(3S4?Z'4B'X7 416X%HW!U\ &H=$!
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M2 !ZH50%;,61 "'Z.FAU8G2@MHT"O^KW@25>(HM8@$ \TKA:%$!1J&6")8B
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MA!*;Z-9Q?@N\4*UC0,T]H!"<)'+: LR= G;A34C<;($M<1P=CI<X'WQ>#J*
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M@7)(P6;OV>XD6@4]&+F!LL8)V^],ZJY0K<"B1-9/X6_.UAHH3M6A/&XQ#B<
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MPG)Y00P^U&=/(QE.KJTQ#,:)7QN2-\2 8C@+SFN'\<T-G7OC;MJ^$J4T\**
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M.Z2RZ^PB^TS>_6FW0W?5;@#-C"PMMI<^X+]]>,MDU<8QG\F//[;HP;UU^ZI
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M6/52AX.9:F3=4:;T'F_/VJ+GF]1?L<MIK*B@$$G/N%8)-X@'RX<'@V$4EN-
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M+.B&C)H%Z'^NE.T_V,!PYU[^!U!+ P04    " #WA%=8.YW*H_ "   _!@
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MH[(&M%]):0X+>\#TSUC^!5!+ P04    " #WA%=8R1$YSG@#  #V!P  &0
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M.9W[[A*S H8,\'VF<0.5#[1 ?=<\_1M02P,$%     @ ]X176.=-?/]  P
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M0#7#JC&,W-0#8BD-C9MZF]-\1V4=Z'XEJ1@[PR9H_S$F_P!02P,$%     @
M]X176'E^0%7Z P  6PD  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL
MC59M;]LV$/XK!ZTH$D")WFW)M0TX+]T*M%O0M-N'81]HZ6P3H427I.)DOWY'
MRM8<QS'Z1>11=\^]\!Z2XXU4#WJ%:."I%HV>>"MCUJ,@T.4*:Z8OY1H;^K.0
MJF:&1+4,]%HAJYQ1+8(X# =!S7CC3<=N[4Y-Q[(U@C=XIT"W=<W4\Q4*N9EX
MD;=;^,J7*V,7@NEXS99XC^;[^DZ1%/0H%:^QT5PVH' Q\6;1Z"JS^D[A3XX;
MO3<'F\E<R@<K?*HF7F@#0H&EL0B,AD>\1B$L$(7Q8XOI]2ZMX?Y\A_[1Y4ZY
MS)G&:RG^XI593;S<@PH7K!7FJ]S\AMM\7("E%-I]8=/I9D,/RE8;66^-*8*:
M-]W(GK9UV#/(PS<,XJU![.+N'+DH;YAAT[&2&U!6F]#LQ*7JK"DXWMA-N3>*
M_G*R,]-/C6'-DL\%PDQK-!K.OC&2]/DX,(1OM8)RBW758<5O8$4Q?)&-66FX
M;2JL7@($%%@?7;R+[BH^B7B#Y24DD0]Q&"<G\)(^V\3A)6_@_2IEM>%" &LJ
M>)WZ#=>ED+I5"'_/YMHHZIE_CM6A\Y(>]V)Y--)K5N+$(Z)H5(_H3=__$@W"
M#R=R2/L<TE/HTWOB9=52T'(!'WG##5Y\IL8^DL^QR$]B'X]\#Y=U=6)4(%9+
M9?B_Y-=R"VRQ+ $N+*3E"=<@'U&!62%7@-IPHA!IMQH7K0!!(6N? ($0@0X7
MLP+>6&TPMO]@;L^+$=SVAM\[P\]\@7#MB$'H"@6S[-8KOM80#> "X@2>D2D-
M?Z@*+67+!R&7L%O]IEB%T+ :=;]V1QC8&*B(09;B,-PI8[EJ))D_[U+/=G\H
MT)(I]<R;I:U%2^:T(:][BE)S675F:(D!U-98SRFX76N[?J1)#%0V9HT$9:]'
M1S0/5V*XEMK F2N>;#4AZ?.W"O0.4C\L0C\IDFX^'/AIDAV4*DLC/PECR)*!
M7R3IBY*]9_7Z \R5=4/N4W^0)=T81Z_K& W)UV#@QCC)C]0S(E]Q-H0H#OTB
M)U_2, &E32GSHW3H%\/(SL+"C^E\F95E6[?"-<2V UUZ<$8P14QZ@W,XRY/0
MS[+D''ZGWK(W CPRT2*EG/AYEOGY('/IQ\.<XB_@!"NSGI79S[.R-?8(.>P%
MF.T'?/M$]ZK&8QP]Z>DX1[<N^0%57]8(.Y<_U9(I&/EJ,3]LSX.N<W94Y#3U
MLRBW8@9Q7-A=L0)]HI2*7UAA:#]^EA0=<)073NCV_QU$?I33)M+F']N<8._"
MHRY?NFM=4]L0#;N[KU_M7PZS[L+\7[U[=GQA:LD;#0(79!I>#JGZJKO*.\'(
MM;L^Y](0I=QT1:\?5%:!_B^D-#O!.NC?4]/_ %!+ P04    " #WA%=8>#F"
MSU,#   U!P  &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6R-56UOVS80
M_BL'+1C:0K DZB5R9AM(FG4;T*)!TFT?AGV@I;-$E"(UDHJ3?[^C9+M.YQC[
M(O'E[KGG>+R'BZTV7VV+Z."ID\HN@]:Y_BJ*;-5BQ^U,]ZAH9Z--QQU-31/9
MWB"O1Z=.1BR.BZCC0@6KQ;AV9U8+/3@I%-X9L$/7<?-\@U)OET$2[!?N1=,Z
MOQ"M%CUO\ '=[_V=H5ET0*E%A\H*K<#@9AE<)U<WF;<?#?X0N+5'8_"9K+7^
MZB>_U<L@]H108N4\ J??([Y'*3T0T?AGAQD<0GK'X_$>_<.8.^6RYA;?:_FG
MJ%V[#,H :MSP0;I[O?T5=_GD'J_2THY?V$ZV61Q -5BGNYTS,>B$FO[\:7<.
M1P[E:PYLY\!&WE.@D>4M=WRU,'H+QEL3FA^,J8[>1$XH7Y0'9VA7D)];?78M
M&O@H^%I(X01:>/.%KR7:MXO($;ZWBJH=ULV$Q5[!2AA\TLJU%GY6-=8O 2(B
M=F#']NQNV%G$6ZQFD"8AL)BE9_#20[;IB)?^[VQOA:VDMH-!^.MZ;9VA:_+W
MJ=0GX.PTL&^=*]OS"I<!]89%\XC!ZL<?DB+^Z0SM[$ [.X>^>J!6K >)H#?P
MGQ1.D3T/]Z5%J+@QST(UP#L]*'<2&:CG@1;A&;FQ@+ZH0"7!;DV&^[( 5[4?
M,! 6N'>2U.GVZH3E]RL,W@A%$?1@"<2^A5]0H>$2J PUCL#Z$4U+8@/R&Z]W
M< %9D89ER6B4IW'(X@SNT%BM%$K2"LD=OG"!M,S#;#Z'=)Z'9<'@<T^!G#\
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MU%% @>X7L'RH4]8:OD=\&R649)Z?VEYF4R"#R]H&^G^L#_::JQ4>J'B%+%/
M<KCPDB.4'WLAH> G7A)FX%,OS0C<*28TZ_XG,**EX&#P'V5O<QON??CT+3HW
MR'SX%5E4'0J_ALRC28JQDV0!!$'0)<(A)EXNB#'GW.5HYB6!CST_I5Z()GW]
M3N154Z#F7<)I+?/2W6Q;FK7C;]T2C>Z(1@U$4UFBZ>RX.ST22?$02?&S(ZEC
M<^N?)X5K+*Z.(H\7J\OQZN.Y6^?X_V'K>8,VK1_I8AYJW \=;<E%5:Y<B&C8
M8L#9BM26/7T&\XXQ'Z/8?6>'X>I(&KW34JD=1M"R:5L3HH=!LK>0NK"R4<+9
MLN4*8GG2[X/BQ1Z?'_%3,O@I>;:?'HKQ3<NEVN;8P>_%F,..'C'NL(>S5,_<
MVD-/U1M5.OJNT0[,2"QWUB 8IU@R;/';%R_0"2AJO;@[QC86X2GC//'NF$[?
M\F,QE R;I]% T^2@4H ?/2XE0WD89.G!2CC@]2M]4&3#.6FW,A8<T[UW@F,_
M^QJRA('&;9\,P^SPX+ILWQD/XNUK[2-3JQ)SI.)+W$I.$ZP&JGT!M0,C-^[5
ML9 &WS"NN\9'(U=6 ->7$O^2NH$]8'B&SOX'4$L#!!0    ( />$5U@,2-='
M( ,  "4'   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;)5546_;. S^
M*X0W#!L0U+:<)D6:!$C;*S;@=BB:WO8PW(-BT[$P6?))<K/>KS]*=KQTEV:[
M!UL217[Z2)'4?*?-5ULA.OA62V474>5<,XMCFU=8<WNF&U2T4VI3<T=+LXUM
M8Y 7P:B6,4N225QSH:+E/,CNS'*N6R>%PCL#MJUK;IZN4.K=(DJCO>!>;"OG
M!?%RWO MKM']V=P96L4#2B%J5%9H!0;+1;1*9U=CKQ\4/@G<V8,Y>$\V6G_U
MBP_%(DH\(928.X_ :7C$:Y32 Q&-OWO,:#C2&Q[.]^BWP7?R9<,M7FOY612N
M6D07$118\E:Z>[U[C[T_YQXOU]*&/^QZW22"O+5.U[TQ,:B%ZD;^K8_#KQBP
MWH %WMU!@>4-=WPY-WH'QFL3FI\$5X,UD1/*7\K:&=H59.>6-VC$(_>1L?#V
M@6\DVG?SV!&RWX_S'N6J0V$OH*0,/FKE*@N_J0*+YP Q41IXL3VO*W82\0;S
M,\C2$;"$92?PLL'/+.!E/_43/BCK3$N)Y2QP5<![++9";6'E$T0X09&X$3:7
MVK8&X<MJ0^J4/'\="TMWZ/CXH;Z@9K;A.2XBJAB+YA&CY9M7Z22Y/.'2>'!I
M? I]N:8"+5J)H$MXP3VA8.VX0[_R:K="<94++N%.6^'+8@2W7!CXQ&6+QQP\
M2>&X@P\50NE!'SVH]><Z$EWKNN'JZ<VK"Y9.+RV5SD"Y'&B)[^1'X(L6MD9;
MZPM/D(33A73M0_R#A7?/(Y=:4F_Q5^A\ L\H&CG6&S1# OU'PF!E+;6\WP7?
M""G<$_RA?3B(PHL;;\-QNK64-/;=C\O#0BK0BJVBN!? +51]?AWX-J-;<D@1
M<W!/:G#-&PNO(<2&7=(L'5U,TS!.DH2^B9\S^F6C;)+1R$9IO_$<:;WCS8!S
M/DX(8:^XEV;)]$#ZH!WY5OP?]L^8LM$X3<,X3=(1"R1[II-I$D;6;QS+^?B@
M==5HMJ%!6\AUJUS7Q0;I\ :LNM;W7;U[0#YR0TPM2"S)-#F;GD=@NJ;<+9QN
M0B/<:$=M-4PK>L?0> 7:+[5V^X4_8'@9E_\"4$L#!!0    ( />$5UC1POLV
M3@,  ,H'   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;'U586_;-A#]
M*P>M&&) C23*LN7,-I"D*U9@68,F;5$,^T!+)TNH1&HD53?_?D=*UM+&UA?Q
M2-V]>\=''M<'J;[J$M' ]Z86>N.5QK170:"S$ANN+V6+@OX44C7<T%3M ]TJ
MY+D+:NJ A>$B:'@EO.W:K=VK[5IVIJX$WBO07=-P]72#M3QLO,@[+GRH]J6Q
M"\%VW?(]/J#YV-XKF@4C2EXU*'0E!2@L-MYU='636'_G\*G"@WYF@ZUD)^57
M.WF7;[S0$L(:,V,1. W?\!;KV@(1C7\'3&],:0.?VT?TMZYVJF7'-=[*^G.5
MFW+CI1[D6/"N-A_DX0\<ZG$$,UEK]X5#[QLO/<@Z;60S!!.#IA+]R+\/^_ L
M( W/!+ A@#G>?2+'\@TW?+M6\@#*>A.:-5RI+IK(5<**\F 4_:THSFS?MZBX
MJ<0>_D0J3L/%(]_5J&?KP!"\=0JR >JFAV)GH"(&=U*84L/O(L?\1X" >(WD
MV)'<#9M$?(/9)<21#RQD\01>/!8;.[SX#-Y0XM_7.VT4G8=_3A790\Q/0]@[
M<J5;GN'&HTN@47U#;_OK+]$B_&V"X'PD.)]"[PG"K=3F%+/)V-/,>L", #5=
MH4PJ$@8ZDD>!')6O^VVA&PZF1'A"KC2@U1!( 6QVY'U4P7T9<)%;(X(#*@1N
M@VNZW_H*OE#TN> 7*^S%2@07E2 :LM.40\_@_8\TAUI>P7SAIRPD(XG]-'5&
MY%,K@G<BDPU"H61#K6;W>JCN(O*C,)ZY<9&X,8[3&?Q%C4^>RY'XRVAIH1D9
MB5U9^>F"P834R2AU,BGU [77O*L19 $_74*XXZ93E7DZ=0@F44\?@K<=P:'M
M'E73-4.-+7^BWDIE]J=!2/$ZXR+#VE[_XY$@88G>2QU?J'XW8"N"Y/7/&E+,
MW&Y>Z*>KN9TE$,_])$VLO0"V\J,EL_82Z(2QQ/FD$"6^3?984C9>&$L@]E>K
M%!ZE35),EA4M%_Z*P/L=K9JV,W0D*T$PJ W)/_>C530;L%Y!M""-X^2DM,&S
M_MJ@VKM71-,QZ83I6^VX.CY4UWU__M^]?^7NN-I70A/;@D+#RR7IJ?J7HY\8
MV;INO9.&>K\S2WIL45D'^E](:8X3FV!\OK?_ 5!+ P04    " #WA%=8MD3G
M9Z "  #P!0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q]5%%OVC 0
M_BNG;)I:B37!@98R0()NT_;0#;7=]C#MP4D.8M6QF>V4\N]W=D+&)LH+.=OW
M??=]-G>3K3:/MD1T\%Q)9:=1Z=QF',<V+['B]D)O4-')2IN*.UJ:=6PW!GD1
M0)6,69)<QA47*II-PM[2S":Z=E(H7!JP=55QLUN@U-MIU(_V&W=B73J_$<\F
M&[[&>W3?-DM#J[AC*42%R@JMP.!J&LW[X\7 YX>$[P*W]B &[R33^M$O/A?3
M*/&"4&+N/ .GSQ/>H)2>B&3\;CFCKJ0''L9[]H_!.WG)N,4;+7^(PI73:!1!
M@2M>2W>GMY^P]3/T?+F6-OS"MLE-KR/(:^MTU8))0254\^7/[3T< $;)"P#6
M EC0W10**M]SQV<3H[=@?#:Q^2!8#6@2)Y1_E'MGZ%00SLV^:/4VKXU!Y4"[
M$@U(P3,AA1-HX>R!9Q+M^21V5,LCXKSE732\[ 7>/H-;K5QIX8,JL/B7(":1
MG5*V5[I@)QG?8WX!:;\'+&'I";ZT<YX&OO0%OB7?!7/ 50'S/#<UEQ9^SC/K
M#/U7?AWSW# .CC/Z_AG;#<]Q&E&#6#1/&,W>O.I?)N].Z!UT>@>GV$^_U#&Q
M)^F.BWTH$7)NS$ZH-?!*U[[6"D[_26@R &W"#KFQ@/ZY@1X+JXP2]P\6;ID"
M!H)NW(,DS0,[/I+Y_PZ#,Z&H@JXMD=AS2EB1F0(R5!0YV+0S0F=2K+EO=ML#
M10/M3&F'P/KG\!KZ@]Y5.O)!VDO2%+X&'^K V:$G*LTN$V##'F-7!!H,>]?7
M'IV.PL&Q]XP/NK!"LPZSQD+N;[%IR&ZW&V?SIHO_IC>S\):;M5 6)*X(FEQ<
M#2,PS7QI%DYO0D]GVM&$"&%)(QF-3Z#SE2;G[<(7Z(;\[ ]02P,$%     @
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MCI<6HFG!,N_%G'=BQ!-BN& ?FMJN#7M;%ZK8%["$3J-B8E#L7!R4^$;E+UG
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MH")?"#]P4( LD$1#0",D6@>F$[S#77EH9*CG* F1GW"WINO%^";%]8/OR B
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MH@5XOVH:.SS0 >,_%D[_ U!+ P04    " #WA%=8(K60.V0)   @(@  &0
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M'H"$2_V]6 U]A._(\P;C=QAC,0BEQA'T#A&]@V=@=^!!O>9%PZ!;AUBKJN\
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M9P65W4#KI93F-+ 'C+\_VV]02P,$%     @ ]X176-K,#7:\ @  Z04  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3@N>&ULG51M;]- #/XK5D"HE:+EK:^C
MC=1V("8QF+8!0H@/U\1MPI*[<'=9MW^/[Y*&(KH*\26Q[^S'C^VS9SLA[U6&
MJ.&Q++B:.YG6U;GGJ23#DJDS42&GFXV0)=.DRJVG*HDLM4YEX86^/_)*EG,G
MGMFS:QG/1*V+G..U!%67)9-/2RS$;NX$SO[@)M]FVAQX\:QB6[Q%_:FZEJ1Y
M'4J:E\A5+CA(W,R=17"^'!A[:_ YQYTZD,%DLA;BWBB7Z=SQ#2$L,-$&@='O
M 5=8% :(:/QL,9TNI'$\E/?H;VWNE,N:*5R)XDN>ZFSN3!Q(<</J0M^(W3ML
M\QD:O$04RGYAU]B.I@XDM=*B;)V)09GSYL\>VSH<.$S\9QS"UB&TO)M EN4%
MTRR>2;$#::P)S0@V5>M-Y')NFG*K)=WFY*?C19+495TPC2E\U!E*6(F2VIN9
MNC\@O!=*0>^.K0M4_9FG*:1Q])(6?MG A\_ !R%<":XS!6]XBNF? !YQ[0B'
M>\++\"3B!29G$ 4NA'X8G<"+N@)$%B_ZSP)<\D24"#U3B+X+'VA.Q ;NV"-\
M6ZR5EO2LOA^K2Q-U<#RJ&;5S5;$$YP[%4B@?T(E?O0A&_NL3.0VZG :GT.-;
M&MVT+M P_;?\CF5P.L979!+0-!6H)5BN"7G?EK].0NCE''0F:L5XJOJPJJ5$
MGCP!%9 K8F<G-/U!#YXF7BMX";U@,'6#P:1OY?'0C4;3/J6C:R9S5L"6-@Z0
M%XT@44MAC9PD#56[,:J"<1B[$S^B[W X;9XR721,9;"A;014I2VU-G2#4="'
M7N2.0PIW)S3!6P*1._1'+8' '4:3_K'N> ?C5Z+<VB6C(!$UU\TD=J?='ELT
MX_O;O%F"5TQN<ZZ@P VY^F?CH0.R62R-HD5EAWDM-*T&*V:TBU$: [K?"*'W
MB@G0;??X%U!+ P04    " #WA%=8.JU)Z8P"  #2!0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6R55-MNVS ,_17"*X8.,.I;+FV7&&AZP?I0H&AV
MP3#L0;&96*@L>9+<='\_2D[<#$V#[246*9W#0S+D9*WTHZD0+3S70III4%G;
MG$>1*2JLF3E1#4JZ62I=,TNF7D6FT<A*#ZI%E,;Q**H9ET$^\;Y[G4]4:P67
M>*_!M'7-].\9"K6>!DFP=3SP566=(\HG#5OA'.V7YEZ3%?4L):]1&JXD:%Q.
M@XOD?#9P[_V#KQS79N<,+I.%4H_.N"VG0>P$H<#".@9&GR>\1"$<$<GXM>$,
M^I .N'O>LM_XW"F7!3-XJ<0W7MIJ&IP&4.*2M<(^J/4GW.0S='R%$L;_PKI[
M.Z*(16NLJC=@LFLNNR][WM1A!W :OP%(-X#4Z^X">957S+)\HM4:M'M-;.[@
M4_5H$L>E:\K<:KKEA+/YO&T:@51ERP1<<5,(95J-H)9PR4P%-]0UN)5=]UT9
MCS^SA4#S81)9"N](HF(3:M:%2M\(E:1PIZ2M#%S+$LN_"2+2W8M/M^)GZ4'&
M*RQ.($M"2.,T.\"7]<7(/%_V+\5X2?^Z\QGX<;$P5M,?Z>>^[#ONP7YN-USG
MIF$%3@.:'H/Z"8/\_;MD%'\\H'S0*Q\<8L_G-*QE*WS?_K>E^W(Y&&U_+O =
MF09TK05J#-8+U'US7GG25YX$CKD$6ZG6,%F:#YW8AO$22"IP:9%B63@BP#@\
M&P_IE"9Q>):<TBF)1V$:#U^!"E4C6/:,!HXE[3@J HU]ZP,0:I2%X['')Z,P
M(U5',!R&"1'M:TJT,V<UZI7?)@8*U4K;C5SO[1?613>G+\^[;7?'](I+ P*7
M!(U/QL, =+=!.L.JQD_M0EG: ?Y8T=)%[1[0_5(INS5<@'Z-YW\ 4$L#!!0
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MA3B,T&U1Y>P1 ,U974K^B#ZPA&@!)ZC.W<!_U/D 80L<M, .QE$;UL@ 1V>
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MQ8,+193;Z=8N)*O,@+AB4HV;YC0#D@+7!NK^FC'YM- ;M/\QQ/\!4$L#!!0
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M34)>R1?S3%:?8%_'^GK%>"L5SQNP'N=I47_3[XT01P#HGP&@!H"& /<, #<
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M^#,5J[20(&-+3>G<!MKEHF[&U@/%-U5[\H4KQ?/J<LUHPD09H.\O.5>'0;E
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M)R=35DJNX(,'DI,RH0+<@OV84+G(%9A665 NP&!&)<ER<:.,7IYG8/#A!GP
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M.:U$3DJX9XA718'9/RO(Z6EAN=93QP/99T)UV,OY >_A$<3GPSV3+;NEI*2
MDA-:(@:[A77C7L>N%NB(/PB<>.<:J:EL*?VB&K?IPG)41I!#(A0"RZ\CK"'/
M%4GF\;6!6NV82MB]?J)_T).7D]EB#FN:_TE2D2VLJ852V.$J%P_T] LT$YHH
M7D)SKC_1J8EU+)147-"B$<L,"E+6W_A;8T1'X 8O"+Q&X#T7A"\(_$;@OW:$
MH!$$KQ5,&H&>NEW/71NWP0(OYXR>$%/1DJ8NM/M:+?TBI?JA/ HF[Q*I$\M5
MQ64/YVA-BRTIL:H>1S^A7S%C6-7P/5H1*B!'-\G7BG"BR_MV P*3G+^3D9\?
M-^CMFW?H#2(E^CVC%<=ERN>VD-FI,>RDR61=9^*]D(GKH4^T%!E'<9E"V@?8
M<EKMW+RGN:V\4>)OB;A"CO<>>8[G#R4T+M] <H5\]T7YYO5R;T >OU[NCICA
MMX7V-<__KT)WZ_C7G>Q#MP(*_O= BJL:&0PCU1YVS0\X@84E-RD.[ C6\L<?
MW-#Y><AMD["-25AL"-:K2]#6)1BC+S]@PM 1YQ4@ND,)YAE*Y!(D*3"]&(?*
M,DJ\M"PU+-0P];=R7$9N%(9S^]CU^SS*Z4?$YQ&3F1L$T:2-Z_DS:?V9C/KS
MD=+T1/)\R(=1Y:4^3,[RG\F%ZW3RKYTXCYO.(C>,GOLQQ/.CF>\.^Q&V?H2C
M?C2[\8.<$&9)AN[NUD/6C$(NM<8D;&,2%AN"]2H1M96(S.^HD<FZF(1M3,)B
M0[!>7:9M7:;&=]3IV6(-IZ[S;$FO1\>]U&^3L-@0K.?WK/5[-NKW6CF,U1I@
MD*(=HT7=JE?$D-LU;])QVPW.S!X=]%*S3<)B0[">V:[S_8'=&;7[MA2XW)-M
M#@AS#F+H47O5,+H6^^&YQ^-#76JR45ILBM:WN7,N<O_W<T<C[6X7GC_@[N@(
M%[MKDA:;HM7NVIT#: %LKT_^7&Z[52GJ\UK;V[Y=N-%GZF?]:_7601]LOV/J
M5Q:?,-L3>33-82>1SE4D?]NL?@M0-P0]Z&/NE@IY:-:7&6"YZ:L >7]'Y8-3
MTU #M.]BEO\"4$L#!!0    ( />$5UA$B**!J0,  )P1   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8Y+GAM;*U8;6_;-A#^*X16#"V06F^6'6>V@-A6MP+K
M&C1M]V'8!T8Z6T0E42'IN/OW(RE9D6Q9C0M^L"U2]SR\>TZB[SC?4_:-IP "
M?<^S@B^L5(CRQK9YG$*.^8B64,@[&\IR+.20;6U>,L")!N69[3G.Q,XQ*:QP
MKN?N6#BG.Y&1 NX8XKL\Q^R_)61TO[!<ZS#QB6Q3H2;L<%[B+=R#^%+>,3FR
M&Y:$Y%!P0@O$8+.P;MV;R-4 ;?&5P)ZWKI$*Y8'2;VKP/EE8CO((,HB%HL#R
MYPE6D&6*2?KQ6)-:S9H*V+X^L+_3P<M@'C"'%<W^)HE(%]:UA1+8X%TF/M']
M'U '%"B^F&9<?Z-];>M8*-YQ0?,:+#W(25']XN^U$"V .SX#\&J =PR8G 'X
M-<!_Z0KC&C!^*2"H 3ITNXI="[?& H=S1O>(*6O)IBZT^AHM]2*%>E#N!9-W
MB<2)<+GC<H9SM*+Y RFPRAY';]%?F#&L<GB%/A8QCC$#=!L_[@@G.L&OUR P
MR?@;:?OE?HU>OWJ#7B%2H,\IW7%<)'QN"^F?6L6.:U]6E2_>&5]<#WV@A4@Y
MBHH$DBZ!+0-KHO,.T2V]0<;;DHV0YUS)C^?W.30,7T,\0KY[%KY^.=SK@4<O
MA[L#8OA-JGW-Y_\HU>T\_O.GG$/O!>3\WQX7EQ7EN)]2[6(WO,0Q+"RY37%@
M3V"%O_[B3IS?^M0V2;8V2189(NOD9=SD93S$'OY.:;(G6=8G_R#R4ODKLHDF
M4W\@3^%,/IC.-)C;3VUE3^VN9U-W,G6Z=E$?GS^=^6YCU]$C:/0(!O5H/YX,
M,BP@03'EHF]'60Y272I0<!+01)H>J7-J=*S+D$5'D4FCR&10D<,.W"? (/)2
M 4R2K4V218;(.O)/&_FGYC?.J<F\F"1;FR2+#)%U\G+=Y.5Z\+6X Q9#(60]
MB^@&\535*#$NB<"9+$!EJMAQ$5&EIF)UG?8+.@K<[EN\&ES[4LU-DD6&R#J:
MSQK-9X.:-^]"_%PO7LF![!P28'J(!,,%WP [(__L9'L,7.=H#UT->G&I^B;)
M(D-D'?5=Y[E<=WZZ6*BA04M9UQ^?2#N\PJ7:&F6+3+%UU6TU0ZZYTJ/FZI0+
MWJG:@RM>K+9)ML@46Z6VW>I"<V!;W?ZKC6)7B*IE:V:;(X9;W5@?S:_4T8/N
M;I]IJG.+#YAMB>Q/,]A(2F<TE<\ZJXX"JH&@I>YU'ZB0G;.^3 '+G4D9R/L;
M2L5AH!9H#F3"_P%02P,$%     @ ]X176)ND6:L(!   T!$  !D   !X;"]W
M;W)K<VAE971S+W-H965T-S N>&ULK9AM;Z,X$,>_BL6M3JW4"X\A22^)U"2L
MMJ?=5=5N[UZ<[H4#DX 6;-8VS:YT'WYM(!0(X9H3;P*8F1_C_S@>V_,#95]Y
M""#0]R0F?*&%0J2WNL[]$!+,1S0%(M_L*$NPD(]LK_.4 0YRIR36+<-P]01'
M1%O.\[8'MIS33,01@0>&>)8DF/U804P/"\W4C@V/T3X4JD%?SE.\AR<0S^D#
MDT]Z10FB! B/*$$,=@OMSKSUS-PAM_@S@@.OW2/5E2VE7]7#?;#0#!41Q. +
MA<#R\@)KB&-%DG%\*Z%:]4WE6+\_TM_GG9>=V6(.:QK_%04B7&A3#06PPUDL
M'NGA Y0=&BN>3V.>_Z)#:6MHR,^XH$GI+"-((E)<\?=2B)J#8YYQL$H'J^5@
MGW.P2P>[Y6!99QR<TL%YJ\.X=,B[KA=]SX7;8(&7<T8/B"EK25,WN?JYM]0K
M(FJ@/ DFWT;23RQ7&9<MG*,U3;81P2I['/V&/F/&L,KA#7IXO$-W_K<LXE&>
MVZL-"!S%_!J]0SKB(6; 4430,XD$OY&-\OY+2#..2<#GNI!1JF_I?AG1NHC(
M.A.1::%/E(B0(X\$$#0!NNQ>U4?KV,>5U4O\(XM'R#!OD&58)O*2-*8_ .K1
M%Y>N6/O)&_!'R"[(-GI^VJ"K=]?5%SIXF[?SK".O ^.]'6-V8QI"VM5@L7.N
M_5^#I3X<_OXHV]"]@(3_TQ'JJD ZW4@U#][R%/NPT.1$QX&]@+;\]1?3-7[O
M2L>0L,V0,&\@6",O3I47IX^^_)PE6V"([A"40X^C?_N&X:K@C7.>JB4O2WMJ
M&,9<?ZFK?6KEF&;;:M,;VZ4R#@1KR#BN9!SWRGA/!.Q9/@7*&AAC 0'R*1==
M$\.J%W7IL"Y@;EUHQYRX+:%/K>R9.QLWK;Q3*W,VM5R[,FMHXU;:N+W:?*$"
MQV@G*P3Q([(_KTLOYE)=W--A:KON;-82YM3,LF83VVPI<VIF3BW'.J/,I%)F
MTJN,*H\? ,<B1$]^!,0'603OB=\E3B_I4G&&A&V&A'D#P1KIF%;IF Y?HZ9#
MYF5(V&9(F#<0K)&769676>_?I,H+?LW+3;'P0BF+?$!7:@TIURJI+&5Y^[4L
M8J^+M*Z\S4[FNFF[AO5&=6DVAH1Y \$:V3"-UW6_\3_R0:J5Q'%=SWDFRZ#*
M3=&BDG(^(>5'3;.6$F/DF%:K2JW[H[LT+X/2O*%HS<S4=F3F,*6VGW/IM%72
M&@L'USE9[769329M,Z_#;.K6S0IQ]-K.-0&VSX\,N.QR1D2QP:M:JV.)NWPS
MWFI?J^.*?$?\BBG..CYAMH_DGC:&G40:HXE< +#B^*!X$#3-]\=;*N1N.[\-
M 0? E(%\OZ-4'!_4!ZI#G.5/4$L#!!0    ( />$5UC:?HHO0 0  $$4   9
M    >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;*U876^C.!3]*Q8[6LU(G?(1
M0I)N$JE)&$U7.U+5[LP^K/;!@9M@U6#&-DG[[\<&0D-"V4;R2PNVS_'U.5S'
MOM,]XT\B 9#H.:69F%F)E/F-;8LH@12+:Y9#IGHVC*=8JE>^M47. <<E**6V
MYSB!G6*26?-IV7;/YU-62$HRN.=(%&F*^<L"*-O/+-<Z-#R0;2)U@SV?YG@+
MCR"_Y_=<O=D-2TQ2R 1A&>*PF5FW[DWH>AI0COA!8"^.GI%>RIJQ)_UR%\\L
M1T<$%"*I*;#ZMX,E4*J95!P_:U*KF5,#CY\/[%_*Q:O%K+& ):/_D%@F,VML
MH1@VN*#R@>V_0KV@H>:+&!7E7[2OQSH6B@HA65J#500IR:K_^+D6X@C@^F\
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M4_DE-U"?WZ4*),J+_)&2ZA&BY?]02P,$%     @ ]X176+!N/'1, P  T P
M !D   !X;"]W;W)K<VAE971S+W-H965T-S8N>&ULS5==3]LP%/TK5H:F(0'Y
M;E+61N)#;$@,(;[V,.W!;6Y;:X[=V6Z[2?OQLY,0$A(B$'W@I;6=>X[/N;E.
M;D8;+G[)!8!"?S+*Y-A:*+4\M&TY74"&Y0%? M-79EQD6.FIF-MR*0"G.2BC
MMN<X SO#A%G)*%^[$LF(KQ0E#*X$DJLLP^+O,5"^&5NN];!P3>8+91;L9+3$
M<[@!=;>\$GIF5RPIR8!)PAD2,!M;1^[AB>L90!YQ3V C:V-DK$PX_V4FY^G8
M<HPBH#!5A@+KOS6< *6&2>OX79):U9X&6!\_L)_EYK69"99PPNEWDJK%V(HM
ME,(,KZBZYINO4!H*#=^44YG_HDT9ZUAHNI**9R58*\@(*_[QGS(1-8 ;/ /P
M2H#W4H!? OS<:*$LMW6*%4Y&@F^0,-&:S0SRW.1H[88P<QMOE-!7B<:IY P3
M@=:8K@#MHTLL!#9I19].06%"Y:Y>O;LY19]V=M$.(@S=+OA*8I;*D:WT]H;$
MGI9;'1=;><]L=0K3 ^2[>\AS/+\#?O)RN->$V]ITY=RKG'LYG]_G_-XXWT-'
M4H*22/M"%P1/""6*@$3? ,N5@!3I>KN&Z4H(PN9YU"5GHEHXQI)(].-";X#.
M%63R9U=R"C5!MQIS6@_E$D]A;.GC*$&LP4H^?G 'SN>N5&V)K)$XOTJ<W\>>
MW'*%*<)YRKJ,%NA!CC9/D742Q%$8C^QUW4$[R@_\<%!%-:0%E;2@5]H%9_-]
M!2+3)WFB$%9H5M5WE]2"+:R+B(9^Z#A/Q+;C@D'H^+6XAMRPDAOVRX4U4-1U
M%HY[@:^MEBV1-3P.*H^#=W7,!MM,W);(&HF+JL1%;SIF4:LFGU9M7T1#4EQ)
MBGLE/;XL]A"KWYI_J*>4>SE?>T>V1-:P/ZSL#]]5*0^WF;@MD342YSJ/78;S
MIF(NX?5:=;TXBIW6H[@KTO=")WCN8>S66B&W5^07SM,-H;13H-O:=JC[$+>M
MKQT8#R,W>E;>8[_B]K[5D_,4F"(S76T4="NF,)L3,RRRJD\DJ$[E7OM-&X?A
ML*V\'1AX4=Q6;M?:3=/K?\-B3IA$%&8:Z1Q$VKPHVN=BHO@R[T G7.E^-A\N
M]"<'"!.@K\\X5P\3T]16'S')?U!+ P04    " #WA%=8K/5RZ7T%   '(P
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M8S47\^K4174CV;H\)?#(I&19>;FB)*9<&ZC/GQB3+S>Z@>;LR_P_4$L#!!0
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M&^O01=>$=1/%Z[:/V7"ENZ)VN-.-*PACH-_GG*N7B6F-^E9X^2]02P,$%
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MY,8LZF"<U_GRC8ZMT4%[ E3+4$V@FD0UA6J:TMS8V9XA/#OZ5(H6#ZB6H9I
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M[$6*V*L4L9<I8J]3Q%ZHB+U2T3$6/<2VS(C]9<:^\Z]?\2Q=O_8/[1PSM+E
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M1X9'7Z,Q1.L25,M03:":1#6%:IK2W%3:NF3H?\?^H;-PO/5".!H,MJ=AM/M
M-8%J$M44JFE*<R.V\3D-_M;BW?LW@3;YK)X$'T93LQB9ZH?FP6_4FBOR;/PU
MJF6H)E!-HII"-4UI;OQL)S(\^FJ.(5J+H%J&:@+5)*HI5-.4YJ;2UB+#(ZSF
M\)N=<X@6(:@FAMMK0X9)N/6V;XEN5:&:;CF&,(Q.-^L"-SRVO1CR2S7\9.?L
M;!<A23PX38?//E<F0S<K4$VBFD(U36ENPFQY,3S*8@V_VCEDVTL_AF?AV=;+
MC S=K$ UB6H*U32EN2&SO<30OUQCUPL#_YH-/]HY8V@5@6H"U22J*533E.9^
M=IRM(I*CK]E(T#4;J):AFD UB6H*U32EN:FT]46"K-GP*YV3=^@*D S=#X%J
M$M44JFE*<U-F:XG$OV;#-PGO7KCA1SN'#FTB4$V@FD0UA6J:TMP@VB8B.?K"
MC01=N(%J&:H)5).HIE!-4YJ;2EM>)/[R8M])&.TM7M@GS^<M9>B."%23J*90
M35.:&[.-CZ_V+]SPS,+[K][P;Z-S"-F/M&8_TQJM*5!-H9JF-#>7MJ9(CKYZ
M(T%+"U3+4$V@FD0UA6J:TMQ4VOXC.<KJ#;_:.8G;%4A\%I]NGYU&-RM03:*:
M0C5-:6[(; 62O/"Q&+NGY!<7<?CISDE#%W&@FD UB6H*U32EN7&T94ER]$4<
M"=J<H%J&:@+5)*HI5-.4YJ0RM<U)>I1%''ZU:Q+3[24AR6#[W:@9NE6!:A+5
M%*II2G,S9GN0U-\Y>";B+I\&Z=]*Y\RA2SI03:":1#6%:IK2W&3:[B0]^I*.
M%"U24"U#-8%J$M44JFE*<U-IBY3T*$LZ_&KG),9;<W(TB%KF9+06036):@K5
M-*6Y&;.U2.JO(#QS\CX?)^G7.V>-U#)4$Z@F44VAFJ8T-Y&V04F/OLPC1?L3
M5,M03:":1#6%:IK2W%3:_B3U+_,X="Y&.Y.UMCD7AVG+B6ITJP+5)*HI5-.4
MYF;,MB&IOPWQO3[>YUH'?KYSV-!K7Z&:0#6):@K5-*6YD;3=27IZ],D8K5!0
M+4,U@6H2U12J:4IS4VDKE-2_WN30R1BM3=::NRHP;)F,T4($U22J*533E/:8
ML7XU,:;.FI>RE^=S4]Z::S.;5<&HN%\T_/)$X=-/@]+<+#_U_O6;J-??^KD(
M7ZMP^?.^92[/[_);\TM>WDX753 S-PTY>'72/$\KI[>3IV_JXNZB%_:"CT5=
M%_/5EQ.3CTVYO$'S[S=%47_]9KF!AZ+\M-KMR_\!4$L#!!0    ( />$5UC,
M-3&R?0(  '@&   9    >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;(6576^;
M,!B%_XK%JJF5MO!-:$>0TF;=>C&I:MKM8MJ% V^"58.9;4*V7S_;4)0UI+D)
M_CKO<XZ#3=(R_BP* (EV):W$S"JDK*]L6V0%E%A,6 V5FEDS7F*INGQCBYH#
MSHVHI+;G.)%=8E)9:6+&[GF:L$924L$]1Z(I2\S_7 -E[<QRK9>!![(II!ZP
MTZ3&&UB"?*KON>K90Y6<E% )PBK$83VSYN[5=:S7FP7?";1BKXUTDA5CS[IS
ME\\L1QL""IG4%;!Z;.$&*-6%E(W??4UK0&KA?ONE^JW)KK*LL( ;1G^07!8S
M*[90#FO<4/G VJ_0YPEUO8Q187Y1VZ]U+)0U0K*R%RL'):FZ)][U^[ G\+PC
M J\7>,9W!S(N%UCB-.&L15RO5M5TPT0U:F6.5/I/64JN9HG2R?2NDKC:D!4%
M-!<"I$ ?T6TC&P[H]12:EXQ+\A>;[?R\4^^% '2^ (D)%1?H#)$*/1:L$;C*
M16)+94]#[*RW<MU9\8Y864 V0;[[ 7F.YZ.GY0*=GUW\7\96Z8:(WA#1,W7]
M(W6_,):WA%*D;!V$$FA!1$:9T(E_SE="<O6B_!ISWU&"<8H^/%>BQAG,+'4Z
M!/ M6.G[=V[D?'HC@S]D\-^JGJHM"<8\=:K(J/3YVZ9^$(1NG-C;$5HPT()3
MM'",UJG"/9KG7;I.-$X+!UIXBA:-T<)#FAO$T>4X+1IHT2G:=(P6'=+4+OA'
M:-.!-CU%B\=HTP.:&U\>I<4#+7Z3]L@DIF.X^. U<=W8":?N*YZ]=Y'H._D;
MYAM2"41AK93.9*H<\^Z>ZSJ2U>9N63&I;BK3+-2G ;A>H.;7C,F7CKZNAH]-
M^@]02P,$%     @ ]X176-YFSK]7 P  ?0H  !D   !X;"]W;W)K<VAE971S
M+W-H965T.#4N>&ULK99=CZ,V%(;_BD57U:[4#@9C M,$:7:BW59JM:.9;GM1
M]<*!DV"MP=0VR>R_KPT9-A,(,U)[D]AP/I[W&-MG>9#JBRX!#'JL1*U77FE,
M<^W[.B^A8OI*-E#;-UNI*F;L5.U\W2A@1>=4"3_$./8KQFLO6W;/[E2VE*T1
MO(8[A71;54Q]?0]"'E9>X#T]N.>[TK@'?K9LV X>P'QN[I2=^4.4@E=0:RYK
MI&"[\FZ"Z]N@<^@L_N!PT"=CY*1LI/SB)K\4*P\[(A"0&Q>"V;\]W((0+I+E
M^.<8U!MR.L?3\5/T#YUX*V;#--Q*\2<O3+GR$@\5L&6M,/?R\#,<!5$7+Y="
M=[_HT-M2ZJ&\U4961V=+4/&Z_V>/QT*<. 31!8?PZ!"^UH$<'4@GM"?K9*V9
M8=E2R0-2SMI&<X.N-IVW5<-KMXP/1MFWW/J9[),I0:%?.=MPP0T'C=ZNP3 N
M]#OT(_K\L$9OW[Q#;Q"OT>^E;#6K"[WTC<WL_/W\F.5]GR6\D&4-^14BP0\H
MQ"&9<+]]O7OXW-VW>@?1X2 Z[.*15XM><YT+J5L%Z*^;C3;*?EY_3^GL T?3
M@=V>N]8-RV'EV4VE0>W!R[[_+HCQ3U.J_Z=@SVI AAJ0N>C91ZA!,8&LU *0
M758D]Z!*>Q(@\:TP4R7HX\9=7'=*[+,H)DEB%V9_*FYL1@D.<328/<..!NQH
M%OL.E)9U#<*>(8(9>)&V#T=/,$A"HS0]HYTP2VD2A].T=*"EL[2?&EMCP^L=
M$F#/FI=8Z1@BCH+H#'5L%9&8+J9)XX$TGB7]P'(']O6U98U'$$& %\D9ZH15
MG*3Q-.IB0%W,%[7;O2_P+<:9"27GW^B$59C0"XN>#'S)+-\]V/.CS4VKNH6?
MYTS&BYG2X QS;$1I<($R'2C36<J'4BJ##*@*[=S.K^W=;-!.L=I,@J837]T9
MYH3)!<@ ?[N>\']?[&.,T\QI0,EHDT_8!1A3'-(+F">W:#"+>5/)UA8.%2T@
M(Y$IN2I0PU1WN=AFRVXK7FU:I=E& ()'VX7I"UJ"T;E)",$8GVL9VT4X)B=V
MO13_I#=PC=EO3.UXK>V!M+6.^&IAJZ'Z7J>?&-ET[<)&&MM\=$-W*X!R!O;]
M5DKS-'$=R-!Q9O\"4$L#!!0    ( />$5UA%K+>R@@0  .07   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@V+GAM;+5876_;-A3]*X16# F06*2^;&6V@<5"
ML0QI$<3I]C#L@99H6X@D>B1MM\!^_$A)D:T/JZ[#Y2&6Q'N/[CDDKPXXWE/V
MRM>$"/ U33(^,=9";.Y,DX=KDF(^H!N2R9$E92D6\I:M3+YA!$=Y4IJ8%H2>
MF>(X,Z;C_-D3FX[I5B1Q1IX8X-LTQ>S;/4GH?F(@X^W!<[Q:"_7 G(XW>$7F
M1'S9/#%Y9U8H49R2C,<T XPL)\:OZ"Y ODK((_Z(R9X?70-%94'IJ[IYB"8&
M5!61A(1"06#YLR,SDB0*2=;Q3PEJ5.]4B<?7;^@?<_*2S )S,J/)GW$DUA-C
M9("(+/$V$<]T_QLI";D*+Z0)S_^#?1D+#1!NN:!IF2PK2..L^,5?2R&.$I!S
M(L$J$ZQS$^PRP3XWP2D3G%R9@DJN0X %GHX9W0.FHB6:NLC%S+,E_3A3\SX7
M3([&,D],[W'V"F:,1+$ CW*, YQ%X)'B#'S$89S$(I;/;L%<+KAHFQ! EW(T
M6]T*PE(0D(4 #QD7;"O7@N#@*B "QPF_EBE?Y@&X^G -/H X R]KNN42FH]-
M(<M6+S?#LL3[HD3K1(D!"0? 1C? @I;=D3X[/]WJ2 _ZTW_?)@, BW143S>E
MUI7@5B6XE>/9)\NI20;^4JJ#!T%2_G>7-@6:TXVFNL(=W^"03 RY[3EA.V),
M?_X)>?"7+J5T@@6:P&HJVI6*=A_Z](4*G,C]O1!=FA6Y7IZK&M]N:H^@9R&Y
M>G;'<K3CG"%$K;B@MY8+F3H54Z>7Z2/A7#8"QM1BV5"6=TNY"4]Q+]#<(TZW
M"$'DP@;WCCC7;84%O<5=2-VMJ+MG3')2=9M3E-T6%=OS/>@UI[L=YWA..R[H
MK>I"SE[%V?O^="NB(.9\B[.0@)!R4;3E_'D4\Y!NLTXEO/:DVG+A.PTA.L+D
MPK>\A@Z]E5ZHP[#28?C#<W\#,M))>]C>[Y[G.K;?X-V.<US?A_:P0;RWM N)
MCRKBHU[B<Y+%E($YD7N>1.!%D<\_Q_^"4T-=DO2^Y$<_&SK! DU@-7']2EQ?
MZ\?7UZFB3K! $UA-100/IA'V+M)<Q[C2\49>RUU*N  ,"P*NI.';$!;*H>M.
MOU>@^T<;$0[@<-1H0+,R#MF-0.A;C1W[%@GKD:@*JQ,]<L?H'3ZC3*XU'LMM
M&XA91Z!C=3F-_G(NG=>#-T6]IJW9?#Y3(<U_J_'DCSOUT&I6M:(%NM#JRA[\
M*K*U=AZDR7.64NI$"W2AU:4\&&+4[XC?VWR<SJ9BC89N<]>>&QF<$UEG>_#
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MO[ZV86@&F&PN>I-@\Y[7YSGX:W[@XDY6  H]-#63"Z=2:G?INK*HH"'R@N^
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M$W$&2.D3:8@[!1>-$O(&8/^KR,>*>!:D_C14W$/%)Z$^JPK$.03Q:/04Q\D
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MPACH\0WGZJ%A)JB+N/ /4$L#!!0    ( />$5UBL.O+6:P0  *(9   9
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MWT*2G:7,+I18IX<%YT(I$:4_5YS!C*T+P/.%$.KE0E=0G&B=_ =02P,$%
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M;8LD@QR+*U9"H;[,&<^Q5%.^L$7) :<&E%/;<YS0SC$IK+AOUAYXW&>5I*2
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MME2*];YVTJ@;UNJ\(^I<#]VS0F8"?2I22'<);&6U]>MM_ Z]DXQC2*Z0[WY
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MX#I W5\Q)@\-_8#F9&;^'U!+ P04    " #WA%=8W,H.ICT%   )'@  &@
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M=<('K@>H^R/&Y%-''SJS_QGT_P)02P,$%     @ ]X176)SS9N+B P  + T
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MO*I;\WIBY,8UJX_28.OKAFO\G %E ;B_E-+L)O8![0?2_%]02P,$%     @
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M*RDG:@!+5*0X%S:6G#@Z(9V+ B?DLJ,RCB#\@73&/_W@#7J_V"(,"19!@L5
M8 89X9:,L$0/GNT:"W5G_C28T%1Q@2(JDI2)%2?H[P_J,7HO22;^L5$40E($
M"19!@L5 8 9%_2U%?>=XN6'YNV3%N1XJK!P[*<4SFE))B4 G.9,$>0-KFML
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M,#@^/?&(:AM0&QA9NSN\E@8[@AN6V+-!V01<+R1J[P+;%OJ_0/H74$L#!!0
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M?BT@Z0")-]HJ\[9FU-(\TVI+M(M&-C?PN?%H=,.D.\5;JW&7(<[F7T3-U2,
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MT2<Y=EV36\$+$Z7(#4N9@<\K,^0(-G8ULC$UN5%5^:RL/#A2^0*B,]+SWY'
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M_FV:+TNEE^]/*W4'ZLTX'3<;ZZPWUGYA8RU;?,X7U;04[F(B)QV ;P;LP6M
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M?4?=B7HY1#8*[<X +/HP;7F*-;A.>;K0!.U3VV$/JOI.N%I#JA4@]2S$JYP
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M8D5^V/F A,RW(#&]R&?*)/E.^:94FBM,Q-PH*/*@$'@5@J:,JP^H%*4Y%WN
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M[NDZ+0K=4 YL*4]9@B[2HO;E'?JO<X8K-ZJ!_'(@O7OM9]B'$;@39]\!&#2
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MJE7%JP.DJB'9MCRTN6=2LKR\W5"24*X_4.]7C,G'AAZ@.<:;_0]02P,$%
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MM#+81QEN[%'&&%83Y."?D&W9SL"!;I\/MP?@\?/A>"0;IRVJ4_$Y3_ =:_D
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M?R2'WW$CR)9\$<E8]1<<FEI# U').,D;L!A!GA;U;_C2&-$!"*'C +,!F.<
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M/B37@S7C=R($D.@ACA(Q-$(ITS/3%+,08B(Z+(5$W5DP'A.I3OG2%"D',L]
M<63:EM4U8T(3(QADUZYY,& K&=$$KCD2JS@F_/$"(K8>&MAXNG!#EZ'4%\Q@
MD)(E3$#>IM=<G9DERYS&D C*$L1A,33.\=D(>QJ05?RBL!9;QTA+F3)VIT\N
MYT/#TAU!!#.I*8CZNH<11)%F4GW\*TB-\C<U</OXB?US)EZ)F1(!(Q;]IG,9
M#HV^@>:P(*M(WK#U5R@$90W.6"2R3[0N:BT#S59"LK@ JPYBFN3?Y*$P8@N
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MXFZ$9KQ/;MA7$W[@A'N"^^*&;N#O2[9W&J:YK#XQN<X*!1Q7A'1.AY2S;"Z
M9J)%6??0I=#4D>MA2G<F2A- ZRLA]./$M.7N%HY^ U!+ P04    " #WA%=8
M'=^3[KX"  "9!P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,S0N>&ULK55M
M3]LP$/XK5H8FD#;RUA=@;23:@. #$J)C^S#M@YM<&XO$SFRG9?]^9R<-+0VH
MD_B2V.=['M]SMN]&:R&?5 :@R7.1<S5V,JW+"]=5208%5:>B!(XK"R$+JG$J
MEZXJ)=#4@HK<#3QOX!:4<2<:6=N]C$:BTCGC<"^)JHJ"RK\3R,5Z[/C.QO#
MEIDV!C<:E70),]"/Y;W$F=NRI*P KIC@1,)B[%SZ%W'?^%N''PS6:FM,C)*Y
M$$]F<IN.'<\$!#DDVC!0_*U@"GENB#",/PVGTVYI@-OC#?NUU8Y:YE3!5.0_
M6:JSL7/FD!06M,KU@UC?0*/'!IB(7-DO63>^GD.22FE1-&",H&"\_M/G)@];
M '_P!B!H ,%K0.\-0-@ PD,!O0;0LYFII=@\Q%33:"3%FDCCC6QF8)-IT2B?
M<7/L,RUQE2%.1[.J+'/ <]0T)S%322Y4)8&(!9E2E9%KO!?DEM?WRQS4<0R:
MLER=D*_D<1:3XZ,3<D08)]\S42G*4S5R-09FZ-VD"6)2!Q&\$80?D#O!=:;(
M%4\AW25P45$K*]C(F@3O,L:0G)+0_T("+P@[ IH>#@\ZX/'A</\=-6%[2*'E
M"P\YI)=CN:IMBORZG"LM\0G][LI]S=WKYC9EY4*5-(&Q@W5#@5R!$WW^Y ^\
M;UUY^TBR^(/(=G+::W/:>X\]LFDL*4L)WFV\OQIP#]V5OYIG8'E,%5U%H3\\
M'_9'[FH[,_MN@>^=^V>[;O&^F^\- N^%;4=-OU73_R\UB2B :/H,BAQS;![X
MG+&>5O@Z3[HD]O>#&H3#X:O8IQUNZ&=>R([$?;=^W]]3Z&X5K0+DTA9_11)1
M<5T_]-;:]I=+6U9?V2?8=^HV\4)3-ZT[*I>,*Y+# BF]TR%&)NM&4$^T*&UI
MG N-A=8.,^R=((T#KB^$T)N)V:#MQM$_4$L#!!0    ( />$5UA!!Z05! 8
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MA0;$%H*87E Y0!8:4$\)H<E>'Q-9:$"]L1*M=V<G+B:RT(!Z2LA=\=XZ,AK
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #WA%=8S+HI%NX    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #W
MA%=8F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( />$5UBQ.!7TH08  %<?   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #W
MA%=8"Q3/TBL"  "H!0  &               @('D#@  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ ]X176 \2LR_W!P  P2(  !@
M         ("!11$  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( />$5UA3DBMHI0(  &X'   8              " @7(9  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #WA%=8>/FBA!0&  "V&0
M&               @(%-'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ ]X176 >EUZRV P  &0P  !@              ("!ER(  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( />$5U@L1EQ:T@L
M +IK   8              " @8,F  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " #WA%=8=P/1L:D)  !Q+0  &               @(&+
M,@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ]X176!6=
M76YX!0  B L  !@              ("!:CP  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( />$5UCU^\F-Y"<  ".%   9
M  " @1A"  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M]X176 8E-;M@"   B!4  !D              ("!,VH  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " #WA%=8Q0BN%60(  !X%0  &0
M            @('*<@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( />$5U@2JHX&Y0(  (X&   9              " @65[  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ ]X176'M8<D4Q#
M32   !D              ("!@7X  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " #WA%=8?7EQZY (   Y&   &0              @('I
MB@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( />$5UA-
M?9 %QP4  ,X.   9              " @;"3  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ ]X176(RW;/71 P  L0@  !D
M     ("!KID  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( />$5UCUE=QPHP4  %T/   9              "
M@66U  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ ]X17
M6$2J,_+:!   ( T  !D              ("!/[L  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " #WA%=8GI\+MYT"   %!@  &0
M        @(%0P   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( />$5U@76^G^R@,  % (   9              " @23#  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ ]X176'5%RQ@_"   U14
M !D              ("!)<<  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " #WA%=8\Z+ZG=(#  "'"0  &0              @(&;SP
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( />$5UB#W!<!
M)Q   ),O   9              " @:33  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ ]X176&.N:>EB#P  [C4  !D
M ("! N0  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #W
MA%=86\4(+G80  #Z-0  &0              @(&;\P  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( />$5UA2IYV:X0@  'D6   9
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M970S-2YX;6Q02P$"% ,4    " #WA%=8O'HV8S0$  !_"0  &0
M    @('N&P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M />$5UCZ<X(&,S   (.K   9              " @5D@ 0!X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ ]X176.44E)/1!   ?PL  !D
M             ("!PU ! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " #WA%=8.YW*H_ "   _!@  &0              @('+50$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( />$5UC)$3G.> ,
M /8'   9              " @?)8 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ ]X176*3+B=#R @  AP8  !D              ("!
MH5P! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #WA%=8
MZ4;(4WP'  #5$P  &0              @('*7P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( />$5UA^>HU!]00  '<6   9
M      " @7UG 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ ]X176.=-?/]  P  ! <  !D              ("!J6P! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #WA%=8 $EQ[]\"   ]!@
M&0              @($@< $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( />$5UAY?D!5^@,  %L)   9              " @39S 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ ]X176'@Y@L]3
M P  -0<  !D              ("!9W<! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " #WA%=8,W%CF8\%  "2#@  &0
M@('Q>@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( />$
M5U@,2-='( ,  "4'   9              " @;>  0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ ]X176-'"^S9. P  R@<  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( />$5UAO0/7,7P<  +T3   9
M  " @6V@ 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M]X176.9$(4I"!   -@L  !D              ("! Z@! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " #WA%=8&762]7 #   *"0  &0
M            @(%\K $ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( />$5UC:S UVO (  .D%   9              " @2.P 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ ]X176#JM2>F, @
MT@4  !D              ("!%K,! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " #WA%=8B*;*6Z<#  !O$   &0              @('9
MM0$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( />$5UB:
M*+]"IP(  -\&   9              " @;>Y 0!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ ]X176 R?A;8S P  1 \  !D
M     ("!E;P! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( />$5UCG;&,V]P(  &((   9              "
M@?'0 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ ]X17
M6)>]<RRL P  EQ$  !D              ("!']0! 'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    " #WA%=81(BB@:D#  "<$0  &0
M        @($"V $ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( />$5UB;I%FK" 0  - 1   9              " @>+; 0!X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ ]X176-I^BB] !   010
M !D              ("!(> ! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    " #WA%=81,U^QDX%  "J(@  &0              @(&8Y $
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( />$5UB N;<_
MI0,  )$0   9              " @1WJ 0!X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ ]X176$FY].3,!   3Q8  !D
M ("!^>T! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #W
MA%=8GT4#R9H&  !.-   &0              @('\\@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( />$5UBP;CQT3 ,  - ,   9
M          " @<WY 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#
M%     @ ]X176*SU<NE]!0  !R,  !D              ("!4/T! 'AL+W=O
M<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " #WA%=8UX_&+7D#   6
M"P  &0              @($$ P( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM
M;%!+ 0(4 Q0    ( />$5UCI=+O=>0(  *<&   9              " @;0&
M @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ ]X176.)^
MB1?S @  40@  !D              ("!9 D" 'AL+W=O<FMS:&5E=',O<VAE
M970X,"YX;6Q02P$"% ,4    " #WA%=8/&9W=F$"  "Z!0  &0
M    @(&.# ( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    (
M />$5U@"SJOV!00  -T3   9              " @28/ @!X;"]W;W)K<VAE
M971S+W-H965T.#(N>&UL4$L! A0#%     @ ]X176+ ?GFNO"P  Y:L  !D
M             ("!8A," 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"
M% ,4    " #WA%=8S#4QLGT"  !X!@  &0              @(%('P( >&PO
M=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( />$5UC>9LZ_5P,
M 'T*   9              " @?PA @!X;"]W;W)K<VAE971S+W-H965T.#4N
M>&UL4$L! A0#%     @ ]X176$6LM[*"!   Y!<  !D              ("!
MBB4" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " #WA%=8
M2E(@CF(,  ",I0  &0              @(%#*@( >&PO=V]R:W-H965T<R]S
M:&5E=#@W+GAM;%!+ 0(4 Q0    ( />$5UB@N!P!4@,  !(*   9
M      " @=PV @!X;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%
M  @ ]X176#@;+VJ/ @  D 8  !D              ("!93H" 'AL+W=O<FMS
M:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " #WA%=8=^C-ZST#  #0#0
M&0              @($K/0( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+
M 0(4 Q0    ( />$5UBL.O+6:P0  *(9   9              " @9]  @!X
M;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ ]X176*-Q(7Y1
M!@  W2H  !D              ("!044" 'AL+W=O<FMS:&5E=',O<VAE970Y
M,BYX;6Q02P$"% ,4    " #WA%=8>N],W+4#  "\$@  &0
M@(')2P( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( />$
M5U@$YHJAP0(  "$(   9              " @;5/ @!X;"]W;W)K<VAE971S
M+W-H965T.30N>&UL4$L! A0#%     @ ]X176,(56%*\!   P10  !D
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M=#DY+GAM;%!+ 0(4 Q0    ( />$5UC_%Q@X @0   D7   :
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M,3 T+GAM;%!+ 0(4 Q0    ( />$5U@M_)A2S00  /H/   :
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M,3 Y+GAM;%!+ 0(4 Q0    ( />$5UCP]7 C-@<  (PV   :
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M,3$T+GAM;%!+ 0(4 Q0    ( />$5UCA!.Y.:P,  "0*   :
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M,3$Y+GAM;%!+ 0(4 Q0    ( />$5UB9;HK4F@(  )@&   :
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M,3(T+GAM;%!+ 0(4 Q0    ( />$5U@QYD:8=@0  -(3   :
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M,3(Y+GAM;%!+ 0(4 Q0    ( />$5U@UDE*(8P,  + /   :
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M,3,T+GAM;%!+ 0(4 Q0    ( />$5UA!!Z05! 8  %PN   :
M  " @=\( P!X;"]W;W)K<VAE971S+W-H965T,3,U+GAM;%!+ 0(4 Q0    (
M />$5U@4 JR1*@(  -\$   :              " @1L/ P!X;"]W;W)K<VAE
M971S+W-H965T,3,V+GAM;%!+ 0(4 Q0    ( />$5UC@@TND7 ,  + 5   -
M              "  7T1 P!X;"]S='EL97,N>&UL4$L! A0#%     @ ]X17
M6)>*NQS     $P(   L              ( !!!4# %]R96QS+RYR96QS4$L!
M A0#%     @ ]X176.=?BO3U"   \%@   \              ( ![14# 'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( />$5UB#]5F$K@,  +M/   :
M          "  0\? P!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( />$5UA@&\:JS (  "M,   3              "  ?4B P!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    "0 )  S"<  /(E P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>341</ContextCount>
  <ElementCount>599</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>110</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Description of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Descriptionofbusiness</Role>
      <ShortName>Description of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies</Role>
      <ShortName>Summary of Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Disaggregation of Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenue</Role>
      <ShortName>Disaggregation of Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Contract Balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalances</Role>
      <ShortName>Contract Balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Allowances for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLosses</Role>
      <ShortName>Allowances for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Property, Plant and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</Role>
      <ShortName>Property, Plant and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilities</Role>
      <ShortName>Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Bank Credit Lines and Loan Facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilities</Role>
      <ShortName>Bank Credit Lines and Loan Facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Non-current other liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Noncurrentotherliabilities</Role>
      <ShortName>Non-current other liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Business Segment and Geographical Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</Role>
      <ShortName>Business Segment and Geographical Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Net Income Per Ordinary Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</Role>
      <ShortName>Net Income Per Ordinary Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Summary of Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables</Role>
      <ShortName>Summary of Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Disaggregation of Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueTables</Role>
      <ShortName>Disaggregation of Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenue</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Contract Balances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalancesTables</Role>
      <ShortName>Contract Balances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ContractBalances</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Allowances for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLossesTables</Role>
      <ShortName>Allowances for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AllowancesforCreditLosses</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BusinessCombinations</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/FairValue</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Property, Plant and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</Role>
      <ShortName>Property, Plant and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Goodwill</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IntangibleAssets</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesTables</Role>
      <ShortName>Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilities</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Bank Credit Lines and Loan Facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables</Role>
      <ShortName>Bank Credit Lines and Loan Facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BankCreditLinesandLoanFacilities</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Derivatives</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OperatingLeases</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Non-current other liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentotherliabilitiesTables</Role>
      <ShortName>Non-current other liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Noncurrentotherliabilities</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Restructuring charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesTables</Role>
      <ShortName>Restructuring charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IncomeTaxes</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EmployeeBenefits</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Business Segment and Geographical Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables</Role>
      <ShortName>Business Segment and Geographical Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Net Income Per Ordinary Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables</Role>
      <ShortName>Net Income Per Ordinary Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Description of business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DescriptionofbusinessDetails</Role>
      <ShortName>Description of business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Descriptionofbusiness</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails</Role>
      <ShortName>Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails</Role>
      <ShortName>Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueDetails</Role>
      <ShortName>Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenueTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Contract Balances - Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails</Role>
      <ShortName>Contract Balances - Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Contract Balances - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalancesNarrativeDetails</Role>
      <ShortName>Contract Balances - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Allowances for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLossesDetails</Role>
      <ShortName>Allowances for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AllowancesforCreditLossesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Business Combinations - Narrative, Biotel Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, Biotel Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Business Combinations - Narrative, Oncacare Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, Oncacare Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails</Role>
      <ShortName>Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Fair value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairvalueNarrativeDetails</Role>
      <ShortName>Fair value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Property, Plant and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails</Role>
      <ShortName>Property, Plant and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails</Role>
      <ShortName>Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Future Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesDetails</Role>
      <ShortName>Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails</Role>
      <ShortName>Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Bank Credit Lines and Loan Facilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails</Role>
      <ShortName>Bank Credit Lines and Loan Facilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails</Role>
      <ShortName>Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Principal payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails</Role>
      <ShortName>Bank Credit Lines and Loan Facilities - Schedule of Principal payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Movement on Debt Instrument (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails</Role>
      <ShortName>Bank Credit Lines and Loan Facilities - Schedule of Movement on Debt Instrument (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - Derivatives - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesNarrativeDetails</Role>
      <ShortName>Derivatives - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9954527 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails</Role>
      <ShortName>Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9954528 - Disclosure - Operating Leases - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails</Role>
      <ShortName>Operating Leases - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9954529 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9954530 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails</Role>
      <ShortName>Operating Leases Operating Leases - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9954531 - Disclosure - Non-current other liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails</Role>
      <ShortName>Non-current other liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NoncurrentotherliabilitiesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9954532 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9954533 - Disclosure - Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapitalDetails</Role>
      <ShortName>Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ShareCapital</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9954534 - Disclosure - Restructuring charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesNarrativeDetails</Role>
      <ShortName>Restructuring charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9954535 - Disclosure - Restructuring charges - Schedule of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails</Role>
      <ShortName>Restructuring charges - Schedule of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9954536 - Disclosure - Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9954537 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Income Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9954538 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9954539 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9954540 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9954541 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9954542 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails</Role>
      <ShortName>Income Taxes - Expected Expiry Dates of NOL's (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9954543 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9954544 - Disclosure - Employee Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails</Role>
      <ShortName>Employee Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9954545 - Disclosure - Employee Benefits - Schedule of Amounts Recognized in Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails</Role>
      <ShortName>Employee Benefits - Schedule of Amounts Recognized in Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9954546 - Disclosure - Employee Benefits - Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails</Role>
      <ShortName>Employee Benefits - Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9954547 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails</Role>
      <ShortName>Employee Benefits - Change in Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9954548 - Disclosure - Employee Benefits - Change in Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails</Role>
      <ShortName>Employee Benefits - Change in Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9954549 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Employee Benefits - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9954550 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails</Role>
      <ShortName>Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9954551 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails</Role>
      <ShortName>Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9954552 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails</Role>
      <ShortName>Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9954553 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails</Role>
      <ShortName>Employee Benefits - Plan Asset Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9954554 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails</Role>
      <ShortName>Employee Benefits - Annual Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9954555 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9954556 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9954557 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9954558 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>9954559 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>9954560 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>9954561 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographical Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>9954562 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>9954563 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>9954564 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>9954565 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>9954566 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>132</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>9954567 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>133</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>9954568 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</ParentRole>
      <Position>134</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>9954569 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/RelatedParties</ParentRole>
      <Position>135</Position>
    </Report>
    <Report instance="iclr-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>9954570 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SubsequentEvents</ParentRole>
      <Position>136</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="iclr-20231231.htm">iclr-20231231.htm</File>
    <File>iclr-20231231.xsd</File>
    <File>iclr-20231231_cal.xml</File>
    <File>iclr-20231231_def.xml</File>
    <File>iclr-20231231_lab.xml</File>
    <File>iclr-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iclr-20231231_g1.gif</File>
    <File>iclr-20231231_g10.jpg</File>
    <File>iclr-20231231_g11.jpg</File>
    <File>iclr-20231231_g2.gif</File>
    <File>iclr-20231231_g3.gif</File>
    <File>iclr-20231231_g4.jpg</File>
    <File>iclr-20231231_g5.jpg</File>
    <File>iclr-20231231_g6.jpg</File>
    <File>iclr-20231231_g7.jpg</File>
    <File>iclr-20231231_g8.jpg</File>
    <File>iclr-20231231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1518">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>168
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "iclr-20231231.htm": {
   "nsprefix": "iclr",
   "nsuri": "http://www.iconplc.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "iclr-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "iclr-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "iclr-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iclr-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "iclr-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iclr-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 511,
   "keyCustom": 88,
   "axisStandard": 41,
   "axisCustom": 1,
   "memberStandard": 51,
   "memberCustom": 54,
   "hidden": {
    "total": 11,
    "http://fasb.org/us-gaap/2023": 7,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 341,
   "entityCount": 1,
   "segmentCount": 110,
   "elementCount": 909,
   "unitCount": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1518,
    "http://xbrl.sec.gov/dei/2023": 48
   },
   "report": {
    "R1": {
     "role": "http://www.iconplc.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.iconplc.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R7": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.iconplc.com/role/Descriptionofbusiness",
     "longName": "0000009 - Disclosure - Description of business",
     "shortName": "Description of business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies",
     "longName": "0000010 - Disclosure - Summary of Significant accounting policies",
     "shortName": "Summary of Significant accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.iconplc.com/role/DisaggregationofRevenue",
     "longName": "0000011 - Disclosure - Disaggregation of Revenue",
     "shortName": "Disaggregation of Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R12": {
     "role": "http://www.iconplc.com/role/ContractBalances",
     "longName": "0000012 - Disclosure - Contract Balances",
     "shortName": "Contract Balances",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R13": {
     "role": "http://www.iconplc.com/role/AllowancesforCreditLosses",
     "longName": "0000013 - Disclosure - Allowances for Credit Losses",
     "shortName": "Allowances for Credit Losses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForCreditLossesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForCreditLossesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.iconplc.com/role/BusinessCombinations",
     "longName": "0000014 - Disclosure - Business Combinations",
     "shortName": "Business Combinations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.iconplc.com/role/FairValue",
     "longName": "0000015 - Disclosure - Fair Value",
     "shortName": "Fair Value",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.iconplc.com/role/Investments",
     "longName": "0000016 - Disclosure - Investments",
     "shortName": "Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnet",
     "longName": "0000017 - Disclosure - Property, Plant and Equipment, net",
     "shortName": "Property, Plant and Equipment, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.iconplc.com/role/Goodwill",
     "longName": "0000018 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.iconplc.com/role/IntangibleAssets",
     "longName": "0000019 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.iconplc.com/role/OtherLiabilities",
     "longName": "0000020 - Disclosure - Other Liabilities",
     "shortName": "Other Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilities",
     "longName": "0000021 - Disclosure - Bank Credit Lines and Loan Facilities",
     "shortName": "Bank Credit Lines and Loan Facilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.iconplc.com/role/Derivatives",
     "longName": "0000022 - Disclosure - Derivatives",
     "shortName": "Derivatives",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.iconplc.com/role/OperatingLeases",
     "longName": "0000023 - Disclosure - Operating Leases",
     "shortName": "Operating Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.iconplc.com/role/Noncurrentotherliabilities",
     "longName": "0000024 - Disclosure - Non-current other liabilities",
     "shortName": "Non-current other liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.iconplc.com/role/CommitmentsandContingencies",
     "longName": "0000025 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.iconplc.com/role/ShareCapital",
     "longName": "0000026 - Disclosure - Share Capital",
     "shortName": "Share Capital",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.iconplc.com/role/RestructuringCharges",
     "longName": "0000027 - Disclosure - Restructuring Charges",
     "shortName": "Restructuring Charges",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.iconplc.com/role/IncomeTaxes",
     "longName": "0000028 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.iconplc.com/role/EmployeeBenefits",
     "longName": "0000029 - Disclosure - Employee Benefits",
     "shortName": "Employee Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges",
     "longName": "0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation",
     "longName": "0000031 - Disclosure - Business Segment and Geographical Information",
     "shortName": "Business Segment and Geographical Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShare",
     "longName": "0000032 - Disclosure - Net Income Per Ordinary Share",
     "shortName": "Net Income Per Ordinary Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss",
     "longName": "0000033 - Disclosure - Accumulated Other Comprehensive Loss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation",
     "longName": "0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information",
     "shortName": "Supplemental Disclosure of Cash Flow Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.iconplc.com/role/RelatedParties",
     "longName": "0000035 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.iconplc.com/role/SubsequentEvents",
     "longName": "0000036 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant accounting policies (Policies)",
     "shortName": "Summary of Significant accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables",
     "longName": "9954472 - Disclosure - Summary of Significant accounting policies (Tables)",
     "shortName": "Summary of Significant accounting policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueTables",
     "longName": "9954473 - Disclosure - Disaggregation of Revenue (Tables)",
     "shortName": "Disaggregation of Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.iconplc.com/role/ContractBalancesTables",
     "longName": "9954474 - Disclosure - Contract Balances (Tables)",
     "shortName": "Contract Balances (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.iconplc.com/role/AllowancesforCreditLossesTables",
     "longName": "9954475 - Disclosure - Allowances for Credit Losses (Tables)",
     "shortName": "Allowances for Credit Losses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsTables",
     "longName": "9954476 - Disclosure - Business Combinations (Tables)",
     "shortName": "Business Combinations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.iconplc.com/role/FairValueTables",
     "longName": "9954477 - Disclosure - Fair Value (Tables)",
     "shortName": "Fair Value (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables",
     "longName": "9954478 - Disclosure - Property, Plant and Equipment, net (Tables)",
     "shortName": "Property, Plant and Equipment, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.iconplc.com/role/GoodwillTables",
     "longName": "9954479 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsTables",
     "longName": "9954480 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.iconplc.com/role/OtherLiabilitiesTables",
     "longName": "9954481 - Disclosure - Other Liabilities (Tables)",
     "shortName": "Other Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables",
     "longName": "9954482 - Disclosure - Bank Credit Lines and Loan Facilities (Tables)",
     "shortName": "Bank Credit Lines and Loan Facilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.iconplc.com/role/DerivativesTables",
     "longName": "9954483 - Disclosure - Derivatives (Tables)",
     "shortName": "Derivatives (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.iconplc.com/role/OperatingLeasesTables",
     "longName": "9954484 - Disclosure - Operating Leases (Tables)",
     "shortName": "Operating Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables",
     "longName": "9954485 - Disclosure - Non-current other liabilities (Tables)",
     "shortName": "Non-current other liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.iconplc.com/role/RestructuringchargesTables",
     "longName": "9954486 - Disclosure - Restructuring charges (Tables)",
     "shortName": "Restructuring charges (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.iconplc.com/role/IncomeTaxesTables",
     "longName": "9954487 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsTables",
     "longName": "9954488 - Disclosure - Employee Benefits (Tables)",
     "shortName": "Employee Benefits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables",
     "longName": "9954489 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables",
     "longName": "9954490 - Disclosure - Business Segment and Geographical Information (Tables)",
     "shortName": "Business Segment and Geographical Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables",
     "longName": "9954491 - Disclosure - Net Income Per Ordinary Share (Tables)",
     "shortName": "Net Income Per Ordinary Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables",
     "longName": "9954492 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables",
     "longName": "9954493 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.iconplc.com/role/DescriptionofbusinessDetails",
     "longName": "9954494 - Disclosure - Description of business (Details)",
     "shortName": "Description of business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "dei:EntityNumberOfEmployees",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "iclr:NumberOfLocations",
      "unitRef": "location",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails",
     "longName": "9954495 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "shortName": "Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails",
     "longName": "9954496 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)",
     "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-45",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-45",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
     "longName": "9954497 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)",
     "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R64": {
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueDetails",
     "longName": "9954498 - Disclosure - Disaggregation of Revenue (Details)",
     "shortName": "Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-57",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails",
     "longName": "9954499 - Disclosure - Contract Balances - Contracts with Customers (Details)",
     "shortName": "Contract Balances - Contracts with Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:BilledContractReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:BilledContractReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.iconplc.com/role/ContractBalancesNarrativeDetails",
     "longName": "9954500 - Disclosure - Contract Balances - Narrative (Details)",
     "shortName": "Contract Balances - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.iconplc.com/role/AllowancesforCreditLossesDetails",
     "longName": "9954501 - Disclosure - Allowances for Credit Losses (Details)",
     "shortName": "Allowances for Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
     "longName": "9954502 - Disclosure - Business Combinations - Narrative, Biotel Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, Biotel Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
     "longName": "9954503 - Disclosure - Business Combinations - Narrative, Oncacare Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, Oncacare Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R70": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
     "longName": "9954504 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, PRA Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-80",
      "name": "dei:EntityNumberOfEmployees",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-81",
      "name": "iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
     "longName": "9954505 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)",
     "shortName": "Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
     "longName": "9954506 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)",
     "shortName": "Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-81",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
     "longName": "9954507 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)",
     "shortName": "Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-81",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-87",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
     "longName": "9954508 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)",
     "shortName": "Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-96",
      "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-96",
      "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
     "longName": "9954509 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)",
     "shortName": "Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.iconplc.com/role/FairvalueNarrativeDetails",
     "longName": "9954510 - Disclosure - Fair value - Narrative (Details)",
     "shortName": "Fair value - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-116",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
     "longName": "9954511 - Disclosure - Investments - Narrative (Details)",
     "shortName": "Investments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails",
     "longName": "9954512 - Disclosure - Property, Plant and Equipment, net (Details)",
     "shortName": "Property, Plant and Equipment, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
     "longName": "9954513 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)",
     "shortName": "Property, Plant and Equipment, net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails",
     "longName": "9954514 - Disclosure - Goodwill - Schedule of Goodwill (Details)",
     "shortName": "Goodwill - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.iconplc.com/role/GoodwillNarrativeDetails",
     "longName": "9954515 - Disclosure - Goodwill - Narrative (Details)",
     "shortName": "Goodwill - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
     "longName": "9954516 - Disclosure - Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)",
     "shortName": "Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
     "longName": "9954517 - Disclosure - Intangible Assets - Narrative (Details)",
     "shortName": "Intangible Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails",
     "longName": "9954518 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "shortName": "Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.iconplc.com/role/OtherLiabilitiesDetails",
     "longName": "9954519 - Disclosure - Other Liabilities (Details)",
     "shortName": "Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
     "longName": "9954520 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt Instruments (Details)",
     "shortName": "Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
     "longName": "9954521 - Disclosure - Bank Credit Lines and Loan Facilities - Narrative (Details)",
     "shortName": "Bank Credit Lines and Loan Facilities - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails",
     "longName": "9954522 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)",
     "shortName": "Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails",
     "longName": "9954523 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)",
     "shortName": "Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails",
     "longName": "9954524 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Principal payments (Details)",
     "shortName": "Bank Credit Lines and Loan Facilities - Schedule of Principal payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-162",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-162",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
     "longName": "9954525 - Disclosure - Bank Credit Lines and Loan Facilities - Schedule of Movement on Debt Instrument (Details)",
     "shortName": "Bank Credit Lines and Loan Facilities - Schedule of Movement on Debt Instrument (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromLinesOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-172",
      "name": "us-gaap:RepaymentsOfLinesOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.iconplc.com/role/DerivativesNarrativeDetails",
     "longName": "9954526 - Disclosure - Derivatives - Narrative (Details)",
     "shortName": "Derivatives - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
     "longName": "9954527 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)",
     "shortName": "Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails",
     "longName": "9954528 - Disclosure - Operating Leases - Lease Costs (Details)",
     "shortName": "Operating Leases - Lease Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
     "longName": "9954529 - Disclosure - Operating Leases Operating Leases - Narrative (Details)",
     "shortName": "Operating Leases Operating Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails",
     "longName": "9954530 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "shortName": "Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails",
     "longName": "9954531 - Disclosure - Non-current other liabilities (Details)",
     "shortName": "Non-current other liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails",
     "longName": "9954532 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.iconplc.com/role/ShareCapitalDetails",
     "longName": "9954533 - Disclosure - Share Capital (Details)",
     "shortName": "Share Capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:NumberOfVotes",
      "unitRef": "vote",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:NumberOfVotes",
      "unitRef": "vote",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
     "longName": "9954534 - Disclosure - Restructuring charges - Narrative (Details)",
     "shortName": "Restructuring charges - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-202",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails",
     "longName": "9954535 - Disclosure - Restructuring charges - Schedule of Restructuring Charges (Details)",
     "shortName": "Restructuring charges - Schedule of Restructuring Charges (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R102": {
     "role": "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails",
     "longName": "9954536 - Disclosure - Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "shortName": "Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
     "longName": "9954537 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
     "longName": "9954538 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Components of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails",
     "longName": "9954539 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "shortName": "Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9954540 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9954541 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
     "longName": "9954542 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "shortName": "Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-215",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-218",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails",
     "longName": "9954543 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
     "longName": "9954544 - Disclosure - Employee Benefits - Narrative (Details)",
     "shortName": "Employee Benefits - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-233",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-233",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails",
     "longName": "9954545 - Disclosure - Employee Benefits - Schedule of Amounts Recognized in Balance Sheet (Details)",
     "shortName": "Employee Benefits - Schedule of Amounts Recognized in Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-231",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-231",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
     "longName": "9954546 - Disclosure - Employee Benefits - Funded Status (Details)",
     "shortName": "Employee Benefits - Funded Status (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-235",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-235",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
     "longName": "9954547 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)",
     "shortName": "Employee Benefits - Change in Benefit Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-236",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-238",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
     "longName": "9954548 - Disclosure - Employee Benefits - Change in Plan Assets (Details)",
     "shortName": "Employee Benefits - Change in Plan Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c-236",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-238",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
     "longName": "9954549 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)",
     "shortName": "Employee Benefits - Components of Net Periodic Benefit Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c-238",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-238",
      "name": "us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
     "longName": "9954550 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)",
     "shortName": "Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c-247",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-238",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
     "longName": "9954551 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)",
     "shortName": "Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c-235",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-235",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
     "longName": "9954552 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)",
     "shortName": "Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c-245",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-245",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
     "longName": "9954553 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)",
     "shortName": "Employee Benefits - Plan Asset Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c-253",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-253",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
     "longName": "9954554 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)",
     "shortName": "Employee Benefits - Annual Benefit Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c-255",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-255",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
     "longName": "9954555 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
     "longName": "9954556 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c-282",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-278",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
     "longName": "9954557 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
     "longName": "9954558 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c-297",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-297",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R125": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
     "longName": "9954559 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "c-302",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-302",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R126": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
     "longName": "9954560 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-184",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R127": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
     "longName": "9954561 - Disclosure - Business Segment and Geographical Information - Narrative (Details)",
     "shortName": "Business Segment and Geographical Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "127",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R128": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
     "longName": "9954562 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "shortName": "Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "128",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-204",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R129": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
     "longName": "9954563 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "shortName": "Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "129",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R130": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
     "longName": "9954564 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "shortName": "Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "130",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R131": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails",
     "longName": "9954565 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "131",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R132": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails",
     "longName": "9954566 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "132",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R133": {
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails",
     "longName": "9954567 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)",
     "shortName": "Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "133",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R134": {
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails",
     "longName": "9954568 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "134",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R135": {
     "role": "http://www.iconplc.com/role/RelatedPartiesDetails",
     "longName": "9954569 - Disclosure - Related Parties (Details)",
     "shortName": "Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "135",
     "firstAnchor": {
      "contextRef": "c-339",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-331",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "unique": true
     }
    },
    "R136": {
     "role": "http://www.iconplc.com/role/SubsequentEventsDetails",
     "longName": "9954570 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "136",
     "firstAnchor": {
      "contextRef": "c-341",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-341",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20231231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "iclr_A2021RestructuringPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "A2021RestructuringPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Restructuring Plan",
        "label": "2021 Restructuring Plan [Member]",
        "documentation": "2021 Restructuring Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202108Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdate202108Member",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update 2021-08",
        "label": "Accounting Standards Update 2021-08 [Member]",
        "documentation": "Accounting Standards Update 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers."
       }
      }
     },
     "auth_ref": [
      "r693",
      "r694"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Noncurrentotherliabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r1036"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Provision for Credit Losses",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1098"
     ]
    },
    "iclr_AccountsReceivableCreditLossExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AccountsReceivableCreditLossExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts provided during the year",
        "label": "Accounts Receivable, Credit Loss Expense",
        "documentation": "Accounts Receivable, Credit Loss Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net of allowance for credit losses (Note 4)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r239"
     ]
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current income taxes payable",
        "label": "Accrued Income Taxes, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r239"
     ]
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedUtilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility related liabilities",
        "label": "Accrued Utilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and asset write offs",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r279",
      "r844"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Actuarial gain on defined benefit pension plan",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r50",
      "r1164"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294",
      "r296",
      "r297",
      "r747"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss (Note 25)",
        "totalLabel": "Total",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r184",
      "r287",
      "r840",
      "r862",
      "r866"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "Accumulated Other Comprehensive Income Loss [Text Block]",
        "documentation": "Disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r24",
      "r50",
      "r713",
      "r716",
      "r795",
      "r857",
      "r858",
      "r1075",
      "r1076",
      "r1077",
      "r1086",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Useful Life",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on cash flow hedge",
        "label": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax",
        "documentation": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r646",
      "r647",
      "r880",
      "r1086",
      "r1087",
      "r1088",
      "r1222",
      "r1253"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AdjustmentToRetainedEarningShareRepurchaseCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AdjustmentToRetainedEarningShareRepurchaseCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Share repurchase costs",
        "label": "Adjustment to Retained Earning Share Repurchase costs",
        "documentation": "Adjustment to Retained Earning Share Repurchase costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]",
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r330",
      "r331",
      "r332",
      "r333",
      "r342",
      "r389",
      "r390",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r432",
      "r645",
      "r646",
      "r647",
      "r679",
      "r680",
      "r681",
      "r682",
      "r693",
      "r694",
      "r695",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r744",
      "r745",
      "r750",
      "r751",
      "r752",
      "r753",
      "r770",
      "r771",
      "r775",
      "r776",
      "r777",
      "r778",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r814",
      "r815",
      "r816",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Replacement share-based awards issued to acquiree employees",
        "label": "APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r609"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r217"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net balance",
        "label": "Advance Payments Netted Against Unbilled Contracts Receivable",
        "documentation": "Advance Payments Netted Against Unbilled Contracts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AfimmuneLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AfimmuneLimitedMember",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Afimmune Limited",
        "label": "Afimmune Limited [Member]",
        "documentation": "Afimmune Limited"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForCreditLossesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForCreditLossesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLosses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Credit Losses",
        "label": "Allowance for Credit Losses [Text Block]",
        "documentation": "The entire disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange",
        "label": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments",
        "documentation": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails",
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance for credit losses (note 5)",
        "periodStartLabel": "Opening provision",
        "periodEndLabel": "Closing provision",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r388",
      "r411",
      "r412",
      "r415",
      "r1246"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amounts used during the year",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDeferredHedgeGains",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Charge on cash flow hedge",
        "label": "Amortization of Deferred Hedge Gains",
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of financing costs and debt discount",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r476",
      "r773",
      "r1081"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r78",
      "r81"
     ]
    },
    "iclr_AptivSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AptivSolutionsMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aptiv Solutions",
        "label": "Aptiv Solutions [Member]",
        "documentation": "Aptiv Solutions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AptivSolutionsPensionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AptivSolutionsPensionPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aptiv Solutions pension plan",
        "label": "Aptiv Solutions Pension Plan [Member]",
        "documentation": "Aptiv Solutions Pension Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r283",
      "r322",
      "r360",
      "r372",
      "r377",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r699",
      "r703",
      "r749",
      "r836",
      "r915",
      "r1036",
      "r1050",
      "r1115",
      "r1116",
      "r1236"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r289",
      "r322",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r699",
      "r703",
      "r749",
      "r1036",
      "r1115",
      "r1116",
      "r1236"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current Assets:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available for sale investments (Note 8a)",
        "verboseLabel": "Available for sale investments",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r416"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available for sale investments (long-term)",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r393",
      "r416"
     ]
    },
    "iclr_AwardDateAllYearsExcluding2018Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "AwardDateAllYearsExcluding2018Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award date, prior to 2018",
        "label": "Award Date, All Years Excluding 2018 [Member]",
        "documentation": "Award Date, Prior to 2018 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Date [Axis]",
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Date [Domain]",
        "label": "Award Date [Domain]",
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r613",
      "r614",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BilledContractReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BilledContractReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Billed services (accounts receivable)",
        "label": "Billed Contracts Receivable",
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "iclr_BiotelResearchLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BiotelResearchLLCMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biotel Research LLC",
        "label": "Biotel Research LLC [Member]",
        "documentation": "Biotel Research LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingsAndImprovementsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings",
        "label": "Buildings and Improvements, Gross",
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r1023",
      "r1026"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r691",
      "r1023",
      "r1026"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r691"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of share capital acquired",
        "verboseLabel": "Percentage of share capital acquired (in percent)",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationBargainPurchaseGainRecognizedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisition-related gain",
        "terseLabel": "Acquisition related costs",
        "label": "Business Combination, Bargain Purchase, Gain Recognized, Amount",
        "documentation": "In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r139",
      "r140",
      "r141"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, consideration transferred",
        "totalLabel": "Consideration transferred",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r20"
     ]
    },
    "iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, share price (in USD per share)",
        "label": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held",
        "documentation": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of ordinary shares issued to acquiree stockholders",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment of term loan obligations and accrued interest",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r138",
      "r697"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of replacement share-based awards issued to acquiree employees",
        "label": "Business Combination, Consideration Transferred, Other",
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to settle debt obligations that existed prior to acquisition date",
        "label": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date",
        "documentation": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, number of shares issued (in shares)",
        "label": "Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held",
        "documentation": "Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r692"
     ]
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction and integration related (Note 6)",
        "verboseLabel": "Integration related costs",
        "label": "Business Combination, Integration Related Costs",
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable and unbilled revenue",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of operating lease liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current deferred tax liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current portion of operating lease liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization adjustment",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
        "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unearned revenue",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable and unbilled revenue",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedNetLabel": "Accrued expenses and other current liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax assets",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "netLabel": "Estimated Fair Value",
        "verboseLabel": "Value of intangible assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other non-current liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fixed assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current portion of operating lease liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-current portion of operating lease liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations [Abstract]",
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations",
        "verboseLabel": "Transaction and Integration-related Expenses",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r1056",
      "r1057"
     ]
    },
    "iclr_BuybackProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "BuybackProgramMember",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buyback program",
        "label": "Buyback Program [Member]",
        "documentation": "Buyback Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CH",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Switzerland",
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_CapitalGovernmentGrantsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "CapitalGovernmentGrantsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term government grants",
        "label": "Capital Government Grants Current",
        "documentation": "Capital Government Grants Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedComputerSoftwareGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Capitalized Computer Software, Gross",
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software."
       }
      }
     },
     "auth_ref": [
      "r1259"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash acquired from acquisition",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r276",
      "r996"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r198",
      "r319"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase/(decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r198"
     ]
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Cash Flow Information",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails",
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in advance payments netted against unbilled contracts receivable",
        "terseLabel": "Increase in advance payments netted against unbilled contracts receivable",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable",
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in advance payments netted against unbilled contracts receivable (in percent)",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent",
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfTreasuryStockTable",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Treasury Stock [Table]",
        "label": "Class of Treasury Stock [Table]",
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r102"
     ]
    },
    "iclr_Clients1125Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Clients1125Member",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clients 11-25",
        "label": "Clients 11-25 [Member]",
        "documentation": "Clients 11-25 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Clients25Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Clients25Member",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clients 2-5",
        "label": "Clients 2-5 [Member]",
        "documentation": "Clients 2-5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Clients610Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Clients610Member",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clients 6-10",
        "label": "Clients 6-10 [Member]",
        "documentation": "Clients 6-10 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_CommitmentToAcquireLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "CommitmentToAcquireLongTermInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment to acquire future long-term investments",
        "label": "Commitment To Acquire Long-Term Investments",
        "documentation": "Commitment To Acquire Long-Term Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 17)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r170",
      "r838",
      "r900"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r446",
      "r447",
      "r981",
      "r1114"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1039",
      "r1040",
      "r1042",
      "r1043",
      "r1044",
      "r1047",
      "r1086",
      "r1087",
      "r1222",
      "r1249",
      "r1253"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in EUR per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r901"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares issued (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r178",
      "r901",
      "r921",
      "r1253",
      "r1254"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 82,495,086 shares issued and outstanding at December 31, 2023 and 81,723,555 shares issued and outstanding at December 31, 2022.",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r839",
      "r1036"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursable expenses and Direct costs",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureTable",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income",
        "terseLabel": "Total comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r301",
      "r303",
      "r310",
      "r831",
      "r849"
     ]
    },
    "iclr_ComputerEquipmentAndCapitalizedSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ComputerEquipmentAndCapitalizedSoftwareMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Computer Equipment and Capitalized Software [Member]",
        "documentation": "Computer Equipment and Capitalized Software [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r68",
      "r161",
      "r162",
      "r385",
      "r980"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r68",
      "r161",
      "r162",
      "r385",
      "r867",
      "r980"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r68",
      "r161",
      "r162",
      "r385",
      "r980",
      "r1066"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Percentage of company revenue (in percent)",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r68",
      "r161",
      "r162",
      "r385"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r68",
      "r161",
      "r162",
      "r385",
      "r980"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r999"
     ]
    },
    "iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ConsultantsRestrictedStockUnitsTwentyNineteenMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consultants Restricted Stock Units 2019",
        "label": "Consultants Restricted Stock Units Twenty Nineteen [Member]",
        "documentation": "Consultants Restricted Stock Units Twenty Nineteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ConsultantsStockPlan2008PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ConsultantsStockPlan2008PlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consultants Stock Plan, 2008 Plan",
        "label": "Consultants Stock Plan, 2008 Plan [Member]",
        "documentation": "Consultants Stock Plan, 2008 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Email Address",
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contracts with Customers, Asset and Liabilities",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debt expense",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r514",
      "r1011"
     ]
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled revenue (Note 4)",
        "netLabel": "Unbilled services (unbilled revenue)",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue (Note 4)",
        "negatedTerseLabel": "Unearned revenue (payments on account)",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r496",
      "r516"
     ]
    },
    "iclr_ContractsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ContractsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts receivable (net)",
        "label": "Contracts Receivable, Gross",
        "documentation": "Contracts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ContractsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ContractsReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts receivable and unbilled revenue, net",
        "label": "Contracts Receivable, Net",
        "documentation": "Contracts Receivable, Net"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_CorvusPharmaceuticalsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "CorvusPharmaceuticalsMember",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corvus Pharmaceuticals",
        "label": "Corvus Pharmaceuticals [Member]",
        "documentation": "Corvus Pharmaceuticals"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct costs (excluding depreciation and amortization)",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r812"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of Sales",
        "terseLabel": "Direct costs",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses:",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r210",
      "r211"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country Region",
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r678",
      "r686",
      "r1084"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax (benefit)/expense:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_DatabasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DatabasesMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patient database",
        "label": "Database Rights [Member]",
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files)."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Debt Instrument, Annual Principal Payment",
        "documentation": "Amount of the total principal payments made during the annual reporting period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r172",
      "r173",
      "r238",
      "r242",
      "r325",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r774",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1082"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate (in percent)",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total debt",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r242",
      "r478"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r166",
      "r461",
      "r774",
      "r1006",
      "r1007"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, interest rate (in percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r462"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r774",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1082"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r325",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r774",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1082"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Periodic principal payment",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated charge on repayments",
        "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid",
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r97",
      "r98",
      "r163",
      "r164",
      "r166",
      "r171",
      "r215",
      "r216",
      "r325",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r774",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1082"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt discount paid",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r166",
      "r1118"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less debt issuance costs and debt discount",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r467",
      "r479",
      "r1006",
      "r1007"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Issuance Costs",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities, available for sale, cumulative amount advanced under subscription agreements",
        "label": "Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements",
        "documentation": "Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset (Note 20)",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r658"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax (benefit)/expense",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r230",
      "r263",
      "r685",
      "r686",
      "r1084"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax (benefit)/expense:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax liabilities recognized",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r240",
      "r672"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability (Note 20)",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r658",
      "r837"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax benefit",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "iclr_DeferredTaxAssetContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DeferredTaxAssetContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Deferred Tax Asset, Contract With Customer, Liability",
        "documentation": "Deferred Tax Asset, Contract With Customer, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ireland subsidiaries additional tax credit carryforward for income tax",
        "label": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration",
        "documentation": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets recognized",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1216"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DeferredTaxAssetsOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "documentation": "Deferred Tax Assets, Operating Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss and tax credits carryforwards",
        "label": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards",
        "documentation": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-U.S subsidiaries operating loss carryforwards for income tax",
        "verboseLabel": "Net operating loss carryforwards, not subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional operating loss carryforward",
        "verboseLabel": "Net operating loss carryforwards, subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alternative minimum tax credit carry forwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other Liabilities",
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance for deferred tax assets",
        "terseLabel": "Valuation allowance for deferred tax assets",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Overall net deferred tax liability",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r1216"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Deferred Tax Liabilities, Goodwill",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r142",
      "r143",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating right-of-use-assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1217"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in foreign subsidiaries",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences."
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit pension obligations, net (note 21)",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r174",
      "r218"
     ]
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial loss",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r1021"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Actuarial gain",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Actuarial gain - benefit obligation",
        "label": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost",
        "documentation": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of net (gain)/loss",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r559",
      "r585",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior service cost",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r560",
      "r586",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other receivables",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r519",
      "r520",
      "r542",
      "r914",
      "r1021",
      "r1244"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension plan period",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period",
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of compensation increase",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected rate of return on plan assets",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r590"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of compensation increase",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities (note 16)",
        "periodStartLabel": "Benefit obligation at beginning of year",
        "periodEndLabel": "Benefit obligation at end of year",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r593"
     ]
    },
    "iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Benefits paid and transferred balances",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers",
        "documentation": "Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan participants' contributions",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "documentation": "Information by defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r571",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r546",
      "r589",
      "r1019",
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss that will be amortized",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net prior service cost for defined benefit pension plan that will be amortized",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Years 2029 - 2033",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution to pension fund in the year ending December 31, 2021",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected return on plan assets",
        "negatedLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r558",
      "r584",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of plan assets",
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r544",
      "r546",
      "r547",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency exchange rate changes",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Funded surplus",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r542",
      "r1021"
     ]
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r525",
      "r557",
      "r583",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net periodic benefit (credit)/cost",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r581",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Projected benefit obligation",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefits paid",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r1184"
     ]
    },
    "iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Benefits paid and transferred balances",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers",
        "documentation": "Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan participants' contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange rate changes",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "iclr_DefinedBenefitPlanSchemeContributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DefinedBenefitPlanSchemeContributions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scheme contributions",
        "label": "Defined Benefit Plan, Scheme Contributions",
        "documentation": "Defined Benefit Plan, Scheme Contributions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanServiceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service cost",
        "label": "Defined Benefit Plan, Service Cost",
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r556",
      "r582",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlement",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Settlement",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual plan asset allocations",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r1145"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined contribution plan, cost",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participant's contributions percentage of annual compensation (in percent)",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r83"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r83"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization expense",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r365"
     ]
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetNotionalAmount",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional",
        "label": "Derivative Asset, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset."
       }
      }
     },
     "auth_ref": [
      "r965",
      "r968",
      "r970",
      "r973",
      "r1218",
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative asset."
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "verboseLabel": "Derivative Asset",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r748",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r907",
      "r908",
      "r965",
      "r969",
      "r971",
      "r972",
      "r974",
      "r975",
      "r998",
      "r1040",
      "r1250"
     ]
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative asset, current",
        "label": "Derivative Asset, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r890",
      "r892",
      "r906",
      "r907",
      "r908",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r935",
      "r936",
      "r937",
      "r938",
      "r941",
      "r942",
      "r943",
      "r944",
      "r965",
      "r966",
      "r971",
      "r974",
      "r1038",
      "r1040"
     ]
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, fixed interest rate",
        "label": "Derivative, Fixed Interest Rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r152",
      "r153",
      "r154",
      "r890",
      "r892",
      "r906",
      "r907",
      "r908",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r935",
      "r936",
      "r937",
      "r938",
      "r941",
      "r942",
      "r943",
      "r944",
      "r965",
      "r966",
      "r971",
      "r974",
      "r998",
      "r1038",
      "r1040"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Derivatives"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r707",
      "r719"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "verboseLabel": "Derivative Liability",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r748",
      "r882",
      "r883",
      "r884",
      "r885",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r916",
      "r918",
      "r919",
      "r966",
      "r967",
      "r969",
      "r971",
      "r972",
      "r974",
      "r975",
      "r998",
      "r1250"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liability, current",
        "label": "Derivative Liability, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liability, noncurrent",
        "label": "Derivative Liability, Noncurrent",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current."
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, notional amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r145",
      "r146",
      "r148",
      "r149",
      "r151",
      "r153",
      "r155",
      "r157",
      "r158",
      "r719"
     ]
    },
    "iclr_DerivativeVariableInterestRateReferenceRateInExcessOf": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DerivativeVariableInterestRateReferenceRateInExcessOf",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, variable interest rate, reference rate in excess of",
        "label": "Derivative, Variable Interest Rate, Reference Rate In Excess Of",
        "documentation": "Derivative, Variable Interest Rate, Reference Rate In Excess Of"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r145",
      "r146",
      "r149",
      "r156",
      "r324"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total derivatives designated as hedging instruments",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Incentive Schemes and Stock Compensation Charges",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r611",
      "r642",
      "r643",
      "r644",
      "r1030"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financing Cost",
        "label": "Disclosure Of Detailed Information About Financing Cost [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Financing Cost"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DiversifiedBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "DiversifiedBondsMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diversified Bonds",
        "label": "Diversified Bonds [Member]",
        "documentation": "Diversified Bonds"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057",
      "r1059"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per ordinary share (Note 24):",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (USD per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r344",
      "r346",
      "r348",
      "r349",
      "r350",
      "r354",
      "r730",
      "r731",
      "r832",
      "r850",
      "r1000"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (USD per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r346",
      "r348",
      "r349",
      "r350",
      "r354",
      "r730",
      "r731",
      "r832",
      "r850",
      "r1000"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income per Ordinary Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65"
     ]
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareReconciliationAbstract",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per ordinary share (Note 24):",
        "label": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income Per Ordinary Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r351",
      "r352",
      "r353"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate movements on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor tax expense on foreign subsidiary earnings",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel related liabilities",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax benefit related to stock compensation",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash tax benefit related to stock options exercised",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workforce reductions",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_EmployeeStockPlanTwentyZeroEightPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "EmployeeStockPlanTwentyZeroEightPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Plan, 2008 Plan",
        "label": "Employee Stock Plan, 2008 Plan [Member]",
        "documentation": "Employee Stock Plan, 2008 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity common stock, shares outstanding (in shares)",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filler Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of employees",
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well Known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityClassOfTreasuryStockLineItems",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r270",
      "r305",
      "r306",
      "r307",
      "r326",
      "r327",
      "r328",
      "r331",
      "r339",
      "r341",
      "r355",
      "r404",
      "r410",
      "r494",
      "r645",
      "r646",
      "r647",
      "r681",
      "r682",
      "r711",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r729",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r768",
      "r795",
      "r857",
      "r858",
      "r859",
      "r880",
      "r948"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r397",
      "r398",
      "r399"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investment, ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r396",
      "r1067",
      "r1096"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Carrying value of long-term investments in equity",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r746",
      "r997"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]"
       }
      }
     },
     "auth_ref": [
      "r1255",
      "r1256",
      "r1257",
      "r1258"
     ]
    },
    "iclr_ExpectedRetirementPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ExpectedRetirementPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement period used as a basis to estimate expected cash flows",
        "label": "Expected Retirement period",
        "documentation": "Expected Retirement period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r740"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r740"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/FairValueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r234"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r736",
      "r805",
      "r806",
      "r807",
      "r1006",
      "r1007",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r737",
      "r738",
      "r741"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/FairValue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r546",
      "r551",
      "r736",
      "r805",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r546",
      "r551",
      "r736",
      "r806",
      "r1006",
      "r1007",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r736",
      "r807",
      "r1006",
      "r1007",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/FairValueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r234"
     ]
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments Measured at Net Asset Value",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "documentation": "Fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r733",
      "r741"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r805",
      "r806",
      "r807",
      "r1006",
      "r1007",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsNonrecurringMember",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, nonrecurring",
        "label": "Fair Value, Nonrecurring [Member]",
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r741"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r36"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r429"
     ]
    },
    "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Finite Lived Intangible Assets, Amortization Expense, Net",
        "documentation": "Finite Lived Intangible Assets, Amortization Expense, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r430",
      "r813",
      "r817"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Identifiable intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r817"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net (Note 11)",
        "totalLabel": "Net book value",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r813"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Country",
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyAbstract",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency [Abstract]",
        "label": "Foreign Currency [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ForeignCurrencyDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ForeignCurrencyDisclosureTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments resulting from foreign currency translations",
        "label": "Foreign Currency Disclosure [Table Text Block]",
        "documentation": "Foreign Currency Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amounts charged/(credited)",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r755",
      "r757",
      "r758",
      "r760",
      "r945"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized foreign exchange movements",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r923",
      "r1048",
      "r1225",
      "r1226",
      "r1252"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currencies and Translation of Subsidiaries",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "us-gaap_ForeignPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Plan",
        "label": "Foreign Plan [Member]",
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1185",
      "r1186",
      "r1187"
     ]
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and fixtures",
        "label": "Furniture and Fixtures, Gross",
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "GB",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United Kingdom",
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_GainLossOnIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "GainLossOnIssuanceOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on issuance of debt",
        "label": "Gain (Loss) On Issuance Of Debt",
        "documentation": "Gain (Loss) On Issuance Of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r95",
      "r96"
     ]
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Concentration Risk",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r980"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill (Note 10)",
        "terseLabel": "Goodwill",
        "periodStartLabel": "Opening goodwill",
        "periodEndLabel": "Closing goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r418",
      "r830",
      "r1004",
      "r1036",
      "r1100",
      "r1107"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current year acquisitions (note 6)",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r1004"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r420",
      "r424",
      "r1004"
     ]
    },
    "us-gaap_GoodwillFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill, Fair Value Disclosure",
        "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1223"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange movement",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment charge",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r419",
      "r422",
      "r425",
      "r1004"
     ]
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior period acquisition (note 6)",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1106"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_GovernmentBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "GovernmentBondsMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Bonds",
        "label": "Government Bonds [Member]",
        "documentation": "Government Bonds"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_GovernmentGrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "GovernmentGrantsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Government Grants [Policy Text Block]",
        "documentation": "Government Grants, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r706"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ICONDevelopmentSolutionsLimitedPensionPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICON Development Solutions Limited pension plan",
        "label": "ICON Development Solutions Limited Pension Plan [Member]",
        "documentation": "ICON Development Solutions Limited Pension Plan"
       }
      }
     },
     "auth_ref": []
    },
    "country_IE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IE",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ireland",
        "label": "IRELAND"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long lived assets",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r82",
      "r209"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill and long-lived assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncomeBeforeIncomeTaxTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncomeBeforeIncomeTaxTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Components of Income Before Provision for Income Taxes",
        "label": "Income Before Income Tax [Table Text Block]",
        "documentation": "Income Before Income Tax, Table"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before share of losses from equity method investments",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest",
        "documentation": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income before income tax expense",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r371",
      "r376",
      "r379",
      "r852",
      "r1002"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of losses from equity method investments",
        "negatedLabel": "Loss on equity method investments",
        "negatedTerseLabel": "Share of losses from equity method investments",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r186",
      "r244",
      "r366",
      "r396",
      "r846"
     ]
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income tax expense",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r1077"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r437",
      "r931"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r931"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Axis]",
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Domain]",
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncomeTaxBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncomeTaxBenefitMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "label": "Income Tax Benefit [Member]",
        "documentation": "Income Tax Benefit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r652",
      "r661",
      "r669",
      "r676",
      "r683",
      "r687",
      "r688",
      "r689",
      "r875"
     ]
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquity",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Income Tax Effects Allocated Directly to Equity",
        "documentation": "The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax expense (Note 20)",
        "totalLabel": "Income tax expense allocated to continuing operations",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r264",
      "r340",
      "r341",
      "r367",
      "r659",
      "r684",
      "r853"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense:",
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r655",
      "r656",
      "r669",
      "r670",
      "r675",
      "r677",
      "r873"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of change in tax rates",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r654",
      "r660"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign and other income taxed at higher rates",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate differential from amortization of intangible assets",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of stock compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research &amp; development tax incentives",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes (net of refunds)",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes receivable",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r1072"
     ]
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivableNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes receivable",
        "label": "Income Taxes Receivable, Noncurrent",
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unbilled revenue",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r1080"
     ]
    },
    "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unearned revenue (payments on account) (in percent)",
        "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent",
        "documentation": "Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncreaseDecreaseInContractsWithCustomersLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails",
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in unearned revenue (payments on account)",
        "label": "Increase (Decrease) In Contracts With Customers, Liability, Current",
        "documentation": "Increase (Decrease) In Contracts With Customers, Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails": {
       "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails",
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unbilled receivables",
        "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current",
        "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unbilled receivables (in percent)",
        "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent",
        "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in equity securities, FV-NI",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r314"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other net assets",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense (Note 13)",
        "terseLabel": "Total financing costs",
        "totalLabel": "Total financing costs",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r246",
      "r308",
      "r364",
      "r772",
      "r932",
      "r1048",
      "r1251"
     ]
    },
    "iclr_InterestExpenseCreditOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "InterestExpenseCreditOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financing costs",
        "label": "Interest Expense (Credit), Other",
        "documentation": "Interest Expense (Credit), Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense on drawn facilities",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r474",
      "r481",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r317",
      "r318"
     ]
    },
    "iclr_InterestRateCapAndInterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "InterestRateCapAndInterestRateSwapMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total derivatives designated as hedging instruments",
        "label": "Interest Rate Cap And Interest Rate Swap [Member]",
        "documentation": "Interest Rate Cap And Interest Rate Swap"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateCapMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Caps",
        "label": "Interest Rate Cap [Member]",
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r994",
      "r1045",
      "r1046"
     ]
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InternalRevenueServiceIRSMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal NOL's",
        "label": "Internal Revenue Service (IRS) [Member]",
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r363"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in Debt, Equity and Other",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r851",
      "r869",
      "r870",
      "r871",
      "r872",
      "r958",
      "r959"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Investments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r247",
      "r248",
      "r267",
      "r391",
      "r394",
      "r742",
      "r743"
     ]
    },
    "us-gaap_Land": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Land",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land",
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale."
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net operating lease costs",
        "verboseLabel": "Net operating lease costs",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r784",
      "r1035"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "iclr_LeaseLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "LeaseLiabilityMember",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liability",
        "label": "Lease Liability [Member]",
        "documentation": "Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements, Gross",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Lease Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1232"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Lease imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cancelable operating leases for facilities expiration period",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1230"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r322",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r700",
      "r703",
      "r704",
      "r749",
      "r899",
      "r1001",
      "r1050",
      "r1115",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r243",
      "r842",
      "r1036",
      "r1083",
      "r1097",
      "r1224"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r275",
      "r322",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r700",
      "r703",
      "r704",
      "r749",
      "r1036",
      "r1115",
      "r1236",
      "r1237"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current Liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limit of shares issued or to be issued pursuant to options granted (in shares)",
        "label": "Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted",
        "documentation": "Limit of Shares Issued or To Be Issued Pursuant to Options Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing Balance",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current bank credit lines and loan facilities (Note 13)",
        "label": "Line of Credit, Current",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r238"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term debt, net",
        "terseLabel": "Total long-term debt, net",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r242",
      "r468",
      "r480",
      "r1006",
      "r1007",
      "r1245"
     ]
    },
    "iclr_LongTermDebtCurrentMaturitiesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "LongTermDebtCurrentMaturitiesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less current portion of debt",
        "label": "Long-term Debt, Current Maturities, Gross",
        "documentation": "Long-term Debt, Current Maturities, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_LongTermDebtExcludingCurrentMaturitiesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "LongTermDebtExcludingCurrentMaturitiesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-term debt",
        "label": "Long-term Debt, Excluding Current Maturities, Gross",
        "documentation": "Long-term Debt, Excluding Current Maturities, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt at fair value",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r325",
      "r472"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r325",
      "r472"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r325",
      "r472"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r325",
      "r472"
     ]
    },
    "iclr_LongTermDebtMaturityYearFiveAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "LongTermDebtMaturityYearFiveAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Long-Term Debt, Maturity, Year Five And Thereafter",
        "documentation": "Long-Term Debt, Maturity, Year Five And Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term debt, net",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Credit Lines and Loan Facilities",
        "label": "Long-Term Debt [Text Block]",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current bank credit lines and loan facilities (Note 13)",
        "label": "Long-Term Line of Credit, Noncurrent",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r92",
      "r93"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r94"
     ]
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Machinery and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r385",
      "r1014",
      "r1122",
      "r1247",
      "r1248"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r451",
      "r600",
      "r809",
      "r854",
      "r891",
      "r892",
      "r956",
      "r960",
      "r962",
      "r963",
      "r976",
      "r991",
      "r992",
      "r1003",
      "r1010",
      "r1029",
      "r1037",
      "r1117",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r451",
      "r600",
      "r809",
      "r854",
      "r891",
      "r892",
      "r956",
      "r960",
      "r962",
      "r963",
      "r976",
      "r991",
      "r992",
      "r1003",
      "r1010",
      "r1029",
      "r1037",
      "r1117",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r385",
      "r1014",
      "r1122",
      "r1247",
      "r1248"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.iconplc.com/role/Descriptionofbusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r265"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in)/provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r200"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r200",
      "r245",
      "r273",
      "r300",
      "r302",
      "r307",
      "r322",
      "r330",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r341",
      "r347",
      "r360",
      "r371",
      "r376",
      "r379",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r731",
      "r749",
      "r848",
      "r924",
      "r946",
      "r947",
      "r1002",
      "r1048",
      "r1115"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r336",
      "r342",
      "r354",
      "r389",
      "r390",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r432",
      "r645",
      "r646",
      "r647",
      "r679",
      "r680",
      "r681",
      "r682",
      "r693",
      "r694",
      "r695",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r744",
      "r745",
      "r750",
      "r751",
      "r752",
      "r753",
      "r770",
      "r771",
      "r775",
      "r776",
      "r777",
      "r778",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r814",
      "r815",
      "r816",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r868"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r336",
      "r342",
      "r354",
      "r389",
      "r390",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r432",
      "r645",
      "r646",
      "r647",
      "r679",
      "r680",
      "r681",
      "r682",
      "r693",
      "r694",
      "r695",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r744",
      "r745",
      "r750",
      "r751",
      "r752",
      "r753",
      "r770",
      "r771",
      "r775",
      "r776",
      "r777",
      "r778",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r814",
      "r815",
      "r816",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r868"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of Recently Issued or Adopted Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived assets",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "iclr_NonexecutiveDirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "NonexecutiveDirectorMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-executive director",
        "label": "Non-executive Director [Member]",
        "documentation": "Non-executive Director [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NontradeReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Nontrade Receivables, Current",
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of countries in which company operates",
        "label": "Number of Countries in which Entity Operates",
        "documentation": "The number of countries in which the entity operates as of balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfInterestRateDerivativesHeld",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of interest rate derivatives held",
        "label": "Number of Interest Rate Derivatives Held",
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148"
     ]
    },
    "iclr_NumberOfLocations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "NumberOfLocations",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of locations in which company operates",
        "label": "Number of Locations",
        "documentation": "Number of Locations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reporting segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "iclr_NumberOfVotes": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "NumberOfVotes",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of votes",
        "label": "Number Of Votes",
        "documentation": "Number Of Votes"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OncacareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OncacareMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Oncacare",
        "label": "Oncacare [Member]",
        "documentation": "Oncacare"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OperatingIncomeByGeographyTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OperatingIncomeByGeographyTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Distribution of Income from Operations by Geographical Area",
        "label": "Operating Income by Geography [Table Text Block]",
        "documentation": "Operating Income by Geography."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r371",
      "r376",
      "r379",
      "r1002"
     ]
    },
    "iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income from operations, excluding restructuring and other items",
        "label": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses",
        "documentation": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r785",
      "r1035"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long lived assets",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities (Note 15)",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating right-of-use assets (Note 15)",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in carrying value of operating right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate (in percent)",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r789",
      "r1035"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r1035"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "iclr_OperatingLossCarryforwardsUSFederal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OperatingLossCarryforwardsUSFederal",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Federal net operating loss carry forwards currently available for offset",
        "label": "Operating Loss Carryforwards, US Federal",
        "documentation": "Operating Loss Carryforwards, US Federal"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OptionPlans2008Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OptionPlans2008Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option Plans 2008",
        "label": "Option Plans 2008 [Member]",
        "documentation": "Option Plans 2008 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrderOrProductionBacklogMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Order backlog",
        "label": "Order or Production Backlog [Member]",
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost",
        "label": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax",
        "documentation": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial gain on defined benefit pension plan",
        "verboseLabel": "Actuarial gain on defined benefit pension plan",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r184",
      "r563"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency impact on long term funding",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8",
      "r756",
      "r759",
      "r767"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income Location [Axis]",
        "label": "Other Comprehensive Income Location [Axis]",
        "documentation": "Information by location in other comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income Location [Domain]",
        "label": "Other Comprehensive Income Location [Domain]",
        "documentation": "Location in other comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of cash flow hedge",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gain/(loss) on cash flow hedge",
        "terseLabel": "Gain on cash flow hedge",
        "negatedLabel": "Gain/(loss) on cash flow hedge",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of cash flow hedge",
        "negatedTerseLabel": "Amortization of cash flow hedge",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r294",
      "r298"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r294",
      "r298"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income, net of tax",
        "verboseLabel": "Other comprehensive income/(loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial loss/(gain) - plan assets",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r184",
      "r299",
      "r563"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax",
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r184",
      "r299",
      "r563"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense was allocated to the following components of other comprehensive income:",
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income",
        "label": "Other Comprehensive Income (Loss) [Member]",
        "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "iclr_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherCustomersMember",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Customers [Member]",
        "documentation": "Other Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherGeographicLocationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherGeographicLocationsMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Other Geographic Locations [Member]",
        "documentation": "Other Geographic Locations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due to third parties for reimbursable expenses",
        "label": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses",
        "documentation": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities (Note 12)",
        "totalLabel": "Other liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r1036"
     ]
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities Disclosure [Abstract]",
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities",
        "label": "Other Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for other liabilities."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities (Note 16)",
        "totalLabel": "Other Liabilities, Noncurrent",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Liabilities",
        "label": "Other Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in equity-long term (Note 8b)",
        "label": "Other Long-Term Investments",
        "documentation": "Amount of long-term investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r835",
      "r1068"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other non-cash items",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r909"
     ]
    },
    "us-gaap_OtherRestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherRestructuringCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other restructuring costs",
        "label": "Other Restructuring Costs",
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "iclr_OtherRetirementPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherRetirementPlansMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other retirement plans",
        "label": "Other Retirement Plans [Member]",
        "documentation": "Other Retirement Plans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General trade and overhead liabilities",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r91"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Sundry Liabilities, Noncurrent",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r241"
     ]
    },
    "iclr_OtherUndenominatedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherUndenominatedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other undenominated capital (Note 18b)",
        "label": "Other Undenominated Capital",
        "documentation": "Other undenominated capital."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherUndenominatedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "OtherUndenominatedCapitalMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Undenominated Capital",
        "label": "Other Undenominated Capital [Member]",
        "documentation": "Other undenominated capital."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PRAHealthSciencesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "PRAHealthSciencesIncMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRA Health Sciences, Inc",
        "label": "PRA Health Sciences, Inc [Member]",
        "documentation": "PRA Health Sciences, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PRASwitzerlandAGPensionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "PRASwitzerlandAGPensionPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRA Switzerland AG pension plan",
        "label": "PRA Switzerland AG Pension Plan [Member]",
        "documentation": "PRA Switzerland AG Pension Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of ordinary shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "iclr_PaymentsForShareRepurchaseCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "PaymentsForShareRepurchaseCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share repurchase costs",
        "label": "Payments for Share Repurchase Costs",
        "documentation": "Payments for Share Repurchase Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Financing costs",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of available for sale investments",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r312",
      "r392"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of subsidiary undertakings (net of cash acquired)",
        "terseLabel": "Fair value of cash consideration",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r696"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment in equity method investments",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireLongtermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of investments in equity - long term",
        "label": "Payments to Acquire Long-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property, plant and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loan to equity method investment",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates."
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1233"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefits",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r543",
      "r545",
      "r551",
      "r570",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r591",
      "r592",
      "r594",
      "r1021"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-current other liabilities (note 16)",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r519",
      "r520",
      "r542",
      "r1021"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Costs",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r18",
      "r19",
      "r27",
      "r109"
     ]
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionPlansDefinedBenefitMember",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Plan",
        "label": "Pension Plan [Member]",
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r568",
      "r569",
      "r571",
      "r574",
      "r577",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r594",
      "r595",
      "r606",
      "r1021",
      "r1022",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "iclr_PerformanceBasedGrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "PerformanceBasedGrantsMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PSUs Based on Service and EPS Targets",
        "label": "Performance Based Grants [Member]",
        "documentation": "Performance Based Grants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PerformanceShareUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "PerformanceShareUnitMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Share Unit (PSUs)",
        "label": "Performance Share Unit [Member]",
        "documentation": "Performance Share Unit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanAssetCategoriesDomain",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "documentation": "Defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r571",
      "r1019",
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Drawdown of credit lines and facilities",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r1082"
     ]
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of available for sale investments",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r312",
      "r392",
      "r395"
     ]
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from investments in equity - long term",
        "label": "Proceeds from Sale of Long-Term Investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of equity compensation",
        "verboseLabel": "Total proceeds from exercise of stock options by employees",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r30"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r300",
      "r302",
      "r315",
      "r322",
      "r330",
      "r340",
      "r341",
      "r360",
      "r371",
      "r376",
      "r379",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r698",
      "r701",
      "r702",
      "r731",
      "r749",
      "r833",
      "r847",
      "r879",
      "r924",
      "r946",
      "r947",
      "r1002",
      "r1033",
      "r1034",
      "r1049",
      "r1077",
      "r1115"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r254",
      "r261",
      "r262"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, plant and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r278",
      "r845"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, plant and equipment, net (Note 9)",
        "totalLabel": "Property, plant and equipment (net)",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r834",
      "r845",
      "r1036"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r254",
      "r261",
      "r843"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property Plant and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful lives",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Range1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Range1Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range 1",
        "label": "Range 1 [Member]",
        "documentation": "Range 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Range2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Range2Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range 2",
        "label": "Range 2 [Member]",
        "documentation": "Range 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Range3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Range3Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range 3",
        "label": "Range 3 [Member]",
        "documentation": "Range 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Range4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "Range4Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range 4",
        "label": "Range 4 [Member]",
        "documentation": "Range 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r451",
      "r543",
      "r600",
      "r637",
      "r638",
      "r639",
      "r808",
      "r809",
      "r854",
      "r891",
      "r892",
      "r956",
      "r960",
      "r962",
      "r963",
      "r976",
      "r991",
      "r992",
      "r1003",
      "r1010",
      "r1029",
      "r1037",
      "r1040",
      "r1110",
      "r1117",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r451",
      "r543",
      "r600",
      "r637",
      "r638",
      "r639",
      "r808",
      "r809",
      "r854",
      "r891",
      "r892",
      "r956",
      "r960",
      "r962",
      "r963",
      "r976",
      "r991",
      "r992",
      "r1003",
      "r1010",
      "r1029",
      "r1037",
      "r1040",
      "r1110",
      "r1117",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Net and Unbilled Revenue",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1093",
      "r1094",
      "r1095"
     ]
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ReconciliationOfProvisionOfIncomeTaxesLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Provision of Income Taxes [Line Items]",
        "label": "Reconciliation of Provision of Income Taxes [Line Items]",
        "documentation": "Reconciliation of Provision of Income Taxes [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ReconciliationOfProvisionOfIncomeTaxesTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Provision of Income Taxes [Table]",
        "label": "Reconciliation of Provision of Income Taxes [Table]",
        "documentation": "Reconciliation of Provision of Income Taxes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r799",
      "r800",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r920",
      "r922",
      "r955"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r799",
      "r800",
      "r1235"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r927",
      "r928",
      "r931"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r799",
      "r800",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r920",
      "r922",
      "r955",
      "r1235"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r796",
      "r797",
      "r798",
      "r800",
      "r801",
      "r876",
      "r877",
      "r878",
      "r929",
      "r930",
      "r931",
      "r952",
      "r954"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of credit lines and facilities",
        "terseLabel": "Repayment of credit lines and facilities",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r1082"
     ]
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfSeniorDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment",
        "label": "Repayments of Senior Debt",
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "iclr_ResearchandDevelopmentCreditsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ResearchandDevelopmentCreditsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development credits",
        "label": "Research and Development Credits [Policy Text Block]",
        "documentation": "Research and Development Credits [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestOfEuropeAndOtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "RestOfEuropeAndOtherCountriesMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Rest Of Europe And Other Countries [Member]",
        "documentation": "Rest Of Europe And Other Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestOfEuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "RestOfEuropeMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of Europe",
        "label": "Rest Of Europe [Member]",
        "documentation": "Rest Of Europe [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestrictedStockUnitsTwentyThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "RestrictedStockUnitsTwentyThirteenMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units 2013",
        "label": "Restricted Stock Units Twenty Thirteen [Member]",
        "documentation": "Restricted Stock Units Twenty Thirteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Activities [Abstract]",
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringCharges"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Charges",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434",
      "r436",
      "r439",
      "r445"
     ]
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional provision in the year",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r440",
      "r442",
      "r1111"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r442",
      "r443"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r442",
      "r443",
      "r444"
     ]
    },
    "us-gaap_RestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restructuring (Note 19)",
        "terseLabel": "Restructuring charges",
        "label": "Restructuring Costs",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_RestructuringPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanAxis",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Axis]",
        "label": "Restructuring Plan [Axis]",
        "documentation": "Information by individual restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanDomain",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan [Domain]",
        "label": "Restructuring Plan [Domain]",
        "documentation": "Identification of the individual restructuring plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring reserve",
        "periodStartLabel": "Opening provision",
        "periodEndLabel": "Ending provision",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r441"
     ]
    },
    "us-gaap_RestructuringReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring reserve, current",
        "label": "Restructuring Reserve, Current",
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring reserve, noncurrent",
        "label": "Restructuring Reserve, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r1074",
      "r1112",
      "r1113"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestructuringReserveUtilizations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "RestructuringReserveUtilizations",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Utilization",
        "label": "Restructuring Reserve Utilizations",
        "documentation": "Restructuring Reserve Utilizations"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestructuringReserveandOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "RestructuringReserveandOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring liabilities",
        "label": "Restructuring Reserve and Other Liabilities, Current",
        "documentation": "Restructuring Reserve and Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r217",
      "r841",
      "r861",
      "r866",
      "r874",
      "r902",
      "r1036"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r326",
      "r327",
      "r328",
      "r331",
      "r339",
      "r341",
      "r404",
      "r410",
      "r645",
      "r646",
      "r647",
      "r681",
      "r682",
      "r711",
      "r714",
      "r715",
      "r718",
      "r729",
      "r857",
      "r859",
      "r880",
      "r1253"
     ]
    },
    "us-gaap_RetirementPlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanNameAxis",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Axis]",
        "label": "Retirement Plan Name [Axis]",
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r1029",
      "r1063",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183"
     ]
    },
    "us-gaap_RetirementPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Domain]",
        "label": "Retirement Plan Name [Domain]",
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r1029",
      "r1063",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanSponsorLocationAxis",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Axis]",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r567",
      "r568",
      "r569",
      "r571",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r1185",
      "r1186",
      "r1187"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanSponsorLocationDomain",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Domain]",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r567",
      "r568",
      "r569",
      "r571",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r1185",
      "r1186",
      "r1187"
     ]
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Axis]",
        "label": "Retirement Plan Type [Axis]",
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r568",
      "r569",
      "r571",
      "r574",
      "r577",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r594",
      "r595",
      "r596",
      "r606",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Domain]",
        "label": "Retirement Plan Type [Domain]",
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r568",
      "r569",
      "r571",
      "r574",
      "r577",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r594",
      "r595",
      "r596",
      "r606",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r370",
      "r374",
      "r375",
      "r381",
      "r383",
      "r385",
      "r513",
      "r515",
      "r812"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r993"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalances",
      "http://www.iconplc.com/role/DisaggregationofRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "verboseLabel": "Contract Balances",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r517"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, amount",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation (in percent)",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r322",
      "r361",
      "r362",
      "r370",
      "r374",
      "r375",
      "r381",
      "r383",
      "r385",
      "r400",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r749",
      "r833",
      "r1115"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Revolving Loan Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r787",
      "r1035"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r1065"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r1227",
      "r1228"
     ]
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share",
        "label": "Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]",
        "documentation": "Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Plan Asset Fair Value Measurements",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts Recognized in Balance Sheet",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost."
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Assumptions Used in Calculating Pension Benefit Obligations",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Underlying Asset Split of Fund",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1172"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r691"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Disclosure of Cash Flow Information",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Components of Provision for Income Taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r97",
      "r98",
      "r163",
      "r164",
      "r166",
      "r171",
      "r215",
      "r216",
      "r1006",
      "r1008",
      "r1085"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of number of shares used in computation of basic and diluted net income per ordinary share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r397",
      "r398",
      "r399"
     ]
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Annual Benefit Payments which Reflect Expected Future Service",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r206"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Long-term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of measurement period adjustments",
        "label": "Schedule Of Measurement Period Adjustments [Table Text Block]",
        "documentation": "Schedule Of Measurement Period Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfNonCashStockCompensationExpenseTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Non-cash Stock Compensation Expense",
        "label": "Schedule of Non Cash Stock Compensation Expense [Table Text Block]",
        "documentation": "Schedule of Non Cash Stock Compensation Expense."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Principal Payments on Debt Instrument",
        "label": "Schedule of Principal Payments on Debt Instrument [Table Text Block]",
        "documentation": "Schedule of Principal Payments on Debt Instrument"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Product Information [Table]",
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r927",
      "r928",
      "r931"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r442",
      "r443",
      "r444"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Charges",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r87",
      "r89"
     ]
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r190"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r185"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r77"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r610",
      "r612",
      "r613",
      "r614",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640"
     ]
    },
    "iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of RSU and PSU Activity",
        "label": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]",
        "documentation": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Information Concerning Outstanding and Exercisable Share Options",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Transactions for Company's Share Option Plans",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r112"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted Average Fair Values and Assumptions Used",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful lives of assets",
        "label": "Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]",
        "documentation": "Schedule Of Useful Lives For Property Plant Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Intangible Asset Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Term Loan",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r383",
      "r384",
      "r884",
      "r887",
      "r889",
      "r957",
      "r961",
      "r964",
      "r977",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r995",
      "r1013",
      "r1040",
      "r1122",
      "r1247"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Segment and Geographical Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r369",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r385"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior secured credit facility and senior secured notes",
        "label": "Senior Secured Credit Facility And Senior Secured Notes [Member]",
        "documentation": "Senior Secured Credit Facility And Senior Secured Notes"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "SeniorSecuredNotesMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes",
        "label": "Senior Secured Notes [Member]",
        "documentation": "Senior Secured Notes"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredRevolvingLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "SeniorSecuredRevolvingLoanFacilityMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior secured revolving loan facility",
        "label": "Senior Secured Revolving Loan Facility [Member]",
        "documentation": "Senior Secured Revolving Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorSubordinatedNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorSubordinatedNotesMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes",
        "label": "Senior Subordinated Notes [Member]",
        "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated notes are junior to Senior Notes and Senior bond holders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock compensation expense",
        "terseLabel": "Total compensation costs",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at ending of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r625"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding number of shares [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (USD per share)",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r625"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price of equity instruments other than options, vested in period (in USD per share)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of stock units vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares vested (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumptions:",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r610",
      "r612",
      "r613",
      "r614",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares per employee (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional number of ordinary shares which have been reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock units to be granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumed through business combination (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Canceled/expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average fair value (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r617"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options Granted Under Plans",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (USD per share)",
        "periodEndLabel": "Ending balance (USD per share)",
        "terseLabel": "Weighted average exercise price (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r617"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r613",
      "r614",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640"
     ]
    },
    "iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumed through business combination (USD per share)",
        "label": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average exercise price of option per share (USD per share)",
        "verboseLabel": "Exercised (USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canceled/expired (USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r615",
      "r634",
      "r635",
      "r636",
      "r637",
      "r640",
      "r648",
      "r649",
      "r650",
      "r651"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range [Axis]",
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range [Domain]",
        "label": "Exercise Price Range [Domain]",
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum range exercise price (USD per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum range exercise price (USD per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average contractual term of options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable - weighted average remaining contractual life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of option price for fair value of ordinary share (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term investments average maturity period",
        "label": "Short Term Available For Sale Investments Average Remaining Maturity Period",
        "documentation": "Short Term Available For Sale Investments Average Remaining Maturity Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant accounting policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r320"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefit, potentially expire in 2021",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]",
        "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State NOL's",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r48",
      "r270",
      "r305",
      "r306",
      "r307",
      "r326",
      "r327",
      "r328",
      "r331",
      "r339",
      "r341",
      "r355",
      "r404",
      "r410",
      "r494",
      "r645",
      "r646",
      "r647",
      "r681",
      "r682",
      "r711",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r729",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r768",
      "r795",
      "r857",
      "r858",
      "r859",
      "r880",
      "r948"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r383",
      "r384",
      "r884",
      "r887",
      "r889",
      "r957",
      "r961",
      "r964",
      "r977",
      "r979",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r995",
      "r1013",
      "r1040",
      "r1122",
      "r1247"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r355",
      "r812",
      "r869",
      "r881",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r901",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r922",
      "r925",
      "r926",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r948",
      "r1041"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r355",
      "r812",
      "r869",
      "r881",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r901",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r922",
      "r925",
      "r926",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r948",
      "r1041"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares associated with a business combination (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r178",
      "r217"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r177",
      "r178",
      "r217"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of restricted share units / performance share units (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r177",
      "r178",
      "r217"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture",
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of share options (in shares)",
        "verboseLabel": "Options exercised by employees (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r177",
      "r178",
      "r217",
      "r621"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of ordinary shares",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r48",
      "r217"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of restricted share units / performance share units",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r177",
      "r178",
      "r217"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of share options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r48",
      "r217"
     ]
    },
    "iclr_StockOptionAndAwardPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "StockOptionAndAwardPlansMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option and Award Plans",
        "label": "Stock Option And Award Plans [Member]",
        "documentation": "Stock Option And Award Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_StockRepurchaseProgramAuthorizedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "StockRepurchaseProgramAuthorizedPercentage",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized percentage (in percent)",
        "label": "Stock Repurchase Program Authorized Percentage",
        "documentation": "Stock Repurchase Program Authorized Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of ordinary shares (in shares)",
        "terseLabel": "Ordinary shares redeemed (in shares)",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "documentation": "Number of shares that have been repurchased and retired during the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r177",
      "r178",
      "r217"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of ordinary shares",
        "terseLabel": "Ordinary shares redeemed, value",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r177",
      "r178",
      "r217"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders' Equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r181",
      "r182",
      "r202",
      "r903",
      "r921",
      "r949",
      "r950",
      "r1036",
      "r1050",
      "r1083",
      "r1097",
      "r1224",
      "r1253"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders' Equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Capital",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r321",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r720",
      "r951",
      "r953",
      "r978"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income from sub-leases",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r1035"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r803"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r803"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r803"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r803"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r803"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r804"
     ]
    },
    "us-gaap_SubsidiaryOfCommonParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOfCommonParentMember",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries",
        "label": "Subsidiary of Common Parent [Member]",
        "documentation": "Refers to an entity under the control of the same parent as another entity (that is, a sister company)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r228",
      "r229"
     ]
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Expected Expiry Dates of NOL's",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carry forward",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_TaxPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxPeriodAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Axis]",
        "label": "Tax Period [Axis]",
        "documentation": "Information about the period subject to enacted tax laws."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxPeriodDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Domain]",
        "label": "Tax Period [Domain]",
        "documentation": "Identified tax period."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TaxYear2024To2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TaxYear2024To2030Member",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax year 2024 to 2030",
        "label": "Tax Year 2024 to 2030 [Member]",
        "documentation": ""
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TaxYear2024To2037Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TaxYear2024To2037Member",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-2037",
        "label": "Tax Year 2024 to 2037 [Member]",
        "documentation": "Tax Year 2024 to 2037"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TaxYear20382042Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TaxYear20382042Member",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2038-2042",
        "label": "Tax Year 2038-2042 [Member]",
        "documentation": "Tax Year 2038-2042"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technology assets",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "iclr_TermLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TermLoanFacilityMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Term Loan",
        "label": "Term Loan Facility [Member]",
        "documentation": "Term Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_The2018LegacyPRAPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "The2018LegacyPRAPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2018 Legacy PRA Plan",
        "label": "The 2018 Legacy PRA Plan [Member]",
        "documentation": "The 2018 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_The2020LegacyPRAPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "The2020LegacyPRAPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2020 Legacy PRA Plan",
        "label": "The 2020 Legacy PRA Plan [Member]",
        "documentation": "The 2020 Legacy PRA Plan"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1091",
      "r1234"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TopClientMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TopClientMember",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Top client",
        "label": "Top Client [Member]",
        "documentation": "Top Client [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade names &amp; brands",
        "verboseLabel": "Trade names",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TransactionAndIntegrationExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TransactionAndIntegrationExpenseMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction and integration related",
        "label": "Transaction And Integration Expense [Member]",
        "documentation": "Transaction And Integration Expense"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TransactionAndOneTimeFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "TransactionAndOneTimeFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction and one time financing costs",
        "label": "Transaction And One Time Financing Costs",
        "documentation": "Transaction And One Time Financing Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Adoption [Domain]",
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r330",
      "r331",
      "r332",
      "r333",
      "r342",
      "r389",
      "r390",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r432",
      "r645",
      "r646",
      "r647",
      "r679",
      "r680",
      "r681",
      "r682",
      "r693",
      "r694",
      "r695",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r744",
      "r745",
      "r750",
      "r751",
      "r752",
      "r753",
      "r770",
      "r771",
      "r775",
      "r776",
      "r777",
      "r778",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r814",
      "r815",
      "r816",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r442",
      "r443"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsScheduleofAmountsRecognizedinBalanceSheetDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "verboseLabel": "U.S.",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unrecognized tax benefits at start of year",
        "periodEndLabel": "Unrecognized tax benefits at end of year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r663"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Settlements",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total accrued interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties recognized as an expense",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to acquired tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Decrease)/ increase in unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Lapse of statute of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r667"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized tax benefits net of potential benefits",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r252",
      "r253",
      "r255",
      "r256"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net change in the total valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "VariableRateComponentAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Component [Axis]",
        "label": "Variable Rate Component [Axis]",
        "documentation": "Variable Rate Component"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "VariableRateComponentDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Component [Domain]",
        "label": "Variable Rate Component [Domain]",
        "documentation": "Variable Rate Component [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "VariableRateComponentOneMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate component one",
        "label": "Variable Rate Component One [Member]",
        "documentation": "Variable Rate Component One"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "VariableRateComponentTwoMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate component two",
        "label": "Variable Rate Component Two [Member]",
        "documentation": "Variable Rate Component Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VehiclesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20231231",
     "localname": "VehiclesGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Motor vehicles",
        "label": "Vehicles, Gross",
        "documentation": "Vehicles, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Motor vehicles",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r350"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares outstanding (Note 24):",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r350"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481097/715-30-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "60",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "80",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b),(d)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(a)(b)(c)",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//310/tableOfContent"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 5.P.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-13"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-14"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "70",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-3"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-4"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "30",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-5"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "30",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-6"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-8"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-9"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.18)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//230/tableOfContent"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r220": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r221": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r222": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r223": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r224": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r225": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r226": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r227": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r228": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r229": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r230": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r231": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r232": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r233": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r234": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r235": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r236": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r237": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r238": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r239": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r240": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r241": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r242": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r243": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r244": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r245": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r246": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r247": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r248": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479567/321-10-45-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-19"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//420/tableOfContent"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>169
<FILENAME>0001060955-24-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001060955-24-000010-xbrl.zip
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MMT[W%*H^A]9.3Z/<_C;\<_VW_K\)^!]02P,$%     @ ^(176*"._995!0
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M<]KE:_"]NG9GW0M_QOX34$L#!!0    ( /B$5U@&JI=8' L  &HW   2
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MFLS .31",/>)>&U%)8D.Z8HSK,B(''&^C12Y[#1K8RD=9LL>!P4J9T<:YH9
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MB:[^=KX5WW2-E9DK\G+1SE#(N# # I[4JV:$SPAQ<Z+=?(K#3A?=+_*%F_A
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MXW _ B]^Q%P)6X&F:3C]FY5+4M6BLRN%)))"Z3:C=SPX^GZ&FIKZ2)P5+TO
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MSYL73>I3T;M,[HLTX !((WI3Q.4YPN0"@6-_PV1K%P9]QP.*EE_'I=>=BV=
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M.^]PQU6]X M<'GK%5_1VWGWXU^-?<!X (&:G\(J(^1>!QW_\@\^RA_=WWG6
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M<:>4:Z\ON@BF:1+3%=V7I"%5*9?WK?7*-?BYJ?A9I;:ROT7^P'59=0V"ULE
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M/U8XU!=/E9OB%=A.JJQ4>;#.=?"BJ+)*4'8WRAGQ"#W05GJLDK5V-\J;\5Q
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M2!8GSG''\=@L?GB)INJQ<*4M"TRQ37/L[35B;X/$WK,SRTWB($A<0%<3D21
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M)P1;)2%U"O.Y"M@[#6,]Y[N4/]*@1'TH\4$R#03)A'-*7O=2:5H"-Z,)\3A
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M)8M4XXG'$E9@?[E]"E>G8$%>DIC"DCBMQ\A'P!^2"6:UKEFF% JW 3Z><F4
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MRS0(>&G2PB<U5\',@L <4R%+388^_R%4&@2E+<@\"(PWJUGLQ$ 7*\%J*L"
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M6%6(L<I(#)*/#)./T!-NF/M(QQ%2/QU-H1M3;LKGJA,Y-?DIW$FB1,<=# ]
M7FZ%22_N=UTF8O@("%DQS4)-[U!>M.W/!'MT<*&44K(TN&#VPMK^",,_C<H)
MPJG<S^WXH4MTC;-VPWB*((I;ZJ2-#DEZ+!J9CI@'$NHRW+AXF/@@5>=#,K$$
M,AUO0#&#GG,==!-1'O !>6\^,$ZGF U$%=:%49$%IS^YX:FZ5?%;H^3?Q9*@
M+)107)*2P&;\18U3&LH<4N/:)=$7J1-*;V)>5TD5(::RIEY?/"WCJ++N3W@
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M:#D?!-:_ J=L.2=G9U\^GGQN40Q.9=*>L81)D_K5Q=GO?_M+]W#O[4^TKLN
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M ?=(&CG&*Q%C,7I/=!,#8LU=Q@93UN816Q\\O$+#K_RG_+\#0\OOGJ.,O;"
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MF U-=LBIG??M"HJ_G.#DMNTY2AX_G@.&2=IIOS\X?YQN-N< >GM4AHJC(I-
MX;:J=7#X;L?[(XWWM&S1H\;$L#;HT[S+;P?X8PUP4956&P46GCZN(#(^:,WY
MO!WOCS3>DX83A,[?OQW:CS2T7N;M=FP_[MA*>%!4Y/%/E"S.$NPAX)@68Y1L
MD!!!6#,4$-S.QT>:#TL.3,#2TX6<03#7^,7M6'^DL::0317D>&'WQGQ)?_(_
M;\G]Z%^5TM2@:=UQV4Q'J@!C/*LM:YT>Q<Q=L&<9.3\+5HZ2<+<]JTEP"V'0
M1\WD<<?+_0?[XP?%M)@='$P>3!\\RA]/'^V-'Q_,9H\?%X_NW__?QP\>['/3
MRV=LP=J:VA<0>B@U#B+WLECOT,JBX,H,#Y"VM-5GX ENML8&X[&K0@1;VP5"
M4I;NE=C) \.C*%*^]"  H+-I<[2%]TK[N1_D7@V+P5(9W$0Y+FBCGF@B3:#^
M\=HB"X_F!64Q4>B57$6D+1:TOV@3_EDW'KK#<,\49"00]I;.QV-E*]DDNRDZ
M84JNBM-85&)[,B1P_.& <M<_"DP^I#B/"@"_EL?X_#P(84 -,C2/*B.T%3+E
MJPH0,[2%ZI">%#WXI3!],[1+\%)L'X5,@?&C[F_"L01SJH.JUI,NM[2<)K^!
M2'@8^9"BU2FV%O3IJ ")FMA(&7H&S?I"K*J7\)BS!*:I#O=;6XV)7>ZA*<M?
MZE-4R[/^C?IE==& [J2V;@;"9V$GY4E)DU2VW:H9\^((J5AZV@G9#)1@:>Y7
M^#IJ.T7#..' 5@U._GHM;3^]O'-81TO.>O+%.6E41LF: 5#&/#^U,D=()&=H
M^<F[()5"VY2N.ZT7F*X)]@IVG@.]I'GO%+Z3#0!T;6F[GNDE-\$6RL.]!6(2
M,#3:U]0'2$3 6]BZ4+IMDZ;R63Y1'*9#!O?-^*3FAF:Y& "YP2CD$QD-G9TN
M9I SR=K_IZ[L3.:I_#P:?%?3[#])*^-+#_C:5D$M'1=)L(&VM0>2]&%S"+*4
M)7MZR\0)E@0T0]2JIO4\*Q.T60KA=!Z7 S/Q"RQ7G3VA.6/"18W#+I!1ET"2
M.CYJM]5V8]OJ!G0LI\TY>2? C="?GP?+IIM34KR2LC$#E?GS*0H6G%7J,.A'
MU'Y@_0T@R<W*23M7F =MYQ,;$(QE"EBJW$V5($Y.N"!UC%P>>KNZ9C4Q149?
M0L,X]&IPMB@R/8WPKWEMJTK>-;%&B@I@B%W;KAA]#$60MA,&J(DBB86DG.X5
M3CC# /@3#8X 2T2%U>O,K'KVERRW,R2@KD3?:QLT3V(!.?*20VR^-M7H0=2=
M.$[0#PS;P6^WE&0I:4+:"GN[&\^TUZNV+7.^R\\%S>T*VI I/,;A\D1"PXW7
M@E4E<9PKFEXY'Y*6ELQ^_ ?=D8XAOMNS54//1P/Q1\5(/&&V9)$Q&E 5!;O@
M>"2<]<Y7F]9Q,'CYVF7H69@DB(V"J9:Y]W1O&#1\,V=:SE\?,MH1<I6@^&[N
M@?*'LY%J]"0:ZYT@;!6#OQ:-D%HY,!H-<=E;5DO."-S7V;7 8F^7[04"SM2A
M?/=GO98^3M8%+HX!-3WASHM.R^=PA<Q\QQMZCQ&'(+DH@ K/N<V6'F$=/N=Q
M2MS_O8"M$".%(*-D9AESH.BH:>I)44R90JWWKLJQ2!XX$Z':@S !(]MQ8(F@
M%?OGBMQ:P(Q<?]TPB(4-)0]1R;+TN$UH_H99[]@EM$R*)D,8&!&6?+20-W;%
MOYBY>B^ZYTX*33U@]= :)J/[ ;F(@',V&T1/E&T'>F[K'(D=EF=PCA;3ZP\H
M^U?TI)CUB*8LA@CIIL%0AD+]L* )G8(G96VX'N9![4I:==P=@&%'V+9!#)&T
M@3[7#?M$OD2;7\/"T:& 9O8??_\]\$Q/7C&@Z8]_C'YN2CI#U_:!@[W]/8B3
M)G^X<T][/V7A#3T7:\KP;NZ]-Q8=1>;Y<-2INMK"&[WA*"1R5.$TO[D'(3Q&
M3-W&Q'WH[-#I<ER.!8IFU  UT*4,"YN2@S,1L3/)001M/)^T'BG>ROS;@@+L
MF5^F0,#A8)'<N3P80@QL%(Y;Z"D69<O_M*9)_H'[<)&BDW-WS3TI6*1"+,:-
M=G?LC.+'I@&^$V745@WP:ZT$4])^+1>03[H@ .'2N%,:6T[AVP_1+]:(ZA2I
MR/CA67Y2-^)(FT1N+S_1Z:0IG*X-+L6XKM^Q)SEA+D"5T#3%76-QZ;56+E?T
M\\311[@6<X0YC086_04"Y\=FNQW=X0[01L9KK)\S#<\EWY]_>]OHT>L:M!SS
M0+3$0\PHQW' *1IX,LW(N>BK'Y0,6[PM"3M_$G"CF,;,1H.WI>T8OW[;< P6
MM?KNXK=<==O[B;_C/W&P_].]T4NV"[B G3*'DK9[(@^?;;L?GTU;__I$5J)]
M0(ZSWW5,68( 7OH3FNQ)J?=(H\!L]$O9CG[+_Z1X+KZ//7Z";9T7)TQHOW'.
MQ#+=+3G>AX-&'WU]H-&OR?:H5R_=QA-);E532>.E!D8I-GN.@*K:IDM_R+((
M;RK,6=^[3;V'D%&T$P0,!?%^Z)IE4[A8Z-TW#"&>T+[,3X)T7<B%\6<DR2<M
M^*VF;M6IA2EIER )Y3).HT=R[T[*>L"@=Y#M0ODLDG[D;<3:UWZ0[?RUP68W
M95),@S9IO)[4GC3&#ZA^P%VX9]E\^B&7_L)SHIS4IH(1W+&0Z.WY9+VHT/EW
MD:$E<':EV8?!](:U"8:T*"?@F3I7TX223=@=_?.L&";;EIVS09!!'S[OD.4'
MA3(*.$?Q%OPD,7*R)YV6;6BK3B0I8^;BW&3M0/";#<?*F1?V3>L$:"]!?2)'
MNC8[)\;;OB"PG3P_&F<]K4&)!Z=L9+@4<%)J(W-\B?@5./?M4=T(T;34XE 0
M87]TKMGYH+S-#[""X^C".>DF'@4\(S8_USICH 9'F'-=$[!^9,YKY?TF(W$9
M0[5@>.JX$*A9W\U)2PC:0E5HSPQ_0MTMU!U+6D-%OY8X=*FPPQP](]LIJ 9S
MTWB-5!PY:670$& 6?"4ZQ&.4EFU$;/+!"\!;@-Y0HOHTD8RT,#:%4H\4W'='
MKBIW\5O6*>2/QBWM9.-#(BY*,PZ)_4UZ%3S7B3#Q^7SF>1(VMHT'.=*V;$PY
M#L+>E.B(8B[)&:LQ0X+W G8)AP ,[ 2;;+Y.DA<<.FLU)ZVA2+4D\$_XLDG&
M19XX;)SM$VD6KC9I%6%4%5A)8..,[6%NB-D"ETROF5__K-L3I4+0,J[TJ&U)
M+AWE3>0+BTEXV#M:7EK#[?*-G':<$DV[SMPF=I@66\4T+:M6_!^N(H<R@PF4
M6[;C!F>O6'?NF.N$+>TF '& _YBL4:V [T"'4L,:"6K4-UND,5%,9"7?$XO,
M6T 5U]<!1!*:K3'7YC#KDC$W;EHHG1TSG,Z72><E'M<[1ES*2-)@AFKF#!F.
MYZ1?*P;YO,+<ZN.U>O<<MAJ\P]^+BD%%3W&!5_$"KR-7[UV-V?_^]-7K$*K?
M??;'/61R'_WMT?>/[^U"P0_/% C\)3ZP,FS&_68#C='GO0(.0:8@=47.;5OH
M8^Z@:\V0=!;[N6],%OF(8?F +[._Y6C%0DR8*QGP" R!U#SS@7<0 H7>$BNK
M&:;;.0Z*UYP*I&]$?@@\0$'JK!V:)'A@V$-5;@@3 1C%B\KS/ON#'+4EUEC;
M1VQ;(IE?"?M;$N+"NP3/4AZ>V14]E'6&D6?U*CZ:D>P@%T>? !?;'?W*4B-X
M@^$!(1^H/A5>2[G';+1:XI('W^+?3&YQ"NPJO5P%*VB7%W2M0:_@Y_".C_[2
MNLB;W=$OK)_T(0_PX',] )BA8>R5:U.&<UZ<E+H !)>;KA(WQFJ3FDW;I5IV
MH-:X6^P>[8H^+#EVH.S*Y.--H77JS'+R:KKNW5SK\\H@<5?2Y$B% W (6@>_
M"3!(JZ+ )YLKH9PJM=7#'.M&@HG:NJXRX\.5*"#CM9A^6CE!%0WH=?^&%GK4
MYA+3V5'4,^,7$S*7K/<VS$RD+#%%0GVK.]6_%'LR2O\5(G5Z ;&*UWLMTWD)
MY"\/BMJ-WEA;M4:2/C0EF1-AXZ*%0%D@0@H<S^[HS9:C@K%=XZ+ "Y,=.:);
M5,+!D3;,G6@OD.").SE_.)W# 2EL8SM*U5#E^! 3+(<'1[#J4ZFQK*9NTGMO
M.<D;!8!N=\AH<;)[+L%RM26F;_4@UM1:*=H '2LPS0'X61N&QY#3UWN%G:U4
M$SJI%U"J3KK7S2A<*5/:DWSHW"KK&2Y>)1M]S)D[>[7<#'=-C1#*!Q)S@UF<
MXT#AJRABW@>VJZJKG?"SX*LWL*6I<YB<^BW@_;%))?2S8X/AT9/9, =/;V//
MHU %Y9M!XF<._Z:1T)$S>MB?0!/CM+"K;/J6D,#FUOK\-&^F,OD*&$?^-(B=
M:7N0]!4T 0WO3B2R$OX4P.6YG>G\G8VGP]:^QCMQ_^&9.Q%@*#'OHU=PN\-Q
MOL7OW[T2FY)>ZLY_CT;/$#H,/>C:'R*IAZ"O1VN&]R&VVB2.P9+'X)RC3!HW
M.$:II2E S@=XX0WW4,E6V,AV6@HAK48FU-UNMW(-!B<=^%AA!ZJ*[J3<Y?XO
MW&0C K7"<UE;#$9Q8+& L*S4'Z<%G8B"@>44@I++1C 218<5 VG""\@I']Y3
M5@:HN5MOL:6RH^3>%#Z4QB>EE3>IE*WUX?*J#\)T$>+VL=?Y"K/D>QZ9,ZS5
MACUKHK,1#8>W"$E.NC!=D(<*D*/<"C-O6;('"* @W="&F[*"XK;%82R\0\U_
MXB&8Q5%G N(0FPY#4I&[A/=P\U 5WU\'5,7URF0_Y_K^Z(\W[-$L+78P-MYR
M*GN#&R$G-6/Y.96P:@OSGR?SNM6\5%*)2%I'DRYGZY3=4:LX@<,!_CUMNTKX
MLY-6*"?M=B09Y=@$;&9+>Z2+7EWDE,\.?@/AMZ97F/8*VBD$>59,I1'6U6%B
M0**2%R^09^<3XA4%6[X+[S#)MD38\N-'(F]^YY<7KPX#&2,<PT7!/<XL9+'_
MP%RJ<*,P1*.WL7\:)NJ9;V1]8D.MW[.T^B\OWCY[\DM(K!].NMCZ0ZN2XKGI
MBHRV"4.<-BC05@'&&M5TO&<M1&%\D:E.HO#<M]SC.Q8.5\WWTU\&WD5#>LP&
MOTPDFN7Q"2=G.^*D/Z-4.,E:[,CJ-#XM!?ESD5J*#Q*?%"I$C"P&F<SCF/N4
M4R;^Z.#K<M)K32>>^#37O$4%7F*#E@X2G3HJ),1 (]\FKM"53;8 BB,6UG=)
M7ZCG)XJW'&"&+%4=@Q,EL:\7Z4%[$[=]Z%,+B3ID.'4UF,0PMX$9,E(:L?7A
M3PT;/+)A9O==&[[=AK40PX-V)$Y*V2D$9N.Q68>MLN+S)X&NX,9K;AD_%?UV
M^5OOX1V1M6*#[ 6XL';6*QI@2OR3L1LSQ3SHH9Y^.=3'5FQP.&=;4GQ63>?J
M0>KZ'A@=^E"F9H-?(N Z?4*EG= T%>'AQLG 2;;ZF_W=QR.3C"?3QAD67B,,
M55G45;%VF1/.Y?'$L2W@X8MP#7&;<)6(Z4I8>^DQY@5VF]P&XMSI1[AA$$<;
M2WI5<6""$(ZSE<_5DC[A1PW95]@!_>PA7XO'@BS3E91R^G*-$ER%"70:,>?O
MXP]VM5'Y!=[I.%\6FLR*+-ZB9KFV;+$:-RY_&MT ,B?.U9];#:%?+O7D%#UU
MMPY11;XLIRP4DHEY.T)# =_4KL,J]XA2M$7=G]1D/"K XQH]/^2 M&L,9OQ2
MD^HB.C9$R>79[ 2*%?_%3'Q]3J7Z\CFL;:^^'T9 XJAIOC1C2Y835<)!,.J-
MQ4L<QM9BKPY8>_YG6<WD^W5K6KP,CQO6<3&G9=4KAV#86T/9A\;L@)-HVZ)U
MRC-V%=_RF<JG-L,MMK5CINW'>/$]L76$2B%  V,*3+K?O%L)?V;%)C'I(CMF
MORA+4A1-?,E-C]OWY7D-&K:["6@A)CV;&A>4#3#F'.!$=B49:20+/>@T );Y
M.82D-Z&1 -?/9^EV_;+ K9<)@D:D&9CO&/!R"HF,V]O<-%JEW/V<**'%\*BJ
MJWZJR?$S1+^WS^<_I*9V<=:&*V"./@=IEZB@3?N% )L^<E_SU31.59R^W=%O
M<2H3J'H D-/\"=5+I>M?\4=M'X"T)8HUDB/]E$6<#,I'$.JE,^4Y.58<PT$?
M1I;3;@0NV$N115_4L"DYH$XJM-E8# \1]J#T./4U/@8T<57%5XM;\A#IAD*I
M8MT*T35OFCR4D<\2&DZ#!%HN2C0P"(,4?B]U&I@$IY-QR4;ORLD[G&Z@N2GF
MLYVIJ,BZKBD,FU 8A*X+H=D8O)6*>"NQ1A,;3/,1HT7X]93Z:2*D-5@MTO/8
M'Q;TA=9B8GG8! '=2L>"B3)B06$AG81.#]\3.3BRNZ-GMHR=V7&(9@TF#80H
M1DA%;I.5P:%>U.1%]48^%4)0<GR8A\86$?ZWGJPBJC%L)'(S2Z- 2TV41_U'
M^Y; E+'7(8N#D\30R+X#022'N>&%$X-.?;BV4'6MN5B<7\7F &4!6@E43[XR
M1@'),(,XI>A,W\)6F1M>K S<WY?;I3E2*FR8]%7UKJI/><>M*A.1#[P'H#R5
MD2RKX!3C6VV?;Y8W<)HB#\2;D_"+T-1 X1BM*X"4)*_GX)#C8JB!4Y1Z%""?
M!.=*W"#L5#8_31'(G& BCJ!EASZAS%@!(E2$.P9FJ[FTX<Q4G9J7%2U(OA_(
MTIK.$*G&VJ$=H E%AQYMP+ARO@<%BT0K=* M9J.M):4;2*G9_)4#^$13+-N[
M];]*WX4CRF&8+$9RB.N8)ROU7P>ZNI(-/NR[]X;6/-) &.NDR.#SKAI%.FW<
M9U X,C95#/=/P.V-[1-?;L+.X0L^4^3BBOE8KXW/4DAP>NLGJGLC.UD $C^5
M3\HI2,M/79Y,_1WFI^4^R<0&3D.C=4^*2*72@IQJU.L9O;%;*-% 6QP-/-4Q
MO0SWO_ *0T7@]TUGW*[J4L&9?]%M:S7:ZM[F28VM)R3;!-!+!HU.\V+T9)Z7
M"V9 N;=QH'*,E\6XKD\]QV7D0&H9;^@#8"01.Y2?PSY5E =9Y50M9)N5T.32
M\(C'C\INC[7IS#&N\ZE8T HW;51>,-,ZX; 8DD2*OM*&F';Z0+U6N5A)BJ\R
M^#U>,#H0F$K% G%%GS7-:SJJJ[)0&:F NE%:$5ZT['&OEC4?BCG-G5:P-4;S
M;$EM$7T;.P[':_[ ELW!=EKN<H84YN7,Y&9;H>]'0=(%'E\]%73#MIW@N0M<
M$YW(!B?TA&'G19 >2Y#+WX7+5>20AL/?BAMJ3[:%O9_J;/C*G(!?0RYH(C9E
MS':T<S[=AH59YFM+)'NC$4Q$G#!WKJLG[J8XX2N]"CG13X9[.H@"K&#M5:H_
M'7")S-@"Q_9D'L6J72WDGVG5W)"66>#'XW:M$$GY7::%.#H%*?+YK&3UP\/P
MW:_\[H["[[O/J8C SX U_(K&97284119+$8_A)SS<PJ$1P=[.\]W1[]&B80X
MG#)S2T= **'0,1.DD7D-Y+=:S=?46[.:\Z=E*W&'F3][PWD;]I Q?/^YDJ #
MBV.Y]+$A)QJ5WF"(-+LV$UL&[QO6=IJF'(<[];"N5G.&2M&TXF@6EBKA5?P4
M*<.; W[ZX1J!GSZ_$7&AT>9_GYA_*?[Q-3Y2G-RB]N+!(8-+J@P,='XWA;A?
M2E@=G.^[LPAUTMK4D#HC>WAVD8RE%S>U3<UE^CO49@/BR#@:[ZE$13]"D8//
M>1C,(+OI2OREJL8A9_),$(,N/9M)2H^!F4G!+E/X2<F@?-0%0KU74G8R!*S:
M%ZC5A=8EM&BV81#)YD[>T2A:\C D6<AG9^&01KH $\8;UWB]T;.\?>3Q),-#
M'[AQ OO/!FF%E9.<W(!K).<10;$#51,]=WJ5$_,8US'.NDX.\R5MCPR&+]N^
M\(BOZVZ,_A5C7%FVR^-U"U)*9-2/:]YKW/:2XN D78YT^B8\5!8<?9BC2ZC1
MM]H"74:)*JO=!,DJ9JZ*H3R;#6F=6.,64:A$0ME _]GRK?@I&&'2)FL][3X)
MU78X:$)APED"%7[1[IG0:A1J&<%F<2F!W4"X9V2LZ)DX?]5#"9*9B*\2 )9C
MANL(ZS'M[[RT04&E(3YI:9#4% ]0Y0NI[T0*)$83@O6 D0\MX[J8OE3K!Q6#
M'V<%%ZI8QF)NGN9F':(?04HCD7^M!.IHJ^;FFHX7M#H75=2#Y3$W7^;:&X[>
MV[>1$P'GY<HE\62T_+*Z\.YDG'#>!<J"*'"7K'.N;:[9U""3K"G'X#GA8+9_
M,\:8 :^-]HS(/_![5Q@$-@9$+4KG/Z&SEF,[9D3B(,V_HKRA?3VT+<4BOL,?
MS5;S&4R=[/RRMX8<Q^[NZ+ET4R\80T=;[M1,@6)=9_H8,!]5<43?+(RKVOVH
M**?HMGCOS$1F-H0%0P:V-@O1I^ :KWT1^),2EWX]%D$M]W7?_)P5TR/L5%G?
M3.,.WG@%S[>IEPW W;'Y-')UO/+'4DAF_NU9TZ@8VTN%5[2Q0X-3V9'?$?>T
MYH/*L-_AJ>I(+ZE;5:BZPN$J$'%@OI2>I<U%K-[8RSDJXSJZUL7=KLO%B18T
M7]<I@I&CCQ+] ^M: 0KAU3?OF[D7Z#?Q+G-V>A!"U)(,M-*"]N\F]Q6K!&^D
M5;JF>+= .(718/F0]Y/Y2D96T93@+XY--_C\6KPQ&#-YLFED0-<78 ]0>_DF
M93-9+13Y?W-WOX82M J?TJJ_[B;@;0T8D:QB/O'DY"RJA&:D6KM#7@//T%PB
MPHI*>M9+$PRG!WX:'9L:HH3^VFU1U4*?RTO>:"C#&AX7$\!]^[TL(9'OC0K'
M 'F7?")<Z&(/>9UVP'#UZ5E4.^+2?STQ%\KQX"V@L--HC7 3Y-&GIOU<G "?
MV"F.JF@;S7:&6FK84*I+6WI67/* &=+'L9\35D 2JL"!\.=J>A0:W,K&?T&4
M9X&C* 1:7EQDDNX^>_/W>S95F>,+8H6Z*?=0J1IK4XY776BPFM?5T0Z.2*
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M/ 9/7*+NP<;$U+4FJ[FT7W.K!=)A(J#+&IYQJK]K@TMW3E5(4R5@W^:NB\#
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M+,B)WEI3;TUM_#?'^2K9V.!.)P#X 0]ZTWN.A?Q!QUF^0=%WL2MWX38X!>O
M#>8NE='SB,5_H_#+5\B6M['8@IL--*@Q[9-!-C=.@%LKFJ1<2ZX-H*4:D>G3
M)V]1B^EP_&5;,0;B2T63=>76K?<-I^D;3@MM$*%K2B1^O*:(:BKGMG,0#6!"
M;L6JE/[XU#+']I5%/4;+E R7]Z#A-E=23=$V1AM<^GY#OY&]H+%@OW_+0SUU
MF7-SC@+::'[0JZD7#J>,,*)1P#@&C5=P(VYML&^A#N>H.?Q7;@DSU+QUX<F
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M"V%(IK@=9Y<5!!\:K?WNX%L8$C]TZ?5F;708FP8R+$Z(F+=VY($\D1>S8#?
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M,U(+C?2'I+PEAP=0<-I@Y"$B ,>5VF8R2-+,#5\YUWZ:03)^,&W"576%16;
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MFS@_O]JX]7/T?LS)XCAP%S@7\H$DB@LK(AQYG/YR,%2VD&#R+#$_:,6/C,9
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M)!YT<]AH55FSH\F]R"5#TD&W$!<UA]JKPQ\>DI'(& D3,5%[S\M1C]O#G9N
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ML*9Y[:YL21HG3*<6Y0^2Y?\L0!F/!$>*B;S^,W7!3*_10V$>(WR'(?Y)=&[
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MEKLUCM)4K >E]77A3[^^<>Y3QX-1D^!3%R+C .0ZPNLC@B&M4QMUCAJ":(_
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MH2E%I30KG)=6-@&1B@L%ZS?O2L6SQ,(%]CL>UE@XO:*TA4.S<<]X\\PMMZ@
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MSU^\^G]A(&_1B?KY@GWUEW&2O(A3C4C#O&IG: L?O#ADDOP6L=N0)6D:A92
M@,K2UX$UVYIR0AM)=":/.NX&MZ1+D=;Q/9"),H7[BB1IF&"^[J#[Y!MUY\'J
M3OWN?J=^M)UZU%73\GZOVE[E<*2><)_]^O/3E__S_\3:;B%9'U65Z%TV@,FP
M(4%#TQ& +4CA206W/3L3FG]RMA()ZT;"8^#8 5^P<:L&'^XTMU@6__3E[S&"
M^"8WZ,[J!OW^?H-^M UZ<O0%1:9\68E+]WQ<^C-W(W?7B6W)(R2CW/_NNAT
M>B1WZAT@"<1=(T!Q@9A9U=EGKQC+FM1Z;O0JP&8FQ"2B[:+)(7FL$"D;OAS4
M9GU4_\[5<B3=&%ZW4H]OD9H"DJ/SE;D)7^'#P\E;5L ]%/UK*9Z/$PMUL6C
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M=-"RHS)4U\55K\<]S%.;L:J1,<J0*=)?F$<0MVNH&E(L%7+J?-FS:I"NX B
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M3\M) 5QAT&#G\2-2M\^M]PI$D+![&[\]_WEO,^=95=2&U$Z]=3UQY (_[WF
M],X#9-STQ(D)^*7IS/B%5AY9PK8V, V(,1:,]HNXL7G63M4KI>GSF,1P*_S>
MO]*42)"#X8*6;*]MW,DI:7;]R(DV5/K/ZF=RS>^![T:UCA8P5=QZBD(I\-4)
MJX?)Z\#?Z.O"3AB!^0)428EKXVW2\T;>[U]EUVZ)J<-IP_=:9E)4@.H8CQ,W
M)W6!0TPRA7)/%ZXBY2C]\GV0[%$)'[E_7T9#%3@8 W%^3%Z;AR[3?-R1PF!A
MX3RUR9WR)Z!?U>LT?\" TZ#3T\-)A;YC]\MZ&;PP[!M9<GX!R\K!L1/7CIPS
MB-:AJ6@38WHBK'DX#&6.\'6@HX#JO9*,1-54L\4L=GYP9.GBBUV>?IW/<S?F
M\D78^-?M:I@)$PZ2--&1.R!GSCU:2*<OO[C,]BX0#ASZ4EJV<72R=[@9N=/T
MP(3Z61!FO7QSPF_&\7"P3/@*U]5V]K0\0S>9(%72M2%T-'X+"M_T!&G>,\U4
MLHB@ 4:P1G@;FOMWC0%[@)&Y:J_PI #QT0M#D'<ID38;U1O*/H&N6=:+%[E+
MC)W1K)B$J89+< VW(A+HZ0)=P6ZMB&"*B7]Z.Q-&J6J\VQP\:W&P(JH]VV)6
M&T4LUKHU[KZ[Y7R@LO0*>CRIDKO%H"-.BE(F>LA]0R)P>LC.U)W;0;2G?W!;
MT46Z(39 MZC(H7+'13*L(UG()$,89LT>3,-* ]P3RZ2BA]<+2WYY2*2'?SXD
MTEU1MJ8C)2[FGE__-Z_G_9F2I?'_O85)L0R#!#MZSI2U<\W0_S.=RAFO+C5[
M*:WA^97D'6@6PA?#91 $E^K)1@<1Q3P2\A^?]Y""BT$VDT=^AX>\ ;N$/VZ&
MU%S9AS;HZ/Y,.X$LF*E;F-,+YYST[N1#]B(WL"DO;Y):*HG NQ?3J3.>?6G]
M<*')&ADV!O>)&*8-GS^CWLZJ$O(N[GO@K^PDO<;01C^_AFTECT1F$RE4]C\A
MG8GT8:Y9//[STH4*5E9JE?F^ZD1/I;KSR61X7VO-@]4$;[P6(^%0X!&-"<2X
M9I!/\7P-NAFYW89>>BOA.L!?.%T:RIC-;I!:G\@_9?KI(GC9=,J!:%XP@+EF
M53^)PD^W"VKS*^Z$]PVTC<Z_:*A%*X#]CQL'_/W>9JBT3XNE"WJWIN0C%Y5<
M)LY8"@2KN/#5^"4D'9#2<-UVK_L43^Z;0\CA)FV(]@3&\Z')V:@3.%2,O?WT
M_;=*'P;R' @(<6&(KC27"?,EV[>(C0NC8W0H.MH?9; )XH^^,O)J9=G/C2B;
MC=7E? &H1]F4'8^51=.7=:XYS>2C>Q=5>9;M3A'#LMT:\=8+PJC$(QY=)-O8
MVWVQ*4_G_N4OI^K*$0+A_7KWA?KS>2M..S;UB=M.+HJS3BD^ [DQN91"E[@E
M1)ZVE,IY&=W=8\U(6AQ(9J1S5Y)<JK--*Q5I:M,\N87+N,F'$7;"4L=*DV0A
MI>-N.RFG6B;R3;G&+)J/&G)S8R <FS#^C:%6$L$*'R)QJGY';5DNS^\VY3B4
MBX0EH8902KV!R\&"U^2(H)<427[:P#&4N_'SXY6PUH%#QKD[+ W%"TQ$/FVB
M^@ 0<N_^-3,_[*,.0B5KIFLDZFP3=L==!5\MC;(QI&:"N[0%=VGI*37U2/G5
M722GA4I5.!,/B_BPB&V:]691VPZ.2;3J_KG PI?U&MQ$=P5G>6P1BV#6Y'6P
M6IZ;OZ[;JRV/#F/(C"+/S?LYNTUBGKTKHR95(.05"*R&FN.H^9P^5DYU+W_A
MW&HZ1%(IG:K@!\FP)C A+: 3[F>H\\(+!R#KNV_6<&-__C4&:]R;QA2WJDF7
MLB54++L/G81=U0T+4OGN*C6NQ&("S;A1(Y*_AM$*N\U&(=5;O=]50 !)(!@<
M,?4K>2_F$_EG4:GM+=I)#EO-Z^HQ$ B,:X(<[D8V=]<-E["\-V6MC(A$H4RE
M]BJ<B>LWMC>J4P$&2$]$'2GAJ?&POHIF03+J,S<!B-MZ"?; N&%7<FL?,K$>
M*L*L.W89YLD]8;R7)#5LAU^_4'QWMF@L#D9&LV;U.P8IT-^R&R8R)"/6,9(B
MNWT:XRI7,ML@"HG"=(NA]1#2(9N6MJ(TM^N#:3>X_:1L0!AJ1:M0[[H^#?D9
MP8TWPQ-_57HJGB([F9?%Z^RW^8@=QC #?;0H<Q1;&A$F3QI?Q10%\(9'!<B"
M\+<XDII@4<WZ&%Z[GCY/LC)E^5K051[$H [,;#Y$*[1%;KP[*X26Z\R?@/A#
MB%,5:R#7SVWG@7J&N8Z0 K)7.8/6J+M<\DK'O&LYM>_[>X6LR=H][?U-DJTK
M0:I<"6HV@P8#ZC_3(R?G4O#>/F3-_CFSL[ON<-DZ[:I3RH/R&.JZ!9E?OQ18
M!#QHMR1.EX(!CSF8O2V437JUBC"RH5N+"YKXL<S(#5<LIMH%/QYU_B+Z^,;N
MTUW)>EB,4TB:LY30P4SS6_T'Q1AJHY+\("H-S#W&3/=NKSI[4 B[_;GO22 A
M<>(N%])\Z!X1E_M+S_1L?285QVL@<)IUU3$E#DZ[(Q9F)V)<G(Y+'@V?F#]W
M_ &+!I#B3%*O,5BDS'X[ 6:O1!9&5W%VY-/:NQ.O*IO]]O?LJ0X^?OWPP<Z#
MN^$ <8I-J$*.],.3%]FC[QX\V/G1O>:W6A36J-ZS@-$*V) \"R(%)QI1B?,?
M9_6Y5=P:*PG"MC00RZ!4:(U8%BSY&4?\2MFGHG\ZXZ;FX==\G(G59( 50>+U
M-=X\6&'QVDCJR'&R8WTRQ*HG6LR6-[H;Z^-I9'*B >M*K!EG8D+1630M8/$L
M SW2BO I4$04BF[&H*52\"O<FN*R=J3I:5HN1RS7Y1K]J!"L:WP?BE5ZBVPC
MA7!I-24!(XDURWV%OO5$N335=JG-57!$8J2QIK:S5Q=EXSUHK<5'UC$WZ?0$
M:9=\OFVH\6=TZDH*R  R<H<03X_*7P)-A_+@$"C_VROG'ETWJ8Q/I:=4>R_D
MS(B'-, KI-_![WQNB+[_J&B(&*L2)BX40B/^5V+B%3]MR.3V/; ZT;G2=LO(
M4MP*)$88@#M2P%$?P%M+Y^"X\UF$),QNP),)"5!\ +RB]HU=?D,8PR0?7XJ^
MS5F;&'JR=DE_@\_V-MK7$2>(X[NMW":)=Y&A"J(][C+\J@I(,X>"Z\D#Y^.X
M )H&S(\977B>G;YK&R:92Z:1_!D8/0B#L(E0INDFI#E@!0D/<P_G^=OC1W<!
MSO/1DAR?-X(\ZJK+8B+K_C#B%3XI)PNB46Y!'/F9) Z0=IA'PQ/3+O<V/-?(
M&R3)6^3EA.U:,WT1YL0W/GI8B6:71<$Y$;5+)<S$V?&NR3H9P2A&HRL0Q&X,
MMR#HB,*22OZQHN@RO:O$E.8 3=O1Z;@P#(\/N>F814 ,]/J9E&<BARPEAVX:
M(@,\DZ1,8S=$&'.8&8N<CYL[DC\?V$;=)R[,(P_"M32A3K9&=WKX:'[/C[@(
M%ZX.->GJ0W/#5-:^OP6C?H^;N:ZQ(?8+#Q;NM"T#^$PK^N-G/_8K--OX>?_H
M>#.$I8H8TZD6J<I^I/:AT!V_6FWOQ.M%\XV69GC+P*1^K6#>N/NUV<OZ0R$+
M<^5A;#)8VI>F&.E\900%.A*Y"B&W'S\LVT8E <#=JN%$]-"A32#;.'YQM-MO
M?BFU8RC%N;@'Z8<CFS:NI\-FP@(P1_2IP'6.K;!F273WIR-UR&B:;$%I6<<B
MIS6;12XN\W7*JVOS>=5H-$ <B.U";9P.WZ- 7DA>CV$JU^QJP\-L[!^]V-3'
ME]7XDA 6D?,RQ>299.YB&8RT?]4[^3TD: WFME%NGV_GV>%+?][GJE>_7,%T
M;>91(N>J3(+M8*F5YFQ= #ENV8K*$3'F7BE(<LU%GEH\YV_D1321''N(Y%B:
M%QN)H(QW8E(/"YDCT9C0"^DT\?K?/=CQ0K4<_RC%12A563:6?M[;?7''=^.+
ME*'5YW+ E(DLMPGH4<\#K4W%F3/Q6H+%5$2M\[[R69$X8E+Z)N<TBR0U]'/F
M3MS!0(V%YAIWC'-J\V39X[Z-VF@6Z)!FLD;=$=_3HQS1*>$TF$IHX-?<XC-
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M%=,MV&I^W=[)-22=RXZ.CS)IX?*KDK<9JE[OXG:RBT7E6_%ISR[D2@N;SOC
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M\W2XT/O(21'M-+LKI14D0\:*+S@^F-J=+[PFH;HRTK]1\,VWSL"I,A5-$3>
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MU%;JR?U;A_[$_=HB^37E3.;IG8MR6:>B4D]&WSJ8QT)(!<J;X@ .P!V ;SF
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MP^S:8/:#5D5G9W%07A<HOTKNO*M+*W?- ;D#\KH .?"U+@PT$8WE -P!>%T
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M.^H%G8.CH__;:?TPXT46T?^$Y8G^W0,O*]0GVL5]W*G3]E%U^_1(ZB,1AT"
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MW^K\I)CG44P -]N?5'X0KXI^E, #L$Z0]0]^>L+BH)N'(52S=Y4C-P^D;P&
MO1YOF&)[2:5(K!H*[W(NJ/;*GGCE36QN#R\.FLW\ P;#$10U8.N. )%@&P^0
M$^AA*GB'HD&IMF!Y/"JNJ.0<4"&(B)ZNY<DDEMV%!T%>NJ:HM4M\Q=NW^]X>
M#!WAE%\UX-_XHK=O_S_Z= B4I(^Q'I^J;1O=-? 7>P)654*+6L9LK%D686!V
M+46 IB% <R,(@#5+/;20J#*(1BAXF'%0#H4IBBSBNK3A:"04D?H<ZY<B#8$\
MJ%,@9&J.FB:-7>41?A2F[):6"("?9_"NOW1!3!QT"I]!6!SC#6G5-383Q(%
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M7LM[G_I=M7$!K),>&WC^VL<K2(";F*SE^'>W^+>Y@KC]@OS[(KB_4I+8.C-
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MP +\["/ .Q"C0=MJ0)Y>G.*G.#[0Q-*$)N8HJL)L!-?B/C4PPD[;+]6R:,-
M"7N0QL&.@](L(FACHCJ+/W8/#Y?2N MPHLI74_ T\\5XU+M'AWYK&7BZB)<I
MNT.0P;2ZIXUB:AXG'6O="?9%@Q.$;6N+J:-2)!2&)_V^A"'(;&%;*)2RJ!0_
M^[5:XN,P*D\#(:E;H<(#U313;I8*_EP#[4Y]L':5!MM9'VQ#(%UI[S4&;].6
MF1F[A7(72:[MQR@H-;24 +(!_06O^AL6:1G -JQV3Y8P9U;%35;:8Q L#X_:
M_N$2H/U\JM"SV/_O=U'XGEK]])^%\$@6$5 YHV2,%U$#567:0/P"#@6/Y5RG
MP+,L8MX*MN4,4>-6+'>$9RD V9RL#6D2:?O\K1>F^<#> SPQ9%//V+<I=T6E
MX6HHT&>*CTAL4BR+SR=''*=)P"5:9PIS!RY,6D9)K"<:WJ!YQ6@MU(Y8\"C$
M84<\I.=D(#B:8$ "@>_O/!#Z62\24O5/E:S/M<V?]_OP0$!^9K-*,I#E]%9=
M1HR&R\A0DL?:U(/: C:$C[FR>I5VU]LDA=F@O1-K=:$EU2PGM?D9>SFCC,-,
M]^6&:I\K< M YY(H::+9*X9A$3K&( :-6,!SM3DXAEDO4!$.@4*B6&_!D$=C
M;7(;*?W,U&%5U+<(3QVA8>'FG)'Q+1LRV#'L7!N!@"%M%PD-\-^<454U>#@2
M?>[3[$&1,TP#9]+8_$SW:64]Y-A6F_K.%V0ENQN L@C5\@-0.?&WN/R"7=1S
M-(T8"[SQ8@2)[5$+6B0!-AJF'_9$ CN//Q P'@J/1&(TN,JRGZX<@UR9J+U2
M;S&FRB")0U!^S12F-Y*65%VZLJ;B8V33G6!E(979/..#=&*!Z1RT,^>"6 K'
MA+,@1K"/0#-SY8#BC6X*,M3?#CEU^T6#<)*IHTAG#4D.K$_,-,Q'C$QW,A^-
M%?<-U6DA$N!U!F<#NP>CYDSV2?@H!(D<[K;2WMK#_NPC#J0E)N+(*N6FTUNU
M:5$;-V>([YMR$;V;?Q%]!?A"MB/;+E)K+J[K8*!]C%_;2B\%D>(+,1#L(?$4
M['H0)2@E\4AR8*]4>YN(F>-<M49-4K0.<S+M(M^Q6]+: !M!K\N0@+)AP2?%
M_H0<&Q]C$%!J];8GDSD:F.%O4B".SY&\B,F4T9G)) :(QZ[:W_3!T%VW\:00
M\,#% 8#,+;Y.\K2P9#=0&$Q&O(''K0^R-@6DW#5@0! 80T*ZTKR&=T.>!EQ-
MG>9QF^01BIB@R>OCC"1!'X_2B^$IBX%F$Q"GW5/DBSF>>64#1$-\0'H>TK.?
MJY"BPHNMKD>B6ODNQ""QN,:\,6+A^_FG\=S()V?*]XPT>"\5)FY]:(C2X!*X
MI5L&.ED>"JJ>CM<4W)&LRE5XP^D@J2)^8OJ@_@*<!Z=F_Q?$=Y#P>ERA/5UW
M> 7#1<-*>H[A10%*$L8P11B.IB#E^RNNQ(?FI#SD$T_BP7MX-2DGPZZT C"*
MQO3<[#==14R::TS++4R=\<HY5.8[NJC@][S0'HK0LT9QK6G$RU-SG2--\/6S
M'_2T@!.JL$$MDTZOJ(%H>LNC2 NF,^=6N-9(/D4SOJ00Q0G_J>]Y?W#R21(U
MJ_3X,P\'&DE!$!1H8J<#@\.E6C2."U\FN871_$]RDP(SO-HC]'!6\97KJKM!
MGI)$'X@TR$?HE0:T H%8>?H,(*&36DG_A6%/VELGC+9N[Y^6, D($9+A18C6
M*?ZZ!#4C(.G)FZN*!D)^TJKV.$_'B50Z![E BY<KOE0MZ9&R)'?BON=2VOQM
ML,8Z&_-HG6M#@ATOA"]AXW%$^%T,*Q\:6$@S%V,IQLF<(1"@K10N2JSNJ^?X
M-F$IJ3_O!-(*-O$9#0@O9..ZTC$15\K=3+3=+Q7'KW3C7^OHH[I;P*KZLA5T
ME:( A%4Y(UX)32A=\: 1@'H$"K0)DQ4C.'8^J',$8GD4[>OA[(?(K8;! SKD
MHZKE>'MP;J,\5( %QZ^<4>'SQW.B_:0PIM'7U&'6L1ZO\!3@+0$W&NHC#ZS$
M]RX!8X0Z['VN#7)TAG7<1R&:AJ@0QC!Y/%GZ;D.0Q_#@\EZCP 4?498D2?@$
M%X7#(D(:7=W^L15X7J50#Q8&;R4DJX3$Z9?G4A]F.]1EKQ@MJM*J&.*55M+S
ML1(>9ZJH@*=_\D!#$4PSEFBJ@4V$X8& B#0<?: B5KN2<K+6!+P@GUD=RK]#
MC,CV*!<"%78X@7L9=BDS<RJ"E7!U8X#C?1U>_;H2M6/NM5<@E?^I3!WP-GAU
MA"1"<RZ9152 CWX]O0[NF)AN82F-Z4)=I'-^C^LS"*VV)::(?$4.ZS'U:VMD
M># ?*^F$:2U:7=<D'ND8)N ,)8$/$()A"7OB53D#%4Z#E-@3^+GAP_(:OJ\G
M3$W R2"UD'9L4!*KP$/TML!E:6*5D"]!IL'+V(BG]X$7630T?AE!,QFD:"S)
M$M _0VD/3/$1YGP8?BVCEV"P$<@YE,%1Q'J1L6:<9^8K'3BE>%X?+1V#IE!/
M:BVM/,MWZOM7<]G(]SZIP6V.OF\AA?W+<+:2%97T0%!X5CDAUJ.%3 T+X\CS
MA5@2L1[01[7^T"$G>!?@W%$.0X$O-()NN0(2>978/+'>!Q[2HM'$29X[QGPP
MU,0M%X80)/@MW4PFOKN\=]0" T2PPOMLO[>\JI0NE6I)L8PL++I?$3[:B%T%
M_2KE#+:IX$8<BEYN/5YYCS&:!\AQV2WG)NQPWH(>$SR)\GAI2Y_0_-+<TD-8
M-L6E\BFPJMI/H7E030+=!/B:YM+[3B:+9%(Y8_D8V81.2?6XD7B5P,8Q:0 $
M0[QTR.8$*RF50<,-;,0'U?8#ABA#F&*=:39AJE9VYU*U56_X7ODYBFCF=P_,
M:T_A'QJP*>A#"S5E%*Y^A)1(G955G(%)CI]_JN6K5]6;VT<#AIH4P=*>#50:
M NX79>Z[F<<XKGTKER^;@B2;&BA05E]IKH25WKZ,B=P%D.@ DL/M"2!Y40WZ
M+8@J,<+8>3+JB5@%9M?">OJ'4JC4?5D&I8XX(%VH7:&4%HP"8<^0(;#(H. 2
M?Y:B%AO=*5P4H?)7DL)@3(%%]"G!L6T4U+8H&BJ^ \TSWB<(2**HP% N"R^V
M'HD78?0DHBCA2906OM#K,Z&5+VE,>+;ET5HS::]("_NN+PQ6C7NLJ.0*5<!F
M[(ZS)F ;4PM"+$,$O[#@5]=WBS;L0AJ_82GV"?7*FU1M*G#30&@?CC8\J.0D
M4+?0_)8F*'?3I923-57(0,=R%H%"@,K!,!;_S76PMEE/J;:92&(Y%&.<.*C"
MHN0$+=#BW8G4A=^1X9RFH&8)"F4FL+6I92'\A[0VX3[G3A&_I**_K17D4J5Q
MJ3/!PWUV P\/M.A.4=+*:47KUW(H"H/I-THZP6P=N(*5==LP0&GW*#D1MS"*
MDL#$HROWF9$2\UAD4L=NDKO:*#)Y&@P9B2]D13+)V%4F4NG9V30S?8NQMQ!H
M@X,D"5&B>(:<L4=)I2]M_PR0DMI+B13\H.E#^_01Q<*/%&%[1A3=(.R>N]+9
M:&[6M4G1NL]>,$%I(*AB9N5)()C"1#^1:B, NI)5*N#MD,?&AXY*LNVG,?YD
M- Z#5"<)Q,IQ-) IO[0U/.:>T2N+]RNT58J."L]&6-"J*0RN0H24X[JJ0YD8
M%4%VMA%@9N&X1T\.&FF5'V\"8  N+=P0&!,CI7H&*1.P-*44;VTKO)I )[Q9
MS87/=000(FF*POQL/SU- ^U1-TQ$ZN(GS0--#-/NGHMJN9)"-] :T4/+G<;%
M20(\M&820^+*)/1^2!.U!7>3WI-R(ZN[K#B@3 6X4WIM,$Q(4TQ@U6C:M<+
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MV:2<*K^(4;SPXGM.*\%DE7:SW2V;QF%VK5I:R M4[ /-;9IY2[6ZHB[1,+?
MFR?BE?K+ZXF?(+SV*S^DE]%#K_.7L2BJ"[VLB:/Y:RG%A\/&@+J'_C<VF<Z:
M;TL9WX#)_[3\>:?3Z#6[I5\U&ZW2SZN&&C3.N]L9J==K='KM!X>B3MIRH2NU
M\AZ/A0#>*'0.+Q/,14I'\SU)9E+#'[V9T"PFVZB?U (O;DY[?9^E.9I;Y-KL
MFN\\CS*EG>LMWS3:RZ]."A88^VIE3 "$OA?#JSXLXMB[WVC?3X42_=8AEH_F
MUN'7?CG%;&&T-)0%\K33L;$LV.O2&3L^;CA7*6:[7"[2 *RLL]:+L]Z+_8K
M W![9T<KK M#XZW\V^]BO* DC4]L36^1Q>6Y/X:]_ADA_.%=^&<(?SZ!PX]H
MU=W>J:^0F?P7?9TNF?PYB&Y:_Y?__(]VM_,ZA#_:O==DQ,RG]\Y9^\59YUG(
M\/ZIK_!W;#W_/IP(;(F+@<%G)[O1//DMFH8(D#[SOI^Z2!L\R0@_AA4^)P.;
M%OQ;!"]Z!UZF%,W=TY?+FS'Q$:WPV8GAMXL;$0KGP_C2NT'D_,[&?'Q$B^Z?
MO 7]_(3Q(O#!&_[K1X%YTD]@XR-:<V]PZBM\3N)8!^U^]\.)Y[R+/3]!N^+4
M155_,RX^HA4>6!CO[!JJ:K78$]B?.)>+$),"IM[LU,54=WCJ*^2(W,4$L;>I
M'L>(/;O..S AL77P):PN$8'SG]YL_EKC)EQA^_G4B^^7^?\G2CI8RK/9BZA]
MI!NZD531P?1 ,XNH/5#;M/LTJO+)G[6T7MC3._,4&#2:;5PQ)@U,2JXC\K7@
MU:DK=2-KNQYD_2 4SAU24(2)+%8+)\ZG^,8+%62=[KMX/!3NU(W"A0Z6QT/)
M;MTH^3%B+(CPQG6NN")5E<HCY[[#XNJ0"DZ/D-J]NE%;"MT-I< 1]<*B85:'
MKBI/_*DY L8'\/MR$W=N8F^RR&KG/>=G;SP50:2TP@P;%3H3<8/M60@:](_0
M1YQI/&Z741"(&^&\0514ZHW:&IZW&PZ^1HZ?+$8,-X&8Y@263!U7L6$QEEG'
M*3<X9>0#3^&S?;Z[;+#A](M.()8/<S=AE]Y1GZQ914VJCG=@AT&9$LX\ S<8
MW:?OHOB;!*_#1H3:I%'UY=@1:Q91;TV$ZEA@^Q6$C)/X#8CMRGB<B<PLAP??
M8S%).'&=]\"]LF//'W_7L#M_7$EB&OLR]1![0>'E4_J2D5 M4;T_4!O5=K,U
MD%UL-*"F\C7U#^_Q9^?YK1<Q W<Y5=DDQ$^?8!R4-?!\RT&(E*#XWCL]Q-)=
M/0_Q9\2]>O3T@2;M9K,GAT/8"F\^AQ]QD?T#,Z('6RU)KS?<>AR?)PP XDWU
M$M=<*TZQ@+LR)6QN#_LH8M<<15VU*9=?/FF0=/FZ*N+)S<&G+B36A<3=T.V/
MOZB>MZ;=ECAG%_":%Q*F)!82>2U9FH#DT^"^X;Q'/ )&%5A:84AF.)U=7AG2
M"\=Y'X;1+<]J=.]\GJ)K_C^?WE^^!;<.T1@#B0LC5S'C_I#7 <H%!K&/YH$^
M R,_<N8T1I%"U;+'0Y@.F)PQ8V#7:11*!! 68-@I/"*^A;_][MTE<L,[>L=4
M1V'=DY.P8+.>P@Q$H5>;'3ZB')X!/GY?HGM8EYS<%>R90/-D>9+TVS=78+4$
M\+F8>-S;Y"T6)<T1MX7^.?.^R<Y.B'Q,,+.R0PG#0KR'7T[SF/MC*;MS1Q(/
M O:S\)R95O"$W3&Y]9,(GM0-U?^X?.-<S18Q JSH?FE7V <C6 M);XUJNP/4
MKZRI\Y=R'===T#[LH,,HP"72H+R00A<XODK>FCH'#DHF^'6#Z3EB=$>+)%A6
M*)\T?$].&_SFA5A@@\-T&PY.3$XI>_X=05A^AE--C>W*1>F5:@_!.NXC^!6S
M@J*JU"Q+4U,:)9M-GD 2^D>?/Y,JYIM[V.P=J\C@ :7VC!"(:ZX7[#C6-:J"
ME-99O1-_%^$$@>DVH+Q<GIZ:&LJD_APIU.I*]"S2I?]8^$A';$A$@+D(>:U?
M)<OE_@=[I^FM<A46UF?9;C2KIGM=]83:6A<%K*^PW+Z(FT6 &*7WE0\NO\-Y
MZ;Q=Q-%<O*8QB@]\"L=LG*F?N2:^?RQN6' ;9D&&O$1Z8@%$N;A&$#\:_P+E
M.9Q^KV37->V6]]R$<X(!KV"HZ-_.61C=(2]AV[N$8,+T\%PP2C/.G9@I:"74
M]C\WKL8-M@%!NS?>-+(N 89*1C#F^TDH[N4O/V#[!X: U2K$C.TB"%_Y,#_[
MU/9HZLV<LS_^_J+:X7P^U=6#/ U.!G&U9FY](=>[WB&+1WW]8N8Z>GU%6;[L
M4[&^4X6JJ'6D3Z^&01&$R(.HH]C5ZM.1GPKS#6B5&ZU4$I:QC%XFG#@*LA93
MZ@XG:^E$?0S@)XSP7B*=.3X1(\)?*N0BA"$F":R0P&-58Q/\8!1'WL1 4#,<
M<W1E6,9_@=\D:10*YU>0?S ;A/\#&_Q/&)DM[='"IR\T1!L";&>.5YY:9'&S
M]C/IH4$DN:>,B1"J8R"Y<=#6@%W!>(BRV]^'P&?I@M'M+G4XY4*'4\SP &^1
ME.@C&>;1I=/20T*MD$T$GY"D95$M'9I+E-.9R&XXGQ!J' FL5U5T,=W<6G3X
MP0]OHT!RRXQ90#HQ4<Z3I>X3O)6,VINQ"OJXX.FNY1F_R P.M,.X]3LBA\-X
MY'#//(TTK&=T^<LGAPQK6<Q.0.C(&HR(SMVR"#X4KZ6_?$*B>H'>4(9%Y#:^
M>LSQ%-QN@6B#^<VNL-UX9FQLJ6X?QHQHC["3 BU&NZ@428%YJ98&#G<S: T?
M+?:NJ2NRIE O+W0XTK4_*O0KRCKRLK\LEE?H3,5JP C/]:65_ZLH."_PC\I*
M ^0_PR,;ZG@$SLE71R_&,*>4\Y]!C(4L(T$&9O$5^5HA4:\+OV8]E 4,8_%2
M_9(Z<NJ>3]>(H4GM#Q&^5$?\G"S2+)N2&&#C,^^[/UN I7H7T5.):ZXBAM_&
M9N>L:U\/W,NME\A6%H#!A;[]\/:"Z"A= _8%Y>315:-)2UA?>A>,W\1SO?0>
MJ:!Q5 [*-S5=O E=XFB/4])/=O:&WP[;Q2V284/P TW1^ [4!;@['NA+$8H[
ME#^)\_GWR]S3I3ZDAS"GH'^# A'>7GUY[^9"GMIMR.R$&?8TNL_I-!H2VZMG
MT723I]]XM_?.51J-OX'V_P9+)5;*0F%:\#/!/^3F]',,TA<T/NM]F)AQ8YZ/
MK^%RLW8V%1<I.%WE%L&:LLA:"KJ,$6>K8YPC1F[FBY![=8E0?HVB[F+XQ"[_
MM]Z&[>KRO=5^H,BGEFM[-(QFK 0QDD5!+FN+;1R])-85"'=3N"\PS!<=4C)E
M.XD/(Z[4;.?L _A@J([6@Y<WORU@?B S2 QEJJ*I&.^*=(@A_YO*22 #Q\O,
MFY5TDAE%(P+14'CA[W2:TO8D''K3JJ?6,LH<U(%\?;/@&*-A[RGJ-C,EL0>?
M97<':*G3I<3XGD_78% 9!8&SZ8%G@K$T!/#.#CP"R^/]IQR)@T4\VK!JM']Z
MJG\8#L;AEVPR/(1^]*,G+P?R8RAQJ:]H?^5=\!;I-"+1D6N.D7DI<V^N0)2D
M&O!D^UW#FYC\">*<D.2O09A%K$PD8#M?A"A)AL19Q#>"(,BO\U+<N*XI':EB
M:9K82JS+MLF@<C*F-0_%FROG9S^2%TSXYLNWGRA#Y]I'[0*;1LU2<XT$@1=N
MJ;<P\:'_$*A:O:W'-2UGH_AL;4U2HU4_J#T^)"ASLR*[)=NV0BY5A>@'8 [
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MQKQC%1Q".R#1YHM\!75Q]NYR-([B;_J@>J#,$DJ-T'?!^I:1+QE2#-P$7",
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M=BSX5WZ28)NNS#==VB49G@7&,V;A%^FM"9!(>&P9U,5=%=B!0<)(TL6*E/A
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M,]\[IFV[/UP7T[9UWNB>#[8"^=IK=,[+OUEWI$&CV:S;2*UFH]W=UJ0&G>W
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M"?UV$P2M/QY4(=V,3-J*E+/=^0I' &.TU.W*)$![FP1H.JL>G0.@J[FM8:L
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M6.]\2QACO=9VT,KZC>'Y=N:TO9$08ZR]'3RO06.PM9'.!]O!/3MO=%KE3VR
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M<*)T*N*<S6-/5-6)6HS2+=VPGRB!IEX,/H.7B D=NBUSU;&2Y8T?BW$:Q92
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M>LL^R2U3W\)K;^$#<VOP@4"D*6WLM2/"&X_/4H7D6X5R=3P<UU$ _(DLY(?
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M'F-D$R03^5+PPHFXC< ]PCV']P9.ZL_8HO> _\.TBK$/HSVD3)[ (@T'40E
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M"E?^26-TSMU.I^G,130/A((!AX.*K24_+6(UDL1>1AC210AB@:"^">Y7:.C
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MS=P\:QP<M7%00.DY>9.@VQVZ@X&U";9E$_3V3LKC$0#'81,DC5S'8FL#6!O
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MVLW72Z-\N?J#?D7?MUZ_<)V[J3^>.G=>XH"-":,CQ3UJ.D 'M>_*F<X7<;+
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M%!-9\I9&6%Y&GT_(4Z2?RHHS0A^0K;.X*4G).(]6T65#.&=^0S0D&)IZ/=:
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M!!!2"8H&:"CO+N@QL@SXF(W]O0_52G4?3R*^EAF?3H71>R18NZ;^Q;(R.AJ
M<29\[)!@,>\Z/1*DPO@DO$>TPNAF-QN,^6=XONIK? O685J"P'7#VU,O!0\C
M<*!H2 F QH?C'Y4$$"3$60(HZT@@PF9@0'_07,A&I+LZ"GZ(NES#56LP$<$!
MMZI$5_/Q$(+AJ";-0"OT/'EJQ3L?U40,VH#=6#Y/-M!M.FQYX&;RXLFL=U=?
MJ]/B4^E_PGD*&(<0;'Q^ 5;00 Z&_H;+NHK!=; M706,@< /\-BWS@.=PXH%
MF_U.-L]]N9;"*^XQ0>)E Y]'+"@,>Q$<^1WX -S@0G,?;%$< H,+-L97PKQ(
M[1K[,1TG*#@9GAJAP,V @QOPTA J1.54L,$O(<L%.2CQVK![H8 ,Z8]%#8,S
MT$=5TG=>2=B/7H.QZ-OH4)AEF>7C'<=6S[$'],"EPX^]%%[43$]];.ER6J3X
MSU'Y([15WK?^"%S(<33R:^>->*@&AS?0R,,/:+N8IO!.VFQNATD[Z^,AV48P
M>]0VO3!HA3T$DM'*19^#U./'6/4VB:)I 5;8B"_'&/&:RXD8$;VT?N/Q=UQ#
M+^Z8#81O"KD2-Q.HQWU'1"0^)G$KKMRM6,MS,&%:!*Y=D.^]T^I+=#MVP$YR
M*5  TY31R/@L[;/E+.Z+^7A4"D;.L$TUWV'C[57SO6$QF5>_L'N(9L&(B[A6
M<2.C1-!3,R<EG3UA)).C>D&;G48]2XI:S@/75M#1$&,NMF(:F8(AS2AV3)Q:
M4^#&8%&W^@ZH<> VPWLT1+5=1QH%L=YT/ E6"$=Q/M+2QLL#S P-D\#$>L9\
M?LDRG?WQ5;)).SI0@:_"YWN?+1M_TGB8*1%=;H!)$!%0?](+[CFZ)"AE%K;L
MC%[C&S@);6/3(?$)5!*_)7+@LFF8UWC,AR(B0/0;( J%.WH*(PMU 7)K]]#
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M :C<@ -WH,M  1JT;GV0,)Z^O=.*J[<3G6"U /WNZ3(68];TW=Z2O[9VN#/
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MPBP!:WD4%>E2,06#-$7@4M0"%MU_NY7$0:<'%JG]3!SOP#NJ_LX#3/-).88
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MOZA@ZR*T=^[P.I#G/KV7[QAB\#D)-M*) B# Q"E>GZI>=S?L#^*4B4A?MGK
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MEIE=[(^A;.!D=,Z2J-8)-:,IL4!&CBIP/+8?>8V9Y347#W'G2B9"\;A;BL@
M9^5_._3A+[]VL,_! 3"4LA1E\B6# [24@BQIHV;B0CKZZI%3STJ+)5/$DL:[
M%/.N$)Y&:XSO;'V.G9W^ .YP,/M-\0@L_\2R3ADL$$8XPZ\/-E"&DVNX<'48
M#S$ZRZ5[L(P4]- VF8$4VQX9QT7?^]H&I!-@ +;WKHRH>0=+"/NM+$G)QJ+2
MV13#=?!S/#WAU!QR1-:I,9?CE,KV58)I/!R\A16^,;Q0D/)!.+9*GR=S!'JT
MWTW"187WY/VDH+_3[H/6X:..O#LU+0:7FF<0\OGD%";CB_(<E=Q\3:V/4&'3
M_@^EAL,C5$@/#5L\73JH0/@8=XNKM86,4@F*YM]$*W-/NG@.1?<6M!H8YS3/
MA -N1(-<86@RWWF@?\[3X8M.UPKM.!H?DE@2NX1_!'?6-@F99*X))@M3A6RC
M=X[$@EA2\^B(!.F Q0Q;O0:'6AZJ6H?<0+;Z6.'O.,/WRIW&:X?;405CX49/
MSN^N"O'^881%1,<9UX>J1SZ53!C0=RR K4><C@:M4Y-'U,76(E=FZHP=(6VG
M6]/!\ACOEX7OUZ?DYVARR<\;*-YY';ERQ&<F;3Z9EWG((QQ0/=MH\Y@S0^ZF
M#8*]A";+W>F@7GBG7%WE;NWP9>MV)('ZP@[ AQQA:@U\YPX5. D':/O5YZFI
MSG Y\ABH\B/CJ95W2G0D?-D+N\H)$8D3Z^59#]S_+,$97KJRI*>&N>1C;B4<
MH@!K?#0(C#-RXPSL9YK+N6&!);# F.?SNGPP>3GC7,'?TSSVNYCFQ<J<T<Z&
M,Y; &>"AXT<I1X?)L+H+U;W,JW6G*)L.[]'")YNU<IQ7F2+GN@[L'_4%E\#L
M*R5QM5.-==X\T4UFR^65 STZ["OA++F#9C'.*M+)Q65S^GBRUA]53.@)PS+9
M'J^* C-L6X*]3O*<:EYXI<:HWS#?$IBO'2>27532Y1V *]N1/ .;\FD;F%#F
MASN&"FPJ-69B]&=XC_TGN5H\L7/T4&33/##.'>A[ZTFQE!+(^?/FH9JU-_N^
MA'W_5P8$5]BJWX>3Q32\3S%:]2=<BBTUDF;@K,62P*QH*KN-N6IS?TJ1;#9O
M*;:$V[L_K;:,PX:"RT')1_)-\H),QT>24$AK."6.Z'%U"58)F3#JR)WHR#)S
MT(TR#Q)MEZ1IUA]PR0ZWC<(QI>C1]/6LRYVX2/R2,;HH7BN0%:L?%M.UL_GP
MSEC-F0*9[* D.OM %1]@YIL-8>-QB'U\QG!XU*>=[,_Z>8OR-@3N2,B9M>4=
M'76G>G#*4%#?7 ]&@QKH*=_P0<8UX52TO8"3_!)<L +\1&49VXQUM./]-?SU
M/HJC;QD(=-@F8L+"+A'ZKKU;VP*SK0]KZ:CP_3&'P[_!!UO4%M;=1:19[&+\
MZ[O<719XZ5(32W>N(,<QYDRA+I9T08IL[=6.CJHK5'U(=)B;5[[$7+EA^&4?
MAY>W>M@P>HYQ53085I5U>,QP847[?(5<FR\W7VZ^7,4OUR[U!,MY.[FGU^2(
M5]VE936KOV!1X7,UJ)?E%2;WJ+_\"A_M4I]YON[D*=ZO[FWG6M4GMI[_9;3Y
M?)W:28O;PG6 6",DZQ[?XL9O4X"R7I1;,2^G%)W=C\!'+  D\,8@(G9?!1RB
MS$WE,[C@+R8COC=;5WD\2^OO"RJ0DBB>XG$'$UO,7VQ;RVK"7$]M22^:<>".
M-%CH6!8$.6H0M=B2HJ[&*DWG0'TSG::A;8(RJ$$68-:\YP)S+Q;IT7\"ELAX
MY_ZF<7\-&_?+VK>_B/AC<X2U^2>:_$X?^5Q:P"H!?HU)I49SJ!564J:RP:"'
M._CT]RKX20I+_0K3H<;]Q[RF*+R1QG2GWGY*D?W8&G,=0P8F&U?DDBO?=>_@
M":2($R!#0FR#!+7/DRD1=DAKV$$)NNF?<-^1>O#%E+9XW16?SM 6_W8%M]C"
M.,4Q/=QEA+OZQ6#M,R;=6X]TF+DC"QQBQ=-SRC.;9BD3:;PG46B>^2RU9<QG
M<6H[N-)SN>-:ZIMI+9.GM:0%XUHZT\>U-$HRK,46,;SPR)9R'0&/SEUAA*&Q
MN2OI9E(*6S_/,2GE6=-P+\) IMB*:Z5*NLJQPIS%UUG&0-\F(S\A(U^;G)'O
MS $ O[\!@)_F1Y@<XFNG_(N7!XN[NOAR?GI\?7;J?3K^<OSMY,R[^O/L[/IJ
MXH(=Q/DFE>K3C&,K"(AO@?+?"P:I>J__^(!62"]X>!]&M RZZ$,> !Y98&1P
M-5&'O[;<4:DRA\AH='FR?%V!K]Z-?[Y_6-D[*OZJ6JD5?C[I5K6]2JVZM[Q;
M[3]VJX+!X)J:41PI_-6BH^)ENW SZX.A1^D'#YEMW@GC<(<7TE]5[MI 96]X
M=($)Z@N].0U*?[%7'Y/9*H<F!')(Y_660 41P%J>$"M#HOH,)'JR1(FMXQ"M
M]B2)XCUY2;(=7UVYBG^45OO/]/)\[+TRRVQ3<)3!Q=*=E^ 7D< YN:(?=CH]
M]9*J]D1 +8\I1O#^*=IFU<^4>=7B<XKX$]]Q6>IPA"0>_?>HE'R.13>F^@93
M;'=!+S=81Z@USRM7O1)H^^+W_>U)[U5"WI8^I<^)(/-E4<A=2EG:V1II6P+.
M[:AVV ]ZZ7]MX;^XB2E+=V^"8/ >>>$XZN!_SBPC' ]/@B3!\H/_P1;(+8\
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MOW?4]*N'LQQ'HGE">AKE-6)+%R\8>J>JK?HM.*D:-=^K5^L-_-%?6\F[9U?
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M4(_X$!!M' 93+9@Q[M;92CDZ1OZT1O^YY8#S']*1*F595+?5.!]V0:!UMTY
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M\PB>BB+T[H]<GTRP4W#J[S59Z,+F-BWFV)5-$6JW&^=F7V_W3;UCJB3\VCA
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MX(&*<+K9T_>)%T)?BH-GZ"?[%5"BY'4L$\?->?XY^W"SOORE.'DV0P8,9Z&
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M*WJM9E081NC(,,+Y/ZD_5QH$HF9@-@JC6<0^RK]\0J^Q9SU_='WB2/30IRE
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MZ12?&:W#+C[K%O:<[/*>DZL+UMJ%!6N=P].Q5K1YR4LW2:*"CE6V6R)9%O4
M"2G*,\=\+F^E3)",U1'E'51SYC99,RG"EM,,%B2):*A=J(>\<^60=U&^ENA+
M8A>\)"_;5(>K4CSKA0IU6?1>U'%0,0#FSKQ\E*;V';BY2]DXI%LF"2924B85
M\8X+K_5A\S(M5T@GN-QL[017I6CNC!OE/LVT!LN# CCG!)8/\9\Y)5&\91Z)
M+"TW=.0YM7?):EX>*,D2[[7<()><HIM,M $M]W_@O2)I<5E*+[5!"1FIX*D
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M@M09Y\-9YKKCL1I'T7,<E<%H0GU 9T(W!ST:)!&%)@BRQ"4C')5P]S/"60G
M);_SNB'AU\W^Z#O_40%3S,4;2"0BF[P7/')0;P:9I<&$+][%8!1KN:_JPR/?
M-1"\ -C&^SH#]A@[_*]B2$E !2DO1W6:A8%+[LM,M14R9"FQ'_LXNM%RGW7N
M3Z.$U<2DIHQ6OFZ^H).2)#U;C'U/,]L_>P"ELSL;;%,FIVJ<Y;)>F]K*(^%1
MD#%PMD!_V>@HF9WDQDS K?_%XGSN26H=$] B^=NDB2>^4?XXMQFN**2ID10>
MSH5>'S%2EH^-\MH!>5>9J@9>(L\TP(I'G#LJ,I HRV?,,G[K])X6=BK\GZ+&
ME4K@, L@QF)@ &2RL7&R(!][@K$U'D!&-P8E9WJRB7H0@NWBHZ8BWGH$(QA$
MC[]\2(. F,],6B"BI-(D\P#'\Z2&.H_8NBSY*R $\0.L3J9@<EHPN("/E"'.
MLKE55A3-IV)3(7L I./9L_X<ASJ)22\SC_U2J9H;I6IV#SY5\Z6DS/Z!)&7*
MB2*1'..1?" 3"+B+4#H[/7<JXG-Z$H(C,LI2S6. V,J3!R2GI9HU6?I$+%NG
M-/&S<<@R=6<\KT7F>J=,?>GI,OSPN HROB:9&9G\#2$%BW)4"JJ,N6SU%]DJ
MEV'9YTGO2 O\11 V7W"#R6Y>9ETW2G.=COF22BK%/]@,1)$8 T:WM?*0HC75
M&?;JHB.M'MUW..!:!1RJ);ZA#D4^DV4;PK3D$C5;2_$'"Q\P;"._I6%J()DI
MOV(1P#*<A7.?&.^:_OW'!4ULQ*ED_#>P]O^9@][%YS$:3>T"]421;2?5D2(M
M63SO4EJ%C$;#+T:N*&#"%C64^25B,;DR41[O$N8<5VD+#B 98:(/4D\GY)@K
M"'ZY*WZV"U1"Y84V SY[1L^*XXJ%N;LM!'G@SKA@2/=](9(+%O-+9P"S+"Q0
M)9<9WDLSA; !0692)_4:$%T-,.]>I(DD/4@$"%YX>1#%&[Y=3B]*<VL*KY**
MBL/%.&,.'3 HDR2K+&Z ,\ZM)VL4J1K=#>H_ZL<CB[U^]POU7J@6/'!4.).)
M(<*&.\E> \0KRP")D);7Z]F<D(&'\*+YI&70(O5DF.["\M)NI4SK* K$J-R$
M72]7]E.::X8#">.=[T!DH?$0/9(H,9J1Y?]%R?.,(D$.F-1!^,P?T='9. ;B
MI-E&XB?8BLKGVTMSD&A/B:M"3ROPI:I:Q-%YKACGNFG,ONCX:\-(BY6+19<D
MFA=$Z6V]D.N6=CI(1NI)X2!<%TE- &5Y;5<2L[-&*9=XC(L$=_Z$:[K^Y6;Z
M_ETD,+X-R6L]M^,YQG27XB&#HXM\$'GG#GV23*Z["(6$,$,V]FA>K@@"!S@Q
MQ)VFU,'+T4B6ARP('RQ?=M@ Q@'T1P/"?3B,*%](.[:E'>FX'9S\GK>6XH/4
M9,,/,6XK:14EZ@^#\"_@ #9+DVB(I*D++7)6]%9-L>ROB%G*\W(%3?0:H216
M/K#4R?1^F:6A&M&'*<F;7.K=)F2 ]1?S^1BA!9LPUQXO22Y.MK78(/#/S"$%
M&RM^#9:LS\3.B^^"7,;!=#KW75N6,>32C9/T"L2_62W:H5R+NLCO+"3W^<IL
MRN%Q<J=O+)9I9#/T>J(7%"NA2*:>(K<BO?6S%0'J^"_!9DG-RN998OHQM11%
M=60NO-( !Y=\S)EU<YF:^1=((U?XL_E^44O SGU@RJ9^ZOQS8 '/8TPPY*G:
MG.&F6DA3NW*]N>S M_IXG):3S?.YX'*IJC;##4;/ P.+=#YBRP[N#^L+RRV5
MSI!?@+'LQ)EIQB$K*$3+!TK_?*(\>2$3TKKM #394%;?42 BV>OB!DG4<-#Y
MV8I,?&-F/]15$3<U(BSC4;<-KJ26C?*^L:>+I$#V>QAP64PR].4^SL,7^S@O
MQY7%)SC1"!UH)5QJ^V(EJUL]\T*U'V0] 8+?</\68,"% RH$_#4%(5;$^T[6
MF_CVW/#__7^,7NM3A4Q]I[O-P'*6PT<]T]%%^IZP'EC#-&]'NX+K(2;6YI[#
M-A:S.!0DH1;1R$*P[0.Y_/PX*8/T"[4_.UM=65"$O;8#U>N:X[X1S-%X'@=8
M+DQ>N54WD.VU333 8U$(XF<LGN?4H(L8\=*%K!E\N(=VPCL%XHVO?0/MFH[,
M\0\1ZTN".T5,0OL<8(CF'>*=V?KTY>+N,_W5^/1>NM$+'_LY(]>Q?.[B[F?R
M&+[ZK-4O3O7:<XSECCV0Y9-V,9=I73?<B$I:TO%?_/_LO6MSVTB2-OI7$#S;
M._8<B(/[Q3ZO(F2[W>L)MZ775L_&?MH R:*(:1#@ *!DSJ\_F56XD0!(@@1(
MD*J)&+<MD4!55MXK\TGJ2:5?^N1&8R\!J.MB+]LKNW+*IA1-*2RFI:RPR@0X
M>',$-RNX4RQ)[,$A"*53&)Z>GH\4?H!IZHQ:22%P1'&1V5%3+ZV@I:-D[7D"
M%7.!M#TF_17VCM-K(XQP&>9_FN$+W3GKL!T*GY<A?@MQ!T3JLDX*[.6,@F4.
MU<_FI+*G9P8!$YUNG+J<8J&<F6;_J&.0%3;G,P\HV,$(2Z[\Q);0%B.VM*RV
MB5)G,J$I66=]:<5BZ0(SYD 9Z,O2##!-L3H"9EP\4K&5Y#6;A^!&&W9U"F^'
M1:303R,"?IM/[0)6?.1J7=93.YO"AVSL*VU*31[(L#MV/4X3V49"$H=!!E5"
MX5Z2F[J4(NLY7XQWLH-(1K*D$4810@H^AV3$R[<"E9.5NG$+EO\\2/E=F[;L
MG JF#:Q59J4RUK1[87DV[4L"9_'H_"S:E6Z6NG5A3&\4-9_S](3U:ZQE)A_;
MD>@DGPEX[IGFPIKBSM!;4!_SDX7+T9(V826=:[ D"\=-I,@G+^F:<J#0=;60
MJ-9]U8+&'EQ4,]FD(P\K9!:Y>#-%B=HKF\*";ZQ5 0=+/FXS6]$Q*N"(DL*=
MH?$9E,B.![VB*DBCO@H2%XG)#W=LVR-94PD92;(FC_21I$]T354<8S36)</X
M7PBW![VLG6Q2_]AI5D4=;A^Q7,I3?4?<AB7Y' ;SCP$#@<:[RG3R=D5^2BZW
M9]ERN3WK4ZZ DR1A\JJR5!^<9%M_Q_TT><,C>F<5*U=*F;6:4A.VGXI=*@VR
M<8<U?70,DD#ILV$<P0$>IX/6J3?N4:OB1$GJ(JK/+VPE@*S1W26^<JJXZ*1*
MV*7G+"+R+OW+>\1'\9S5.]>GRZ9?>K_^>!39C5F5E)CLUXDTV_;0E$P4Z&36
M:/+B1-:'0(:_E7]N2$-#K?Z5-)0K?U[W*%D>&KK1RT=9NQY5,7,T/1<02M+V
MIXX=.RSA/-/-U]E'3?)E^OZ4HWQ+>IR:H__)\J][S(4]$?63E/I6ZN\_K)9J
MB+5)M5);PVH[/9E2]K6KP;VX]BNCE<)IM3>MY,X$OUOEO-<Q'*JY#SWC:K4.
MCSGE";^A58_!$AXQB=[V5J\?,TN]*^^5C4P/%L+8<^$H-VG79&N2T-L-_L=1
M^SJK3MLZO_USF!0(X]Q4&LLMH\E@<YR[.1 F9.S.'2_Z/X,;M6&@^NO/!(3Q
M+H$L?'1^KLUZ?^<OYS>3(+Y)7@(" :0A5#32L$\=W)J*+*J2G0:IZ=(W[_H/
M."!46(T.ZF^<MZ^%MZWS\[8VN#4L5=0U@_,VY^T6>=L^/V_K@UM-DT795/O#
MVQ?BKO?>Z_M(/;Y(4&[T6I=9:;;/2E5R@:)G2.<7/6-P*XN:#H9%LHX5OFJ6
M/$KX7BMGR.?G#!,Y0Y<,4;),SAF]X0SE_)QA(6<HMBS:QSNC'7!&3PWVI:1I
M4H-MW,C2019[7^?_$J5//;_TV2A]LF6!]/7177ZMG*&=FS-T2:*<(2NBH?8H
M2?#J.4,_/V?(@UM35T15T7O(%SVUUY<68,ORC<)#[$WA,\XO? JJ95.#$%L]
M^EZ"!U*M<<;9[ZMT2:4AMJ6+)N>,'G'&V6][=$E#SI!,$_Y_M)//0^R^F6PZ
M"XK'UAMB=_:+*%W2![>J*$$$99E'YSQY!-469YAGOR?1)6-P"URAJZ)J'GU/
MPCFC-<XX^SV)+M%[$ENV^E5VU'=3O5X0FA0%J[#72;#$?I.=5<']M_*/0>QX
M!U5,=TJ<GHCY?S21\QZ(N36XM419D439+"=7^2FW<<H]2)3:@UM3-#595"U^
MRMV<\ODS<K(TN-5%S9)$2SGHE#NWI'^C_9/UF,B[,/+.U)^ZI1]7J>S'52$6
M7H99^VH"I!6YL" G:V9EV#8(Y1#,L:=XYN!1P0(CX/I(3.&E0P)<0-:?,"&(
MM$U1MW"&"_THB.=+C$/*$ <&&=6E0ZLV:2R4T4RV8P+LVP*O#DJ/[+I]A1Z.
MQEK+:\Y'K3P?#8</,B$4/C@>'>Y=Q8Y[$ZI^ 5KE O1!8]SNLLZ@P,-W_B0;
M2%/=8*[+NV>4GA?[+TI0TVE'-O+RTH<->12XF'6&4P#7O/&['I&GT.>MGZ?-
M6S?DIFW>ICI4-;NUAFI3;^]1V]N\.^F4/N[RLJ=MDX>UXU8Z6=?01;K><7MH
M0OSPGDZCNW[POO=TME0PP#)M#+!F1XIB[DXF'CFEX_Z!68]L,,<;IVQH2IVN
M1]\)]B,]LW_73]6^>AB%-0G"=M0Q,KY(?:GO&2]$C4,M6OQ@*?!__>C:H_8N
M,CD+7SX+[RBX;(^%:96&J<NBK4L]8>&6;L9[;9ON,(2A@(2(>3@.R<2-*<8L
MVBD_B(F@UX,P7-%]V)L6]7I&T\]!^"E8CN+ITDMCRUQ$&DN(-K@%?U57RZ4J
M^SL/_%*T-2;8H1D[8@)]<*M(HFXHYV>"UK%OCE"<I^>5JF31&Y_$AVG+1J3I
MLPBUH$;=L1=F&<:"K/P6@EEJ+#"T]=:T)5%5RC)SF%_1C($[K M]7>Q2HW#;
M91=:9V*J>#795J=V=^SR&AS4/]+D>YX^V<S'OPH'M47_M/;VAHK,1X9FWEAR
MK,&MC>$;[XKK#R/L\%&[800;&<$4C>-34?UP5%NH)KDX3[;JVE/$ 8,'&K]C
M:7A-Z<&V2'+ANJFA]_^---9$BH3EY*:FB(K>LC/7EDYH.:/.I8U+6RO!TR'2
M)J.T&98M2L=#9IQ?VBHJ!'<6I_6@AJD<+C%33IS0+U0P!:&P<%9LV!+.;&(N
M@/!FG-:AT;'O[,M>4M#EDNBM\$+6:Y_V+'TJER2<HQA*5I2FQ5":-I2MEF9>
M*$-):3:HHO[GNFKR19U\4>KVEU\!^L4>!3RB0'Z.":C4!0E1EITGLA=0.Z^?
M:U8_=V@YXK77Y_6GNK,O<W#^0_@X<_PGPLFTE4R_5)$IT=GI M(O)%.Y3E4!
MNFVJQ]$/[W3E_.'9PU]#+>LAUS&\#O#R\P?GN%)2E-:NE#I%YVED4[DP7+XP
MG.-:35%;NU;CPL"%H<5"R!)L1 2+AK^MY9B_^..0.!&!T([^]XN?2LE+JU*B
M8=.Y*9<Q8H[R2LXD'DUJP2ZE?*&>M>!T(>;?REWM,M<#RU]E;(3M\RD?Z8-;
M:5AV.T[+12<\EE]::8&\K$AFXT[D3<6-R*LH+6NS]Z'*]\D0 0Y5ZK2&U] U
M49?*@(%G;7YH(!.-%?LU<]$!'O317)2,VC%%33O&/>!<U!LNJ@$LV^$31$6N
MBHYF*YS3HYFB5%%BQ)FJ'TQUI,NY%U=5JJI]O4TLF1WV O'T<ES.UU6D^XW$
MPHAA0_$27%X4V)4S7Q5=WTV>D>T>DN@(.#$FD[LGQ_6C.+T.JB@A;&I(56EP
M:TJ*J)OR\6'W><MT3ZR_FF14N3+@RF#?F.R<RD >W.J:+9JVQI4!5P9<&9P]
MM*Y2!JR<RO5/I100YDI71+-B; A7"OLJA2:72ETJB)Y(17NY@2.E84M^0%4'
MMXIY?(+@S*Q_WMQ"&>U[&[8W6_@_EU'L3E>#_=M^UK[W?D<G4&T*I],6H4=W
M#D<HS)V5,'&G4Q(*(Q*_$((E_D2(G-B-IHDP!%,L\J=:&B'"@A'LCD)*1RD>
MN.#ZSX$[Q@?B3[!KAV3?=>9I8['G@ P(<2 $"$2>,K^ U[,Y+OE0^&^"3<C
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MGC&8ZVSO%.$.W"QP[6 I+F@];,TE8X0T?)D%GK>Z"5X0W&WM PFG?/EX_TV
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M+72C:AE763&2?7/8ZIE&M'/XI")\DET/GW2Q<$CUD#Q*)22/NF-T\9;KM3)
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M7TM@U>F*XN+@,[_=_0,D [4M:#,XL 69N'AF0)N['Q\%2Y&&@G 'ZW'],6R
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MRG['<J C%NB&#J8LG3D0J)#7Q>XJ-U[BUJ+-S:1[B=@RHV29(7D.O&>,0[W
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M':%SH( .I>1_P)=[? D:"H<E8:F*8E<V,5U6VWCO^=]X#4U\Y^7_64A(8PG
MI*:LB5;%+,2K@8[IAP28W )T+ &?@V786  4>CBBKK;5+,!-0(T 6-P$="T
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M^TO'VZRZ:*Q@[,&MW6H6N8^CH;C4<:FKE;I&*;]6I,Z6I,&MU6ITTZ.)4;M
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M@)R9+3! V"4A*SU3-@M%ZWPFR&R["4(,,U4MFH;6M G:,5#R""8( 9340;?
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M!-*3A;,'8ISX.47:@[5X,Y\FO3%6M])L@81COZ1SJ?<>%C! &"VE<%A #$^
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M5"1;;<H.J53UH'6'%R%1-;-#,:!^_KV.9!)/SYTXFS:>79>=S-B8@6R:GL*
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M,JQ'B[*.3O&<8AG!H"6>45L8%'N9=$L*)06#/C\&-5K(H*;<Z<M=ZWEKT&8
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MN<JMUCE\,L \0<BXXG6"Z&WXJ0;RB'>FS/X9OMNS8,Y.XN;2>Z_[+O9H:NS
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M@1<7%!O\B^W*_F9([?1U2Y+5=4%[>5*H@=WZ!%^= 2I;5PLEXK+"@F69V,\
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MZ4:\&GG5_\SVZI9OU1>V4U_'S .-OBYVAWFCNYV*R@7G5._T;5529$6RE:9
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M'P;'HY!'RA><S2O=X["P_RSJA^G @F+02\"W0S)P(C=:WVEAI:J=C1%%QF7
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M^I5P40/S7T']XG^L5]GQ@H''"[GR-5JO?-MPNL#TZRWXX"-V2HI*(_?J5L,
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M:M"7D::LCB#78)$?7L$+:J*$GLLR\G# /(4+1.C:MV_X.[.4*H;@2&U2#.[
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M'0MS"<8V,+: \U$-6C'Z:D-U&OBN/&$?2B=D_*0*(N:0=5"00HJ:->*H,&T
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MKI"0KKBT03D?@SF5&K'BZ=!%4&L#T;% 7Z/%_NU(S]!EN:X8[F/D^:EAT:Q
M\H:FJL3(]P"Z\_.+=^US1<V#1DP1?)Y7ZHQ@FRVV ;ND(]3-3R;E>V6ZRT1
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M8 J@4K!D4=L G&%4TG!OO&I,C3N!;$,&^^S(L/^<-Q/_VW&(XTEG (^$\XG
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MYW"RVTH=H.YJ'PK/W(W"21L"Z38]82O1/W4(72O1MYOK/INJ_1+FGPCCN[/
MOHKW/:;9IVGU"VFO7$T)JR5SR]$N:;VL)Z?<U'I@$FI?N"@E2EY:'T\^#NE6
M_'KJL+O6JN4 0FU&P.O!3N?7PA=%918C&1(+HI#Z,])T^8400BUGDS#7SH,Z
MI]:5@A["M!6I?K!3\*9R>HI*$\7&(KN>"?0QY")V 05:@.8)70Z,96T:\^BQ
ME2;VR]7Z$":TI1Q]">-)O?^NH=KTR@=,JWGWK&ZS\;(X*;PA&=7CO80<HI.*
MC%/NK0O(L'D?AUTQ/H/(SWUY=F^^:&LQ-D_6^3@[2O^U&L_Q 9#:".N#91!R
M[4..DDP<EQ((3 Z%K]GBK#77=H/X'")%FW.M1RGV1[5Z ;O$^<G5PV6I B9D
M F((M=@R\3\FVN5,*:G4V$/&6M\U;8-K4(5;GXI4^\JK/R;15)")M/Q>JW N
M:T<)>O6TOF6DO!2LVB_:D85$_G<"[Y0'7OOG>%*MR?65K?HPNN>0M=H[J]K(
MKC]NG3M@N/AMWC5EXH9UYC8+IM V+7TMV2K (D^*H<J"MPYG?PC3<P@7[9U'
M^\BI/_9LND3UQCC+4P#+:C?=KAI5;4T20A'<)DX^>O.B+EMB>PZ)L+VSJ87<
M>F#5Z]4TGV_#;V=A2B^]1Y(.YG=AOCX78*Y(5!I8]A:4=0R\UPEXP!!]U"FT
MCU#>'MYS2)SMCUMMI==+<9BUIWJ7I9<"[<:&>Z)ZK9]72NT/:P-PB[)@XBA-
MZV/BK8 ]@RC6_H\6]A58KP6ZSR(]?@F3>D.R./]Y\?5*Z ?YI4MR61?7 6U9
MK'NG![0HW/WX$>U9Q+N[=;IXW&5BS-KD<3(X)VLS<<E230?-X S]*&5FW)5(
M/EIZ:#+O?<+>-U3CR:3&[:\__?+#%R/N$PM*2."FUD1TC(%3T0'GCADIL8CF
MP<P;P0SAL+*=H&]=*#610;L[H\ED]K6NHM>S^:^S55R6U>2.Q*]0L/898&!J
MZJD*PE5L""4GK;W!$G7KT*OMD WBN+$_MO0@GC9A#G>,EG;?D><R)NT</5G2
MIN><ALAE(G-=R41.GPQ*/58%_GXS>+.5WK968/:*?-/$:/98C19PRH#C*$)&
MI6C?;JBWAZ71=I7:M0",)E/:3)=MC&GM,)W%D=%R3*5H&F<PZ$#Y4,"SPD'H
M$(S@F:RUUN')6P$;0H7\UB3I3S*-M%A7Q'D\/<I?JI(]=Q5IN.04'M4HC\7R
MCVF\MF5?U;LRB^ P$DY?)"BE"7LD)8_2N<2+E$+$[33'?D#VFH3-P>%?[Q67
M+"DSH3SXPLE9]D)!S)$#=U9'Z6IS].W4YB,!#$>K'I!%U]3O(2379J%M1KJX
MJA,6%Q5/SJ%F+4W7?C#*6A*=T7?!TD:BZ1>.);*CRH,.ZEX(!F1@#H]F#877
MYQ'('4%\B]=A//]'F*QP5F@TBW'N8KQFTRZ5;QV1]>[]47<<O1BOTQP>?4+2
M]/D-#E#ZFX]&3=+N +@)%!\Q%J(5*8 WJ9#S8Q"\J%5V2TF2N6*9;WTCN N^
M'L**-SUK?6OR9KK$.2Z6BQH439IAFKOHZ*H"G'96,%_ L!J,&B.YHBY:L/2M
M*5(XS5I?QS>$/X0-OW>&;A& ?!#Q]QD6OVD 5W)\:,^IFT@>V6BMU#: R=&
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MTG*96R=\]#NB(>4I#FFM#)!/@UPC;Z;+,/TT[IP*P1F&7#24%&DP6=>"HKY
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MR,8$"989LA@P> B:$U;)310F8 [-S[MW!3FHR[7!<6UG,3X)V\X*]WEF$K/
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M'R<@9Z->K,^5"/^\QG+]BNM_1XD)C\%D8#F3X2B"@N"UA"0PH HJ\.;NTTX
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M"N<+__Q$N'OX\J__\\^STY^^X60Z'(_^[2_\K^PO/^$HC?-P].7?_O+[YU_
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M9-VP-GL.:F&T7H>T;'*R :AM#(J'%&$=D-V:$ V)&O<EY8:'Q/W@(A?,*%/
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M><VD_%JC.!VR''O%TSU+<G?B:I=E>?70%]<>>J7L,I!?$SRI.+I:G9M%U<D
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M^]'W=,W?XRNO8]VK;$LN6C )AMP14,%F""DJ$%I*'E%&S7J]O7@<[!]<LW?
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MA2PPD;+5EJ'>+(MCTR?NWD9I1]*X;PGWX"7_'?,7.BU?XW3X97%Q/M=Z[^G
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M[6C35JQ #/15UI89+831I;>N$4^O9'<K(K<HV=V&A=ZR"U==)C LDG&=P=C
M:\5G@$@^"%@R[ZRW3(34NN3_@&[W#R?,V8:A'E1G.;UP%32E2S%(MJ U7))!
M:.AM05Z !_0,:?VZ^9W$/7!^9/5IQ5(?AU.E 7\=?L-\-4)PO;JC=YR5%,!+
M JJ"YQ!-822*Q(7GQI7FZ:O;(?R1U:Q'+GOPYGX=C[Y\QLE93:J\A#?@:+DU
M+H)6I2;:>0,QRP F\"1CXIJ9UNDJ*X'\R'K4G9FU*9 M$QO>CK[A1>_C%JD-
M]WU<]^2&C<$V2F^XZ ;](4QFWS]/PF@:TLW.U99>?F]8!&8"$IU:0%#>D1U3
MFXD$%0NV+FEZ"%/7'>53.L%\?HKORYHG35]^O_&3>=P,R8V@)0>0,J=%\"P$
M*\"BX#QD%9AKO>,\"NBND@N::L[MK:5_BO:=&S"=S*ZM\LU_G@]GWW_#V<DX
M7VT!=_\6\5TXPWE<1.E8.')R<DNBG=L)#=[)#%JXF%%GGU391!\)R#5=I.^N
M]+ KQGT%RW>@/>,]L-C0K*^XU^&Z"*)L@FR;N/@#>G8_FMT&OW?+ZKA72G:K
M--DQR70D7#X'VO-M!&=5!I.5CX9^6-A&?M\!*LN::/:AZLHV3+3NP/-^E$*Z
MZD>79?0Q2C4?)5*+ODV]<E8@8U'.E.!<V:S/SLW/W9WKU5K<XS:RZB%.N&*(
MS5Q)4[8F)8%@I9M?&G/P5B*X:+G3R2KO6[<,70/E^&V*EEST$(]9!:M^.<'E
MN[ )P)YNU!\$MY];]"94;J >W7GH(73\,%!/;P-3)H-CJ7;M\+1Y^B A29V0
MHPG9M;Z!V).B/' EOA\]V4;\/9L*7K/ ;9V$RN?]89B':(R$R%(6CKNL<CEH
M4Z$GJ=]C,6PCL@-H;,(""NO)P-'2.5 ZU(N$7,"ZG+6+R9 =U?JJ^M ;F_0:
M2NN3H(;Z-%?M3R?CR:Q>*=P&?2TL_N(;3L(7_(A5M#6O-<SJ"KY?C#$4KFCG
MG09=BVU5T@Z<(*&9Z#AY4EJQVYGJ:W:0[EB.1)'VP4SK8^:FJM]>PZOSL_/3
M11N/LSHZ\T7^%D8)\^\C>O2G\SA-D^'7.7-?:/^>KW7 @["9%P="AMJ_C+X*
MP00(6:<84S".;W92-8=V3&JW7]YZ\)[>CM*D3H-_C8O_OATM @M7B_SEV[OA
M(+EZJYX*^!0#'>HN0 R,DQL9BPW!T7]:M\G?#-F1*%>/=/30UF<E)L\*4[S6
M&-4Y6$KZ "Z@ X;*QE(L<[QUBLT/H!"=1=VPL\]\!WPU/CL;SL_7S^,+#V*9
M=W'MZ!U$+YW(9/OS'!,H+@QYB%H!)ATP>>XQ;6;V;/:\(V&]+PG?58+. ^%7
MWRR\_V.$D^G)\"O96(F^)_-KH*)%Y%I#RI$$$92DPXU;$/5N06DCT+>NNML8
MW)'H3;^DW-4>TX_VT.)CMIH1HF2D!66X@KJA@1&UZJ)HTNJ-D@@ZZ\JQ["@M
M!7Y7#VP#\W-\1MO;=/H+R6,=2*^#LG6P9LEAWO",%EY\AB1X1DD&LG:MRY4V
M G9D.M*>C+L:XWJ(WE]M:^_+/\:S>1_NQ?B/Z<7YF0<8N0@R!>"&-CVE2-F]
M%A(8_2\9XV3(N?^0_@9(CTRG=D#7727S?23MWDQ,7UZ_CLL]V>N=LGH[/*]%
MVF^KY3;*"UYJQCV/OU)8984M,ABR9LBD42&D.A:WME?53DC))&E1ZYC^%OC:
MY0L__-27WW\+_S&>O#H-TXMZ>^8Y"^0]@HS1 1WR'EPV#HKB&(U-RC<?0M8)
M\*[RAWO3L/6YQ'W3M^^<X@T*?*XO<'ZUC!G)PHBTU7M7KP]ITP\R!Y I"D-.
MKK3-PTA;P-M_MD_O.K-Y<58G[G9;$W@%]%J.W"9P^^JTL1W4/?7:Z(OZS56L
M&6\'H&XZ%\%1&+)I<WT+I8:HZNLO!%J5DW%!'Z.:/=1VXT"U;!NZ>M"N5^?3
M&7GCD[EW5M,Y3X9?I\L4&\;KI  .6=<QJ4X[\+X@^.R8(2]<R-+ZC+P'SAY*
M3OND<MP/#SVD.KVOG_-^\F$RSN=SE_UE2/\\'2\[JY$5*I+BC)QF#* X>>PU
ME1N$M](+= XU;ZPE]R,Z;D5IR$8/V\GG2<CS^H"E[F8;K4\J 9,F@2HF0H@A
M@(C&9>EBY-C:#;R-X;CUH9/$^QBV%&;TN.DE'"6XI4?2BNH$9$5*6)L'63 <
M+1H5B]>M4SIN03AN_KO(NX><C<^83D9CVH^^OR10=Y>_ ,FR\;)$2[L45Z B
M8^!E4.!%#(8EGB1K??^V$;#C5I7VW/0PS^D>@?QM,IY.!]:PD+@W(*46H!AF
M@J8$2&=2K-GCLODMW4.8]C#9:U=1Q*9T]-%8=SV^%RDM$B4QOS@;3V;#_YI;
MU@-M R'4&;3AD5ZA)"$*+.!4$BB9+\$V;RJX-<H?4Z5:4+;;$,P[G U\9(45
MRX'-QR7E1#9WL@6,+ I%LJZ$UKUB[D?T8RK/ME3L9+S4'9!-6C$]\)GM+V9W
MTI3I[>@"[<-ANBMEXD;Y4*U<9PP91#Y$4J:@@1?N@N&RM#<E'X.SW67L T]?
M7,5$5X3WVD',=<.,A5XQ(VH71:$#,\))W[HSZG8(=W7=VKM.K;]V;4[4H=RS
MKBO795GFHJ4%EQ;C/VR=[9=!&A52$EIDV?KFX6"[);0G?\,V"=N0L)>J]TT
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M 78)*SIPT*']85PSZ1"PW_4!6C*^4Q/W-G3M71] )28LEP)8#G76&-:)\]I
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M("T=[%9E[M$J;*TK.PK@](E@0W+7Q--[,=/ADNC-?'GYKOR.YW> 7-8B9&]
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MSQE"CWO''4W=HZC\UA=7:/A9=$'+DFD+TK7UT?H"6-7Q>:+D*#BM7&@MNOL
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M1;Q"4=##9*Q!3YUB3WLK!.V29TK'@L/&'(S\X!U/W2&?=9W4:R8Y#^3Z-N5
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M!6D0F+%0> HJE.!1#5(?."SJM]*^[\#\".-VT+[_\_>S$K**A!Z$S9JB<J;
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M^[,.DC':!6\AJ%3UZWF&D'BL.F=,225+4JW;/I\%M3>Q^'[^,._)2X>HZ4F
M-PGS$(B=[FH'P-O/_6UC8L>XS0ZL[,F!5"B1\4@[=@X$U61;]10S1,S>>".Y
M2OY4'.>9^^#]^\T8,CKXRXUH2,5W.UDE2AD<5\!6K>LH F!,$9BT)LEHZ61O
M/;1]#<3T*5=SJN8M[=SPHNA>8;SECC%N/$5NO+9(6"373@$$&FN#UU4=ZRC;
M"1H9?;V58(S%.K2 _/SZ3#FEN'0!6*G3E)TSM#'5M@:A4A8B.^.?NBH9Q]G/
MKX^=LY$6:UCH?XO@S;_.A'=8>"8WX9KV#98]!!$4_4<62J#C"9]J\QC'V9M_
M'3MG(RW6H7KRV\/@KJ1<>QNQ4"C@HJM#/E2 X +2<2!=9$9%9EO71CV.Y*4E
M:ELQT*%I9QW5[3#J ;@F2<GVW:S3@K=G76$'HW?/N.[A8YXI*W*=@FT*90[,
M VJ5P89(NZ#F@9?6;[G3.L.HW*JO+XRQ=?,I))<?\^);9,N;8S '43*+'+2N
ML+1.@ DEY!1+[3Q%/;!V8_-G[#M5VI:$>7L+MJ['^>7-N[<_Y+_R^?QSA?7[
M_/RJ6G;YZ^S3[#*G]]??@WM1#P^&<ZL02N:"HAZC $VB$\^B4L69.@YG$-UC
M/_D4G*"KM5M_YU]]OIS]=0=Q'9L6UDB#N8XMI421>P8^*@]).&:8588]%#':
MX G/?- I$-_2E@V#OA6V][^]^OWOV>7_Y@7A2:]^7D?G>8P&"R656.K[.+<0
M$EJPK"B)C/(59@8Q_>Q'G0+7;>W9(?5[?;6DQ&:Y?!7_[]5L.;N[!F:>"U/K
MN%PHBC8;3P$+.2!(EV5)21HE6[\.;X!R^LE?"PXF<HWZQT7^^K5X'F"G-/!9
M</O)!YM0.< ]=N>A0V;X/%")T0A/WS\K@ZG]1!%"CI:"799TB@IY<SG3/3G*
M,[GB?OQDC/G[1I"W38#,.N$HU"DITN$GK03'A:V1CTJ*L2(#;A$V[BM^:,S
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M6CYR6$OO J]#^ES69"N)$'S.8 VS6:#4J/H/U7X*X0OUNF:D33.\>,"T[[/
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MUP9[)!XU,I<2G0$9*#)0$25MNZ&V4R,EXV0I;"YMU 3X"_7"WA1OGF3<]UV
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MU:R&?VR67YLAK\IQ;C\ WCP+YIF4TBAA.8A2ZK!,+L QNI[J,V"24><<5&M
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MPYR*3@6*J9&LVT0'OC81H"N<%[0JVM>.M-.$;1_5#@#7'RF"6GQ!O)7RN:E
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M71J>F:H/$O$ =_7#\2LA<;NB-3%P,M$AXVR!(*6!PM Y%@637#;6_".D/#,
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MLR/I)(0<2=V4#Y(+K.GL.X/R'GX-=Z3+ZI%-E/1R>8@.8TYS#(RE!L1"L/^
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M;GT-F.K0_6Q$.Y]E &%!(H#02[["L^H]\^<A)>2)Q^J7/3)7'NSD,=;JN2X
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M]^P_^@9O*A&$Y=,Q>L7+6C\5)Y6OP%>/P4?S0O5NYLDY5*3XV3V8IO[0A1P
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MA=<ZI;L$.YSSHHSVB#$ J$SU4L@WV!IX.2$K!QP!"D"Q>H13DL9TZ"O H3A
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M:-;M"9-I6K;)=C6:W[;#:GN-^,.@H,#(&NCC5P\CE<?76SO.K!2.<\@Z?7W
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M5(0C^?,8TVL-DY!:+D?9#@"U7H@PRO]$6!7$EG5%4%H4%4YS4.<O$(!49<I
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MT'#3$*N ,WX+.,!C$#[M7FJXG?_V(N3W;U/<VOWF)T9!R55>*F#M:!V7A]O
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MUB290C40R8Y/,%09\/RN"M]3EN!9SF8S^&12H18#>M ++8C1CQY"&BUV6UG
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M_$2'235M_8]M#WXKXAE2UP9(!=&&F1T7:_T'NJF!O[Y5Q[ZVE^:I._LP\7C
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M%1U&EAH"ON]! _:0FT@<0/>5$Z!T@EX9_W]8-R")H'P :64NVI-N*9D(1LM
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M,Y;,SO:Q&54:J&LW,V)RL@"()F2C^>R.9YP[2S% +D1C2;?W@:H"0#47^M&
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MH&?C*X\XKX^=C7RM%XVR1^[I+%#K).1TDOS3O@/*"P$NARU_ @2]_-]*9F-
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MNM$.:L^.$49/0TA4#ZOZQMM3!5</Y/H$%ZAIR(WL2%S5 (E0#XNG9()FS#(
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MA!@$*)358L?\LV]GAR&X>=59$@303<1*_ZO34H:*ILAX#KC8 =.V:@P]RPA
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M.5+%#VD'[.S.T>5^%T2*CN>OQATE.C-X<"4(0N_FUDS8\RX16WEHFAQ2LI?
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MD $8*R^X$!RZEI>_:SJ3!5R&L5DLJ(64!F_0$5O3,;4=.VHM#W3^4SXD7E'
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MF6KI[6MOBSO0#[,:%)]^-9$.F1OZXIM 5#?[X#_L@(^I!_4!PD@6<@>@&%.
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M^Z4-$LA>1+ ?NM[?&0HJ8E'L*CD/!N#P)#.VLO"8*QY0,O"H8)9%N1>JF<:
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MI$>_T=LOV&QD"*R._GTH#"=Y'JR;L NB1<@J U(FP'DQ_-61-CT9' Y@PH2
MJY@5_:S35]Q*_;\;6,Y?5S[D"1JS(<:+C<J+ :I,V).D #01^C#ET+RU-,8/
M%)6&+K[O8-[#GNRZJ<.$/>U$\X)UFMAC8@SX%6L('W<?@B;@+&GU_S;=N:>O
M:LR:O?0?V,NR\#Q[X>]#^"4V3QJ;1Z&8B6&6)$=<_&>:K)NOSTE"A.I9J3#4
M19E,LKJ4Y'>?0(H0B@'U9(E#9F3T+3"%># X/_*"B5KRN%]C,N0CMP1HHRFS
M^VVFZT/YH"8,2,V\41A#K.H'//0GXLF,7MPC";4NC!4FV>P1TS@WXSG64HD
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M^NUNXPR)NR'MR@JO,8+T]^"O><H8H<GKL^UWDDJKKM:YEI8)W-I7SM*R3,9
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MFXI03S: .4F$(? K*/_=(_ \HJ"P<1,D@ 6YOV .\OSI@:,,J"*:Q4Q^-^!
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MX+[-U!KDI)0'KK!OG-NC&AF</S#.Q,'TYP#-L$XJ>96WX4YC'IA-L(5 6;"
MA8G&-ZA] &LX[O2M=5K8+X>J7@#H=+RF(\GH#IWT2 1IKH-\?ZFB!LM"3A<9
MD^I%^B32[(N!R)\^Z,DEKZ+[H>O\;V\F9<W&7&4A>;*+CZO#XM[Z4"#??KSW
M^[<4VGCJ21;_0QGOP,YC[$F'!AV.S4JPZI>O7AP#AQ5IE]56%?7SXWH9_2QA
M\^<0J5TVQ)P,0GVX$#ZK<9BAZ00Z"&V$(#=!Q''6:<:X!_!RJ+R=\KCP;2ZM
MVJ=]Z'7WR5"6")&V4Z<J9/IYMV 55":0KNFR(.=.$DN+F*E@&,_9[CH65;V:
M!0EB#(D'LJC"2SC>XL<UXF]@)VL)C 7-$W(_^ _\Y-F77!^/V@4D)M^YLXU[
M5&3]']0$U(L\)C2J-^SQ3UWUSI3N=3DSG$:!KYV#"C+T5-YN D#Z(F3EAU\[
M<60 'LBD:,LTP2DAVJG(8)TY'M[9GW*0;UXGV2-YC:PS).NK-G@NOCU6-6*<
M&!KS_/XH-JU>?D?L^Z4[@Y*0J_K7Q;_M/3G;\3VN/5+NB$BD8E09QN>RW][3
M:5=L:-<A%H5F4X_B])=C;^30K[0K4HLXP&4%L,\3Q' I)GM-*!8XE,('^ ,F
MPHJ'MWEX*.U*:,4> U"$A11JNM%]#G(FJ/#&K\8'%I<KF,-[>>-YKF.GU6L>
M5I>H)0]>[>P1V*6]HE_9;]8TJL.4#3MA^  *D@B*)5H)C4KKLD8;&7H-S2B%
M#<G-'O%/)R&Y'SO:&'01!I#:(_I5DG \S32JAGYI&N1G@E \^&D#Q) H2?X&
MHJ]H @MT:74(A@>M,YJ#" 3NE)5=7*&0]*D?L=21F[GJ*33U3LF_6Z!%KO&_
MGFMCH]?"DJIT@E4^V%IF=<MEQHB_&\V10.??@"BU3VGSYN=[B)C%;='+IF_?
M,6W>[Q'E3<D,*S&E;O=_S;^=TH+Z\E9CFL1+<4$-V=R]D%I>0:%\P-R9DNRH
MFC(/2[I_.Q<\%LQ;85"5.7KS?JJAR"Y5I5Q3!$_5)6F_#((@6&#Z+GH?PRS]
MRZ&(,\UV=FFZV/^M<>D:V5 LVNK:%H5_ >@:1#W=TWZ+[HMU4Z_?,-(\=:B?
M!2HS3-T*)..I%(OBJ;!%OIGH?H\U5,'=XAJV'7Z-7YQK&1Q0_NZC4QU.]_+_
MY.'4J$BFFK A7KL0GEU &8?$F-*0Q>I*6R-PW.08Y ".:"1-:KCSD!*@3]7)
MI8JK0X)M:GA'J:[?\Q^: @;)4W"PD)\E=W[H3OGHY2!1J[[1ILRC8 [OS1]=
M=)^,?!\+U$D"M)Q+,;HK))=6?=8F0Z<)K(,4N@8ZU[LXP;^!I[ "T@7HRAJ]
MD%F3^DZJ;IX8P"+<T!0;(-,K*6*)MYO=_"!WY.J<UHD#,U![GAJZM&+5;UOY
MMJFR/]WRY3R$\=@1R!I*B* L#]4_%XCR!P=]G?.D3"E84V"8_42^KJ :G:]F
MG7^;)&:NB.>:TV8G^5K0$'G_R]VPR^Y\-Y]0P'2R4T[+P <[+>C4Q-U]G^G9
MX$>^'^@_6H EJ6>U*9GEWP]NGQK17:('/BSBI%$DBH5D1ZDZ%*1L"DV)":KB
M2V4(-,<-9=5TF@"WK3&=!N-2>'G:7^1/BR_0'-D0Y%Q+R; X;X!9F!FUO.#.
MF?'++X,[CJ<[9.<=)"GH4;MZ2E,I'=&#AEO"90\-!'=!F5PAK)/!-^4\#+$Q
M;*!Q(E.+K#6S Q7CY7B,TZG"S"YD2@9_<9<:KA56W6SBS\SBM@I)4>'DWO.]
ME&X%,<NW>?TKF#/C$HUX\&]9H1VUHX5[)Z8+X!]M=T'Q"K79/W]NCOLKUL.:
MTC'LRW[\Y+R^^Y-ZB1;2@2,#O6]71K+W/Z*:O"297._M28]M>EYZ0*&C]6P7
M&>3%.W^1%/@:[;/YNAVU:U/.N61\G=HR!F::/N0G0%(VP*8R]7=20M[.1H+$
M2W?R:-1%"FGP?P!9J4,"5*J%^$,.!N^5]?ZIV-/S.NE"1W.N.=O?-[I7L1^.
M;UQH=%4$Y15 6;8BYAQ5?<M*+$7*/AW 4@!=+HTZ)>5IE<<2=1\S94:=-A7
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MX,BS:!\*\;&6;5RY!#,H81BUZT8(<P<:H,HP)U_!!#DVG&L@PX2"@0>S=6A
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M4EVT:I#B%%(N(#(@*NV/'N$ N[@>T"#769E^Z =?!X-[,.Z#+ETT/&.5&_Q
MLMSDZT-.FQRH3<B!FL#BYKC5W"@ ( MW:[;.Y+*HX^Z!%_2+VNTS)0NQ',+%
MYNK$6B?76,029R)+%^C?N2KD+=%R+\_P8Q[3C8NQ(*&;H,'$CXRN=NE%#_9X
M(+6JM_6!RCD[-@"P/PP"#7#O*LSS_[MO":7/\\9H+#4;X\^ ]VTV@'8;$V:\
M>\86E"Q@!LG O80GN_4]Q&FHRXNAK$>8&S"N@0#X0,(B"( 2O&8S(RH=H]"R
M. 5:13=+LPI1/J6^EIBM,3%P L-^AQ8AC"!PS<G38.QF0@1QZ!%?"(O]+ *E
ML,T)="@IW*_F,KZY9.6'FS'6>P[8F//8\"'0DM;\K-7$L0!(=()QF16=)#H&
M>2=U("$:@GAX))4LSXI;>]VR % AJ1VF=Q@Z$11O.)")[ Y#&HGC3[Y3D.#)
MA48BS!%!=B28-5HO,"W@PO+*:!'GM5 L1Y'3!['5-4K^1&.7;(FM#..QJ#0R
M/$OYPSK8*/^ZDFFR*.6CHTY4%B]0IM$@6^2=S.9"OQ?!$G\NBJ#.@)C&&0H.
M+6=:I4%>@ID'##-0?R"48#XD2+%H<#!7N\\(G)F7.SQ%,"/YU2L/,KS&= :9
M$%$F8"A7'.@D)T'-H0  ^5+#65E/EMSK"J[DV;T'<(&(<GEB>J)4080<"Y:1
M[(L7"!B7:-EA7]>K(BXY!YW/-1$E#ED0Z>9"L\&$,* $F2!?$KF.-S8G?_6T
MRB'G<L>M17 CM8O+'U"F)#NN))S\TU%+75H34"FL)S\"P"-C,X%)'L9N-8V7
M <;'S8-XDIBM0\E7H%,65.K$2S0-3_HR&I<!<DAZ>IF?G?RI1*K_\44A,=T,
M8Q@#&78F+B.(6:A!#7C X]@A.$\EE:&,>I#3I&8A ).I2<A:$*WAA"F?V>.Z
M'E(^O'",,=Z,YDT+EI8H*:RMP.0*JO()2<(*9)U; R5[W"G7ECSB"&+ED %^
M +B#U#4\0Y3L3XYC1+E4P'Q[9=[6'O"VKI8I,+GEGVX%\@C%[!:X>N4M;[=F
M3+H)-[C#E2T ,@=8Y#Y7N=!-[G2E^]S'3$!FT=4N=1'SVP)MM[K@%2]UK_+%
M%H[WN0(<0D@D9)B^AI=_*/F3<]%;7^K:MY<;O>]^]>HS0]&7O]'5B!)HTT?X
M'K@O'_"N0=!K$=V=-L#DA8R+<D+.]E9W_S)]J8!4\4M<@MSCOP X0(33>Z0U
M=CBX!3G8@1M,$.*D:T(H)H@0AN)*$@NX0.;=((DS+#I+ED;&I2.+K#)B8/Q&
M!:DV!J:,F4S>@= 8;4OF\5B\T BZ7;C)P./PC9W<E]J.*<MAY@H/U2I:3FJU
MOP)E;D'=.I"OSH5;M]6I0'P P+J6YG0SBBPLP2F7Q!H0I99L+$SRVLN/E+6;
M&M!,D>4R*<MZ!#Q+!=MR:=+%L3V:?7KZ%"(+@D+FE80X#*.2@3-M$%0UD(,:
MT<!/PPC)SGH6?KV='*4WR2%T,+$T<E:S$,@S)08/Q+5\+*P2#M!5_XGN 2-8
M#\L\?)&(,H?1$O]E3GV<#6UK0S):I&/T2:^];6EK!$) ]':WR<UM<X_[W*@K
M4H"P6FYT8VI ]7JWN^F=;GM3"20Z-O2S[_V[,E]%W.26=D;.&/!^'WS>""_W
M0#1D@*4D/.%;FR\8%6YOS!:XCA!O]P=\4,>#URLD$T]JO4N$DI3.Z=MZVC;*
MY_1'@T>\(2C1#?%>3G(N569E]8YVR46G(8U7G#DMP ,:1_[STCVIQ@"O.*9\
MFG&;3^\.K&;YQ[E$5!URB=_HEK= 6LGSI>L<[)AVB/-^OG+#K#Q842F[P:/Z
MJJ];7'%Q[=G;UPYW6!>E+J)%20DHP&[!\$?7C3EYH@H=^)J:U4;&PW19K3."
MT:H" *Z-^=!'Y7)7U!HDK,RY? E&@,<*%J:"I$W>W97>1CQ4<Y G8.Q<.C-B
M9IIS,&[[%4HS2\.[+?ZR *#*W$M]$%EHH+)6K.UM@\V6TN:\E -)=@S_83GP
M>#D?^C$' $%1+M'H7U\I,=#^\W=S]N=_'_O.9TZUO!]^\)_?_.E'__K77?[U
MJU_[&?F<1#D(__??W_[A=PBXGA__[.,?_+9/VDY)  '0_)AC8 Q0 ?-O ?_/
M^4P@>1@0^JQO:PP  T)$ A50 ^@E^R@P [_M=AS0_?1OX*3-->ZAB_(O_(H$
MXZPM_0J0 M7B \_O^P!@YAKP!;<F)DH0!^\/A79N!K^M0MRA_WIP @?B#YZ
MO8P0_:1-!>S ^F!P 3U0(Y*$_D80_Z)/<AQ.Y7!0"F/@;[8B_H*0"7-0"D4B
MKC[0_+3D[,BP  $  I?0#8NP!I&H#.^0!&FP_R BP0'ZT __$! #\0_OX0ON
MX!X$$1$3$1$CP1U8P ND01H441(E,1+.(!@B<1(S41,WD1-G@0*^ !,Y<1/O
MX0B"X1!%$153D1.E@0*\0!4U\1[Z@ )"\141$0KNP07PX ]JD1=[L0]GP0OP
M(!*AP!<%T1V<@!&*41"EP1._8!:4,1!GX1$NL0^)$1H=8!;0 1]VD1:O43=
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M1 7 #00@ %2T0T$41E^T15<T %9T164@#P* '6B3 #AT0U442#DT2&-42-U
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M%QFGNWJLG;J@ZY:KB=BDG3JF4]=NF[I'C[I'H]HZ#9J)G[J@*]J'23MU*SL
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MH5(:KOH@IL):I^6U:^;C'ETZGE^JIZKHG92RGOJ@=@NH&4D5J!T:IN7YHU#
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M2K\MN[0LFIVB26+V%B,_AI]D05F(TZ.P$Q6AUA&G_SL+7TJ[+?NJ=%"Z"NP
M23!7+I=(.(2B\"L#4#"I^:O 0TH&I>L 8BA__)LF+;NS$6R=(GP/Y#FI[H"[
MW'E$E>-LU&)E)::F[/B5X48=_$F>PXJ\M_O UDFZ.WL/$3 [$>07=P3$1! )
M((S"9$"[Y N>($P']09G$\,1*""Z#VRHQKNSMBNZW1D)LS"6YL.%E)&/#TP'
MD4 $3YRA9-#&DOJQ@AH!^>(E)1)%:1C"IPN>#H"A?IRHM@NK<^<F8<*%J*O
MY%NZ+,JB$4 'R,NS.5@]1>4::SRDD3RD)VRI0<#(SJLMFJ1.:3*[$CL+)#"?
M"HRZ]\"]@BJZ?]59^L$0/?\LQ)$LN@(: ]?YQ"LJ7:W1+NUF%Y&,JF^\M&Q<
MQID: R P)GF7;'ZRQ5!<O\V;P&1 #W <"2ZP%?G7H[\)QZ*KR;8KH)'@ /1
M!ML R0Z E;^A/W):O*?+HKF[HF#J +. D[?L6[F7>GYQ&/()R:);K"!<OM(P
MO/+KQ.5Y),WR'R5C*OP)HJ+[PF1P#P1*!/![ 1%0NL9*4TK"%[U3O*^+NRI\
MLO*<A>C;O:WX:4U#;:]4E]'X&H$&;H%#7/([J8HLNM+@ IXK#9Z[LTLK+<KL
M)0_3Q;1;Q?9KN^0; ]NIP 943?8R%<Y,!/=PJ$XML.=[TVGBJ7=\.Z,SAL?[
MU*7_:KSAB[[EC+P4)1UDO6]W=C>V-;WW4FOQBA$S\T8B003?]59"@11%&\[=
M.0M] ,+=2X61X XQ$*1B?#G#Y#X"T;+SW,E$P W#*KK<4*50, M0\$47,HF5
M$0$2W:&HFJ>1$,YYJL#VL->SD(558QM=LK#?@3VRY3H]BF#XW!$1 +M?ZMB\
M.]7#RL;;"9>C>$RI%@#\V<:S*PW<X *1< \XW<2Z7)YL@565@QJNH[@*Q3A%
MYW(V5L,"$=OSO,5TT <.< _@.]SG>Z#D:4]25$@,L:ZV7--Y&@.1  47&LXQ
M<+*YJZ,I@3[T( ))<*&\"P5]\+WT^Z4;' -DH,'2D+C2_T1 0?@UY95;T%8H
M.%>-6G0!24"%4&#<DPW"[C +^KVS=YB[/J$IO^L;Z"L#$@T%S=O)TN#$!(Z3
M48QP\K4EEN;;\7F^3TW@UDSBHUWAS1L52N&#[1L $LO8X^D +'L/9,P-6]S'
M+=I!\C:R!R$!B"JZ)^X &4X'C-V], #)*& =EB)24^$"*- '4HYP3;S9X\D2
M&*JD)R-[>>08(F#ER O1=Q@)W:O?ITL&42R%:8UW"W$012O?D=T'*+[*%T#3
MX8FJ>+0D?V<J-OVQ/TP/J"J?MDR_>1VD-2-1WS<3(^[4*\JR95SF5?@.4!#8
M*Q<<\Q04[VFN1JW7G8R^WOVL8/].Q]<Q+JG]0TF@#WW0QI.JP>%)W.>,C2L*
M(FW><I2VZ<,J#1V.OK"[Y2U;K&Z0'%M"9JD" KE< WW]V" JT41 X.A+7)$&
M.#:ABO80!+GNW=N.O# Z"[- XD_=HICBK[AI:DD Y_T<B[,0 2( NT%0$MII
M$ZSE?]\';3?"6)H74MQSBM+6<4D0 6*NTS(PGLUZY)&MWW3P?N<$-,/QYOSI
M#LC[HY)M#_K=US* JE55/OM3J5@X"QD^EK1+H-Q@RY%=X(T'1GT6;P+PYZ^[
M\A? PBY?K,!>X/DQ2#^Y))>N:@5%,OY:ZB:B-[MU<,?U2A/#1;4QQTT]"S#0
MQA*]["__SX0O^(M0D1T@3.&X.ZPNP-?<0  L:E+C=Q<.P2*(8;XB *:Y2\8P
MD+SSK ^ O%[4Z#C%<<99(SPV:HU+P6H'/9K?7+^SP,*"2N<M*ZGQ2VF0=DRO
M\;'A:;]D_-\!+=''OK]\?DO.B!^EL=:8]I>DL;49MKT*O+P/3.6+;]0U8.+E
MN3UA(UC<-9*TJ\':^;F2ZIU&W<8DD+LO5D*5519RC\)7V,:IW\0Q\ Y4BD$C
M.JXSAQHDXV3^Y3Q?F3O1:X51?*BJ[@ B7-$#_JK/I6D]LRAAB*%@?(4.@ 8*
M//*3S9\*K!_)4EA!LJ%_7*PD'@E&3>(QX-  ,0O%!0($!- C_Q! 84(9 608
M)' A"!$H9%Q(NT!F5@TH05#,(B.-B+19$2X<).!&@$.&*0.@]"B2SBQ]01Q(
M<\#'9J08LUPX(()080 W] (8%)#P)0$9%U! J3B+S@4B/8D0(.(@B$TZ+QV^
M;)C0Z,FC"27.).(."C<Z,1QT1!%C)!220=PH?>F&:( +1ALF#:(/:E9]%VI$
M$A@D$A$8%2-I7=E0I=>%#_D2Z$.1C ,ZW*#2LTGDPD6G)8TR55A4X>FD!(-H
MI$/W-4UZ%.T2T(@B@-'=>BU#%- 0X84(4(@0$8@B$AT!RB/(V#KR.0&C*O$F
M//A2HKZ?,SM#O3!:6D3<LZ 03,IRY?_1W:M=:QQ)A"UG&;EM;B821#OVA\$3
MHG[HM<'NJ0DJ&?29)3\7C).*H84$"$XA@H8B2# '8),!N2 N<,"!T2*A"XJ"
M()00+)?\XXL[J6P+(@8R,IR%*7IBT\^W!ZL[K3V5!+!NI98D7"FIAOHCZ[3^
MCM*++Q0HZB-!&=0BP+..Z.#,A1BZ(DJI( U2B$2)R*@(.;8B(2.(V(Z+82L#
M350MKR!]C XHD&20!BZZ] %MI(@B=/""+%5+$BD(HWR*03(ND,8%CZ"89</R
M\N-QH0>/ZF^RZE(SZ*^$]!(2HDDS=8G+R"(!H-12DVAHJ:22]/,D 0B"$3J*
MI%EN)%K=D2K_"*GZX_+'L8SBL2T4ZJ.K!B)"HK4C&:!B"KO_4LN1GB3UN5(B
MNNZYD*)[(D$AI*O<L Y0O(!-25K4>/0QO8=L1$VI2M']ZE4E0;J #FEP)>(I
M7*5!001N-(10R,C8V]2L"XRSEM8+Z8J$3) 0I$/:E3B=;#T?DY3AU8DIXXTO
MA20CMS+V1J;GHQ>S<D<N,&GE*3]:@^B/1,O:U(X>1*6!#JI[I &3+I H8I0,
MHJI#ET?JRHT(.2(RO!"V"X/ :;D^ZDP)M:+DG>RN@ D>4BQ6U5,I[&;?M XU
M?7 M\Z+9H-!*(S(TZH@@O5"K3*PLJ3+O7P?T:1)MJ%W(%T$H,I87_UC?# H[
M)GXY=)GM_) #R@&Y4IK8)8F?A7"B69+X-Y*)(L%I-C+H".R>P;-$U]F7Y,T(
MJ-=B0"&T!&W"U1UNZH29QQQ9LNXA J#N2#$B,I.F3BE+TT=CC[%+TD=Z&IK(
M==OHB,0=K>@P/4V-1"#7,F ]7B@CJ/IP^R,HR&R2CJ>2;?:HI#1N]C\9GG(@
M=N-L.D_7M;(RDR;PG]4+JVRFN3)EA7PQHHJ(F**1".C%9@0+TEX0$A$JN>"
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MX9)4 8YXI!MDV\>-Z3V-^0U8+ B[*(L'=(V3X!3)(!'_23F2@O23&'HDF[D
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MP@ & [A!6-+CPY B#[*\@#%A28IN#C),:)/ P)D@W63<R%'D1H<E!;!\:5+
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M;C I(XKHT[0[*NB^;S\AHY%5#!/*RDC:@Y*=C9P&&$Q22:^O>ZF-R"J7G81
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MM_Z+Z#Y.IR)*=4PB3=BOJLX&VWA/(@2%9&:'( 3K5.!#=K!-H+*F.:P&,2Z
MV,*$CCIP(9P%/+!->"A%Q/"BH8ID8)B#*>IG[$JK*D[/L>1'6'((*EC&TZB$
M'ERCC9X$[NH#>\>"9F=^3I T*BOH8O?F0D>H!H.J3&E41F=$Y %E3&:6:XR,
MR9':Q;\BYN@DY.G(97G :LTB:R[0JHQTST.P@_Q") :'L".J+SFPABQN@[\:
M8M!Z$&>ZZLN8@UCJI+](#8<$2I-N U-DHCAXT"&(ITSD;S,$+4W.K-R6#FT
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MLYJ:75::T3EEQ_EW(9J5*[>66=J9H_\7FKD:GA^:EEVZG%8E"#*Z)9I9HR,
M!5S@HM\!"ER@:JVB%)M8F.-YF[6YF-':#9RZGUT:<]'Z O8YE]'Y9N7:92-:
MG46 G2_[ OB GW<9!,!WJ]5ZFA-:EUU:GP5ZE45;JWFYG7/YEO_YJ25ZIJ.9
ME?/9J==F91CB I+ !=#WMXE 'S2:"/@:"E*;/E E>A/Z=FE9F9MYI'F::D4
MNE>ZHNF #R2"F-M9F67[=HVYFM]YF5O[H5&@H<?:H%_[FB4 G5EZE5$@H,4[
MHM4;!6[8F3$WH24@ -2:MNO6G\D;M<M9KI<Y GCP'7AYO-]ZF8N9FLN9J!-;
MO1?:L$O[N\__VI8;&ZP#(*(MFYD?.@A6&9GANJ0)H+FI6Z&Y>J?/^\%'6K5-
M>9S_608F^V9E>I7)&JTA6J#7^<2CFL;W^IM=6JD]_,>CN\&AFZ%MV:I/_';%
MFII9FI@OO+W[V[%3EL-37,*I^[&1?)I9N:VK.7J'O)AEV0TFN\"QO+.1/*VW
M&7P;6K9C&\IYNJF!FK4%'+;3&JBA_+DK5YZ3_'?EF]@FNP/IO*61&;H_6[1)
M:AL7)4!?TNMJ BV^T#:9Q&,S0AD3B:%T)=$.QTKH  K(X':I13"LI<3EF6J3
M  62(*83NI7_^;$W.@GTF96UX0(2^K1/O9JU.@*2 *)%()WM =7I_S8)]EF?
M:]T-1$">"]H>AIV644 $ J#6<UG8YYD I)W8:YFK:3H([ &LM1H$4AT$5MVW
M]4'9@T#885T?:IW6P3UES3W6J5D&H)W:T9UWDT"K;_G8Z> "6%G8Y=VCT1T%
M[ '>J;F@I5T"M'W8P?W=#2ZYZ& 64" (/-T%B  *@F 6RGFR,%?:>?>?4]VJ
M39F57[O>[6%N6YW6X9L E-W?E3W55UT$Q'V>RWW8M;K9Z6&S-UO>JWF?O?T"
MWL')W>#4E;V?49VZF_T"?OW8C3[$Y7F5U=W7[1H$0&#EB]P>])VAV7W9:9KE
MF[V5A5W9):#=MS[5M0'@Z3;E"6#=DT &E/\=Z<V=;H^]XQG:TN.B0(*@K]=G
MER6>"/P9"J" H^7>L2@BF?^YWV.=H4N<FMFYWETZYEG>R:G]X \^WU>]E5>^
M[/4A"53:\6^=WH==K969ILF]FI59K7/9'KR=W7_YEK<YU85]I*L=R56^\[?>
MM[4]"/ LT,:9[R_@ B3@UY$;"OH L,F #K:A:EOE_L[[F-L^YOV]Y$=^\%UZ
MY+7Z\IMYZQ^?"$[\VY];WR]?'_:Y[@];UYN>G5=^;A,Z[?&=G7_WW,]?X%W_
M\@V>X]W@'<#=HSD^9>?YW&LYW_,_\0$"11("^B)$&"CBH+X@]H(0(2@"1)(+
M[R(D)"!"GX@@^I+_Z',!T>"%A/;T83P84H0,$0(7EIR(PAX(.A<B2#3IL6&0
MB"("&$QXP5[,A70BT D"0@30ET%.#M080=O(FP0\/DTXT28=%%63<HQ(AP (
MBQ%6SN18%.9/ B6/!K$*,>E4EE7U';6K\>36JBCN'K5W(:E(H1F#;,VZUN->
MQ010V)R8)"F*MQK1SL2(8BS;CD$<=QSY\P+<CAT;VQ11=R\=B8'IZ+.7FJM5
MM )7HKAHU65?C&-5,F7XV:+$E:]EEQX;571'KAFO'@2]U&Z0G1)]WHY P*!'
MPS%KDA%!4ZC'N@/=!* G@$!Z&>D#N#\?@$  &?'-7W!/GT#^  +2NZ'W_UY\
MY^7A   &&NB"'@$*$( ;\@'(H'SQ,2B #/+)$($+1(#$'WUN1"B? !<0<-1&
MMU5%(@H%8;330AMM-)8$1T6@#PB3H;8=:D>!8&,$.[7(4%5!V+03B041Q:)F
M,];H8T0T!ID$4C1&<(%K2H[$$6P;T;CBDD%NB5U8.X*05T86L;A10<IIH\]K
MAG5&XT:N$=D0F#^:Z",=,K8)FY>H"? A ?1\&, %,D!!)10N0$$$$1= $01_
M\[E'#T-  A961C.))H%!)$H 8P2@#IE9GL Y9BF7V,%&HT!&&G2GE 0\Y.-E
M)>JS#TT>13 90D,VR4T2G:HXD)4OMGB;8<,6&?\6D<<:E-><V$699I-#UHC:
MEB[^Z.RUF1GVZ5A%1F28<ES"-NE_^-$!DH47H, H$2B0H:A#213*WP44BKCC
M.\J:*2I-5C8YJIO:BCNG/GP\VV:>+!IL9)<%J5AG$.^HZ#"O!ENLSZB9.CPG
M""2VR"NSU[Y6DZG5&E8/C>>91Z&^04!!AC1!C*@/$:YI",51&Q(PXJ#JG0>T
M3:".+&ZV.X6)94$[5<GDG0J_:*22H))9+&\,B=:BC"S"BEI#//XX<%Z[BISP
M6)R6I*:PJJ*Y;=D--=DDUS95-B4(S-:HMY@UWEB7N%'2>-:QE6U))G8ONDBB
M::4-/')&3C=;ZLA/ZEC_4]39WFA807%&WO>H8^5%.)7"NK;PCRA@#&Y&? !V
MMD:B880DF!@U#K:;2?]86<(6<=NQG-DQGG#;H#9I^;$P_E4UE7-KSJ)C*-[E
M,+EB[L3YQT^?/22GT/I]]ZZ=';M:E\@>E2G&@;=9+*FOU46CU\;^Z#;:N(/<
M,+B\]L5U1$[#B(+4O4AO&Q&6>QQ$'_?HYV4$@)F Z ,@ 0UM/NK1EWOTM4#W
M"" 2!S(0'>@C(A&=!U 7[,]_S&,A @@J 'U!@0N"D$!)A?!# C!*3>B 0XR
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M5ANKC5F@UN>2%0*S)RH@AWF@,MNQ#X2*Z5NV! H?1]H>:#JO0HFM&WIA;!K
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MH+4SL[P%7AG+F\XDYS\K2?]*(MQB)H)D94K^!<PS)NV4@K:D'UN*I5NW=,W
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MK6001G!-#.=Z+>1Z[>5"K=_26NHR[NAR;0RF[=NRD^B.K?]L+>:"KMEZ[<8
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MF)@YSO')62(A9-/0MAS1,N-^<G(F!<MEWIOGWT##XMR5\SV*LYX&>JZH?N$
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MSI;_:O+]-H\*S(P5<>)'86N<M5,KG#8BFI317V58=1?7HO66UZ.XNYZ5;[C
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M>@V]P 68.CO?2%2LE.<75^SA)O?O&PKV1RB'%],;8+)^,K([2YV&V""E5"X
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M__]:I=XZG-9SK>8 C'M"A(P G)1CE*4 E(P 6EHQK:4 6FL >W,9:WL 2E(
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M&1 AA.\A2A A&3HQI=8AA#$0WN\9A,7O__<Z:W,A4CH(>Y0A(5)SI3%2YKT
MA,4ZWN\ASGNEUBE2YN_FQ;76UEHQ<XPAUG,A*6L0I912M;4IK>\ZC)3OQ<Y*
MK8PAG)0 0@ACWF-2M>8QI9094E(Z>\76Q<4QA(0A !!2I;T(K<5:M8R$M8Q2
MK3%2I3%CG)P0E(12M=Y2I>\A<VL &3IKWJU2I8PZI:5C$)0A<V,0<W,(E-89
M2E)CI=Z4YF,0E)QC8YP98V,AA', E+T(O>\ &5(9K<4IA'MKK<5C,90ZO>]2
MQ>___^]KM:U"C(1"G-8 8VL K?<(K?<ZG+U*I=X9I7.EYEJMYEIKK??6UM80
M:W,  !E:K=XQE'N,M6L .ADIO>\AO>]*M=8 I=ZMO5H G*4 0CJEO5H(O=Y2
MM6MC,80(>W, 8U( <V, G(0QI:40I=Y:M=8 I>8(I>89I=X >VL G-8 2EK6
MUL5KK>8QK:U"A(1CE)P E(0 6E( >WL9:W,    (_P#_"1Q(L*#!@P@3*ES(
ML*%  1 C2IQ(L:+%BQ@M5H"X44#'CQQ#>A0)<J1)D!M3CE3)<J7+EC!?KDQ)
MTV/-"C=SVMR)DR?.GT"#"AU*M*C1HTB3*EW*M*G3ITZ/X)1:@:K5J5BK9KVJ
MM2O7KUO#>M4JM2S9LV;3HEVKMBW;MT?*RJTZ-R[=NW;SUMV+EZ]>NG$#"QY,
MN+#APX4WQ%5\A+'CQ9 ;1WXLN3+ERY,S6]:,>;/BSY)!BPY->K3ITJA/JT[-
M>K7KUK!-?Y[=F/8&V[AKZ[Z]&_?MW\"#"Q].O+CQX\B3*U_.O+GSY]"C2Y].
MO?KS+[>Q;]#./;OW[=^[@_\?+[Y\^//DT9M/SWZ]> NWX6^03S^^_?G;U6&'
M_T4__O[[Y1<@@/_YQY^! A8X((($'@B@?A ^*&&$%$YH88487JAAAAQNZ&&'
M(%H(GP4 6J"?B5^@J.*)+*;8XHHNQ@BCB22J8\&(*Y)(HXLZVLCCCSL&:>.-
M0])(Y(U&)EGDDD@VZ>234$8IY9145FGEE5AFJ>667';IY9=@ABGFF&*N@Z29
M-Z)I@9ILGNEFFF^N^2::=,(IYYUUXFEGGG6:Z:><?P8*Z*""%DKHH88FBNBB
MBC;***!%^!GIFI.N$ZF9$DBZ#J::<DKIIA9D^JFGEH*:*:>>BJIJJJR&VNJJ
MKL;_"NNLKZXC0:BNWJJKK;GVFNFNP/K*ZZ_"!ONKK<@>JVRRS"[K;+/0/BMM
MM-1.:VVUV$K[Z[:V<BN!M^!V*^ZWXX9+[KGFHKOMNMVR^ZV[ZK8K[[OSJOON
MO?CFJ^^^_/;K[[\ !RSPP 07;/#!"$N@P+<+*\SPPPY'W/#$$%,L\<,49XSQ
MQ@YKW/'&"X?\L<@DCVQRR2B?K'+*+*_L<LLPO]QQR#0K7+,"-^=L\\XX\]PS
MSC0';;/00 ]M=-%( ZWTTDPW[?334$<M]=145VWUU5A/[=#67'?M]=<-4133
MV#*1;7;9+YVM-MIKM\WVVV/KU-/<<M?MDTUNYPTWWE#U_^WWWT6Y)3A<A ]N
M^%F%)W[XXHJ?M4%52S0&N>1'1/YXY91;/OGEFF/.N6)+@"YZY:.'3OKICY>N
M^NFFAY[ZZQ7<%COLLM=.^^VSQ^[Z[K?QOH'OP/<N_._#!\_ZZJ;S)EMJJN6F
MO//0]R;]\]-'3_WUT%NG_?;<=V_]]]57[SUP[JEG?GOGEY\>=NR#U_[[[L</
M__SRUT___>SGOYW^7_#O__X [%\ _R?  O*//PCL'XE2I, &,O"!"XR@ R7(
M0!U5\((6K%&*\#,B#GJP@R"<#X1&-$(1]H>$)S2AC52(PA6B:$@P/)*18CA#
M&=*0AO,948GFLT,-ZC!$0'Q0"_^'R,(BOG"(,F+@B91XP27ZD(D6=&*)E'BC
M%!G)BD.R(I*T6$4G<5%'9/)2D8C$Q1,AR8QD;!(:573&,FXQ25U\$H^:-,<W
MCK%';[Q1#L&((S[N48M_%!(>9:BD,QJ2D$Q"Y"$+&<9&.O*14VJ3G>Y$24E6
M,DYM<I0F'[7)3G*24;?:U*5P)4I3K:E4F#KE*$.)2E+R*I6P)*4L=84K6MJR
MEKB\I2YSR<M=^K*7P/RE,(-)3%M&2@*1*H*NDKE,2S53F:$ZIC1M-4UD4O.:
MULQF-8M9JF0.*Y?=+)4OPWG,6EK*545 Y["8&:IGZLJ=[8RF,[L5SV_5\YWW
MS*>Q?*7_SDP=4YP _:= D350?Q+TF]:$)C*7R=!H-G2A#HTH1+\ES7=6M)T7
MI>A"E<G1C7I4HR!=:$B5.=)WD52D*#VIO=Y)+WRULZ7W>NE*VS53?-'4IOJZ
MZ4IWNJY[Z;2G/H4IO(9:+Z(*M:A%39A2EZJOAD7LJ4Z-ZKND"C&H3E5F,<NJ
MR9A:,*<^]:M>#>N]Q'I5?'GUJV@]JUK->E6MNA6K<'VK7.-*UYCM[*X]P^O$
M]LHPONKU8H"UF& K1MB+S?6P)]/9SVKF (<U=F&/E4!D)^O8H67MLE #FV8W
MRUG-3J0">MB('CPR6@&0 R*A%<!H00N1TZI6M*1M+6IARUK3_\Y6M;==;6E/
MRUK0JL0E,@%N2X2[-[VUC29VH]O=E,M<Y/(-<$]Y[M\81]W&5=<M/Z%*5[:K
MW>YF][M9X2YXQ1O>MR!.+6190NS6^SOVJC=UNG,O>^.;NO>Z-RZ6PV]E\NLY
M_3*&O_F-'>4$/)FJ.,; BT%P90C<F09#1L 05DR$I2+A"E/XPA,FS68V[& .
M<R8SV-M-;$8L&O"%^,36"Q^*56QB$KOX-<UCL8Q7C+W9V+@V-_X-CG>LXQX_
MSSCWLY^0@TSD(1L9?4A6GY+3=[[Q.%D[3_X-E*<LY2I_)\I7IC*6E:P._$#(
MR_T!<Y?A\V4RA]G,8]Y F>_CGRZK^?\V;HXSG.?\YCK+F<YV_HV;Z\QG_JB9
M??XAD* #S2 %&=I!ATX0HA$M:",7^=$""F*'=$CI#6:0ASK*(10W_<1.3['3
M/!SAD$1(1AN->H8G/#4,4ZU'(ZG0TB=Z=0E;*$0.2OI#N)XT%-NHQC+ZNM?
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M<>G)O1L_K]UZ>O;=U:,W_UY^>^;>ZZN/;_\U_.;\[^M?#S_M[,..P/WNPZ_
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MD!(L69(DB4#'2JL)M,#!XL"_@BSDTJPN^1+4\JP1#$$3?),29*W'DA/G(I-
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M>V&@HN$)?6'9@V$DYCT;5N(-?2D'57(4]D_GVRJ[T(^C>N+>F[X6]5#S: T
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M9$GQ)<PE)V4:I%G!)LZ9.FONG&ASY!&@0E4&#4I3IE":054J'3JR:84-+C<
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MZL?,_.T?&Y\R]:C,.:I1B1H=SO%_/455!1B  *A_!JB 4:6 ^>%47[558,6
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M4B3'DC$]RHRIL69+G"YIYF19<B!-@BMWKBP",:;#=0^%&@S:U.%3BD8-0I4
M,:72I$R);FU:A.M7IEZGAN4J5L)6I%Z32CU[M.M3M6K/CIWKT&C2MA3/RJV+
M5V]=H4^3#JX:^"Q>M%D/>Q4:M&U>JH7W0F[K%#+BMX\K/Q[,^.ECSX8?3_T,
MF'1DQ)LUKZ;,VK5FO+%7IWY=V_9MS@K6*<#=V_=9W;Q9"Q=NF_CJX\/;.FA;
M7$+RV\Z?3W=]G/?UZ=)=,]<./+O_<>3*K5/W?I;Y=PGGBY]/7YX\^N3COV-O
MK[[?>P7W\\^G7AR[>O*P$PY ^K+CC;OI$$30.P7^HTY!_@[\#L'K*N2/.0@=
M%+ ]"3>DL$,--^PP01));- \$C%\SD+N0*SPQ!,QA%% &5?DL#X<&SRPP0]Y
MA)%#!1344<(67PQR11F#)!+)?H;4\1\HHY1R2BJKM/)*++,40  ]*A# RR^W
M]#)+,LLT4\HMR1%SS2[7!+,"/;Z,$TXOO52S3C?SQ'-//<.DTT\\R=FS33OW
M'+2".A,%=%%$OU3T44@9A3121"NU]-)*_=244DXQ]?134$,5M8(C*BT5TU-)
M-1714E,%__74)5J5E=0C8F55UE9533566W.UE==2-SBBU%AK'1;58H6EU=AA
MC]@ 466?91;87XV%M@)I62456%V/K8#79Q$M=HEGLY4V5F'+555=95M5-]A:
MLPT6VVVCI7?8=%7%UEE2RYT6WV'1W79>8X4EEU]I_4V78& 3WM?9@"%>^.")
M)2[8XH4-MAC=C#&6N&.0/<YX9)%#3O=D9TG> .654Q8YY7I:_H+EE4=>^(@O
M7&YY9Y5UYMGFFF=.V>2:2_ZXZ)J3%GKEI9/&^>><TYV99Y]CWF#JJX>.N6FD
MDV8Z:*^_'OKDJ[V>&NL-K.Y:[;+;-AMLM.-V&VZPZW9[9KS+/O];[[GS]CMH
M=92FN^TOU-G[:\(1/SOPPQM7? /#5[9 \L=GGGR#RR\OW''+]68\\+(CO_KS
MMC4//'.F1<][<L,CSSORU@OWO//):_]Z\\@GEQWWSC?'O&S=7<]]]"]\#]YX
MX(G_O??ACX>=]M]KYSUZX@VW'7G>A__B>-N[S_Y[=:2W/GK>Q0=?>@O&MP#\
M[6-'G_SP-T<(\_7C5U_\^NO?'O/"\^]??NO=CWX#G%\!:V? ]OTO?/3;WOH*
M:+WRI:]_"'$?0M)WP>A9D((.O&#X KA!#%Z0@A%L'T*V5\(.-M" *[R@"CFH
M00W23X3T"Y\%7=C &EI/@S4\( P;.$'_$-J0AS 4(0QS&$0>)M&"0R1B$(FX
MD"9&48I3C"(4+6A%&$)1BU=$"$BRB) M;N2+3Z1B&+G(13."\8QJ%&,:%X)%
M*V[1C&]LHP4KXL61A$2,70P)2%CB12A.Y(I>G @6]VC(A-A1((<48T'4&,@S
M%I*+%3FD'_68E8YL)"6-%",E!9F0-V;$CXXLB4@Z^1&3)'(B&$GE'?-8R))T
MA)(:>0E)0#F0E,BRE:!TY4XZLDFB6"0BNNSE*V]IDXT,)9DY828F@3(4Q;1$
M,3#Y"3.5B91G1F6:5JD)3>P"$[I@TR _4<DT@6(6F&!3G5-9BU\. Y=VFN8S
MXXRG.(7R$\&H_V8MI>DF/KV"S[Y,)C",^2=AJ@D8Q;Q3H8PA#&T"HY5[JD:A
MIY&,0A-Z&HJRAIVM4:A$^=D;ATXE-+^!C4=]DQK9D%2EL]'-;X+CT-ITISPR
M76EU=M,;FC;G,<[1#G1T"IX2L6>G)=*,B *$GAOQU#WT4>I2G5H>]AAU0^W1
M:7R.*J&DWHBJ6#W15?D#G^DTR491C5!5N;I5M&HHJQ3*ZHC8.B(/F<A <#60
MB02TI!<!"4EU=8"%?A0CO0+6K49*$8\FM"(G^75)"=+1C?KJ),2&:$?I.5*+
MBA39(5EVK HX4V<]^UD\I4FT OAL:4&[IM&^*4Y<>E.?P'2G-OEI3O]MHJV=
MY'3;/P5J4X[B[:-Z^UL^!3=1G>KM<!W%*4EEJE'+]>VH5O4I5SG7N;G2UZFL
MJZWJ0A>[^N(NJY:076NYRKK?-19Y6T5>4Y%7O<<*V,!T12OO1JR\_ZI5>A]&
M+VWEZEC" MC#-)9?6_D+8KS"5K+8R]]BN6M=_)J5O9J%KEY9B[_SDA:\\*6K
M#0287NW2&,#2%>"7A0QB"(,7B#LF,'N!;%_Y,IG$^K7B%6OL9B;#%L@4%F*=
MX7AG'_.9T5@68IIA#&5+XS'9>DPUIQ5M:D-+V9)!MC2T[=AN8W-6U)A6Y:.1
M;69J:S+9=IRWQRGY;2<[7-F>5C,N.UEP9]/_6=.>9K6_[<W*;\-:E/L6MC(G
MKLZW"YO=^BRW,?/M:Y=37N(,[;A#?^UYJ1M=Z1 7NJFI+LS+:QWD'+T\Y<4Y
M>7%VG:-CQ[?.">]OMN.;YGY7:=\-3WN+_O3Q*,T\O#6/>M.[7NRT=SQ:5P]Z
MO$.>^;RG/O;9NGS\<]_5?$WL! (;V.9KG?_LI[\ ]@]SZB,@LO%W0 +B3X$G
M?+:OGZU 9R,P?A(TX;@=V&P&.I'<T':A^UQ(O?Q!\-P</*$&?]A$'DYPB"IL
M]KR7R&\1UA#<2WRAO8\(1"+VVX='+"(5_XUOAT<\X1%GXAHEKL$X8IR-B+QX
MQ/'8<8LS<H\:!*3&__%X<B@ZTI(GM^#*6\[)A;"\BY#DHQZY6/*:9T3C&U]D
M&QUI14(V,N4Q_Z5']%@02ZK2Z+KL(RU#\A"ALU&04(<D+54"1E(:G9*FM'DI
M2TYTC_0DE4C7R$6*#LJ/D'WE8#^EV'&Y2UNZA.S6](A5K,(4BMBD['&G.S3[
MSDR^VS.:6^$)6^RI%6EFLYMY/PI=]$)/>Z8E-G$)C#NW297$.X6<CB%+4,*Y
ME,7<TYR%D8WCJ^+YNOP%, <-Z&8<8TZ\\(4SH2%-.&,_&<W#AJ%PX?UE&L.:
MU)"&\X"9C69. ].2$A\QQZ]IY2VZTGW^!OG-/VEP8-/2YMR4^M$IJO:5DX5]
MZ?BGJ)JYSTS'_QKQ5S4\_>&^>X9:(/=WIZ?L1^J 'D1_JM)?_-"QZE<)]%.A
M6H_U8ZK#.BNW0H\%.0ZV(A #3*L"]"JI>L (C*L,F:OY8!&YBJN[2JK)PD '
MN:P6&2L@:1+%NJLAF:O&JL"^RI$*6<'K ,$4 1(7A$$31"S* JPB(9(G_S$M
M'NQ!*-D20D&M"O!!(K22T5*3,(FMT!( )(03W K"W0JN*)Q"1I$3W;K"+X&M
MY:K"YBHNY%*N2?'"X_)"[=JN5#E#2CF"XN(M-#3#Y^HNZ1*57K&5;X$5.Q07
MZH)#/;26!%N652&6\)J5ZX*O><$O.J0O]AJ7!VN6.XP8:K&6.GPO VL8@K&4
M$:NP:@&Q#7NQ7&&7=:F7$2.Q_WJ7>"F8.GR7#D.Q?B&QAX&8>]F7@9&Q340P
MCT$QBR$Q45RQ6JP8%L.Q'&.Q?:$8$CL8=/G%%CO&(CM&&TO&7SPR(T.R9T0:
M9]29>DC&:!0RKRDR9ZG&.L,8H<$:)NN:GU$9<?],&W/,1FADFRK3,BDSQW"D
MF4=3L[M9,\$9&S2C1SL3G'FLFR@#LWU$',8!-;KYFWGT1[0A-#Y3'-+9G85<
M2$;;'<0QM7V$2$F+-8N$'# [FXLDG( \-=E!'4CK2(9LG-/QR.2IGM^9G8"\
MGMEYM9-$'=^!-4QS-=VA2>5QGET3M4KKGDT;G_W1'YZ\GJ"$GJ$L-G8+2G@3
M-F4K'J.4G^AIMF$#2FN;2G(C'P/2(663RA$BMVA[GZTDMG #-[%L(7.;MO\Q
M(0D:-ZM<(!C*H VJ((/CH'S;H&F[RADJH :2(0?"';2TH;@D.'J;HGL#(;TL
MN"*JN/RA.!3J2X@#.<?_;$S'S#@V&KG'G"*. [F8PSK-S"/.[#G/E#F.0R3)
M=#@X(B,IHB/*W#DXPB,MPCDKFB67RZ3,5*0Z CK:'+FB^[FO2[I/DB2;F\VM
M\[E3$J2L&$X^ CNB"SKC-"5DDDU0 B8U@KI5VJ5?NCJ<J,ZR,XF[\Z6,("9>
M4KICNKKJ-(EH$CN9R"6Z\\YK:J;U7+R*B"7Q/*C$DT_)^Z:8H,_-<T_&V\_4
MZ\_(H(MX@KR68 MT8CUWLD]\ M"]J"?3H[QZDHN# JB4:BB-LHM@\BAND@OF
M8PR1&KS6^ZB-*HWEZZB*$@VM0+[\]*CIBPS/ *B*XHN4ZB@4I8P1=3X2_8W0
M_[B]Y#,IT=@^DK*^R@!2'WV/'UU1ZI,_]P,/G_JI]XNIHSJ_KQHJH2*K!8E2
M\_,.H8H_]R,KM%H.!D$1!^R_K$(1Z*A ^>!2L() +/U2 DS $IE G5*1"?3
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MO_WNTY__!O9_D?W[]]N/?O70'_WVMX$!&K" &^B? 1.X/\W58W\1;*#_L,?
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M1H@3@(H21ER>Z1V%3WS$YHT33Y3$-Z5>0V7%Y)T36C34.CE$.SU%0XB$[!F
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M?K0%O^HWL#\_&7UTY>#/>P\?'K=S\\CWO^]?_CW0V'./-_4&U,P]_293K[X
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M&$,A<A"(/MRA O[11"<^$8I1E.(4J5C%*@I  .3 8@6VN$4K?A&,88QB%P7
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M^_CSZ]_/OW__"@(( *  Y 18H #^):C@@OD1&." $#XHH0!Z"%@A@!7H@:&
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MC? (,.R8,2>#M"?F+^FX+O-H9=LX9%OVC2@&93P3-/SH9/]CIK4E.65;"[9
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M$]MUAQ-O0E>U=MW*/W__W4K_-GG@XE57_TUE]KK/]"W8+_(Y/VW^_>O:KR_
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M!!68/PG&[X !K( %03C!_(G0?Q\\@@@'N $.DE"!)JQ@ "TXP1EV4(,A3.$
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MAKK(*]V8#N*@@KCXJN+ *^1H!=&H#0NP#K>*C@;H*=6(#NZ@#@OLCZ_B#=E
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MDU1'K=1FN-1HK-3\O53[[7+[I2EJG$9JF :<YM^=5O/_\4;^Y<9/'=51,6
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MW!\??>VC1_]\^]L?OQ[MO[ ?__O3%[W^T<]_!/Q?_^:'P/@9T'_?0Z#YT*=
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M@@V\(/XR"$$.6M!Q$P0@!4VX01*JL( 2X& +5YA"#780@B.<80PY*$(&EK"
M'WSA"U-X0QD"<88[W&$/CXA ).Y0AT*481&3^,,>EA!_3U2 %87X02EJD(I,
MO.(4?^A#*EHQBT-TP!BC2$8N7A&,3S2C!K\X02->40%%G*,76ZC$)-K1CENT
M8ASU.,8QNG&*"OB'(0^)R$0J<I&,;*0C'2D  9 CDA6@)"4?_XG)3&I2D9&<
MI"0IJ0<!5%*4 M!#)4-9R4I.L@*F)&4J18E*2[JRE:_TY"MAZ<I7IG*5L$RE
M*D59RURZ$IC$%(@P?5E,7QIS(,ELYC*?N9"%<"2:"7$F,JF)S6QJ,YL>"0E)
M'C)-C33DFQNARDPB8I0*?/.;0%GG28QB$JR4DRP$X<E8IF(0> J$G"GY9E"(
MDI.K\-,K\XR*/5.2$GQ6A";X)$Q0[@*6E3!T*"993$4/2AC#6%2A[60)1AEZ
M%[.,Q9Z(:0ID\C+1N QFHC9A3&0BHY>7NA0VC[&H14\JT].$!C.@X>EK2'.9
MGYX4J#XEZF@J<]2DED>GQ\&.9S"#F__>4 >IP-G 4ZNC':1Z1S/362I6B8,=
M[7 G04O]3%<GPQZODE4_6GW.>=[3GO:D5:[N^9!_[#,>_^B'K'9=:UR-1" %
M1:A"A-6KB@@$H?%8:$8!*FQ^&(LB&A7HL2*JK(\B1!X'V>=$)2I1C8P4'\UJ
MJ$4<X@]C07NC'RV(1C<J48R,]-H8"0E'I&VMCF*+'"])Z5&W92V39ELF,&W)
M2;M=DW#1E*5!P4E)/ *NFP1EI3\IMT^F@NYRJ6M<ZU*W3->U4YRJE*<\82E0
MA.)3H,9[IE<9RD^:&N]W/86J0>DJ4>N-5)G<"]]OM1=4H\JO?X_%*0#_24ZX
M<@*@(D6L)E3_2DY4,,2L+'6L<SWK6=?HU+'4,>$,J\I5EK(4MS0\*U=)RPD.
MEE4KCN4L$/M*Q N+6,9>#../R=AC!5M7OT36+Y3E6$X[KEK50H;CI0'Y83CK
M,<1F#&2/=2Q@3SNRRWPLLJQ)^<<!N_'.=#PT($,9:CR&&),1=C-V]6MG6]ZR
MUWX69+N];<HM6QK1?CQEG)7-RU);<]6(=F0?A_ED1RX;E@N'M(F%V<^*Z[/7
MID8Z+TMLT8J6E]ON?.B9O<UODS[;H]=V9\X)SM*5[IO:YG8\3J^-='QSM-]^
M5VKB0<YUC/O<Y1#W.L/ISE^)MMWP2*V[YK%Z>+/&WJY3S6O:&6]VXJ^KW?.>
M9SYD?XYXZH.<K7&'.?5AKWO78S7A5$<ZV(&O=]=>G+>7I[SU3=MQV=:>\*I'
M[G.;3WRO2S?_[,>^^.UN?NM^=_[FAV_ZU2_?]K8?"/EG07W7T-_><Z$)*<C"
M!29\>S@$G@M9:,"'8[""-I0AQ"U.0QA:O!](/+C&%]YQB_<PXR><H<E';D0L
M.I&%!K]XQG.80RTVL8M$%'D3YTCS.S*QBFRD><J_F$4H'E&-0L_C'J$HQZ(O
M\8]B%#H8O:C&#\:1C"^4XQD)R<5!SK&.38<ZT[/^PZF;,8U7KWH?Z=C_PDVJ
M?>UK'^4H/>E)MLM=[FX')2EQ6?=1RC*5L6SE,'5Y=U8&?O" 5V7A_U[,9-+R
MFL=,YC49OTQK2OZ9D[_F$8IY^<=W1"' 3$@XL=G-A4ID]!<)?4P*,E",)#2:
M'77+1N)9>HGT9/0>>8E-R#D5SX/E)JXGBUMP@E!\#L4K[$3]0Q>:3JWXDRL*
M#2GSCU^5Y2M&*FE1"SM](D_#V"6F6;F^\PTSEYA>?Z73!\SN21I2N=A%,.M/
M:4JUOY:19H4OW$=+1O62T<C@E#0R'6I1:=I_/34;RR$<24531%6 A;$=6L6
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MLX^=[_#527_[]:$_?WKTS0_? O3C)XCRXNEGO_S[V[=_?/5=+GW^@U\!]7?
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M]_@'OOVAK]K3/A_YWI= '/:/VN^#GOO8E[_ZG3O<[A-WN@^X[G6[.W\EU%\
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M]MO2WK!3_$OE]L ).N4_OA+3^;L. 134094K#R14!+RJ_:"K6H9 8(8J[R!
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MDN?A)5XOA6CJZ:<TU>>%8M/FQ1Y14%X^W2=0N$5)M*<2/X9=:&B)DNB)OL6
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M @$$Z%\ Y/"?  6P/P,>$('VZY\> $C _@$0@@/TW_\"2$$*,K""#_2?!BN
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MZ*>C/QJE4+H9TI$<]8<>]^<91\537M6E^N%5644=7L4>VT%3^1=6 WB ;*J
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MUD$.)$+P=D$65&SIUD+C8Y=VB4+[%I;Z1F]7>6T<M)-Z^4(D-' SM' $!T*
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M/_V9D(*RZE6GQB>K6%T-?=#3H:S:!T'8H>N(H@,?]%!(KE\M#XG^FM>^TJA
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M\RD[FRJG$F&E*CQI=1;%TS/'"PF/<'R23$F-?.$2VHAMQ9:(G/Q%#Q>17$=
MPPG*AV$3TBJNTFJ76.$3'I>5&&LI2B%$:U>R!@H<*E=V51>R0NNBM&%U39>V
MNK2RDC2ZLK1*S\I)4SV42+V\RM=+HVM-TPJ\(O5W]70E0J)19[TE/F*P"%AZ
M#;77I_0G LM-#TN 3<N_"JRUM"O=&W54[WW#3K4 [+TK@MC&3FPOBEB_A&S!
M>&SB(WXL8C7%G"S(GDO*HC5:!Z-::V/'L'5:2XS,"D#)=/[EZYC-:CXW5ME?
M^RSJ2UG+Q+5=-YF7_T$9[+]CT7[9$KB-SLC,T_9CG=7CH<GM.';9[D^M\%_D
MUFIM.KJMFT$9.DZ:VFHV1(KC;,?9/@):I*7.YE1:[4<_G@&NHC5N85O.J7&_
MWRJ:X*;.2I):XFZ.:CLNJFT XCR/UZ3:Y%;NK,ED<]M__;O:?$-W>%<E0!S9
M('#@AH(%"1(\N%!@0X,&%7Y!N/!A18H0*R;<(''@%X4.+VJ4*+#>PR,C1UI\
MR!&CQY4K%5Z4R)$ES9<>659,J3(G1Y(;=:HT6!/H2Z YCPXMJM2H4J)(F<YD
MFO3I!G5%;0)5ES6KA:A.'WK=('9KU*M?SAH42S2I6*]HJ6H=J]:JS;0;K__*
MY?BVK,2U-_OBE1KX[=' $K>6!>H6KU:_C=$^CCQW,E_)A2V7S1PY,6?/F@6#
M?NO5PF/+<TFCIKPU=>O(GV&S5DTZ,FW9I3OG_M)Z]FW4:''OKIW8=NVQMXO;
M#FX!^5CC%D@SWZT.=W3GU(%GQRX=^MC2T'=7]QX>^/'OP:FSI@X=/'?6TZTS
MI\W^>WKR]$F_WPX<_W3XX+%;[[SZPAM0/N@$/##!\PK$ST %'<1O/>\.C%!"
M!#&LD+X%+62/0P]!A+##$4=<A\0333S1@A17C)!%Z(JP,$884RRB1O8D8&]&
M"V)\$;H4?:1OQAESA!%''7_D\4@3B3S22 N*5!+_NBC98S%'%H%L$4D;J]2R
M2RYC[''*%F=,L4@3B^0RR1ROI*]-)I6$,T8JEX1R12[1-!%.-N'4LL@V<Q33
MSB1M5!--.P\UTTX\>61R'3#O=%1)+@.5E%)$+ZVT43LUY9/3%MO,%%1+#RU4
MTBO!/)3-3R50=5-/5XV552A=A;76667-%5=.UXFU5UYE+8+/7']ETT9BCP5V
MUU8+]558*)%E5MI'BWTT5F-[Y5-8:WNU%MIJKX7V6PG8;)5<<<W%EEQNUY5@
MVW?3S?;<8=TEEUEJA9TW6UJ%/7;=?K6UEUYS\PV7W'>+M1?:=@5FN.!NI5W8
M7(@;+E?>="66^.%\+ZXXVUU[LTV86XXYKE?@?>TMN&)K&6Y899 ]COEDF6FN
MV6:/%>@X9P5N;IAG"7[N6>B:@P::W*)M5J"?BI$V^FBFG[8WZ)]Y+GKIJ!V0
MVNBJMQ:8ZZ>+SAILG[V.FMRL@Q8[;+.[UEIL"=0>N^VVT9X[;:W;_EKOKJ?>
M>NF?Z^9[; 6^KEOLNKGF&G&X!4^\\<=Y-ISNQQ&O.O*M'5_<<L8)!SIQQSM7
MW'.CT1:]=,PY3SWTS3O/VG72&7?=\LL5>-UVSPF??7,'9H<[]]I]7QUWS*OF
M'??(<W>@'],)___'^>>ACU[ZZ:FOWGKK!1" G.PKX)[[Z\$/7WSIL]]>@.[/
M+]_[]-/7 _WW!7 _??@KD+_[^]<WOWO]O;_???SO%\#Y#?!^V_,? ,\'P  *
ML (,1& #$[A  DJP@16TX 4K> 0,-E"#&_3@_3J8P0]^,(0C-"$'*W $#980
MA1UT(08UN(05IE"&*+1@#7%XA!JF,(4KG.$,:]C!#=!0AS$TX@Z+*,.&]%")
M.U2B!H=81"8VQ(5--.(*HTC$("IQ($4L8A2;.,0N#F0)9)SA&"N012DBI(Q2
MA"(4F8A&A_!0C#R$XQ<=<L<HBE&%2]PC$2>21BI&485C5&$;$2D00<K_T)"!
M+(@@)V+&B<Q1DI#,XR,3HLA)'N22&NGD)D$22DZ.<I.1]"1&0D)*C4PR):<D
MY2M%:9&&^(0B!*G')T])2Y/L,B-,*4E(B"(0J, $* KYI5"$>1.EG 25$$$*
M,V.2E*!LA)E-D>94I#E,;/9D*=V4RE2^B4VPL(4I8K$(-^E2%W5BY2YPX<HZ
ML_D5Q;S3,8*!ITT0 Q?*&$8J?_$,9.R9SW7")35]24P]_TG0H5PE-3/1S6HD
M YK*+#2B%86H<R JFH :=#(3W4Q&GQ.;W6RD.)TISFQ^<QO/E+0\R;F.</0S
MTNIH)SN\:8U)G>-2],@T/LJ)SW#@0]/D]%0[_S,-4'R(,Q[I4$>IU6$->_RS
MT^VLAZGT:6I5O?-4^6#U0AD2CU>_0R&H4M6KZ4'0?1@$5?9D-4/\X<^!&M2=
M#&DU1&,%48'BZJ /:8BO*O(K?H+4I;\.ECY92I*#=N2EPBY6L81546++U-@@
M&?:P4FHL8 6+I<J"ZDE"0E*<Q&0E)!V*L7"ZD69_%-D](?9.3M)3:U\;*42-
MB;9MFNUI%_4HV$9V52M:E:)Z.ZA/<7:X9^K1<66;J$OA:U!_6M.8=/O:,]TV
M6;IB+JK6H5OLV@A?W=55L!+UVSFU=KO=G1.UBL6O]/YJO5<J;W41]5U6^<I=
MZ766=UEE7V4-JU?':O\6I^KK+UK5E\ #!C"Z^DLQ]08,2L="6;[&52YT"3C
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M#,J\3/_[[_F.#!#X-.%KQPE?K5#X$BY4V-!@0H0$#4:,F-!@PW8,+2J,B,G
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M Q5H0?%)T(,:E)\)9>A"'4I/A4*TH1)]Z#TKND^*9A298%*FG=RY48^X1%;
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M<A@3X]/)_&UB8$S$CRK&2 O_V^+_MP# GQ# F2! F3# F$# "U! !DP+#7)
M"&2*O#B?")2?"KP+MK# #M) #L1 N)B+"P3!#?3 !QQ!$>S $R3!$$P*^LF@
MH7A!H-"+_<F_LL $97 )?'@,*(HB0IH1R/ R("0-'DJ-U A"(_R',1NS,N,A
MV?B,US S'!JBVL"-*-P#@QFD^M@BYFB0,_(S12,D[2 V/6LC,[(B\L@1*GH.
M]% E01NEZRBD1-(V,*(B-TPB-.HC*O^;0Q[$(CNDCSC,(CW$0SG,LSW,0T(4
M1$ \Q#]\-#B,HT1LQ#H,Q$5\PSN<Q#ZD0SFB1#]T1$:L1$[41$ST(E LQ$&$
MQ$R\1%)\1$^,1$7\1%3$P^C@LQ*ZD3C,M/3@MCD"#R@!B3U@$ETRMW$#QB"I
M "O<*BKXJ&!*QF&R)DM9IXYZIG=CIFB$QF5RDYA#IFF\1FM<IF?4QBKQ1FFL
MQF_D1FP4QW#L1G+<QFQ,QW%<1W<T1VI$QW>41W@$QW@L1WK,1WS<1W6L1W8\
M1WYL1W^<QX $R'[4QX,LR'M,2(842(1T2(6T1XG\QX6$R(:\QFFR$F;D*%#I
M*&0<DV&)%5O_:2E9X3F6JI63.JF2+,:/F(*;PCI_B4F F4F9K$F:O$F;S$F<
MW$F=[$F>_$F?#$J@'$JA+,J9Q*F:8H>"^1$+*"NPLIBR^KJOFAB'49B,>1F#
M& C%^BZW@SS<:JS!NB[.0B^P!)K8:CO!JSR^<J[BNIO?XCW+TKO7 ;[*HCWQ
M&YK,^TJ9:4OF*HBFJ2W'B:RC89V_01W$2YV/B0CC.3W*P<JVY$O2\SO5XLK;
M0HB\#*W$Y)N:N3O5ZJ[FVZZ\JPCE^ARRS*WC&B].""Y-P"S7 1W%0YS,9"N:
MT;V-.!S/,[^+0+W,K+SSP@C.NLW+ZB[KZDS,ZTV^B\M0,![.(ZZL9 R_O ,A
M6%F_YVF_E!B6:P@*#.L)_(-!#2(R[Z2>[Y2?\#0R\01/\RQ/]"1/O9 P[ES!
M#%1!$YPO^$1!^4Q!^ZQ/_'S/^]3/_.R*I<C.)-,P)!/0)'O!^K.Q%X1.8K&V
M0;,T55K_CB.,T-/H##!3#0GUL@JU#2*LT" R,S3+C0[-C3VXP9 XC!12-BJK
MQ!3-PD'2#FT;0QQQCRRZ#T(ZCE53I2I*$04XT1EU-$ KM%%+I$EK-B&-T2"M
MHB$]TA_=0A9],R;U42<UM"95$2F%4BI-1!M9TBIM)2W%4E@TTBE=0R\M4B -
M4ULC4B0%4RL54S3MTC:-TC%-TS)=TS-54CA]TRLE4@(A-1V)CS05-!UE(JTB
ME@HXDB/()6%,5'$3DF'!!'7#DE,A$W!DE6K4R'2TU&/"U$J%N4V]DTSEU&("
MU369DD_UU$XEU5.]5%%=%50-55-UU58=555]55DMU5AEU5F]_U5-A=5<[55;
M]=54_55A#59BY=5A-=9BK=5DQ=5C559D?59GC59F7=9=E=9JG59HQ59K755,
MG9(V4950C3E-A3E2Y9+Q*%<'4"]8V0"@0ZE>02F2',E?6:E<&18[(+JBJSI]
MW5=^[5=__5> #5B!'5B"G2JLNZE9\ VNX[JOBLJ)><JFM("0M$O:(QW;H[Z*
MC1S9BKW+Y"Z>V1W%6:O?XDKM\SZB6;V#0#[CFZZTFQS?8YRQ^9JG2<NP=$[N
M"I[,.2V/,1VGZ3R4:2O.JYVW A[.L;[)4;O1))K82AW.4KWCREC)_,VQ.3W7
M3*WP<\[A,Z[:8;NIE;RRB1VWK%JWRO\[X9&[F"4;N%O+[J,ME!W.VLNKZ1O,
MJMV[G)F:\;*=J=7:GPE)E9#.]0M)##0Q)EN+ XW ^3S<_?S _BQ!^O0@PJ6)
M#)K L; _)8M<R)U<R\V)S*5<"=Q<S\5<T*W<T.W<T2VRSQ5=U"7=U#7=TI7<
MU75=U8U=UGV* \4) &Q/N- _\ER+D#1#+81#,D2."QW>(92AX<4R#94A,7-"
MV/!0"J70#KV-+=O%CT"B4^1!)V+13CQ2,D*C]LC"0\.B_HBY30M33[O1*2L.
M-K1%+!1%2CJD',%"3VO?*7I?-[3?3,1?]Z5?\>7?^O5?]N7?^:7? 6[? I9?
M5T+@^-TV_>W_7_\]8 8&8 A^I 6FX ;>D1)IHBZD15$C$2T:(?C[""J0I6"\
MI2_X15FB7L#8QG%$U7:3)G<+QU5IMQD&IAI.1DF%$QO.X1ON5!KF82#^-QW&
M82'N85?]X2(.8HXTXB'VX1U.8BA>8B5&8BF.8BJ^XB>N8BW&8B+>XBSF8B?N
M8C ^XB\N8S$VXS!.8S(^8S96XR9>XS#>R!:N)CA1IE1)1G/TXCFI!9=P@ETQ
MR7EMUY)*J0U04)FRJ8,M6$5>9$9N9$=^9$B.9$E>.F=9ED%U HI9F*DL*ZA4
M&*C49(51T" HR^MBFL$YK)NIOJ"9K-XLOE)V",ETG(>XKJ)!S(Y1_ZZ/I2[4
MNUO5 3S% CS2HBRX$JROW!O#M"W'(F:SV4KP6@BM]1MCCDSBDV::02^1)9J[
M=:W+22SHPHBY#*[M4QW'XSN.J3VN5"SP2AW%9+O%1+R\\BW*Y!JN;!F=-3^W
M!,S/#&=>%IQA?F7?:CMP1DO(U$KRTRW53+R@(6BLO:YXABRW55GB_%J045<#
M<(*2H$[H63\%K0(E:\_UQ%V0#FF1'FF2!FG$%8N:$%R;*%"9P"^C<.G[HQZ8
M#C*9KFGYF>F6MNF7UNF8OFF>IFF?#NJ=%NJ>'FJC+FJD!NJC5NJDSFFBYL#[
M8^G"38O!A>JHJ(F,T>!"BE$J@]#CC5 MN_^-K[8R 2 S'EI",(M"&%IKZ/TA
MT+@&E]@&3^M@/2,T;5O2%25#1;QK'[QK%TU?0\Q%1?I? LFV^CU?PW8U7#OL
M,4IL,71L7%OL9(LRR(XUR5;LRD;L <;LS7[LSH[LS&[LS[;LT*;LT=9L_>#L
MU/;LU0;MTQ;MUB;MUS;MV$9M\.73.]K"'(4S/JPU\^@$E[@&<E/47T3A((D"
ME^@$%Y:3EY.X>@/75H74Z&ZX<Z7NF4NYZ@ZY[,;NZY:Y5O%NZ>;&\-YN\+;N
M[YYN[>YN].;N\Q9O\QYO]7;O]&YO\E[O\IYO^*;O^*YO^6;O_/[O]PYP_!9P
M_R;P^R[P 4]P!%__\ -O</M^\/YV\ B'</ZN<)K+XW2,U'G3<.A6QBX)A> F
M9)>"5Q&7E7?=%;@&"0B@*:0D2A<W2AA_<1F/<1J?<1NO<1R_<1W/<1[?\:.L
M*9S"!Y>(@H1YV+ ;NX;UNJ9<!PF0@ICB/MW['*=]K5WNG/,KK'_^&])!67A>
M6]M1V]CC'9HEOL,3:+4Q6\RA/. :O:PE\Y3QK)4E+> ;FJ5=/M[Y&U7F/L69
MK+/-G#3W\[HR&^*"G.V[9N-,O'TFYN<;3L);69"]/4B//,0!S=C3/LK:&4N'
MO*C]2\S2KG".*^;;9H6P6\SY'>?;2Y"-6U0/V]*A<YY%&YJAG'7^/<T[7-F@
M&=0HH$Z_91Z20&Z0L ,#O5RHD#_"M9[:[>C"36ED7W8)I H-2W9GYPEHA_;)
MC4%K+VFGQG9MWW9N[W9O_W9P#W=Q'_>KII[;;8N/IMT:# H[&/+R/4,^&M_Q
M_QCK(RS>YZ5W&I)>,EM>L_8AMW8-$%4SV_ V W"%.KS%#E;? N8S*TI#>+]%
M)P6D6-S2!/[@N4ZC&1VA'90C01P/2F(D%6K#P?YX/ZK%C@]Y]2UYDA]Y-P)Y
MDZ]%E/]@EE<CEU]YXWCYFF]YE=?YF1?YF[?Y+@+Z,!)Z5.+YGS?ZH$?ZH5?Z
MHC]%, I#2LO?+\W2'KTS5V@S$A:W>KBEX;XE7G()5Q#B9?1(9/3(>:KC2#%[
M&Q85M<=CM'^4ML]C2$U[NH?[NF?[NW][O+=[OM][O]=[P)_AN!_\O!?\PI_[
MO@]\Q/][PT_\QF?\Q5?\M9=\MW]\RI?[R;=\S8_\S?_/?,[_?!K>J#%Y-V:\
M8Q@>1Q9F86GJA39KJ90Z<5X)%A+_E5RY.2!GEJ*[_4G>?=[O?=__?> /?N%G
M*B"__3;3Y"4W\HOA9+!*?@L@>%J(3.7CN]HBK]H43I;ES5P>3+*T=5)F];L:
M+^IBKN$)K^;$YYZA9<PK9]F$S%+V*^#*K2I_*XV &7RN6.GJ?L1!S>?Z6(!H
MAR\4/GR<!AK$5RM4K78$"1Y$2'#A0(*:$#H<2)$A1(D#!3[TR%$DR(0>$>*[
M&#(D19,'*:I,.#%4.Y ;\=4,R:EDRY4X0[8[R/%F1X(8?3Z\2=2C2IX/!7H4
MJM'H2(LH#ZJT.O.CQX4W,PK_#!H5(5&J,D6:#'DR)M"M,BDN-5M2ILY:!NX:
M,"1AKP0%?/_Z_<MWG2&\!I9=N( IL6+&C.<TCNQX,N7%E!VWLCPY\V7.E#UO
MUHQ9-&/0HSN33FS:<>K$K25/MFP9M&;9E5VSQLW8]F[=HGG[SAWYM^[@O8<+
M)PZ;M_+FR8LC/^Y\.73@T:<;-XX]NO;GTKW7OAS;6"K+Y<5_O^!Y]NL+Y\4O
M,YQ$ 7WZ$AS0QU]?@8.^]_G_YY<"_Q!8H($'(IB@@@LRR*   I#S8 422MB@
MA1=BB."#$0HP(8044JB'AQ.*V*&)'$Y8@1XFJCBBB889 &!_^_G5GW[US5C?
M?0'N_Y=C7S3.Z)]^?=T(X'Y$\FACC?;E2..1-OZX8Y$RYO<CDU8JT,^55>*W
MHX !2BGEEE[Z".600<Y8II@U"HGDE4JR&:>:<'I)9I1FCIGFG6O6J>>;8*+I
M)IMT!FKDH("V:6B89R8Z)Z)R[DEHHY$^:N>?C$)Z:9Z"+KJIHGC&:>FAF(K:
M::A^CNJIHZ2BVN23 0XI8Y1<;@FDE?_-"N,1&_"ZZP:^[@HLK[W^NL$7POX*
M(SOX+<N? PXL^^RS"C0;K;3,3HO?M=+RYRRVVGI+;;;A1MLMM^5J.RVZY(Y[
M;KOJOONMN?""ZVZ]],XK;[KZLGLOO_;F*ZZ_ @>\+L#[$O^,L,'X*AQOPOT6
M[/#"_S(,<<,#3_SPP19SO+''%7],L<@:@USRR!FC++'*&#N,K;GL"OQLM=SN
MNVVV-%_;K;7>X@>CL>I8L$'00W^ASA=$#RVTT$8;#2,#3T,=M=134UVUU5=C
MG;766W/=M==?@QVVV&.37;;99Z.=MMIKL]VVVV_#';?<<Y]]R=-V0XUWU#!:
M8($$%JQ3Q#I^ RZXX(&O$_CA@EL (UI3+5524@EE1)#D(GE5E42U&"303I@S
MA)944DT>D>6;IU640DBA1='E K'E.>88(;23Y9.OQ'E2'5W^>.A:%3056D5Y
M5?M8.6F$TD@7(73109+KOE14("'_[]-%%)%^ENDVI63\[M%WWKU4&9G^4.FP
M;ZY64A"H/SSGMB=_>TNDZX[67+;7#WGIQNN?%N=L-<][XAO>68KWN]P)\'.[
MNXI(GB*\RKV%@$*I'_E^DKGT73 DS--)088RE(JT[G?X@)%@ %-"$\((/2HL
M#B9:L1L77L8ZL8'A#&-(0];<\(4VW&%E<N@:'RH&B"WD80U7")L8BJ<U2E3A
M$F^#GB;&AHE(=&(2IQC%)UI1.%6DHA:S>)PK;A&,7>3B%\=81.A@9C*028\7
MJ6B9-;HF%7/0# G-Y)]:'4E'^LD0'_O81Q=]*)!^'.0@3=2A%;E(1(B4T")3
MM,A#NBB2_R72 XP$Q"4L[0E'/*J5F#"%(_MTRTN61-6M-&FK)JV)5C02I2@-
M)2LJ5<E)+UN2+).D(U@^Z9.@A%,N\W-+7NI1EP(")I.$B:0IT;);N]QD,7VY
M3&3:\IE.BN8PF9G,&QUSFC?")BZ#Z<QJ0G.;O[0F-;.Y2G%*\YS&[&8SE0E.
M;:Z3F-<<9SCC24YTOE.=OA1EEUZU2E#VTI7,A)*M:.6S8!E+6,#Z0K$06JR'
M;J ",+(9M+S%#IY)ZZ(UVY9&-0JMBN)L61Y-ETC#)3.0WJRD(44I25GJ+)6F
MU*4G'>E+9?I1FL[4I#?5*4Q;BM.=KO2G/:VI4&TZU)P&E:=&7?]J49NJ5*<F
M-:HQA>I4GVI5J?KTJE7%*E&UFE6N(G6K8OWJ6+L*5J!^]%K1&BG-V*K6C)IK
MI![5*'^L=5*0LH-O0BO:T?;*-+X"S:\6X&O0G)8W!N@-;W9;+&(;R]C'.C:R
MD)VL9"M+V<M:-K.8W:QF.\O9SWHVM* =K6A+2]K3FC:UJ%VM:EO+VM>Z-K:P
MG:UL:TO;V]HVM[C=K6Y[*S6]38V$@_L;<0G'N"(0[F_#M8#@8$2\CF P%,_E
MR@*!)Y:>%$0J&Z$>1L32%8X@#WE8Z:#WMO*4YQE%NR/)'EM45Q3NS@0FOA,@
M]OAWNH[4EX,>7!T';W*1RXV$+/<=RTC(XO(3[QGXO3C)7N823%V<9$1X/A%+
M>LD+%/NY)7OZE8A/Z+?>[GVW>RR1KH"-=[WS<@5T):8)[0+,NJV,3GD><0I&
M/!P_!LIEQ6?A( "!(I7OWH3 #S8+=,V20?>FA;P1&2_P'D)"P03FA"6$47C6
M4QTL]F8UJI%A&<V(QBZ#^<MB/B*8%[,:,Y,&S5=4LYC#XQTODYD[88XSEU_3
MQ-38>8IX#N.;YWQG,H:YSGQFHY_U#.@VHU$S5N9RG*UL:".*IY*6[)$F>0G_
M3$)B.M,$VA"(1J3I3R^(D88D$2!'O:(/I6C4AHQ0JEE4R7[V*$D_0N6;5'G'
M(O6C2:ZB$I9X':M+GO*6DXZ3+/,8RV*W,DQ?$G8K\Z1-/J'IV9)*IAZA+21I
M5RJ<UJ:VIDZ%;59]V]GGW/8]R:WM:9<;W>?.=KB]/6YUM[M/\8[VN]E=;W#?
M6]ROFO8_9;7-3@*JVMBNI:NBI*N'+I18"!\6LA Z47$%+&?-XJC+)FXSC-YU
M6PFSF5T/QG&*;ISB%T?7QT=^,Y%KG.0HE_C)WVKRC6:<Y3!/:\I;GE&0J]SE
M-9]YQQE6\IUCG.8R#WK/]?7SH5.TZ"'7.=*/[O&5_S^=Z5&_^<N)CG.;QWSJ
M6?<YU+E^,XB;/&;PTMG).\XS@1DLZ#X;K-$LP#2V#Y9H?QU:VY5%->#2+>]Z
MWSO?^^[WOP,^\((?/.$+;_C#7PWOC5W\T_A&N.46M[B!\YOAANNX 7-0QBRN
M\(9'%Y;O60Z"&I:(3327/@L/!+T'SF]W'5ADZE[0=#B1,.U__.&G.&_VJBM)
M!4E,D[8(3\:FJQ_K%$C\F\ O= HLR?!%Z!/43?#"),[)!05\?!$SQ7_.USV'
MRSM #09_P[A;7?Y>+Y+G;8Y][]/\ Q&XD@\.'W7OSR[HJF\6#I?E^O>M7XR1
M4I7ZBH[P)<_XF,_ZC9^"B?]0]"T%_E!%^:$>D@V8YR'$DTD97P1&E.U%"L69
M& 71!G*@&VF1<E#'E9'@")J@"(K@H6W@$&%9EV%"*GC9"ZX9#,*98M"@=-S@
MF-G@#'[@;N3@</Q@>\A@<@3A$Q7A#M;@$.)@#\81#R;A$2JA#D8A$#(AI#F1
MHDF&$&+9=EC&J_%3HHQ3M3D J)$AA@ 2AW!(&:KA/P32B#R2&[8ABW!:B\AA
MJI6(ATC:HP 4D503.Y52+%T;'@GB*YF2,_4:*S4305V2'>E)P2G))EF3?DBB
MK!$3*T'3L[63L/D3MPT;)UWBN&4B0&TB.6$B)_8:L9$B*)IB*:;B*'ZB*TX3
M*[[_HL"MHBJV(BW>HB?&HBW.HB[V&RS^(B[V8C#MVJPPVR,Z":@D4RK!4L\8
MQL(IE,(U'+$ RZOI7$=AU,M0%,W4E<S4E;-HH[6LU3>V2S?>%3:6(\V-(TJ%
M(]6A8[V88UJ]8SN>(SG"HSIZ(SO6BSCFHT?1HSS:XS^NHS_NHSL&9$'6HS[&
ME4$JI+;P(UZ!(T("9$/&XT!&Y$(F)$%BY$1JI$,R9$=69#]>I$=FY$B&)$2F
MXT/.HT1:9$I^I$GB(TK>XT/*I,:Q5%L%73Z.9#[:9$*:"]\0EM*P'6 -)= $
M96$91M0HWMT@7E,ZY5-"951*Y512955:Y56J#6-535X9_P;B)%??*!?C$-?@
M'-?@.)>06<Y+5 6%O<X#@L16+ 5V_=^&Q=[J@%#[C!@!F==1%-#]T8104-A)
MJ!X$WMB+?<3H@9CJ;%#_5%>)94__K0Z-;=Z"G9Y^;81Y22;M89=:&H]2[-?O
M[9A=DEA3A"9:Q(3L-5D '69E'AB3M1@$EL1_<6;NI.9VT69HGIA9<*;US9]1
M)(0!+41@^EYHYF6&D5Z(01"1N0]?*F#HZ25Y$:>2"5!RAICYR)CD/!D&5N"4
M&086:5D6N5D(.L9[3 9YCF=KF"=CI&=BK*=[H.=[4@8-AB<3_AD5@88Q0(=I
MP!%EK)%HM.=^JA%T_"=Z].=Y7O\&@#I&@:IG:R#H8P@H@Q+H@QYHA,+&@(J'
M@K(GA%ZHA/(GA?HG%WY1>YS&%M%&"R91)5D)O>62H-3'&KJHAL3AJ+THJ(7(
M&7*:JCT2J]6H'-9AAY"0-Q43,G9)D7RA(3I3COR;I35;K02),J42G.R:*Q7;
ML=%'KN61KEE2G8#2K12<*A%B*@V4)?)(F,X)D +;H)CIE_(2F49*FBHBF$[)
MFZYIG(HI-M%IF8:BG([IG;9IGM:IF_ZIG^(IM^FIG9Y2GQ)JH";JH+)IK0DJ
MHG9*BL[:-U%JI2WI(=*)*.:*83B4-%*CIT+40RD+N.2<NZ#=N,Q,S.2DN.P,
MUKE+J\[_'+S :DYBRZQN8ZWB#*VR:J[>ZJY^7:^*%*]NHZ^FBZX&ZZ\.Z[$6
M*[#27$0F:[.ZJJP*Z]79ZK-6*[5.J\E=J[9F:\UMJ[=V*\M]J[B&ZZN6J[0B
M*[:F*[<B*T:E:L^)7<ZXC,OMZME9W+>XHP.LW=(<S=#XJU 6I=P9EE(R96+U
M%F\A[,$J;,(R[,(Z;,-"[,-*;,12[,1:;,5B[,5J;,96[-0H%E,R -]X)>*$
MY>,A5UBN W%=7O)PCT^47VQVSG!N'^XTF/5D5^_@Y56@#WL)CP*)V$9D4.NQ
MWH#IWOM0#W7R#O:AIG]EWT-D3^^%SP&>14S8CP"*#O5@W@">Y\3O#&WM1-A<
M$E]ATIY]*4]=3B?S25 '?2;X.&U!5!#M(1!B*I\ Q6UA&JW6.D38TJU"W"4&
M19?1DMCLF 7SV)[8^JSKU4_N^5C>'J !A>9<:([B1A=YG:;O!,7.0L_W=-]H
M#@2,I"R4[85V<B=>N)D2N=!\FF 3.A$<B0;K)F@9N:Z#0D?L)@;M7H#MTFZ#
MQA%DI%FB6>'OBM%BB"ACX&<0]>[P)D;QMM#Q0IKRGID'.H;S,J\126\4(>\%
M5&]N7&_V]L;V_M#TKA#WXH;W=F#P_F!W')%L %%LG&^(3D8=31JL*>.2>/_)
MC-JOC0J2_68:_J*(J'D(B]PA) &P ,.A%V(*K!D;L074?\ :E]X1LWW2DTHJ
MM37;K"&B,":;G0I*DUH:K2AI! LB)#ZB(F:BF"B;F9HP"5/P"%<PD;*P(^[;
MH004FIYP";\P)KDPKJBP".MP"\=P#:]P#\.P&,HP"M_P#*>P#Q,Q$//PD"IQ
MK3%Q#COQ$$/Q#DNQ/O7A'?5))AWJ(EXI ].2,^(%-(*J-#)4-":+85#=OKSC
MQ=V5N[Y47,'Q3<HQ1]ECN[A5&^_C'+-5':O5'>^Q'=.Q0_+QV1&R(/?Q(?_Q
M( -R30;R(B=R(^NQ'\,5(]^D(U.R2,JK) -R)F/_LB)7<B1?\B2#LB9SXRAW
M<BE_,B=;<AZG,BN+LBNW\APO,D]R'$:&8T7.2T[*\BD7JU[)'6 )<](@C=(,
M+.-A93(K\S(S<S,[\S-#<S3[W5(&EV&8[')=<UF*9=]<WF7:3W.NIEK(IO%<
MUP(QD' &T$+ F&A2Y^E]A9 %&9,%YHQQPE/([.7(E_K IGJQGUP&68>)IF="
M0-#>YNW4V(-Y\^N!G_G%U^D(C^.*7XEUK<L"!3HO4$UPIMS2WW0=V.E(!0 9
MF$HX&#^WSU=LSU@8F%"$3DS 1>91A4#H3N<]YUZ29D?T6%RX3O#$6$^X#NMD
M4)"=6/VH,SGC\XO16))!_]=LCI!AF-!VABY?:"#PJL?U%L=^(F^>M=&88;4*
M:F%V9#5LS %Y"N]4]T98 P>C@5'I9G5X,AH4J?6AL36B@:!7!YK[TID5O74/
MQO5=S[6<U34+R35E%"_T0MI\:H:"]FYNH&BFAM(Q4IO^ONB- E(%0#:F27:G
MO>&*<$@=-A*%I-J$]"^*EG H02F6V-&?O%,'+TFF<DI!?<J[#=L+>^F9(IL[
MX2($@].D%EN4AF(API,L\38G4BD6N_9O)^,I]O9PSW"L(1LR*7>:^C9Q,S?!
M[39R"[>4+G=T9_=S)S=V0S=W7W=P6Q-XC[=W=S=OW\D2PR.ESJDQ2JEI_^&6
M*O_ P:%Q?7NJ0E42R=WKS8%=LY:+V65=O)Z4@./K6Q$X@<_,RU'<@1==@N_<
M@BM=@Q>XO4#XU7T<@R?=A--+A2NX@4=XAF/XA7^XB%LXAS^XAY<XBG<X?X^X
MB<N<BU.XBI\XBZ<XC:_X@+>XC+]XQ>',V+%Q3 F=O_ CV*FJ7=VK75'+VO55
M, ^EVQU-T1 S4N*%QX+LQTKSE6-YEFOYEG-YEWMYV!CLXN&=R!K.5TJ>X)1L
M<9TE=$FN0>O$YQ'0T;H?0:,M4J2TA>F?]LA?!TVT\)5>T8:/SP)0_ 6N<BYF
M_QF@_(7MBRVZA/U/U'IM !WN6& ?0-OYI:?> R9Z R;_( $YC^P09FH^GW+N
ME_OXW^S0CZ2CI5[R7\_R941KCNSM^8?YK>^!#^]9A88-;=A63O&@)E)/GSW#
M;?*T.?T-N^H@=46$+5LPK>8H7TTD)T508 5>X.C>Q1!A>_>6F>H.;WVFM7C:
M-6"'>Q:"N[@;46K(YU=7Q@T.MA01=H5*=1>UKQ7Z9[R7T;P7]GC:NX#N.[SO
M>[W_N[X'O'J.T0OR[ODF-KE+(;USD:3M$D#A4R]5]AKR[X-,_" EDHF4R"&I
M&L>#MAP&\&0;DJ1I<&/3(C)26C+VFQ;_6I!V<1\R=B1FL+%Q\:60"6JK_)&.
M=YU:L(UHR3%^H<_3O"*:R<_O_R'12XG19RG2"SW0(VG2#WW0WX?24\HB4CW.
M%WW4/WW3'[W4.\#5%W'6.WW/3[W6D_W7F[W5I[V_@?T)BWW7;WW9C[W:SSW;
M#_W/+\J:J/ _;;&F3N(D4BG2^YLO'93"@:I#(?ZG3A1)610YTO*JDB1":F/-
MT%5:33[/5'[:M5SFIR/EX_*]8/[G[_(BF^/ED[[E@_[I:[[GDZ3I5W+II_[K
MH_[HR_[JAW[KQ[Y.SOZRUG[GWS[LT[[NV[[J^S[QWR/K S_O"W_Q]_[Q__[N
M.^OR.[_QN[[TY\LMCW+9Q3$>V[);0>NTSI6W[*N3D__;"7/;03E?'3,U_];&
MNC_'OO]__,/__,M__=/__=M__N/__NM__P/$)08""0XT6!#A08,,&#9T^)"!
M 8D2UZTKLLZ"18P2+%C@R+&(1X\8+UJ8*+$=)WRA5K9D&:K6RY8JV[G$AT\E
M3)TK6=KLJ;(E3I_X:K*,*72FS7;M6*9,*E,F4Z(YAU:E*O6GSYI2G;X\NO*H
MT9U>H1(M6[9K4DU3\:W-RE+E4:!B@^H\6C2L4I5KL=J,V[1E7IE_\=V52EBF
MX)M4Z3;>&E6I4+B%QZYT:U.Q3,F4G>;=?+@JW:*!H<;,W')TXE!+,;/DNQ3N
M9+L]RS)>#/;EV;IM*:/>O#?H7+^HF\;M2U=H9]V,!9M6/=2_*>[?P9]J'1KV
MI $)"B1T]_X=//CL%\B7-W^^/";TY.>43Z6>_'OR\"_0IT^^%?S[]\WS3[^^
M/@#]FT_  ON[8 [Y"/POP/;,4]# !2\PACWY\I-PP  OE- \!P/\4#WU-OSP
M/ _U(U!$^]8S<<$0+QAQ0!9!U%!%]&0\,44&2V00QQ=KW+%%%'W4L4,>A81Q
M12,#S)'#\AS,L,@%4V%PQ/4@)/' #ZL$L+[L')#@2P<4X&[,+[DS$\PTR]Q.
M@7__W'P3SCCEG)/..NVT4P !R,FS C[YO!/00 65,\\]!>A3CT/]/#31/A5E
M]-$*].B34C_WK%32[,@$<\Q..>T4U#'95,!,,L\<=;LTPRR35$_%/%7,5,,<
ME51.:3VSUE+5!'556%E=L]960^VTU%!G15.!?DRU5=1><PWUUF>E]7387IT5
MM=I/KS655VT_I=98;U\%M]M7MXW6VF^Q#==<=;DE5EQHLVUWW'7+7;/>=_'=
M%U1TX^UW7G[)A9=>>=D5V%Z"$=97VG,#GC9A?K<=UM519W4UW'V9[;?83Z/=
M>%D%LCMB Y(WJ(=DDX_XPN1Z2MX YI1CAKED+QVXF52<_V_>F>=6>V9'9P6
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M9YQ=+.=H!UF@X55XQ5.'[X1GO(X4C[W%4UYV'$*]Z]FW?OG5[W[YVU___A?
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M^:!.KJD^F%P1?OBC).\<!TG82:5VK,.A*''G.L^)TI8P*:;T@,A(QO_QT6[
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MQVRQ.B 4M7&D&@K=.,4(R=X@!ZNJ6M^]I*G*$:_RNE)U0J^O(G?6PBT)6\O
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M]LK&.L%#(J,'G8PQ'.,RKLK&Q@,'1Z,SJ!"-/%"ZJ@0#.R2S-.LWR' X_,,
ME8NJ/L0ANBL.S01-P&M/"*95\.1;ZN2\K.Q@8,4/'R5#_UQE8*"J3?R$"FY"
M7? D5_:04]QE>*J 4"K%QC!!B;RE$EU"4(PA%29%3IK,MP+1(:Y!$1VL4BX
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M\N=&,&I)ZU1_+-&E;%1U%$I/37$5^:05_/1/_O1/8'$$ 658"*50+#A1@N6
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M:X)X:#00T(=-,KH0:D3)CO=YALQY'/I(QF=(EVP Q@#();$::#HC\!E*G:<
M1X$3*;%Z;KH0+J1Z\]=&X01ZGO\12@7!G(XWI6U:$-,A$IWLI"[T',)WH6J4
M$E+@I,Z736/$IZ\G1T.J=["L$IE4S$YJ2T/%2/+!1K^<)6X$S#_Q2-CL38E7
MQGHG1WR41K G?NA\==C\0CJ8$%RQ?_@D%E\ %OALJ/\'J@D8J@,RA@*XAO[Q
MJ'&8AMUQT,MAP!!6&FV1@CTH'LAQ302H%F4R&:MQ((WJST<X5#RHA*#D%L7\
MANAAA4+E3(O!4R8X('#%>8]$.PCM?.-QA8-A9 MA5P>8':KJJ#)XTDRXA Z]
MA-T1T81AT0C(%B.5JD XA*!\5[O*TFA1)BUH1[F4@7YA6 BHALD!@C.-4 4=
M()M*AF[_:*X*L0&1U5AXJ(=I#2%U2%D+BXU_R([L&"P=1M<>9EUN@H@]RXI*
M^RD<"RN6Z(ZNZ-?BU2*IZX@6VXE%<M<2D8Z"X@1,0#.R*+;'!5ZP4F':]4@U
M$B+LL!TWRXA%6V$L:R/(6-=[4K4(2UW$.-E[38X$=-A+N]JG^"'F*-MIZULN
MO2^+O=<$AK:(/=H"]MMNW2N/'=FL/2F+6-,J0;."4M?-_6%R;;6!+1'V""W*
M@H_V2"TN1KS)=FDHF6=OR8^6%KF'%F; UF-(8V.FF]QY<F4N8[&7%KF:$ 7"
MM2\XJ39 Z=T_V9"CMC'BS93:,C\\)C7S7=P<X9&UL#9CB3+L_W*XV5)E0O,S
M4U:04PF5^ZTMZV(N_=V/O]8N""D14ZRZ#*XM7";AD*.3$/,UW.(UV(LO[6*2
M*J$SHTOANAN3)).27-8$A6,W@<;>\!(N%YEG5_,3>V-'%,<$J_N4'%Z\+O.6
M$(,N2H,O\>*3CL.7"4$Y"K .?ZGE5QYM@_F<HM/%ID-RYDGF_LN:_3LZO+G0
M%Z1MVT$_ K<1]*.> \>>](8]+_'F"S<].<PZ&X-!1CP_SV.8&J<ZVRD^<!/
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MD3JIZS%X=F6M7H6!H?I7'\U5%)55U#JM[_H;0:73&_4;<9'X8K46MWKVE:R
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M5.H+7+X^K4M2\[0-7)72_HC2=8@I-?6L#JF1'AP_6D60$!0_#_2.5$T4%"E
M,*$"#9S!A]A!]4-!%=FIRAK!%EE4M@IG :$1_SL(S9J##)2+#.F_($P03(AG
M*O^@7W96DG,V@!A9%&-XP8/@$GCFXQAL$!?IP AYCB:X/W#ND&EV"&4X:":A
M9H4&: N1Z R9@U9(:$.)YVM(1)YJ0$8MYL(B$B)D$H^^/W(^"#FL,/,RK4TA
M5I>^0F%)UI?V5=U2EF/YPEO!:2ZT%3"4%F:-5I;Z&D[!65$4UWL]ZF'DUVE$
MPY&]G1M[V*6&KC\D+PI3FS^$1)(]KC;TV6HA26,4N'3)W.M2PUKLQS3)59GA
M&7HM#A7KV7%1V4PAFEU]V/(R&:IYZEI<QG,9Q6G5:P A281;V/^""'<A%YY)
M2*HN,7W)Q!W;0V\1Z_X:V$@K[!?#%L3>F@<C%XQ$1O+_DD; #@TJ !C1=L88
MTYK.WC%\O;6C9D-'Y%@#P$:]<9MNW)LC^()MS$9J4;, 2DK"3:#6%4G:S1V+
M',?&>9S9X9QYS,>(%"">_!R9;,DT:<K!:9T NI_!54K/N<B[KLE&DEM(HQKI
M#L>9'<A]+)T3 V\KLQZ_?9W;^9V]18@R"^^CI)Z^1=T#LFXNH\6W_33C^5J;
M]+/6%4A^[%SXUAQ:-&[?T6^&@4G):9WAULGZ%HT#FMK?@4KJ:30+_^W+=5M[
MW/!<F\J#>"#?'?&JW-W?S2!1:EX6$J.Q3,ZD0SJ+&^ $5G$O4JHF$"*@VEX4
M.LVB([>%B+?'5,XN6CE\PW'O_P C%D;,2Z*:Z-7,FYMQRS3+F#-._(5A>OZY
MR+2YX[RCU=#QIPL>$HKQB^#R%/O*2%JYW"S@X#3--T+-->)+;$->C--RU&3R
M2BI@XXPD'J^DK5C+"LYAZSV,)B\Y\PTZ*O]Q&!:-'G]Q1K<X%Z=A0#^(YMSA
ME*!.Z-QAZ42)B3JE/W:E5UKB/VX^U#"[&NV-L#/1K8B.KY GJDA/TG!1)-V*
M)G!/H&#3XW E-C6/MRBHHH!U6"K0>;HH.?[BHLAU=4*G.#Y/4@H%R7*G3[Z,
M*4XG9!<+6H^^]UB^^AR*15:/(^[EO\B*T+@&=2(*X7,[;&]B83\E?V(]P0//
M\QPGC]."];1C4P!M=8APN[2KCAWE]A,%IVR7)J"")6^O EP*#5T73S#^T.I@
M==.[CYQ8/J7 ]CIF*>T#YE!Y"!'14RSMP?-CE"^5P0=)!6/P^#4%*O6;$K(Z
ME#^MP:VXDD@=Z:V@@A[\*XR?*D_]T]&B9II'*I.^ +?"DFCN>07Y4BZF9P-X
M$!^2>1^1$\E2^D:5"Y&7$TP0P'R.JY=/E)W/$92_>K^**J=G5,DZ*R8QZ"&\
M *@2"Z&'9RIP D2]AM%:P)%64Y(W5:'*9YS'/X1X:K1&+KK6_\29_OM3"=;9
MDA7 AT+<VJWA,M8I;!:>9I:=1A;?BEES$15P&1>)Q=;^PC =&^KLFJ^5M;-Z
M15AMQ3%SK9C]TA;P*C!VW3$9*Y?FLF:2]9A;Y'MM949;S#3F4D)_=0B%C:Z!
M&5AXU5J#'5F%<8)ED$1-(1XD-&Q.V5AQQ;&U:5B(M9Z%Z2X SUCQ8MF<47YP
M:1JA-E> @7V'6(:M)C.7O?Z@E7W<KQ9>S):V[7SI7U<>H7TU)&VHGC&^UT0:
MVU5'K!F <"#!@8*!$A0@5&!@X<(C&QP^W%!O0\2*#B%>I)CQ(<.%#@@Z8/?Q
MHX*0']F51$ERI4B0)TN.-!FR),R9-O]'JJ0)LN5)G#4==&2X+";1HBIC.@EJ
MP(G1CTH-%'60-"C3F#F;*)VS4JK2H3B1&FCBQ,DRK5:5-N%)=&I')SJ!*GU)
MM"1;AE5K/K4*D]TRM"E+8@WJ]2A!OWKS_G49-?'/GQ_G! [JL^Y"IBISFLP+
MDJ[2JF"I[JRI,*Y/KD'ME*:)^"3EI3(5.U5*V'1;F(D=1&9HMG3,E#$A/[UL
MTW94X7/ELO2]=W%RO<==XNUHX8N%#1;4?5%7W<)T[-ZI8[\.?D-0!N897#JO
M/KWZ]NS;FT__'CY]^NSGFV]M8'W\_@ST.]$>.T_55Z!ZK=G!WWE)B17%+ F:
M-Z!2!E+X7V?_[IT7A5(0JB=A1TE@:&%03)QWWWEV* 4B?0BRTUYK ;JH%(D5
M=BCBB =>2"-]!  70.B_AL@ BA/J.%]0AJCH7X0&))&$$TS,@IYZ/#IIHUWP
MO5ABE.SDMA"'"\K8X9!%FLC @$THR21[["2Q87U?KMAE?6'&>-J:0%(()3L_
M?E@?B_Y5J6.+8MJ1Y4(*ZEBH?5&&F:A_0G8DP3H62 "I!44\2JFDZU@:J:;<
M!85/*/APXJFGM7Q:JJBA?GHJ/IK@TXZIK(IJZJ>NXD.JJ+?*ZFF:0YIJ:ZFI
M5O%4KJ&T5L6GJ.(3;%!)#(M/L;&2VEH4S88BJ+&B=G*-4M."6JNLAFR+K++_
M'S9;[*>DUI+MMJ6ZVMHUT,Z*JK"Q.ML9O:E6JU05W1*[[KV>_DJOK;C^&V_!
ML>H7!3[8SENJK>V$ZNZ]3WG:3JP4'SMJ**%H&!2WLWY*F2'[9ERJM+=V,B^R
M%I?*A%+ORJKRPJ:.NY R28C*JJ\';ZP?S*V:&NK.H4)\[\/(4MLJP**2FBNZ
M^.(3E 134UTUU059/750%W!]P1Q=@XT)V!>D(C;79G>-]MAK7V#,V&JGS74K
M:*.=2L<,W1PWUV6#?7='9X_]]05^5T:X(7 #_E05>I,M]E-A7_#XVG _1;>V
M'2D3!=MG9ZE,$YL#WG4JH5\ M]I5[+JUV9A<WI'F_Z&7[38FE7<]A]U!>5ZZ
MVUQ+3CKKVT[>NEULW^[QV,(O]+K:JRNE#":M<#T'+8)>L[;MF*0^_.3;E_X[
M\*6#/O?F=&\./>2@ARX^^EU+71!" [D?/T("$6100@C]D[_^^_/?O___ S"
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M=FP A]&K'2)F%KU$S"VD?:JS,TL66F@L9"0E(0K72'*.RPRO"G.B"E6( A/
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M<1WMGFL,$4(8J/R!TB!GQ0GIL4(!GB0_CAOIWB,=A!2\*"(Y0%E,<IJ><F<
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MFH#"!J:Z.$Q[%JQBCN8(3\4/E>8"[A#_;5(&9I#BO,J%!)WF"AEL$54"PQ0
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MO9/] YS%W=W;G2V&R=WCW3_T&)O=O9-E^9R.CIZQN9.!+D1):>$[+]LQPS4
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MP$M^Z-M<W5<U!9I]OJ==P$M<P^=^5T,RQ 6^P,6]RJ6\].> Q*M],J._7!/
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ML\8Z]?P33RC?1%-%,).,,\T]M]22SS+Q7'/#!"V0P()UBEB'4DTKE2!3  M
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M7N"(1[?8E8YOPNN>^#)7P-#Y3X+S^V  F0<Z^JENA'3SD012J,(5NF6%+I2
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M+Q8*A^@]S2.&9L@[AYAIXX- N<,[6B8^I+-H>Q:(&J1H+":&6JB(E[AJ*<9
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MJ,FZYP<MRJ<JCKM< B.A_3>  :@P!'.Y^G=@\\6 /4K /RJD-GJA_Z6A,_B
M.*.!ZI6!2'K 2$JB-PI?0EHT*D@V5$/!/&BC6(/ &*S &RBB*LJCZ'7!-'J!
M(2S"*K.,53 P>K,.>2.$3;H.1>@W?U,$%.H$]^.'Q1HZFZBH';2((M2I4SB%
M_<-B>]J)P..)E!K$=EBF7'J+I@JI< BI\&.G!O% NMBK,+:G"*2+J%H]<6B+
M)$2GK,IE%!2G_VGX._/#.V<*A??39Y?89*E#.79XAZ9(/;N#Q(:S.<\CA0JD
MA;1#AG,,0GDZQB'4A6*J/Y]88YZ3IY*L:I53Q9@3/V@LJ9?XAWELBOB#B5"8
MJY^H9J;S/*_S::'\9 _49-.S0"^LK,MJC,Q*802+;F04C0$IL-KZ$5M$%!')
MK28!;-5*;[YV%2+AC3NT$]-X1 J)1<,<L6;AC4X$S-"H;Q,Y17F4;NZX$=",
M16^TL'-0%=NJ1M<<S%LA2,RLR]%VKM2<C=M\%^I\$5&@H.JDEN.$<AOYL1O[
MD0HG /N,</W<L?[\DJ^TLK.TLA)7 8<@-X>)(E)2EX!I4GG93TJ)D?]#5TE5
M>]&%*7,$EYAGQU)LZ]'L8;'1)'8,!91G5Q@_R;@<8B5I:5$O"]&#^[(.1;47
M)2 K794>1;4C/73*\4TKE[8IMW4R[2-C2=$\B2)<*9<%5;.#-]-%ZW8DPI.#
M5TX@ I<L GA:"9=!RT[P49E[U]1VJ7=MF7=HZQNYH1"'8%.5^WA?$+EBL@$,
MK1"&\+FHQ9KY65J3%9R8Y=>G%9S]B57^R;X#2EE)M9ZJZ;[TV5J.Y=B,O9R;
M!5NFU9X$"BC@&9Z@UU9J-57!^=B]29_XF5F+A=C&.9OH2]J*'9VHM]CS.9ZA
MG5:VI7J_A=>@G2K%N5>2O9^YS=?^:=N2)5;_LDW;J]U]JTE:IHV;XQG<!ZI6
MSWG;VND -U0*#3J R86_^OM__O<OI2 W.9BA)-S"%"B"'7Q?&HBB)5S +VBB
M#[R#;A.C)SS!Z8W>)XK>\%W>"ZR#++S>Y!VB(VS?]GU@$;RB'ERD#+; $OC?
MY*W6":$)2%B$3)K##[YAW&U+1R:F<>K*<EIFX$-E+41!EI9JFVI!0WP[':[&
MBI.K8OJEH C(CKCA;&P0$-! 9IA!JK:)959"35;CB(HX6\J*K$RKAAR)5N9E
M<O9 J#:(=[QDK&CC5OP]2UX_:E:++8[C),9JD:H[#41E+(;BJ4IH%PZ* A3F
M'"YEKXH]\A.,D:K&G%(^BK[HA(<*Q:IC0&V<R@'T9BG6/+(CYVK.J5),IG$Z
MJ%\,:#W&.#>D";),0XG.$,%E ,HPD1 9L-)&C0U[SO2ZS%TQ1/4Z$N.,Z7+$
M;\@FKA<1KL',Z2WQK<?&SEUQZ0OY$M5LKMRVK@4K$_Z:0Z7^ZO!FRP@9Z?IJ
MK[G\:P=[K[8NZ0:[KN4F;.M&SL0.L/6F$\I@2VN'UC?W(_\ O;$$C1K4;G 0
M9QJLY$FG$1LN"4NG9+(8=T-"I9$V<M)M-W)_^4YV%Y=TAR,C$N]U2U%8G95D
M_7:/:=5G.9ANM^_F82-_)[A/O4PV1W9(N;AZ279V";@ME946"TQA=]98BW=+
M:4E*>>[I 5,_ZR)P^;<Y&Y1@^>[W7ATTDM7K?K/28;49I7,@GYB7]%(:_Y9H
MR9@['2 >#[@#5TDL;YA02[<DO1B:L"4X=5-P;2:=Z5-&3[D;<$.<4'_<.WK(
M6WN:.W^P@IN:%[[-B_6!)7Q/U=J;3;K4HO7GJ[FK]WYP);JS/;W1:2]=C[K?
M6[JS9U=3?WEFK[US'W^LM[F^FR__]AE]Z+M]PG=Z>@^\EH?VV]N=8+_WPZ>\
MFD>^Q+O8N0OU[#G:IWM^[?LHM^OXEW]^RGM]V6MZP@N<=Y)_!F (]XM<#&H!
MRI4P]^LO-W2 ,;C!]RW? )[ *,C"'XS?ZNV X\VB4#,U =[?&YK@^NW=TW7[
MX:W!!DS>%6S!.<C\X9W!N^^"49/@'3B!*FPSQM_"/EC71RB$@"/^-1R$1_@W
M$K#@!C '?MR&')Z+P]H_<(Q D[@\)$1CB#.+FS@Y0AYC0 P0[=KA"S4P5"U\
MG :V"X6/X,&$"PDZA-B0T\2#&0DBO-C0XL.-'A-2K-40H\:.^ PB%*E09,F2
M$Q5&/"D3_R-&A@0OWA0IDN;'G (U3@39,J='F!ECAFJHB>)-IRF=^DR9$N),
MIRI-MB39,*=6E3PW3C0X<BO&F"F/WG1I=FQ!@E-OWF285.S,IA%%EBWK\R/2
ML3M[FF6I-2W)B5'OVD3Y].K3HRP+5[38EV9.JX&+LN4I&9]<I8.15EYFP+0!
M0Q(42&#=FO5JU[%;&SIMH JF"Q=PZ\Z]VW<KWL%S]TXUG+CQX;N1+V<N'+GR
MW'.,0T\.G#GUW,8PI9*^''OSYM^=]YX.7G?QY.FOJQ]?7KAOX]W;8[+N??U[
M^^;I7Z]OW-AS]-Q[3K_^\&//O M2@0_!!=O+[SSR'E0.MP#':_\P0@0Q;$X^
M^:#[3CSPQ,.NBMH,4: ?!U1;+44%6I2 Q15?5+'%U13XYT8<<]1Q1QY[]/''
M'RL00  A!2!GR",% ')))IO<44@]*M"#R"F+M!))(H>L,DLAKY322P&BS'*/
MVJJ@T44'^J$Q139?//-,&1UH4<XSZ433S3OEE''.-Q5H,\\98;RS3S8'-?1/
M/^-<TT5&^^13Q1EKC%'.0OFD$](UU:QS3DS;9+%21&G$-%%#]S15TDL%C;%4
M.BM]LU5%_]23T5E?W5-40 =5#4]''<4S55Y[Q15.3NV<=%1>5?.4UV4-3;10
M68-5]M89W71U4E*%[?7652&%,4X5"^7_EMMG<9W5S5%%51719-7===M2RW56
MT4;##=?9.4D\C8H--CCB"'_[!3C@#;X >."#!59XX KT-:T*!R+V,V('V/%S
M8DHMII@=BCO6F-*.)0[Y8I!%CICCDS&NF.2-57:YXXE11IEBC#7V4V.;4Z9Y
MY)!WWEAGE47&F6638XZYYX]7IE3ECV?&F&2BD]99ZI:5EKKIB9]6FNF;N:X:
MY:"I+MEDD8,.6FFTH0Y9;*K%1GOGF:W.>NVU:^Y:Y[=[OMOII6&NVF>\[_98
M;9#W_MOCJNWVN^*MX7[9[*D5;[SPM"-GO.Z,'S\\\[+A=M@0*BSX0AT+-K"@
M=-'5^2+UU54G_WUTV%'?P&$#IF#@=MQOOX2!W7/WO????1=^>.*+-]YXX(/G
M77?FEW>^=^B;;S[ZYW.GGGKEKY]^^^J=/_Y[\*WG7GOO<<<^?/')5W]\[M%W
M?_WNR6???.+AMW_^Y,\O7G[WO[\__O8!L'S[$^#_#(@_Z8FO>\$[X #[1\#D
M94^!$4P@ 0N(P M>\!*TJX(%UN%!"TC@@Q((80G74803CK"$*"R"!:A0&R>(
MY2]NJ<E ,C-#IM1D*9;IR&%$@X^EH&4P5=G,632"0QF*A2=#)$I#@AA$&](E
M)241RD2>>!8AXL0K(PGB#6T2Q+_$Y#-DX8I<VM$1OEC&B#?986>:Z/^0F("1
M(&<D"Q!%@T4G_C"'8(PB3T S&K=XQ",K><E>.),7@5"D+#L43""3R,6>$/*-
MH+&)4TK"Q,%@QHYBH>,; 0F7O(#RC63T)!WWXD5#YA$L3)0C8SBSE,DX$I(C
MJ:,3RB2;7>%2E[1S0H9\J1SY#$<Z%[H/>Z@S(5\::$#+M-"!TM,*9%X FAI2
M)C6+*4SD*(B9N9EF-I6C3>1T,YGS<69[P*D?;GY(FMA9T#F#*:!CEA.=$DK.
M?]R#FVZ"*#?@)&9TBBE._XSGG **D#C[F1Y]:JA!"U4/.P'J&UN:!G1K8E:D
M@O4L9=G(21OEZ$:QE"605J"C(QWID*Y$)93_)JE(7#+21X_4)9.R]*3,J(T!
M.D&O8;WI5BBRJ*1,Y:I(.8I%X"*4K59T5#A]2UO"4E6W*(4N=A4+38MJE$\E
M)2]4(0NK\+KJ5,MEKU[!J%57%=1%*:K45=4HJ%W-EITRFJTZF?6LEO*I6(F:
M5+ >:UE =:N[BOJHK^JTJA0]:T\)BU1"0;6JY,HJN[[UJ</R2;+7:FI<.775
M=J5*LD)-%Z)"=3&,4M6H7I6JNN0%UHJRJ!,U74 %$$:PUPZ,8 %[[<(64--.
M\.UG<HJ; IS&,:+YMG/")2['C+LTX$KLMW03+LV6R[CFS@VYRCU9SRYG7=Y6
M]V+ !1OE+D=<[(+M_[D^BQIUOQNWPHFWNM_]V=FRZUZ>+>Z]Z.VNWGJ+W;XY
MM[W<G2YUHXO>F^TVN3R#7,G "S/^YA?!G5.P>>6[X.U:MV;:U:UY!WQ=_2)N
MOPOV&\LFG%T',\W!(*;P@\D&,O7:%[M0BUMO979BK5'WPJNMC29,9[K8J0YU
M.L8QZD:'.M3IHZ80J"#]%GCD!B89@_EC'@4?*#PG6_!X^GLR\I9\Y2-7N<@9
MI+*6PZ?D#'K9R/6;H /%;&4HSX_,7,;@F94W936[6<YI-K.1H_P^+,.OS YT
M\OGD=^<YHP\?-:4%"0U]ND,GNH0D3*$):U%33.3%BV[<RT HV42..&8R!O^Q
MS%I"0VFTS)&-1SRB6^KRF)XD!2:AIJ0@XWC$6'*RU+#6B%U@31.%>)J6HLQD
M9>J(1#W^I"]@5+5>[(*74*,:EF&$2$W"Z,A4,Z8PBM'B8=Z2Z4-N,MI384DH
MP]*32.(EEA=)9%16 FUT5^3:LW:E$6U-:;MH\I.[;G>W5PT83?@D)V9D-D<B
MPT09%@8OY?:D6]2BF:]P)128@/0Z="D;V.22-0ROS3(P])L(>:A"\KQ//)/I
MH8Q;LZ'3X4YUPK/-DX^3G+H!#LB5V2&4"R>8[Z3G0@LTG?YX_ (PKR8\4[X<
MFN,FH1#J.,>W$_.2CY.8-#>YSL-3G^V\LT,WC_D8,D64<:H/)^M'#U'6C5.:
MVM1"5;?B:[IH_T12M*?]1B=-4I+4_G8?74E,(35IE<2T)9AV:>YYCRE,!5!3
M*EP66_,REIV>:BS!LDE3X[K8GH"5UHSBR5N)W>M=R<[8G"95\$A%5U;E%:I?
MV0M6> 64X17%6+LVJ_&TNKQ;5?_7S[?>[/1ZEU_S%"^U8K56Q4I699?JU= 7
MOENT(NNJ0$6M2X657$-]?&2OU=:N'A_QG2)6[FWOV+R"=EBU4FJ<-#7X=44?
M4Z*O*^:IE?EJ:5_R@WUA;6#;+X7--F$)@W]M!U;3*<C-NX ;VWI;O%[\VJV\
MT1JB43"J"1L1RQO'X9R]B3'T^IFV0<#\"IN=,9S*01H&2YJSD:Z/T?^:".R;
MC[D"G\$9S)&NSJDO$6P<$A0:!L- O#D<P1E!H^$<H$&;JXE!_AL:NDD:'5Q
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M"T[S6'3L6'JD(D<:1W!\I((XN&,>297LBCF:-VQVQU?[HBT:#'X,-KF@I)A
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M']ZWX6P?W/K94"N^>D-U=^XPZ72+S3G2D#-4-O&UY\YUVI>#[OG5K]?N=A5
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M-A$3K[VN&W&%QT:X\;KM=Q6.WH:G=^(4L]BVCG-=B1=7N!4;;K^"PQW>'.R
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MW/?#/V*_+6X%XF]_C,W_MRG;?\XJT#*:L8QO^1\ #N!RZ4PK $T4A(* [4W
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M[">Q5 $"WX301&D5LB"9#HP%PW>'_A9\QU__P<P&<XS+N,P'NVA_N\R*AC
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MTJZ']F@U$O(/)&X5>ZT5VVTG^R0KWR=-KBLQ&_19RFW95O1O,FF'4O,77Z<
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MICRY$<UY],.<X;B&G^/AZ'-RDQG1<.:D)I5,25>:4GZ>Y:4@+="$9O]:'>H
MZ*;[@6A.&:K3GN+4-#0-JE"'.AX(;4A((@)2@HX:(AJ9YT-%S9%3IUJ=?D0U
M24(RDE2?JM2K2@A'OP'K5%TTG"5]-4A=:I*-@K0F!5BU1QIZ:Y?FJE2S5BFL
M-&HK7E=DIR\]2JIC"FQ:_WI6-8&I3W$RTYWZ5",8Z;5.A'*48>G4ICQ9:K%:
M6I2C!N6FPV;VLIJ5DY/X-%H\6:I/A1(4G#2+J#*I5D^MBJUL-Y6JVMKVMJ.:
MK6X]A2QE&:NWOQ4 .80E7%T-][?/RM5Q826M5QVW6-"]EG2S-5UM#:M:T:6N
M=JV[W6Z9J[K@71>ZO@M=>9E78OQ"KWK3R][_];JWO?!]KWHE=K*"M:N^%RM9
M>O%[WWQ]JVCUK<#1_)NMA\V,9@6&6-&FAK.2L0MI\[)9>A',,J+!MV<R\U?*
M3*;@_F[8P%G[L,T\]K.<28UF2P@9R$8,,:!UK<5)0YJ,PS8VC97M8U';6(ZS
MIC:*,2UM:<,QO;IF8[GI#<AJ.[+@D.RVP.DMR4Z.\MR>W+8F&[G*3WX;YO 6
M9257&7"L8YWDOJPVOJGN"*)CG)9/QV8QDXYN?#.SF.N&9LNEKG9P5ER:"X?G
MV?GN=[0#7>_8A[[UY>[/N#/T^0+=._LQNL^%WIVDX_>\UMW.T@%4WZ6Y)SWE
M ?!ZXA-?\D!-/O"-_YK3UI->_4PMO 2.3X0-+%^K&YB_ /IO@;-VH*XO>.L*
M*O#7O8X@K07(P1%N[X*N)B*P9XA&"SJ;V4*,]A MN,,J5MN&5S3B#:G=PC7R
M4(PAC&$)S;C%.?H0A^"6(1?!2&YT:Q"*&)2A$4](PW3'.XYRC/<>WZCO/G;1
MC>?.-QO]O4=\ZQ'?=43(MP>RQG[KV^$,-\C#NRAQ0AJ<CW[$^+[=R'&-=SSC
M(-]W(Q_"R)'#1)&G3#G*5WX0I_R%+W$!BBQ?'G.8RYSF5OF+RV%9\Y[?G.<_
M5TLT9P[TG0L=Z#8_9F$&P_2]-!WF3H\ZU*$^E6C>DNE#7PI9MDZ9I<.%,O].
M_[I0O,[S9E)SZEMO#-9YCA>V% ::;$<F9-9.S;8T4YN<:4I>]/YV;S8SGGD7
M3-[CN9G([/V?B_'[:]C)>-\$]#_NA#Q)B0/Y@+(3*2(MJ&D&&B" PO0UOME\
M3I%#'(J*GJ+]Z;Q#"_1X^  UH!ZE3T5[\_G9/X<S0,V]3 4D(*(JJ/?F$=!V
M;-H=^%#GHQ^]#O%SVAO7^_[YT*$.]*%O5.I %3UD?5"$KOH@K(YU2"#"_I"V
M&GZNRHBN8OV14_D:HR:!?Z[J=]*)["K_I([_1VM=Z_I_TP^^YI]-\B=8HO4E
MA255!(@F_@=_*?)_7+)8?T4I@P6!G]4E$GA8G34T67:2):]566V"68O5?YFE
M)6%2*9PE*8R%6*>E)BIX6:U%)@KP6HBE*%XB@XKR@J45@YNE)/^[M8.?@EL^
M^(.JPH,\:"R\DBS)@BO$HBO%%2O#PH3!U5S XH3(\BODX%S0,B[CY2M.&"W:
M4E[5A5W74BWC<E[=M5UD:"YDF(9JN(;PPB_Z4B\:YH86PRY%XR_H!8<D,S7Y
M0B\Q@V %9E]^J& 4<X<K9F,5EF#UTC3I!3-3\X=/LS)/@V.22#0\EC$(4S7J
M!3,O=F*&>#)+$S16XV-1,S128S2F:(BC.#(=8V(_(XHT@XH8MHFB6&,E]C1A
MLXIJ0V=+ V5<PXM3)F5,QF5-)HS$:#:'HV5A!F9?EHQDIHR:,SFL0SK2^#JO
M$V;#@S7:4V=4!FB%5CQG]F:#-CJ/PXW_W.@X?',XXTB.B*:.A-:-?B9IYB-H
MK0,^;+-J=$./!]1I^A@_@[8!]>..B89I>.8[ SD_MB8^K5,]V>,ZH.:/\)AJ
M#81IG>9H$]F-"ZD\K:9K[Q-KAB9JQ):0$.EJ%;E!#[1KMX-LOO9L*@EMT 9
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MI),W(AFDE5F*F:4"ZY2I0)9ACKDFFFMBV::0<"I8YHUMRFFG@@[,J>.=>TJ
MYY]^]CFAG%<6NB>:B?))J(YZ^IGGA(Y*("F<@ JZIZ2. CIHH)VVJ2FBH7H:
MJ**3^@DJI:9V.FJHI9+**)Z5MAIHJGHJ@":HB":J:*J*\OJJK\#2.JJMPPY[
M*[#!(FOKLIB2BNN?OB(++;/1WKHKM-/N:FJSW69[+;;1<OLGL]_B2NVDUUJK
MIP/@1ENNN^!J^ZZZYRK ++OKWILNLO_X^R_  0L\,,$$&W PP@DKO####3NL
M<,$12UQP!0((4($>%UM<L1X5:_RQQQ6'+  Y&W?_;'')(X]\\L@:IZRQR#&?
MG++(,%]<,\XV5Y!SS##WO//-0>\<,]!%XTSTST,K/;0 1R3M\])1&RUTTU);
M??703E>@==91<WW$$DM_G?427.]\A-EGJWUVV%N'#?;6%6S0M=-HQVVWUF#K
M7?;.<^N-]]I;'S&WVW^7#3?<;*-]^."+VTUXW6_++3?CA_M=>-P;/+ZUWYKW
MC;;>=\^MN=.C@YYYYJ"7/?KDI0 -0/*_H^TYZ::7S7?GM,OM^NJXGSXXYXUW
MWCOLC>>N.?'"^]XX\*5C7GSQQQ<__/&KW_Z\[]/S3KS<V#,_^/;=._^]]QLP
M3_SXX7,/OO/UB'_^^N*3SS[\[8__[_L&7[#O/O?SUT^^_/FK?[__WO<%_L%O
M@/NCG_[<AS_Q&5!]#-S _Q2X/_X9L(+K&Z !#RB_#$ZP?OFSG_LXZ,$)<A"$
M(93@"1_8016B$(49Q* "8:A"&<*PAC'<GP53>,/]'60#ZI@A"5D8Q/K]<( *
M&>(+?9C#)8JOAQ8\HA$-Z,0B'A$A#QR@$YO(P"(J<8M#S*(53<)%@H01BF'$
MX1FC2$0<@@2&!\$B$:48QS+"T21TO*,=WWA$/9HDCW1L8QNM>,>2\-"*#*G?
M(<6H2$ JTI"./"1%&!G)12JR)!QYI$D@F1*!8/*'&^%D1'X"$X>$9),<P4@E
M12D154:R_R2??*4J43F2H+0$)P\!"2T]\DF2X(0J0PE*4#)Y$Y7<<B<H@:11
M@)F4A=3DEJUDYE!>PI)E)N4G5IG*0R9B2XGH4IDBX<I.A"+.B2BSE\G\BEK2
M615ULE,N<WDG8N*93K;0DRSVA&<]&_-.MRPFGOW,9USN*9B [E.@ >4G/".3
M&N+$1*$RV8UN)--/SD"F+HOIYW+LPI-_ F:@^/0G/.\9'-BPIC,C=8U)*8H9
M\E"T,,LY:3^E4QN7GG0XP?G.<KI34<^ ASDO9<Y.8S.@TC2G,D8%3TZG,]3W
M*!4\-^T.5+_S'O-LIS]6G2IZR!.C 6GF/C)BCWOZ,R*BCL@_7__EJG@$)"#Q
M7"BL%SKK6PM4UNC,-:QCQ9!<T1I7!MUUK1NRD%_;FJ*\JO6N7'U27A,D(,+N
MYT@3*LUC@R0C*XD52(MET8WBH]C-&FFR-J).9-4ZH2W]Z+)'VM)BJ>2E+)'V
M0E4:;9K^VB'9NBA)>)TM;MVDV]V:R4I(.I.9=BM<-@5WN*MZU*+$U \=+==0
MR7WN<4ME*5;%:56]8M2K'B4K[4:*N]C=;JQ.-:M1A5=8UA5O=B'%J&(52UF0
M"J][H36N;+U75-]2E:/:.ZYJQ5=<OY+N? .LW_O"2UC_%1=[K<6M>@TKP=NJ
M%H3]NV#_3FN^^3H7@JG5CWE5^%;ME9;_@Q?L+5OIMUW\;=>Z-ORL1#E@8BY^
M<< >)N,9TSAA,+XQP5"V,0&<[&,ENUC&."9DDNWX92-+&<M IK,=+[EH/B,R
MQIS\LYGQ[&=/-MK3ID8TH6F9RUGVFM6XS.6TQ0UK9N[:U>I&-ZG9K<QE'AOJ
MULPW,*_-:7,.'=_R;&<UXRUO:N/:G/7\Y\,1VG&&-ESD'(>ZU]TM;KE;M-_X
M]K<RVVYGA9:>\M3,.MBU;@FDNYW@)-WH1#./<[T[7*=)Y^G7@4U[F09U\%0=
M/?1I#GK0BU^KA5?KZZ%O=<TSWZZ]MVI7#YO6W=,?KM\';.<E$(#-;I^SY8=L
M:=,O?IK+8/ZR_ZUL""*P?Q?DG[0YF+\'CIM\_[.? ;GG0!.2>X#<P[:W.W@_
M"ZI;@1^\8;T=N,,.#E#?-&QA#D]HP7\#G-\[Y.*^5ZC#?\/PAP)?(QF1>$0J
M(C&% W]@%7N8Q2J2\8DVK",0.\[%1*+QC6CT(P;'V,4HFE'CA=1D(^UH1S;2
MW(Z!U.,<^3C(G/.<DE;<8R%E#L4]UA'H,-<DTALYD$YR4NF4/"8E)SG)2TJ=
MZ<BD.BDSF76J,Y+JMO0Z,:DN=8ML$^SFK.4KT:YV8.HR)[@\"4-.>?5I_K*4
MXI0[3V:YDI] \R8Z 8I+LN)W6GHS)^'T95:B,I6> +[LV+RF4GX9^?^K2-Z7
M4*G\Y1>?^:V@LYV>U\I=@!)Z@I+>G6@I2V0ZH_K(.'3UPWF]ZTUZ&LG07O8:
M!4[K/6K/N%Q4H/J\)T3]&1GC].8Y0)U]4RD*4><TU4"8P8OR/:H9Q,AT-V69
MOG:B[QS5P$:EVN<-[EMJ4]]@_Z?/";]U?H-[XE?5,C:-JFK"ZIWX7P>K9L6J
M_;>JV;3J5#H#<BM1>=5G_4=:I0=]Y,=9>9;^Q1648$:(V$A]'(B16(9@L0=8
MV0A^3."':$@ (I8'VM8%YD<$A@B44,B*E,B)F$B*"(AA8:!<$0B0R,AJR2!D
MS<B/= EL84F/8(EJT=:)C. -4@F* &&3/*"L;'V)$0Y)$=Z@<34A;SDA%&(7
M<=')F$R7%)Z)F S*H4#7<757=:G*JFQAH;@*<AU*H4A*IX *&6Z7%'*A=Y$7
M>H6ALZ1A&WH7@*F*?&77'0**?HT+=\G7I\P*@+F7L3S+L13BIL!A?TF+@+U*
MN038@3V8@1T+NM0+?05+B:V+L. +@E&8(7Z8B(E8O,3+A2G8K?0#NRS+OMC+
MN7S8M7"BNH!B*F)+*I(++7H8*__BF"X63(WUHB]"S"[N8LMXS(^%3)#QF,HT
MV8[QC)+5#)0E6<B(#,LPHY1US-%<69-=HY1]V<UHHY9A63=&C9@!C=.$(YJ5
MV3@BS9F9F9^1&9NYF=N\V3JR3> T6N @#I\)SJCQV=O<F>0@3N4\3J(5&N+X
MC>M,VJ<96NM@SM[HS>5T6NJT#N&8SMT@3^S4S>50I$%*VD$NI.ELVO1@FD3:
MCO;T#JL-CN5TY$5.#ZQ9ST7N6J%AC^ML&NTT#JW1VO2\Y.I ST?RV@;PY+ =
M6[4MV[1YVU"6C[.!S[9%&U-"F[TM$%)*&P$1C[LM4+]!Y0&!D FQFU-J$ (Q
M&U1RY0;_W0\#E=M3!EQ5NM"V85L2M1 07=%:2I )'8$(R9!:ZI!;GMP.V>4*
MV>7%^>5=PJ4(51S'O243B=P:09P6!5%ADI##Y5 /[4_&2=P7=9%D=IQE8N9!
M<!S"0=S04:8<31$<)=+-S9'-%9UG%AW(Z9S.H=S3O6;7^5PJ\1$RT='1Q5$;
M39W6O1'2/9(A[29,8)TKD5(N[5)&U))-(!,L[9(PS9(8+=/:/9/8Q9+:E9U/
MK%(H&:<T =,F%45,_ 15^%TE]5)2S%(SY:8K09/BI5TU$=[>N9)59)[B09UW
M3D1.B--.@"=['EY80%Y:\.?G!:B <@5!>5Z!BI[I=92" I1!_S6H@IZ>[XF4
M[H44@C;4ZE7&3N64ZNV&AGK&4<E3<A3?.V54;Z >1L432HF?ZJ'>.Z'43?5&
M:'1?:BS?3HW48L2&<#R&3DG4]:UH4N5H3VF&81B53E55\LF4D4;?CPII4'FH
M]DE55@%5@5145>$?6145?. ? %HI5MW56:V5E]+'@ 0(!?J56+F'6W$5755&
M7D'6F6[5>M25C8C@7@46"CK(8-6688'@8$F)G_:I#VJ(F486E1B)"Q((D\A@
MA=2@"D;67WG(7+5561E6"=X6$JJ)8V4JF&1)#^I(IW:J;*T6$]K6DNA@%(J)
ME&CJJ:XJF]3AFPC7%GYA'8)7D%AAH__4R1\N"J>D%W*A(7)=(:[*2AX&BQV6
M(:[BH:S2H:NHH7JQ(1@&(AU25R(2(IP,F'JA2K/:%R0J:R?2U[:62HA%HH0%
MXH%9*W\1V"$NXB<ZXGZM6+I(6(0URX5YRRJ&2XB5HBJRF"G.5X6UB[;LBRN2
MB[7@(KB0&(75"[X*[+4$(\/^RR\^;"\V+([I&)'Y&),-(\N<3(]5S,LH&915
MK#,2(Y!QK#):&3GDS,GJS#12S99A6<M^69=](]1XV3H>03J:(SR*S3G"6<ZF
M69W5XSU:FM:(FIN9C9IASCE6 *H)K: U;=WPX]-RY)N%3M_<#4$"6MX4FM!N
MI*:%FDTFI$C_\H[6/&3H* _D3([:1)KGN([;/ ^G11K@B"VD74_A($^F20_K
M?"VK3<[;:EJN!1O?)D_[G%KSZ.WM%!M/.N3A'H_Q=(]+,JZRW211)ANS&=M0
M4NY2.B7[S*7\.-#]U /E<FY7MH^^C1O]>*ZYB4\$F2ZU41"XD9L0T>7@B-#F
MDH^XQ=#L7AM6TJ4$J8_ZE-!9)ISOHI'J%J_M*MSONB5?!A'PAIP0/9Q:7MR^
M#28+\27UZN5E&J9C9J_%P25HSA 7%>;$_27Q,E+V-J;+<2\8$=QHIM$?Q9P9
M-5)A8B;0B1'/[1S*$1W^EB;)]6_/U>_[OB]K8A+3U2__^B9S"B=P_UY='YE=
M;.;F;RKP+*E2UDW=-X'2TAWG<!9G2VCP;DZ$-5GG*^'G!4/$,>72>4)$+]6$
M=[J$W&E$.&63Y(DG+WDG?VX34.C2X W>?0(>3QB%?]:G$%]>-D%%,CU%?GZG
M$ _H64A%YS'Q@TKH[X7>1A$HA?Y>05EQ%7\4%TLH1TTH2$T4[SW4Z[D4[7VQ
M.TV4/(FQ7FB4ZOD3;G ?3_'&2SW?'#LI\07'\,U>\0'':J0>]PT?63R?>91Q
MB>)H]4E?]!'?]A%?&5<I^"'?=4"I?'S'_*D')#M'=I#?(\<?)@,@</A?EL;'
M*$\5FJ8'G9ZIEDI(!V;5 L:'?D!57#G(*?_?1RI32&D@EG\L(&*-J0$2R 5&
MB&CM%5C=%066X#%[JF6-5I3PB!*ZUF;)X%8I"8+4L@JN2&M="8KT8 _J<J,*
MX0CZ2"R'2:7J"&FIU@Z65JBN239K"3LO,ZO&LSS+<ZS"*J9"83T?JZM&5ZUV
MX:OVH;#JLT"_X;1JJW@-*[+&(:U.HGDE='ZAUZ^PJ[A<2D'#H;6"JQXJHK'0
M5X)MXB26J[.XUT5/F+EVXKQ"XB6VZ[E.V+RLM+=\(H?)BTG#JX+YZZ[DB[_2
M"KWF-(IYF$=GRRRR8L'ZM+Q(+,-"+%++F%'#&,8J68\5XS%N[,C:3,;F#,Q
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MF.07/RKYXY%'2KDDE%A>":5]4T*)Y)1;1DDFDDCV^"2:4IJY9IM)6BDEG!:
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MV(?]9QYIV)9CD(*[DO]-JVBP [2K9I !:3;SF&N;[=DEN3B!VSHB"9,I>;C
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ML?.D8BJ[[#0[96(FP].E94((O:,[L)NF>D*G6Q+/P3.*O',\QBN\PQ.)IU
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M4T<XJUES%%JRP5EHE)L\NQM_[$=W7%JG9;2-%+18V\BHQ;186UK-*;:GO=I
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MRQA%A:"1B$E421Z!J,<H M(E:,0C(/]HR$(.)(\202011X)(1HIDD(Z,R$9
M0D2)&"0HF&R((S-"DT4VI"0W">5"1OD4I51D(:+DB"F5@A%+:O(EERSE*I<"
ME)$XDB4VH<I*@J+*2<YD(<#49%,(8LRI_-*4,MD(4'ZI29\<TRNG/$I5@+)*
MJX"%)-I\"C&[XDQK4E,L0^'E5#K9S:-@4R[J7"<[VQD8O;!E,NY<3&3^HIG
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M5[>T)_BWJ_NZLWN[N_N[PWN\PW64MW>!D'M\$_BD9[JFX_( ^/N_#P 6_+O
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MQ=<07:J=,JHM/I%]/7$0EVHO9BJI]"*H5/$37RI_C\JHDFH1OPJKAFJ HZ*
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M)4TE%5%%)4T0-9)DQ54L.9(OV54E=9(H.586U0G2E%)D151,A5,EQ5%%Y52
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M^==?P0CDQQ=_^1_HQY]_^>'_G_CLMS_\$3!_!D3@_\8WOO6M;WP#_($5UC=
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M!^).< 24'PG)QSWX4<^"Y@.?:;1'../)D(/B/9W_]4P&X!G:3[CG _" &\A
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MR_G<G"C)DRP)G3P*#/3)SKF)GG#_+,F&[-(!"LF"G9Z\;-5)7<S^"<W2+*<
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M(;!^6)V'E>YG[RO:O[Y4Q&_5H^QU_'!I#/G@&CZ]:+^M<)FK^-+OO?-]Q2^
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MJ(6,B!6+J(8@,19=\7R*R(5<$8IZR(AZ$8ML<19C"(MTT15@Z(2,<8MT\0J
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M290AR9-*2943LB 1LI5?&98.4I9-B2$I$I9N"9<P"9AV"9@^<I=%LI>"V9B
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MP]$7J=&.=>"0@<B'^E@7P[&+_ZQH&A%9^Y-1' N9&[<(C0I9'OM('.E('1T
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MLB5E"2A]TCF3"28ULS;+,NO>,SS3,SVSLZ@@"BG5L[;@4J1XBT5S4K"XTK:
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M?_X5Z^N@0_H*S&^]^_+CWS[^UNN_?OO^ZT ! %2  P0HP  :4( .D, "$6C
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M:=D;7?L.P;[-W>]T^\M?_O;WOLVEKW\#/. #2P3!"%&P@*.;7P+?%R$1;O"
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MHE=IK;4V6VY5_8%:<(T ]P=RQRV7VG#+);?<;Y?U05,EK&UWW7G7_4%>74^
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MN,8U!I&-;J2C&\WX1CRR$8YYW",<S3C(.@JRD&6$8R(ML %"#C*1COS"(S?
M2$DV,I*+I*0Z)KG(148RD90$I2=%.<E13M*4D43E*4E9#U*J\@M',.4&8"G+
M21[!D[7$)2YG"<M=YI*7OM0E+7_Y2UDN 985H*4Q-X#,(Q@3F?\5X.4SA<G+
M83)SF;2$IC0K\$Q>&O,(V?QF-J&Y!'&&<YOG1&<ZRZE.<ZI3G0(X)SPK($]X
MUG.>Y+!G/?$YSWK"4P\"^$= !3I0@A;4H <]J)JX@00D>**A#W5H1!LJ48I"
MU*)@4-.9$+I1CB)T %CXJ#@^.H 7C+2D6!!'#4!*T@'40 TU..D Q%%2F@Z
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MW7_QF.53789!/HS1O8EAEX+YE^R3W=V;OH>!W>'S/G.! >KS/HFO^.USOB<
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MCN= #N\<(?NPSA3Z3A#RCOGT[QB*8?E,SQ1B3P/##P63C_T8#_<DSO+XS^W
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M!9UQA9\-6E$<&GJG-Z+Y:9^R-U\0:EU$6GS7A:$^JGT?1J/F]Z+>MZ>AAFN
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MA 71CG[T7+[RE*C(12R.)HRBMQ(4O?S%TX%!C%T @QA3?V4VDR&+8L8R&<+
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M:_YV>]>R#<#ER4_]WB_^:H!D #!Y\6\ R@%Z@6;H^6_I]Z_IEUX LY=[EX8
MP5=\*Q!I3(9IW+=])?"!T<9QY/?K,_!J=K!M)M!O2%!P+'!ORCX$&X=O$$=N
MN,9_H] $5X<"!W@$L>;N"QALT!X#U[Z"9^?O$>?O4\=TL@=U*@<+>Q!T)@?Q
M85#N92?R5X>$3?AP;D>%5=B QA!X9ECSDV>&/_^&S7 -IP<.BYA]QN<%]O"'
M[Y"&7U_U99]\W+"'[0<0<;_UA3@1_;#W%?%_\,</&;&)A3\5&Y& OCCY1Q$3
M.?^Q^8V_#]7X$]%'A-BXCD_Q%*5_%E$H$S5HCE&1AD8QB531&,E__/-XA4(H
M&'VQ&#F(@X!(BA29_%]Q&+=H&9/Q&I5QBJ 1&ZG1&@'"BI$?/ZP0//'CQ D?
M")4@/.$P(92$"1E27/C0H1**!PD2C#C1(4.1%1-N_ %E8TB,(R&63(G2!\H?
M&TEJ= D38DL?(U&JI E3(T,?2GJF'(GTATR>2HLVE2FT*$:G18E:/7JUJ$B>
M*K4^M5H4*\^L9'EBK5K5JEJN;,>B54OD;,IS6H_&U0KVJ%:Z=WT<A1*7B))S
M@(G2K4J$9V"P5A,/?FP8\F,E@0O3I>M#!F4EE $K\2S_H[*,RTIDR/",.JYI
MTX$W"^;KN?6YRJ]#KPY=F@CKW;:%Z+;=^[=PTW!,M[AM6@CRU<J'A_:=F_?O
MXL"I'Y=QW;KQ[=BY7\^^W01V\<=]RS"/7O=Q];9-Z';?O;CNXL?AFSA.?_Q\
M&2:*]X_?G0STW==="P3B5Z" W0DQH! &'F=@<7 \*" 1]]T'H8/8,3C>A/^U
MT *''L)QH( 8]G=AB!&F^""*$K;H(8@8C@@BB0_>R* )-]QXX8[]R=B"C1.V
ML(..!NX(HH-&WF!DB$P"&>(.).[())4Z&EF% 5INJ:4R3E1QI8]5[E!EF%<6
MN2.9.U2AC#)<O@EG$S?L0":1_W/N(,2<AL#))Y?*5$'GG'WVZ82::L[)YJ!]
M_GFHFBZ0R6<53;C)YS1J[JEHGU4\.N><CW*ZPZ>A-KK-J*">.JJG9'(ZS0VJ
M>OIJJZV&&LJGJHH*:B>B=G+#K"ZXT.D-G8PZK*VAMNJ"KYZZ4.NCO";KZK$W
M?/IKJ-6ZL(VSTQZ;[:?% JOKM< BFRVYS(+;Z[3" OLILK_^NJZ[X%*;;+G3
M8NN"KNXB.\V[R>;K;\"_]ALPP04/'.Z[X<+@+\,NN/*OP/]VXK#!+C#L\,6_
M8OSPNPSW2_'&(O\:LL89<]PQPQ!#S+'#$)L,<\L:ZY OS2X#TS+#-$-LL\:N
M<&PSSO\8PS"TR3O;W//00A/-],5,+_W$TDWK0#324S-]-0PT4XTUQC9K#3;5
M3X!=M0LZC(VUU4^(K?789W,-P]IDPTVU EPK4'7>>7--]=U]DVTW#'CS#<,5
M=0L.=N"'XXTXWH$[;K?AB?_MN ZNV%TYU>SHH(/AGNN@@-V</PYZW9%WSCGJ
MGX>.^NF&LQXZYJ!CSOH5M,\>>^P.2)"[ PI(L'ONP/.>NP+!&_][\L4?KSOQ
MNQ]/_/##!Q]]Z,,G?WWVV&_/NP32<R]]]]A[3W[WXGO_N_GHEP^^^N6;GW[Z
M[\]/?_WDK_,^_A)80#[_WA>!/P#V[W_D*T+^O*>_ ?H/?_K_,Z $UF%  _IO
M@?NKH/XH*$#^31"!1=B@!A]8P0]JL(,6!"  18@_"T!P'2OLX HU^,+]H="%
M%A"A#-=A 1J>4(4UO&$-?\C#' )QB!W4( ]Q6$,D_E")01RB$Y_81"A*\0M0
M5(<3J?A#*V81B%3<@ 6T:$4M>E$=7["B%RW01322\8MI+*,%O.C%,J8QCFND
MXQSE2,8ZRA&.>-SC&_NX@0U\@8^"+.0@X5A(0:I#D8<<)!D#^49#;F"1@91D
M)1-YR$1>,I"-Y*0G/]G((USR"Z(,9#T"*<IZE/((I-RD*%>Y 5C*,I:HI*4H
M*V#+7![AE4=8@BXK\,H- ',)N_3E12U[>4QA"G.71Q@F,F-9 6)*LYG K  N
M@=E,8D:3FMJL)C6M"4YK?K," FBF *QYSG"><YWH;"<YV\G.=<:3G.?4 STK
M\/^/?.ISG_SLIS__^<],&< -2/"$)PI:T(,J%*$+/:@;!+HE@$ITH@#%P@!>
M,( !6!2C&\TH1STZ '%LM 87O:@X2HI1E(+THQAMJ4I="M.+UJ"E,T5I.6B*
MTYM>5*<OJ"E,9WK3F0JUIR\(*E&!^H*C)G6H1IUI49-JU*<.E:A+7<%0F?J"
M(<S4JDO-ZDTQRM4A?/6K0N4J56LPA*2J5:UB[6E;R^K4MK+UIFU]ZPI><->T
MWM2J=[5J6I]ZUY[R5:U<7<%7_UJ#PN)UIFT-K%P-&]C$+A:O2>WK8OMJ6,KF
M=;!#J*ME^RI9R&IVKV+=[&5+J]G48E:SGUVM:5?P6;S_8M8(LG6M;6W+VMKJ
M%K:PE2UK>PO<(;16ML*M+6:/B]S;\G:YS&VN<YM[ N$N-[HK.,%TN0 40.N_
M =L?#,&ZO(WN";#[W>J"%[S=%6]VJXM>V(;WNPII[WBM^P/U&@&^]%TO-^![
MWA7$-[[Z/2]W^4N1_I[ "/W=KX 3,E_]#G@%5N@O@Q_R$ -?),#QM0)"%#S?
M@3"XPOM%2(</0F"#Z+<C^^6(AS>\X1,89, B7G%!$K+B%6LXQB8NR(A3?!&'
M/,3%+S8)1!H289!\Q"4_O@E-,.+CF]S$)1:)B).9C) F1QDG2FG(2HY<$Y:(
M9"$DF0A1%@(4H,@D)"OQBTBV;):N-$7_*60.\V=NPA2HJ.4S8?8+3:#BY:7D
MI2I >3-1H, 5+[^9RW^>,UB^8FB\O(4Q:_DS9!CS&<>D!#"%B72D]3*7S@C&
MST1YM*<[79C%1+HQE?:!J,_1:<<4A3:4[HRF4Z(9W;Q:,(%9#65@0^M6D^8U
MKW8-<OBRG&#?1@G*.0]RBBULUC2'.,JVC7-^ QSG7.<WTV9V@*;='.5,6SQ$
MR': NOT<<(-[VZ$ASWFX[6T$A:C<W;&0@M1-'O'D)S\0BK=^#B0$?(_'0":B
MT+P5)"3L0*C?H2&1A21TGP$-G @K@E"+B" D MDH0@)RT(H0;J,4H>A!<'"0
MC2S.HB E'$- _R+1A"8$\A8\Z4E7BM&*J 2E*ZE\23-7.<=E/G,Z"=0+5;"3
M">ADIC)UBDQAHA1$NV0()M&)Z)UJPM'?Q"A(/=T+0[]3HI[.I3RHR5)#YY/1
MX:2,IF/=3X 2U=!1=2LR^<I4JW)4J-+>J6*Q/5UD>A6NZMZJ=(W+5<@B4[;(
MU*RVLRM=_6J[J\Z5+KTGOE? VI:XU+YW<6TC7;SBE]ZM):MI;:-??*>7XCE/
ML'OMW6#3^I;!IM$M@&T^8B3#5[[N]:R!C0M@_TH]P<*E+X4U;&2RU[V_<"\Q
MABTL8.%Z6<"$/S*7B<QAS%_^KUC&>^6GS&<P@[[,JN^TCKD"9]/7&?_+BC8T
M\ /M^^(W&]&<!@/N4\W\Z#?_U-Q/_IDQ;6M@<W_7SC8WK5UL;.:GV]7P7S5N
MHS=PTS9_(S=ADW]_HS57H#6#@S@+B("-@X"+TX!AXSA$,SB#\SH5"#I:0SF"
MHX$ZX  <&(*5<X$=B((,"#H;"#LA> 6&TSH+6#H*\#H.4#JO@SN8\SH*<#FA
MTX/(DX,]F(/3 SS"\SS.TSV^@SS:<X2_0SU.Z(35LSW&DX3G$SM66(51J #]
M@(7ILSOP@SY<>#[4$S[QLS[R$S[LHX;N8S]HB(;V X=Q*(?W@T @5$$%Y#W\
MDT!WZ$ IE(=VJ#\05(=_&$(@1$$39$!^Z(?_-F1#BVA"@JA"CRA")U2(D8A#
M,H2).81#DHA$^T.),"1"//2)$*2)1R2*2*1$2$1#211%J0A$KAA%4N1$6K1%
M7%1#M,A&MWB+6)1&:/1&7_1#<N2+9\2+NPA&:N2+:[1&PJB,PFA'>>2,:G1'
MC_1'C^1'C,1)T A)</1(U@A'?X1)B]1)V>A)@Y1)VSB.F@1*E91*[,A)L$1+
M[WA)L-1*&W!*\YA+^1A,^JA+&T!,M/2/P81+P=1,L?2/VD20L81,P 1-QU1-
M_HA,KV1-"KE+U]1+U31,WO1-XQ1.'>F1']F1Z?1.(YE.\40.[R1/Y"!/Y*22
M B!/% 63,<E/F4)0_PQEDP9UDS:)!%0 43+ID_^D41IU4A8E#BGU4>6 !2)5
M4B'U4365E"5E43XEE"[541T54U?I4T4IE2]0E"_E4S.EE41E5#)%5&&)54-U
M4425ED[%EDHEEETE57%)561U5VTYEUU%5DFE569E5N6@5T6E58"96$#U5Y5E
MF).558.958+%F%(55HRY59!95($%F'Y)6:&56.5@68-I67I57)2)5YIIF*!U
M5Y99FFE57)PY6I^)F;&55J*U J^958,57*ZE6J.96[$%7+FI6L.UF[^)7+X%
M7,?U6R] 8,/)7,:%7-P@7-*%G,\%G;LUG,()G;S%G"MP7]>)7=B)G=;%G/_<
M!5O,J5W=&9O<99[J=5_D65W@F9[IB5[6!9[MA5X)9F#6E6#W=6$7YF#\E5\
M)F .EF$0-E\#=F$=5J /46 K,%_U66$+RF#])1 #1F$11J#QM: 5IE\-QA$9
MJF %@1 ::F$>:F,C6F,1.J("X1$&H:(#\6(J6A L:A ]=A!%YF$MRJ(G,!$1
MEJ,'H6,6\6,EP1(_MA,_!@5$5F9!*A-381(E464;H1-@YF50ZA-'!A5@5J5;
M$1-9*A1/ZA2.=J5-:F8^$6<;L11*L6=&0:9ND1=$T123%A9IJA-KH1.*IA=7
MD15BT19IH:=LL6AX 6E\.A:F=A:8\6:8 1:D 6G_E6:HJ\85I(&HBD:HA!H9
M@BH;?Y88K1$9LK$9H4%IIE$:N $:@V%K=*$9?'%K@T$;N4$9IU%K@L&IKBIM
MNP$=N$&KNC&KMDIMQB8>R78;Z7$>NO%LO\H;U!&K 4*LLHJKUE8?[_$;\)$>
M)O"LYO%O" (@ZI8@ V>M\#%P_B$A&X(@'P*M]*$A2E(?_M$B!%(B,((=!U>M
M]V$A$7)P%S(@)E<A$B=P2D(?/*)P+/(C+F(B$]<?!Q<A(C=Q)G=Q/'(D3C*P
M-3*P1I(G0((B:3(D)\)R8D(D3;)R.N(%F)(I/ <H0J<C@1(F1$(G'#MV5= I
M(<LD5S=V!A!V.O=TA6(H_W/R=2W[L8UR V/G!)S2LES2!*@"M&0R+*_2**R2
M=D;+=IQ"=\""=S=0*TG[=J@'*ZF2>-*2>=("M:[R=]"2=[:2=U\K+)YB>= "
M+[6B=UR;+?>B+NKB+J[R+*V2+;HB>M)2+]2R>;IB+6E++18#>].R+X-'MKTW
M,*+7>O#R+G'K>P*3,!)S>X6K,;2',M-0,A[C+R^#,M-G?"C3?!T#,]2WN<JG
M,C'3N3)#NB;#?3F3?47S,S&CNEYS,5OS,*Y;-K.K,^%W?E?C-$]@-O9W,3C3
M-P]#-^W7-7+#-;NK?_-'-G%C?@+(-_TW?V/C-FAS@&Q#.,GK?P_H?PJH@(H#
M./\3F#<.6#>'$[XR*#B+@SKEVSCC6SF2PSKENSF&XSNSLX*<@X/E:SNGTSGV
M6SNMP[\X> 4V&#D G#LY.(3,TSL##(7%8SW%<ST*3#S+4X0/3(36\X38 SW4
M@\'GLSY/B(7B$X55Z#[R\X5F2#[C8SY?N#[TXX8E/(<M[,)WF$#^(P$.-,/E
M<T$@M(<"=,,--(@"9$(/Y,,;!$("5(B/6(D65(@!M(B*^(E';(DH],29&$,]
ME$0DM$1"]$,R!$0^5$2L6$-%U,54;$1-!,:O^$1,)(NRB(MJK(N^"$1K],;
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M!+P;7NR:=[SA[6Y[U2L!\L(WN]SU;A&P>U_TRA>_^^7N.NIK ?_>M[P ]JZ
M[1M@_ZX#P/ -,'P!;($#6^"^_Q*FL((C[& "4_C ]J5PAA7\X0=7N,,A5O"(
M22QB$Z=8PNI0,8LE_ 4*NWC%+V:QBP=B 1E; ,8Z5@>,=TR0&?>8Q3<&LH1O
M/) >%_G(0$ZR09R<9(7P&,8#<?*3!4(0)T>Y(5?>,D*R;)$>*X0A61XS1SCB
M$#.3Q")JGDA**,(1C*39)'!V,TA0 I*2U&,F-E$)GV."DS[OY"8]D<E/+K*$
MBQ!:)S39"%*.(I2<S(0IB=9)3A!-:)]DFM"1UG0%B@+IK3AE*:/V2EK&<FI3
MMX4MJ';+5\XR%CV )=9JN4RM;5T7%(*!,) ! PK%:  J.(8P2*""%_=R:V3C
M!0LU$/^'9E!CFMAL9C7.5@.S10/M 53;-:0IQVM(XVW:K 8W+YA-;D2S'-^,
M6SC>&<YL=N-N<A,'WLY)#A:\,YWP="<[V\%.OJ\#GW_C&^#$D8_ &]2<]XCG
M0A>Z3X,@5(/SG ?@(N(WBN S( <MW$,[6D[$,XZA#2V</R*'N(6D(Q\,21Q#
MU$'YAT0D(@Z5?$;+$9'*(32AB-,(1B_GT()<5",CU.A&11H2T7D$)* ;:4E*
M+Q'1O42DIEM)2%'WDI">- 0P.;WJ4']ZU[W^]!,\"4YA!]23P'0GM"\H['>"
MU*/8SG8F\>GLBI)[V]$^=TB=25AZ2A*@Y*3WO"]*\(Y".Z/_]%[X52WJ!)1B
MO+=6(*J_KRI3G(K\X[TE*V\E25MS"M;B.;^H8%WJ\ZX*?>>'U:W.=[Y8C^=\
MZUF_^-+_BEBF(GVL7C^LUU,+"I("UNP!5BYQ48M8^UI7\<E%?.#+ZUW%GYCQ
M.2:O:3U_8?YJ6,J&+R]V]0O[\G)7P?+5,? W3%\MPU;%H(_][EN_9NJGE\Y$
M1OZ"#4Q?^AH9O6K&,G%=+%PSD[_*<#9^GHF_^V.9HR&9_^L9!#R:G$D:GA$:
MIS&;J_&; BP:KGG KY$8!R0"KPE GBD;"=1 J;' G7D:H4&;M]% LRG!$SR7
MK$$;P:$;M=&<%8Q LG$:O"$"%20;_ZK1'![L01]4@LOI0?%)G,OI'")$G,61
MFR!,PB0T'=))G,SIGB><PL-Q0BD<'=4Q'2N\G/U10B7,'+G)G-L1PS#\FR%T
M'B1<G>EY0O+I0C0TGN<10Q.('C9,GM6Q'C;LG<L9'^OAPO&1&_H)'2*8'N=Y
M'M(QQ.V!GD),'>5Y'NMY'SH<G^@AGS;4'^$A'R*@1$O$'_.YGDKL(/QI0Q R
M'P[JGU#TQ H*H$F\GAL0 @W"(.OA(% $Q0SJ(!@Z(!(R-F-3ABKH( Y"H!MR
M@LDP!"_HH1TXH!NXAA,:H1Y*@A,2(ER,(6&4#%X<HB(ZH3PP(RM2I":8#&5H
M@FT4HCU (?]%>J(;\B)E<((:<@$OB()BY"$5D@P^<B5S=((F: (G4$<YXJ-*
MXJ-R_*-*"LARG*1,&DB#[,=^U*,[XB%'XJ$V"H4J B9Z_"0>ZD=2:B2!A*4V
MDL@;&*0; *97HB1C:L@FHDA#NB9*PJ56\B0VZB4_"J67O*57>LF5_*2.U"20
M_"2-?*5B^J1>VB60!"=M(J=JTJ9H$DIL"J=[$B9OBB9E@H%F>DILPB=D.DIM
M>J=MVJ9:>B>N!">(,BF"XJ>&8B>!\B>$(JBS+$N2@H&R#"F16LN*XJ>*PBBW
M_*>U#"FPY"8=("J6TDN_/$N54DNPQ*F^7"G#-"F^/*J@0DR-VDO_CF),I/JI
MH3),K*JJHEJJI7JJI+H"I6(JS*Q,SCPIIZJKA0K-C%*KHX(JU(RKTF1-UU3-
MA5( 5UBKK5)-'7" LU(KU\3-N'*%PE(KN<(KJJ*JOB+.OH(KP/JKNE*LY*PL
MR'JLWQPLQ^(LJ<*LQR(MVG+.ZURKS:).TWHMZM2LU JMT\(MX3+/UY*MVJJM
MW&+/W]*MVB(NWD*NXJI/X\HM_$RN^7PN_N3/ZJJNZ HO 8VN\DJN[P+0V)JN
M]9*O 9VOZ=(N 850"*.O_/(O_;I0_"I0_MI0#*VO=4BP G,P#X4P!6.P$)4P
M#&,P$HTP^W(P^;*P!RLP%!6Q$I.P N,P_QOM,!:5L!I-L1Y5,2 -4B%-,AU[
ML1'[,2--LAKKL"&C,1\S4AZ3,AR;LBAU,B"S4B3S,2B3,B'+,B KB"\-4X3
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M2F"IJ)N6ZFFJE%K*ZJJ3IHHJJK!B:D&HJ'**:ZJYUJJKK>OT:L&DP&X:;!'
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M=JR-Y2I?*2M9R\H@L.?0;& SBU@B?#:TF56"9TL+!]&"5@B@!6UB$2N$Q)I
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MX-+PS=*;8/SN#0>FX/V^;]>SX/[ZS0N:_>$TSOX&< PFS@TZ3N)$<-Q?CDB
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MHS)D$S;D][P?LS@<*#B$0S4=.(!D S=2XSH?LS:(HS6&(X%NLS@JF#B:HS?
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M_5>: &P:I_F9H\D:K>F9HQF9M$' J3F:KED:JY' "!0;M%F:JDF;"E2;#-S
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MFM9.?)6M3_VJ6,\J4;2V=:QC_2I:ZXI7O+Z5KGRU:UKO^M>VZN"O<Q5L8&$
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M4ICI4J X"BJ_<BO'>2N3TIN9Z:/4^:=(,B^Y62O=62XI:BD_2I_&LIY]2:/
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M%2V(" 9Y_'N1&LT_&:_HC\F('/N8&,^(C3SYC"PY&.% "/:H' &"2 L3+63
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M?OONNV] _/+/3S_]RBAC@#*&Y%]___['_[X "O!] \!" 0]HP &\8  U4,,
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MD\$ES/?I,\)___=]/X@/E$ S#$*-F,,*],*4*$(#8,.&KXDAY$ ZK(DX3/E
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M'0J1U^>89_\-_!SUZ.=;*U'?/K=XZ:;5$_GN SQ]\.S9(\^OG[Z2__J;KSX
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M^M]AP/YY[&?7?O8K?@_?>..M_QY[\U/?GGKKK^_]BO:ME[_W^76XPGWV=7!
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MV+T!WP4_[?N9C1&:CD$: <R_L!' JV$:EM'= $09JFF; 1R9!7P;"]0:E;'
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M)4P:R6B6R9MTII3,YI,,RIXD)YZT293_-,IQ+J=Q-B=R&B>F-$ITRB9Z<DJ
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M.WF3/QB961?O4[_E@QGG6QGH(]ZML9GJ:YFH.9BDF1B>:;_8;9GX<[^J83^
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M:G1&169&@) @4,$Z@@(/(DPH<)U"A$42%F$H\"'#B @K+E3X\*$%"1(M2I1
MD6-&D1XE=&28$J7 E1T[LGQY4J;+F#9IWD3YL@C-=1$MK'OI$RC*H$5Y#N@%
M:D$HSYA(E2Z-&56I3J \IRX-NA0JUZQ;OX(-*U;K5W5+S8;]LE3M5K-LUVY]
MN\'"%[-SS=JE2U>=VKH6W/[U>U>MV\*$U<ZMB]A"8KY[%3-^''DN9;J5-RB^
MG/G+!KX;,'MFS)DSY=*D3W]&#1ISZM:D68_^[%IV:\Q':'.^S?KS[=<;COC^
MW5KW[>*\A6^HA]PX\>/-BR\1?B2Z\0K2EQ2W?N2V=NF_K5>8OB$\^"/AS4]/
M3]Y\>>SNMV,WC_U\A?KLV=>W3WY__OH"_/=7P7\"$EC@@/\A:*" _^DA(#D"
M,(B@  _^_U.AA1=BF*&&&U;H"1*>>(C$#P:02"(W'X;H88HHJM@BBQ\BP:(G
M8)18(XD<XI@CAU@,H,8 +XB#10T_!OGC $42.0"/+_1HI)%,/CG D$Q2*0Z5
M1"X9Y95;U@#DED]:^6.778K))95=EO/"F%2FN::;:KX IYQ=SEDGG&NV"6>>
M:*JYPIIWZ@FGGX'6X.<0=*8)YZ%QOC!$HGTVVF>7@\HY:*+E##IHH34,$:>?
ME);CJ*,OK! JIG%V^FF7CJX0::NCPEHHJ9S.VFBBK<[:Z@JIHGJJKKEV"BNN
MO^HJZZ]#Z.HKJ< BNZFNQ"X+;:M&1$NJM-4^:RVVTJZP K7#?O\;;;?:CMLM
ML>6:BZZUZ>J*K+G(KKNNN^E:RPV[I-J[+KO[\MMOM\B>D&[ *PP\L+TG<(/P
M"0 /@7##!T-,<,0(=_N#Q!)3K/#$]JY@<<<5*QRPQ2.?4'+"'Z-LL<(@GT!R
MQR*+_+(1%=,\,L$S6_'R"4:TW'/++__0LQ%6[$QRT$8<;?3'5M@<M-,K,-TR
MSS]8'/7022<-M=-5C\QUT5SG'#75)T3-M-9:M^PTT4$K<4+;;3OM,]5BL^VV
MW4'[D/;=4/R0-]X]]WU"WF\+WC+?A5/M=^"#_\#W#VW[\'C:?ONM!-]O/QZX
M$HUK;O?@GC_.]^5NY^V#Y:&'[D/DIE__[@,4FYLNN!*NPPY[['W3'OGLNK/>
M]^ZJHY[[XZJ;3KSJNP]?O.60([^[Y<JSSOKLR1,_^^_6'Y]]\=M;__KQYW#O
MO?/0<W].]T1 ;SD14*"/_>_HFV^^#_$K4;_I[?N _OKMF\\^Z_N;;WU*V%_]
M!+@_ \I@@#)(H!("R+X!ONX<"TQ@ .GG0") L'T8W& #(2@#(E!P@B(<X02%
M0,(2GC"%1# A"#_(P@6V8($M_* ,:RB#&,H #C#<(0UOR$,=^C"(0,0A$7F(
M0R*8((<[3"(.A\A"(9@PADC\(!.5.$4I^G"*((2#"6*HPQ8(H8M*Y&(.JQA#
M+R;QBT) HQA;_V "+G91C%Q$HQ?7>,,VNK$%.B0"%_DHQSR6L05GG.,=]>C#
M/.J0BW/\8B+CJ,<N*O*-:P3D'/-(1SK"09"0?.,F'RG(/-[@C2T(I2 K:8(=
M")*4<R1E%U-Y2DV&\@:?%"4<=B $5)I EJ/LHBQWP,M<\M*7GPPE*GU9S%RB
M,I;)W,$.8MD"9HX2FC=89C.1J4QF O.:L41F-6.YS6E&<YK3;"8SF3E.<Z)S
MG.(DYSK5R4P7O+.<ZX2G.^%)3GJR<P?VM.<T\=G/>-8SG_@<Z#T%JD^ PI.@
M!+U!)YJ94(<6] 8WF,8TX4!1>C[TH1*%:"=N@%%]3I2A"<WH1UU 3_^*WB 4
M(;VH1J?A H\F-*0NZ(1)]3G39J;TI1?MJ$P9*E&*NG2B-36I"[:ATY[&]*4=
M96DHB*K4IPK5J=MPJ4D[$5074-6I+K5J5)WJU9E6]:5.I:E6P>K5K!(5!D0E
MJUEI2E6U?M6K<#7I7,U:5U=X%:\N4"M-^;K7O_ZUKW0U*5[5:EC PC6Q?\6K
M7@];V,7^];"2/:P.(KM7PQJVL)B% 0R P=G#7G:SG^WL: WKV<N&U@4Z4*L.
MGL#:U%;VLZJ5[6H-6]O9KG:V+G!M95M;VMYR=K6U9>UGA>M:&+B6MS#HK7*7
M&]SG.O>W"G#N=)TKW.A>-[C3O>YVK>M=&$S_M[JKW>YVK[!<\H+WO.K507B7
M>P7V6K>\R]6! \ +W_N^5P'OO4)Y%: #]II7 ?[-[X!U0.#IOI>][-7O@@W<
M8 *SEQT 5K" %>"*"F/8OQ5V "XJ+ $'9%C #OBP! 1<8@64>,0J/G&)/XQA
M$)M8 2/V\(IIC.(;DSC&-T;QC%N\8X'T&,4#:;&/BYSC(0N9R$@>\I*3[&0F
M0UG(3BY(0ZILY2N7Y"(444A(+N+EB7ADRUU>R498(A&8^"0G)@ES2\Q,$INH
M!,XH(4E*<&)GGQB%*4&)R$^<DN>=0*4H-'D)H96BE3F3I=!7Z4JBJZ*5GWRE
M*E[IBEBVDNA*8QHM_VT)RUS^<A:]>#HM;?'+6?H2&+CHQ3&=3DQD(+/J4ZNZ
MU7R9M6)4C9C,B(;6H0$-KBF3F5G[>C>CV35K/&.:VM0%-[2!S;)WL^S1Z"8X
MI&F.;(Q3[>,T&SG>\0ZUF;-M;W.'V\()SW>N@Y[Q<*<XV]%.>GZ#G=] QSSH
M/L]\X'.?[4Q'/_E13X#ZO>_^X&= !5(0P1/TGP<1"$()1U"#(*2CAS\<1BJB
M48W $",521SC&M=XQE?$#1O5".(BQ]$ E%3R+)F\'%F"$LM+SJ0P14E+1EJY
MS+]D\R>1Z05I*A//X81SGP.]2U9ZTYYT#B<KU2GG=.*3G!*U]%8]W4Y.A_]Z
MJT(5ISQ9759TTGFGT+0H/TU]Z5QGU*0\12>J,PI25S\4KLS^JD:M*DZ%"M76
M2]5U2T'*6)*J.J]2=:IER<KJOY)5M4)5K$^-O53)6GRN<J4LNY=+\(_'%KFV
M5?EV9>M9Y[H\O3JO>7)I?O.BS[SG[[4";LR+]/\RE[Y*#_K0^XM='#N9O6;_
ML(4%K&$H2YCN<4\P@9EK8.PJV>^)7_SC"]]<'BL9SV3O,]K'[&,_.WW  G:R
ME'D+<!]K&M!V]K.G<?_[@.N9%7A6_O'_8&H_FUK.TM^R]@/M!^WOFMZV)K7W
M=ZS]\]<;TZ8F?Z0Q#=4@C?S]']40(-.4W]B43.3_&,[8$,[<$&#<P(W;_ T#
M;D[+$,[G2,[81 [5/"#A@*#@L WG?([N4. ),B #7D[C;,[K+(X)T@X)!@\+
MLHWNC [D^(X(+@_IB"#M\&#Q9$[DO([;0,'JI([DC,_NO(X+%F'H0(X-ODWV
M.(_WB$_N:,_OD _N8,\5<N'VF([\;.'X* _XC(\ ;8\ L4\:"I#ZJ.$7ND_^
M0 _]N.'_J,_L8%#^N(\#V4__8- #^>'Z)) ,2% '45 &-= $\6$'7=  -=#^
MJ.$ASA &?9 $M5 +'5$-"8$"5:(,O) 0@) G<N(,B5 2B9 )"9$-;:(-%=$I
M!M$J#A$F@I )6*(,R"(M_\ZB#X&B"=B1&"F1$M7B%_DB"'G1(2E1#(E1+!KC
M"@DC,;J1'0G!'A6C+PZC&PGC+L;0,YJ ++[1'252-)Z1+"XC(>51%TV2-BH2
M$KG1.3H2$GV1(VUC.XYC'F&C*452)H'1)XUC)K62)O$C&'&1++62*'%2)@D!
M0/ZC&QGD+E62,P'3,Q6D&_F2+!%3+KF2'CW3*#V3/4KD*6WD-#TD0F;D,U%D
M,SV3,]D2,7T3-IU3.W53/J6D.[F3.7'3.KDD.:&33<)D3<[33>9D/D543?(3
M3Q[4/P743A+E4%+44(+401640O733T$4/"W542K406741:E41EDE3FVE6%EE
M4_]993^AU$_UTU"%5%@FY4C9U$6!5%JBU$51E%%M@T]AU5!-@UP>%4NQ%$RM
MI4>QE%-YE$V9E%%=%$R)%5#AY5KY)4SM%%899ER9%%6QE62&U6#)E66N55J]
M%6;2%676U6#I%6-5)FC5E6*9IF5V0F6Y@&@ZUF!)UFI:UFMVUF,QUFFI%6U2
MUE_%%C \%F?ME6<MEV[^YF295FD%YW&.UE[%%G(M9W#F5G01EVUM5FT-EV]>
MUW"M5G)EUW(]@7+B%G(6%W/RUGARIW5EUW5"5W=5EWV%)WJFUVJ]%WOZUWO2
M9WRF5WB-UWOB)WO&)X/)9X+-IX"-5X!>V'^Q@W_I@"O_ .AX.=A^.1AX"6A_
M:IB%":B&T5>%3NB%5=B%D9@KN!B&+9B,85B.>=B+B9B.A5B,'=F,\5B+!=F/
M95B1L2B1M2B.D9B+LMB(&9F.VBB-XJB1^6B2'82.*AF6(820&FF2'D27==F:
M61E,B,1'3 1&F-F2FD2<>1F46@1+@ 1"I(1%R$1%Q%F8<JF8-L68W@2:6@6>
M]9F>(06?&=J;YIE42 6A#06;%AI5<$50\.E5Z,13;(6D61JE+<6B?856("JF
M*>JG*2JI?<5;A-IB1(:GO86D>IICS%ID8*JD;FI@T-IC?.IE3$:MD2JM:<:N
M;89G< 9C,-MIJ(.OO2IIB$9G_[P&:A@;:KS&K,I&;"C;%^A&MB6'M@F;<-2J
MMO7&;=2#M5G;<CC'MXG;<\ ;NDEKO+G;=G@'N87'NY5'=YS'?6 K>KP'=V@'
M>%1 O?$;?NB'M_)'?R3(P!4<@"A(@R3<O!I<!>B!A C(R.DKADC<AU!<B8#!
MQJ%(OX((P1HLQOTKR.WKPE:(DP")D@3)D*#<S#ELS;F<DI0#Q7X)S=V<EP@=
MT/U<F0S=F1C=Q_+)FZQ)F9QLR0;=U<F=T;ULGL"LV-4)I7#*F\S)U]%LFVB*
MH;@LG2Q*KT2*RS)*FJ0)WMT)KL *V8G*HW#*T3I+VBG>I!#>KC0>V@$+H_BL
MI]R*I_\T7K0\K:O0"K$TB[08B]Y)B^ M"[SL"N)=R]M2GKJ0+;=8WMMFGKY4
M7NJA2[=PS*[T[1!P@[4 ;KMPS+R0RN#Z;>N=WMXNKM^:2]\6;N3^"^0&G[LT
MC+L,#,!$3+<LS,5DS,9<C/1!S.=^+LV$C+TL'\^<3--47\*$C,? +L:('^#P
M3/.IS,S83,KL#-! C<XT'_R%S=+(C/C%3=P@C=!TG\V(3='LC-6L3=EL3<<D
MC=Y<#=EL#?0VK_6B#=5L;\G C0'63?B63 1>C?A.(/@B3N/4GP:*C@-Z;\N4
MH.=@(/Q2H.- #OT*80OJ[P8RSN? #@4*(1+*S@ CS^7PC?3_:,X0/J$+F@[N
M\$[JD([SY. 4'L\ ]V_U/,\4+L_Q%&$&RX[V^$[T["#Y2"$0OB'W<.'U@,\5
MDJ'QL"$:MD\:UF$5=A -%P_ZP.$8=E#QR \!^4\-.V(0OPX!+6(&)1 (79 :
M/B(B=I#^X&$2&Y "&?$$':+YI- )*1 )9?$5TR(5N= 7@U J5N(3+1 0C7$/
M76(K\E +O6(O M$;ES$3D>(4M;$.55$T9A$S^A 9T;$7 ^,?5Q$9-=(W$G(:
M[7$:R=% [K$G9N,9W5 ^=I([IF,9\=$A$P$EE2,:^1$D>Q(G+Y(CI>,[!N0C
M+5(F*](:W0 J3Q(_IK(@K;(H@60Z_[KR++D2*=G2, %3,NV20B+D+^VR+3=D
M,G71,H63'D4D1O;2+>V21)K3,[5D1^:R/&53-N$D-TES3*[D,UN33\9D/-DD
M3C+E."U433;3-/SD3FK43:8S5?ZD/VUE4VYE8&Y44,XS5P9F28540WV4/,>S
M3('42MTS0Z%E0+L43@&51-&43363/E<53CE56_[43$7T2_D42A7505NT1TWE
M-- 43.4S0+N56'F44*V46;E 4]TE8&Z56(5T5U6F2*%59,KT4E7F6-6E5Y'5
M2I<58'U52+N56E$F3RL66^F5:UYF9 E66L'F4JLF8A$6:%JF;,;F5,>6;M+F
M:55U;VZ6;?_*%FMIEG62UFR]5EC3EFOI%EA?5FP55H+JYFA5IUC35G16EED_
M)W#MEG-])V<=EW4] 75"EU]_%W:%IV!39W>M5WK=IW?EIV*C5W?=EWK.%WHM
MV'I9&'PU-@SDEWM9MH)EMH$)V'T*V(5I]H']UWY%:(.%-H0Q&(96Z(=B6(<Y
M 'O!V(_-MHSUPXF:6)#!&(FMF(KM6(W^]F_S-H[FMHP2-W'CF)0U&9 -&8\6
M&9(&*90MF70;F7)3]T%8MY)J=T*,699QV4D<!)1FQ$.P67B7MYO-1)OQ&9:F
M&4.T]YMAA)VE=TW0Q'K;]YQ.!:*Q*7[CF04 JE!L!:15A:,%:IZE_@1/+%JB
MD06D%2I7&.JD'>JB2OB$,VI8:!I:L(6F06J&^P5@L-JDLL5AG-JD-D9?;&JL
M08:K20:O\46OY=JJ\EII,(:Q38:I#MMNZ"JNQFIML*JT[6IMS(:R#:NO(MNO
M]@:V_>JU8=N2*RN2-ZNS4FN[@5MW5$>Y?>NXR=NV5NL&N(=]A*NXKBM]Y!MZ
M! BZ^MN9]]N!P*N: \B!(%R"--R$&)R$_S#LOFY<PAI P JLB_#YP!9LGW\<
MR-U(G>LKQ#()C]1 EH1)EF"!."0ZS/&(D8A#E.Q<E1QZE'"LQ=I<I6M)SG$Z
MR99)I9LLRQ;=SKYLTMG)F"P*UA'*S!(MSR)*H,BLT05M.=#*IN0=V4E*I]!=
MVUD=K_PLU1$>H[#=LL!=T;)*W2'*J Q[KX\=UUD=X+V=W=7*LIR*X36*V?*=
MUWZMME]MMCO>X8%>W)([W&)>M+#MZW'>Z)5+O'2>N-@MO&/>N]#+W^[+Z['>
MZK%+ZO$[O>L[WP*N]0D\ZJU,NCP,LGA,\"E\P7#N\#4\PU??[W%N]0G?U!",
M]Z6+Q;BNRJPNS?^(+O$EO/;9S,]X7]6PC.W6S/193.U^W_;=G]-8_-@4;]HD
MK\O+O-J\?,>P'_[)_/[)7_Y)S0$:8 +V7P068-"DS<S+O @.?=,'3?N&+_B"
M[_W6C?_:S>AT8.'@X-U8X @>L.3 H->_(-6(CNUXCO^63@ _H0[:S>R(H +G
M+_#H+P^V8/X.3]FS8.Y0X.QX3PF?SA.Z?1*F</; _09781:2L/:X<!>*H>#+
MSQD.\>O43^3/,"-&OB/:81L^/O;LCP[WL.3?3P1UD/40D!O&SQ\VT ,!,2%^
MD!+(D.L?8NM;D"$&$",2@041$ W=/B.>@R2*L0U-4"H&/PV!(O&WD"G_7K$9
MH^+RVR(LVE ;KV(3&='TLZ(=WV(N&B,TRF(N6G\H-K\C3Z,>@R(P.O(G7F,?
M U(;F9$/.=(>CU$<P8$P+N,PQO\;H2/X;V,ZHJ,<L6,A 80,."U,P"%BHH4,
M@@,+'H2C$.%#. 43+EQ($6&+%D(T"F&H,2-&D!,9WB!HT@3*B2A1[A#"<N,.
MD"9?GLS8XH:)E"E/]N2Y8Z!,G$-WF,PY-*?,HRUV_-Q9-&51ICN:PJ1*-6I1
MJC>@<M7ZU6O7K5I-B@5[]:Q7M639>G7!-NU9N&^YTI5K=ZW6MWAW[-7[MRY;
MOX'MVNU$N&_?&],0#TYLN&YCQ8SW,N9ZF'%1_\DN7"R^47=OW<R=%4^^T=DO
M9\:C75BVW/=UZ].G^QY&?7K:MM6S.WO&?%IV9\J^.<\>7IPRY]:Z.R%7SCMW
M<.73BBMO/LUV<^4NM*O>/OU[>.K=M\/@3#Y\<_,NUI_G[(JS^?;PNYN'OQY^
M?/WY]=O7[R*_^]@;4#X "3RP0/\4-' ]&.0KT)4'&83000(5-$\']AZLT,$-
M.]20/6 ZA.$)'>0S4<,,.32Q0Q79RY!%%UAD$08::[SQ1AM-5%''&TL<D405
M@WRB1B)U(-+!'9/,T4$%<&3121RC5))*&)QT4LDKK;SQBBRM-/%*,*',$LPO
MN_P2307$M-(5-6%P0/\'-^64,TX%U-3A"COM7%.!-M7L$L] N]QSST'5)!31
M0^-T0 (']-13 AT<5<#1.!N5X%$%,.W'44PG]3331SW%U,Y+/V6T5%1)O513
M5%O%%%95-9U5@EAA?95636'=5=-^+JU5UEIU%;;66XO=E=AACSU6V66=?1;:
M:"58I]@BII7V6 MJU58":XNEMEAMO;V66VJY[=;<8ZGUMMQMPT57 G'33;<(
M"^8M8AU\B\ WWGZU_;??? 7&%V![^35XG7\33M<"A?'-5^&"$ZXWX7@3=OCB
MA@5N^%][#6XX7@LHYMCCC.OE^.*,%R:999(S;IEC=1J6F65UOFCX9@MHUAG_
M9XYOICEGF67>@&<+B+8@YZ)U#OJ+H9=^FNBF?[Z9:)NMGMKHK(G>6FNILY9Z
M:ZFOMCELLHW^(NP-T%Y[@PW441MNLM4FF^ZVT;8;;[CAOEMOO?ENN^^VZVG[
M",#A+MSPP0G'&_$COB@<[<(=WT!RRA^WNW'*-<^\\LZ7V%QSRC\_8@G/"Z]
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MV !C+VB5-O0,5O]UK2AJK5:%]<-''-AB3=@4P]@D_-A.PU2!PS2*PS>TC=R
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MLE8 K&@]:UGUH-:TIE4/8(5K!?Y!U[K:]:YXS:M>]6J OOKUKX -K& '2UC
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MF5255:$I5F3%55Y5TZ=)FFA%#JJ9FK#I5JR)5L,YU'L56&" !$B-!+J)FVZ
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M,1""0U< 81!SY0:%"]=P]1 2D1$/,9$!L-<1$8<:$+D4T=<2X1 1(3D;$=B
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M0"V987>FV(SI-52";9=@NT(SO$$-;RSC&=7P9C?"@4&RK5UMU$@;,]K6S6[
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M&WVH1WBD:[I2QWUH''JXP'V01\0!",3Q![Y!G'O\ZWSH1[Y:G(+,!X&LW(,
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M:E$%<-1_+)6I377J4Z$:5:<BP1.>H.I5KVI5K69UJUWM*E6[Z@8#C)6L936
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M$?9G3%/KZOAZ.+M6S+6CTYG1+.<UV*GVMYOS[=W0ICCE]O9VM)/N[:R[/#[
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MS3[<H]R8-> JCC@<+EB-==^ /#_J ^#V@\C9H\BW5>$N!$(N#D*JW#X\9$/
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MU05B^/9<A@]N'Z9S]S;Y^-WX&K=SU>]C"J9S^47[(F9C[F_Z:L;@#8;Z6O<
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M<'\ML" (4PB'$"KPA!^$H0*%H$$AH!"%+(PA"U$XPQ:PT(0B)((/?4A$'IH
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M%OPWP";807\)K-X )[@%!18(?;DK7R$4N" 1'O!\"PR'">^ P03> 7TC?(,
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MM[?+PVWVA @^[TE0?-2S'O681][+N<)ZUE/O\N"[W?M>3KSC/1]_MSO@%%(
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M3L[N4JX1&I$1B858&UF&Z$YO]5YO]FYO'5Z&I/EELQYFLRYF^W9 9=;K[K5
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MM$9E-$9A-$5M-$<WE/J$3SX;15ZX"Z[4"Z[:Q#Q_I#OG)5W6\UB**Z_D<[=
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MYYZN<;/#>1]J,1+CH^*I<5=7,:2 *CZO.4_DID0/IE@$1E"D0XQ3IM[W!+0
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M/O7_Q#WYI$_V?,_-&R7[G*?ZY$^P@T__[,_V%%#YO,^YRT_Y-*8!%= "/<\
M[<\'-=#_5#D'55 (95  %= $A5 "=<__3,_[W- %[5#\G"0.K5 %O= )S= 0
MI5#9:U 1/=$6S;KUM- 9]<_G\U"DVR?7<SON\[[P(X<?+;\@W8N\(-*$^HO\
M4U+ N#\#T*B*DBC&<+_ZFU*04K\E):G::*F7"D#<* TL."F7:BDO%4"5JH'7
MX"F["L$Q)*R?2D*O*JW&DA ,] ^\FD ZO5,EU,#N  XU5*W-BM,H/*H_Y9 -
MF4*B*L''$BHY+0\XG5/'"BPAK,*FLBO(&D/2,BNK<BH4_T0MRW*0QF)4,4RK
MRFHJRE(JSJ+"-5PMPF+4HSHMQ*+3U%I3)RRM04416(54.475T.)4!;&J/ATM
M/GU"]F"L+U",+T%6.P0NX.(MVPK$,G$30,1#9Z43)LM(<,P6YP+(7$DR05$9
MYV+%9:0:44G$6H0490&P6/@%YGHN %,R-SNQ: 04\PJ7]3JRJ@F5>I64G]%'
M%".7CWPN-[,9<2FP>FF89$P$+2,OZ#H6;U6:5J0R48&R])(9G%F:'.,7>IPR
M4)G$C/56+E.P%\.NG'E7BB6OD2TS(./6DV7%E 79*E/9C2W9E179EEU%"2/9
M>LW%;)PP_@*5[.K6;)TPFO$Q@?^I,@>K640T%()%F>.:+YO-QUD)1OJ:+X8E
MQ80E+IHIL&M9L^CJ$ZDEKX[AUH[=6.LBEOG"!L50R3[[,QEP&SO[FI-$&T";
MLT [&T$;&T C-#A M,2 37_;2H)3-%4;GT\KH7Q+M^0<2^*<M(4S',-]2L!M
M-X6+M\!!7-C<S7VSW,@!W-.!M(;+M0-RW%?SR]!QW%K#MKZ<-=6M3-8-'-6<
M(=6$W<XIM>A!M9QL75.[W>%QMD7S26ESW;Z97>#%S=<-7G@K7N$]W@48WM1-
M7N2%-I[DG5]#7,69M[^]7N'M-'1K7M1]7N;-W<4\G&'C',=Y-.347$HC('SS
MW603. G9JB$,NMS=G-])JU_Y[=S!N5]+2Y]JVY]5DUY6&[;EK#;)U;4<HKB)
MJZ**H\XD<F".VR$ILK@'%B+O[$X=BJ*3PU&PVP@7'3T)S5'\5#JSPST;C= 9
M';[Y_. 5-F$:)5$1GCX#;>$7IKL156'R/#H0'D\3O=#R]& =ME$;%F+3*V$/
M1F']S.$@%CVWR^&_ V(>'F(?5N(9/N$<#>&WF^(G3N*IVV+\'+X:)N$G[N$L
MEF$IIF(H+F(B_N$=9KHB_F(V5F+M2] 9[N"J.T^64(SN"S^Y**@^'JB%.O\H
M+%72)ET,]D."D*("*H6,BH*_)A5DB(HI+U4-VAB <CB-,AW3W?#2U+#D2CX-
MFD+ Q+! *]R0!WQ#$L21'EF.!4Q!-!Q!,(01N H1!63#$0E6+CS"O/K 6G5!
M/J7EWQ!"/]4.)'QE6=X0$<3"41:K J$.PT+40^T1-HS4K/*L/*42,\14:7YF
M^*!4%02MJ>+"$=1"9!XLNNIE6*Z/5'814FY3$+G!6CU#)&SE989G2(61$7P1
M[DCE788.UV(3WXH3,Q$3,K$"/S03.8Q6/^RM-/%#.AG&-ML69"F958$4B6:9
MAIW%8%D49L$6ZA(9F2&7]S)$> 3&;>P9@NS7A=G_67*%6&]A1EF<1Y2YEENA
ME@BC:1P3,B&;E7Z41)T.FE4!6X4L%Y;)Z>,:%>2ZE0J3VHF<F'X\Q$9A2)..
MQW$A:GOAEYOVQJ>V:JG>Q*O6EJUVFJGVZEV)ZK"VL)+.2**^E(H.L%SDEZ]&
MF&PY&/4B%>-J,[=N&8\<:VL<2'L,5T[L:RMSQ(C.EJN-F5C$+K;&:(]%Z2*+
M,)#6%($Q[, &ZI!F+F,1R3XCM)<T&[.I6Y6DR;R]6YO\L[V%&Q-0#+!<-KC,
MRO4]'A Z(4_+7*9T3>0Y'M:6G_B-[>7<2_(I78=;2K*<[;6,7_[E2;"T'*,<
MR]/M;6,+;L8-X.7F'*+4_YWUQ>W%+:"MO$WK+FZ'<^[E!N_O%F_O)N_F-N_9
M5DWL7M[U9F]92^_BG2#7/:'R!M_)W<GXCJ''7%W1\=ZP[._I$4OH!?#_MMSW
M9C2@=%\9"D[6U.^G'-[3<<Z+\R'H'*(%[B$'ID[KM,X@TO I<@#M]#COU& N
MGM"E0V.T@SDF;KX;1G$KUKO'@SDQQCPI3F$TCKP.=>(EQN(KOE$P[G$XWG$6
M7F,C?B,CYKLD3F,4U\^8VT_?4^,R%O(49<\7A^&96^,J'L\B/V/'BW(EM_$8
M=_(C9_$N3^,?IW(H;_$J7_+=FV,=GG$RI_(ACCH2]U DOW(7QG(TK_$QQG+Z
M-/\E,$\D']UC\0L_\3LHN\B+1T8_0FZ+'[!2Q5 &*F"_*76#1[]211\-W.!2
MUWBI<C -F_+2G+(-U'BIF8*I ?1TGKI4RW+3"-RK:>[4J-*L+<35$"151+73
M$"S#^3BKL!JKPYJ21;WU2:6JI@)4":$L^^@L&X3!8Q^J4X42T7I3Q:K5K1)"
M'=EEL&JLR[I3]^CE2(UGLQIVQ%K"LVJ2'8$LY BJT6K5P@)V%IGGZ3!W;F\K
M-2W5T&+46\7WQ JJTV+!9$9V64^KN*K3=_]WIG*M9,TM@7[6.ASH9V56(UCH
M'P 3V2+HX>K::_0N>0U8?,R9G+%8;&D:FVY%7"B"H<W_5U4A,EVQL  #FH!-
M,);6L&Z56')165Y!V)PI,07#6'QA,6^%%_?JZG?%VJ85>9P-65-Y+Y,]&2LK
ML2,#&'I=653I%99.E$0,>9YIV*R>EWUUQ9GE^F_Q^FF)%RX+>_@:16TU>_L2
M^[0O^Y'U6$61&:,!F*-G^8&=EYGN+VA)1JE7Q*3?L00C18^M;"ES[(_-E2E3
M>DK95W=9>O!Z10>+!?=J5TS4,B53?'AU>6O56I)5%)E]ZZG7^?A*V\0@&[[5
MFCQK =5?VZ_1[+MAVZZI6Y2$&[F16[JYF[YM"Z1$',\MGE@['0/^WM=U'= U
M(>B&'!?B7%Q[[MUV-U]#3N'O_\N_Z;3"A#7;/6_,@=R  TSS\3<7:K@9VK04
M*C?=9MWYQLW?S>WQ[;9@LZ#P?^W9:7_EA\S:+G_8/O_0E=[[)__\!X@%"R@)
M+$BPH,&$" \B'*CPX4*(#@429$C1E\6&#2EAG.A1H\:,$BE*%.DQH\6##!F6
MZ@@RY,N7*V.J)$GS(D-?&T?*C"E0I\V80#^"'&H2H5&?"W0RK*/294Y-I90N
M7>C2X5&?4W?"!*G2 %BP"A3H4'!%Q]FQ9<FJ;6MV[5BV"G"Y+2O!E82X>O6&
M!=N@50--#?3I&]P@,.'!@ LS+MR*\6#'D0TGKJR8<N._D"T3WAP9\F+-DT$;
M?CPZ<__HS*HU>^[\E_)IV)(K,UY,>K7IQJDCATYM6S;EW[1+E]Z<FC-OXJI;
MOQZ>NW=QS,T3^V:N3WCSZ)6QS][LO?5UY:+#W[X\G+IRXYC!6U]]&W5M\;DG
MVYZMV#KVW;GC(^?^739YV3T'FV^QH===<.L!V-YH!,8VH'WS'7C@?<"15YYC
MJG$WG72-@0==AN9U*!R")*8WWF\2AGBA>?:I)YAEC^G3EP$"5'"CC17DJ(>.
M%?!H(Y! DB- D#H*\ ^222JY))--.NDDC5%*.6588+CA!AC<4$%EE$]Z^>63
M6 PP@)CBB/D"F0.@J0:9XJB9YILUB%F#&C6@B>:;;]+X11'_?/II001? .IG
M$1'TZ6<$A@H:Z*!]!MHGH(=*^L6?CR+J9Z6.]CDIH(I":NFFE 8**J&+EAJJ
MI:>62FJC7R@:Z:*.8KKIJXPJ2FJHN5(J:ZBKJJIIJ9<ZZJFJE6;JJJZ]3OJK
MJ\(RF^RLNT;;*K357@HKI\0&J^NVKB8:;006\/JLL[I2>RNSV'9;K;+&+CNI
MI=0BNZZIO:H;*JRPVAHMOO$2:^F_OO:;Z*0%2QMNJI\:/.VHUAZJKKR$UNJM
MJ@F72N,)/QB1<<96K/!#QRML_(/'/Y#\L<=&_/ QR":?8$7&+5O1,HW83)#(
M!#E3@LW..^=L\\ZXY'RSSCS;+'0L_T1/D+32$PB-<\ZQ^.SST$TG34D12$,=
M-25*8X.TS5MO_73529O--38X,SUT(K^L'30V3..<=ME-YZSVS=C$O?0$=#MM
MM-*X !VWS45/$'342C.M=]1[)^WWWG?G++303>L-M= [C\UWTELS3?G><R-M
M=>%6&\[WT)WKK7GJBK-=]-5^_RWVT%^[SOKDLF]M.]2QCZU[[63SC?OLK_\L
MO.\_]]TXT9U+SCSJ4$--_/"V'QYVU4XO7;CSSR=N_?.QX.V\T;TKC?C6?S^N
M../2ZTWY\^7#7O7HM%^_>R(VQQ*V_HG_+'WM=B:^JHVO=4.CGM\J-SG7]4]R
M22,;C81@@O\6R* %)H"####8 B%8<((7K& &+:C!#U*P!43P(!$R.,$27O"$
M&G0AC8C"E8$,A2I!F4A*DF+#&VHB(CZ$24UVPI&L]- F.>2)0CBR%8$4,21U
M:&)!2E'$K.Q0ADI)25!04D4K>J4K I&B5C2!D1XJT8@WK$A$LE(1'?:$(T@D
MB1MO",<LUG"+ ZF#'>5(PR7ZA!)XS",:;Q)'+L*1C5T<)!77^$:L&!*(C13B
M(],8R80,\B=YO&(=]>A#16J2DI,LY$@J><@?$B6(@NRC+[82Q#A"<2!DS.1"
MG-)'.8K$E'JTI0QQ64M:;D03LNQ)219YQ4Z6\HPXK"&-R)(6M"C_LRS,7,LS
MVP(7!XR%F@IP@ 2L><VQ9).;V,0FC1+#H? 8*#"B$<QB8%08= X&1NULCCOU
MP4YY4F:>]CS,8]1I3L;<DY_UQ.<^UPG/@:9SH)I!IT 74XO:Q/.>AD'H/M]9
M4'\6-#+ZC.="+3I0QPCF-1!MZ#\+6E'"7+0Y&;T.2$<:T(C2<Z)_ :E&38/1
MQO3SG0\]9T@E.IB3MJ*C))U,2M_I3XX>1J")"2H]&7-2?9S4G#(U*4-S2L^;
M'E6J[NSI/V-JU)W2=*,V3>A66ZI3ID95HU6EJ%#3BE6JAK6F9(U,4S\*5<4@
MU:<KK6MI8/K3IRJUJRZ=*EA9>D^%EO6G)F<=JUS_.EC$9K6M7ITJ8.:Y' <A
MAT9 NE&/<J19'0U) $/*;&=#_PNFT9)V25PZ+6I3VY?2LM9)8SI3GK!0@P'4
MB4RS%1,6RJ$F-]TI3R_@[9M>4(,].<H"OT*8M)25*&+E*E'&=5BY)+:JYTZ7
M3Z3"%:*H*S'JD@I<VH5NMY@5*(D9#%[1.E6XZ#6NXO*KO<ZR+K/.:ZWL"BN]
MA3*N?;T;7?9"2[ZN^FZS:#4JZJ(*N^\B5W._Q=__,KB_Y75O<2V67WAQM\'\
MFK!ZZ3LL[C[7N=BU6*$R+-\/%\M@ ".PA2-,+N3R"L,./AB*'VSBY%;,N@ .
M%(U:QK&5Z7AD&?O8"8RP@IFQ[&4M YG*5C8SCAG!"C12X-_2=C2G=<UO3-N?
ME'D6OO_X[:]KB1-<WN"W-KD5SGRJ*_/=M.R_-4=/<I6#,N6\W+ROJ=E\K4M?
M(A9GP/S)F6B1(]S.K/PW/WO9?C>3FP/OC+HM-\[+6@8?HBV'Y9[%K]#94]N8
MW=QF\G4-RDVS\Z!QID#!R7EM?^NSJ(=&:@/F#M7::S6K3TW 5\N:S:M.7/[8
MUKE(NVYIO[!S^A;8OS/S^7(VX]GHFD?KQ9&Y9Y&SW*<9YSTP0SG2:P.U_U+-
M-FE?+M%Y6S.868TW;R?;U&&NV^O$;#0%[N_:G%,SK3$WZY_1B(02/*$%,ZAO
M#.)[@C(@P@F)8$$BP,'?&"PX!4>(\'];,.$FB.$<M>(5J%3_D2!2N<DF)SZ3
M@D#E*EQ)I P];G$^SK AK?S)2GRA"9/X48UF1",5,_Z1H[0DD!%/HATICG(O
MQOR+'E]*4U;N\:L,L2 73R-.C$[R0!:=B23'BDR>J,J;]V3E']=(S:TR<JI8
M7(LRS/H,F[Z HU,RZ4X7HMG'OO1C,H3L$1>[VZ%.P[:O_2ET1_O<E8YWN*]=
M[E+IB"EC7A,LVOPJ<6>ZX>N>]K@#7NT8A\C/+:+S0-:0Z4;WBM2YKG6/-+'G
M/1<F*8>YPYB?_"B-MV'*;0YV3&9DZ&=W2#+/(GMGIH4MM9<+7)P9E[RP!2X*
MZ.;OM3F6<+)&.KN)CW@*\QK P&;Y_T4UC/.;#QCFAR8[UI?/82Y35.9K/SG8
M;SYDK&^:Y[LH,T55_F3.SWS2K!_ZTR?_]K,/HM%P7YRB43_\JR\9\$.?G +J
M$/K9GP"2DV3HG_OUWVMT'X:87_HI( '^7_,!($ %( 0VH/^-G_=%"/R1GWLX
M7_E98 "&8/N]G_*%GP&N7_TE'P,*8/T]('1$X&1=GP:>7_9=H @^WPN&GP2R
MGPJ"8 W>('$8H/*=8/SEGP328!%F( 3J8 Q6W_=98'8,80*F7_B9H/L58 )6
MX12Z!H!<ACYY1V30"&9=5F:5X645"9$8B9&T%AL^B910 1* @6K-X6FUH1V6
MB9BDR9H,@/^<B .=O(DXH EL!>*8X(D@\N&9[,FJ  R"T5AW<<N!81>$"0RB
M@)AXK1>-05>['%C%O!@EOA>P>&*_N$M[+<PH*HRTZ,M^^5<CZ@K!K&(H!EB)
ME0K$,%>LU$N-<4O$;*(LMLN]_-<K*M@J6F*_0!?"H*(KSEB[J$JGM&)TT2(G
M8B(RIJ(PDA@JR@NJ4.(RQB*TO&*K,*,M(LQU[6*ZV JJ;"*-E$S&C,S(Z-B1
MF0R/E0R/;<R2'1G*T$Q?&,T ;8_7"$WAX [5" Z4 4[TZ$WW;(VSF8_G7!JZ
M?8_M/-#23(^@,:0^]F.;Y4WID$WW;,_G' [R],U#_@^N]8W]($[_EET9JU'-
MO-'._A@/^<"/^60.]R1.UXC.LJE/X[C;19)DME6-[0@0N[U.][2DLN5/Z' .
M1IH-FIV9\YR-42IEHCVELC$E/Q:E04XE1JHDK66/N;69S\A;]4BDW2S.0OH-
M0E9D4?Y"[DQD]:S9V8RD $5D3RY:J@WE 3W;U03E6+H.WF!;L '0NBT-4<:E
M3+X-X!@E^BR0\>1:\A0-XOA/O5$0!^D;"<F P7V0PH'0P+E0!;E0PY'0!5VF
M!='(+N$0$#V>)]&$SC&2%V$<&(4$+-T$&UG<SY4=%N52Z+7F%)FF0:120Z@<
MSN4F#<$F+ET$'WT>S)4<0AQG;?9<YWU1_^>=W *\INA5G!UQ4MH!$B&QG,E=
MYW9V$4)T7FVB)NIYYQ9]GG#.TGF:IW5>TL8M$A5)T2\I1&RV9GE.IR^U9@[U
MG151IR4]A"B=!"&!WGVN$L859W"Z'&^")X(F4GW*)T0<11GE9G+:G _)YT$\
MG4 DDUI<03-U*.XIDXBZPC:UA0/XGEQXT^]YDP007V;8E8<$!WA$88K0QV>@
M1H<TR'Z@R(K0AV[HAHPF"!CV!AA.R(SB1H80:8$,:8ZR2'UT(9)62&T4J?$)
MZ7ATQY'J:)(6QY)6:91." DV2(Q,:9#RAY=>1X @!W7,Z'/01G58*8YVAHHT
M*91B!I%.:9?&J?^6VBAAA"EG@ :9!JJ(Q"F:'D<72HB/W@>0"FJ:\FF?4JF:
MTFF?%@>>PBF?[BF81B&5MFF9#JJC/H:A#BF;!JIG",>.FL:.$JJ7CM-\I*HY
M>6!C+%4#6%:/X AGV<AGG:$9^DB1V*&O)DF4* ,8>((G(($;; D=)FM8_&IK
M%:(>#H"9W%9P.:MLT9:T_A9LR58@UH!NT4@V=F-X\:(IQA>J=!B*:6,FTHM_
MW=>C6,PDXHJ+65AUR1AZG2N%V1@LONMTQ6LR[LJ$Y=>_<A@H'@RZIM>)Y2*,
MT5BXYJN)=1@O8MC"MHN!T0N_2DNW7%>[7M>[HMB'G8N]RJ*"82/%:.+_)+Y8
M?B&L*S9BNWYL-7(LOLH*RSJC*WXCK40COM+(QP"9.^HLDL%,SA*9R0R9/9),
M/.JLD_5%WRA0^G29T3QFTJ:9ESE/LN%9]FR/0!K/2NJ9W,3"KS6MY#R:T_*9
M]JP-F"VDLF4/+G2-J>DEU&A9N/DCI9TMHRT:+A1!GR%:18K:0R*;6UZ:J>6:
MM^5-E57.W%295/(E]BC-N!&- CV;MO$-J74;4CJN2U9M_# :MLT;FEUD5UYN
MKV6N\6QNJ*T:1"(:V$1: W59FBDM^,RMM5U:MWD:WXCMMDGMV#Y/7_Z,Z"ZN
MW&Z9VV*/[:).Y3CEO'WNHKTE 6UNIR5NKJ6:_^!(F:JACI8A;_*R&YV1+O_0
MR,(AG+^)D K]FPE44&@F' <EG/@.G,,)W JI4 G!@1! 7-X5!8*FYU)8'<>A
MY]&M'C!IA<IM7-&9A(8*1>M)Q&JR)U*\)WA.9^3=[T60'7HN)]'-48.2YR@E
ML$_,9\EY'-BU7D9L\&]V\.DM0.8)Q!.E9],UJ$ML< 1'T7@JI]FI\&VJI\_A
MTL]Y\ $WA TS, 33, CS, X7,-#]L _OL!S5,! K\/PJ*'%N1 CK)TCD\,X1
M,5'8KS')\ ?C)A==G-"9GH0J9VDN* M[G4?HKX#.<-B%\1F;<7!VTM.UG>1Y
MW0/_YR7QW (D$UKH7KQ9+%-<Y)Y;I.A>Z,4WC05>7!/P*0"-Z"@-3BIB%&FH
MND>,'BFD9NF7\A^D0NE_;(AK0'(E=V"1_@<G1RIM;+*86K*"X,9G6,@CCS(G
M[^ I?S*#9+(JQS)\2$<IE]-D>08J6TBBFE\J_^DMM[*DYK(O2RHH]_(KY_*<
MUO)YL+(6BO(L\S(P#_,RP_(J0[(RLX<P_ZDP(S,87K,J__**&'.=2G(D?S)Q
M:$(!JD<GBV&.E*$[VX@>" F1=):1=/\6L_JJE! K$A0K%2B#LBKK/9=6'K*)
MF;P)FY1#'L(6;4TK0O,AFA"B(&[KG@"**O;7+QJ+NG[*+([K@\$*PY3B1M.8
MNM"BMG!T=DVL1MNLN=BB>$67R*+B<CG+(RHLL'3*P[QBN=8T2T.B=4TCO=:L
M+$;LP&9T(]XB1<\TN!+C+6[C+9Z8HBSUP4BBM;"*-<Z+OYB8AX&T?\F+OS!L
MAJ4T*5IBNU*LN'I+@E&L?^T+O8X*N;1*CI6,.IY,R^@LRHP,7*,,7BN978],
MS?A,ILD;3,ZN_PC/ BTMZIQ-YO3:V+*M8-\E24I;4HYMZ?RDLE'-1B9:1^*-
ML\GDU\HDZV3_V5=RY+R-3F).F^Q<3^"@=K+APELF&U+>C=LL3^\4CN"<I:$M
M&D-RI5SB-D2")>Y>3[6EFUR^Y65_&N3&)4K^I5!2F>.,9/'B3=HV=UM6#YGY
M#?7@3G(/SN$B;]"\I4+63=O$@NP*T+CYS-Y6K4P&V_*D#N_.FKO%#JY)KKG)
MC_'F)+@9]T&^MO3FFDJ:&_7L8TRFMOC$]OP )F%/ (U8I@8IN/AZD/<NG DY
M./M.4 J-4(1S9@LDW&?"[]7AY^991=E%D0OW)A&%N!//L2X-*!8_A']:Z(K+
M40"#WA?#I@7',8/ZI@43DQDAW3%-!25()]9Q74?XITP,.9#WTD*4_YZ.K[$!
MG^9MVKC_PF:,YQV1:YR'L]Z5HQ)!5/D2<SD3;_F1DWB6JR:8:UYY(A(8.V@;
M,S$%;YZ7NS":4YUKYF?2X3B-%SE+[.;,#2=\.M+2C=& #A$9:?F@DWFA%WG)
M)2>/QP08B9UZBG& +GF <N@=LP-;D*@@[_$58/H>QP5>G*A:.  N8--:9!/O
M<5-<A)-836I5<9^):#.@MD:H:H>8.G*MEW(QG\9[Z#*$"*F+D/)Y]#(B=[)L
MU.@KW_*BCE,V%_NE6G.P1_-X]*":ZJFS(SLY6T>TNP:1ZOJR4W.M8WNDSJDG
M9[NP(VHCD_+Q[:"UCS,HDWN$+,>Q0[LT;_\SH!)SO<,[@90J,S^(+C][L%\[
MKU^R=F#[K)OI=DCIK9LSK,M?.7>((?3%9KWSKJ;A&:)A0+=AE,#A/GN"'/XS
M0%\\F+S6M-K6LQHBF>B6'LX6F\A)#?#6;0U77Q1*3/-T3R=L-PKLS1_7BG68
M5,^KQ4J*QO+BO +LR_9B>GUUO%IB?6E8R0X]2G]U4$LCN%B7TF.8U=.T(]Z8
M<:'LNIPLN$ILA16*U'M]BM5KNLY*O)(K2-]7TRM8Q?:\@!5]<W%LC%5,W;_8
ML)0]44\U@8EUV!LL.9;UW*.7<X5T$6B]JN LD@&9RNALS#"9/0*MDO7LD>W8
MT89%\SJW;"LFK8W_VL\@;^@<)NY*6[%96P.536 NCMHNYMT0;[A]F^HDCDX6
MV[99#V..]DSFSJRY;:,]CUZRV0.UKDTJ[M=:VNLJ]ISUV>LS&U\B+VOOY+C1
M[J;Y#^E#Y*+!FW'+?JQIFZ$A[]^^6O<?[^X3/]VL&EM^6>$$IO>(#>-X+?L0
M+INU[4;BS.KGF>1N6_TT+;+Q?M^8#4#@FA!K0J*!$Q :)(AK(4)L" DB+(B-
MH$&)$@T^3%1QPL.(&"\6A(A0X,>#'1U^U'A0(41L)45.*/E28BQLE$**M)CP
M9**;,E=>_.EQ(#8#1X^::"%#J5(9+4S(@"/UZ=.H<$Q,)3*UQ=*E1)9B_X4:
MENK8IF&%(#VZ@-("MV_APO75-B[;MZ7JVLT;E^Y>2G/S^N*K5[!>MWWA_D6\
ME_';OHOU:EI0"G!=Q7D?'W9<67-BP(LY0ZX,V6]BTXWI7F;[.:[DSHA9=Y8+
MNBWI!;XTX5T@>?3KP7<Y8X9+V;;LWZB'!S_,67GCX\)GOVWNG#IUXLB!%S<\
M>;KCY-H17V<<OKMQ\:6S8T_OW?)VW7N#:Q_O-K=QTN>AK[^-N#[CT+Z?4^^]
MZIKKJX[^%DM-N?*<D^^TZAQD;S=*#GP/L0BYJTU"OQC<D#T-V]+D,@WMJH_"
MVM0R0($K=%! @19;=#%&&5VD,48=')"@QAUYY/\QQQ\5R#%%?1IH@,@CC6R@
ME2*/;.5()*'4!\HEH32R2BF3=#))+)O<DD@JKXQR2R^MG-)*+\7D,DTRN3Q3
M33;'Y))**^=\L\TVP733S2?A_/),+9],D\]!V114SSO9K//.0<TTE$] ZZQ3
MR3^CC%)2.QLMLT\CP4Q3T4HGQ1)03_4<M=1#NPRTT$,O)5345#D=,T] -7VR
MU3VW_'13?3I-%,U?9W4U521-Q1/56%5EE-4XA5425EYEI?176YG%]5E7:U56
M6VME77/14/V\D]9OUTRQ@@H$.#===-E-5P!RW&T7W73U$.!=>__)5]]]^>W7
MWW__3=$ ,#SQ! E/J%#_1N"%&6YX88 ACAA@+,09 (L!+![@!8O%J>'B =30
M&..--RYG8RQ,%IEDE0=(\8LOBH#Y"PLBF+GFF&.6.6><98[@9IV!WOEEGGF6
M&6BC8Z;YZ*1_YKEIH&EV6N:H>Y[Z9YHC*)IHI(>N6FNKC<9:Z*![5OKKF+.V
M^>PO(E":ZJ>E%IIJL[O>&FV@TUX:;YC%MKEOJIU.6VBGT>Y[<++U%IQKP%]F
MO/##T5:\B)_U+OKOI_/>^FFO>Y;[9\7IIIMIGZNFF7&H-^>9[IOA7OQSIU?7
M6W2R(=_;<\29SKWLM'U&^W"KTW:;\KC5YISKR*V^6^@4?SBA^1^>=]Z*%7XP
M_\)YYY__@7KM?Y@>^NV=I]X*[)]/\2&0:MHIIH@HH4@D@MIOWZ#XSR?I(ION
M%\HB]K&QJ"7_L7&3_I%D@"=!R474MS^'J(\C,7%)1]0W@?8)A"<#H:!,)%A
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MZ5)E+_R<+S94])T@4)25-)>7R4<E%?6*E$N/]$5U.9B96?H"HY*=0P"'-$$
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MPGG,7EZR&H%00BT5L<U%0O(:G"=FD(+!IBA]$AB&? 4P@.0E4!(Y$9XHQ>A
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M^-V7A(]^0DW/4:2<)2\50:@A9'-2^ N '"MU:6WDS]+;V+\"_T/E/W.<XP8
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M5]XT_T.>^5V?JGXJDMX?]GW?HY9I,ZLI#FDS-H?S_'6>)TW1$UD +:'2[6T
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M1BR4H4%@AF&3113VH 8F O&NSQY$-DE4AA@C=B;2;%3GAER A%Y$A5JO8E4
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M*0M +KLRC8*!&R !$GC"Q7N"$KA%Q=NRUT$\UMF/,!<S_QRS,"?0  D0 ;U
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MP&S%7.TJC>PUY;<5TG=^I1?(,)1:XI<JQ5?*S.QZMZS3V-8EM9?,3'@DQW)
MGO(O[RS4]NM_+8W5F&#2PI=7EC58R!?.WH2L8@Q/&%?$_E*#2V70GDQ8#L;7
M0K,I\H6_+J4)KB$*6 V E;@IWF?  L6"8=( DGA1AK@!FBI,*86%"?07BB<3
MA>-2@#$2C>NE4')3+4W8QYQ"V(9&V79&V83&V)"F:'+_1CO[>&F, SJK39"Q
M!@FXQBG 8)"MQI"-PX^_C6W.9FW$DSR]D]W6[=SV)F_01AS:QMPTN0:.SM_*
M3CX'*'>P;G@(#N/HDTA1IW<.3G..Y]_Z#9;YK93M#>&25.,&M$OOTSY'^>K
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M6!F!D;2"(59NA5>#"%>"F+0MP+1X11F.F!PJMEX DK79J)*5A2,<IHGGF!L
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M$&!VVF^O70!R<.<]=W($ /YW ?XAOGCCCT<^>>65!XD*3SQ!PA,W6G(^>B3
M@!",YZ&G0AF7E@<__.4'P&*  5X80!STR3^??'':QZ*<]M%7?X!RT%\?B_KQ
MM^B+(OS_0@3^!T  #M "$8@   ](P/\!_N]_"WQ@ AWX!0!*L( 4G* %&1C
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M\ A<*(L5%(N@P 8AE!#$: RP2 226 RN* *@$/\*QR@*%+FGP1B(M(B*MY#
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MSNVT%X #'&R#.(1PN'2A@HV+@B1Y3Y2C&WS_XURK:8G3]TRFM6<3&)NW^B8
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MT$9/_"!U;FPC-Q+G!MVSD12QZ<WMDW]&1M;@D(4\)!8F&<E".G*0U!] #=2
MR.M;GY"HR60K+\+,@18S(J=\)DB/Z5!KKM(CY3=I,=6?T?%O1),=M<CYZW_*
M88;4I/?W*/_[X=]#[%+]@5]%B!\"&L3Z-1/FB00MB1\ 2E0$.(&O4$%!Y-]
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MI,#]G@C^#*/[^LCVC.^;JH^1;$^,;B^5H(^9=J^.$@F:BH_YT"CYTL_X4 \
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ME@UQJK-^RCXD SJ&5B6N(K!^-CB>8Q@!\6[Q-F]]8VO#UB,B8 +_(N!NMS%
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M&O(R;P!^*(?*@8:2.JEQ2(9D:/2DFO-RJ :6*&'!=?D2MHT>L)"2SP-Q;Y$
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MK"26B>'(6E1I&IK0A9=%6<EFF!D=D!A&.KB B6I.@YUL;H42*@%,2YICDNO
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M [@V/<X3/6X !E?9-U4IELE6;%A0 ^_3/>/C;-\3/\OV N)0 VIPEN8CE^5
M/PT407N40AE'0T%';R540$D4<'RI0'RD0&"4<XCD<FW40T2G<N?6F(-4<E94
M;G-T02L'1X;Y0P2$1D7W09>IF9_I1E DF4=42'RT0'[9F"8$F86YF@A7<8?$
M0G(D2$XT09QY1X>$0EPT<"$DF+TI=)4)2*))G'LYG+DYFT"TF]KFF\A)1/CS
MF- 9G$BG1,VI;]HV2!M$FLL)00]D/Y?Y1(Q$$5P7=9!D!8_T$ D!2IVD$.-I
M=0;AGI3T=6<A&;R42B\!4O6$>MO!'/\L-53XU$Z,$7BPYTX+A4JJ@1[ \4_3
MUQY.\0N2AWGUN9\*55+(=QE2L1X:\17GU!4Y51LNQ7VF5'9^MTO1!$UMYTK"
M$5$%E5%)Y79#%5-I\4V[A'KT%T[)I'G:UQ@0):(I\7YX)WWUI'J\5!=+X:'C
MA%$QP7BN]$TG94L,%5"*84]T(1U,ZDZQ8!RQT$ZN]TLQ-:$L151ZL7XC>J/_
MI$HE^G[9@5#VA*1[$7[K04Z6=Z8R6GJM1% )RG[AY';:]W[AE$JF@50] 1J<
M 1=,%1\'$E6(FG]591]"@!_X1R #6%4-0H #2"!8100,<B!CA8.ZTH;'XEX+
M "4AXE?:15S_F'@BD6)8FJ!<Y"5:FFA<<\5;?.)6H%4AK*J#.TB$-W)=B5B&
MC*B$L)JK@I(D1_@GDN*"E:6LZ_6"R$(G@5@B8MBKG3I?@AA<K8JL@'B%,4*(
M/2B#8L*JKBJJK_(I'4@LKFI627)7KKJ&N!I98UBL1(BKR758SKJ(],HHK,I=
MPW6JKU57^QI>R5J$6-(A:RBJS2HFQAJ)R3*M,I)8UOHA!ILGI?JI1O*PXDJO
MS,J&CHA8F>@G\UI7OA"N[04MUF*R_'5?_35@"I"*!;:*KH N!J:*X3(N$K!@
M&X9E\^@T0&9H9)9D,_-H3^:3/E8S'V9D/JLW1\9C$,9D2&8Y%08R_TM[M)9C
M8YN6LX_&8CC;:/1B-$(6M80S,MY(-(S#CAA6M3KSC35F+ST+861C-EI;CG+6
M-3=6D2 &CV!FD0P):@Y99L]8CX2&CJ:CBT:V8[R(C6L+:.88N%UCC0OSC2/Y
MM&Q+8I(#-"^&D=< EL#6CL3(CX0K:(N#N*"KM;\(.,0(M6NKMPPVM#V#LVDV
M9BM6,(@#:H<CE/=B8RQF-7A;-%R+.;L+9K +-SF;:4Q[DTC)E$S):J?6:K;C
M:F+IO+V3N1A!!520E5KI"6[@E=$;EL\K;-UC;&D9;0,0E^ 3;7")/M,FOLVF
MENO[ MEFFRE'0PZW<!<7<@,$;\9I<>D&F?^TZ7)$!$;?-II?I&U3I)HB9YL4
ME',EQ&^$"9P=I[_T>W,,[)OA%D0GQT9%QY<5_)<$S'$JE$$6!$ )C$-R=$-7
M]'*?6<$5Q$6J64"VV7$#9' B9P$";,! =,'OJT8,S+\^Y&X(W)DG=)U MW(H
M!W$[)YSO5L.P><",29W]MD&M^05.5Q _,!%15Q%3C$E4_$D2,1#G^71<?! G
M\'4!U1*M$1I]AQ)C%QU06J2?81I5,7M]<4MD>DO&8<9644Z)\7NPH4]^)Z)W
M1WB-UQS+Y'>_H*7))WZ\81N.%WZ"\1IY;!:"5QV0Y\9YG%#B(7[.U!QI1WD[
M]1L'BAIX=Q[3!Q[_S:&BB4=2Q42CC6>E0XK&U!$:JY>CB!Q0KK$=E5=^DXQ3
MN;Q/.Q5[#F45QE=2@&H:/OI,[Z0:4:&C5HI3YF0;HE%^M>1^Y<3(Y1<:5)%X
MDO%XOM<7GJ%W;#%X>3QXT$%ZA1H6OG'&>C')MN=+M005]_<?#6(" #(? 4)5
M^5<@ /BH\OQ5!<C/ IBH$Q*LAZ5;L3J"ODI<&BB%L3JJ*,BO:Y(GEW@D#AA>
M$CVJ@>A8,8A<*0*'Z=J(IJ6PRP(J=Q*$MBI9"+TI*:*J-^BP@R);!FV(ANBP
M5R*P.VC0KPI9&#N!Y*4AYJJP_UI7!KM8KI*%O)(LOV*LI;4G>S73DN73_ZR"
M*6R5T7;"ATSH6L#%)ZJ*74&"A]T:JMZJK0L0TG%2L,)JT!_=K ";7F'=)E(H
MU =;(KM"B1L=5U[-T<IUU\V"UG$MA-_Z)S^H6"$K@8S"B=8B+9Y(BBI+8.""
M"ZBH+><RLX^=BJWHBAA1:?!X9H8;ND[V8!@9.:*[M4';BZ(S9DY;,V33N;;[
MNMF8V2*C.:O[DCF3D !9,3W;D.%HD<S(8%%;NV]VDRGVD"3YM*O+.;6P,+G(
M:0V3DQZFV_[R,Z]-9/$"-8T;CZ;;C1:FD)<F9],MM(\CV]9X-.88C&X#WJ1+
MNT<SD%D&-O3"-]H;'QT)VHS#-(];E(.6D9J3,/^<9K2HZ]TL.6E*VVE(>S$T
M$S8)B9'//;E'"]WT>-M\"[8 2=L&_MV;MKCM@CH8D93*RSJIYFH</CM0N3O<
M*Y;NW3?36STD?CTB'FO))CYN>6QFN6QRF3[B4PYF.>/>(^/B<Y<H',"Y>;\0
MQ)K3.4$XC,/':<1ZJ4AV=)S\.[])KD$19)M=M'1+E)<DK$!'')LMC)@?O'2N
M^9=^E$=$7IQ?'D.(I'+<R9RF64$*UT6A"9@?=.9:#IS6R7)2;L)C])V!&9Q0
M;,*$B7)!Q)H>#.1H9,*I^>:5B>5*;.5S[ISG1D>>*>0)A#]2G,53;,54=P(*
ML<56MTGF^9X*(4J[5,K_F0%4#0H:9!I,005,,3%.!Z7'T)%2X,2?&IK'3+&G
M^?1*..6D-S7JV8=\!'K(@8H6I;2C1N5/*E$$!MJ?;!I3*B54SGY3C6'L)$6?
M0<6FK83&R 2BQ Y03:I+S?3,+C5.SI$=>[P7FE>@=#JHQJZ?@1$7/!&F/(I]
MPSZA:;&AY%X>TM'&Q82B2T4)-2KN;WQW+B7M)U%+Y:Y\!'I*_K3*I4X4S\1]
MF_Q0LCY/B?SLNVSOTC130F&CV"?-T"ZH;VRB>6I0Q/%2324$!QA6^$=5 R)5
M)K#/]N%54B6IE.H?\^%4_U?/G!J#M8JO8S*K*0A7)>A>;YC5>1VMH+K6-VC2
M_YZ:6FT-]"QM7-^%]-S*(KSUU9E25G#=6S^-(X!BA2B])1A+62?]]!YK7! +
M6_ :JZBBU@1-K8"UJT.RK6,"LDL?(V]M6!N;(GNE(5B_@W=OJH)_]I2"(11[
M]L]E*(!_TVVH]F+_7LZ%]RG]@I!_7,Y:L7/"^*0J@>F:*3DH]V\UT(:OL1T[
M^C;H)CK]5X6M /:E7RGK+2FK  #F7X]-+J&XLN)B8-^B+NQBN&L3WZ ]:":V
MDG1;CUVV8Z%]W)Z=LRTIW53FM+H[9;6;8DTFN"03W7J#NMD=MYW[NV3[MZ_;
MVZK=W21CN<!-.;/;8I\-CJV]N4%3COS-N]>H9I,[-)J91F>E&[>CRX^>#1#Z
M6C5HH*F!/GT'%;9*V/#@P(4$!S9TB/!@PXD)&388J(DBQX(4(2H4*)(@R28&
M5*YDV7)EE8\Q26H\:=%AQHL/0^;\Z/%B3)H5/W:T"=+CS8(\1P9=6'(F3XX"
M<T),6).GS(DZ-64=2O)GU*M0*W(=N!&CT+ 6N3ZM>+!E!;@5!,"=.U<N7;EU
M[^H54%? _S_ @04/)ES8L&&7B14;4,9X\6.7AR5//HQEP #+EFNHP7SY1><:
MF<59_OQYLV?4-4R_:/GE2Y'7L2/ GAW;0NT($;[<ALW;-6S@L8/#EBW<]>W8
MR8=_T4T;^7+EQH/+1M[\=W'?THUK?V[<NG7:VG%W![_;NO;@Y8/[)A]=-G'B
MY^%O7Z_^>NWMMW,G[SY_^O+_S',/.@#1,]"^VRQ8SC<"S<LMO/2,J^X]\;3C
MKSS=](MPP^/*&S"ZWN0S;S[\"F10P (;+- [%,5KT,#N3H2QQ.L"Q-"VVA;,
MD3[N,K2N/Q[?:\F*%7XXX8<BBR3RAR6/5-*((Y>4LL@?C*SR!/\CK%RR)6P2
MF6 "2K#Y,I8O)\!E C+!Q(;,6,0L\TLOV7R33"_1A/--,]6LLTPYQUQS@CWI
MM//+,.LD,\P)L#DST#SC1-/-0O&D4\P][\1334KY;#/--/&L<T]&/^7SSS=Q
MP2;,,\$L(DU%[<2FRPE^(?/,3D4MLU) YR3URS,1S=736U\=M=-!O82UU30-
M?=-85&&U-,Q"7_75V$H##;/3:^\\5=%6;R74S31-E3/2,GU%LTY3IWV4SSG'
MU!:7;.%\]<Q>Q13TUW+_7)3=02U-U%A34W47U$1I!3=/5MW%5TUU%9;T7X65
MC65/6KU5.$QG^[73V%H'3I1=9<ML%5'_2F7E%5\RW60TT6M%E;-3<=5L$^)B
M$R6V)2'@D*$%&71NP82?3= 9#A-V%EIHHXEH(6<B@";"Z)_AX)EGJ9&.NFFB
M6UI@:ZX7H*1KL+?^>NM2-*D#[+$7T"1LK]E>P)>NOQZ;$E_2%MN74MS6>V^V
M[?8;;['=3MOOL.G.FV_$N9Z[\+;;MEMPQ@WOVVO $U<<[KC/MOSNPQLG'&VR
MXX9<<<8=KYOKS@,76W/*#Z=[;THT?YSSTOF>N_+-[UZ<]-P]5_UQNF>?'77;
MO:YC>,$Q;YSTUT5W7O+>(4][[>3]IE[UWH??'72YHV\>>;UOOQQ\YRW?'7KR
M$^]^]/!Y_[[\_^()7W]Y[H_7.W7VRX:=?O1Y1WSPZ/DO;LJ;G.U.1T#L"7 !
M^-O<W%JB  7HX HZB. $+5C!"$*0@AKD( 0= $$)4'"#"OB@ B0 012:T(,M
M:8L^#((3M7A%)C.<85IT@A2;!*6&+32+1G((E8V\T(<MU$<MBH(0J;A0AA*)
M"% 40A BRO"%8@')$14B1(,XL2@P3&):AC+#*59E(F&$HA([4D89:O&)7)P)
M3:IX$8,<A(P^O @;>P+%I)S1+&5IRE=H:,.&D+&*0$E(%G6XEC=6D2MH.:))
MF*C%BL01(7Q,XA:/N,A"*C*-7EQC6][HE!8^Y"/7@ Q+I-!(MJ"EA_]^G(I#
M'LD4/#*2*;-\XA+9\L@ZJI&1<MRD32;"$%D>Q(BA1.,/U:+$5'+2F("$XRN5
M.<4L-K,5+>G+7:RIA[U4 )M^T>9<]%#-;\J%,N,DYV!*>4YT0J:<ZS2,9T93
M@]%@IAP#^ P6YOD9-=2 GN*@)VKPV<_2B.,SK>'0A\"SGP"1R +TL4\1<K-0
MAT(T A#]#9#\,U&#-C0Z!\4HA*ACH(C6Z#4>2I%(X=-1D)ITHQ+5:$)3ZAR4
M>J<Y+66H='*$4I<J5#8T)>E]F$/1F);4H?O!:)!.RJ.2IA2GWJ'HBI9ST*:.
M-#U13<]W7JI2%6'U/@O=Z4BIRB*'3O6GQ?'_J%B3.I^-:A1$(+7J4G_:T[66
MM*@K:HF5DF0%).6U2%BR:Y6HQ%<JK< *)\#KD8Q46":UI$P!VQ:@3@6Q5#DJ
M$7WZU63]Y26! 2I9;K)3LC;FK\L^*K.8W18E1(:H/5%J6V=Z[+U$QJ9.S4JT
MC[53JDSK6-/2B5.+!=;'(G:K-F$L$=LZUFV9]:7'NLQAN^H3FVAKV531Z[7]
MVNV])*NQ1QG74H[B51%N*ZE7#9=ER%INIXB+69H1JTNM[1=C31O9.PDL98Y*
MU6;[Q5[)-E:\N<H4L7)EJDQ=:E;K_6[-<D6LE'E63KCZK77C:]J#M6F]@XK%
M+X:;+<ORU[Z>Y1=W_[>;IP:#F+;$XMAG&YRN?SWVN>TZL*?.Z[#*?E:X#O/P
MG=K4DIWUK&A$HYK1<DRT'YN "#Y+FM5XUK2?M6!J.R.RDH70DN M[W1NFW("
M2U'E!4[YRMI+8 '#MF70N8]^5 8SV*['/M15.<I>_MWINK<^\(%ORG#6&P+A
M%V8V#ZX.FN!R +N&Y?]A6<U=+E[7^&SH+&O"=6[FVJ$'F#;\]?E^>*;TWLH<
M9^R5.8"+$UZERW=IXO&M<\ SG^C.ISH[^YEK@W:< @G]O%)_;LSE(Q^F3RWF
M^>6.SNF;'  59S_*@2_28;,?I_^<ME1CC]>12]R<MP;H*9^9S8'C]:W]Q_]H
M5R//V&!+G; ![3MPM[IK#YP@!%V!PG-O<(/ESF '(WA""I8PA2<\MPD=(($/
M?E "+5%*+#&2DZ/<\(8Z;*(386@4BQ0D*]!,R\%=Z1-"/C&4E>RW)]=BS*Z8
M)(=5@3A5$+Y$K( $EZJDXA_W>$6T> 4G:5P*2#9RQAA&TRG ) G,0?YO)D8D
MFA"O.%*BXO%%WC**9@G+R8N)RJQ0LN2?I'@AR2(6'NY0AE29>"^AWL2I+]V2
M3Z%Y(Z-HQ2I<(PDI:<G8KX'*KD SE#"WXEFD8DA1GISG7PS)%W%R\(RT_=\!
M#_D@GSAWI,@\F;[<8C+]OG9..KS?8$DXX$7N1C?_NH4E<<&+7K"930&0@R]R
MT;Q?V/GYPZ13]*-7">A-;YG.:(8TEUE]9S[3SWYJQC2<@?U 6=(BH2*5.;IW
M:7?(BM"-TN9!NP_0C#@T48WJ9T?^,2AS:#0?(,65^#M%:XA&U"&FYN9&UH=.
MC)"/(^'_2*W<QWV0UFHA\CM5JP$ZT8NL+_VP3E]'9;T._.OO?K!./__5?ZM/
MLUH@$:$0Z/,1'*&1GHJ_[)B."8$.Y ..Y4,_D2(K^;LJ"?F^XN,_ +RJ$P$^
MJ[*H^WN-(0DLO=*2O2)!)H&2*V$2*D'!)3%!+D&4:"D53%D8U'*8F9D9C4$5
M?JFM7\DL\(HMBY&M\6*L_TT!L7,I%>+*&#-QL$;YED^1EFT9KHS9%Y"QDVN1
M+S6APGX1KY3!%U.A&/+BK)/IKQ[DKTAIE43X!3VQE%@XPWBQE66)PWMAK4NQ
M,4(I EJI&)2!F(RY+M%ZDVO)E#])+>72$V'Q%1RDPIFIDQH\&?K"E]3"PI.Q
M0X&!%G!9$S\L&)E!F?Z*PM":DR)DL(,!,4'Q+'4IK7E!KDE<PV\!%#6\%PZ+
MK8/10F79EU/10]""KWR1+C,Y%3RL0OUZ%)AI+#+T$U7L%C:4P8E9%ISY&:B1
M 2&8FJ,A,I]9,B7K&6R,&J/Q&: 1FB2;QI[1&@;2'^8A&VE[-;<Y,^WYMFE+
MH/^_L1QRU)U'HS;FP1U=&[.RP9QD6S.T 30&:I\%4C520T=3@[5.6QY(H\<[
M,T=@*QO664A*XT?$D;;8$<@Q\S7HX1\!RC6"%#?RN9[M*:#F"3, 6C:3##;:
MX9[+&3990Z"15+8&HK6]L<<WJYS;^9M%&[9GNYS1D37/84>>!,B[Z<EO$Q[E
MZ3/Q0;/D41_/,1NP(:!NJT=?ZS5Q*YTWZQH&$AZSP<AVE,=P&Z"\F9VHA,B^
M23:1G#57JQUY?"!W&Z%V$Z$.4C<22J&W=(!XLS<0RDL "$#WOWQC(:&X.*^0
MB)@0/+4PI#AJ!8;+I*( S)J B*13)KH#S,)4N6!JNSQJ)<N,I*\JRJ*@LP@A
MPB5$>KD_HHB8<+A,VLQ,XB4]JHF;$,V:DPE1LKK/O"*0ZR1FFB0<<CG5](HY
M8CR!XTP_ZDS*+#R,\\O)O#J,$[K%; N&(SK,3,VM XKES*/09 NXH[NO2Z/=
M1(CL3",DZDZTXXC=S(JHH",QTCFH4+GSM+C S#F],\[K1"2P*$S!7+SV/#Q(
MZB6'B,QC&CBM8Z48:D\WVLR\HSMJT@O,LZ;-XXMJ$H!M_S(]!PT,THO0<WI0
M=N*,SQB-T9BGS-!0>4*-U7L!>,*"$-6GUS.-EABJ! DJD7(K $&I[VBJI6*^
M XS G%I1B?) F.(1%Q6.&(5 ];M %N6]&NG1&DVHY5,/X&M1BJ*.&34K'M4]
M%16^CPJIZ7!1&+4J^@/ )0T/'MW2M8K2E8+ CGJH"<R],96HJYJIA2+2+OVH
M'8T_!R33DUK3D4H.[=L_IGI2+G6.*653*IW2#_D/FF(^_E-3"0Q2IWK B^*J
MED@2(\F2(P&LPQI!%)Q4OHI4O\(KP<HK*V@)4W&L9=DLV@H6-VFL7UFQVH(5
M6/27$=,L$[,5$D-%9_$2"'O$SO]Z+!031M!*E!%#1G=9+WO!$Q_$E4]5%O3R
M+P\+&>3ZKN#ZL%C(57A10T,9U?VB+5P-UF!QEV*M0\HRPM%B+]TZK6ZY,-!"
MKX>IPR?403 Y+18;UE)]+V>UF,5"QF:5UUU9$U1MUEA]+_+*57R1U4JI+V_Q
M04\10DC<&$%9,<ZJ$V$QKPG[+VA)57910H*916TQ+7*%L0M3F6[QU^ :U3S1
MQ?_"KU]%UEZ$,%RTE0M3,&_9K._Z$VQH"6Z<61,XFB#[1FWD,:!A,JA)LJ'9
MV22#&A/0&K(IROU!2Z1-RZTYQ]\IVN'1-.-1-(-,6E4K-(5,2ZEU6JI42Y3\
MRJ,-28[_7+:CY5JR7+5<XTB5E+*S-=OVX;4K<[2J[++Y.1NT;30O0S9M\Q^H
MQ;*KK#6-;+11@S8N&QQVM+: W-JW$4H%TK.LW9^^3;.Q@5IZM)N]95JM75K$
MM3*N%;1J,[2QQ%MN<[:Q?9N$)$EB:]RK_9^T'!Y'F\H PC;D 3/)35PKB[8L
MLQO++<=Y++3IT5JQ;5ICRUIM TJU-#9(^S:VE""XA$L2VB!YJS<=^"#FK3>Z
MI,L3FLNYW#>6D,W >[NS( B? +J=*$_%Q"/<7"2R.,[N!=^]^S<QRL\?8LYD
MVLS9C*&(L#K(8[S13+S:++JD8(JY<[F6FPGF)"*?,Z3BW-\8_S+-U]2[B:.A
MH/.XZAPZS[0*B-@*(*J[_]U@+4I-F0M-"NZXH@A?K-/@2<*CQN2[WA1?6D+@
M^<TYM4/,M'--_QT\J=.EJJBZ NZCC&NC3WIACH.\C'M@8;(BHFBXB-B(8K*Y
M6:*[(VZ+"-Y@$O9/9;K,K),Z#MZ[^A6*MX@+ [6+S*N+SLL+S/,\"C6]T:,"
M)7 #)&AC-W8#-P #"36 ,RZGU//0 2B'U1,HUQL SM!C?BH-@!KD%Q"'UMBI
M._T_E;*_JA)2%P&_Z_-1 5Q1\<-3]1L^',$1WV,^(/&-X6,/^TA2_<O2%JED
MXOC2\B._X2/4"90^2,X/14VI"N20(O\U$":MY4G./O4[$.^PD0;Q/O$PP.B(
MOJ$"OA9QD.&(98-ZJOJP91.Q#_%0OJZZ0)7"C?( Y5[.9%86TA]UOO-K$!%A
MOKIJ$BM!0<-R5,.*$A$\+$BU@DI5DB+A$@I;%V]%EC3LK%ZL%DU\%C&T%(&5
M0@C;U=_ZDY19+_\:F0"KP7&%PI!91HG]%8?>PP,36%R &1-;14]TKET]5H#9
M&&%9Q8X>+F1]%2#\0EXQU3@915QYUB-4Q&W9+8$Q:64$5?.2Q&]9L,Y*:?^R
MQ719KXIA%'@Y&(#>E5UU:!@<1)+VK4,AKXYVQ/"BYY.5%TS)K &30MXBETIY
MZ31LPUTA%QK_NY2 V44^\1*.J91:2<460Q<^042QWD3'<I.8F=:3)I8SY.E>
MQ&G. D(EC->CIL*5%E8OU)B8_A.2:8F:Y48AR[$>V]F<R<:=A0.LD4;(SD:A
M'1JLP1JBC1P"0A^7E$G?^1RYH4E+HY[;B<?T><F_O;.;5%SX\86U06U5LT?O
MN4A"DYRO.4J$!+1;2\J?=!W3&36T=,B.A$>G[#*'',B-K%K>KNVO#&VAE$C*
MX39-J)NUT9\HL[/0SENE99OCUAU]V.X!BA[<_MKQ'MWEKMJ=1)RQM,C1;9T%
MFN[()6VK#4INX^Y^U$FRQ,FF%:#Q/FW .5O95MV5G+3" ;3K 4GP_XY)Z*;=
MMK'<L$TU=?3*_:ZSNRW+W39+.V/:!Q*A<E/>#))+MY1+#[I>!\"%#\(%#LHW
M"7"%$[I>!>!+II.XDWBZJ?A+YDQ?0-JEFSM/L$BDPT//3PHC,ZK-+P).]]6A
MPK1.QY0BV=1?WD0\^U4\VUPZ(2^YA*/?TIS,7=K.KN-@/]JATJQQ.Q(*1NJA
M]T7-6F+,D>//\FQBWA3R(O*D'G<E)Z<CL; C9QIR@C/BD7/?#!9/W+0B)^\Z
MQ'RCY?PZ"CYAPH.Z#P:XFJO,^ZQR):[Q!ZYR5!*D,6<YUURE_]PDQ;0)+A<Y
M8+HX9!IR+#**J#C,4N_,E[NE.O]Q?: F:_\ZT ,-XV[JIFV:BSH&O7-2!BH
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M%T4:&A!WF7N@X[(G0.B),(-;-"(/Q?BZ"4!*"$)H@0S@8 (BR&"-)C !'&3
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M5R\YO8#WZ@D<>*_AO?\2*U[,N+'CQX_MVOWA"4EER9@S:S:@#$QE3Y[ ;#8
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MQ*XI+3 ^^>6/3\GYOIA//OKKF]_^ I3X4LH"])_OOOSPK]^^_?&K[W[Y\@?
M ;+O?^PS7__T=[_V*1" #=P? C51!P8&,'T/C%\%'>@_]!G0@ LD8 #K<,
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MFR@4 EDEY@7BBLLKX)6OY#PK=SG+62I$EL5TB$"":9#4&P0AG3@E?)P U,M
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M_ R7A0N5-5K3H W8M R9B8M0CF6F"1N@,:6RH274_ +?Q"176J6P/63FQ%G
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M(?!/_P;A+_\.[H/^!>Y ".AW8//9CW[Y4XC^\W=__?'/?>U+OP4[<'___2\
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M<BF9LBF=<KBNR[JDLKO::[W,"[S4ZRK/2[ZX$L&\\BO!<L'ZJTS($L+,,L(
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M-'F555F5YZLK8?F593DL:3G!%JPL%RPKQ')-W/\D*P0 +MDR)*B "L  #-S
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MZ*6>Z+FW&,UWG:X (=B!&(W_D9\DBB"0D>RCL4@.HAOE]W^A47XA@H 52J$
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MJ )<T5!V$+2C$5WH2"6*"P<0U &XD.A$)8#2B#I  C.5:$U9&E&8TG2G#E#
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M&45RCX/\3?_>TZ0\7JDWD=Q1,_^2H_P4<YO/'$I^2E2J\@3T1]')4&#24JO
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M_)'SA$Z:G)'G%% E^5 L64XL"4W^Y$_B!%#Z5$T#1<KVE$\%E<H/)<L1!9)
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MR#."M&.#G'.#R;L^CK."Y1,^1*B"TKLX26CS1Z@]ZH,_-XB#-D_SU5L__\-
M1MB%24^$,WA 3HB$6YB%ZRL_^[N%!#3U5CB&ZVN'&Y2_ ;SU_BM#6T]#_*O
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M+& !LY<E_1W(@P]<X8HX^ K[K3"&%T*0#E<$Q".>\(0Q7&&&A%@!KDA)B1T
MXI*,I,0K3C%#8EQBAG D_\4J24F*8YR1'=-$ 3MF24V$H@!<Q.0H/[E)570"
M%"@S)2E/%DI3K#+EF4A9*E>V\E6FTA0O=R4K1C$*F-%BEC*;10']./-:U'R6
M-+^%+6^A2YWM[!?&9";/B,$+9/"\&+A,AC&$48MJ^&R6O4#F-(@!M&84O1D]
M+WK1@CYT8B#=F=)<6C6/L0UH./V93[?&TZ!!3*=M(YO8 (;3PGG-J6$#&^8
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MKFF;^>._VW4_MMG=L($;JBD;X.U=P"F<PVD<O9G "5R;O3E>""S>PR% PPG
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M@!AVH1F*H??H ?3_\.$'IT\=ZD\>DC#]T&$;(D$>@O *2U ##9 $69 B+M
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MM^_^BORWKW]^[F/'_1100!T8<'Y7<(4!^T? _3G@@ ?<G@$I.$$)ZL !$G"
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M\*N$QQ&[7+,5\9XPL\4_0!&O#S_LK/,)0#\\\\X_QWMTO3[[K'//04/]0\Q
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M+>G()$8PC_D+9>9BF,Y@YC.9/DQC' /JSIBZ-8ZYC&56LVI5ZZ8VBJ'-:)8
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M5.B$X1,]JA,[N.,#SD,$6;B$UE,^]I,_]X,_9GB&:$@^)E! $50]0B! 8SA
M;+@__=,_.R1 =OB&#-2&U;.&=WB'!N2':WA A+B&?:@^@WB(?WB(.)1"_[-$
M351$)?2(;PB),Y1#5]1$.V1#_]-"'20$G$A 1-!%-*1%CTA$>Z2)5T0$J0A%
MU7-$8&1#&+1 >[1'M A#.92+-P1#(\2+9<0_L:A%</!%<21&@T2,*F1(QMA&
M<(!(:G1&S=A)7@1(LCA)6M1&-P!#CS1(B42-?J2-D<1)VYA&Y&A#DR2-?61#
MCC1)C53_29M4CI+$C;[42JB42N(HCI*$2:#T2JTT2_DH2O7X2[&42P(Y3))T
M2[E$3,ZT3<&$38TT#:0D3;QT3.%D2LLDD=4TD=C42]_42Q+93@\)DB(Y3OUT
M3->T#26931\%3-[42!X)D@K52-%$DN)T42XID_-$DRF)3C-I3O=43PI5DRW)
MDP@UDP8E4$'Y4?04E.@43Q?%40#U4#.IE!_U41Z542_%4Q UDR,541W%E1-E
ME2\EEB]5EC @3UYYEB^%4T'54>>T4N<454^%5$,%540%4W5YEW1I5F])ERNE
M WU95'-Y5$&U5$ZE54H5575%53"@5&TUF%6U564U5G>552X0_UA"15AN-5=F
MU9F-F9F5U9E_15:D"5B2!5=\Q5=WI560-9FFJ9F>55B$U9J5)5G(59NU25B4
ME5>LE9NRY5F[65I?95JM-5N"=5G+-9S#>9O2=5F=-5K,:5NZ%5K(J0.WJ0 .
M\)P*X K3Y0J=U5G,"9[.J5S:J0#:.5VC95S.-5T.@%S<%5ZVY0K;-5WV-5[P
M59_M95OP99_095_[.5[S%5\!*J#M95\&VE_^A5_Q!6 *RJ -=E\.^E\&]F %
MYF 66J$4%F$,EJ$<"F RUJ$9:F$2=F$>BF(((1 0QF$GNF$LBA N*A$V=J(J
MEF$\]A H>F,UMA 901 W]A UD6)!MO^C$I$1/<JC0/H1.&$0&0$2)$$3-Y$2
M2_9D'C$34'9E699E-K%E.Z&E6!841B%F<Q:F=@848"866#$661%G=-85=K9F
M7\%G<G9G>T9HA@:G9D&G=W874A%H=F$7C'9IZO!H@EIHB#9IE89I<N%IFT9J
ME99IBU$6BRIJJ%9JDNIJF^%JKR$9F7H:KV8:PA9KH.H;O28;L,$:K]%KI6%K
MP+$:O/8;NW9KQ:9KR:8<L-ILT*%LS!8=UL$=T]8=W!%MX1$>YS:LY<$?[.$)
MWY:LWK9M[D$%Y4:LT/H/ZU8A^58#6% .!P(A&Z)N'&*M'_(A-: &X3HB_F8B
M)4*N]\8B 5?_<"$2(0@7< [W(S]R<1W7(_(J)3HR)2XW<1(7<3X")ULRKT#"
M=!IG<70R*!O'<C82=5&"(W0R)W4"*&V")#4@)F@R*'LR* B+)F8"L45')B!+
M*1W;* -K)T(')Y8B=9>"*/_Z*(\")4V'=7*W<RN0*(PR*5T'*UNG*F+7LV97
M*Y6RLSY;L[ZBL[VB*XE'M'9'M$EK=F-7M%"KM+_"*,)"+%2;+%0[+-@R!#^0
MM5:++LUB>(>'=V!K+=G2+=YR+/32+]IB+.9"+LUR>J:'>G2;,Z[7+_0RMPMS
M+[!W>_DB?/PR,'[K>@7#M[.'+Q,#+\OW, K#?"*S,1'#,<PGN2#S_S(FDW[/
M%S&ZQS(M,WWDES,QDS-(T[F;BS+;)S04<P(1Z# 7^#< .'])(W]+4S5F\S1D
M<X#M-X%APW]&0SEP@S<*N'\,^#.T&S?&>X&*0SD(B(+,ZS8N.(,HJ#8(V#:
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M*YK@M1C](QJGT1G[JYG^8YKCW9FIZ;_G%4  #,"R^1H#),#J_PT;MDG !%1
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M26O;SXELEPY>.O3HYXC(8-\^NOOT\HD(>2__OGPX\NOC9T_?OGO_!0B=>RU
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M83_X8R,2N=$>[_$U5E$BIV,<$9$9(;(VIC\ZWA$C;R/\WW\[]A$H[_\?Z3]
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M6 7T5;*.?:QE"RO9Q.K  8CU[%XKJP '6#:QI4VL W!A6@F85@$2<,!J5>N
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M7&;[ZD_]1H;^.@;\ EYK>J9G#'[_>B;@Z0_^(-YG:J;[^F]U]2__X.]IT*\
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M:9_M4<,*6D/O:1[X@</XP9XX%*#Q60<$JJ ]K!\#NA\,LA\& D0#\B &"L0
M&J !4J 24D0/(B% O" 'LJ 1BJ$-(J$8RD1-S,0<"J(+\D04"J(<LH D(J <
M.J$ARB$8@B$<XB$>$B(:8B)2%,59/"$C:B)9A"(>6B%<3$5?C"(J2L4B$B-U
M^"(LFJ,N&J,Y\B(R:D8X4D9GA*-GE,9I?",_\B,Z0J-$<B-"VD9$2J1O;"1Q
MA"1Q_"1+*B170L=*8B1U["1UO*-:4B5-8J5*LB560B5>NJ596H)5FB5?\J1?
M"LA\)":"1":#)*9CXJ5F(H>";"9GDB>(C/_(:=HF;:K(;D("-P"#=FHG*CBG
MBZS(BJ2"C1PGB2S)B.PG<0 H<:@!->"G@QJ &L"GF(1)@<*"B=JGFEPHE62H
MAYHHC$JICVJHE!(IDF*I?((JC8(ID\HGF"JIE;(IFXJIGC*IFJ(HH:I*JZPI
MK9*IK7RJJ,*IJ/2JB]*JLK(JEE*I(=BICJJJJC*IK-(ILORJE<*JKTHKJUQ+
MM/2JM20JK,(JNBI+K>JKMS1+IEH!MD(KP7JKQ_I+NB0KL!),PVRIPJ2JI1*L
MO01+M7(LQ-HLR<*LS32MS^I,SK(L(P"MSN),U#JMQEK-T@K-T7S-T8I-V#S-
MU5HM;A@"Y=JN%=#_S=O4K2&(KMU\K=[<K=W\3=X<KN!*3N%<SN!LSN,LKM1Z
MKNU"+O8*SNK4S=RL+>R\+>OJKNJD+_)Z+>:BSO&TK^\\,/-"3^JT N_*KPMC
M+^:R@O'T+O:$L.5R3_M,KP'[3@)CK_J4S_V$,/\\KOH$K__T3P'+3_B23PA;
M4 ][4/UJ,/R,T ?U+P'+, !C,1H#+X18B!=S,8?PT QKB(8P"!$U"!LC,1,E
ML8B "(O(L:%@B($0B28#"1NET1W#,:"X,9$ B1=-,C'#"!S-B(3HLB7SLBXS
MTH50LR;3B3<+"B:#"J&H"8DX"BA-B#JS4B<]4JR@4CN["CK#LY%(BT)#_S0S
M-=.[,#._\+*Z^ NE( I.6S.XB%-"^XO&>#1'6].;2(NUD(S(P+)/&PR[$-2_
M&(R^L(M0DXL_7;3(0 M4>XS/>-38D(%8 XU(%0W7N(Y)]0U,+373H-1:T[5?
M,S;?.#7A&-7K.%7;*-5;8]7MZ WT& [I\ [[  Y;G55WPP[EZ(W-B#9M^]7D
M* UEJ[;L@(_X* [M<+<!D8]LJP]^:X\ R8]F#8[]H-;\: X(H3:!XX_\()"$
M.SCG")&*BU:&8[B"$]=H;8$?&1!V"SEU33@3V1&!B]>5 Q&84Q&/BU8B@;D?
M>9%ZJQ$5H1$E81& +1*8N[D>.1(L01(;(1*%??\ZG8O8+8&2(?$XG\.YG9,Z
M.5&3.2&Z-<FZCI4ZD/T20"FZ-4FZ.4%9K*LZ/1D4+&D4EV65LS.24Q&50[$4
MORL411D4F#6[1LD4N&.[40G::)F52U&\. &547&\I(6[I.65I_44M)N544$\
MII6\5P&52'F66?&28H$4Q_N\85D\H]W:OH,66[F!SIN&9$&[6OF59LF6TGN6
MTM,7VH,6='D]UTL]O:T76I&7O&67UF,7:FF7VQ-<WTO<>U'<X-.7P^4]<W$%
M@B&7[>L7AH$8E/D7R66^R>4^Z8,^Z&,_[O,8SPT9\#N_F2G=E;D^FFF:F($!
MG.F9E<$9F&$9GE$_]I/_&=1=&:;!&J+!/_R[/_G[FJ[!/P%\F0'\FN--&@?<
MFKK9FJ>!7K51@+81FK;)&J>YWA!$F^J-P++QWK[1G+KYFQ/$&QWXP!#$&P?
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MZAN_X768CLG=U=69G[%YET= ]WOY^GMY V29WN6_D0% YQ5Z!T3Z_TM I#_
MYVW YYT;O!%ZM'$ J@G!$QP<#7P;ZA6< S1?L']Z]07!O2%!^AU!LE%?_E6
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M\ M;$%A4T S+,%^8, VQ4%W8L%_"Q5WD,%V,Z[9,ZP[S<+3PD ]+2UQ ZUL
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M%]<S*!=U(%<S+U=O'Z<T+W<_.D=S5QIR1_IM3;IR*X>E/'=S6P-U-0>EV29
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ME3^")T(2(PY")5>")O\Q9?\!YL$C=B5M,L1I\F(%/\16DL-WTF,&/\4>K/!
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MO1RP[GGC^][W\H:^&8KO??,;X :Y-\#VX6]VKPLA_O*(.^F%,( CW-T941C
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M35(KS9V@8YSP\1[A0=+W85+90;H%BCKQV1\RW;OI\1XS!=/FV3PGW9^NRSH
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M6>KGD9%?;Q'IM5'O+?87V5ZM9E'M"39E_S4BK=$7G9\;:?:V&I+S,6L785+
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MKEILAMIH#OTD*_TIR\IQR@NN_#RRN++/^R;/6_TMB_)N,N>XX?(RG^?$A#W
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MW\GA<M!I_UWSX(7/W7?<;1>^]^5])Q[PXRU_Q0[II<^!^ND!IS[[WZL/87?
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MF^D-HPD.Q2F9YE .Z? ..R":\O A]+ /__FP#OWP(+[A#PDB#@>Q$ EQ#SE
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M D'G/+,ISW/>4YF_U"<_N5G/?:(SH.9<YT 'RD^!9@0A\#Q(10QBD)=\@"!
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MWO2E-M4I-PN: V?NU"PLI:E):_K,LQ@5'*@I)T@+NA:C,E6H0BTI2I-* ]0
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MPJ_^HDK#._TF.S"J"X/3<,'Z0HQJQ C_NNS#%UL< L,3;XQPOQ\W//#"%=-
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ME$,B)?]]Z<8^,LB.0I=\3.\]MF18MLAIC/&$S&61?&8A[V=Y"2>M\O&*K)F
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M$JG*2S[2E*]$I11#6<I39G*3I"PB.$H)!%5B$I)\Q&0I*SG#4/+RD2%XY#N
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M L$1$-.P&1G) #'*#(D1HFPQ A$Q& ,QJ<RQ&2D1 ('*!U&1$ F3$],- .$
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MB1B5:9JQR9J6HSJNH1JP@9J?<SF=L]*2:]*><1LOQ1NE\](.Z)NCT[J](1S
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M_CLC &2_$T*E?\VC?U6C0_HC_TN</#*C_K.^>K6^BHU #*37!RRA"6PB)II
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M8\XKT\T\ \Y$_R[DYWRS5"N35*.U78E.5VFT50FUYL3/4,&T1X.T4'%.1N,
M<A$U3%L5=Z&T7<-D7+LT9^.247,5[81._+1E6''/\SP67?DU],2U:[&U;_$6
M7N8T<T-/21,W6P$7::NV;=.UF6%F9Q&W#,46B_F7?L$WD<$W6/LV: Z6D^&W
M@S'0<%Z99\8WK0EGE3%GEMFW$[TWF&DW"E71G)'G?%$Y@.&9'6V7F.&9GWG1
MC4,9G+F8BLEGG5$YG$%H$A7HCH/2F.'2@PY1LJD9++V9(Y6ZCY,<@1D;C;YH
MM3EH+14ZH$F;NB%3.NTYF7.YIB,;-_4;.7VY-\4Y0:4Z0H5IYIGIH_^3FL.9
MZ<;QNI9VZ:>3FSPUF5.8F[>#FYY+N^K14Y\&U#_]'LCINSFE.YF>.F?%.Z"&
M4TU=O*M>G-5QG"ORO*@FO+U#GKMS//L1U50='\=3/,];Z_")55!U:_&Q'@@2
MHK$C(,\+ULY3GB#*U?W)O-2;U-S#/-$;;%]]H7R=50YBU1!JH "R5FG=/>"#
MO5EMUQ0"H-Z[/1;:(6YMO17JH7AEO?(3/L_&5M:+/A#Z/O++5A#25X[E;#S*
MHN>K(VB5;1/BOO #[3!:5S+RH>E;HC#R[3M")/LK/C_ZV(M%H2^:OH\%0(HU
M0(G5O_^#)"<:)).E5ZU5H^3^/V!*(V8J[C3_4B9?<J)->NY;^H#Q1F]D>NY3
M&B5L@B1#BB<I<N_TEJ+[+B?JT:3Q3B< 5&]E4N_WKB;X'B='@B5H^B9WTJ5X
MLF\PW*0!9Z3Q'@AW&J=X"B<)MZ8%IV]P8B9DHJ9C&B;]EB5HDF]CXB9V@O '
M9R=XHL)YRB<Z7'!2HBB9(J4Q+,*%JB06!_ Q'*E\0B:'XJ5]XB473RB#P">&
M"O(?ER<?W\(:/W)YDD21.'(>)_)]*ET0' @ME%R.2@DP[*<A%PE^(L-%^G*-
MRO(=AR<B]T3&;:C2?=VC^JF. D3$G42>\BE+;,,V7*:*$@B@>MQ09-QI) BK
M0L5E#"JEZJ>0< I%_Q\(81RL:8RKNR(K1U^)6QRKH$ )7P0*K*BJL3)T7_R)
M3&<)W"TLB&C>V?6(((!&HY#&GC"):EQ%RC*M;BRM;\P*=OQ>Z^5&LF +=F1'
M=>3&8>QUK6B+MEB)AGC?9)>+"EC?OJ!'93]?@!R-TGB-_V7(?>PMX@)(X3@-
M:>?'?32.Y'H.^O4,VAB.:Q</CCRNU:"/SK"-E4P/:0>/D'SWW@BO>U^-\ C)
M\JC)\<(.[& O\!BOHQSA&$GW?X^OGBSX[V"/EDQW>A_)#-,P&=9)$+:.\ZB/
M%OXP&<&1I)R1&;$0$0$1L<20J#P1"]D0'BN0%_&0V"#B*99B'M:Q*I[B)__N
M,:G\$8Y78B[F^9[W>28S8R"IXZ#O$J*/L]2\3#W6$D"Q8S5.%$2&^B7#$]9$
M%#9YS4 .SM9D>M($Y#\&%"[;S4)FSD:1,TDNY.2T34/K>CI1-.MTM%,S>]_<
ME5#^9$Z>SEF.M$JS-O8L3G<YSU4[SV_ASDY3-&DQ3^SL-&)03\3_SV/^-%@V
M_&:1Y?@<4(*9-LOW3VJ)_ 8E%V;6%FWCM 55%E@>YDY[EVM&&/\4EP)-EW@!
M_7.Y3Y8Q_5D)&9'3_!L%-UGYMZ$)%W+;T-9'Y_S$?1*%YM77Z&194G!N%PR-
M:.1?_G&Y47K;F20=?GX>FJEQYY4K49/C495SF57_!__P-X IP)C'2H*R09N.
MJYBD\=";J5*.V_X>/1FBFSF@VU+T3__ZCYJ4DVJ:!@@2)(@)+"@0G\&$!0DJ
M'$A"4,.&$"-2)('P8,*)!C4F5*;,P$<#!I)$!&?P(D>$$R\6-%F08\(/*@6Z
MK)CP8LV2-DG49 F$9LN=)# U_,E3(-&<)HTF%=B!J$*7+A&:=$FCX,6K+*L6
MO.H2ZM6P0R->17HTIUFE1\T"75N53UL@5 L2+3M6;5FY1\N6E7J6A-BT@-F6
M;3K8)-_!?[D.O@I6L=7&:[U.;AMY[^'%DAES%=N9IU?*-!!G%EV5-%?$I"F#
M"WU6-.#5)NM^3NHY+./1_[%-Q^ZM^S?HRL!;]R;>VCB-WTM;CW9-W/GPT.#
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M!T35"0V++@L:!P'WNL<)SVB:6Z$""0@P -*/>[/;F.T8*#^^>4]\O./>L'S
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M08B 1 A'9B2$C(AZX)>$. A/$@=,?N1\L,=)>DA.RJ1.OE=S#(B&%*5^<$B
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M/Z?$M/8[S=8(@!ZP]))N?TI;'%!WZ92:_TY'-9;>].<,#LZ=G)5&]>?DS>0
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MZLT?/WOQSW]?_/3'#[]YSX4?OOD/F%>>!J>I+_Y[V"L?\X!G/W   7D?,.
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M=@#-\\XW4WPTQ_[R7//0*!?==*C_5&WUU5AGK?767'>M=04"" "V .2$7;8
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M-J&YS72^ YW#W*8YHQE/<[K3G><\IRWON<UR?M.>]'0G/PFRSX#.4Y_<G&=
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MF1RM89Q"53HPI1B-$52P^9R8J]-VX5+/R;F\Z=)'M;NBP=0U_9N0BX)/-?^
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M&<R-(-.2ONSE,#>23&KZDAC)]*8UK^G+9UISF1L9R#DWPDMULG.=XU0G-CN
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M3?"52O2$<(E63?G544 %\I:63B2!'J558I469[%C5&V$/SI%2O%-$ZP6^^(
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MV%JL74HZ?YJQE=NUE&BLH;-](IN#R@FN'5NP)=NO*!NZZ%JR@)NT%!L^\[-
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M.O?=CW- "&#]B#? !7H/"/C[@/XHF+L.5K"#^*.@]L#QP1#RCW\E_.#D)K?
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MP1]?<-:;3]_Y$% GOW?GX3==?N5YGYY\]VW_P/WNC=\_!)[C7_+X]X%W '"
M_V,= !^7@^[1X!7=.R $:9 #!18P@ <,H/_V=T#4#9!T$ZS_70!):, .VNX5
M&4Q> T, ! ]:$ @E;"$X+)@#%:IP@CF88 IM!T,-!B^%$DS=.X9(NA!0T'U'
M!,<1=2A$&O2/B!9L(11I\(XC!I%_;TMB%6WWPRH^<8DNK& (DDA$,L:0AF8$
M8PA^:,,P)I%_3$QB#*O8Q!9:D89DA. <CQ@"'5Z1C&FLXQ'?X48_$M*.-JRC
M&?^81C+:D8Z%)*(DF6C%,;K/AF1,(1D-^$@R:O"1D\RD(PM)1C;VT8J3?.(I
M/VG*4UK1AF8,8BNC2$M6LM**KFRE*W.YRUNFTI6;]*4N/YG)6^[2#IM,81!R
MD$QG*I.,R71E$%*X26F&@)G,O"8S_['YBFURDXS@#((IL\G&;6(3G8?,9@[$
MV<Q-NE.7XY0G-ILY3WNB<YSIE&<2#-#/?MHP!YD,*!DC88>!-C.@!@5H"!BQ
M4#]F,@K^-$ 3PIG.$-@!G^.T0Q:P*<^-=A2;& 4I2.<9@BP$ :,816DX/QJ$
M(' 4I3#]J$H_&E*8AN ?.=7I3GG:4Y_^%*A!]6D%!"  H@J '$5-J@"$VE2G
M/K6G$\G(12(2D7!L9"-7A4A-#G(1K$H5K"S9ZE3#6A*$4$0A*K$(1!*B5;=2
M5:Q75:LP8E(3G'CU(SW8B5C;>E:/'$0E,Y%K7+?BE8U(9*]6T:M7',(!P$J5
M)#U1"%V]XO_8D] U'CSAB6,]\I.</#:RG'5*94G+%K64MK(,$0AED0*3K'"@
M-#"YRFI1*Y;8QJ4AI3E*;EE;EK_HM3%S&4M:>@L8PRQF,'ZARW"7:]S@)A>Y
M9.G+=*'K&;GTX#$#R2YVN[+=[ [FN]8-#&^L2U[Q>N8;7-$M<\XK#[J2QKRL
M4>]QQHL8Y30G.+!%#V?T4]_6T!>^H0%.<8XS8.3\5SSX'4^"]<,=[F0G.@;N
M[X0A/.$'UX8_#,[.?K]#G@EW)SGUD8]X^J,>#(/X0/CQL(I-_)\1ZZ?$\I#/
M>_RCH/K8>$,>5A**&)2>$MMG011ZSX[.@R$/';E'36*1B7;<HB'_E<C&3G(3
MCU7$* $U"$J (E&=N'RB+..X1F>24YX$M20:"6K+4D9SEUO%)P6I&<Z >M*2
MSF2I,0=I3V,VLZ ZE"8RXPK-7\IRG:T<*DHI2LJ.@A.9:66I-W'94:5R%9U:
MM:E+G2I8K4(TG=GDYC_%ZM+%FA2G7I6I6E%*U)Z>E9K\-*M@ 8E5HRHUKF"%
MK%;7&EYH2E:FC36I9/7*6E%:UK&V-6QE&0M9Q?[1O'XUKFEM2UV^8K:LNL7L
M<T5[9--N=JX]YK!KI2M?H#I%S+!MKY@UK-O3NEFW6)8L?X%;5A_0U[EEM3&/
MM;O=Z8X4$.;-;K+16URC@_>^ TZN#MB;_V,WDYG80+6RD^6L8PJ?&<#"%C.1
M01Q@2A/:Q--]-*'53&E]6[C)M :UK7F-Y$O[&,KQ=N^O 8[A6FN;TF#7M; U
M[N0A?UK;^@8SA_\M<&*KV[\A1S7"L>WDJP/=ZEJ>.:4O#W)S<WK9H([TH6-N
MZ7YKG.*"-[&IL\UJSTO<Y[!>M]UY3GRYT]OCI&<QVU$.<[N+G-_8=W6[+WU\
MVY/<YY;'/NQU77E%>QS:GR9 M)T]>WQWGOWH1KF)58]WD'><^&SWKLI?_O"S
M>][LUN?WS,_O?;]3GN0%US_)DV_R[T.;$C=HO-6CCXIO(R+\^B>XV7\1C%]<
MHNS%U[_:H\^,N_]?O>V_N$4M"I^(KZ>B*HU/R">N<8G*:S[RH<]ZW"<_^KP/
M?AVI7T<NLK'X8;1B%M=81<_=,?=F%*,4JYA$$B(Q^K+D/B&AZ$ _[MZ42XS@
M%*._1?"?<HG,"/PL28\(\(MRZ8DFR?^*3Y>6R/T.4(\"Z916*?A,B0$#, (1
M$)<&L  3L/WHSP$5T %WB0 E<)%T*85RJ9#6J 15T)3PZ)!>*0)), ,ET)3^
M*)3R+P:)J9=8*99.*05Y29=@*9ELR)N\B9U"((62,)CRJ9S(20E-Z0BEJ9S&
MB0FM\)ZJ4 FOR8;DZ0KQ*9R2\ B=4 FSL*+RZ17LZ9G6< K':0HDR@#_F""E
MFNFBFND=7"J:B"F:F-"@4HJ,WE"BI@"=LL .\HD02\JD5&J:!G$0"S$1\? 0
MR8BC)!$/&U&?3"J<3LH)*Q$/H<H3/_&IE*JHCHH40=$43Q$D(*(C9.(ANNH@
MNHJK,D(6URH5P:HCX"$D7!$D7E$F5E&L'B*V8C&P,F(IK.JPI.JQ5B(9?3&O
M4 (ACG$KDH(5-4L7A2(D.LNO @LI8#&TH,(:&4NSF.(:F:(ERC$GBN(<8^(L
MP.*UOL(KLD(J,"(H6(NTI"(AUJ(>4P(NF(NX\/&Z<,LG L,?8:LNFBNY9D.V
MF LNH(NYR"*UG$LPX.(NT&(B9Z,BW\(BI2(C_S&2([&B(RD2'R_2(^?B+=J"
MKDH2)4E2)4]R)4W2)#'#-%(R)AD")E_R+6 2)V]2)VER+68RO5##)VV2 UXC
M-Z#C-K:#-;1CO&:#OYX#.^2K*'7C*77#OIC2-]@K-<*#.98#P)QC*[-C.I"2
MOHP2P PLP:!C/"@L+1V,PX",P2X,1+[#0$ZLPKP#Q=12/S(,/!QDQ01DQG3$
M/^2C/FCLQUR,R8;L/,Q#05XL0(R,1#1$QQ!SR9(L,1,S04*,Q[;,1"C$1GB$
MR3Y30YR,1,)$2-2,2@"%0I#D18*D,W$$Q\:,QU3S3D0S28Q$3JBD/%0D3)C$
MR:P$S KM/]J$Q^8,-O]EL\O(!$SF1-((1$K\[$8H;<[.1-$\K4[N;$].DU(6
MQ=!:9<Y(I3D93<RV<\S,Q-(\I<Z.Q-(P33TQ)=4LQ5? TU?B!%I>A=9T33W3
MTU,,A==*#58@1=9>I5%ZQ3^'Y3W[\UGFA5E8Y5BH)4\6=&".;5VTI5SF$]E&
MYM7DY=F^Y4$G=$._+5G$1=NX#4,[%-[$!=OPP5\X)EX0YMV\!44]9MZZ36(>
MSMO*+6(ZSN6B)EEF%%EZQNWT[>*J1E9 +EGL3=\^E$>%E.+2+>.$QF@L;FA
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M,FJ>TBJ:5FOEV2K:XBR89BWATBZ>8BZS B[+TBW+PBWQB2[UZ2O?0FS^Z9_
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MWN$0_N$2'N(4/N(6?AT87N(:GN(<?N(>WN(@KDIAM;$*:A\"@$-@=1 YNR%
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M<9FHN(@*J0Q:U*.IQQ4@THO"\-2E@4@YOZ]8,U86U=PUWO]U[EH%,("Z(HH
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MI5/&1U=2)5MRI5J^)%JN)5Q>I7>9Y5%B95O2I5)2ATN0UE:)6Q$Y4F@89+=
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MS7R@\[8\U#I+,SE[\]"ZLP.K<SR?LSVW,S[[QSQG9&;H<SV/LS\']&GP,]7
M\T#?Q#^+L]+D,T)WLT/W(T0CJ3DW-$/OLT(?M$4#M$8O=-9DM$<+-$=_--@0
M-$:'-!#O&W*!L,H!(8-L5PI';@48'&\UP35H$49*:Q7RH66AM+36=!130;5<
M,W[,=!3;-,*%*^Y%=$%F9Q+NT'0%&17\=$0T05"GJYVHS8CHP3<IP[$*@,!I
M)O+H2!D!AVBZ2.CL)F]"H'VT4%4K"8\ !4W;-#*&"5  =5_U,*BHUPIC5%97
MA52G457_4X%RH%/H"$ /CY$2/RY*2+5S$+9 #&+G(01@ S5AOS.>83-;4395
M6W5N2J$C/@]-%#55S_79$"R2V#5GI[,X;[;$!,5M_49C<S9L8TEKN_9CNTN3
MQ#50HXG >6O&&.9$K_9(6S-Q:TQ'DW1"2W1!$ZMRB_1))_=#/W=)+[=)4_=T
M.S=(7[=V9W=T+S5W2S=X?[=W"S<[7W1UHS=VAS=Y,S<WCW=Q0S=\;S=[6W=W
MR[=]'[=QA[-^4_1YJ_=[Y_?B#:O?215^O&O^X8>&E,7=0H067;55U,X&8Q/;
M[,65%I1U?";L"L0Q-V0K<7CD#""!A6*-S-R%>*2):O4K-O-"_XTU<$9'1A&G
MBP-EBE$EC<_XA(T8*]<XCMMX6/:XCM_XC@MYD!.YC_/XD0^YD2<YD"MYD3/Y
MDZ-6E+>4E,\4E9_6E&-YE6?YE6MYEW/YES/7EH>YEX\YF&?8F8=8CEMYF;,Y
MFI_8CZ^YFU<FE,,C)D-Q1-CTN&Y.9HHF!$KKM%P#N8GU!6MK?+P>50NU'<9V
M"&DF<37G$BJ.P#9/NT7K3APZ1#0!83]L!B=:#QN $^&&<)[3.$%DEC2+I]3H
MOX&0L:)3<RC''NXTZOVYM$A!*WCJ3RB+9^9U[.P+2 7<$!8+(4W+8)/A$MW8
M_\3C$Z<POW+KN#;&K)=*H,M$<W[51:9PEJ9GQZ5+3*(#)&=V)E,<A;9O.XP#
MNP# NFNA;KF?NT0X449<>KM7E+8W@5?G4&8>YFF2H;B;REBV>9K#N9C+N9H#
MO+\CN9/'.<$O^<&_><$W><-#^< O?,)#_)PK/,5/O,"3><#_>\8CO,%?_,:;
M><<[?,5C?,A'O,=S_,F/_,<S_),C[^A>"P[YK3SJT5KGV'4(1"TO:^A\[,:B
M(#LR(Z?O<HO/_PF9?/@]O>+1LX<8YN%B _V*N155.&XUEU:]FASRU-E)DOBB
M9'W5MVIP=SU9PIK7IVC?AKW6XXR4H;U02HC:D_VG@CVIO3W7^^O<$XO;<]G6
M*W/=YWW:\_W:W_W?>WW@#]O:EWUH/^[@M[W@G^CB%[[=._[9*SZ#X+WA^_WC
M]SW=8S[@1[[<9S[A2W[C4S[CL_WH;_[D[_WIBW[JAW[IL[[G<[[IM[[>Q[VM
M0;[LPS[JU_[8?W[GVW[OX_[OQ_[K"[_NFWWNK_[N)W[R]RUR)NF^[&MEB=JY
MWWE$J"^R,!PHAA854E:EQT0K+#L('V5/0,QH30S;&'NWDC-!"&Q3Z_]T1 CU
M40I[$85A#M/^R93*JP@A=YXVT@&$  $5!!(<J&>@P(0"##1TV# A0H,5)")\
M^%"?0'("+S8$HZ^CPU8*"[8*>=+ -8,'%VX4L+$)2HQ@0E)1.#&D2H4N7391
MUI'E2HH"J,CL"*:@G@I&+]J\*5"I@*A17Q:4:I)I$STQ@;H<:K 5UZP()4H5
M(/8AV81>-=8T6U5 6*8-M3Y=R[#C-:M4P<YU6%<JP:@N0[XL:K0NVX0AE:(]
MJ?,L4\@\]\J="]AKQ<,/;=(<:W7SW(4&,P<M.Y4@9;A?*VIT;1KVU\"S59=F
M'7OVX->V6]\6_!NN:M^]3P.OG31V[]RI=R/_'QYT>?#7SWU'/YX<-VKIJXEG
M-]X<>W7MUZDK'P^^//3SV]/+7B^\N_CO[..;GP\_?'':Z.NKOS^]/_?^XRZ_
MB ;D+3SK^"L0.-WH8U#!!]N+$+\)WP,0P@L)M/! YP*D$$,.]Y/P0PT1I [$
M#4OLD$']'*QPQ>A6L\K V49S;2+G9+S.I99H;##'C?CZ48!#FA**QAZYRY&J
MJ'+<T,,;I3R12.W*8H_(&0?ZA\LNO?P2S##%')/,,)]4K<PTU5P3S"F3S%(Q
MTJ;;"[B%1KL2R"OC?%/*)_W,\L\^ <U24#L#/91&0P>]$=%" U74T461E)12
M2".]=%),*X6TT48Y_ZWTT4D[7?133:4L==131065T%5-?1)55BU-U5-7:4W4
M5EDSO;706%^UZ]=><PW65UZ+E?584Y--==E-AS7V662C579:9JMUUBY>8;WV
MTF:[U;;2/9L\$Z^+KM&CHY%H#"TE :XI#-*M_'JH"8+J5(C=AC*"3@#/YJVW
M2L% FI>N;,NE]]-W.Z)J(X+R-2 C6+'ZE]\_AX3+SH'S0LE>@Q&,<ZJ#'S+K
M49$=0LH@=#O21V%XJZJ@98KW3 CF>?,UQ*;20FKB(%AC=DBQ'AV;:R2#",ZY
M8CY7TCBKGR$ZU5^_>&;R82HZO@FAN$)"*F,#?I+ZZJ$XZ@A@OL@:.JNPL?]F
M3 JIL68II)J)EI=HD 5B^K*)KB2J(RHFSHJEAU&RT392N54[V&T-3AQ8<%5=
MW'%O:X5<U\8K?_SR4"DG]G##-X?V<VE#IW9T:TO'-O-63_]V]<E3QYQQV!U7
M_'7:8[=]=EQ;][QVW7N?]7?)>;_==^*!-][X0!6KL4^$EA?.1CE3I^K.;%OS
MBMU#F-,2<2T;ADIZ<IOW$<H:E7M53S[97)_]-><<K?WXXW^_8CRCM!A_Y^>T
MOU AP[^?</?3CXK,)[T*!7!)"#P@PW"T(_!@C$K:V4YFPF<?!0*H@OZY8 ()
M""3P4#!$+C(@!D-8P \F)8,"VB (.^A ^J10A"?_[%D)/3A!%-+0A?"!H0EM
M.,,62I \#/3."F_XPSH%<8<U1"(.@<B?).:0A$8DH@\C>$0G,M&*+\3B%"GR
MQ"9J48I"U.$6Q1C%*G)1B/)!HQ>S.,8PCI"#9RQC' 'X13?*$8XLQ*,,H61'
M 59/-G92S,Y,9I,FM0UA:#-+PR2"MKGH94A#>1C7[&2R1PI&2G\CF$Y0DY/9
M#*4G\%H)0AZFCZRQAF .T4D>)94UESA-)EQSD%#V)CZ:G<1'X]&D0_:UF$U>
MS9&2Z9@$!7<T7'GR*4Y2)+_($4RCR-*8=G')Q4!IR50:P)4TNF9*,&FTO(#O
M1GIXF(>V"<D<4029?G*FVTST,B-O7F27[/S3SC9),)(PJ9Q_J@ 5#-&45%*2
MG_/:B>]@1$4=23!D'DQC#%\6PX7RD)$F?*@2-?A%%3+PHEG,*(X<FD(';G2B
M'^UHB$0J48\V$:0GM6)*28K2D?9QI2\MG$M-VM*8UA2F 61I3C$JTX/>5*$J
MU:E/*RJGG<X4J-$)*4V#:M.AXA2I3VTJ3XU*U(TV%*H_E:I2A=K3K!:5HU^]
M:D2G&E6OEE6K9^6J4\>%1N9!CR5!TQ$@+V4W E*))8SB7XZ,]!!23*HTTM%<
MG:J#I:0%BT?HB?_>8N77V,:*SR6.E6R9GG0QN7+OH#RDE04M"T#FZ:VN<TT:
M-7\T0.F1#U%M74AG!>71S](/5H5[K99.)5O"PC91METL;6,[U]OR-K>^W>WR
M>CM:\;FJ?+\E;G"-J[3%)7>XOEN);EF+7.H>][G7=2ZAM(O:[ JWNM]MKG>Y
M"U[LEG>\_T-O()4KW8&F%[>"-.]V:SM?\M87OL"5;WZ7NU_V1K=4T WO>NTW
M8/S^U\#%1?!Y#UQ@!BO8P?2%<#@?S-P%2[BTL[4;KR@C/969BV\7>6_?W!6W
M2H9XFP8 6$024DJ%3&6=*"E:=&#I%ZMIDVPLSA$L:^2PD.SK2HB\IKK_2 M(
M_@DDGB?I)2U]V$:K8!*7%[-3C4EFD6A*I9B7V:T>DDPPG+U8,(2TU]Y@B22$
MX"V5OIS+E\<LJ+U%)L4CJVR,3X*RFY09M#UR"TGH-F30CNTB*YXFBK>Y8K%9
M.<X-L<EM$KW-1>M/*G3>FH<)G6(IM-B>E56OV&BG0A\QJ5,#9-YL_23J>_VV
MU*,^]6Y3O6KJH3K#KC9SJ%5M(U+'VM:R;F6M7\UJ7/<:V+36-9UV/>Q;TS78
MR11VKIE=9- :&];(GK6RB]WL:3O*U-:N=K*)C6U>7_M0V>9VN+]-;6]#V]?2
M-O>QGZWM;I,;W<[6:K?9/>]RG]O=]=8@O:/=_VYNZ]O3]X:WNS<=L/<%DJ[>
MRY*5V'M*7">\W0TB7X\FDKWZT4QW2JE(-R^WX>C%)]V1B^QD29ZF@Q>DY"GO
MTOMFYB;#KHJUY/G=>9\H+$ QU'$(BE1J/=QI2K6UU[\">N>8)T'&#7UW15^U
MT%.V]%LA?7I-9S;3P1GTITO=ZJR"^M&Q3O0Z&1U<6P][UY/^=:=KG>Q1K[K7
M;03VRHG][6GG^MK+WO:S:PKN5)?1W/<^=KJKO>]Q_SO?W:[WPE]]\'Y_N:Y.
M"7+,V6MG>D S)2L0M88@!&V-)XCE.;, J%"AQH;$.%'Z>1&NK41P5" +RT[B
M\(0D^1JM( OH(S_0G/]8#,X7X5] 39^DU*^^QNG#C;H1POEO-OYX!7<]+DL[
M$4>V$R<$D_U NDP%I) R].\E2#"O3Y0:*WKT2\D+IW&4>2GYI":K%YPIK7D2
MT:.V++(Q?D,@V:\L&R W _F]5%@/+XKO.4[B*2.^9__Z1<AT[RDVPI.&I/H\
M#_O<S^$@3R:LSRR^CTC82?7XCRDR4)Q. C J#@+YC\J>PF%*KR:Z[_NRAO?F
MPG[ZC83D+<"N2G,X!>=4AP8URP9%I08?SWIPD =_S05S< =]#@A#[KG\+0@?
M;PC=JPAA4 E]D B)SW5T$ J94 IYAPIK: :S4$:VL >U, >_L O#L FG4 S_
M)<@+RQ +SS ).VT)8S"MS% -;>X&P? 'KY .N1 -R1 /T[ /^1 )C3"T% O?
M#HNPE&/@AH^\8*T%X01'^LHA;HSC=&SC5(>5<NKB^DWXU,B&2$OE/O%+($L@
M0+'D0"U*JF(/I<2B"!'>1&B \$JCCBR0\".J7(ZB0FKTV"*A N,5G^S=[*,7
M\:>./.U[*&P8@]'@O ,9C5$9W\K-GJTXEM$4FW&EDE$^I/$7_0,;/PL8G5$8
MJ5&GK+$;JY$9K]$;Q5$;S[$<QS$<US$=R7$:S1$>LU% MO$0W[$=XY$=,0H=
MZU$=]1$?^=$=_7$>N3$@C:H?H_$?Z5$A"_(>"3(?_QG20.SQXPZR@0:R(2/2
M("%2( &2(Q$2(R?2&<<'CJH).F8F/08M)"Z-\Q9-(/)%('@LD [P(2B))!R)
M1E3PQZ#B(.J,) 3"^&X,+CX,GGYR(&#):JA"S/1#;D3,/2I-7^S")W\R*!\.
MCO@%*OMF)=Y$!I'C+J2B]7XC:UJ!"K),*,/,GA2BQFP2*G"RDN:OG7Z2)AWB
MRZK,DJ;F5'CL-3JP(Z0@:TAB_GBR7[;F+7SQOB)B+CW"*.</(O"),*FR)HS*
M:9I 7&J/)*82,",38^Z2?-;2*)O2*?<REA;3_1H$)7@&,E&"_10B,"L),UFS
M)B+J)573* 6G%;:RQ$!,+<1RR4UZT1%-R"0]#;MF"=*$T[F($Q.'<WN"T[2.
M<SF+LSF]"SEK43D)A#J=TSKGK3I+XSJE\SF3$SNY4SO#$SFZ\W^F<SR],SOW
M;3O+,SW/\SO-<W_B\SWG<SV-4SW%DSW),Z[J<T;0<S_STST#%#[O,SH+5#_Q
M$T$'5$'M,T$/U$$9%$+_DSX)-$+[TT(IU$"/31<KM$$U]$$YE-@82(@PBYE>
M0SUA4&RHZQGMT\@P#NEDT>(&95N8,IOPK<A0<@PA#H$>_P5-2!$43VY+@%2R
MA'0&N[-'4)*S6FU0TLB^3/'5^.>R1'$1%XNT=C%I&FY\%,XJCPRNJ E/O/1]
MP)1'"9%,VVV_%.-,A<M,F?2P#&M-W_1+W?2_VK1+\4M-Z51,M21.ZQ1.]11/
M<Q)0BRM/[Y10!=50F:M0(6Y/%Q5-_71.$S5-$951 W6U!E51*?51&U53?8M3
M+U52IVM,,7520;52#]54-]52I>Y4,S55/755P:E52Y555155:Q56;U56;=55
M<3438RU,;1&WSB=5D(G$%,(Q]*("EBDBDFS)#LDMG.0E39"7KJ1JC'(V@>(I
MXLDIL@69>O*;= Q91>F35O!D7O_C6E\,7PIC9G3T1^CL]*3LUO;**AI-6ZEG
M MD/])R"')SU,V,R_>[B82"CZAS))5<"F2"M813I2<Q/7;.U*!4"S2"&SS!)
M7);3FGKI)R?V\D8C76N37"$6(^Q2:XX"A3ZV,,?)*A0P7!=B_I[5^:(U1VCS
MGD36(:( 3Q[C+R_S-16B]5R#'%"6)%06XP2'+;,&;61I7 ,M NDUPFX$KL0E
MX29.PH+5Y:;T;?Z,2M7KXJZV:JO':^]+2\.6:\=V:V'+:L^6M]*63[ 65LD6
M;<%6;8F+;:E6;.NV).-6:]OV:_?6;LL6;PF1;N66;^^6</]6;[UR;G$E< UK
M</TV;]?_]G C]W$5MW !=W(%EW$SUW$W%W(UUU :-VH]UW(15W(_MW-#EW-'
M5W51EW69S'59SAI]C5BEU$AEZ)Q(:B0+3A _S>"D%1(5K0+R1/NN-/PLJ#>5
MQ[[<E4GEC4@_D4J?U[&H= _-!E*8EUC3;4JS=Q&?%K!F5UC+D4WCT1?)M!##
MQG;QC4YO%SK6UT0CSBK95S;<%WO#CTWK%W'J%'])<KN8E'ZK[7_5-W[?5T<"
M>. ,^.;L][#V%X'YMX']=X 9.((!>((%N$PE^((I.(,M^%'E-_XJ^(!!.('S
M-WU#>(--N(,)N'U%V(%9&()/>(3YMTKIZH$'6/D:I1B%T4G!_S70;!;_A.18
M>8QZ)DE=MY(H_T)17"QEHJ!EMT< )E;V,.EALD;C:.9=KJ$*K&_&WHE>YM<U
M8$G*7.S%F!C$+O*)0V+&G'07J8<Q^]+@/$Y:'\1>.>--4"(#@24KE;:+_E+,
M>#9=9FB4W$\PT2G'N@>65..(P<^'SLP HN :RE)I@?(Q&>7=WF9@RT))^!(H
M@,-IXM*)H7@_/.E)B+8@.ID$)1:--W-GG+B4J)C%P+*0D2,$WPM@M15N]LR'
M8"DN\THO5X*,'\*3,<;X9LPL!(?/(B)=F6,R,\X4$U%\5SA\R;?)?O,;]0:'
MF[34KKE%[T2;J[F(E'>;K7E1=!1,N_\9?+MHG+&Y^=(YG+^9FL\9!LDYF]G9
MFZ<YFBO9GFD.G]&Y?]29F^D9GLWYF?D9G.N9H-]YH./9G\6YG]LYG_MWGQ7:
MH0_ZGDE-H@WZH@,:H!-:H*69HO79HCLZHD7:HH6%7C'KI N+>A/1HTGFC_98
M=4VT("RN1D\+?D]NP"ZQ3M4K1*>QAZ0WY8P4J.5'?N,+U09(13T+I'<ZI5VH
MFX)5?W67=2_6[@#(#F_C1+E4:LMGFJ TU;AZ5W=T1>>JJT?TJV6KK*'P1F<Q
MK%-QK+-Z2-QZK84OKH]:JMO:KL':2O,:K?&:U>::?.KZK^]ZKP=;KP7;?/NZ
ML!.;K/V:L>'_VJLS[+ C&VP5&['/NK$7&[,AVZPEV[(I^\\^N[,K.[,OV[-+
M&[2]4K35FK!-F[0YF[4G>[1#&[5G6[5K.[97^ZH!N^=L>XB&3Z7_[DKE1"G[
MAI16QH=-:5D+ SB8#T97 OT>0AG 1P6I53'K]5B%SVFZE2!PV6^-LBS22?N6
M*9#,55_B#Y=S:2ZYVP@9J,L\,)O4I70#:4WGF/[>9W >]GN<^R?'S/R*VY;G
M"BEI)FL6<(3(>Z89H[_5=6??9F(SXD9E]V42_%@3Y6Z8+_J:@B>E9[N-DKRI
M>,\Z9L^H&),Z_#4Z0AF"6?P6QC!7PFFF>SJ4+*Q]S+@1UO]J%FWXR/7)IEB6
MLUM*UMOUS-L G.+-A+Q;EQ:8J5N:W7I$V)I/[5HX6\.W)>2![)#*M\,'KUPU
MLOR L-S*NWS+OYRP*6Y'M1Q%Q5ROR3P5S1QCT%RQU?RWV!S.=TO.J4W*P/S,
MRQS/VUS/Q]S.;U7XYOS._7S*]US0 =UNN9S0%3W-_[Q7 ]W1:172"WW1W3RS
M#_W1$]W2LQK3)5W3^[S1*3W4&?W-+W>TK=?)@WOQ[%>-H5SX\A"E$;("@M<
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M1X\H.9HD>?*@R8\C6UYL.--ERXPQ;X8$:3-B09P-7S842,6 4:.'A-K,*5+
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M]_U&X9M/&/D BW]^1^5O;U?Z\B-,/TO5MV^\[^PK7W__VL,?]^(GP/D1D'D
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M"J(WVJ13NJ-+FJ14&J4C6J1P>*1<BG#)T6I^(IV$05\,07M5%'EQ.6,U0DB
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MA1IFJ2^F6F.AF\YZXY^=!COIE>)=VN=N)VV6Q=A2>QO6B*CXU"-#0.I0@.U
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M0@OB+X1I :$*,YC"$Z[PA3.,(0MA^$$'YE"$ $P=#7=H0QV.4(@]/.#)C+C
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M^EE$WHD4V\>'O[>S$%!O _%0RPA^NS@O"2ICY';]0E9UCRUH?W4T&+02-<N
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M/43BQT/;BU,#APJHO+"+_]U4RU$/A3W3.[E,K+',6FYU#)L,*]V,-6XU;KB
MV+>4NFOHBVKN=5&,[+Z1\;YC__4>4/:U[T?%[=,>[HE&9?.^9>6>[Q%_[_]^
M\?U>\,V'42#?Z!,H[AE_\MG^\,W9?RS_\3L_\#]?\D.?\PN_[A5_\PF?A S_
M]$^<]%7?]!L?]2N?)@.'WL&=C@X[4AS,U\O:PDU<B54PMVX[P\2>]P44ZDF4
M%ILJVPY(Z=><\$@1YFM>[)SWA.)OK>D'9;]7UXN;[595Q"7^9!GDJWZL5<*\
MD."1>(-CNWI];+U6RTVIC+>NMM7<K&D&\V?[(595XUDT^0&B@@ !%?00U".0
MX$"!" TB%/!0 +F!$R4N7&B08<**"A]ZW(C1XD&%)#6&3/@18L*5% >F',FR
M9$N+$?]C@A1I4^5%F2(K)B3I\V3&C"%Q[BPH,V5-G4N!#B2IE.7+F!Q1FEPZ
M=6=5EU>EFN2YE>G7KD=G0B7;<:S6IU;%7LSJ=&?4MVKCGG6;5B=8MESQHJ7*
MURW6NC?O9H5;N.UAPF85JT7<N.]BO8#E_O6[UC)FR"(-/V;<V3%ES'9%#QY=
M6O)GU(E5C^8<=F[>IJT%>V4=V39=W*%=GZ:=6_;EU+IGY^S=<^;-H)ES"B?J
M<:]QY4>'\JQ<,?M3GP:O._T)OBA)E41A[KXK_7CXDM;KFO=N%#C,]M7CQOR'
M/[_^_?S[^_\/8(#_!':20@(>B.!_S96'U%?,V00=:-K9IU?_4#4Q&&%]#19(
MFT$3-?2>>@5>1U]Z#/(F8D0/G@C?2AE2V*)F1H58%D\XG?A@C>%%U%2.,6[8
MHXY" EF9B#(1V9R01[YXDY$L(0FCD^8%&>.2>46II$!0-IGE15M25Z663((I
MY9<SECGFF5V:Z:.(;'9I95UM#IGFG-Z]&::7=<+YY)YY*H2GE(#Z*:B85W*9
M9Z!\3EGDHHHF2JBC>\HG)YQJSM=BB5)&Q*>*9G%'(XGO30BJ0*0J.=&&23%&
M*8LVGLHH6R>J1Y]\TDT(X:%9MM<=E[1Z1V6#&-KHG*HKVM7FB\Q9.-:)GH9Z
MVVFZTO27IJB!ZF-%4W6'JU!7YA@ATXNI>KO>M&AUBVE!T8*&%+K"CJ?M;:QB
MQV&*B):JH4X[JGI<<H"&!-RV?RY'YD[I>MDI>X>ZZF"7K1);<(S/NOL6M"/F
MRN^"JQKL)'0;#UQAOH6&K+"6BS[KXK]YHES@R"R;YS*B&\9,)E$TGVGSR3+G
MO/+.*F_JL\D]U_RSPT&#_/+,.A,M--!,(WWTS<<V;?334HN\-,Y%2QQUUE-#
M;;776 ^M-=5<ATWVUXO>6!_%HN9ZMKET60M?CN\BQ?:[,.O+%Z6X3<9CPZPI
MVS=9#V=<\J[_,"7(>...XW>A5$\]3KE_S6(9WV544NQWE<R>UVBPJ%+W,JXL
MWGUQ9J;[*_-N+WVXVMO<AH3NG++!SO>EZ89[T&VR3^FOW+MW%#R[O!(_H?!W
M>YR\\0=[&-GAM1:/XO$,42\]\,U7_SSVOZ(.?6_9 ^F]CM9#5/[OY&\_/O/1
M?S\]^_!K_[[YW<MO/_CI8QQ__>J[+[[YK<]__*-? //7OP/^#WD$U% "M](^
M!BJP@ .<X.AHU"%,S<AM@J-7K+ZC&Q Y;UTD\QW<\%:W$97L=+S)%D8Z**2E
M^$XVP"(8Z\H"&S!Q)C&S@\P.3S>L#X[L@I_[F*#LE#+490ID-<2A_[U&,\2,
M9=!B(T'/;3AXK1J%93W'65T3?U2C58DK7V\;7 J54YZ'N/!@*TQAYS37NKAP
M!%SC(6'F.*;%B-%K<X'9DO5X%T<NC;%T:,SC!F-X+O3QBX7^PA:8F*,PUH5O
M67BLXNIJ5TF\7?*1F9P=VS!9QZ)L\I"AM&0A0<E%3SJ2E*F<R2HI64I-GI*3
ML50E[6C92DG><$:1'"4L<^G+)-5'EZCLHRU'4LQA!A-&O9PE*XWIREL^4YG.
M_"4TB8G+:RX34<W\9#:IZ<UI=O.5PARG-*T)3G(R,V78%&<2:Z7$2W4QFKR\
M%SU-6,AYHJQ7WEK;DV2$.)"(L%YP&I?P?/_T1D,&U$^E8E'E'@I1_.B1)!%]
MZ-J0"+J$V1%62@Q=("=ZT(RFYYZI Y&=UI@RW'T1G]1BY$+K"#V_!4R,%OF>
MP8XUT#*R!S YQ5AU>!K0U/5N+3TEHXN ZE(@(G6)$%JJ37=*U*!"*TA%31Q4
MG5+5)/XTJDDED5/SMU6L2G6A7]7I4;G*U+ *=*Q*1>M3SRK6KC;5K6"]ZEKE
MJM:69%6HZJ*K65_H5Y_:5:]L]6I@C0K8N*9UL"U=+%SO"J,B:E5B"_3IX5#3
MN;]B[G)VS,GU.DHN%@&N852*K##Q%J1BD<9';52M?"#9)+J9#8:*]2!G54=/
ME:8*GD1T(!MC.RK_1)+4..6!%;CF=<&)B9)TC:KB;??VLF:*;CJQ6MT\X<5<
ML5BGD183F F'=;3I_O.FI\6K/$MTW(SF4%?M(L]([;-/$Z6%D<D*59A<^AI[
M.O&"HHE23)]H1+W*,V+'4JG94'I+&9Z6: 9^K\\:W-P'0W'!6H,PA0L\8<QA
M6,$:;EN&X[CA\8+8PQP>L<(LW.$3?YC )!8QBU5<XA>G=,67"C'"4CSC&->X
MQ3<V<8Y=O&,8 QG!R*0QD=NKXR/_M\<R3O"0%>ID)@?YQU)6,K7"^%*O..2=
M0Y.6?/7+4L*P$&](4BZ-VSO@"[4174T<HXI)ELROO7:_!*FHG1V'0Y%$_^3.
MCO,=1XL[7&;]T:H?59_B0/N1)5-7GY4*\'VGRD2W830ID!ZBI*4<DT7OAF:<
MFFR76\E%X79:A4X;]7L^#<U0MQG4?10UJY=F:E6AFHRSMFJM/5WJ5]^:U%6+
M=7EV?>I<I[K5JQXVK'4M;%HGV];+QG6OD?UL8P-;ULWF]=E\'4M72]M(DO4M
M6EB6--Q."XM )!YPUTI+)+(POMQVF&;[)<7FXJO'O];;6PEW*RQ;R[N!F1 A
M'4U;I_TIUMXV+Z.%.C5 ;VS.3%VWX#@Z[H+6Z&$+&]U8*9,F9E^L1)M=$Y;Y
M2N?)V@Z?SKJ)&K-KVEU*ULV3C?=^;47FNJ*;O* A J]PQ5U?-)M)J])2M83P
M8B[\YCN4"6TM8K-M[G+#.\]9_CBEFPZQIRO=Z9*#>J:=4VFJ5\SJF=SZU*->
M]:]?G>EB[WK2WTWLSY8=Z6I'>PRS#G:ONQU8<!^[U.>.=:ZS79%K]SG?\4YV
MP-]=L'8/N^ -3WBSMSWQ>Y<M(^FN=[_#A8J,Y_)GH]U=H(HTO#R/L#G/V+&T
MZIR^::=PHS^*_QB%\WGU!Z).OUC?^I[+7)B3CEWGBV-YV8+<P7BIO7HU$CX;
MWAY3#8;+O+73TWT+$O@'#);"3;H6E\>GR+\!#&>W#-Z29Q=VV?_8Y[AO]&_M
M!OR6/\_WW5M^\>>%_.0R__C1WW[UFX3]ORVA3NB/Z.4W-OTP/'GR,:A_^*=\
MVP=_]0=NIE* ^4> _R=]Y\> VG=' @B "[A($QB!"3B %_B WO=^&^AG'5B!
M#0B"W?>!ZX>!%NB (0B!*4B"[F>">U5S \:!/*%F[&)Z^00PJN4Y )5/*PAE
M>6-S_V8L'$(<A45!Y3:#(T=GSN=<\7==F85A<6,X_==!;;5#H96$$O]':+/7
M<>$V/%%D;";7:.DE0TJG<"YX7N%W5K(G1'_W)8'C%LO4+5<X&5@"'*$&@5$4
M*3$8>B_5+3J()P;U70OW&?Q4;+SG*37(-),$4$)7==Y2?*>G<!)8-AA'?20T
M?.\2B;GC1Y?H.DW#)-:QB0^1B:*87YP8BIXX':6HBF3!BDB&B01%?*=(BK*H
MB;0(BA4'BY^8.#6H:*YHBZ98?;W(9:.8B]=W9:L8C*WH%J_XB\VXC+NHC$(D
MC+%(C<R8$LZ8C,!XC=+(C9WHC=#8C<^8C=%(CB:AC<9(C)"(B^LXB\,(7\6(
M(M&4001#0ZX%B"@7@KOW1/0A0(1%&H%DB"K_R&.A,F^O=F[B%A-Z 'L-V1]8
MP8L"X) *LG%MF#=5<Y'!=4<[F#;>QE])$E^XXX6>!W W]U:'5GI%9X,6HX.@
M5WK" Q4#,Y AIW@S69+V(X4UB9&%5Q0 QI--N%(ZF9-L9Y-AEG9%N7E'N9-"
MZ9-,:9).&91$N912.90^AY0P>4)/295-N95::953^955J91BB9-<&99F.99H
M699>26P09Y ]B$@.QXM%968QEX8>A% GJ9'#<9!-MH4T@HPSIB9OY$DBAT"$
M&(97B8]],70)E6@6>%U]N!V*UWLH.9@EJ'^)2$+#^&\G!9<-LX\RM9@PI9!)
MTBB:9X>UT9(7IRN>_[)T3+28]:AO&ADO!JAY9N:9*6>/\4225O&,TP)VCKB6
MNMA"=>5[0$EX;K9_:8*0/]AN<?-H/$EPFO4QT=EUT\EXU2F9V8:=1Z>=EHF'
M?O>7W^E8K=:=X^D[ULF=XMERYLF>0D6>>AF?7#B?U)F>VQF>+]F>=*:>^:E1
MU_F>]G6?X.F>^@F? UJ>_(F?!?J?ZVF@ GH>_6E('.F6"&II$W6%5H5.5#@F
MC_B8%ZIRU'%D>H1O4A2BG:$V6F8@$\FB V(4=M*B^A%L9/1+IKA+A?:<#65T
M=>B'Z*=PK#EI!TF";D9D%1J0[5B/8G<^$4EHPN&$*@1Q_45R];=+K4FE;/_V
M&%<*)E8*6E6:I5V*I:^AI?4DIF"ZI5]*-V$*D69*IFN:IF=:IF_:IHA'I'CD
MIF\YIW*'.&I*IT.W+WI:IT37I[95.(#JIX5Z=GL*IW>JJ'F:J('ZIX]ZJ.HU
MIK 5IWAJJ8P*J8BZ>)NJA229<_8C7HC5.3C56:97F!$)AH[F+L$W-_6Y'FM4
M1$8JFO-H:NGU+Q]ZI/ X7LBWJKFWH[8W%,('.B5*DSV'7VSXJU/'<,.G/"2C
M:7*$:<LXF#/AF%.Z/!'GI/85*^!8F917,+J:*(J4&5UX74+J7W\2+YX:JX9D
M.JOQF-:E)..CCR]G0S7*D2,I(\S!F11D5$LJAL><>A72$3";2;#YJ!0'*[!,
MH; !EK"54;!SV; D-[ 0B[ 5FQD1.QUNIK&&,[&_Q[ 6N[#1(;(.B[%QT;&"
M\;&M>;(!:[(AF[$7"[,H*[,D&[,C>WDTB[/DJK,O:[,]2[$SZ[)!^[-#"[)%
M:ZTUF[-&R[)"F[0[R[%*:T8R"&"S.B+&U6]/RETRB*L1%D1!$52W U)2E7GS
M&'=8J21\_\A(,<JB!$)FVS40;.NB4\B%-P.L1-)W-$E%6/17VYJ0?#BV#N>J
MI6H_!I:LC/:C890L.J<740E9;>&20C:9\)&&*B6#E=NX=H*YG**Y]66YG5NX
MF9NVGBNZE$NZG#NZH8NZIJNZ/P&ZHO*YJ0N[I=LOI^NZLILKL<NZL[NZM=NZ
MD^N[O'N[NYN[M*NXOPM2FSN\P5N\O7N\P@N\S]N\RRN]!7FYMAN]KX*\UQN7
M5V9\V=44NC2$./9U%RE>S+J0/U=9QR.2^;BW>JLN&1)NA'N(MUALH^:+Z)&R
MMCE,LE19(2-"PHFVX3NB#I:*^WFO6JA.?3F2NE=+%/(Z%Y%SC/\4P<!9&5M#
M98D+KK#Y-PI!1Y9U;YHV>8FD0<=(4O,K9NJZL&:[1H8VH4:I4\F150Y<A1$7
MN72K8YA)0(>;1SFE;JK;<<B98$%LESE&Q$494T<,Q#B*Q#2AQ+S[Q,T;Q20V
MQ3!6Q4;,Q$L<N%I,M4W\(5<\Q%D,Q6(LQ61,Q69LQ6B,Q5L\QFQ<QFY\QG"<
MQG*\QEW,Q3_<QG8,O>!*>@%<PLQI?]>*<&.+>V/";XFCF@(\? FWB+]#?OPT
M>9_CQW@J6!(IMQ/)=^PT7I.#R56;+P<8D(YH<_EV66(E-C?)?R5E4_Q6=#KZ
MMYZ\D;4GOYI<;^9#K/H:24K4EU_T$AG_"6"]O,LZ",S\>![#O,%?8<RLB<Q?
MX<LWE\S""8>]"\W]U<R\S,S!O(373,Q7\LQDT\T"]\T8&<YQ,\Z_K,W'K!?E
M[,SGK,SIS,[3[!HX2,[O[,WT#,[V+,[X/,^T2\,WZ'8PW%'R2[S^#'43K#&_
MJJJ-/+YV9,/<1*LK620.K+G6QU>*;',(?'21";"Y-3:ZC(4MMW9\Z\HLIU!Y
MZ'CS580$W3=R<X_%Z2^X.5P_2:@RO-"\A:PTV(<FK<(W+,'9*]/RW#I^#(Z&
M/$.!25A-?!FH-,HK69N("7H:##X8O7#1.B=*>$.X?'N*.)WKJ-6JQM7.6GBS
M+(O!N6@O0M;5_W(E9^T79AW699W6;8W6S S7:_W6G>36<FW7<=VX<\W*7IW5
M8)W7=(W7#ZS76_W78\W7MV78!-75Q/;5B!W8?>W8A_U!:BW95"?6E9W8ECC8
MK';9EJW8?LW8@/U%<\BTO\)[::6(J+S1B_7#K]E7;Y:ME==5E^E/M7S(GKVT
MJ3@1E]RVH3:P-?44PTW<Q6W<QSW<=5FO^UM^<T&X#6R^0<,[NE5>7PAE#-=M
MY9G;'\E&OL='=9U"#.W=Z<O9GQI_@LC='GU$'BG<')E^Z'W#Z+73[SW?YUW?
MW7W?ZFW>^+W>X0??D6G?_4W? A[@^ZW?[EW@",[?!B[?!+[@"G[@S_\YX P>
M7 X>X>G=X!0^A!:>X?]LB]^*+Q7<J 6LL[P*9Z6)73=:WM%M?YBJTE0:E?RZ
MRO(6TZ1'2MK!FS^:V8]L;C27P+8M?P:7M3A-H#Q]XX<IU498MPJ:A[B'@R='
MG-A9<K7,P1 3%8R8VJ],GQ+6S((\4*O+.7*=I!O;GJ.*ROV[S3M=%8\7PIW-
MPB GU$4^0AO-=;U,WV1SRX7RW1"=6'G>*82JDGMNMH]UPGH.Z(9>FH%^Z'^>
MZ(@NK<_*6*;-Z(_.YT-%Z8/>YX4^Z7Y^7XO>Z8V^Z9K^Z9>NZ* ^ZIS>,9Z>
MZJ:^ZJ3NZ*B^*ZH>ZXF>W_+MDAIMP!\4XH8:">1*"--GU*HW<LXIBN*2#L@Q
MZ#:R*7J*S!O_OMVBT'HD3U&+*-0=Z.,2TH[MU\Z83Y/KHPDV*JZLA%R)KGUL
M<IFA6*N&]KI:6SS;"3UTVW.D=ZM]] LKEZZ]+SW3F08K@G[O_I;O-.?O**[O
M],3O X_O @_P3VOO!A_P"Y_P>O;O*=[PQ-KO"D_Q#&_Q,?WP37WQ&\^8'2_Q
M&:_B(0_Q"$_R'*_Q)__Q*3^\$\_RD^OR(]_R(L^W6UOP'I]%W'OP#J_R.?^Z
M\([N1FGFR'7SS4S@*IF /VCD 7?2PM?TQ[-29TCL04R&*0S;TYIF O??2QGN
MSW'7.:/<9/XWSY7*$]C705@I3HIMJ&?UDUV1=RF+NUY(LWBVI]K*_Q^^\[F9
MF0%WVQ$''JX*WE)[1U3%][0)\_&,HZ'5\1$;P7$^J>[(R'B)D>F>6J)LW=$J
M^;P4IH_.9IO_XY#D^1RM^7#*^5L:^EL+^J3_^0^O:D%_^$CG^L/U[J:O^J*?
M^F1:^J./^ZM/\JTO^C,/^[__^KZ_M<!/_&[II3A'^[MO^ZS?EL(O^YE_^Y::
M^]-O=K&?_-7O_.XJ^Z>/_=X/_=EO&F-X:/MF2O E?Y^<^%^F_O [E^=:KD &
MX%4>F&P>:#I$PC'';ELF;I8,$/\$#B18T.!!A D5+E0H0$ %AP+(/=1#T>%$
MB \%5-0(L8(>CQU!=J08,N/'DPY3:APY4O_CRXP36ZZ4>%%E18@N)[[<F=*E
MSY,X<:HD6M-H3YLPBWY4JG1F4J8K@UJ42G3FT*8KD<(4:K2JTZ\[97Z5BA7H
M1J99EZ+-VO7G6JYJKZI]R3*LS9%DK=ZMF1?NV:9BV>JU"U>P7[HY^8Y-O-<P
MWI"-W_*$W+APX,J$%3_N&UGOY)B9_SK&W-GRYM*,-;--/7CT9:VB)2]V/9NS
MZM>H8YM>#3HI;MNM$7^F/7RT[Z.UB=]6?KRX9^?,C<M]?IKU;N!\-9OM"GCW
M6=_(!2_MFMS\5O!1A[J,&Y7U>*23QVOG3-;L^Z+4V4XN'1KL]?UT@^HU]+KS
MRJW-Q,MO*@'94ZS_.P-_XNX_Z^Z3BS(*>Q.0+O0"S"TZ##?TCZ81R>/PIA.5
M@F] %M6C:BW0UBL1Q8S:,_#%\-+#CT+8"*2QJ [[0Q%#QIX2DJBJY/NM10N]
M:_$O"!-#;JKX<KHL2*^ K.]#"N>SJL<0GWS1LIZXFY'!'[5,;DH3DWS0NIK<
M1*O)Q^0$B4[,['2/3/WNA!,C&-]<+<Y Y_RSSST) _0_/P==-#T\8],S4BTG
M/=121Q&EE#),N7S4L48]U?320D/EL]-32TW41U05'3735EE5==/08CW1UKLL
MK3#7BH*44S@-]3LTRQ03-#9-%[]K4L8/V=1H/)TJR[)19J,U;] WP1P3_]NU
MZ NSK@H8$G=<<LMMB%8 5R561*QL!-,_QJ1LZL C5W4635-_/59"JNC,D30&
M;RRKL*?X/1.J*/>LLM#S!C2X30^-O.X^U%:<%LWV(M8-JR"K33#,\ C^N,20
M][62Y"1%W@_DE$W>B&4856X)9J=D/MGAEC5^&>687>88X"]]IMDGFW?&N6>=
M?W[7Z()OOACIIHU^NF:A>:8ZZ:&#QMIJHJL^^NJHE1:1Z7VS9JEHL0$\V^NI
MN][Z:[?#-OMFN;G6VLB=T,9V0H6113C$9=7:>ULH,P1ZW@Z5[#=C4^>[;TJ/
M7VOXZJ7757/$A/VVB'#[QBSS2<5K[%S?'_%>DO_Q$DDW?7'L="9<Y%Y+'QOR
MUS]W5T=K*V:8+CAW"STW"Q?UE6_-?9VX-")/'WCY'3%.*U-B#SO^8'!!=YXY
MUJ.3V+V9@XW>IH"3!QQ')X5=R4B,+>;>V$V_7_=G=0&S>.'7UW>][8CLCQKN
M_".7F'[1^0\U^)/=_0#8/[U%Y( %W!\!R6? PSVP@0N4X+'XQT +.E!_&:3@
M!CUTP0I^4(,"9,T($PA"#_XO@BD<8 =)R!X7GM"$/JM1#&FHP!6^L(8YE*$-
MD[9#;;&PA N$R.>2E38'E8YU2/R5X^HR'D:%3SO,LAR?#.>^(#EQ*T9L5TIF
MMYTK8BZ$&?L;O)1WHYT%9.Y;U]K_B+G<^$8X'B1_S7O<=PYGKV211GT,LUT>
MS5<X*IV.B!$JW^#P"*#?M85P][H<DWJ'2#N>9D)DU,N,\D:]T?F-D=^Z9/U
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MK#%0+$0Z;$0^9,1-=,1!S,13W$348[/7T\#2$RF[^Q&8:C&84ZZ->[Z:4KZ
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M#T(8H8034EBAA1=BF*&&&W+8H8<?@O]8G0 CDEBBB2>BF****!YR2QA[2$(
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M1F,YHN,YJB,VIB,[KF,WMB,\OB,YSJ,YNN,]RB,^TJ,^VF,^^N,^_F,_ N1
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MSN6/B30CM!@Y)SF"ZI ;D20>*[E'LO117IITY"07*1-//O(ND1PE)TU9R*2
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M:F\;V.-&=I7G?&YQ[_C/IFZWM+&=;'8OV]C-)G>]]7QO;J=[R^OF=[CGK>^
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M 7NRD1/X111Z1":2D'H^>2> (B@;]$%_\I.@-V(P 4I4P2SX8I&4(5WO%2?
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M#CD%+N(.CN,R_N$+CN(V7GP!_N,Z[N(\SN$^7N) +N%"GN0PON0L3N!(_C(
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MN/'A[W/Z ^#]P*:^^H6N?0M\W_42F#0#JHYX :S@\+I'00@.L'8/K!L#S>=
M#';P@/^36PE#&$$$IE"!*_3@!5^(N1,2$'TFM. &KX9##=J/@S"LX0=52,,<
M^G"'0"PB"6>8NAXJ\8<,F4Q*8A4KG?]\"U=^ LJM7-:K7J7) !T95Y,P$JJ5
MS<F+9^22)-Z2-9J$ZDUCE$26T"2FI$31B@7K";$PLI")Y.E=4*(6 3@U2$)N
M2E*4LE0%**4'3!72D85\H[52E1,ZEH5/$=E(0J!DDXMD,56^(HP?80(8E6CF
M))C$34<< Q)466E*5:KC&F.R2BEB95M+@5512CG+VK"2*ZX4%"S?)<NUT+*3
MMARF)JW%2FA]J9>U%$N>E)E'8CJ33- $ID5RR<S?#.J9QXSF*[?Y'4L:\Y?(
ME.8H8PF8<G[SG.$,YCBKZ<UK@C.;N%PF.7E9SW?><YKKC-(^4=E/E*13F*+<
M93'=Z4E_JG/_F.P4J"Y_65!QYG.>JEQH*RD:3XM"5*'\9.A&M=G1@'YTH"&]
MY3\?6E)KGE2C*74H0IM)3Y=.%*8'U>5,,0K2ER8SICGMYDYKBLZ*4M.C+94H
M43EJ5);2-*GP'"E3$XI47RHUJ@"=JE.K"E5\2E6G;1PJ5U4JTZ""]:D-Q2DW
MV\E3F_HTK?HTZ5E%VE6L?M6<*'6K/(^J56S.=:Q 76M8T:K7I@I5KC<E;%8-
MN]7!DE2Q9F6L7W^JUHA&%K&.M6M&VVK0Q&:6K5:EZTH?>]>><A:S927M9HM:
M5]1J%K1_I6Q<+9O7TP;VL+3U:FL_*];)PI6J?;UL;FT[6],*M[+ J,4M:X>+
MW.(J][CVE.Q;+PI9YJY6M)X5;'0[J]OL!M>YLJWN4K_[6^AZ][K<O6USS[O<
M\B9WO<\EJ'G)RM[XNG>^\,6K>N\+WO;J%[#X+:UU]TO>^OHWM@3.KX#_R]\"
M*_C ?.VO@WT+X0:+UZ>_,<F;, .K26[268,A$9.$DJ8F%)0H_JH()^6(1A:7
M.))S)5=$S'0F#<,22GZLHEF/@A'O $695?Q*5/\2\D@B$QE2E5+DI2)59"8[
M:E?MBF06LX8M6%T16*^Z(RG?=$5^;AF*58P2J-S($IF,ZEYX29:/$_,K(+LK
M8#A^IY=_:2MFM;DV;X8+JN2L9EVR)),3.>::T:P30/?Y2@S#LZ AD^9"L]+/
MB [T4_?<Z)0\VLV1WNJD[UCG+U_ZG(J&(T,HS>EXM1'3T-0TG:?<Z3N?&IRI
M7K.E6_UI23-ZTZLN=:&S"&I8&]K.IJ9UIFVMZG;]6M>31/6P8WUH3^^ZUH2^
M=;%9#6QG"QO:Q&;SM(\-9T_VVM',GG6UDWWM91O[S'D>M*BCG>U<GYO7RO:U
MMMW];'5C6];41O:KX?W_;7,GFMYS+K>\_6WM>@>\W0,?=\'C?7!7QWG?E08W
MOKFMYX>3FE@21_>BR;WPBV\[XZ$&.,?_/&^"AYS? F]XMRN.ZXZ3/.$FAWB_
M4T[QC9^<X<%^.9]MWG*$Z[OF,4<YSGVN\)V/O.<._[G%C3[S=,-<Z9 6.M*)
M#O2;BWOH3F?YTJ.N\J1G'>I6ESK6I5WU?(==YU3G.=,U/O6G-[OL7&>[U]T^
M\::?O>WA?CO-XS[VM&]=[V)G=]_!#G? W]OC[^XZW[4^^+_;7>YXI_O:"Q_Q
MP__;\8K_>M[K/NK'8QSQ>P_\XC4O^<N'/O.1!WGI#>_RJZN>\JPW.^<Q/_>/
M_WL;[:)'O>WO[GG+R][TM/_\Y&7N]\VO>_5')[SKA\_XXMO[]6]F]Z]*Q2Y5
MY3A74E;8+_$E;IJL.(U_LQ49$4( 0[#8_%HJ\7M^EAXS<DD9R,JD+TER_?#W
M"V7K$CE@FKQ_32&9D4B&%/X30$/)#;:X"DM3$F72L9GP$X4XL8%AM>L+II09
M)3A;LP-TBSYRFE!:B0SS$SE1)P5,FR_[, \$,Q"$)1'<P O)$Q.$HM?X)Q64
M%PYTP(PY00PL"PV<01;L0!M\013,P+$QLPJLP5FYP:N206FAP:#@$\2(009<
M02)DP@_$P9':EB'4DR(\,5&K0GRZPA?,PBD\0KI*PO^?X4$M;$(8#$$HW$$I
M;(LT!,(<%$(P+$$?A*(XM,(17,(WI$(D9$,E/$,Q_,$N+$,LK$,C'$0_S H]
M#$0^',,G7,0H#$-'3$0R_$,S=$,7O$-"O$1#'"9-Y$)%U$% S$0[#$5+C,0V
MG$10=,(U3$527$53;,44[$0Z_$195$-:?$5,C$5$W$11G$,2O$5?/$5('$5>
M/,0MG,4@_$)A;$%<Q$,O9,12),9EE,-FW$-6S$5FG,9>5,9MO,9N3$8XY,1=
M],1GK$9PS$-)',<^1,5C/,<>3,=H+$1;1,=OI,=:=$9YQ,=RA$=[Y$=R!$9L
M;$1MS$=S!$@T=$=C#,9LA$;_?VS(@GS(@13'8>Q'BF1'BQ3(=XQ(:KQ(CB1(
MC]Q(A@Q);QQ)5_S'?53(1T3)CC3)A6S)DFQ'EM3%E'3(>81(F=1(F*Q)EYS)
M2B3)BKS'D^Q)G1Q*GN3&C#Q*FDQ*5?S)7P1)H0Q(I Q'I9Q*IJQ*I]Q)K%Q'
MK5Q*H(Q)J5Q)L"Q*L11$J Q*JQQ+M Q+M3S+8FQ+K^S!!UPTHV@E/(JB-OH(
M,N&3Q<")&=N2-<&9,7*616N_\V.Q-1&67;D+,,&(-"D2'S&S8SHTK6B-R=@E
MI!B) >1,1($4<CBR23FD"NA,_@-$C%$60EN(G-F,A[*S;.,B5).RNZ1,/WM!
M/FO _[#Q"KA(LS])####EMU,C-YT";@ 3MTTJEK),2IA3E;#%^$L"N)DSNMS
MSGI9)^6$HN+\33!$SNN,O^R<SBF*E^=,SN^T%PD43SVR3M<T3X5!SXU13U&B
MBM@\3RI*3XA3#=Y<SO>TEOC,S^'<3_N$3_R$3NRLS_4<T. L3_IT3P'M3P)=
MT"L#3_[,S;<IT/;TS>8<S_6T0 D]4&X[3@N-4.K+4.K<4/D$,0]M4 1]4 7U
M3@8MT?MT4?:$4>W44/^\T!H-SP3M3AI5T1CE41%]T1^U41/%T1&53@H-4?(<
M4A(M4AGMT0YUTAUMT2B=3R*ET@IE4A^=4B7E3B'ETB1U4/^-8(9;. 1RJ( T
M3=-;  -5N% L]=+J1%']G- Q75(.O=(NM=,OW5(I%5,6U5(\35$]!=0[M0=5
M  -14%,U_85;J(-D^5,0Y5-!I=,/-<Y)G5, K=-"Q=3_C,X Y50Y]50#75%)
M%=4<A=,]/54D!553/=%1Q= G#=(^S=-(O=15;5);W4Y<#=-6O=57155"==4C
MS55?W55@9=5-'58(+59E_55B[55G/59H]5-CO5%FC59+G59LK59IO=89[59M
M_58K'51='5<P#==2?59NK55K-5)V+5=WA5)T;5=O?5=PK5=QO5=RK51UW59\
MC5=[G5=:#5A]'5A*U52#G56$_51 @5W83&U8+8K-A!DH;N(Q=WJ52!.A:EF(
M-)$")AD[0GNCPT1,\ZL3_$PQ+/.4))BCQ#%1=KLB2AL_+@.D;[&5?O\:LM+L
M3 !4LDK1V2:KIWW1J'3:K!LK&&BS2PWC4QL<B0-TQ5O2S#:9) J<S"L)E"#$
M2S@IJ%[IM"JZ6CG,VJF]N*Z]PU#J*O'46JHE6W5CP;-%';'-I+4]IY8,6Z+E
MVI6:VYZLVRF)6[R5,KU%6[B]6_G\6ZP-7+O-/L+]VJ@Z7+X=W"A:7+<%%\%-
M7,@UVVEJ7$'I6\6]7"E4%LHU0S^+7,Q]6\0-7:OMW##\7-.M6J]-W<)L%=!M
MW;)M6]*=7-:5V\(%V\RUDL<5W=>%F2WJW<K]W=KUW-C%7;\=W>,E%=G-W>55
M7>1U7.)%7>.-WN9-7LZU7MC%WND]7=?=WN#_5;^MI5[PI5O>)=_OI=WS+5WO
MG5VV9=_;==_G!=Z]U=S''8MSTMK5A195^(5%/8(C6 (!3E,!.((*6 !5R%^<
M,-SVO=_R75_ =>#A55_XE6#Y?> *SENL)8!%953G5=[Z1=\\H84T#> *V  4
M7@(//@1FN.#5G=\01@@/K@!R^ 7N%=[T?=\-WMU.>A-FH.$*4&#?K=[XA>$,
MWF'=9=P)UF'Z#5_[I> DAEX<'E^UE6$CEEXD=F(L[EXMON(7SN(HWF(P[F(Q
M_N(&QF SUEXNSF$K7F,R;N.Q/>,>3N,FGN,EKF,WMMPG1E\]+EXVKF(Y?F,T
M/F(UWF- 3EM!/F0X_P[DS5UD0@YC.QYD.BYD27YD2HYD/RYB1DYD1_YC3@;A
M2<;C2M9D\P7E[+WD4<YD1?YD2"YC2VYE3'YE/<[?+-I?E?PD>RFK\1LC*=.I
ML;T+C+I#-1G9&;3.A/""DE5F S $-!O&:2F3ENV,7ZQ+-TLQ,=$(T]!,;3;"
M+Q&DGQW SQ3GG@7G(HNRDZ)9[%M-:5,T6:FC/+TBI'WGU' V/0O>/A)9?'X)
M2IL5"-6R3-/GG^MG!?UG5 OHJ1MHY"SH5SMHF$MH$5WH.&OHLWMH\HSH;IMH
M?BXE@MZPF]6SC+ZCBMX8:@'H/Z'HC5;HCB[IXCQI"K1HE39HD]9HEQ[I)/]9
M:<P,:92&:)AF:)G.:9J6))N.:9:>Z2.]Z(_VZ?#3Z9<FZ:'&::4&ZGT6ZIXF
MZI\V:IZ6Z*1>S:6N:5IQ:I8H:G_&:HS6:J01ZZ:FZJ?>ZJ@66:].:["VZK.>
MZJRN:JB^:K2F:[4V:X[&:[*NZ[6^Z[GV:[WN%[EVZ[R&:[LV[#WZZGV.:[X6
M;*3^Z[U.Z;Z6[#RKO[<IVXSUZE\(X ,6X TX M$>[<^N@  & TQR(WWV,55X
MU*/-%H$A[(Q9;(_&BXE@!C?M9W?.SBH+1<9^:\=6; 7M8!0V[B4XA"@3GMD6
MZ: ^[# [U ,^[=+^[-*N@ %>4S=EI[8&;L06[M7_%(@T'> !/H);8+3(ONVR
M+FQ=(0+=+K1/(0 PH.$C4(5>3FS KNV;OF_*WFG+3N_)7N_*1F_( .GA%O#G
MONS]#O#^'O"+!7#:AFP$_V_FYFKG[N[!5G (/_ +3_#OYF^F;O VHG"V_FW;
M)G#UUG &E_ 3?_#FENH5=_ 1#VP8%_$,=W'N-O$8M_$*?W$.G_ =)_&C_G$/
M7W 0I_$"Q^\(]W$6E_'\;FR!YG$<UV\B3W$C7W(=I_(;+_$IA_(@'^L.[_(9
MO_(:S_(HW_(G1V@S%W(F!W(QSW$R#W,G#VYF F_-]B,*I&<^VBKZ\TN]R278
M1(@TL3+I@RB56.9E_EA9_ZG/C&'9,[F&)-E?BDA12:>*A_:SE(E982DEBBAG
M >392@'-1NKT0FH/>3:7&CM&>P&D&BLS#X3A6GJ,6B$0.>%+9U.I8$HFFC!!
M;Z$:,?JR&NL3-]%UIHV27\83@]A+:HJD72_VH,H69'^E7#\58M]T9S_VCDCV
M6%IV:D] :[\Q;(]V:1KV;F[VO[AV8'<-)!EW$*QV<_]V=.]+9)]V<F_WK3CW
M;)=V'V/W;G?W7\=W<9_W?4_<N[CW<%?W@*<+?K?W=__W@]?WA!]X7_^-AA=V
MA(<(A2=XAC?XBG_XBX_X:?'WC9?WC@?97@?YB1=Y;+?XDC=VC<=U@"=Y7F_Y
MD/]_>8=G]GK/>)H/]I&_>8R7^)J@>)[G]H]_,J!/^6VG=Y\_>:.O>8[O>:)_
M=G!O>J%/>J@O^*E7^9@O]X77^71W^J$W^:*'=JQ'>H$/^ZB'=V5?=X@_^ZO?
M^:Q_^K9W^3YQ=3?#,2?A9568;@&F[M,F;=$F[S3]A<\Q"TE0A4.H@!O6"AF!
M3IB/>TRG;4MJ"/D6 -V^)M_.B5'\^;%_^[)G^P0D +X/ != Z+]@T?Z%8,;;
MKZ]ZN?]U9/?LO<?N%$[ATH;]TZZ /:"D?D=YLE_W&:;N%#Z$4D?[H(=[.^P(
M(!8 VV\Y4I!OT6;^(PB#F[5YL)_YW._\M?=XU:=^KZ=ZLY]^IO^O_I67>6_O
M^G@?_M3O?L[7_O+G?O'/?O+W_.L_?ZG_?JW'^<V7__1_?Y9G?^_'?^L'"$D$
M[)$::,^@/8$)#Y*RYS A@8&2("YT.%$@@88-,TH<6- A0H43,SZ$*)'B1(LF
M-3+L2-!@R),D'V)<*)+F2H(M*7X\2%-FPY\G;ZK$R)(C3Y@_%\ZT&-'FR:(1
MCWY4V#,FTZ!.AT:%2G)C58]*G68M6?-B5[1?=UH=BY*AV:=H*WJEZO+JTI%:
M34*EJ]9N4I!YX0KMF[*N3J1M!9/5&Y>KWYQ@[[J]V93OW,-_$X=]R?CMY;-O
MI:Y5+/:SY;VBB2*>'-AG8\);#>,TRIEL,FJ@CVF3!KP8-FC5<D>W9GL:>.K=
MF6M/O?T:J^/"RQVZ?DC2X$6Z"7M>#)IRX\.P(57JE(H2O*3J'@\2,.#^O8&*
M(VLW%-D$/O[\^O>_5V;@:6WR,26)%/EY091 W &'$T+EV21@@ JI!-YY_Q#]
M<R&&&6JX(8<=>O@AAP((0(Z() I0@8@5@+@BBRUNB%1597%&'@'9I91=1-E5
M5)!,V6TT$8\?D3(2D.1II>.0%47U$4G1'799>05I51][-Q9U$)+880DA==0U
M166.Y.&8I4HU<AGEETR9*2"1.VIIII7A>3FEFG&.Z6:9.AZ&)ITCK6EEF]^]
MJ6=)04DIIY]V#HCGHG%V^5*?58K9J)=YGFEHFHE.&FBEE&J'::1ALKFEH)8Z
MRB>BDHX*9Z><?CIGJJ("2FJKM+X*::Q_7LFJ9Y[N"6JNBKJJ(*^_PMJEIJN2
MZ6NAQ^J4[*R\$DNHG+@BJVJTR[IJK+7/8KNKMO^V<GOHM;*"R^BVS78+IJX/
M2COHI<ZR*ZRMT\:[;IV;U@OOJ<"6V^Z=I3);+;G>FNMNN,6J6_"\^KYK*GF/
M,IROLNB*NW"FWR)LL<($9WQPP+5V+/'' 'MJ;[^[)NFCHT(.]1(!%1RQP<PU
MURSS$D?4O(',1U1PB*M,J7+(B3]'9&:0$:_I;; .'_;C@ZT240'51^R!8Y#'
ME>13PM22'*K)G$I2 <TY'['$(5TM3673%0L\K$/,Z*(SSS33W#//.NOM,]6J
M])1DK^EZ##:/DM!\MLY&+Q24F2.C^J^="U ML]]/%:07,S)K/K,JS>U(';3G
MOGWQX&UGR['7CQL<]K[_$-\Z<>@;C^ZXOZO3^_# 7YLNNLBIU]ZPV[W?"[O&
M(0=.NNZ0.XWZ\"7?WG7S8#_/?,KXQFX\RA&K#OSIL_LN+\7="U\]\2"?S*_V
MOX?/^_&T@W_]^:Z/Z_SRWD>_N^SCI_]^\?'GOOWZ\M>^[UFO?\-"W^OH%[P!
MWD]Y"\Q> J57/_U%$'_80^#\)/A #&),@^)C8/6P9B."M$PLFJ%+5$:H*$R1
M<$OAT1(*-\814NC'.U>RSK.:X!_^\+"'\#&$CPC&(&7L\#W76!/@F'*E(@GP
M4;-RHED65Q+LN*B*5FP1BDZ4HA*)Z(I>].*;P-,9UCRM4U($B0VW(QN(I#$]
M_UK:R$QN8D.$+ DR\CG-348X' G=:#TX<5!Z9!2E!_FI+W=TT.<L B8Z>0M'
M=NPC(K]#DT4*48^/)(MJ'J7&Z S2DH:$9"8!24F)$9(]G\1D%$4I2$.5<H\P
MM$HJCS3*3KKKDCR)Y217>2U'GO*6?Y2E+ANIIE["\I>YY"0K/3F70X82F,C<
MY3"7"4I<*C*85.*E-%%IS&H^4YB%S*8OC71,V22SEL3THSBY24YH?I,BS*3F
M)M?I35."LYCIC&>:YNE*,:$SD?ADY#6CZ<YI;O.?E31G/?LI277F,Z#MY*,V
M[QG(;CJ4G@.-J#\G*L^*[O.=!=5H0UMI2WMF=);EQ/_F1<-94FN*])R1U"1(
M =K2A+Y4E12=:4I)NE"#DG*$9?KC*UT2R)\<0F\](QO.=K:YNE&-&9?A" %^
M,3F?_:)&Z-$7I"SG4D1Z1R)[,8PJCJHS55A),7!187FZPU)EYE2ACR* WNQV
MA%\\44I:I6DSQ_FE'(6U:CW36<[N-C.DUBUQP]&K3-D*4:;X3*E599P:0ZK8
M5S)$%6<CVQ$$T+EL2@(,@!UL!:Z60JX%M:;.W"A.%ZM3F)J4G195K5MMBMK)
M\M.TB#TH2F%K6X8F%J%MW2U/:9G;TN:5M[@5J&Z+&]R3(I>X\(SI<1_JW(^V
M5I\CC>UI)>O;Y#ZWNAR]+G#_H=O3[4Y7HMY-;7E7>E/:>M2\:R5O;94K7N$V
M-[[=?>]P[4M=_-:WO>J=+7S]N]/Y,E>Z^G7O>@-,4 0#.+\"9BU_#?Q@V6K7
MP0O^;X7[>^$!GY>]&X9P@G6D1!K]5"0PZ8EG GF=K7U.J#Z)8X4BE$M%MB<_
M$+)A9N[CPQWW$(\H69(DDI ?RYUX/?8D8Y]P@V,8/XF0'/DBE*',Q1%M\411
MOC*(")41$4L2B6WB52O!PC47EOB/M/)<2F:2)*2Y\&DPC)IVQHSB1*[Y:6V"
M39VW!" Y-VBA>0:="PV2Y\;1<7%]EMB=6[@F07^YD((!TJ&CE.@_,UK/CN8S
M-?^L_^@T [IQES[)G/T\Z3M7VM.F?'2OTJEI2G?ZRX6&=*9''>A6Z_G5J::S
MK!=-:T+C$-;;7#6I=_UI0\>:S*S>=*U[?6M1&SO8R.8UJD.-Z&;/^MG#]K6J
M<\UI:Y\:T[_6-F,&?>UE3WMMSA9WMT$=:4.!&\^-3C>QOTUM77-[S^HNMKFK
MC6Y[QSO;\][VOFTM;4G_.]SOYC>V<5UP=UL:W@EG=K[I'7!E#YS="R^UJRF^
M;EIS'./)CO;&D=UQ83N<W 2/., /+O"0 UO?*L<AL83D)$W:*G,56(+=\&8S
MF>4\<7PC*ZLR\@M=X$UQ:8$IK>8C;U8Q<2"LFA(!5"& N/_*[&JI+.NMEV;P
MAB/<Y!:/>$%NOK<-I*TI8EL0Q.WL<CU?+JZ#+:S/!$NWGIFMJECW.+2]/2F+
MX-SG1R@[EV6X\DQ'?>HVLYHD-2.YPR6N<EV^"BL7-?)Z#W[I:I?XRT&.[\NG
MG.N5]S?*MV[JKE><XR+'^[A++_+3DYST+&\WZDNN^I9CWO,:WWQXSIUYO2L\
M] P?_>=[SWG19USSEL_]VH%_^^-/?N+&!_WP?U]\WJ<=^;57_O.%;_W.8Y_Z
MY8Y^[%V/^^;O_M[,9SWEEP_][1/_X]X_.?A;'_SJD]_VV:<_^IW__J_'/_WW
M_S[[29_[F=_ZU5_W$:#V&>#T(2!)_AV;_AV'7GC$S$'1RHP92)Q=67W'"E5+
M5Q3*>&"'(121>VA5XWQ50G@!CZ4@?P 17$C@I-08?O!(XTC>G[G,!;I0S'5@
MX#%1>?_4");]((MDD1!.&1 6(8;XQ!S%TF@Y735=R];DT>?4AUBD40="A6M
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MHN-<9",O;B,N8N([?B,E"@@Q7B,Y(J,YMF,NUN,N@J,\KB(]2F(Y#N0O>F-
MWB,[SB.388>8.5F,X*-YS.(3'@)F-1;-_ (8' T![($J@ '/(<[A@$$9$@!&
M#I;/W()78=++0$E C>*;C=F><(4D[,'<-1XL6N++G)"-!",U)N,YE@E<O9W,
MT-5+?E5,WB)!/N2$J 1.)D[>Z P8=,[1[ $8W()&[LP1E-4U 64I+9F80954
MSLP2T)43-<A".F-@8,1-VHS9=(X[2:%(&F5HA:%<5)2*)>0^!F4_.J0TPJ-
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M\HE]+2>HA2-IYZ#'H-?)HZA9M*1?Q+<E*AG3JV/Y'$03X!:G'@\8H+1*%6U
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M(7$%8Q(1P=#^]# 097( 7;(08?*O[# .:5(G%U$H&Y$H']$H@W*PDG(FE](
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M:?=(*666]2KU*IWUN!Z4(/643?:E1PE22)!$YGN_.OO948_A1D<Q6BR//.1
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M+>TK=WO<4'(2N'XUI6M_VU= 6M>WT\TN(UEYW>XBEKG2Y>MX>5M>SMHV_[J
M%>]RT9M#P7[O(TN!"_WL9A-A2I0\S06@+V-HOWHQJG]P(XSXLNF2%C6!= 90
MANH:)0D&2WC"F'-P? EB.=(]&(J]>B.N.NS6#QL3).YC8PAWB>#HJ7C%T%N>
MBY6'/!;+6,:'JV_^+M23O<U.A_S-+T?V-DE1QJXO "1B?NE21A*GI"2.\_&
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M+,?Y2&P=23_P_+9^(1(7<>/GN! !$V,A$VY'FMNRYP8HN6>3$7.%E1R901>
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M$_&Y1$EJ$4S_O+(3[9$N.PB<F91X53H VJ]^6YF2_^R7H_QMID<Z24J-> 7
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M!,F2@,:+I SHW&G 9D>1"DLB;**,I]&C2),J7:KTVD:,$A]R+&HT:L>K  =
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MN8Q>64AQ#-AL*QBR6KB#DI%1MZDC3-?#X!L_JR&/N9R.&NE>55,]]72]Y6M
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MM8>:K@=ZQ-3#IN=ET8RK\C')#;BTGR.3;4>U()0K#[ 3H0UB.:VC'P3TBI%
MI_W[N?6IHK]S&(-:D>0 $))+.>I;"QT"G/6[(7!2,A+2HFW;0./H/@-$I/Y2
M0-3X&.# EZHZH 1*#K8"/QF$P0&A(_&KF/(3IQ[:%WL!.S)9F6_B)X_;$;)J
MKRTBF'[I*A:"+@2$.ND!MP_,)(Y)H+MA&?M).L'[E.9+/KZ#/L-#OI[Y/=C#
M.N$#O2],O3,\OC0DP^)CP^@;P[)[/N.30S>D0S"T_T,QQ,.]6\.W0\/9>\,Z
MC$,^%,0\_,/IN\-#]$/@*\0N[#TU=$1 ;$-&%#P]?,39\,)!Q$1*7,2I:T0S
M]$1#!,5+3,3"@\0Y#,6S0T5-C$1./,4YJ;E71,1)5$12)+M5)#Q9%#M:U,7E
MPT6Y>SU6Y$4)#+WI.R(.G!"Q8,: HB2^*@\%K*%K,IX" KF?*8X4V;]+HQ^I
M:X_HR;MV6K+[H;XK*L((0L? 0,=X"KAVI*?[<!D#]!'E,KIMXCEDJCIGU,:%
MX+A^?!>'8I>'J@!_)$AND9PCHQH;.PL,H3;LX@H&FA_$*RJM>+'5$)'9@K$2
MBLBR2LCHDHT)89]!F2\MB?\;\&I!\/B865$K\<B.^K",'BLK<XN:7)F56[D-
M1Y.K:-$RQ\J-@M(/C(0KG;Q GE0W]T"LG'2;G:S))[(2H*25I!S*I=S(&'%*
M^]HFFFP1IJ1*IK3*I\!*Z=#*G^3*>_'*&O.OJ13+C>S*?S'+GCQ+G Q*J/Q*
MF/1)BAQ+)6++IJ#+MSS*N/2VJ,Q*M+1+M23+O$2OHKS)OGS*OYS+LZQ+N%S,
MJVQ+Q&S*NQ3*QG1+H[PLI&3,R:PPS?0LSI1,O71,OMQ,OQS-P_S,Q#S-R"Q+
MTLQ,U@Q-U'S-;@,8&NJOKSFZ=K,VI5O""J,5*>JL\RC)Z#@0DC(L"\/+=OLB
MXTS_F0?#S>S!%JF0*;?POG@LL!![RM,R)_1 #KT[L '<-),T$_Y;&Z;3%0MD
M#P5C'R TFL_P3A94/]UHN'JKMZ>J#0L\D/4,3JIY+'/BGI\<MXFC+X9,C\":
M,G=[)N\Q&.-IN,52H10KHI94%?H8DITLSY*R% <AT*$LHE.1,J)J"M=8$?&$
MK*)"SZN)&69,"BV*D2B"D*!",""K%I=139NL3,+$2Y$DRM7,T0 J3!Z5RL=4
MS+44TL DTM8T4J5$4M.<3=<TS![%T:W4T<OTS"E-2R#=428%2\&$S"4%S"Y-
MTB<%4\RD3"K54BN%S3/-4JU2TQL-R\%,4[F\TCC]TB#E_]*]!,VJQ-,PU5/9
MY-,M]=/2W%/+I-,U]5$T==-#A5,O+=(^-=-$;5/1?,U&'=- ?5,IM=-'%=0-
M&HH,BD\>/4^&W#0C*T(,$PT7T\'PZT"EDCGM>ZQJ>4A:69_JM*AKFZK_T,9T
ME ]844>7:()_<\=A319KN3OZ\-0IJ8YI(5%O*[#%&K>"E%9OR;B'"LAI]<?7
MX)2?N4+Y::<@5"&J<[K)0:64D2R'BQKU<#)]B9XN C\IK!^!N2V=TYQ9%#^@
MD*+SBY,HV;_::*(DBYN=$SJT*Q@#PB(CQ+$=M!.(>4]M,C]W8HYIK*'-*\"'
M?;LIRD"&;9YXU2%V2IGZ$U6*=?_8CH58C$43C6U1CF4<M#/9A17&BB79BTVL
MDWW9D5W9A 79G:0\F+W9CY58AFQ8E4U!G/W9D@I:];%8EIU9E]U9FQU:G\W8
MFA5:Y"':J&W:J0V/JJ79JT7:F%5:A0U9U^/9IZV*G!U*KB6?I-5:IA59K/78
MLBU:E$TC?_':M0U;!1I;JH7:K6W;KEVACPJ,;]VR@2HWFFA"!-(YG'NKM.TC
M"-,<;P))__"GEILD6:292BH0KNHH"D08^GJY7KPR E+/_VLJI?,_:G0O()I7
M#0-=LJN<'],.!:2_\<NH/IK/^6.:BXT-$AH@FAL-;86Y)B(B;30?(XQ$^MDN
M++J_6=S_/']2/P9)H/SY6I$!7,]X6"9\#KUKW)M[IB2A1' E.I%KBX,DHR-*
MWK#A)PUM$PPTHOS!/B4ZN76M063\OS :6"J$HGQDP7N=C(.E";O5V;Y-V[K=
M6[856Z?56[BU6@%N/P)68+X]8+<MV:6]VY[)VZPMX H^V@'NV0<V8+Q%8 SV
M8 W>6+\EVXA=X @VX01&80@&80F66; -8!7FX!-N61).V146X1;^8 L.X;?E
M81R>V][=X1N>X1?682 VXK-E8+KMX" ^8A^&X:\UVXFEX09^XB6V8B2N81;6
M8J MX2XN8@J.X@W&8JULP!<QN6]Z"BA:F@@$UY_*/"Q<0/6K-5=/A W'A5^0
M_3W!6BFKP8SUXQ BSL??0]TP7E>V8$=B961B48:"<:](YK+VY,$=I@XARC 5
M_Y,$;,56@#P7C.-DCMLIYK&6 :0Q'9,WVY0Y6P&OL4*1&?6@FUH*BT))[OM!
M[Q WD1&467&9@[RMSC)6%N0)"+5-4P;"XZDN<4-0J>&Y($W6W,Q.!=M&+P(0
ME#HQ:I/F"Q6-:N[1!Q.P3K&DPITW$:E07'8?"56B<;[F:$X+;19G:X;F[6SG
M<"9+=8YG @5._ZQG>,XI=E8W>DYG?O9>? 9G?0[H;F:5;P8/=!X4@<80@EYH
M5FUHA"[G; ;HB5;)A :9?/Z_?:9H;)YG@\9H<@;I?Q;I%7/H*X'H<Y9HE/YH
M?^9HAG;IC*[HD.[H@Z;IDH[IEN;FG(;I@K[I%]JP___<Z-&ZR>@P4%A5ZJ<K
MI.(0#HUX:H?#KO",N N1$J !V(/:/NH%*7D6SB);W=!U'XO$9.L4423J*8]Z
M+H-R$0MUCE>I3A1D#@4#M[T!0MW:,M>8SE:VJC!RSJ!*7:C$J_W2:% !/Y:D
MIG&S$^+"+UN-2/N%ZL=^J5>ACKK(,B4)K8DS&).,KU3+0)LR(\JV#PT:YIVS
M:[>8W/T1H=6\Y;_=L''#BWT1,VA1YN;L3[>K#MIB$/W*%R-]YGZ69Y.^Z9%>
MY^#>:27#:9+^Z8A&;N*^9X5FZ>:>:>4V;J"6Z9ZF[I6>YHW&[N+6;G?V:)^N
M;N:F9@,4[^^^Z.GV;NC>[FW_-N_L9F_P3N[UYF[RYN[WIN]MMF_WUHOSCN_T
M[N[GKN_H+N_^AN\!;^]W?NGQ)O#[-O#\-N<$#^\#U^\&YV][!F[T/ND S_#_
M-FBAYFPRTU7YBH_"*]&-S&K;Z-6.2AB0Y-:HC$_HW0F7W&N^#8T8(S/BO1#(
MKE"VC.TK:N0@%Y8D."^UWBE541[NH4F-:C#=(-WA"&5IK=9TN=8HKS@<_-N5
MG=N--3D,TZ$;^G*50YG1I6V^03*8FY^\@\CI>]?>U4)[Y)H;Y-]L=* 1?"'S
M/4D W"ZF4-K%5F*P0*<X*MWQD=[P77/^"'12+?1N13%$[\62<KG]^;DR-]\5
MQ*#Y_SS"_'7TOR-T3#?T1L]T3F^Y14?>0P]U\+WTMF%T2D] 5&<[3U]U0&EU
M2W]U52]U4"]'6J=CL9YT65>Y$=QU29_F&4ET2"?U(<+U2@?V]K-U9&?U7U=T
M6+_U9Z_798_T%.GU0YEU:S_V;)^4:H_V9O=V8G_T3A?W8<^08C=W7D?W]57W
M49=V9^=S#/XF__0-5[Q00):1?K*5\"4Z' MD $7VQFWC1Z<8CY/'7-_H2-?<
M<-+R-.]?@C)/:U3=Q[- \\'?L0:?)3KD%'P0@VJL=?V[]!5D@Y]W;MR*R-W?
M+21X:JSWN4M>,;>9YYG8$WO>3KQT[L7R+F3 K%ZP?0_?#?_R1NKK^4,N>/*K
MFLX>(2M$6F3R7>25/Z>VI78-E=T&%#7I6*\=.=M.$J5?P GL=W8[$LEI["FA
M2=1M$7=K]>T0=./MWW@?]W0O=W@_=TT_=5UG=G:W^USG=KAO]TUW]6#']K^_
M^[ZO^P)U][E_^\,W=;X/=[U'?,#'^VMW],@O_,<7]KU7=LP??,W?=LZO_,;?
M?&/W>\^'=M)G_&3_?-2'?-%?_77/?,MW?-:/?=<_?=CO?-D??=P/?=6_?;IO
M?=\'=]K/?;&/$@K,4$'K)OQ;_)3+&/?SBNY=HZ0&QS@N'W$4(L)]*V[U>%%7
MXHT4V[Q)(;JJH 4T"B%'?V5H DC_C]#8#3 .=+J>N, M+F2>>A"CL'*"]&2!
MS'^) @A)]@B0(F"/E#V!" D:+'C08,*! @_:HSA1( &!%R,^?#BQHL:*!3\B
M!!DQHTF4#TN6#.FR(@&4"T,.C/A18L6<-&D>Y$DJ)$J,)$7F[$C4Y$V<+WOF
M5,DQJ4.,$5L^Q1FTJ$&:/U,>Y9ES:].2$&\Z+$@5)\>2.HL.)5CS[-N!91MN
MA,O1)%&W#?'&9=@1K$*^=^\N7$CQ[EZ_9>L*OMG6,-S$<YE.;<SVJ]RXB"DJ
MIFO2KF/,>@]_E-S0<^7!H?-"YFOZ+V/5EUEK+LUY,F#2L_D6KMWT]FG*@66O
MI;UW<^'@_[E![^Y]W'9RV)\M%[_M&R9PZ:E7\\[\_'?TQ=.)=Q\=.;OX[;L)
M>]>-/3SJX=S9FW>-/KY[ZM:_OY>K//9\CUW7%VX KB<@?P3^-QYW(Z55G$IB
ME0:401'6-!A!-#F5(79"$85164@5M=55'>V$ED@?3>3022 V]9*'+S+E%8LV
MK013C%)M)%]7OZUXE(U!JG66BQ%ZZ-9)9@V$9& ELK@1DSWJY6)5(R[9)(S@
M207353QYU>5A-IX(T59 X2A2B8<1B=>/>E&%DE\_\K6C=UZB.1&<'''HU$93
M]<E943B=Y>!?"Z)(UDLE#O7@C"E:A=%5,YT$DU@W5DDE96K%&/^FC6[A*5Z4
MGJ)%8IF!BGBDBFH&5Z6#*T[9X6=D1IGD6M]1!26<MP+IH7BXCIAG;E^==A.2
M8_UJ*9Y]JJ6?<_F]EAZ/U='7&G+^:1<ML^V=!Y]P^9'7[+;60NMM@]K:Q^UR
M^DT[X+/X,5<=N.>*ZZZZ"#I[7[?OED<M=//F6Z]H_(+G;[KDK9M@N_\:;&^X
MG2D<8,#LXELPQ,;=BZZ!TC(LK\,4'Q@QPA-GG&U]U78\\K?FFEP@@Q];W##+
MZFD,\L4$HTR2DQ#*N6&63L8FJ: I;0JLAF<YE5N?6_:9%69W:0716EN*.;60
M]@UVX5).8YV65!&>YA>MG1%@ -EEFWT<-MIIJ[TVVVE+$>-<%GKDZ*Q2.0B1
M3)DBR976:/]&_0_@@0L^..&%&WXXXH57((  BS?..#F,)SXYY9437M.?2TG"
M=)M102TG7FN*^.%EFVO:(U>;)W3<A3H9!KKI4=\*]=X:?;YZ6*YCGA7G('E^
M^I<LX9V0Z#8Q;='N+.%5N_%O]J>ZZE'CCCOTN".DD4/'$\\FYWOM&%-4J^LJ
M2?C3XVG]@]_'*?ZIY4=_ONK7DV[\^K&+Z;ZQNR._O^WU1XG]\=[7(>_-KW_A
MLY]+\+<\]/U(?0?\'_$"F#_>[4]^]'O@^!2H)P86<'7^RZ $%QB_]"$%?-T#
MX5,FR$'^>1"#[0OA!D?8P!)^\(4I%"$!6;BY&MX/AO#+H04->$+_&UY$A3+L
MX Y=V,,;QA"(54GB$)=81!Q6\(DF;!X106)$)SHPB@GTX0"KV$4L2E&+5+1@
M$%OH19MH,(9H2L[>#N@[,Y)/=[+S#P4[-1OY?:XWYJ/C=[HF/(:<[G^WNY3T
M<*8FI%3J5P\,4_7<DT:=, E\C 2DS%I"P2EFCX^S$2",7K>L2+HJ+2%,51UU
M4SU1#DR/]S-5D"Z9EZI9QWB!\M3K @4]"N+F:]EC'_-0B3?E20\SJ4*6L: F
M+@@9I7I+.5Y6<CFU"3YI>HMD4PM%I,R+^+%-VR.=2WIWS3B-19RS8Y^U3'2I
MZ)B2;U-+"NR YSLWV9%ZF0&F/+62NO;I_\\PV]%>00)8R-R]\Y.ZTIXM;8<\
M\E7(:43JG@ZO:#L43K&)8J2A$K_(Q!]>]()K!.!&PXA&*_)0HQ7EZ$C'.-$L
M_K&?)/0H&4UJ1HNF%*,?C6!(73I#F*ZTC"WEY4N%&%,V@E&G2)0H.F7ZTQ6F
M$8I#!>E)11I4-3X5IU$U:D1+2M2< G6G0NVI4@6(U:8B%8%;O6I7CZI5J,X4
MI5-U*EC/VE:I>I6J<67K4H^8U8S*-:]<M&E5&<I$-]Z((7$49RJA=[K#T!-"
MK]->'8'ZS?0IDW=KBE[=YE<[X:WP(:)*Y259=YS:019WO5/=<P@H*C0=LI-(
M/<GZ,I*$MM&VMO^V;=OQ EH^SQV2EG5$I30GI5!\>D^<!+ <<I-;.<@Q]W&-
M4RYTH7NBJS%J="09$Y;0HBRK&"LTJ<KLFF22)B.I)RF'58C4YE8Z%,GLF%KK
M7*<\U"3W_,AYE'G4&[U2G2PU$T/8R=17I(98@C*&4#4JU7I@U5\AQ61NJVU4
M@C'GMR>RUL$6A+"T%%Q-!@\K,]>]6E(DO."G=?C!",ZPB#=,8@L31K\ASFW^
M5GRW"Y]8,!J.L2E+3&,7FPK&V'25CEL,XAZWD\*>9?&'X4GD4AHYH$@.\)!O
M660Z'7G&0E:RE)E,92=;.<FZ7/*$M]S@+D,9RUB9\NBXG*LK?SG+84[_\YC7
M[.4(^[C)<7;1G%%<9S$'.<\V3C&.@?QD1YG91WXC$82! B40;9-2RTO6U53B
M*N&%1%*?A=6L0L24T<17N^U4<M*PF3L=644M8)+OK^P4-D42:E*D:DIF1Q63
M4K+L:#8"6HBQ8IOAA!?7H4MGA:B4RPEUBM)-4PI]AH-LL'F6U'N;)J5>E9ZO
M)8EIZSMH:*!6*C@IVTR$NDIF>Y;=2I>',AQ2L%/27.E (ELPKY;+T+0IOUVW
MKFG$YK:_YC0I1R%[4[^A\*(O4RS(Y"V6LYY- +76ZT?76T:9IAV@T_1AJGUW
MFIJN)K%,2>5#NW/ CJX*0@RL;1Z[><0Y'C2&__^\9SCWN<QM/K.668[R&E-W
MY1R>.<EA_N:;DYG0+S>TR07=\Y37',T\E[/+Z6QT&2/=YTJ/^='QG'0]+_WD
M0Z?YBZLN]*83/>M09[K4G4[UKUN=ZU@'<] K?/6< UW%90][U]'N]JW#_>PE
MG[O:S<[V&_\X[W7?.Z#[7F6]1UGGTO$,G21=ZD;?$](M>GR>JE0H>*5;0ZA\
M+Y"*C4VFD0C2@H;M+\]$+%1WWC_%8\JR&N46)ZN74.LVH?M05Y>QW;;VMF];
M$ZKGEU@C6GMKEKQK'+^_JEB2,!F)+O*1[[CE-S?YSD\<-26<6,L69[@ID>;2
M- E!TAK36D6:7C=5V?]Q:XJ)<XVDVKSM3=BZ&ERW8Z8-K"+I/% >\E,-3>3H
M.,7)4QD\EN$4RSGM3(Y=CS+94OFECA_I3O3L6XV4T*DDT_8\V_8LX)8TH &&
M$P+>DP+>CJQ\&2C]431IX!Q1X(58X'!AH' EX ARX(1%37>!8 2FWF^QH%&X
MX -FH 3.8*VTH ,>8 J*X 32H G^T0EBC@H&X0[68 ^BH(X<H0[RS1!^H "%
M8 X28!)&X0M.80SJDA5"80$681%2H0QV(0-^(1'"8&2-H355H!E*(02F(1>N
M80FV81:^H1.2(1MZ8!WBH!J28 >6SA[^8!7*X1_:H ^2FD4P'GWY34_YGUW_
MS%OXV5->0!#V:5'L4>"#R<D"7B)[_,6O@:$&*I:5#$;ZO46X:9/35$@#:DXD
M[M8FQ=(Y!=?X^-]4O"+F 9\S)9PMYA\DE98HIE8MQM*/%5_\](ZFG4ABJ4;L
M05,$RN%*$! %=I.U)6*&88\(CA(EI1YQ!8F=)):F, _$"99[)=4:"I0A)B$W
M'B!HA=H-/<V07* ,XM_YM!D$62)$!1>YT2)7L)[]B!H))1#6:!(;?9KL;5#K
M5-)X5%\>=9MW;-CX^"(Z&1*CP)BGT.$-"F(?"J%%'J(1 N$3EJ$>7F03>B0>
MSF%(<J08QJ$?\N %MF1*LD5)%N(2NN06PB0ALB0HN&HA'-KD2BIA2X9A36[@
M%6XD$W;D(/8D%HJD46;D4)YD4;ZD4'JA4]+D3D8E2 *B4D+E"C8E5J)D4&ZE
M5';E4WXE$H:E(8YE58+E59XE5=[A3?ID3MHA2;YE4GIE6I;E6LXD4#:0(HJ.
M$CEB0ZH?_V1A.I(@=R@$, H++3I,,W[3LR5>^ND3+/Z;-\5./9Z6J5BCAO3-
M" ZDFU@2/<4$ 4C![96F:1I $J@:*879A4V?GN@*@\5BN'W_)D,\GVU23G-%
MCG-5P&WV9N#PR+G5Q*SP2:KI!M@0$]P(V^,YV)TH)LZ 2-<<)Y05G&36()@
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MEF/:\H$*)S3=DBVD!1KC-0\_%'JN(S2H DR!AZ\>T%0)2/9@(GQHT(R>T7^
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MSE;:D8T_#(QXAHB;:%EF1P5EFC,1*<[6!%*2C\J,/"T#1ESU*D6"05>14F1
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M04X0-BUP8X0=1A@"YB5(^%*.!Q\B%E;M<X AP6'W9UZ< 8;QQS6% 1Y)QQ\
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MS:KHLFOJ4DC?NZ;+NUN UTX\.L%(E3Y["C#4IB8Z-G&9))#&Q-R0Y[SWULS
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MV,G[)+S[6?21[]50PU^ Q?^Z?*5&I,S[OI_0T!C\R4_+O7_\TT^8U:^>RB^
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M^.*'G_WZ[K?/_?ORQV]]_>6SO[W]^N,//__GYP]\_TM? -5W/P#Z3X *-.
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M?OCMG__^^O'?7__^\_^??P#T7P )Z+\L,"$)!E"@ 9*0!";HJH"W.R "%ZC
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M?([C,FGS!"_P5G!:)JLF6.UU&% XZ(R5TDB2-J,#:S";S Z30(,%P0-5.C
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M91JQD1FI,1NKD1NW41NA\1O%,1RE$1R]L1RO$1TGA!T?(P [+@D![R+F"8L
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M-,/EHTR^<TF%_X)>JDR7Y^G<?[?: 4.7'B;WE^9]Z&&,!REWJ@LB@1R(JH+
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MCD8JN9D3?Y[VCL-'>N*!>Q?!J=IGMEQJM^M#$(%9F;,6;-O_!JU:JH_MHIB
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M19A!MY)K/\3+^X8\,<</?!#AWZ(QNDL"X/U>&R&[NU!BMPL?W,(CD  !P,!
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MZ@CPI='FG>1R5IY7.J;2P"9HFIVZ:9UAXED1(N1"YB=^[J="\J=^]B> _J>
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M%>I:F^PS(\I].8=V$6;9]@].%PN9&M7?OLIG1,M^F^_RB@_Y<*^ @<^ C2^
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M^S$X_+U_@4^8_-/?_,L?_4.8_=??_5,8_M]?_M6__DT8_\>?_N??_@$"0",
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MN:O#.VZ;N<4L.[@*I:C$NC6T/)V+R\I,3.OPQKX2OF8A"NVD%D[,-3&<0;6
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M0VOC-FB?XL(CM+)RI</>M&C;-0$B:_O?ZU1.T_ROTP0_+4)3*_UW?Y@!1",
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M(K_(2#8V$I*/E*0-)ZDC1U(2DY:,9";7R,DZ\C%2 !3A$H/X'RE@#Y78F\*
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M_QUQ# LQ$@^Q$@>Q#K$0"C.Q"S<Q#SN1"T]0$@E1$2>1$0T1$S^1#R^1'K*
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M+HL)+&E#$P=A8DGHF)=X9G5C;>BW8SO391C15?Q&5732F%OF-O\Z5C(!]V^
M]IF.<BG+QS1O4V]NXS:M.36O*62P^6^S262UR4BVR9HI0RZ:V9N\&4@Z YR[
MJ9I-X9O%Z9JIN9K#N7_XIIO-F9S/N1/163>/29W(F9O8N6/.N9V_R9S9&9NX
M&9ZT.9WD66_<B9KCB9KEN9SGV9ZWJ9[F*9WR*9S0Z2KQZ9W:^9W6J9_VR9_I
MJ9QJ(YX"^F^SDINQN6C]J9NV9F,-BIX(VBOF!Z$+>J#U5IH/JIGLB:$$]YX%
MZI^O^4L?2I_P&:$,2IH@&IT7^C8BJJ'UV9VC.:$F&J(!ZJ(12J'_*2GR9J%K
M1*/,HJ%(4S-8(PA1):+>LC4#<30,!SC_/Y.:)R.:AP29F7FD)?J=358S*O::
M"D6E7'J:JI0VK"DJ#A<=$Z<8P<4F66<[2-=;S1!VW@,[PIAV\JA9=G&FB+.F
M99<5:_IR=>HF=$5=>FE:1W1 T4B0GH<7?6H9XKA;",0ZGH5WB-59%Y=W33=U
M\/@\54>.K=4,?9J-)&8ZQN6,;*&.7%>0::EX=86IU0-8E#4EJ=.-',)7EW-U
MD,<^GNH\GG6IIAIRL(I#:(<ZSG$]BC.L?R6LK6>L9:4?D:6LE0HYR-JLR3JM
MTEJMT7JMQ4JMV,JLVUJ.W0JMV6JMX?JMQ,JMXWJNYIJNWHJNZZJNX.JNY=JN
M\OJN\QJO]'JO1?::K\?*KOBZK_#JK_4*L/VZK/)ZC26W/'M)J1#B>[7W>I;A
M81:FL)3!L 8 ?&&!I[>G>X]56INUL>11):=QI".S9 #Z$/^)V6*'F;*$<K)>
M1%64B"QNB$]^68@T&[,W)8L,&%%\Z(;DYT])\U2KU)GAIT:9Z8I#:&YF&)B6
M:+0]B+23I+2CZ'Z!>8J_Y)A1"TU=-HA06U522[14RTA6R[58>WU)2[1+RU53
M.V:RM+7?ETU96[9!>K5N2[9/:[9RJTYO6[=Q*[9SZ[1K:[=\B[=T^[=[V[:"
MZ[=5VYEW>[2#I+=A:[B,^[7@YU. V;>-2[B/6[F'>[F)JX6:&[EJV[F4NZ&;
MVXD0.+6+V[1>.[2%^[FJ^[5,-;IL!+IK1%2>2[JTBX*Q6[1HN[H^9KMLA'ZY
M.X:[>[8UF+:U"[:>B;NO&[K*>[O_L]N\O\MK:!BXXB=^MUA*!I$3@B"T+EL2
M4Y 3"0"%6!2S9O:#ZE>S: @W(S4GZJM&#PB_N1B)93.)C=N)X'>$#5<X!!L[
MZ=.QHG4<@YH[A=JF=E6J'3)7?1<<Q.<[I,$>%;=R6U<:KLJ0W"B-(2<^O;-#
M?7%VMP&G@:6I#ME;_EM#K?.1!BQ=?H56V'&/E&&O<WH>G^&.!&2L^)%9-]0:
MMG5[B7.-]Z.,C&J6QA@@)ZQY@.>,L<,\.3>0<-60VT.,J[=  S1#,#3%-&3%
M52S%6AQ!&<1"6<S%(43%)CS&6$S&6WQ!*&3&8)S&9=S&9]S%8NS&:^S%:HS&
M="S'=AS'_V\<QE>\QVSLQW<,R'H\QZVUL3M9=<4'D5T!8;4WD%6!EV."<@7"
MR'6I='6!ET&0C[\AP:;COJRKL_<[%"Q[1BI;RA0QRHMBH5C*H3R:F9$)$@N7
M:G?SI8,S3DJ6GZ Y2TF(,:1[;DDE<+7FBIJIRKIF<(UIFR2K2D^*8UJD19Y2
M:,MLS'+DS#8%S3W*S/E&S<G<ROTIS3:&S%[*S6OCS=PFS"/*RC^J:NJ\?M;L
MG^2\SL\\3M%,I<<<2K>,SEX;S/H<S\I\S>^\S]4LS_Y,S].<;_PLSG1#T-]L
MS\.,SQ[8S 8=T/WLS@I=SNPLT!0-S-H<SL2<SOJ\T??\I1X-T?_+JV1*]LL6
M/9D2#:4HO<X@'9RLC+HDS=#'J3;Y/-/!6].SC,WUG--0NM/_[+T77=,M_=$1
MO<TG7<P5[60^;=(9;=$OK=/]E$GX]C?M%C'!>Q&:6'N/(@C2( BPX-5>30)?
M'=;20!"?.!$L6LYYUBH,VJ,J?4W,YRBM""XV[=2?.=34R:))[=3=XBME"I*O
M4SSC\\%\*F)R>JDSIXVXYW:A%8]QBAR.S*O(0QVE\ZS,*%D6UZIYQ4'_I8PD
MG!99Y\@':9:,78_0<1^_U77Y.,"LFJAR!1ZKNMJ&+-BB%7H>;'2.#-I5!%M)
M[*L .U@ .=A7QW:9I1;$,]BWC;"8)8S_:*%#B36/:B=@I45@ P9@UTW=TWU@
MV<W=U8W=WZW=TCW>X07>VUU@Z-W=Z1W>WGW>ZOW>[+W>[AW?\#W?]DW>Y57?
M^.U>^EW>XNW?[;W?UDW?!'[? "[? @[>@.K82_>Q JMQSDV729#<@Z6Q@65R
M=&F7K*T5&NNL]$@@PM&*7J4T+HO*8&3*IFSBC>*WM4B<B+N](!%^-7N%Q'O5
ME7F'70N#QAN]Q+:#*7:!7&C.9*M50'Y,2SOD2C6C0&M-6ZJ[/Q[D/&OC]R=5
M11ZT4X7D5 [EZROE3NX42HY+1XZT1*[EQ-3D->[E51[EWSOE3QZ+:F[F1Y44
M:;[E:][E<D[F_TQ.M^K[$W@>3G"^YU]NY%<NYDD^YV6NYT,;BGW>L_>;Z'SN
MYG3^YXX>Z%;.Y6=^YVY^O98>YXEDZ$!8YY?>Z5"NZ:!YB(4^ZA&X1::>Y9F>
MZHA^NJ+>ZI\NZ;"NZ+)>@+0^YK=>B?/FXVB.ZK-^?:GXZY#NZDZ[YZ!<1R(%
MM'7H?<B>;BAN %G@O0BX[-N$MTRKZ8JKMC-5$E%U2G!XLQKXLY8^XIS"Z9-)
MO)425J)#=:=:V\YZJ+$G1:O*6@LF=[_5'[=7.QT;JX;7CX%A&PO>C#R4J SL
M6E;7X#&4V_$QPY[Q\+%-Q'$R.?WN=0T"J:[#V(K,PZUMP?!HJ)17I[[5DSJ\
MA? A)O 8K,B51?)ZYW/N4?!(1]N2>EH!-'->)\3 0\%"[,);U]G8Z/,KI_-
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MA1AI((TL\![:833^S#69*5"G@Y@_751\\?]'T>"H8P,ZXC$XVQ&Y2H-4B_O
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MNHPD9!<GK$[_$,36N!#^#'Z@><^WZ@4PC>7'.S[\X7->6!U2N,$-GD "$MQ
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M#'#_$'  #U  M6]7) REC$X"%PRJ=F^RFJ^KFLYO&FQB- JZF@%W@(=:YLP
M:$>^HD\**")W7&NZ^HJ_ZJLB# ['XDCF1(+&<!![Q =]2,$JS@=]K.+$/($*
MP"('_XTPH(1C1W9HFAC**_ 'X#1.?R NCCJ,Y79D@%AN2- )U)KLS'JH6?BB
MV+AP(G8((YJBB^Y(C&PBD.SIQO)'GO:GB;+BD7JN(DJMSC CV#1"\#3))\#N
M*@JJU5A$?@J*)J -6+:)!L>)@[IL(D(@HAXBD/)"E'SMF^[G#YU-H!SH#SUB
M3JQLCD;.[EZ.A>C0A5;I#%NH68JH(ZKI/ XQ,+Q(%"D"21I1(BK)?QKD%8?"
M#65.%FTH"8&-.I9BA&RN%@U )#:Q.YXB,TKBFGPQDU:I@_ BM%!I#*DQ2;8)
MBY(0W00DB."G#+L1FRK.$BV.EQJ.HEQ)"4ED$>WDU4IIX_^&1!O!T1TA"1Z]
MD1W?L,\J:>3B\1N+,1S3<!S_+!KS<:"XT1U;B2 3T2 %#H^R\8!PT0UC"1Z]
MJ<-N\89^S2%]R2\$X2RD01L9$<[HB!;9294LZ@TM:B$7TA*7D'X0RI_J@Q"Y
MR9L:BB$=:I<0LN*PJ1HO<2*HR_N2JV(D9:0 )1K2RE&(CE&,<FR,9^P&3U ^
M:@,?Y5TT"S8LBQ,GPEW.BQ/=RJ9JZ%H\A1-5C_;(CF6X<JH0H+& BBP'3ZE:
MA?6"$KKNIM*T\B>!Y[4NI[&^!BNK"/%VI2HKHZ8F)5S$DBKI2E9HINO HBX3
M13&_DBEYQ5L<+0G LF!:B_' K@G_IA+NH,1T1"]6P@HN,3/K9J6Q).6E +.L
M+DQJM*6E5"4U%[,"D>X#0XJJ2(=2(B7H'"<W:=-M>+,I<=,VC6ZR='-O?A-S
M$DLX?XXX>Q-UE',WG],XH[,VD_,V;?/"K+,ZL7,XYZ8XJ7,[E[,[FQ,RJY,[
MCS,[L1,\H;,\P_,\S7,Z??,YE>HRYR9F'HLH]POR!NPV)Z4$3U"W>$4%)V(7
M1,K[/$WN=),U)8) >PNQELLNSP^P1LZ+6C$=@3$AC#!#I4=\O@?%U-( D"!$
MN2?%.N('T(<(K4)#:6Q);!!.2 X>91#(3@W;%D[/2BY%^-(RGLS*G*TA?BA$
MF,TDQNS(_^2(S/)#TD;QU_Q-)$IP(HKQ2$]M22I1(>10),YBUIC1X_AC.R;C
MAX+ )@AK*FJ"1R7C1Z7CSB+2XN("VA1C1FOM21DB1VTH2>BP2,-B/7B#UFYB
M@"1CBY;G+83M:IS-3X]L2Z6B3S,&BXJMC,!#G9!T>8SL+/QB-EABL]I4DBJ$
M3S."4"4"0^*4.OP-S[Q$(%(-,DY-."3)5!N#+C@M4CN12LUH0;@T4 _U-)K1
M+U+5V585+SKD2HN"-Q (+XAB4PG+WH:$R'ZCGX:L( _(SVKI@.1D0AJN69.U
MEUSM(&D#R7B$1JU51_X#R61.3 "HWJ(5/Z:U1NV-FV24-9@57?^]I%L-*L?:
M<5N#9%R?M%QI\3[$%42N]7\>CDELC!>U<.2&XUL+:,MFT%_C9"&DX2R>HDS2
M NO^U$'8E4(TCMXX+3^V+2W*4,CH,4;1=:'"]5T-[N;TU6,+EN9JU%E)$B-\
M[N=,1K!HT^F&$K9J5OC"\JOLZUGHSJ;8LC*QY>^*AF-P!6:.A2Z(#P$4DS(%
M90IX@V!<QJBV1O:: %8&930XRU029>V"!5LTZVMZI5E"[S#WJS/X2_TV2E8$
M%"RD8&,H3/P*4+A.RF0&)F"$5BI@931LKUK$*F".5C0#16*9P&_OUL#2]C,C
MI2JKMFD+UZ=T2V++)6C!(G*35J0D-O/&3@8MF[8]UB4*&M?M $4:1J$IY&XT
M=T;YPE:J @4V?8?O'":Q#$5P._=SJ45QU^5OXVZ_"I<)K'8*L*XR;Y9L8-"[
M+F=X/^MOC/>ZD+=NZ+/ZMHMODK=YH^]YBY=YC2=ZK]=ZH5=[J_>]EM=[1Q!\
M(Y-[OW>]NM=\R[>]ME=\WXY]@U>YSE=]XQ=^TY=^PQ=]?^Y^:[9X(H=F]S=_
M587HM&]>#O1T=DIBC.%]#Z4#)>(_Z64H0W %J??"I/=OB/9/JXW36/2&_U0T
M0SMB>[PG?+2G>T+8*JA 1)'@!XJP@T4LG?@(A,:Q$#%J8F'X?[QQHLI1EPPU
M1Z](-EAQE9(H"F"8-Y!M4^EA&$OH"\/BDQZBA'"R535-&*OP''4H&=7CF"HQ
M@U1(+@))2&O#%&U#AOIC-%Z(C9 QC.-.EUSHE^[)1-X(V>#P'I%Q)RV)+Z/
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MDZHT1>CKFEHR9G#+EO4\6^;_=[SFOVI66/[\1J%Q$91T2>:'(A/K%L\IP5;
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MN!'JM5_K=RZ[^3U)HUW/)T;5 F3E=5>C)1 -J1#P,@I# I[\%7K:236<(X!
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M^^-<DS.H+EIYR3>GD4.@D#::'6F4' < _Z,XB4*A03WQ Q0$BCU!%VY009Y
M%YC:0(KB)-X6:DFG*50!9EBI)'2WE8!I<[(6& *"JY-V(S_5C=WD'0,G)\'8
M&D!2%3]E(Y'BB # JQ)G'+?2%I6&$BAR%M.D)8%XGL!B(B71-.4Q=:'92<;F
M0UUR2GP71>PHB%G!JPMQ:>-4<GND*KF*2TW!(-#:DNP!;<O(&(X(G.#V(#29
M)J-4)NN6:*_6(0<WK<2*$L:Z5=CV=?7JKJ\Z=?44'_M*;5;BL)9"JV:2$IG!
MC3GIC,V::S3$;K[*'V^9DR-AK:I!;+1AL/F!L=V13+/XJOJ1LD2R:GQ4'89R
M0+]"*';B=Q&K0O^.V'6:QFQXV4^I6BM$^[/%,BM3DK2>4K1,FR7B]+3S$2@E
M-T5"ZW;$]I9 JXU7UR5<2[64LE(KNW=<6RA@YTHH!W1$YR>U>FBRFE"%5I%6
MVV?<FG506YJMZFEG$9U,( WM=A<K>D-C.[3WJDVKB2F E[2-"W(Z"1(>MU(5
MN6?$&':/FT!C@G5T"ZRQ@GBG@S^**&1Q:H?.$WG>^5I-&#)BM7LUU)VH&U[+
MLS2M"U35]Z$*<3CG Z#@5;MPBBTK.A?;@FV-8X"*)ZC<932PV[O)8X#8!WV!
M2BU00X%Q)#:0X5M+4SQ'D0#YHI_R,H 52GJ0-3D4JQVXMZ&3=:"'X5O_XF<0
M[%LY#DHX$]I8N9,T3M.DM&D[ [,1[]<4:K-=ZKNGJ'<P#6BBX6>]!:.?!9$T
M!"B<<>,S!YPR&E&\_\L8ZT.?.&,QCQ88"^.<'BB'H2= :!@POS=69DC"IT6%
M@!7"3JC"N-F%)RS"+<R&)LR&,=RGSD7#B<K"-US"*<S#*#R&,+S#0AR%X*O#
M13S"-3S$2HS$,HS#/DS$+\S$4GS$5#Q6-AS%8.C$/1S$3*PR<!6 +.-CGA5Z
M 3S#%58^H6NM@Q@O*MR0]A-C'+'&-'8M#>F'HGN%EB=B%I-W7\EW@988IGIF
M%+1!2)!F2G%!3?&):F;(HBC(3T&8694F4!FT_]\HBS/E;G.9F95Z2#C4(PW%
MEUJBP7/1EOAHE]]6L21;D*AL $*G<VU)C_GZ2@*52[B!E*R\(RHIR]@TL@T5
M D 2)!4RKC.YDG991KJ<:)=RLM"V'%S$&8TPRJKQ)%G)BMK+E?G(J]9A4 <)
MLXW85,1<D)F42^#:&/U1:13EH +9:N2K':6\D#CDC]#<RQ45D'^211$9<'FW
MCC'52>Q<SE>1S[O2BDIYBYIK$N/\'MM<1?8(N>"H%M.$K_QZB@2R'+^L$\XD
M9EADRB[GL)P!T9H!D\$L)10;S*/9L*T*=]_LE*"<M0?4TIQ,9J=IJ2Y=R3!-
MS?DX:!VITE0ITW<KL?\T)9EDH<E7.T4,M=(F>5&(&W<YI9<]G=-%O=.8B=1L
MR=2),JG7'%)M--/#MK,%_913.T/D=$;Y! L]% 6"8"@YE:Y:P\Q7K99Z9T\R
M5Y7XEM3[!%5B^8^P&-5>?=(W"=0?-69,IY:$M6$JJ(,/$0T?EE@^.+H<H9TU
MYBQ3P,YJPXC(63G4*;\_VEGEHI]]&IW)T3WP>US6%5:2)<'(F:?NQWP7?)[R
MPU:.%ZFL93PUU*)ZG%GR.P7:PE>4)7V0(Z#U&3"2#:ZF%=L4*IXBTUSI$J$5
M(:+,0IUX%5[<,BW\N9ZVW:;+-0K>-'X7:C+30J+M]<6=E5GG6Q$U2S<;LUG_
M%)R'K%,YZ<TT%UJ<S*=8QM:B+&9D4=K8'Z9Z^JTW.);?--;?_(UA LY?!$ZF
M&C;@ )[@<1S@"E[@#G[@+=;@#+[@"/[@%'[A%A[AIUNE&M[A$E[A()[A(K[A
M8_SAD9=X3WI= @$.=MK8$W.GURV;<!AE2=9A4K.H,(H ?\K *$S "4&H7),O
M,JK"^A7;*KV5-5T5CPQ"1R&J&Y2)"?'D%13EFCBJB=P43 X5E>S*(F=T,V=$
MX&AS/7<LW6HE9HMP(LL?7]ZVP+'6.L($?RKFV#&,>LNR:ZXE+Z(KPB0?8HN3
M591RYG09U0$LTHH:!MO0D):LYATE)@+.$JW3;_'F_]J!&XY^SP:$JF!.%4.2
MRYF4D=:QM"[WYS52UXDQ)%UT(@>7Z/9J0C6I(VZA?0K"!+2;'B9AZ)L"L+#.
M>;<QZR5K%L*ZY^=Y$H@>%KD><JM.&<3DM$,D$K'.Z[3^',B4=WSRTD2U:7!D
M&LC\ZDH=L@$MYJF.YTO":BEAWJ5HZ!\+)1(2RP[]<XP>MM#\V7HN2=YF>'WG
MMI\F:XF;)P,G*?B.<(_B*O>J9][Z[UI+U/<&=5?7M/8.%SSKK8'7< $_:T7'
M[)FB[Y?;K&[;N5.+N7M7=17_TR='C+UB\=SZ\%3UQV5N;T:+[[%VM$W'S"GA
MF)"!UGFA\36K$&C=\("D)O_^OO!)EW5*[?&[MNZMTHISPM%!/_1>OK.E6'9R
MF[GLV&+1 @Z,+2YB-:<*JL+?%0URJ%?:>XA5[]OW@Z+3Q02V<<".+11KJ!'/
MO=N_]][J*\ Z8;LS"KQGGS6>97XGD][?P[[0G1!L;SS4K;Q,,$"UN2U9\S?
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M=#EC;N5^EDP66&?!ED%>1&G&WF7U%T_K]#[/5GW9YD&/Y^&=SD/IE$57E\<
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M]P# Y5T^__1/_R_)QY)__[_/_,'/4P !H!&]1@ ,'#Q8L"  @009#EP8D9Y
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MQ0Z)L(4O= X [9>]]VDF-N79RA'7LAZZF*4O,MG%Y'ZT"S/^KWMQE.-*Z*A
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MHV.NC]/8GS+SVJ5US?W O#6#D )QD1O3P@:JD+*<S0D3W?(B,.\1,?;B6,C
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M-[:YE8YQ:N,:T.%V.*P7G:FSW[SX%6)4[C A2]5TUK1+#F3]4X>$-=8Q"I$
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M> R#Z14TFK>IO,JM_,JQ/,NU?,NYO,N]_,O!/,S%?,S)O,S-_,S1/,U[.@I
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MW1[NRQAQ7LF __IM/+;PV\&+.3L,O!ELYL28(R\U7/9K::<^-U-V7#;VVL$
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M_\5)G.Z!697<T]>R]@=D;_UK6P$;3L?FE:Q8O>N7R@0SR XV3IB5&64C*S/
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MV/[RA[Z=]6](:>J\_/LO (RIHP(\70*+^YN_ 7RL MRI ^0R-CL> \0^JKC
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MXQF=!_I7=-(DG<6B7>( &@"(*DRB6A)@*^(FS(()]LO8 JQ 6=!I6G=!/W)
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M/SF1+TF4->F3^ZB328F4)QF01RF42PF53>F-*6F40;D+DLB*6KD'LR<2!]
M5(F2:\,01<54WAA:(0%5QE"6E7, #89ARB=ONMAA#T8S$7:+> EN"/-A^Q%4
M$=8P^>)K^K1$TL8D1$A_Z1=_B E_];>8\Z>8D-F8D9F8DEF9E'F9+Y:"T.:
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M6P_J^QT&&JV,4(8<B9RY:ARB\SF=_YNR"+P2,U(&,1FD"SRD,D&"1.H_BI!
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MM(JC4[L1*XF>E(Z/#![XBA&YC(R0U#_OH4O#L$OSVLNY)*WFRLN_Z,NZ#$S
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M*(U3.YU3/*W3+M50)WU3/>52/_520/U3/JW1+2U40>U31&V&/2"C!%2&2$U
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MF6:.V6:;NS1P )J[<%EGG&S*F::<>?9)IIA_\@FFF&K2N2:<<_8I9Z&[''H
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MN8=-;6Q_.]OG+C>XWTUL9D-[W/)>M[?1'6]U7SO?\'8WO[5-[GE7F]OI;K;
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MU2P)UI<<P!3TH;[)DF/9&B^EDBI)E".V4YP0%C(QXF5A%H-\%E2>R*3-G8E
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M+=;88Y%--MF2P/#$$R0\H<*QDZBM]B1EL<U6V:!^)8J>7KOZEEMND2K7VZ6
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M9S;V51#D=5PF2*2VJHBTRH(;:(F\JJN>"*R^.JO 5:O$6J7&VJL"^*O*&JR
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MJE\U:EB+>E6S6I6J0F)3H2II,FM"*&'FB1"$>/5(A$R!K0R[4(2*:0"]MLD
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MZ$!S9= 03EK2$-WH0S/:+HZ6M*'5\NB7 +!U2-MT# VMU]-)!C&@SMI#3,=
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M,Q\,FE PS/]P65EFVL]*F1L-FM1:F:QNHZOFMJP?CJ&)ZJ[5VI(4XP,$ .H
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M8X8SMA;C@]W=EV*& <3P8X\YCK;1%J-:]F5K@8R("4<QQ3)"9O^[4]F+ DS
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M5RG9=9L/FZZ0G+8@FJ%(JC'R)GFS&Q$J#.E2&SI%3#'RJ0]--0 '0/B_(ER
M4T)H*B'3!LJCR5(5Q+1K7P.X4FL(;B75H.D;_"S8;-?D#8.]-LWY/%,^%LX/
MA%V)GX@<13-VK"(<MW(\A]@M-E/\B&H42,!!#0\D483A9@:"OM3)\#51565%
M9%RXDB 1(4&\#*MX&,'1';''3%A,T/+)A&N,$H*(Z;%9/IE#A[20(/>8LB'_
MJPR]ZEWD)1MDZT&:0)%=,*$)36!>F/$R$S!3Y'*<&>*1,\(%ZR6$S6J\<D3"
M'),>(Y24=TY([5:IO:K\,GZ$\4O?%O+GO!"$< =I<6LTN9<>&R *8AEE M8W
MZ,U D"P&)O-6QFP *B FSH=Q2(_+S)(H?^0>?8K>X-C7M]<D^<2,[C)")@+G
M'5X0F 9H@A2>G!$F,"$)3;!4F=V7@%(S.]"'&PCA/&@49[\YQB:22AIM##^7
MV)HAI>XU56AH@!MN+WY?YG.;YQP1:#<%?97!-M\6$E4X'S )S"/D"IMMOM.A
MN)/&"Z0G'?*87%O;CGUD-\*IK/ 4,_R*?#EXM%-<_YL] C+7%K=UI:VH:0^2
M,I)T7&,71<,6J*!2C3W)#,J1 D9(2OR,'Q?*:+IH&)8/'.-4%CA($!X3MQ1$
MB X?2*X#?AJ]!+SF:A2?^8*H&J&/,N=;V;9AY#9RPDS-P?2!<'S<1N$*-Q/L
MTKG),,GC!O=ZQSK<4(T;> D>](0=[K)4FRRW?C:Z7YAM]$"2@*GE*(%-]YMY
MHI-797HE#1EJ=]OU9JIVUA%/=96I^SN T@B/$/*&*4F+0UG.7CSHIB'H93@E
M5:<(6ML'Q>P_]#V(J4)%H,H?Q$I<D%.F.K+=% %(1+)'4^;^J<XMR4AU"8&0
MX2?D)"BA:%&%DN>&5 1YS?_;?K!(?5.1>#JP07$U50@BG/)CI!KNXK[V=>U/
MIQJU_?[.2/4':8:01)0K%;&*J)J2588P9".G[LI8X>0K-YMOIOWGM/\2"L Z
M1O\&$&3TA*[X;T@$\ "[I;S^CP#]SP =L  ;T%P>< (OL ())O\DT (19@,)
M+  3$  7D 0CD $Y< 0E2P$1D 5+T 7QJ@4Q\ ,[, 5%T 1?$ 5/\ !I4 5S
M4 9AT =Q, 8AL =#<&)LD <IT -_L @S$ 2;D B', E7T+] [U>:94/09/+"
MY6-.J@ #+%X:#X 6,&K$:J+\X[S C[]F1-#,[?7,A&B01KI D%?>2E_<KPB/
M"C?_%JSN&HQLS@;O[H[NOH8084D_]..5J(D0PP::K"8B'NGCAFXSR.*/M*AZ
MM.(C,*DU*-$V1$(U:N<T7FS6U(AP9F-\*L?-<FB#,*@JDJQNHBP5T^UXXHW6
MTDTIL*QT4,(3^T?6L$=XC&@/)@B"MJPJ?C$6>3%R+@HHNNT54>(C4@TDG-%V
M0(>4?(@K2@W&1JG3,$(N<,P375&$*FD/M)$)_.U^J*/7Y&CI-B/2"$TP2)$V
M]LS=JJ<;,4W.:$ASB*+;V,+>9.(FH*TNVFU_:*['C$@KA(=1JJ(;)R(H%+*4
M*H*&ZH<@:&@= :,;C:C$NF@5UPV/@&S&^HC:XH8A[C$GIA;"AY1B) 'CTE*D
M*GR'(FTM,Z*,VA[C'[T-=S8#T;QL(:@Q=8RQBBR)Y[ '':'.*3+.Z)3N(R'G
M=6[.,)JRD*!R+CSQ*)SRB*3R;^3BD#0)A5HNA1P"Z9*NDFHCCGSBB9A2CHBB
MY8 N*)=2U]KR$M\'YLA2R-Z"C=YRDHH2+%")XRYI*-]"D%"Q;U)HB_H"E+@(
MBR+R+SR1@W ((0:Q:]H&PB+,#QO_ >XNDSENX@>PPSKX;)C*XSR,B9C,CCHP
MLYFH!L&"(S(U#,,B##XB8J[<3TG$RE<&2VGZ+UVTBJR:A@D(QT?8SV?ZKTV^
MCYQ>[T8:Y,_Z3JHP9:=NXH!B9 HB;7%NKUV2Q#^T49ZRD*+\8[U:9% 8Q?4.
MX-*8(*.Z+[[F:IW0I*9XST&"Y#N_[ZI@D[*, 1;V0-N,I:$L!&",:EC(Z=*2
MX+N*!J4(!SQI"D/^+$!3[R:F0D#CLPW1;T%'1$HB3;_ RJ4J2]04(D;H[\_2
M)$:^\U40)*Q.*OTNI)\<M*U>9:,6Y:E&Q?^61KS"Z45%I3;-9$;]Z?_4Q*B&
M+T?'$)QB_]1&Q9!' 4Q'JQ-(751(LTN<] ]&:Q1)=U1)^\Y'F[1'F91&J_1&
MAW1)LS1*QY!+C[1(\P1,I_1*B91,<=1,K11-MS1)QU1-M51*W[1+9;1-G31,
M?]1.SQ1.O;1.L;1/T_1+\U1.W310_11*"?5/V?10!95+B61'IV7Z6F8Y\]#O
MJ%3\ FQ >(9 TBNR *H9R*E"492?'L1G4$3U@L1G\(N_]NN^KJ19X.H!^0X,
M#R11(B+!5!-7[6/NN*;K=A7#M&[#)$QKP"8_)BPU6].5# TP_X;@A)+D/NZ0
M&.+2R*3%C(PZRNC2E)+3,N<21^HM9]'+9HX@$:):=Q'/1FD@Q/_1TBZB7$'R
M=\!M#WKL(D'R)9RRQIAQCG8-@*;1(WG,6_'BQ>K(=*"B3Z!-RVY"@2ZQ(7WM
MR(QN/'."++A'X;!-*7J,S69B4-J57@^'8;WLQ%@N*?45(9J =&9'F0:M+T=I
M6AW2*YBB\\J5*>35,%XL)C_(&MFQ3\*L8O\57%'6,&06)$J-(AUN@&;N)J<-
M84'B.QDB0_LLVZCG8U]CCYZV(Q;S(<9S:@G"8K<B8SGV#3'BB+[S*(0';!=-
M%7\()\RGQPRA*9:V6R^B?QC"1O*LW%ILR-@'*APB+D+BW$9N'B'6?C1Q+J:N
M*CR#TM"(:?\BXP97<1'7*QJ7Q$!B;[G_+'+-#'(+R<S(PBYLCBI0KNJD-GT\
M;B[C,G"===,(",70,3&YS)-:=X3JR#,<+HWZ:'-+X^? <B_ZMMF0<B.CM>;T
MMHE$]EWSEC7<B.=([.>R3"O9;8,B8NNR+FV&PYKJ8\(RS#0O\R:00'NO8R<1
M@NS, SW:[NVN]Y8F4^[:)I92T^ZL9C\2(D-$)@#Q!44:8*"*Y0IEI4ND$X$,
M3R0Z[_:.A?'4<'3ZX]B@)#]-I&:*@D"[L&2:K_-.%CW.\:\>IO[(;T%"#_!:
M:H#]H_,8I3PSM&;$I&9>)CT1)4,.ZIXTCZ_(SU4YF*P8^,S(ZMBB8IO ,*BH
MX]A:^-BHHZ"@_R3]5F] >G,ZL2^^"NJ@0MADO>_\*F6#]_=6++B";Z)61()P
MRL1EQH]H)!#^;(]P:*<]F2 Z+9A< B5F^'-)U0NZ"H:,T_@.!:2,!>Q%B2^#
MXQ2-=:N-T]".S[@]V5B/Y=B,Z7B/\QB0_1B. ^N-Q]B-^7B0#_E<UEB0IY20
M$1F/YQB2&5E=')F2F322&SF1'UF3+5FA.CF3XQB4U5B4_[B2%3F5/9F45?F3
M7;F56=F087F691F345E-U<M14<^UOH_O'*LVR?1V^.E;^+,99 _RZG<-F\3S
M)/5.0!& 9*0ER!.:+0^<'N1-<*4Z8:6&MZ6;R/ @BK7!&A%]R?E8R?\9E@8Q
M;>1N$<LY,M=9[SH';\;H->AYZ5RN+%2.XBJW@R!8F>IG,5],([?5.<^'%7.B
M&VL6*&!Q)W",(KI7(JZ1SG*MBUML>6R,$DV'*BEB6C5'B&NMCQRZBQMB(Z85
MQARS<X)B(G."9DGGHZT1);O-I&.R(Q.BQ6@')\%6:54#VBZZUMY(%V5#7?62
M+AK'I/W9.0-(UQ3C6V7B@7%:?9"-.F)R<<M-=AI"J@\*Z!;"(M6G9E_,"30G
MWVS,SY*:(<JM< KB([X')F 1V& ZIT/R/_WV/V,RK,DVC$Y'.KU8;J4SZ6BV
M(N[Q79-2%\VUJ31'S:XU;I,V@I3Z:U<#DZK_N1ZAJ* WC7N8.LY<;7%<NHK+
M(K++*'239]%"!V\8CNG C8E"Z"W-!^DZU^%$-W0V=^>64K9ANWIJFQWMIR]2
MERFL\G31U7%1^[>'.X^<-2GG9M,,KKBMZ&\!8WGS];D!$\1TCI!:%W/'4N<J
M%S0>S5JIAY^O$H^^V[-SL0]_%1$9L3BN)FW(-^PN@@JVMS,]DYA"TYAX":(3
M@KUM"5<?C.NF:;_1M\)V S;Q<+6 E$-L3Z>@1F?0Y*C]N4!I=427Y9_[HSBE
M4QT_%6-8BIPL'*F_:KBL)?)6M89U"V DN\-O9+MR19DD6(/==Z/ZZ8=/ECS[
M;J0:IAG2KU4*9<.5_VE$%.1A@,H_&AR"\:2JR$E,3EPB7LH\Y1/R8AC)/\15
M,C6"5;4-!Z3"G_Q"N$^ F9RE<)Q)Q//)"^=>C@53#[P!EB]63X6ASCP'9[3W
M#H#-7=#-S1S-K?3-X_RMRKQ1X+S.YWS/\9Q2Q0I!^+S-]7S0 9W,V>O/^]S0
MUYS1%?W0'UW0';W0(9W2Y;S1"1W3+5W3\YS3$5TV)[W3 _VD(KW211W4T_S.
M);W4+]W349W56<K4-QW63[W51SW1:YW6;SW5[9S.;5W679W4@QW70YW78YU&
M9OW5>\K8ZVK$E05#*M3T6A1%Q)"QS!1%?W//$8U1//6<.((\,TI4Y8DC\/^D
M:-X02\J=7L"=H5CU("[+0&!!VO>/20_F?[/E%&QU>J=WG:O7?'?U#WVUFMR&
MPP!<6(%5>AO,FN"F<N]!E)(WK\55N"6>;R^QDP3;G^?U&9%\'1TB8JVL8[]M
MT]PZKIWB)C.B3TYMXSL\"2#^L6^;@I[\' ?IY5$[S ]B(;8M^ XBSP;BV<SL
M@<DVHE42/81^]7A(F9B-'A-B,+3VR3N>7Y75V'@VE-#Q@<-<X]/B>*X^V)0I
MZ]$MS-\MW)0I;(M>->8U7<T^%+5"W#H(%B]Q;E%-YKM(R$.1-DH#D(3<Z"6M
M*0:B[G\:*;#MB"Q\[_,L)_[Y@>#6-DS:Z).@*#6'&NBYQ\DY_EG)$EYE#BV#
M,BQ)%S#YN7-!.VMA/KR%^_-'_[.]5K=#O_13G_1'"9.,CA(OP\2PN^(R;G)!
M["[U+"VUM>__<BYIGC%T'S8\([?'0KRGLJE/%RH'TB^?.WC]MG&-TNA$B2ED
M([)].\:+#;@MOX,J(Y'4J"XIWK - ._X_>#Y75=U_R._F\F]>8F^O9<\U(XZ
MQB,[P$#HUW\]+"Q]T[=87PD@&M$3V @  ((&$B8\L*NAPX<-FQF+"'%7,X<7
M)>YBN&LB1(G-$GQT>.J 284H4ZI,*>7 18LPFZT$^5#*2H5)*.YB<K-GDI -
M.3Y\:='CRP-)>BJ=8E/EE(S&,F*$&35BTY0//5;%N+5B,YY*E;8\!?'JRIP.
ME:D\^E)F6*<7R3Z<21%D@BDJDY@D>G+I5*)U=Y%U^[:GE(V CR8MK+#E ;E5
M)]*%^I6Q ; H'Q=U:#8OS%UT/<)$:CGA8<V40:^M2K0R2Y(;,9>6T@SP4)%#
M-TO=Z%)TQ9@3=^_U[57WY__AO_\&/]X[>=WE1YL[AQHSJ/3DU(5?_YV=N<;I
MQJ-_QQ[>^GCNY7F?+ZY1^_J1[;T3AP_=_/S<\<7?5UY=_?[G_2$'7G[V.0=<
M@-NQ5Y]_!G:G7X/I"4@>@0P.N*"$Z%&(H8((OH??A0G2U^%_![I'HH,%6C@B
MA!J&^.&*X'&W53-<F%0<<"8QU-I_=A4EE6VV-902%1V])!L3@!U9DDNJ*83D
M9OWQE4!*";"&40(764F4; 9DA.5H-GX79$1:^FCF7V<*B5)!!QG$YIMNTN/F
MG *U2=! <KZ99YX'X5D007'^:5";??[I9Z%RVLDGFWW::1"5"42ZAZ241FJI
M,9+_WF/II E442FGEH8Z1:28DCI%J:%.>FJHD7K**JI,+%:: 4F0>E>IH"8@
M*V-25!JJ6BFA2BF7M":0:Z2[)L1$E9>N9"RK"1#;*[._JK1LI<80&U:MHF+J
MK*^X6JIM6-<:NTNDP*)$+:;)EE8NL]^&VH1*46#;;F'E<CIN8=RRVEE*_2:0
MKD*:0JOKK ';&JFSPEKJA$K3<LIIJ0V'^O"L!DBA+;<3/_MIJ@YC#+"MH()Z
M[UG)UNLQI^2":LS)/BE\Z;X]O0OJO"QY'.D4N[0[JJ\7HU2KJI?"?-.UJ.Y!
M<\R;BLIJQY:*C%+$!A]<&K?A1JT2LZXF$/1;46RML[%A__=D2+60-HTLP@8;
M<ZJSQT9*;*VHOBSRLJ7^W+;,K*ZJ<]Q\4PLXI:M"?:G.7:]\+K66)MZPQ(LW
M[/C3DD;.ZN0@FQLXYFKO87FHG$-+<=6DERZQKSN?.VK%;AL\>-44CQKW'IIF
M_:K"IY].>N*4A^JVY!_K['?K%7?J>MNKWSYVZ:V*7KK>S%>9O,=^,ZMWJ9ZV
MSNRXB^?Z\^PR0W]X]'=];$Q*=PIJ**"$LB]HHP+](__\]-=O__WXXY^2,F!X
M@H0GGJ""2I1!!?_Y#PQ*(84!/8' F^3O@1#,'YL&TCX*PHF" ,#@!0NBP4&E
MY$>LB4I7=I2E9AR@ 4/1476 9/\EHT0$+U)KR7(@LA*OP+ G0C$A4WAUKA^=
M:80D,<F_Q&+"792M,<GI"D4X<D24^)"$#2D346ZH%"80:R-UH6(-05+#SV!D
M:2CA&9H(@Q+G:#$AWUG2 8;8&"46R8T6 :-/H%1$ZQR@B=NR44R^1$:%.,0W
M9UR)%56BQY@$LHS!Z:)V[F@9O7#D/'U,"$2VLH>\Y"A,.[1,%!@"'=;PT8N@
M%$QY?#B5APRF/J34"6P(E,I0GG*%_5%E0U[Y1%#:AI:P3 Q$<%G+4JX2E;%T
MY2B#><MA[D:6HF0E,7=I3%LR4YG'%"8TG6G*9NJRFM.\YB]S2<UMUE*;L[1F
M;K )S&C_%C.;X_0F-WT93G2R,YGE[&8[XPE.>'*SGKR$Y3OSV<ISTC.=\[PG
M0.WYS8'R<YFFY&1!6Y.F+X4IA.NY9!09:B:-P((+;9%12&B2D90\*2(J(5,D
MR=2DA(@1F1V!R2FTB)N).N1+DXPC5GZS)-&4$#ACF@X<?72 E!2J@H *:J"&
MFD$X_?10'=0@!2UH08,LE8,37%^@FMHF"U+I=8(C'^E45:I=N*QWO%L9M')5
M*CR^95E89999>Z(,V$U);+Z:VU@3\"\JJ&V C;,5L=IJ*F:U"V_08@(;&3:^
MMZ8$5/? JM%2XH2Y?BM7BRT6Q'RUDJS]*PEQ&^Q*I-#8V\F1_PEF;1JFEN8Q
MAOUL=&N]"<<81RJ\-@]6\7(:Z$0KMUE=2[ >)1WK?%=;J>7D=9R*;!)P*S3
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MS_W-+_[3#_ZO[_WG;_ZU3_[9S_X[??;"37-2<1]J3VV.GU$NI"4M95.V21T
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M4OG,+P8SO.";KXEQ,-I93<4KE_R!JKS[&J+ZP@U#L:U9E] T4Q#3,1[\'K>
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M@\2/'A2/OL9B"U9C+$A&?%I<[.=ORH]@E@PU,K9R[J50'<99BM9ISH]TSL6
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M[_=N[^UA[^YV[_*>[^V&F/Q&;^X^[]#U[_C&;_NF[_0F</U6_YD#[^_]5G
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MF-2D6$-IBK*:%KZ#-.]_UW-;SJYV-0!R[&,;2U[U&C9  .(-:&"<6.%61C'
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MAZJ5AM[>CEYHY8'HC^HH2-AHC)IH]-'HD?+HD/IHCJ+G\G%+<(8G@U;$*1Q
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M:7&U5=5H9SWVTV['/=7143=]%=A,J\7UVW+C=5173U^U5MM+=85VWD:_=?4
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MS.YP 187I/(U&^FGP7QT"DCV5$4O*JF+?D]\)A?@IH+<<D0UJGR'NLC+E6P
M)ICN=F_5;M8Z?-_(]DMXV%VJM(R^X<%]#')Z<]AE:]>L:+F7M.\5:<>\]31D
M80RPRP+;XE3W5:5-CU8I@YB%I=K5P,(N=W7UF.L8QKRNCHZF1S<P? T[W[3A
M;*9RD]S9*ORN6N'LK17#*6F]KM['74ZDT5)PT6<GV]7ESKO+E=[$SNNNQ=^=
M6X+_19[?HY<Q@%%6<!1NN]Q!1N#&@E7#Q17[M-Y^U,'&MEP5:VOR=/7YH=U.
M82E3;6Z+5;;H\HMQ\/5=W-+*O.1B3&!-U^W86?;YY44>8V9;\%T[YSO3YM1J
M\R(OZ G7UJ=?E[;,'=N'^1L]S,V^:X83?_7*6_>^\<JX'*YN\59/+Z2AWUW=
MYYGA318XNJ=\4A,[=$,YA#4S+\-5.I5[LC=@M.<OJ+==EQ,%*D%R#'5D058^
M G11/_9C,C$_+O$#[^,&(>@)[J,2I)!C)4$2/380'KAB/2&#&+B! <0IB5(H
M!R$-*B$%&U1)N[%.N(1F&00<7%%F7X8EK>%Q&#<GCK%._TW4:$OH0LX4<"*R
M0P %:J=V:DYQ %!83TV8A&ND0B3T:L%49>343(_1;^$!%4BD3F02AI+43%BD
M'%V(1Z1QA)^&&_)107V1A]UT'@+B)*'D2U?H0?\$AG6"('F"3,:!).RT'^9$
M)NU$&A3W1G:&(M3$37Y$%=XT'-J$A&@H%6?A</ETA6HFB@.B:U>61'\X16!V
MB*S('*X(9OI$3,.$&K1XB[9((?21B[:VBPX"BZQTBH'X2WO2B^.FBZ>$C%OD
M2,681L,XC+[(1<#(C#V4C*UHC<>(C<Y(C,VRC<74C56DC69TC?%$(LH8CI<T
MCNE8CL8HCK+61R^TA:2A:H_(3O\NPHY)"&M32(9A^&QY=&UU]&FA<0!@ 8Y+
MHB$*621-MFKD@4;P5!MWDH_%9!]!^$S;9D_/5!ANX8J&2!85^2=UQ$B@84VC
M 1LK(0TF9G,IUBDE9H,+-6)#%D 1I5 XV%%%85$G)I,-M8,$H0RJ@RVT8WN-
MHUX-$W9_)8%)4WITIU.LE714MU) MV'YQ3!^Y35S%5M'B3'_!ST85ERVI8#?
MAUQ55V"DLPM=8WN;%96JYRH.-G5JDY7QM7O2XEP2$U1D*5_% C$-2%_'979]
MZ2O$DI:K)WC5Y3;_=U)&1U[<U10NXS6CY5EBPWW"AY1%8W90E3U!HUB[97?F
M(EH>HU?__(=_>_E89QDR$S@W>I,YYI):]]5XVN69>YE^GV.9VE.8O7-W_X5W
MHD-7Z*(J<8EU5$==EN<VIQ-TX^=5Y;>;DA-28",R&_: N0DSQ>67NZF:GSF5
MY0)X>5DZ_E5^N)56ZM<NE=EV>84[F8=?=?-<6<-W%V9[4A-\K;<K#I9789<X
M6KE^U_55P/4PQ&4\7%4RO$4Y.'68_\>:2 .8J@=<695A!WAZ ):>K[F6,7-U
M3V4V#4A32: 2*\F2+@>B$85RG0*#*^9B)0$&*'@35" _+(@$^;.")($_^5.B
M^^,IF$(4E.)R1L:CF@(4*Z%O!8)I5GB&9%@CMW%OM 90FP&1_VHF&X:T0&-8
M)C022:$F2-Y(A?BH2\LF4.JA)6O6<9B(%O<V3GBQ'HCA)8.HAGO"9XC1)4M:
M:<H4%W1A:7349T@R'Y@T1:ED3! 9I" G'J\61_'1B/@DAX81'WF:B!_'ITCB
M),\!0X=*:/IH(#AB)&3V'M1(&$$:I:C!B%.XA61$)*P1)([!0;]Q;Z1X; -Y
MJDCZAMK6I5+4JF.1JM6FD;0VJV/ZJJNJI[D:';M*;KVJJ;4*JQ:"3+Y*K+R*
MJ\,*K/'&JLSJ3LHJJ]"JJL&ZK(&8K-8ZK=C:K.WVK-P:K?O&:K-V1"^$C_,1
M33+2)&VV0'^ZB:AF3*,J(GP49[#P%/_Q.I"UI!R<IDIRP4&HR&7\P6RI47&[
MA$>D>"K4"$KP=&C/-G&5&')<M!)(MJ,5JY,72[$J1SY"MH$RN'(CJJ,=JU$E
M1P\K,07@B9HINUQJ]W<MBYWP";/5@S;$1S5]!UI[R7DWFRU>"5>H]W8N-5_&
MTWAN:9NQ%7V$8WJ5PS;-1YJS-X'4A7PI\WF\4S.M<WHY.S%<!WRE.9RG%UYE
MY32W":!!-RO6I5M1N2_>5Y>W=SW?DH J>U-2=V&LYUM@0U)2&3076G5%R3)F
M1SP+PUM(A;3TMSJN@RMC&UVG29\C,U[/\WY^Q[?+XCH!>'C. C"0%[2OTWE]
M"W^J(SC&%W=_U@=]RP=XO)F94)MA?&F9G4.Y>P![/^.8+^LX^7>87\=VH[DR
MJO6UK1FAF$N?B#=]28MV*J.V(&-XF8FW21.Y7*EU:\.R$+H[6@>6;2LV9>MZ
M\W)_TUMYA"NSR?-[O?M]:1M[K(>RG<.SG+E9"09Z@ >>-[42+4=S+SFRAW(I
MYO]3H^CC8I[ 8SVF#/$S/RIZ$SFV/BYXO^@S0"J'@Q_*<HP2/@WU44RFJH.$
M%NRTJQ2B2+L11W+$%5KT9R;$A&+(A8P!D.F1AI-:'EATA*DXCWSABGW805I(
MB-01AI[H&?JZ%AR,0R],1U'QA".40D;(1VM:'CW<%7:H%D$XCI9:0A5$DFY&
MAV98':WT:HJFJ69ZAW)8AK.40DP,'%1<&)((;V+6J=\1I9IACNP&;7$FC_RD
MB%FJ'GIBIYK&A)N!P_%:279\2XE1QV-VQWR<Q_ZZQU(,D!T<Q73LPGC<P83<
MC,80R&(J2L'4C8Q\R'Z<R".\R(W,CX-LR9&,R7?\R!;_5R&2G(^(K,FKQLF3
M+,BPI,BG/,J47,J0',J=G,IX/,>64<?15$G(4698'+"(^&1%U$ (68L!FR5P
MBL8":Z=NL4X(^28A])&QZ,&&>(RG8*__F!B%S"(9'$+@>(_DN)%L/!5TV&EB
M:'&"4<$,&9$-5\-O\<"%,H,,?!'^8U'C\Z$QJ9,\Z9(0@9,.18/Z7%$XV @?
M%05)I[?MVSA59SOZY9]A)9>C^WX66F"A\S+'J[R).U]F^YG 556I4X (DRO4
M>9GLPC887;YCDS8'B+P F%1"([Z^>WJOQ3+XV;G](KA&\Y9J>[>T2;QE*7?&
M!U:\&YTMP[S!RYM^^9XV_;=D_WMAFC6X\#*;N7=6\M5TU$EYH:F:*(U92D5<
M. .9O^5;YE71^=<\L!NAKQE==SN6V$6UY"66M@+2M6N7\+591MV6F)D 5MTQ
M#K;27FV63;V]X"M59@NT6%EWZ_G0#!UT3*N7=O>U,#,K0_N?OG6743EYTNE6
M6_TMP?G7E O9EM.@C4L]M1MVM_N8"X9^&VT[X%NS?VW8?$V>/+U4=]DQYZ?8
M7V=@LY(L,GU]CYUTWFE70?NYJVMX:0O3T%,O#XR!(LJ3/CJ_!7P^,=$^,=9C
M(\&"^YL_8$ _UGT3SKT3&?AR,XBC&^L3H "D4JB$FD%OWV&E=KH>\DH=0WJE
M$7EQ9/^1D?-:).W-;TI*D*[:B/L]D'F*;2M4JOHF3WH:0T\V'WS1D,_Q&@!>
M)B$)B3#<J(WJ'/PH:1&.CZU\1_M:%G6:J8PJ9Q32)CJDX!XRB7=A%8HZQ7("
M:_?8)W7BXF3"&]E1IZQX1(R&CG<:D.7:%ZJ&)=TLXPB'L+QQ%;&JAZ.Q)4K,
M&+0A'Q+)(WIJ(4?20C<T:!PBY9)Z'0)GY7CJY.@&Y5O>Y%/^XEH^B5PNYJ!&
MYJ5JYE@^:U5>YF'.YLE$:6^.KL5:J<^FYG!NYUQJ:TY:Y]_VY73>Y50^YWG^
MYX[6WX(JPR/$3O1FJ@5K0E;"I-@X;5K>BT(H'*I!%]X\&&3_*AJ()L&02J1!
MG,'^>N1-J!49'*J#MN!-S.-*DF[>QI%HZH?E=DR^(2@J\0HR1V0=&SX+7+_S
M^R@^2K$9^+%'MBB.TBDHMQ#D;8$C]3&\!3RQVS+"VS9#^39YY91=506OR])1
MAX#LJ7_3EWI265BVIY_;D].'C576_CF7&Z#$J2XI;;1$NY^V.^YH%8'Z/KSV
M@BXY[33.%;?J67A2BYU8RYO]SBX"DWJ;%7=^K7G*>=GK5=%1/5YMYSRI,]1K
MZ[;;2W2HJ=#T"=@P>YT\_5T @W3X7F'(J=+>XE]4\[TL[2Q9(+Q6R_%RAUO8
M6;[GE3:3U2S8RS0SFYHB;=.>I[(+_T^]V+M8J?OQ7WM:N&MA<MNTIG<P$/]2
MB+FWJ>,M#_\L-'^4GY78.YUY4N_O1;M69)>UYN[N7NLKWJ[V0%\X^M6S[;(P
MYVN:-%]_AQVY2*.U@Z>SE8L\&WTL0)=;AD=\7D<WW>>R-I^\1Z-9SZ>ZA],L
M^EF4L[T2NPZ_+0G/R:ZQGL+=.3$_^NN" \&B_SOZ,3JCV_WY( &B\RR3!XS
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M&$0I+,&E;K37$@G"1CWP$^#]=C)ABYP"%K)T3O>HPT#(" >&(^EQ"+LC0J3
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MH'_YK5>@>P @D,1XXC$Q10+&)# %A@EPR.&&&7:XAX<=)E %AR*2V.&&*":
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M!=:L65[TW\^JFTF3<U_TZU^R09OYW/27'Q\@Z#4",+"@0(( !!X<2' APX<
M$$9LV.C@P800+U9\J''AQ848-5+$.%+DR(TD(9*4:'*@2(XN,Z)DV!*D0I06
M"T:$.'/GSILC3_Z,&=&F09A%>THDFC/I2I1#27J$"9+HT:%-FYXTNG1J2*8T
M>4K5.18A4*!F58)%J_2BT+04M8;UV50LU+ICLUKU&;,C69T,X2)$JM7O1*A7
MO<(]NQ8Q79F/G?(%:I=R5;Y1XR96J5>RW*Y6&:_\_/1PT)>8R1Z>VIDT8K^%
M"Q+5G%;Q59V7/^.F^G=PV?^;()T:;OG[=M+@=X]^5+J[=-"VH:&7OOSUN$J6
MUX,_K_ZZ]W.Y7$<C?<@\ITBVTPGSC+UZ-NKAT@'#1?KVJN_ZZ+>KM6Q\;GC.
M4 E6TVQA+9=9<R7U1:!3,_$G8('&B>;=1N8IMU=MC?RCX88<=NCAAR"&^(\!
M))9HXHDHIJCBBB>*Z.*+("JTE4$-">68:J\=Z%%</]5H88\4?G>??14-"62/
M/LY(CT_Z+;G=8$OBZ&1_AFTT'G)19KF4CU-J2>24[75%VXPU^D:??4E^R621
M;,K()I!@BLFEG!P92:%R9G8)9YMXVBD1G5'""66=/056:$>93286E^L1:B96
M6\[_:6B@=[JIV4N!1JK6FI.E:9M7-/(YZ*# -=HEGO)IFF5W8K(9*D&$4LI:
MHV.:JJ1\E:8IY)NY.C;GI9L&>:B:HB8)&F9E[B=L3<F6RNFR@'W*Z)''#ADG
M;ZNNJ26PS[I9E;3%OEGM7]=B%:Z@W&X)[:@YAELE6]L>*FE4T):J&)33WF9I
MDZ]VNN-;W]FU5<#:DKOG@3HB3"J9T\X[9K-Y\KFCKPW6>J2X128+L:BQ,NHE
MHG5:.S"K_19*)J^=]L;;N+0%R;*PH^[Z\<'&TLKRN&!63*>. ;;9,,7OTHA?
MPN[6K&VKE"HLL<TW9AIMM^TBJJJG#1:-L=-8FW;G3J$Z__USS3,K]3+(-JY6
ML*+\PM9=ME^[?+6J?2Z-9,9=:WP?TH;^N?:$2G8Z-:#X>JPTLG0;MG%J:#]9
M-<\T_XCWQ?\"C3#%9_,X(;-G3BSHV_CZ[':W&M,]]^CE,9SOK5 ;>^FOA5LN
M(^NRZJLR=1WO'"R[#(O.JJ0&ZZUH[&XM>WK)K,\=MJQ*KXHYUI0W>[F=ENZG
MJZ3:Z0XYJ;F"1COSJ$]?\=:+?V]XQRNWJO7K''_:,_*=<W]LJNNAK7/\*&<N
M,\&P;XQ\]I+S*G7K+?/2KL86K3,1;%TR4Q;H?$:]B.E-3_ZC%_I =JK$501&
M&,P@AUC$P0YZT$0:#"&( "29GO\8Z#2;"8YH?,>J"@U./74Q"F7*0L*GJ/!&
MULD/J,[CG[FLI#@S?)EO5A@^ Q&Q+"F)(620(QQR_:AI3M24D=Z'%]%\1HF1
M&F+>%A<T=6'I0C[T"G@V@Q.PX$Q@9MS;L4 E'B:=4(W@XP\;)62=XIR-/6T,
MRGV")Y[<(*B'G(+/K-K(E3<2$3V=X8X1!1:\*DG0AULC3B++:$,%$<R1>B39
M(TMXQ,40:)(N;.%X$J5)AJG-.6:$3R45J1YZD1*3BZND:^R8H/2<4%U)_"3?
MQHA$ X$QD3S,H2[UD[@;KC*/OG(0&Q]H20@))I*;&E!4')3+:IF$C\TLH3;/
MF!+<;4K_EMYY%!,?M:!)UG&-[H'D^-8)R.J <GWEA QWIJDRS,SPE.VQC197
M.4IW7@E^S,10$^V9QC#=#F[C9&09QWE-2RK.ERNL8G02RL=C1E-9;*&D1P8D
MT5#6AY-$ FD>E[D[+!Z3G9S:YQ3C2,EN;@DUM?S6E^3SGA3*1#'8E&,4F:,U
M)L6,I:4QX\D\^4P&$=5WTD1A2M7(PCK*DY(+PM]$LXF?J&(4J%XT54B?R,IJ
MHI*H2_2A]EHJG5KR-#)EHT\OP^I4F;YTE"=<Y$=GB9VJ9O)!BA,,(2EG'"G6
M%8X3^8HTW9)6LP),J53-'$_GN+ODB#2,%]4F7N:S3:$Z$Y?S0J2J4UT)4P0!
MTW$AC2DTFRBAN&J5G@.5HD8A([!'L6RR.JVK6V/ITN3H\Z<T#"Q4)7/4(/JV
M4HOB6V_[2D*RRO9"1_\4H7)%],'F.K=%RXUN84-&OYQ!T%R;BQPSF7>JZ)DF
M?X!2(!3?9ZZ)92MJ\]HJ28_6-[<E[6BU@Q_;@B5 Y\$KM*5SGO%B%37TOHTJ
MN-R:Q^;G-XP1KKZ>RVX1C6:^@"[L<^"57G@/?+&R_?1_$#Q>PRR'-.B)+JNY
M&V0L#=8NBV$/OGK2E>>8V%^?G@NSZ8O;>:^EO'Q1T(!3$V[O5BS?*Z&8QPD<
MG/F^N>./]5B"/S9RD/,ZY*4"CF/<_+#$;,Q?(3N*O@9L+(T'[&2C$1<V3AZO
MW<C70 =>3G8'"]F$2^P]<,D1>^6B+I;TR"Y,_=B"J]-RF0)(6RX7SGX)AAG_
MEHFFY +J=E\\MN[(.DO%EE&Y<9ZJG-S2)&?X$G/1.$I9AJWFO93AF;_CXQ&7
M=Z8Z\*6N>)^K\H5%-NH%YRVKRW.PJE6-L_W*+U[Y&:^4)QC!0).NS!::[R,S
M3&7B(+!TH&Y;UAZ77O.BN'V0>N+_&D@_2U/O:J#=GZ.K1N,"WG=/(JZP?V=%
M[!R5FK  "D#UOX$6<2,W)VH&3JK=W25SZ%BS0-R.V&M-KK7_#OIG5X*8I^\&
MFZ&I=K+CG1:K_0:RBBLHQ M7=]A7IE;"AQR];^FOP_+*=*LI^#<MCQ)7K@SV
MB)<J36\_KGS(OK&40 UH;](;=MBV]/<DGK,Z"P[-)Q[S[US_-U9)GTW-+U[Q
MGJ,8Z4E+^><"S]T 9XW@4#\8VN%K\,>17C!Z1/?J&WRNUC^(]>6F4KQ=G-T6
MNTR6ZNWSC[#\XENQ:U(\0C:EDR4R$FT[50>&NKCW%+NQL0O&H/YPM6N/>U[P
MZT(4^G&EQ$&F&POJ:$_R$HZT4_Q82U['NZ<=[7U]/%H;@U8LRMVON*6H9?E<
M65J^TSF4Y2</T=.?HAK^J9?G>VT]L\7_J'WMSU3EMH-J3#8"WNVW?ZI%QWAX
MW-'0K:U1)]&%C])3_O$MGA?M6OU-N6!><F7/SV2%3F]JSJ>KE;JW%N81!U3&
M7$; RT&+]4TX:#&REIMSIWUF, G;_\C:!U-G%8LJ>R_WP*2GFS@66LJ4?=14
M=OE'2[ 2-/JD?\7E3[S41@O"?L/7,ZB%3K-G:OLG5(.$17NW'<%72_-A>Z-'
M'_:R&:.B1+.4;6>%74(T6L>5&B781T!C@(S%4.$4'=>76_A4@: E590U0U9U
M@C!D@N)'4"!U10882.\74$%4'I\W3$166N7C>8D7@ 48?TI5A-*G>([U?Q(U
M?<'D&MQ72#O%( KT?P H18PF.ZB1A&=G2F/G@<-T5 O5&^Y'<G7WA7,12X84
M=7B%2F\$@9$245]G@6LG?!#22!*H%X/50S%(7A?X@'EW0' '>9:D>]AW6Y\E
M?Z8E60Q8B?^(!$F((TED)8:!P7]%%8HCM8>(,T^NV(5U*!1(B#"G%W]$EWMH
MXHJQI1N4Z%>-@('+MWC@]%NGM'Z,QD1^=$.AA$W\1$MU:(SCAQ)=UW5;5XT<
M-(TB5(7P<C]@XVG<YF,MQF#BDUXA=V-ALW!HI&Y^!H1V)C2. C',=F_7XU[E
M%6TUQE*QHW,<9F\YICRO5DJ1UC<G9C(FHX4&YH3LY2OZ4S^#I%]^IFD0F6XA
M1GK71C:=(S_Q^#OTY8L6]W3&\U /ICD'5(!NUHWTF#'#4W,4R6P3QB\#HW,
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MNL+(XL(4IKT^"I@2IW0GA\2 B6A+K)3)4ZIY-6[-:<<C6J"5(6.TPIY$BF%
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M=FRZWNM$)NS(\BN^3FS!?FS$7NR_GNS&2BP/9BS)RJR[KJS&MBS'SJ#'YNS
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MF'X(.'[<MX!=5X!5]W_QEX#D5W_]9X$'B($1N'\$>'S_'?B '[A^O2>"]N>
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MG.1%>J-(!J,XXJ) 6N0YQJ1*CB1+UF1%?F0\\B,M2J2Q]:1)#B1.AJ1.SB1
M%J5+'F4W)F6XJ"-/MJ-/<B-(RJ-2#B4[WJ-1WB149J54:B0V-N5"/B56!B4P
M;J4]$J-7_J1#?N-*DF55NN55 N5#"B5)EJ5'VB5<RN1:<J0V1F-?IJ18RB5-
MTJ53?B5:XJ5:ZF5BFN5BWF5<[N1<=J5BOF5AEMIA,B5D\J4Y@F5:+N-C7F9D
M9B9&&F9E(F9I?B8\^J56DF9;8B9AHN9FJF9GLN8V@B9C4N923N1>ZJ9K:B9$
M^B91>F9P-N1PYB55YN9@[N9D_O]E;"ID:R9G;1(G8+:D:=)F3J9F<7*E;&KG
M<[YF=V(G<#JG<%KG<EHF>%(G2J:G8S(G>R*G>W*G;7HG6T[G?,)D5-IG>1[G
M>59G?5ZG=':D?B)E6/8G@0KF2QZH:$[E>N8G@-(G?Q+G+(42+3H35%#*2HP.
MAXSBV*Q5T 2--&G<2)#BV@1:HO195LR3%J;ABSJ2%Q1H2C3!%LZ)%\ 9GAG:
M62T53,J&MMV%I#A(7U B.6G-01EBDIK*(-9*K2@I((97AG3CK$E+HGG;N<#:
M\&C;V(AHM%D*)W**34F:E5K&POA<$J[(L<7ANDA2F.KAKW"B1QPIH)"HUW22
MT8V+(37_1J^M$6EM*)_8:1$J8; M4\P(J1H!': ":F<HH241*G_P:<?XZ<-L
M$Z/BZ:.F::2R&DS\::5>1Z/J!*;N*5(<:DPYGJ(&*MZ$7)X:X<5 2I_J4Z<N
MZJ=>JLAE*JG"*J=2ZJR&Z?"Q:J&N3:E.ZM!X:J]BHJBZJAPB:KNA:I>JZJ#:
MZJB^JJ3&ZJZFJIE"JYXFZ[ILZL UJY4^Z[ @:SURZ[*>ZC8Y*[:*:[1N:\=T
MJ\-]JZ7ZZK@V8[F:JJQ>*ZA2!+WRFKN:*[ZFJ[["&KN2J[_>J[4&;*UJ:\$*
M:[42*Z_>Z;P2;$8T@1<H0Q(DBB%X@1\-:[S2JL0N;+T:;,>B_RNXJJNC3FR_
M-JRN/FR^*FRK,FRN>FO)RNNQIJRARBR\TNS'"H0>>0'&<F$3- &P:NJ_(JS)
M"NRO0BJN4BO+>JRQKBJ_XFS3SBRJUFS4WFRPYFRB[BS49BO,BNS*SFQ"$,#%
M/M+&OBS1,NV[<JW5\BS6AJS*;BVS=FW$VFS<3BW;TJW;>NVZXJW64JW.\JW=
MPBW8RFW@MFVQ$N[7JNVTZNVY#JZ@^JWAYJW1MFS"@BSE N[C BS2INW2.J[E
M/NWB3F[C*NO!7J[G9J[IVBO)1FZXHNS?%BWJCJ[DQJ[FSJ[K*J[MAFK6YJ[#
MUB[L]J[LKJWHUBWO[JOO%B_M'J_P)O\O\88N\[[NR0XO[BZO[D(L\@XL])XN
M]KKLZEH)?"@-N!33SVQ*4(2,&=%A^] B'GX)'H+HV@C,AAY;1N@1'\U9ZQ%*
M&,)H_\[)+89;L52#)"A*#?!OQK*A'HH:-X'244C2M(;)INY/ R]2HQK$DSZI
M(*(2*F&PI\W52TR<L0$3SO73^X;5)H)-JQW248S)S4B*,RW5NO@2I%&%O%@*
M>[#)3WA%F^H26KW1PL71!RN+*SK%)2H22D";H^Q'(;&)_")$''G*$1-3"S$&
M*#HKI#T:%&/36B3Q;%@QN&+Q46@Q#'$Q6RFQ:#!QIPCF&'],&5/Q)E8B&#OQ
MEXD(&3=&%P__Q1?_V1SWJ1&#"0 W#APKE1SO&AW[AAT[L!E[<1SO<2'WL9?^
ML?"=L1XWL2-+JA][#!Y7,2-7\AJ361O?L2+G,2>K,32RL3TF\ALO\;%(BR?7
M,2BGLLD(,I66,BF>LA03I2RO\A7S\25#<B:+\B8/<B.[\B'#,A('\RRG<2N;
M\B>C,C*K,AJS<J-FL3/C,B"'"QS'F8WBV18RRJ(]L35'LB8K\S0/4S6_\C-/
ML2Y+,R];LA;?F:(PRCH'\BH[4A*$,4K<\C@G\RX3<C%C<DW8 S?SD9S@\S31
M,C/;LCCC64Y.,BDK-$4 ;:(,7^/D<CVC\0'/R3S7 ->9*E]8-#9'_[ _$W,S
MI_,U2_(B#W,G-_- DR&A<>PUL3,EUS(Z&[,Z7W0VDW13:+2<S',RB3,P1S--
M1[08![4;SS1$4[-1GS0_#[52GS-3WS1*D_-.U[14!W0H/_5*7[4^'[56)S57
M%[57-[50AW5"+S593[53G_4RIW4XES528S11O[4A9W4LSS54YS-<K[59Y[58
MU_4CTRE;_S5:1[5:WS4TM[4Y[[5=_[)<ZW0[_[-)]S5DC[1DE_1"QS58%[9;
M'S9?)S8]1S9=?[9C#[9?CW8ERA%>(!0;/QJ65 0XLS!(6I5;+)HI;NBT:(9&
M0<HYV8E+STD3_%'/[@D!^Z__KB@M\<JA"!W:G&C!*RE#<].)H:V96)I)GOQ$
ML(QB9 R;>C6BK/_Y80<;(I-JFGA?VLMT"RI+H1L]:V%LZ8\2W#N9B?KV[D;H
MX;A,7JS9VA6OU$<P32S21RMWFPDGUWXSZU1QQ2IR""?%VNV$5.*,#N?E:G_;
M]Q!FQD'MTFQ[V/)->"03BX4K!X:7;UALN/1UN,=\.'[GS8-K^':KW8FO18HW
M. &Q.(F[^+?!.(DP^(7#-H37%8<W+85GJ8J328WCCX0'N8?O>(CW>(NW,HXG
M.8HO^8H_AX^7^(M'>8Q/>9%7N9,S7HZS\)8[>)?;^)-?')A7A9C3.)D?^>ZM
MK)#+.(\;N=H@N00K.8A3N7][>9VG#)RK^5QE>)E_>9;K.)YSN9X+.I__JY66
M&_J8(WJ; [F=2WFCK_FCMX1TDV$?49N?4SJ@CSBDFSBAAWFGBWB7;8ZB>WJ9
M]+0!:,%PWUN>VH.,7INE.)(A?&*?WSF1.WJ@@SJ62SJC$_F=& )!YQDD,5JH
M_SJ)Z,2J&X!P6_JINWF?B@.QRTD>>E()W\C"]40\)\IS^]HX=82JC8L8$5*3
M)WJTBWJ:D[JY]SJ4V[FP1_>+RN@16_F-GWFZ2\2?ESKX1#B1#@"W3W>_J;NN
M5SJOTSFZ)_NH$WRJ\_N/(SNN3_K"[WN]F_FTH7F^K_N<0WND0SRPSSC#4_R@
M)_S ?_S$[SG"=WRA2SR['SS'+[K*ESS+;_S#_[^\PL>\QJL/JN\[QJ\\SO>[
MRS,\S]\\F[<\S0=]'F8\T<^\KZ>\S<NYTN<\RM<\R3_]LT<]T.\\TO<\U/^\
MT6=]A6^]U7<]TT^]T%>]P2^]NS<]U3,YSO<CEYSHU*XPB>Y<("DP^]JTX)0J
MFE[,^+*;T1PP)&'A*!9+#5 #LQ\WGFULL$TQ0=A)%B;*N-PO'SF[MIRO!:O5
MA;8;)JWWI0P+ Q<)0YAW(6HPK'#PZ*\28U?*9Z2;O5.YW4[K"H+J"LNPP@Q3
M]!Q4;(LH0D/A^O[$-84=5_[239&5])"[)^;R(7]1WAB%$Z^$,M4]96A,1)%)
M\^_:\V?XO(TP;+Q3]?_?A/.?,59BJ62!,%41D/5G"?:7K_9+/UQT_^V@?V3K
M22^._U25_[6O-D2 _VR(?]\#Q(L! [ 0)"A.H)J!"@LF'(!P8,&! AL:A%@0
MXL$!%,45E%AQ8T2#6" J', PI,*,$D-6Q$CQH4"-'#V*E"FS)DF')PTZ7#FP
M9="+,2.*:]G18,^)(CV67*A4)4Z@,&$.76F49E*04ION1.E3ZE*71%\6/5I3
M:<B1![U")9HT:%6Y9K-^5,N5+4^>%:.*%"MT[LR#:+<RS6OR*\^??^>6%4R2
M\%W#.O4F[@N7JL7 ),]JE;R6,F*WB^-J-OT8J=V;DYWN3?F69>:RCCG7M;G_
M%'1KR["G*IUMKXDR \.)%S=.W) 6F%TKCPY;>C9LK(,]K\[=EB]OQJ9I3X=<
M'7=.M16]'#=@KT8-E$GM*3.D3.35 >:;#"PG$6_HI]E)RR8KO3/5PAM)-P(%
MZD@<0\Q;T !EM,!"H?L"O&T\ YO;B\'Z<#MP,^]2HU"@&I(PKQSJ-*J)*Z/0
M,JFVAP8J[SCT:M#++M\>^N[$M'*RJL,)T\JO0/Z>\X]'NJ@3L$(UVF.020,,
M&:"&IJ+\3S[;?F0-N]?ZL[%(P5B$$D;C9+30)*3 \@LZ*G'R,#+K=LSR3,RX
M[-'*PJYK3D@TB:3S2!"QQ%/+(><\K<7OD 023L4$_QVKRT(_O/).T?*4DU$^
M#?4STOT"U7/0[GRT\TU XXRM4P#K_"Q423>E%#!"V02O0N94';6W2EW]%%4R
M-:5UN^BJ[!/25'=5E%-;/3W535U=XS7-1E\]],]9B66U,5.!!579W;8TUMI+
M@\W6N6);/?;:7&4=]C)2N?W56VS/779:=<<UTD8.:511K<M@4N^I>PF$52%[
M7PMI*'YK#/A&WJ2""*FU7A"N."V@+*R@&LI)+[T!+M9XQHT][AADCL5);^09
M9X2RAI'S"DJA&HXC $HHM3#/"[0<D@AA@TJ$"3JKQLK7H"E9_$EHC0OZZI^D
ME5Z:Z::=?AKJJ)VN0  !J/\6@)RJLQ9 ZJZ]_KII_#HJT20B0:H1BY1K$JW"
MU,BF\5^4"K4)WQ?JGNXFI,S$-^>S(U+[;QO'LCLIPAG];C6[Q*ZM8>O6[&EO
MR TR::.Z:9P1YX$YPZ)$CSJ_;7.F2G08*WQ#DHE%S)_::?//.0<O])%&1['T
MPH$F2'6>6%?1]<]],]USPP@W?"G4 \]\=X)ZAQUXY86O';_;TTX*X:&=#U[
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MM7G9"G6[,3-6LXDS;L6ZL%Q4PT]78JGAT#7&%Q/%>C' N[<!9?:P]!47D?B
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M6Q5C(Q942E.-E6:Q!C $8GDCL>)N]+,Q-0"V2*+5DKPTLA#ARTA^]L"ONG
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MJU.1IC_RJB]33^=4#JB)B[^J+JUDE)21,@^1HH-P*P%J/MS\CUG<$1N1(VJ
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M1I6TJ(FBR)%/J(<J6=W )M,(LRMJ[)/>N62#S[GY>*]-T;(V]6W)W#'R1^#
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M/7JHEK\89BH\&< 6X?,3>^ .=P/ B3+@ CZ3H/$GM4H03NP2E32&!"N$>X&
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M0S$*\P%0_000  ]K**+%KOC/:$ZBAMB/5V#&*(@(8@[P[:SO6>SAAI)%^)*
MOI[#6(;F!> E)A*PNE"M(IZ/U)B#9,1#.W3'.T*K_=+M_XA&8V?ZKXBB!8S$
MQFANT+1R"ZSPZ&W,1?A*QB;<:\F"QBE2R]7 @P@M,$ML95GZ:&DFZR!ZT.:H
MP@L,@26$$.<R$"J*KVIB8FB2KURV3VU<3U[PAC&HXI.F2(SXKNYX#O$J+^^\
M+NT*+^:,3@[?3O'T3NC>T/ @;^OFD _K<.[4#A"A3A#W4/#0SA#O4.P2$? J
MSN:"[NL:K^_L[N@"CQ);SA%U#@\/+_(&D1'ECO ^$1+;CH5&D1,'+^>(#A0#
M41))[^M:<>@<[^E2L>P(L1+M\!0?+Q)5<1%9L1%-\151\>^"<1-ID1A=\1:S
M[NY6<1E+L1DQ,0Y%41BED?&:#O\.E0.VS.[74$.#EO&TFJYK,&+VF$2)N ]S
M/@50+(@\?D\1%0Z4XHGSH.W<O.+4]DLR4NB#]J0@F.^RM,!&?@B1MH(X+H('
M8>]@;@UE+JDS8LT%A\(04,8>M0WAVD@-G^,V-.,DU$/;#+$<-:/92!(PD@W9
M\*(D59(M! IC/(DZ; GB&@N\-"V%9J,C*LV6-B3>RA$FW^_43LLJX@DS=/(U
M$BO>6LG!6DF/)LAR/#*L8(L<,RT>(6LBVDV*I$J0_HTT@BV4FHC1+&FO0 D^
M+,A?> V$] PD1\]?&HTRM)*C-LL-,VWS8@HEV!*GFDBAQ,(J_8Z)D [3[-*Q
M\!+32HK_,?ARBOS2KQ3MZ]K2K_2R+ X3(V&RB1;S+F?J+;DN,GUR,B.GT2P3
MT3"S\C13\YAN<SQ3,"\SFT13+DVI-.N2$QLS+PLS+C?STY3$- -36@8S-)%N
M-.?2-0$3-G=3-7N3-6WSD5Z3,8<SX0S3.%WJ+RL3-4&3./?2.1.3,C7M,]V2
M.B'3.MT0.[M".QTSFV22,$FCT?+LNC1IPW2CSU"JT*2C41JME3(2VVB"9_*E
M);R KK!B]8;+-I!"_OA3CY1*#6P/K)(&:]:Q*::/L; B7P82U'#"(&ZE.9*@
MU;P H$ P7R9I,<8KL&K@0DW%-SIK,7IF+"["N KLN7K0M" D_S]W2Y,,@?TR
MM,K\$#[R96*2IB"(*@+S4QF,(C<FK3*.PO1")EPHRRF:0KE<PHXDPO;X$X..
MA?TT(S>]0_YB+X2H0T$5 D(70ZF>*F0(0QE\U"76:XT,HM9@HCI2E/56RWLD
M(@F%@@\IAC?MZF#L1DJQ0$T+RS*@2M)T@ZG2ZSX9XD/9$"4VPEA *UJL(I)D
M"[ \8]1N1@M8\&Q.<$X?0@TDM5R.25#31B"\5$(;S?<D4QTM)=^X+[%&*"T1
MY?!<(S69DS:S[CH[,S=?=3ICE8UJ\SD5,SNE<SMSU3=;\S:34SQE,Z!DM2^_
MLU:%$U8?LSEWE59QLUEQ]5F3%3&7=?]:E=-99U-79S5;B_57QQ-9O559.5-;
MC=4\1>Q:)9,N@W-;J[5;A?4XH=-7=9-;R75>>14\3_->XS5?O?-<P]5?@=5:
MRQ5;!?9=TY4WJS-:P?5=S[)'.*PI*0@^XG$[T+/=4,W2.FK<_"F2;L@H.=92
M)H(%0VDB<O)&B-)$$!5:?X^"*,TX7$-J/$+]M(KY+$EJ"D8+RL'2M& @WT9.
MM0H,[_,=@2XCU=2JT*5*Q @6#6R EL2F[))C,V4EK=8M4+(O^N)J2]*:'NE-
M(_;>.!:2V(,GC5:*%*4[\!&$WJ\PD,8?_T7B\F_)W',^TD<DHU(W_1)CE00T
M)F7T4L@XH 3_YQ0C5 ;DN+!C9<G#-RZO14 B5%Z2AG@%.=EN5HB.9C&$)_?K
M5..50;1'7:&6TPJ3Z&33<\T$=-=DR42,= G3=!^%5D7H65D7'9/I=-\R=65I
M=6>B=%')=O?5=YAS=L>(GWP7=H<W>'>W=7OW=9<U=D<W>6F7>)F7,YTWH(17
M3*#2=(P7:&07>H<7DXJW>8^W>SMW>3EG>T77>KT7>Q>(1=!7=3GJ>A<E>]U7
M?+GW>1&M5&4B5,X69@>BAHPV@Y:CI=1Q,SP/0BQ#Y< +2U]PMG9&+"YUMDPI
M@F&B(GLB_/A3O\KOJSPT7U O1MA&3,/-(6PO6EYCB$1+4=P+U&PO_UPJS_L0
M9OND1@4[:8/S"B(7$F&:(%B.A8$-0'"4]RS#A8*) B'B!F383RAFU!X 5^/$
M$&S*A8GUXS808F?R95_"(K6T1388F(;48PQ3^.R4HK=L([50SPRIB]0VJT%O
MQA#*0CMJ+U8":XR;,&8%ZB@DHO<B)EI 2-]6\"O"A4F)(H;&F"7*U$QA)B*T
M2ZR,XD!GV$V7%"VGQ4@94AX]0@43XB($5%K4(+<,0; 6^4MKP)&UPXSUZX(K
ME$E 3B8-5T$:MU/ S4KF3G.1MWQK=WKUK'IUUY:E]WSM-WUWN6#9\7-O%TZG
MC7.%V75]F7K'%W^3V7RU]Y?AES36=W[;=Z=<0Q*8X[>:ASE\F?E^U9>7P1>7
MLWF:D7D\E3F:OUF;J5F<(U>=<[F9P_F9;WF9XQF<@QF=H;E^U]F<DX:;TYF?
M[YF=SYEWZQF>RSGJ+K))AF32OLWE$&?<@HD-I3GUV%)I4B^4DC$K7/@V<6W=
M.&)N462_)B0L* HV52G:"&,A64B?-%4E)*M,#QFT$D8 *0LY4Z1PV1A30R-F
M&1<]DJD@0X>7?HX>A_^MH[B6:T]2B[0HJ9OM*G,*3FZBJ'<M$IMH9/FPG=,C
MUVB7-02SE,KI;!:&-?QHDPIDT2"GC&;VC0SM*==)V$8HKH"*CB#64MZ6:<UK
M-(Z,)QLF--G*??,2D_Z%<Q-)JI0LK&%D:LVBEF1.-GE"0\6B>0K46E()/1N;
M,!\;:$IT=FB"4$#)D!B[R3!;V/9-(SE[LK-$9+O"[AR;M-W6M,FGL]U/M2U;
MM(V6K5[;K6$$M4WVL4.[RF[;W[YCLV.;MST*M*,ID$0;LHE[MSV;MG^[RX*;
M9O5#M_W#N#_;TI)[+*:;N6';N6>[LJ,[E;I;L[_[NI];O+<;IVS4O*T[/[#_
M&[K7N[5Q&]#.&[[3V[?G>[3K>[COFRKB6[T;B1YS!(Z<)#P9*;3)=@GIM-,,
M39)H4[F)<ECXM(&SQ;3F,_X"!RN"[V &\I,BRTW#PC1VNH@](S^%SX7],VSR
M:  ((%^2H$8['&*4JD4^%"5"M-76*_BL!%B>*S]RV "V*IA*W-9&"R.P-(G%
M5+Q+%D7#U,)?<$9KU$G2""7XE")=^#!,^RJ(V(01HL)_F%(/8J:E(DB .KLD
MT(%N C]6^")0?$#GI@$]C8C;9B !AOT^&?S<E"EW[1SQ$V+ RJ53FS21 HJ-
MQL)E+S9@?%_:BDQ;S<ZW(LCI"M9 7#VE,%\XYBD)_Z/-E>+-8X+. [U+AVM?
M1J)''WU84+PH+K@!L1JD.K:P ZY2#/O.$-L_%!NY^XV[E]N]V1/ \WNQ][N\
M2_N]?3V\]3O7V;O+O)O8!2+ CYVU^5NXJ[O7F_W7<1W:A3VWJ5VVY2.[5_NR
ML]V^F9W;*?O9P7W7AWW;G1W8D9V^I9U$QGW=K_W<VSO=)=O:M;O=HYVZX5W=
M\?W;;1O=M?W>C9W=L5W@Q=W?"W[> [[>![YXY#W?#][A$[YR+FTK>6H]]6,T
M+IJD:99(W(F?,[F\M!(D90B$0'N&:$F*&BU1C7K '&JP2PT^H_J.!CQ.4=!/
M= C*(\8+LL98*%HU<FW:'__5 "8=*<+:T/ALL67=J$'N370*0*5>+9QZ);,V
MV:K>V(:RY, V3 )W;4Q;?T_+'U,7-%[YZP#4-+B-:,1Q5<]>6-X-JN.JI(M2
M+"@M3/AQ0LK27%%NPCW#AS)^;'X"8_[XI:KO'X?C[X$F'37D/#+:GPJH'L4E
M&&W3F9;"IH 1003[JMUND\3Q63$_%35_7?<#;-.PSH Q\[>:]&W#]-W.\OEP
MY7_M,C9?)UT_&&$_]45_]>&R](68ND4L])%Q]'N_]7\?]5-1]6F?]1GB]C^_
M,(5?:GF?ZXR_TYX_H*)?UJ>_\JI_\J\_^*-0^I>_^)O_^,$L]O,0*..1^LO?
M^H'_O]?"7_O'G_T[7][>OP3]4OS7G_O;W_L!8@ 6@00+#AR@!F$-@FH6'GPX
M@*"X@PDC#GP1<0#&A^(,"G0H;N-$C1$QCOQ(\"!&A"59;B2)Y>1 E1TK)NQ8
MHX86 SQ[^OP)E&<2+$13#AB9).A/94H-&%(SL^  +T -V6N9$$M.>T&]#,RZ
MLZG8GEY8QM0Z8*Q:GA&S6J3ZTY"6A04)C%5F[Z*X&D$-M<TX%:@R+R]&;MS:
MM:5%+'#7-BUKL2#&BB^E-G:,V:G&DX4%3J1;@RE0R#!;7HP<."A!NI<S_R0)
M>R7&&ER;9E09>69K WA?8@FK5O1H@B^!N^XYEWA'QE6O_T)<.=#P@(6[>RI+
M<I3C8<G<I6-Y8?RX=>P=22:L'E>X3Z]%*U:?NQPUQ(GEIJ,W@/TTS)',EU[U
MK49XF%V'VGG!J4<64='])MYZ$4GG$G$9801=30H9I5=,L'UEVE\1IN30AKEY
MU%U4$O)GT7(3R825:2%"AU)4$)7HD4DF:G@6B^:Y*"&(&,K7$HHGWJCB6:A-
MQJ-^,X5XXY'9U?@D1YX9R1UE,8J(EHQ DB3D:5T6J2.2,+V8&Y,DXM8EET1.
M&29+8_:XY(\DV@CEEVS.*.9V2E[9)(W/19GBG4Y:F2669LZ(9I-T2IDCGF[J
M::B<CJ:Y:*"-#IIDI%K.">B0!O^!Z2BA9/JXZ:2*=HKCBJ%F"F.A?29:YYJ7
M5LEJF9(Z22FJH.*J7V6;273:0_5!%&Q\%<T47X246?@90XJ9V%FP+<GVEZMP
MQE=H00GER1T6PQZ)(FZ%=M;J7[*A6%A4Y%Z(;+>&E1>7%G_EI$43#8KEQ5PY
M'1H?M0L61)M@.97$F519=13M42DEVRMW$N[Y[[$BKO1/Q19?C''&&F_,<<<:
M"R  .2!7,/+('I^,<LH9>\9E93&5B]M+(XUT+,+/LLQA.0ON922,7_K;H5%F
ME4:2S#"VN"W+0+/$GX4O[\ATA5,.H'.R$B\]4-4OK1221W\F#:>;7FHH,9>K
M:;A20C7_X"8VT>+R3)#.1HFT8=<SBR2MVPY?[=G2OJ6X<TQK]PWL4=2ZA9O$
M;\<&>-?7XLA2U6AGU_73T+:].+5LPE@AY E);O.*(OT-]>63U_WTX\92G:.:
ME5=.J]!T:YXCYXT["[KKH\N.N6DVH^ZXDBOBWKJ-KY,NINF_=QX\\,0/;_SN
MERON.^.;1\;\\Y.+3OCT(^YG?>W8WYYS\91+'[ORX7.ONO:A6PY[XM_/_BS[
MPGO..O3G=Y^^N^NG?K_5Y2YZ_),?[T['/-NQR7VZ*V"+#KB\QBFP=>73'_<L
M=QN9="UI=M,<A9Y4&9-\,&TBFIB$$J*V@Q7K4PZC7PMC(R#,_Y2E(\FBF[W$
MTX2,6&@E[QD<;*830Z_DQA#W\LO96)(4&0:E!B0<R U_8H^<\,<>" )*<@@2
ME!Q.YS0]U-91=-(5=2D,"U542A.">!JW"*UA]3%$&=?2A":448L=&LC@U*8%
M(@(EBC6HR.OVT\>(*"4)':G/0O3HF.J )&_3X8L9(S(L%<'HB3Z1UW2R@LCC
M&+%F Z%B@Z+8/"<&)3FM^MU!%N))I9!&3&8)'KH61I3[9"8B3.1.$EUCQ/)D
MI#I\%%SJ:*>15 ZG/"9:VT2ZJ"&!].<X6H =06Z9&2,:3IG0= UV7%:WA?DF
M@MO[TR^[]:G P0V#=VN1]R#XO^9EK_N"W3P>[Z@'/MK9SWGL?)\[SZD^>0*0
MGI$SWP7C]\!\UF^?Z^RG!>&'O-[%<Z#J))]!VXD^ PH4>!,<7CT;B$&)^D^?
M#5W@10F8T8!NE*$5Q=\ ]Q?2THV4HN/SZ$/M&5&19HZD+:7@2S$*4)7.E*7M
M^RA*<YJ\E2:PIA:]*4B!JE 7#K6G1OUI0N&IU!3]K5Q%<]*CIH:D&M+J=7:$
MB!I)"#23# Y98OP1U_3"M+RA<$='XQ"5+M<VN<%.5;FQ&^HBPR*YK=%Q)#S3
M &KCDQK(K5X\>:-X\K6O&O!LL7AMEWXJ0ILJ1G$Z1/U@:=X6E:H-;6HXFZ9G
MC&F[IO\M3&6D+6W*2"8 U(HL9" SK6M=:ZV88<^>9 T;S-3$.,CM26F\I0B?
M=J@8B84+6Q%BF[B4(R&L.>FQ-W/49HB5G6\5#G$/3%@X*9>E@C'..\^=6W&U
M&S,A@6VWU+/=@IADM=AH-UKQ$>W!/@2Q)PGD6WC+9KH(-CE"88@NI^I1",$I
M'X1Q1G_ZE1%_H>1? /M*2O=]KLT*[*,UFI!H_ST("QN<K@?7,<+];=AQB7;A
M >=WPW&2L (K'+00TV3$E^4P@CT<M 4'"L,$)C%*3-Q2%(.8P2+6<(M+W.'<
MQE@J/%ZQC_\&Y!<+F<)$GG&/H8;D&P?9;P!6,7Z/_".TX#C_P1^6L=*>S"TM
M:7G*0_ZPE1T,9;,"R;<K9I*95@*E[:@1NL4R7>&P*:3.<-)#T(4-W[;KVW)M
MS8M$(6QFDF!)F-3'+70QK%*4H<6]N&TW>/F71A #E!P:J2.4S(P6ZK.CA8C#
M,7B)8;]V.<J%8 34=[''!\LA&&5036R[L<JO9H-IGT"Z<-$90*>K(FO ^D02
M5&JBC[,BZFJN9=<#4+8!+$FWP%'VUSP96&G*%A7J*&5,G%ZV/4PMO*J",3$?
M#'=J?&)K7U%[+?(B(6ABJ);DD+4\E'8.2_1KHW+DQ+!8K>GXBGH2@<A2+8@&
M5,#7W90<\F<CRZRDM4VDPOG2,B@$_SK-NHY5:WN+21S.%DNET6H27[M&BZ03
MN7@LN6+%T$DJ"65;6Z/D-."&S=+>>AB$T ;FJXKYP'_B<IEOXV0CIWGGW]L3
ME<U<Y"L/?;]%G[".O8QSH8>9Z5N&,9,MG'0T3]W 33^Q@IO\9:GKG.IDOGJ*
MLY[AI7.]ZDO6\9G3OG47]]SJ;D=[C7\L924?_>Q!5WK<DSSWME?9[BR.\ICU
M_O,=]UWK8U][V9\.]JC[O?%R]_?>%1_VR4/81 IAD4U&-&AG0<FMB4<SV/"^
M,)N74+1Z5HYQN?/R(4D7+2A4+.E?#KD)EN;$IIRMW@;]KISLAE[V<G1F(&W'
MA23M:/?EEO]TA(\@0WAA8);ET."UVY"'30N_OQ+C<TXMG9&\=OSC!]EJ48M^
M\JO?8S@K4F2H-Q]858A.* IDS^<_M(/,56;?9/-"=>LAT39CEA(9>E5LI:$C
MTO(T71-EU:5](F),$Q8=AQ,TXZ5]>Y)7B")?TJ-5SJ1&-T&!  E ]K\H4C <
M CN5\542EELVXW*]Q3KA4T(<X4-!EBI<$DA@]22$<FJ<97%7Q78S*%9@PT'6
M)X"=,S[<TH,J0H- B%LX^#A%R(,RB(0_Z&=+6#WWXX16<H2\M1=*2"=,:(7)
M]81*YH-?Q(4W6(5W!898"(5:6(/F8H;@\X4[J(9B&(5D.(5=>(9$F(;-Y?]O
M8[B%=_B&0P@X5\B',U>'?VB#-).'@[B'6-*'A]B&$:*(<(B&<EB($ .)93B)
M@JB#536'@>>'-F=_6X0E*F@A)[)RD'-'EW0S?B)S7K4:$2<2J]@R(H5;1N)]
M4B5?-=,M Z$% \<330 9_:4V>U$.P.@@7Q05E=-%= -$B8$:$8&,/I$?1)&#
MXS86<V$/F51M^,-+=$$2-3!PI#$004%(1"-'5G0HSS@</,@:^,*./Z$%U# U
MOB2!.!$1"*<4B79N/*$%UF@4<D,MHP:-8[5]($@XJ@0P^6A\VLB-!J!\G95[
MV]985H5,A22-UH00WF>,+T!%#SE(6C ;*I>1ZKC_9']6#GEDCAEA?ZZD4H/C
M2@<A3)E!<F[(- .@#,9G'2SY>;XF6:HV=A-6'3/D5S-!;?*F&"7I&%?T/1&1
MDZ2F,"SC)OVX%MC!5A/R(X%$5Q,(3I_'5RR8@J4AD#<3>_:8A=L3B4&H<SGX
M5IYXB:7(AIHHA)VEAY;HB(88EX"XB73)B'9)59B8EXDXE[G7EVYYEX")EG*Y
MEDW8B'\)EXFIEX/)EBSR09_XB('IAGM)F)U8F6]92I@IB9+)F'[9=74%FFKI
MA95HF([YF9 IF(L9AZM9FJGGFIDIFK'9F8?YF*&3EE1(B74IFV?)FXJ9FL"9
MFZQIFK49BT+6>FT#9R)D_U6A*8&.2#\;5)%4@I#0"5?'%7*E%(&5DD8@-#^Z
MJ#:8.(JT:3=BQH"=HI9!V4ENY!/?-HUC(8S*\!N+H8+.0CK<*54SV1-25"VF
MV'Z6M9\:Y)@]4C/E4G\WLGX-BC+H9WX1*@ .2J$6\R<4^%R*]2%]97US1B8B
MB)V<A1))XU@ MB3O\G6=ES<9LGLM@DU-I#!;(V TX34$HRPOEI\VB%;:AV&P
M]V\TRHO0(5WG\H#_@GOBR5T-@X,/@5Y@^8$1.55EPEU71UPA^BLD"HC(%5_>
M1%R;%:):05<CF*5HM:7C X!>>A+(%J;\"5_=YXA<*C1SEJ8?L:8=8H-:^J9F
MVO^E<LIFMC<S;&J!"7-;J@=QUV46?FIIH1>H;(EC9\JGU8*H&XB@$\.HI^*H
MAJJFFP:HE#ISH[>GF$JGFFJG-DFF>4JHA,:(F?JGH]JF@CHB<%JH'-&G==JB
MK5JIGAJGH JFHEJKB]JIL(JJG*6JB3JIG,.H4*,XMM<V$F,E0<5<&2)IX7EK
M@!(M(7*5$K=;V15;4T(F8S. %_)5O^,6]X4C"O*+G=8$T@<89Q%)WK<0[S@6
M7G 5N@2>]395N9:,ZR(0O[@6ZAJ5<5IHZ^9&KH:-/A$T#8<<I0&OJJ1J>Y%%
M_$5O@D$8DK$7 3,<XR)QT@AIUB&O)2$@O7$2HE6JV0?_IA%A:/%:$.5A:$,!
M%;!Q<P(!'A3W'_KC7!;F;/99$AI*E3TQL"]0L#WQ0Z7*0TMA"$A(>]V%L+SA
M:@?+KVHA?;HD7_JA6"<[2,.X(S*2<9B3HQ:A:@K98-YD$,H:>G84CU5I22\[
MDD=!M?NH6,KZ0[5V1;N*6ZP4LT !=,TGE?567!HQ+$T+CZM6-#93'^*PMJ.D
M;XS#-?N*C$E0%FZKGM,:)XNCJ=TZ<V+[=0!HI:VGJ)Q:IJ?J?\(:JJO:JYQK
MJBL4JZD:NL3*7,;ZJWJ:J[(*J;2ZN:S;N:8;K%\:J6)ZIT+[JJY[NJ"[JZ([
MN[Y7NY3XN;@KN\5*O*5KO-6"JKK!J[ICZJ:#:KO'.Z?0*ZFKN[S4V[QH.JN\
M.KQXRKT":+W?*[S**[Z]Z[G."[RYNZFTR[SDR[[("[[HR[NW(K_>&[OUJ[WI
M6Z0/Z!;K-8AXZZU8RCMHZR'PQWVLI(#S UY\B2SF)7IE\[6?\2Y,"KJ?Z:S$
MRS#322<FZ! " I)*\1O_**__J 7_"!AF\STLTBP&C%;B2'%>8$C6BF(^XU@V
M TQD(WA>RBZH_Z.L%2K$&".A$)I:0^R@GP6+6U9?L^AAUOEO+S$X*S'%44N2
MA.,L"RH1>JA ]U8@?$8BIV=T? DD+=E9W;$HXJJ+O*92H\DR)PA.3=Q*A;JW
M^GE5NJ=01 -:*0HV045"&F1,\7>]/PHW6-I5E!.6R_@2FA54@.0ED,<VO"@\
MNF<\N.4[5>Q,D"<VDTG)B+QRCER+7;8W!(A_MN7)\@7*VIEX',K)EG?* >?$
MH;S*?-;*IGQ06&F/JFQV4TC&!$7(EIS*TR3*D4S*:SS&MWS)CWRYP57,6'S,
MW83+<*/+FBS)==/)R!S,F<S'S>S+0_(^T8S)D,S,O=Q18_/-R2S+N__,RM?2
MR7"<5>V")%4L-/MQ?Z '3F*D(_JEB_]"S('F67?*-\#4J5(\([RH3"Q)62M<
M'HOL6_WVKE[@!?!)%OE"64P$$3$(&(FE0X%$2_LR:T 7%5G12;\HT4(AC J3
M$R_@)=?FBTGPE 8@C/("&E0C6#5=RJ?42"F-%3-1+^D8C!!=#6)4'X,+&+Y"
M2SE-%P:(U!\]70%(6>6A;QK]5Z-$2S"&P/JW2X: KOE26Y7A!<J@2QRR36:1
M?%$MU5,X.1RBE;,VU&QM(O1V2W*D+T==T_HF-R$E)#4M6!6=--@F%14-&OY7
M:/;PU3\A1P3 DI&X<M8V /72&HR[2IL%3Q7_W4AS:RF32)'.$H%68ITT=U5
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MBB^U515O*,/3QNTBM[L;^FYM$5O9YUJIL9S3ZH;4^R3VWM:]EH5O;&Z5'?>
M1*J/HFP1X0;6@<D67?Q5K'0NXR2(+95S)>R.MF12&)/JBE)P.I;K? D=!LJ%
MIX$%(4'OI&*Y)4M=-O%*<FUBK*#V16*[\ANA!B6=&^\$=L,E\>TJ!4)V<N_"
M:HF(%Q@*(WO,,$=-B!$ NS/@>MWXF_@JX Q! \($6J=BBB/DXI UR8U]BL
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MP-JF#T2R#_D0::'#@L$M%93')DR2K727&C ( W@RA=*"C:@![5'$"-*HB?)
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M)_(PKTS+D I,,1UQO3 ECMRL,[1P2@VJ3_F"G455T:^!,$Q:,IX))5PC1K5
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M?:DV1QF4D$\)[#Q.F%-TX0P:S02Z/O?XU%>J82.'](-Y;0C6Z^@Q1H!X,6
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MEW8HBF8D1":VY5Z8DZ\D$=5-8:=I-;S_@!:L:1][D]@-0!/LX*+.Y6[]Z&N
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MO[OGQX#6(@IB$R;-S*E_'DG(%R4QFU;B)U<\]QI_O0NW\8NKV6Y$%YEYQ38
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MZ<WU&G#BK/4DB6EAFU6-%SW4,&^IEF3L00RE-9R^/X)$L<+3";HA2L.Y"/)
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M15",16+\C#TB/_D9G^=1)^89QDAC_PE"L3QS,CGTFL.7N98O#"-T>JUCQ )
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MD?W4WUF1ZZ^Q8KMC4]QR#<.23'.+Q6NLY>@LDZKXWHQJV89&-6P ,"%5C>?
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MP__[Q;_\R?_\K7_ZT[_Z#;_VU]_[WW_\X]_\YQ_]V__ZZS__[U_]]Y_] :+
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MON(ASM\C_N(H'N,M;N(L;N,N/N PGN,RON,TGN(W7N,XCN Z/N0\7N0^/N-
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M=?112".5=%)**[7T4DPSU7133COU]%-00Q5U5$(+JM&  FPY#,?#"J@QK]A
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M'1-N/W=2Z/>LTE<ST5_[%(BR,_)5;@T39?$CE]7QDZLP9@*%[_"82A)S'WB
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M^[\7-!R&5GEUS^24\#"F.X! 5V @08$#N20QH' APX52N! <>"QB0X52(A9
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MQY@W9]JD"5-GRYPF=PK]R5-F4*)#<18%BC*I3Z5.CT)%2G6JU:<V)Q+<2M"
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M!Q]>_'CRY<V?+R^@@@ ]Z]L+4 \?_7SZ]<,W!SFVJ,7]_?W_!S!  ?\')+!
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M0"XQ')>FHKR]LZX+:<,#"3@+F<,*J4,*N<,)R4,)V<,(Z4,(^<,'"<0]>D-
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M=;3C'?&81SWND8]]]&,> P( .U!+ P04    " #XA%=8LPW#*7<F! !7+@0
M%    &EC;'(M,C R,S$R,S%?9S,N9VEFS-KE4QM0URAZVM)"T0H.A;9(<6B+
M2Z&T0'#:XDYQ=W</P1V".P37)+@3@A5WUQ#</>=YSGO/EWON'W#7K-EKS9X]
M>W]<LV=^TC)2 H*&=,2F./986!]NL)]C8<ECL6/])_Z[%_J?JM\]H=\Y9= U
M9= ]7;BT.W)PBL%@=B]OL"25L*25L:24/[*PT#,S,S S8RDJ8DDI84DJ8,G\
MIU' DOJ%)?V?5,*24L3ZJ8@E(8<E^1M+\A?6C_^LREAB2E@ 92P5%2S ?QH
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MU:JOO;,FOYLGMKC#\"?S6W5U>$= (H-T:YCSI)G]-+\O!4Y 0YB'"P[^F]F
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M="':8]K$IEHY:>7MN[EY'01/7]<3O95!D04IGU5HQ6BOR#Q%U.H T'[=5"G
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M.-,]-$=<B57M$&,FK_P[& 0 &N;NP-02&&)V]QJ7DD501M/"(SRM%#XP-P#
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M_:[/01*L_*CHA7W^7>4;SF)Q&8J+9_[W*^M-?>%$+.5OH2(V\L^,)A/*%GF
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MAJNF(W1HB_-'<7Z8C&UROTB--)ZR?TP/@<J,?"OO#]6FH+(LK(T,8_H9BN:
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M @*DDAU> [WX*8(24T)"U8-F0OPIF4.,S$++GLI;N[FIF_!]QQ6K_A#*<1W
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MR[,I=9UFZZW=VXYFFQ2T@^7#:Q2XZP%Z=+S#7UFM+;\\HB0[U_.^[0U_"&^
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MHRNMPX69@6J!H'H(B-#O.R>Q@V0=J!WRK9G,I8TIK!<8!H>$]6OB5&V'#6&
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M^BT\X\UY.,_+C&OFS&>RF<\M,E^&9F*Z"=S#,[7&T?"QL@A9LO IDGNF4I_
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MT51[2P=RAD8^E^\00G:*H#I'65OM&)&PUZ&M-]CXK^2;B(J:'O9PR80[1V\
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M?P^BL*YWFA_&X*@A.K9=\$/WL,WN\Y;YA1G4PL'^$M[!"OO!FN+!1@OM*,T
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MOHW];P"W4'^@X1__-MBS2*GF?_FW']O\L3_E'AX?_0/@_G> &S'UNZIBYR^
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MEP\Q$NYVEOJ43@Q/8Q)NM%@2_$/7^ TF%&GPZM2>58^A7[%!7OWM:6(W41#
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M+_A-7FI]CJC_M\X=(-C,(>0F?0(JH8_@OHR+\4W.XL62(&"$#$#_1(00SLI
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M,]VUNJ2.2E[ZDZH3DWJRM=!-!NZ!C2CCN\TF2+J&_Q1EF>:.!U!Y>^,,X"G
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M&UM;'6/\+-8$'6-^&6/1$V.)3K"^3&#8BH>^^ %1M:K0M!//MEQPM-/,)7_
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M)P7T@/*YT?*LS(K',_"@K8IOYI58'95F\? $U_*]W$H\U@I--\3UQXH3XXH
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M6[98.SF<C5Q0EC<FS5_..OT>=*A3\!**?J83);2L_T:Z*\&P"]QC[6J. _1
MB+L@W2&[IH'6[Q*RV1<^=^VU4X]:F>A=:S6/NV^<8N4\DIM)@%'!I,M&[+J-
M/:Z^LS45?J5+B8<^?L\0W]#U48$CV@/SQMCA7Q^SE3Z>WF=T96\?YH>D7>*<
M>H;&60#ND42D1$MK?%\H9DIIUW/("<469CU!%3OB"&4HB:I'PY^O::';/@_W
MJ2']^SBXW!=)GZ?4?]KY/B ZWI(D(=JB]Z"'ADT-BMU?[R 69:T]7"[MT3&H
M<9-R*3KX;GUP_E_#M74[^+54U"61PUB_M7KIFG7??F%_7QTJ>DN>-A-PUC:
MG0G@1' 3%+^D:E DB#,DHAZ9M.[3S^X)UR.Y#[T9X=RS>">F[7%"GU.DV?"E
MQ\6J8HR7NG:6+B<&Z_HJF[0!U2"EN(@K]KSJ<\$N\@FN*J6B/'J[T[M2> %7
M@<6XYPZFQ:H!RDWA/.B39,G1TI94]#\?,RK^TI'5=^2GJ Q!?7DS1$;MW$QD
M-/)@W(A"N-10'</1D<2QU[Z80W5Y(@'1]C(.2])FROJIQ$211/6W43BN<[O
M1+GC5/B$:HG[>!SUE/:C(?F?H_I+"E_[.SBC!XRI.[UL1'[>]CVE1BUF%QJ(
ML9[MBI:'CUN*]=*(]42?MB$T/DNX3P<8=]>'3QJ/]?+@P;B@L[USI%WODB*I
M7HK]FFG-&AV[*3/=4[I_W\"+[V!BJ5\PJ@,"@^;TL><OU\8R'LR+$,ZH0Z=3
M]D S^C(.]BA ./K!+I_%W!0%D2*+_@3@=?\&=*&65^T#L@_1@.;IF#\0FY3%
M;KTOGKJQD3B<0U9\7[S&TUG,KG<XGGRHI$&02=V_O+CT6-HK6V+VP1B5!DB$
M?GX<Q!E4O 2;FV_01U.OHFM>S+6.B5]+3%.7S.!D-Q+-K[10LV:$$:^*Z4W:
M]$HU&#6B5HJHEPCQ)QV653@'&I^;3#<K#B;K%U8^7$2]GNVG)D91KQL9D'X5
M1PW.Z7UU, 2H>9 ?]T9I3.564/1\ &H\8O_]D+UC;GUZ1S-? ,P_RKYOM' _
MW,$'@/,QX1:OS7UU=+"QQN>'E\__Q-NLCM8P/_Y%;XCZL?_IR'[#K-K@"LHF
M]X8AQ&-3A64C?6!$PW SPI;S!H/+T7:1KH)%J\7],<,&D<=V4\<'KHIMHB?L
M,J0<4!OAXCN@D.^2LM0V>PL+/\_&-*%B7\0V7>JZI4<^V\\. 4V@I])F="^*
M].U8HP'NT0<JWT#-,'F^ @E-<X-&\D\FH^)*A?/[F6WL(_@C2@C>>AHPVN/@
M)L0$C?I^?E>PDKISI*%#O7]P2"/5E,46:BN,BMCIU&\A2%U__7I30&H[&MV
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MJ/6\^%G)6$UW4G$@JRTZ*OS^_GCP^".T1]Z$5OW#D;[>G->/5\!O$M^ YIQ
MKQ]34T'I,IM39#J<LN2NWUS12?G=6UA"VEBZ(?G=0&;A)&S=J&=U+#5;V&Z7
MNCH0U^8MH2GD3"$%\XV,'@O*LDXA"G;M"M$1!8O:;(H&V[#(@PJ@Q5-S0:%U
MO]RW #1N^TFV-E0#]2D**-F[4)JPOGW@^VLJV=0"Q]Z) LBJ<FPM<!%C7,J<
M]:ND=RY]L,@;FP7)D/D+U>,IA6$IJ;OY%LHWJE&R4CWL!B]U6.@^?R/'4\)]
M"O_:'L"9>$GI.F+8IR#QC-TH=_!^OB0K19?_%H/K55Z.A"QA#IIGNMHRUWA@
M-XB0;4SJ&<R>U[+*&AF>U/J[CX*87=K=Z(MEO6SZJFBH-MB#VN7+%GN+_7MN
MQW:7= WH=U^Y0@ ?^(/7_3;V&W=7FT5#9"$H''*Y9=@O1/ 3JGM1NCU>!$!Z
MX(E4[:(KK68:PZ_Y8^?JW:[O\$1K#I?:0RG?1XC6_E[K@XAXXHO5G6R-P0!-
M$6+(L[U9I-L]OH?+_M$J"O+^+P7WGO#C'-#6I!,H%&DKXIGQ*O%(L:+C/;G[
MJ<4:"5-HP7J$EP>>4QK=D]HX-8^['(PI)2@5T-#B06/6DM\]])3N%R%\+"/P
M6G(Q-UU'D#B(S)^C7,8HB+55QDN5M<%\$L#2F;1B2< MI:+*%Z]&(::/-Y$<
M[I9#\IJG1R%F,9I(^E+7*!MOBC[A5:\Y/8=.!!DA+VIUC#821[@[YPL[=G:V
M!V.C4U8R;T!!3M!#'XQ<J($!>",QHV$\R^?Y78U";,(<.5UFH'4 ^GMH+O,&
MI$AGRRS-O(3Y>=83.9!%^H,/,AMI*A&G!ID_Q9\MIA+[RZQ92G,'9;B'3#/*
M9,J#I@MR]'-K"DI<=2[,P6DFW3FJ%;W3D^4\$\F;8">PAJG;B)*\#6+"(-2F
M*N?>K^MO!7<Y0MZV=CTUU+9N6SS/!KG?B&-7_[L.P)*>KBG#4*C&'Y0%1_T.
MM @OQ["R>'NN6:@-_5U9M]/Z> =Y$'1'-9M3V,XMLMT<,+PV%7$KC'Q3XE2;
M3<KSYEKG2Z7I_ QM3K3/+(Q/6DCH1^5I(097T;<!=];."WO+EUU8EA0\J42>
M().4#)_>P^R;W[NY'9X/69EZI5$,H7S\7=,GW;*$M[N=XHQLO"T2ZJ83,#%6
M[-/"&P-1_N*)U; JGP@U_GQ4CW!G;B?5UNW1\$O/6_XT62T;\*+70DJAJ":^
M$D^"OL,3US&U>]T+P.O$ I>U[[]%$J95'_,9,P?<M_YRS2&Z=T2L**N_<][.
M (G:[54M1+CMURG#;0\:[_'=#UL)E-V/.FGO]_9[.0;=CP<V.FO0\.MGAL%P
MGT+NA[/F$42/,,B^::(\S-@L53Z37M$MAD=DBX>XC]!8;@]O@ 28C@'W\)'<
MR$BL1_,;U&7L#XO<*]ITE]HQLT:+^]_XT0-F$R8:#EHB9< 5%)<#IC"<*]A/
M/XCZ+J],=!%YB<K==>KMJT_1'0@"V^*C6?V!)_&7IY^LB.L[[Z7IVYSC#MTW
M872W-8P$$P_E7GW !3SW'I>HCL=3_KD]C?U.\&/V8:CM#@\E =?G9J)&/&<)
M1^+[[LSPGH+(T#%4.A3(=-]**ZQ@S^2XB)%CUMD=;.U_C,J8G=U@O#7\&6S,
MQI 6\5;8('S(Z['<\K..[*P-9OOH,.ML!DGO>ADY^YBXHNPW',$]"F?[T2F[
MV8SO==Z1+RN[W?^DFW^"YDE\HL:'1:23A7_VZ=5M5X3!3M?Y*R[)!E557GDB
M,OHE:21]X; 3]G$/$_,%:K EGPL]0\-BU=.BP"?C[028H#11]P(85'Q]T+<\
M2(20UU4LM7MX\B8T5;#[IL'47MU-_X'_);%EZF& RJ[?PYN\KLOB&/LNOW!1
M/%X*7>>?4A^MP^CF\B4O= ;C7GT,XG>H[>#/Y8H$3]/!*S<E+08LXEZ:F%!"
M#(=#I7XR97;PQO9AG VZ#[U\<7Y"*^36H^3M=^S[>&^)<&]*E55MU<-?:/,N
MAKS0W?Z=+L]X >TD4#V^9=3ZY9,<]33L\?R[^T^Q&L6%7TI#QHLLG6 ]L85:
M3=@392%JF15A.:HOF;NNP+'$6D_R!89[6LGK<BT>B>G%4SR9-,Q]F?3V6EI_
M+>MS=4!6P><WKTN2=)3,EE\DF_$55:A9,E+)915OJRZ)9,1,(B)>%A 06=]R
MSY0&[CYR+PK>4F#;4>1,.(YJ$-VSM+F2H%2M4O-[5139U]M?TTAD#-8O-+AF
M26S"&$]Z^+*$2$!NXJ$W?P2<K8!P?)KC=NV$%17/^OU9\D3LH_$:>'2&161H
M2\.X!I@P-+(S(12=NGQFLGN\9,>W4[YE0.I#1OW"N D,GPQP:KK9LSNNP5Y\
M@ -L?L)>YOUK8^$)*[#EOHK22MJ7&^\23E+W5,'J-&%9;": !+Q4O&P4J)F6
MX&[7_IJ]G-\;E.!6UU>=2FPG%7S-^ QP7B7_\*NZ#A5O 1T_XJT1.EDSI2%@
MB]^H0K>77L:J^.7H9NEA^T_]]6V#6(]CS[<EO\_U3(MNB23:%HHY',%4QNV(
MMWUG-;]=N<)6H13HSAK9SP 1%B-6+7!(@TU8V-=:+7QULJ:R.;8H#841? XK
MBEGBO)1B/8U#-<%2%UM;*RF,"JXZK4;17YPV<#1_-+RSQ\YP.0.&*WCJ5/PZ
MC;]\/GUD<^)A$/UAD57A%DRW*B&Y'?28Q[^[;U%O!S2Y(516ZHFW^PW';:IQ
M?1M1'AEN/2.H/?2<!/!M[J:/](,,=^SM3&16R@P.QEE>3695=-,<.FEV9.9T
MI3)-+\6,X#QIG#9'(=Q7=GUS;TJ+];@HQ*MH81-=Y[YJ"@-Q[C7Q\50GE^=6
MH].MMTQ)J69Q.5S:1G?-DQ ./:9\YPYFE#:Q#V]FZGGAY]B]/X*Z,*:1Q-)-
ME 853!47X_[C1=+@ABX!$F&.%9(+=Q&ES5-GJC4J%PK[ETIR&TI3@R]HMP8-
MV==(&? $ )K<,94-6YQ=+'2BM#:EPOATA5JW8_Z&ER-:>VN!-13^%_-U_8%%
M%=^7A-'6=L@9H7O)W1K4KWW'4N1<Q^E9_<ZO _:F2VK,XO4L._7RB1-! D!M
M?^B=%?2>2Z0&9WRD\&O[,B;MA=LX=(\!6VQO@<2U[H6N\H.6R,,,.]>,4_V?
M(EDW*]4%0H-(\OWNWKNUCR[? '8))EVP+SM9.?J)%@1NF>KS%63WA^]2Y@^I
M*&EJ""8YJ\^I/L]1HB^>V-5F<OQVT]:BG3L+O=GIV,U-R9I"C7CR<K6A-IT!
MXJET,;Q#S%#[]'^]JKAI1U\#:%GP$CR'"X:U]ZG?2S"HZ>N9>?#Q.;_Q-[G6
MLBIPL;KJ<"' \KYS<GDIXTUL[DUJ[OTBWYMRZBL*XQ?VN=.+0+'@+X+W]UHV
M(&>[*X2&\+G[:+K7T4][Z+GKNRJ/Z[=TZ4X$,^O87(+:.XG.F>->HIIVY*0^
MO[IL6SJ\=(Q]VE7<.2J=6O)</5OUV<CHJEU>R6L[3:@\$!7$9HGY-;GA6[&A
M^J\;SM+JUB/@N-@)$F%R'7"1U R2X= FD^PT&H]71P<JK4O+ZYD[>6Q8RPG\
MM-\, )O]$M32U2"CDP[TB#VCBP]P?)7G=M;EL9+WZDK+XT#"/GF"+3%(\U.2
M/G3=9(I4OC3!R_Y"6S:)T:K+&]8=$N[G78H56LX46I$D6VP>6KTI0Q,D'1YH
M ]8&:0L\=Z\A##(#Y&S*Q0*U<YG>ZYC+J <9S5?[AP3Y^&Y/$FLSL?AC*!_S
M S$=;=A\PCV(PT4>F>/E^5I<V,S[ZI9WF9E_-D"<N__HYIH(LC^/4?QB1O)U
M*D*EVQWCL[O+)PD DVLP?P0N*>-IMX,O$^WA)D\O4,@Q/[S"*9 V/A# X_$;
M:+Q_'C3*YU#YQ>,[B3FM.?U:=\3^L =M;:@_D6?DYDMW&2RD7Z375$0"TZ_T
M90*C-MY>,J\0H\!Z;:]<@1!C%UH2<GO.8-?,P-#/P7$1]Q]#Y7OB%+?BE'O>
MR3+'JPMQU&UJLT^%T@J!]OFB:,SLF 1?ADF!>!/"C#>U R;Q.O,CTF7BI&6,
M)60"A( 6$TS.;$QVDN8_OO=H@-Z&Q'7_LKWTQ6GSI=<!MGS[X)</M!/RC9^2
M?"5D3"GDR:1%S-&3:%@3\3T_QF2*U2K N'4\GHSDHR,Z";N 97P\XJ5&X%1
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M4J8KV*TJA=TJY7<JW^R$L<$JY $(350%"P2A&XK0$T$8N%4$7B%X0A'J,PB
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MQ3TB;-L1)57AUMO$^].TT '2NFVYL*$2V[4O^-OPNZ8"O(Y<D>VCE)WNQAW
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ME!9220:B6L',1JC-DO(ZD*FC77A.#9(#UE8-0[5L&4S=OCQ'CD%TT&!KL+?
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M .<0#'L3MD0$P9L 5M_3D*D3K52V:A#4_K-%8AE2"];=%VGC-+U/[4W-&,?
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M)M"21>/_N!0[VT%W35\$TN7IK_#_Q2W7%=9+%_$=;N^1\6X"1#M!SP!^\\A
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M'=^I=,V3TAZ@>?PQLO#4"T\FD@ [&7U1 >^D^'.Z5U@Y[S%N"S%][#- ]!_
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M>&XD54@_>;-<P0+>RK8V9^(8LZHAWN"Y^HI&WL/5Q=P1VR^+XK@>6\WAA1V
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ME,>4;&&4>Z_CM$_Q$7J8#O_5MF557T&F3I!]AN)CA0G*%!';QT,1L1MZ&U"
M"$&"W@\&SB^TM;)9>ZK#F#87:CN(V36AF&BR-8*_\&Y*5?-U(I8;]7Q7!BM_
M!J*SQBJJ/U"X1;&CTV?HF@+R.E4UNM;+O&S',EM4-7S9]$WFA1QLU&0%65V?
MGXHI&3XWVE5TS1MF'WN][8IBN SAJ"F[#.,?F\6915DI65CK(^$5JJH$? 57
M9;W0IA=\SJK& B?R;%*-8O'L.^4XF6V<::X:_N%T_V/QN)7L9!-1/S&]OO&M
M.ME@RGU!]<VUH!I3\[31.7O/CK*S.1U%>W31,<XA\BJDO1XH%U?KEJGAYT$C
M:<L8D)6GK\EOH*9+4,7DNR4Z[;4=2/(1YJRQ/FG^XS)]\*IX]"M+4_*/)*4_
MNQYGV=3>,>7W !_Y(MB!-T6],&,R^3(7VQ+F-<)R(#BC=Y4QJ ^K:V$%L;7Q
MU%Y.A&E O#QWW_7# Z'G/LC6"M=%SK.NX2@EVZTMEX_I06U#5E./2(K <:W<
MXJW1:3;@X6?0I]>*E/<\CI?D6: =<)^;<, S<;R89>?-QCH\,Y+FN0J6@>0H
M6I$I*U6D,(?.(?91+\__0T_OXXAS=*.^VPY.+XHBN^P2UV81D%;,C:-*Z4">
M,(]\'NL]$8M5F%*>+O"AQ"$.:@H<-TI .^:QX* ###<C6\YHU/:M?G/4S$9]
M12GE55-VCI*N44MR':/9US9GP*0QAN$/"AHZE$O^0R?,0'*K#[% H:R>6,T.
M3*/X85JOV^&*T3;#$T>G]YE<56(/)*_.1UZG+O3$5$1V!<P.$DEDO DE^!*0
MUEGE@!%NHYR]/B;)U4T5HY9T77#,.DKB]+U6V>R9VN--<4$&M71&26M1^Q^G
M5T7K5JQ;0%8BS^^H":TJU[2:6$/"%.[Z9"@*<]/4SGB==]\! J=C5%<^A4Q$
M ^637'JL5FK2& _9HP"6:@F36J W+Z?X4[S)?E+F : EH;K5-7MS<8Q:GUZ2
M:CQ"C(K$W&-]M/7+AUG=D.K\_!$0>W8N:]*WT!*&N<@B^QQ,H.N4*B6$3Z#X
MY$<>S3],MNGYZ7# +0%H*/T]$P]-B^&>R3XI^/?S,;.KLGJNPAJ1ZY[5MPZ>
M*\%?YT.0/?KO=JY(UG\2*^!U>)BUX[)QHR6*216-/W+.%O$!G0C3=30S;/A-
MX?0DV4TGRS!!LM;<F,ZMSG5-2E7)RWI_I(/C^%"@N!O:!3$6CD:P,PZA+]I"
M2BK3[I^AM^:%EBJ/6GN':O:1X;I]A5J[]JGE! M 7^('U"@ ,[[I6 25NZU2
M#$N-M8J=9V=XQ^>\E Z]+]G\+37D-34WXE]M:SZBMMGR%EYFY0GVN=$?$7'E
M#?^SEQX-F;F;MHD\*BZG)$(>F>R@(VM%6)!-J^"HFDBKF\DYHR6(&:\%:*C.
MK]>XZ!/UU#3@Q[TPF6BSQ%!Y!G*6:J*JF5JW87V3G2N9,Y"W^=2Z9%-@I^^R
M6-L9>*,R5UGU3<4 S0PY57ERV%9FM)8-P 478++5ZEQ<^"J\??J-]#ZMH7W3
MF-6+P/A.(RSP\\O1,XKF1% GIM?,0KK,1I/4+ZUJ$=/BHV]+D9IO?Z.]AVA8
MK^\MY-<T)),L\$K,(6$/.&/ \3[*EY%8Y [=+QN\ ?Q'51K]=L ",$"1@LO<
M6UU7!(%'+<O-(ME&VDW$'S PI'5$;F\).6P4;TG!=S]EP:1OR',85*_KJ4FB
M7MCZ83)#+,8\)]+5M55U'RE_<U%Y^:X&-0/P:UQ2XO?/*@QP7\<#F;BA6\)0
MS?&\LD[I*<[Q/N4IW SMH>JO@LF'[%O@..&2,/F+ZLPB?M/RUB(7CD<+Q<>*
M[J'D\JE,;+,"XQ=NRPG!R@4%+42V&/GUVI9DW1FWJLCCQ1N.M7J=F]S,.XCR
MPLUCZU,NM1!O*;E<BRY3I!!E27\L"M#NWF]C\]>] R__KB\OJ[%Z<5:+N=UR
M9ER7D:4^=4;KWCK !>I3PP/WE*#=Z*9;F9H*) C)=]V_>,U0IKJ!]_>E 0-"
M"5=>&RD[7]II4BMA8Q1U8T4J9=IGJUE,I>@,HNO=U;F-21DNW9M+SR'B=(J<
ME=0O"YQX>13%E@N+XZ+MTTI+K')=50$=K]6'X3)VU3?XF5O]OWWP[$54'W 3
M!]/6;%4X%"0!)3JOGHV<I#/QMX"_62L>K"YB47'9,;DJ5:^U8E'4FL?QX)-/
MR[7$E7F9%5*G_A<ZP YE7BP:0=[C8Q:!#@B"W*]0/V^*,YM1A$_5#15SG F;
M;R.K%)^>QI3(G=LF+],13_<#&)_:,BSX;;^.[DJU9L;8M\7&<_.W\6PKQIZJ
M@S)]JEM,^&Z6 [=P_?'XKT6LVQ>.8=U75U)+K:CLYZ7#G=HA<=P[$AF*5P(H
MT]Y74VKVI 7:6CQ)[L@_I.G]9I-'<"3^L_SW[]8R!V9<TMNY)*7^!;[\Z?!S
M)CZSZQ=9>Y*@YQD#V[1^5J4I.Y +H"Z.-HER%9; L2YL%G_5$-([HO9_L+MN
M<H:L6*,.4*U&BO][$*V75JT;"20!DQSJA@A[!I]::,I;6>=1NZ+):0]'>&F9
M\O5P6Y=H:G;324;^88Q IODGY]=;RJQ"*TRH;2'L:?HFZR4U^X4L6MMF%<Y-
M6A&N-!8N2"LE?_(%%.G4<2RQRV?M(V<B%*4%_6TC0J"/W4:<?^2:GB%99JXJ
M O2@1E36)3"V35(P9N 97O#RU-4U70GW:L>1PB'C&?-11=2&:^%#FVPDQQ1L
M5R3D&#[7X$(X\!6PVEB[-66];T"L*^#X*"-4)$9$'!!FFU84'Q1UF3C]SMI;
M/II6/1(+P6RM.33+7(!84VJQC>F&P+%<5\&$'@J@=;AN\ V!@-0L9'ZDJW,@
MD-RYD>?"/5)=O^SS" W*N^3R19>BQ%'N4O=\E![5,HSEY<ETMSMLTR"TUBC<
M12'($+./\@E U%5(#4%'$'G[V*I.1O.9LIP/ =<[TXW%H8S@73/![T%^MA'(
M.7;<&TKB>Q^.$RIUOC(/DX_!^300$7I;RK"8(&T5]PPU@A*&2,)X]U*_3Y4!
M+5)@FPJE)OIO4 *GQ/UX]C!KRU4R@J^)3 H8BBM!"GM<%E+0C:BH<3IMN@/=
M,FG'$9@ 3Z;_X$ILY(BRVC#Q.UE9NE-Y?YFDG17[I<?D]-7@?$\49H6T[]_C
M%#S=N>F-F752$W<#3182P^CI) XM]L$N/QE2.FD"8T>!_!TR'Q=27?$I/9 I
MZ2,EP8S.FM3!1#PHVJ<9W3LNY.5Q(D2^&[HV9'@!+P-RQXGRTY',=&-I2T>&
M-QXA%-'%";2H*:]EEI$R*18RWE2@)&QLG67IF&9=YL,O OIO-QG5XUFUF20S
M*$FUJT \2VB1CR^8W^NE)%[*DG&9UE&'WGO$*G79-4(;Z)H#S/D(RVR;)VCD
M2)8;-W:00"MH,D0XSEHY1<M927D!>CFZ>$=SN8G*. >,@#_#))D1%#Z9:;U;
MI+^C3-N5X*SDL^'4%567_4RZ!Y5WL4E)]TX9LGPOXZ0J\"T3DHN8A688(;YR
MC]4%XY2*R@"&Y(M(<Q,7P[;Y+%"C;=403+TBZ+UHH;KCL>:>A6%[V:^X.5<Z
M[H(XH0\PTY:G6*2S+%Z0AZV53<UJT2?+>)*SF O-9 H\IM*C8(H1)])C,Q,/
MG0(&EG]A7E-$IM\:@SAHG'$JS?Z^ 8$? 6CLT:6@JE+'9&=#5^\4&U+Z>9*]
MWVJI4#,E7G7=)\Z/J8X;%1Q(4./?.$$"_7DC+4H'F5(:[6[SB5QA/O;%>)*2
M,I+'Y;ZLIYCZ$UGN.KJ)NQ"&TB\LQU&]95+QXQ*-H59-DO[_(H#R$*9=STQ\
M[.PI3Q]^!JUW<,"/X["?5%:DBZ$YV*$FZ\4!T(J@)_.(#LI=;UA/DTUV>/7:
M2G"8() RVO#[<O#D+=3>1[,/5YDI-;WI0<9#,<7?TV[&AW1OUQ+CNBHA_5.S
M8K6E5Q);>K:K63C0,D!\/1-'+P+/PD1JW2*K+=U4LBKC.2F+VU 48K3-HR<#
M#59$!&Z_=4+=&'.,!;$W%1L0]1L699E_>\31^\216"K:N)N,ZCDUM'BL$G@9
M<=N:E$!O$"K4FV**QF,+I;)E==F&([-OD0V$PWQ,B%R0F!(71\"5$-&C"?V<
MB0)8:L9[)2V .\8]OP6>?BTO43Y)E?=\*_#-MM9BL,2?,0>X$%,O7X&#;'Y
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M-MWG O1I6'5"(8<-=WO]["0\R?Q,9[G/V6DT6L]A_ POB:^"SG-,F1JK*>5
M'W)F00Y!@)YP<X2R=X14NOOO$?=@MUBF#5R,BR+#=CN-Y\Q;)N<R[[P$.*J;
M;X[KYWH005,U^5SU#2OX\;#+=:%@06 5I<%,"\\5'(G]&;(:/R!/*8$25O8W
M4XG9&?*'R'^EV\EDWP=LMI+VLL>L9,F8]._+EGHZ_MY$^:_E&08YA8#RT'6
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M6*BW.?*1HN*^XL O1.E(+E;(ND%>1>QP^'!#J4:^@@0GQ:%,?HWC0OKE1-<
M$GE]CU!/%\]J?[AN%(NM0CY$NI,P4_II9><).2=:N><7Y_@)^0_$2;2JL11
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M-E'Z.1BUA<:O$)XI(T8D%;/<3L'<_COY!KOP 5^Y2C>&D;P1)I,.*,ZIIJG
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MZ?9\ET_MKM?R$5J B2BE.0+Q_,AN64(OAKN#:T#N)$WT#9?V4E?+.??:N;I
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M\M$&/Q!2$&V8?\H4/1)V/PO+>012% U+UFA:V I(?.HP80\A^QE2H!C%^1>
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MVK59&5T\$MT>&#EE&5*$6E4 M%!7VGP!;H-0]_=JXR\/*(3^8<FY_429"LS
M;):=7 '(L)PW\3-<U-8&3.Q;,-9DD\IT6=-T$SM]6#]V*I3NR;:Y)I4;6B4"
M-(4)'U4F".U$M /M9*H*E'LS]NADVV4UC?)'F;5V]F#:5"!%]H4*ISW+:*'J
M$K8P5+[:N"JE3'1TC;S:='$!NY2\JGP1O%QPHXX01^.4JW\\#)YOA15PL>XA
M 0Q3Y(K =,%Q07\BXFZIL@:%[:S*'/58Y5F,FC8?,6-1QBEZV6=YA_NGPFAS
MB:>,"#4NBITK.7IG)BIQG&J%:^NVJK6-C(QX^=$5YN+&B__9RIL\5:!\X,V<
M^'^?*,Y:9_2UK8FD@NF,S,K;!]>K[;"]^M:2O0'V7D.5\ T GC+%(R';=A _
M>X-"5DG_M(F&X1Q.]^[E&F7D11WT2 ]NWL5FV8&:$8FS63_HL49_*VL2LFWM
M:U>:#;D./Z3K3:YX94QQ"X9\D/]]IA\M32)@3:,J3$\ W$/TV)HJJ/',JYP;
M$4'^2PD+)FKHV=I NZI0LWV&J$(#-BR\<3&RX]LP"PWN+"<'_!0<(?\N%NW?
M,4?,D2+:OF%O9"X'[F(#]RI/W.&L)5&A.9LY;/=4!@TB:/F'0.Z 4KI'/*O
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MX&H')M^8IK /JXTE-W+;>VN2168T%.<C:<NKT2)22U6GW&W:)Z8[MN?#\-9
M B5Q[\'8*<RA^SMWI0=#QM?:JQSK#4"QU4!=E%/Y.OX;\@J)8).*0/U@3S+<
M^SV[B<C<=)CP<,N7M]C,/+=45M4B3[N(@JI]@MTAY48.>X=2XVW#H&]O\O'_
M!QE YK_JM.6\P7?\4"O=)?-LN7I>U:A=M;@EJYKHX(XVP/A&8?1ZG& SD:TA
MKZI.?\=FB:A;O3"!#\X*_QN;W(^J6*N'+7+2MJ7@[":?,?F4C[HPR*#AC5*L
M,9+SD7=A"*3MO/Q#*EWTS*@D;@Y)%S K"*P"^_MX+<6\KGFKG#+R#&<A G<'
MY)2PCZ'JZGFWQ2_[9[7I^^N2C_P"-M]?;L6 T$-2TT-8_T,X6(BHR'BH:&A8
MV-@(Z>@X&&EYL+EYPYAH>1E:F,2YB5/Y"$I"*1F*V<HZ.GL(25DC<Y@K2&AC
MZEGK6N/+>6.+6TO,V1H<>IS:C"AZBWQK#:W[^/PXZ<RKJLT-*MU]J2BC*.ML
M"SO;3BT<6RXY_I@;"?H=7<C4[_\/,*# @00+&CR(,*'"A0P;.GP(,:+$B10K
M6KR(,:/ !AP[>OP(,J1'C21+FLS8ZJ3*E2PK=G.EKE+,=:YZ[+(4KI:E>Y6V
MS;J6J49,;CAK#>4):2C-=<\@\8RG+J<LI/$LU:.5B>JAJ(;4<:4US]N^H)ED
MR9JT"BHV86*W,FM;Z=XDI#W9YO]L6K<MVZ! X46#QG/FW5AB>[0\C#BQXL6,
M&RN$1E3FVZINA9*E%UE<9+Q*85(^UDCP4FQ_KWI3Q@D'T;>V<)@ZY9-TV+/2
MGGV]=3:MSG*5Z6XNQ/5WL\E_?PH%OC=TUZHUNQ:WN[NW<60]\S;U:YTLZ,K;
M^1)R##Z\^/'DRP/,KO8Z7TSJQXX>M4NNSMNCM;7/]#EGH9O=\:W%FAE^ELGV
M%W/'1><=3;0MUPQ]/EDS3E'3(>=?;0RZAY=MDSEXS((7TF.4@=U5E5M_BS!%
M(5@97O.2>2Z^"&.,,BY4H(KIW!@;7-@=J*,N[GDV''>O)8'@?[;<\!HJA:E8
M(U KO@/_X&7#_ (6:DFPB-H!#[H3&F4.OJ27.94%&*!NJZC7S9?/V3B*5UV.
M)15T2=UEW6K9Y6C8C'KNR6>??OYID4B"#BH2H(9.-,NABI:TCIIVXL1>E#@2
M=0\ZVY@6Y9+0>*@?G-.P4R$SR3%I'"]&QM9I6!-BBEV*Z9UHF7#MH,IC.H;(
M-P^KB<#"*7O-D;5+A.)XQ]JCW@A[E:BE!NF?-KBNLVBTTD[KIX2PZA-,/>TL
M:!^('?)FXJ_VU4D.@O#D4VM1JMI9BBDV[#@9DN["!9E5I#GS%:C6HAFI@/X&
M>Q^(N+77B*6B7'IKN;<\I9.Z^4"9X'KJ2B@,AVFJ*J:%X9RYJ=DAU'X,<LCA
M4?SC3[R"9IJ<^O!&G%J?$%BFRG\97"2VZ-58;L31L6CRP2@?#.%@F6KSU:S_
MT2GTSM9^0ARL0T>(IS,&"V<??^5"W:K26Z8RCE;XL?J7R&*/379)E 5(<H'H
M$DCLI]C^*M-TT+P&#,8ODY(DD/4!S;:S2T>'*;.H 3/+X.P\DB6];V-%<)'F
M&LTL+MV&.>(L7C?>'S5,;LBSXA..>.:82YO_5G;III^.NF*$KLXZ1ZD?>LOK
M9%N5GZ92"O*FJ64)3"Z:!_+'FUSYBGAMP_I&W1-M#@)O?-_9/B\)4J(Q7BR^
M3?-X>]IG#TTR."5S"V!PL7*7H-YR;FW3;F;)@U6^&4K9Y-'?R4Y__2+O55WE
MO6^7=,=X,0\]8@DK1&!1"I=\1+[<!>,U!U"6D0KA&E,0R8&XVXKSUG4=AG7.
M7_Z3&?4T-2Q7)9![[VE.;IPTJNGXJCHB=(_PA!,F,J6M<I*PGPUON*CS-<TW
M/:*=Z/ 2IX:E*&KB@]2*#CB7#WDJ8GVIF=.8MH\58FQ3X$HAK4;ELJ: #WS^
MZ@D E2B:(:)0+UJ!_V&]//A ?K5/C$O2AP&_!1H<RG&.>Q)B6QBVQ("MC4Y
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MR[*TS9#&Q(G,J,W6V*;/NX?5X(+5OMZ)QL*[W):;G^?:ATSW^/GZ^_S]_O\
M PH<2+"@P8,($RI<R+"APX+QJJ7SU&U;K5ZNF)FKJ.K<-ES>"!T8.?*&KI.<
M!O6X07(D#E0V6AZ@!"]CCY@DD[CKH2O9*9DV:-YLF:0;SI$Z8PUMB4.>4)E-
M,1T=B?%;RHL]Q3&:>N"B(*X=+W+]").HLV_/()G+Y%56RDGQKL%5U-;;W)J(
MT@UZR+>OW[^  PL>3+BPX<.%&RA>K-B!8\<-^C: S+ARY'^6+1?,K-D?9\;Y
M/B]&C- 4Z=.H4:?$BTSK((K_K[DI\YI6:>Q&-8FUH^D1:SAWX*1YK0<*-NZP
MT%S??N?[4FMIXGZAU48VG-NX-JUVE/><YEWGL<_:CB64M_#DUKK/,HXV/*&U
MR;8'7W^]M>Q5E%+KW\^_O___I6&B'C.Y8>?>63U9LHR!PUQWCH+HU':>=/$I
MUQR!B,C4E2O?S>-@@=G1YA,.-G"UX45 />@*#C(E4>*+,,;X(E"/L$B4C#C"
M2",O8&7G''#8&4B))@(6&>(QUZ"C"(CE!6E>>TP*15%MKA$"X)589JGEE@]=
M(PR1/J[6B77G,9E7=@.2AQ\L:ZJY7$8>X7+@>-")696(JA"99)WV40DDG"+6
M5Y%/_^=!5^<[$D&IU3H;B0(?G4]B6-Z"]5CG%)R&=#=./$8*&:BAR-0U'GE<
MEFKJJ:A>>=6E:K))"S)3TH>2D6W6I%Z2^#$BDTF0,L,24],0D@10.>8X;$MQ
M7@A)B<>29,,U4_'Z9K3K$-)C;X5 A6)+S\Y'J*+?"D*BB<&-%>@@S8Y4K+$R
MQ06KAQ("ZLJ"/M$[[W%687LKE+NYDNJ_  <L\, $X_/98Z/Q-1G"G $DFF*;
M/7Q9/Q(;+#'$6PI3\,9\;?>>DI;^6)Y;EW)J"74?!IM1I>U]>B!RFW18H8HJ
MYR8R2-^P' U=,Y<#\J!4UCSGA'L&I^DQF3[(WC!%\_E,O_^%%F-SLMK=625\
MS7$JH%W O09SN/9P+/;89&-9'4>8,MVK)"MG#33;F[ZS&MB_P<W<D46RZ34C
MOY+45+SQ4>>J19'@,&ZZ&KZ28JLV:NCXXRDBTCCDE&L8E%0R]8QDD_.JO'/7
M7EIZ,DKOUHT1D7=)UR>40?.\-RN_E"W[[+0;1M[@P,@:,NB\V9;53ISW&E:E
M;%78M/"7--K,;A3:>7=(/O[IO*%DQF>.SN)=I=?4$"K#R=*C#EES+=NO<[O<
MHN8>,MQZ 9_TSJ8S>$O>0H==^_WXYU^:R6$FDBB0>JI0\WS4KYC1S'L.NL:N
M" >-OKF$% ZLG 0W-++K' YQW HUSR"B]2 .DL=<IAL$5$BQHZIY:E$9,1RS
M*.>3:P$O@A-D8932 CM=I,Y)QD-AR397#'<HKP?_^@NB$(=(Q+]PYC$.P)AD
M&)89ASTL8D_T3!0OID0MM:F(M(O.JGHX,CQA*GG0:U/1+'0^ZHWI0IT:T"_8
M@RT,I:E,+^MB\"YBG[E]C6;5DB/GV .;#YW+7ORK7D3:TD91%6(MH0HA@ZI&
M,AG@ACMUN=4;(]&^6-D$BYC,Y-@ *#7<(3 BV C@[^;7O3Q:;6]L2YH<[WC&
M);V-&%R)2BGZ.)TVGN-P,22).[25P*_D<H*7L]8O)=BM2TPE*?1[Q7,26<@
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M(#!9EH^F%LEUC8]E:_'8AT%W@>)H9%&35&:7@AAA4]MR=<VV2D;U."Y2?_
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M*+Y2)(Z5/AO>?#UD]3!BQ8X7=YG2U4,A-X^5RJ7\I'+32XKJ<-62R(I>N8
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MD*S.1\8K:N,6%\.;]M-T_+3$.H>6"OO8HU S7!L\P:4X*WK*6P'395\OI-4
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MH2;[E6B4HP&+%$Q)))+AK;7K5),TG _54MOZ3< AN^C+A^6J4^C:OI!F>ME
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MEY[K>[/_H+XC3,(X2F$[.ATXV*3Z5T1:AC14%;H<6KBY&$K]D;"]0$QI"PO
M5X8T5T*588Z>4I40TPN^9FG-JSP5,[W4&QY5&:9 5A@<*HVH %'(ZK!!.[(
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M>:N%P5@HB-1ZJGGQIA 2BRI?1&JJ)X*QG@I]8<B$\X^[Y.YSP<FA79:DLZG
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MJ#(&EI!&>91("1TMA9!L=7,YQX8.B%0:173H5#,% 7XHB$>1)7?GMX7_*B>
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MZJ<=T;0/$.%A#V@)Q)F4TPF7[SEB?=:/1,:/2V(4)D>'AI! F;S@>JT)89'
M:< 6FP751P%#:[-42S/TF+.%@];"A<7UCU2BEJZ)CC#%GA9EAP.3>6BFA06H
MFM0V<L E$!JI<OAP%___N:,\VJ/1B!@)65;=,I+=-$R5E6C#(&[Z5J3G*#O3
MB!G51A?Y64TUQ9##YE^XR'!A678B:B4[AV$].9,4V))9>6H)"FO;]*3):8ZX
M@5;BPG^3L:!.:BI(!YF=Z8< XJ-,&:$8%83&IVI&F*0A.4[2J&%I:3?XI&TV
MD'^UI$R=TPB#(USI=3>ADF&,FDS[XA4==T\FYZ2+:D6V-)4->H^(P$HQ(4&D
M(@\'XAD&\2^@&DO&8*H9D7\U,7)S5*J+6DL2!'Z<.JM:<JFS.D%60Y+NX2KJ
M88M/""5E=U^I2:=U-PAZ"HU8-(CP29_#<PDTA)I?YX.^V'XH5V@#A:7@V*+_
M;92'2E1QB4BB[!94A_>LP4AT.[EC8V&"T2)_@T L"9)Q=ZDAFO$ES.H7<TEF
MN:4; 8NM/TAO0*55T?J,G06:A0B?;6F<C>FN3FIPH^")2:1BCO.IC7I+V;(?
M8_.'^/>JIW=G+;A+)VE802%W'!M,MT2L8@-YL#FR'1N>LQ,3@0&L8B.L=4EO
MKJJKKE1.3]FRP9JIX2I'=B=_!3E;!OLIBW-^1*4R"SNU5/N?62>M8%J67->D
MN,5/!1M7MAJG.!J+TL>#\EF;8%MFQ@>C>L>KQ[F *P9W%T:$LF>GK1" M[9%
M8+2.#V9[V4F(;!0]3YD<79%^*L,R2(A:1>IX708C_U4[A5B%9"P")S5XJ'6T
M7#,E17;9*4FR?_V("E7D'C7!'ACJ'[(4&,#3&*%;&+$TADI$.W"UNH0AK# 5
M$+!TKX6Q*U*!"ZM*7U94$JX"J:P[BID ,*UR&+*GL<CRNR5A+$_3BL4*N/(8
M1D]9E9'+6+'SN) +M6#BA=1V4W*VK6V68^)9GW]6G0B8CBP*>V,J@M8[GA#C
MG-=I3)9&I-I).LKC;WQ7",R[?Z,@NQDJ>=?904F4>378F^5IC?IYONM[6\<#
M1]HKA=@IN;+FK+Y6J6%[P1T%8W?Z#QH6$1R*?X51LJ\ LKP!P+4RO;&UH3CK
M.UZR7 0RN[TJ-N6'PC#AO_]'6+JZN[PCW GG9;RUY+$]9L,E@03V)IW8VGV7
M8YJ)9+A8];49S';KI+Z&$L%6?,42"&7/"(O^RH8B1A_]RJ?AL7I?^IL#>9//
MQXN#6K'I:[U>VL%!%4ELIDVG8+>=(XU2G(T5PXS+FH4AV:W-F)FH1YZ-HZ13
M&LB;>JBSZ9T@DV18K'7+J&>269WD6Z&D6&Z*&$\A-@OI!RT)RKQN(W_)HB96
M :I0 \J#<7I2.L-*8FZH7"O" TL!\AZMRPF]:S; >TM K+%C*!:XK!/&VA C
MT3<Q7*SA ;V%44K[RW$.%J+/0U)WPC,TF1R/7'G?V(,P=(MY"838>[I-RQM6
MFL&I@^A)WQI?:1:QHU5S>\(Q!,MGW/I$JS91X3='W22<>7FA>MR,P&P#_)RK
M-UPY@.BZ^?5#Z\=KC G/>S%HL(/(@ +(B+;*O%#-D(QLN$=EPK? F%*F!D1N
M.^93-<5HH 5RS#',@_#*K:(7)MP+)MV\!@I;K=9R)"T*HPP,O_PK-YNRU8@(
M*TVAZ!O3.^VK1S)QL[P?L&JC/QTP79O-=YPZ\FIJG>EM]OM1K_\ET51=U5&V
ME%L,8[TH/-XY1:1\7F@IP.\H8I\IC9&WN]R[HM)C>#T%DB7:N,0G9EQ7HV;!
M..1'EWP2R 'K,;3%&,%E/WE;:,>QR'*-S6YLHC4GT+QZ1TPH%%9-=2*##XWW
M1L[9RP#+I8!AS^VY._<\/R61P#4]&)YKF7?#2:)4(#\7VBG<%&5$T:J=%%0#
M2[L,O'^VJJ\-U$=-P]19TJ,D-B4+3#&;VS';'2E-/\"HC])4$&;F@=)[(\CP
MV!#7UA#"FD'FD@4-3^ #6$S+Q>6LH'_Y8F8<78RIQ).+OA0KG/-II&KI<S;(
MF>IV9$,V3W@Y90YUVZ%8I4L=6=?S(6[_JC%\Z\[AS#'JVTM];+A%"=W1%J)X
M*MX#JSA@9UM<Z96+-R4?/ \J)MS!?-K1>PGV?8^NQ],L[*O&8$(UV>&[PJ&Z
MT>'!I#(7OC6Z.WG"#=1BHN*F:Z)@AV0Y-M]SMM_ENM!^.HNYY2,(/N0 ($#?
MOT1N4EHLB:CH6/^S+>"LW"9SS%4ACNQM?E\H6(!=A/MH<&K$E@.[=#8Z;_,+
M$$K,/<Q,MCZ8E>YRO1OMO5O.U5Q-*E$\8^"[/ %MW0P=2JLC4<RLM8/LR$7N
M9/F(9UX=78<$/OU]N?@-<B,X,+^;J96 R_K'S[#\#XO5:*":2)#>S\9;JV)!
M._N0Z?T,S'RE*ZTR0?__DD$'4*M=LA*!P\^@+.F-RL^HWDFHK.FHKD%^=F+W
M 3@B%.HPX2RMX"_^<KS"_E73:<AE[.8^!N1K9C2J\>>/1HYF6.97_I)#F6\1
M&JX"Y]%Z>^=H'95:B(LSQ14^N-C]-A$S9VT+OBHD]2K87EB\RFC/)D;TQL<>
M=.NIS+9"T:_W%CO[:D8)#+8."<[49* PA*XXA0C0'F4L28T:PE_]$[!SV(41
MAN[KS);SRD6*CIN[WDJ^SM*V(.S$D@0BWUULLQ.:/NGI=-,9\3:=&-.[\,+*
M938A]/$Q ?.?OL\V?X]+-<R\GO*__B*;WL^HOG\M ^JP_FE)[2E<8<$BBJXZ
M_SC'T[FY[;3P5G_UFW.UDGBH4?IXT*DB&@<DU^;O,)C=F>S@H96>#_KC=)RX
M"K._JX&>M%@P:8O0@<??0/8X#D]K[)2/R(-TSU:F<!=O7=\7,(F>:T9B@B=K
M:N7$:LR9VVTO6+]DY2[ RN[W;#Y@=>^ZX+8*(=C%3E'AD="_MP)>O<*\^U(1
MZ[DJ'#3ZH0A>O@OR"^**F/#/*.%4-ARRKF:\)%]>3F5Z^VT(O&^TN(+OJ?Y=
MT!*R.7^\WS4KM/T1HEU)M*+\6/&1R-D+?%F?E-3%:R=HD3.$E3CY2J;Y9AKY
M-Z:&U?4IH:>9XSCM8LFTB<U ,;J?:IZ'ZR\H_!FF\/_;5>-,\(#04U/30T(X
M>'@HF,A8F$BR&#E8N B):)DH*(BY.(F826AS<T!::EIJTSAI*,GHV4EHJ"HK
M*8-(66.IJ>C)F[M;8]LK2=P;>SO\V=JY; R\S,DD/4U=;7V-G:V]S=WM_0T>
M+CY.7FY^?OZXZ:R,G)S).4C;'@_JWLK;J8N,">I8_&J2C5,X[ DZ9<I&#TV:
M!IY* NP5P87/#B5!J) 00QP7)_JK0?#2(H>D;A@+=<J7)H1);'B@2 C'*(0'
MDM@CU#%A#P\:8^8LA:/?+IJD,B[42+*4S9LX:.)@J'&FJ8+/?A;5N-'J :J)
MA#'C5W&0L(_]+-7;5(S3OD,*0H79DK3V)D"5-?_0V;V+-Z_>O7S[^OT+.+#@
MP80+&SZ,;=4AQ(P;<ZN$#];7>_+P&:3L#MF_7O7NR5+%+C3HR9=+TVU667$[
M5YI8L=NL>9XO1C(JAHW(FC/H=W'1!MPE&7-F@+?[G4XF^VNDY,>"=WHK-N#N
ML+-KYWN7.IERQ8N\"AT]_-<Q1IBL8P_67+PBQ^S;NW\/'QNLF[OIWG+]4?-J
M_.^8\;>=3%);!>36<)P(F%$O5B7QTFH[-75*,Z>DHHXR D;4PX(-:@>A*:3U
M$%)Z&2+TE(,]= B4/P*6]-)D(YH"D3,K;M7@5U)YY Z*I+BH(XW!'7+C 12*
M=Y!3J/58HBHX8N;?=:C_Y189/")1MMUXOKCV8WQ:;LEEEWKI)Y<KKV$796:?
MJ'<E<,)]A:5^8TD'#9SM_"A,F]SEQB2>D,U)Y6]8)H??A_=1%^:=RRGRV66P
MW6E?F8*ZF MXQ+V"@RA!ME3BDY8!-\^D]LTFYIF;BCI;F=G-U0QJOAG3&W.]
M> EKK++.2HV<J<K)J(,J 7H2=:U\9AZ8IH*B2Z U"%@06YT0E62.)$I'2(@W
M676#91KU:":(4U645+7277@2M1L.$V1)APJB(8:'8 LJLSS-=R*)YX+TT+B9
M+/A<#>F:R&YTK>77I)J>,*<IF09/!YY8 6<6[*NT/@QQQ!)/3''%%A>VS,4:
M_S/17SRW>AS:K6RITL-8C@IK:YYP5=36P,V<A2?"'_VJ;B-OSJ7LE"9/F9M9
MQX'L"W2@K67MGKY]+$B!J]&7,WK]$5OSP: " YT^W4'[(Z@\DRS:24_/!?.J
MSN':M,#!C;5QVFJOS3%=1 --WLF=DOHSI/GI*1".VZ$Z"((JG5(M:;?HB,0R
MX![WDTU? 7[4=#JF<C2]*;:"),XQ(?0M0B8)OE.00^*R8HPNSIBL;0*^@^QU
MC039[K.*INYT)"&R;#>\VOG;)YH 8M(;KL 071?;P@\/\>^V._*;@3F+C?L^
MN$3RIBN6>"7:N3NW5DG<2U?)B_/:<[9+[V)N]K9_4?\:]R.\=N*,OLJ]OK\J
MPG&:=G+ZNKKC\Z,]+53CP>N4')W]V"YF8\L'\"9!O5])*78'#,YWU&.W_!QP
M9XLAG@4OR*7Q"<=G94N>S$R%"]WU23G1N]NP5H6L5#D%93U('?*&,A5%/21*
MD7C<1Z05B:0L13*G\\=#5*>(<BUE&(SCWN5T(@]%K+!*+0S)5P3D+?MX@'7
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M6T. ]1W_R>,C[+O@Q#&5F-_2;_(>_!N2O)&A[/HCV>[:$ ]9=XPD%J^*$=*
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M.]\F7@VS\4K5+6/#.BKFP89):K=1LJ/S-\C0\%'.+T/:;%P+Y0MZT;IQ!$J
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M1B*)]@^-U3&+!EAEYV>5%&DSZ F>16',EQNTP"R.)6#A!PJ>PPB5X4<7LW<
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MP96)8[GU.9,1D1\%,ESE*50PI'27N75GU7,PRTNE$+XMW(//AH"O@TG"*7N
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ME":<==HYYIIL9@0FGPZ<N=^?>#;@T9>%"JKGGF N>B>;BFX9H&*25EIIBO<
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MT1LL-[4$LJWBX"%.M8U4J)5T-HW @#+PFPWDX$_'L;_4@7CXV$T!&ELN$5;
MHS7T6 [)V\"5D:^UIYZ[>XWD*7@6_RQ/I?F70\2=TG? T6O "*N=P#6Q7%F3
MG/:F)-BHHD:+S?6IA1--GBEG"WQ[;>&6->JYQ\E0$I.) ^6R7<@[G&JSU.;
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M%.)XUFPB-9[;%B),L=K,]WJDFWBE2_M=&:?5,\*AZQ!K$C7@3O/G%&E!)8Z
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M=M4.6A@;^O,?:BZO_W,9O3O:L>JZ"IY0@M/3\AKU\A]J]&K!<,ID#3RF^[3
MK]K^_0A;=J?IBK',]FGXN3&=/?A)ZBBG2*6G\R>+@&M^YQEX)U6==V^7!0F"
MU#]%I8 I07FC\3VZ,1L26%U;5ER(=#2ED7:"1!%\)R]Q$GEPAT55MFR^TT02
M%!.ME';E<T*S13B\!2(1!'\V>(,(U38 1G(E9W(HAX,#06! .%9M\49RE6%
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MKW$1D,A4]!6LG3& B",+'M4H<1H/W3I4DE":2QIHP$FJK5=J9E6!8@FBL$6
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M(MR)**:HHC$@G0>:58DLQ=%Q"97X77,=DM6?B(J0EN%$W( X&FI8:9)/5=7
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MKN1ACMNXB_CR0>%Z,#V%4F^#7)&*6Y.1$A+99!DI(U=AJ"":2  G9F1&FCU
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MQ?V%[,/<&0(B\>UQ#WRN78R]2>/ WXB;#!A!<;-%!IC++('<I&O+XN.A>@*
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M4&S:+"$X=A&((5*9CM#B5O\E64\[R.>0 9TYLP7W7$<]"@PPP]RN0$S$M ?
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M?E9'LS)]:/>9FDDZD[1^*D!.9]:$6!>*YE) )Q: 6#>7W(1609%Q #:8QME
MHL4I -2,1+:21\@N**D]1!4J9Y>-6M=SRA1H=B6*I&B2SJ@ZSU0HM?98[5)N
MD"9B+P:6(R16A_,YPM"$KQ:<5<A?U?DW%?)ZKM(D<OF>< (MU'B< )I0:%9X
MR&A"7NDA_VYX@V\9CJ/8)+)S")<9<IE'.H!8H0!6=R<%FQ-E$*+Y=[U9$!@W
M,!6JH>/'8Y"@H8_3E,0#FV>((VY9()1IFGUF7W;B>_'T>356HY?8@F89H#[*
M0#!)E,B1D_E6@2#8-MY5@@E'<!O8DQWXDQ]XI$=92POG74;I@2=H$#]J%7]I
MBW[#3I>6>11$COL4A5.IC'QF7QGFC4$DA/)DA=>(ER9V)5<5G9VVGCQXH$-'
M5HX%/(!EF&*JE<KEC8M68D^AB[!V:<=21<K)&P]" EL:J?0"ALM(&8ZY?&'$
MGFL*FH+Q$V&J?E8G:U0'::$F5<"H)EN7".1X*7^73W.FHR;&@[Y5M)I%IX9,
MB9? -Y\!)9M#$R*T2&EJV7*0*JG$FBH\]V%]A5, =E2S%HPC,EQ?N2QAYHL?
M-WQ3.1*N4I(1IGP4%FNA=RREJFA*P7P&A(5-$8L+UG3G%'DJ62@EMI(XEZR;
MF2_C<DEW59@"PPS%NJ^F0I?5&%'TM*.)YJ@3&FPJT7Q;5W(DLJ!PM8MJT@/]
MDZ:>!Y;&")7<^H+V.E=2QY7TBJ.9*ITU.J W:&@>EV8^B#Q@1)TR<9;FMJM$
M=83#_\JO,BM=W"6D0]H=16HV4HJD.^DU85.45>JD[,&33"!P&"BT0QFE$<A>
M[<4D,_L.T.2J2:AG $%X;.1S$O9R_*!Z)1LKE[<[1V.M!%,WR51.-"BP@Y<X
MPIFU9]IZ1[=6C .GHPJ6.H@B \:@OPA1+J$LM_AS*R)-XEIAAO"TA$L?7-FN
M!U1]0O>7RO=.#;N7[TBK?<FH!"IH#Z6H;ZJNIH=,>\>Y%9F66@AG'#>HXRF;
MU"J-5)NR=QF'A+-GN)BWLB@JWEBXM&L<%(N@7 : <TMG18BA3JBW!\I,H N8
M98FXN^FW?HE,VND[+O0YA#I!#+MAAZJG'9NYECN6Q96PK?_VMB?"HVTUES<8
M#-8HF@>C(@&X%+6;OL(QND6ENU/"5\!JO1CACV\8L(SF)&IE5]N4GY0+:KS[
MN-RZ@G\HN@$LN!X[>*(JB5V6N"_$88?Y*F7GGP.,MV&EGZ984.J;P<(1I,-!
MI#EKM#@;DT6II$,Y2SOI2R4\2T>+M"D<-B&\I*9B:AI<#@@&C'9JE8);P#]%
ME:*RP_5J+'D)%U27<S&SJG=U$W/H02BY@G&!Q",7M=F*A/]G1I,2A$2F8"2)
M&=GTB/-:8_O%E!P[FI'FL-R(3F:Z.#.<QE@AAP*1Q.B4>"YBO]0H7Q:;C&$!
M);,W5&WY,^39Q;;7N*1+5W83OD;_>+U1.(WODI9=UF" ++6 1Y6%RL# :Q0G
M0DYP^"%JG,GU4$FG>V#+-&)@3(V\V9^<8XM3M<1F+"V1NU5FJ7*&/,5-S!",
M2Z/X0HS+*2S^P*RKXX)C]JDL"Y^;)K[I5K'LBZ'%]2\QHE=/J(>DH,G.' \1
M-%!/^8C,N;)9R*"ONZ.&IX,-^KQJVL=R*'3ARLEBBJ]J6,Q]F;;JB:Y>O!^4
M3,[U2XRX)\GK^I6RZ3]L$89S\<S\/ \<W,%$VL)&*34DZ+,"#:5(BX$";= 9
M>*0+_<(V.R3.T,_>0$(/DL<R@LJ^N"^(J1_3U+LBZYA*]&FK1[_\VZD'N'2G
M%\6#MDG-_U9? K:6E+6%B8,0EV>_]0M2%\UR;17..I2C(M1L0&RF[YJZD/7#
M-@TLST#13)T..<PJX)FMDP-.X])R<=F]7^E#="F5]9JO$YRN%9P8)9*#0+T0
MHC/2L;H1Q0?+>QHQ)AJZ[4R-Q/MWBP?!;=I55G6F3^VZ]=EG[4*#\VQ\33W8
MXS#/VAIC[=B]E6NYV:*_:U+#X1G'O-PKGO!UO9=.C!RX[[B[9,&=E^W8/!2G
M*4?,42U0C"PM89W9! :_9B?9Y0J[>[DSA#W;X7"^6HB54LFH?2U[K%V+80VH
M\QNMD)R]*TNNMVI<F&6W=UG/QEW&=ZV6,(K "BM\G_6BD1V'P!& -%:MNE#9
M03R-H%K%TLY)5O^T7=Y<\V\B?&\#_<$N',+6 =$'S;14ZG#Q;9-8:H'6E<(X
M&TOS\@N##9DRE(8_I'K,BE74^PS"2+K82W5F)J=4W)5_3&JU=M74S3<PHL!@
M]MGV:I5Z0]I>=:B7?'L0.VOSA,-9R::E-EA.3,#-N7O1/1$Z%ICF;=ZV6L]R
M[; #O)&GVH.M6MV<&KI<: R*DQ]"?#![17JGJLC^NVC->[L6=K7O9&!#?'-I
M^+\.6L76'(OXV:P^N&.)^$'>G*\I,>/FG=B+_5BWK(2TT2I<.VDM<N8>[N4?
M#HU?6FZ6Y=F[DWOD"*@"N.00'KE#;'J"NM$4?&/LB+6.G%D&*[D@+KC_^'QA
MGTKFY3V>OB?FC,:]KOUNX3F?F^/&ANZW7IK9->RFA%R_+4KE0!Y#2%[<>AU@
M@+V[J$=X85N*'G98W0R2Z)EF!XOD-]+@J@XODC[C_TP<,SF4^\T<[W"E]0W#
MY\W026O?\CW")*S"^YW>1?(9@SV<PXG-&EO5V-E3$ZS($402C L4N6F]\53J
MBQ:ML?;2LJ'=LBK*9#O*4^O<MZNR9A*$ /C8;AL[O([A08?*O[PW_7+6X0(E
MPY55<-DS'78@P3[;$K'%X[S7N4B\J6VVC"[E&D*W$WOC$269X_<_8(2_C.W%
M-ZI3HP+GNBZ>TZL\0_[CX%W6%>;B=9RRLDC4_X@>\?+Y\54'=(?S\(2-0AH]
MZFQ)?:.(SK@7N\DKQ][,= 3BR_O"+W=;K].ZV/LP<S>_W6]:-*F-P!T!4'GY
MF(HIU^=RTT;O+@(OA5Q"\R7.[==9+;$3V9H-]-EN(&0FTVIRHQ/.X^NJ>:[9
M]NNH]4:(NI3MB6PMTQN2Q5+LOYKZUMNX[V9)9')\8;$WM]K.JC,*#(S9<YT'
MU :[VYQ"][0][,2^W@_G@ \(#_!]T-@U[3P)[<RN@<>^<!#-5,]$V"O-FAEA
MS5<+V0^;L#_-P/#9G.Z5SC"'.I2A4Z"\8WX*TVEJ/+6:=)/OBV1-IM>\9#0-
M>@:L(_@<FA]KVWQ<O?^!?L8?ZQ(F8:B/(/IU_Y90W.Z+*6GKEN5@W:FX4O".
MI>G96Z:IRU>L1KZ 4--34T,R.$B(F"BX:,A(R*CX> BI2+DXN6CYF,E)Z8@8
M"ND962B*2>J(>;G:"HIZRDE:6IFHFDFBJ2O*:]JJ^WLJW-F3*WMXRZ2\S-SL
M_ P=+3U-76U]C9VMO<W=[?T-'B[N'*RKJBK36MQ)NTDK>,MK//C:DUY+7'/?
M7CG_RW@+EBR B.+ERT1ODT)VH>ZMR_?JW:A:PQ#:LN6.E:A;JA"E:SBJ%SZ1
M^/@M;"1IXZ63^RR6Y >/8*>(OA[2@SFRIJ]''7/VZEECG-"A1(L:/8HTJ=)6
MI<T\.:28*^'$7HJ :D3ET)\DERM=SK(4L&4H1P%C59Q5RV YB:<^[NR*2B"P
M24#9\3,FUVO&8W'W[D5+R2RA?2(+^G45."ZQJ(JOSOUK$2XRC"4EYX3_Q32S
MYLV<.WO^++2!Z-$.2I<6#9J):-.F1[LFS;HUN-6G7]NV77L;[=JW;R_;[>"U
M-=BL>Q./W2!UMY"$E#M_+NY=K(MP.65E?E:1C,",\[F#=*^EV+4I[>H#"S!F
MXIWMNIL46/?[=Y/=KY;7>Y&K>HJU"!^TV1=S>:'UWS&,153>39'@M9)[8^4E
MGSJ,35;*= I6=Q* @ $#78<>?@ABB$K]4PPEUZ6'6( +VN68=71Y,F$_?6G5
M&'F5O<@?0X7P1=5:WMU8E87[Q63@@X,12>1-]E$WX'WNX 4C0O4! Y9')/JT
M2HPX49AA8WBII2$GYPB&8Y;Y#2-8#R*NR6:;_VZ^:9:#5!)8T90")>@>@8]-
M-9<^<S(YY(JL;.>GCI"Q5QU/ H)Y(XO\K6<GCB3=)Y>%<CY&XY63;14F386I
MN)!&6FD9*9E+YN@D3*G^F!ZEH;P):ZRRSKJ4D::&A. \>:Y3Y9$EZH7@2Y)<
M=VNH/*7ZEY* 2D?95V<ZFQV69VFRZ[,#/86AI.@$J&&V\$7(%RG56:4M8 =:
M9B8K.+4'Z%;D"NLHDU.^0FN]]MZ+[S6X%9><<@W$QMMKR/4;#G#&&>?-O_P>
M3+ R!KN&C<( #PQ<;O6VDV_&0^U53Z7B[K*CE<SR*9,ONE9883U/7;9B9(3$
M]X]+Y 8IX$'.EN*I@/\I!:1CLQ6)O IA!BD+\\>)^(=2H+_Z\A2#$.:HZK'?
MXN-6.2HQYY]4ZO0IS)B791N5QF*/3;:(6_.))I*QJ 7MR_K=6N"G&;UKJ2#[
M#*WSC3D;5+1YO-Z-(=(P'W82@5ZC$NQ/::/[4,]/#W(BF8?/YVJ\;^/RZ9^8
MWXGHGS9I67;HHH^^F6&-4EJI,=BFF&#-A7G:T]J)-?[SV45ZCB*OE%$^9U=7
MVV[TBUW&/)U>*Z=M47<Y:Z[UY>^4>KHY$\5>\Y93NQXNNB6S1;S./3E">OCB
MCQ_.8E9CPNC(/$Z4_4C4PV-9L.Y#DCCZ7='-M8J; WGD/UE))2=L(0UGP^C_
MF& B4A:TA2QK^)C9E0C(,GN,PFMG29_-M@>97ME/3+4#65K>TXB1P2THY"NA
M"4\HC7VUIF&I.<[$BE,4TC!,AN*0&,.>\;#1:*-B+QP8OMR!0O%A8H#' Y(_
MOB8+4&C)9AAR&N+.]CTRQ2TNA)*BH3#E+/G-#3\#X8[C@G$N$:(M4ZT+%'WB
M=2K?30EYL&/B [NF'B@A3UT'Y%;W<!>5/)XBB'SL8_@B1"$TKB]J:?*2C+(3
M*;9);7]8<AXM'&B=9$DH2ME"%N[@URCLH,J#AWE)$946P:E)17?,>IWCTJ2K
MXDG12JO:RB.J)B5'@:M]&_*C+6^I,>LE#QD>61S5GZZ5QKI0$E?"(YD8S3@8
MDH0K>*Y$7I*:! OE81)QF[IC@R ($RV-$#WK^@3-WD*E([;+9A\)8^?6,RS?
M-;)8[,%BDBY5QF+N*1BXK*<]966U/&TH6@^BXQE/418G@NN;W>)>S JU15M!
MLE!(\Z;;O"@33MUI0DX3DH\&&*8NI1%&ICJ9/%K5K/ \"E2]2Q?GBMG/>982
MB:!<F;#$>4EE,?_BGC2MJ4T3)C&*+66&J"&*PGJS&1XNC(7V&LE-?^A!Z81Q
M/-32EF.TYDQH'1&= KV2.2WZ/$#BRE5%V^;UYI48C"8MD%;,JD3VB40)OJR5
M94(+_G+B1#N9CI$%Y&?G%+,8N7E4)\<\J""."MC =D9[E?R@/\&YUF9Q-*9?
M(Z,F/AFG@1K3;IMDE"07F30W:DY1JT2H3M0:O4+IAS\JPQ[?)(G518C%B6",
MFD'3%KLP*JMR:GR@4_*&RD;.5+"\[>U1<.O9T,YGC4E-K#BU,\4I9O25V&L1
M!)?+OTT([7=TF>.>)B7*#7J,5?$0IQ;;9\G-=E*RC)7/<;LH6JU%L6?_ZYEF
M<I4)U::Z=A"^K:]]RT>G31HT?Z1P:7K/5EOT%+) 4/-E!R_;NO9V,F^C/:ST
M&FS'^#HSLLQAK>+@6KGU.13 F2S0\F;"L7:,YZWK?4_F>)E85M'WOBQNL8M?
M/+YJPCA$ VD9X]BUW3?FYZ2%O9GV7#M(+L4RGNL:LBLPZ+%HA?.@3Z66Z0@G
MEVJIC8M0IC*32*G.FQ&XH%L.X9/?)8M/?I&@/UKQC,_\8OJ);&>,8" '&;)$
MA<CU=-!;)NV@^5'::?.9#$Y%FTT*X=:*RKWCU:]GE_8Y]7FEQNI+*9#EYC)Q
M396DSXR3N;HG9Z5*VHUYQFVF*FT(-(NZQ8,6_]0IB6LDS\8H<YCL8)22'$*4
M 0,H56PN<6U\99)UVEH;4K..HVDT=X@4K:_<BG]+O31FSO/.JM(C@X<'EXXM
MFV5#0JZ?AA?KDBGQ*S!]]5]'#6[?#GAIPA35D].Z:BWG=[[8FW(Z$=LX2?D(
MRTA2H+F\-4M"Y6^N():O-5DK4HV"DJ6C7;1FXXBF2;=;RX?Z[PA['2:&AM)
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MJ7D.Z(I-I2X(= E,M8EZ<@B$IR,S61[X.6Z%JJO8P)7JE92E:I8MX8;"R5(
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MJS1.H3NAC&-)V4N[O![]@"/)%5/U)0/1Q: ];]WVN&19U^.$8>ZY/48*V.\
MHUZ*PU'9M0='=]BTI_O#:O0;V#SNYF_>(><LKS0#7_F$'_+<H SBALD&X8F=
MC*_FLL@-A!R9M;AW-2>;T5[6AD \-SU*X22JMPYI='7<Z*W @::9Z(5MV\+G
MTX-."G NFSKH;Z+^JQKFAOP)Q#:JWK)Z7D3SP#\Y)?<@T&T:@(E8R6,[HZ-;
MLR87W\.$.PL=O5%&CF!-C"@;ED.]O!JD>#!5T;0 ZJ\YX,VW(19VE4F^<$;F
MQ%0,[$3.OZ3IV8ELCNR*NY;M/9)B?+:-I8#4?KA'S&B2ZB0>A:VM5[U&;-;V
M"9FSBU>=I=N-]NRN"9F%):HHQZ&KRL.&EE$AC>V II[=7<;%B\35[E:IIL-N
M?4>3;8'8"<L35$<AS))7ZECU..1,N\XQKI(;F<)F_];O*:_ROY424ENI(!?M
M+%[JW=?J9U=P4ZK7-PV6[<C>%"F0M#ZN5(B*R=?+OO1^P)4WCK R$JJX[";4
MLHNR'+ZC2?^$BG;$?^$?*\^:KS.A*DN4<^PKA8C'0W>"0NA9;TE,'Z/.75K/
M"DJ(*3Q:3=S3NR!]\EA0/,/7SXI-[R+D6)WO(F^,'\<GC"GHJ@A%BX,76H^7
MRTBM&>ZTK@O12%<XK*2D3USVT.:\M5P.@@?!QMI0547=,5=ZWZFU$M;(!M^U
MSJJA:^YWDQ_?S7-LUL[F-"+-WN92!J'X=SGSD3KU/8MS=O%UL*6T,4R);,5D
MP%IB;J&SI[0Z_:V_W2XG2/^.>F\UP4];= ]O]I)P"[ Z%W%9K.XM^7;_]^3R
M/2!D6ZJ0^^FO_MN TE*;:9#C^N[*T](/==AF:C__ON;QLXN.@A4/"#TU-3*"
M@C6'AX.*B8N#)(8DB(Z3E96,E(R2C9:*B)*7@Y^',H^'H#V;EI.<BY"BH:RJ
MCINOL8:FN;"QGYFPF(2MN)FUHI&CKH[ F*>LE,:7J,J53-76U]C9VMO<W=[?
MX.'BX^3EYN?HZ>KK[.WKR<^-GIS#SJO'@J^)MKV\^+&E:O ;5"K?J7H(]?E*
M!6U:OU3#Z,%;UM"?18;"HC6,^ S9O7Z_^-F29D_9K'T(X\63EF\A,7L9-\[J
MA6O_GD.,*_WI(\EQ(TQC+#OV9!BJA[NC2),J7<JTJ=.G4-4IL@6,D,=;,X4^
M*DG1*E&(*COY_'GSET.J%:NJ!5HTK#QH$L4ZPVDI8,!0_&QJ;31S9ERY$@4%
M/)D+&-JYH"K=U5NSK5A-JVX])JD5L*. ?S'3+/OVK;VHH$.+'DVZM&G2$Z'Y
M5>CQGR_+R5(&6U5(H.RN<C=GK J8]=#7;0?6@RGM,.2UE>4:MTTP9DRJJNAB
M?>G:^6&RCN=*;MY6^NNNK4)I[D[]^\O6M3P;/<V^O?OW\./+GT^_OOWY\>[K
MWY_-[=F(?NWBV4^"I<4<;P,BUQHMNSW$8$.8H27/8I.@_V)+0<SIPDQY)8WU
MRG(&F2<93A*Q!M<TX=63ETL593</893) V)Y;UWW3US#(<<7>&+M1%$KF_ G
MY)!$%BGDB0\>&):!#N7&8F "^L31;_-0&--=,%$('"<?JA5@74S>ILN39CU6
M9DI@>4+>2%Q5MF-9+O)BD4J$,8;62#V=J:%J#2J'BTA+8A+=6+<8:>BAB"8*
M58=3B@BE>IUT^>" 5FWF6X:5?%F477K&%F&(=/Y&B8V%C15B>"-JEZHS&+;9
M9H'T\.1?8E0"A2-!9J6)B):HXCF-K*X\MVN9EY88&&'38,DE8Z(()Q BBD8K
M[;34?O,KI+ IF^%SMP('YYM;2CCIUH?$H(2I@K#I9<^@9(J+U8_M_J5FCITB
M*&*%"FHK#*UF+:>1+BL2:BY=H-X*JBQL@;2=L:9VU/])M1!'+/'$%%=L<53F
M7JRQ. =/U:2_QX TC+,;FCE)A"K%="_!2':K;F0AH^FNG,Z=B-M4S0@::V0?
MY=98H$T"N+.K'V%KM,"=)IS3R_[.5O/*2\+6,RX;5VWUU4CAO)V#YA+7LDDI
M1HGBN8GQ?%%02-.;<KCI+LQ=G@X^R6]LF8+KFL]PKNJFVP\ABRN\=-/]%]%0
M"MYVV\SN/4QM9(W\HC]81R[YY. @28M,?/]KT\UE:O<7R'7M>V*K\IYYX=Z-
MYQTI<':)67:8SXJ<Y%KJNNQ?2IJR_?,N(>W\,V2IJRPSHXF-I_58!05U7+!L
M-3H)Y=!'3WG2F]V^W>E>^S[_*%%XE>X8]_NL'76-?>)+YE?W4!8GYIJ0,B;Z
MA^O*7=#F4=1T@SD&F&#@+/_X9>V.HI6%6$0@^L$,:JLZA/06R, &.O"!$>L(
M!"GV&H5L#FJ4*ADR8K0GO0&N8TA+$I\X<Z 5E>Q2L'/?>9[F/%&5KH7/LM_Z
MF#&W5$5'?YU3V9P,TZ??G:]G#OO6N3*T(A3BK5(*G* 2ES@D ZYJ.;+BT:B<
M9[X?L@)#SCJ++TR$MDMHJ7O?XJ"D=B&IY2EL?U,;7_/H%S#:.=$3I+J(U!)8
M+Y/I,!:@JUO4 /(]#]DDBZ*B!A,'2<CYY ];E@B8[$@4NSG-\8B#&\Y50O81
M":D._X93%*$E4;@ACX4M30/\X!9C5BIGR.I.5;2,*#.Y%<^U*I4%(J#.<H@9
M;2$Q5V.S)'9D$\.M >T9A0RF,$_#$4XJ9HN0')8:?:FVXVA&D8'T'MQB=3QP
M88I1<M0CYZPGM65YJT85]&;8$,>[!96$3=U2)>I.1:APZ:B5O/&/D@:2'6BJ
M8ICXS*<^]]G M_#34+)TF!E?!A:BD5 CRRC.+AMF-P-)!WX'!*) ;X(]"_HQ
M-NH#8(]\UY ZB3!\)DDE=KXXKU\13G\GF07C +0UX\&C0GUD9,Z0M4IFX:18
MHOBG3G>*#K8Y<I6KTUO?O/>,P5 I*SXTD]985M1E%NY1>\.IGT-3:KMM-LYO
MBDA>2+D60BZ)@G$7 B'F]'A-1R%,=)^4*E,S%0V# 0M,ON.I7.=JK=2EABOL
M4INJCD76@I:,HZ6ZX+7BUA*;*LU2R=PC2)LQMEX:;&4U+%I.+)=6/*;H=.&#
M%"]W2-FOK3";4%+?+\OUM<35I$Y^H:MJ5VN-T6H0J  4'BQJDU6K)A1FP!JH
MGCC'0CF9<FBWK"TWU^*;U:RN:]NJGAEQY:K%VFJ2#LV;8.V5/?$AM[)0)<]L
MVBC++J[_A;7@#:]XQ]N._) W/N-DYZUP2C,EZ<5?<73<GHC*"<W MK&,+"!?
MHJJF&7'V:+FK67JE2](W7M$EJ&I?<J%[KP(?<[ F"RJO/.O2C)@0=<Q=Q'DW
MC$\R<;<K;8ROV"3I&$OJ%7 /OLS,[O&IF";M.E5$HQN5F5A4QKA'=50(>P-:
ML*;N]:<=K-6P>@S+AG$U29SR<0_L2Z?VQHE9'(YR(0\RW*_5,)JY^+!/3&3-
M 74Q.?^])B;S5+@^(EC,AY-G4?*:R.RZ$W8PE617;*F>/,IWG$]LUIN@4UHF
MNX2>L46@3:5,Z"4&C20H8R=M)J6DA>!0;'1<<&<$G<D!FR>._]W)[=A*VK<T
MPN^=")2ND1NCK?@J,K$:I;%F,RS;V;'2=34326\K'=VV%/K6N,YU,-TG"%V/
MQGS.Y5\.-6U.,_-MFA1=(W=-U&@]C>=ZO Z)BW&I0WD-4*IB,9ZFQ-0N')^U
MG!#-K&_C>43=Z 0Q:4%JJE@*ZKC!IAABBD02?4UOK'TEE&I<Z\'::CB2D=5K
M:=NVN?\JMQ8)U$*X,?-^@4&ZV!$\C89;17KP"VE..ZVHM5.%18-Z-'&'D!?<
M[>:HU"DS*;YS:+%$F"#KS?*-V35QX@H;-#\N-:W2%YLP7.]D1NVN5M2&S]+L
M+*=Y*.H6<=LK-P[W5WE<O35I3MK3.?^G."/;&-L9%([_\"B)9I%%;O:CY6"_
MV'3_UD[U.C)]CD:1*A)=1]:-4G>SY0[;T^6W9P\E*XY=I$]?WG-L^_2.254N
M+J_J5F _ YUYOYG !7_+;[ZO2=CY]HD&DF0-A_WRF,^\D1RB^:4D)RY:1NCC
MPZ++[Y0MX1K<:'0[:?K/#Q;/+[*.HN,%QMW.2D8C%&%?9UB0AG]TA+52M/!A
MH4LU\7W)1NZEJ[LLQ,AS!$O0ZKST%16_,C*TV\DOWXP9,>%$V'+I5';WJLV^
M'3^+?'W!B;/XBJXJRPY^TA.U8E46K_1?$MV.:RSRM(W/[&*'?L(N826#,'T$
M>"CLDW?69Q&31M0U;S)\$09 7/8?HU=[3\8A?I)A=L9*4:=@*@0I_V-X%"AG
M&0:"@1=F:"9@;V=P#3AY6,9SGL(\H*91$<$IPQ<C!7B#1,)L1W-5S:).$6@R
M(I9[N&%,3V=B$!=^+J-C>D4>( 0>"7A&#@%]S)1 =J<,6!)RJ?='@O)OJ-)H
MF_4*SU1?3F(=2==L,\8<FT!G)*<=_SC8AF[XANLP+W"8#BK&=\5V;'"!58,G
M64P%-\U%>@A2#.6'+G@C;H %1(S#5J+S9^H'26B#@N>Q:%;7/X&S@1WQ2@1$
M6#I8=M?7?-V$;_[Q?8TQAZ08'Y'G))B8:O!7?LP34I[A*TMR82<3=.4F)R[U
M9(+(@!.!/6-'-]!A6H3E3C2E(=MC7)Y&43=7B,/H<7#';V='"KMS<6LTA+M#
M,/PBAZ68C>PA1:VGBH](<UE50:+60]\H>9D3&57HC*QW+\$E3]$F.(((6NG&
MCM)8=8<W=(T(/$(C;2!E@F1F=/FW@JZ69BWXC]9E>ZR@C0I9&E\%/$T7CMKE
M9,G6BSU$'?_>!9!VU4@&66UCLA?LTHCH]Y#OUVF>(S(3ARFR%G'@DY'819!A
M1E *AVTR%FK3-2ALADB*Q":?L) \V9/2)PN]YI/>4'HJ!&261B]WPFY%MV\R
ME31/U8JWI8!_@COKXDT>=&@+13ARD60&>1B^)VG:A74C%G\,HU84UUGJ!'+>
MQUPK*4,.R".?!A=<B0I"69=+$6AG]F?%)$YZUE@8%CSKAX39YXO[&)-*4U I
M.%JNF):R)88NN(1QV5X!8T3VQT8]1EPG=VDR9UAMID7.EUQ \D*!50-V69I'
M\6R&66=E%G*X:'BSE#,&ATUIQ)IF!V+&)X(PB90>=W0Q65CS95;_?H5W!XE\
ME?)V\22#9:&'F+:#@MEL8.(V,!=^EL$:F^28I&F:V"D5NU=F@80,+?:'D&><
M'725&C>5U'-:J4$J/^A#MP54Z)=!:%ED%;E-S@)(6Z8BL'F5;5)\0,1\E=02
MTX$<I0=C8YA#\I@(V9F@"KI:9;*@K15HN"&*6\-M$-EJYW9<HO>.9O6)$@DW
M1%A)R9F5_\B4$=F)=<:2-<1EE)E427AXB^85_G8](LF=_7E)-"EZUP@7#KJC
MX;!9Q92'!3I'B<@]-YE_A$*42"=N*95F]K0TXS:A#7E0KJ=\B*14H3*<S9=?
M969N=I47("-&0 :*W*A@E8*D?HE(#Y5FD251"CS:IMVP/[GC;NUUHF?8;J]5
M0IY 6RJ)3$0V5-:3I_2"/D3*FP#:@C6ZE&/%,'X5)3F*9:O&DED:D)S5C/2S
ME[Q#H0AU/TSB$F[:J=D029?#8!4((?*T/>.IA6E3F<OSE+T1*9?U;^?H&7/G
M?HO*@IP849$ZCN5)*'IJAY/5G8*J;NXW&\;V6'/:=Q)H==__X:G,VJP+!!-M
M^EL@L8P'=A5B5HYWBD1CA&)6&5&+&H1X"$ZK:#\RPT%P-D0K-B_KR20S9SV;
MB*$.&8) ,S#DR:J(*9TS0J"SM&"HMJ8KYZR=RCP[D9?;.40>I5_]8BJDXE5.
MDHD[&!SDDT+YB*R^T'#$B:;O\YT.AY&5,AZ %&#>PHJ,RDL\8DS&A'+NR)AS
M<Z^W2J,VI2\ RZPP5:R,:3E<2%I4>FZ-((!IB:Y]F9H&5*L@>" \VWX'FK/!
M$T5P%H1CJEV)@6DW9G"L67O1!(KZ-R%F<1<+ZZ?,H88?99,1^SPQ&[!/TR%1
M:R]E66)!U[0S$YKGVHS4Y8]&BK)5_W6ID&>L\(>I?Z@C^E)QE*"UUQ5DI3>T
M0,M'4@,BY3BJVOI@M1J48_NXD"LQ-N&F<K2(;+F'0IM\WV8G"X6W[7JH2BF2
M'-MJ=RI*-Z64GS1QVR2=MM6A0#8_S92R+V,Z;K)X@'FS1_93*M6MNG6=D<NC
M4D1/7WE?&=5W+8JJYME^K[6RCG>,XN>. J1R@]-T1LE?4,F$;,9S<$DV0*F,
MKVM56H6'<T1=R':ZK>A;$7AOEO.[T;HX_&@R%#*PG5N)R"9R^3FB,=>RS7M^
M\#E;_N.,$A5LV?JWC!>94'K U7BP&6JJ-,$N!(JAOLJ13?D:7R2E1^F4;,&^
M/+IFQ^JV./\K;,7F0K6FJ!QDK_Y6(M"9JX[8@>M4PH6HL'?5=#;'KR2F('>F
MEF?)?@[3J\(U@O%JB*^VE2I80B!YIDXDMAJ<Q$I\))\1K69ZF:^RL>OVL[UG
MH!RI@;"G>L0!*LRK>C.)L\?Y7)WI5//E8 2\N$)&38\WB>,K4@.[<)D&'JG8
MMEL!B;T5>HK:53FUQ E*J=6H9ONW,,2&M[=72MID#(#;;1MYM6\V-1HW9(R6
MH6M\JXB%D1?;LKMZ?C\8:?HXPI9\.1>KM N(ELKZQSR;$.O!Q]C)>EY%G#D<
MQ-$)?)&,MH'BM9RKF9[%1]WJFOJ+D,G[+L1"2@C<45?"7!X[:P9:O+H8QJ+K
MQ'[36X:K>(0IS)BJG)VU2Q:R>,F>F*<&LFR41$3:-R932V/@3*G/>9F[FKJ9
M<(LDNRWD0H'#2F5QVYG)*QO]]W"U%DXE*G32JL/:QL\_-BXU_,G$_UG-!GW0
MQ%3'OKO!DN5+49K+"Y>]6"DWR7@CI03'^;NA*\%7S+)QG(G/KSJ.1IQ[!,P]
M#;M82WHRN4*M;0>%X$FG(WESQ3>,_4EU9WM/"%V:E.I@U4$9PM'%&RBLSSNI
ML(M_RX5&0;JOWH&Q!.DWKBK&3!UX!;:[*4M.GFA4M#=@I"LE0HU[S#A.-)BH
M 6P+.:W3MTG1Q!>64Q5JC3<I'ZDYCXAO@H75*IA7V6LT<8USHAMA_I:^BD,C
MPF:/VPS"G&RB20*N(F7,IT)3G'1E2/+&BEFQ0E'6=CD_?S>ZQO58B^S4@9=@
M6]NS[>PS-^1(;Y4=*"H@X.J^^/>,.@&-Y_^\BZG+PEPZ/)F#(8VQ=F-)M9L6
MLC_WG'B\1BM5&%QG>91=W,;M#IP7L.&IC,P94"S"7C*85Z@)DU5FVE"\GHY=
MEC,=R< Y>2EXA9@Z?$.!1:UKA8^)%U,\Q@?CS;*325C8=@*9<RYXW$+94/BU
MG/('UT+%LA$\,]!'W?O:M0_B9T0F2N::3H1L<>K"SK)<SY8XJ?,,Q?#L9$*[
MV&68&[ZWDH?CU[NIB*9-WSZY".2]J0']OZL-554J.Z%GIAS^>H=Q:NCJ7S-'
MHH$=TYWCKN^UU:]SOK(,.UX:Q#BVU<M';5>'P3LW>ZZC3"U6X-  XCU9I1*N
MMV594B;+U.GMW$S_[E\=V*[9A<]F"XO*ZX4 ^<6/JM&0BGVR21<^G;:8../D
M/(E/ZV:3!JIFM<E4X^1XGN?>,+F=&C/RNUQ#_=7H[9OD&S?7 72!3.=P'<:=
M [7%6=$M,J2Y"-!3_' 1OJ&B>4#(&2@?>'QJ)LS ?)ZY#9%@5A7&H^?:&*#3
M^CA$C3?W\VCFV'A:KCP$<M>I.H7'.K&N'8FM#FCF^'.=K5C?1-.92H)[G<S)
M61WTBS1ZJ-00[$N]O70O/.:IC.IS:'*/[;I JJY1*S9:I\)F^YDF;</6=;*7
M'6P%E$U1M5?79N4GMXGMW-R<SDP'VX<Y:LR>K,SME(@0IY6$2=S6#H<@0:GL
MTMXZ9KX\TWW9!?=!E/'/9<NETJ6'>*0;C4K'8ZC  1Q$@GZX(BP4#/S2BA&Z
M$?L;=)T0_7)!4_XOM&O1$NE\_P'_\GD.K9X:@_KIG]+\LCZ,J*7>(EJ.KEW>
MF[M-1_RIBX1[XC^+=H*)IETL#,J2ANIGX=>;.F!.X]UN)E#;$U7\,2A/X-!L
M##!/BE,(0WEQS#K?NA"*/':;<AEB2^]=E5?Z1VD.-2;$$TU?F-S*.[PBRC2O
MQ8,38F5[?R[YZ8!-<VZCP((=[QK[]=<NF<,3;9#]T;5L[*"[?D9+*;=+HVW<
ML_NM?.Z&4\CRQ-(.]/K,EQIXMO$#FOM;>"4Y>S-KC;VXQ8C*GY*A^ (O'A<E
MV$((U3^$WY('8VK^FM#V>Y4%EA.KR/*I%4,_^@CG%8F\D>E\N?U%KA-*+K$K
MS2^%5O^Y;(00G=LX9*&M';1(3/OB?] 5T:P*9Z[]O+9O]<M!#XQ@_.*_\\A"
M/JC+'A:#H69-4\01FB>9#4: T%,S*%A3:#A(<FA(0CB(Z$C8*%G8HQ@)>;B(
MN&@)B5D9J?DHZ#F:B4HJBNJ)>*EY6?.JVJHJRYA:R\G$V^O["QPL/$Q<;'R,
MG*R\S-SL_ P=+3U-71V]^HF-W1I:.9F::QOZR.E8.XM;BD[+6IX9*Z/].?XI
M,UJX[BT>[EX3;TYNW*ELI2AQBB505D)TG0;%2TC0W<!N#@^V Q?18#B(A^SY
M U=P(3U!C0I*PF1QDT!K+%NZ? DSILR9-&O65&BN)+F'MC#_1IRX#Z<V6!(G
MZ6MX2ATDGB9/-L28E)1.J>]H&06%L*?2IDB'LFM'#UXBB2@'IM28[9^C?_3F
M:3WIUNM8<B@]4@09RRU)K*#2R7N*R*;@P80+&SZ,.#$R1[,@TL7)U>FVOF5%
MQ?K6]NY(E)2CXEI5B^M4B ^G7HP+FB]<S_U^4C7%KV._D$$!9Z8;V6]/LAS1
M^FT[^^W3>XF.]N4F=*11HXJ;.W\./;KTZ=2K6[^./;OV[4PXQ\V-*B]%M2;-
MPCKT[7MJ]1]]LC\M'F3JR[0=\V.44+.M?VS? <WX'W[K>7-71M_I%)ERO7GE
MV2E9;1904 !-&)PE^C'8"'<:;LAA_(<>^M(95),5HM8\_*TB5BALY1,A> [2
MEMPCZ=U&$C[E"<73>KO!!M E5^U8SEZM=6-:09AQQJ-C845E'UEOR0/@D0]J
ME%N- 8T6(6.>Y15BA5J52. J'XY)9IEF%D;B/B9EU1]O,;Z"99#RQ5>;.)><
M^-E%8&:E)56N"-)F?@QF:>-DK9F(EI5.EO4-G?45I^9'!?I$D84]$H=*?U/Z
M-V*0F_XHWT8M[G-GEE@5*,B9JJ[*:JO, !>II41!B-YF6!:JEZB,L4<<C_==
M2.&OJPU(Z)^I%$EA*)M.V-1]H;K#8GCW8,F0@) =Z:6IDE468((ZH3/+LK$%
MN^"FJ?^ZBFZZZJ[+;KONO@NO820F2!><O/K9+"L(=KI5) C]")2@FHUV)+ F
MM?F7C+7..9RV1,H)W(W$+H4J7,8"R>S%H3;,VCA,*3PN:N%Y*BJHG'DDEWJC
MQ,MRRR[3Q W!QOKJFL1RNK9M/;H-"I^3CU**L7ZZW"PQQU^A%VFR '\&8\5Y
M;IS*/\C.=I65 I5D+Y-V4O:DTSD-J1NFHW II#LHN_CCRVJOS?8S.6WRU=>H
ML595-I#ZG&S.7:%:<,B;*5DDJ#3;)=?5 -':Y;;5%OT8A ".5>4\,PYKT5(9
M8X+PMMVRD]G4OC;+.-$[YVE2VZ:?COHO^KHHH9(45INKWES_V]P@Y:&_Z!"]
M[R'^VL[&X7TTSQ5)"G6,<F^"<MB5I5PQ4=:*7GM7^B+)[9.PYU*UA(M"DGKW
MWG\/?OCBCY]853V "3:E?$)FN2U\V@=HZV^NJ2RNA@:7-(JZWOB[H+D^E#FX
M36EL\8-$7A#6L,NU(UH3(Z"(Z*.*< 5+*#[RV,4*0AZNN>EFQ](/V0)#OA"*
M<$PA4UG<0 :M86$J8X(2#_KLQKJZ<<I_9D&?D<9FPI],HC\WY%J.1'0O^=2O
M/0YLVK<4!9X+AN@VCSO($'>U0!K5R7XT3)\!&5>($6IQB]N!6TBX9 CTP0Z+
M2P0B.-['0MR,BA E,HT2B=<I]8RQ_XF@NUOQQK$^-.*J(0C)$44>=$2_Q>AV
M:]3'[,)X0JM)IA(EFEGB"I6]E'7M(I[@HB4O*9WU&2=0I/(:_2PC-A0IY8J7
MTES&)F<\FQUO1VB4G.->.<4(,O%P!NS2$(VVQS)JC&[C>HI:2N6W#[:G*/G)
MX"U1F*3]" ]3F&RF,Y\)S6A*TR8C0I9Y8!@L'E(R3K!Q6NT.R:G[P5$VD$JF
M8S+X).6!TE3=7(MHV/DU_A%Q7Z<QV$Y\AT)\-K!N*Q2=H>"'/6].I94V^^$H
M:S#-A"J4&I)S5D>$)"L@K; T$PR-[0"Y3]O%LT[#ZZ$1,RK,.H:.E/X G,^6
M4T+DF&\W0+!LBQ_3Z9:E_<UX@E26RK#E"E+^;G=^H>=0%@K4H"Z#@[U28'M*
M%,!2BM(JV\18[HB(LZ;=RY!4O5S#UJ%)IC'K6QK#F^ND%QO/X12'"U()1Q_!
MR78^37=-3 WB..DFK)'FDX>,A5#OBE=AR(Z2A5O.@NR&S?OUZY%[_6)#<5FU
MJ21OJ4(AK"MW5=7=>*0T^%#C8-7YT#L&Q5%)\^9Q*B+5)R+P-VEY5F#!NJ3I
MJ;0O4__)JVM?"]O8RO9#@"&I!<]7R%$5\!: Q>-_/%>X7?9%C+3I(U&[ECU%
M H^/7:&3B(CS4HRU\E\1$N8 91F\>E*0B:JD79W02$_G#HNS;\2<=GLPV_1.
M\Y]QL^=><%M1D5EJ>XXK!WEOY-Q)(6>48>'K+3B2E13A9FEX,]<DGS5'J(GT
MD%>KHCVCE4N>3LR^,63L+M&9K\\A5+T<=F;L%!52B$%O>9A%)V>)PR*(@E&8
M*6NE&3L&LH6]T#;+M.,Q$XF2K/+UFRH-Y6']B0ES"8ZGM4"G$B/\V<1=[T(=
M;O(EMY;:>28LN (*DTC@26&8PIB]BFID K.\XSZ)N8X;BT__]*SE0(=6M[PW
M3I/94!@?"%;/5&[T7XZEFN3!$I)<G:W@A)P,Z$ +>M"#WJCAH$+0QXCXN/XM
MS_OBU-:_K4^#QIRR%^\I/^#]=ZM0HFN8;=E9*@$-H W5='W_J$L OYAS<03H
MO"S6%T++VGN(IEH"I>>M4'8N;R(+YSGVIQ5QF?#2^".U/.=VX!Z7TXWXO#4W
M(9<HH^K8+ 21*SCQR[ON3BV[D5.G O%\B%F+^W3^8AX8>0OG/&F3RC[6"X'!
M.F(G4;1HW#RQ*1W,CP17MMTS_2^?(,Q2LQ[ZI&';-K0WR+$Z>QMB!-9J%8.]
M2$)-NA+CKOC:A#75"5.6RIC]=K'0_XR]#WM'8)S^:]!$[7 H&\JGFC5MO[;L
MYIBF%MR]1)!?61T7,\?7?(UJ4E)\6N'H-L3B1"^ZT8_.-F3+D=[&:HR7NS3Q
MQMH-O"_GLAK;R[[<K$C2E>+GW?38THZNP[_5?F*H\CM61':R?3F'I<Y3GK6[
MF77.Y7EZKX7(VYGR".E\7Q?9G^==_/W7R'S\=('Q#!9M+,L\"<X5=Y^-.^5!
M^(6ZBETXZ2N_:5<W\&&*^RP7'I&X^PC4W9CQQR'$$X7'A2U];[VK:%GY1\$H
M\87B7=X8&#64]S#([Z7IW'T;D#:15^FG[RVQKMJ)OB&BTM]9-XRR&GD:SY#M
M)@PQ?%?_7$IPZBS4F&=B5EP/?E7QBI[ ;VS7KUYYX0[RE(7O#;&K/&:6KE2G
MC<YT_X);>QUA?/?Y7_JB;$\9PP=JC[,X)K-[^S-D9C=W;)1GG_\5?@\(@1$H
M@891:A?R'ZKF1)(!:8AS?@92&6*1<DH%*QH6,$N3'@86:>S6@'<S;U?'@?N4
M)A8%8\?6((^F91\7<4E&-E>1/.;$6>+2;1,HA-RA4;5E.1H&>]BV:FB54][F
M.NQE,7JV.\"U?N-G56?E$6]W($GV?S+B2#_6&RGR;*5V5LUC&=ER:VSF,%H%
M<O+3;V"'7D,HA]=A7F94<,Z"4QW54_PE4>3'9ZG6<F1F9[!D:N 2<X:E3ST"
M;$9C)X2(=@:B-1)V?IOC/$5!-3#DA_7P10 X*>N6"G,(BM2!>4P(5=\V.1XE
M.]\46*WF)Y!U%CQV*^]QB50T@"^F6+7_ID/_-&2G!7H#$U#<%BN=$2>3YG!
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M8J/:K&I"(R?1"(@[_%H_JDK8PC+"K"?:X)!4=-!A9C%)WLOFX@ ',/3,+W1
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M\HOJ*)?\)'#1MRR N'%O(H.ON$BTZ'W&UYAME1BQQ$A[V&Q&IW%Q<9>B&1$
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M0S.08NRJP"O_9SQ:M30KRZ>D,C-D#]_AP;9M0[.<7B3^T;2E\R&1^2W!@V7
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MV7ZS(P#]?K_(?0EWNQ)!Z]BHFN7Y*4O7EHVZ4SERI1O*7\+0$48!5Z_ K=6
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M_F$J./*_N:U\%E MC<OQYWGY00EV9H\'8O:>4%KT1J<O56DSN@_\4Z$GU6Q
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M0]4N8H\;5_." O(]%(W59LJ>GH=SUQ'U[F^J/1_#2JYQNS2/ADE!4KB)_U8
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M>=NEG; E#.'2GLC2[N+2\?W2@??2B<'RJ>WR4=CRK?=REVW!=^]R;_@$_L"
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MJQ[^]DON@M'O .OOJ>FJS>[\U&&GBK,[/7\^+&8[\5I"%%"O;4,LJ=P.$(,
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M2\"X'TDO]BT:_PAE^"%KKL20*"U/VR%'ROMB=?I[79#,:RTQ)HL5&^\>NG?
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M(Z@.8,%PF%H/;&H(7VB(O&^()FB,Y6N,US+W1"[$2*OS Y7YTQ6/T#9$:38
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M1>X'4&A,-SGM1*B,C,''I-UN:F%[H!PT%ZM4LH?.@@6DW9V+4W_;P^AO'VY
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M/M,;NWZSA%_.<F[^%XR[8L>ELG+M?H)M0()C9/L?,NZIRX6'[6TUPX(!ZD7
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ML=R7E3^_23B3<0O\WG;Z(\OE5AQ;DT805R2_]4]/0)<RQL>3L#-/XI&F5#'
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MS?Z (<YZUY/L/Z!HZZ_-[QC1W^&M]DH^.LA@JSZ^5#W,HM'[<58-IU(4SI/
MSF4L00%\JD7QPC#J)"7S;,S0W\L://=:IXHC-?5C_HPWW\Y)09D9+IS9MY/M
MBO&I49R;."5![UG%\3.G8:.98TF<2G) .,, :SDI68\RV@F-#QXOW; HWXU4
M?C!WJA0D'Z I2_PS10ZI0(&VX"GO1X9Y@1K,6092H#58\*(*1>2"1K8XYBHT
M2.(N!J]&:FE:$+ :<!/D2L2;GJX>4R6?V***^[,^NM;<,BDV];K=&+\17X_W
M![8Y]?Q[I5BG6$8SQ1EW]=1O:9/;(IW]JB87N=2(=C\*E(T0//8ID0IS)"!%
MCO=W&89=&,(U83:=+A >_4=.X?A!  @<'[7/@<3B;5KL.?@Z1NA.E++0*PFF
M7I4;MJ?NS<8%J$CU_KD9S37EX;6/$)F@^K;78E5"4FS-PY$\F[7RXS$?1='6
M>6Z*1R[%9EXE+8#[JI012!NHDJ0ZEZF[F]B#F]Q_6RIJCE1")2X&S E4R-P9
M]]09+'_<+W\]@/"L1%OQ&E#QMH08(1$ 2ZX8R:U ':I ;ZK .*C 1*Z,OR['
M 57B':@0%L0@,*,*[NC52J1KQ&,+!1GPAP9N(554S@%C<]W-1$OKP)#K7B^;
M_;2V#5W"34[MCV14$M1$'.S$EA9LQ9S?L7TZ$XN!P(S)!&L?7OX'BM+(P?]5
MR%U_1<$P:!\W0!HID9(01!H$I$/I!@7IDLX!Z>X8A@YA&&!H&&#H;J2[<^CN
MD :!V<5[GV?/[GGWO'_!]?-USO=\&+H(2Q,]PAR3$U$$BIW+:088,JM-A ]?
M!/_>Q6'E,GN^G6#$4\T.+JVJ*ZW^ O#=#K[*2*O=^FGD[MBX9V=99%R?Q/C#
M&8BE#<\RYFE]YA_+^XK\--W%&+^6RTGU2RTC*?#W^[ =0RP>0U(S<+Z%1L%3
M?L]1@?1:<8!-8[T&L#JPT5,6C0?IQ@@$]>GP]=?_OM60(I5-G$U!_R4. YD%
MIZ23[3>V#N1\,2_KD&_JLF[JD:=,QV@:&&AZ[0DEW>3A<WPNZOS<!%2;:RA#
MHY/P*2?09E*99SX]8%;Y%V/2S*<\,<=\9^F6(OI*L)L=X3/?F7"IL12,"2S!
M*697LP9ET2DP__QK2OX@I7W=],NFI6]$M!CYT,DD'M4BW8)J[R(CG%?U1T7Z
MWF#]6[*6S[<_I9GHT19*5IB^KI$E 3N_\A;0#_1+G?FY0Y*IXQKP7.I^U:H6
M#=[B(NQCKO#J\K&R)='87R)>]O7;LWH^0<VL"[](C0L'\\2V=1 ;G5)GA<M]
MK9(CPQTL0$Y/=!A6TGPAY*H 1;"#2O8OA;)@K0<.<5K5[<OB, ./TI^W$H2Z
M[! /K[2+FB'Y'N?!@!\A3>[P'L_!GL[&*A?L7O_!J*PG5<?A'VDBJG#?8I0D
M_T(E3G$*C:8=C+'2YA+1;. $MO!_$+EW Z_\B1]4Z0VA\)'$Z\^B8 NU9KQ1
MZ??$%!55L2(?^,)$V\=>Q<9Z6M=C]):Q,>CNHYMT%3?[QVYQ(#T]9V;#"[Z-
M)&5(4'JDC<=H77/- 6']0DT'1T^90HR4!RY@ 59KPV6571MGU/@!,R4:+WW>
M0T/?RWN20F.]#3O2Q*ME(=V4?+#'O;.%K#)AWYM1?/A73M/VPH!0U>G A(VC
MTJ]>9EK:IZQ]\? . Z^4/0%:E<:O(CDDA>!!<0<WB2ZK!04_-MTVX'XS.F:[
MEJ!_@,+XNWLGY.)L#V/Q.//0./GL"#W.Q =%?Q/C?I!A,^73/ ELM3X)KH:#
M:/;P(15'EHD_,%,$T65&LXZ)=%X&BH1WGVR@5QXVL<G7"1[AX3,6]Z&PM,5!
M[B=>;IMGP2RJ*@=38YUT+;%H'616XD1B)E_J=,!!DC:$7%[)V+;W\>KS+)3G
M;W'SZLEQ$A]<\\P.FRW2AIO"<]XSI0:TXZ*.]7X())//<)/G+YSR $<6AL:Z
M<5;?"FP8#NU@&X4L.K@QS_2<S&I*T-!S.@D054>_Z;!TZ):=ANUBEN%V34M>
MUF<T!R7'HL!66Y5=#*#-OH7RG/*&;_V,6UV_J'<5,RH>3L_5S+N_&42NW@5D
M^)&YW*,?ZLZV"X]S#BTNZNG$SXVOLBZM*RXMG_<L12[MINE@5/>'--7):<[U
MR\ZFD %L&RH6/<>&M"=O6%5KLV(%+B9Q"C0/[]6VNLJ_'8[%U&;RP::N/Z8D
M#9H6PL7'U FZ:3WL)%!V/)_GJXTDH _.A]*FK/(0BW!K;]#+E*VB6N*1_EQC
M@A;&%^71/F":!PG0?GW%E[C:7+8J/+]*DV:VKTM\,"E(=*IT)Q'<X[<F--S?
M!^:7N4EAKY2NX.CR^L"6YEVR"__N&EB5LOF% ?#\20@6/Y1-D TF V<>'_+)
M_Z41T=2\I6M)<^1#]P!YIF@: \86KB0U$=E&8NBEM.$D6)YFV)20RN)NF970
MHAL^)]?'K!D=4RQ/ZG&<X=OZPNI3*2/-, 5?2B[9Q0\:WSS<3<?=RQSF8&_>
MS07LQ;Y(0WI+FPCGW+3-1.!7_/XS7;>^Y[S=%YS+4I%A>#!@\Y4UEJ9SF[-N
M(VAP@:=[K_/3BKGS05J76Z; XM77/%UXU9VW]"K9?'GE0;9'-9P^K:1@<)C7
M_6G^WJP\0Z\"K&PBXD=PJO^<]0Z@6?U@E(>NR._TUVA#&+'68CP:(<7A:CSX
M);[[U$$8$%^Z/:"QXT1$G5O/==*GUY_$["(&I#D=DMI_N"L0Y&V;]A*)OJ2T
M/7J;,7-$ZS\5I@'8I?,RVHY!%2]*4UD7P1+-8'HZ=ZCH'LM =19B!<5@/\PO
M.1.,_H!T8]E[3&[9SU=_+ G9G4O;B7ZG3..A_\+KC1G QI4A%.QUUHN^._^)
MU6Z1>GF9.0F>\3O_@Q8DI5=WI*5#GTBT[*+YQ I2WROOJZY()26,FV9/2-!G
MN!PAA\.R?- 9<QG=AE <UEPZN:"BVS(48A?E.**VI7US<0%:/I9U/[(ZMN2B
MNBDZ@]^,7AV?^#2(9=LDJS"%^X[4S3X\V>2*.QBE5EN&MR5@\2X#7 Z?YW18
MG6"S!HW\"3I)6XD0E?7EOV)\F=D"Z033CU2<U&E'3T4(7)>:89%)UB&\'0]3
M;V1/GK\]'J&5^//6#=[L:V,"@:X#,-L=J(-?BD>-'%EFHB C2Y/3[/Y(1I\?
M'C]<OVT29T>>*2//E?<><UMVCBK8%0 #74+R,;<-D44#A8/D0H/"(L*C@N0#
M$X/CPF6BP9(R$%"P]".'FY.<F1J=%)L9'@++CRXM \G*2<B5%<O7-&=75@65
MR1;W2O+40F0E OHDH=%-@X,\\J-C@64)(1-!$K4]V<$9F>T=>TF]O-/=#:'@
ME7')ML61L>VZ8&C<4NBE'O,SV[FW#B%T^ 2S-N35KFA18UQT>)GB[ZX@3^]"
MX=H=P9CQK.4)7U2;+.(T^\0[>XW:8P(G?SZ;JR 4#)444LHRPYO&>2=Z,)5#
MXJ#=)8W]IQP;]81&(3>0!%G(\M81S!\5% 5#;%@SMIJ\2R$>=]]_KR3&(\<D
M1I  GWVKF4GFO7=NW*P$B?DF.06B82%'0;N(N&8PG1&KT2U1FP>29SMYFH\O
M)#OO(SIB0M0+=::E5&#VI,UO!J[;9'7&.,0DLDR,U!J*>\D:/<_>::0 /_9$
M##;6'B^W!6)1_7=MVU1_MCWZM[:]79)6J+!>'FYNO#I>Z0BG4FYINCG;F2@R
M&&EI_G-ULCZ0KMS:<O_G^FQ_>:2U%7E0H?E^Q0^%V&+%'YT>MA* S;.S$MC#
M?QY!$*@5CZ)3,N08_UY>C02+TR=L#8]%=8QP[6F,I!DI+9.B1!!2<!"E3LFV
M7S,0A7L-/MX?/MW+, %"\P\9E&FD_OX\ NW=]T V!#QH(H@R*C!3IMJ9EB[R
M"\'61ACC:8AJ8B;+')WM&'H<,8<<]%SQ4T,QGS:^J!,8!0*/K0_Z7O7K/)!
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M!0PSWRVP3[0J3"A<52<M<,^N $HO5*630Z+F2$$Y3/EFVO&KLM W9)F,!""
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M=\73@Y'+3RA7GHFLW&I8T\.[%*\JF+B&4996<%NZC,T6EPE$5N]LEE[ZK))
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M7GJ4QUYAZ?]EW[[ZB]^^5/;ZW4T5[77:SS[2E.K_Y(G@?P!02P,$%     @
M^(176'UYRJV5G0< Y[P) !0   !I8VQR+3(P,C,Q,C,Q7V<T+FIP9^RZ!5!;
MW?OOF[I!6]Q+BQ.D18++V^(6"B&X%"=H@>#VEA:'4"10@A4+$$@H7KR"%)<0
M)%AQ=RM0X/*^/_G?._.;N>>>N6?^,^?P3?;L-5G/?M;Z[+7V6L]:.^<CY].
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MRCTRD)[4?G7&K VM3I73 [_1CEP[=DCA';Q$T&C#U%ERSZ=^7XGOQ<V_DH#
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MH!*+P93^('(;D1KW\7=OJ.\_PDY"("/"2EHJ/NB"!NB 3E];$R_IT'1)?7K
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MM%>M[N*8C8LI'U"K4!+P3N::;'K>_WF6_6OU5#WZJ)KQ)&NP4_D@R- ,Y=/
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M/H6..[E8=L26G@[?T?B\!CN]9KA!/3PE/JL 52YCN]U=SQ]K0 %KR62F(Q_
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M4O>_YS)JG5XCQW]T0_^MO[MA?4JV)^EV_'5Y,-L/8!)"&_C34K?>H;JO;;*
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M(HL]:@?WJ(A;LF(8&-G 4]P@;#"';8W^1<Z;EN@O<I2#J>6*^=^I)1N!7_6
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M="^]V0[ Z^]?.%HP^_+%^OOD3!DYGU9:G(,H"TFQJI%ZB%$ZC+=P-E*<LY6
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MSDL58*0>Q]?]7&W\S:6JSBY)X&5@W'A7M*@8PRW@5IX-NV/)J"@>M*T=@2$
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M5UL\QEXHR@*,1M\&,(@8CT"GUQ3P,?(3G,L>?\ WQ<KW2@/W#_\.)("*+!K
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MZ 7DTW.. 2]%46A"%\$L0<7JQ@G3^VX; ,7C/07"D,&_ "<;-!P998"Z =!
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M+B/LLDG/[I[$[ZSW'H2N5!Y]5).ZQ$[YH%D73T_$ZM #[SY"ITGC18AF5,&
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MR*L;RU[,IABT2NRF51V."3FE]CGU&-U.3AYWN"+KDBR_:MEG64,?Y-YP2\-
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ML$/V0TW9E-\_ZB&_\$5>NF]O&TZ,+(RW*-)D)^,J-IDVI/@8\J6JUVC5V'$
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M&57T/XID/29N_$#-PZ9X P"N,$!]HL?I&NT].F4!^>96O9@Q! _+0S?1/\+
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MY<+DPQK%.4$&%@<15J71$ A\186L!V2/147W:6@>E\O1/K12ELP6Q<9$ <A
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M5V%&(ZE'./K-)'=>G"0='3RJ%R<F-<]+RPU)UFM6I<Q6E1P?V[><)$Q&U&S
M8(3,HV^&ASBL;*9F(_;)DX4>#,4S9N4; E@__$M%.L?F/STFIPGXTK5'JKO
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MK.9U)-^6&4V(F5&XBXU$C_4O9\K]1Y\VIW<;"#)O!*NS;3FP:V:IAD7X")#
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M/BXA#<HY7 /..Y$7;,A' 6IDBF*"_+#%;3;]5C#@M,Q7/)3#^R<])F?9W/\
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M_!=?T]]LE' R:*MV NV0P/#HHUGFMA T.7KEX_)GOK3/JYY#UO1\+"X@!U=
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MHU"R!OS=: )[7#.CX*TK1*9 (0! \) #.PQ+.E!23 / %3)3\A$F1PZ/YPJ
MI)(7X <."<4;>$IP/&CNQT\?/]WZ @ZDQH)5 O(2D.\6DL@'W@AO1>[=01HE
M10Y@B++ZD*FDO\N'@RJ@N:F12MF*T@]S2T!VHJ)O^P&TZON!*MU-@B?*2FT0
M97P^_K-27/:@ RFW(;]]37I<[U4QE>KE*SUM1_GM,#$J0JJXE%K& U*!-VO5
M155/IQA, ZE$1G(7>3[VK[KZMHZ$6C>>Y'-C/("Q1S0-1UFGLJ\NON[O'%^R
MK.BZ26G!T0NUA$ 8Y&=TBU)C!V=3M1(HXUQE[=FQ[F/X,[UT]*B5\B'A'RS*
M$9. >5O3P]WP)2W@THT9?&_9]ZG]N:.Z_)L3*[/]0YBK]5=>&Y7ITQH.MRWH
MD+H4M-AUD/I)V:MZ+V=;KKI]^D8:GE_VE7J?.ZM&\^"H+3-E6JV>P8J:\>[\
MY(4X_.I!J.1K]T/L+Y541@1E'=1J#R4VG7NYX)](I"TS+6?Z"#JQ+37]M/HS
MW.3D/BO1:HU(*CO0=$A-R&HHRD:EYI*@;YK95GTKD$ ;"!?_I,3%O3HJ;&#?
M2Q7RS1[:AW^C2$1^UK8V(;@_V&6]V1B/+RHV-D?367G)5.3%4B:6E@WK!.X\
M7HQ047^_1X%J05*+,"2=E]:\:CIF$Y8U$Y(2MCYZ%*%:] U6=N+29""N[LK>
M"<OFH2HUG7]3N.%+>2/4?%[BD1O^M U/:!%)]]H75Z8GVU+LFA;9^T\Z>4O[
M("PZ#NBHS\*4<TTGC 9G];D\%,DXKT8Q?W OFK L*&/FCR/QS%@CJOLBMK([
M.#/)=W3MVECN 8[[5&KP;BU?=[7*X$N&-KZYMM B9@/,VO:9&2-,2ZV"[EY@
MBF""8IC987MTA8;2D*W.Z$YF< [)4%ZL@U\([/%+#K'W\Q:!)A(\/="&P"_!
M$T9RO1$?6NN*^LVX2TQBF#)*KY[VY'GWV7T>/(D=L\0;8!I-;6.XX?HI?/E;
MN$:!A@A:ZFA:'-=H(N]!L<[HE./<ZH%W>*Y[L*EX^@+4M/OY1!59/1YSH9AS
M=D: 2V7B?+"N7S7'PY54ZD]Z%KT.5?,N6JH.>6;?70\T=Y_%XZ_Q!?AGL]V^
M:9 ;GJ 98V?_Q-F,O[<T=4#$&IY;V"+[,4:G+(#P86F^[%D?$\/N43,FDU%?
MY?P,#3?^/8Y-?2]4F<M9*!D@0*;,GU.2 A[N/VTHNQFSQ_\<S![?$(; E?QT
M<N"*MX\4[EL %;G+[Y(".;==@7H! #B_8X@)7@D#  (8..TW@Y-X(?G3:T
M@$*5(JB@D0P@YW3<-G(D(9CGI6B *S"$<+8"5 @<^#<BP<E B H PL $((7N
M,_^&0 R4JPE.4Q@T<'BK)A:8Y_#HX)A9U]I3E-[ Q)#D-* . N1T10 ^$ HU
MPCL9R2,5P&03>6EWI9*/U*T60>0$(62H28KVAB;EA?-S*I)O,1+KM;N'H>LE
MR[,?N*+XQPKT7F>VF?4M)NG-\GUB;A/_MS?E0=PR3/[[-N5!F/>=I=NH+@IH
MVYA]$C(02I.5MK#]KA!W2.=)))U"EIB40*Y"SDGCKS(*S(T/O%#  N,VS4=
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MA?C3B= %4N^M:<:@IZSGV+KN(#TW"!:6=RN"*[^ :MWU[F/K'EA%DM=@Z]:
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M+X;\GPR;P=LPGAM==A._*$E_,BK7UW(V::RQ\74Y_:+\Q2B/<S3U4\7X/ZD
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M(,9+<Q/1UKMF:3IQI+5F&WH+U>.B%#&U$)->QB;G]%%IQEIUOO,HR/]%W5L
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MZC0Q[&)MY"SQ78>*@8#_QI]NR^)7?JHUIV1=/0=.\<X!"FK=1X7N*5YE!>?
MGLB)6ZCSA[Y#):USX$E"W9\&QTX8'+%C+IN7;U2:*=A.RB283]?<_<\[^7.[
M\9SMF:OKG[Q6[@@;^V01>O37U;&>14B?[#D_ Q8%%*O1C]JBG[DUEKI\B?5_
M;)KT$3GNQDD2&8^]GMV0POC3([;9?WKVMD=VVHR(?N'9^@OT&%D/?8__\G7)
MRF!VDC]6WTZI4(9ZP;;5CQ23++HE7\SJ,YV SE06XYUZ#BB:3E@4"49]GW@#
MP#X>US]?-^/L_BAI":IK/]M[NSS@U O99#_!BS.X>LLP1\N]*\>P2$G5YF<:
MJ54<1*GR63YH;EG8E5KEZFZ8BQ$3MYN*RO#PJ*_.7JS]?F#M"U(SB7R%3S;=
MGDARNX[H!<"$B3<X%$G^N-DXAPF\8M=E>B)NFUFF/@)="$LJE0GM(:I,=\US
MTHJCSXN=I]"N#6:P.6BS_1Q.H")II3FE1/4C'MX:O&ZCLWNH,LEE3D;LF2GG
M */ZF.Y)+MIY,T@IW;7C:L9'&SGEA207)[DS@K8?/[+',>SE^M8^)/.2=#X,
MPZB*G$\21KB5"JG3G -!H,VLJ*I9?G6)..=WIDA?E;RC-H57-Z,@B30&H@3?
MHV(*'+U3JJ-DP+I[9U,+>M)'683$][0Y.I"QZSF9;\GH%C_'!)40RTQH]I-U
M60:EM]AE(=H\3C/C#^+&[FCG'L 2R9O-4R)K(M8@'NE:^::E-MWPRJE(RZL9
M]AY3/_H22V79/RR1>:9]MM5(@A[K!^4LK>_6T'IT5B_P?AUBAG=\E2WL8S3]
M66+%TEMJ2?12\JLCFWMSIWY_ ,/5:@S(U(N3$S4KR6R G#[^GUL1&!M]="S6
M)#PEOYV3+5^31EDLI[*^-_7@R^>I&&H8QJX(G><;C!_4*=V_T(N<W3JW'SR>
M=.-="]6?Y/22^"BT:>I5JGYW2PS DYK^<S'Y/VWRSNPU&6/L!;P_JB='GWW;
M*^^VMX7F6!S0]:DKW74I03AU;RNHWN3,F&=I2]Q[8AG#JZ!4TQ55/RI<^"KA
MG6Y6)?-<:-B BVP<J79>\T8A;*\G).<)ZPZ85(NFV)G%D<=X<LBI?.<X"5O>
M[;KY\4C&AKR.H?UT/8^DU/*I[]R]#O95I1.%AUKXS<6EF$QYKRWPL?@#U@WC
M)F2-9U3U38[I8"3XV9#;>1&"1BX@#1CI?IF8JU7BR(&;'39YJ;I-XFWS,,O%
M%AB=9]O&_3R.66WG?:FM]:#MKBXLA4(VAY+0#CIZS9$"3<%E")R$,)3<CDYN
MVXKY96A!_TCES2IE[2>Z*LQS83A#-]N)^1S%7<TK,V+E[U,E&SDW.0Q)11ZV
MY]YJ5*O*#H?NTX6V&FNI;K(LQ_@S,NDP,B?>"+!SM7GT*WM-'9J166#T8&@+
M099O1C"2#&JJ3:I8+%FJPC5P-RZ?T8X&?7V2/V"]G2$OMKIIQ5:8ZDAR][M5
M.IR]*Q-L/I$F';C)Q1BB/.MOD9J6D>ZI+],?0M-9A>Q8^V+;7F']0*/ASO.J
MU[2>Q+KW@Q.DDH+J?R%^+ISXBT-D]HM*/BX;?M'^D9\<T5/*S$;>XUU:FKGH
M&)R9KQ,#6A?SF$OH-.)4T35?63GNBE]FXY"$3^!WK2OR3X3LB&K/J4+3TZM6
MM#2*QQV;VTCMXOE4TJSTD+Z@TQ):KRYHT+L-S'CO3[Z=8D[-HE2ZS'U*Y1I5
MZBXV_7OC9ZT#QT:U2@O/(U3TF<D<W1-> 5C_V',3S6/_N""_0:]%^^_E\%G?
M.K-/) # D9)3.+?=P*[44W'*X:0T[K;3_KS;\?(40\OT?])J1 *1>"9>0=YR
M^ Z$#%_$Y;NV_N;O2C5MCP3Y.QR+U8W;ANY9G0^\F!HD$PDAW<QC2?J'^OP-
M6'F9D6:V^$\<HB)K D\\6!I*&&"BSCF>?07%P8I!F<7-G]4*L,:I_=U!>YN3
MP?I"B.!7]V%3(38AUL%B7DZ\^BH_RK3]\@[X2 44V<Q$!_?/ =L2'4JC['6[
MD4>\)#03'>4O\GAI<GLROI?N);]?4Q-DKUR/9KR.&HGKFQ^P:9_&*+.FP5AO
M'-]5[=7-*1/#@3@'#G@FU \9NL<HM,<S!>6V<*;2<N-Q<!JDA]4>/9=\"5];
M84H+0L*B2D".= _DO_??U\+"&%N QEC2N*+&+ZO4GC@ORA)T:1-D]J$"UMKW
MJ:&07S:$XY:3;45< 68E.H_2H'6@#0\LD&OMF0S"59/^6Z9CC@5U9N*-2-D?
MBSH_%C"+GWLU%JM55D#",!&(2-JVL1Y8^9 (O_6AO3!>8VD%90"MQIP9AG5+
MS9' QF<$\I9>F'E6V3+_N^ \;K-WTJ,;4Z&"5=D9B1_!Y,T.M3G)<MH?6 ?E
MM$U+1954HV-"* 9VVB=,T]HB"Y03TQ<S=-A-&[9^MEGD@],TYUQ+JS^Z>F0G
M?GBA".%W5;/ QNU3E8A2Z2X*6C^.E8W\7,-F %.CS"CE[Y.MF(^7M&(;E'2P
M+-!5[>)XK6X:8T&39?)SL,)8=7A4Z-O=2=;Q_9I.&E7F?HFF_B%+!VA!XN0A
MY@TBBI[Y'?6Q=643U:#F$9/! ^Z#V'$N%V77)V%$\GH+<0QFVV"RY-L3^)'2
M:AISTTV\2184K3T"L'1,\69-S9(^29X/W\:/)[B/TQ/'"M3-.W5MP*6ZDD2F
M.>+\,F-2R/4'RCVBL)*DGZV:>4T)J6W"G%K.J;5(RY'#S2U<#Q>/\8V\ )\-
M,4^4G:1W?(A*V(&D0)E:?D]\_!BK5V482Z=RL'-,>^@>/R<L+986G-1[^"5O
MIO,KE$UO.^,K&V%V$S%.%,V(B@J47[/.;$BY?S'=.I_*[XO1C1RRF[/@EG0H
M5D8I:,!73@^K!H%OEFS3]ET<T9H9L24BZLDTY@67?DZ-4->&^JGGZX+DA]O=
M+,3U<S!N]C5H8/5(^Q\=!)M$&'EYFA@]Q3%2#Q'2/6!<+])XC,M@'3WX>>55
MMA%W;  5'^EBN7MQ (C*R"]*5U[]U1^]TAK5*_V0"5T#ZL9RSG'OS1\7<^&E
M@J'BV1&CQQ8$>;!AL2<]FLFO>EUJWTD3R<LL$1;H<PU$$&).?MF7)?1C\H5M
M!-@(V6)JRB^JL6)9!3 CQ"1OFA\=@ONZ;ZW.9K5MA*B8%( +*E\]!F5B+]"D
ME8(Z6.P5P@>E8NGM)/)G=4Z6:^VQUWJ'8PXMZ9N>P:O>G=HLVIDU0ZW6A-B(
MHZ2>.CR&"!:R[R56UNG_C%6'@H[3JJ4%XJL%U91Y,[YP2_NS%1<7X_>WD?[2
M5+?,4YUTU35^\=#_K*54@!8T&#D?Q-R+]73X$_R&/JVK94VHG5NS#I>G_R8/
M(]/C[JNZDC3*'*^EAO@$.TJ*6+%R6&7ZZ\OHHWM3TES:$[[\_2FAW\.VY'\/
MVS3/_G'89O*O-0W--)*INRYGQK4I_UZ\\!'?^[YWC69-C8],D+/I9Y%$RIS8
MRM-8V/'T.<"PFQ12,.)15TNY$\ZG3[U"VP_<^OM4R17J;V FN><N8#!4VM#H
MH5?VIY5]K41GO3:A92/3O8&&[=FM6\T!M2-0GUW?CE=]&&.LO).A1W:/HVQ=
MY=8R4Q]HCE: J\SK>9KR+/)B+1;-I@8/M"/C>_.39&0J#))8HR.V].J=TL8&
M5-B]UL 6-)EQX6I/S@PZIW2"E_W??IJPL-(\!]P,"Z?>GP.[1!_CW34)/IK=
MWI),JL+63/F^7M&B2[>A01UGJ*D)RZVLV')Q>G3+N@I,4MR4OK3AT.LK)Z,!
MD5RG'!!0%\8M%3.[;A 6")T?BC*35*Q>+(-.[3)D-&OQM*MFN:9%D-YLSTG_
M5LQ+FY(]:ALX!5VT:DO0/:3CE+HOG-0B36YS';Y&L6<UC.@D_0PB<#66>2]S
M\ B(^T7VB'R?D9EYO[#W"3+/Z'4I--'7T!1J_91GF@6\:J/RJMP%IVU3K69R
M8[>F7E<L\8,Y3[[50VMOZNDJ^?@F'/G2*!.6&!;#*O.#3<LZ>-84UJ]C^3&,
M!C6DW?)N"UUN!_5!8D($L;I@X RS3I*>)CR^D51Y(."Q49863G],3%O=W(;\
MV6"^E%CA)*DI14&XHRS=7+91B4LLMZF.C3BMJOQPT,MH-</'F/XWOB_[2EM:
MSD?RWY^"QL.B(*JK.33!/6^A5D03MP-+++[_:J/:1)XJ&'32&SS MUR 70\A
MF8Y[O*[J 8<M+>JD^]IUE4=J?/5+B\(3=VWD%#+R)&7+1W('5FMWRNU.X5HP
M1SS@L&DQTGEOIC2]1AMD$ ,V 2>9'PYP%RE,PG8?#59Z>I?=Z9 /HAKM>Y[?
MLF+EHK?P7&:)7Y[+V':8=>^^6=*R+EG$VFS$HQ$[^Y@ZE[$GATP]XNZ5LO*.
M4/ MZK==@\:!741%'BO^X]7"O>-T^?E&R>82XE$<CM R36[AU7#5H4/# 8.:
M6:8E"PLU6;WYH: PS[&Z;W9)W=TD.:6)G8L23):-3D1C%JR\;8S9M-*,(Z3$
MFCO<DV;%!CNMGXPZ3%AA^!WRHD1=1!)=-RNK?NSW1QE\P9/LRJ@PY"/BL;1Q
MX1ZH##U.%^=*=WVUS->9';]$JIR \^OD.=E'>%M1XA>/<)^#_/"'A*4/*N6>
M=\41M\Q%Y)HENI81!($(5N@EE J#;_XL:-!0Q%'JVUVU$@P7%],]>Y#U8&X\
MG'7VEA8;$8EMN:DF@5*8(R?4:F?6#MN;V,U/22?VA>R/H8=7%_[S^HC6Y9'7
MG^_RBAKN/CNRTS\'EGP/MQ\L8V9MI96<&?'Z_FGTNH!KPEZZ.G7Y+NTF_5DA
MG?\G'B3]ZU!6U$ALL,>46<+A') XVN-;S(O[[P:T_Y^V*V7%HOM!?UD6GOZ?
MR\(E%GPQO".@%[>*_'>^)PQA9=)'2LOR9,W$<QUXQ^V,W ]_]Q#P,+L%7/W_
M#TFA6/J/)='OHO+PO1.JSX'W_5XVC"J_3/M]J & #R\N5LWD<=F84-9F^9FV
MG#__L6.U]]YFM-%6W9@0[*^TWT^$4NFK7/\B+D-_5\6H^N\.7>@8JB5??>W7
M@83V2E[EY2D+=7+D17PIM;5Y9*0C\OI[R9XSX2JM6(*0VIJQY:80;,C.O+Y8
MYXO"&DT_-<\DA*8/YX%H BN(_\RERR+/P90VO[$,IT]W5DFBLO!%%R1O#;F
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M".X-UL L&0DDM/2 ]Y0:0NT-TD:)1:IAA R286G?58B.<-D&%554+9,S4B%
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MG0-X\U_'*+@#+_V/$)DO^,@ON!_Z^OW]B[%<U?%8,N[W'_$4I95OU "WY &
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MTAT?\#']YGI/]@=01U&JB/C<;DBU%06:)J32>#/4<9995W@FJX% ]9K@8>#
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M]9^RW,7E?0">)_WSUXMY .2"%Z)_2>$ W#TWG$"G22WW4;!9U$L [EU'.0"
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MW<O%#YO5W4SSASQM2GZ47 M!V J_8XE385&]5#?_(ENP29&G!;3_7O#[UAG
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M=6$<W+FG6ZI'\*C5O8JK*-MEEU]DTC839LLDE*@FHM7ZR"@'#@0C,R<WE3U
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MB9-YHE3DZS2&,\ G$_0*"A.O<04!4Q5MVPT)5T2.*O3'Z"KJI>&C,I$P3)0
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M49<3X[5)KQS2#T)#?4[]K&M@J'T!\M1;#G[R^)7/1]TD S/3'9#[O!?[D)#
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M-:KH)B%<+ 3Z_6P+E]DG&-J_@#!'(!%)* &X?M)97!1?U:2Z6.!DLB/SXC1
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M),+R'Q !6E^+U2.^P-II1G^T\^LAN(\#&1>=.P6D^MMY#APB2"P,/^ZTRW@
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M:_$X&]B8T]U4),TIMF/)!JP&U**@3^<^!*=1#S>OM0H6^3^=W0:OGS;)Y?1
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M(* IO"8C1)"#*<JVK_V$<4NO _^T,\4MK:-C=.="B%C;NX=.@\?Z6]<$B@A
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M(TW/;%13-@EY]%4\9&@\'B;@ZU9RWHJZ8T_?:V*X/U;G3-=8T8*>X67"$W#
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MXRBJ!@)>PYY*)SF582]?'LNY/ #KTI77"G0A^92^^G C'T@^C149Q#@+>H(
MW"M>G/S^1N=?QI3VZ=ZX6C-I%&L<3I%P-CTD:#^MJ;4VJ+0?.[/9<ZTH20,M
MEZK^>2G9Y(UU $ /RU< ;RLM E!]Z5P/  #JN937SE&J6CO3\H&B7C=3BGUF
MI#Y;'%]9]PTNB,A@?]V&QQ?7;9?CK%:58;#3GB%&][Q5$Z6U)S_OA[H16#K\
M#D"3G;@&.+^<'G, NBHA5P,U=GX'_?*I(GQ+0M5UHN&X:Y23VQ,/BH.JD+<&
M<O4'_2OU  Z%T&NE!R  OZ>*NB/@8IS-_^3\_W\W'&\CDU@IM>GRCB#@]I\
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M]6:E2<WT]:,1E9@(%I1@KX!EL[I\"16 [;* /^/SOY5SA!1F24+\?_P'*P$
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M2;0WPRA[NK9SQ."SHKP0JT W3K!7,IBB*5/>]VE7U,C/M78*41Y^\<6E461
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MJ0+7'[0(%=7AF_5T/$ AUM[P-UT;ZLI7YM*4<XOM8>JKZ6,#T6;HL&9@5+-
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M^^KWB:QK9&>I%DSD_]Y[)=0#7/CU]!3N'WW5BQ\N4IC@H_"/ZT;*AH0O[QW
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M@>"G G'C?//=1+C1>=-/V9%ZHF+_<58YWLO5.,-]?CM+VM]#*MZ6)X0:.U<
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M\VW5%80F-X@DJ":GL]\6$9%D=IU;7M'?M,'Y5L/^4#/-=>7%$F:NO+JEH[8
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ME\8@L*<CZ(H[J7T@+&@,%"'28IE+.\'Z /6@>$S,X2E\:FVF,*R[$A<Q%[[
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M+_.MWRUDUO5 V1&?RTQM-UU6W$J$XYK3AB 0X.#WPF:/??C*^^DL&GJ=_!.
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M?(XN=)QRR 7[7/Y!_I4L]IRZ_C'^04?S"JXE?O!F!923I4^*T-J%>GP%R"E
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M-LTXWROAY@M]:3K2Y(CY5"DNR:7[I@ J/04"U6I+K++H']<.=:FTB'L *HI
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MKNY?@HL%#X1M&\@\S/ ;F-8I79*D'95>L1::;I>>L8&KIT21S@ 6[<;CHF>
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MYI),<O$[GX\Y7U:QKGFFVOKAY&Q?F.$48I1.*_/0+NWK*KUG@#78&4!;\PQ
MJ79+9#O*_\,BJ\?S-OJXFMYG-#'6G#/0/.=WF<0=!C !*$.+D_<J(G5"G^"
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M+=+5_4)49Y CMQNN;@S[N3EH;'48=3?;<?OQ?P\#JR7PB%+'\S0B6_>6T\.
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M^A)#R#'>8G%3P.O$K]]A=3H1O1)PC9U3EA.6B$[=A7)\FZYT96;";FN5I&:
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MQVLDL.?'6:<N@R;Z;IT#$:$XI0.#,$87=9KHG9P&F<R>$W%S1/#S6!]H;F"
M_2I9%*J0!3\7=_MF6K/?P^)NHT^\OK*3-V)TY_%'=1O4KV'OV=Y'T2=Y/"[-
MHA+9D?J73/JF-VP,75R+LA%^ZIT39)[2?T@Q9%_FN]_>ZAHJJF&6"MK<:S*Z
M]8>4O,TOGQ5<G$>GNOY0]8<4V?!SU]MG@&> 9X!G@&> 9X!G@&> 9X!G@&>
M9X!G@&> _VE D(SN_#N6];>U3$SV/?Z/\\=3)A2?W$U%YD;N F-6F!^*!).W
M-[K*3O)8C4#IB]6#EV<JVQ>M?1UXW;US?"\MEALLK+HY:SP#R:JKTCH]"$3D
MVRQ#OEIPP.-!GIIAU-6 BZH P/F_-2[W?SQO\D^C<]0_"E/_MZ"[GM6O>;A_
MG%]I>P=@_JLB/P(HF^WBX0K/]U]<^ZN[H?ZY=%[5U"YYC]%L:87EC<-M?2["
MX$@W[:!X5)?QHXG0C=+E^U5J >5&IKU!<<[*?!0NS7;8+HP3P=9. .6Z>32-
MP$YF20G0%J9O,M<]>-15T,M#73?46ETA#4-,O#5]N+;_1G:PA&A=/\9:9^*3
ME$CK/?QZH\/#/,GA&!*^O4)GVQZ<Y]%\"G@U9LTI.4?[VK6>.FQS6IS)OH5J
MP<:13V$?.3=2?-\?C<$8CDOI-:R=;-Q(B7^C*7-E3:*9XKTT"1ABNV]S-THV
MQ4"/&FE3:#]H1FM&*V?$Q\I=6"HO%?G$$;/?T41T%^TZ<*]SJ1(?LM$J[8@=
MJCJ7G>#=I"_<)$BA6S)7D23L&FU&ZALV@$A1*S6&GP*P@E,# @B7IG@NWC=0
M]_*0NG;F^#N+<_X9=Z<=S$;K0#I=8>$U]YNUH=_HF&D=0;2+'#9VW-0)3BU4
M!%<;8WJ',4KHMI&@-L9C<T+=(VS'I.9XJ3TKH2C\8)$;BO6F0$QP16$*"+9.
MU4.%(#:M@B6Y)\U;Q>4O@%EOR,8<ATWK#!:68M_[XZZ;(BC"0S&YQM5:A$[4
M\BG \FEX9X>V!$(<8ZI/HAZ*XJ/4*AE!H3"K87Y& _FA-KR:H_OTU'+J.)/T
M/&4/[#2]E[0;:J1_A+-<,&RHN(;5[G,25$;'G71:O+*5RMBQLD_E_B]9(8CT
M9 3Q>DP802F@RM%Q9Y<?S/5EI%0@;/K.&)TY;8H?O2G*TT.U4,$C?G3S%%#'
M@Q%+7O4J*&RP$%0-L^.[0"UF="_49>JZ3")M-M#S1G?PXKH_MK(S^S5RV8:3
M[A:MK=TN:Q_CPT+,E\.70T4[):KAJNU1R^V""1L" <<;A8Q(OXFKTRKLLBS]
M)*;+@;-?LPE*UU-<H?K)E@4^$^N^88D1O A]NK>W:"',/>H95YU?.W.47SER
M2=;Q*W4733AD8ST%/ _3?43@;2GW-AA8IR$.I^<'EWZ2M]V(:Z9=QU"VMWXZ
M!>!C;PHQ@+,AJAVD+#IN3=6\3=KEXX6:QD48W\-$J%:*E-JZ,<Y79*F0K,:5
M8]JT-^4YX%[E/_N7^:_I;]Q9R?$S '"-(\K0)QSZF+4OUD/1->JP!]0Z Z\I
M2LU7,VP^>-HL^J22A8).%YD)T<V/T1_E->;^)C6^22L7'16HOY&3D]"W_TKI
MCF0C:Y;%4IQ^1)G@B>1Z6S>O6X@Z[OKKM%C=#N6F>K=!IF/D+<*^<<(I@&S4
M1+'0W:T\V^MS^:9/6VYJC-KS.;=BYH ^7AWY]CTZH9,LP4XU42'3'"/]+#/B
M5'"#T;OZO5KC)L:'22R+UT\!/LU'TMU3[HVC^;"]H2^Q&V(F:]HU/BM?%0[A
M ;G;DB=_%GORY\Z2C&SV$AU$1[^4*W]TD!^-7)*X61_"=M7[Z2E@?"/@EF>Z
M4WPF[_$Z]<;--\$C-UTP(Q-6+\75!GUB"\8/Q<GVF XBI=?_ND634[#?+(HD
M+V><M:O =E_P:SO)Z#G<_T/IY;^ VO=,+MKCA-3M>C(UK;ZITE]=+_UTUT7J
M; !G S@;P-D S@9P-H"S 9P-X&P 9P/X3PT@Y@\ V=P? /)_ =#UI>[18+'_
M_9!>NXRJ5@TFQFT_%6=,+45WWBR3T>\67DW]>,!0-DDO33D5,@G1$'>N>]N^
M0UG+W)G7RZ(VOOC(?<MGC#0%\$CTT]L4,5:6\G;ZVO7J7KNE*G)MR_2<>JP%
M[FJZ#XXUD@]R"K@X8:'T,!,])DBN_"G\H#U>JRX.DQJ(<(X+J:X62,+KJW^.
M,1:\^PJ]Z4</UD8.N$=MEQ:"E\6D7H1 C,/<Y+FYH:H$>_G 5-8.;=698JN5
MTDY,PT!W^*T)>[AP_W(Q+ RDLKA%WD/0@[S*O^W0.=OEF:[D":8OGMF&G0*2
MP6VU!MX*'9FFL=,9XKX]\0HHT?/V3IT&LCHZU;N/6$M1M&,IJK9>L_+KMR41
M\5)K6]0>B=A7E%DKPF#[WCFJO(H'R@:!YCD).J> &T(9ANM^><8& E8FAM)/
M@E?<B,J&U=M] @'=P)%1RM4T*_NZ*R%>X^6"73'.JITT7PX2971O4LB"F*;C
MV(U_/M:N*E"OVJH>_^:?:I62(>UII+]O'I*_(]@5)U+)8Y^(4#4W&O>*YN8V
MTT=SN0D9\G%I3H6^7C5_M"YF/EZ3E+I>4&<J@9-LE<^P ['%&\E4R40&I,(:
M-*A1G))PCZK*W-PO'])RLK(C-:\PV:M8F2!K@PKZ9TEB*,KMS1QDE#HI#1B/
M9R8;]E@K&N.GV<M+/[=.73>DKF%Q+R@\J#/D"3Q9,C=/SG13M R/FJF=XE B
MN0]^RP3)IV.GR@]MSDNP3#G9N-4#3#?POQPQK5?O7*>V'"Y=?23)^RK@:[B!
M*BRO;E),*)S#_!004O)UB;;<JK[*!(:MZ%VU4OYT0>NK[ 41>7K[ 3ORHL")
MZK"IK9H5F[%+O,=IB\I'.GN8BZ.?%V+CQ)6]HP]F&Y:.*PK"Y8]<*BN>^.MZ
M:YX"*(]7G\Q]!!8O;"E4K+![Q-ZK,%P2AI;H/>:&521T;_IYGBQ>[S3($/6V
M<$RK%7C@F?(RJ-VVR3,D(NYA@<]+#YQFTZ28)M#%5P9>CKI&*V*+9HE(21&R
MDY0O0!N, (, 58;.LWM4H\PHY(*:YQXI"><GNXH2W_!3@+]U!\=P(MYF05I0
M)&R^T9,V+B[ZTI087)$Y6K(D)-R8OHLP,&Y8/5Q=_U*-6JE"O*+,([0&-_$D
MO <XD2PX4,GX-?%Z<TDZ)/3N<9YM]5!.QTY2")1>UNM#T; M#[7H^\7%>U:D
M:T;<:\P3T[S<1KD=5V>6;)+OF%2C=QE;"719J'G+<D/;/54.K8\+&." RP".
MW$#'BM$JO=>UCS&2NW>XX Z4C[(@JCI*JT>J%4@>^@I>Y3*^);FX:0B)X"@#
MNS;W*--K.M1A!,4NP/)I'<7R1Y9J2#^//)8FTS!-Y);H&!)T:66B+7#P?3A&
ME"7%YLFQH]F0E\H6E:^:>@^N"B_[$I9PO@FJL!R'@O[)=C_?\#R;<1OSDH*K
M<F![8Q_?J*R?+*;'C&_R M'H_+49^Z-'P^4FG2 >GSV&3JJ%79S<LJ](++QO
M[EUT32B^_04)+MPYPJW*]%/%N)OAPAH<OR0$];8>G)G859<^-Q728',*:%P_
M;K@[15/KD4XG*=CDNU]0J=.O92O$H  $>DK6:$7L)SNM<T("A+_0R;]Q])Q-
M93Q9S?,[TGBL'OUKQYL4:N0SA[]/A^Z-M?GN1Q,OQ-4J/6(+ZA._7O=K5_]M
MOMWT.P7439W<VY"9E%3_?7XV%.L@&N/VSS<MO_'27_Y6#_!KE\(?W WXL]8?
M\[EO:L"Z9_U;WS_47@XFWMC$$+?\ 8=1Q^II>W_6^7UZ9FO?.]D+W7_3^(=2
MS]_'<+/J[IGV,^UGVL^TGVD_TWZF_4S[F?8S[?\A[=YWW>?^4&F>CW#_!.[&
MYZ+0Z8=SJ9\(C\9_7]M>HMKX/(=#8'$!6@%ZF'>._OR>#_#&"=1-3-Y#O+#.
M6=;A;F-5@[NI03(!6//-Q^FG@-?.01$.?$1%2C!5-[(@/;KEV$+K&V<+U(]R
M$2M:E8Z99HG@2$GGA#OIG@*@6]AZZCQM+;=:=\$@UG6N;<M3 .!.\CW N;\Y
MF><G,RY%^4"G'<CX%RQ0G7&+'!4[9IE3D.TVVV6SHG9PI*[\9C$3@G.T'':L
M3E@]5OFF9)0DH-0"7'*:=KF%;Z+5;:7[UF[P#%OF]BZG";_OYRZ*EO>\U/^2
MNYT4RYUOGK@UT)8BPMN3G''N@R_]9]Y74WDI4OM974)XM5. (.$48-GM,_EY
M^(I1OCI+3U<@'=?F4@> 1.W#OTAX_D^C"R\  +(C\&O[2E2DF?^'D"P]O!0R
M"MN\V/#TYY^@M_K\5!40EQM5915XJ(>M#S:D=1'US+'/5QDF\U@X<#8?'):-
M#S_W09GW/>L:3 -=N.:&P&I7QYOA_,(M>=&YP+I6:4^']!)]M"]1F:O$W0::
M.P0<GTI/9+\V0S',JA%6G4[SJLS]35&6(4:[0X^E,!J-1L;;L&$M-M2HRTQK
M? 5UEBQ0V>:)VJUEOK[,MCET8&H<#>9G.<NQAM=0.\"YB]5DP[YT)MG-Y%-*
M/OY9<_X%&;;')S<@:M[UYQYPU$S?ASU5='NDK<)M7:PSQ@EU0U\$XPYMVX4B
M80-#5:X3X$Z_M:G.L&S.AG(5\,\Q%=5WELP<G\U^J4II!OF1[,J27:VI:^O(
MMZ,M1MQN5,J/**@^ALC>!<E*6(4=D<K[:Y1PPP[$+"@$84N>R,6T+R5WHL'Y
MTH.O[LT,D;W61I*16+UX-,<-%RG8#JV>6N*XY]\ELP>*''M$@;C3R(4*\8D%
MSVT7[Y!6@E<-OCT,ZFHS5X-)YU"M]6XJ><(9@CHD@K*S<Q(&IMJ(U PDDTC4
M#+(<YU;2R0;N&@Z/]IN5%;)\HM#5J<07K_5S$2'4:2!BDN%3L=:H XD:*=BM
MQFK9:ZW%KS9XTC#H23LV398G$'"!ZL<W_N*?^+3]!=V^&2O#!Y9F%FBFCVK_
MY'JW09Z^/WOLMKQ%A-WNG4A.#QV07.I>0(W5*,R'L8):U=R V1[.8OXVTFPO
MJ>]K[M2:A38\-Z_+9\ZU3WJBM*&B78?E\*X <4OR9MV@*/TT*>=DPJ-+XEJ8
M5::<J-6\M("DB:6 BP$:A#M4IP"JAPUQ-65V]1J72<57@FNW][;VPCF:?94_
MM]X4SF.9L?IXZ;+>WYXT..2Q#JV-'PTH*<J09WA]-]GWY,GP/)4U6Z?1GPI5
M4KBI)GGF6U# W@/FJPCGON8A+;CT-YW)EA)?[[#'1[7.7Q/1K0XUC[4,KS,L
M]ID55I5*;QR[\I[S??E3O6KV8RK&!6'97R^]HVEY:O#]RNT_79$>NQ(G?3_)
MG*4F/;7W_MHK-] !LT1/L#G_F=B9V)G8F=@_5\SD5S&N[V+G_NV._[[)[;]0
MU7^E\?_/W.HSL3.Q,['_W\1^S%&R"T5[3YDO.;]+^(GIHDK9\L?X48$R:BJM
M["YUNI@2N(4A+3_@IUE5)AS(QD*-'#,F59:!'N+%M"6> J[KZR1H3[/(D58;
M9$YGH E6Q3Z^K)7OMF2SO=FK#Q]+NF>2)U"? @;H3F*/O_5@<ER##S$#$6_^
M@X4U+GK9#?Y16$/GM\(:PEE?VZ::?9W%5,YW.\&RZ-%[E\7$-!@K\6LHG-NF
MU*.<U >A6*T&E?$#7<"Y>W\7;^3?2=>ND[E\^*N'1SY<_/DOV0_//;L&T/J-
M]RSW'V?AOTD@SSQ'?/M&[KE'2@MS8Q11"GYA1HS&"_"<L01IBYX&B*H-CF96
MP_U'WMW,ZPF4'AORWXPGHM>LNSE""\N?;.7?HV^K/\D]!7 >;J&DV)-N'ST5
M90:X)K?^!ZH'4<X6_KEZD)'^[DTK7ISX>/PGIE#*C:95@4[WP[O"11+R<<N[
MDH[/7;%OW!0^ CZ._H/OU_]&YV0 \RI6$8Z#A13Y\3<Z!;64A>9?WKF+6L0N
M=IT";**@VB%\L13\1!"^F45>>U?ZV7%.4RH-;6%&U7,2:S@_2T1ZA)^W%5:2
MI/@4<)3=76+3 3>FJQO.RHGN[FO'.$X5&.=M(V),*^VDVT+#,O?SLTW+9#,Y
MHPN+!@M![2#U9]51RL)P6;9D\'+B>>5!1/UUDR7]$7W9BKC\8J=IPI<EB8D2
MKZ+\BG.FU[J\]=AMS/,B5'M;=A6&@!@,AKIBC?90E:"\P[5EN.R0J R4-=!3
MEZ]FAC6/" =8(E'C64=R''S)LC,.LZ)N1A5"VF^=N?W9&S'@"E4X7EY[P=7<
MNY9!3FPWN+U+G[6Q$C%+(4PGL6B=KS60/T8Q4J*+V7&GKZ50U;$,%$0'.VKC
MF$?O9];H-,K3?=EX;^6C-Z.!6K>4R;5,U#!-86] N,C+GT]<*CH1[N/1\2(S
MRX@^*!/0LI5'[Y$>^[D\R>:2?9N#[;0HEC>FI)3,KL7WUK0:KE%K)YNS=R[;
M(;;4AI+<A%\(*I>QN>JK]AUN&V[@B?BA&M2N]RD@=V-!FGIT+.1!"0&, \GK
MT6&$N@E#(ODZZ_[L/"]M*FL& T-L%=6$JH3[A01J3'A<7%/-8HV(QE#&"A R
MOH,9\;@6/$5/_<2MTKY"5HYH#'J91(T.,.\5U2\Q7J7FT-NXV _K)RB*+=)4
MP"&A[M'=V7M:XP_ ::-BP7%TW*N\[#V;T("TM2H?7G6F3AW4!"^'QF1V0A@G
MCN!-]YE^-=A9]5#!,R/IO8N>37[;7OF=(=9.O?PM1^VC5(*7,^O%)MUK\:E:
MU-!,>Q]88584SM5U:RPN)N*N!Q+=_*T9PL!ZQ2C4V5%VT,<1-.U!Z[&"@@7
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M[\O//0D]03MR#,Q^JP6%;/"LOVP*Z;>N&&CG%H\8W='"'_I9;GC%&!63P7'
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M/A:@9,"0.E/4Q$_L\A$?,A+Y!8UP3546;6M/SL4V48D>7E2;JWI:+/69]WU
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M 4W:"^'>E=7X=Y:C3?M)@?9(ER!%MO<)XNO1X^FO)V*/AV[?K+7R#I#W]Z\
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MF8][5[+U3!-^,IR9Y9N"\F*0LM<*##V#:^9<2Z3 *OF<XQM@<WEYZT3P&G]
MLK[;X?4)B&NV*D)WT7L.!SF,J8JM_X*/K,^5V[7K_25MJ'/-^*R"#)HWN'^]
M&;JR-VL.;DA_# JJN&25+[@%M#_MBK/<\*P3C-<E]HE!,P?7 I JO]<HFG/^
M/>Y[\$X,QVU\#@@.]M;+7JAU:HA2C0L\TP8AY;EZM$.FN]ZY@,FW;+P,D(\:
MI>*%]&^\IN]LN1=O/&!I@XI\SA&[[Y2QGT(T[>(C)$X1NL.%\VJAN$O58FP#
M%%+3N-^194!SJZ_4/&LMO8??\J=[JMK#_48I/=5-Z2]W<28Y]P!%@'0KOD6F
M@4[@$%&_W\]B9:FYKJS4'\)1/DD>ZF&N/D7V"/T0$D%9MR/3Q,3PA['W&-&)
M,(1AC>ZT8$]UQER%M5O!,*R7W^) V!$S3.,:%6]D$YL;)E4YU9A,#JFNIO'&
M3RWS)(&-HZR^RZ76')?XF*=)&Z0WCWP/,";FH0;9) @-!F;>=?HI/3QN$J;8
M5\C:A9*&^F\PM1P5[4PQ@==JN@!NP0UXX'QD=6O&]@"X'%9K/GD@@_;@_KVN
MO]8ZKO&0V *38DW #2,QR01W('-!%*&LNZG2Q70 ;RY'ACFGTC#O"Y2G_,3Y
M;%T%9_\'2=!ONOAPN?7L1U<@J&NXLDL,/)]XF/<7A2H>G7951T^^B-_9-L2^
MZR;L&&Y\25A%GD,Z( ;>VWZQ@RCKW?K:T,'PM5M7/:HHDU*#+\PZA5?"#@)4
MER^B+X;F8 6T]$OD?;1Y^#859V+PDX',%U2^VJT4ND%\>/8HE+/)VMMZ+VX1
M3.;4_UAH_7L%F-U.O8BY+X]EB"!([HPAI#F#HUK#O3L"/?82@O@L=S*27+8$
M&Z,&SF>YA]K+2=(10Q5^H,W'"EXT0?<*.L?T$SM9Y1?HLJ%X:-3%+0 8>Y[)
M*+P5 <Q-"^7[R7"HN'G++\]=18KC-;3KTP<8,]>ARVCHSL-N!>40XX/&ULCO
M;UWY2,DV7O[>UKDFW'PS?T."M>5@0L^KS/+K!22 5]4^&"%]BCIFPJU@Z"*W
M#*..1A=9+$3JPG;GP6#$A8>Q$^[U1CD*S9/!G\\OF%S++@0ZXG$_EZ&)%'8P
MFS<^6:%XN%/W][Z.P*N_&X=_<I6BR4MB&V?EW'C WNX.9^AJJZ@9WW2\45RS
MML]QI=AS?(CC(F.X\D6TBLXE!=S'A'QVWG]E]I@KUY>0:+4M]G%H]"&AC#(T
M0'76#[G/-VH9&$I/[!></TBMN#Y:7FU8?9(QLADD&U8^IMU^(NAG%';<>*<^
M8W>!/Y75$ 0&^MLULV*5.<24C::/3H2I@FT'XZ_C&L6SXN6U9#/F43&3U/7=
MN8.8=YJ@2JKO2,9=L<.-0(/E&3:W$R\9U7[:5N/I0.1V\[R!Q/@;_70N)CW^
MI+R^Q%XJEKYM#S](-M"^&PTH-2LOTQO)-N3E2G1.<W1RNS<6(^4OUW +HIZQ
M4]LCSBG<ZV14[GY75SIQ^8[E$1^@W-R8WUW:)7F2G?^ 5 X"'QFS=O]D2'@D
M43ERQ(4*75ETP,F3"F>,JD+D(_;L[;F_6;3>ZI*'W>[]X)>/$%,"!EJ'!":%
M$Q*8$:9):YB); > _._S*OX1MSTCT6,=/Q*9 OHC-I&I0>13"T7,ZC)".(RM
M3H GPE ()58P1^^4F'S*4/OIO^G ]'?Z_VU)TZ10KY^Q^A\N_4AQS67>N-^F
M>\X^<?_M7_B0_[<A4>3'8,YE4GB\688^?9P<_!^#FC-T%KD,=JZO?/RE+^A^
M,/FME.0_@UR^?OS?S%?YYUAYMTLU4??E\;^8/M[^K[DM*H;_TT"74+LK21*0
M3N;*KYL?+X:]U0=V-?_M4TN./BD[+3"T^YH^L.3[3O]^\(=ON2\8!/_UW[12
MC%+7VAIN3"T2])UPD)9+19NIKLA_R-Z70LC:ZHELRSXZN/7\'21\#O^O EO+
M)9(:$]]PF_TL(JLT$0]& SI;D9)HCL*]H7Y"SJX T"^\#F(GOHBK 9*R:5]C
M,K\9*X](3[!*:ES3C_X2"[T8(,9:PO57^F9YC&VBQ4?AWKQQP%5[WRV5DTQI
MLD6984(:E@:N]IZ4]CT"?W5[66+>^&NBFS.BXJ$&%;R]T\6>I]AI<8B[VU'I
MO^,5%@4J.S!*KVS(EWU9V^/:: 9I+CUY$-E(S%DO)COZ MQORBN_\I^K=):7
M#H"/S'71$S,CATJK#23!+&R]_8+K%E6TB CKXR/2BU&Q1O ?:,T7K::?46B\
M3VS':+L\(.E0 <T]A%O%"*";S Q,,,W4]D:"$0WR85*&E6Q9W6R <29U(T(F
M ASAD0!,\:\/^LXSGO7()]6<.3)SP)K.,RR(9BKW6H.QP ;- ,GLB5<!))L<
M[#U#[P\0%FI>?@1)C$V,)E7G3/7A+V;#ALS=S&PVBK47T]?WA)-YRCI&$V!7
M]M--(7_M9-NR(<QEU!I^&U-L']FNWQ5[LEKFT._9UXT?;E_PZ)_IE]4'L'[M
MJ*Y8&4T+&J&^)_FPV",>/@<G22,#17,4U-7>240 52"](8L^Y?[,*'MH?Q/O
MKH <-*64^0.$B8K.]R0!1O6RI<B]%?.:1I+@/;32I,@D .3@?_;DOH<Q]UU^
M*V&$FY@499^]Q[$8"L=PLB1+$Z=U"(3=1<06AS6LL$LJ5<;$<K6HV"F+$Y8>
M<A+(C=@2(VX>U.^0S4<EK-2&Q0M'P/T0R^ZFTIVTO'6JB4]J6I'[F6U]Q3,U
M3LF_+9I?9>+ J2IX>%48+2*'0*AV"]^):0]ZUV1']S( UHX6@,TEPP]\'43X
M],:E.5DUE4>YLN#D*DK6O78*4DBK*8";F6E5;#RRU=@#5NQ?Q1N^1*.[NZOU
MS5%L^YW>0,4?3P7DETYX!LGAD=!X'!Z[WL__ZY<6TS<I<<?D-$PBWD1+[X<:
MXZAB9T^<YZ/!1FHJCJ=+BFQ<V2,(VL,L?_B=L0-I81["\;5:Z\:>WRS=-RA'
MBS_N+UT+@'YF8=J['/4Z+$YQBYN(;GACY=E'S::D6:Y/Y#;E.#=T<G14L/1S
MZ?$M%2:&PX5FO4\63273'&.*>*YRR?0A)_!1< =Q'<&<Z+86LG[@_=;]PPYJ
MD(;#6)]G(SJT'^(#)[J4NY?&81>8PZEI7"Q91:S.??!Q,FF>HW>5+[IU->4G
M@QC^0[:Z8LT1'\V[:03N#J=?E,N_*9,WYR B\E&B"TG:\$L>14KX78/_8[-)
M HS;M5=D@VDWU6FZ;,4CRZ!PL=&"CN^KW/0O<2;0O))Z(I2IT56:@!C04#17
M]E4XO",X 6QMF(JM&T]YF64/?H<MU!VO&-*M[64+@1WIT13T5R,'RI;[3C>*
M'85A6VN1!3J+R6[OO%U,\!*[T&RE*/C<H^W+M"V?*0I#36>8\*J&_95!<F,-
M)9+'>CY,2EO0N$P=4,%554[%.(=M@ *5-N5/-Y.Y!V:,_C5!\/)WXT8.<_A+
M>43$T>SA7Z%2R$#H,4[4:20[VZL[A*+ZFP#6Q-3<72.:.54(]=#,![K?=*\5
M.4H#Z"UC*#PY>TAUF6K/ARW).$_S+M(N'<O*G5X3U\2)WN7DX6-_WQO&5YSH
M4+Y8NUYK#? B#9E#](@O]F=5)!>>/_MK!VG+EF,QP;;R.25B,$#UH6J<UA_Y
MV7ZMPYC;/&GO+_4[-$"I+'*G3MG#@A)8OXZ;>@P;D7T2925KY^@!LXF#.?*U
MOTZ2^_XW9<\V!!2;#N P/0S@DOF65@S\9\];_VO/MZ$TMRE&IB>/JTXSUM1L
MVK$-.5T$%'NP\ Y)0E+9R#2.DG50AG07[?">7?&PAA06.W!?U2H;S>Y+@<,4
M9NP@X U;2=!ZH.[A]7]@O BO'S%"C!VD>RJ$>VFM/\P6"(>S%+X"%5P#2G(6
M[APLFX!3*/<,?6+)HN1VZTI:BJEP1RG54SD=<,C<?X\'4DAJ8V.*M]H0-YH8
M;%1-6:,O[/_'ZX&^X.O!7.KTZM8!Y ;3:M?,'-WY4=&LA^)I&,)L,[&_%,,W
M#%$=Q\]WA0E;\<VSMN,TB?GZ6D74*._*T5'*AD@VO^55PUZAZ&( M@):(#I'
MUT[)SR5WC3)V]KS#RYK(T,C_QB#M2S@\&9*T\DG+_\E@XO->.400X[\.COSA
MY5<QO\$Q^5KL;HOIV\DA2HJJIV7'(V_=?86#7(-'RA_LHSZ'(_B=EC6P&U'-
MUG&V^V6_B0:R,3$*))L)DVW,Z9&_.L/OS6>VBCKW.A([?![[3O;.TM;3PO58
MYW2#0&5= I.]$38P7X#/0D.*T(>R#UJ$/'#^9+P^XK_^X3&K&0Y92 ?@X4E:
M"5@,&3*8JD#@&JI8=>,$1A8A\BR;]?*!1R(PD] E[%<G:0YX\#NWO.@.<$O=
ML/,\<8AR2XU+IM,=*=@C7/AU5+YQ'@P,<FZK,)D[WJ+X>&%3P[*6W.GNSIVR
M7QI2?OGXM3OMUT2ERG2ST.EAHKD^<'_%T*=#/H79P*,$=L^DYSG!CU5X;/Z?
M[Q+:5S:O'J&E\3QS3W.A"Y=KCJH_5G/RS2O1!SB;V_87*(E::0UH4&MB@'U'
MWAB2X%# U49MG??KTL^,RH.77,=)3>S$K>3ZD 1:?$&!+PV!@'IZ9*5X*I<V
M+JJNWN%DBNS/8Q03PK)&8&)PUX -ZM'M[:%Z@7^V[E%'ARI7963% D]/X WL
M\6 5WI3.USY[7_!8J+"5*=%-I8@J<:8NISE'L5-^AM2Y=Z\A]YG&>T_EC^?%
M,0&LAM0B1S'Y):]86+WIXE4->K:*[*R 7V (M[":*)3 @C..*>U1=,,[?;/S
MF>"*E^A.@?RFGZ]'>&MRF!@JN1@1FFFZ5:3K\%E?5=YC\D2XP'K?W?2)98SV
M%SZYW)M@?41;Q5!_*S+'W:K_P1T?UZ1?$U[.>G*ZA9G=!<05'=C<:K8K])!5
M[0'5A.K'-58BACMW]\#J?ZS&!3[%H_I9$(#%YA+SK4@ ZA.6DPB;W7 FGJ">
M>#AX^V^<\)T%=!AXC@*H-^?#[XS&LLJGC&=*J<GH?UQ4RWE\_TB>:6;"S!1[
M10'_I@#:!U]6N^,*:9TR"S3,?=G[)X$['U?L6>'O%9=N7%I!SW<>1=OHGPP]
M""I=?D<EUPI8' XK XU52A?-FI.?CVRGKO;VB9N;HQ7P%J)Z*V1NLUNK)ON5
MR<-V8H4XRO?"0>_:+AI\!_,1/]3;B$HW[?=(+@] V%A0<RY#2QEJ_]#YA6^O
M(UI]O*V#T_OD)".&:&80RU\W%KR_0U$(@C6/4@)#&_)U$LMVYS*MY8RJO'2T
ME T(*9Y*R6;Q8-6=*P!O"2$1T5X\1 .E1"U+^)R#H,.V\;,>[*?N<68;H[EV
MHJ0#O]ZX:=7T<MC.YB-K:"7@5+ 0:E-\2 -Z>MH.A0S]61^2[F30:H8$6^)-
M+/XS[7OTC&YU@(\=;'19X6Y\M>1K1+O-L"N.#Y*+H"]P/!40;7_WOK<5S1.9
MC;P/J3S?Z)X'I5'V)9V10QRJ.D49=#<[5D2&&W*&9EB+"W,=!N=9)W&<B=_A
MM.TL>.(Y5\Q3K5XVTLMK"NH4S$0KKA5>1D"Y9[Q"VLL _F>1U3T"@S*0YXF^
M*ML0 9,'6M/*XM]7(;:[CU^-GXX[[ZJCIQK<G-F&/#Q8[G4<&*)625:88\8,
MXI?%0RMMX;@M50.(+-]1+?F4W.<'KEUNFGADK07V$S?X33O+VI0.K:[$C2*R
M<HW>5M]WO-J>E ]YL0GL1HBD;,B32&%ZRX;3OPT9*VV4T3;E$"-FG0TWYF;\
MK,:[0&-79>[]/8@4TJ?RVV\ =K!KQ5NRWM.5)$.ZSEY<- CK&R+T7/YN0WTR
M1/9:7.7'FC=WP-!<CPG/9 Q)[Z F*[Z])/N-K1.826,B]<]A$E4NEU0FSPP9
MS%A_$(O]TAZ.9!GLE/"5-;7(;BC5+Q-.23MQPE61AVN' N$;5:<3WL56+T;7
M&LT$]#\!Y$7:$",=Z97B0^]ORPR,QQ>F^XOUR542^GV\U*IFHDI&1BF4<R>^
M*3LS#T(<X350[WNDIR\ZY#!UU\F,_S)<,<+Y9"0N$6]NXIO>.C )"H56CPS#
M;3T1XL?(+_FZE"/>Y ]MIZ (&Y[40(";*.4';V5=G^9ZOL@]%$D_:^<0=OV2
M0F>$.3*++C:=(WCNQ"JSU_78IG:9$]\-PO^CIO7'AJ\&*K4UL-CD$R9IR98W
M',T]%;*,P.LB.0(AUWAOW ""YFAFR#DZV9K[K+":8?Z:O2($8.+5,%9A+#)!
MIZ\%IO?SB?<)Y-2Q]T04?? %X:B'%796$'!,_*A1,]\O]F(N 9(XG@TOKJ((
M=HU7&D4WP!TI?G/<,KU'DH["B1&=3B%$9;-H\5 3>YS7\MXMOP-H\NDW#=#;
MQV,5HAC;F>2Q>8YT;KN]/2FPSG9N!Y2)[[6Y*IH6]))![[])P3%PXY[==R#D
M3,X@/)DAK@+KX&%:YBXP/]RX,NJNP+Z=4^2]W_^_3BR%W4]U>]@FD/_TVN/)
MB#GZ'S55_YBI^)\R_"^=3;]>ZER#'L%=^0=OYA@ 3_\G[]2&['^9JGI7P^\I
ME=GQ& T+D#7.@/5G&EUW>?_=D,>]U$E/E([BM]/(Z&85C9A[(A/QE 'QW[52
M_Z=>_]F,]X]_3ICP7R<?_W,SGOO_#YKQ4@$OSMHBG4[_=?.0L;(UHJW2G(IQ
M2N)Z&QDFU$7[!O$A1/H7Z<=E\<PDAX*R+4MT<(^T;DTIQ&U/*</[_?$?)OJY
M(KN6,[7';1*2O]6/K,&)YTM/KNREDS#JL3FE#;&V:M!SH SH9K_IJ?4.-:CL
MZ2_\[<\^E@WIV(3D%^3:N<@;^CSFJCLE!&KFZGTR^G!#[SF5$^X$C:ZS\KAD
MP;8M#_HE- 5,3/=<#!^E($4L_35Y&/QYJABPG-RL:,+!JZ2X&;ZA$,4Q]:+$
MO6YSLQ>610-#?R"U"UAQTD7 'F!^/$Q2@#>D7A\1Z#B2V)0:YR#M'%_X^3.B
MJ@LL:>WA5=YR@;%*MS1+F/U0N:(?XA4J>Z@N?+?7T>(WM=>>C^Q\)%G)6$O'
MXA*=@BH#Q):T34?MR?!$H?A5*>XFH5LW*PSXVLL)8Y(>%+!RKU%S75L[:#:$
MN@QH'O&OF8:4L5Z9X9[]H>96/0R$U7E18X6U:^N"9YJ[_*;A#Z[;S.V[=U3Z
M"2@?A[Q(LV0 ?;,/5>9.W$6AULQJ19U&J;V5NB1?AUK%L;"$!OVXN[Z16F[#
M 8(%M>]%=7V0Y F/>@54IQ5Y-8VMR;W2\=CJPJTP1#&FR 3T&K72#C7*FKP/
M^L6ZFXN3 737WP@2]FMTQY V8[5]O)H0D(5RST"PBSVIH39 RK9<Y.68MIQX
M2[WLWRMML\71.7H'HC='[WWIC=F2-GDFU757?B$J&\Y]RS\H>AF'FM )QRQ7
M^BRM4*#K=:&U(ATN=MSZ":FP$=J=]=.:F.7W&B9O9D*J@*YDT,#(0D7+C^H:
M),MV?K8T F%JP]EI*G6O^S1_P%C.\6V)C^EDYJLTM!!Z J=@K$D_V)O7VBN,
M*_[E.]G-[I:V $*,DR)_\(74>W"LTGG+SG6X6!%8[!_*$H$T)\F#Y9WA?WK\
ML"MP]4RS]#(/787SO\O4T9$IJ.%-J[V^^7OYA!2M+G>,M[EB8KT^)!E7,=J/
M-7:P53KU1=.E8@H;,J&L8+&5B;O7RN=Y_K#&?BY$"A8G!96+B-RPQ ?NS"O/
M"PZY?YM+Y;'Y%T/94Z94_I7,1TQ+LL(+EJD,F%LISMVLO(X.J_>O6&VWYR.P
M<=!8(813?&<.!7A8&_HU^PW7IYCA+'NI<F7161?S>QB^9+K[1Z;,J8#'Z]VL
M:E5034+]H*FZU@=/.1]W$2O+B7MJ?]IS;)>F2B:A]=]E?Z!/I+/9O&%T>,")
M]<8I/WB'4?;"0OGY7F1^I_W.2X8"1!ILJEG-A/VXV::5#E Q%. R.CSD8[)1
M/5S_A8T)ZZO=(H[>GPP^3T%YI&^2+R\_FYW_VV<AE$KK?@WJ1/*6!^FN=K>+
M?OR]?!4Y<Q$;]O)@Z7?EXE)"^,]%",CP<"V*?+9I2(VG/AX5OHW+)V<;,RH-
M@F=T\EXS\(J(_B?^8,HJ_?[:.,[I4K/Q.$@V8-68TWRW0>D!X\;@A[I7#=@
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M&1Z:5004^<DPK=/8'M227G<*=?TR):-][EQ5\++W!_F'Y0_!^WI5 .LGL5-
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M\E9N\1;]_^+N/:.:W+JV47:Q8Z,IU2V=4*2%#FZ%4$(32.A%.B1T""V@SU9
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M;QKHP]]CW"T/O:NU?@=6OR>X8MCEC+M1>XW;O7D)GM>MA+T\&ZKGM?1-$PH
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M*AKU=EY9M9AGRCN?I832P&]'7P*#CGL,[M>UH$MI>HWF4TP:;]^N*^@'OD!
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M1K8H)2>6,3,>C0L'%7O)F4*<0)QETT??.-=K@ADU*^HQ&<TLE;<_'Q9$2A(
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MS*T^5ZK3ZFG)M]5RK;0PLE(";O>4A0"&8(SWJ7B&*/AU<_[V(-G<PO0$5;Z
MF&/!,*NYDG0J"HBQN5IT#9(89UIXAU58QP##\(O#/TN&C^!G#0YWWT5<.@3<
M \2@HMI<J<MEK:.#VTAN/]5.5X,2F.VL)ED$G%490F>X'/7_&3YO-_(S0:AM
MC%R*_ DE\!?KAM$)Y22<=X#U=GP M$O&CIES-:/)U=3B^5)ZZ?U53#3IGE;J
M#3@.5Y;6PTM,5_$L,243=O*^Y7&BRZM.;.=9.*&XPG3\VC(]O$/><__ZIP5
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M"PG>GB#VU<,4VX2,38\4)Z663LF^B? %@YSDE&%Y3K%6KA@EOXDGG999VOQ
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M3'T>BQ6K.8TF#O'HXBR=0?%Y6%UE0A1*<+PN[7"@5VW)N38CM1F\XV*YWGI
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M648A]%/P5*H,5NJ2;GHNB%SJ,UY9=99(,6\B68_+IM:;;UE<+PB+ !9E>(P
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M<]QE(U3IOJ'> )!6"SS,3)I4HXA2)OWZ;UJ#]UG6DC=L$C2 _'8;@<[(D$L
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M?U(0!O_TR@O _[_0KK@KOS<^^OW'67YC![!>602(BC]]]NZW2@$94>BCUQT
M0(4PPS_M/%Y@O?_R3[("6*[^5G%5[R>[GY[]89[R>^F5Q9]>B$O*_+@ZAK^^
MTXMC]AG^@Y'Q]Y_X_Q>BQRIPHM11,^JT# '!6#7+4GZ.R>;7F@L(]W_VX$5O
M+0?ES=L&[A=X4690$EA/+CP"W9[9;4;1$H\WYV5P2P960[1VC8S:V*1,<^V2
M"SEZ>H)7#"J9T\ P33VY?T:B.Z#P$*QPL?TCM)O4>&'04&^S(TQ5ZS/!D=&D
MF,ND[ZZ86;JK<R9(+%I2>L*3!*F]P9_\5-8Q1"$\,,D(V* 1WE%+%'592$3E
M<V*K!(VF[82LGBB_U&]84):&**("*L7N".B_6PS-:F+WC^J,$28 O77Y64Z.
MUU(5G,K,MB5M@XYF"''0&+ADC=5SBF[=MMB(D$*DG+3%U9F'0W&8CMW:F"4G
M#!91O.'&E0.-EMJ6L39TP4RM>>"*\U-[U%G.G118YD81$LGC;GZ(IW#/&U]W
M?53J-*JN>;6!XE/IGM]6\FI$!Y3\J+BZLK2)<A)IE&W=,46$C8 -Z.V1\1@,
M_CH_<XIJ6VB#NKB99\3.0UFJGEYK">7O'\/Q3 OT#7(\3(ZPY71D/^]2G=SD
M#-A3"XR-@DS1L?D[2DMA>,IIB9.SW)L(=(="; B6H]C^8<G?-W%\T;:J',7'
M\([UAM^C2:L=1F:YHL:8>6E'Y.Y3_6L2=1 PI*/?# )JC5I8W\Q?;K;#A8J7
M5\_&<KJL.D?NQ: CJA>/P%$L(.'O& P,5I*,ZR:G69ZO8T!J;RLES+BQZ5N:
M/:M+'F6D39IMGM')1X ?J9BKLD\R6D*YJEA\BV;,W_!2:4G7H7+J08"%N+<:
MD'UG\%?!SLF=FD[76I-NS]IJ(;>0$A7)WF3^.9'D01X>/OX)CXEJK/E)BB%_
M^H%FWO4YOVH=B ;,H/8 FWLLLC-#F9[Q;'+ZH\-<>TARK=J<#K/M7Z%@SJYG
M4BG6">$?OH#;/IOZD*U!W>"W/BOKPQ>:J3?G)+KCYYNG[NI"[O,MC@DB/ML5
MP-&'#NU3- MH$ &;I):SJVQ&#YC$!NU<^S$N^Y3'N^YVZ+WX<F*[\.8?,U8_
M^IHRT ,SKO:3!6)0[K;4\N0(A>:V\(9V-1:?;@UCQE>OA="6>"/*,<\_,J+9
MXY:LLC&?O\\\,WE;3JH+U7Y8C$ET;EDTK(PSX>[&[LW,&*M&]UVSTWE%J^<?
M\XC5RW K*0E$&HF/$/>22<\:BO09;SBU'C+SV#Q?)![LR=^4?]06T)M&J#.G
MYUEW4&.J>OY,B.3T.4R+MI8"!C)V9.K%W!&=/,<JH>RAF#Z*]'& OH^8/J-1
M=BN49DF0+];,U*(^BX3$;)'W[?/N6-#,6DWNC SI-@M:3:Q@\\HZ[>(-K[K7
M(<E.!9-LGQS&:6+5?G%CII(Y6EC-QW[SXGU]>Q*JX;J=G1.P)S+>[IUF2!RK
M&H[9RA&7F/G%N20"-S[S9EZ=T&FF F35?XROPHIBT6XS$(@@O*O\E:SI%<CU
M(%'WF3[$BM[!NQ^ <3)A^AZ<#RK]_A)@_;\IRO]L_$<@1O5C?1,+$PCOU;KL
M'N?T6W4//ZMNUNX.3_FBZZW\]V'B(CCLQKA3J:^JC?@Q-VG-7'0@[X[$==1+
M$=3G@SC_(;+U=I.&VQB-)AX_[BZKXTPUXM-+!<]G?02A:?JBM)<RUWKK7':H
MOK%HN#CDIJ874<FZU[:D?/EBT<#1EK5"P^"P.U[$P9=K&8C1)WMZ^SO+>9.*
MULI/9*ML^_'7EP*(Y-M>8-Y,Q9\@&D_>/]X9%S_0FQJN\OU\-1L*@CJ\C[<=
MN 2 7S* ,%S)_7?W1?12:V)9A1FSTD1_$@<X;)W79H9. 9G2Q1B%+LBKJ/)?
MK*JB/Z_JC7,7:W$+3.@P$?[#/)P&X<L3RBJ_N3"X$-3VPOH+\6&']?5/)%:;
M76!PA2&\9AR'%4@TL^;S*[,W 4'Y/>_/LX-'QZ[=13=YC"Z$[;H=2J)/0_!G
MNS\ )K;<L&B$GO]M:Z31T _Z6(F%GGZ-HO0[($7ORA_95WXO?? C/-U@!UP1
M?_I7M0V?WTO9?GQP^^W?]\__'XN._&@9LVMW?)K'@V>-U9@>T\LBGO A&V=>
MEX8RZ["N9%.MA,)5VF0.WA=E/@N4!W6M"OB#3#BF@;-=B,Y::S4^R"1/\ N,
M65G)YF(U46,\EPO\ZE9COU\>:.S]&F@4:Q=;4)#HG]PP_DVW;":&28GFR+.!
MC4VW2Q=U"#6G/'E#9@Z9E'WG9NJA?SY=NW^JNN H)HLP"?<#%<^QLJ1->'Y;
M2.2DIJ:Q@8E.+<+ZE5'LZ)IO)C82P$;"!*2)^N3UTJ<O8Q5R[ 8*\$_%5M\3
MW0MQ ED@4\7Q9<$=_\PI@7E781%BX2/U09QH(I)6^\A,Q9H:AP=>Y:GL5CW&
M^1\14]7'MLJ+4Z(:T"GN6BF<N<SIN4;N 9KTFZ;CPGN9+M&W*'T6^J7G954A
M@K@?>V\8)]1U>G287P)NOZ#J@UA.@_,8.O":_?<V5(<,E"; C4?NOH7)S7*9
MG:$AMQ^$.Y=D<-6[%B6=:'J.P;VW8B25*K[-CI6ZS"&#$0YQ"!!AKR>V.3YU
M+,"(:*M4R#L@$)T:7S*NI=L4HM"H:V@,IDWHVV<E)#=:3)-G#,Y6KQON.JYZ
MKD=>_RMK)IDS2K)HWI3E^WIHKJ*HW*)1L2YNL3(^($'*.!8Z K:"[P<5OG:;
MVL0^>LB %'%=SN!Z?^#3W1;*\]PON.'D<9T'+X'J-E57DK,;,E463U B[H[H
MDOWDN >SAH@;)N/O"1=.7AW@$L@(1@QGNY3^^!M&"XPNVT3<?N'&D/TK0QT)
M+S!P:$W[<B33<,V+8V/F:H0L>VP%B8T1?V4CO;2&3-,;RR:[[<X<W<Q/>+N8
M+OCJB3/IK:]\#;U<XQ8PHX&;B3WXD69^::H3U5UA=S8XKTT]0Y_5<!JY#-&7
MD^[68!L'IZH=;!(,IV'*;N,G;I+K/%;S*.S\ )ZTGI8E2'5M'U3;D,25/=OJ
M1")G/3MJ[X IW;PW58KC' 4)U-=GM8?$DU2DXJI13O;PH#T6?4UNF0/O07SX
MI=A@FJ5]9(9>#/_:&V+.65N:.VE"K*2GP*W57F\P;W#[[]2F[WC9^54>3>2.
M?T='')-!G R>8J2%DG]B3)S,H"N([TZ\#BF9;!K.GT2KM# .QF;!5!6LJT33
M+-.3:!R_XPX=Q*N:Y?;@W9UA7,A&R&+F?1=C=B,V&\_2'T>0F]%WQ1#B<]4R
MZ@KZ0;Z)<I-R@PC^@)%^R?*L,SZ%^(I.(&%&QZ^:LH&#0*\2(KEM+G8/8_ %
M3(^G>*;FH["S [6YV8&;[MR";GW0T%$.:M?B6V=#VXVNHTCG>G":J(J%]4CP
MSQI4/T=F,9J%1XJ%"/#,=7C?(J!O+?&U"IDI'4:V4 V%(2BSO/7G7RF*K, \
M/H>HL=^E6$GNV'37E9>!S-B\TM:[>8P7UYLL5LT(S^=*BPWWD;_0!6UR8@+2
MW12R\131$XZB,J*;5;6;M806?=-_M_]Z'7O'W=F0V%Z57/'A85([3D+L2 WO
M?C&,O>>NO(_^E)P2$8V'WM3.^>03!]MY]+)W-IO7]D%#MY9^T[+7]*&_N"=*
M(*GB)=(2WPX*QX=#7ZR:=ZTA-V&0"-DJ@JC<-!2WIRCRO<1,*54W!'E:YKC)
MQH6#W*RK*C O2ISK-KPKS5OVM3;HL&7E=.Y,29V+$,O)[ZBEND:-"MA6NL'V
M@:Q\N^U)<.-"A[.JX:)Q]- E8*A85=*<-.>?=(X\ASZ(U=W6BD4..;3O>[58
M\'_ZO%I,)9L1^>TV/3W]-6Z,8LKEXS6@$/Z$\*ORXQ)(8A*$WMK4XC<TE]\^
M%QRY\WAAN6/V>%\Z@!OHOU'OZEY9N*SMS@HYJ9?KS 9IW!D[_EZ>"$\,<W.@
MQH"ZAM4<YJ;W&Q;8[W3:Q9JGM$.LQ$-0RM4%@A?A11K"=I,X/;8A7M;'<#D^
MLY,ZJQAQ"$<(0=ER-3_%HL"MIQ(")EN/2.P9M4734Z;X+>:KID7^>$W YL/T
MQB#[=Q&-X8/3<X;K\P)LMVLL5EQIWN&]<'@6R":-M-K>5]'8:ZAJ;6\DD]H8
M\5;_J@@DS:XL8ZE5].W<_MM2QVK]P';683/3]H6MKRBE^QW!6^HL2<QM >0,
M<ZS(/+R]7;O6NF'*=F?3DWU99,%W=/ #/A=D WMVGRI:ZB8JKO2&1BNLU0DO
MRUBX!'"YX9U,&HRHO^PG9\[V_N"^+P?41JO=:G=LK*L&K;8#.Z0_I$:844U4
M;S[G/YDQ5'ALP93P#O*JS>P$XX+8#.3')IQ4*PL&3<"HNPPZVRB>U%^I[3P0
ME1#=K-K7MHVI%2W'+-X5.''<5^0H5UIAUMA$>3X/@#?Z^O_$JZ[JAA,!TV*E
M$Q#1D1=_;A233=VHM<TIR739?'=:E%XK+1X%S!S?_Z3]91@?M>W?J&/SE"F]
M;O&?C8*=GTFVK;^4H[9_$ GA ;D1O0NW_<=!+KTYV!XG8LHCA;4[0=7#>.O*
M3A.];+K<+8I!H]*=MZ864=(_?[)#UR4NZLNEI=^F]>CMD6>]$5Z-.GTZ&5S6
M6N&67#V."=GL>MD"F@'N9B4V[%6&RB,EG,H-Q4NQD/;/9?-<HOW',H_!J-9?
M9\4,<#H1S61=6%[BAOF9!W#-6R2F2_&'NC"E6-$"'0DE$CF7 (R^!J>1CTEM
M^6D:9NWD0UQ&XI2;5F]*$S#J(;:V)["9LL&H?Q_;[6^</E4H\"TWY5#+]$S(
M&XNL8D-X6*(]ZYOQ"^<.?=QZ,L1-]QM15\H*LR.E9*XP$3BK(+"-RF_#"TE&
MS-,MCLW^ E7F6YK^NAH"!XU^_F*BTHUR@>6XDQY<W#N%S/)O>'$FFOBX #W_
MYP)T2E45$JF:HA==)T@/IVROMHRCJVQ$)<BF'<??R= R:VO!PH;C  -R'^.@
M8^>>?"^F=AYE7N?[&8F2)_2ICZ3RS<>[BVC%T]S]JD@#.'X#Q&)$39+OQX&6
M0Y08S[-<K?05<I\^H_!(< 9F-#Y=_J83QV>*"%O*)2  'Q[1SZ9M6OUZ\MP/
MQ!KOU0Q$OXY=A9=-!8SG+M5/L@-G-N=N=X%RJG#T;^ _P6^M:T8P<:@VR#7>
MHN:6YT2>G37S_G,TD1&?8>M<%;9:5CLRAO7PULR.REIW2!KWI$N66VU]R+ )
M0Z_U7 (&6^?3DL?_^+P^U#_U@6S-1B4Z39U.:/=DRY"G#WX1KQQYZ^FY43G&
M]+.0&.S4P[7#M&B0X=6IX(,.2)HTB2KSLU,SWV'RH.8\=#/\9^V0X)>8#-3S
MW5*'; GC!I7\]V^+YH?PQLI!%D]%_(TU%F[8*E4,O1HK%9[/<!5SB'8W3?*!
MUT(KWJ/ZJC0_U"IC:WR[\_5(-IP+F2 56+3HRM8B*TU7A)*".14$UM.7&B9#
MQX)1/6^^C)EC9@Z4HM6/C5-%\*EAW;^805ARFK*UC\:EBX5+CXMZ'61D%4V[
MU1\T:VDP9?/WV!X>4_(%E^6OZ9&*PC<6JN@T]UKN*NK^OHP$E)W!I\_IXIW+
M]^6_T?E#B+*%*%W$M;#/U83/SH/H&70 P\M:2-;*G]0_"MOB@TQ(EH27-H<U
M"GH0.LY4BAC]F5+**O'@6PAJ0C\T93+T565GC"C!/'&5G[O<Y,%KE.I"#P>%
M+KFS/U+A.\A5:*KD'Z<#4?TY5P2FG9OP_$7.U%9"G?[/1#<IF( C_XWY;S_0
MZY[M@6V=-O?UV9YM@;!*';X'Z'\B1XPV!/-'>&P4?E%KR*GZDQQ/D@@XN;.#
M;D]L>XW%IL2B3BW'B[_+0RL;A52H9./X&#LK7LCK90E6V]-QY%IH2":Q2DO<
M6E3%+Z*(W&:4\G6-FA\C[,Y-2,*;(:DDZPV?8<MD[M)C5E[Q\GGK3"F2MINB
M#^/4W#PKT*<3CH8^IY4\6JX>#*ULP>0UF2G23(WT"R1 8_NO!-C)R<_0'845
M+[/3P6 Y]C@DZ<NZN8T8L\G FM!/U^D2;'1;?BS13J_AX_=_LF($'GGE-+EV
MQ5'N=#W37=EHBLFXX@5?MU@-17&O9]3U05B!O6JZ,*[GDT64[X1#FG16-D+_
MQ:A9T (6@U_.6(#_V>58[>L;0*@[K.(+<!/PC!KDG6&FZNOJR@1U/#[FS^/,
MY?%)%U#"1Z9:7@RD(93]IN,.'CY ];P5/XP5C8WG\T6BT?S4<* .-/.5PH?V
M[_HLBE'S%H8JQ9I1Z;NR=DT2!6(FS.'L58@!T)?ERC=_@@?R6Y_).4D><&7_
MB->$ I>%Q._=^O\=K_OGF&1=*RT6'2$3KI%PA1-Q"[A">'UM8"9^#*S.T?"M
MSSWZ)KD;!.+#_6'!TU-$<0L&9G^=_KZOQ29B9-*W= FP8=SQR'',A6><7T<*
M"WQ$,#V%(#(VP_"3;&@5DR1:GEBCMI97;LJ^UHLS$6]L1A7'_J$$2('\%^ Y
M+L:7<%I< F;-7XKVBEH=!W]XE)4BSAL=? Z!-,") C=EY:N_YK@;7@+^&!R>
M/6/WQTZ:]9%]X44VYKDJ,O93?['#DSL@;J.<JGV6+58AGG$^V)NQP'SDF#^V
M(,L$QKQOC:&JZG?Y:^OI K_-YU@+9&@!KL;^#T%*],6)%DOU(,]M#?ZJ)QC[
MP$D-5_@)6[QU;K*KJZC3E0[ZW>=UT84J/MWX3823#GU5Z ],"JI.Z4%I$A9!
MC,^WS=5QZ9&UF,6.0-,L53N9TB@AHVY;4S#VO1LSU0Z-FO.S_I_.>G9BIR "
M#98KJP[A_+=(&9XR,X=9'OP*>V*?<]?M.P"27W^_J@M :R*G7GL>*@O3A5W,
MX(%HMQ!#+L]0@AICX:193)[R[B5 FOVMKZH-R[B/CFD;%$Z[M?=(X,4I&62H
M Y4 6IL^-;D/[MX"'_$9%I#2AP:%%1O5& ",Z7\%XM^$_^//,J3)O+"@8\5K
MH>9S%V\8]_FS77)8;6R)]Y$:7&:R\814*6$]><^O $86 .9_$./_KH&CUO2@
M ?)&"9BIB'9HDW*ENN*B39,_PP CK"E+:HXXJZZ(\YDUD!)DC=)$M:"U268J
MD9"X-K#FF1DJX2%E,'J=$@?,W2S)]Y=ULIBU@>J=G1U^;OG2/\O^8IZ43_A4
M;4:'AYKJ% :BC67S&O+N6W0/ZIF%M1]9-3<;E\:#,R7N)XC!OHU<?=$WSTDI
M9)T21,C?U,WE-L?@L G3TM=#:Y:1(J/'O16S_=WVCBM):VQ2I^2\1\]N1N-E
M;3?E2'*XSUDT["5 D33OK31T?U0<=HA3UXQ2T/#I9I.-2?%4?RY@'QZ^>(0,
M]C!B+A<^MCI2>V<(+HF.;U"Y! @1ZA]KI12[C[R@3)8X7[,84R:^H_8)/8SO
M"O)(3'F-.G3 9(1"3&D+YX?:&]W=FW=PN7*D0 8DO/FD=,'W_EI,NX6 8)3@
M5.@$MI+7>"VPB9TMQ<_'2,9CT_0!V6UOD:7JQ,TFP=49WV[.ADP1<2S-2.ZW
MMZ!^[P@JIS0*<M1Z*'\J+.^0$6+LOI<\LCRF"1X\WX_Q#Q!,8IQE$E$1SC(Q
M.['15J.GR*AFE6]N/:]+D[BM'!*FB_#1=?^T<+C8,<9>OG&@HI1S%)+B#LI(
M;CR;&LB!" OW>E',8"F52^T4,1N!=U*C6;L2_$GDXI)W@8L7VL]BR>\JK4U!
MYABL.]%\M#Q1)(_PE_VW/M(DG=!HM>)UC:OTKX4RT&-E$4KRA)[S1(%!-6B$
MR&S[1\*4P+1 Y?=1A0 C\RE64[Y/GVR=*WCUJGV0S2-3YJ)^KHOH=:>Z0%*W
MR^'-8=BKYFZO!#O4];&J=-NE-9O/_4$7ZFWTNKT;$!@K6I1KE4UG+<OR^#!]
MRJC.<BRTH63B1N])K-J#KY5N_"DHG37RR7A]$2XCO(#Q/XPN6CO?R#_X]V01
MN3F<B2=?6VZ>HR20,EV4.!'U1\FPIAG7VE+Q>#TF[Q>+1F!H4)SXD1-CBUIY
MC70@D(?9D.1OF1!!P#KI"NX<G<E? HZ^Z#S2;_=[%Y!W2SL%V@XQ;<#A6LBA
MR4$=<'!J\]JDI'ZQ$:^]'WIHW=WV)W]3DY81"Q:7<T-2=>,3!PR^>9.C85)X
MM#+-3-FR2_?G37B=XVZ.A[$#$FWC71N[+&D>?1.D*W92O_I)1JHUY<*$E@TP
M@<R%NIF-Q]C74(8ES"RVQA/(<[#/KRS];<0P=80\&WVCV/*RNR''+H,"#A_O
MCH D?LX8IYV_.? LU:T-TNW.,(+?9S)TJIX])1=\'W7$55$UB),G)P1:2!_2
MTPL9!I?^E3L?J6VY18(P)6&0A$ 5V$56YO#:L+%[NZPQV^?\O0'?.8\#7$[\
M]].XCU&.IM)4J^G-2T"9 8E7J;=WN[:LV:!.MKP]>=9-F=9G4-6N)D;DEB=L
MIYE5)PG,>A.K.S3$UEG )S)U-GQQ)^%:]@5AV$-_I3[*W*X(1499X]2DS6KF
M4"?L8ZQ-$[IL8N;LZ26 I]A5_,.;./HCA'Z,*5S7]?Z)NKGGKY88KT--#J2N
M:?H&^?7US BC[M/U>Q..K;_89<$T/(I+:R:#9BWX+>X:AT/WV>RU=4T*FR1
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M0--8 G:^[<T.B_N]DJ'9^7GW'[6MY) 0W]..O9&5084.,/2C0!YNSRY!TBB
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MTVM!JFEQ4A F]U'X*8O&4O WK9+Z!JRS#Z\I6W)3)BJC-XF%LW+%&G@R87A
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M)FVMB('3ZW]'-W4[S?0AZZ)S;E/:TTR0AC/;?6Y[QZGUN\QG:YLHCR()?F/
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MUZ^655SN'S=@-Q-U$)B;.2:Z%)/H&GEZ7?IC;&CFZ]W69S\3("A3$Y2U R,
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M>0J]X;5>;AXW068FW#U**(69TA(/6[H)--\@%_:#09,C;>M-R*!%Q>9NMY&
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MZ(LXM8S6!-BY*058>OG 8V38>&@R]8.(S4< ]X@H#>6PQ0P4^E9XHQ"D#3)
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M4BL/J(P8F_S%BI7^ 5O=/$?ZRJ1$"NZK.7>I6J\CNV\X4N0@@%G^$2</?CL
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MDX>$E>H;3'EE>0/8BL"'LN!)]LA!\I$N.J9F9K]4%IH"51:H>\L17Q'2:+W
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M]'0!F+^F;ZG/-Y>:,DW>\]IK61'^D)5C3>%(5'S)_]7,<*.2Y<;W'&K*RM&
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M3ZR[E9S5F:E@KAGLE0*+9]LT!&:T)0<%H9<%Q YVE55_/ZC2A>JNK3PAJ8.
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MSZMY#_^N;H6V*9;:*XA.[(2.!\$QDTXUTA#BH,<C#WD(7]8/FL5CG7 6WKM
M=L'Q8!:IH5QKL&DKC#6#9D,[G^;*7_]_KD3\_]*N/#1FN:K[J^30/D#ZKXHK
MUF\ -W[IN-^1,/YGI>/E=1;A&ZN/K1/TGMYH$J;]R]#9F(7FYX4_V!$2)S(?
M$N)<@^5%^[S,M^) P4,UP !X%NL%OJI-7?]5#T' 7-''(9QE4F2)\#GN 4D_
MK!D"!?NHA:SQ!:S"%F%;=X<6ID520S7_!(@6R?RJ!RPEI].PROSL_K+WSV%5
M_AH#W<\QR+$)TSXM6KAD?.U7Y];,GRH$"OU+9I&M]%.>Z>"0)%P-*0.5A'U*
M/\H7X1I_<<;/=9?R!E-2Y5 4]V#(:^QHHJ CHMHN0M73(AA3U+)@VI>&F>A(
MJBYWXRK0I1$&XVAI,PZ:'*GM/80T<YTW-,O:PC2,_S5#EZP1+/1P_%_,5X1Q
M"<Z9"Z"L-V2-U@F9_9_A9F5OHI^LPOZD\MCBL8&V) 1,6+<*]_I!0UV)JBX0
MWOM-^UYPIUYPIH/]2K/)5TRV2<RFP8G_/2]Q@/B+Z_.-/V@T8SZ]I+R9*7_:
MG6;[? N]07\.4E..-E?-M#P2GXWS%L_]'!U=^^KU2E'VSNSAYVS/U?L.J=U'
MRNV_%[[;/L%@XO>_=.:+"@CI8B?+O'/=8M=VQ)_=#*@>#.V0O T_;3:SS&HO
M>50:S&LDI3_Y@R;U^C7FM^2*+C%!W/X/FN$RHG2LFTLN]T7KL<XZD*P@S^K1
MWU>2/A H(_=(;JI% W/R_/]B[ZWCVGK6O='4E0J%XA7<6]RIH"%X",$"+0Y!
MBA:GI2W%*0%""1"*!9+@[E1P+8$D.,4A.,6MM]WGM^6<O<_YG//>=^][[WO[
M_)-\9LU:WYEG9LT\\UWSS,-3I&128<)GK'Y$J-[HJ]> BHT&&I >$KSLI'B:
MALS:(F5-+,YINM0Z!Z:5+-'[Q)XANDU1D\ K(4;+/: ;6^@Y7I>#<34L<Z')
M;0^"$JW[(9V& 3D;'A@22LLJJ;(JU;Z,IU['K>M-6::T.<57K!_UNBTV?5>7
M0S$FWFF.$8+Z>+';U"&.V\Z>J3+^^FV\O>FFX$"47.VJA?DW;A9@5N)$@(:^
MO.?^PN=[#;:4(UA 9?_'(5B/G#JB1*H8HB(']9<>L:[@:;9>BZ=5TA4AD19^
M # =3)K:$]UTT 9=F/=': WD<CQ1(VO@(:I;&=00DU3VO89^@O&2WE:,+BQ'
M+/$*&1LCO%M96;N05\QP$WG+#21:!F/D889( J>#HW%<H1F@&DZW19SMG4R-
MK93OJS<7!+<4H"SI??;Q]CP"7Y>0EM]!L3KR6LV/7!G.3V12>..M?-VIFSZ!
MW1>4R110J7:5W4EBJK49RGNR97BW?76G+V3[8:_VP8[^L;Z05]+7;\;=WP#N
M&>\ %_[S-QC*^N(?IE?N]SX2TVMCX1?NNI=B(18-@:1/*%&WP11@IP,"?D4?
MR\">X<^CV.9TX3,M7D*X33K_N/'25)0A9YCDU!"0E5*6)U^F]_V/J&T#OZ*V
MX5=Y3-JW[\64!;)U _BU?^:G;3WY@O9Q^0E&,.NTDBNE(F(3\K6_5RV&U*?W
M><NI/K>H*HJXHT3P=-:E".#1>N=(Y\=%BQ1.:R& +#G-$CBW<,I"=GJL%51#
M0';$!U$"&3_?69#0R=U.WI#]]B</EJM@;DIF%B(OKKA-K?L21EFP"UV=RIT1
M/X]K+>FG5(3-:F4(?B/(P^NON\J)QGE 2OCU](I[6#F+BV_RQ<M-==/$>M9G
M2I;F=SP\$_:/=?6'G*7\-1 W<>@OTT?JC>7;C:I'=(.W7[_,\_Y[AQBNPUXT
MA,[,X=6<T4.I&*]UE3VS\425&4;0^OGY=R>ZG]_VJGXM*/ KVD;K.P#[/T0N
MUF+3W6B3C51]LOOBXKLK?PVN(:/^-U$W?,Q.1_%#6VZ4MOYYGE#\<W3NF."]
MHOT,=;/6A*^SKF_4;GM%=Z9J ]C_R^K^/R_4S%>MYF;9,>D!(*WI$ANRN4LV
MA4??/IEY/":/URDWCHT8L^9@3*,]Y7^W?3]3J>(14PJ-H662^#2)JSJ?Q/.,
MP-(<5FT$5Z*BY;BL*Q49^G2<J%F='I I.<;KBE15,891/'-IV.AT,Y<*K-+R
M/Q4*,9>/J+Q.\;'4UC6]D\B&EMR5T<>EV^!;R%JOFX9Y!2_WCI(8?>BSRMMD
M/(E,>J30H<ZVZKI D55D%$_E:)ZSHQKH?%PQ%F9$:53%EMZ_0I.70#7.B4V/
M4M'OG5/>X6/)QY%GD#\ YR)KO1F/O]OGE9"=0'&@,YJ8>IQJ]-2V%#([_(T:
M E,;1OS4GZ4I=EO9(@QAI'X]!/_!4?%FF[[8HKQRR3?7]/>,%& .C@.##U/S
M"=G'/(@@B6&[9L)KA%(NOHNR4V[=/8%<+R],(6%ZTAF']EF0\T'9D"3%+HFQ
MQO%#"UG-NU^!3:8KS0.RPHU K Q[OOU#K0\$_[T"Q912D>84,.Q6?D6M6=8E
M&/4CVSIC[/;ERB]E?@Y:8K$0N3&ZCS;,ZE,Z8#R3&6D6\>FSWJ@:N*YZCW&7
M 2].7VN:#A38%-:B2^W*<ZY?"K^GSY25\,HC#9%J[%W,NN:V#:QU=\'.=B2!
MXR=PW',=:2%G'P<1#8V5C*'J73X^XF+?96Q#\:DWS<)\.;_0A=G;VX>%\;!&
MX:P?W>PU(KI'4;QD+:LW^TJ0F;ER0/XVVZ<GRA8+8;U#,A6]GQRBT;E8MQD-
MKRVD&+GC;>I38[)8EMP9B))/[Q<-]O@D#5BL1">W>9HA,/OK\/676*4F8^S4
MZ723<Z'IT78<Z1J*WQ%%W8=Z)IVF+!:#H7D.,<(!B^&^:T,PZ.OT$98ER[4R
M-@X&3+YY._4R+\9@>P&YX47NNA]J:?>X@!J5"HHK +W1Z1OX(+*=R^=7TSB8
M1QJTS#;ERL^UK2^OQMB@]]ZN()5LY+@SLU4$-7R>#:$7GX<8A#D9TI1Q3.!R
MYEP\A0#MNH;YD%)J$J&//2XWALWM?=Z&4@=[1W37W=C44Y.2/$@,W"3I](2@
MKMBO<GYI!(>7(*J$OD 0M>9#;'>H;>^+L^&RU4(<$9GPQNB8W.>3N%FC+ .P
MZ?<B(W=>O5W:UC8%BSZ='I5TF4TQ;9"6J,>2BM@AG<V4<N6DR!?R%*R R\)$
MD^%K1Q(>"MCJU=6#ZC6!5"['TUZE&/3)"9YJ7&\I]<?\U%.Q4/=.C)N K)*D
M#'"@&WTK3PDEY'C]B<]3##H]G]=V$M;'MFV4;"+()G:3JD'+6 ?(4JZ'?6-<
M.E'&F(CQAL\AO>]9)D*S;X<.*%S5#;QLR'S6:.=M/E(C]9=VR&/P[V3G/)3S
M11F.[G*B@ >'. EY@>D&>J0Z2S^=LX!Q2U7E%AK"A[]BBG%(]!!2NO#XF[IF
MW+"F.PC;@NQ%C6V76SHIRTN)W4J28M-A7$O9J!E(G*" X=+V,V^H7F*LT\VE
M+]?=O=WN'4F0T_B,654_Z+JL!V%*S+-@X 7E=MFL54383GHENI>MSCH:7_CL
M"JW+FU9\E%(RX3LZ>[/#*<VO\-X-HA&I(!<?LU8WL'+34"=!FL&N]TAM+R&
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M@]DHYV#)RWRH[.%K@W=;:OCJ@M(3><>9C'5 (ELF1(49(.C*B2*3Z0)L-N+
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MC8.>M)G>-]NX\KENOF2$OK:^L#*EZS-1OT),RYAU^8;NBDF@F?(6>61-ZV9
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MM6![C^ON<"_J4D\$M]:II#RW).2?XY#GD(*=8W*_#SCUAK/]9Y<]F76AY":
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MTL(9E(+U_B@[SHF6>QQ)ES!,C$+,X5ZOJZO(>+':N*>UBA'B\NB)='C)GII
MF]LK^0+"'L%R UC1V%B=TJ HO4D>MN4$5&ME4W@WUUYKBM76[C5Q??0><C;^
MF]JQ0:V@207<6O):OY;6YL09;=5@8*#HQ?EWG('YGG37I.@P@=C^=ZPJ:@:N
M'1M2B5>=WDFXS6Y_9NX5Z[N?OM?0FW+'0%UV@KMW7^ZA]4JVLX'_4 P8:RH7
M6%S18+:)EF\< 0ZR6.%'M]11Y"U*SM/1&W)>ZD5P]_;G?W3XEINGYZ;D,AL\
ML1X0T_O5*9S4)L](!'/C XQLSP;CH/S%,\Q]*(C9W" 31^KI0SN563SPPC\R
MF^EOO0)"-:7=^4&Y;A*FHW])M-I1);X2!Y;% <2'"O*(L/18HBL*YHBHR@[D
M#OK)PM6)<>(RTA+MIHG0=8CM].DDJ7I#,G!ZL=G,]:8_<%PMYH_$B>CZ'!.$
MP6<1D?,WZ1K_2B,-8RH!YCLEQT:*0N\[I8V*JW4*Q,?^K)QH'OK0">ROHDMW
M&SQZ3L/Z'WQ [_; ED59F0+_6K/B\+=U)\1Q4X4OQ66_C 259_=F8*.\LN[I
M10F39V6M2ERJ[!"MV$GG:#&MI?Y  "KK,/6<CN^:>E%@K:"&Z2'5=1>82;AG
MSWP=>2YILZ]EZ''59Z>8P_C-5\\JHK%&;J/L!)\<#:Z!]0^06P\DI23UU)-<
M78]Z2^%JRD.TK8L\)IX-]A4G9DTV'/T3_8NO&&$G'RL+8VM<_I3W&%<46N1H
M[4.OX;*6?P:5LLS=8:ZR9%6A-@,?WR\1.%S;S;VUR5SGW;HX5D<W8=,3\-B:
M694NS0/'NX:_[H=7_WU5\EI]]]_^!/PW%*L\O7D#H!>-+*GQUF'EI[AFM1F0
MQ^UF(4[*_?W^LBB[ %RTQ@JD,/OWT:H<00\K4;B(K.Z*^\ZQXFHWY=WCOD>(
M)J#7]WYQT9-WQ^H\AOZ(B6*%'"%]39^/"7M3%62X6HR CTO[W=2:N2*?BG0H
MV]#D7.6RH8HW,;X7HM<-\E*)<]$M:;=:7Z:,VD!FU/Q3AA=?R+&7'67?K/1)
M(:ZHKO)T2XH F103AS77I"1-I[4UK1YY$48V>H<(/L4++?:30+W&"NCX'1:T
M;3+#1PV&;E"^YY=TEYC[<Z7X+Z)2M> T_V;9X.%;"R5QX1_ WN7?&H!IHK42
M9S>JZ86 H#D-S<.:[1IRCWIP(K+X26V:O8K&H&)^@EX-&*U!/,2U3SBIPAG8
M.^U2Q0.=LE1N9":D&(K'RN/=H#]YJIHIO0#($&^#\;CB@595G6@/:FFZ+Z#-
M\'/_6"*^<M05[OU&J>(:-??QD)%2[PEN[S'1;ER#'O\>/OF8&X%(1O&Y= =#
M=I?[E,"?P?PC3A$R8$Q[6[B?RHI2B2:G(H##TUXZQS>96=/LWH'4_.YEG*L'
M:\2M?3W77YPFRF,8&5/HT(ZT8,E*DOD<U\*!Z*G.>_Y"<83\L@9*VKFB^LG>
M*5:F20FM03(4?Z I<8N835MI!LK3.?;TUEWJ3P!UW5#(37W <O2,"/]0PR<&
M%F$/*IER#T,BW2+%0],\]!K7A,;O^"_:*VJ_#$E!D^-<'8/^9+F^;[:U<R88
M^K$S>'R0 -;(JPJ=G;&]NAP(@E\-H5F%1O.@E4?!;6,6*:BIK<>:MJDYBY*C
ML7\U:]9:\9!#FP#^:,IPZZK5JK7SGMAQ[H;V(Q-)<Q&NM/E28-(,S\=%2]04
MX.Q()!CP8NLX:](G*]=M>2(R-9SJ?LQ.D3CUG^>L;_<R33-W=_=EE&+^348M
M>([RU<7%E+!1_8Z_NL3J<0LG.'"6ZK\@];"3>6J(J8]2+:5DX'^Q 6/4Z&W\
MX"2LV6X:(/4\LA41Z3<&[,XX3%[4W"C,U5N6MO3SVM?FGW0*D,_#M&$H/)-T
M[RS1B88VR9O$^?XWP<VQ_2;8&JK[+J-$0&./283N>63VFPDYFVU_B1SFI5?5
M?'2%8)V!+4<;WTY9ZKG6UMH2A:IDPD1OEI3M*LDO=_$T\5N".70@:;J%QO%_
M<^;>_PKKYF)O!]J([7^6]B=H1C?\PKYJ0^'Q5[*#VD^*P+RUQJJ%WQM':S3X
M ]2CD8F?&P52O9"# Q9R%F(_:$+J0SU9FL2@M9;U[]42"@(E[OS1(&.ZOBDE
M:3[PTKT<C.>L[6EL@%6=ZEQI@L%19'YW9Z79&?VV7WO-,#"ISCY$K1*W+=9
MY+GI2P!'",:1R'W!Y)'\MKY-MY_/0&-WDSW]R.9$,.X&G?ERDBD!KC#Q_00'
M[ IJ'P3?7H'X?7X(K@BG9;TS:U6-[*IE<6A>L![564Z!E$>?.W=#@/0VKS$
M(<%@[^#+ZDD\)V:*VVHG4]XI!76GHIK[T914@TTG4S9!N'$1QGH;VX:#- \-
M$'[01*02<%G6*F7^0&PD;^_?2Y+">T%L'E&Z*Q!LZ>\4D47'">-^'DIGCE\D
M'V<"RAD_K-=4EL#1TST#!H,,["&:)I*"%?9%&%+^9J^EM^U&-451)M(Z-Q6T
M*,E"P3,%VK@K0ITJ)SS@GGGC)SKG-X4X]!?IDHI9"RIU'3LS\*!*K_$$".G
M0']L0I5%6;L>.1WX:..F@E]U <_'NAJ\=8U"3L$7EG=>4+/Z5.T-ZDZ-U,)
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M6R^FV@%K7>U.6UQ?=Q+BAW]O'?ADS5:@]R'G&D Q?Q'$OU0-2:H=!D.TC %
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M/#LR<?<1OP:GS[LT  *JOU7FJ;&/CU.3AVAAZ5TV7N&AE)PJ>$3_>1J2*ZT
MQ"+<1"^SN(=<G?09!PK.SRNG@Y5_T' _\D'MXBC(F1#A<.NM]-<DIQD<M:&
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M(*6N=OCCN8@(TY(;UH^WC6<+Y!#T: 8JLYX/:_BVA2LK-,(O'4?D(=DQ1%.
M:>[P008H->M<M^8\*%2&_D#1*#K&T.1K420G79J9$X95,<[.?C?D:BB.?ZA;
M^O:^UEQ!B /!3]3"2$+VPP^7F%&^G"E+O!5-=E4U#*H5M3@ [A/A];9B1\V\
MA7:CR&87/^Q*SD_T;HJ^(>*84GV]]Y[@05:HBVMS+'UMA"C4U7G#<JC^N85
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M.IU#L%0#I+ZJA1,*GD]IE8)TL4Z 7EI7-*$N;F!7P99=<>@8@_,=T-,#,>D
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M*8HR7;.NXQU.A!L05:GJYC^,)=DDNWMXJBH19V!"_6!/7&R\+LX"LWK6@=H
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MW;SW5:4]G51&(+"-%Y7I@87,X1?C:]H?UH4.@8C[#>#W,<N2MQFFW+37HU%
M3%3W4X.;O-K&T)Z>RK368>%W% &>3R9M"/XK^V(N&\0#OX'K@P]XK2>3!W\B
M5G^'?769J]_,>L9O/@=J[P^_A.;[7,JEO-:\[WS7ZZ2S2O5!*3R4^GF:C1*0
M$%96-(C(05T]*"SF_QSBP;,N+."PDH>/%_)UVBR'^"PN'D=,_A90:9<4&-/N
MQ])[_YC-?HA\'RLYFQ\VYO'6YI!O4L- FV^OWY 88/^P#A5866WE:R2?XPGE
M1A9<\C,;&$RY5AI H1;9&0/$<E:VG!H$2C%=G>#>4[CJ >-;U28LD4H<S;DI
M&O'.B>-9VZV[S4"UY.^'%8,\A\&./W7C#E)SX+<DTW?)>.'IF';W>[KD;8<3
MVS@-EZEA8K551<C6OI&)J>S50WI#8XFS:5Z=C"F>S\F13CD9I.@-3XA#U)1C
MC<;IQF)!AI$!IA8Y.XE?C=T=6*S)-XN8^SU];:,Z$AA#FRB9RNQ?S&!0F4'N
ML1=SM>4@.Z\+.^:#^"<WI[@#S]>RB>@9WS1?H]$./4"&A9&8!;<,5&L5.NDQ
M$#.9&IUMCG>PR<WU]KG+<YBA#.H85U>*1T4=/-6=H/QT3L(P]6+\TG$/,6^"
MH*Y7#2Q8/(95?Q3"T:&->X'0<G(^LHI%RM].GD8H]?F;?&_CSEZ_V@:P65K[
MW5O]]YDWO@""/3:^?!X]L&#ATC"9*O9.IJOJYE77V1J9+/3QG#U\_UFPV*R+
M1DAF<*&.M5L=(?+])^KD393NC$:YRR_MJ*N[5_;6"3GG9$(?T[<EEO/D-7AE
M6+LD+_E&U!Z5%,SX&$+XCU >K/?ES/5 (J70E4^I:;)VUHD!M)Z287"5@ &6
M<H#B6K6Z9-]Y?5!F,:$ ];+IQ?&T<($'M4BIJR%6RVK)F><0F%*FVDQJ@S]N
ME]'#N[1!)25/?%<XJ"UB"A::I8"PBN==6?VZ.?F\TBJ^=J'.ZK7[.>MBPYOQ
MQ G8RR7EY,H*F0UDDLRZS+[>,FIM-Z$G*LU+T K@,B$K91)%T?Q*=JL5(\<'
MUI8=)K1=+'^$PG@7TXSV&S9[;JE[<@.'HHQB-Z58"T=:$AP$MX8YY:XJ3,X&
MZ#=G&4/V<3Y.)%1/U^QF[Z+@$G;F)US$0;3\ QOMWPSQ/_7*!4L)90) "+I;
MD>F _LJ&[6 DB-93)D[,(!&% -N52_EK9S\6(YPN1R9LSK0$#32$3NA(P:@5
M*_5'0 43$P34GM,'BW#UYQ$>51G7:]/!MB0T%$M<X5 +]11)7^/L'JXHGW4=
M&1AN_W:4L#I]EI[1WGC*TIF=%>K(:TO_@6PMR K<QVDMC\;W2Q4W*WE[27PP
MK&+EC7<XKC:(J!?#TS$_E8U)]LU=<\O-QV=^J?PDSRI:6?>]W.>6'WSF#47.
MT9P)@JUR9Q\=B\NJYTN8#E?/B70$C*E(,; YVS:B$)70=DRV#'^"9F)ZTXV5
M:FA+]W<?=L";FVY-=\VLC:]%K*-E/M6F-!D]93*NU#<9TDULZ!L&R4YA3R.H
MVG,/R&3A.S/=GZG_!^_@BN!_-JV]'OJ?WW0*>5)^J2(3KVIVH!%@C @INYWA
M2+6JOM3&M?(R5.\T1Y$@UCAQK:_BE1?WWF+\?E.3DL-%3IQ5A*;:JUM>->>_
M@D@NOZ)):J^N_%OOA!H5P):"!BT[J5YKI3)^]=^"1Y/V_XHJI0V> #RL&Q]G
MX/Y;4<<1YW_U,Y<3#J[R#6#KR3)\U]&(HZ.Z_H^Y:9A^-8SX5;CQ3/P7*5IP
MLTS(GU1W:!C%!*XX_*/$@HKJ(_6?G53Z%0TTT8_T&7M*+*A,+6]T?::Z\_/&
MSY94(M2GKY^9TNY3,;.\^L><S+]=?MIX14O;E6CW^H!Z_I4I[>=_5 Q =O^Y
M'OU?"H;ZGUW&_Y_&=:K?'X A/PE=_R1"/?]/,O_UT[)K1+RB3T6=Y_FKI3KM
M%7^J3_7_>>-_7/8?XQ/+*]K?/%)>T3R$4OTV(I@0JB[Y2[V96AC_\Z(KS_VI
M&"VY/_XVF,I"]TJT\S]6\(GEWS[<;WG<80?=A7J,@^0U4[I+-O4\'+$6U$87
M6'JV<;$ODP6!9F2J&-:^1K,TBQ6K&7;P9P18>Z!$#&=&0*J>T>=V/"P533M2
M-S1!!G">['#1G*_0W 7%A&&@7?#3- L)B]EL)_N&QY-C!*%[D=P)B9N =QU>
MP\/<WO:<!=%2JU)2,5^@??V.HE* T,L<+&&)Q5Q=B2Z222<P?JF7)4#MT^$#
MXM?2M3]THSJ@,!J=.H%Y*Z#P2'[7BA.ABK"U/_$$[R6?=)\M2@[S%8Z]@RP^
M,B-U^O9.=%R#[S?HPR8(!5E33<@3Q0LWJ*-B@T[MUL=RB8_'4ZY &$?.^H63
M3$#^#E"OTO4- 9O,MT<(ER)XZ_7/&S+1Q,FAOJ9),;_B=^A\/ASF+CUEF?./
MC%Y33<4D+82>\+K0!'/YNJU&P%9:I5Y4EG0N]MLFR."FRDO5>#A,611*"1GD
M,BW2KO53-K_IYW1^-[N!6E<V6F3@H/.\61.FJ* EF(=Z4A-K?/)0H%J/5X8&
MC[Y!'X^LZ[L J"HJ"8RXRR;0PQX)NQ)UA6B(J_G)1CS<4UMM\9KR.'7WY_I=
MUF:^(R 7K%*ZEPFE]'+;"E3RAU2T]T4T/( >=?R4Y^&4B"<EX(?N#?1?MT:[
M16)MLB%I^V.6N:>ZR>!W/]$XP0U135W[HGR!]04@T5/=LYP)^XQL7G0(NVYH
M)V+P!1WX*Z<^!$6,XB@_\OS<Z 88%2HP]NAUO5ZN>(-:I;EZ0CNA8^1)3R:/
MJ/9DWI?#?F3"-L1WBPW?<B"'-IH0(CC:8#)M^28FQ$*(9+&W&+C;15MJ[!]F
MA;>'AP8;'=!"X;(AY+L'(Q(5>V!I4D);!4JE+,?PIJ!8[OCI7X]K[.I$JBJF
MU/6XQ^8DCMF1WT5P(2IJ::Y;4$I:"K+\RW!4S]=R175)<<&$2.J\^?\NR#]/
M]2_)_WD*7]7_.T'_[^/_F'JVWW*(R&>E%D[WR'#(9R^#SC2-'[Q9ND:^4365
M/2\D9VY-_Q#+&&@"Q1#R0T0&5?7K9,NKS+SSJ0.$&4:B;XSR9L<MT<7DDX6S
MXN$9%8;707NB-ELG44)H#TF9U3G%F8N^>I%L?/<3"*UF%JM4S=AF2Q X5)9+
M$:S6.C%=X&D&'WHI+KE-?M_X9U>1%?@J/MT]DD2>H$3&7KNGS5E@KGH#9$<L
MC.6Z*1+1;P5;4JST]C)H*"J,TIJM-U_5HT<(\9% OR,3WC_E(\@HWSKC)#BE
MBM6XU2:[38+ A-6FLGK;QXRYTP]F!I@M-9@5?) );8H&KCP)9\7*A^A BBG:
M<1TE,!0O"@O6>%Z),I@?S]1+\I3;MJO.6%(V5<$%1IT*$FQ16G.TR;V)8Y>V
M:,Z,)4BUKR[T:]P.MA#*F'Q8.B3AE]G$7ZJ(3/S=B7?4ZLFG'PY>"_/Y4 UU
M6)OU67>]2:0?D(@%#B-@7=L,!=FDIP')CL2$CK3Z.)-=B[=.(2$D5\7WZNRK
MJ7"N.##W$<12*&#+58:WVYP!;"P(N?7@-:)BHG6;:YZX%U].-NP"1PVV3)B>
M>"7*R2>1IQ'E$];A6H+B,5BEI+0T_ 4+\_/<OZG"YY2/?Z2P"^0GB,HGVMQE
M8E+[GH9[?!1C<^AYGC,D&K?8B88+YIKPF\M<) H_)Z"C:6"ZK9 <P/QY[<.5
MEL-#M_J.^V7=0J#&+;^U5>T7CD$$6!VSYI>;9"A38&,4H,"SH[$M$4IG9*3\
M^YVDA=:1-NA>=>=$Q>P%3T>8C0T?OC"Q@QG-(I?S:C+&?;4M7LI%5CT:_BPP
MJ/B43V(3Q5KEWB=[U&]$]-F 5VJGTL_V?+?8]I@6HS?F%8_3+"SF;$)=_"$9
MR]<PF^M@#K&M&5:+#[_! -PL-/MIN!3F8"._3=94N5MR/X7I!=8TN1QJ/U;L
MYN(CXGT!-E/OOE6KE0YKDV57W6F+ZE8OBEPF]51<XOFD9FN'?J5BM-^@VP:>
M\^NEY$WMU31SW[-.F2WC,H2HR\KO3D.3$M0!.Z%%Q(/\KHLB?/D K)_18Z3A
MPN4 LHF=%'38O5# -")R$YVVN"%''0U[7+0C555+@38,:B%24R7L^_.5MTX[
MMLN(#:*ES@[J"3JSM\X56#[YM3Y?L>L*X#D(M_GC!S9Z7&'Q\2/"2+:ADI[Z
M%_KICS50M8Z6A-)M9R_[YWI@(=8(49\2K$ U5!B(63TO/.?'K$'L4(W9H&TC
MM1]^SN4&?AF91;PU4\5'M8ZBYB N^1>Y?AVI4P$:AHM@B+?8["IK4B(93+*)
ME9$_%RF?&V6J8#(&L5-RAL<L,%HB0+!Z&($2C-* ?#Z" _/C;\N;%Z^*SH@D
MRHC:\Y&0$<\__V401>D:WVNSK>EI]7)<UA"?Q\\7A&L'#,I_0,MVU&L[N_I1
M"-7:J,W$GAR^;F-K]N#!P2D.&'H3+G,K^*5/J\ZGJ#[RI6TZ'343D50%".&5
M5 8NA@9FLKHBJ*%L/$XY";&6O.J]=%7"12B:XF8]OK[K-NY7\N,S#<%.F'"B
MTM=&V^W %R%>@D8YS LA!B:HKX<C(7E3C:=64XK5CD((55?D ,#5AJ,L$#3B
MP4EHJJCSFQ,^MY6X9;%:NO/RV<ZX+/[^P$LUL!DGI^>8J&6;8[V7D57/1<Z2
MN7MAEII9S4!$/3@5V\Y4>0>L!]&3+%-"*4TV.K\4'PY^AM5.?VA6>1MNPHJ)
MA1U5>@J**"G4J-=EBY38?%%,I@U?3P4XUE9-L_JFG>Y<7(N+0@5.,"4E;$DN
M63:G%.GLVM;M)/\H7X<I;'UP"TL*Z. U*4\_.D1DCO*JRP8H,=0XM)F8.>-Y
M8/UZ//?2W74Y+?>6P_G[Q?(4S4%TL;@#);HRYY.+6W;.=V=3\XL0UOB,1..R
M-ZG(C,T1F[%S*:!N4FY9-?ZF.'?'PGDAO+BV?,O5#!%^5^0I9'-N7R>/..<3
MWBA'H!C$PE:+@T\+S]7IGZQ5&A_\354G:^K?W.ZHW&B+.G@$>UF6?#DCWB5Y
M3V'SNV7S''U<W8\DXM%ZJ,'[YB;[[*-;)S'X2_X#GO/X7\+YH(00&1=I8S,]
MNL;U7 ]"MVLMD(LKC'M,&<#T)F>R<M6[6VS\(%DE!>Z^FSAS;SD5<F0;3+;7
M-<-MZL%L6 ">FI(=*7$^?ZA7L:.^%-?FZLZZGL2T96/D]CCZ?-OCO6_[]C]Y
M@CVU*88=XJ>V)N.//G^*%*Y\^;'KF<#6B(]D9R?W)(C+I&T^V#[C1K(7.OS8
MM2@%&H=5BCD-6M_]H%UH9YKH*?;=$)(Y3SS-L)",+=MY;L,!UP1R=KMRXNJ
MF,"L,HO\V/M=?CD*S@2<!Z&;*(I :GZY9K!1?8J&F8N/ -V2>2>J>W+L*! Y
MTT-091!=KK6_U=5S^8@J]Y@^FR=EWG]3!56&LG %PR"29@4$H7VS"D3:H>)@
M"?U!FX%K29*^^%&"QES7BV3.^_:W/Y9&YE2;C (YP!">\7H]:/<*\Z@YI0 3
M1XC3X#X<"NZQ)JT_+#2C ?GJ?VY?'65Y3HD4,QX9I> 9M$8Y' X30PJ,7D/(
M0WJSS*/M##0TA"@X <ZFU?X$)M982C&G)I=N;#NRB$V%@I(_0<F:X<+Y3MP-
MJ!=>6Y2LO^+6++IB"YWR8+Y,%TAYXZQ[:XU9K2=&1GH&T-I4MJU]BO'A4[M:
MO8H)HTIFX,B<"4K0E"PAFET%T" 1@%YUP?=[1,_6X+Q]>:6] (_/Q\#86!__
MZ/[;NNGFR6<)R3SMW;9>!%D%P650:A.AL"&%*+Q5Z2T0#64WC6XMJ,W*;$T^
MO%DUA99#\P^K%@NGK=8(?L^D"5@N:!XI5(P6RYF,A07Q13Y?QRV2#OF%'C'N
M@J!\>8I!(.7EP^&);>D]D?(A)?B8VD+)9WL1XTJEV]W .JC06BB15&(8$>(J
ML[$B:JR+]D916^0B4<[NOI'A]' [W9WG2=$&@WKPGP!2A7(Y?']H-$$$TDTV
M0[AEBU(KFUBQY4-E\2PC7]A>R+A9O81J_8#,$@.+!RK13Q2.>3G8O!?3=X+&
MH\6E5B!/83"8J+2'_T6(D7QF3)]UM\64/T40GVT*I_49J 7ZE%OEGOZ49EE3
M;)L)&" Z:G*V+1C+&^2F7VXE<"SEM45T$UMO2>=G638C\U#1WJF]_;BGX'\S
MVZ@U+3J;K6N&)5!E::]6<Q)D8L_ *NFX+28/YP_SMB2.VC.$0DYH(BM4]PR>
M&Y[EZV[O4JEM]*;.A+>0BZ_:_#6K0,;7Y^/9-@_CLN=7G>5V-NXI\.4K.1A,
M!]FM[&![S.+7+B@[M<,71MG19- P(I"!9''>%KF,48]:@=S?#2A*;84CU&_R
M/<@Q@P/G$[8"^4)T3U^K]1P/#/;KO?@8O-?-UGE$.5]NJ2 X\KXT"$H-BLZ/
M9]6AF!XE\A$+8=&=/>!UIXWM$9%P<2Y8;9_=$'[!/;56ZMNIU\'6:7;-RZWV
MIM'$E;0N%)XO;8/;[-$G.!%(G_MI2"OFH)XYV+XEHWQH.MNN0SYB=O;:#)=3
M6H/%H7F^-YDK0T_>3N(6.+* $X^NX_%JNM=LF"]J/1L3+<YS.S1XT&+V[ -*
M,(&]:-AB*)(:B%TQ8E"F<32(GG(.E>+WRK<UD1[O3"WM=ROS];\>L'>S+T ,
MI4&VC7L,&'&&-V!5C.?3\V7.QLWQ,46Y!7F)AMFBFBNIWW.K1J X[^%]I89D
MBWB(SZ)VM['W04=%0OQLFD/0PEJQ#Q%-0P,7_&CMX\Q'+*-G,UX1]]VZFBC!
M5$6@*,Y!=6+^+^[>.ZRIY=L?YGBL@(TB55 ((%VZ5 LU5$D! @040N\E=/ <
M"](A 8*TH/0D!"3T+E)#$2D!0Y4.H4F7ZD_/.=][W^?>[WW?^_[[FS\FS[.S
M]\SL-6O66K/G,Y^)[\M>_&EPKXXBR<\VQS;?=PX.&IU[/M-5BX%\4XH-1;CO
M,[VAL?9=L/RUJ^=RCB;8W\HI$1%SA@FO+&[^E%9M5_ "V;!,FJ$%J'H+OHR*
M<V*[,&Y=CD( +9I&#/;8IZ47DO?X! 65W2QH>?D(Q;[?Y;"].;KBM3CA*JN"
MG3!5UYY&AK"!-7!)1ZG?LYAP^64_0DF:B9N<\'&/E9WY/<@0JT$;:J_5&P(T
MY5E[53[@:H$!N7AX+(0LKXYP1J"^#9(+&^Q,*L*8^:.Q18W]]^TJ#:(#>()#
M]5:$2TPYJM13O)H7S _DH/GH' Y#@XF32R[@WTVU5;GZ*[Q<)^NUK*][P(JP
MGYN8KYH XC1:=O144! =LL+BKW!K,?VZ![4HQ)HR,O-4(BJ/(X]TH_0/3=60
M-<*81FO^)CFUB'*4V/ZR<<T;_9SL-EXC'3CCP2 !T"H8\/E<<$D+E(6Z)"DM
M(\>]"5TW[<@X]<&K>I1:6MPHP^6:!*T="%HP=A@;ZUF;?;KY#-5Z\$J<=&+T
M.-'-+\Z*8.5>.'G/K#P3FR/,KMK_95W2G9)P7^(C[C:R4BTZ]<-79[?=(.I>
MZ):RM1^AD("!X-#BZV>TA4 @,\>!X9+!1^+N!5W94Z:7)9;0XNG7#VM"1XHL
MC(&J*H][58+E]>N9'H;@T57TGX> :)WE+?^:XM<IUTY>E_TB?K^!"W]>%[V4
M*)!SW0 HIP]JO#B@]6#"3G.EO.>SW6>WCK&?&I+/-54UJ;9[DL)F'%HPWOC=
MH[U9*\VXMQ:1^V095T (RY,%D84L]WH1U1_:?)9_AN5NQ=9_',%$1 .GC W<
M\U  5 !8H4?X3<N.W%"5H#@<XE0__V4M^9._*ZBEW4D0V_A4:S'^XN@<)L>W
MSXAKF35.P]1Y%W8PR #WP+]%RT.U4+F9L=94F>_.VF5,PYI8X^^+%[[%A+%'
M^TV:53"4FPU:O[2"/+WSB('@BDDN"IPF63K$PY*V:,A$^9]J0C8^FT1:78R$
M"2]73]#P-+MD08SX^N\<0B [T7R+?/:X[&="X7;Q,,8 R#R288*5='?9E3"F
MR0EV /0,.Y^0@V K66()J_7>/%SIQ8.J?M7DAXC*/#Y^A[0;Q4U/K^-VWJ1?
M[M(I,>XV%NE$>_+L,RO)YLA=E><$?FG+<DY37+:-W&4<&ON6/BH--:FP-$QR
MQLKQ?V]<C#FP26L81***R!P78@NJ[9<*M0RM##OO?6EO)PND._!XJW3ZA"^6
M#8]O!5'+B]D)X7%S'5 ^9[PS?TI/:J";@@9N L)V^7-TZUH!;4;VW2.95Y--
MCYAJV%Q!2FYQW1UR>\$J493!7B 4(-,>$^P_*%&35(1UVA2[@LL?W^:?&78/
M=;/I@>V%$48\.M45!Z)>8#ZU5MA^/ 12]6XB8C93>?$=R&VUV$J*GAYCOQ9:
M:H/B;A7092)H)C&UWW5*78FJU65D8TQ >OB\B=]N,/E!]\&-6T5RX[YH8E*K
M@6V-QM^: &,M!I.U]51=NR^+.?%7CZB5[E=.X'$B,ZEV&/@Z%Z\01%<8-V84
M*V B:(#.@H.KWA2\+C#YI$!%(;2<BD8XW_1_&VQ@;[#[>NP0A\<&.3%QS X%
MTDKJ*!1*T1'09KL(D0E,)&:Z!U@II8YT3*<[E"Q&>3I]HEV>8,2]<5:BQ[="
M<^.T*^Y1?IURZ.8FZ($O0,6L-+#=1]M[759?2]J1'X52RYX4^^&]=J/O$GT3
M*>Z<9"8S!UN2;;>GL+"(&TV<& .031Q2E^V)O_.5%J\+6[$L510&*S1!L0X2
M-:DM2DDAQZ,!<[Y+4R_,/@S#7?#SPQB\AI&Z86ZD<=Y%8=U]!#4P=64>BW/S
MY:(/\$MH7R-Y^#$O@21>1E_KY8.Y*3;J9S%4U(G6#\AC:RSMH?=](\5])>BX
M7SWX__I\\S/1)^J.J9JJ[^Q \$-ACB3[7/LV1FDX>P6HO5V[Q:]L-P@51IBH
M MII;C:^2Y^TNS)Z11:GJ&>Q!%.5 .+<6/6>X-[A3 C[/T-\*1-M<0G>FF'-
MN0-YL:.?'O'^E1%QUF$%\ERH>DIYO@7R\:#I\(":SM1#TY:1Z%?X#<_EE\N?
M1/2TR@5@-*UE/*( 'V4O&2?S4L?SF.S;&@V6]7*3#^HD3LU,BCT?<<]/=U/M
M2M/U\]RUP)0U,O?V]90L6W6F.&#R]3IP5.GGOFD^*6_,V6FT HJ)GLQ@!T]0
M;DG:$HW>O$'3Y#[4>J'J2*@Q>\2-D.KL5 SI_W#*0R#U-E8>+#:.?)S/RZLL
M]MUI]"#-%$N_FA=^MGQ#ACW\N5):INDX#C=CRSG\<3_;.>O.]',L&68@]Q%3
MT$[IERO1[S>^OZ.R&ZD>JD,#Y2OI]FH ^=.C)WJVH1WN;ZNZSWIWP'XJM=QP
M_+"2D)R_;#)Q^ ?=UXI^6IRS:%Y^&B:;X-5G1)WQ1#;.:[K@[.0TQ>U$!U]&
MMH<\C9KR?IOODA>%)D9_U!8ZK[[QB&;!@I0T7\*+ .P)MZ-QMU7(BKY5$(D0
M8C(+U,^WDM*5H!HW['+8I\I2V473F0LMSDXK5BB#]J@WN^LA[7#"^+FH.%S\
MU^ZVHJ"US\8PFDGIOKP1CC._BSN3.,;'F?=L>,YJSLD4,"4CSTD?F(TF-1WF
M\B;-LH).R@>!2VB75)=S=GP#D,^F0-S9H\-)9(< 8SU<MSC?3@)^[3-D0.%0
M9=(._X,.X/'DPX2XY485V(!/!-)[DI*I.I3$8D*KQMO7M>[)O&S7P*4W,B\'
M%.8V?EZ/F(O"XAF/G1TVJRK](+JY7#C7'W2@/BB.O2=EU.]R,T74M#R$2W.$
M0JO^_!JM%/3&XCGM[6A[HLLNER$;9,IWKIFL!?*PN;7FLWC9X,]&Q1I1Q%Z@
MY(IX*'5?].3WO>![.9E%+J&#YX/$#5TDDJYXSTW4>>^3XP0-=56O@:2_UU;"
MW$D@_.)9Q]0J4HV]24GPN;'30^LQJ>]Q6@9!^&# <'R?5$"U$ F?+=>\@W*S
M'76KS9)KG[4200I.MA;@=MN<O_._>VO#!R;=J)O0[&P;6_?IUP8S@X0Y9.0L
M._:>C:;Z ]6#WQ78:>I#=CW+H,C#9"<7Q+LR"WRZ$?@FW'*5 M>O,-<?3*I&
M)6=K3JQ;J.]E><^<OI^*?4W9)I^GCP9' 3,Z@KDGLEH#<8(N=_-<I0UN]&\)
M$HP#+-V$357<FW?>%Y6NR4\8ADC4V,EBXH_T+ ^?)$-KNZ;N?C>UF'JTRO_!
M#6F3[_&<C59PM"?4<5&_4T(/,-#!)>].2S$M&5.[Y_>U.]1Z)_Y62!"))4\V
MYX)0S:4=J?5"E/V8&+F\S]I11\HW#AO>+W-8U;Y8#$_6XN7Q'8,IZ?5%[ ME
M;#_;&%?[\E$+"'0,<1V*-9MW";Z4Z"WV[@XH/5%P6,.)_ITSV^T%CN3_A0WZ
M[^G_HH4TW .)D0?GGS"-A3X$*\:F*/>=G#]VO_M@0$YZ\!?MK?U[B@O %3.Z
M<2N]L*^G>F\F*#>G=:=")#77JRKZ6P0I2=ZL$C>W+23_,GO689&H.VR>%[FI
M]S%()-_-'U%9]M2>U*M=PDQ;V((;ENGT/[(24:KN,)'0<5$;%/]!%U*REM2L
M/%*Q]SK$C?]K@<Q&N]^2)+&[3-4O:'',91;GS9</N_\%*RLQ*Q6389<FX$$D
M"X1F5CF_-C''\P>I(C.91Z"=#>AR^2]B'A,I,#[3LLX9ATN=N;:W40.EUQI#
M:D_;ROCT''%(._G;N#"=_8]S&H:#EB&> _-NC:$;1Q)W.1BCB@S2W'R;U@UM
M'CYJV@KMWOCK2"?;M>=95$FR5"!C!'+C3M?$Q1J1EI4?=/+CH8%AL-@6UH1!
MJ-YE0R!C#[4X-/%JPJ,^EO4T.'N/CA)[EL5AK]K<#MSMQ%A<LU9TE^E!I[^8
M"MM]P)0_X@.+%W= R7-YOKGLM:>$HA),GK--J/)$NN7B[F7)6G#KL3 CA%G[
M<9?IPJ)?HLJIM%!"9__,3(GC[J[XFP1;:Q+D!UUPU:S7R_P46Q5P$'=LX-:C
M5&Z*R"+6FS@QCID0#SG$ZQZ%E *Y(WK]5A +V!6HOGQM +$BN0XXGN$Z$U^1
M>OZ.;P=[CEA_7%&EAPS5[QUV O*^IZ;@S3.>,J.PR];?CT-CM4.TKK%KX5]I
MRD9-66#K/OZ@:Q,]:;2.V1+\?AZ,<5)TYZJYE7ND5RWTTW5\93\ZY_T8;I.Z
MDN2<%K<;$P!VB/"/07_7)#-^=]O6719'@QMC3]235YIWCX325BX+U#BEZ_&I
MD=2XRV1P=P_.2JH\<IF(RZUA2L]LRMK2AKMC *C^;"!SUD>/^D#\,D[\!OEI
M(77(U*"A>=I9-OY/%0WK^AS";=)#T[V_R95L;JZHHNY_8YMYRGM6!3IHLJ63
MT?J:,Q1=<$1MXHR2+%])J:J:?<I[1S$^]-.$3F,50"[]B_3$K^AN)\_5GZ"J
MRJ?'++H<E/0L[9$L)#EJ!)I79$ 6D,OF @-P]6(@SWO7D('53Q?=TQB299FT
MSR&Z/Y"ER<J\O(U:?TJUMHO;Q3U?0AM3%:>L;VIV%=_)L>WOG @97^0AXZ:N
MR$1ISY5^6K.7+!K@N;20C=95O=EN.^)W)&R]-G"<<_M%6%_'ZLU-]D>I[.V5
MYAEZ@>,O=VL$JY_6O=S=92I]2@7RCV=(=&4%W5M^/PM("^20"Z;BOZ0.\\%8
MY19N<RBVRS\#^7 $7_:!F?*+IK0[OUF:"]KK>S2=5J57<M- ^>L.W/8LF.]]
MJUAE6C5(6N'-TA-"%#T/SR<U[L; UF1TA\!9_T8E#%A)=B_$FN-2)T)?2I'+
M"<DF?4-DK049E:VY6:&/;>SL- B?DOT46JGK,*!<Z%?[+32,S-N),,GTS<$X
M+[T2[\E;2(N*$S%WM"[/NG\S-=.H*+@T<<_?V8EC+N;/)N%6_]L)&"$@@!@<
M]G$N?U:;YY8K%$.]#<SB!*":\)V:#)[SE_43];A6%NP)G)]*V<X=%$XIQ==+
M$LF&/ BFZ:CA8=V?DTBE$L6A^6]8G6^M1_! $2?,54UM#,B(R_.GN]'CJ9M,
M*QKUK,V]"TN#X(S$?$2I-UR32;6<&<:/ND(P]+YF:;A5G=VIU3S_JNY-[..G
MX&LT4=5U:-?<:R81G]J^_:K5\L?S_\P!X\]8\6UY5T%MW!W6),-K!^5(3OS/
M#?*'A>Z+@V@AR@"FE?&\V*186G6H:9'VS^X7%>M:8T!;BBRQ7>^KX2*<SZD
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M>I/4S2QU\YS,-$;>]&.O:<6)]PJ2X>Y6-\P+(]Z8;ZSQJ9GE-QM;I )O@#W
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ME0R +3E)L<3.H?"K$70XNO_'2?'EG_[S"'F%O&\Z,VTA7LKZFQ.GK:9'>J?
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MG"+>YT2A@+1FCFXR<U9X$JFDG"8Z3,FB9)RQX<M8!-E[75!:NHZX>K'3(K\
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MGR-/]Z"PWVBT3(W$&T7'5^M9&\;5U5K9NS&!\:EF0(;7Y+F0CR*X6%E1#%^
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M!)BZ44U:,X:)>&1L$V[R*KXH^49C"=;RK/#0JG]U +$L;_Y4?J =PZ WX0
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M]F)NS@9(CP9(S:FV_Q&O(SDG']$9F$9%Y$.U2Z726-^=\_ECD"U7C;FNI^@
MW?)1V, -JGJGTZTY#.%N!2GK%V"2AEF/W:AO%%"_?#NHLG[-K;UXM,_&&:\;
MFGD=R$E9<$B$!'4!<H2<ZUX7L.0ZQ=' S?Y^QIWSHY'VK_$Y?*0CKA&>M7A)
MV25] 96RYAHR 7K=2L\F#$^C':>A_<>51_\SR>D=ZM;[F8[BE-PT^Q@)O-,F
MS-,%4H(5'-,2:)W5TSC_C4:G,!,A,Z(R<K=WN&-?)[?HIH9GN1H'=3)=T2_$
M(1WQP*?Q].2*!&_=;T]>FCJ8>L@941^EO54J:6N39%0R?(!HA$S-WC&CG+?Q
MRA@9QR%<\K[(X;D9GT(F&%SHF'4L*EV?EHX>MNH0>&;\'YZKJX#&\?8*(!O:
MHG'3*.*#$__"#+99Z)H;J4LK(M]@4#HS1/7KKJ9/BC9\5R&/31_BG'1S)F3%
MOI9<*^1KMCL;&D(YP(IMQ)7S#Z5]SASX_0];<:% (=.F%+-[C*X%S<A%$X(S
MSCX+'A_9()M<>&2B#XG*^"F.?]XG;,.V$^7^=8EIKA[.DJ)I#0>Q\QS\@^.?
MK2$RX5LL':R>Z0R?\[<PJ317^O@&_^5C@H9&IH;C!CG&&W =RV\V&SK@Z"-X
M#/-D_T;3*.LW?[9CVQ/!&(DPSO-V(A9@8_&(B8PS ,C$5T:-8TNC]ZEL!Q@6
M[A 2))#1![Y=QV(I++-56%A5M&<8NMO@7I!JLU%V-6G)QV2?.N]H/5(P$?J\
M:MY!N_#D!+2BTC"3ZQIVL5'/S'HJ=M,M%:X2E^+UB(3#\YWUJECM^J[D%K#4
MN-2S.8](M5SR?PR]'7TGU&Y@V)V^O7C6FIVA_S-05[T,*YX**JOE.C%.@6FF
M:"!&<@5SV)Q7-6O1U5^?69[Q2'8U@]#F3Q>/'FXN-008?>J;_WZ72ZBK62'_
M;&KI&TU3[N$(D.&L=%O\K'K.54\#V[!E6C%(,G<5HJAHFQ>]0(>SP'3A#H@]
M-G^&(C(;7R-3*5B^E;7ZB?.8)M%*,)(Y +2.3O5TU=V=TG1:J66/JFVR<'\/
MC':QJVO1ZR)/(NI?EPMI94.YLH[N>C@6;7RTX TJ3PH.80\(RB] :\-YD0I\
MU.$S7 %DP^^5X3>:ZH=GK"]W-*>#!"K:7BWG]A,BUV(PDFLP:W%/<Q\Y[MN%
M48D:@_"8>?7\J!ZZ>?!.]%61DRNJ@HW,4D@9 DA:?R'4.G[+H3?;K]><&G!S
MNHR'C\^&8L(W% KUS\+J*F7*5NR4R:?)R.C'%W!G2@J'FT_I ;OJGU))L17]
M>V$64^?*_/H<\IO1JJCY\Y5P8;X)+]WHAN)9D]V,OGP(P4#'Q$+&FC\99>\+
MP _9!.(M7!WX*\L/A\V+]"QSXYR7=FN;>$6^T>S<WPA%SXUIL!Y?M;TFS"3^
MN'^G Z)H\5(Z&Q_@BG0:(DM+,7<*P^J*]X3%WZW'.'6C9J,0)8[6@39BWVCH
MI)TLRI,ZBE!S'7GKJQ6 ^G6R3]E D7P(.UZ^X$FY#'Y/-8@*O&1/$BM?R$K<
MZ58FA6&B,)H#?9T< 15$]8/,1?\\5Z;P>5#?VVZ1NH>G3[->SY="!_/2QUO]
M93XN"J; ^)'N&=8*8I%YZ9JRGPB]7%$L6#==;.-68#>8(J[<!@N([XK]O<9Q
M O-)5!P:T9*B<U4/"EKQG,OVR::]6-QW$E^J_O;=FK#,+#*"XW2.W$@KM)!
M0*;3M%P, _N7?=R )4T=7Y&ZNVA;V%J_" *ADIG4Y_E*W?WWQ(6^'!IMK;GP
M=PGG))'O(AY:>.>BU33EHHLL/#%5)H*>^5E8V:?96R\)T/6<<Y63ZX.%-DS$
M1:@6Q_YXA\L4-_$X1M\/ #&RS%\!@/WU!V0:/4I03H3Q#=:G4#W2;0Q;WM<R
M#X[G*22&"+A!Z;5O-&FG/7/Z_N'+GET1SSU"$S/3DP*#%K#=,$+EMEBES]3L
MOJ$-@'=SL_LP>X+A/<*/_AO-P>+W2<$Y@LRG(Z0)6] K!(S9U4/OCEFZIPPD
M;S5"7 PO(N7-'_0%7XN,O63'L=K;YEX.UJF=PI_ZCP#PF6Y3J,-ZA;3J=^(?
MGAXE9\O3<[>Q0TO*[&+J3+GR<MRY&!.B5V0]H$ZYFT0R*-J$N@#7]<A@4;/F
MS\BPBX>\\G*\V_1ZK=2T5AC7=^Q!A\XBE8%I#:*V@-W7BV<S@WQ(AR0Y]N-L
MRU;B$$49O2YK0Y:?1Q&OA6)J%K(>]"JEB [O>6.@#4-"-84-6T6'J8KO@6>6
M,\E=9JG&R<F#A47XZLO9"'Q%M$_1>]C5E<CP*E>H^@IW/3]UWL]<O9D2CFMK
M:X:Y!=!5GI7"G'-0E6>>QJJ8$26<BV0?0#8EY!=2[X>YE-L@]6[[)8Q:L-5"
M]5*YED@%X[+$HJM9\Z0&&N(_)!D>JNVVQ:GH]<2B7 LB9I=JZKO6I&GV\3G"
ML? =I3#3V=X^&SD N36O'S__JVRG)2A,U\VTHF=L?E =Y\HL&S_Q_F!L\%.3
MBT48CW>KJ6O^=3\ (XC\C>;V."7;N'@ZA)IV)NQLBL]'Y3W&\:_Q/]H\N][\
MX+DLJL\-5Q@9E _NCP\?LH_2+-4XZ(VY'KPJ#7_Z19L,V;+ NXW;8/7\56)$
MPACG$DJA9?/BJ@0[1_.%Z&8'6<D8*?>S62@W;Y2Y^U9344?J[\,GON8/.-I?
MU5&R'(V;!V.Z>K4Q!-D2Y_?7R&R)[U8]MW!\-1]*NH^*Y1ME6_<N56\\W6(]
M\W@LF3?Z0-AO-XKG8DBL<K)/!VX(6H?./G\[RR5^E<[S&PU]XL*<# X4:YKQ
MRJ?S03GZR?YT1Y!HV?425.E1IH:)D=Z:1PAOU@71R"(6,9W0A.<#[*J!F[LG
M%,O%C!!_]B>!BGF]%ID"6-?=L9^F=6GO]_$]BY6Q#:N3J[WK83G"N^'?<)Z\
MD,3B_-AB7.V:MXF.FKB6419AK+CPJ\$HK]*$8']51?AS]%2$'T386(X(T>&Y
M#!&R ?L"3--+AJ@Q'59\+CDCH"&,4;GK4[.IJ?CWVN/5Y5.K_HDWDHSAHOAP
M0U6)/2WE'! @YG[F(EV^J&=_-) $J-(E2@/=K57S(=VLH(D7WXUC8,M43GTM
M>G- 7$/<_2Q7)5_=M^@6W_Z@K&8N_NB$;R/Q*\67: =/=\ /Z1;E)3GN]Z\H
M=*]2YW"$343\E5FJE21 HVJ[3N1JK5QQVE-BR%QL\:A536=/T,<@0P[-%"+(
M&%Q[3 ;KGV0TOIA\Z+<M:@'(P!,P2&R*)"!GIN=,-K?M30A.PJ_BZ[;4F @Z
ML)Z[S6D%>VRR\.FIXV\W9T4SB4A@2!#/++#;YM[XA-_WW>B"P&>9VUE:TV,9
M=?HU4N"-A8;.VC!-3-DT'O_) ?B2.HM$NXA4*U,6TA93)^4_DKR3,KC36?)3
MY.^5S[]\5[E"/]^E!P5KYLXMXJDR6ZG/[24555M0<!-T0S>(2XE!7O62&ZF^
MLM\G\U*>FQ80X\:E=PF-DNN8'S96K_L$WQUOW @WB5[JT_>H,37ILQOJ!6G&
M#<44%!JHYH3:VKD"G9Y_SN*?WQ#(P<GZ^Q65P]CIXB]5N>9K*+87YQ5 7/4R
M#/6KT>^MPM23](>Q\]&9CHM9G*5E;G)'=3E<L[54)Y2[YVWY[6A #DK+]]$H
M]=V$OG3/ %''IHQJ*=AJU;=[1K^^\ :+*FFD-?XP5TY6UM\=L.4%0[C%2WFY
MU!<RXX5@[\9+*V.O8Z.P96?NMHGBAO8;TDXE)+E6YE$37%%Y/X&M]74[^:$
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M]Q5B+O<"PE5CRS(UI'6X8H#@G6UIH0B1>L;8"7? 8$@>MK9/3T<:NR/HB.>
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MN'\,Z'"MUZ^4OZR6L:W'V[[F/V4R:*U<\RKNR.+W"B,=L)Y$;SY#^&MCA=)
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M<A<@7Y3=.!;D1E6Y' PV/PT^"YYC2/,,T0>>6>X7)&DIFI=-A[$]<BG.JZ6
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MR:DIPQ,V>9;<ZZ$3N 5L-4W/4(E5RBT7IRM>E1G/6#/#A.YKYF\SM'@\O[L
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M.:@&8Q'\R/A1GUYQYRT,!YL#GBZ,3AMEG T)J39W_8O%ZJIC@9P.DL#K@Q8
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MV5'_]VC$CF'?,0C4((>P=>T7B2VN5-\ONL_541>(^UJ\T_F=YC]GY%I:^/_
M/L:WWG\.4[$P8C%":B.ZE?I!0D[^+-:IBUQ+ 36@:0E&RQ$] <W]Q] ^C?#]
MQ],%'M7:!'I*1RS0F"21Q]AP5Y[RXBYTEV/ACFL2L_7VX"<==0%WN<:XWEO%
M](W^*R9R<3C:LGE_Q?OSN?LL)6NV6ZZ?]!SSLW.J!^%*XL$9[D[QTTX!YU<M
MTPA;9[5?E>PRHMY;[0K$7G,]LXZ4_C.[@!C/+7,X9&T:VF)D=]RP].!KKT&F
M&O$?JP5$%9^8+\^^\O9. ?*)LPB\D"T?KB@?,/_KN-96>'2D8F; =]Z;>VB)
M]'(D?N[EA(&!UM7%Z/'RO4JY#<3CPJC7N4G?:8(?GZ%?G."?!66'EF2=MSU^
M]T58OB7F.TU4[''JYS&R7NELG#(\M]:FT+SV(?^PDRH_7:(G[TZ6LEB9)@5T
M8B)0V?Y:%O4*#G=G==W:+X,(BO*YF6F)6F,DKR7B-\[;^S&(+>VQX_4?A-I7
M)BP?JG;Q@U#'&)G.0Z>76(9E;$8P-)5/H=XY_JI=,1A21KDD,D?3/9D\H7M\
MHNO@]\I>/UYL!.QNO@?,/C358/:6XN3TC<]P3OOF_*%J?6=W30W)>[[5=M-.
M%HB'FQ;^D5Q:VF\KN/$D*G;#*R%5T3N;VE:#P9XQ$@X;?UEMGM"@;^[OCXUX
MLHBUPHK.K*23SWL]S[?>U]F]*0E_V"1M3_<(!<'/.2Q-G@\@1!5&5P<"4DOR
M%;-*EKI(IVZU3P=[@<9O/0*R#:D6-3Q$8_&+"\_?8UNS:F;_JE"(.?0*(^N.
MGJ8DP(U9C_:MBPK3$!+';#9]6(MX'57])H+@=-Z$YE$=^SN I1L4JL<_4-_-
MPOQ%<!\RK6IS CY\BYT-R:5M'Z'M-@R43HEW>(6H=&/(NV9MB8?S5K0G:;';
M#AC@@KS%J-4[;("$(&O.!;W0>)MA!Z87B98C,S(0@=;CKP;!>"<C3.:,R\MK
M0<RW$A5E#), 6PAOYB*5/C.3O ((VF.+(S>K_2KGD#M];FR$R97!1$N[>(8^
MA^\TKN_WGWZG@7[Z-O*X_>Z;ME,A69#<=YKO-(Q57]\;]@-8K:MN[WRG^2EK
M+7=<LDC/;$VJFQ_#/5VGYSI5SYL&O9  IO9E#;R6S/^L^72H#*(G#!^G'H$<
MDQENGFO,)0Y7"F4IA@L[1;KFY:58+29&MI?A8<-^%),VCALI^'J&_7Z/9)L5
M_\58:Z%P&08C;@,<G1U(S,LW$R_[ OL!5.2RQ%G&1L;JG'%8/S%LS0\3+>#[
M3M.:8G@XF;F1OB!FB)-GN5;418&-MY4,J)9=%;@"FF"S&.Q4\41VQ<"8"N#>
MZRO-_86O)RY#']FJ%N/+=5[!7*D*R%IG=0XOWVX\G ^ST)T5)^F2.U ^FH*P
M"8C-:E<IBM_+KG]2D]\F^)V&I[BXP=E/+[9X%'T,8C'*Q/QK%\/Y?&VII<DP
M9Q]$]W#V4D@Y?+T-XA>6/9$C'D94;B5?A6O0:Q-(5 1/!M R-FJ: ](P[G61
MD!(RA1%MN8UU[G!RX(JS2?8G^8APL!GGUP,\P^ON/?KD[JLS,$R=$PTV'3(R
M*RS4\K5W)F6Y336B@E' 9'E)Z2%PNK4L-;&H4I0JB#$TL&-AJ< ,\O$G.57,
M><JH#$6-O;5WH_EJ<O5>Y9P(;0=_6OD6P9&A7L$6IB!"]/24EOI33-B]13XD
M?:2Z2GO647<\X%!DQ:79-T28<*I)Y'(*=GX<T_2FI)Z>G*E4W[>RK44=Q54M
M]M;PRHM_H2QA/$2[AS&)%BB&H;;;E7,AR<3<(49@$Z33?TYKML(Z1?]# GQ8
MOAWPV#+R<<^WU<\KMK<\S)-013?DZ8UC/F=\&0K\2R_"I6#4 M[+A!O1[N3C
M]\T@]K=)R;A"]IQJ6_T^L6' +I':W9QP!ZN15U2HS6'#K_UN Q'8.Z[SHA61
M^FF>/K_UW<PS@I8%9$Y+.J56/]M--)R 3F>B9XR"K%"GBLEQX2LFS>%'MJ4M
M@[W"3RRF9-@H2\[R^O)<8*_JP0FI,#'3875B^5G<='@EU #;/HQE^IC^ "<F
M960=[:JXYI/F#[C':( ]KA;7\>0#EGU]VP4[(D=&BDF9 @O(#VJD'?<G6(,$
M[=!!BA^+6"PW59UKQOG"'.\0#@<OZWCQPYV$BIJ^_HE7;+L3+,B\ST_F^VM#
M[?+@+?9\?#D0")8PW:@H-'<407OO8F+QB[:==Y;#*SY/E2:' ;HB,XERG^O'
MDQDJM0F5J)W%1?%F):'"NN?KA(KE^J.'?%2?[ /R^ #.U_<L=SWO7EU(#2;I
M6SC1Y%N&9%\+3 YG[!U'!)=G;?:SWF]FF)$=L+.OU*$7D!O#G+/R<7*YQ^-K
M -(FRX9[5Y"))5>:19G?^V;*Z'"RPCYP"O@R!":#OB'$OR;QGE]Q5Q6233Y3
M3!4"-97&CF5[*\\C$I%O=QZ-E\J6FN @(5W=^$*B%>K<R6(OB*EJ*#;,T$E1
MGKTAY8S9O1)U:_#;Y8JGHVM[<FR4F)<X4\<(I>21=9[,JF=]JTRW()Z!',L;
M.:3(+"2UD\DYY:KN@4>7FI!B/6E+P)Z3M-IZ0#DQO@D@%Y2VLH)ZJ=&^.GQ(
M:]F9V274VV6_+]7U$@872+OW46G&'I'%/:G"7OU7:6M6E]="5^&O;NL(-M0^
M(.1'D]P/ _7)?7."H;"S*$&TEZ%%+]_@Z&8ISIZH.V/<\S41;$/IW_;'.!R(
MQ0XI-=4O?]CWX934DZ<-<<[<;059$)O>H394 ].PRQXO;B"7]'.ROD93F4AJ
MQ^MT-W&<_G0L1^$A(\,2>A7QI/IO0=W%38@7,VZM\YNJKZ6TKX5]IZ'+ML!7
M6YT&J!U NOKDE&2A2YLB+,NQGU)%NI=(6QH& ".Y3[Z-CKU.<!P%&/OBA?4L
M[^XJR?61N#%OW4BG1XJ<&K0=('F[A+J!$(1TU[>.\&9::WL$1P&RBPOV/U,O
MY[6QT6*PF0/N[\CY1U6ORE$!7^RHQN(G;[1'5'Y[[Z.BJ/NV8ZN?VWG%P71G
M?IU<](V4F>D</,K_R1(;G(VPY+:E;!K7\K3AP@T2F=E?.87H*\AJ&7:_NM=D
M-=J#6;0MX'F[([\=15#4ST[Z<EC*A/5QKAULHW.F;Q&F%UWTOV+-"O$+7EYV
M:IOQ>OVQ4G8_J'K2N=S,UJW4&O]\7'<*LMS?A-2C:G9'#7<$S#D) XUUM 0G
M_45HE.C_^YQH+?[:8)/C@/D(4COJ+"*S8.N(MDC[O$>6V;UNP<:D@(=*VK'D
MRUB,]S2+J??7SM6-W%Y^43<XM>MNP55H/G7'70464/'Q!4<> FSSFA;*X^ F
M$'5LRY6=DJMK>Y!'B'! &EDL-2-2$P4V/BX-H2/TEC>6?-%R<3GAV<U#5Y,>
MEF"L7#Z94TK<[*X.9N'%W;%)T:&^A=BVAL]V*1E)WQI[5%9[>=2C/GXZ&VW.
M\[/)]LT@X%O&J@HG1Z-B?#-?DM8*'&<.7KP/TO?MI8TUZ8CJVD,)#.600AI2
MQ*EG6MK]0*/+1B#;[D7^U'6Z&[B;871L-Z5M15><=4EM8[87%\<2E?O TM1]
M%<QO-1INR[^74"@B<E?5.;D.YST0?+Y?<?V];&\\_*O(G$7<8A19;*IO_?-$
M.\?\0R0B%>S_VCI%5V_,2G \SDZ#$MQT8L?]K,;[*GW.2ICC]<,Q:7'-D+1F
M/WB?N$=SGF."K^Q%X\]4G@;[I4Q3MY_VOSI ^!(;-<OQIP*$T2X,'H7CP*Y-
M4(Y)]U5Z'WL>$L:J?I2DZW]C)D]^LB.6BI)LJ^JY$;G7JP_=[/2K'E8DXI/W
MY"R&=H$@Z?!C8".:G5[VF3*('OV!:2X?R\U)J=7%V7$.^WCQ>SHD?HD33'N4
MO.7W"J@J?@7DQK+C,!LJ9GGZSJ.X9H^321_61W_=# )?^I;*[U<>U7@21PG^
M&L%PS,5E9\94%FL8L?HM\9<QKY =JTB(0?R$J6WY33[;Y=U44*W*6<[6D5X*
MK?.M02/N4-4;@Q/4#$[L?'RA+4_(ZE&6YZY)1$P[[,<0F],(')VOLUG,B_DX
M8>'.)K]^E HJTO%/ZD'3W[(7W>9_V8"H)V%FU%EQL#&Z6_$\=>(>:NU7:$'8
M ,PWW7?D<E<#%EI(>9&ZIQXR6B\DAMY_'Y*TZ&8+%U_?5$W]V/\%=_]\2O7%
M=YH?L.4DR[-7(V7[TS?*XZZXZ5.">GV\9##*.=%H42F$X3O-]M:U$RVAUKL]
MU_VU^B)S5_Z$P)6N?P""Q/%I? Z!T^1"NV$[CJV'\C4*"07I)2Z/).Z%"[<,
M4U-T2S=V>@[VI7+/"K;7O.,4::MF^#%L>H^H[](T0F)]A_4XUPZYEQV1A*09
M)1$+,.>KX4%?L*V%X9Z 1:)LF"4]QE"9NYE@2DSNBT8K%MG6IG]K+-IEK^=]
M%LO2?<T/_ JGCQ0+@3V/ET8LS"./TRP.SR:Z[&6W(B6*VX<FA?-%X#!1+*/V
M"9_OB6N+!WZIM<7$/C?I^OYCBMGT %]^F-A>H3'T F:SB=W83;C\15LFEO)>
MR!$3_';KQC,#=^H,**J4V0B-OL$S^O$%:G&X=U#D+@(TH1/8R#@X(5QH:MK3
M.7H65$GGX#)L#M6I4.FNKMH_[FF(H"I_BQ+=+&ET4@/))ICO<VKZX!H?CB@I
M#7P3<%:N%'<GXM&TM+G#!K*%%)=+8[O0ELWS)V;]PC6U@,_R:=TRJXY!6>*L
M&T;;O=RDR)3XQ#_&>W+_*-WPJM75#?HH)H?5OEO9C:CX/-!Q5J^CEIF!JA77
M\1_(E<&$!)\[GX]]IWF8M&\8EC_^[9L)-C!/Z/C%^]CPM;DF=HE/+@,M"I&D
MOJKQT_ON3UI06VP"^^(NP/K&#[4;/.P>2@JMR+-UZXS<5+J1%CPU%V?_@N2!
M%PPK-U=3 $M]8VR2'3%PTJI<<PQU3WN7KB@039R!?DV*5?TZ$B(@."JQ9Y)=
MZ^\6&'NSG76%XE'>2W78-[K0,M?AS3LW2THR\_'X3I,&EL,& *B_;Q]UJ6BQ
M8 R<Q(U"][M.B _C+;5;H@-3Q8X/0]1<^V''=R#"<!&Q_=&"/+*)[AA?];J4
M8^*;#9=ZPM@#C$1>WL>A# %N?O+!P:$_2GM'I:U5Y %J.?XC(8FS'<0B&VO\
MSC2K)PX$ERC'CGTD6G7?P8[66N*C63E+("Z?F:ONBOLQ3LH+ -$YGV5@A6B]
MU-MB'6IO'O&S-Z^  /VPOBXC35_.)CV;VM78L]ZDUP.A1OY<+X81:CX:GWK:
MO?^@;O3^2M*O+X.S!&\CL(1=^#=3FQ\C!7516(548F. T]V[K=']1MB,NW)Y
M"INI"O604"-8;D=IHTNT*H=BQ9]:$;+T;Z9CXCV&8#536*#LS'J@-L.X6HM$
M*\$)0EN?.P-T+T/VNQ0M8B;!=\5\<6W/$4N8L2M'(C'CI_(5LZ,D^J,*(O38
M*Y3):NEU"MA?:\'U %4A)?"!?G6[W7#5*T#-6K#,*6U 3LO#%K9M;H/R/8Q2
M4UBE/7]5L_5,WQJZE2[>,4U;&X$NA4QMCSN-\H_8&&6K7*/GD_1Z.@.;Q@[^
MU8ZK(G=]10$:KX5VV7=Q6D@.N(.^K3FO.(7Z#9K+N$YF(]**T"[UA0E;IPN9
MC-YPH]-#PUXYC-OR6XA-B!#LWWY4^[^P7T-]Q0[_7J^O^TUQ(%.\UH&SPIV^
M#*9G:K;&&SXMZ&593''654P)KONY%V!V #=,AG6\-'DYYN4N"JANMKK@W"P$
MKU#V@"U6R$>E&.<)U;<DQZ/\\E8?JR?+G?<,-."\NDTR*X\&C=PP:4> AE\4
M_TQ7A#<\,TC:9B73QM2/\!NEP)&ZBWOY7P?SW(847C%.ES(/-!S;"7AD+4_Y
M=18=HN3C]WOF%ST2)!)=\K+M>K6U(&8XXV,*2>#:]6 479#:I?+G^AM77CZ$
M2WIOCM7*JY65Z7$6+]1X+Q6UUE-EK#RO/B_D?/F@I;HM"6FNVU9OCP)4 *IQ
M;F$&J65I']-K,D2SNQ1+(Z/$D^6NI^!,/X.RI;SK\UOA%4P51:<"ZUI#IA$'
MGF:#QJSQ9^\G'YO\+IMA M72<TD8@?X*F@9PVOL  E!;%KLVF37%C]3NZ=,_
M,ALE]L3D/G1)482<'.)2'TX1ZG9"D_>5YVHS)'@+:D&#%* 9*7EX4P\W/.)3
M4P<^9^I7]XY9ZWU AJGX< ^O)F_.]Y; PSOOT>5=KR4PA$&@=+8?Q)G?62U'
M1@ZH&UTV,]5Z)[M7J1I !C,%,8E_@9H^:^:0^G3@SQXSTH^M-ULL"G5/!G6D
MU8+8@AADM@KBAOS-62^DGN.[BM8#'^2DV-F/O\%C;^L'7'TZ\)E:>ZTI^GEG
M(#P^_).LT<7)5%U]QH*B>8JN3F>R#S*:KG;.33YQ5TOK^/K$Z937*S"K8'M!
MX;)G(9RZX^V$SG-\O>I[J2F6F RTJ4S?R*%0$8'"HJG1:DFN<W6F 3DDD,7X
M@:\![$][); OP4FB00]3:^F8=K8LDX9?T#U3[OU5.L$OK8+>_K1=4#=ZP^E4
M$U_!9VS0O<Z<G=7-'5V.X/Y.\_%;Y-J_A'?X/\([1;9L=%=.H=*FX'XN&2QD
MJ7C L94*ZI@DS?3+[989=@P=O(C*B%7LK18YPH895?9.J&96H1'>CF$':7_,
M-;'XR1("#2(T-WW3>R/[':=)AXCVYJ_ P#8&N%0J4#<_SXGOQ;SR(?Z-UL%(
M<*T*@+7F61ZJ<D4*$X<X]+=&YQ9?4VOJMERO]F##KW?I!Z[.IFW[F6]U6\@=
MR2>\;C/?I^P_GN#+CM2/KF*YB9:3 7</^R=XI CS?C +3%'DV[_-]TL6\6O'
MGT4^):T"A@,:1LPD [Y#]C9_8V^JO)A@3T"$V( ]'N:Z,6O1S2O52]5Q2AJ0
M[I7V<9DP\7UAL*\BP+M&*SY2!I87JZ6K^W:\B6#<])9X*RR+XX82,0W$B$3G
MI82K(D-D@#&3;9T1:*,FA*>%*&'LVY51*(H0Y;N;NZG./04KR;V7C4\1-4\;
M=ENPI2W%4ROJPS9/>F6/=,<J?7+[=+\QE>/7L#I:=B&Y%94&P^_2'Z91])<!
MH-*-X/.Q="A(#$WI.8L_2^,Y[MPD?Z?)'_K5%) <Q/0$8M4S*_"=YL.CE9-X
M^;[RF3-D\TBAJ1',*3+53RWCBUB-;AL\"^>SGBPSO\'QZR7!P)U_:(4WC+[3
MY(6"0CXQIZ2.BJ1D'#+JHD\F[A5&$U+-8U/O9@I^#5Q:UT*L6$B1Z?]*[1%%
M%A?7:XX[=UYM?9L=CZST@&]X@8 AEE^BZF53)@UZ67C=UA"N FAM43L./<XC
MO_49<*!13P3T(#[6DWG0;&3::7)[5K%4NX,RO6%Z&_FRKL*M\?#;\Z6,NZW&
MA6>CCC#%AMSI5HNX2Z^+;;XT#)FY"\67-CWI8'! 6+<M1LO74P#;";O0,LX%
MT2V_.-W-1R#5W59&MXK#;)"#M+'@TJC8,AK5UUY2P13T3BJT@#G%5VKROG_#
MX6^8HOP).9Q8U>2(O.4LY<1PV(F62_-0I$PDB B6>S@0)S_MW?D&QHA*'&VH
MART,4^?7RT:ZMZ/",8_HV/6)*96?/^R2ZYW=[)K'.K"G+BN6APQKNSP/5C'6
M\DKKV1\\"956DZ@:\K3>!R#>G0B#K-I_8HV%-$)<^BLT]R&%\1V$4ZW4J>%$
M^NG%8J2!J)I"P/7GH2Q_\+6PDR.5(\SW*G6DK=!0:/C#\=;I>>BA;7,:/8_,
M+PZB]2#WAD]T+$_5"\2Y=J4<?$2R*E:Q6[T G_X0O"I&MVK8(8/IJ9&]QSAH
ME"+-6GSCZQ4M3R)F[-L-GN7@9GD$=+IA!_FQ(,MA=G)/.DL5FX'%X&LDSOP%
MQ9=?YPB'C#R<FI\(?FO=2\\G.\;RJW!!FG9J("\D# ,7!6W.KB^E:,^V62%^
ML<+#BMG6(2(0A8FR&#2'GW;7X4ROU?#<#A(HT8GWS+0K_$[#^6J%73\H/_.@
M\%-<?]NA2_^^,[INY?KTB-;4XCQ1.W^M)%)HT-W?D&)>62?1,;[\!#_N3D#%
M&6D:;58=4OQ?@"5>,3V[9H\)N5)VXZD%L,%YJ)*HP!?L53?H*5)37]?1\+M7
M41XCE AB<W7(3XA4.!2>3JOH0U;=Z-U8(IQJ5G(Y!"?>$WAS>RY&U(\!M!V@
M*LP&?J[CV2C;R5#CB;+64Y 4J(\JP)&^\'($-E%[)'TJS2$.^JZB:1)U#^M8
M"3Z=0#+GC9,7UX=6,_L#ZL?7WK>9 LV-!%25K<7Z+(2NR<Y)D(I9G6]BL)V/
MVD\_Q/!))CX^1OZ] I=4DZ, K-U_H%?=<O9LW?!FM@' C?D]4C2TO.Z&='1A
MB/_Q0,?!0K\E,? 1H3QT\FFUQ$UF?X#4AE8MG,\-"V9/EV#<R=I1CBT)/$T)
MR(B^@'O&F(F^#&U,_:I/.,ZN!@BW;7</*ZQ3SM@SI.9B;,3CG'(_&B7S[TIG
M"0K=M%1U7MHI?XUUP-AM'<7^O>GB\,K'2&PR_]B0T?3U#</'@4ZQFD><<?G1
MS%ZFI=TKD./2!+N@+D0"C/-R;&C%U!JOGKRU/-]%J4KB#/4K6BOV\;'[JQV.
MQQE1Z&?@ N^&2R442T%J%EHW<^D[35M$<'% XFZBB+3?XGK1N,)0M]B&[XQ[
M"I?P589/WHXD<\1O-?Z#"K;'M7NHQCC7;1C]Q0.MXS@[\<4NTG&_A^LY0,R'
M=V@"+*[$Z^W.>I=EXZSQ<J2O;M#SUA^%A)??NR[AL?M::Z+&FSUCG+A-H5=I
M=EZ3;!,3"PXYKUS'0%SU[J!I3</C$8G2AR567IGHW2(C(U:>F&Y1GA.K$YSN
M":0NJ(*!*UUB#,E7"3EP?P7#NP7Z8%; _''1%.GV<EM&EW)?4K\EU?R)7E9L
MZ_H/PLU?W#"HI4W2K\U4P%G(N^"QIR+XO64+?^ZRUH9ZSV^T^E"(;)[,!?'E
M1MS&LYH!H 60%+$]G!]/JK*&\7RGN?Y^ALBATG32EC4#?AY#_+BC)W*OQ &7
M1UV'Q$&W\TI>NZ01^-M_:M%#-S5]#4_]^AK/Y4(GG;\8YSACO\B=Y'D^<<DK
M9(&1K/,E+2"!^6/\YYD6FFE2J\OXK*SP&TL#ASQ7RI[?D R,@1@D3SBO%/U2
M7^PK?XPMV^^N;Q\35!F 9TBX=7^GZ=?:9_S R1TS]+K<Q.!%7JE68$VG"8L&
MVH(_-CT-^9-.!V66Z6L3_-Y9A^F['(OU$VD];O][6E[T-RWG]=PUTK!OZB>O
M<=C(<Q%(>7CT7>>-S06?Y8:&O?IRQ:CB433'*?&(C B[#(G/=7RD).NS6U%]
MSL4,F$XDS/XY=+&41,3AUPG"8Q,^7403M)9BEP0LB/>YL.@H:H%VBV<6EE76
M_\:>\,%Y1/<PNAA5M"%2WXTI)@=[OD?0:7SL6M\ -*"UU9+W@<,&-Y&](^&5
MD%/G-(33-H.X_+/:*0N%S#6W/_&%>41'V 6/:BX!E=^3D<KHZ9V$[Y:M?O$;
MBUQ7JU;^RXAN$:$TWP_%J35%J=6@<MS5'(*3]8 RYEACE';*KXIBKV*$'E\#
M5#P'S=9P3+G43&4+*(2OX K=O6P>W^**1(/9EUZ"\A*$'DLT5_CV$YW* : K
M'E%5LK)[-D*X"1)$9^D=T3?] +X<VY:@>=RCQMV29!"6(&H<70 C+)@(F+O=
M8)LK%'Z;OJ*H_\TVR\S#"+-.N$'D&JP@=9O79L5[R(YCM7FW>$,FVC[\@K73
M8PZ\?0/T>62R\%'GTZ.:$C/@7QT+P;EG]:>.TV3OMW4N2#QY#4M7N>:6\)*$
MR4T0*JV R1^-KS5$920)]:I?!#=M ;]Z8^1%DEXFK<=N""8)L"C879J/$S*(
M!B-6PBY+D8LF,F7_F)!S(;8#L-W#9^<374&[(+4K@RSDAI2D6Y\TSXPL).,K
MT'R6!>8A88F.53=R0WN'+A; ^^CWMYR^TVR,?*>!OUIXV]6K;;RC;=;7._,1
M'\R#3V(W>/,,&E3ENYJBM?58W,'/=JU$,'8N*ZNXK&BY >EN<XIS2Z#,4^<\
M!;]] 5PWYB:^?&7RQ<"\1KT_IHWW8BA#E&G.N\(OS\<I:XYY:%;)38,9M42>
MX;0IFEEG:YMLJ#PM@I.2XNP,V-*QL#M%]Y]ULZQ<+F.;7:V28>\M?#?F93OY
M!7F<YAMP4E45E_"'UU36\1\>GF3(*EZ$L5(7*UNBPS<^]2[4V ?9'Q;.7PMT
M/:OO_D/8C1IT'RU?BN"\E=MX336S5V'_V* F0[[<._C\R.Y]5!_PPTW+95 7
M&#"Y^PR;D$!,;?UDSAZN"+E :EFJ&"5Y$II!U( ;,@LFPQK>O<2AW_UP^EM-
MW$XX)S(UP9;3E"O1V4;5@\P>1B=YD3<:AOVF^3H1 WVQTG5O=[4!"?1GHZV1
MQ&D-PH,\W.NT7E0\76W(W+%TB<P:$V/^(C>Y+&,:'TXTFC&L*MODJGI1^'(N
MN*@P.R\AX4;FBI;Q9(6#IT/@JJ&#B6J #(6DI.N8G^SJ:H,J)??9\6UP38F9
M::AE[XGYZ"SS&%_1@IXFJ4.6\LU_'53Z[3_QS__]&N'_?V[A5?<;3; XI2)E
MO7J]Z%!ZJ/\>D!^!_EA:(#L3"RLP370BY:Q=9 ]O4^WL0%LFOU/O=_D] ()Y
M22]3S31B]XJ.67OOJ<)-]Z1\W:1RL]V/57A[6&(()6%41 11!":$9@-^I]%U
M2)\"^4*702IK?UP:B+1)^1P70Q6@:V<3=)B.M1#1JMY-!9I.L/1BU<0.JQM6
M]Q9L3.QBMPM\:K0,6)YHC[[ :2]ZX!%!*Y*9C^"_>SW+V-1_;9'=SK7&LQ6W
M=3 <H ]AE;ZV!2G?#($6H?.@W6.B?Y0G(ILJUV,,0(";$\I'Q"FQD(PBM!"X
M<_1!&EW4K(:$M:O.+;G2^W^=$&NO006JK1_DIF3I0HVQ'Q,LU@F8'>F"%9-;
M0O4F43O)\O".K(2L<*:TV\#A]4.*H;=AK%=6IJ<4RG;YKT_!UJVLHGY^ YT&
MX%^5XD?;%7L\GX-86 S5'K4']%B3G*@Y<G2:OK"Y1 N 3U".+8"/!O_QBECG
M%6/AZ9:JRVN,YZ\?8#C=WG;K'A,J05(;\M8C6EHRZ#4"J](<BT'0=)R]HKRR
M/;)W["@0_%6PHJ-"-X4C/6/\5KH=BK_6_FPC5SJ6R=S,K-4K(3!GV!%1YHNC
M4/I?6/<<F30HM[.)N8N+;GN;M=< QJ?ZVN7QE(5>RSZ4IDA.,KL@Y@LMADO[
M4S/9JF$N[K$!K&IP@C_OE1UH2/O"@VERNRR)A!C$&ZZU996CI&-2@0B]/!OS
M$XI#3IG.L<'EF \*B$VC:(EJS!Q9$L!H?+ N/8U0C34TM=]):XY0\MC3%/%.
M*&"B8\E6/KH=Z>I.TA#GFRX>,V\OG'):F-'ABULDPUL3JK7,I@-P=PNQ&:7*
MSE_/5<2^,8$?^*!W#Q:W/_O-'Y:FME:_##4)06]!6<1 3'"$1YASU<LI6W*!
M3 4LCVEB:V](8K:(XH$W G)6QFXL+@+R.Y0>H?7^7&LEW*V3C_$819X"^H9X
M=53(W6*(9@0EN"NS1JH&EL=*_2LNT6L@#WRP1RQKO-N]RS%<Q>OTYO748I3?
M_!EZ,R#1PXJJQ#HMG,\' ?F4'FR&!->5+02?#O*FJQO$#N6QBY5*LN>O1E]E
M;F-+%Q6=<2JP6@@_GTV*X"@N-!(8(@JC61R$B]R"3W.!'<2O>8[P$A<EYL7M
M 4MC28O$L+-#W\:1;C"R )T5L(-0+LST+]KGQ]Z R3 ^CW',SBZ(R4V1G=4"
M\I1!,E[/:'5/W5__XTZJ/KV3:WHTP0IK?R%H3P?4+??_HF.B(V1)+P. [-C%
MAS.QO?0&(6^3N^W<8C#ZJ7^M/LZ6ZJ+ :XC[$B9*.C%__G!X\W(NV>0X(F\#
MU4Z*WF@9YV1B+3.^LSK>2_$!*%11IATQ$WXCL:X%Z+OR]/"\(\HC9>MI^X]%
M,8Z:^>K9F =-JG3;XJU5Z2!+KA%\1I:4;PRKEX.G.Q,QU_H:C'?K=:&_7+>[
M.-V[_8[3# $#GA6$8I%Q65+?V\*J9D]6OV?S./=K]) VX,WI]4=;7S!;.LQF
MYL!=3&?2JQ\QE7P;*=?J/]JVP1+6)6*U?O=7V'<:7&G'E+EOQG)RZ-X]];=S
MK=V "B'>^MX_WOA5Q8B9,YCI"(@[*?_'B)NT+G.B$MK8,5MYD:I6E,[EY,#A
M.-;%)S]#[DY!JW)VB)MES 9W4_(1.0VV/HK=]CAS&CW'V?OMM6*QCBC(49I3
MQ:BR]9+3+D<][<,,6M\ M,!0'!E'":BF3&TS6MC@%_,)P5[I"UU/JP>%!1SU
M+098?JH%_KMVNYY<21P#L;@WX"'PJ!/#D&"<PR#L$^O0(([?&JHQ= XNF,)\
MXQM0^]7*45HZX[IY %ID-F<X<Z*\-.9A,<B2S<@(K*KI_L8L"V"U /=*-2VR
M0(4*AQ(^*42F;'E&WLW+HU(<Q]9WWQ=NB 0M,*',6*[S#T)UYUI%^5V\4X2)
MK<>:-399.0E^\:@7V@XH<L&'3-!^E^[N4<J>40SJ7>F/T<RXI9, YLQ()<?$
M_,:<J_[Y58)%^5U>2IIHZYEZBQ5)('()Q.P70S[/3(L9O9@\,=C.-&2*%=T-
MHUI'D#A@</Z(X>\T@^Q+'O@:XH:BRAI/1]9'D7?2BY6OJ[6II64/R_MCA.'K
MCM F4:&0#Z2T!$JL6IM)_QRO514KU!MJ#I+'O$X"AC\$-R6HC0M!#6EX986;
MIGCQZ99/_%_[Y45YU9-%PP27\K/MO<! S@Q\1N3B(E#@%J;40>)V0?!G-7FI
MNS49')L3$X;I"=1#BI%KA'Z=JMS/8:6GK/3R1DP2@UL!V))<!2_U'=L"')XK
MKJ],2 =N<$V6EI<GUK0:\"Q:5M1F)'B"4GG*4OM0SR(H#YV-IVXZ6M8 G<8.
M^J.*+#"<8:KTI0<')7)7-]HE&@SA@HB%R/+K+W,>FE=Z/RSPEVLWB0.N<3X.
MZ?ZJ 9U7WG(ZOS,\C3\R!?4=*;?Y8ZB.4]"MP_U<,99(GG3N^2CS>3*?(T2V
M-V9K&"MLIP<M:#M[/V(] \]KUMH+EZV;[W0(F\;!.-GDFOOH7.O+^99J&/.?
M2*S]=.K1<3++)TOK=RSR*JI1\Q4V]\/;($YY>H")MBFWJ9:&JC0!9(%L6G K
M<AUQ8(*K- .1X*GMG%;M.&Z,8!5&JU,AGM.UUG)<)"5W#"3 _207LML(N@'0
M?B>58R3=*G!FI'6@,,;9>#<_QH?RJ<_,W1HH/)CDGF72^P"96]CJ5_Y4-Q&-
MIM?SV9>P=$F=1X5Z9X=42E4-#4P)YSLDW)#KG?Q[4LZUWK;MI ]93($&K/"C
M_3W-HMQ-;K/S?S"'<< $5@T?(5'>5YFS]1'NACX#>3>$\0Y41)B'$&](+N0\
M5\42F8/&* J[OM_^]8,.)V:G#613_PE:8+^3&ACL/MU*TJH=/1R7 "&Q$>)A
M#9I.CI)41&?;_4'J@\;G9[704(OLO/Q$YV-IH<)TUX80R=]'(CH,\YN-Y,B,
ML]A:P90+?FA^B=E<X%J^XHR83W-QJ(\[P-$WO?9L+(C8Q%8VA2BLNKXA3I%6
MMVB9K2G . 9=$GD'(*VS*!319Y&]6VM3@2Z(<:?%VFN(T,*&7ZVAV_X!L7')
M 2(%(B+3V)T7#"O0/13#IZ'(TA^3(I2A5"S8H16)US;K%A=PN%LW)LKG^^&D
M8WEE^WWZ\VPWC5A7*J;!:C[;EF<YUYD W=C#GR]J\*;=*=DU 43JYH4P2]",
MUOP//Y_\ OI]C])_V6,;J:7.2]D\/-;@VLZS%K?)S S\:V;;=]JCPE*D_AV0
M4C]8:UE M6V_N_ D[2[>U*PO)<>'?Y_UZ$8EW2!@X@98Q+VR"WY7>!DUI+BO
M>:P,A@QOJ*JLW>PHD,ZY2]#5%X$:^ H$*O/,>+W3NT+,845UUQO)!@_DO=IF
ML(G4U$]W+N(WB('WC%J],63/W=<]<Z\09_:<5?9N6ZZ=L12M7]CY,Y:^K?'N
MQ/;P06?U0]N#?"Q\<@#*L;X;C+-&TP'BBD=M4W)O"O@ =90V:A5&M[[3^#.W
M!8:HMZ'7743"M[*,%+,7'?8.9:S;ND.-7A25)QO>8AI,$/@DBQH8U&,QXH<E
M/2]TKLP*Z\;D-]Y@J!FA3&X(%!87I&1]O# O7D_DS7OVY*7YL"#Y^A#8'"S;
M>F;88H5'N6[DQF2BC8D<SO"*Z4:.K_SV_4ABF64[V!V/ILWU!/1N(OLYKFCH
M#L8DF)>+_8DN+4\R9J_R<3NRJ,_+VN0N^D(ZH?<._'MQ[H_9)#L?'^Q9O_+N
M?@2M5T ,+4.BIAN=5$ZZSILBAHF/!F&:=[QX(9&*H*+]VKXG;,'5O8&U(!N1
M2NNL@NWD";4\L,E],P=MAA3'"B$Q(%EG/(88S%&-7\U)P63);TAMKF,6G-1S
MOUK32VOQ(SOY-[I.N L;]E%JOUKBF3O,/](F?-%4T(:0?.&#Q(=5MB)$$WQ,
MT2$=Q0]PO59E*!949-XM]HU1/D:RN,6RQ@/$7%[NSY1KMATX2:V?#@FS?&W/
MQCO'P3R[P_+L(_-V(C2+;. ^'=EP.4%O3=!=PS_U56$K=88_<$.7+=2)7HQ-
M/_BJ.']""/2RC[S*E\V:D,NZ3")/D\P09CZYVU89#N(1DA6!+G?,IHKV-&1W
M$7"2S6&@H85_LLI>;(<(XVPV)NRF+*8TO2TPJY9MRFS)-R8MF5.N]8([ >$/
M5*M-;PC<!6\G4R$G/^+43-V\I9-K6BR10U#]>KQ"_M(7D9^/02EPOB5WS&TK
M^-2I8G*;>@H.O5I;/[6QDSQH"85G_YC5/14G=3,B\])4GA6Z G\$ZT-MI6Q/
M0P;[UI10)NZ)JW8?B_(R93/$2< =A*0%M09*$?Q.XZ 2+1%[)DUL'+'U)ND9
MF;#(%,R^U)83S")@5I3Y-[P4AE>^JL9*CL* Z55ZP@O!R\LB".W,^>4WI(O$
M4JTCE+!'0+1C'DHZA#T^GF@\C7NZ4!"1CETKB"O0J[UG" KOUTL.Z/;H L4L
M5/UA-]P("FB\XF_@O:U8XQ $L_.)25'M)%(]D(KU%C;!7?4OQ:)16AI$61QK
M1H5VG6P<E:EE1$S<KE9<FM]SF!(:!N2:;OXH4[/V$_^BVJL?-FQC );*>^F-
MEXKN.!KF/_&414FDVYF!$[VWNCFUGG2W N@0!D7X,Z1JO05XKSYT[;AVC6?'
MKVEO+FW-E7&*SEMSI)WS"%.ZE(KM[CFZ;E#5?"=?'6S]444A"_KW +/]S:]5
M77!C#+$=J3BEKRQ&"@Y:N(=H.41.0JK1&!'SPHEN8(%@B*K+!L+_L&[$L9E%
MO/F5^T2^%]3P2*XU>;1MBZ5YB446Q/#7>.C:^^4J$-=*4-X/!GB?-8Z9U5S?
MPD+0_TR[=N39N^9!X%-QLL)\!%?'XCB\;1GON>&T#"RT_N/@37#3NV1S:D>^
M4U[&N=V:F&\%M!7M>/"@5?KAJGIKVY3^[@+B;BWKP^(R^XZ]R\H<F(L@Y[U%
M)"&#5T22,<^1*-4*&&U83>5\9U[:AZJ47.WQD0>QA.ZG]K.+_6Z>A4FN$-"R
M76XM@;UA!F_M?B[SHK9S,A2%&7"M  HF?LS=8?GE0['"RQE?/#CB*_$X@7A0
MJ2/V#$,T['6S1EE&YI1:ZBLSJK#%$DKBM_%K;KFYJ,,[9'$]!U^< ZBC=IQH
MHN2PI[H=JA5:4 MJY?)GX1*2YLDKH&S@WW\&F\4$U75V%/NXQ/FAD*V5^B'N
M?9B(=[NZG9@SU^D1!(#H^8,'JU5KZ >^N3F!JQKT@,1H"UVJD*H9+Q@U3&9^
M%<%%&^13\>=<&[64]'S(0BQA0<"@ZM>%$ 9LV@"Q-Z-R<=%FI!*O[6Z8RNY
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M'0-:2_J]B2M. 71$=[LP1+F,>M77>WZ0ZV8UU G?81,/UWB^O5[L+&P02F/
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M%AOM F[EJF>V0#"0@VA/=#3)%B>TG?CJJ-K54G>P^%UU(. OV9=C\I(!6*I
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M&>]V,;:3@18+VOR^]T:;U) B$)#4HV_ ^R8OB9?I-/!]FHC'"( ?G[K: "-
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ML[@O.(7*2KHBW8J087W4U+MXRC8<C]LU2/#P18D1*/9"^$SN(>KIB74#3>C
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M&&TR)7,Q8VR7QY7I2JT/"&G"?_VF41(O</M^_T6$=^J=\L$436N1S#" 37&
M):'KJTM3Y(:S]8HX/]C9N-92 U!2^/3I&<7M^KNJFIOI.7:!-9Z44:$Z9R)'
M%EML1=)[-*JZOL^%D"U?5N0K@B<2?[((Q](X!T633\U$6#XG$.\(,)K1(0X
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M ^RK3:C?G;&[2L:R7"^15F1@#19K]!([0#4LTKL;)M3Q^1&1')A116M^0N!
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M@RHRO?_U'OS6N%RGXJ.$<LOYXE]_D'(R&AT!3PB*B\]=UR@7^42PJ]!>'[4
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M TJ72NR7Y;'.BR%ZZ"GIZX]'H/6@H#2:B5"F\G-(M:1-?92B:L_Y#]?)WIR
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MS7_$V!V5OOCI%]>$R]+QM+6HLHKB<#7 O0G_#B(NWPIH'T?(:31SJ-90KD
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M+CI9R?!J Z5<=04I-,6TV&SU&E*_$2TIV/]@1OKPW.O2#=$!FA&I[-67K(V
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M50I96HI)%M^Y*$JR5$]P+D*=4CO]3K+_W/$%\46S>JL]U<1) [[+:!HZFI.
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M%$B$O:'[PC!JEX:(LI^.<8DL $Z\) *..4L_ >2>?@7X!0H <-\%G/@ .!8
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M;OTTDM9J?]WWX3_Z!H@C'>E(1SK2D8YTI",=Z4A'^CL=_S;ZOP!02P,$%
M  @ ^(176,>?#!DJS   W=P  !0   !I8VQR+3(P,C,Q,C,Q7V<U+FIP9\R[
M!UA3W;8N'$1$J2)-$(A*!P%%FK2("@@(2.]$I8,(*$@+B8KTDH^N("!-1$H^
M2@!ID2X@THET$GI/J(&T&\^Y^Y1O[WO.ON?Y_^>YB\RP8*TUYQQCCOF.]YUK
M+>HOZCS@O+Z.G@Z CHX.\ ?M!T#% &RU@SQ< 0!#0X 4   X"V"@IP,PT/;H
M:$6?GOY??O\N )/S_[K_^\N$ W#Z7__/RV%RX=_W?Y\'H(O\" !4PJE3@+N
M4W1TOS__>Z-GH/^]G3E]FIZ!\0PCX^]R]ASSN;-GF<XR,C*Q,C$QL] VQG-L
M[*PL;+_W?U?R^_+?5]$^+&<9S[+\7V_4;P".LW1+=!/T=%<!ISCHZ#GHJ!T
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MZT52@E.2DS8=K](J"(<\Q:M'5&B*!>4(K$A[J4Y)DLXS+2!1D^)8]A@C'U+
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MFR>P^+R,;R&C[\#RF*8M5=>UW1]GS,2K7S$>)4 -!G6T(3D!K;<L78+-BWM
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M*#/!F @+VL.Z?FGH)@E#190C?]SU6K9G5S+WGWY_$6,4C*W*,U;^<3WMBTZ
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MI=7ZJP=58/KU)96B^&\NR 6%3)2,6\&,PG;N0$5QE8EYTRVL-)#7G2?DT_L
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M,<GXZ\OC;T(A@7HQ5 NZG2_0GY%/$4$R1\\CBBAZAJ/%PHSF,X))2MR$-:.
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M$_@&=ZB+TY:N=)WS_\IQ:/KUK\C.BX?K5??R+7[ &Z3W0):8^:^0G=>S@J<
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MI =UK3OX:PC_^G&WF@VK^;D/<TQ2\%OP?DR-$/D3_VR,4AN0D_*13R'F\;9
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M8IKZ3M+"'G!13Y,<6-5))69N"0BD!)RD^GJ>H0@1/&.D$%YX0^7!M*6-ZS3
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MJTVJ1)VBT>J496/Y<>RG(<>VT0,R@Z6P"?["1GX-?CP:IF>$ DI3(IKGX.%
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M5^F*U8RQS^"H?E"UB:N\_E;:&@MF M5:U_ESEKDU8YW[.#Q6"<TUO1+B7+Q
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M5;G)+BIGY7 &Y,G2FKUZ(,D8^_GID/ F/W.":>J3"W_T7P@OI&;-8[#^'8+
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MX).PG_X&]2/N+<4+^-9'PUR;J)AB)P:K#XKCGH(E'QM]S6E1SV<?G[A_(66
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M9FYN0=,X/U?\_Y:9_Y5 KW/_#E!+ P04    " #XA%=8 :^\[M0F 0#?,0$
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MV&MZVP!<S 8OR801IV"8,0Z1N'4P#'0Q7K21\+OFAG7S@ZSQ@P>P5QT<%U[
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M,)RLT9X#,F7=J_R)_S?@C&K^C/QX:\2RWV4>-9I34;"[?4Q&$.H9'1#8E\B
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MU)H="R!/$L2;^R -3EXT_XGL0_TDHO&.JS7S0TILTIX&>DF-8K]FU\70.2V
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MGL.$H;@0]\A&H<*&A2JIYPWR_TV[/!9[.NJ.D?-YYNJQ(&?SOR%Y>*>!21:
M+-$L9]<F8&D4BA190@I09C!BVU/P.>N$%KJ%G>"7C,H(^1#='GJO?>AU):,_
MD7.P%C1P50+(E$ \I0R$X016ZBH((8US%OWJ!AG:ZAV./ZH\Q?5Z^+G6W(Z;
MR43B9Y.(O)UMX'!@.AQ+8J:G(QX;E*TPKPX[C*CK9J'+/SUYT"9H 9_>=N.^
M,%:3BS2:WANBS_3H#OL=V&B,QGRC@]\=5.'U)Q.3=>IF)G?':Q78N(T:9/X&
M4XQA@3-*E=4UP^N(YY2<51-^V-7-2[^:JU(^/.Z_8XNFVR/_S*C0.*FM)&P
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M.\)=TGWBR;^DY4S,'P3[EEI^>FW:'$N(OBF3;7,J-K[Q8][+,XO-I%>0FD,
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M'&O7S(Q7F$AUDIAZD&0Z(K_W*D'L;[  K)K1@JB*.(UK6F1EHER^Y6-*"(>
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M DMLS5^A*\:XF_:PAIR<A)$D)OKJU6<0Y\&X7:EL#\P7XS/E+TX:G)'/9B:
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M 7OJ#\PA#9PQ9491G8G>__RNC'.QAM$O+/4T\%(+5YQT\#BVNGP08J9S5'&
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MV=--Y\=P:CU_87G8A#\#,3@1+47JC1G=]$Z!82N#.6US.:$?1R&T9/_@551
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MESVAJGN'V(<I1(&P5A<IAF!\*>7V2-DR4!7Q(8KV9.WOP:Y6@?PB/2<9Y=S
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M8E7)EF:UP3%>N.MW7'>>V1^J*T"$4=/L^\N]+HW_&;"JH30$#K0DU"%4];B
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MN[.P6%W !&OZXQXJ@.<*1*R<"J>;C43N'OK_\?]<\'!'_QM02P,$%     @
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M:\BLJ,_6J,L1#U:(,=PLG2HOU#-PV82_JY12NYOG3?Y.8/_^3U!+ P04
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M^ZSU^ZSUO.]ZON^S%G^8SP R#K;VM@ "@8#K@@/P)X&W#2;X+ !.3D 7 (
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MHV_5"/#L-\P$O=+^D#0>J47\"_D9[24?B'$T;#/\!N/U'UL76X&--GFAB;0
MGM.E8QB*B4<+8?!49,2)*YG&2]K?@C<@<T@U%.,A4AAKZ,-Y>(RZ(OCS;@U6
MC-^)*/ZF6/BA]N,AL&,1?9JFRM)C%*=N:L^9Y%T>(K/+THP-.J<\TU.TM4Y0
M#:4+2XM-%:,L;)3>$?;1?,A(7)LUCI%.4N)5H\[Q 93K^C9F RG"R;)NK<O]
M&:=IK_9<.&R'F>PUVQ]5ZM<]<%QYY*8H FL2'_:,T\/,F_J%C,#J:-J'1CTY
MRJE]_Z-024*1# ?$PG<2UT=0@?I"7:(N1<?<3[BI-!QSG;,,T_5!CZ2UFZ O
M9%Q8R!]?*;.0C)XQUD6LV48:Y9+B*J:)!:&+%^*67\_V]=1K?JK,*K54Y^6U
M,H@M>W!T%3M.Q89=O'<]Y_F4ON33!/6N:QO;RQ,__;(PG]P/H(>B?',%/4P6
M--#;6F#V,8-276U8:G<F<4H8CT\D\0V\H4CMQ65;JWL=!3(ALW>=1Y!M)DO.
M&EZ^_8,?L4OL4U7)(X=W@4,-Q=[8'A*\NOY#8VBON<F4+]MCH.Z'03IY*/#W
MXH23N$ J>W]R9L[$:>QR+\YO@J--P[<&(H>--N7''\4]GE>@#=498))6/QUM
M)D4<S8P:!(E&@^<H^7S R$,RK<1QP\GLTB9.=B6FUXZ54I%1,[2I7)MD*)EU
MN_NSGST,'Q3>^R$7C45]Y8/)G\+#9Q+VF9\_>3O,VN%3@*_1JPAI:/; ]ENX
M@ %(6OCNZ$N9ED+XQIO'_7DY*L0\8K[SZ==Q[@I?>MJNW%7+@\*S=*VE.M7V
M?B=/-@O1VM</M9#]%7.#SR8=S-7\AG3M.^>Y=Q[)'_DG4$L#!!0    ( /B$
M5UBD!5Y&++H! '%J$@ 5    :6-L<BTR,#(S,3(S,5]L86(N>&ULY+U[<]LZ
MEB_Z_WP*W#U5]V97&;U)$'R@S\R<<EY[7)5.4HEW]YF3NJ7"T^:T++DIR8G[
MTQ^ #XFR7@ %4LR]75W9B4T2:_T6^<,"L![_]C]_/$S!DRP6^7SV[[^$?PI^
M 7+&YR*?W?W[+W_<OH?9+__S/_[E7_[M_X+P?[W^\@&\G?/5@YPMP9M"TJ44
MX'N^O ?+>PG^-B_^GC]1\'E*EVI>/$#X'^5M;^:/ST5^=[\$*$"XN:SY;?'G
M@(=!S'  PP0IB$D<0(88@CR,5!+2 *$HN+K[<Q1':2"##,HL9A SF4*JA/X;
MHB*E@0B#4)4/G>:SO__9_,'H0@*MWFQ1_O/??[E?+A___-MOW[]__],/5DS_
M-"_N?D-!$/W67/U+??F/G>N_1^75(2'DM_*WZTL7^;X+]6/#W_[77SY\Y??R
M@<)\MEC2&3<#+/(_+\H??IASNBQ1/RD7.'B%^1=L+H/F1S!$, K_]&,A?OF/
M?P&@@J.83^47J8#Y[Q]?;@X.27XS5_PVDW?&MI]ED<_%UR4MEA\HDU,M??FT
MY?.C_/=?%OG#XU0V/[LOI-K_V&E1;#W52$F,E&%BI/S70X/]=H;XGN1=[LKJ
M0;A2W8^^9#R&Z4=OXMYJAI#]"]P:YFR1JQ?JW4P,]>ZNASI;]/XE]O5:S)=T
M.L!KL1FF)?+4_."#_EL]C'G0$3(MQZFINR6J_+&4,R$KMMQZ-,C%O_^B_S99
M+> =I8\30^9B-96?U-=[6LC7FG+%F_G#HYPM2B8O?[JX7BWOYT7^3RG^T,\M
MOB[G_.^?'LWO]<PX6[Q^?O=#%CQ?R,]%SN47.KN3MUJ(UU-]W20@<9;$202I
M%#'$-,*0! 3#)(VHGA[3%&7I9+G^2B9R!O_XVBA42CVTR+\XH+\\P"):A/FJ
MX)OY]V&Z;U+5\ZF9@;/?9O1!+AYI?8/6VS@K%13_\77U\$"+9S!7X&9F_)!2
M3_!FKJ??8J;=&O!IM32SL7%Q@/X/J)6C;"I!B0>H=%_\VV\;6$?Q=DQ_0IM/
M>S:W40:6.H+/]+ET3:^+PHAK_GY5V_*JL;($I3Z@5 A\NRVM;A0#I6;_[T&;
MS_F6#E/CO<V+EV:8\PN88<.O"XU@:0-%%ZP$L99&&P1%O\GI<M'\!)J?E"0[
MH,"_[7Q&UT6#*RWXB?>ION(W;K[EQR7<>K54,7^XE &6\TM]@=7+J('Y!<P+
M_1"]A-L#\@Y7?2[F7$JQ>*]!^TJ-H-=/-)^:C^']O# _^2KYJLB7N5R\E6PY
M84C%#$42QBP2>EY",:1QI*!0 0ZB2&8I25SF)5<!1C?+: G-%$,;J8&>:L#"
M_#2?/<G%TI"/XP3B;!2[Z:!/J'LF]T9T8#YNT&!NA 0;F:_ 6A^HC0#-9?Y8
MO"MZGCC9>?A!&;8K."_YLO-SW-@OY]-B\GJUR&=RL=!\S/)92<=Z^*?<;(#1
M:<MEO)GI\>CTFO/Y:K;4SN+-C,_-LF8IK\5_KZI/7/^V6$GQ[H?A=DWI,_%I
M>2^+-ZNBT+_]D%.63TNQ)RA6B+* P91K]QY'1$ :J@@J)@C'- FXPC8,>DDE
MQL;"M>! UI*7[OS<R YX)3R8;J2W8^.+OB3'&?UG,7W/LT*# &A!< 5:(+07
M?E>@Q@%L@  ;)/3DL<;B"C3OT[OV^U0" FI$P(>?ZGT2]6Y]^>R?_KW:TN;_
MQ^^7M1,S!L-6CI"1I/1N0E0=3OSK164;Q$L: _J-IS4*6;JM53]HF3^I-X44
M^?(]Y>:ASW^A/_*'U</K>5',OVOYWE#]+>N?3Z*8H#AD#,J8<XAC', ,D1BB
M%,<49PHAZ;1.=1E\;-Y1+2=@C:" UY*ZK4N=#&"W)NT+UIX]#R.V68%6@H-&
M\BO00+T6'KPY!;7S2K0+9IY6H4Y##[H"[0+*R]5GIV=TXS+-HX6D"_E65O^]
MF7UZE 5=5B/D2\VY;+$L*%].6)!*364)5"HD$/.80"(4AUD<L"C+HB@6U(7)
M[(<>&X^]N3=;GPN0S\"\$1G0Q4(N*P>JM<3[LQNS.9C#CM?Z ;EG5FN$!J\:
ML7\U6*\E![7HX%LCO,=3$G?$/'&:P\"#,IH[("_YK,,3NK'9%SDMHQ]HL7R^
M+>ALH1^IO4?#IS=+^;"8,"%03$4(,1,!Q%&@-'V1%(991N- AD*3F0N'G1IP
M;,Q5RPM*@4%+8O"M="5*H0]_3-U MV,JGU#VS$]GHNA,2;;0>"*BD\,-2C^V
MRK\D'>O[NE%->6+*7IZCM@[Z7S]O+JGC *Z_T\(L3_.B6NJ605J3@(H <Z29
MB&=ZA4B%A"R+$224I2+$'$LFG")L?$DV-O*J#JG-WGHM)G@LY72,BO%F.,O@
METN88\ 8E[96[4 7P)[!WE@8HYN)?EE;\?-Q*[K'N?A&W%<XBS>YAHU:\0WG
M3G"*]P'.H/2=T)B6'(M:D-<O!2G_N-6C7L^$"97YJ+^=M_,'FL\F1 B&. ]@
MBD(%<1)E,$-1 ,.891E*$T8I=V9WST*.C>A+28$1%7RK)'1T27NQI /=7] ^
M/3._BVFZ$7=/V/GD<-\B#D_G/8&\E]G[&LN-Y!?%<O+N'RNSDRJ7]W-Q4P;%
M2=GZP#-**6$B@C*0(<1AD$+&,8-1&F,L4A9'C-A0]>FAQD:X-^L(P2M@I'2D
M70MLCY.G7\1ZWYUT!<N:".UQ.$9G^BDM*M/_VM"8Q0"#D)&]H@VE.-S1=>_P
M2<Y6\HLTS\IG=]JE+(^?M1Z?V#2_*ZG+G"USD_^3/^A+/JFO^J<+5>TL5#YH
M.&$T8RI3$HJ(!!!SAB SJ:!,!%Q1$@<!<\J8\278V$BGUNL*%(UF9CW?J ;F
M:]VNRG ZHQU8ENJ9$\]%2\&K3AL!W@QNN[\YO!E[WP>M+;A6"K2T I]:%FP4
M [=K"W[=LJ#O30#?<'O;6_4DUL![L'[!W-VK]?S\CDDHVD,U_FD=./1YOE@6
M<ID7I:M:IL!\GD]S_CS!-%%AA#'D.(LA#B*S99LHF*4I#@B-.*;2*?G$<N"Q
M47@M-WBC!7;-+;'%VHY=^T"P9_9LP-N$7&Y+#4JQ-3.6@H-O]7][20UTA<]7
M,HGML,,FD3B"L9,\XGI_Q^W*=4[?%\GG=S.3MW<C]!"YRJ6X+L-1KKEVF0O]
MKYEHQ3_JWZT>-)&:=)9-+F\H%18)03 19:8W(C"3(H B#HA*64 P<CH;]RS?
MV+BOE=;];J']4KJ4"_./]S0OP%_I=%7]L](3-(J67WM+55#KVC6SVX_I+;<V
M+V?0OL^S:LV,P3:Z@8URMF8<*'_;*_[>D[7]2'>AS&ROT!Y.P_8[3$=WM]IO
M7=S.ZS&;<'RY^+V8+Q83B2(AHS""8<(0Q/I_)N(304:"B&01%H&4DW;]EM-N
MVHDAK3CA9&D:KUZ:?M"]B44T>PXKMLA%;EA_91+DE_3O>B6R *]F<FE^S^GB
M'M#:?K\Z^L.GC!&R2 4JPE D-(0X30)(4\IAS'F:<A*F*LR<UAP^3#'@?%O.
MJT]F7EU#K3]N;0]9'0%[AMMRV>$1Q+Z7&[6H8#EOIC&PD?8*E/)Z7%%8(N-K
M)7%JN&%7$);*[ZP<;._K1OCE<N3#?'9W*XN'S3'&8J))/=%W$$API+D%"P&)
MQ 2F 1(RB6A,D]"%6PX--#9.:8EF LQE>;X IUIPH(=_ *\^SI<29,R1RP_B
M;$<J/M#KF4RJ_0HC(S1"@AN+$B/.%'(*!T_4<7"802GCE+(OJ>+D]=THXJU4
MLM#>2YE?*6_ICY8/^E$N3;!J0@1"D,0*:Z8(0YA% 8>2(9YRI2*!G9* 3HPW
M-L)HQ 5+^F.=YO-<\P0*''GB%-AV=.$1PIY98XU>)2K0LK87T5= B^N//BQQ
M\<0BIT8;E$PL57_)*;:W=:.6/<G>NZM@L[ZU6 ?OYG37J>$+[4*99TQ8S'$H
M2 93O3Z".,Q22+,D@90'"!/$-%,AM[7KH/*/;R'<" @>*PG=J&Y8X]L1Y_@,
M>LER-7OV/<NM3,N=SZM]!4.NP/JM^7SBK7&F]XM8S]-D,:SL@TX]%S'+RXGL
M,D)T];B+_$F+^%0+4X\W83(B,L$!Y!@E$$=9!BEF"J:*4Y*2+)&9<O.T]XXS
M/@^[$;/*J+]J"J>YNM;[4;5UJ<_&JG=7>@W3=073FQ,P=?"?CX+@S6_>/\K
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M"NS\G([]D/-9OM0>WI/I;J&_U;M\[2N:0' 6*QQ((J&,%(<8B0"R,$"0BB3
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MFC W?CXRVMB8MY'.E4"/ 6I+C9Y@ZIWT&CDK=\^<+E6B>N^Z806)-X8Z-M;
MW&.A]BZKV-SD?9U^S?GJ857V,6J'4$_"+!(9$AE$VJV#V(0O,\4IS%2*F<)*
M$NI8N]1=B/'%@+0$!;0EJ;>UYB%SG+W^/ ?B<:Q)V]A?VV#O<Z%Z K[^%Z^'
M!!C+@O8$0 Z+W%-/&B!MX_M\$LJ,1)03R.(P-84!4LA2AF"".5*A2)D@:6])
M&]_G8W.K]*L:]YBRH0&W8[@>8>R9WKJE:WR?7RA98X/=)5(U].CC3=380'-6
MFD;K,5WJGMS30K[6SQ<F&4[.%E7WE:(P#<;+SBK/FTOJH:]-R<!/C^5ZM([:
MN;TOYJN[^SV!0!/)>1P$20I#64;34 D9S1!4J8R$7D*F26*US3>,N&,CS%I@
ML*PD!JP)#.0;F<&K? 861NV%Y6G00*8_SL7C,VC/U%TJ DM-0%M;T%(7O'X&
M[>MJE4&ILV']>M.P>2]JQ<&^@-%1O0LNY5K&]$X,5=%E+.^&8]67H4QUO#!,
M[U(,6#MF*$2WR\L,-FJW9=?-[$E6[>"J-/V;NL/R)*2(")DIJ+V(&&*%J0F-
MDS#.1$!E(ECH%JM[:*"Q^06-7" OQ71;4QU$TV[QY .CGJ?:C8CKPAXWIYIR
M.R^$3N'@:<5S<)A!ES:GE'VYACEY?8?%RO5Z1V>W?$=5TGQQ_WXZ__Z?4MSM
M[RII>JJ:"C@I#9A,6 01%7I1HA""C' %14 0$QEAJ;*OU^A-K+&13%G67_L@
M7"L E-8 W!L5'/Q*?Q:S6$M<Q X]$]E&)["O:I'1X@H8Q8#1#)2J7=4_?JF>
M34_A/DWHL 2XB"D'<O7]FO3:7YOH?I _ZKG[&VTX#]T[0EN>N/^G=_.X]_CP
M;[2CGXMR4W(^*_LK*UD44H23!,D@"TD"91B:WD)20);)"%(4)UB2@)N+'+QP
ME\''-FF^WK-#=V5:'F_$!\N-_&Z>NY-54!:@0' ,A2R;MV()LT#_,Y,H2U$8
M$YDQEV#NWJPR0&CWFPO@;[>:Z@O5GAV3_1GJVS#?6L#LO.KJ@I>GE9C3T(.N
MSKJ \G+%UND9W2:7IG[_W_+E_9O58JG7A\5.<QVE4,0C&D J8I/U&!-(L@S!
M '$>ID@A$B<NDXK-H&.;3/Z825K,-IU'ZK0?[)CU8X6W8$BD1$4P8SR&F.)
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M;=3C^OY"M!_W8K)/C/79^IUYD'X1\H*6;W5U.8<=^Z4OAH7+9,3I'I@7UYJ
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MK6H;9]#;)@SS!FST,]ZCC89@K2+X?:LD:&GI2%P^Y]Z.ZZXTHP/3X]B3V2.
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M:NRVSLABM/@7X)6D8&[DKO)OYPM: $7Y.@?WW=?%2H(P=HS./8JV'<%=BN'
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M$RTS9;/PA3%!"4XE#'DLH,D*@BS *<2F)YV28803I\/L(V-,C1I:(CJ:$,<
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MHU"D?XHSZE12OVNPJ;%<'=XJM,2N)E,'H+8FDQ^8!B:G+XOB ?Z0Y1,P M^
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M5*:AP"+B3AFN5J-.C4&,M*7_KRP^(G=RNU&('>)V9.(=QZ&-U0;"\B\MD6\
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M-[*5'I2QHZ_WYLW6M?):LS&X \9G9/5V6GU[:X9 ?S)!TGO"_<5"HD\!ZS\
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M8EI=(:X@#A*3N,=BTZJ 1(JXV-;[CY_:A_O[4K]BX+F6T<V$.@#.S@+J#\?
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M)'9JI=93CJE9 NUV:FT%P$Z#LM/:MCI':_8=(VUZ3IS=+FJ$Z1AXO=]K;-?
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M!)DNKU9E/Z<V[>,4%/W+3KS=^C>5R1QX :TJ N[I"?;Z<=Z 6F-0JPR,SC?
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M4]5H6%Y;&^Q;)<%6RQMP^V@*Q V07W0U\KZSD/H+]#JY2E<#>#:CZ?HG7W<
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MJ_5P8!T.,AQD7Y[T1E83^_UUT$DB:1RE NI=O3:.)(X@Q5D*PX1F2FA<2=!
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MJS^WOI9BE_,U"V*%::(B*#BAFCQ("+&( H@95DDHN")QZ%8=R&98JP]CU'I
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M0P<5P.WYK-(I4'IUK?YZEQYUBU &ZZ>>.:K_+KI"N?T*:(-KN7>QY9W4W:^
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MDI&$7&,%D;8:?CPGD*<Q8QE&+,%>Y03<FAT;R^Y* ,IM"<!B#E1I.EAM;9^
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ML8T2'HLHSI@ZT'U@I'IF>&NMS;ZO[ 7&X'I59&MR)^TB!RA])(W"0CJ4TE$
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M6AT;[3>G@-OGM<M,DXGYU<KQ9(H?[FY\'!S-GFGVS''JVW- ACH@?1R8?H]
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M\!2S[FK+V(*,QI526N&G6EOA3W]1E4.>YWZOZ2.WJ?% R/<<'FQ!;^M/5HZ
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MC3E$<<0@UVD"$TRT5G$2LSAQX= 3SQ\;)U8F F/CS-9ZKJUTX\53$)[GN0#
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M??L/'W8W[ZAC!]MUQZ_R7VBIBP9_-B$>F_T_Q9:?YO*C>?8T52I)*290:A.
M(4XT9)BF4.<LE3S2B!$G^<YSC8SMXZWM!)6AP%H*C*G VNJ^\'(2TLNK+R&
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M*>T6)'F*,,DU@TF>1Q"E60R9DACRR'1YEA)I7.RV?W30UMB^Y/:&1S=-M'/
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MS""E-#,3+I1#FB8<B@0CI4C"<>2D??3VP6.C!6M;&8(#:YW[D8 ]L,Y_\-=
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ML(PC#)%2&2914<&DRJJRBDE.46PE*FX^]M38MS,=:MO!UOAUU1-Y =I^H!T
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MJI-948Z7<Z/6GJZ5*MTQ-9!??]+Y,ZL7WU06I_P_DQ;,4)RD&2\+F)=1(@/
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M)64$44IB6&*&8%+A/$FRBF>QE0#RV Y,[57^1NVPS3G[-Z[\4(E\?WQ]J_/
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MW2B;%@-SP[<DM #($P69C#@J^5A L$\[-E\=63A/Y22M7MXO%"_JF%#;>O^
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M__E/Z]_(/U3_^?_\I_\/4$L#!!0    ( /B$5UATX=%T_2\! ( 6#@ 5
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MOL?E)2\8L&C:2."CBZ"2*N!1Q-J=(#,9.'D+]SWR/PAM]]#33W#6(;1:R7X
M.*I=+JI _C%>?GUYOEC.SG"^DMAO\]GB:G-80<;9TN:PLG9]U)&!\]4Z1XO%
M.XK-FOOF>Q'6SU"!#L_*YMH8 ,3>KYC*>+U=KCAQP29!\@*GB7X5%$(0.8,.
M3"2I'?)[6QH=@JO=U/0S?Z [,#62^P 0]&&.W\(XO_[Q#:<+)&?R=/GU8F-<
ML<2954[S IS5&R^>"TFJ=@ODM%MH6P1S[^360Z"T!UG]C"OH#E.M-3$ <-5^
MQV?X.?S C0-]Q(.OZ90,2=:DJ_<:HE8!M)1%%%>R%O>UX3L$3EL)Z6>,07<
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M[:AR'9"5D^2M&^D_GLK>F_<^;?*L.PT.%Z/_&2;GN)W!R!TJK0UD)^IK)RW
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M^O'B-/\-\Y<;G8VVX*=PJW(AP!A6;U]U0HA"2-!,U"'&,<K0WG8<3.ZQ!N:
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MYS>F-ES5#=,6*24$8#K)6A7G(4:RYL8$YKC+*9K6&=:CB=X/E\_M@N!I=3D
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MI*]A_N48NW3/UUI8I'V);=:7;V,Y ME'G-2))M=1WG5L9RB$4B*"3%Z",B5
M5)Y3/.5Y"L*JTKQYT][$M6R_L77)U<"7C=@R!.=$%L"<KG5*AC:%K:WEF$S:
MK7*"K8L\'TEBWSWYND#5?;TT6FMM .[^#O;JR,GY=WSQ\S-]Y[2LPIKK3EV&
M<87<$WYRG:X6!?B$%F26D0E13,;6[OX!9/;K[O<*SF;:&^A9>S5Q^9@C]NY'
MVCP9N)>T1@?JU2K;RENC4Z4P [(^"5%&&,*3*.""<FBT48JU[LIT#SE'W3.N
MO_L"RVR.5VO<+J)U)19'_JFM,Q!4'9P<H]$@D*$Q7.IB]KM1W&.Q?L^[5DJ_
M<8'86L2#.M+JP-#9='496JZ8NZC%?H%3+./;R3JO"JJ4->A,#"IM:DFV3Y!#
M$CPA*TZV]C^/(+??(ZXU'I]:?X."ZNM2,*UOHR[X_$C^0FW?-JWUH.L653=Y
ME<92C*PI%.=UTIKG&5R=\J$U<W2."^]\=_'!X^GMM\2G>[!VK,%!H?75!0'$
MY$6#M1M=!&^QZ=!*KLBYC2[;.I(^0_"T1[G D*.(@;ON'A _BM1^BX.ZQVAW
M>AL"/->#!T_+]<W(;+%X&>;SG^3=_!'F>2-,=S$+X80'PST2;TG71D<6DC/>
M6V$3EZW+7QY#WUY [&R\9V= [$I#0T+?E?#J/ =B$:>K>9?71E\PSIAVX*.N
M<[DBK[/I#?&E;- !E9/-7WKN2=M>J#//%G4M-3/0S,CKLV^3V4^\](Z/2(_L
M^%*+',D^1#9*E-0(@J*%-89K%FXY7G?GW((Q([).EB7@Y'>!*CI!T"6#=CK*
MHF4,J?4CQ4>0U\YY.SF[',]PV1IZ>C&;Z=-7Q#MUPE:G8D2"%%4M'&"V5B5[
M<$F6X$+QI73U,/V1I/:;G>D*:;N=N>[T.(#C].770 9Z\7;Z83[[/Q178;ZP
M%J=Q,EX/=EM<U6.>EMJCZ\JC?7->+4>MY#Q?K/_H]NBWPK/W(H/)O#[XL72:
M,/I9\I&9[*52N766ITM^^DT#/17P!X.( >R.:R/P'I<78EC?0]Y*,.C,D_<)
MT-7&_8F3#^V(-YZC"T@ZZ#)%="]I_6:#GMY8M]/3H."WFA?Q;;7W?E_<F1OA
MD^=>Y@0&HZLAG(,0DX'"=396.#J*NKLHOI>T?A,]/?@*S?0T+/C==8%6-6=5
MP'/\2C*^RL=NF3B62:*< DCPN7;=R8GB2<L5A7^)R9Q1H>GN7>Q1I/>;'AJ$
MJ]N1G@<%[[L.SMOIZQ\)%^3$;'5U;A\KB1P7)C1(9Q,H+PQX'PVD8IE. 4GV
MK2/:9L3WFXMZ>H@_I:X'!?(Z'#)=3.K>R5W.*:907THHE+5 .  =6 (<.A8E
M-Y';UN^5'D?A7G"U?QZX-M?:H#!9:PPV(LS+)_6WV2,^G D.M.1(7KMBX)+5
M]$N%W+*HT;?NR/Y($O="I?OSH+*]WH::Y_^O\_'R)WD\]"UR?:H$SE8MQ#XM
MB<--P;\\]BG"H4LUN2EHP6:K9@L;788V5]XL _]$5& ,%&%=0N\:X#XXM%Z"
MRYP +D6 X)F ;+(3]4(KQ-:IF.,H;F=-5VN\J&ML4K%2X>DZ)KTHB[[]:%$'
M%$I0-+IJ=JX"1O+9301M:0<++X0HW1G80ZGNN;'"TZ%TMQE^$H4/RF'8P7']
MW<7)^?+K;%ZCUM_)#,TWQ% =I\6+GZ]_X#R-%_AA/D[XL6:Y-T:O%DPQYPA&
M*D$*00W!T5DE2D@E)^,HAGWJ+7 T5SVWGQOP%GE:P QT"UV(_*06!&T:C1H"
MKU%RG<V\W44M2@HMG #.* !6!@5$9Q"*C,ZB1H8=#NIMP4'/C?"&M36>" C#
M::>WW2JLWG:-:URS$L+OT_%R\0'GJP:7];;_ZC=7@MIQM*)+V3++0 :5JFYJ
M<9/+(*6QG"EM;7ILY[WNJ.VY2=_3[X)AXF X&^,]17AA\?5.V+=]L()0/C&I
M EBKR8VL/16#,!3E!R:S+A*3<X_$^J,(Z/=ZIG_X=J>M@:9C+L>*?\(O59AA
MFG_#V9=Y^/9UG,)DHQ?Q$8WI'[E$DP[UQ[#5*.URL?9'_%;'J4R_7+^;+DYR
MFR1(D>K\])(AYD(!(WFZP2:;0VD>&>V@Y5@G^"-^Q^DYOJ&M_)JD-I^&R<OS
MQ7)V1J!]\?-:YB=S#'>2F0PMM\)#$746G*J5T9PVKJMA0# \)=[Z9N0(<OM-
MCC3!TFW']:F4U_=A?/5FX^+)\!5KMST,[C5/4@9@SFM0T5IP@FLPP@9M9:1P
M]/]G[TV;G$J2=.%?Y'=B7SX"571C1@,&5(^]G](\-E!W(C&2DBKFU[\>2BDS
M23*56N+HA.BY-K>*I3J/A_L3'KY[W.GUW?6+XX83FH)J.$YWY>NO[\SBP4M3
M>])FTT^KU5K7:<6[UP@O'[I()AIET;N:+ZJ<D 8P( <F QD1W(B<AUO^U_HT
MX\8 !E&2G8B^4_/Q35Y>7W7RYM[.TV2*\^\K"_V(P89/_,@F<PWW(;N1.?@[
MSJ<$RNKWKCYU@\XL68XZ(Z3@,JAL-3CG&# ?3;"\Y*1:[_-YC):&=0CWOO <
M%V1(3--OD\NKY4]EG%QQS14B%+3DN5EBAL<4H(1D:^2WY#C@0(!]2!W7#&R"
MH2U%"(,);6P3\$[Y3_H7Z>R<]CNKE,*G1/:*T:XVE)/-&U1.0"Z_M;F^("'L
M9!D>2<BX!F-3^)U<+IT^H<]BO/IRM0IP_5P9?%,3?-!3NNN/;O&D'G2,1D_K
MUF_?%E?3J_^VU $2-ZLJN<[D>Q!Z>#"$'N, $Q=0=+'5"U&Y>97&@:0V+%K=
MC8#[NE[2#?;>@G2N3B?2 KP6=7E$#DALDMD/V'!P",GC/M2G0.26$M?!9=RI
M+OUP]974XBKB>WF;3)B5&M-_>3G[LTD\>_^/M-"O1QZM54S[#A6;+_]^_0>+
M.R NGC"30/J:AW%)0@CD>/.HC%+96^V;Q[=WH*OA=+[U%QZ6R4_W*BOI$ OX
M$ HHLXIUU:)=E830L:@T8(1G+U)'CG&WQM:6\7R#";!3Q?A;7L3Y9%5O,BMA
MG1R[WCAZX.ZY+3^OS1JZ70ENI-G>SC_A=/*_UR79L^EB=CE)F_K_=W=.<6>[
MULW&K3LI:*ZT7&T:X(G>4),B.4*Y0-"L2&MYMKQU+*<)X>UTX[OY+%W%Y?WG
MZ,*$E+@C4X8NDJUE30C.Y@R)9<:<#YRNV&!:\!&BQM5WIT?<XPJQA=0ZR-,0
M&VO#Q?RZ:F2R^/?U(/%G?TT6%^A,\LH:$ E]W5N4P#LM06.1FJQN.DKK&.,6
M<D9^:ML*_OZ\DT92Z!%0]2"_S;[@9'HA"RJ99(*,LNZAC73S&!W*>R-2\$4I
MWGJ3YA9RQIXAU4CD3T'I0/YW *7;;.!/A_I'_A+R_*)8%3!*#PZ=($9%1;9M
MB1#I0*P4I;UJ/=SI2:(Z@]6AXI\-*8L1P;68+R]NC((?\LWUYJEHA7=$M8B)
MD;/$(@19#%CIDV?9EJ1W<L3I*W? 1+^[!=)6 D8N;QGDD6O'\;%A<UTM<?<(
MZYL5N&!&F0(V(H+"DL&;2.YOLM[*D%R4.TV]?@HVCQ$PCLYI*-A9:RZ/")58
MY]?,OU_\\>$B,UU8\*1Q&:E#NBX9 A9-"E@H4L4&I=XV>7J1X__[-/OV7^N?
M> V-]6]ND7'[O1%AT$9HLZ,X.+)Z^/UJ/ON:UZ]A<$8I5=&/9,<IB0Z"LO0D
MIIBS<@*SW"E1]H1&N/O-<=Z.]M(_BI=CETVLLD>WC'B]'IRRV!A)1&M!KXEV
M)*68M )O-8+V7#C%))=:_0B+Q^IEMWYGG*K"]E!HS=(.G)H'_+[G>1H_?\'Y
MOU?OIK5&>CH+2%.;>G-2X)(-X%0R14J>R!\</NKR TTC%ZF>.O1RN#RZQ-?F
M-!LO4,<LB%W C>#$++HOF)(%+^B<,4HF<^LAWT_1U)G+?!0"GH37$>+H %X?
M\#(OUG7=;_)RK8-MR3X6E8&[$$!Q7B^@LV!+5?E698:J,:8>)*0W(!TCZ_N9
MAZ,9WP%Z?E;@KR?3_(H\R,5%<:BC* %2*F0?<$NF03$,B$L2?<XE^-:QO"WD
MC-N5/NR3UTH*(P(JY<G%[]/E9/G]S56]"&_+9M'(XD('.@/3#(3#0NI:V[H7
M$*'P(EW07DN]+:.\<;KI$]<8HE_<0F?+A\=5/LV$.FO+X;$=L@WU-V[#1;+1
M>$0#-B-IX2 "N9.*=*:QL?H,.N5[KODC/MA//WK<Z&UK!#1@7P=/SN8 +U8Q
MI4E=*O'?Y$5^OL;V=?LE0=IXYD0V#E(='JUT8N!*,1"Y-AJC5=*TSG7O1MFX
MOE=K3 THE0ZP]I,!^"[/ZQ_@I\PO6%2Z9$F/M2.>*5D2.)8TU.=:6^5\DJUM
MY&WTC&O@#(6K9A(X&$W?\CS,!BW87FVXFY4/DT_329E$I)\95Q'SR?33U]GE
MI"ZZN^X-6M4]O<^+J\OZ=U4*+V?S3/^[%U=TGFG\_G&.T\7EBJ0C2AN')JE-
M,?@)V=:N26=-W[L-?9L:-LV$ML(YR#QJNB-H 6U,D*62@86,6K:>]O\X-<>J
MS7O<O>V14SK$0(>T)F6ZM(H4 8\%+,:<>*E+FUI'0A\A9?36F!8XN*\K6["]
M@T?WH;M)QR#9_ TGT]JU\SS3*U-W@5YHK4+@68$+WH/R64)((0(3B3--YR*K
M8EA$;2-O7)0U@<-VB#63S?ZP\]>PF^9/M<?KX\ ]5;N\-;\OEI,OE9@_%KE<
M7=8Y&(M9C?>0\;O\7J>_UB%<=2KZU]4<_:'?YP/I.=WCW()AP[_,-EGN"QF9
M(=08K_0*/,H$DJDZ=C'[E%JW<@WW,O_ W&=WF'O[ /G !$H&&I&T0_$(0:V2
ML;$6%*+4JK5&?9*H;E_K?;#Q0-"VH2@Z>+=_B'$_?+3K4#<:K[1AJ>Y*)']0
M&EVW>64H)L7$)/V='&X?T';:1@_YMH3$ME:75O(9N41K-3]]E=-E406E$@>A
M:A0SB01!UJY(KP3C600C=G*@GJC/NOE@1]TKS60Y.Y:Q/:!AG4C-WLGDHH7L
MZZAD%!G0L (Y9L><]?27.[6F[(*',7/51PCKOK@/X-S( O_'9#KY<O5E3;A.
M3L28/#"FZAHJ0KUSA'69>)(6"Q=AIX#L$R+_X:,C"_T0D<U:\&]LP>-?=PB7
MCON:IX*B:WL5G9@(5PX"H^<2Z9_.[I3K>4KP=S\Z7G%N$\$?S+\.#,U'G[P[
M'7?1VESHX0.OZF2V2("NYX!D(QGH19EBMA7J-W5C]FQY/4TW4&NC82CA](RW
M.ZUXQ0=$%QP8E22H7 ($R\D35-$IRXH49H!BIZ?(ZM2=.10*NT+M0+ET +7G
M5\31R?336C''J+#4;BLK/;E[3,3*';+I/%ES(I8@FV]$^I&"3@%TJ(!GS;@]
M=A54G6=V13_K-D0P32_PZV2)EW7WV(=96?Y)/%Z?S%GGB%$<2JS%A;YV:63!
M(:(SL<Z!%ND>CAZID-KKLZ-73PT"GH'9WX$2>GDUGTZ6=<'O-+V<_%5_M>G-
MD:QD.HN$S V9!Y(AN+JW7&F+9"MPKDOKX3Z/4S-Z)=6@RJF1%#K TPUG-N1+
MZ9.6$EC*1+03GIR6H &Y+5HHGD)IW;!RCX31:Z4&1<XQ_.X +O_,GTG'WH#=
M")6])KV):34/E)YFS"&#"(:%R+CCLG7^[4<*QET(-C18CN!V!UAYE#NO;ZH/
M)4JCT-<GU[%:<BIJD2#2%2CT'(O,POU]<L-Y9J_WZD8Y30/FR0,!AXFF9[!M
MZA=*O@@IJ6C)GXV^E.MI[!@3F7JREJ=*IU)L/4][![(Z=>,.1,*N0#M0+)W.
M+SVFIN95K:3Y-*$K?;V89Z3:H\?(&+OD:"?V#%]I5+=_,V4%)%Z'[%HL] I;
M!CHJGX..VF/K&.)PE4:W;\PKXEJ9D"^35ZNA[C/[^J7)3C,MA8-4BVA49!&0
MV4*LB-Q&U,6YUC[!?A1V6X.T#VH>+PEI+J0.WNN7CY_G^?=_X+]F\Q>7N%BL
MXM FVNH&!2@9JX]4$GA9(MCLG2B2<V5;W[T]R.NEV*0]2NX'/0826=]HO#W8
M&_RR<>HXYQJSK1LHD)RZ),D3B]) )IL\TSLD'+;N"-F3Q)'+VX>"RNZ0/%IN
M'<!RL[YQM6"\]@-_GGS=! -\0!N$)JM9T@$4]PC.^PQ6Y1R+RUGM5E.W3X?C
MX^1T"[?C87"_Z;&13#J U]LJEK?S=7LHG>4YQG]?SC8IMV#)'Z,G@2ZFXO16
M(+E\106(B=Z0:(S!TKHC;#M%X^:L3@FRAI+I &<?YYARY<SFGJB S&7+B1>E
M5D81?QP3'H+"G(SD*$1KA^(^#>,&^4Z)I:.XWP%Z?L,E!ES<D!^+]3+G#-I&
M7T<;(GB3$EAG& _.EGA_U^71X+E'PK@9JE-BYQC>=P"=CSE^GLY(;WY_3H?X
MF5W7AV(8 ^<B07'$&U6+;)$5NAXEYA24) ^^]3NW$V'CYK9.JJ*:RZF'9H>5
M=U-2$<H%!+D:JI)T@"#1@K<L,E\L&8K-6AUZJF(=+!IQ.'M[P,3F">8N)4P6
M1)*5;+HV3AI!+"C>:B:SMCOE/<^K 68O83W2 +,/Y\;N@_BA@<,QXTM=!2AU
MG6NJG +O?0%;>-WE$:PH.P4QSZ\!9B^1/=H LP__QA;\#PT<2@A)'&# .!E.
MRAM)@$\.LLI9!;*F@F]QUSML@#E8\ ?SKP.;\XF'[V[X\S;%GK'8(F0"9Y(A
M<&N$8'( 129UT<%&)EN7;AY"9R^5,8.G.@878@= ?=S OU.;P7W0V1<'TNH(
MBN<"SDD+5L@@6=+)8/,9/CO0-6ZX>7AT[)SF.%!4G9;1_#99X*=/\SHV:+58
M=SV!^YA%P-M_8I-5P'L0W:A.9?V)EX3,%[/IJM3@OR?+SYO4Q$WY@4K<\H@,
MM&?T *\6@ 2G21E*AREQEDOK@K<=23LZ*/@#T]]NF+X>UQV9%8J4?D!>KQH=
M&T4P8#29D#&H[%SKU-@V>L955D-@Y:<P82MIC&ZX5[V]YLQU=MK[9')4I*P3
MJUHU>$ ;-,C(@S%"61';6._WOSPN:MI)=-:,O2.#H\8ZWY8?SK!9MF2<2!8]
MV"AJ :OGY.>X0IZJ5SH(>HY#"]?^40+&<_./E>BL-7O';OW\./OZXG)RI[VG
M6!UJXP=#HE@I5N/CG ,6F1VB38RSIVR8AW[P>")O)*=9(Z:-+?!KPA=";U+S
M,:8L"P-AD70CT4M>9YVGS10:$7@JQ>PD\'L_>+R(S@ "/X9IG0C<<+99B9>9
M4\Q)R+4SHLYY T<^%QA!ZBZ:FAFU^TC\YB>/MU=P.)$?QK9.9,[Y#6*E]\(&
M;T'3LT8VLLO@=-' "O& )>Z-V&VMR4\_>ISB@F&E?B#CQA;[:A?FC76SJ?'+
MM2E7<N#"V6K\&K)T2H;L#+E0W"1SOXELVU+1>S]]G)3_0,(_FGT=!$D?\8-N
MPWK<NF BCQ )OJ!$3N Q"XC.)<%YM&JW\6;'QQKVB](/5@+0W',<1!0=0.N)
MP,SO?\7+JSH I\9YZ?]2'=N.BHO,C(14M (EN840R5#B]&:Z8*W"W>H&V@7T
M'B*SR]#%@3B9G59HG0;F-V=]CI<XC7FQ^?WBSSN'/Z9S=;\/M C;'W&D$T?Q
MN>522$GX";7_&NO<6),\>!YTEJ@(O*W;WTX4Q7\^N;S,:?.%]SGFR;?Z3BPN
ME"Y)2I,A\.)!T34!.F4$>CTR'3L6[UMG+AXEYCSB]_N@Y*=9:TWDT,&;^NSR
M<O9GO<XO9V2^7H5EN;I<M^<N;H]U0<YE2&@<"$.>B++$*[2:?,]2&&,QEW1_
MY-KQS=P[43:NZ78*J T@H=;[:0Z>^K=^0&Z/\;?Y;+&X8"BUR#R!,I;^(82&
MH+F&H@R3)=!-$NJI]W'K%\8MRQD2->T8>[ARFBWQLDTWYT/<J44<J]-<KVU:
M7A2KG%-&@66)K$5-:A=C(I-1^T3(E[ACG>@^?9V[$#9NT\LI5%-[^1RAF9:#
M**0WF0[ O7.&5*L1+),[DI%\<%D@)%-DW4J0[F\SW%T=T<\?MVME#&6T+U,[
M546O)Q@FEY/E]PW2)9/*2^ZA%%MW3Z<,SA"C8M!!<<>--*UM\%WHV@E@YAP!
M-IAT.K&0GJ5OU?)[A]]72U_IWM#/?O8))]/%\H]I^,$)N6L,%I59DDR!L[SR
M4EGP2D1 C4[D$#Q'N9/&.I" G1!GSQ%Q)Q/+V*F<5],XS[C(O^7K?[^:;D[T
MY];7/F'PT=.AA$IU!#XJ0(4>I"5VAMHK[7>#WH$$[ 0]=[;0.X58^H7>XBXS
M%S]I^.P<%I<,1,M(PYM4P&D>H:!EH:C('--'8F\[!3N!S_^"X&LHF$Z>WA>?
M:U_69'JHKL^I=BED![;D0JYV74"DZ,A>BDC,#Q[CCD[#<83L%HME9XO)4\II
M1#_D&.7_+L]CO85,6%&2XZ"YR=7\B. 2UD)3BU[(Z+@N0S[-:SIV0^19I@=.
M+:5^7^H'/;&'CNNX#TQR!REI64M7JW4<)&3BN@E8%.;=EKD<3\MNP#S+9,(8
MTAH;G$>^#)LC&PPV^R! 6W2@F-7@K2.>6^DC.71"Z'B*AWPOD)YQ[N+T4CN3
M$I(W.)_3S_QV3'?GDS]SB$*1[82?NC8D>NZ]JRDP0QHLAFKOU3PIHY>U;I,)
MX4P[/->?>9]K$6J=K9WG93;_4D7P-EQ.KJN[?O_K:X[52YI\H?_D;?E ?[HH
MN!J9>%UQ&"WY9RI9LC]X'1HEZZC$C""YS^2MJ=A^=G0;RL^DZF0/_#U22W=*
M"7=0HG+TJ3\L<;[\#9?7,Y6LB44F7[O^C0+E4JPY)P$2M8U%>67#0!6AC4[0
M!<Y/BL'6U^!P0/P*U^'U35VOTJ1L)'-@K-:@O*S6O Z0R:2GP_DHW$XKYD]Y
M%5[W4;3_*UR#PX PMENW:I+9.*EU=<B76@I'?D)EZ,?9Q\^3>7I']YO^ZN5L
M_CY/OH2K^:+^9>7%=)$7%[ID'5S.P')=TURP@"L^ W$;R3,(7.2PDTMW/"UG
MKLP/A-!/34^GD^?8\#TT@:>+4J+.H*;SU'J9ZE#;7,BA+B)BRCJ+W?KBA\RK
M]JMN&P#U%)+K%YU/9/@*TXF)E$&S&K5VCLZ'SD")D2NE;,;"CX1G@]3KT&&Q
M3O'94':_2';6&M0ZHH5B5EF_DL'5*>V\1"DU8D*S6Y7**;*S0]<(CXK:4TJR
M ^_MT9+I%T3+9/F:WHVU67.A4M1)F  BNCH,-@1P7'E@3F83G,A)M5[;L#MU
M710MCP7<@879 4QW8O"%$X59XP44K>I"Y;J*W6MR9I,6.J9H;+"-$;H385T4
M/(\-SO8B/!=<KG. ^"E?"&MT0!' &Y] H:/CU<QUEJDH+@6SS77HGB1V42I]
M%E@]4*SG@MIM7*;_P626^$60VG(1_+47J8QEX+2-8+CW+" +IOE.Y5:T=U&7
M?18X;PV$,RUON+CG<[8I<+C@)REQN$_\39'#?QW(K9LN\ 4!YM:\S,>,$'GR
M9[;@U'Z$MUU+_V/+X4T*'GE05MDZGZLN1LG*0L@F@33*8XA.%=UZ?=E6@DXS
MP^'][/*21/ GSM,%\SYDQR-DQ<EI+D;6M:N2'E'! TJ9T;+6'-B7R"Y6U#=
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MJ4X5N,.P"Y--P;JTGOYG!10]^.!3J-?/ARR4*#]M4#R^-/QQ<L;578,!JI4
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MP<<^12*9\)"22[7P2B*H%!-XRR1D83*R*)AOOH*TJT0R,\S&&A=F+CDZ?^&
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MKUK*<GK@0#9[PYWTY!+QJK*+KU-A!8CBD(Q-YTUL7:+^)%'C1ET&QE=;D72
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MT&6G897AS/@@B_,9.$4])+#::HHR0#2>$S<"(VN_4_@Q2G9+P;)3 E0#D7<
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M-N?I=E>;*T9KJ4#(K$$):^G&CAR$K2THB4MG6[<3/T=/+P@Z5.M/PNE %70
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MKG'U_;(7@N03HJ\+='V=B^!%!H=%@I$6L:Y6T:SU[)L72)JXCW&*^^I O70
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M[0Z<B5!Y@(XZ . ?BQ5Q]7DQ_^\-"]O0;GWYMD&<K^H&Z9_Q\O]GG >FE1+
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MC@6E'JZ[ Y3Y%"SVD.S4N6ZB_3\QK$A5ZM-2,,FV5E):(>JB,Y!.UGR]0S+
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MG%2XL41PW6V6Z[CR&,#7_;O*1>\,UR65W7; GVKAU]XX:2O;#CR<W9X8#6+
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MLP6XU'0AFQQXN@O(X%511$\*Z$;M"CCQ/NI!@!C<1SV$.[W#;5O'RHT+@ND
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MF0>/9%>+B#H:6]"%>^V-YUW)-8C9!U5R#:%\!SIIMR>$*"*9?<X@)%>[&5.
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M1%M',6@[0A9GMZ-UY2KOB8/[X!J!*>-GBK=_47^)=.K__3_^/U!+ 0(4 Q0
M   ( /B$5UBPAV)__ <  "U    3              "  0    !E>&AI8FET
M,3(Q+3(P,C,N:'1M4$L! A0#%     @ ^(176*"._995!0  WR   !,
M         ( !+0@  &5X:&EB:70Q,C(M,C R,RYH=&U02P$"% ,4    " #X
MA%=87V5;K<0#  !J"P  #@              @ &S#0  97AH:6)I=#$V,2YH
M=&U02P$"% ,4    " #XA%=8!JJ76!P+  !J-P  $@              @ &C
M$0  97AH:6)I=#(R+3(P,C,N:'1M4$L! A0#%     @ ^(176)JK^2VM @
M_P<  !,              ( ![QP  &5X:&EB:70R,S$M,C R,RYH=&U02P$"
M% ,4    " #XA%=8S/P9V.8,  !(3   #0              @ '-'P  97AH
M:6)I=#DW+FAT;5!+ 0(4 Q0    ( /B$5UBGKA2:O3L$ )=R+P 1
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M &EC;'(M,C R,S$R,S%?9S$N9VEF4$L! A0#%     @ ^(176!PJFS\X#@
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M<BTR,#(S,3(S,5]G,RYG:6902P$"% ,4    " #XA%=8?7G*K96=!P#GO D
M%               @ $?,!\ :6-L<BTR,#(S,3(S,5]G-"YJ<&=02P$"% ,4
M    " #XA%=8QY\,&2K,  #=W   %               @ 'FS28 :6-L<BTR
M,#(S,3(S,5]G-2YJ<&=02P$"% ,4    " #XA%=8 :^\[M0F 0#?,0$ %
M            @ %"FB< :6-L<BTR,#(S,3(S,5]G-BYJ<&=02P$"% ,4
M" #XA%=8_E[YH<0+  "+#   %               @ %(P2@ :6-L<BTR,#(S
M,3(S,5]G-RYJ<&=02P$"% ,4    " #XA%=88?52WL$*  """P  %
M        @ $^S2@ :6-L<BTR,#(S,3(S,5]G."YJ<&=02P$"% ,4    " #X
MA%=8'C;<X/T*  #%"P  %               @ $QV"@ :6-L<BTR,#(S,3(S
M,5]G.2YJ<&=02P$"% ,4    " #XA%=8I 5>1BRZ 0!Q:A( %0
M    @ %@XR@ :6-L<BTR,#(S,3(S,5]L86(N>&UL4$L! A0#%     @ ^(17
M6'3AT73]+P$ @!8. !4              ( !OYTJ &EC;'(M,C R,S$R,S%?
=<')E+GAM;%!+!08     %P 7 -P%  #OS2L    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>iclr-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iclr="http://www.iconplc.com/20231231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iclr-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-10-02</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-20</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-20</startDate>
            <endDate>2023-04-20</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202108Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-24</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-22</startDate>
            <endDate>2016-07-22</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-18</startDate>
            <endDate>2022-02-18</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2024To2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2024To2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20382042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20382042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2024To2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AptivSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-07</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-13</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1997-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-05-11</startDate>
            <endDate>2015-05-11</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-11</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-16</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2020-07-24</instant>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="employee">
        <measure>iclr:Employee</measure>
    </unit>
    <unit id="location">
        <measure>iclr:Location</measure>
    </unit>
    <unit id="country">
        <measure>iclr:Country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="instrument">
        <measure>iclr:instrument</measure>
    </unit>
    <unit id="vote">
        <measure>iclr:vote</measure>
    </unit>
    <unit id="segment">
        <measure>iclr:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-40">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-41">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-42">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-43">0001060955</dei:EntityCentralIndexKey>
    <us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-957">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-4" id="f-959">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-961">http://fasb.org/us-gaap/2023#NontradeReceivablesCurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-964">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-4" id="f-965">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-1012">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-1013">http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c-1" id="f-2">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-5">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-6">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c-1" id="f-7">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-8">333-08704</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-9">ICON PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-10">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-11">South County Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-12">Leopardstown</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-13">Dublin 18</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-1" id="f-15">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c-2" id="f-16">Brendan Brennan</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-17">South County Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-2" id="f-18">Leopardstown</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-19">Dublin 18</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-20">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-2" id="f-21">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelEmailAddress contextRef="c-2" id="f-22">Brendan.Brennan@iconplc.com</dei:ContactPersonnelEmailAddress>
    <dei:CountryRegion contextRef="c-2" id="f-23">353</dei:CountryRegion>
    <dei:CityAreaCode contextRef="c-2" id="f-24">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-2" id="f-25">291-2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-26">ORDINARY SHARES, PAR VALUE &#x20ac;0.06 EACH</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-27">ICLR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-29" unitRef="shares">82495086</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-30">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-32">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-33">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-34">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-35">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-36">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-37">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="c-1" id="f-38">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c-1" id="f-39">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c-1" id="f-44">1116</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-45">KPMG</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-46">Dublin, Ireland</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">378102000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">288768000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">1954000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">1713000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">1790322000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">1731388000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">951936000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">957655000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">65797000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">63658000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-57" unitRef="usd">132105000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">137094000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-3" decimals="-3" id="f-59" unitRef="usd">91254000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">48790000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-61" unitRef="usd">3411470000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">3229066000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-63" unitRef="usd">361184000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">350320000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-65" unitRef="usd">9022075000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">8971670000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-67" unitRef="usd">3855865000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">4278659000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-69" unitRef="usd">140333000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">153832000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-71" unitRef="usd">78470000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">70790000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-3" decimals="-3" id="f-73" unitRef="usd">0</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">21380000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-3" decimals="-3" id="f-75" unitRef="usd">73662000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">76930000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherLongTermInvestments contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">46804000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">32631000</us-gaap:OtherLongTermInvestments>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-79" unitRef="usd">16989863000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">17185278000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-81" unitRef="usd">131584000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">81194000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">1654507000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">1507449000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-85" unitRef="usd">915399000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">1005025000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-3" decimals="-3" id="f-87" unitRef="usd">13968000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">41783000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-3" decimals="-3" id="f-89" unitRef="usd">110150000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">55150000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-91" unitRef="usd">2825608000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-92" unitRef="usd">2690601000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLineOfCredit contextRef="c-3" decimals="-3" id="f-93" unitRef="usd">3665439000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="c-4" decimals="-3" id="f-94" unitRef="usd">4599037000</us-gaap:LongTermLineOfCredit>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-95" unitRef="usd">126321000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-96" unitRef="usd">131644000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-97" unitRef="usd">45998000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-98" unitRef="usd">38260000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-3" decimals="-3" id="f-99" unitRef="usd">186654000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-4" decimals="-3" id="f-100" unitRef="usd">239188000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-3" id="f-101" unitRef="usd">899100000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-102" unitRef="usd">988585000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" decimals="-3" id="f-103" unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" decimals="-3" id="f-104" unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-105" unitRef="usd">7749120000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-106" unitRef="usd">8687315000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-107"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-108"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-109" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-110" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-111" unitRef="shares">82495086</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-112" unitRef="shares">82495086</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-113" unitRef="shares">81723555</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-114" unitRef="shares">81723555</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-115" unitRef="usd">6699000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-116" unitRef="usd">6649000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-117" unitRef="usd">6942669000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-118" unitRef="usd">6840306000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <iclr:OtherUndenominatedCapital contextRef="c-3" decimals="-3" id="f-119" unitRef="usd">1162000</iclr:OtherUndenominatedCapital>
    <iclr:OtherUndenominatedCapital contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">1162000</iclr:OtherUndenominatedCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-121" unitRef="usd">-143506000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-122" unitRef="usd">-171538000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-123" unitRef="usd">2433719000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-124" unitRef="usd">1821384000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-125" unitRef="usd">9240743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-126" unitRef="usd">8497963000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-127" unitRef="usd">16989863000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-128" unitRef="usd">17185278000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-129" unitRef="usd">8120176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">5719949000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-3" id="f-133" unitRef="usd">5527045000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-3" id="f-134" unitRef="usd">3972612000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">768559000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-136" unitRef="usd">778753000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-137" unitRef="usd">585330000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">585950000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-139" unitRef="usd">569513000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-3" id="f-140" unitRef="usd">314987000</us-gaap:DepreciationAndAmortization>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-1" decimals="-3" id="f-141" unitRef="usd">44176000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-5" decimals="-3" id="f-142" unitRef="usd">39695000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-6" decimals="-3" id="f-143" unitRef="usd">198263000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">45390000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-3" id="f-145" unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">7164024000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-148" unitRef="usd">6946149000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-6" decimals="-3" id="f-149" unitRef="usd">5102297000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">956152000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-151" unitRef="usd">795237000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-152" unitRef="usd">378529000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-153" unitRef="usd">5014000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-5" decimals="-3" id="f-154" unitRef="usd">2345000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">574000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">336699000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-3" id="f-157" unitRef="usd">229731000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-3" id="f-158" unitRef="usd">182423000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">624467000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-160" unitRef="usd">567851000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-161" unitRef="usd">196680000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">11749000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-163" unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-164" unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-165" unitRef="usd">612718000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-166" unitRef="usd">508440000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-167" unitRef="usd">155346000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-168" unitRef="usd">-383000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-169" unitRef="usd">-3136000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-170" unitRef="usd">-2161000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">612335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-172" unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-173" unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-174"
      unitRef="usdPerShare">7.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-175"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-176"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">7.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-180" unitRef="shares">82101813</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-181" unitRef="shares">81532320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-182" unitRef="shares">67110186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-183" unitRef="shares">82717640</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-184" unitRef="shares">82468363</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-185" unitRef="shares">68068311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-186" unitRef="usd">612335000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-187" unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-188" unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-189" unitRef="usd">26221000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-190" unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-191" unitRef="usd">-60617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-192" unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-193" unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-194" unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-196" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-197" unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-198" unitRef="usd">1567000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-199" unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-200" unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-201" unitRef="usd">640367000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-202" unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-203" unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="INF" id="f-204" unitRef="shares">52788093</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-205" unitRef="usd">4580000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-206" unitRef="usd">617104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-207" unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-208" unitRef="usd">-35477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-209" unitRef="usd">1262895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-210" unitRef="usd">1850236000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-211" unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-212" unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-14" decimals="-3" id="f-213" unitRef="usd">-60617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-214" unitRef="usd">-60617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-14" decimals="-3" id="f-215" unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-216" unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-14" decimals="-3" id="f-217" unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-218" unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-14" decimals="-3" id="f-219" unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-220" unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-221" unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-15"
      decimals="INF"
      id="f-222"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-15" decimals="-3" id="f-223" unitRef="usd">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-16" decimals="-3" id="f-224" unitRef="usd">118512000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-225" unitRef="usd">118589000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-15"
      decimals="INF"
      id="f-226"
      unitRef="shares">328634</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-15" decimals="-3" id="f-227" unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-6" decimals="-3" id="f-228" unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-3" id="f-229" unitRef="usd">133553000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-230" unitRef="usd">133553000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-16" decimals="-3" id="f-231" unitRef="usd">853000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-6" decimals="-3" id="f-232" unitRef="usd">853000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-15"
      decimals="INF"
      id="f-233"
      unitRef="shares">27372427</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-15" decimals="-3" id="f-234" unitRef="usd">1960000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-16" decimals="-3" id="f-235" unitRef="usd">5656195000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-6" decimals="-3" id="f-236" unitRef="usd">5658155000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="c-16" decimals="-3" id="f-237" unitRef="usd">209399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition contextRef="c-6" decimals="-3" id="f-238" unitRef="usd">209399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-17"
      decimals="INF"
      id="f-239"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-240" unitRef="usd">6640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-241" unitRef="usd">6733910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-242" unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-243" unitRef="usd">-90937000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-244" unitRef="usd">1416080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-245" unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-17"
      decimals="INF"
      id="f-246"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-247" unitRef="usd">6640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-248" unitRef="usd">6733910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-249" unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-250" unitRef="usd">-90937000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-251" unitRef="usd">1416080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-252" unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-253" unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-254" unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-24" decimals="-3" id="f-255" unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-256" unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-24" decimals="-3" id="f-257" unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-258" unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-24" decimals="-3" id="f-259" unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-260" unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-25"
      decimals="INF"
      id="f-262"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-25" decimals="-3" id="f-263" unitRef="usd">21000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-26" decimals="-3" id="f-264" unitRef="usd">35807000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-265" unitRef="usd">35828000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-25"
      decimals="INF"
      id="f-266"
      unitRef="shares">241116</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-25" decimals="-3" id="f-267" unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-3" id="f-268" unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-26" decimals="-3" id="f-269" unitRef="usd">70606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-270" unitRef="usd">70606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-26" decimals="-3" id="f-271" unitRef="usd">17000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-5" decimals="-3" id="f-272" unitRef="usd">17000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-25"
      decimals="INF"
      id="f-273"
      unitRef="shares">420530</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-25" decimals="-3" id="f-274" unitRef="usd">28000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-27" decimals="-3" id="f-275" unitRef="usd">-28000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-23" decimals="-3" id="f-276" unitRef="usd">99983000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-5" decimals="-3" id="f-277" unitRef="usd">99983000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts contextRef="c-23" decimals="-3" id="f-278" unitRef="usd">17000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts contextRef="c-5" decimals="-3" id="f-279" unitRef="usd">17000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-28"
      decimals="INF"
      id="f-280"
      unitRef="shares">81723555</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-281" unitRef="usd">6649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-282" unitRef="usd">6840306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-283" unitRef="usd">1162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-284" unitRef="usd">-171538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-285" unitRef="usd">1821384000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-286" unitRef="usd">8497963000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-28"
      decimals="INF"
      id="f-287"
      unitRef="shares">81723555</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-288" unitRef="usd">6649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-289" unitRef="usd">6840306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-290" unitRef="usd">1162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-291" unitRef="usd">-171538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-292" unitRef="usd">1821384000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-293" unitRef="usd">8497963000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-3" id="f-294" unitRef="usd">612335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-295" unitRef="usd">612335000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-34" decimals="-3" id="f-296" unitRef="usd">26221000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">26221000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-34" decimals="-3" id="f-298" unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-299" unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-34" decimals="-3" id="f-300" unitRef="usd">1567000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-301" unitRef="usd">1567000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-302" unitRef="usd">640367000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-35"
      decimals="INF"
      id="f-303"
      unitRef="shares">535705</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-35" decimals="-3" id="f-304" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-36" decimals="-3" id="f-305" unitRef="usd">50923000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-306" unitRef="usd">50958000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-35"
      decimals="INF"
      id="f-307"
      unitRef="shares">235826</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-35" decimals="-3" id="f-308" unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-36" decimals="-3" id="f-310" unitRef="usd">51456000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">51456000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-36" decimals="-3" id="f-312" unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-1" decimals="-3" id="f-313" unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-37"
      decimals="INF"
      id="f-314"
      unitRef="shares">82495086</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-315" unitRef="usd">6699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-316" unitRef="usd">6942669000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-317" unitRef="usd">1162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-318" unitRef="usd">-143506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-319" unitRef="usd">2433719000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-320" unitRef="usd">9240743000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">612335000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-322" unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-323" unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">585950000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="-3" id="f-325" unitRef="usd">569513000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-6" decimals="-3" id="f-326" unitRef="usd">314987000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">8686000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-5" decimals="-3" id="f-328" unitRef="usd">28767000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-6" decimals="-3" id="f-329" unitRef="usd">20037000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-330" unitRef="usd">41546000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-5" decimals="-3" id="f-331" unitRef="usd">45215000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-6" decimals="-3" id="f-332" unitRef="usd">45339000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">-383000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-334" unitRef="usd">-3136000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-335" unitRef="usd">-2161000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">6160000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-5" decimals="-3" id="f-337" unitRef="usd">0</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-6" decimals="-3" id="f-338" unitRef="usd">0</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:AmortizationOfDeferredHedgeGains contextRef="c-1" decimals="-3" id="f-339" unitRef="usd">2407000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains contextRef="c-5" decimals="-3" id="f-340" unitRef="usd">0</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains contextRef="c-6" decimals="-3" id="f-341" unitRef="usd">0</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">16402000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-3" id="f-343" unitRef="usd">17749000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-6" decimals="-3" id="f-344" unitRef="usd">12890000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">55667000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-346" unitRef="usd">70523000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-347" unitRef="usd">133844000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-5" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-6" decimals="-3" id="f-350" unitRef="usd">-14434000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <iclr:GainLossOnIssuanceOfDebt contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">0</iclr:GainLossOnIssuanceOfDebt>
    <iclr:GainLossOnIssuanceOfDebt contextRef="c-5" decimals="-3" id="f-352" unitRef="usd">0</iclr:GainLossOnIssuanceOfDebt>
    <iclr:GainLossOnIssuanceOfDebt contextRef="c-6" decimals="-3" id="f-353" unitRef="usd">-59460000</iclr:GainLossOnIssuanceOfDebt>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">-85403000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-5" decimals="-3" id="f-355" unitRef="usd">-124985000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-6" decimals="-3" id="f-356" unitRef="usd">-60616000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-357" unitRef="usd">-19706000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-5" decimals="-3" id="f-358" unitRef="usd">13009000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-6" decimals="-3" id="f-359" unitRef="usd">6054000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">-24332000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-5" decimals="-3" id="f-361" unitRef="usd">-11324000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-6" decimals="-3" id="f-362" unitRef="usd">-4480000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">83296000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-5" decimals="-3" id="f-364" unitRef="usd">420695000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-6" decimals="-3" id="f-365" unitRef="usd">-113513000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">-4716000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-5" decimals="-3" id="f-367" unitRef="usd">332592000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-6" decimals="-3" id="f-368" unitRef="usd">17656000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-369" unitRef="usd">134566000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-5" decimals="-3" id="f-370" unitRef="usd">192944000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-6" decimals="-3" id="f-371" unitRef="usd">-69121000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-1" decimals="-3" id="f-372" unitRef="usd">-170810000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-373" unitRef="usd">10121000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-6" decimals="-3" id="f-374" unitRef="usd">108259000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-375" unitRef="usd">1161027000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-376" unitRef="usd">563315000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-3" id="f-377" unitRef="usd">829142000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">140692000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-379" unitRef="usd">142160000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-380" unitRef="usd">93750000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-1" decimals="-3" id="f-381" unitRef="usd">71766000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-5" decimals="-3" id="f-382" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-6" decimals="-3" id="f-383" unitRef="usd">5914475000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-384" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-385" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-386" unitRef="usd">2450000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-1" decimals="-3" id="f-387" unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-5" decimals="-3" id="f-388" unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-6" decimals="-3" id="f-389" unitRef="usd">10000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-3" id="f-390" unitRef="usd">2616000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-5" decimals="-3" id="f-391" unitRef="usd">481000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-6" decimals="-3" id="f-392" unitRef="usd">497000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-3" id="f-393" unitRef="usd">2857000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-5" decimals="-3" id="f-394" unitRef="usd">482000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-6" decimals="-3" id="f-395" unitRef="usd">480000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-1" decimals="-3" id="f-396" unitRef="usd">0</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-5" decimals="-3" id="f-397" unitRef="usd">1906000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-6" decimals="-3" id="f-398" unitRef="usd">500000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments contextRef="c-1" decimals="-3" id="f-399" unitRef="usd">13954000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">5612000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments contextRef="c-6" decimals="-3" id="f-401" unitRef="usd">4077000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-402" unitRef="usd">-226653000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-3" id="f-403" unitRef="usd">-145867000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-3" id="f-404" unitRef="usd">-6024235000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-1" decimals="-3" id="f-405" unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-5" decimals="-3" id="f-406" unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-6" decimals="-3" id="f-407" unitRef="usd">30328000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-1" decimals="-3" id="f-408" unitRef="usd">370000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-5" decimals="-3" id="f-409" unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-6" decimals="-3" id="f-410" unitRef="usd">5905100000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-1" decimals="-3" id="f-411" unitRef="usd">1265000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-5" decimals="-3" id="f-412" unitRef="usd">875000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-6" decimals="-3" id="f-413" unitRef="usd">877780000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-414" unitRef="usd">50973000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-415" unitRef="usd">35844000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-6" decimals="-3" id="f-416" unitRef="usd">118589000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-417" unitRef="usd">16000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-5" decimals="-3" id="f-418" unitRef="usd">17000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-6" decimals="-3" id="f-419" unitRef="usd">853000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-420" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-5" decimals="-3" id="f-421" unitRef="usd">99983000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-6" decimals="-3" id="f-422" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <iclr:PaymentsForShareRepurchaseCosts contextRef="c-1" decimals="-3" id="f-423" unitRef="usd">0</iclr:PaymentsForShareRepurchaseCosts>
    <iclr:PaymentsForShareRepurchaseCosts contextRef="c-5" decimals="-3" id="f-424" unitRef="usd">17000</iclr:PaymentsForShareRepurchaseCosts>
    <iclr:PaymentsForShareRepurchaseCosts contextRef="c-6" decimals="-3" id="f-425" unitRef="usd">0</iclr:PaymentsForShareRepurchaseCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-426" unitRef="usd">-844043000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-427" unitRef="usd">-864173000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-3" id="f-428" unitRef="usd">5114728000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">-997000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-430" unitRef="usd">-16720000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-431" unitRef="usd">-7727000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-432" unitRef="usd">89334000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-3" id="f-433" unitRef="usd">-463445000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-3" id="f-434" unitRef="usd">-88092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-435" unitRef="usd">288768000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-22" decimals="-3" id="f-436" unitRef="usd">752213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-3" id="f-437" unitRef="usd">840305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-438" unitRef="usd">378102000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-439" unitRef="usd">288768000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-22" decimals="-3" id="f-440" unitRef="usd">752213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-441">Description of Business &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development serv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ices on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2023 we had approximately 41,100 employees, in 106 locations in 53 countries. During the year ended December&#160;31, 2023, we derived approximate&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ly 40.4%, 48.7% and 10.9% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;of our revenue in the United States, Europe and Rest of World, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON&#x2019;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#x201c;ICLR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <dei:EntityNumberOfEmployees contextRef="c-3" decimals="0" id="f-442" unitRef="employee">41100</dei:EntityNumberOfEmployees>
    <iclr:NumberOfLocations
      contextRef="c-3"
      decimals="INF"
      id="f-443"
      unitRef="location">106</iclr:NumberOfLocations>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="c-3"
      decimals="INF"
      id="f-444"
      unitRef="country">53</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-42" decimals="3" id="f-445" unitRef="number">0.404</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-43" decimals="3" id="f-446" unitRef="number">0.487</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-44" decimals="3" id="f-447" unitRef="number">0.109</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-448">Summary of Significant Accounting Policies&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination and income taxation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3: Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments in short-term debt or equity as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by Level 1 fair value measurements &#x2013; quoted prices in active markets for identical assets. The changes in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses, other than temporary, which reduce the carrying amount below cost are recognized in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts charged/(credited)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value Measurements ("ASC 820")&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Any increases or decreases in fair value are recognized in earnings in the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable, net and unbilled revenue&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable early payment discounting&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2 - 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2023 and December&#160;31, 2022, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and  Equipment &#x2013; Overall&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16 - 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of goodwill and long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for these plans in accordance with ASC Subtopic 715-30, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans &#x2013; Pension&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;("ASC 718")&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of Recently Issued or Adopted Accounting Standards&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounting pronouncements, effective for the year ended December 31, 2023, did not have any significant impact on the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following accounting pronouncements have been issued, but not yet adopted, as of December 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting &#x2013; Improvements to Reportable Segment Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2023-07&#x201d;), which amends the guidance in ASC Topic 280,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Segment Reporting. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis. Furthermore, all disclosures about a reportable segment&#x2019;s profit or loss, which are currently required annually, will be mandated for interim periods. The additional disclosures required by ASU 2023-07 apply to entities with a single reportable segment. The amended guidance is effective for fiscal periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with retrospective application required. The Company is currently evaluating the impact of this ASU on disclosures within its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax Disclosures, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;which requires disaggregated information about an entity&#x2019;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-449">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-450">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination and income taxation.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-451">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3: Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments in short-term debt or equity as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by Level 1 fair value measurements &#x2013; quoted prices in active markets for identical assets. The changes in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses, other than temporary, which reduce the carrying amount below cost are recognized in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-452">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-453">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts charged/(credited)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <iclr:ForeignCurrencyDisclosureTableTextBlock contextRef="c-1" id="f-454">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts charged/(credited)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ForeignCurrencyDisclosureTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-455" unitRef="usd">-12916000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-5" decimals="-3" id="f-456" unitRef="usd">25997000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-6" decimals="-3" id="f-457" unitRef="usd">14316000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-458">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c-1" id="f-459">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-460">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-461">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value Measurements ("ASC 820")&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Any increases or decreases in fair value are recognized in earnings in the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-462">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable, net and unbilled revenue&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable early payment discounting&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing &lt;/span&gt;("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-463">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2 - 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock contextRef="c-1" id="f-464">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 25.75pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2 - 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-45" id="f-465">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-46" id="f-466">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-47" id="f-467">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-48" id="f-468">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-49" id="f-469">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-50" id="f-470">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-471">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2023 and December&#160;31, 2022, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and  Equipment &#x2013; Overall&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="c-1" id="f-472">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16 - 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-473">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16 - 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Intangible Assets for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,090,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;541,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;536,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,147,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,109,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,292,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(830,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,855,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,278,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-51" id="f-474">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-52" id="f-475">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-53" id="f-476">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-54" id="f-477">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-55" id="f-478">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-56" id="f-479">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c-1" id="f-480">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of goodwill and long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="c-1" id="f-481">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-482">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-483">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <iclr:GovernmentGrantsPolicyTextBlock contextRef="c-1" id="f-484">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;</iclr:GovernmentGrantsPolicyTextBlock>
    <iclr:ResearchandDevelopmentCreditsPolicyTextBlock contextRef="c-1" id="f-485">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;</iclr:ResearchandDevelopmentCreditsPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy contextRef="c-1" id="f-486">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for these plans in accordance with ASC Subtopic 715-30, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans &#x2013; Pension&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-487">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;("ASC 718")&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy contextRef="c-1" id="f-488">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-489">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-490">&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of Recently Issued or Adopted Accounting Standards&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounting pronouncements, effective for the year ended December 31, 2023, did not have any significant impact on the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following accounting pronouncements have been issued, but not yet adopted, as of December 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting &#x2013; Improvements to Reportable Segment Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2023-07&#x201d;), which amends the guidance in ASC Topic 280,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Segment Reporting. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis. Furthermore, all disclosures about a reportable segment&#x2019;s profit or loss, which are currently required annually, will be mandated for interim periods. The additional disclosures required by ASU 2023-07 apply to entities with a single reportable segment. The amended guidance is effective for fiscal periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with retrospective application required. The Company is currently evaluating the impact of this ASU on disclosures within its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax Disclosures, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;which requires disaggregated information about an entity&#x2019;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-491">Disaggregation of Revenue&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer profile is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,453,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,291,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,188,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,112,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,743,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,585,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,077,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,012,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,853,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8,120,176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,741,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5,480,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.676%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,751,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,790,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,731,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,742,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,689,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.031%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654,507)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,507,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(702,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(549,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(152,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and December&#160;31, 2022 were $333.0&#160;million and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$406.3&#160;million (see&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; note 12 - Other liabilities&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services as at December&#160;31, 2023 decreased by $5.7 million as compared to December&#160;31, 2022. Unearned revenue increased by $147.1 million over the same period resulting in an increase of $152.8 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2022 and December&#160;31, 2023. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The credit loss expense recognized on the Company's receivables and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;unbilled services was $24.6&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and $17.8&#160;million for the year ended December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$14.8 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.7&#160;billion as of December&#160;31, 2022. As of December&#160;31, 2023 the Company expects to recognize revenue on approximately 52% &lt;/span&gt;of the unsatisfied performance obligation over the next twelve months compared to 52% as of December&#160;31, 2022, with the remainder recognized thereafter over the duration of the customer contracts.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-492">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer profile is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.656%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.658%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,453,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,291,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,188,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,112,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,743,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,585,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,077,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,012,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,853,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8,120,176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,741,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5,480,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-57" decimals="-3" id="f-493" unitRef="usd">721309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-58" decimals="-3" id="f-494" unitRef="usd">683546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-59" decimals="-3" id="f-495" unitRef="usd">441173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-60" decimals="-3" id="f-496" unitRef="usd">1453508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-61" decimals="-3" id="f-497" unitRef="usd">1506087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-62" decimals="-3" id="f-498" unitRef="usd">1291946000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-63" decimals="-3" id="f-499" unitRef="usd">1188943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-64" decimals="-3" id="f-500" unitRef="usd">1112636000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-65" decimals="-3" id="f-501" unitRef="usd">752325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-66" decimals="-3" id="f-502" unitRef="usd">1743539000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-67" decimals="-3" id="f-503" unitRef="usd">1585739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-68" decimals="-3" id="f-504" unitRef="usd">1077073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-69" decimals="-3" id="f-505" unitRef="usd">3012877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-70" decimals="-3" id="f-506" unitRef="usd">2853378000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-71" decimals="-3" id="f-507" unitRef="usd">1918309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-508" unitRef="usd">8120176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-509" unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-510" unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-511">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.676%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,751,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,790,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,731,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,742,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,689,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.026%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.031%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654,507)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,507,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(702,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(549,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(152,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:BilledContractReceivables contextRef="c-3" decimals="-3" id="f-512" unitRef="usd">1821855000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables contextRef="c-4" decimals="-3" id="f-513" unitRef="usd">1751950000</us-gaap:BilledContractReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-3" decimals="-3" id="f-514" unitRef="usd">31533000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-515" unitRef="usd">20562000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <iclr:ContractsReceivableGross contextRef="c-3" decimals="-3" id="f-516" unitRef="usd">1790322000</iclr:ContractsReceivableGross>
    <iclr:ContractsReceivableGross contextRef="c-4" decimals="-3" id="f-517" unitRef="usd">1731388000</iclr:ContractsReceivableGross>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-3" decimals="-3" id="f-518" unitRef="usd">951936000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-4" decimals="-3" id="f-519" unitRef="usd">957655000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:ContractsReceivableNet contextRef="c-3" decimals="-3" id="f-520" unitRef="usd">2742258000</iclr:ContractsReceivableNet>
    <iclr:ContractsReceivableNet contextRef="c-4" decimals="-3" id="f-521" unitRef="usd">2689043000</iclr:ContractsReceivableNet>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-3" decimals="-3" id="f-522" unitRef="usd">951936000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-4" decimals="-3" id="f-523" unitRef="usd">957655000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent contextRef="c-1" decimals="-3" id="f-524" unitRef="usd">-5719000</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent contextRef="c-1" decimals="3" id="f-525" unitRef="number">-0.006</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-526" unitRef="usd">1654507000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-527" unitRef="usd">1507449000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent contextRef="c-1" decimals="-3" id="f-528" unitRef="usd">147058000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent contextRef="c-1" decimals="3" id="f-529" unitRef="number">0.098</iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-3" decimals="-3" id="f-530" unitRef="usd">-702571000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-4" decimals="-3" id="f-531" unitRef="usd">-549794000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-1" decimals="-3" id="f-532" unitRef="usd">-152777000</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent contextRef="c-1" decimals="3" id="f-533" unitRef="number">0.278</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-3" decimals="-5" id="f-534" unitRef="usd">333000000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-4" decimals="-5" id="f-535" unitRef="usd">406300000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent contextRef="c-1" decimals="-5" id="f-536" unitRef="usd">-5700000</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent contextRef="c-1" decimals="-5" id="f-537" unitRef="usd">147100000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-1" decimals="-5" id="f-538" unitRef="usd">-152800000</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense contextRef="c-1" decimals="-5" id="f-539" unitRef="usd">24600000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense contextRef="c-5" decimals="-5" id="f-540" unitRef="usd">17800000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-3" decimals="-8" id="f-541" unitRef="usd">14800000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-4" decimals="-8" id="f-542" unitRef="usd">13700000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c-72" decimals="2" id="f-543" unitRef="number">0.52</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-73" id="f-544">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-74" id="f-545">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c-75" decimals="2" id="f-546" unitRef="number">0.52</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:AllowanceForCreditLossesTextBlock contextRef="c-1" id="f-547">Allowance for Credit Losses&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and December&#160;31, 2022 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-548">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and December&#160;31, 2022 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-549" unitRef="usd">20562000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-22" decimals="-3" id="f-550" unitRef="usd">7081000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="-3" id="f-551" unitRef="usd">13358000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-5" decimals="-3" id="f-552" unitRef="usd">3913000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <iclr:AccountsReceivableCreditLossExpense contextRef="c-1" decimals="-3" id="f-553" unitRef="usd">24550000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AccountsReceivableCreditLossExpense contextRef="c-5" decimals="-3" id="f-554" unitRef="usd">17800000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments contextRef="c-1" decimals="-3" id="f-555" unitRef="usd">-221000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments contextRef="c-5" decimals="-3" id="f-556" unitRef="usd">-406000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-3" decimals="-3" id="f-557" unitRef="usd">31533000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-558" unitRef="usd">20562000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-559">Business Combinations&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;BioTel Research LLC Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#x201c;BioTel&#x201d;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$68.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;. Cash acquired amounted to $1.4&#160;million. The purchase price allocation, as of the date of acquisition, was based on a preliminary valuation and may be subject to revision. Preliminarily, the BioTel acquisition resulted in the initial recognition of intangible assets of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$36.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; and goodwill of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$23.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;. Preliminary g&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;oodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of BioTel and the expected synergies of the acquisition. The goodwill recognized is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Oncacare Limited Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare") for $5.1&#160;million, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$13.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and also gave rise to an acquisition-related gain of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$6.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;PRA Health Sciences, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021 (the "Merger Date"), the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The combined company has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Topic 805&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The combined company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#x2019; commercial success through the development of much needed medicines and medical devices. The combined company has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received, per share, $80 in cash and 0.4125 shares of ICON stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Company incurred Merger-related expenses of $44.2 million, $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#x201c;Transaction and integration related&#x201d; line item of the Consolidated Statement of Operations. The costs consist of investment banking fees, advisory costs, professional fees, retention agreements with employees, accelerated share-based compensation charges and ongoing integration activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 the Company incurred approximate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;ly $16.4 million, $17.7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; and $86.7 million of Merger-related financing fees which are included in the &#x201c;Interest expense&#x201d; line item in the Consolidated Statement of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Merger Date fair value of the consideration transferred consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,308,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of ordinary shares issued to acquiree stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,658,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of replacement share-based awards issued to acquiree employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan obligations and accrued interest *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.018%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, &lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;934,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,084,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(380,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(739,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,119,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(204,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.434%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.134%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,938,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement period adjustments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(151,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; * In the year ended December&#160;31, 2022, the Company incurred a $2.2&#160;million amortization expense which related to the year ended December&#160;31, 2021 due to the timing of the measurement period adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-76" decimals="-5" id="f-560" unitRef="usd">68100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-76" decimals="-5" id="f-561" unitRef="usd">1400000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-77" decimals="-5" id="f-562" unitRef="usd">36400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill contextRef="c-77" decimals="-5" id="f-563" unitRef="usd">23400000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-78"
      decimals="INF"
      id="f-564"
      unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-79" decimals="-5" id="f-565" unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:Goodwill contextRef="c-78" decimals="-5" id="f-566" unitRef="usd">13400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-79" decimals="-5" id="f-567" unitRef="usd">6200000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <dei:EntityNumberOfEmployees
      contextRef="c-80"
      decimals="-3"
      id="f-568"
      unitRef="employee">38000</dei:EntityNumberOfEmployees>
    <iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld
      contextRef="c-81"
      decimals="INF"
      id="f-569"
      unitRef="usdPerShare">80</iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld>
    <iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld contextRef="c-82" decimals="4" id="f-570" unitRef="shares">0.4125</iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-1" decimals="-5" id="f-571" unitRef="usd">44200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-5" decimals="-5" id="f-572" unitRef="usd">39700000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-6" decimals="-5" id="f-573" unitRef="usd">198300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:InterestExpense contextRef="c-83" decimals="-5" id="f-574" unitRef="usd">16400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-84" decimals="-5" id="f-575" unitRef="usd">17700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-85" decimals="-5" id="f-576" unitRef="usd">86700000</us-gaap:InterestExpense>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-577">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Merger Date fair value of the consideration transferred consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,308,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of ordinary shares issued to acquiree stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,658,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of replacement share-based awards issued to acquiree employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan obligations and accrued interest *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-82" decimals="-3" id="f-578" unitRef="usd">5308646000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-82" decimals="-3" id="f-579" unitRef="usd">5658126000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1 contextRef="c-82" decimals="-3" id="f-580" unitRef="usd">209399000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-82" decimals="-3" id="f-581" unitRef="usd">865800000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-82" decimals="-3" id="f-582" unitRef="usd">12041971000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate contextRef="c-82" decimals="-5" id="f-583" unitRef="usd">401600000</iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c-1" id="f-584">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.018%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, &lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;934,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,084,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(380,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(739,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,119,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(204,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="c-81" decimals="-3" id="f-585" unitRef="usd">259971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c-81" decimals="-3" id="f-586" unitRef="usd">934308000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther contextRef="c-81" decimals="-3" id="f-587" unitRef="usd">125156000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-81" decimals="-3" id="f-588" unitRef="usd">156851000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset contextRef="c-81" decimals="-3" id="f-589" unitRef="usd">180601000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-81" decimals="-3" id="f-590" unitRef="usd">8084314000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-81" decimals="-3" id="f-591" unitRef="usd">4919000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets contextRef="c-81" decimals="-3" id="f-592" unitRef="usd">25190000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="c-81" decimals="-3" id="f-593" unitRef="usd">33928000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="c-81" decimals="-3" id="f-594" unitRef="usd">50259000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther contextRef="c-81" decimals="-3" id="f-595" unitRef="usd">380048000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability contextRef="c-81" decimals="-3" id="f-596" unitRef="usd">36506000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent contextRef="c-81" decimals="-3" id="f-597" unitRef="usd">739278000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability contextRef="c-81" decimals="-3" id="f-598" unitRef="usd">147204000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-81" decimals="-3" id="f-599" unitRef="usd">1119762000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther contextRef="c-81" decimals="-3" id="f-600" unitRef="usd">204291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-81" decimals="-3" id="f-601" unitRef="usd">12041971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock contextRef="c-1" id="f-602">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.434%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.132%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.134%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,938,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-86" decimals="-3" id="f-603" unitRef="usd">3938000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-87" id="f-604">P23Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-88" decimals="-3" id="f-605" unitRef="usd">500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-89" id="f-606">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-90" decimals="-3" id="f-607" unitRef="usd">202000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-91" id="f-608">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-92" decimals="-3" id="f-609" unitRef="usd">168000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-93" id="f-610">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-94" decimals="-3" id="f-611" unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-95" id="f-612">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-81" decimals="-3" id="f-613" unitRef="usd">4919000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <iclr:ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock contextRef="c-1" id="f-614">In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement period adjustments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(151,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; * In the year ended December&#160;31, 2022, the Company incurred a $2.2&#160;million amortization expense which related to the year ended December&#160;31, 2021 due to the timing of the measurement period adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.&lt;/span&gt;&lt;/div&gt;</iclr:ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents contextRef="c-96" decimals="-3" id="f-615" unitRef="usd">0</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue contextRef="c-96" decimals="-3" id="f-616" unitRef="usd">0</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets contextRef="c-96" decimals="-3" id="f-617" unitRef="usd">14465000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment contextRef="c-96" decimals="-3" id="f-618" unitRef="usd">-6137000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets contextRef="c-96" decimals="-3" id="f-619" unitRef="usd">-11744000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill contextRef="c-96" decimals="-3" id="f-620" unitRef="usd">70436000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles contextRef="c-96" decimals="-3" id="f-621" unitRef="usd">44000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets contextRef="c-96" decimals="-3" id="f-622" unitRef="usd">-147039000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets contextRef="c-96" decimals="-3" id="f-623" unitRef="usd">-1166000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable contextRef="c-96" decimals="-3" id="f-624" unitRef="usd">0</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities contextRef="c-96" decimals="-3" id="f-625" unitRef="usd">-37496000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities contextRef="c-96" decimals="-3" id="f-626" unitRef="usd">1865000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue contextRef="c-96" decimals="-3" id="f-627" unitRef="usd">19623000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities contextRef="c-96" decimals="-3" id="f-628" unitRef="usd">10454000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities contextRef="c-96" decimals="-3" id="f-629" unitRef="usd">193837000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities contextRef="c-96" decimals="-3" id="f-630" unitRef="usd">-151098000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod contextRef="c-84" decimals="-5" id="f-631" unitRef="usd">2200000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue contextRef="c-97" decimals="-5" id="f-632" unitRef="usd">16000000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-633">Fair Value&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2 &#x2014; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short maturities of these instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.075%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.075%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c) Represents the fair value of the interest rate caps and the interest rate swap. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-recurring Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are carried on the Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2023, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $12,878.0 million (December&#160;31, 2022:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; $13,250.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) and are identified as Level 3 assets. These assets are comprised of goodwill of $9,022.1 million (December&#160;31, 2022: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$8,971.7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) and intangible assets of $3,855.9 million (December&#160;31, 2022: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$4,278.7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s debt was $3,793.5&#160;million at December&#160;31, 2023 (December 31, 2022: $4,650.3&#160;million). The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value, due to the short term duration.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-635">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.075%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.075%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.&lt;/span&gt;&lt;/div&gt;(c) Represents the fair value of the interest rate caps and the interest rate swap.</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-634">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.075%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.075%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) To determine the classification of interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2023 and December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820.  Any increases or decreases in fair value are recognized in net income in the period.&lt;/span&gt;&lt;/div&gt;(c) Represents the fair value of the interest rate caps and the interest rate swap.</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-98" decimals="-3" id="f-636" unitRef="usd">1954000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-99" decimals="-3" id="f-637" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-100" decimals="-3" id="f-638" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-101" decimals="-3" id="f-639" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-640" unitRef="usd">1954000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-98" decimals="-3" id="f-641" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-99" decimals="-3" id="f-642" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-100" decimals="-3" id="f-643" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-101" decimals="-3" id="f-644" unitRef="usd">46804000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-3" decimals="-3" id="f-645" unitRef="usd">46804000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:DerivativeAssets contextRef="c-102" decimals="-3" id="f-646" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-103" decimals="-3" id="f-647" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-104" decimals="-3" id="f-648" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-105" decimals="-3" id="f-649" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-106" decimals="-3" id="f-650" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-651" unitRef="usd">1954000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-652" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-653" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-654" unitRef="usd">46804000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-3" decimals="-3" id="f-655" unitRef="usd">48758000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-102" decimals="-3" id="f-656" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-103" decimals="-3" id="f-657" unitRef="usd">2411000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-104" decimals="-3" id="f-658" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-105" decimals="-3" id="f-659" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-106" decimals="-3" id="f-660" unitRef="usd">2411000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-98" decimals="-3" id="f-661" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-99" decimals="-3" id="f-662" unitRef="usd">2411000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-100" decimals="-3" id="f-663" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-101" decimals="-3" id="f-664" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-3" decimals="-3" id="f-665" unitRef="usd">2411000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-107" decimals="-3" id="f-666" unitRef="usd">1713000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-108" decimals="-3" id="f-667" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-109" decimals="-3" id="f-668" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-110" decimals="-3" id="f-669" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-670" unitRef="usd">1713000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-107" decimals="-3" id="f-671" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-108" decimals="-3" id="f-672" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-109" decimals="-3" id="f-673" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-110" decimals="-3" id="f-674" unitRef="usd">32631000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-4" decimals="-3" id="f-675" unitRef="usd">32631000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:DerivativeAssets contextRef="c-111" id="f-676" unitRef="usd" xsi:nil="true"/>
    <us-gaap:DerivativeAssets contextRef="c-112" decimals="-3" id="f-677" unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-113" id="f-678" unitRef="usd" xsi:nil="true"/>
    <us-gaap:DerivativeAssets contextRef="c-114" id="f-679" unitRef="usd" xsi:nil="true"/>
    <us-gaap:DerivativeAssets contextRef="c-115" decimals="-3" id="f-680" unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-681" unitRef="usd">1713000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-108" decimals="-3" id="f-682" unitRef="usd">12000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-109" decimals="-3" id="f-683" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-110" decimals="-3" id="f-684" unitRef="usd">32631000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-685" unitRef="usd">34356000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-111" decimals="-3" id="f-686" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-112" decimals="-3" id="f-687" unitRef="usd">3670000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-113" decimals="-3" id="f-688" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-114" decimals="-3" id="f-689" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-115" decimals="-3" id="f-690" unitRef="usd">3670000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-107" decimals="-3" id="f-691" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-108" decimals="-3" id="f-692" unitRef="usd">3670000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-109" decimals="-3" id="f-693" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-110" decimals="-3" id="f-694" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-4" decimals="-3" id="f-695" unitRef="usd">3670000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-116" decimals="-5" id="f-696" unitRef="usd">12878000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-117" decimals="-5" id="f-697" unitRef="usd">13250400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure contextRef="c-116" decimals="-5" id="f-698" unitRef="usd">9022100000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure contextRef="c-117" decimals="-5" id="f-699" unitRef="usd">8971700000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure contextRef="c-116" decimals="-5" id="f-700" unitRef="usd">3855900000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure contextRef="c-117" decimals="-5" id="f-701" unitRef="usd">4278700000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue contextRef="c-3" decimals="-5" id="f-702" unitRef="usd">3793500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-4" decimals="-5" id="f-703" unitRef="usd">4650300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-704">Investments&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(a) &#160;&#160;&#160;&#160;Available for sale investments (short-term)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As at December&#160;31, 2023, the Company held $2.0 million of available for sale investments (December&#160;31, 2022: $1.7 million). Short-term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. The Company classifies its short- term investments as available for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short term investments at December&#160;31, 2023 have an average maturity of 3.6 years compared to 2.8 years at December&#160;31, 2022. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company's practice and intention in respect of these investments. The Company recognizes the unrealized losses in equity as these unrealized losses on short-term investments have been considered as temporary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Available for sale investments (long-term)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company entered into subscription agreements with a number of funds. During the year ended December&#160;31, 2023, capital totaling $14.0 million (December&#160;31, 2022: $3.7 million) had been advanced under the terms of the subscription agreements. The Company determined that the interest in funds meets the definition of equity securities without readily determinable fair values. The Company therefore concluded that the interests held at December&#160;31, 2023 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820. &lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There was an increase in fair value of $0.2 million (December&#160;31, 2022: $6.3 million) recognized in net income during the year bringing the carrying value of the subscriptions to $46.8 million at December&#160;31, 2023 (December&#160;31, 2022: $32.6 million).&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;December&#160;31, 2023, the Company had committed to future investments of $66.4 million in respect of these funds.&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160; Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On July 24, 2020, the Company obtained a 49% interest in the voting share capital of Oncacare in exchange for consideration of $4.9&#160;million. At that time, the Company&#x2019;s investment in Oncacare was accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare. The Company recorded its pro rata share of the earnings/losses of this investment in 'Share of losses in equity investments' in the Consolidated Statement of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has recorded losses of $0.4 million, $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of &lt;/span&gt;&lt;/div&gt;Oncacare, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-5" id="f-705" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-5" id="f-706" unitRef="usd">1700000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod contextRef="c-1" id="f-707">P3Y7M6D</iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod>
    <iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod contextRef="c-5" id="f-708">P2Y9M18D</iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod>
    <iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements contextRef="c-3" decimals="-5" id="f-709" unitRef="usd">14000000</iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements>
    <iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements contextRef="c-4" decimals="-5" id="f-710" unitRef="usd">3700000</iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi contextRef="c-1" decimals="-5" id="f-711" unitRef="usd">200000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi contextRef="c-5" decimals="-5" id="f-712" unitRef="usd">6300000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-3" decimals="-5" id="f-713" unitRef="usd">46800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-5" id="f-714" unitRef="usd">32600000</us-gaap:EquitySecuritiesFvNi>
    <iclr:CommitmentToAcquireLongTermInvestments contextRef="c-3" decimals="-5" id="f-715" unitRef="usd">66400000</iclr:CommitmentToAcquireLongTermInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-118" decimals="2" id="f-716" unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-118" decimals="-5" id="f-717" unitRef="usd">4900000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-119" decimals="-5" id="f-718" unitRef="usd">-400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-120" decimals="-5" id="f-719" unitRef="usd">-3100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-121" decimals="-5" id="f-720" unitRef="usd">-2200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-78"
      decimals="INF"
      id="f-721"
      unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-722">Property, Plant and Equipment, net&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;781,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(419,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(400,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The depreciation expense recognized by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$126.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$106.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; and $75.5 million for the twelve months ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2023 and the year ended December&#160;31, 2022, certain fully depreciated assets were written off as they were no longer used by the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-723">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;781,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(419,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(400,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land contextRef="c-3" decimals="-3" id="f-724" unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:Land contextRef="c-4" decimals="-3" id="f-725" unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross contextRef="c-3" decimals="-3" id="f-726" unitRef="usd">70072000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross contextRef="c-4" decimals="-3" id="f-727" unitRef="usd">70880000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-3" decimals="-3" id="f-728" unitRef="usd">550119000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-4" decimals="-3" id="f-729" unitRef="usd">500135000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="c-3" decimals="-3" id="f-730" unitRef="usd">45856000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="c-4" decimals="-3" id="f-731" unitRef="usd">50600000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="c-3" decimals="-3" id="f-732" unitRef="usd">56217000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="c-4" decimals="-3" id="f-733" unitRef="usd">59946000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="c-3" decimals="-3" id="f-734" unitRef="usd">55000000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="c-4" decimals="-3" id="f-735" unitRef="usd">65167000</us-gaap:LeaseholdImprovementsGross>
    <iclr:VehiclesGross contextRef="c-3" decimals="-3" id="f-736" unitRef="usd">79000</iclr:VehiclesGross>
    <iclr:VehiclesGross contextRef="c-4" decimals="-3" id="f-737" unitRef="usd">41000</iclr:VehiclesGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-738" unitRef="usd">781067000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-739" unitRef="usd">750493000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-740" unitRef="usd">419883000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-741" unitRef="usd">400173000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-742" unitRef="usd">361184000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-743" unitRef="usd">350320000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-744" unitRef="usd">126100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-745" unitRef="usd">106400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-5" id="f-746" unitRef="usd">75500000</us-gaap:Depreciation>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="c-1" id="f-747">Goodwill&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of goodwill for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior period acquisition (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,022,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There were no goodwill impairment losses for the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-748">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of goodwill for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior period acquisition (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,022,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-749" unitRef="usd">8971670000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-22" decimals="-3" id="f-750" unitRef="usd">9037931000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-751" unitRef="usd">36750000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-5" decimals="-3" id="f-752" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-1" decimals="-3" id="f-753" unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-5" decimals="-3" id="f-754" unitRef="usd">-35692000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-3" id="f-755" unitRef="usd">13655000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-5" decimals="-3" id="f-756" unitRef="usd">-30569000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-757" unitRef="usd">9022075000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-758" unitRef="usd">8971670000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-5" id="f-759" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-5" decimals="-5" id="f-760" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-761">Intangible Assets&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Intangible Assets for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,090,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;541,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;536,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,147,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,109,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,292,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(830,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,855,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,278,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The amortization expense recognized by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$459.9 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$463.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; and $239.5 million for the twelve months ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#x201c;BioTel&#x201d;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$68.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; The acquisition resulted in the recognition of intangible assets of $36.4 million, comprising  customer relationships of $12.5 million, order backlog of $3.9 million and technology assets of $20.0 million. These assets will be amortized over their expected useful lives of between 3 and 16 years. In total, $1.5 million has been amortized in the period since the date of acquisition.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0&#160;million, Order backlog of $500.0&#160;million, Trade names of $202.0&#160;million, Patient database of $168.0&#160;million and Technology assets of $111.0&#160;million. These assets are being amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets was finalized in June 30, 2022. In total, $1,128.5&#160;million has been amortized in the period since the date of acquisition, $451.4&#160;million has been amortized in the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2024 to December 31, 2028 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,180,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-122" decimals="-3" id="f-762" unitRef="usd">4090393000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-123" decimals="-3" id="f-763" unitRef="usd">4076435000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-53" decimals="-3" id="f-764" unitRef="usd">541302000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-124" decimals="-3" id="f-765" unitRef="usd">536934000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-54" decimals="-3" id="f-766" unitRef="usd">204653000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-125" decimals="-3" id="f-767" unitRef="usd">204621000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-55" decimals="-3" id="f-768" unitRef="usd">170366000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-126" decimals="-3" id="f-769" unitRef="usd">170238000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-56" decimals="-3" id="f-770" unitRef="usd">141257000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-127" decimals="-3" id="f-771" unitRef="usd">120984000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-3" decimals="-3" id="f-772" unitRef="usd">5147971000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-773" unitRef="usd">5109212000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-3" decimals="-3" id="f-774" unitRef="usd">1292106000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-775" unitRef="usd">830553000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-776" unitRef="usd">3855865000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-777" unitRef="usd">4278659000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-778" unitRef="usd">459900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-5" id="f-779" unitRef="usd">463100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-6" decimals="-5" id="f-780" unitRef="usd">239500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-76" decimals="-5" id="f-781" unitRef="usd">68100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-77" decimals="-5" id="f-782" unitRef="usd">36400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-128" decimals="-5" id="f-783" unitRef="usd">12500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-129" decimals="-5" id="f-784" unitRef="usd">3900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-130" decimals="-5" id="f-785" unitRef="usd">20000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-131" id="f-786">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-132" id="f-787">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-133" decimals="-5" id="f-788" unitRef="usd">1500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-86" decimals="-5" id="f-789" unitRef="usd">3938000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-88" decimals="-5" id="f-790" unitRef="usd">500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-90" decimals="-5" id="f-791" unitRef="usd">202000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-92" decimals="-5" id="f-792" unitRef="usd">168000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-94" decimals="-5" id="f-793" unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-134" id="f-794">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-135" id="f-795">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-136" decimals="-5" id="f-796" unitRef="usd">1128500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-83" decimals="-5" id="f-797" unitRef="usd">451400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-798">&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2024 to December 31, 2028 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,180,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-3" decimals="-3" id="f-799" unitRef="usd">344518000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-3" decimals="-3" id="f-800" unitRef="usd">229106000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-3" decimals="-3" id="f-801" unitRef="usd">214869000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-3" decimals="-3" id="f-802" unitRef="usd">202539000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-3" decimals="-3" id="f-803" unitRef="usd">189539000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet contextRef="c-3" decimals="-3" id="f-804" unitRef="usd">1180571000</iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-805">Other Liabilities&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Other Liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;395,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;915,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,005,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;f $333.0 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; at December&#160;31, 2023 and $406.3 million at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock contextRef="c-1" id="f-806">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Other Liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;395,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;915,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,005,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;f $333.0 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; at December&#160;31, 2023 and $406.3 million at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-807" unitRef="usd">463882000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-808" unitRef="usd">530204000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-809" unitRef="usd">385499000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-810" unitRef="usd">395862000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-811" unitRef="usd">36414000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-812" unitRef="usd">43657000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedUtilitiesCurrent contextRef="c-3" decimals="-3" id="f-813" unitRef="usd">11078000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedUtilitiesCurrent contextRef="c-4" decimals="-3" id="f-814" unitRef="usd">16896000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-815" unitRef="usd">13532000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-816" unitRef="usd">12852000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <iclr:RestructuringReserveandOtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-817" unitRef="usd">4951000</iclr:RestructuringReserveandOtherLiabilitiesCurrent>
    <iclr:RestructuringReserveandOtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-818" unitRef="usd">5512000</iclr:RestructuringReserveandOtherLiabilitiesCurrent>
    <iclr:CapitalGovernmentGrantsCurrent contextRef="c-3" decimals="-3" id="f-819" unitRef="usd">43000</iclr:CapitalGovernmentGrantsCurrent>
    <iclr:CapitalGovernmentGrantsCurrent contextRef="c-4" decimals="-3" id="f-820" unitRef="usd">42000</iclr:CapitalGovernmentGrantsCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-821" unitRef="usd">915399000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-822" unitRef="usd">1005025000</us-gaap:OtherLiabilitiesCurrent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-3" decimals="-5" id="f-823" unitRef="usd">333000000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-4" decimals="-5" id="f-824" unitRef="usd">406300000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <us-gaap:LongTermDebtTextBlock contextRef="c-1" id="f-825">Bank Credit Lines and Loan Facilities&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,251,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,201,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Revolving Loan Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,701,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,696,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,665,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,599,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2023,  December&#160;31, 2022 and December&#160;31, 2021 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Company expensed $16.4 million, $17.7 million and $86.7 million of transaction related financing costs, inclusive of the amortization of financing fees which were previously capitalized, associated with the debt facilities used to finance the Merger. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of merger related financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and one time financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Includes costs associated with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,030,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger").  In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million (the "Senior Secured Credit Facilities"). The Senior Secured Credit Facility and Senior Secured Notes were issued at a discount of $27.6&#160;million. On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin which is dependent on the Company's net leverage ratio. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;the applicable margin is 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. As at December&#160;31, 2023, $445.0&#160;million remained undrawn under the senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Borrowers&#x2019; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#x2019;s, the Borrowers&#x2019; and each of the subsidiary guarantor&#x2019;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.25pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2023 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $7.9&#160;million (December&#160;31, 2022: $7.8&#160;million)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.25pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, the Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;drew down $370.0&#160;million (December&#160;31, 2022: $75.0&#160;million) of the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;senior secured revolving loan facility and repaid $315.0&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(December&#160;31, 2022: $75.0&#160;million) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;as shown below. As at December&#160;31, 2023, $55.0&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(December&#160;31, 2022: &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$nil&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;was drawn under the senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Drawdown &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Closing Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#x201c;Offering&#x201d;). The Senior Secured Notes will mature on July 15, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;The estimated fair value of the Company&#x2019;s debt was $3,793.5&#160;million and $4,650.3&#160;million at December&#160;31, 2023 and December&#160;31, 2022, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility is recorded as its carrying value due to the short term duration.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-826">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,251,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,201,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Revolving Loan Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,701,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,696,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,665,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,599,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Drawdown &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Closing Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-137" decimals="5" id="f-827" unitRef="number">0.07860</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-138" decimals="5" id="f-828" unitRef="number">0.07092</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-137" decimals="-3" id="f-829" unitRef="usd">3251213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-138" decimals="-3" id="f-830" unitRef="usd">4201213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-139" decimals="5" id="f-831" unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-140" decimals="5" id="f-832" unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-139" decimals="-3" id="f-833" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-140" decimals="-3" id="f-834" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-141" decimals="5" id="f-835" unitRef="number">0.06720</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-142" decimals="5" id="f-836" unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-141" decimals="-3" id="f-837" unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-142" decimals="-3" id="f-838" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-3" decimals="-3" id="f-839" unitRef="usd">3806213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-4" decimals="-3" id="f-840" unitRef="usd">4701213000</us-gaap:DebtInstrumentCarryingAmount>
    <iclr:LongTermDebtCurrentMaturitiesGross contextRef="c-3" decimals="-3" id="f-841" unitRef="usd">110150000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtCurrentMaturitiesGross contextRef="c-4" decimals="-3" id="f-842" unitRef="usd">55150000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross contextRef="c-3" decimals="-3" id="f-843" unitRef="usd">3696063000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross contextRef="c-4" decimals="-3" id="f-844" unitRef="usd">4646063000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-3" decimals="-3" id="f-845" unitRef="usd">30624000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-4" decimals="-3" id="f-846" unitRef="usd">47026000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-3" id="f-847" unitRef="usd">3665439000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-848" unitRef="usd">4599037000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:InterestExpense contextRef="c-83" decimals="-5" id="f-849" unitRef="usd">16400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-84" decimals="-5" id="f-850" unitRef="usd">17700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-85" decimals="-5" id="f-851" unitRef="usd">86700000</us-gaap:InterestExpense>
    <iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock contextRef="c-1" id="f-852">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.338%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of merger related financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and one time financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Includes costs associated with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;</iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-3" id="f-853" unitRef="usd">311019000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-5" decimals="-3" id="f-854" unitRef="usd">209189000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-6" decimals="-3" id="f-855" unitRef="usd">93809000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-856" unitRef="usd">16402000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-3" id="f-857" unitRef="usd">17749000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-6" decimals="-3" id="f-858" unitRef="usd">12890000</us-gaap:AmortizationOfFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts contextRef="c-1" decimals="-3" id="f-859" unitRef="usd">0</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts contextRef="c-5" decimals="-3" id="f-860" unitRef="usd">0</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts contextRef="c-6" decimals="-3" id="f-861" unitRef="usd">75391000</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:InterestExpenseCreditOther contextRef="c-1" decimals="-3" id="f-862" unitRef="usd">9278000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther contextRef="c-5" decimals="-3" id="f-863" unitRef="usd">2793000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther contextRef="c-6" decimals="-3" id="f-864" unitRef="usd">333000</iclr:InterestExpenseCreditOther>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-865" unitRef="usd">336699000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-3" id="f-866" unitRef="usd">229731000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-3" id="f-867" unitRef="usd">182423000</us-gaap:InterestExpense>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-868">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,030,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-3" decimals="-3" id="f-869" unitRef="usd">110150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-3" decimals="-3" id="f-870" unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-3" decimals="-3" id="f-871" unitRef="usd">555150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-3" decimals="-3" id="f-872" unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <iclr:LongTermDebtMaturityYearFiveAndThereafter contextRef="c-3" decimals="-3" id="f-873" unitRef="usd">3030613000</iclr:LongTermDebtMaturityYearFiveAndThereafter>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-874" unitRef="usd">3806213000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-143" decimals="-6" id="f-875" unitRef="usd">5515000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-144" decimals="-6" id="f-876" unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-145" decimals="-5" id="f-877" unitRef="usd">27600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-144" decimals="-6" id="f-878" unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-146" decimals="-6" id="f-879" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-143" decimals="2" id="f-880" unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-147" decimals="4" id="f-881" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-148" decimals="4" id="f-882" unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-149" decimals="4" id="f-883" unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-150" decimals="4" id="f-884" unitRef="number">0.0060</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-151" decimals="4" id="f-885" unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-152" decimals="4" id="f-886" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-153" decimals="4" id="f-887" unitRef="number">0.0160</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-154" decimals="4" id="f-888" unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-155" decimals="-5" id="f-889" unitRef="usd">445000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock contextRef="c-1" id="f-890">&lt;div style="text-align:justify;text-indent:14.25pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2023 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-156" decimals="-3" id="f-891" unitRef="usd">250000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-157" decimals="-3" id="f-892" unitRef="usd">300000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-158" decimals="-3" id="f-893" unitRef="usd">150000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-159" decimals="-3" id="f-894" unitRef="usd">100000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-160" decimals="-3" id="f-895" unitRef="usd">300000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-161" decimals="-3" id="f-896" unitRef="usd">200000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-162" decimals="-3" id="f-897" unitRef="usd">250000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-163" decimals="-3" id="f-898" unitRef="usd">200000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="c-137" decimals="-3" id="f-899" unitRef="usd">950000000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="c-138" decimals="-3" id="f-900" unitRef="usd">800000000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid contextRef="c-137" decimals="-5" id="f-901" unitRef="usd">7900000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid contextRef="c-138" decimals="-5" id="f-902" unitRef="usd">7800000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-1" decimals="-5" id="f-903" unitRef="usd">370000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-5" decimals="-5" id="f-904" unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt contextRef="c-1" decimals="-5" id="f-905" unitRef="usd">315000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt contextRef="c-5" decimals="-5" id="f-906" unitRef="usd">75000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-3" decimals="-5" id="f-907" unitRef="usd">55000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-4" decimals="-5" id="f-908" unitRef="usd">0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-164" decimals="-3" id="f-909" unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-164" decimals="-3" id="f-910" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-165" decimals="-3" id="f-911" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-166" decimals="-3" id="f-912" unitRef="usd">180000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-166" decimals="-3" id="f-913" unitRef="usd">100000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-167" decimals="-3" id="f-914" unitRef="usd">80000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-168" decimals="-3" id="f-915" unitRef="usd">50000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-168" decimals="-3" id="f-916" unitRef="usd">80000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-169" decimals="-3" id="f-917" unitRef="usd">50000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-170" decimals="-3" id="f-918" unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-170" decimals="-3" id="f-919" unitRef="usd">50000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-171" decimals="-3" id="f-920" unitRef="usd">75000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-172" decimals="-3" id="f-921" unitRef="usd">65000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-172" decimals="-3" id="f-922" unitRef="usd">85000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-173" decimals="-3" id="f-923" unitRef="usd">55000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-174" decimals="-3" id="f-924" unitRef="usd">370000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-174" decimals="-3" id="f-925" unitRef="usd">315000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-175" decimals="-6" id="f-926" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-175" decimals="5" id="f-927" unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtFairValue contextRef="c-3" decimals="-5" id="f-928" unitRef="usd">3793500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-4" decimals="-5" id="f-929" unitRef="usd">4650300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-930">Derivatives&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps expire on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap begins accruing on December 31, 2024 and the interest rate swap expires on September 30, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2022 Caps and the 2022 Swap are designated as cash flow hedges. G&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ains and losses are initially reported as a component of other comprehensive income/loss and subsequently recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;      The fair values of the Company&#x2019;s derivative financial instruments, on a gross basis, are summarized in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,600,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,201,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, the Company recognized a current derivative liability of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.9 million within &lt;span style="-sec-ix-hidden:f-957"&gt;other liabilities&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(December&#160;31, 2022: &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$3.3 million within &lt;span style="-sec-ix-hidden:f-959"&gt;other liabilities&lt;/span&gt; and $0.01 million within &lt;span style="-sec-ix-hidden:f-961"&gt;other receivables&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) and a non current derivative liability of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$0.5 million (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December 31, 2022: &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$0.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;within &lt;span style="-sec-ix-hidden:f-964"&gt;&lt;span style="-sec-ix-hidden:f-965"&gt;non-current other liabilities&lt;/span&gt;&lt;/span&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; the year ended December&#160;31, 2023, the Company recognized a gain of $1.6 million within other comprehensive income/loss (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;: $3.7 million loss) after a reclassification of $2.4&#160;million from other comprehensive income/loss to the income statement (December 31, 2022: $0.1&#160;million).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; the next 12 months, the Company estimates that an additional $3.2 million will be reflected as interest expense in the consolidated statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="c-176"
      decimals="INF"
      id="f-931"
      unitRef="instrument">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount contextRef="c-176" decimals="-6" id="f-932" unitRef="usd">2101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate contextRef="c-176" decimals="4" id="f-933" unitRef="number">0.0042</us-gaap:DerivativeFixedInterestRate>
    <iclr:DerivativeVariableInterestRateReferenceRateInExcessOf contextRef="c-177" decimals="4" id="f-934" unitRef="number">0.0475</iclr:DerivativeVariableInterestRateReferenceRateInExcessOf>
    <us-gaap:DerivativeNotionalAmount contextRef="c-178" decimals="-6" id="f-935" unitRef="usd">1101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate contextRef="c-178" decimals="3" id="f-936" unitRef="number">0.034</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-937">The fair values of the Company&#x2019;s derivative financial instruments, on a gross basis, are summarized in the following table:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,600,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,201,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssets contextRef="c-179" decimals="-3" id="f-938" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-179" decimals="-3" id="f-939" unitRef="usd">1871000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-179" decimals="INF" id="f-940" unitRef="usd">1600606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-180" decimals="-3" id="f-941" unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-180" decimals="-3" id="f-942" unitRef="usd">3363000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-180" decimals="INF" id="f-943" unitRef="usd">2100606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-181" decimals="-3" id="f-944" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-181" decimals="-3" id="f-945" unitRef="usd">540000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-181" decimals="INF" id="f-946" unitRef="usd">1100606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-182" decimals="-3" id="f-947" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-182" decimals="-3" id="f-948" unitRef="usd">307000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-182" decimals="INF" id="f-949" unitRef="usd">1100606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-103" decimals="-3" id="f-950" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-103" decimals="-3" id="f-951" unitRef="usd">2411000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-106" decimals="INF" id="f-952" unitRef="usd">2701212000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-112" decimals="-3" id="f-953" unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-112" decimals="-3" id="f-954" unitRef="usd">3670000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-115" decimals="INF" id="f-955" unitRef="usd">3201212000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-103" decimals="-5" id="f-956" unitRef="usd">1900000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-112" decimals="-5" id="f-958" unitRef="usd">3300000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeAssetsCurrent contextRef="c-112" decimals="-4" id="f-960" unitRef="usd">10000.00</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-103" decimals="-5" id="f-962" unitRef="usd">500000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-112" decimals="-5" id="f-963" unitRef="usd">400000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-5" id="f-966" unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-5" id="f-967" unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-1" decimals="-5" id="f-968" unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-5" decimals="-5" id="f-969" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet contextRef="c-3" decimals="-5" id="f-970" unitRef="usd">3200000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-971">Operating Leases&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Lease costs recorded under operating leases for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Of the total cost of $45.7 million incurred in the year ended December&#160;31, 2023, $37.9 million is recorded within selling, general and administration costs and $7.8 million is recorded within direct costs. Of the total cost of $52.7 million incurred in the year ended December&#160;31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9&#160;million incurred in the year ended December&#160;31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained, in exchange for lease obligations, during the years ended December&#160;31, 2023 and December&#160;31, 2022 totaled $37.7 million and $28.7 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $8.7 million, $24.8 million, and $15.4 million, respectively, as part of an office consolidation program (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 19 - Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2023 were 6.72 years and 3.29%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2022 were 6.90 years and 2.45%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2023 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental &lt;br/&gt;payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $36.4&#160;million and $43.7 million have been included in &lt;span style="-sec-ix-hidden:f-1012"&gt;&lt;span style="-sec-ix-hidden:f-1013"&gt;other liabilities&lt;/span&gt;&lt;/span&gt; as at December&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-972">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Lease costs recorded under operating leases for the years ended December&#160;31, 2023, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-973" unitRef="usd">46820000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-3" id="f-974" unitRef="usd">53880000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-3" id="f-975" unitRef="usd">51200000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome contextRef="c-1" decimals="-3" id="f-976" unitRef="usd">1103000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-5" decimals="-3" id="f-977" unitRef="usd">1165000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-6" decimals="-3" id="f-978" unitRef="usd">1338000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-979" unitRef="usd">45717000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-3" id="f-980" unitRef="usd">52715000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-6" decimals="-3" id="f-981" unitRef="usd">49862000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-5" id="f-982" unitRef="usd">45700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-183" decimals="-5" id="f-983" unitRef="usd">37900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-184" decimals="-5" id="f-984" unitRef="usd">7800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-5" id="f-985" unitRef="usd">52700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-185" decimals="-5" id="f-986" unitRef="usd">48300000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-186" decimals="-5" id="f-987" unitRef="usd">4400000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-6" decimals="-5" id="f-988" unitRef="usd">49900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-187" decimals="-5" id="f-989" unitRef="usd">47500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-188" decimals="-5" id="f-990" unitRef="usd">2400000</us-gaap:LeaseCost>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-991" unitRef="usd">37700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-992" unitRef="usd">28700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-1" decimals="-5" id="f-993" unitRef="usd">8700000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-5" decimals="-5" id="f-994" unitRef="usd">24800000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-6" decimals="-5" id="f-995" unitRef="usd">15400000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-996">P6Y8M19D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="4" id="f-997" unitRef="number">0.0329</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-998">P6Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-999" unitRef="number">0.0245</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1000">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2023 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental &lt;br/&gt;payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-1001" unitRef="usd">40894000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-1002" unitRef="usd">34585000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-1003" unitRef="usd">29172000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-1004" unitRef="usd">23254000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-3" decimals="-3" id="f-1005" unitRef="usd">15023000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-3" decimals="-3" id="f-1006" unitRef="usd">33998000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-1007" unitRef="usd">176926000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-1008" unitRef="usd">14191000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-1009" unitRef="usd">162735000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-1010" unitRef="usd">36400000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-1011" unitRef="usd">43700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock contextRef="c-1" id="f-1014">Non-current other liabilities&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defined benefit pension obligations, net (note 21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-1015">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defined benefit pension obligations, net (note 21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-1016" unitRef="usd">14738000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-1017" unitRef="usd">13033000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-1018" unitRef="usd">31260000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-1019" unitRef="usd">25227000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-1020" unitRef="usd">45998000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-1021" unitRef="usd">38260000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1022">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next sixteen years. These leases g&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;enerally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 15 - Operating leases&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2023, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and 2021 and future minimum rental commitments as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-3" id="f-1023">P16Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1024">Share Capital&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Employee share based payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, 535,705 options were exercised by employees at an average exercise price of $95.12 per share for total proceeds of $51.0 million. During the year ended December&#160;31, 2023, 188,800 ordinary shares were issued in respect of certain RSUs and 47,026 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December&#160;31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December&#160;31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#x2019;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A resolution was passed at the Company&#x2019;s Annual General Meeting (&#x201c;AGM&#x201d;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This resolution has been renewed annually thereafter.&#160;On February 18, 2022, the Company commenced a share buyback program which was fully complete at&#160;March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <iclr:NumberOfVotes contextRef="c-1" decimals="INF" id="f-1025" unitRef="vote">1</iclr:NumberOfVotes>
    <iclr:NumberOfVotes contextRef="c-1" decimals="INF" id="f-1026" unitRef="vote">1</iclr:NumberOfVotes>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-189"
      decimals="INF"
      id="f-1027"
      unitRef="shares">535705</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-189"
      decimals="2"
      id="f-1028"
      unitRef="usdPerShare">95.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-189" decimals="-5" id="f-1029" unitRef="usd">51000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-190"
      decimals="INF"
      id="f-1030"
      unitRef="shares">188800</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-191"
      decimals="INF"
      id="f-1031"
      unitRef="shares">47026</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-192"
      decimals="INF"
      id="f-1032"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-192"
      decimals="2"
      id="f-1033"
      unitRef="usdPerShare">102.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-192" decimals="-5" id="f-1034" unitRef="usd">35800000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-193"
      decimals="INF"
      id="f-1035"
      unitRef="shares">195029</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-194"
      decimals="INF"
      id="f-1036"
      unitRef="shares">46087</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-195"
      decimals="INF"
      id="f-1037"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-195"
      decimals="2"
      id="f-1038"
      unitRef="usdPerShare">111.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-195" decimals="-5" id="f-1039" unitRef="usd">118600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-196"
      decimals="INF"
      id="f-1040"
      unitRef="shares">446404</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-197"
      decimals="INF"
      id="f-1041"
      unitRef="shares">44132</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-198"
      decimals="INF"
      id="f-1042"
      unitRef="shares">27372427</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <iclr:StockRepurchaseProgramAuthorizedPercentage
      contextRef="c-199"
      decimals="INF"
      id="f-1043"
      unitRef="number">0.10</iclr:StockRepurchaseProgramAuthorizedPercentage>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-200"
      decimals="INF"
      id="f-1044"
      unitRef="shares">420530</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-200" decimals="-5" id="f-1045" unitRef="usd">100000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-1046">Restructuring Charges&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the year ended, December 31, 2023, a restructuring charge of $45.4&#160;million was recognized in the Consolidated Statements of Operations under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected a workforce reduction of $34.1&#160;million and an office consolidation program to optimize the Company's office footprint of  $11.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net charge&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023, a total liability of $7.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $3.0 million of facilities related liabilities of which $1.0 million is included within other liabilities and $2.0 million is included within non-current other liabilities. The remaining provision of $4.0 million relates to workforce reduction and is included within other liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.104%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.106%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional provision in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts contextRef="c-201" decimals="-5" id="f-1047" unitRef="usd">45400000</us-gaap:RestructuringCosts>
    <us-gaap:SeveranceCosts1 contextRef="c-201" decimals="-5" id="f-1048" unitRef="usd">34100000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts contextRef="c-201" decimals="-5" id="f-1049" unitRef="usd">11300000</us-gaap:OtherRestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-1050">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net charge&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-3" id="f-1051" unitRef="usd">45390000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-3" id="f-1052" unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-3" id="f-1053" unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-3" id="f-1054" unitRef="usd">45390000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-3" id="f-1055" unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-3" id="f-1056" unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringReserve contextRef="c-3" decimals="-5" id="f-1057" unitRef="usd">7000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-202" decimals="-5" id="f-1058" unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveCurrent contextRef="c-202" decimals="-5" id="f-1059" unitRef="usd">1000000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent contextRef="c-202" decimals="-5" id="f-1060" unitRef="usd">2000000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserve contextRef="c-203" decimals="-5" id="f-1061" unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c-1" id="f-1062">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.104%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.106%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional provision in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-3" id="f-1063" unitRef="usd">6022000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-22" decimals="-3" id="f-1064" unitRef="usd">10311000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-3" id="f-1065" unitRef="usd">36704000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-5" decimals="-3" id="f-1066" unitRef="usd">4364000</us-gaap:RestructuringCharges>
    <iclr:RestructuringReserveUtilizations contextRef="c-1" decimals="-3" id="f-1067" unitRef="usd">35727000</iclr:RestructuringReserveUtilizations>
    <iclr:RestructuringReserveUtilizations contextRef="c-5" decimals="-3" id="f-1068" unitRef="usd">8653000</iclr:RestructuringReserveUtilizations>
    <us-gaap:RestructuringReserve contextRef="c-3" decimals="-3" id="f-1069" unitRef="usd">6999000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-3" id="f-1070" unitRef="usd">6022000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1071">Income Taxes&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(352,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(270,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(278,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense allocated to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ireland's statutory trading income tax rate, the rate of our country of domicile, is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate differential from amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Decrease)/ increase in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investor tax expense on foreign subsidiary earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in foreign subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,073,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,158,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(825,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(911,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $1.7 million and $331.4 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $1.7 million U.S. federal NOLs, approximately $1.2 million is currently available for offset against future U.S. federal taxable income. The subsidiaries' ability to use the remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. All $1.7 million of the U.S. federal NOLs are limited by Section 382 and expire between 2024 - 2037. As of December&#160;31, 2023, U.S subsidiaries also had disallowed interest carryforwards of $204&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected expiry dates of the US NOLs are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024-2037&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2038-2042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $42.9 million. At December&#160;31, 2023 those subsidiaries also had additional operating loss carryforwards of $12.9 million which are due to expire between 2024 and 2030. In addition, at December&#160;31, 2023 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowance at December&#160;31, 2023 was approximately $43.0 million. The valuation allowance for deferred tax assets as of December&#160;31, 2022 and December&#160;31, 2021 was $43.4 million and $45.5 million respectively. The net change in the total valuation allowance was a decrease of $0.4 million during 2023 and a decrease of $2.1 million during 2022. Of the total decrease of $0.4 million in 2023, $1.1 million was recognized within income tax expense and a increase of $0.7 million was recognized in Other Comprehensive Income. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expenses and $1.3 million was recognized in Other Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowances at December&#160;31, 2023 and December&#160;31, 2022 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and tax planning strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company has recognized a deferred tax liability of $52.4 million (2022: $1.6 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. Given changes in various tax laws during 2023, the group has taken the decision to repatriate certain excess earnings which will not be permanently reinvested and consequently have provided for the relevant tax in the current year. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#x2019;s tax treaty network and the EU parent subsidiary directive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to acquired tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The relevant statute of limitations for unrecognized tax benefits totaling $65.0 million could potentially expire during 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Included in the balance of total unrecognized tax benefits at December&#160;31, 2023 were potential benefits of $160.0 million, which if recognized, would affect the effective rate on income from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2022 and December&#160;31, 2021 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $217.6 million and $202.1 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest and penalties recognized during the year ended December&#160;31, 2023 amounted to a net charge of $4.2 million (2022: $7.1 million, 2021: $1.9 million) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2023 and December&#160;31, 2022 were $27.1 million and $22.6 million respectively and are included in closing income taxes payable at those dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. In the United States, tax periods open to audit include the years ended December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <iclr:IncomeBeforeIncomeTaxTableTextBlock contextRef="c-1" id="f-1072">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(352,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(270,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(278,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:IncomeBeforeIncomeTaxTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-204" decimals="-3" id="f-1073" unitRef="usd">624642000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-205" decimals="-3" id="f-1074" unitRef="usd">432963000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-206" decimals="-3" id="f-1075" unitRef="usd">231893000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-207" decimals="-3" id="f-1076" unitRef="usd">-352532000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-208" decimals="-3" id="f-1077" unitRef="usd">-270440000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-209" decimals="-3" id="f-1078" unitRef="usd">-278413000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-210" decimals="-3" id="f-1079" unitRef="usd">352357000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-211" decimals="-3" id="f-1080" unitRef="usd">405328000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-212" decimals="-3" id="f-1081" unitRef="usd">243200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-1082" unitRef="usd">624467000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-1083" unitRef="usd">567851000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-1084" unitRef="usd">196680000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1085">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense allocated to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-204" decimals="-3" id="f-1086" unitRef="usd">80427000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-205" decimals="-3" id="f-1087" unitRef="usd">53248000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-206" decimals="-3" id="f-1088" unitRef="usd">18469000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-207" decimals="-3" id="f-1089" unitRef="usd">-42428000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-208" decimals="-3" id="f-1090" unitRef="usd">60753000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-209" decimals="-3" id="f-1091" unitRef="usd">35478000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-210" decimals="-3" id="f-1092" unitRef="usd">59153000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-211" decimals="-3" id="f-1093" unitRef="usd">70395000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-212" decimals="-3" id="f-1094" unitRef="usd">48003000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1095" unitRef="usd">97152000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1096" unitRef="usd">184396000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1097" unitRef="usd">101950000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-204" decimals="-3" id="f-1098" unitRef="usd">45253000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-205" decimals="-3" id="f-1099" unitRef="usd">-6166000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-206" decimals="-3" id="f-1100" unitRef="usd">553000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-207" decimals="-3" id="f-1101" unitRef="usd">-143323000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-208" decimals="-3" id="f-1102" unitRef="usd">-118475000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-209" decimals="-3" id="f-1103" unitRef="usd">-52717000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-210" decimals="-3" id="f-1104" unitRef="usd">12667000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-211" decimals="-3" id="f-1105" unitRef="usd">-344000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-212" decimals="-3" id="f-1106" unitRef="usd">-8452000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1107" unitRef="usd">-85403000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1108" unitRef="usd">-124985000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1109" unitRef="usd">-60616000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1110" unitRef="usd">11749000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1111" unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1112" unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax contextRef="c-1" decimals="-3" id="f-1113" unitRef="usd">-3903000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax contextRef="c-5" decimals="-3" id="f-1114" unitRef="usd">7211000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax contextRef="c-6" decimals="-3" id="f-1115" unitRef="usd">1776000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-1" decimals="-3" id="f-1116" unitRef="usd">301000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-5" decimals="-3" id="f-1117" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-6" decimals="-3" id="f-1118" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity contextRef="c-1" decimals="-3" id="f-1119" unitRef="usd">8147000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity contextRef="c-5" decimals="-3" id="f-1120" unitRef="usd">66622000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity contextRef="c-6" decimals="-3" id="f-1121" unitRef="usd">43110000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1122">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2022:12.5%; 2021:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate differential from amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Decrease)/ increase in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investor tax expense on foreign subsidiary earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-1123" unitRef="usd">78058000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-5" decimals="-3" id="f-1124" unitRef="usd">70980000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="-3" id="f-1125" unitRef="usd">24586000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="c-1" decimals="-3" id="f-1126" unitRef="usd">-71223000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="c-5" decimals="-3" id="f-1127" unitRef="usd">-59330000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="c-6" decimals="-3" id="f-1128" unitRef="usd">-31228000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-1129" unitRef="usd">35778000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-5" decimals="-3" id="f-1130" unitRef="usd">52464000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-6" decimals="-3" id="f-1131" unitRef="usd">51273000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-3" id="f-1132" unitRef="usd">3868000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-5" decimals="-3" id="f-1133" unitRef="usd">2608000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-6" decimals="-3" id="f-1134" unitRef="usd">3120000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-1135" unitRef="usd">-1068000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1136" unitRef="usd">-777000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-1137" unitRef="usd">3101000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-1" decimals="-3" id="f-1138" unitRef="usd">3154000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-5" decimals="-3" id="f-1139" unitRef="usd">-300000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-6" decimals="-3" id="f-1140" unitRef="usd">-128000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-1141" unitRef="usd">-54347000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease contextRef="c-5" decimals="-3" id="f-1142" unitRef="usd">8392000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease contextRef="c-6" decimals="-3" id="f-1143" unitRef="usd">5246000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount contextRef="c-1" decimals="-3" id="f-1144" unitRef="usd">39165000</iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-3" id="f-1145" unitRef="usd">-11487000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-5" decimals="-3" id="f-1146" unitRef="usd">-8756000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-6" decimals="-3" id="f-1147" unitRef="usd">-9083000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-1" decimals="-3" id="f-1148" unitRef="usd">-2413000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-5" decimals="-3" id="f-1149" unitRef="usd">-654000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-6" decimals="-3" id="f-1150" unitRef="usd">687000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1151" unitRef="usd">11749000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1152" unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1153" unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1154">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in foreign subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,073,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,158,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(825,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(911,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-1155" unitRef="usd">7547000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1156" unitRef="usd">10927000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-3" decimals="-3" id="f-1157" unitRef="usd">16108000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-1158" unitRef="usd">23260000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-3" decimals="-3" id="f-1159" unitRef="usd">39014000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-4" decimals="-3" id="f-1160" unitRef="usd">37150000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="c-3" decimals="-3" id="f-1161" unitRef="usd">950055000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="c-4" decimals="-3" id="f-1162" unitRef="usd">1078302000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-3" decimals="-3" id="f-1163" unitRef="usd">52408000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-4" decimals="-3" id="f-1164" unitRef="usd">1587000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-3" decimals="-3" id="f-1165" unitRef="usd">7982000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-4" decimals="-3" id="f-1166" unitRef="usd">7467000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-3" decimals="-3" id="f-1167" unitRef="usd">1073114000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-1168" unitRef="usd">1158693000</us-gaap:DeferredIncomeTaxLiabilities>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards contextRef="c-3" decimals="-3" id="f-1169" unitRef="usd">124150000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards contextRef="c-4" decimals="-3" id="f-1170" unitRef="usd">88697000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-1171" unitRef="usd">9082000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1172" unitRef="usd">6010000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-1173" unitRef="usd">20190000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1174" unitRef="usd">27593000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-3" decimals="-3" id="f-1175" unitRef="usd">2166000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-4" decimals="-3" id="f-1176" unitRef="usd">3602000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther contextRef="c-3" decimals="-3" id="f-1177" unitRef="usd">17605000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther contextRef="c-4" decimals="-3" id="f-1178" unitRef="usd">21862000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities contextRef="c-3" decimals="-3" id="f-1179" unitRef="usd">84928000</iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities>
    <iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities contextRef="c-4" decimals="-3" id="f-1180" unitRef="usd">66933000</iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities>
    <iclr:DeferredTaxAssetContractWithCustomerLiability contextRef="c-3" decimals="-3" id="f-1181" unitRef="usd">23748000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <iclr:DeferredTaxAssetContractWithCustomerLiability contextRef="c-4" decimals="-3" id="f-1182" unitRef="usd">66565000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-3" decimals="-3" id="f-1183" unitRef="usd">8774000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-4" decimals="-3" id="f-1184" unitRef="usd">9155000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-3" decimals="-3" id="f-1185" unitRef="usd">290643000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-1186" unitRef="usd">290417000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-3" decimals="-3" id="f-1187" unitRef="usd">42967000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1188" unitRef="usd">43379000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-3" decimals="-3" id="f-1189" unitRef="usd">247676000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-3" id="f-1190" unitRef="usd">247038000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilities contextRef="c-3" decimals="-3" id="f-1191" unitRef="usd">825438000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-4" decimals="-3" id="f-1192" unitRef="usd">911655000</us-gaap:DeferredTaxLiabilities>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration contextRef="c-213" decimals="-5" id="f-1193" unitRef="usd">16900000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-214" decimals="-5" id="f-1194" unitRef="usd">1700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-215" decimals="-5" id="f-1195" unitRef="usd">331400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-214" decimals="-5" id="f-1196" unitRef="usd">1700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <iclr:OperatingLossCarryforwardsUSFederal contextRef="c-216" decimals="-5" id="f-1197" unitRef="usd">1200000</iclr:OperatingLossCarryforwardsUSFederal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-214" decimals="-5" id="f-1198" unitRef="usd">1700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-214" decimals="-6" id="f-1199" unitRef="usd">204000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="c-1" id="f-1200">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected expiry dates of the US NOLs are as follows:&#160;&lt;/span&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024-2037&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2038-2042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;331,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-217" decimals="-3" id="f-1201" unitRef="usd">1744000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-218" decimals="-3" id="f-1202" unitRef="usd">271434000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-219" decimals="-3" id="f-1203" unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-220" decimals="-3" id="f-1204" unitRef="usd">50685000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-214" decimals="-3" id="f-1205" unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-215" decimals="-3" id="f-1206" unitRef="usd">9251000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-214" decimals="-3" id="f-1207" unitRef="usd">1744000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-215" decimals="-3" id="f-1208" unitRef="usd">331370000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax contextRef="c-216" decimals="-5" id="f-1209" unitRef="usd">800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-221" decimals="-5" id="f-1210" unitRef="usd">42900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-222" decimals="-5" id="f-1211" unitRef="usd">12900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration contextRef="c-223" decimals="-5" id="f-1212" unitRef="usd">4300000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-3" decimals="-5" id="f-1213" unitRef="usd">43000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-5" id="f-1214" unitRef="usd">43400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-22" decimals="-5" id="f-1215" unitRef="usd">45500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1216" unitRef="usd">-400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-5" decimals="-5" id="f-1217" unitRef="usd">-2100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1218" unitRef="usd">-400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-224" decimals="INF" id="f-1219" unitRef="usd">-1100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-225" decimals="-5" id="f-1220" unitRef="usd">700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-5" decimals="-5" id="f-1221" unitRef="usd">-2100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-226" decimals="-5" id="f-1222" unitRef="usd">-800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-227" decimals="-5" id="f-1223" unitRef="usd">-1300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-3" decimals="-5" id="f-1224" unitRef="usd">52400000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-4" decimals="-5" id="f-1225" unitRef="usd">1600000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock contextRef="c-1" id="f-1226">&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to acquired tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-1227" unitRef="usd">217584000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-22" decimals="-3" id="f-1228" unitRef="usd">202065000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-12" decimals="-3" id="f-1229" unitRef="usd">19078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition contextRef="c-1" decimals="-3" id="f-1230" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition contextRef="c-5" decimals="-3" id="f-1231" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition contextRef="c-6" decimals="-3" id="f-1232" unitRef="usd">170047000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1233" unitRef="usd">1161000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-3" id="f-1234" unitRef="usd">16098000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-1235" unitRef="usd">204000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1236" unitRef="usd">918000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-3" id="f-1237" unitRef="usd">5442000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-1238" unitRef="usd">1695000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1239" unitRef="usd">4552000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-5" decimals="-3" id="f-1240" unitRef="usd">5701000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-1241" unitRef="usd">18613000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-1" decimals="-3" id="f-1242" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-5" decimals="-3" id="f-1243" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-6" decimals="-3" id="f-1244" unitRef="usd">844000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-3" id="f-1245" unitRef="usd">62363000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-5" decimals="-3" id="f-1246" unitRef="usd">838000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-6" decimals="-3" id="f-1247" unitRef="usd">3338000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-3" decimals="-3" id="f-1248" unitRef="usd">160016000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-1249" unitRef="usd">217584000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-22" decimals="-3" id="f-1250" unitRef="usd">202065000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit contextRef="c-3" decimals="-5" id="f-1251" unitRef="usd">65000000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-3" decimals="-5" id="f-1252" unitRef="usd">160000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-4" decimals="-5" id="f-1253" unitRef="usd">217600000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-22" decimals="-5" id="f-1254" unitRef="usd">202100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-5" id="f-1255" unitRef="usd">4200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-5" decimals="-5" id="f-1256" unitRef="usd">7100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-6" decimals="-5" id="f-1257" unitRef="usd">1900000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-3" decimals="-5" id="f-1258" unitRef="usd">27100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="-5" id="f-1259" unitRef="usd">22600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-1260">Employee Benefits&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 were $40.4 million, $45.8 million and $23.7 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension and Postretirement Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 16)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition to the specific defined benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $12.3&#160;million and $11.6&#160;million recorded to non-current other liabilities as of December&#160;31, 2023 and December&#160;31, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;ICON Development Solutions Limited pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Development Solutions Limited, a subsidiary of ICON Plc, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 and December&#160;31, 2022  consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans - General&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The plan has been closed to new entrants with effect from July 1, 2003.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded surplus&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded surplus&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded status as at December&#160;31, 2023 and December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit (credit)/cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic benefit (credit)/cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used at the commencement of the year in determining the net periodic pension benefit (credit)/cost for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other comprehensive income/(loss)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain - benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain) - plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income/(loss) into net periodic benefit cost over the next year are $0.2 million and $nil respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Benefit Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used in determining the benefit obligation at December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Actuarial gains on the benefit obligation during 2023 resulted from changes in the assumptions compared to those adopted at December 2022. Changes in the assumptions reflect the changes in market conditions from December 2022 to December 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's pension plan asset allocation is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company&#x2019;s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December&#160;31, 2023 and December&#160;31, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plan Asset Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The value of assets held by the plan are represented by quoted prices in active markets for identical assets and are therefore classified as level 1 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2024. The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Years 2029 - 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Aptiv Solutions pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 and December&#160;31, 2022 consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans - General&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded deficit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 were 1.5% and 2.3%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;PRA Switzerland AG pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2023 consist of units held in independently administered funds. Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans - General&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded deficit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 was 1.5% and 2.3%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (loss)/gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c-228"
      decimals="3"
      id="f-1261"
      unitRef="number">0.045</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-228" decimals="-5" id="f-1262" unitRef="usd">40400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-229" decimals="-5" id="f-1263" unitRef="usd">45800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-230" decimals="-5" id="f-1264" unitRef="usd">23700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock contextRef="c-1" id="f-1265">The balances recorded to the balance sheet are as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 16)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-231" decimals="-3" id="f-1266" unitRef="usd">6321000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-232" decimals="-3" id="f-1267" unitRef="usd">6492000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-231" decimals="-3" id="f-1268" unitRef="usd">14738000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-232" decimals="-3" id="f-1269" unitRef="usd">13033000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-233" decimals="-5" id="f-1270" unitRef="usd">12300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-234" decimals="-5" id="f-1271" unitRef="usd">11600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock contextRef="c-1" id="f-1272">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded surplus&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded surplus&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded status as at December&#160;31, 2023 and December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded deficit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 were 1.5% and 2.3%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Pension plan disclosures are presented in the following tables in accordance with the requirements of ASC 715-20, &lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Plans - General&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.544%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded deficit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2023 and December&#160;31, 2022 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2023 and December&#160;31, 2022 was 1.5% and 2.3%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (loss)/gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="c-235" decimals="-3" id="f-1273" unitRef="usd">20999000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="c-236" decimals="-3" id="f-1274" unitRef="usd">19558000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-235" decimals="-3" id="f-1275" unitRef="usd">27320000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-236" decimals="-3" id="f-1276" unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-235" decimals="-3" id="f-1277" unitRef="usd">6321000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-236" decimals="-3" id="f-1278" unitRef="usd">6492000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-236" decimals="-3" id="f-1279" unitRef="usd">19558000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-237" decimals="-3" id="f-1280" unitRef="usd">41813000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-238" decimals="-3" id="f-1281" unitRef="usd">42000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-239" decimals="-3" id="f-1282" unitRef="usd">117000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-238" decimals="-3" id="f-1283" unitRef="usd">975000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-239" decimals="-3" id="f-1284" unitRef="usd">672000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-238" decimals="-3" id="f-1285" unitRef="usd">19000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-239" decimals="-3" id="f-1286" unitRef="usd">19000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-238" decimals="-3" id="f-1287" unitRef="usd">318000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-239" decimals="-3" id="f-1288" unitRef="usd">514000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-238" decimals="-3" id="f-1289" unitRef="usd">335000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-239" decimals="-3" id="f-1290" unitRef="usd">18636000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-238" decimals="-3" id="f-1291" unitRef="usd">-1058000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-239" decimals="-3" id="f-1292" unitRef="usd">3913000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-235" decimals="-3" id="f-1293" unitRef="usd">20999000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-236" decimals="-3" id="f-1294" unitRef="usd">19558000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-236" decimals="-3" id="f-1295" unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-237" decimals="-3" id="f-1296" unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-238" decimals="-3" id="f-1297" unitRef="usd">1015000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-239" decimals="-3" id="f-1298" unitRef="usd">1258000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-238" decimals="-3" id="f-1299" unitRef="usd">-910000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-239" decimals="-3" id="f-1300" unitRef="usd">-7305000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-238" decimals="-3" id="f-1301" unitRef="usd">70000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-239" decimals="-3" id="f-1302" unitRef="usd">70000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-238" decimals="-3" id="f-1303" unitRef="usd">19000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-239" decimals="-3" id="f-1304" unitRef="usd">19000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-238" decimals="-3" id="f-1305" unitRef="usd">318000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-239" decimals="-3" id="f-1306" unitRef="usd">514000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-238" decimals="-3" id="f-1307" unitRef="usd">1394000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-239" decimals="-3" id="f-1308" unitRef="usd">-3676000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-235" decimals="-3" id="f-1309" unitRef="usd">27320000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-236" decimals="-3" id="f-1310" unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="c-1" id="f-1311">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit (credit)/cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic benefit (credit)/cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-238" decimals="-3" id="f-1312" unitRef="usd">42000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-239" decimals="-3" id="f-1313" unitRef="usd">117000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-240" decimals="-3" id="f-1314" unitRef="usd">134000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-238" decimals="-3" id="f-1315" unitRef="usd">975000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-239" decimals="-3" id="f-1316" unitRef="usd">672000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-240" decimals="-3" id="f-1317" unitRef="usd">665000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-238" decimals="-3" id="f-1318" unitRef="usd">1015000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-239" decimals="-3" id="f-1319" unitRef="usd">1258000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-240" decimals="-3" id="f-1320" unitRef="usd">1171000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-238" decimals="-3" id="f-1321" unitRef="usd">274000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-239" decimals="-3" id="f-1322" unitRef="usd">-228000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-240" decimals="-3" id="f-1323" unitRef="usd">-625000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-238" decimals="-3" id="f-1324" unitRef="usd">-272000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-239" decimals="-3" id="f-1325" unitRef="usd">-241000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-240" decimals="-3" id="f-1326" unitRef="usd">253000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock contextRef="c-1" id="f-1327">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used at the commencement of the year in determining the net periodic pension benefit (credit)/cost for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used in determining the benefit obligation at December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-238"
      decimals="3"
      id="f-1328"
      unitRef="number">0.049</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-239"
      decimals="3"
      id="f-1329"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="c-240"
      decimals="3"
      id="f-1330"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-238"
      decimals="3"
      id="f-1331"
      unitRef="number">0.036</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-239"
      decimals="3"
      id="f-1332"
      unitRef="number">0.037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="c-240"
      decimals="3"
      id="f-1333"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-238"
      decimals="3"
      id="f-1334"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-239"
      decimals="3"
      id="f-1335"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-240"
      decimals="3"
      id="f-1336"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1337">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other comprehensive income/(loss)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain - benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain) - plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net gain/(loss) recognized in net periodic benefit (credit)/cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost contextRef="c-238" decimals="-3" id="f-1338" unitRef="usd">335000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost contextRef="c-239" decimals="-3" id="f-1339" unitRef="usd">18636000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost contextRef="c-240" decimals="-3" id="f-1340" unitRef="usd">2097000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-238" decimals="-3" id="f-1341" unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-239" decimals="-3" id="f-1342" unitRef="usd">7305000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-240" decimals="-3" id="f-1343" unitRef="usd">-1176000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax contextRef="c-238" decimals="-3" id="f-1344" unitRef="usd">-274000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax contextRef="c-239" decimals="-3" id="f-1345" unitRef="usd">228000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax contextRef="c-240" decimals="-3" id="f-1346" unitRef="usd">625000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax contextRef="c-238" decimals="-3" id="f-1347" unitRef="usd">849000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax contextRef="c-239" decimals="-3" id="f-1348" unitRef="usd">-11559000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax contextRef="c-240" decimals="-3" id="f-1349" unitRef="usd">-3898000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear contextRef="c-235" decimals="-5" id="f-1350" unitRef="usd">200000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear contextRef="c-235" decimals="INF" id="f-1351" unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-235"
      decimals="3"
      id="f-1352"
      unitRef="number">0.048</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-236"
      decimals="3"
      id="f-1353"
      unitRef="number">0.049</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="c-235"
      decimals="3"
      id="f-1354"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="c-236"
      decimals="3"
      id="f-1355"
      unitRef="number">0.036</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod contextRef="c-238" id="f-1356">P19Y</iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock contextRef="c-1" id="f-1357">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's pension plan asset allocation is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-241"
      decimals="2"
      id="f-1358"
      unitRef="number">0.78</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-242"
      decimals="2"
      id="f-1359"
      unitRef="number">0.88</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-243"
      decimals="2"
      id="f-1360"
      unitRef="number">0.22</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-244"
      decimals="2"
      id="f-1361"
      unitRef="number">0.12</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-245"
      decimals="INF"
      id="f-1362"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-246"
      decimals="INF"
      id="f-1363"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-247"
      decimals="3"
      id="f-1364"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="c-248"
      decimals="3"
      id="f-1365"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock contextRef="c-1" id="f-1366">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-249" decimals="-3" id="f-1367" unitRef="usd">21312000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-250" decimals="-3" id="f-1368" unitRef="usd">22887000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-251" decimals="-3" id="f-1369" unitRef="usd">6008000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-252" decimals="-3" id="f-1370" unitRef="usd">3163000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-253" decimals="-3" id="f-1371" unitRef="usd">27320000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-254" decimals="-3" id="f-1372" unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-235" decimals="-5" id="f-1373" unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock contextRef="c-1" id="f-1374">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Years 2029 - 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="c-255" decimals="-3" id="f-1375" unitRef="usd">379000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="c-255" decimals="-3" id="f-1376" unitRef="usd">420000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="c-255" decimals="-3" id="f-1377" unitRef="usd">679000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="c-255" decimals="-3" id="f-1378" unitRef="usd">662000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="c-255" decimals="-3" id="f-1379" unitRef="usd">612000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="c-255" decimals="-3" id="f-1380" unitRef="usd">4028000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <iclr:ExpectedRetirementPeriod contextRef="c-238" id="f-1381">P10Y</iclr:ExpectedRetirementPeriod>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-256"
      decimals="INF"
      id="f-1382"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="c-257" decimals="-3" id="f-1383" unitRef="usd">6441000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="c-258" decimals="-3" id="f-1384" unitRef="usd">5806000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-257" decimals="-3" id="f-1385" unitRef="usd">6261000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-258" decimals="-3" id="f-1386" unitRef="usd">5681000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-257" decimals="-3" id="f-1387" unitRef="usd">-180000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-258" decimals="-3" id="f-1388" unitRef="usd">-125000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-257"
      decimals="4"
      id="f-1389"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-258"
      decimals="4"
      id="f-1390"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-258" decimals="-3" id="f-1391" unitRef="usd">5806000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-259" decimals="-3" id="f-1392" unitRef="usd">7643000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-260" decimals="-3" id="f-1393" unitRef="usd">109000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-261" decimals="-3" id="f-1394" unitRef="usd">146000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-260" decimals="-3" id="f-1395" unitRef="usd">136000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-261" decimals="-3" id="f-1396" unitRef="usd">30000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-260" decimals="-3" id="f-1397" unitRef="usd">93000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-261" decimals="-3" id="f-1398" unitRef="usd">82000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation contextRef="c-260" decimals="-3" id="f-1399" unitRef="usd">645000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation contextRef="c-261" decimals="-3" id="f-1400" unitRef="usd">218000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-260" decimals="-3" id="f-1401" unitRef="usd">-13000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-261" decimals="-3" id="f-1402" unitRef="usd">-23000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-260" decimals="-3" id="f-1403" unitRef="usd">-134000</iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-261" decimals="-3" id="f-1404" unitRef="usd">-182000</iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-260" decimals="-3" id="f-1405" unitRef="usd">-511000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-261" decimals="-3" id="f-1406" unitRef="usd">1527000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-260" decimals="-3" id="f-1407" unitRef="usd">-578000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-261" decimals="-3" id="f-1408" unitRef="usd">145000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-257" decimals="-3" id="f-1409" unitRef="usd">6441000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-258" decimals="-3" id="f-1410" unitRef="usd">5806000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-258" decimals="-3" id="f-1411" unitRef="usd">5681000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-259" decimals="-3" id="f-1412" unitRef="usd">6964000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-260" decimals="-3" id="f-1413" unitRef="usd">133000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-261" decimals="-3" id="f-1414" unitRef="usd">29000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-260" decimals="-3" id="f-1415" unitRef="usd">356000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-261" decimals="-3" id="f-1416" unitRef="usd">-987000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <iclr:DefinedBenefitPlanSchemeContributions contextRef="c-260" decimals="-3" id="f-1417" unitRef="usd">215000</iclr:DefinedBenefitPlanSchemeContributions>
    <iclr:DefinedBenefitPlanSchemeContributions contextRef="c-261" decimals="-3" id="f-1418" unitRef="usd">114000</iclr:DefinedBenefitPlanSchemeContributions>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-260" decimals="-3" id="f-1419" unitRef="usd">93000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-261" decimals="-3" id="f-1420" unitRef="usd">82000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-260" decimals="-3" id="f-1421" unitRef="usd">134000</iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-261" decimals="-3" id="f-1422" unitRef="usd">182000</iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets contextRef="c-260" decimals="-3" id="f-1423" unitRef="usd">645000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets contextRef="c-261" decimals="-3" id="f-1424" unitRef="usd">218000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-260" decimals="-3" id="f-1425" unitRef="usd">562000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-261" decimals="-3" id="f-1426" unitRef="usd">-121000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-257" decimals="-3" id="f-1427" unitRef="usd">6261000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-258" decimals="-3" id="f-1428" unitRef="usd">5681000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="c-262" decimals="-3" id="f-1429" unitRef="usd">7747000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="c-263" decimals="-3" id="f-1430" unitRef="usd">5345000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-262" decimals="-3" id="f-1431" unitRef="usd">5529000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-263" decimals="-3" id="f-1432" unitRef="usd">4059000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-262" decimals="-3" id="f-1433" unitRef="usd">-2218000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-263" decimals="-3" id="f-1434" unitRef="usd">-1286000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-264"
      decimals="3"
      id="f-1435"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="c-265"
      decimals="3"
      id="f-1436"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-263" decimals="-3" id="f-1437" unitRef="usd">5345000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-266" decimals="-3" id="f-1438" unitRef="usd">4990000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-267" decimals="-3" id="f-1439" unitRef="usd">417000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-268" decimals="-3" id="f-1440" unitRef="usd">404000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-267" decimals="-3" id="f-1441" unitRef="usd">132000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-268" decimals="-3" id="f-1442" unitRef="usd">20000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-267" decimals="-3" id="f-1443" unitRef="usd">456000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant contextRef="c-268" decimals="-3" id="f-1444" unitRef="usd">325000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation contextRef="c-267" decimals="-3" id="f-1445" unitRef="usd">753000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation contextRef="c-268" decimals="-3" id="f-1446" unitRef="usd">844000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-267" decimals="-3" id="f-1447" unitRef="usd">795000</iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-268" decimals="-3" id="f-1448" unitRef="usd">1125000</iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-267" decimals="-3" id="f-1449" unitRef="usd">-711000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-268" decimals="-3" id="f-1450" unitRef="usd">627000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-267" decimals="-3" id="f-1451" unitRef="usd">-644000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="c-268" decimals="-3" id="f-1452" unitRef="usd">48000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-262" decimals="-3" id="f-1453" unitRef="usd">7747000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-263" decimals="-3" id="f-1454" unitRef="usd">5345000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-263" decimals="-3" id="f-1455" unitRef="usd">4059000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-266" decimals="-3" id="f-1456" unitRef="usd">3017000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-267" decimals="-3" id="f-1457" unitRef="usd">101000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-268" decimals="-3" id="f-1458" unitRef="usd">29000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-267" decimals="-3" id="f-1459" unitRef="usd">-52000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-268" decimals="-3" id="f-1460" unitRef="usd">87000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <iclr:DefinedBenefitPlanSchemeContributions contextRef="c-267" decimals="-3" id="f-1461" unitRef="usd">456000</iclr:DefinedBenefitPlanSchemeContributions>
    <iclr:DefinedBenefitPlanSchemeContributions contextRef="c-268" decimals="-3" id="f-1462" unitRef="usd">325000</iclr:DefinedBenefitPlanSchemeContributions>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-267" decimals="-3" id="f-1463" unitRef="usd">456000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant contextRef="c-268" decimals="-3" id="f-1464" unitRef="usd">325000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-267" decimals="-3" id="f-1465" unitRef="usd">795000</iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers contextRef="c-268" decimals="-3" id="f-1466" unitRef="usd">1125000</iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets contextRef="c-267" decimals="-3" id="f-1467" unitRef="usd">753000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets contextRef="c-268" decimals="-3" id="f-1468" unitRef="usd">844000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-267" decimals="-3" id="f-1469" unitRef="usd">467000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss contextRef="c-268" decimals="-3" id="f-1470" unitRef="usd">-5000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-262" decimals="-3" id="f-1471" unitRef="usd">5529000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-263" decimals="-3" id="f-1472" unitRef="usd">4059000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1473">Equity Incentive Schemes and Stock Compensation Charges&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;PRA  Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#x201d;), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan")  were amended and restated and assumed by the Registrant effective as of July 1, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2018 Stock Incentive Plan (the &#x201c;2018 Plan&#x201d;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2.0&#160;million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combinations *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,177,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(348,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,378,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(535,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Represents stock options issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2023, was 4.42 years and 3.89 years respectively (2022: 4.69 years and 4.25 years respectively).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Outstanding and exercisable share options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Range Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$20.83 - 96.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$103.81 - 121.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$125.74 - 147.26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;233,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$159.33 - 233.88&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$20.83 - 233.88&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;902,806&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;142.96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;654,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;119.67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding include both vested and unvested options as at December&#160;31, 2023. Options exercisable represent options which have vested at December&#160;31, 2023. From the date of grant, substantially all options vest over a five year period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value of Stock Options Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options granted during the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Share Units and Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.  No awards may be granted under the 2013 RSU Plan after May 11, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#x201c;2019 Consultants RSU Plan&#x201d;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#x2019;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors vest over twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.116%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;308,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(188,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;621,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of RSUs vested for the year ended December&#160;31, 2023 totaled $35.4 million (2022: $34.1 million). The share price range for the year was $159.33 - $265.96 (2022: $137.47 - $265.96).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of PSUs vested for the year ended December&#160;31, 2023 totaled $7.5 million (2022: $6.5 million). The share price range for the year was $159.33 - $166.51 (2022: $137.47 - $166.51).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The PSUs vest based on service and specified EPS targets over the period  2021 &#x2013; 2023, 2022 &#x2013; 2024, and 2023 - 2025. Depending on the actual amount of EPS from 2021 to 2025, up to an additional 49,340 PSUs may also be granted.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income from operations for the year ended December&#160;31, 2023 is stated after charging $55.7 million in respect of stock compensation expense (inclusive of employer related taxes). Stock compensation expense has been allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and integration related *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The income tax expense for the year ended December&#160;31, 2023 reflects a net income tax benefit of $20.0 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2023 was $10.9 million. The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2021 was $23.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-269"
      decimals="-5"
      id="f-1474"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-270"
      decimals="-5"
      id="f-1475"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-271"
      decimals="-5"
      id="f-1476"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted
      contextRef="c-272"
      decimals="-5"
      id="f-1477"
      unitRef="shares">1000000</iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="c-273"
      decimals="-5"
      id="f-1478"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="c-274"
      decimals="INF"
      id="f-1479"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-275" id="f-1480">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-275" id="f-1481">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-276"
      decimals="0"
      id="f-1482"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-277"
      decimals="0"
      id="f-1483"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1484">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combinations *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,177,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(348,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,378,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(535,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Represents stock options issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-278"
      decimals="INF"
      id="f-1485"
      unitRef="shares">553746</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-278"
      decimals="2"
      id="f-1486"
      unitRef="usdPerShare">108.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination
      contextRef="c-279"
      decimals="INF"
      id="f-1487"
      unitRef="shares">2177130</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination>
    <iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
      contextRef="c-279"
      decimals="2"
      id="f-1488"
      unitRef="usdPerShare">108.78</iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-279"
      decimals="INF"
      id="f-1489"
      unitRef="shares">100299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-279"
      decimals="2"
      id="f-1490"
      unitRef="usdPerShare">177.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-279"
      decimals="INF"
      id="f-1491"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-279"
      decimals="2"
      id="f-1492"
      unitRef="usdPerShare">111.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-279"
      decimals="INF"
      id="f-1493"
      unitRef="shares">70186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-279"
      decimals="2"
      id="f-1494"
      unitRef="usdPerShare">128.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-280"
      decimals="INF"
      id="f-1495"
      unitRef="shares">1695460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-280"
      decimals="2"
      id="f-1496"
      unitRef="usdPerShare">110.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-281"
      decimals="INF"
      id="f-1497"
      unitRef="shares">108643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-281"
      decimals="2"
      id="f-1498"
      unitRef="usdPerShare">229.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-281"
      decimals="INF"
      id="f-1499"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-281"
      decimals="2"
      id="f-1500"
      unitRef="usdPerShare">102.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-281"
      decimals="INF"
      id="f-1501"
      unitRef="shares">77698</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-281"
      decimals="2"
      id="f-1502"
      unitRef="usdPerShare">143.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-282"
      decimals="INF"
      id="f-1503"
      unitRef="shares">1378119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-282"
      decimals="2"
      id="f-1504"
      unitRef="usdPerShare">119.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-283"
      decimals="INF"
      id="f-1505"
      unitRef="shares">82472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-283"
      decimals="2"
      id="f-1506"
      unitRef="usdPerShare">232.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-283"
      decimals="INF"
      id="f-1507"
      unitRef="shares">535705</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-283"
      decimals="2"
      id="f-1508"
      unitRef="usdPerShare">95.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-283"
      decimals="INF"
      id="f-1509"
      unitRef="shares">22080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-283"
      decimals="2"
      id="f-1510"
      unitRef="usdPerShare">196.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-284"
      decimals="INF"
      id="f-1511"
      unitRef="shares">902806</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-284"
      decimals="2"
      id="f-1512"
      unitRef="usdPerShare">142.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c-284"
      decimals="INF"
      id="f-1513"
      unitRef="shares">654386</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-284"
      decimals="2"
      id="f-1514"
      unitRef="usdPerShare">119.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1515">P4Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-1516">P3Y10M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-5" id="f-1517">P4Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-5" id="f-1518">P4Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c-1" id="f-1519">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.298%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Range Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$20.83 - 96.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$103.81 - 121.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$125.74 - 147.26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;233,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$159.33 - 233.88&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$20.83 - 233.88&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;902,806&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;142.96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;654,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;119.67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-285"
      decimals="2"
      id="f-1520"
      unitRef="usdPerShare">20.83</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-285"
      decimals="2"
      id="f-1521"
      unitRef="usdPerShare">96.15</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-286"
      decimals="INF"
      id="f-1522"
      unitRef="shares">201306</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-287" id="f-1523">P2Y3M14D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-286"
      decimals="INF"
      id="f-1524"
      unitRef="shares">201306</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-288"
      decimals="2"
      id="f-1525"
      unitRef="usdPerShare">103.81</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-288"
      decimals="2"
      id="f-1526"
      unitRef="usdPerShare">121.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-289"
      decimals="INF"
      id="f-1527"
      unitRef="shares">132964</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-290" id="f-1528">P4Y6M14D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-289"
      decimals="INF"
      id="f-1529"
      unitRef="shares">132964</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-291"
      decimals="2"
      id="f-1530"
      unitRef="usdPerShare">125.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-291"
      decimals="2"
      id="f-1531"
      unitRef="usdPerShare">147.26</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-292"
      decimals="INF"
      id="f-1532"
      unitRef="shares">249194</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-293" id="f-1533">P4Y5M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-292"
      decimals="INF"
      id="f-1534"
      unitRef="shares">233371</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-294"
      decimals="2"
      id="f-1535"
      unitRef="usdPerShare">159.33</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-294"
      decimals="2"
      id="f-1536"
      unitRef="usdPerShare">233.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-295"
      decimals="INF"
      id="f-1537"
      unitRef="shares">319342</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-296" id="f-1538">P5Y8M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-295"
      decimals="INF"
      id="f-1539"
      unitRef="shares">86745</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-1"
      decimals="2"
      id="f-1540"
      unitRef="usdPerShare">20.83</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-1"
      decimals="2"
      id="f-1541"
      unitRef="usdPerShare">233.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-284"
      decimals="INF"
      id="f-1542"
      unitRef="shares">902806</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-283" id="f-1543">P4Y5M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-284"
      decimals="2"
      id="f-1544"
      unitRef="usdPerShare">142.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-284"
      decimals="INF"
      id="f-1545"
      unitRef="shares">654386</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-284"
      decimals="2"
      id="f-1546"
      unitRef="usdPerShare">119.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-189" id="f-1547">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1548">The weighted average fair values and assumptions were as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-189"
      decimals="2"
      id="f-1549"
      unitRef="usdPerShare">85.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-192"
      decimals="2"
      id="f-1550"
      unitRef="usdPerShare">68.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-195"
      decimals="2"
      id="f-1551"
      unitRef="usdPerShare">49.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-189"
      decimals="2"
      id="f-1552"
      unitRef="number">0.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-192"
      decimals="2"
      id="f-1553"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-195"
      decimals="2"
      id="f-1554"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-189"
      decimals="INF"
      id="f-1555"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-192"
      decimals="INF"
      id="f-1556"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-195"
      decimals="INF"
      id="f-1557"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-189"
      decimals="4"
      id="f-1558"
      unitRef="number">0.0418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-192"
      decimals="4"
      id="f-1559"
      unitRef="number">0.0186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-195"
      decimals="4"
      id="f-1560"
      unitRef="number">0.0078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-189" id="f-1561">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-192" id="f-1562">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-195" id="f-1563">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-297"
      decimals="2"
      id="f-1564"
      unitRef="usdPerShare">107.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-297"
      decimals="2"
      id="f-1565"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-297"
      decimals="INF"
      id="f-1566"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-297"
      decimals="4"
      id="f-1567"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-297" id="f-1568">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-298"
      decimals="-5"
      id="f-1569"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-299"
      decimals="-5"
      id="f-1570"
      unitRef="shares">4100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-300"
      decimals="INF"
      id="f-1571"
      unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-301" id="f-1572">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock contextRef="c-1" id="f-1573">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2023:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.116%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;308,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(188,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;621,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-302"
      decimals="INF"
      id="f-1574"
      unitRef="shares">152420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-302"
      decimals="2"
      id="f-1575"
      unitRef="usdPerShare">192.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-303"
      decimals="INF"
      id="f-1576"
      unitRef="shares">582612</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-303"
      decimals="2"
      id="f-1577"
      unitRef="usdPerShare">207.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-191"
      decimals="INF"
      id="f-1578"
      unitRef="shares">60374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-191"
      decimals="2"
      id="f-1579"
      unitRef="usdPerShare">232.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-190"
      decimals="INF"
      id="f-1580"
      unitRef="shares">308963</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-190"
      decimals="2"
      id="f-1581"
      unitRef="usdPerShare">218.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-191"
      decimals="INF"
      id="f-1582"
      unitRef="shares">47026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-191"
      decimals="2"
      id="f-1583"
      unitRef="usdPerShare">159.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-190"
      decimals="INF"
      id="f-1584"
      unitRef="shares">188800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-190"
      decimals="2"
      id="f-1585"
      unitRef="usdPerShare">187.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-191"
      decimals="INF"
      id="f-1586"
      unitRef="shares">60512</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-191"
      decimals="2"
      id="f-1587"
      unitRef="usdPerShare">198.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-190"
      decimals="INF"
      id="f-1588"
      unitRef="shares">81764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-190"
      decimals="2"
      id="f-1589"
      unitRef="usdPerShare">216.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-304"
      decimals="INF"
      id="f-1590"
      unitRef="shares">105256</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-304"
      decimals="2"
      id="f-1591"
      unitRef="usdPerShare">226.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-305"
      decimals="INF"
      id="f-1592"
      unitRef="shares">621011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-305"
      decimals="2"
      id="f-1593"
      unitRef="usdPerShare">218.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-190" decimals="-5" id="f-1594" unitRef="usd">35400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-193" decimals="-5" id="f-1595" unitRef="usd">34100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-306"
      decimals="2"
      id="f-1596"
      unitRef="usdPerShare">159.33</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-307"
      decimals="2"
      id="f-1597"
      unitRef="usdPerShare">265.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-308"
      decimals="2"
      id="f-1598"
      unitRef="usdPerShare">137.47</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-309"
      decimals="2"
      id="f-1599"
      unitRef="usdPerShare">265.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-191" decimals="-5" id="f-1600" unitRef="usd">7500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-194" decimals="-5" id="f-1601" unitRef="usd">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-310"
      decimals="2"
      id="f-1602"
      unitRef="usdPerShare">159.33</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-311"
      decimals="2"
      id="f-1603"
      unitRef="usdPerShare">166.51</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-312"
      decimals="2"
      id="f-1604"
      unitRef="usdPerShare">137.47</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-313"
      decimals="2"
      id="f-1605"
      unitRef="usdPerShare">166.51</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-314"
      decimals="INF"
      id="f-1606"
      unitRef="shares">49340</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-1607" unitRef="usd">55700000</us-gaap:ShareBasedCompensation>
    <iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock contextRef="c-1" id="f-1608">Stock compensation expense has been allocated as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and integration related *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger&lt;/span&gt;&lt;/div&gt;</iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation contextRef="c-184" decimals="-3" id="f-1609" unitRef="usd">26595000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-186" decimals="-3" id="f-1610" unitRef="usd">22854000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-188" decimals="-3" id="f-1611" unitRef="usd">18551000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-183" decimals="-3" id="f-1612" unitRef="usd">29072000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-185" decimals="-3" id="f-1613" unitRef="usd">47669000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-187" decimals="-3" id="f-1614" unitRef="usd">41457000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-315" decimals="-3" id="f-1615" unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-316" decimals="-3" id="f-1616" unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-317" decimals="-3" id="f-1617" unitRef="usd">73836000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-1618" unitRef="usd">55667000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-1619" unitRef="usd">70523000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-1620" unitRef="usd">133844000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-1621" unitRef="usd">20000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-1" decimals="-5" id="f-1622" unitRef="usd">10900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-5" decimals="-5" id="f-1623" unitRef="usd">12900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-5" decimals="-5" id="f-1624" unitRef="usd">7700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-6" decimals="-5" id="f-1625" unitRef="usd">22700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-6" decimals="-5" id="f-1626" unitRef="usd">23900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1627">Business Segment and Geographical Information&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#x2018;CODM&#x2019;) in accordance with ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates as one reportable segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#x2019;s transfer pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland acts as the Group entrepreneur under the Company&#x2019;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#x2019;s global network. ICON Ireland enters into the majority of the Company&#x2019;s customer contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland remunerates other operating entities in the Group on the basis of an arm&#x2019;s length return for the services they perform in each of their local territories. The arm&#x2019;s length return for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The arm&#x2019;s length return  is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model has been completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The geographic split of revenue disclosed for each region outside Ireland is the arm&#x2019;s length revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the arm&#x2019;s length revenues attributable to the activities performed outside Ireland. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There have been no changes to the overall basis of segmentation or the measurement basis for the segment results since the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Reportable geographic information at December&#160;31, 2023 and December&#160;31, 2022 and for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;a) The distribution of revenue by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,984,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,574,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,618,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,175,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,283,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,574,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,581,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;884,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;358,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,741,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,480,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;b) The distribution of income from operations (including Restructuring) by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland *&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;956,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;378,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span id="ib1b5cc593b5a4d838e37be253e511406_6-1-1-1-225727"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1628"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-1629">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Reportable geographic information at December&#160;31, 2023 and December&#160;31, 2022 and for the years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;a) The distribution of revenue by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,984,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,574,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,618,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,175,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,283,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,574,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,581,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;884,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;358,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,741,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,480,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-204" decimals="-3" id="f-1630" unitRef="usd">2377104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-205" decimals="-3" id="f-1631" unitRef="usd">1984567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-206" decimals="-3" id="f-1632" unitRef="usd">1365909000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-318" decimals="-3" id="f-1633" unitRef="usd">1574783000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-319" decimals="-3" id="f-1634" unitRef="usd">1618350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-320" decimals="-3" id="f-1635" unitRef="usd">1175515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-207" decimals="-3" id="f-1636" unitRef="usd">3283790000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-208" decimals="-3" id="f-1637" unitRef="usd">3574610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-209" decimals="-3" id="f-1638" unitRef="usd">2581007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-321" decimals="-3" id="f-1639" unitRef="usd">884499000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-322" decimals="-3" id="f-1640" unitRef="usd">563859000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-323" decimals="-3" id="f-1641" unitRef="usd">358395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-1642" unitRef="usd">8120176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-1643" unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-1644" unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <iclr:OperatingIncomeByGeographyTableTextBlock contextRef="c-1" id="f-1645">The distribution of income from operations (including Restructuring) by geographical area was as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland *&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;956,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;378,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.</iclr:OperatingIncomeByGeographyTableTextBlock>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-204" decimals="-3" id="f-1646" unitRef="usd">432026000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-205" decimals="-3" id="f-1647" unitRef="usd">218088000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-206" decimals="-3" id="f-1648" unitRef="usd">131961000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-318" decimals="-3" id="f-1649" unitRef="usd">153450000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-319" decimals="-3" id="f-1650" unitRef="usd">253799000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-320" decimals="-3" id="f-1651" unitRef="usd">177863000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-207" decimals="-3" id="f-1652" unitRef="usd">310343000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-208" decimals="-3" id="f-1653" unitRef="usd">254849000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-209" decimals="-3" id="f-1654" unitRef="usd">39132000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-321" decimals="-3" id="f-1655" unitRef="usd">60333000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-322" decimals="-3" id="f-1656" unitRef="usd">68501000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-323" decimals="-3" id="f-1657" unitRef="usd">29573000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-1" decimals="-3" id="f-1658" unitRef="usd">956152000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-5" decimals="-3" id="f-1659" unitRef="usd">795237000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses contextRef="c-6" decimals="-3" id="f-1660" unitRef="usd">378529000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c-1" id="f-1661">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span id="ib1b5cc593b5a4d838e37be253e511406_6-1-1-1-225727"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:NoncurrentAssets contextRef="c-324" decimals="-3" id="f-1662" unitRef="usd">199051000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-325" decimals="-3" id="f-1663" unitRef="usd">143025000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-326" decimals="-3" id="f-1664" unitRef="usd">94046000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-327" decimals="-3" id="f-1665" unitRef="usd">99721000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-216" decimals="-3" id="f-1666" unitRef="usd">159245000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-328" decimals="-3" id="f-1667" unitRef="usd">213311000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-329" decimals="-3" id="f-1668" unitRef="usd">49175000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-330" decimals="-3" id="f-1669" unitRef="usd">48095000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-3" decimals="-3" id="f-1670" unitRef="usd">501517000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-4" decimals="-3" id="f-1671" unitRef="usd">504152000</us-gaap:NoncurrentAssets>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1672">Net Income Per Ordinary Share&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,101,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,532,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options and other awards outstanding under share based compensation programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,717,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,468,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,068,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income per ordinary share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1673">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,101,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,532,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options and other awards outstanding under share based compensation programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,717,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,468,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,068,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1674" unitRef="shares">82101813</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-1675" unitRef="shares">81532320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-1676" unitRef="shares">67110186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="0" id="f-1677" unitRef="shares">615827</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-5" decimals="0" id="f-1678" unitRef="shares">936043</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-6" decimals="0" id="f-1679" unitRef="shares">958125</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1680" unitRef="shares">82717640</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-1681" unitRef="shares">82468363</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-1682" unitRef="shares">68068311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1683">&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income per ordinary share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1684"
      unitRef="usdPerShare">7.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-1685"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-1686"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1687"
      unitRef="usdPerShare">7.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-1688"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-1689"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock contextRef="c-1" id="f-1690">Accumulated Other Comprehensive Loss&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(175,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain on defined benefit pension plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(171,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1691">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(175,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain on defined benefit pension plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(171,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-3" decimals="-3" id="f-1692" unitRef="usd">-149148000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-4" decimals="-3" id="f-1693" unitRef="usd">-175369000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-3" decimals="-3" id="f-1694" unitRef="usd">-7803000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-4" decimals="-3" id="f-1695" unitRef="usd">-7559000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax contextRef="c-3" decimals="-3" id="f-1696" unitRef="usd">-2161000</iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax>
    <iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax contextRef="c-4" decimals="-3" id="f-1697" unitRef="usd">-3728000</iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-1698" unitRef="usd">-143506000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-1699" unitRef="usd">-171538000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="c-1" id="f-1700">Supplemental Disclosure of Cash Flow Information&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c-1" id="f-1701">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-1702" unitRef="usd">317975000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-5" decimals="-3" id="f-1703" unitRef="usd">210918000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-6" decimals="-3" id="f-1704" unitRef="usd">106205000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-1705" unitRef="usd">163778000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-5" decimals="-3" id="f-1706" unitRef="usd">116322000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-6" decimals="-3" id="f-1707" unitRef="usd">55105000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1708">Related Parties &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Subsidiaries of the Company earned revenue of $243,000 (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December&#160;31, 2022: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$428,000) from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;of Corvus Pharmaceuticals. $101,000 (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December&#160;31, 2022: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$231,000) was noted as due from Corvus Pharmaceuticals at December&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Subsidiaries of the Company earned revenue of $45,000 (December&#160;31, 2022: $235,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $47,000 was noted as due from Afimmune Limited at December&#160;31, 2023 (December&#160;31, 2022: $263,000).&#160;&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), a specialized oncology site network in the US and EMEA regions, with a third party. The Company invested $4.9&#160;million to obtain a 49% interest in the voting share capital of Oncacare. On April 20, 2023, the Company completed the purchase of the majority investor&#x2019;s 51% majority voting share capital of Oncacare. The consideration paid by ICON to purchase the 51% majority voting share capital was $5.1&#160;million. As a result of this transaction (the "Oncacare acquisition"), Oncacare and its subsidiaries became wholly owned subsidiaries of the ICON Group. Prior to the Oncacare acquisition, the Company recorded losses of $0.4&#160;million and $3.1 million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023 and December&#160;31, 2022, respectively. The Oncacare acquisition also resulted in goodwill of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$13.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and gave rise to an acquisition-related gain of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$6.2 million&lt;/span&gt;.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:Revenues contextRef="c-331" decimals="-3" id="f-1709" unitRef="usd">243000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-332" decimals="-3" id="f-1710" unitRef="usd">428000</us-gaap:Revenues>
    <us-gaap:OtherReceivables contextRef="c-333" decimals="-3" id="f-1711" unitRef="usd">101000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c-334" decimals="-3" id="f-1712" unitRef="usd">231000</us-gaap:OtherReceivables>
    <us-gaap:Revenues contextRef="c-335" decimals="-3" id="f-1713" unitRef="usd">45000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-336" decimals="-3" id="f-1714" unitRef="usd">235000</us-gaap:Revenues>
    <us-gaap:OtherReceivables contextRef="c-337" decimals="-3" id="f-1715" unitRef="usd">47000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c-338" decimals="-3" id="f-1716" unitRef="usd">263000</us-gaap:OtherReceivables>
    <us-gaap:EquityMethodInvestments contextRef="c-339" decimals="-5" id="f-1717" unitRef="usd">4900000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-340"
      decimals="2"
      id="f-1718"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-78"
      decimals="INF"
      id="f-1719"
      unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-78"
      decimals="INF"
      id="f-1720"
      unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-79" decimals="-5" id="f-1721" unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-119" decimals="-5" id="f-1722" unitRef="usd">-400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-120" decimals="-5" id="f-1723" unitRef="usd">-3100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:Goodwill contextRef="c-78" decimals="-5" id="f-1724" unitRef="usd">13400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-79" decimals="-5" id="f-1725" unitRef="usd">6200000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1726">&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Company has evaluated subsequent events from the Balance Sheet date through February&#160;23, 2024, the date at which the consolidated financial statements were available to be issued. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;O&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;n February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $500&#160;million of the outstanding ordinary shares of the Company. All ordinary shares that are redeemed under the buyback program will be &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Company has determined that there are no other items to disclose.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-341" decimals="-6" id="f-1727" unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
